Citrus Sinensis ID: 005526

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690--
Protein Sequence
MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKKSVGSQYSSDQLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKKNDHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNFLIFQPSSNLSSDSAPK
Secondary Structure (PSIPRED)
cccccccEEEEEEEcccccccccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccccEEEEEEEcccEEEEEEEEccccHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccccccccccccHHHHHcccccccccccHHHHHHHHHHHccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccHHHcccccccccccccccccccccccccccccccccccHHccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHccHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHccccEEEcccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEcccEEEEEEEEEccccEEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccccEEEEcccccEEEccccccccccccHccccHHHHccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHcccHHHcccHHHHHccccHccccccccccHccccccccHHHcccHHHHHHHHccccHHHHHHcHcccccccccHHHHHHcccccccccccccccHHHHccccccccccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccHHccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHccccHHHHHHccHHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHHHHcccccccccccccc
Coil and Loop (DISEMBL)
mepnrtrligeyivgprigsgSFAVVWRARHRQLGIEVAVKEIDKkllspkvsdNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLihrdlkpqnllvstnevtpvlkigdfgfarsltpqdladtlcgsplymapeiiqnhkydakaDLWSVGAILFQLvtgkppfdgsnqLQLFQNILTstelrfppgaieelhpDCVDLCRCllrqnpveritfkeffnhrflGELRQTVhaeqhsvvpetkpMVELlnsstpedrhslhsehptnsssknpksacssACDKVILntgdqgnslstrdlhefipnmacdrmkksvgsqyssDQLKDLMESIEKEYVLINShfastdgfsfyldaslqdnsmakvsicpskkndhsaitmqtkdmpsdsasgaenslfhvpapletsnRLFILKEVqgltvlhpstglqLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSwltsmshgelpgpssayghtpvqggissdpnsennvdfsspfsvstWAEQGFILAFDRAEKLsynirdsdgaaempDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGeaaslslyppfslnpsdkkRIQGYINNLQSHqsnflifqpssnlssdsapk
Flexible Loop (DISEMBL)
mepnrtrligeyivgprigsGSFAVVWRARHRQLGIEVAVkeidkkllspkvsdNLLKEISilstishpniIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHrdlkpqnllvsTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLhsehptnsssknpksACSSACDKVILNTgdqgnslstrDLHEFIPNMACDRMKKSVGSQYSSDQLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKKNDHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNflifqpssnlssdsapk
Low Complexity Region (SEG)
MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPTnsssknpksacssacDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKKSVGSQYSSDQLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKKNDHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNFLIFQPSSNLSSDSAPK
Disordered region (IsUnstruct)
******RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVH***************************************************VIL****************FI*************************ESIEKEYVLINSHFASTDGFSFYLDASL****************************************FHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTS*************************************FSVSTWAEQGFILAFDRAEKLSYNIRDS**AAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLN*****RIQGYINNLQSHQSNFLIF*************
Disordered Region (DISOPRED)
*****TR***EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS**V**NLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR*******************************************************************************************************************************************************************************************************************ELAEAKYDAGLFLESFSVELVVLAIWKKALQICGS******************************************SVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQS******************
Disordered Region (DISEMBL)
MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS***************************SACDKVILNTGDQGNSLSTRDLHEFIPNMACDRM***********QLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKKNDHSAITMQ************ENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNFLIFQPS**********
Disordered Region (DISPRO)
*****TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTG*********************************************EYV****HFA******************************************************************************HPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSM*****************************NVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNFLIF*************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKKSVGSQYSSDQLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKKNDHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNFLIFQPSSNLSSDSAPK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	692	2.2.26 [Sep-21-2011]
Q3ZDQ4	941	Serine/threonine-protein	yes	no	0.375	0.276	0.389	1e-63
Q52EB3	982	Serine/threonine-protein	N/A	no	0.371	0.261	0.399	2e-63
Q7RX99	932	Serine/threonine-protein	N/A	no	0.378	0.281	0.402	7e-63
Q2H6X2	943	Serine/threonine-protein	N/A	no	0.433	0.318	0.376	9e-63
Q6C7U0	710	Serine/threonine-protein	yes	no	0.365	0.356	0.418	4e-62
P87248	675	Serine/threonine-protein	N/A	no	0.369	0.379	0.413	5e-62
Q1DN93	969	Serine/threonine-protein	N/A	no	0.375	0.268	0.421	9e-62
Q6BS08	875	Serine/threonine-protein	yes	no	0.371	0.293	0.421	4e-61
Q6H9I1	952	Serine/threonine-protein	N/A	no	0.377	0.274	0.390	7e-61
A6RYB8	952	Serine/threonine-protein	N/A	no	0.377	0.274	0.390	7e-61

>sp|Q3ZDQ4|ATG1_PODAS Serine/threonine-protein kinase atg1 OS=Podospora anserina GN=ATG1 PE=2 SV=1

 Score =  244 bits (624), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 121/311 (38%), Positives = 184/311 (59%), Gaps = 51/311 (16%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           +G++++   IG GSFA V+  RH+  G  VA+K ++   L+ K+ +NL  EI IL T+ H
Sbjct: 23  VGQFVIDKEIGKGSFAQVYSGRHKVTGALVAIKSVELSRLNKKLKENLYGEIKILKTLRH 82

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV---------------------S 107
           P+I+   + +E+   I L++EYC+ GDL+ +I K  K+                      
Sbjct: 83  PHIVALHDCVESATHINLIMEYCELGDLSLFIKKREKLITHSATRDIARRYPIEHNQGLH 142

Query: 108 EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV-----------STNEVT-------- 148
           E + RHF++QLA+ L+ L+E + +HRD+KPQNLL+           S  ++         
Sbjct: 143 EVITRHFLKQLASALKFLREGNFVHRDVKPQNLLLLPSPLFRETHHSAKQILSASYDSLM 202

Query: 149 --------PVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAI 200
                   P+LK+ DFGFAR L    LA+TLCGSPLYMAPEI++  +YDAKADLWSVG +
Sbjct: 203 PAAGLPSLPMLKLADFGFARVLPSTSLAETLCGSPLYMAPEILRYERYDAKADLWSVGTV 262

Query: 201 LFQLVTGKPPFDGSNQLQLFQNI-LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERI 259
           L+++ TG+PPF   N ++L + I     +++FP  ++  + P+   L R LL++NPVERI
Sbjct: 263 LYEMATGRPPFRAGNHVELLRKIEAAEDQVKFPRESV--VSPELKSLVRALLKRNPVERI 320

Query: 260 TFKEFFNHRFL 270
           +F +FFNH  +
Sbjct: 321 SFADFFNHTVI 331

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.
Podospora anserina (taxid: 5145)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q52EB3|ATG1_MAGO7 Serine/threonine-protein kinase ATG1 OS=Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) GN=ATG1 PE=1 SV=1

 Score =  244 bits (622), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 123/308 (39%), Positives = 185/308 (60%), Gaps = 51/308 (16%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           +G++++G  IG GSFA V+  +H+  G  VA+K ++   L+ K+ +NL  EI+IL T+ H
Sbjct: 16  VGQFVIGAEIGKGSFAQVYMGKHKVSGAAVAIKSVELARLNKKLKENLYGEINILKTLRH 75

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVS--------------------- 107
           P+I+   + +E+   I L++EYC+ GDL+ +I K  K+S                     
Sbjct: 76  PHIVALHDCVESATHINLMMEYCELGDLSLFIKKREKLSTNPATHDMARKYPNVPNSGLN 135

Query: 108 EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV-------------------STNEVT 148
           E V RHF++QL++ L+ L+E +L+HRD+KPQNLL+                   S + + 
Sbjct: 136 EVVIRHFLKQLSSALKFLRESNLVHRDVKPQNLLLLPSPEFREVNKLARPILTASQDSLV 195

Query: 149 PV--------LKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAI 200
           PV        LK+ DFGFAR L    LA+TLCGSPLYMAPEI++  +YDAKADLWSVG +
Sbjct: 196 PVAGLASLPMLKLADFGFARVLPSTSLAETLCGSPLYMAPEILRYERYDAKADLWSVGTV 255

Query: 201 LFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDLCRCLLRQNPVERI 259
           LF+++ G+PPF  SN ++L + I  + + ++FP      +  +   L R LL++NPVERI
Sbjct: 256 LFEMIVGRPPFRASNHVELLRKIEAAEDVIKFPRETT--ISSEMKGLTRALLKRNPVERI 313

Query: 260 TFKEFFNH 267
           +F+ FF H
Sbjct: 314 SFENFFAH 321

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Autophagy is essential to fungal development, production of appressorium turgor, and pathogenicity in rice blast disease.

Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) (taxid: 242507)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7RX99|ATG1_NEUCR Serine/threonine-protein kinase atg-1 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) GN=atg-1 PE=3 SV=1

 Score =  242 bits (618), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 126/313 (40%), Positives = 185/313 (59%), Gaps = 51/313 (16%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG +++   IG GSFA V+  RH+  G  VAVK ++   L+ K+ +NL  EI IL T+ H
Sbjct: 21  IGSFVIDQEIGKGSFAKVYLGRHKVTGALVAVKSVELARLNKKLKENLYGEIQILKTLRH 80

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV---------------------S 107
           P+I+   + +E+   I L++EYC+ GDL+ +I K  K+                     +
Sbjct: 81  PHIVALHDCVESSTHINLIMEYCELGDLSLFIKKRDKLITNPYTHDLARKYPVYPNAGLN 140

Query: 108 EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLL-------VSTNEVT------------ 148
           E V RHF++QLA+ LQ L+    +HRD+KPQNLL       ++ N+              
Sbjct: 141 EVVTRHFLKQLASALQFLRAGDFVHRDVKPQNLLLLPSPHMMANNKTAKHIMSGSYDSFT 200

Query: 149 --------PVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAI 200
                   P+LK+ DFGFAR L    LA+TLCGSPLYMAPEI++  KYDAKADLWSVG +
Sbjct: 201 PAAGLASAPMLKLADFGFARVLPSTSLAETLCGSPLYMAPEILRYEKYDAKADLWSVGTV 260

Query: 201 LFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDLCRCLLRQNPVERI 259
           L+++VTG+PPF  SN ++L + I +S + ++F   ++  +  +   L R LL++NPVERI
Sbjct: 261 LYEMVTGRPPFKASNHVELLRKIESSGDVIKFTRESV--VSQEMKGLIRALLKKNPVERI 318

Query: 260 TFKEFFNHRFLGE 272
           +F++ FNH  + E
Sbjct: 319 SFEDLFNHPVVTE 331

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) (taxid: 367110)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2H6X2|ATG1_CHAGB Serine/threonine-protein kinase ATG1 OS=Chaetomium globosum (strain ATCC 6205 / CBS 148.51 / DSM 1962 / NBRC 6347 / NRRL 1970) GN=ATG1 PE=3 SV=1

 Score =  242 bits (617), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 134/356 (37%), Positives = 196/356 (55%), Gaps = 56/356 (15%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG +++   IG GSFA V+  RH+  G  VA+K ++   L+ K+ DNL  EI IL  + H
Sbjct: 19  IGNFVIDKEIGKGSFAQVYSGRHKVTGALVAIKSVELARLNTKLKDNLYGEIEILKRLRH 78

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV---------------------S 107
           P+I+   + +E+R  I L++EYC+ GDL+ +I K  K+                     +
Sbjct: 79  PHIVALHDCVESRTHINLIMEYCELGDLSLFIKKRDKLITNPGTHELARKYPVAPNSGLN 138

Query: 108 EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV-------------------STNEVT 148
           E V RHF++QL + ++ L+E +LIHRD+KPQNLL+                   S +  T
Sbjct: 139 EVVIRHFLKQLTSAIRFLREANLIHRDVKPQNLLLLPSPQYREANKMHKQILSASHDSFT 198

Query: 149 P--------VLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAI 200
           P        +LK+ DFGFAR L    LA+TLCGSPLYMAPEI++  KYDAKADLWSVG +
Sbjct: 199 PAAGLPSLPMLKLADFGFARVLPSTSLAETLCGSPLYMAPEILRYEKYDAKADLWSVGTV 258

Query: 201 LFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDLCRCLLRQNPVERI 259
           L+++ TG+PPF   N + L + I  S + +RF    +  +  +   L R LL++NPVERI
Sbjct: 259 LYEMATGRPPFRAVNHVDLLRKIEASGDVIRFSRECV--VSSEVKGLVRALLKRNPVERI 316

Query: 260 TFKEFFNHRFL-----GELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEH 310
           +F++FF+H  +     G +   +   +  V+ ETK  +   N      R S    H
Sbjct: 317 SFEDFFHHPVITGPIPGLVEDDIPKPEKPVLAETKSRIRRANPELSHTRRSRAGPH 372

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Chaetomium globosum (strain ATCC 6205 / CBS 148.51 / DSM 1962 / NBRC 6347 / NRRL 1970) (taxid: 306901)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6C7U0|ATG1_YARLI Serine/threonine-protein kinase ATG1 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) GN=ATG1 PE=3 SV=1

 Score =  239 bits (611), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 125/299 (41%), Positives = 178/299 (59%), Gaps = 46/299 (15%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           I  Y +G  +G GSFA V++  H   G  VA+K + +  L+ K+ +NL  EISIL  + H
Sbjct: 4   IKSYTIGNELGRGSFATVYKGEHVASGSPVAIKSVLRAKLNRKLLENLGSEISILKQMKH 63

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAV------------------ 110
           P+++   +  ET    +LV+EYC  GDL+ ++ K  ++SE +                  
Sbjct: 64  PHVVELLDFQETPTHFHLVMEYCSLGDLSFFLKKKKELSETLPLVASLLRRYPSNTRGLH 123

Query: 111 ---ARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV---STNEVT------------PVLK 152
               RHF+ QL+A L+ L++K+L+HRD+KPQNLL+   S +E+             P+LK
Sbjct: 124 EELVRHFVHQLSAALEFLRQKNLVHRDIKPQNLLLCPPSLSEMDAQNANLYGRWELPILK 183

Query: 153 IGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFD 212
           I DFGFAR L    LA+TLCGSPLYMAPEI++  KY+AKADLWSVGA+ +++V GKPPF 
Sbjct: 184 IADFGFARILPASALAETLCGSPLYMAPEILRYEKYNAKADLWSVGAVTYEMVVGKPPFK 243

Query: 213 GSNQLQLFQNILTSTEL----RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
            +N ++L + I  S ++    R PP        D  D  RCLL++NP +RI FKE+F H
Sbjct: 244 ANNYVELLKTIEQSNDVIGFGREPPSE------DMQDFVRCLLKKNPADRIGFKEYFEH 296

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Yarrowia lipolytica (strain CLIB 122 / E 150) (taxid: 284591)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P87248|ATG1_COLLN Serine/threonine-protein kinase ATG1 OS=Colletotrichum lindemuthianum GN=ATG1 PE=3 SV=1

 Score =  239 bits (610), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 126/305 (41%), Positives = 184/305 (60%), Gaps = 49/305 (16%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IGE+++G  IG GSFA V+   H+     VA+K ++   L+ K+ +NL  EI IL T+ H
Sbjct: 22  IGEFVIGGEIGKGSFAQVYSGHHKNSKAAVAIKSVEMGRLNNKLRENLYGEIQILKTLRH 81

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK---HGK------------------VS 107
           P+I+   + +E+   I LV+EYC+ GDL+ +I K   HG                   + 
Sbjct: 82  PHIVALHDCVESATHINLVMEYCELGDLSFFIKKRDRHGTNAATEDMARKYPVTPGSGLH 141

Query: 108 EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV----------------STNEVT--- 148
           E V RHF++QLA+ L+ L+EK+ +HRD+KPQNLL+                ++N+     
Sbjct: 142 EVVTRHFLQQLASALKFLREKNYVHRDVKPQNLLLLPSPGFRKENSRPILTASNDSLIPN 201

Query: 149 ------PVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILF 202
                 P+LK+ DFGFAR L    LADTLCGSPLYMAPEI++  +YDAKADLWSVG +L+
Sbjct: 202 AGLASLPMLKLADFGFARVLPSTSLADTLCGSPLYMAPEILRYERYDAKADLWSVGTVLY 261

Query: 203 QLVTGKPPFDGSNQLQLFQNI-LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITF 261
           +++TG+PPF   N ++L + I  T  ++++P  A+  +  D V L   LL +NPVER+ F
Sbjct: 262 EMITGRPPFRARNHVELLRKIEATEDKVKYPKDAV--VSKDLVKLIGKLLTRNPVERMRF 319

Query: 262 KEFFN 266
           ++FFN
Sbjct: 320 EDFFN 324

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Colletotrichum lindemuthianum (taxid: 290576)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1DN93|ATG1_COCIM Serine/threonine-protein kinase ATG1 OS=Coccidioides immitis (strain RS) GN=ATG1 PE=3 SV=1

 Score =  238 bits (608), Expect = 9e-62,   Method: Compositional matrix adjust.
 Identities = 131/311 (42%), Positives = 176/311 (56%), Gaps = 51/311 (16%)

Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL 63
            R  ++G+Y     IG GSFA V++  H +    VA+K ++   L+PK+ DNL  EI IL
Sbjct: 22  TRDVILGKYTKIEEIGRGSFATVYQGIHNKYRSCVAIKAVNISSLNPKLKDNLKLEIEIL 81

Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-------------------- 103
             + HP+I+   +  E+   I+LV+EYC  GDL+ +I K                     
Sbjct: 82  KGLQHPHIVALIDCDESTSCIHLVMEYCALGDLSLFIRKRDTLSKHELTRDMIAKYPNPP 141

Query: 104 -GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTN----------------- 145
            G ++E + RHF++QLA+ LQ L+ K LIHRDLKPQNLL++                   
Sbjct: 142 AGGLNEVIVRHFLKQLASALQFLRTKDLIHRDLKPQNLLLNPPPSTYAKGLLRIVPYKTR 201

Query: 146 ----------EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
                     E  P+LKI DFGFARSL    LA+TLCGSPLYMAPEI++  KYDAKADLW
Sbjct: 202 EDSFTPLVGVESLPMLKIADFGFARSLPATSLAETLCGSPLYMAPEILRYEKYDAKADLW 261

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDLCRCLLRQN 254
           SVG +LF++V GK PF   N + L + I    + +RFP     E  P    L R LL++N
Sbjct: 262 SVGTVLFEMVVGKSPFRAGNHVDLLRKIEQGEDNIRFP--IQTEASPPLKKLIRSLLKRN 319

Query: 255 PVERITFKEFF 265
           PVER++FK+FF
Sbjct: 320 PVERLSFKDFF 330

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Coccidioides immitis (strain RS) (taxid: 246410)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6BS08|ATG1_DEBHA Serine/threonine-protein kinase ATG1 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) GN=ATG1 PE=3 SV=2

 Score =  236 bits (603), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 127/301 (42%), Positives = 179/301 (59%), Gaps = 44/301 (14%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILST 65
           + IG Y +GP IG GSFA V++  + +    VA+K + + KL S K+ +NL  EISIL T
Sbjct: 17  KTIGVYSIGPEIGKGSFATVYKCFNTKTNESVAIKSVVRSKLKSKKLVENLEIEISILKT 76

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK----------------------- 102
           + HP+I+   +  +T    +LV++YC  GDL+ +I K                       
Sbjct: 77  MKHPHIVGLLDYKQTTSHFHLVMDYCSMGDLSYFIRKRNQLIKTHPVISSLLERYPSPEG 136

Query: 103 -HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV-----STNEVT-------- 148
            HG ++E +  HF++QL + L+ L+ K L+HRD+KPQNLL+     S  E          
Sbjct: 137 SHG-LNEVLVIHFLKQLVSALEFLRNKSLVHRDIKPQNLLLCPPLHSKQEFKDGGFVGLW 195

Query: 149 --PVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT 206
             P+LKI DFGFAR L    +A+TLCGSPLYMAPEI++  KY+AKADLWSVGA+L+++  
Sbjct: 196 ELPLLKIADFGFARFLPSTSMAETLCGSPLYMAPEILRYEKYNAKADLWSVGAVLYEMTV 255

Query: 207 GKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFF 265
           GKPPF   N +QL +NI  S + ++FP  A  ++      L R LL+ NP ER++F EFF
Sbjct: 256 GKPPFRADNHVQLLKNIEKSNDRIKFPSAA--QVPESLKRLIRSLLKYNPTERVSFNEFF 313

Query: 266 N 266
           N
Sbjct: 314 N 314

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) (taxid: 284592)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6H9I1|ATG1_BOTFU Serine/threonine-protein kinase ATG1 OS=Botryotinia fuckeliana GN=atg1 PE=3 SV=1

 Score =  235 bits (600), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 123/315 (39%), Positives = 179/315 (56%), Gaps = 54/315 (17%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           +G + +  +IG GSFA V+R  H   G  VA+K ++   L+ K+ DNL  EI IL ++ H
Sbjct: 20  VGSFTINEQIGKGSFATVYRGTHMPSGNLVAIKSVNLSRLNKKLKDNLYVEIEILKSLYH 79

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH---------------------GKVS 107
           P+I+   +  E+   I+L++EYC+ GDL+ +I K                      G ++
Sbjct: 80  PHIVALIDCRESASHIHLMMEYCELGDLSYFIKKRDRLADNPTLYDMVQKYPMPVEGGLN 139

Query: 108 EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLL-------------------------- 141
           + V RHF +QL++ ++ L+E+  +HRD+KPQNLL                          
Sbjct: 140 QVVVRHFFKQLSSAMEFLRERDFVHRDVKPQNLLLIPSPEWIAKRAKGGPEAMKASKESV 199

Query: 142 ---VSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVG 198
              V  N + P+LK+ DFGFARSL    LA+TLCGSPLYMAPEI++  KYDA+ADLWS+G
Sbjct: 200 VAMVGINSL-PMLKLADFGFARSLPSTSLAETLCGSPLYMAPEILRYEKYDARADLWSIG 258

Query: 199 AILFQLVTGKPPFDGSNQLQLFQNI-LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVE 257
            +L++++TG+PPF   N +QL Q I     E+RFP   I     D  D+ R LL++ P +
Sbjct: 259 TVLYEMMTGRPPFKAINHVQLLQKIEKNQDEIRFPSRGI--YSRDLKDIVRRLLKKKPED 316

Query: 258 RITFKEFFNHRFLGE 272
           RITF E+F H  + E
Sbjct: 317 RITFPEYFAHPVVTE 331

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Botryotinia fuckeliana (taxid: 40559)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A6RYB8|ATG1_BOTFB Serine/threonine-protein kinase atg1 OS=Botryotinia fuckeliana (strain B05.10) GN=atg1 PE=3 SV=1

 Score =  235 bits (600), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 123/315 (39%), Positives = 179/315 (56%), Gaps = 54/315 (17%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           +G + +  +IG GSFA V+R  H   G  VA+K ++   L+ K+ DNL  EI IL ++ H
Sbjct: 20  VGSFTINEQIGKGSFATVYRGTHMPSGNLVAIKSVNLSRLNKKLKDNLYVEIEILKSLYH 79

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH---------------------GKVS 107
           P+I+   +  E+   I+L++EYC+ GDL+ +I K                      G ++
Sbjct: 80  PHIVALIDCRESASHIHLMMEYCELGDLSYFIKKRDRLADNPTLYDMVQKYPMPVEGGLN 139

Query: 108 EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLL-------------------------- 141
           + V RHF +QL++ ++ L+E+  +HRD+KPQNLL                          
Sbjct: 140 QVVVRHFFKQLSSAMEFLRERDFVHRDVKPQNLLLIPSPEWIAKRAKGGPEAMKASKESV 199

Query: 142 ---VSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVG 198
              V  N + P+LK+ DFGFARSL    LA+TLCGSPLYMAPEI++  KYDA+ADLWS+G
Sbjct: 200 VAMVGINSL-PMLKLADFGFARSLPSTSLAETLCGSPLYMAPEILRYEKYDARADLWSIG 258

Query: 199 AILFQLVTGKPPFDGSNQLQLFQNI-LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVE 257
            +L++++TG+PPF   N +QL Q I     E+RFP   I     D  D+ R LL++ P +
Sbjct: 259 TVLYEMMTGRPPFKAINHVQLLQKIEKNQDEIRFPSRGI--YSRDLKDIVRRLLKKKPED 316

Query: 258 RITFKEFFNHRFLGE 272
           RITF E+F H  + E
Sbjct: 317 RITFPEYFAHPVVTE 331

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Botryotinia fuckeliana (strain B05.10) (taxid: 332648)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	692
255548075	676	serine/threonine-protein kinase, putativ	0.959	0.982	0.648	0.0
224130696	673	predicted protein [Populus trichocarpa]	0.966	0.994	0.617	0.0
224068187	710	predicted protein [Populus trichocarpa]	0.995	0.970	0.598	0.0
296089024	669	unnamed protein product [Vitis vinifera]	0.933	0.965	0.594	0.0
147856746	715	hypothetical protein VITISV_012721 [Viti	0.955	0.924	0.577	0.0
356522466	690	PREDICTED: serine/threonine-protein kina	0.956	0.959	0.581	0.0
356560221	682	PREDICTED: serine/threonine-protein kina	0.955	0.969	0.583	0.0
297821080	626	kinase family protein [Arabidopsis lyrat	0.893	0.987	0.550	0.0
18412205	626	protein kinase family protein [Arabidops	0.893	0.987	0.548	0.0
6899894	648	serine/threonine-protein kinase-like pro	0.882	0.942	0.524	0.0

>gi|255548075|ref|XP_002515094.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223545574|gb|EEF47078.1| serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  865 bits (2235), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/675 (64%), Positives = 518/675 (76%), Gaps = 11/675 (1%)

Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           TRL+G+YI+GPRIGSGSFAVVW +RHR  G EVAVKEIDKKLLSPKVS++LLKEISILST
Sbjct: 9   TRLVGDYILGPRIGSGSFAVVWLSRHRNSGTEVAVKEIDKKLLSPKVSESLLKEISILST 68

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           I+HPNIIR FE+IE  ++I+LVLEYCDGGDLAAY+H+HGKVSEAVARHFMRQLAAGLQVL
Sbjct: 69  INHPNIIRLFESIENEDRIFLVLEYCDGGDLAAYVHRHGKVSEAVARHFMRQLAAGLQVL 128

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
           QE HLIHRDLKPQNLL+S+NE TP LKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN
Sbjct: 129 QENHLIHRDLKPQNLLLSSNEETPRLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 188

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
            KYDAKADLWSVGAILFQLVTGKPPFDG++Q QLFQNILTSTELRFP GA+EELHPDC+D
Sbjct: 189 QKYDAKADLWSVGAILFQLVTGKPPFDGNSQYQLFQNILTSTELRFPQGALEELHPDCLD 248

Query: 246 LCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHS 305
           LCR LLRQNPVER+TFKEFFNH+FLGE R  +  EQ S+V ETK +VE L+SS  ++R  
Sbjct: 249 LCRSLLRQNPVERLTFKEFFNHKFLGEPRLEMDPEQESLVQETKSVVEQLDSSGSDERSL 308

Query: 306 LHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKKSV-GS 364
           LHSEHP +S+ +N K + S   D V+ +    G+   T  +H  +P  A DR ++ + GS
Sbjct: 309 LHSEHPMHSTGRNAKLSSSFVHDDVV-HAKVHGSISGTESVHSSLPIFAHDRTRRMIDGS 367

Query: 365 QYSSD--QLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKKNDHS 422
           Q  SD  ++ D  ESIE++YVL+N HF S +  S+Y + SLQ NS  +V +CP KKN+  
Sbjct: 368 QCPSDHHRVADSAESIERDYVLVNCHFGSMENLSYYSETSLQGNSTTRVFVCPPKKNNQD 427

Query: 423 -AITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYV 481
            A+   TK   + S   A+N + +   PL  S    IL EVQG + L PS  L LL++YV
Sbjct: 428 VAVAPLTKQCAASSVDSAKNPVIYGSDPLAASRASTILMEVQGQSRLTPSASLHLLNRYV 487

Query: 482 HALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPSSAYGHTP 541
            A+ ELA+ K++AGLFLESFSVELVVLAIWKKAL IC SWL S +  ELP  SSA    P
Sbjct: 488 QAVAELAQEKHNAGLFLESFSVELVVLAIWKKALHICNSWLASSAGSELPESSSANESNP 547

Query: 542 VQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEI 601
             GG +      N +D   P S   WAEQ F+ A++RAEKLS +I + D AA+MPDAMEI
Sbjct: 548 DHGGRA------NKMDLDRPSSACKWAEQEFVAAYNRAEKLSDHISNMDAAAQMPDAMEI 601

Query: 602 IYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKR 661
           I+Q+AL+VG   AV+EYM N+ SA+  YSKAMLLLSF+V EAASL L PPF L P++KKR
Sbjct: 602 IFQKALAVGTSAAVDEYMENRGSAAISYSKAMLLLSFVVEEAASLPLNPPFLLTPANKKR 661

Query: 662 IQGYINNLQSHQSNF 676
           IQ YI NLQSHQS F
Sbjct: 662 IQNYIMNLQSHQSYF 676

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224130696|ref|XP_002320905.1| predicted protein [Populus trichocarpa] gi|222861678|gb|EEE99220.1| predicted protein [Populus trichocarpa]

 Score =  843 bits (2177), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/696 (61%), Positives = 511/696 (73%), Gaps = 27/696 (3%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           MEPN+TRL+G+YI+G RIG GSFAVVWR+ HR  G++VAVKEIDKKLL+PKVS+NLLKEI
Sbjct: 1   MEPNQTRLVGDYILGSRIGRGSFAVVWRSIHRFSGLQVAVKEIDKKLLTPKVSENLLKEI 60

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
           SILSTI+HPNIIRFFE+IET ++I+LVLEYC+GGDLA YI +HGKV+EAVARHFMRQLA 
Sbjct: 61  SILSTINHPNIIRFFESIETEDRIFLVLEYCEGGDLAFYIQRHGKVTEAVARHFMRQLAV 120

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP 180
           GLQVLQEKHLIHRDLKPQNLL+S+N++TP LKIGDFGFARSL   DLADTLCGSPLYMAP
Sbjct: 121 GLQVLQEKHLIHRDLKPQNLLLSSNDLTPQLKIGDFGFARSLASSDLADTLCGSPLYMAP 180

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           EIIQN KYDAKADLWSVGAILFQLVTGKPPFDG++Q QLFQNILTSTELRFP GA+EELH
Sbjct: 181 EIIQNKKYDAKADLWSVGAILFQLVTGKPPFDGNSQYQLFQNILTSTELRFPQGALEELH 240

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTP 300
           PDCVDLCR LLR+NPVER+TFKEFFNH+FLGE R  V A + S +P+ K +    ++S  
Sbjct: 241 PDCVDLCRGLLRRNPVERLTFKEFFNHKFLGEPRLLVSA-KSSPLPQVKSVAGQFDASAS 299

Query: 301 EDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKK 360
           + R  L  ++ T              CD+                +H  +PN+  DRM K
Sbjct: 300 DTRSQLEHDNLT---------VLEKVCDR-------------NESVHGSLPNIVHDRMGK 337

Query: 361 SV-GSQYSSDQLK--DLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSI-CPS 416
           S  GSQ  SDQL+  DLMESIEK+YV++N HFAS + FS+YL+ SL D+S +K SI  P 
Sbjct: 338 SADGSQSLSDQLRVADLMESIEKDYVIVNRHFASMENFSYYLETSLHDSSTSKASIYLPQ 397

Query: 417 KKNDHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQL 476
           K N  + +  QTK+    S   A N   H   PL  S    IL+E Q L +LHPS  LQ 
Sbjct: 398 KNNQDTVVATQTKEFTGSSVGSANNPEVHGSEPLSASCVPTILREAQRLPILHPSIKLQF 457

Query: 477 LHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPSSA 536
           L+QY   ++ELA+ KYDAG+FLESFSVELVVLAIWK+AL+IC  W+ S    +L   SSA
Sbjct: 458 LNQYAQEISELAQEKYDAGMFLESFSVELVVLAIWKRALEICEHWVASTGGSKLHESSSA 517

Query: 537 YGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMP 596
                V GG +  P +   +DF  P S   WAE+GFILAFD AEKLS ++RD D AAEMP
Sbjct: 518 NESALVYGGTNLTPPAIGKLDFIEPSSACKWAEKGFILAFDHAEKLSNSLRDMDAAAEMP 577

Query: 597 DAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNP 656
           DAME+I+Q+AL+VG  GAV+EYM NK  A   YSKAMLLL FI+ EA SL L PPFSL P
Sbjct: 578 DAMELIFQKALAVGTSGAVDEYMENKGGADNSYSKAMLLLHFIMEEATSLPLNPPFSLTP 637

Query: 657 SDKKRIQGYINNLQSHQSNFLIFQPSSNLSSDSAPK 692
           + +KR++ YI NLQS +S F + QP    SSDS  K
Sbjct: 638 ASRKRVKSYILNLQSRRSRFSMLQPFPEQSSDSLTK 673

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224068187|ref|XP_002302678.1| predicted protein [Populus trichocarpa] gi|222844404|gb|EEE81951.1| predicted protein [Populus trichocarpa]

 Score =  823 bits (2127), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 427/713 (59%), Positives = 513/713 (71%), Gaps = 24/713 (3%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           M+ N+TRLIG+YI+GP IG GSFAVV RA+HR   +EVAVKEIDKKLLSPKVSDNLLKEI
Sbjct: 1   MDLNQTRLIGDYILGPIIGRGSFAVVRRAKHRSSCLEVAVKEIDKKLLSPKVSDNLLKEI 60

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
           SILSTI+HPNIIR FE+ ET ++I+LVLEYCDGGDLA YI +HGKV+EAVARHFMRQLAA
Sbjct: 61  SILSTINHPNIIRLFESFETEDRIFLVLEYCDGGDLAGYIQRHGKVTEAVARHFMRQLAA 120

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP 180
           GLQ LQEKHLIHRDLKPQNLL+ +N++TP LKIGDFGFARSLT  DLADTLCGSPLYMAP
Sbjct: 121 GLQALQEKHLIHRDLKPQNLLLLSNDLTPQLKIGDFGFARSLTSSDLADTLCGSPLYMAP 180

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           EIIQN KYDAKADLWSVGA+LFQLVTGKPPFDG++Q QLFQNILTSTELRFP GA+EELH
Sbjct: 181 EIIQNKKYDAKADLWSVGAVLFQLVTGKPPFDGNSQYQLFQNILTSTELRFPQGALEELH 240

Query: 241 PDCVDLCRCLLRQNP-----------------VERITFKEFFNHRFLGELRQTVHAEQHS 283
           PDCVDLCR LL +NP                 VER+TFKEFFNH+F  E R  + A+   
Sbjct: 241 PDCVDLCRSLLCRNPGTDYYGEIFVLVYVHMLVERLTFKEFFNHKFFEEPRLLLDAKS-P 299

Query: 284 VVPETKPMVELLNSSTPEDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLST 343
           ++P+ K +VE  ++S    R  +   H  +S+++N     +S  D + +      ++   
Sbjct: 300 LLPQMKSVVEQFDASASNTRSQMG--HCLHSANRNAILTSTSEHDNITMLAKVHDSTSRN 357

Query: 344 RDLHEFIPNMACDRMKKSV-GSQYSSDQLK--DLMESIEKEYVLINSHFASTDGFSFYLD 400
             +H  +P++  DRM +S  GSQ S DQL+  DLMES+EK+YV++N HF+S + FS+YL+
Sbjct: 358 DSVHGIVPSIVHDRMGRSAYGSQSSLDQLRVADLMESLEKDYVIVNRHFSSMENFSYYLE 417

Query: 401 ASLQDNSMAKVSI-CPSKKNDHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFIL 459
            SLQD+S +K S+  P K N    + +QT+     S S A +   H   PL  S    IL
Sbjct: 418 TSLQDSSTSKSSVQLPQKNNQDMVVAIQTEAFTGSSVSSANDPQVHGSEPLTASCVPNIL 477

Query: 460 KEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICG 519
           +EVQGL + HPS  L  L+QY  A+ ELA+ KYD+GLFLESFSVELVVLAIWKK L+IC 
Sbjct: 478 REVQGLPIPHPSIKLHFLNQYAQAIVELAQEKYDSGLFLESFSVELVVLAIWKKVLEICN 537

Query: 520 SWLTSMSHGELPGPSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRA 579
            W+ S    ELP  SSA   T V GGI   P +   +DF  P S   WAE+ FILAFDR 
Sbjct: 538 HWVASNEGSELPESSSANESTFVHGGIDLIPPASGKMDFIEPSSAYKWAEKSFILAFDRT 597

Query: 580 EKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFI 639
           EKLS+N+R  D AAEMPDAME+I+Q AL+VG+ GAV+EYM NK  A   YSKAMLLL FI
Sbjct: 598 EKLSHNLRYMDAAAEMPDAMELIFQEALAVGRSGAVDEYMENKGGADVSYSKAMLLLHFI 657

Query: 640 VGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNFLIFQPSSNLSSDSAPK 692
             EA SL L PPFSL  + +KRIQ YI NLQSH+S+F + QP    S DS  K
Sbjct: 658 AEEATSLPLKPPFSLTSACRKRIQSYILNLQSHRSHFSMLQPIPEQSPDSPTK 710

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296089024|emb|CBI38727.3| unnamed protein product [Vitis vinifera]

 Score =  768 bits (1984), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 409/688 (59%), Positives = 492/688 (71%), Gaps = 42/688 (6%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS 64
           + R++GEYI+GPRIGSGS+AVVW +RHRQ G+ VA+KEIDK+ L+PKV DNL KEI IL 
Sbjct: 8   QCRVVGEYILGPRIGSGSYAVVWESRHRQSGMVVAIKEIDKEHLNPKVKDNLFKEIEILR 67

Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
           TI+HPNIIR  +AIET ++I+LVLEYCDGGDLAAYIH+ G+V EAVARHFMRQLAAGLQV
Sbjct: 68  TINHPNIIRLLQAIETSDRIFLVLEYCDGGDLAAYIHRRGRVPEAVARHFMRQLAAGLQV 127

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVT--PVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           L EK LIHRDLKPQNLL+STNE T  P+LKIGDFGFAR LT Q LADT CGSPLYMAPEI
Sbjct: 128 LHEKRLIHRDLKPQNLLLSTNEATTAPLLKIGDFGFARDLT-QGLADTQCGSPLYMAPEI 186

Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           IQN KYDAKADLWSVGAILFQLVTG+PPFDGS Q QLF NIL+++ELRFP GA++ELHPD
Sbjct: 187 IQNQKYDAKADLWSVGAILFQLVTGRPPFDGSTQFQLFHNILSASELRFPQGALQELHPD 246

Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE----LLNSS 298
           CVDLCR LLRQNPVER+TF EFFNH+FL E R TV  EQ S++P+TKP+V     L   +
Sbjct: 247 CVDLCRRLLRQNPVERLTFNEFFNHKFLVEPRLTVDVEQPSLLPQTKPLVVQFECLRGKN 306

Query: 299 TPEDRH---SLHSEHPTNSSSKNPKSACSSACD--KVILNTGDQGNSLSTRDLHEFIPNM 353
            P D      L   H  NSS++NP S  SS  D    IL+  + G++ S +  + F+P++
Sbjct: 307 LPTDSTQSPQLPFAHQLNSSTRNP-SLTSSIHDVNSKILHRQEHGSTSSNKGGYRFMPSI 365

Query: 354 ACDRMKKSVGSQYSSDQLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSI 413
           A D            D + D MESIEK YVL+N+HFAS +  S  L+ SLQDN  A+ +I
Sbjct: 366 AHD------------DPIADSMESIEKGYVLVNAHFASMETLSSSLETSLQDNPAARATI 413

Query: 414 -CPSKKNDHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPST 472
             P+K ++  A+ M+T ++ + S    E+   + P P   S    ILKE Q L+VLH S 
Sbjct: 414 YSPNKNDEDVAVAMKTTELTATSVGAVESPGNYEPDPSTPSCASTILKEDQELSVLHSSR 473

Query: 473 GLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPG 532
            L LLH+Y HA+++LA+ K   G FLESFSVELVVLAIWKKA+Q+C SWL S +  +LP 
Sbjct: 474 RLHLLHKYAHAISKLAQEKLKDGQFLESFSVELVVLAIWKKAVQVCSSWLASTAGSDLPE 533

Query: 533 PSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGA 592
            SS     PVQ                 P SVS   E  FI A D AEKLS +++D DG 
Sbjct: 534 TSSTNESAPVQ----------------EPSSVSILVESEFIAACDHAEKLSSHLQDMDGN 577

Query: 593 AEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPF 652
           ++MPDAMEII+Q AL+ GK GAV+EYM NK SA+ALYSKAMLLLSFIVGEA  L L PPF
Sbjct: 578 SKMPDAMEIIFQAALAFGKSGAVDEYMENKGSAAALYSKAMLLLSFIVGEATLLPLNPPF 637

Query: 653 SLNPSDKKRIQGYINNLQSHQSNFLIFQ 680
           SL P++K RIQ YI  L+SH + F I Q
Sbjct: 638 SLTPANKHRIQRYIIYLESHLTRFQISQ 665

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147856746|emb|CAN81351.1| hypothetical protein VITISV_012721 [Vitis vinifera]

 Score =  768 bits (1983), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/719 (57%), Positives = 502/719 (69%), Gaps = 58/719 (8%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS 64
           + R++GEYI+GPRIGSGS+AVVW +RHRQ G+ VA+KEIDK+ L+PKV DNL KEI IL 
Sbjct: 8   QCRVVGEYILGPRIGSGSYAVVWESRHRQSGMVVAIKEIDKEHLNPKVKDNLFKEIEILR 67

Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
           TI+HPNIIR  +AIET ++I+LVLEYCDGGDLAAYIH+ G+V EAVARHFMRQLAAGLQV
Sbjct: 68  TINHPNIIRLLQAIETSDRIFLVLEYCDGGDLAAYIHRRGRVPEAVARHFMRQLAAGLQV 127

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVT--PVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           L EK LIHRDLKPQNLL+STNE T  P+LKIGDFGFAR LT Q LADT CGSPLYMAPEI
Sbjct: 128 LHEKRLIHRDLKPQNLLLSTNEATTAPLLKIGDFGFARDLT-QGLADTQCGSPLYMAPEI 186

Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ------------------------ 218
           IQN KYDAKADLWSVGAILFQLVTG+PPFDGS Q Q                        
Sbjct: 187 IQNQKYDAKADLWSVGAILFQLVTGRPPFDGSTQFQVLITVVVNSLREIISFNSYNHSQK 246

Query: 219 -----LFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                LF NIL+++ELRFP GA++ELHPDCVDLCR LLRQNPVER+TF EFFNH+FL E 
Sbjct: 247 LQVMLLFHNILSASELRFPQGALQELHPDCVDLCRRLLRQNPVERLTFNEFFNHKFLVEP 306

Query: 274 RQTVHAEQHSVVPETKPMVE----LLNSSTPEDRHS---LHSEHPTNSSSKNPKSACSSA 326
           R TV  EQ S++P+TKP+V     L   + P D      L   H  NSS++NP S  SS 
Sbjct: 307 RLTVDVEQPSLLPQTKPLVVQFECLRGKNLPTDSTQSPQLPFAHQLNSSTRNP-SLTSSI 365

Query: 327 CD--KVILNTGDQGNSLSTRDLHEFIPNMACDRMKKSVGSQYSSDQLKDLMESIEKEYVL 384
            D    IL+  + G++ S +  + F+P++A D            D + D MESIEK YVL
Sbjct: 366 HDVNSKILHRQEHGSTSSNKGGYRFMPSIAHD------------DPIADSMESIEKGYVL 413

Query: 385 INSHFASTDGFSFYLDASLQDNSMAKVSI-CPSKKNDHSAITMQTKDMPSDSASGAENSL 443
           +N+HFAS +  S  L+ SLQDN  A+ +I  P+K ++  A+ M+T ++ + S    E+  
Sbjct: 414 VNAHFASMETLSSSLETSLQDNPAARATIYSPNKNDEDVAVAMKTTELTATSVGAVESPG 473

Query: 444 FHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSV 503
            + P P   S    ILKE Q L+VLH S  L LLH+Y HA+++LA+ K   G FLESFSV
Sbjct: 474 NYEPDPSTPSCASTILKEDQELSVLHSSRRLHLLHKYAHAISKLAQEKLKDGQFLESFSV 533

Query: 504 ELVVLAIWKKALQICGSWLTSMSHGELPGPSSAYGHTPVQ--GGISSDPNSENNVDFSSP 561
           ELVVLAIWKKA+Q+C SWL S +  +LP  SS     PVQ   G+S + + E  +DFS P
Sbjct: 534 ELVVLAIWKKAVQVCSSWLASTAGSDLPETSSTNESAPVQEVAGLSLN-SQEEEIDFSKP 592

Query: 562 FSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGN 621
            SVS   E  FI A D AEKLS +++D DG ++MPDAMEII+Q AL+ GK GAV+EYM N
Sbjct: 593 SSVSILVESEFIAACDHAEKLSSHLQDMDGNSKMPDAMEIIFQAALAFGKSGAVDEYMEN 652

Query: 622 KASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNFLIFQ 680
           K SA+ALYSKAMLLLSFIVGEA  L L PPFSL P++K RIQ YI  L+SH + F I Q
Sbjct: 653 KGSAAALYSKAMLLLSFIVGEATLLPLNPPFSLTPANKHRIQRYIIYLESHLTRFQISQ 711

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356522466|ref|XP_003529867.1| PREDICTED: serine/threonine-protein kinase ATG1-like [Glycine max]

 Score =  758 bits (1958), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/676 (58%), Positives = 489/676 (72%), Gaps = 14/676 (2%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           ME    R+IG+YIVGPRIGSGSFAVVWRAR+R  G+E AVKEIDK+ LSPKV +NLLKEI
Sbjct: 3   MELGGPRVIGDYIVGPRIGSGSFAVVWRARNRSSGLEYAVKEIDKRHLSPKVRENLLKEI 62

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
           SILSTI HPNIIR FEAI+T ++IYLVLEYC GGDLAAYIH+HGKVSE VA HFMRQLAA
Sbjct: 63  SILSTIHHPNIIRLFEAIQTNDRIYLVLEYCAGGDLAAYIHRHGKVSEPVAHHFMRQLAA 122

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP 180
           GLQVLQEK+LIHRDLKPQNLL++T   TPV+KIGDFGFARSLTPQ LADTLCGSP YMAP
Sbjct: 123 GLQVLQEKNLIHRDLKPQNLLLATTAATPVMKIGDFGFARSLTPQGLADTLCGSPYYMAP 182

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           EII+N KYDAKADLWSVGAIL+QLV G+PPFDG++QLQLFQNIL STEL FPP A++ LH
Sbjct: 183 EIIENQKYDAKADLWSVGAILYQLVIGRPPFDGNSQLQLFQNILASTELHFPPDALKVLH 242

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTP 300
            DC+DLCR LLR+NP ER+TFK FFNH FL E R T++ EQ  +    +     L  ST 
Sbjct: 243 SDCLDLCRNLLRRNPDERLTFKAFFNHNFLREPRPTMNVEQFQLHQSERLTNHQLGGSTS 302

Query: 301 EDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDL--HEFIPNMACDRM 358
           E     HS++       NP    S+A + ++L   D   +  T +       P +A D++
Sbjct: 303 EKISESHSKY-------NPMVVSSAADETMLLQRKDGKITAGTTNAKGKGSTPTIASDKL 355

Query: 359 KKSV--GSQYSSD-QLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICP 415
            K+V  G+  S+  ++  LMESIEK+YV +NSHFAS + FS Y +AS+QD+S  ++S+ P
Sbjct: 356 GKAVDAGAHLSNQPRVSHLMESIEKDYVFVNSHFASLEAFSDYFEASVQDSSSHRISLFP 415

Query: 416 SKKNDHSAI-TMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGL 474
           SK+ +       QTKD+PS S  G EN   +       S     L++   ++ LHPS  L
Sbjct: 416 SKRTNMEVRDAKQTKDLPSSSTEGLENLKSNKLEACAASCEFAALRKEHQISPLHPSNRL 475

Query: 475 QLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPS 534
           QLLHQYV  + EL++ KY+ GL+LES +VELVVLAIWK+ L+IC SW+ S++  ELPG S
Sbjct: 476 QLLHQYVQIIAELSQEKYNTGLYLESLAVELVVLAIWKQTLEICSSWMASITKSELPGSS 535

Query: 535 SAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAE 594
           SA      +  I+   ++E  ++FS P S+S WA+  FI A DRAEKLS ++++ D A E
Sbjct: 536 SANESISAR-DINLPQSTEQKINFSDPSSISLWAKHEFIDAVDRAEKLSCHVQNMDKATE 594

Query: 595 MPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSL 654
           MPDAMEII+Q+AL +G  GAV+EYM  +  A+A YSKAMLLLSFIV EA +L L PPFSL
Sbjct: 595 MPDAMEIIFQKALLIGTSGAVDEYMEIRDRAAASYSKAMLLLSFIVAEAENLPLNPPFSL 654

Query: 655 NPSDKKRIQGYINNLQ 670
             ++K+RI  YI++LQ
Sbjct: 655 VATNKERISQYIHSLQ 670

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356560221|ref|XP_003548392.1| PREDICTED: serine/threonine-protein kinase ATG1-like [Glycine max]

 Score =  753 bits (1944), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 392/672 (58%), Positives = 481/672 (71%), Gaps = 11/672 (1%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           ME    R+IG+YIVGPRIGSGSFAVVWRAR+R  G+E AVKEIDK+ LSPKV +NLLKEI
Sbjct: 2   MEFGGPRVIGDYIVGPRIGSGSFAVVWRARNRSSGLEYAVKEIDKRQLSPKVRENLLKEI 61

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
           SILSTI HPNIIR FEAI+T ++IYLVLEYC GGDLAAYIH+HGKVSE VARHFMRQLAA
Sbjct: 62  SILSTIHHPNIIRLFEAIQTNDRIYLVLEYCAGGDLAAYIHRHGKVSEPVARHFMRQLAA 121

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP 180
           GLQVLQEK+LIHRDLKPQNLL++T   TPV+KIGDFGFARSLTPQ LADTLCGSP YMAP
Sbjct: 122 GLQVLQEKNLIHRDLKPQNLLLATTAATPVMKIGDFGFARSLTPQGLADTLCGSPYYMAP 181

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           EII+N KYDAKADLWSVGAIL+QLV G+PPFDG++QLQLFQNIL STEL FPP A++ LH
Sbjct: 182 EIIENQKYDAKADLWSVGAILYQLVIGRPPFDGNSQLQLFQNILASTELHFPPDALKVLH 241

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTP 300
            DC+DLCR LLR+NP ER+TFK FFNH FL E R TV+ EQ  +    +     L  S  
Sbjct: 242 SDCLDLCRNLLRRNPDERLTFKAFFNHNFLREPRPTVNVEQFQLHQSERLTDHQLGVSAS 301

Query: 301 EDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKK 360
           E     HS++       NP    S+A + ++L   D   +  T+      P +A D++ K
Sbjct: 302 EKISQSHSKYHV---VDNPVVVSSAADETMLLQRKDGKITAGTKSAKGSTPTIASDKLGK 358

Query: 361 SVGSQYSSDQLKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKK-N 419
           +V      D +  LMESIEK+YV +NSHFAS + FS Y +AS+Q+ S  ++S+  SK+ N
Sbjct: 359 AV------DAVSHLMESIEKDYVFVNSHFASFEAFSDYFEASVQNISSHRISLFSSKRTN 412

Query: 420 DHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQ 479
                  QTKD+P  S    EN   +       S     L++  G++ L PS  LQLLHQ
Sbjct: 413 MEVGHAKQTKDLPFSSTEVLENLKSNKQEACVASCEFAALRKENGISSLLPSNRLQLLHQ 472

Query: 480 YVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGELPGPSSAYGH 539
           YV  L EL++ KY+ GL+LES +VELVVLAIWKK L+IC  W+ S++  ELPG SSA   
Sbjct: 473 YVRILAELSQEKYNTGLYLESLAVELVVLAIWKKTLEICSFWMASITKSELPGSSSA-NE 531

Query: 540 TPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAM 599
           +     +    ++E  ++FS P S+S WA+  FI A DRAEKLS ++++ D AAEMPDAM
Sbjct: 532 SISASDVDLPQSTEQKINFSDPSSISLWAKHEFIDAVDRAEKLSCHVQNMDRAAEMPDAM 591

Query: 600 EIIYQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDK 659
           EII+Q+AL +G  GAV+EYM  +  A+A YSKAMLLLSFIV EA +L L PPFSL  ++K
Sbjct: 592 EIIFQKALLIGTSGAVDEYMEIRDRAAASYSKAMLLLSFIVTEAENLPLNPPFSLVSTNK 651

Query: 660 KRIQGYINNLQS 671
           +RI  YI++LQS
Sbjct: 652 ERILQYIHSLQS 663

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297821080|ref|XP_002878423.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297324261|gb|EFH54682.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  709 bits (1829), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/674 (55%), Positives = 462/674 (68%), Gaps = 56/674 (8%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           RL+G+Y +GPRIGSGSFAVVW A+HR  G+EVAVKEIDKKLLSPKV DNLLKEISILSTI
Sbjct: 5   RLVGDYELGPRIGSGSFAVVWLAKHRSSGLEVAVKEIDKKLLSPKVRDNLLKEISILSTI 64

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            HPNIIRF+EAIET ++I+LVLEYC GGDLA YI++HGKV EAVA+HFMRQLA GLQVLQ
Sbjct: 65  DHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGKVPEAVAKHFMRQLALGLQVLQ 124

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           EKH IHRDLKPQNLL+S+ EVTP+LKIGDFGFARSLTP+ +A+T CGSPLYMAPEII+N 
Sbjct: 125 EKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPESMAETFCGSPLYMAPEIIRNQ 184

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           KYDAKADLWS GAILFQLVTGKPPFDG+N +QLF NI+  TEL+FP  A  E+HPDCVDL
Sbjct: 185 KYDAKADLWSAGAILFQLVTGKPPFDGNNHIQLFHNIVRDTELKFPEDARNEIHPDCVDL 244

Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSL 306
           CR LLR+NP+ER+TF+EFFNH+FL E RQ              P V    S+T   + SL
Sbjct: 245 CRSLLRRNPIERLTFREFFNHKFLREPRQM-------------PDVVHSGSTTSTGKSSL 291

Query: 307 HSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKKSVGSQY 366
            S  P+ S+++   SA          N    G+S S  +    +P+++ ++ +K    Q 
Sbjct: 292 PSAQPSTSTNRFKSSAD---------NVHKHGSSSSAPNSQILMPHISFEKTRKDTEGQC 342

Query: 367 SSDQ--LKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKKNDHSAI 424
           SS+Q  + D +E IE+EYVL+N   AS +G S + D SLQD+    +             
Sbjct: 343 SSNQSGVVDSLELIEREYVLVNRPSASLEGSSDFFDTSLQDSGFPNI------------- 389

Query: 425 TMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHAL 484
            +   +  S S+  A+  L  V  P  TS   ++L EVQ LT++HP T LQLLHQY  AL
Sbjct: 390 -LPRNEKVSSSSLEAQRPLSDVSGPRPTSGS-YLLTEVQRLTIVHPPTKLQLLHQYAQAL 447

Query: 485 TELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGEL-PGPSSAYGHTPVQ 543
           TELA    + G   ESF+V LVVLA+W+KAL+IC SW+ S+   ++ P P++A       
Sbjct: 448 TELAREMGNTGQVKESFAVTLVVLAVWRKALEICDSWMISVGENKVNPDPTTA------- 500

Query: 544 GGISSDPNSENNV-DFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEII 602
                    E ++ D +SP S  TW  Q F+ AF++AE  S  + ++  A  MPDAME I
Sbjct: 501 --------PEFSIPDLNSPASAKTWVTQEFVTAFNQAENSSTQLNETSAATHMPDAMETI 552

Query: 603 YQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRI 662
           Y+RAL+ GK G  EEY+ NK SA+ LY KA+LLLSFI+ EA +LSL PPFSL P DKKRI
Sbjct: 553 YERALAYGKSGGAEEYLSNKESAATLYKKAILLLSFIIEEAVTLSLNPPFSLTPDDKKRI 612

Query: 663 QGYINNLQSHQSNF 676
             YI+NLQ  +S+ 
Sbjct: 613 LYYISNLQHRRSHL 626

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18412205|ref|NP_567122.1| protein kinase family protein [Arabidopsis thaliana] gi|14334752|gb|AAK59554.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] gi|332646764|gb|AEE80285.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  695 bits (1793), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/674 (54%), Positives = 456/674 (67%), Gaps = 56/674 (8%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           RL+G+Y +GPRIGSGSFAVVW A+HR  G+EVAVKEIDKKLLSPKV DNLLKEISILSTI
Sbjct: 5   RLVGDYALGPRIGSGSFAVVWLAKHRSSGLEVAVKEIDKKLLSPKVRDNLLKEISILSTI 64

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            HPNIIRF+EAIET ++I+LVLEYC GGDLA YI++HGKV EAVA+HFMRQLA GLQVLQ
Sbjct: 65  DHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGKVPEAVAKHFMRQLALGLQVLQ 124

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           EKH IHRDLKPQNLL+S+ EVTP+LKIGDFGFARSLTP+ +A+T CGSPLYMAPEII+N 
Sbjct: 125 EKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPESMAETFCGSPLYMAPEIIRNQ 184

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           KYDAKADLWS GAILFQLVTGKPPFDG+N +QLF NI+  TEL+FP     E+HPDCVDL
Sbjct: 185 KYDAKADLWSAGAILFQLVTGKPPFDGNNHIQLFHNIVRDTELKFPEDTRNEIHPDCVDL 244

Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSL 306
           CR LLR+NP+ER+TF+EFFNH FL E RQ              P VE    ST   +  L
Sbjct: 245 CRSLLRRNPIERLTFREFFNHMFLREPRQI-------------PDVEHSGFSTCTGKSLL 291

Query: 307 HSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKKSVGSQY 366
            S  P+ S+++   SA          N    G+S S  +    +P+ + ++ +K    Q 
Sbjct: 292 PSAQPSTSTNRFKSSA---------ENVHKHGSSSSASNSQISMPHTSFEKTRKDTEGQC 342

Query: 367 SSDQ--LKDLMESIEKEYVLINSHFASTDGFSFYLDASLQDNSMAKVSICPSKKNDHSAI 424
           SS+Q  + D +E IE+EYVL+N   AS +G S   D SLQD+     +I P  +N+  + 
Sbjct: 343 SSNQSGVVDSLELIEREYVLVNRPSASLEGSSDCFDTSLQDSGFP--NILP--RNEKVSS 398

Query: 425 TMQTKDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQGLTVLHPSTGLQLLHQYVHAL 484
           +      P    SG        P P   S   ++L EVQ LT++HP T LQLLHQY  AL
Sbjct: 399 SSLEAQKPLSDVSG--------PRPASVS---YLLTEVQRLTIVHPPTKLQLLHQYAQAL 447

Query: 485 TELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWLTSMSHGEL-PGPSSAYGHTPVQ 543
           TELA    + G   ESF+V LVVLA+W+KAL+IC SW+ S+   E+ P P++A       
Sbjct: 448 TELASEMGNTGQVKESFAVTLVVLAVWRKALEICDSWMMSVGENEVNPDPTTA------- 500

Query: 544 GGISSDPNSENNV-DFSSPFSVSTWAEQGFILAFDRAEKLSYNIRDSDGAAEMPDAMEII 602
                    E ++ D +SP    TW  Q F+ A ++AE LS  + ++  A  MPDAME I
Sbjct: 501 --------PETSIPDLNSPAPAKTWVTQEFVTALNQAENLSTQLNETSAATHMPDAMETI 552

Query: 603 YQRALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRI 662
           Y+RAL+ GK G  EEY+ NK SA+ LY KA+LLLSFI+ EA +LSL P FSL P DKKRI
Sbjct: 553 YERALAYGKSGGAEEYLSNKESAATLYKKAILLLSFIIEEAVTLSLNPSFSLTPDDKKRI 612

Query: 663 QGYINNLQSHQSNF 676
             YI+NLQ  +S+ 
Sbjct: 613 LYYISNLQHRRSHL 626

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|6899894|emb|CAB71903.1| serine/threonine-protein kinase-like protein [Arabidopsis thaliana]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/703 (52%), Positives = 455/703 (64%), Gaps = 92/703 (13%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           RL+G+Y +GPRIGSGSFAVVW A+HR  G+EVAVKEIDKKLLSPKV DNLLKEISILSTI
Sbjct: 5   RLVGDYALGPRIGSGSFAVVWLAKHRSSGLEVAVKEIDKKLLSPKVRDNLLKEISILSTI 64

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            HPNIIRF+EAIET ++I+LVLEYC GGDLA YI++HGKV EAVA+HFMRQLA GLQVLQ
Sbjct: 65  DHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGKVPEAVAKHFMRQLALGLQVLQ 124

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           EKH IHRDLKPQNLL+S+ EVTP+LKIGDFGFARSLTP+ +A+T CGSPLYMAPEII+N 
Sbjct: 125 EKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPESMAETFCGSPLYMAPEIIRNQ 184

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           KYDAKADLWS GAILFQLVTGKPPFDG+N +QLF NI+  TEL+FP     E+HPDCVDL
Sbjct: 185 KYDAKADLWSAGAILFQLVTGKPPFDGNNHIQLFHNIVRDTELKFPEDTRNEIHPDCVDL 244

Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSL 306
           CR LLR+NP+ER+TF+EFFNH FL E RQ              P VE    ST   +  L
Sbjct: 245 CRSLLRRNPIERLTFREFFNHMFLREPRQI-------------PDVEHSGFSTCTGKSLL 291

Query: 307 HSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPNMACDRMKKSVGSQY 366
            S  P+ S+++   SA          N    G+S S  +    +P+ + ++ +K    Q 
Sbjct: 292 PSAQPSTSTNRFKSSA---------ENVHKHGSSSSASNSQISMPHTSFEKTRKDTEGQC 342

Query: 367 SSDQ-------------------------------LKDLMESIEKEYVLINSHFASTDGF 395
           SS+Q                               + D +E IE+EYVL+N   AS +G 
Sbjct: 343 SSNQSGGLLFAILCLISVALYKIVLLTYSCYVIRAVVDSLELIEREYVLVNRPSASLEGS 402

Query: 396 SFYLDASLQDNSMAKVSICPSKKNDHSAITMQTKDMPSDSASGAENSLFHVPAPLETSNR 455
           S   D SLQD+     +I P  +N+  + +      P    SG        P P   S  
Sbjct: 403 SDCFDTSLQDSGFP--NILP--RNEKVSSSSLEAQKPLSDVSG--------PRPASVS-- 448

Query: 456 LFILKEVQGLTVLHPSTGLQLLHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKAL 515
            ++L EVQ LT++HP T LQLLHQY  ALTELA         +ESF+V LVVLA+W+KAL
Sbjct: 449 -YLLTEVQRLTIVHPPTKLQLLHQYAQALTELASE-------MESFAVTLVVLAVWRKAL 500

Query: 516 QICGSWLTSMSHGEL-PGPSSAYGHTPVQGGISSDPNSENNV-DFSSPFSVSTWAEQGFI 573
           +IC SW+ S+   E+ P P++A                E ++ D +SP    TW  Q F+
Sbjct: 501 EICDSWMMSVGENEVNPDPTTA---------------PETSIPDLNSPAPAKTWVTQEFV 545

Query: 574 LAFDRAEKLSYNIRDSDGAAEMPDAMEIIYQRALSVGKIGAVEEYMGNKASASALYSKAM 633
            A ++AE LS  + ++  A  MPDAME IY+RAL+ GK G  EEY+ NK SA+ LY KA+
Sbjct: 546 TALNQAENLSTQLNETSAATHMPDAMETIYERALAYGKSGGAEEYLSNKESAATLYKKAI 605

Query: 634 LLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNLQSHQSNF 676
           LLLSFI+ EA +LSL P FSL P DKKRI  YI+NLQ  +S+ 
Sbjct: 606 LLLSFIIEEAVTLSLNPSFSLTPDDKKRILYYISNLQHRRSHL 648

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	692
TAIR|locus:2079527	626	AT3G61960 [Arabidopsis thalian	0.439	0.485	0.714	3.8e-170
TAIR|locus:2065680	733	AT2G37840 [Arabidopsis thalian	0.387	0.365	0.648	6.6e-121
TAIR|locus:2084440	712	AT3G53930 [Arabidopsis thalian	0.382	0.372	0.650	6.5e-120
DICTYBASE|DDB_G0292390	668	atg1 "ULK family protein kinas	0.371	0.384	0.429	1e-63
TAIR|locus:2028496	408	AT1G49180 [Arabidopsis thalian	0.384	0.651	0.423	1.6e-61
ZFIN|ZDB-GENE-080723-31	1038	ulk1a "unc-51-like kinase 1a (	0.406	0.270	0.441	7.4e-59
RGD|1589743	1057	Ulk1 "Unc-51 like kinase 1 (C.	0.384	0.251	0.439	3.1e-58
UNIPROTKB|O75385	1050	ULK1 "Serine/threonine-protein	0.384	0.253	0.439	1.6e-57
MGI|MGI:1270126	1051	Ulk1 "unc-51 like kinase 1" [M	0.384	0.253	0.436	2.1e-57
WB|WBGene00006786	856	unc-51 [Caenorhabditis elegans	0.369	0.299	0.452	2.4e-57

TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)]

 Score = 1145 (408.1 bits), Expect = 3.8e-170, Sum P(2) = 3.8e-170
 Identities = 218/305 (71%), Positives = 251/305 (82%)

Query:     7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
             RL+G+Y +GPRIGSGSFAVVW A+HR  G+EVAVKEIDKKLLSPKV DNLLKEISILSTI
Sbjct:     5 RLVGDYALGPRIGSGSFAVVWLAKHRSSGLEVAVKEIDKKLLSPKVRDNLLKEISILSTI 64

Query:    67 SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
              HPNIIRF+EAIET ++I+LVLEYC GGDLA YI++HGKV EAVA+HFMRQLA GLQVLQ
Sbjct:    65 DHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGKVPEAVAKHFMRQLALGLQVLQ 124

Query:   127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             EKH IHRDLKPQNLL+S+ EVTP+LKIGDFGFARSLTP+ +A+T CGSPLYMAPEII+N 
Sbjct:   125 EKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPESMAETFCGSPLYMAPEIIRNQ 184

Query:   187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
             KYDAKADLWS GAILFQLVTGKPPFDG+N +QLF NI+  TEL+FP     E+HPDCVDL
Sbjct:   185 KYDAKADLWSAGAILFQLVTGKPPFDGNNHIQLFHNIVRDTELKFPEDTRNEIHPDCVDL 244

Query:   247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPET-KPMVELLNSSTPEDRHS 305
             CR LLR+NP+ER+TF+EFFNH FL E RQ    E       T K ++     ST  +R  
Sbjct:   245 CRSLLRRNPIERLTFREFFNHMFLREPRQIPDVEHSGFSTCTGKSLLPSAQPSTSTNRFK 304

Query:   306 LHSEH 310
               +E+
Sbjct:   305 SSAEN 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)]

 Score = 912 (326.1 bits), Expect = 6.6e-121, Sum P(2) = 6.6e-121
 Identities = 175/270 (64%), Positives = 219/270 (81%)

Query:     7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
             R++G+Y+VG +IGSGSF+VVW ARHR  G EVA+KEI    L+ K+ ++L+ EI IL  I
Sbjct:     7 RVVGDYLVGRQIGSGSFSVVWEARHRVDGTEVAIKEIAMDRLNKKLQESLMSEIFILRRI 66

Query:    67 SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
             +HPNIIR  + I++  K++LVLEYC GGDL+ Y+ +HG V EA A+HFM+QLAAGLQVL+
Sbjct:    67 NHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHGIVPEATAKHFMQQLAAGLQVLR 126

Query:   127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + ++IHRDLKPQNLL+STNE    LKI DFGFARSL P+ LA+TLCGSPLYMAPEI+Q  
Sbjct:   127 DNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 186

Query:   187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
             KYDAKADLWSVGAILFQLVTG+ PF G++Q+QL QNI+ STEL FP G   +L  DC+DL
Sbjct:   187 KYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNIIRSTELHFP-GDCRDLSLDCIDL 245

Query:   247 CRCLLRQNPVERITFKEFFNHRFLGELRQT 276
             C+ LLR+NPVER+TF+EFFNH FL + RQ+
Sbjct:   246 CQKLLRRNPVERLTFEEFFNHPFLSD-RQS 274

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)]

 Score = 890 (318.4 bits), Expect = 6.5e-120, Sum P(3) = 6.5e-120
 Identities = 173/266 (65%), Positives = 209/266 (78%)

Query:     7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
             R+IG+Y VG +IGSGSF+VVW  RH   G  VA+KEI    L+ K+ ++L+ EI IL  I
Sbjct:    15 RVIGDYAVGRQIGSGSFSVVWEGRHLVHGTVVAIKEIAMARLNKKLQESLMSEIIILRKI 74

Query:    67 SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
             +HPNIIRF + IE   KI LVLEYC GGDL+ YIHKHG V EA A+HFM QLAAGLQVL+
Sbjct:    75 NHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHGSVPEATAKHFMLQLAAGLQVLR 134

Query:   127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + ++IHRDLKPQNLL+ST++    LKI DFGFARSL P+ LA+TLCGSPLYMAPEI+Q  
Sbjct:   135 DNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 194

Query:   187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
             KYDAKADLWSVGAILFQLVTG+ PF G++Q+QL QNI+ STEL FP     +L  DC DL
Sbjct:   195 KYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNIIRSTELHFPADC-RDLSTDCKDL 253

Query:   247 CRCLLRQNPVERITFKEFFNHRFLGE 272
             C+ LLR+NPVER+TF+EFF+H FL +
Sbjct:   254 CQKLLRRNPVERLTFEEFFHHPFLSD 279

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

DICTYBASE|DDB_G0292390 atg1 "ULK family protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 567 (204.7 bits), Expect = 1.0e-63, Sum P(3) = 1.0e-63
 Identities = 115/268 (42%), Positives = 177/268 (66%)

Query:     9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK---VSDNLLKEISILST 65
             +G+YI+  RIG G+FA V++    +     A+K +D   L+ K   +++NL  EI IL  
Sbjct:     4 VGDYILDKRIGWGAFAQVYKGFSIKTNEPFAIKVVDVCRLADKNSKLTENLNYEIRILKE 63

Query:    66 ISHPNIIRFFEAI--ETREK-IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
             +SH NI+R ++ +  ET    IY+++E C+GGD + YI  H K++E  A +FM+QLA GL
Sbjct:    64 LSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKKLTEEKALYFMKQLANGL 123

Query:   123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
             + L++K ++HRDLKPQNLL+S +   P+LKIGDFGFA+ + P  L+DT CGSPLYMAPEI
Sbjct:   124 KFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPFSLSDTFCGSPLYMAPEI 183

Query:   183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
             +    Y  KADLWSVG IL++++ G+P ++  +   L  N L + +++ P      +  D
Sbjct:   184 LHRKNYTVKADLWSVGIILYEMLVGEPAYNSGSVPDLL-NQLQNKKIKLP----SHISSD 238

Query:   243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             C +L   LL+ +  +RI++++FFNH++L
Sbjct:   239 CQNLIYSLLQIDVEKRISWEDFFNHKWL 266

GO:0070265 "necrotic cell death" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016236 "macroautophagy" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0031288 "sorocarp morphogenesis" evidence=IMP

GO:0030587 "sorocarp development" evidence=IMP

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IMP

GO:0006995 "cellular response to nitrogen starvation" evidence=IMP

GO:0005737 "cytoplasm" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0048102 "autophagic cell death" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0015031 "protein transport" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0006810 "transport" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA

TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)]

 Score = 629 (226.5 bits), Expect = 1.6e-61, P = 1.6e-61
 Identities = 114/269 (42%), Positives = 176/269 (65%)

Query:     8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
             ++ +YI   ++     + VW A+H+  G E  +K  D   L+  + D L  E+  LS++ 
Sbjct:     3 MLDDYIAKSKLSESLTSTVWLAKHKLTGEEAVMKCFDLSKLNRNLRDCLNNELEFLSSVD 62

Query:    68 HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
             HPNIIR     +  + + +VLEYCDGG L++YI ++G+V E +A+ FM+Q+ AGL+++ +
Sbjct:    63 HPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYGRVEEDIAKRFMKQIGAGLEIIHD 122

Query:   128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
              H+IHRDLKP+N+L+  +    VLKI DF  AR L P    +T+CGSP YMAPE++Q  +
Sbjct:   123 NHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHPGKYLETVCGSPFYMAPEVLQFQR 182

Query:   188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
             Y+ KAD+WSVGAILF+L+ G PPF G+N +Q+ +NI +ST L F    ++++HPDC+D+C
Sbjct:   183 YNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIKSSTALPFSRLILQQMHPDCIDVC 242

Query:   248 RCLLRQNPVERITFKEFFNHRFLGELRQT 276
               LL  NP   +  ++F    FLG ++ +
Sbjct:   243 SRLLSINPAATLGIEDF---PFLGRIKNS 268

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

ZFIN|ZDB-GENE-080723-31 ulk1a "unc-51-like kinase 1a (C. elegans)" [Danio rerio (taxid:7955)]

 Score = 553 (199.7 bits), Expect = 7.4e-59, Sum P(3) = 7.4e-59
 Identities = 132/299 (44%), Positives = 177/299 (59%)

Query:     4 NRTRLIGEYIVGPR--IGSGSFAVVWRARHRQL-GIEVAVKEIDKKLLSPKVSDNLL-KE 59
             N    IG+Y    +  IG G+FAVV++ RH+Q    EVAVK I++K L+   S +LL KE
Sbjct:     3 NAMESIGKYEFNRKDLIGHGAFAVVFKGRHKQKHNFEVAVKCINRKNLAK--SQSLLGKE 60

Query:    60 ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
             I IL  + H NI+   +  E    +YLV+EYC+GGDLA Y+H  G +SE   R  ++QLA
Sbjct:    61 IKILKELKHENIVSLLDFQEISGCVYLVMEYCNGGDLAEYLHSKGCLSEDTIRVLLQQLA 120

Query:   120 AGLQVLQEKHLIHRDLKPQNLLVS------TNEVTPVLK-IGDFGFARSLTPQDLADTLC 172
               + VL+ K +IHRDLKPQN+L+S      +N     +K + DFGFAR L    +A TLC
Sbjct:   121 GAMSVLRSKGIIHRDLKPQNILLSYSTGRKSNPNNICIKLVADFGFARYLQGNTMAATLC 180

Query:   173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
             GSP+YMAPE+I +H YDAKADLWSVG I++Q +TGK PF  S   +L Q    +  L   
Sbjct:   181 GSPMYMAPEVIMSHNYDAKADLWSVGTIIYQCLTGKAPFQASTPQELRQFYERNRSLS-- 238

Query:   233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
             P    E       L   LL++N  ERI F +FF+H FL     +   ++ S VP   P+
Sbjct:   239 PSIPRETSSHLRHLLLGLLQRNQRERIDFDDFFHHPFL---EASTSMKKSSPVPVPVPV 294

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0000166 "nucleotide binding" evidence=IEA

RGD|1589743 Ulk1 "Unc-51 like kinase 1 (C. elegans)" [Rattus norvegicus (taxid:10116)]

 Score = 551 (199.0 bits), Expect = 3.1e-58, Sum P(3) = 3.1e-58
 Identities = 124/282 (43%), Positives = 168/282 (59%)

Query:     1 MEPNR--TRLIGEYIVGPR--IGSGSFAVVWRARHRQL-GIEVAVKEIDKKLLSPKVSDN 55
             MEP R     +G++    +  IG G+FAVV++ RHR+   +EVAVK I+KK L+   S  
Sbjct:     1 MEPGRGGVETVGKFEFSRKDLIGHGAFAVVFKGRHREKHDLEVAVKCINKKNLAK--SQT 58

Query:    56 LL-KEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHF 114
             LL KEI IL  + H NI+  ++  E    +YLV+EYC+GGDLA Y+H    +SE   R F
Sbjct:    59 LLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHTMRTLSEDTVRLF 118

Query:   115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVST---NEVTPV---LKIGDFGFARSLTPQDLA 168
             ++Q+A  +Q+L  K +IHRDLKPQN+L+S        P    +KI DFGFAR L    +A
Sbjct:   119 LQQIAGAMQLLHSKGIIHRDLKPQNILLSNPGGRRANPSNIRVKIADFGFARYLQSNMMA 178

Query:   169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE 228
              TLCGSP+YMAPE+I +  YD KADLWS+G I++Q +TGK PF  S+   L   +     
Sbjct:   179 ATLCGSPMYMAPEVIMSQHYDGKADLWSIGTIVYQCLTGKAPFQASSPQDL--RLFYEKN 236

Query:   229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                 P    E       L   LL++N  +R+ F EFF+H FL
Sbjct:   237 KTLVPAIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFL 278

GO:0000045 "autophagic vacuole assembly" evidence=IEA;ISO

GO:0000407 "pre-autophagosomal structure" evidence=ISO

GO:0003674 "molecular_function" evidence=ND

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0005737 "cytoplasm" evidence=ISO

GO:0005776 "autophagic vacuole" evidence=IEA;ISO

GO:0005829 "cytosol" evidence=IEA;ISO

GO:0007265 "Ras protein signal transduction" evidence=IEA;ISO

GO:0007409 "axonogenesis" evidence=ISO

GO:0008104 "protein localization" evidence=IEA;ISO

GO:0010506 "regulation of autophagy" evidence=ISO

GO:0010508 "positive regulation of autophagy" evidence=ISO

GO:0016020 "membrane" evidence=ISO

GO:0016239 "positive regulation of macroautophagy" evidence=IEA;ISO

GO:0017137 "Rab GTPase binding" evidence=IEA;ISO

GO:0019901 "protein kinase binding" evidence=IEA;ISO

GO:0021707 "cerebellar granule cell differentiation" evidence=IEA;ISO

GO:0021933 "radial glia guided migration of cerebellar granule cell" evidence=IEA;ISO

GO:0030659 "cytoplasmic vesicle membrane" evidence=IEA;ISO

GO:0031102 "neuron projection regeneration" evidence=IMP

GO:0031175 "neuron projection development" evidence=ISO;IMP

GO:0031623 "receptor internalization" evidence=IEA;ISO

GO:0031669 "cellular response to nutrient levels" evidence=ISO

GO:0032403 "protein complex binding" evidence=IEA;ISO

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA;ISO

GO:0042594 "response to starvation" evidence=ISO

GO:0043005 "neuron projection" evidence=IEA;ISO

GO:0043025 "neuronal cell body" evidence=IEA;ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA;ISO

GO:0048675 "axon extension" evidence=IEA;ISO

GO:0051386 "regulation of neurotrophin TRK receptor signaling pathway" evidence=IEA;ISO

GO:0070969 "ULK1-ATG13-FIP200 complex" evidence=IEA;ISO

UNIPROTKB|O75385 ULK1 "Serine/threonine-protein kinase ULK1" [Homo sapiens (taxid:9606)]

 Score = 548 (198.0 bits), Expect = 1.6e-57, Sum P(3) = 1.6e-57
 Identities = 124/282 (43%), Positives = 169/282 (59%)

Query:     1 MEPNR--TRLIGEYIVGPR--IGSGSFAVVWRARHRQL-GIEVAVKEIDKKLLSPKVSDN 55
             MEP R  T  +G++    +  IG G+FAVV++ RHR+   +EVAVK I+KK L+   S  
Sbjct:     1 MEPGRGGTETVGKFEFSRKDLIGHGAFAVVFKGRHREKHDLEVAVKCINKKNLAK--SQT 58

Query:    56 LL-KEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHF 114
             LL KEI IL  + H NI+  ++  E    +YLV+EYC+GGDLA Y+H    +SE   R F
Sbjct:    59 LLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHAMRTLSEDTIRLF 118

Query:   115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVST---NEVTPV---LKIGDFGFARSLTPQDLA 168
             ++Q+A  +++L  K +IHRDLKPQN+L+S        P    +KI DFGFAR L    +A
Sbjct:   119 LQQIAGAMRLLHSKGIIHRDLKPQNILLSNPAGRRANPNSIRVKIADFGFARYLQSNMMA 178

Query:   169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE 228
              TLCGSP+YMAPE+I +  YD KADLWS+G I++Q +TGK PF  S+   L   +     
Sbjct:   179 ATLCGSPMYMAPEVIMSQHYDGKADLWSIGTIVYQCLTGKAPFQASSPQDL--RLFYEKN 236

Query:   229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                 P    E       L   LL++N  +R+ F EFF+H FL
Sbjct:   237 KTLVPTIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFL 278

GO:0005524 "ATP binding" evidence=IEA

GO:0000045 "autophagic vacuole assembly" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0021707 "cerebellar granule cell differentiation" evidence=IEA

GO:0021933 "radial glia guided migration of cerebellar granule cell" evidence=IEA

GO:0030659 "cytoplasmic vesicle membrane" evidence=IEA

GO:0031102 "neuron projection regeneration" evidence=IEA

GO:0031623 "receptor internalization" evidence=IEA

GO:0043005 "neuron projection" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0048675 "axon extension" evidence=IEA

GO:0051386 "regulation of neurotrophin TRK receptor signaling pathway" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0070969 "ULK1-ATG13-FIP200 complex" evidence=IPI

GO:0008104 "protein localization" evidence=IMP

GO:0005776 "autophagic vacuole" evidence=IDA

GO:0010506 "regulation of autophagy" evidence=IDA;IMP

GO:0032403 "protein complex binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;NAS

GO:0005737 "cytoplasm" evidence=NAS

GO:0031175 "neuron projection development" evidence=IMP

GO:0031669 "cellular response to nutrient levels" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IDA

GO:0042594 "response to starvation" evidence=ISS

GO:0010508 "positive regulation of autophagy" evidence=ISS

GO:0016239 "positive regulation of macroautophagy" evidence=IMP

GO:0017137 "Rab GTPase binding" evidence=IPI

MGI|MGI:1270126 Ulk1 "unc-51 like kinase 1" [Mus musculus (taxid:10090)]

 Score = 547 (197.6 bits), Expect = 2.1e-57, Sum P(3) = 2.1e-57
 Identities = 123/282 (43%), Positives = 168/282 (59%)

Query:     1 MEPNR--TRLIGEYIVGPR--IGSGSFAVVWRARHRQL-GIEVAVKEIDKKLLSPKVSDN 55
             MEP R     +G++    +  IG G+FAVV++ RHR+   +EVAVK I+KK L+   S  
Sbjct:     1 MEPGRGGVETVGKFEFSRKDLIGHGAFAVVFKGRHREKHDLEVAVKCINKKNLAK--SQT 58

Query:    56 LL-KEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHF 114
             LL KEI IL  + H NI+  ++  E    +YLV+EYC+GGDLA Y+H    +SE   R F
Sbjct:    59 LLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHTMRTLSEDTVRLF 118

Query:   115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVST---NEVTPV---LKIGDFGFARSLTPQDLA 168
             ++Q+A  +++L  K +IHRDLKPQN+L+S        P    +KI DFGFAR L    +A
Sbjct:   119 LQQIAGAMRLLHSKGIIHRDLKPQNILLSNPGGRRANPSNIRVKIADFGFARYLQSNMMA 178

Query:   169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE 228
              TLCGSP+YMAPE+I +  YD KADLWS+G I++Q +TGK PF  S+   L   +     
Sbjct:   179 ATLCGSPMYMAPEVIMSQHYDGKADLWSIGTIVYQCLTGKAPFQASSPQDL--RLFYEKN 236

Query:   229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                 P    E       L   LL++N  +R+ F EFF+H FL
Sbjct:   237 KTLVPAIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFL 278

GO:0000045 "autophagic vacuole assembly" evidence=IMP

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000407 "pre-autophagosomal structure" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005776 "autophagic vacuole" evidence=ISO

GO:0005829 "cytosol" evidence=ISO;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IDA

GO:0007409 "axonogenesis" evidence=IDA

GO:0008104 "protein localization" evidence=ISO

GO:0010506 "regulation of autophagy" evidence=ISO;IMP

GO:0010508 "positive regulation of autophagy" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0016239 "positive regulation of macroautophagy" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017137 "Rab GTPase binding" evidence=ISO

GO:0019901 "protein kinase binding" evidence=IPI

GO:0021707 "cerebellar granule cell differentiation" evidence=IMP

GO:0021933 "radial glia guided migration of cerebellar granule cell" evidence=IMP

GO:0030659 "cytoplasmic vesicle membrane" evidence=IDA

GO:0031102 "neuron projection regeneration" evidence=ISO

GO:0031175 "neuron projection development" evidence=ISO;IMP

GO:0031623 "receptor internalization" evidence=IMP

GO:0031669 "cellular response to nutrient levels" evidence=IDA

GO:0032403 "protein complex binding" evidence=ISO

GO:0034045 "pre-autophagosomal structure membrane" evidence=ISO;IDA

GO:0042594 "response to starvation" evidence=IDA

GO:0043005 "neuron projection" evidence=IDA

GO:0043025 "neuronal cell body" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=ISO;IDA

GO:0048671 "negative regulation of collateral sprouting" evidence=IMP

GO:0048675 "axon extension" evidence=IMP

GO:0051386 "regulation of neurotrophin TRK receptor signaling pathway" evidence=IMP

GO:0070969 "ULK1-ATG13-FIP200 complex" evidence=ISO;IPI

WB|WBGene00006786 unc-51 [Caenorhabditis elegans (taxid:6239)]

 Score = 551 (199.0 bits), Expect = 2.4e-57, Sum P(2) = 2.4e-57
 Identities = 123/272 (45%), Positives = 172/272 (63%)

Query:    11 EYIVGPRIGSGSFAVVWRARH-RQLGIEVAVKEIDKKLLSPKVSDNLL-KEISIL---ST 65
             EY     +G G+FA+V+R R+  +  + VA+K I KK +S   S NLL KEI IL   S+
Sbjct:     8 EYSKRDLLGHGAFAIVYRGRYVDRTDVPVAIKAIAKKNISK--SKNLLTKEIKILKELSS 65

Query:    66 ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
             + H N++   +  ET   +YLV+E+C+GGDLA Y+ +   ++E   +HF+ Q+A  L+ +
Sbjct:    66 LKHENLVGLLKCTETPTHVYLVMEFCNGGDLADYLQQKTTLNEDTIQHFVVQIAHALEAI 125

Query:   126 QEKHLIHRDLKPQNLLVSTNEVT--P-----VLKIGDFGFARSLTPQDLADTLCGSPLYM 178
              +K ++HRDLKPQN+L+  N  T  P     V+K+ DFGFAR L    +A TLCGSP+YM
Sbjct:   126 NKKGIVHRDLKPQNILLCNNSRTQNPHFTDIVIKLADFGFARFLNDGVMAATLCGSPMYM 185

Query:   179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
             APE+I + +YDAKADLWS+G ILFQ +TGK PF      QL      + ELR  P   E 
Sbjct:   186 APEVIMSMQYDAKADLWSIGTILFQCLTGKAPFVAQTPPQLKAYYEKTRELR--PNIPEW 243

Query:   239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
               P+  DL   LL++N  +RI+F++FFNH FL
Sbjct:   244 CSPNLRDLLLRLLKRNAKDRISFEDFFNHPFL 275

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0016773 "phosphotransferase activity, alcohol group as acceptor" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0048675 "axon extension" evidence=IMP

GO:0007411 "axon guidance" evidence=IMP

GO:0070265 "necrotic cell death" evidence=IMP

GO:0008340 "determination of adult lifespan" evidence=IGI;IMP

GO:0040011 "locomotion" evidence=IMP

GO:0030163 "protein catabolic process" evidence=IMP

GO:0030516 "regulation of axon extension" evidence=IMP

GO:0007409 "axonogenesis" evidence=IMP

GO:0016477 "cell migration" evidence=IMP

GO:0040024 "dauer larval development" evidence=IGI

GO:0006914 "autophagy" evidence=IGI

GO:0012501 "programmed cell death" evidence=IGI

GO:0008361 "regulation of cell size" evidence=IMP

GO:0045138 "tail tip morphogenesis" evidence=IMP

GO:0040014 "regulation of multicellular organism growth" evidence=IGI

GO:0032880 "regulation of protein localization" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0043005 "neuron projection" evidence=IDA

GO:0043025 "neuronal cell body" evidence=IDA

GO:0030424 "axon" evidence=IDA

GO:0043277 "apoptotic cell clearance" evidence=IMP

GO:0009792 "embryo development ending in birth or egg hatching" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	692
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-100
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-93
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-80
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-73
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-69
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-68
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-65
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-63
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-59
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-59
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-58
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-57
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-55
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-54
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-53
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-52
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-52
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-52
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-51
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-49
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-49
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-48
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-48
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-48
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-47
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-47
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-45
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-45
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-44
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-44
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-44
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-44
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-43
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-42
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-42
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-42
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-41
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-41
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-41
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-41
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-41
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-41
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-41
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-41
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-41
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-40
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-40
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-40
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-40
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-39
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-39
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-39
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-39
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-38
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-38
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-37
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-37
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-37
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-37
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-37
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-36
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-36
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-36
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-36
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-36
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-35
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-35
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-35
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-35
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-35
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-35
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-35
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-34
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-34
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-34
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-34
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-34
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-33
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-33
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-33
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-33
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-33
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-33
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-33
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-33
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-33
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-33
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-33
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-33
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-33
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-32
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-32
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-32
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-32
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-32
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-32
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-32
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-32
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-32
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-32
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-32
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-32
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-31
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-31
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-31
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-31
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-31
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-31
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-31
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-31
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-31
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-31
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-31
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-31
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-30
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-30
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-30
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-30
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-30
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-30
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-30
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-29
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-29
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-29
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-29
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-29
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-29
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-29
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-29
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-29
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-29
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-29
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-29
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-28
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-28
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-27
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-27
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-27
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-27
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-27
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-27
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-27
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-27
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-27
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-27
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-26
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-26
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-26
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-26
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-26
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-26
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-26
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-26
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-26
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-26
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-25
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-25
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-25
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-25
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-25
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-25
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-25
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-25
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-25
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-25
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-24
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-24
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-24
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-24
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-24
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-24
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-24
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-24
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-24
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-24
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-23
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-23
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-23
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-23
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-22
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-22
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-22
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-22
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-22
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-22
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-22
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-21
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-21
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-21
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-21
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-20
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-20
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-20
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-20
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-20
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-20
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-20
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-19
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-19
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-18
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-18
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-17
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-16
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-16
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-15
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-14
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-13
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	8e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-05
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  307 bits (790), Expect = e-100
 Identities = 105/259 (40%), Positives = 160/259 (61%), Gaps = 5/259 (1%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +  ++G GSF  V+ AR ++ G  VA+K I KK +  K  + +L+EI IL  + HPNI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +R ++  E  +K+YLV+EYC+GGDL   + K G++SE  AR ++RQ+ + L+ L  K ++
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N+L+  +     +K+ DFG AR L P +   T  G+P YMAPE++    Y   
Sbjct: 120 HRDLKPENILLDED---GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D+WS+G IL++L+TGKPPF G +QL      +   +  FPP    ++ P+  DL R LL
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWDISPEAKDLIRKLL 235

Query: 252 RQNPVERITFKEFFNHRFL 270
            ++P +R+T +E   H F 
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  288 bits (739), Expect = 8e-93
 Identities = 105/264 (39%), Positives = 152/264 (57%), Gaps = 9/264 (3%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +  ++GSGSF  V++A+H+  G  VAVK + K+    K      +EI IL  +SHPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +R  +A E ++ +YLV+EYC+GGDL  Y+ + G +SE  A+    Q+  GL+ L    +I
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNHK-YD 189
           HRDLKP+N+L+  N    V+KI DFG A+ L        T  G+P YMAPE++     Y 
Sbjct: 121 HRDLKPENILLDEN---GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 190 AKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
            K D+WS+G IL++L+TGKPPF G    +QLQL + IL    L F          +  DL
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL-GPPLEFDEPKWSSGSEEAKDL 236

Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            +  L ++P +R T +E   H + 
Sbjct: 237 IKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  254 bits (652), Expect = 5e-80
 Identities = 94/254 (37%), Positives = 148/254 (58%), Gaps = 12/254 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG GSF  V+  R +  G    +KEID   +S K  ++ L E+ IL  ++HPNII+++E+
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLAAGLQVLQEKHLIHR 133
            E + K+ +V+EY DGGDL+  I K  K      E     +  QL   L+ L  + ++HR
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKA 192
           D+KPQN+ +++N    ++K+GDFG ++ L+   DLA T+ G+P Y++PE+ QN  Y+ K+
Sbjct: 128 DIKPQNIFLTSN---GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKS 184

Query: 193 DLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           D+WS+G +L++L T K PF+G N L+L   IL       P     EL     +L   LL+
Sbjct: 185 DIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELR----NLVSSLLQ 240

Query: 253 QNPVERITFKEFFN 266
           ++P ER +  +   
Sbjct: 241 KDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  235 bits (603), Expect = 8e-73
 Identities = 94/266 (35%), Positives = 149/266 (56%), Gaps = 12/266 (4%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           E+  G  +G GSF  V+ A  +  G  +AVK ++    S +  + L +EI ILS++ HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 71  IIRFFEAIETREK--IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           I+R++ +    EK  + + LEY  GG L++ + K GK+ E V R + RQ+  GL  L   
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD---TLCGSPLYMAPEIIQN 185
            ++HRD+K  N+LV ++    V+K+ DFG A+ L   +  +   ++ G+P +MAPE+I+ 
Sbjct: 121 GIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
            +Y   AD+WS+G  + ++ TGKPP+ +  N +     I +S E   PP   E L  +  
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE---PPEIPEHLSEEAK 234

Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
           D  R  LR++P +R T  E   H FL
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  224 bits (574), Expect = 3e-69
 Identities = 84/253 (33%), Positives = 135/253 (53%), Gaps = 42/253 (16%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G F  V+ AR ++ G +VA+K I K+  S  + + LL+EI IL  ++HPNI++ +  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
            E    +YLV+EYC+GG L   + ++ GK+SE      + Q+  GL+ L    +IHRDLK
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQN-HKYDAKADL 194
           P+N+L+ ++     +K+ DFG ++ LT    L  T+ G+P YMAPE++     Y  K+D+
Sbjct: 120 PENILLDSDN--GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS+G IL++L                                    P+  DL R +L+++
Sbjct: 178 WSLGVILYEL------------------------------------PELKDLIRKMLQKD 201

Query: 255 PVERITFKEFFNH 267
           P +R + KE   H
Sbjct: 202 PEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  223 bits (570), Expect = 4e-68
 Identities = 93/257 (36%), Positives = 149/257 (57%), Gaps = 13/257 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G GSF  V   R +  G   A+K + KK ++  K  ++ L E +ILS I+HP I++   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T EK+YLVLEY  GG+L +++ K G+ SE  AR +  ++   L+ L    +I+RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
           P+N+L+        +K+ DFG A+ L +     +T CG+P Y+APE++    Y    D W
Sbjct: 121 PENILLDA---DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G +L++++TGKPPF   ++ ++++ IL    LRFP      L P+  DL   LL+++P
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-PLRFPEF----LSPEARDLISGLLQKDP 232

Query: 256 VERIT---FKEFFNHRF 269
            +R+     +E   H F
Sbjct: 233 TKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  215 bits (551), Expect = 7e-65
 Identities = 92/286 (32%), Positives = 141/286 (49%), Gaps = 35/286 (12%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP--KVSDNLLKEISILSTISH 68
           ++  G  IG GSF+ V  A+ ++   E A+K +DK+ L    KV    +++  +     H
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           P II+ +   +  E +Y VLEY   G+L  YI K+G + E   R +  ++   L+ L  K
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--------------------- 167
            +IHRDLKP+N+L+  +     +KI DFG A+ L P                        
Sbjct: 122 GIIHRDLKPENILLDKDM---HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST 227
             +  G+  Y++PE++        +DLW++G I++Q++TGKPPF GSN+   FQ IL   
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-KL 237

Query: 228 ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFF----NHRF 269
           E  FPP       PD  DL   LL  +P +R+   E +     H F
Sbjct: 238 EYSFPPN----FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  212 bits (542), Expect = 1e-63
 Identities = 104/298 (34%), Positives = 155/298 (52%), Gaps = 55/298 (18%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK--VSDNLLKEISILSTISHP 69
           Y    ++G G++ VV++AR ++ G  VA+K+I  +L + +  +    L+EIS+L  + HP
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEK 128
           NI++  + I T  K+YLV EYCD  DL  Y+ K  G +S  + +  M QL  GL      
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------Y 177
            ++HRDLKPQN+L++ +    VLK+ DFG AR+           G PL           Y
Sbjct: 118 RILHRDLKPQNILINRD---GVLKLADFGLARA----------FGIPLRTYTHEVVTLWY 164

Query: 178 MAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ--NIL-TSTE---- 228
            APEI+  +  Y    D+WSVG I  +++TGKP F G +++ QLF+   IL T TE    
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224

Query: 229 ---------LRFP--PG-----AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                      FP  P       +  L P+ +DL   +L+ NP +RI+ KE   H + 
Sbjct: 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  199 bits (508), Expect = 6e-59
 Identities = 93/275 (33%), Positives = 141/275 (51%), Gaps = 25/275 (9%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y V   IG GSF  V + R +  G  +  KEID   ++ K    L+ E++IL  + HPN
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 71  IIRFFEAIETREK--IYLVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQV 124
           I+R+++ I  R    +Y+V+EYC+GGDLA  I K       + E      + QL   L  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL---LLA 117

Query: 125 LQEKH--------LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSP 175
           L E H        ++HRDLKP N+ +  N     +K+GDFG A+ L      A T  G+P
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDAN---NNVKLGDFGLAKILGHDSSFAKTYVGTP 174

Query: 176 LYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
            YM+PE + +  YD K+D+WS+G ++++L    PPF   NQLQL   I      R P   
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY 234

Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             EL+    ++ + +L  +P +R + +E      +
Sbjct: 235 SSELN----EVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  199 bits (507), Expect = 9e-59
 Identities = 85/266 (31%), Positives = 138/266 (51%), Gaps = 19/266 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEISILSTISHPNIIRFFE 76
           I  G++  V+ A+ +  G   A+K I K  +  K   D +L E  ILS    P +++ + 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + + ++ +YLV+EY  GGDLA+ +   G + E VAR ++ ++   L+ L    +IHRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 137 PQNLLVSTNEVTPVLKIGDFGFA------RSLTPQDLAD---TLCGSPLYMAPEIIQNHK 187
           P N+L+ +N     LK+ DFG +      R +   D       + G+P Y+APE+I    
Sbjct: 121 PDNILIDSNG---HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +    D WS+G IL++ + G PPF G    ++FQNIL     +       E+  + +DL 
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG---KIEWPEDVEVSDEAIDLI 234

Query: 248 RCLLRQNPVERI---TFKEFFNHRFL 270
             LL  +P +R+   + +E  NH F 
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  197 bits (504), Expect = 1e-58
 Identities = 86/257 (33%), Positives = 146/257 (56%), Gaps = 14/257 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G F  V++ARH++ G EVA+K I  KL S +  + ++ EI IL    HPNI++++ 
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPNIVKYYG 64

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           +   ++++++V+E+C GG L   +    +  +E+   +  ++L  GL+ L    +IHRD+
Sbjct: 65  SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124

Query: 136 KPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L++++ EV    K+ DFG +  L+     +T+ G+P +MAPE+I    YD KAD+
Sbjct: 125 KAANILLTSDGEV----KLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTS--TELRFPPGAIEELHPDCVDLCRCLLR 252
           WS+G    +L  GKPP+     ++    I T+    LR P    +E   D +  C   L+
Sbjct: 181 WSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK-DFLKKC---LQ 236

Query: 253 QNPVERITFKEFFNHRF 269
           +NP +R T ++   H F
Sbjct: 237 KNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  195 bits (498), Expect = 3e-57
 Identities = 86/249 (34%), Positives = 144/249 (57%), Gaps = 11/249 (4%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHP 69
           ++     +G+GSF  V   RH+  G   A+K + K K++  K  +++L E  IL +I HP
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            ++  + + +    +YLV+EY  GG+L +++ K G+  E VAR +  Q+   L+ L    
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYD 189
           +++RDLKP+NLL+   +    +KI DFGFA+ +  +    TLCG+P Y+APEII +  Y 
Sbjct: 122 IVYRDLKPENLLL---DSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILSKGYG 176

Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
              D W++G ++++++ G PPF   N +Q+++ IL   ++RFP        PD  DL R 
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKVRFPS----FFSPDAKDLIRN 231

Query: 250 LLRQNPVER 258
           LL+ +  +R
Sbjct: 232 LLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  189 bits (483), Expect = 1e-55
 Identities = 80/261 (30%), Positives = 139/261 (53%), Gaps = 8/261 (3%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y +G  IG G+F VV++  + + G  VA+K+I  + +  +   ++++EI +L  + HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           I+++  +IET + +Y++LEY + G L   I K G   E++   ++ Q+  GL  L E+ +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC-GSPLYMAPEIIQNHKYD 189
           IHRD+K  N+L + +    V+K+ DFG A  L      D    G+P +MAPE+I+     
Sbjct: 121 IHRDIKAANILTTKDG---VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
             +D+WS+G  + +L+TG PP+   N +     I+       P G      P+  D    
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGI----SPELKDFLMQ 233

Query: 250 LLRQNPVERITFKEFFNHRFL 270
             +++P  R T K+   H ++
Sbjct: 234 CFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  186 bits (474), Expect = 4e-54
 Identities = 88/259 (33%), Positives = 131/259 (50%), Gaps = 14/259 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G GS  VV++ RH+  G   A+K+I       +    LL+E+  L +   P +++ + A
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL-QEKHLIHRDLK 136
                +I +VLEY DGG LA  + K GK+ E V  +  RQ+  GL  L  ++H+IHRD+K
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK 127

Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           P NLL+++  EV    KI DFG ++ L    D  +T  G+  YM+PE IQ   Y   AD+
Sbjct: 128 PSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADI 183

Query: 195 WSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           WS+G  L +   GK PF    Q    +L Q I        P         D +  C   L
Sbjct: 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC---L 240

Query: 252 RQNPVERITFKEFFNHRFL 270
           +++P +R +  E   H F+
Sbjct: 241 QKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  185 bits (471), Expect = 1e-53
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 16/263 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G F  V   + +      A+K + K+ ++     +++  E  IL   +HP I++ + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             + ++ IY+++EYC GG+L   +   G   E  AR ++  +    + L  + +I+RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+ +N     +K+ DFGFA+ L       T CG+P Y+APEII N  YD   D WS
Sbjct: 121 PENLLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177

Query: 197 VGAILFQLVTGKPPFDGSNQLQL--FQNILTSTE-LRFPPGAIEELHPDCVDLCRCLLRQ 253
           +G +L++L+TG+PPF   ++  +  + +IL     L FP      +     DL + LLR+
Sbjct: 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLRR 233

Query: 254 NPVERI-----TFKEFFNHRFLG 271
           NP ER+       K+   H++  
Sbjct: 234 NPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  181 bits (461), Expect = 3e-52
 Identities = 77/259 (29%), Positives = 130/259 (50%), Gaps = 14/259 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + R      A+K ++K K +      N+L E  IL  ++HP ++  + 
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +  E +YLV++   GGDL  ++ +  K SE   + ++ ++   L+ L  K +IHRD+K
Sbjct: 68  SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIK 127

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+L+  +E   V  I DF  A  +TP  L  +  G+P YMAPE++    Y    D WS
Sbjct: 128 PDNILL--DEQGHV-HITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWS 184

Query: 197 VGAILFQLVTGKPPFDG-SNQL--QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ 253
           +G   ++ + GK P+ G S  +  Q+     T+  L +P         + +D    LL +
Sbjct: 185 LGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL-YPATWS----TEAIDAINKLLER 239

Query: 254 NPVERI--TFKEFFNHRFL 270
           +P +R+    K+  NH + 
Sbjct: 240 DPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  180 bits (459), Expect = 3e-52
 Identities = 89/260 (34%), Positives = 134/260 (51%), Gaps = 10/260 (3%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKE---IDKKLLSPKVSDNLLKEISILSTISHPNI 71
           G  +GSGSF  V+   +   G   AVKE    D      +    L +EI++LS + HPNI
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +++       + +Y+ LE   GG LA  + K+G   E V R + RQ+  GL+ L +++ +
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII-QNHKYDA 190
           HRD+K  N+LV TN    V+K+ DFG A+ +     A +  GSP +MAPE+I Q   Y  
Sbjct: 125 HRDIKGANILVDTNG---VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
            AD+WS+G  + ++ TGKPP+     +     I  S EL   P   + L  +  D     
Sbjct: 182 AADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---PPIPDHLSDEAKDFILKC 238

Query: 251 LRQNPVERITFKEFFNHRFL 270
           L+++P  R T  E   H F+
Sbjct: 239 LQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  180 bits (459), Expect = 4e-52
 Identities = 83/252 (32%), Positives = 139/252 (55%), Gaps = 14/252 (5%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           + V  ++G GS+  V++ +        A+KE+D   +S K  ++ + EI IL++++HPNI
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-----SEAVARHFMRQLAAGLQVLQ 126
           I + EA     K+ +V+EY   GDL+  I K  K       + + R F+ QL  GLQ L 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQALH 120

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           E+ ++HRDLK  N+L+  N++   +KIGD G ++ L  +++A T  G+P YMAPE+ +  
Sbjct: 121 EQKILHRDLKSANILLVANDL---VKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGR 176

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
            Y  K+D+WS+G +L+++ T  PPF+  +   L   +        PP   ++L     + 
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL----QNF 232

Query: 247 CRCLLRQNPVER 258
            R +L+  P  R
Sbjct: 233 IRSMLQVKPKLR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  179 bits (456), Expect = 3e-51
 Identities = 90/289 (31%), Positives = 140/289 (48%), Gaps = 33/289 (11%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y +  RIG G+  +V++A+ R+ G  VA+K++  + L   + +  L+EI  L    HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKH 129
           +++  +         LV+EY    DL+  +    + + EA  + +MR L  G+  +    
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--LADTLCGSPLYMAPEII-QNH 186
           ++HRDLKP NLL+S      VLKI DFG AR  + ++  L      +  Y APE++    
Sbjct: 120 IMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-TSTE-------------- 228
           KYD   DLW+VG I  +L+ G P F G N   QL +    L T  E              
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236

Query: 229 LRFP---PGAIEELHPDC----VDLCRCLLRQNPVERITFKEFFNHRFL 270
           + FP   P  +EE+ PD     +DL + LL  +P +R++  E   H + 
Sbjct: 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  174 bits (443), Expect = 2e-49
 Identities = 81/258 (31%), Positives = 144/258 (55%), Gaps = 14/258 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V++A  R  G EVA+K++    L  +  + ++ EI I+    HPNI+ +++
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 77  AIETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           +    +++++V+EY DGG L   I     +++E    +  R++  GL+ L  +++IHRD+
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142

Query: 136 KPQNLLVSTN-EVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
           K  N+L+S +  V    K+ DFGFA  LT  +   +++ G+P +MAPE+I+   Y  K D
Sbjct: 143 KSDNILLSKDGSV----KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVD 198

Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQ-LFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS+G +  ++  G+PP+     L+ LF   L +T+   P    E+  P+  D     L 
Sbjct: 199 IWSLGIMCIEMAEGEPPYLREPPLRALF---LITTKGIPPLKNPEKWSPEFKDFLNKCLV 255

Query: 253 QNPVERITFKEFFNHRFL 270
           ++P +R + +E   H FL
Sbjct: 256 KDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  172 bits (439), Expect = 3e-49
 Identities = 85/257 (33%), Positives = 141/257 (54%), Gaps = 21/257 (8%)

Query: 18  IGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G+F  V++   +  G     +VAVK + K+  S +  +  L+E SI+  +SHPNI+R
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIH 132
                   E +Y+V EY  GGDL  ++ KHG K++         Q+A G++ L+ K+ +H
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LV+ N    V+KI DFG +R +   D      G  L   +MAPE +++ K+ 
Sbjct: 126 RDLAARNCLVTEN---LVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 190 AKADLWSVGAILFQLVT-GKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL- 246
           +K+D+WS G +L+++ T G+ P+ G SN+ ++ + +     L  P    +EL+    +L 
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSNE-EVLELLEDGYRLPRPENCPDELY----ELM 237

Query: 247 CRCLLRQNPVERITFKE 263
            +C    +P +R TF E
Sbjct: 238 LQC-WAYDPEDRPTFSE 253

Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  172 bits (439), Expect = 3e-49
 Identities = 91/268 (33%), Positives = 143/268 (53%), Gaps = 20/268 (7%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           G +IG G+F  V+ A +   G  +AVKEI  +   PK    +  E+ +L  + HPN++++
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 75  FEAIET-REKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEKHLIH 132
           +  +E  REK+Y+ +EYC GG L   +  HG++  E V R +  QL  GL  L    ++H
Sbjct: 65  Y-GVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFA-----RSLTPQDLADTLCGSPLYMAPEIIQNHK 187
           RD+KP N+ +  N    V+K+GDFG A      + T  +   +L G+P YMAPE+I   K
Sbjct: 123 RDIKPANIFLDHNG---VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 188 YDAK---ADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDC 243
                  AD+WS+G ++ ++ TGK P+    N+ Q+  ++    +   P     +L P+ 
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP--DSLQLSPEG 237

Query: 244 VD-LCRCLLRQNPVERITFKEFFNHRFL 270
            D L RC L  +P +R T  E   H F+
Sbjct: 238 KDFLDRC-LESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  172 bits (439), Expect = 5e-49
 Identities = 82/256 (32%), Positives = 134/256 (52%), Gaps = 11/256 (4%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
            IG GSF  V++A  ++    VA+K ID +    ++ D + +EI  LS    P I +++ 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSPYITKYYG 66

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EYC GG     + K GK+ E      +R++  GL+ L E+  IHRD+K
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125

Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
             N+L+S   +V    K+ DFG +  LT      +T  G+P +MAPE+I+   YD KAD+
Sbjct: 126 AANILLSEEGDV----KLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADI 181

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS+G    +L  G+PP    + +++   I  +           +   D V LC   L ++
Sbjct: 182 WSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC---LNKD 238

Query: 255 PVERITFKEFFNHRFL 270
           P ER + KE   H+F+
Sbjct: 239 PKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  171 bits (435), Expect = 1e-48
 Identities = 80/267 (29%), Positives = 131/267 (49%), Gaps = 26/267 (9%)

Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G+F  V++ + +       EVAVK + +     +  D  LKE  ++  + HPN++R 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVVRL 61

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH---------GKVSEAVARHFMRQLAAGLQVL 125
                  E +YLVLEY +GGDL  Y+ K            +S      F  Q+A G++ L
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
             K  +HRDL  +N LV  +    V+KI DFG +R +   D      G  L   +MAPE 
Sbjct: 122 ASKKFVHRDLAARNCLVGED---LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELH 240
           +++  + +K+D+WS G +L+++ T G  P+ G SN+ ++ + +     L  P    +EL+
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLEYLRKGYRLPKPEYCPDELY 237

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNH 267
               +L     + +P +R TF E    
Sbjct: 238 ----ELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  170 bits (432), Expect = 3e-48
 Identities = 83/254 (32%), Positives = 140/254 (55%), Gaps = 16/254 (6%)

Query: 18  IGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G+F  V++ + +  G    +EVAVK + K+  S +  +  L+E  I+  + HPN+++
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
                   E +Y+V+EY +GGDL +Y+ K+  K+S +    F  Q+A G++ L+ K+ IH
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIH 125

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG-SPL-YMAPEIIQNHKYDA 190
           RDL  +N LV  N    V+KI DFG +R L   D      G  P+ +MAPE ++  K+ +
Sbjct: 126 RDLAARNCLVGENL---VVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D+WS G +L+++ T G+ P+ G +  ++ + +     L  PP       P+  DL   
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC----PPELYDLMLQ 238

Query: 250 LLRQNPVERITFKE 263
              ++P +R TF E
Sbjct: 239 CWAEDPEDRPTFSE 252

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  171 bits (435), Expect = 5e-48
 Identities = 83/283 (29%), Positives = 146/283 (51%), Gaps = 17/283 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTIS-HPNIIRFF 75
           +G GSF  V  A  +      AVK + K + L     +  + E  +L+    HP + +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T+++++ V+EY +GGDL  +I + G+  E  AR +  ++  GLQ L E+ +I+RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ +      +KI DFG  +  +       T CG+P Y+APEI+    Y    D 
Sbjct: 123 KLDNVLLDSEGH---IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W++G +L++++ G+ PF+G ++ +LFQ+IL   E+R+P      L  +   + +  L +N
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILED-EVRYPRW----LSKEAKSILKSFLTKN 234

Query: 255 PVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           P +R+       ++   H F  E+      E+  + P  KP +
Sbjct: 235 PEKRLGCLPTGEQDIKGHPFFREI-DWDKLERKEIKPPFKPKI 276

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  169 bits (431), Expect = 8e-48
 Identities = 88/282 (31%), Positives = 140/282 (49%), Gaps = 32/282 (11%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR +  G  VA+K+I  +  S  +    L+EI +L  ++HPNII+  +
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 77  AIETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
               +  +YLV E+ D  DL   I  +   + E++ + ++ QL  GL       ++HRDL
Sbjct: 66  VFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK-YDAKAD 193
           KP+NLL++T     VLK+ DFG ARS  +P         +  Y APE++   K Y    D
Sbjct: 125 KPENLLINTEG---VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVD 181

Query: 194 LWSVGAILFQLVTGKPPFDGSNQL-QLF-------------QNILTSTE----LRFP--- 232
           +WSVG I  +L++ +P F G +++ QLF                 TS        FP   
Sbjct: 182 IWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241

Query: 233 PGAIEELHPDCVDLCRCLLRQ----NPVERITFKEFFNHRFL 270
              + +L P+       LL Q    +P +RIT ++   H + 
Sbjct: 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  168 bits (427), Expect = 1e-47
 Identities = 73/251 (29%), Positives = 132/251 (52%), Gaps = 10/251 (3%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           ++ +  +IG GSF VV++   +      A+K+ID   ++ +  +  + E  +L+ +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEK 128
           IIR++E+   + K+ +V+EY + GDL   +       + E     F  Q+  GL  L  K
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLYMAPEIIQNHK 187
            ++HRD+K  NL +   +    +KIGD G A+ L+     A+T+ G+P Y++PE+ ++  
Sbjct: 121 KILHRDIKSLNLFLDAYD---NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           Y+ K+D+W++G +L++  TGK PFD +NQ  L   I+      FPP + +        L 
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG---VFPPVS-QMYSQQLAQLI 233

Query: 248 RCLLRQNPVER 258
              L ++  +R
Sbjct: 234 DQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  167 bits (426), Expect = 2e-47
 Identities = 81/259 (31%), Positives = 135/259 (52%), Gaps = 25/259 (9%)

Query: 18  IGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G+F  V++   +  G    +EVAVK + K+  S +  +  L+E  I+  + HPNI++
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLI 131
                   E + +V+EY  GGDL  Y+ K+     +++    F  Q+A G++ L+ K+ I
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFI 125

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG-SPL-YMAPEIIQNHKYD 189
           HRDL  +N LV  N    V+KI DFG +R L   D      G  P+ +MAPE ++  K+ 
Sbjct: 126 HRDLAARNCLVGENL---VVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182

Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           +K+D+WS G +L+++ T G+ P+ G +  ++ + +     L  P        P+C     
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP--------PNCPPELY 234

Query: 249 CLLRQ----NPVERITFKE 263
            L+ Q    +P +R TF E
Sbjct: 235 KLMLQCWAEDPEDRPTFSE 253

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  168 bits (427), Expect = 3e-47
 Identities = 90/297 (30%), Positives = 146/297 (49%), Gaps = 52/297 (17%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEI-SILSTISHP 69
           Y V  ++G G+F  V+ AR+++ G  VA+K++ KK       + + L+E+ S+     HP
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF--YSWEECMNLREVKSLRKLNEHP 58

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYI--HKHGKVSEAVARHFMRQLAAGLQVLQE 127
           NI++  E     +++Y V EY +G +L   +   K    SE+V R  + Q+  GL  + +
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL--------YMA 179
               HRDLKP+NLLVS  E   V+KI DFG AR +  +         P         Y A
Sbjct: 118 HGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRP--------PYTDYVSTRWYRA 166

Query: 180 PEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL----------- 224
           PEI+ ++  Y +  D+W++G I+ +L T +P F GS+   QL    ++L           
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226

Query: 225 ----TSTELRFPPGA---IEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
               +    RFP  A   + +L     P+ +DL + +LR +P +R T  +   H + 
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  168 bits (428), Expect = 8e-47
 Identities = 94/303 (31%), Positives = 144/303 (47%), Gaps = 60/303 (19%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL------LKEISILSTISHPNI 71
           IGSG++ VV  A  ++ G +VA+K+I        V D+L      L+EI +L  + H NI
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKI------SNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 72  IRFFEAI-----ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           I   + +     E    +Y+V E  +  DL   I     +++   ++F+ Q+  GL+ L 
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL--------YM 178
             ++IHRDLKP N+LV++N     LKI DFG AR + P +         L        Y 
Sbjct: 121 SANVIHRDLKPSNILVNSNC---DLKICDFGLARGVDPDEDEK----GFLTEYVVTRWYR 173

Query: 179 APEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL---------- 224
           APE++  + +Y    D+WSVG I  +L+T KP F G    +QL L   +L          
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 225 -TSTELR--------FPPGAIEELHP----DCVDLCRCLLRQNPVERITFKEFFNHRFLG 271
            TS + R         P   + +L P    + +DL   +L  +P +RIT  E   H +L 
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293

Query: 272 ELR 274
           +L 
Sbjct: 294 QLH 296

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  166 bits (421), Expect = 1e-45
 Identities = 101/335 (30%), Positives = 159/335 (47%), Gaps = 29/335 (8%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHP 69
            Y +  ++G GSF  V+ AR R+    VA+K + KKL S        L+EI IL++++HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 70  -NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVL 125
            NI++ ++  +    +YLV+EY DGG L   + K G    +SE+ A   + Q+ + L+ L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-------PQDLADTLCGSPLYM 178
             K +IHRD+KP+N+L+  +    V+K+ DFG A+ L           L  T  G+P YM
Sbjct: 118 HSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 179 APEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           APE++         + +D+WS+G  L++L+TG PPF+G          L        P  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 236 IEELHPD--------CVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ-TVHAEQHSVVP 286
              L P           DL + LL ++P  R++     +H  L  L+             
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295

Query: 287 ETKPMVELLNSSTPEDRHSLHSEHPTNSSSKNPKS 321
           ++ P+   L  S      SL+S   + S  K   S
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDS 330

Length = 384

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  161 bits (409), Expect = 4e-45
 Identities = 90/262 (34%), Positives = 144/262 (54%), Gaps = 9/262 (3%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +  +IG GSF  ++ A+ +       +KEID   +  K  +   KE+ +L+ + HPNI
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQLAAGLQVLQEKH 129
           + FF + +   ++++V+EYCDGGDL   I++   V  SE     +  Q++ GL+ + ++ 
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNHKY 188
           ++HRD+K QN+ +S N +  V K+GDFG AR L    +LA T  G+P Y++PEI QN  Y
Sbjct: 122 ILHRDIKSQNIFLSKNGM--VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           + K D+WS+G +L++L T K PF+G+N  QL   I         P    +L      L  
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLR----SLIS 235

Query: 249 CLLRQNPVERITFKEFFNHRFL 270
            L + +P +R +        FL
Sbjct: 236 QLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  160 bits (406), Expect = 3e-44
 Identities = 88/289 (30%), Positives = 140/289 (48%), Gaps = 44/289 (15%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++  V++AR+++ G  VA+K+I  +          ++EI +L  + HPNI+R  E
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 77  AIETREK--IYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
            + ++ K  IY+V EY D  DL   +     K +E+  + +M+QL  GLQ L    ++HR
Sbjct: 66  IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHR 124

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD------TLCGSPLYMAPEIIQNH- 186
           D+K  N+L++ +    VLK+ DFG AR  T ++ AD      TL     Y  PE++    
Sbjct: 125 DIKGSNILINNDG---VLKLADFGLARPYTKRNSADYTNRVITL----WYRPPELLLGAT 177

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTS------TELRFPPGAI- 236
           +Y  + D+WSVG IL +L  GKP F GS    QL+    +  S        +   P    
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237

Query: 237 ----------------EELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
                             + P  +DL   LL  +P +RI+  +   H +
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  158 bits (402), Expect = 3e-44
 Identities = 76/249 (30%), Positives = 132/249 (53%), Gaps = 10/249 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G+F      R  +    V  KE++   LS K   + L EI ILS + HPNII ++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 78  IETREKIYLVLEYCDGGDLAAYI-HKHGKV-SEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
                 + + +EY +GG L   I  + G++  E +   ++ Q+ + +  + +  ++HRD+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+ ++      ++K+GDFG ++ L +   +A+T+ G+P YM+PE+ Q  KY+ K+D+
Sbjct: 128 KTLNIFLTK---AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDI 184

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W++G +L++L+T K  FD +N L L   I+             EL      L   LL+Q+
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI----SLVHSLLQQD 240

Query: 255 PVERITFKE 263
           P +R T  E
Sbjct: 241 PEKRPTADE 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  158 bits (401), Expect = 4e-44
 Identities = 80/251 (31%), Positives = 144/251 (57%), Gaps = 10/251 (3%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y+   +IG GSF      + ++ G +  +KEI+   +SPK  +   KE+++LS + HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQLAAGLQVLQEK 128
           I+++ E+ E    +Y+V++YC+GGDL   I+    V   E     +  Q+   L+ + ++
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK 187
            ++HRD+K QN+ ++ +     +K+GDFG AR L +  +LA T  G+P Y++PEI +N  
Sbjct: 121 KILHRDIKSQNIFLTKDG---TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           Y+ K+D+W++G +L+++ T K  F+  N   L   I+  +   +PP +      D  +L 
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS---YPPVSS-HYSYDLRNLV 233

Query: 248 RCLLRQNPVER 258
             L ++NP +R
Sbjct: 234 SQLFKRNPRDR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 6e-44
 Identities = 74/263 (28%), Positives = 131/263 (49%), Gaps = 15/263 (5%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--NLLK-EISILSTISHPNI 71
           G  +G G+F  V+       G E+AVK++     SP+     N L+ EI +L  + H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++++  +   E + + +EY  GG +   +  +G ++E V R + RQ+  G++ L    ++
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSL----TPQDLADTLCGSPLYMAPEIIQNHK 187
           HRD+K  N+L  +      +K+GDFG ++ L    +      ++ G+P +M+PE+I    
Sbjct: 127 HRDIKGANILRDSAG---NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS-TELRFPPGAIEELHPDCVDL 246
           Y  KAD+WSVG  + +++T KPP+     +     I T  T  + P      + PD  + 
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS----HVSPDARNF 239

Query: 247 CRCLLRQNPVERITFKEFFNHRF 269
            R    +N  +R + +E   H F
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  156 bits (397), Expect = 2e-43
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 21/271 (7%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI----DKKLLSPKVSDNLLKEISILSTI 66
           E++ G ++G+G+F+  ++AR  + G  +AVK++    +      +V + L KEI +++ +
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           +HP+IIR   A        L +E+  GG ++  + K+G   EAV  ++  QL  GL  L 
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 127 EKHLIHRDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQ-----DLADTLCGSPLYMAP 180
           E  +IHRD+K  NLL+ ST +    L+I DFG A  L  +     +    L G+  +MAP
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQ---RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDG---SNQLQLFQNILTSTELRFPPGAIE 237
           E+++  +Y    D+WSVG ++ ++ T KPP++    SN L L   I ++T     P   E
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT---APSIPE 234

Query: 238 ELHPDCVD-LCRCLLRQNPVERITFKEFFNH 267
            L P   D   RC L   P +R   +E   H
Sbjct: 235 HLSPGLRDVTLRC-LELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  154 bits (391), Expect = 2e-42
 Identities = 78/235 (33%), Positives = 131/235 (55%), Gaps = 18/235 (7%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTIS 67
           +G + +  +IG G F+VV++A     G  VA+K++   +++  K   + LKEI +L  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 68  HPNIIRFFEA-IETREKIYLVLEYCDGGDLAAYIHKHGK-----VSEAVARHFMRQLAAG 121
           HPN+I++  + IE  E   +VLE  D GDL+  I KH K     + E     +  QL + 
Sbjct: 61  HPNVIKYLASFIENNELN-IVLELADAGDLSRMI-KHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAP 180
           L+ +  K ++HRD+KP N+ ++    T V+K+GD G  R  + +   A +L G+P YM+P
Sbjct: 119 LEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPF--DGSNQLQLFQNILTSTELRFPP 233
           E I  + Y+ K+D+WS+G +L+++   + PF  D  N   L + I    +  +PP
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---EKCDYPP 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  153 bits (390), Expect = 2e-42
 Identities = 86/265 (32%), Positives = 137/265 (51%), Gaps = 24/265 (9%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFF 75
           RIGSG++  V++AR    G  VA+K I    L P    + + +EIS+L    HPNI+ +F
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 76  EAIETREKIYLVLEYCDGGDLA-AYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            +   R+K+++V+EYC GG L   Y    G +SE    +  R+   GL  L E   IHRD
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126

Query: 135 LKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLA--DTLCGSPLYMAPEIIQNHK---Y 188
           +K  N+L++ + +V    K+ DFG +  LT   +A   +  G+P +MAPE+    +   Y
Sbjct: 127 IKGANILLTEDGDV----KLADFGVSAQLT-ATIAKRKSFIGTPYWMAPEVAAVERKGGY 181

Query: 189 DAKADLWSVGAILFQLVTGKPP-FDGSNQLQLFQNILTSTELRFPPGAIEELH---PDCV 244
           D K D+W++G    +L   +PP FD    L   + +   ++  FPP  +++     P   
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFD----LHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237

Query: 245 DLCRCLLRQNPVERITFKEFFNHRF 269
           D  +  L ++P +R T  +   H F
Sbjct: 238 DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  152 bits (386), Expect = 8e-42
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 27/263 (10%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVK--EIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G GS+  V++A H++ G  VA+K   +++ L        ++KEISIL     P I++++
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL------QEIIKEISILKQCDSPYIVKYY 64

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            +      +++V+EYC  G ++  +    K  +E      + Q   GL+ L     IHRD
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
           +K  N+L++        K+ DFG +  LT      +T+ G+P +MAPE+IQ   Y+ KAD
Sbjct: 125 IKAGNILLNE---EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181

Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP------DCVDLC 247
           +WS+G    ++  GKPP+   + ++    I        PP  + +         D V  C
Sbjct: 182 IWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-----PPPTLSDPEKWSPEFNDFVKKC 236

Query: 248 RCLLRQNPVERITFKEFFNHRFL 270
              L ++P ER +  +   H F+
Sbjct: 237 ---LVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  151 bits (384), Expect = 2e-41
 Identities = 89/261 (34%), Positives = 137/261 (52%), Gaps = 17/261 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV +  HR  G  +AVK I  ++ +  +   +L+E+ IL   + P I+ F+ A
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 78  IETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDL 135
                 I + +EY DGG L   + +  G++ E +       +  GL  L EKH +IHRD+
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDV 127

Query: 136 KPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           KP N+LV++  ++    K+ DFG +  L    LA T  G+  YMAPE IQ + Y  K+D+
Sbjct: 128 KPSNILVNSRGQI----KLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182

Query: 195 WSVGAILFQLVTGKPPFDGSNQ-----LQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           WS+G  L +L TG+ P+   N       +L Q I+     R P G       D V+LC  
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC-- 240

Query: 250 LLRQNPVERITFKEFFNHRFL 270
            L ++P ER ++KE   H F+
Sbjct: 241 -LIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  151 bits (384), Expect = 3e-41
 Identities = 85/292 (29%), Positives = 136/292 (46%), Gaps = 52/292 (17%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR +  G  VA+K+I  +     V    ++EIS+L  ++HPNI+R  +
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVS--EAVARHFMRQLAAGLQVLQEKHLIHRD 134
            + +  K+YLV E+ D  DL  Y+           + + ++ QL  G+       ++HRD
Sbjct: 66  VVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------YMAPEII 183
           LKPQNLL+        LK+ DFG AR+           G P+           Y APEI+
Sbjct: 125 LKPQNLLIDR---EGALKLADFGLARAF----------GVPVRTYTHEVVTLWYRAPEIL 171

Query: 184 QNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ--NIL-TSTELRFP------ 232
              + Y    D+WS+G I  ++V  +P F G +++ QLF+    L T  E  +P      
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231

Query: 233 --------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                            +  L  D +DL   +L  +P +RI+ K    H + 
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  151 bits (384), Expect = 3e-41
 Identities = 90/297 (30%), Positives = 139/297 (46%), Gaps = 48/297 (16%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI---SH 68
           Y     IG G++  V++AR    G  VA+K++   L    +  + L+EI++L  +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 69  PNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAG 121
           PNI+R  +       +   K+ LV E+ D  DLA Y+ K  K  +     +  MRQL  G
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR------SLTPQDLADTLCGSP 175
           +  L    ++HRDLKPQN+LV++      +KI DFG AR      +LT   +  TL    
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFGLARIYSFEMALTSVVV--TL---- 170

Query: 176 LYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQ-LFQNILTSTELRF 231
            Y APE++    Y    D+WSVG I  +L   +P F G+   +QL  +F  I   +E  +
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230

Query: 232 PPGA------------------IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           P                     + E+  + +DL + +L  NP +RI+  E   H + 
Sbjct: 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 4e-41
 Identities = 85/290 (29%), Positives = 135/290 (46%), Gaps = 45/290 (15%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
            +G G++ VV + R++  G  VA+K+  +      V    L+E+ +L  + H NI+   E
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A   + ++YLV EY +   L       G +     R ++ QL   +      ++IHRD+K
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK 127

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL--------YMAPEI-IQNHK 187
           P+N+LVS +    VLK+ DFGFAR+L  +        SPL        Y APE+ + +  
Sbjct: 128 PENILVSESG---VLKLCDFGFARALRARP------ASPLTDYVATRWYRAPELLVGDTN 178

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-------TSTE--------L 229
           Y    D+W++G I+ +L+ G+P F G +   QL L Q  L                   +
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238

Query: 230 RFP----PGAIEELHPDCV-----DLCRCLLRQNPVERITFKEFFNHRFL 270
            FP    P ++E  +P  V     D  +  LR +P ER+T  E   H + 
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  151 bits (383), Expect = 4e-41
 Identities = 91/282 (32%), Positives = 138/282 (48%), Gaps = 38/282 (13%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           ++G G++A V++ R+R  G  VA+KEI  D +  +P  +   ++EIS++  + H NI+R 
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHENIVRL 63

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGK---VSEAVARHFMRQLAAGLQVLQEKHLI 131
            + I T  K+ LV EY D  DL  Y+  HG    +     + F  QL  G+    E  ++
Sbjct: 64  HDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK-YD 189
           HRDLKPQNLL++       LK+ DFG AR+   P +       +  Y AP+++   + Y 
Sbjct: 123 HRDLKPQNLLINKRG---ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179

Query: 190 AKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-TSTEL-------------RFP 232
              D+WSVG I+ +++TG+P F G+N   QL     I+ T TE               FP
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239

Query: 233 PGA-------IEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                          P  +DL   LL+ NP  RI+  +   H
Sbjct: 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  150 bits (380), Expect = 5e-41
 Identities = 78/245 (31%), Positives = 134/245 (54%), Gaps = 11/245 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL-STISHPNIIRFF 75
           I  G+F  V+ A+ R  G   A+K + K  +++     N+  E +I+      P + + +
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + ++++ +YLV+EY +GGD A+ I   G + E  A+ ++ ++  G++ L ++ +IHRD+
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           KP+NLL+     T  LK+ DFG +R+ L  +       G+P Y+APE I     D  +D 
Sbjct: 124 KPENLLIDQ---TGHLKLTDFGLSRNGLENKKFV----GTPDYLAPETILGVGDDKMSDW 176

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS+G ++F+ + G PPF       +F NIL S  + +P    E   P+ VDL   LL  +
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNIL-SRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 255 PVERI 259
           P +R+
Sbjct: 236 PAKRL 240

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  151 bits (384), Expect = 5e-41
 Identities = 94/295 (31%), Positives = 147/295 (49%), Gaps = 49/295 (16%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN-----LLKEISILSTI 66
           Y  G ++G G++AVV++AR ++ G  VA+K+I  KL   K + +      L+EI +L  +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI--KLGERKEAKDGINFTALREIKLLQEL 59

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVL 125
            HPNII   +    +  I LV E+ +  DL   I  K   ++ A  + +M     GL+ L
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS-------LTPQDLADTLCGSPLYM 178
               ++HRDLKP NLL++++    VLK+ DFG ARS       +T Q +         Y 
Sbjct: 119 HSNWILHRDLKPNNLLIASDG---VLKLADFGLARSFGSPNRKMTHQVVT------RWYR 169

Query: 179 APEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQL-QL---FQNILTSTE----- 228
           APE++   + Y    D+WSVG I  +L+   P   G + + QL   F+ + T TE     
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 229 ----------LRFPPGAIEELHP----DCVDLCRCLLRQNPVERITFKEFFNHRF 269
                       FPP  ++++ P    D +DL + LL  NP +RIT ++   H +
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  150 bits (380), Expect = 5e-41
 Identities = 81/265 (30%), Positives = 134/265 (50%), Gaps = 20/265 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG G+ AVV+ A       +VA+K ID +     V D L KE+  +S  +HPN+++++ +
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYYTS 67

Query: 78  IETREKIYLVLEYCDGG---DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
               ++++LV+ Y  GG   D+    +  G + EA+    ++++  GL+ L     IHRD
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLAD----TLCGSPLYMAPEII-QNHKY 188
           +K  N+L+  +     +KI DFG + SL    D       T  G+P +MAPE++ Q H Y
Sbjct: 128 IKAGNILLGEDG---SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE----LHPDCV 244
           D KAD+WS G    +L TG  P+     +++    L +       GA  +         +
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMI 244

Query: 245 DLCRCLLRQNPVERITFKEFFNHRF 269
            LC   L+++P +R T +E   H+F
Sbjct: 245 SLC---LQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  149 bits (378), Expect = 8e-41
 Identities = 84/264 (31%), Positives = 145/264 (54%), Gaps = 11/264 (4%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y     +G GS+  V   RHR  G +  +K+++ +  S +      +E  +LS + HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 71  IIRFFEAIETRE-KIYLVLEYCDGGDLAAYIHKH-GKV-SEAVARHFMRQLAAGLQVLQE 127
           I+ + E+ E  +  +Y+V+ +C+GGDL   + +  GK+  E     +  Q+A  LQ L E
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNH 186
           KH++HRDLK QN+ ++    T ++K+GD G AR L  Q D+A TL G+P YM+PE+  N 
Sbjct: 121 KHILHRDLKTQNVFLTR---TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
            Y+ K+D+W++G  ++++ T K  F+  +   L   I+   E + PP   ++  P+  +L
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII---EGKLPPMP-KDYSPELGEL 233

Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
              +L + P +R + K      ++
Sbjct: 234 IATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  151 bits (383), Expect = 1e-40
 Identities = 80/247 (32%), Positives = 138/247 (55%), Gaps = 11/247 (4%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNII 72
           +G  +G+GSF  V  A+H+  G   A+K + K+ +L  K   ++ +E SIL  +SHP I+
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               + +   ++Y +LE+  GG+L  ++ K G+    VA+ +  +L    + L  K +I+
Sbjct: 82  NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIY 141

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKA 192
           RDLKP+NLL+        +K+ DFGFA+ +   D   TLCG+P Y+APE+IQ+  +    
Sbjct: 142 RDLKPENLLLDNKG---HVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKGHGKAV 196

Query: 193 DLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           D W++G +L++ + G PPF      ++++ IL +  L+FP            DL + LL+
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGRLKFPNWFDGRAR----DLVKGLLQ 251

Query: 253 QNPVERI 259
            +  +R+
Sbjct: 252 TDHTKRL 258

Length = 329

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  149 bits (377), Expect = 1e-40
 Identities = 77/252 (30%), Positives = 134/252 (53%), Gaps = 8/252 (3%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G+F +V   R +     V +K+I  + ++         E  +L  +SHPNII ++E 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
               + + +V+EY  GG LA YI K     + E    HF  Q+   L  +  K ++HRDL
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
           K QN+L+  +++  V+KIGDFG ++ L+ +  A T+ G+P Y++PE+ +   Y+ K+D+W
Sbjct: 128 KTQNILLDKHKM--VVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIW 185

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           ++G +L++L + K  F+ +N   L   I++ T   F P + +   PD   L   +L  +P
Sbjct: 186 ALGCVLYELASLKRAFEAANLPALVLKIMSGT---FAPIS-DRYSPDLRQLILSMLNLDP 241

Query: 256 VERITFKEFFNH 267
            +R    +    
Sbjct: 242 SKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 2e-40
 Identities = 75/243 (30%), Positives = 133/243 (54%), Gaps = 11/243 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID-KKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+G+F  V   R R      A+K +   +++  K   ++  E  +L  +SHP IIR F 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
               +  +Y+++EY  GG+L +Y+   G+ S +    +  ++   L+ L  K +++RDLK
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+N+L+        +K+ DFGFA+ L  +D   TLCG+P Y+APE+IQ+  ++   D W+
Sbjct: 129 PENILLDKEG---HIKLTDFGFAKKL--RDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWA 183

Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G ++++++ G PPF   N   +++ IL + +L FP      L     DL + LL  +  
Sbjct: 184 LGILIYEMLVGYPPFFDDNPFGIYEKIL-AGKLEFP----RHLDLYAKDLIKKLLVVDRT 238

Query: 257 ERI 259
            R+
Sbjct: 239 RRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 6e-40
 Identities = 87/289 (30%), Positives = 143/289 (49%), Gaps = 19/289 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN-LLKEISILSTISHPNIIRFF 75
           ++G G +  V+ A+ +  G  VA+K + K LL        +L E  IL+T     +++  
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            A +  E +YL +EY  GGD    ++  G +SE  AR +M ++   +  L E   IHRDL
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
           KP+N L+     +  +K+ DFG ++ +     A+++ GSP YMAPE+++   YD   D W
Sbjct: 128 KPENFLIDA---SGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDYW 182

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPG--AIEELHPDCVDL-CRCLL 251
           S+G +L++ + G PPF GS   + ++N+    E L+ P        L  +  DL  + + 
Sbjct: 183 SLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI- 241

Query: 252 RQNPVERI-TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSST 299
             +P  R  + ++  NH F  E+      E   + P   P V  L S  
Sbjct: 242 -NDPSRRFGSLEDIKNHPFFKEVDW---NELRELKP---PFVPELESEI 283

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  147 bits (372), Expect = 2e-39
 Identities = 87/281 (30%), Positives = 151/281 (53%), Gaps = 14/281 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG GSF  V + R R      A+K I K  ++S     + L E ++L+ ++ P I+    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + ++ EK+YLVL + +GG+L  ++ + G+   + AR +  +L   L+ L + ++I+RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
           P+N+L+   +    + + DFG  + ++   D  +T CG+P Y+APE++  H Y    D W
Sbjct: 121 PENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           ++G +L++++TG PPF   N  ++++ IL    LRFP G   +      DL   LL ++P
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAK----DLLIGLLSRDP 232

Query: 256 VERITF---KEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
             R+ +   +E  NH F  +L       +  + P  KP V 
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQLSWKKLLMK-GIQPPFKPAVS 272

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  147 bits (372), Expect = 6e-39
 Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 43/295 (14%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTIS 67
            ++ V   IG G+F  VW  R +  G   A+K + K  +    +++ ++  E  IL+   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADAD 59

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
            P I++ + + +  E +YLV+EY  GGDL   + +     E  AR ++ +L   L  + +
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA--------------RSLTPQDL------ 167
              IHRD+KP N+L+        +K+ DFG                 S            
Sbjct: 120 LGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 168 ----------ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL 217
                     A++  G+P Y+APE+++   Y  + D WS+G IL++++ G PPF      
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 218 QLFQNILTSTE-LRFPPGAIEELHPDCVDL-CRCLLRQNPVERIT-FKEFFNHRF 269
           + +  I+   E LRFPP     + P+ +DL CR L   +P +R+  F+E  +H F
Sbjct: 237 ETYNKIINWKESLRFPP--DPPVSPEAIDLICRLL--CDPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  144 bits (366), Expect = 8e-39
 Identities = 89/291 (30%), Positives = 141/291 (48%), Gaps = 52/291 (17%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++  V++A++R+    VA+K +        V  + L+EI +L  + H NI+R ++
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + + +K+ LV EYCD  DL  Y    +G +   + + FM QL  GL      +++HRDL
Sbjct: 67  VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDL 125

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------YMAPEIIQ 184
           KPQNLL++ N     LK+ DFG AR+           G P+           Y  P+++ 
Sbjct: 126 KPQNLLINKNG---ELKLADFGLARAF----------GIPVRCYSAEVVTLWYRPPDVLF 172

Query: 185 NHK-YDAKADLWSVGAILFQLVT-GKPPFDGS---NQLQLFQNIL-TSTELRFP------ 232
             K Y    D+WS G I  +L   G+P F G+   +QL+    +L T TE  +P      
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 233 --------PGA------IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
                   P        + +L+    DL + LL  NPV+RI+ +E   H +
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  145 bits (368), Expect = 9e-39
 Identities = 84/261 (32%), Positives = 140/261 (53%), Gaps = 17/261 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL-STISHPNIIRFF 75
           IG GSF  V  A+ +  G   AVK + KK +L  K  ++++ E ++L   + HP ++   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + +T EK+Y VL+Y +GG+L  ++ +     E  AR +  ++A+ +  L   ++I+RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 136 KPQNLLV-STNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
           KP+N+L+ S   V     + DFG  +  + P++   T CG+P Y+APE+++   YD   D
Sbjct: 123 KPENILLDSQGHVV----LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVD 178

Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ 253
            W +GA+L++++ G PPF   +  Q++ NIL    L+ P G          DL   LL +
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL-HKPLQLPGGKTVA----ACDLLVGLLHK 233

Query: 254 NPVERI----TFKEFFNHRFL 270
           +   R+     F E  NH F 
Sbjct: 234 DQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  145 bits (367), Expect = 1e-38
 Identities = 80/259 (30%), Positives = 139/259 (53%), Gaps = 15/259 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL-STISHPNIIRFF 75
           IG GSF  V  A+H+  G   AVK + KK +L  K   +++ E ++L   + HP ++   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + +T +K+Y VL+Y +GG+L  ++ +     E  AR +  ++A+ L  L   ++I+RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           KP+N+L+ +      + + DFG  +  +       T CG+P Y+APE+++   YD   D 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +GA+L++++ G PPF   +  +++ NIL +  LR  P     +      L   LL+++
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNIL-NKPLRLKPN----ISVSARHLLEGLLQKD 234

Query: 255 PVERI----TFKEFFNHRF 269
             +R+     F E  NH F
Sbjct: 235 RTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 2e-38
 Identities = 81/285 (28%), Positives = 145/285 (50%), Gaps = 23/285 (8%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH---PNIIRF 74
           IG G++  V+R +H   G  VA+K I+       VSD + +E+++LS +     PNI ++
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD-IQREVALLSQLRQSQPPNITKY 67

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           + +     ++++++EY +GG +   + K G ++E      +R++   L+ + +  +IHRD
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRD 126

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHK-YDAKA 192
           +K  N+LV+    T  +K+ DFG A  L        T  G+P +MAPE+I   K YD KA
Sbjct: 127 IKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 193 DLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           D+WS+G  ++++ TG PP+   +  +    I  S   R       +L  + V  C   L 
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC---LD 240

Query: 253 QNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
           + P ER++ +E    +++         + HS  P    + EL++ 
Sbjct: 241 EEPKERLSAEELLKSKWI---------KAHSKTP-VSILKELISR 275

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 2e-37
 Identities = 89/297 (29%), Positives = 147/297 (49%), Gaps = 37/297 (12%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           I+G  +G G+F  V++A+H++ G+  A K I  +    ++ D ++ EI ILS   HPNI+
Sbjct: 9   IIG-ELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKHPNIV 65

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEKHLI 131
             +EA     K+++++E+CDGG L + + +  +  +E   R+  RQ+   L  L    +I
Sbjct: 66  GLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125

Query: 132 HRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEII-----Q 184
           HRDLK  N LL    +V    K+ DFG +          DT  G+P +MAPE++     +
Sbjct: 126 HRDLKAGNILLTLDGDV----KLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181

Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
           ++ YD KAD+WS+G  L +L   +PP    N +++   IL S      P  +++      
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-----EPPTLDQPSKWSS 236

Query: 245 D----LCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
                L  CL++ +P +R T  E   H F+            S   + K + +LL  
Sbjct: 237 SFNDFLKSCLVK-DPDDRPTAAELLKHPFV------------SDQSDNKAIKDLLAE 280

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  140 bits (354), Expect = 5e-37
 Identities = 90/284 (31%), Positives = 145/284 (51%), Gaps = 31/284 (10%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           I +G++  V+  RH++     A+K+I+K+ L+       +  E  IL+   +P ++  F 
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + ET+  + +V+EY +GGD A  +   G +   +AR +  +    L+ L    ++HRDLK
Sbjct: 69  SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128

Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR----SLTP------------QDLADTLCGSPLYMAP 180
           P NLL+++      +K+ DFG ++    SLT             + L   +CG+P Y+AP
Sbjct: 129 PDNLLITS---MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           E+I    Y    D W++G IL++ + G  PF G    +LF  ++ S ++ +P G  E L 
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-SDDIEWPEGD-EALP 243

Query: 241 PDCVDLCRCLLRQNPVERI---TFKEFFNHRFL------GELRQ 275
            D  DL   LLRQNP+ER+      E   HRF       G LRQ
Sbjct: 244 ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQ 287

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  139 bits (353), Expect = 5e-37
 Identities = 87/291 (29%), Positives = 139/291 (47%), Gaps = 52/291 (17%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 77  AIETREKIYLVLEYCDGGDLAAY--IHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  +        +   + + ++ QL  GL       ++HRD
Sbjct: 67  VIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------YMAPEII 183
           LKPQNLL++T      +K+ DFG AR+           G P+           Y APEI+
Sbjct: 126 LKPQNLLINTEG---AIKLADFGLARAF----------GVPVRTYTHEVVTLWYRAPEIL 172

Query: 184 QNHKYDAKA-DLWSVGAILFQLVTGKPPFDGSNQL-QLFQNILT-----------STEL- 229
              KY + A D+WS+G I  ++VT +  F G +++ QLF+   T            T L 
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 230 -------RFPPGAIEE----LHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
                  ++      +    L  D  DL   +L  +P +RI+ K    H F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  138 bits (349), Expect = 5e-37
 Identities = 89/251 (35%), Positives = 135/251 (53%), Gaps = 11/251 (4%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y V   +G GSF      +H     + A+KEI     S  V D+  KE  +L+ + HPN
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR-KEAVLLAKMKHPN 59

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKV-SEAVARHFMRQLAAGLQVLQEK 128
           I+ F E+ E    +Y+V+EYCDGGDL   I  + GK+  E     +  Q+  G+Q + EK
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNHK 187
            ++HRD+K +N+ ++ N     +K+GDFG AR LT P   A T  G+P Y+ PEI +N  
Sbjct: 120 RVLHRDIKSKNIFLTQN---GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           Y+ K+D+WS+G IL++L T K PF  ++   L   +   +    P     EL      L 
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR----SLI 232

Query: 248 RCLLRQNPVER 258
           + + ++NP  R
Sbjct: 233 KQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  138 bits (350), Expect = 7e-37
 Identities = 76/221 (34%), Positives = 122/221 (55%), Gaps = 17/221 (7%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI-------DKKLLSPKVSDNLLKEISILS 64
           +I G  IGSGSF  V+   +   G  +AVK++         K     + D L +EI++L 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
            + H NI+++  +    + + + LEY  GG +AA ++ +G   E + R+F+RQ+  GL  
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT-------LCGSPLY 177
           L  + +IHRD+K  N+LV  N+    +KI DFG ++ L    L+         L GS  +
Sbjct: 122 LHNRGIIHRDIKGANILVD-NKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ 218
           MAPE+++   Y  KAD+WS+G ++ +++TGK PF    QLQ
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  139 bits (352), Expect = 1e-36
 Identities = 83/311 (26%), Positives = 138/311 (44%), Gaps = 57/311 (18%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVSDNLLKEISILST 65
           + +Y +  ++G G+F  V++AR  + G  VA+K+I   ++K   P  +   L+EI IL  
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA---LREIKILKK 63

Query: 66  ISHPNIIRFFEAI--------ETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMR 116
           + HPN++   +            R  +Y+V  Y D  DL+  +     K++E+  + +M 
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYML 122

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
           QL  G+  L E H++HRD+K  N+L+       +LKI DFG AR            G   
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQG---ILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 177 ------------YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQL- 219
                       Y  PE++    +Y    D+W +G +  ++ T +P   G    +QL L 
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239

Query: 220 FQNILTSTELRFP-----PGA----------------IEELHPDCVDLCRCLLRQNPVER 258
           F+   T TE  +P     PG                   +L P+ +DL   LL  +P +R
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299

Query: 259 ITFKEFFNHRF 269
           +T  +   H +
Sbjct: 300 LTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  137 bits (346), Expect = 2e-36
 Identities = 81/268 (30%), Positives = 139/268 (51%), Gaps = 18/268 (6%)

Query: 12  YIVGPRIGSGSFAVVW----RARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           YI+  R+G GSF  V+    +    +  ++V +KEI    L+P  +    +E  +LS + 
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDL----AAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           HP I++F  +   R+   ++ EYC+G DL        H    +SE     +  QL  G+ 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEI 182
            + ++ ++HRDLK +N+ +  N    +LKIGDFG +R L    DLA T  G+P YM+PE 
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN----LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176

Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           +++  YD+K+D+WS+G IL+++      F+G N L +   I+       P     +L+  
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS- 235

Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
              + + +L ++P  R +  E   + F+
Sbjct: 236 ---IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  138 bits (350), Expect = 2e-36
 Identities = 76/248 (30%), Positives = 134/248 (54%), Gaps = 17/248 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHPN-II 72
           +G GSF  V  A  +      A+K + K ++   + D+     + E  +L+    P  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVI---IQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           +     +T +++Y V+EY +GGDL  +I + GK  E  A  +  ++A GL  L  K +I+
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIY 124

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLK  N+++   +    +KI DFG  + ++       T CG+P Y+APEII    Y   
Sbjct: 125 RDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D W+ G +L++++ G+PPFDG ++ +LFQ+I+    + +P    + L  + V +C+ LL
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP----KSLSKEAVSICKGLL 236

Query: 252 RQNPVERI 259
            ++P +R+
Sbjct: 237 TKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  139 bits (351), Expect = 3e-36
 Identities = 91/314 (28%), Positives = 141/314 (44%), Gaps = 64/314 (20%)

Query: 12  YIVGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           + VG R      IGSG++ VV  A   + G +VA+K+I      P ++   L+E+ IL  
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH 60

Query: 66  ISHPNIIRFFEAIETREK----IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
             H NII   + +         +Y+V++     DL   IH    ++E   R+F+ QL  G
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL----- 176
           L+ +   ++IHRDLKP NLLV+ +     L+IGDFG AR          L  SP      
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNED---CELRIGDFGMARG---------LSSSPTEHKYF 167

Query: 177 ---------YMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNI 223
                    Y APE++ +  +Y    D+WSVG I  +++  +  F G N   QL+L  ++
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227

Query: 224 LTSTELRF-------------------PPGAIEEL----HPDCVDLCRCLLRQNPVERIT 260
           L S                         P    ++     P+ +DL   +L+ +P ERIT
Sbjct: 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT 287

Query: 261 FKEFFNHRFLGELR 274
            ++   H FL +  
Sbjct: 288 VEQALQHPFLAQYH 301

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  138 bits (348), Expect = 5e-36
 Identities = 99/324 (30%), Positives = 161/324 (49%), Gaps = 27/324 (8%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISIL-STISHPNIIRFF 75
           IG GSF  V  A+ +  G   AVK + KK+ L+ K   +++ E ++L   + HP ++   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + +T EK+Y VL++ +GG+L  ++ +     E  AR +  ++A+ L  L   ++++RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 136 KPQNLLV-STNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
           KP+N+L+ S   V     + DFG  +  +   D   T CG+P Y+APE+I+   YD   D
Sbjct: 123 KPENILLDSQGHVV----LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178

Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ 253
            W +GA+L++++ G PPF   +  +++ NIL    L   PGA          +   LL +
Sbjct: 179 WWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL-HKPLVLRPGA----SLTAWSILEELLEK 233

Query: 254 NPVERITFKEFF----NHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSE 309
           +   R+  KE F     H F   L  T   EQ  + P   P VE      P+D   + + 
Sbjct: 234 DRQRRLGAKEDFLEIQEHPFFESLSWT-DLEQKKIPPPFNPNVE-----GPDD---ISNF 284

Query: 310 HPTNSSSKNPKSACSSACDKVILN 333
               +    P S C S+ D  I+N
Sbjct: 285 DAVFTEETVPYSVCFSS-DYSIVN 307

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  136 bits (344), Expect = 1e-35
 Identities = 93/296 (31%), Positives = 140/296 (47%), Gaps = 62/296 (20%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLS-PKVSDNLLKEISILSTISHPNIIR 73
           RI  G++ VV+RAR ++ G  VA+K++  +K+    P  S   L+EI+IL  + HPNI+ 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS---LREINILLKLQHPNIVT 68

Query: 74  FFEAI--ETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
             E +     +KIY+V+EY +  DL + +        ++  +  M QL +G+  L +  +
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------YMA 179
           +HRDLK  NLL++      +LKI DFG AR            GSPL           Y A
Sbjct: 128 LHRDLKTSNLLLNN---RGILKICDFGLAR----------EYGSPLKPYTQLVVTLWYRA 174

Query: 180 PEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----TSTELRFP-- 232
           PE++   K Y    D+WSVG I  +L+T KP F G +++     I     T TE  +P  
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234

Query: 233 ---PGA---IEELHPDC---------------VDLCRCLLRQNPVERITFKEFFNH 267
              PGA       +P                  DL   LL  +P +RI+ ++   H
Sbjct: 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  136 bits (343), Expect = 2e-35
 Identities = 93/320 (29%), Positives = 157/320 (49%), Gaps = 25/320 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL-STISHPNIIRFF 75
           IG GSF  V  ARH+      AVK + KK +L  K   +++ E ++L   + HP ++   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + +T +K+Y VL+Y +GG+L  ++ +     E  AR +  ++A+ L  L   ++++RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           KP+N+L+ +      + + DFG  + ++       T CG+P Y+APE++    YD   D 
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +GA+L++++ G PPF   N  +++ NIL +  L+  P            L   LL+++
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-NKPLQLKPNITNSAR----HLLEGLLQKD 234

Query: 255 PVERITFKEFF----NHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPED-RH---SL 306
             +R+  K+ F    NH F   +          + P   P     N S P D RH     
Sbjct: 235 RTKRLGAKDDFMEIKNHIFFSPINWD-DLINKKITPPFNP-----NVSGPNDLRHFDPEF 288

Query: 307 HSEHPTNSSSKNPKSACSSA 326
             E   NS  ++P S   +A
Sbjct: 289 TEEPVPNSIGQSPDSILVTA 308

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  136 bits (343), Expect = 4e-35
 Identities = 88/298 (29%), Positives = 146/298 (48%), Gaps = 52/298 (17%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G GS  +V+ A        VAVK+I   L  P+   + L+EI I+  + H NI++ +E 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 78  IETR--------------EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           +                   +Y+V EY +  DLA  + + G +SE  AR FM QL  GL+
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGLK 128

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-----DLADTLCGSPLYM 178
            +   +++HRDLKP N+ ++T ++  VLKIGDFG AR + P       L++ L  +  Y 
Sbjct: 129 YIHSANVLHRDLKPANVFINTEDL--VLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYR 185

Query: 179 APEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE--------- 228
           +P ++   + Y    D+W+ G I  +++TGKP F G+++L+  Q IL S           
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNE 245

Query: 229 -LRFPPGAIE---------------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
            L   P  +                 ++P+ +D    +L  NP++R+T +E   H ++
Sbjct: 246 LLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 4e-35
 Identities = 91/280 (32%), Positives = 140/280 (50%), Gaps = 45/280 (16%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFE 76
           IG G++  V++ARH++ G  VA+K +D   +     + + +E +IL   S HPNI  F+ 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 77  AIETR------EKIYLVLEYCDGG---DLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQ 126
           A   +      ++++LV+E C GG   DL   + K GK + E    + +R+   GL  L 
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 127 EKHLIHRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQ 184
           E  +IHRD+K QN+L++ N EV    K+ DFG +  L       +T  G+P +MAPE+I 
Sbjct: 131 ENKVIHRDIKGQNILLTKNAEV----KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA 186

Query: 185 NHK-----YDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEE 238
             +     YDA++D+WS+G    +L  GKPP  D      LF+ I      R PP  +  
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-I-----PRNPPPTL-- 238

Query: 239 LHP--------DCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             P        D +  C   L +N  +R   +E   H F+
Sbjct: 239 KSPENWSKKFNDFISEC---LIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  134 bits (340), Expect = 5e-35
 Identities = 97/324 (29%), Positives = 158/324 (48%), Gaps = 25/324 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTIS-HPNIIRFF 75
           +G GSF  V  A  +      A+K + K  +L     +  + E  +L+    HP +   F
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T+E ++ V+EY +GGDL  +I   G+  EA AR +  ++  GLQ L +K +I+RDL
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+  +     +KI DFG  + ++  +  A T CG+P Y+APEI++  KY+   D 
Sbjct: 123 KLDNVLLDKDGH---IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS G +L++++ G+ PF G ++ +LF +IL      FP    +E      D    L  ++
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH-FPRWISKEAK----DCLSKLFERD 234

Query: 255 PVERITFK-EFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPTN 313
           P +R+    +   H F   +      E+  + P  KP V+     +P D  +   E    
Sbjct: 235 PTKRLGVDGDIRQHPFFRGIDWER-LEKREIPPPFKPKVK-----SPSDASNFDREF--- 285

Query: 314 SSSKNPKSACSSACDKVILNTGDQ 337
               N K   S   DK +L + DQ
Sbjct: 286 ---TNEKVRLSPV-DKKLLASMDQ 305

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  133 bits (336), Expect = 7e-35
 Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 23/275 (8%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN-----------LLKEI 60
           ++ G  IG G++  V+ A +   G  +AVK+++   L   ++             L  EI
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVE---LPATIAGRHDSRQKDMVKALRSEI 59

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
             L  + H NI+++     T E + + LEY  GG + + +  +G+  E + R F  Q+  
Sbjct: 60  ETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE 119

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLY 177
           GL  L  K ++HRDLK  NLLV   +   + KI DFG ++    +   D   ++ GS  +
Sbjct: 120 GLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 178 MAPEIIQNHK--YDAKADLWSVGAILFQLVTGKPPFDGSNQLQ-LFQNILTSTELRFPPG 234
           MAPE+I ++   Y AK D+WS+G ++ ++  G+ P+     +  +F+     +    PP 
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236

Query: 235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
               L P  +D        NP  R T +E   H F
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  133 bits (335), Expect = 9e-35
 Identities = 79/264 (29%), Positives = 136/264 (51%), Gaps = 23/264 (8%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIE-VAVKEID--------KKLLSPKVSDNLLKEIS 61
           EY V   +GSG+F  V++ R +  G   +A+KEI+         K    K   +++ E++
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 62  IL-STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYI----HKHGKVSEAVARHFMR 116
           I+   + HPNI+R+++     +++Y+V++  +G  L  +      K  + +E    +   
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 117 QLAAGLQVL-QEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFARSLTPQDLADTLCGS 174
           Q+   L+ L +EK ++HRDL P N+++  ++ VT    I DFG A+   P+    ++ G+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT----ITDFGLAKQKQPESKLTSVVGT 176

Query: 175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPG 234
            LY  PEI++N  Y  KAD+W+ G IL+Q+ T +PPF  +N L L   I+ +     P G
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236

Query: 235 AIEELHPDCVDLCRCLLRQNPVER 258
              E   D +  C   L  +   R
Sbjct: 237 MYSEDVTDVITSC---LTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  133 bits (338), Expect = 2e-34
 Identities = 91/310 (29%), Positives = 147/310 (47%), Gaps = 59/310 (19%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPN 70
           Y +  ++G G++ +VW+A  R+    VA+K+I     +   +    +EI  L  +  HPN
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68

Query: 71  IIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           I++    I  E  + IYLV EY +  DL A I +   + +   R+ M QL   L+ +   
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALKYIHSG 126

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---------YMA 179
           ++IHRDLKP N+L++++     +K+ DFG ARSL+  +       +P+         Y A
Sbjct: 127 NVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENP---ENPVLTDYVATRWYRA 180

Query: 180 PEI-IQNHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTELRFPPGA 235
           PEI + + +Y    D+WSVG IL +++ GKP F G+   NQL+    I+       PP A
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK---IIEVIG---PPSA 234

Query: 236 --IEELH---------------------------PDCVDLCRCLLRQNPVERITFKEFFN 266
             IE +                             D +DL + LL  NP +R+T +E   
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294

Query: 267 HRFLGELRQT 276
           H ++ +    
Sbjct: 295 HPYVAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  131 bits (331), Expect = 4e-34
 Identities = 82/265 (30%), Positives = 121/265 (45%), Gaps = 26/265 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVK--EIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G+G+   V + +H   G  +A K   I  K     V   +L+E+ I+     P I+ F+
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK---SSVRKQILRELQIMHECRSPYIVSFY 69

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRD 134
            A      I + +E+ D G L     K G +   +       +  GL  L   H ++HRD
Sbjct: 70  GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129

Query: 135 LKPQNLLV-STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
           +KP N+LV S  ++    K+ DFG +  L    +ADT  G+  YM+PE IQ  KY  K+D
Sbjct: 130 IKPSNILVNSRGQI----KLCDFGVSGELI-NSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 194 LWSVGAILFQLVTGKPPFDGSNQ-----------LQLFQNILTSTELRFPPGAIEELHPD 242
           +WS+G  + +L  GK PF  SN            L L Q I+     R P     E   D
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244

Query: 243 CVDLCRCLLRQNPVERITFKEFFNH 267
            VD C   L ++P ER T ++    
Sbjct: 245 FVDAC---LLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  131 bits (330), Expect = 5e-34
 Identities = 88/280 (31%), Positives = 140/280 (50%), Gaps = 34/280 (12%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++ VV + RH++    VA+K+      + +V +  L+E+ +L T+   NI+   EA
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 78  IETREKIYLVLEYCDGGDLAAY-IHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
              R K+YLV EY +   L       +G   E V R ++ QL   +    +  ++HRD+K
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCHKNDIVHRDIK 127

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD--TLCGSPLYMAPEIIQNHKYDAKADL 194
           P+NLL+S N+   VLK+ DFGFAR+L+    A+      +  Y +PE++    Y    D+
Sbjct: 128 PENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDM 184

Query: 195 WSVGAILFQLVTGKPPFDG------------------SNQLQLFQNILTSTELRFP---- 232
           WSVG IL +L  G+P F G                  + Q++LF +      LRFP    
Sbjct: 185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNH 244

Query: 233 PGAIEE-----LHPDCVDLCRCLLRQNPVERITFKEFFNH 267
           P ++E      L    +DL + LL+ NP +R   ++  NH
Sbjct: 245 PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  131 bits (331), Expect = 6e-34
 Identities = 88/300 (29%), Positives = 141/300 (47%), Gaps = 59/300 (19%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR R     +A+K+I  +     V    ++EIS+L  + H NI+R  +
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH------FMRQLAAGLQVLQEKHL 130
            + + +++YLV EY D  DL     KH   S   A++      ++ Q+  G+       +
Sbjct: 69  VVHSEKRLYLVFEYLD-LDL----KKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV 123

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------YMA 179
           +HRDLKPQNLL+  +  T  LK+ DFG AR+           G P+           Y A
Sbjct: 124 LHRDLKPQNLLI--DRRTNALKLADFGLARAF----------GIPVRTFTHEVVTLWYRA 171

Query: 180 PEI-IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP-- 232
           PEI + +  Y    D+WSVG I  ++V  KP F G +++    ++F+ + T  E  +P  
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231

Query: 233 ------------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                                +  L P  VDL   +LR +P +RIT +    H +  +L 
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291

Length = 294

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  130 bits (327), Expect = 9e-34
 Identities = 82/258 (31%), Positives = 135/258 (52%), Gaps = 16/258 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           RIG GSF  V++    +    VA+K ID +    ++ D + +EI++LS    P I R++ 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYITRYYG 69

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + K G + E      +R++  GL  L  +  IHRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+S       +K+ DFG A  LT   +  +T  G+P +MAPE+I+   YD KAD+W
Sbjct: 129 AANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP---GAIEELHPDCVDLCRCLLR 252
           S+G    +L  G+PP    + +++   I  ++    PP   G   +   + V+ C   L 
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNS----PPTLEGQYSKPFKEFVEAC---LN 238

Query: 253 QNPVERITFKEFFNHRFL 270
           ++P  R T KE   H+F+
Sbjct: 239 KDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  130 bits (328), Expect = 1e-33
 Identities = 74/253 (29%), Positives = 132/253 (52%), Gaps = 15/253 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           +G G F  V   + +  G   A K++DKK L  +  + + L E  IL  +S   I+    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A ET++ + LV+   +GGDL  +I+  G+    EA A  +  Q+  GL+ L ++ +++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           LKP+N+L+  +     ++I D G A  L          G+P YMAPE++Q   YD   D 
Sbjct: 121 LKPENVLLDDHGN---VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDW 177

Query: 195 WSVGAILFQLVTGKPPF----DGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +++G  L++++ G+ PF    +   + +L +  L    + +P    ++  P+  DLC  L
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-MAVEYP----DKFSPEAKDLCEAL 232

Query: 251 LRQNPVERITFKE 263
           L+++P +R+  + 
Sbjct: 233 LQKDPEKRLGCRG 245

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  131 bits (330), Expect = 1e-33
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 19/286 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILS-TISHPNIIRFF 75
           +G GSF  V  A  +      A+K + K  +L     D  + E  IL+    HP +    
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T+++++ V+EY +GGDL   I +  K  E  +R +  ++   L  L    +I+RDL
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+         K+ DFG  +  +       T CG+P Y+APEI+Q  +Y    D 
Sbjct: 123 KLDNILLDAEGH---CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W++G ++++++ G+PPF+  N+  LF++IL    L +P      L  + V + +  + +N
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-YPVW----LSKEAVSILKAFMTKN 234

Query: 255 PVERI-------TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
           P +R+              H F  E+   +  EQ  + P  KP ++
Sbjct: 235 PNKRLGCVASQGGEDAIKQHPFFKEIDWVL-LEQRKIKPPFKPKIK 279

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  129 bits (326), Expect = 1e-33
 Identities = 71/232 (30%), Positives = 131/232 (56%), Gaps = 12/232 (5%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTIS 67
           +  + +  +IG G F+ V+RA     G+ VA+K++    L+  K   + +KEI +L  ++
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-----VSEAVARHFMRQLAAGL 122
           HPN+I+++ +     ++ +VLE  D GDL+  I KH K     + E     +  QL + L
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPE 181
           + +  + ++HRD+KP N+ ++    T V+K+GD G  R  + +  A  +L G+P YM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP 233
            I  + Y+ K+D+WS+G +L+++   + PF G +++ L+       +  +PP
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPP 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  129 bits (327), Expect = 1e-33
 Identities = 84/278 (30%), Positives = 131/278 (47%), Gaps = 24/278 (8%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           E  V   +G G++  V++  HR  G+ +A+KEI  +L   K +  ++ E+ IL     P 
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN-QIIMELDILHKAVSPY 60

Query: 71  IIRFFEAIETREKIYLVLEYCDGGD---LAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           I+ F+ A      +Y+ +EY D G    L A       + E V R     +  GL+ L+E
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 128 KH-LIHRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII-- 183
           +H +IHRD+KP N+LV+ N +V    K+ DFG + +L    LA T  G   YMAPE I  
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQV----KLCDFGVSGNLV-ASLAKTNIGCQSYMAPERIKS 175

Query: 184 ----QNHKYDAKADLWSVGAILFQLVTGK---PPFDGSNQLQLFQNILTSTELRFPPGAI 236
               QN  Y  ++D+WS+G  + ++  G+   PP   +N       I+       PP   
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD----PPTLP 231

Query: 237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                D  D     L + P  R T+ +   H +L + +
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  130 bits (329), Expect = 2e-33
 Identities = 77/282 (27%), Positives = 146/282 (51%), Gaps = 16/282 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + + E  +L    HP +     
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++      T CG+P Y+APE+++++ Y    D W
Sbjct: 123 LENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 234

Query: 256 VERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +       Q  ++P  KP V
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLSI-NWQDVVQKKLLPPFKPQV 275

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  130 bits (328), Expect = 2e-33
 Identities = 91/329 (27%), Positives = 154/329 (46%), Gaps = 35/329 (10%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK--LLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G GSF  V+ A  +      A+K + K   L+   V   ++++  +     HP +   +
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T+E ++ V+EY +GGDL  +I    K     A  +  ++  GLQ L  K +++RDL
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ T+     +KI DFG  + ++       T CG+P Y+APEI+   KY+   D 
Sbjct: 123 KLDNILLDTDGH---IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS G +L++++ G+ PF G ++ +LFQ+I         P     L  +  D+   L  + 
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-----PCYPRWLTREAKDILVKLFVRE 234

Query: 255 PVERITFK------EFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHS 308
           P  R+  K       FF       L      E+  + P  KP V+  N  +  D+  L +
Sbjct: 235 PERRLGVKGDIRQHPFFREIDWSAL------EEREIEPPFKPKVKSANDCSNFDKEFL-N 287

Query: 309 EHPTNSSSKNPKSACSSACDKVILNTGDQ 337
           E P  S +           D++++N+ DQ
Sbjct: 288 EKPRLSVT-----------DRMLINSMDQ 305

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  129 bits (326), Expect = 2e-33
 Identities = 75/260 (28%), Positives = 135/260 (51%), Gaps = 19/260 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  +  G +VAVK++D  L   +  + L  E+ I+    HPNI+  + 
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMD--LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   I  H +++E         +   L  L  + +IHRD+K
Sbjct: 84  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLT---PQDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
             ++L++++     +K+ DFGF   ++   P+    +L G+P +MAPE+I    Y  + D
Sbjct: 143 SDSILLTSDGR---VKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH---PDCVDLCRCL 250
           +WS+G ++ ++V G+PP+     LQ  + I  +      P  ++ LH   P        +
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-----LPPKLKNLHKVSPRLRSFLDRM 252

Query: 251 LRQNPVERITFKEFFNHRFL 270
           L ++P +R T  E  NH FL
Sbjct: 253 LVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  130 bits (327), Expect = 3e-33
 Identities = 78/245 (31%), Positives = 131/245 (53%), Gaps = 11/245 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTI-SHPNIIRFF 75
           +G GSF  V  AR ++ G   AVK + K  +L     +  + E  ILS   +HP + + +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T ++++ V+E+ +GGDL  +I K  +  EA AR +  ++ + L  L +K +I+RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+         K+ DFG  +  +       T CG+P Y+APEI+Q   Y    D 
Sbjct: 123 KLDNVLLDHEGHC---KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W++G +L++++ G  PF+  N+  LF+ IL   E+ +P      L  D VD+ +  + +N
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EVVYPTW----LSQDAVDILKAFMTKN 234

Query: 255 PVERI 259
           P  R+
Sbjct: 235 PTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  130 bits (328), Expect = 3e-33
 Identities = 69/202 (34%), Positives = 114/202 (56%), Gaps = 9/202 (4%)

Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
           E +IL  + HP I+    A +T  K+YL+LEY  GG+L  ++ + G   E  A  ++ ++
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLY 177
           +  L+ L ++ +I+RDLKP+N+L+        +K+ DFG  + S+    +  T CG+  Y
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQG---HVKLTDFGLCKESIHEGTVTHTFCGTIEY 166

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           MAPEI+    +    D WS+GA+++ ++TG PPF   N+ +    IL   +L  PP    
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-KLNLPP---- 221

Query: 238 ELHPDCVDLCRCLLRQNPVERI 259
            L P+  DL + LL++NP  R+
Sbjct: 222 YLTPEARDLLKKLLKRNPSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  130 bits (328), Expect = 3e-33
 Identities = 76/247 (30%), Positives = 132/247 (53%), Gaps = 14/247 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTIS---HPNIIR 73
           +G G F  V  A +++ G   A+K + K  +++    ++L+ E  I  T +   HP ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
            F   +T + +  V+EY  GGDL  +IH     SE  A  +   +  GLQ L E  +++R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKA 192
           DLK  NLL+ T      +KI DFG  +  +   D   T CG+P ++APE++    Y    
Sbjct: 126 DLKLDNLLLDTEGF---VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182

Query: 193 DLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           D W +G ++++++ G+ PF G ++ ++F +I+ + E+R+P      L  + + + R LLR
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV-NDEVRYP----RFLSREAISIMRRLLR 237

Query: 253 QNPVERI 259
           +NP  R+
Sbjct: 238 RNPERRL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  128 bits (324), Expect = 4e-33
 Identities = 85/289 (29%), Positives = 141/289 (48%), Gaps = 39/289 (13%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRFF 75
           +IG G++  V++AR +  G  VA+K+   ++    +    L+EIS+L  +S    I+R  
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 76  EAIETREK-----IYLVLEYCDGGDLAAYIHKHGK-----VSEAVARHFMRQLAAGLQVL 125
           +     EK     +YLV EY D  DL  ++  +G+     +     + FM QL  G+   
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEI-I 183
            +  ++HRDLKPQNLLV  ++   +LKI D G  R+ + P         +  Y APE+ +
Sbjct: 127 HKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184

Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ----LFQNILTSTELRFP------- 232
            +  Y    D+WSVG I  ++   +P F G ++LQ    +F+ + T TE  +P       
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRD 244

Query: 233 ------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
                         A+ +L P+ +DL + +LR +P +RI+ K    H +
Sbjct: 245 WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  129 bits (325), Expect = 4e-33
 Identities = 85/242 (35%), Positives = 121/242 (50%), Gaps = 20/242 (8%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL----LKEI 60
           R R + E+    RIG G++ +V+RAR    G  VA+K    K+      D +    L+EI
Sbjct: 2   RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALK----KVRMDNERDGIPISSLREI 57

Query: 61  SILSTISHPNIIRFFEAIETR--EKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQ 117
           ++L  + HPNI+   E +  +  + I+LV+EYC+  DLA+ +       SE+  +  M Q
Sbjct: 58  TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQ 116

Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           L  GLQ L E  +IHRDLK  NLL++       LKI DFG AR+        T     L 
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTD---KGCLKIADFGLARTYGLPAKPMTPKVVTLW 173

Query: 177 YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTELRFP 232
           Y APE++     Y    D+W+VG IL +L+  KP   G     QL L   +L +      
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233

Query: 233 PG 234
           PG
Sbjct: 234 PG 235

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  128 bits (324), Expect = 8e-33
 Identities = 73/248 (29%), Positives = 133/248 (53%), Gaps = 17/248 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHPNII- 72
           +G GSF  V  A  +      A+K + K ++   + D+     + E  +L+    P  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVV---IQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           +     +T +++Y V+EY +GGDL  +I + GK  E  A  +  +++ GL  L  + +I+
Sbjct: 65  QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLK  N+++ +      +KI DFG  +  +       T CG+P Y+APEII    Y   
Sbjct: 125 RDLKLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D W+ G +L++++ G+PPFDG ++ +LFQ+I+    + +P    + L  + V +C+ L+
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP----KSLSKEAVSICKGLM 236

Query: 252 RQNPVERI 259
            ++P +R+
Sbjct: 237 TKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  128 bits (324), Expect = 1e-32
 Identities = 84/294 (28%), Positives = 145/294 (49%), Gaps = 27/294 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTIS-HPNIIRFF 75
           IG GS+A V     ++     A+K I K+L++     D +  E  +  T S HP ++   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T  +++ V+E+  GGDL  ++ +  K+ E  AR +  +++  L  L E+ +I+RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+        +K+ D+G  +  + P D   T CG+P Y+APEI++   Y    D 
Sbjct: 123 KLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 195 WSVGAILFQLVTGKPPFD--GSNQLQ-------LFQNILTSTELRFPPGAIEELHPDCVD 245
           W++G ++F+++ G+ PFD  G +          LFQ IL    +R P      L      
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IRIP----RSLSVKASS 234

Query: 246 LCRCLLRQNPVERI------TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
           + +  L ++P ER+       F++  +H F   +   +  EQ  V+P  KP +E
Sbjct: 235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL-LEQKQVLPPYKPNIE 287

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 1e-32
 Identities = 98/302 (32%), Positives = 146/302 (48%), Gaps = 54/302 (17%)

Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVSDNLLKEISILS 64
           VGPR      IG G++ +V  A H+  G++VA+K+I   + +    +     L+EI IL 
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIKILR 58

Query: 65  TISHPNIIRFFEAI-----ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
              H NII   + I     E+   +Y+V E  +  DL   I K   +S    ++F+ Q+ 
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQIL 116

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTL---CGSP 175
            GL+ +   +++HRDLKP NLL++TN     LKI DFG AR   P+ D    L     + 
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 176 LYMAPEIIQNHKYDAKA-DLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL---TSTE 228
            Y APEI+ N K   KA D+WSVG IL ++++ +P F G    +QL L   +L   +  +
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233

Query: 229 LR----------------FPPGAIEELHP----DCVDLCRCLLRQNPVERITFKEFFNHR 268
           L                  P     +L P      +DL   +L  NP +RIT +E   H 
Sbjct: 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293

Query: 269 FL 270
           +L
Sbjct: 294 YL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 1e-32
 Identities = 91/321 (28%), Positives = 158/321 (49%), Gaps = 44/321 (13%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISIL---STISHPNIIR 73
           IG G+F  V++ R +      A+K + KK + + K   + + E +IL        P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              + +T   +YLV +Y  GG+L  ++ K G+ SE  A+ ++ +L   L+ L +  +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHK-YDAK 191
           DLKP+N+L+   + T  + + DFG +++ LT     +T CG+  Y+APE++ + K Y   
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D WS+G ++F++  G  PF   +  Q+++NI    ++RFP   + +   +     + LL
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRFPKNVLSD---EGRQFVKGLL 233

Query: 252 RQNPVERITFKEFFNHRFLGELRQTVHAEQHS--------------VVPETKPMVELLNS 297
            +NP           HR LG  R  V  ++H               + P  KP+V+    
Sbjct: 234 NRNP----------QHR-LGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVD---- 278

Query: 298 STPEDRHSLHSEHPTNSSSKN 318
            + ED  +   E  TNSS  N
Sbjct: 279 -SDEDVSNFDPEF-TNSSLLN 297

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  127 bits (321), Expect = 2e-32
 Identities = 75/243 (30%), Positives = 134/243 (55%), Gaps = 12/243 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIE-VAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G+GSF  V  A ++      VA+K  +K K++  K  D++  E  IL+ I+HP  +  +
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + +    +YLVLE+  GG+   ++ ++ +    V   +  Q+    + LQ  ++++RDL
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDL 157

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
           KP+NLL+  +     +K+ DFGFA+ +  +    TLCG+P Y+APEI+ N  +   AD W
Sbjct: 158 KPENLLLDKDG---FIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILLNVGHGKAADWW 212

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           ++G  +++++ G PPF  +  L ++Q IL    + FP    + L  +C  L + LL  + 
Sbjct: 213 TLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFP----KFLDNNCKHLMKKLLSHDL 267

Query: 256 VER 258
            +R
Sbjct: 268 TKR 270

Length = 340

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  126 bits (317), Expect = 3e-32
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 13/257 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+K+I+ +   PK  + ++ EI ++  + +PNI+ F +
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPK-KELIINEILVMKELKNPNIVNFLD 83

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   + +   + EA      R+    L+ L    +IHRD+K
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQVIHRDIK 142

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+    +   +K+ DFGF   +TP Q    T+ G+P +MAPE++    Y  K D+W
Sbjct: 143 SDNVLLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILT--STELRFPPGAIEELHPDCVDLCRCLLRQ 253
           S+G +  ++V G+PP+   N L+    I T  + EL+ P    E+L P   D     L  
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP----EKLSPIFRDFLNRCLEM 255

Query: 254 NPVERITFKEFFNHRFL 270
           +  +R + KE   H FL
Sbjct: 256 DVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  127 bits (320), Expect = 3e-32
 Identities = 74/276 (26%), Positives = 140/276 (50%), Gaps = 22/276 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE-ISILSTISHPNIIRFFE 76
           +G G F  V   R +  G   A+K + K +L  + + +  +E   ILS  + P I +   
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A + ++ +YLV+EY  GGDL + ++++  +  E +A+ ++ +L   +  + +   +HRD+
Sbjct: 69  AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDI 128

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL--CGSPLYMAPEIIQ------NHK 187
           KP+N+L+   + T  +K+ DFG A  LT   + ++    G+P Y+APE++          
Sbjct: 129 KPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDL 246
           Y  + D WS+G I ++++ G+ PF      + + NI+     L+FP     ++  D +DL
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP--EDPKVSSDFLDL 243

Query: 247 CRCLLRQNPVERITFKEFFNHRFL-----GELRQTV 277
            + LL     ER+ ++    H F        +R ++
Sbjct: 244 IQSLL-CGQKERLGYEGLCCHPFFSKIDWNNIRNSL 278

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  125 bits (317), Expect = 4e-32
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 35/282 (12%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFF 75
           +IG G+F+ V +A+ R+ G   A+K + KK        N L+EI  L  +S HPNI+R  
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 76  EAI--ETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKHLIH 132
           E +      ++ LV E  D  +L   I    + + E   + +M QL   L  +    + H
Sbjct: 65  EVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE-IIQNHKYDAK 191
           RD+KP+N+L+  +    +LK+ DFG  R +  +        +  Y APE ++ +  Y  K
Sbjct: 124 RDIKPENILIKDD----ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQL-----------------QLFQNILTSTELRFP-- 232
            D+W+VG + F++++  P F G+N+L                              FP  
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK 239

Query: 233 -PGAIEELHPD----CVDLCRCLLRQNPVERITFKEFFNHRF 269
               + +L P+     +DL + LL  +P ERIT K+   H +
Sbjct: 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  126 bits (319), Expect = 5e-32
 Identities = 86/282 (30%), Positives = 131/282 (46%), Gaps = 37/282 (13%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G+F +V  AR +  G  VA+K+I K   +P ++    +E+ +L  + H NII   + 
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 78  -IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
            I   E IY V E   G DL   +     + +   ++F+ Q+  GL+ +    ++HRDLK
Sbjct: 78  FISPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT-LCGSPLYMAPEIIQN-HKYDAKADL 194
           P N+L++ N     LKI DFG AR    QD   T    +  Y APEI+    KYD + D+
Sbjct: 136 PSNILINEN---CDLKICDFGLAR---IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDI 189

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLF---------------QNILTSTELRF-------- 231
           WS G I  +++ GKP F G + +  F                 I +   LRF        
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249

Query: 232 --P-PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             P     +   P  +DL   +L  +P +RI+  E   H +L
Sbjct: 250 PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  125 bits (316), Expect = 5e-32
 Identities = 84/293 (28%), Positives = 144/293 (49%), Gaps = 53/293 (18%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++ R+++ G  VA+K+I  +     V    ++EIS+L  + HPNI+   +
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 77  AIETREKIYLVLEYCDGGDLAAY---IHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
            +    ++YL+ E+    DL  Y   + K   +   + + ++ Q+  G+     + ++HR
Sbjct: 67  VLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------YMAPEI 182
           DLKPQNLL+       V+K+ DFG AR+           G P+           Y APE+
Sbjct: 126 DLKPQNLLIDNKG---VIKLADFGLARAF----------GIPVRVYTHEVVTLWYRAPEV 172

Query: 183 I-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ--NIL-TSTELRFP----- 232
           +  + +Y    D+WS+G I  ++ T KP F G +++ QLF+   IL T TE  +P     
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232

Query: 233 ---------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                            A++ L  D +DL   +L  +P +RI+ K+  NH + 
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  125 bits (315), Expect = 6e-32
 Identities = 77/282 (27%), Positives = 134/282 (47%), Gaps = 33/282 (11%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS+ VV++ R+R+ G  VA+K+  +    P +    L+EI +L  + HPN++   E
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 77  AIETREKIYLVLEYCDGGDLAAY-IHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
               + K++LV EYCD   L     +  G V E + +  + Q    +    + + IHRD+
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC-GSPLYMAPE-IIQNHKYDAKAD 193
           KP+N+L++       +K+ DFGFAR LT      T    +  Y APE ++ + +Y    D
Sbjct: 127 KPENILITKQG---QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVD 183

Query: 194 LWSVGAILFQLVTGKPPFDGS---NQL---------------QLFQN-------ILTSTE 228
           +W++G +  +L+TG+P + G    +QL               Q+F          +   E
Sbjct: 184 VWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE 243

Query: 229 LRFP-PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
            R P       +    +   +  L+ +P ER++ +E   H +
Sbjct: 244 TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  124 bits (312), Expect = 7e-32
 Identities = 73/258 (28%), Positives = 135/258 (52%), Gaps = 14/258 (5%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTIS 67
           +  + +  +IG G F+ V+RA        VA+K++   +++  K   + +KEI +L  ++
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK----VSEAVARHFMRQLAAGLQ 123
           HPN+I++ ++     ++ +VLE  D GDL+  I    K    + E     +  QL + ++
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEI 182
            +  + ++HRD+KP N+ ++    T V+K+GD G  R  + +  A  +L G+P YM+PE 
Sbjct: 121 HMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPF--DGSNQLQLFQNILTSTELRFPPGAIEELH 240
           I  + Y+ K+D+WS+G +L+++   + PF  D  N   L Q I    +  +PP   E   
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI---EQCDYPPLPTEHYS 234

Query: 241 PDCVDLCRCLLRQNPVER 258
               +L    +  +P +R
Sbjct: 235 EKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  124 bits (312), Expect = 9e-32
 Identities = 77/255 (30%), Positives = 130/255 (50%), Gaps = 10/255 (3%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           RIG GSF  V++    +    VA+K ID +    ++ D + +EI++LS    P + +++ 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYG 69

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + + G   E      ++++  GL  L  +  IHRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+S       +K+ DFG A  LT   +  +T  G+P +MAPE+IQ   YD+KAD+W
Sbjct: 129 AANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G    +L  G+PP    + +++   I  +     PP    E      +     L ++P
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLFLIPKNN----PPTLTGEFSKPFKEFIDACLNKDP 241

Query: 256 VERITFKEFFNHRFL 270
             R T KE   H+F+
Sbjct: 242 SFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  124 bits (312), Expect = 9e-32
 Identities = 75/261 (28%), Positives = 131/261 (50%), Gaps = 16/261 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++ +V+ AR     + +A+KEI ++    +    L +EI++ S + H NI+++  +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 78  IETREKIYLVLEYCDGGDLAAYIH-KHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   + +E   GG L+A +  K G  K +E     + +Q+  GL+ L +  ++HRD
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLYMAPEIIQN--HKYDAK 191
           +K  N+LV+T   + V+KI DFG ++ L   +   +T  G+  YMAPE+I      Y A 
Sbjct: 134 IKGDNVLVNT--YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAP 191

Query: 192 ADLWSVGAILFQLVTGKPPFD--GSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           AD+WS+G  + ++ TGKPPF   G  Q  +F+  +       P    E L  +  +    
Sbjct: 192 ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP----ESLSAEAKNFILR 247

Query: 250 LLRQNPVERITFKEFFNHRFL 270
               +P +R +  +     FL
Sbjct: 248 CFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (312), Expect = 1e-31
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 23/261 (8%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW         +VAVK +    +SP   +  L+E  I+  + H  +++ + 
Sbjct: 13  KLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQLYA 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
                E IY+V EY   G L  ++     K  ++ + V      Q+A G+  L+ ++ IH
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV--DMAAQIAEGMAYLESRNYIH 126

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV  N    V KI DFG AR L   D      G+     + APE     ++ 
Sbjct: 127 RDLAARNILVGEN---LVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182

Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
            K+D+WS G +L ++VT G+ P+ G    ++ + +     +  PP   EEL+     + +
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY---DLMLQ 239

Query: 249 CLLRQNPVERITFKEFFNHRF 269
           C   ++P ER TF E+     
Sbjct: 240 C-WDKDPEERPTF-EYLQSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  124 bits (313), Expect = 1e-31
 Identities = 78/280 (27%), Positives = 140/280 (50%), Gaps = 31/280 (11%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G GS+ +V + +H++ G  VA+K+  +      V    ++EI +L  + H N++   E 
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
              ++++YLV E+ D   L         + E+  R ++ Q+  G++     ++IHRD+KP
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKP 128

Query: 138 QNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPE-IIQNHKYDAKADLW 195
           +N+LVS + V    K+ DFGFAR+L  P ++      +  Y APE ++ + KY    D+W
Sbjct: 129 ENILVSQSGVV---KLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185

Query: 196 SVGAILFQLVTGKPPFDGSNQL-QLF-------------QNILTSTEL----RFP----P 233
           +VG ++ +++TG+P F G + + QL+             Q I     L    R P     
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245

Query: 234 GAIEELHPD----CVDLCRCLLRQNPVERITFKEFFNHRF 269
             +E+  P      +DL +  LR +P +R +  +  +H F
Sbjct: 246 EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  124 bits (313), Expect = 1e-31
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 11/256 (4%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+K+++ +   PK  + ++ EI ++    HPNI+ + +
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPK-KELIINEILVMRENKHPNIVNYLD 83

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   +     + E       R+    L+ L    +IHRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+  +     +K+ DFGF   +TP Q    T+ G+P +MAPE++    Y  K D+W
Sbjct: 143 SDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHPDCVDLCRCLLRQN 254
           S+G +  ++V G+PP+   N L+    I T+       P  +  +  D ++ C   L  +
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC---LEMD 256

Query: 255 PVERITFKEFFNHRFL 270
             +R + KE   H FL
Sbjct: 257 VEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  125 bits (315), Expect = 1e-31
 Identities = 90/324 (27%), Positives = 157/324 (48%), Gaps = 25/324 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK--LLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G GSF  V  A  +  G   AVK + K   L+   V   ++++  +     +P +   +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T+E ++ V+E+ +GGDL  +I   G+     A  +  ++  GLQ L  K +I+RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+++  +     +KI DFG  + ++   + A T CG+P Y+APEI+Q  KY    D 
Sbjct: 123 KLDNVMLDRDGH---IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS G +L++++ G+ PF G ++ +LF++I   T     P     +  +  D+   L  ++
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-----PHYPRWITKESKDILEKLFERD 234

Query: 255 PVERI-TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPTN 313
           P  R+        H F   +  T   E+  + P  KP V+  +  +  DR  L       
Sbjct: 235 PTRRLGVVGNIRGHPFFKTINWTA-LEKRELDPPFKPKVKSPSDYSNFDREFL------- 286

Query: 314 SSSKNPKSACSSACDKVILNTGDQ 337
             S+ P+    S  DK ++++ DQ
Sbjct: 287 --SEKPR---LSYSDKNLIDSMDQ 305

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  125 bits (316), Expect = 1e-31
 Identities = 86/307 (28%), Positives = 136/307 (44%), Gaps = 55/307 (17%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEI-------DKKLLSPKVSD-----NLLKEIS 61
            G  +G G++  V +A     G  VA+K++       D       V         L+E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
           I++ I H NI+   +     + I LV++     DL   + +  +++E+  +  + Q+  G
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL----- 176
           L VL + + +HRDL P N+ +++  +    KI DFG AR       +DTL          
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 177 ----------YMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQN 222
                     Y APE++    KY    D+WSVG I  +L+TGKP F G N   QL     
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248

Query: 223 IL-TSTELRFP---------------PGAIEELHP----DCVDLCRCLLRQNPVERITFK 262
           +L T  E  +P               P  ++ + P    D +DL + LL+ NP+ERI+ K
Sbjct: 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308

Query: 263 EFFNHRF 269
           E   H +
Sbjct: 309 EALKHEY 315

Length = 335

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  124 bits (313), Expect = 2e-31
 Identities = 81/284 (28%), Positives = 150/284 (52%), Gaps = 19/284 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   + +  G   A+K + K+++  K    + L E  +L    HP +     
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ-EKHLIHRDL 135
           + +T +++  V+EY +GG+L  ++ +    SE  AR +  ++ + L  L  EK++++RDL
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K +NL++  +     +KI DFG  +  +       T CG+P Y+APE+++++ Y    D 
Sbjct: 123 KLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----RTLSPEAKSLLSGLLKKD 234

Query: 255 PVERI-----TFKEFFNHRFLGELR-QTVHAEQHSVVPETKPMV 292
           P +R+       KE   H+F   +  Q V+ ++  +VP  KP V
Sbjct: 235 PKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKK--LVPPFKPQV 276

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  123 bits (311), Expect = 2e-31
 Identities = 85/311 (27%), Positives = 157/311 (50%), Gaps = 37/311 (11%)

Query: 1   MEPNRT-RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE 59
           ++PN    +IGE      +G G+F  V++A++++ G   A K I+ K  S +  ++ + E
Sbjct: 8   LDPNEVWEIIGE------LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVE 59

Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQL 118
           I IL+T +HP I++   A     K+++++E+C GG + A + +  + ++E   +   RQ+
Sbjct: 60  IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM 119

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF-ARSLTPQDLADTLCGSPLY 177
              LQ L    +IHRDLK  N+L++ +     +K+ DFG  A+++      D+  G+P +
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDG---DIKLADFGVSAKNVKTLQRRDSFIGTPYW 176

Query: 178 MAPEII-----QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           MAPE++     ++  YD KAD+WS+G  L ++   +PP    N +++   I  S     P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE----P 232

Query: 233 PGAIE--ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKP 290
           P   +  +   +  D  +  L ++P  R +  +   H F+            S V   +P
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV------------SSVTSNRP 280

Query: 291 MVELLNSSTPE 301
           + EL+  +  E
Sbjct: 281 LRELVAEAKAE 291

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  124 bits (312), Expect = 3e-31
 Identities = 93/314 (29%), Positives = 153/314 (48%), Gaps = 31/314 (9%)

Query: 18  IGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNL--LKEISILSTISHPNII 72
           +G GSF  V+  R       G   A+K + K  L  KV D +    E  IL+ ++HP I+
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIV 61

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           +   A +T  K+YL+L++  GGDL   + K    +E   + ++ +LA  L  L    +I+
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLKP+N+L+   +    +K+ DFG ++ S+  +  A + CG+  YMAPE++    +   
Sbjct: 122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           AD WS G ++F+++TG  PF G ++ +    IL + +L  P    + L P+   L R L 
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-KLGMP----QFLSPEAQSLLRALF 233

Query: 252 RQNPVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSL 306
           ++NP  R+       +E   H F   +       +  + P  KP V       P+D    
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPFFSTI-DWNKLYRREIKPPFKPAV-----GRPDDTFYF 287

Query: 307 HSEHPTNSSSKNPK 320
             E     +S+ PK
Sbjct: 288 DPEF----TSRTPK 297

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  130 bits (327), Expect = 4e-31
 Identities = 75/251 (29%), Positives = 133/251 (52%), Gaps = 30/251 (11%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           + EY V  +IG+G F  V+  +H++       K I  + L  +    L+ E++++  + H
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 69  PNIIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGL 122
            NI+R+ +    +  +K+Y+++E+CD GDL+  I K     GK+ E       RQL   L
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 123 QVLQE-------KHLIHRDLKPQNLLVSTN-----EVT---------PVLKIGDFGFARS 161
                       + ++HRDLKPQN+ +ST      ++T         P+ KIGDFG +++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 162 LTPQDLADTLCGSPLYMAPEII--QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-Q 218
           +  + +A +  G+P Y +PE++  +   YD K+D+W++G I+++L +GK PF  +N   Q
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251

Query: 219 LFQNILTSTEL 229
           L   +    +L
Sbjct: 252 LISELKRGPDL 262

Length = 1021

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 4e-31
 Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 39/287 (13%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP--KVSDNLLKEISILSTISHPNIIRFF 75
           +G G    V+  R +  G   A+K +DKK +    KV   +L E  IL+T+ HP +   +
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVK-RVLTEQEILATLDHPFLPTLY 67

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
            + +T   + LV++YC GG+L   + +     +SE VAR +  ++   L+ L    +++R
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR 127

Query: 134 DLKPQNLLV----------------STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           DLKP+N+L+                S  E  PV K    G  RS      ++T    P  
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187

Query: 177 ----------YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS 226
                     Y+APE+I    + +  D W++G +L++++ G  PF GSN+ + F NIL  
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKK 247

Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFK----EFFNHRF 269
            E+ FP      +     DL R LL ++P +R+  K    E   H F
Sbjct: 248 -EVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  122 bits (307), Expect = 4e-31
 Identities = 72/260 (27%), Positives = 125/260 (48%), Gaps = 24/260 (9%)

Query: 17  RIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           ++G GSF VV R      G   I VAVK +    LS  + D+ LKE +I+ ++ H N+IR
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIR 60

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLI 131
            +  + T   + +V E    G L   + K       ++    +  Q+A G++ L+ K  I
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP------LYMAPEIIQN 185
           HRDL  +N+L+++++    +KIGDFG  R+L   +  D             + APE ++ 
Sbjct: 120 HRDLAARNILLASDD---KVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCAPESLRT 174

Query: 186 HKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDC 243
             +   +D+W  G  L+++ T G+ P+ G +  Q+ + I    E L  P    ++++   
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY--- 231

Query: 244 VDLCRCLLRQNPVERITFKE 263
            ++       NP +R TF  
Sbjct: 232 -NVMLQCWAHNPADRPTFAA 250

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  123 bits (309), Expect = 8e-31
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 27/293 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTIS-HPNIIRFF 75
           IG GS+A V   R ++     A+K + K+L++     D +  E  +    S HP ++   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T  +++ V+EY +GGDL  ++ +  K+ E  AR +  +++  L  L E+ +I+RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ +      +K+ D+G  +  L P D   T CG+P Y+APEI++   Y    D 
Sbjct: 123 KLDNVLLDSEG---HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 195 WSVGAILFQLVTGKPPFD--GSN-------QLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           W++G ++F+++ G+ PFD  GS+       +  LFQ IL   ++R P      L      
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIP----RSLSVKAAS 234

Query: 246 LCRCLLRQNPVERI------TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           + +  L ++P ER+       F +   H F   +   +  EQ  VVP  KP +
Sbjct: 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL-MEQKQVVPPFKPNI 286

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  123 bits (310), Expect = 1e-30
 Identities = 84/284 (29%), Positives = 132/284 (46%), Gaps = 28/284 (9%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           RIGSG+   V++  HR  G   A+K I        V   + +EI IL  ++HPN+++  +
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 77  AIETREKIYLVLEYCDGGDL-AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
             +   +I ++LE+ DGG L   +I     ++        RQ+ +G+  L  +H++HRD+
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHRRHIVHRDI 194

Query: 136 KPQNLLV-STNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQ---NH-KYD 189
           KP NLL+ S   V    KI DFG +R L    D  ++  G+  YM+PE I    NH  YD
Sbjct: 195 KPSNLLINSAKNV----KIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 190 AKA-DLWSVGAILFQLVTGKPPFDGSNQ---LQLFQNILTSTELRFPPGAIEELHPDCVD 245
             A D+WS+G  + +   G+ PF    Q     L   I  S     PP A      +   
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----PPEAPATASREFRH 306

Query: 246 LCRCLLRQNPVERITFKEFFNHRFL---GELRQTVHAEQHSVVP 286
              C L++ P +R +  +   H F+      +       H ++P
Sbjct: 307 FISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLP 350

Length = 353

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  121 bits (305), Expect = 1e-30
 Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 31/281 (11%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G G+   V + R +  G+  A+K I     +P +   +L+E+ I  +   P I++++ 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 77  AI--ETREKIYLVLEYCDGGDLAAYIHKH-----GKVSEAVARHFMRQLAAGLQVLQEKH 129
           A   E+   I + +EYC+GG L + I+K      G++ E V       +  GL  L  + 
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYD 189
           +IHRD+KP N+L++       +K+ DFG +  L    LA T  G+  YMAPE IQ   Y 
Sbjct: 126 IIHRDIKPSNILLTRKGQ---VKLCDFGVSGELV-NSLAGTFTGTSFYMAPERIQGKPYS 181

Query: 190 AKADLWSVGAILFQLVTGKPPF--DGSNQL---QLFQNILTSTELRFPPGAIEELHPDCV 244
             +D+WS+G  L ++   + PF  +G   L   +L   I+        P   +E      
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKDEPGNGIK 237

Query: 245 -------DLCRCLLRQNPVERITFKEFFNHRF-LGELRQTV 277
                   + +CL + +P  R T  +   H +   ++++ V
Sbjct: 238 WSEEFKDFIKQCLEK-DPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  122 bits (308), Expect = 2e-30
 Identities = 90/295 (30%), Positives = 138/295 (46%), Gaps = 49/295 (16%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL------LKEISILSTISHPNI 71
           IG G++ +V  A++ +   +VA+K+I          DN       L+EI +L  + H N+
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIAN------AFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 72  IRFFEAI-----ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           I   + +     E    +Y+V E  D  DL   I     +S+   ++F+ QL  GL+ + 
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQN 185
             +++HRDLKP NLL++ N     LKI DFG AR +    D       +  Y APE++ N
Sbjct: 126 SANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 186 -HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTS---TELRF--PPGA- 235
             +Y    D+WSVG I  +L+  KP F G    +QL+L   +L S    +L F     A 
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242

Query: 236 --IEEL---------------HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
             I  L               +P  +DL   +L  +P +RIT +E   H +L  L
Sbjct: 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  121 bits (304), Expect = 4e-30
 Identities = 69/245 (28%), Positives = 131/245 (53%), Gaps = 11/245 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTISHPNIIRFF 75
           +G GSF  V  A  +      A+K + K ++     V   ++++  +  +   P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T +++Y V+EY +GGDL   I + G+  E  A  +  ++A GL  L  K +I+RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+++ +      +KI DFG  + ++       T CG+P Y+APEII    Y    D 
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W+ G +L++++ G+ PF+G ++ +LFQ+I+    + +P    + +  + V +C+ L+ ++
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYP----KSMSKEAVAICKGLMTKH 239

Query: 255 PVERI 259
           P +R+
Sbjct: 240 PGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  119 bits (300), Expect = 4e-30
 Identities = 72/271 (26%), Positives = 134/271 (49%), Gaps = 17/271 (6%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI----DKKLLSPKVSDNLLKEISILSTI 66
           E+  G  +G G++  V+     Q G  +AVK++       L + K  + L +E+ +L ++
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            H NI+++         I + +E+  GG +++ +++ G + E V   + +Q+  G+  L 
Sbjct: 60  KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-------TPQDLADTLCGSPLYMA 179
              ++HRD+K  N+++  N    ++K+ DFG AR L       T  ++  ++ G+P +MA
Sbjct: 120 NNCVVHRDIKGNNVMLMPNG---IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PE+I    Y  K+D+WS+G  +F++ TGKPP    ++L     I     L   P   +  
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM--PRLPDSF 234

Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
               +D     L ++  ER +  +   H FL
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  120 bits (303), Expect = 5e-30
 Identities = 81/283 (28%), Positives = 145/283 (51%), Gaps = 18/283 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + L E  +L    HP +     
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +T +++  V+EY +GG+L  ++ +    SE  AR +  ++ + L  L    +++RDLK
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK 122

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++      T CG+P Y+APE+++++ Y    D W
Sbjct: 123 LENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 234

Query: 256 VERI-----TFKEFFNHRFLGELR-QTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +  Q V   Q  + P  KP V
Sbjct: 235 KQRLGGGPEDAKEIMEHRFFASINWQDVV--QKKLEPPFKPQV 275

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  120 bits (302), Expect = 7e-30
 Identities = 78/283 (27%), Positives = 145/283 (51%), Gaps = 18/283 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + L E  +L    HP +     
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +T++++  V+EY +GG+L  ++ +    SE   R +  ++ + L  L    +++RDLK
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  +T      T CG+P Y+APE+++++ Y    D W
Sbjct: 123 LENLMLDKDGH---IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   +++FP      L  D   L   LL ++P
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFP----RTLSADAKSLLSGLLIKDP 234

Query: 256 VERI-----TFKEFFNHRFLGELR-QTVHAEQHSVVPETKPMV 292
            +R+       KE   H F   +  Q V+ ++  +VP  KP V
Sbjct: 235 NKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKK--LVPPFKPQV 275

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  119 bits (300), Expect = 1e-29
 Identities = 82/267 (30%), Positives = 125/267 (46%), Gaps = 25/267 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS----DNLLKEISILSTISHPNIIR 73
           IG GSF  V+ AR  +    VA+K   K   S K S     +++KE+  L  + HPN I 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 74  FFEAIETREKI-YLVLEYCDG--GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           + +    RE   +LV+EYC G   D+   +HK       +A         GL  L     
Sbjct: 80  Y-KGCYLREHTAWLVMEYCLGSASDILE-VHKKPLQEVEIAA-ICHGALQGLAYLHSHER 136

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII---QNHK 187
           IHRD+K  N+L++       +K+ DFG A  ++P   A++  G+P +MAPE+I      +
Sbjct: 137 IHRDIKAGNILLTEPGT---VKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQ 190

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           YD K D+WS+G    +L   KPP    N +    +I  +           +   + VD C
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250

Query: 248 RCLLRQNPVERITFKEFFNHRFLGELR 274
              L++ P +R + +E   HRF+   R
Sbjct: 251 ---LQKIPQDRPSSEELLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  118 bits (297), Expect = 1e-29
 Identities = 82/292 (28%), Positives = 143/292 (48%), Gaps = 32/292 (10%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           I+G  +G G+F  V++A++++ G+  A K ID K  S +  ++ + EI IL++  HPNI+
Sbjct: 9   IIG-ELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIV 65

Query: 73  RFFEAIETREKIYLVLEYCDGGDL-AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +  +A      +++++E+C GG + A  +     ++E   R   +Q    L  L E  +I
Sbjct: 66  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGF-ARSLTPQDLADTLCGSPLYMAPEII-----QN 185
           HRDLK  N+L + +     +K+ DFG  A++       D+  G+P +MAPE++     ++
Sbjct: 126 HRDLKAGNILFTLDG---DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE--ELHPDC 243
             YD KAD+WS+G  L ++   +PP    N +++   I  S     PP   +      + 
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE----PPTLAQPSRWSSEF 238

Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELL 295
            D  +  L +N   R T  +   H F+              V   KP+ EL+
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPFV-------------TVNSNKPIRELI 277

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  122 bits (307), Expect = 2e-29
 Identities = 68/219 (31%), Positives = 114/219 (52%), Gaps = 14/219 (6%)

Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHF 114
           E+  L+   H  I++ F+  ++ +K+ L++EY  GGDL   I +    H    E      
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ---DLADTL 171
             Q+   L  +  + ++HRDLK  N+ +     T ++K+GDFGF++  +     D+A + 
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMP---TGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF 231
           CG+P Y+APE+ +  +Y  KAD+WS+G IL++L+T   PF G +Q ++ Q +L      F
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291

Query: 232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           P      +      L   LL +NP  R T ++  +  FL
Sbjct: 292 PCPVSSGMKA----LLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 2e-29
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK--VSDNLLKEISILSTISHPNIIRF 74
           ++G GS+A V++ R +  G  VA+KEI    L  +       ++E S+L  + H NI+  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKHLIHR 133
            + I T++ + LV EY D  DL  Y+   G  +S    R F+ QL  GL    ++ ++HR
Sbjct: 69  HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127

Query: 134 DLKPQNLLVS-TNEVTPVLKIGDFGFAR-----SLTPQDLADTLCGSPLYMAPEII-QNH 186
           DLKPQNLL+S   E    LK+ DFG AR     S T  +   TL     Y  P+++  + 
Sbjct: 128 DLKPQNLLISERGE----LKLADFGLARAKSVPSKTYSNEVVTL----WYRPPDVLLGST 179

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGS----NQLQLFQNIL-TSTELRFP 232
           +Y    D+W VG I +++ TG+P F GS    +QL     +L T TE  +P
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 2e-29
 Identities = 73/256 (28%), Positives = 125/256 (48%), Gaps = 28/256 (10%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW          VAVK +    + PK   + L E  I+  + HP +I+ + 
Sbjct: 13  KLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPK---DFLAEAQIMKKLRHPKLIQLYA 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG----KVSEAVARHFMRQLAAGLQVLQEKHLIH 132
                E IY+V E    G L  Y+        K+ + +      Q+A+G+  L+ ++ IH
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQNYIH 126

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV  N    + K+ DFG AR +  +D+ +   G+     + APE    +++ 
Sbjct: 127 RDLAARNVLVGENN---ICKVADFGLARVIK-EDIYEAREGAKFPIKWTAPEAALYNRFS 182

Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP---DCVD 245
            K+D+WS G +L ++VT G+ P+ G    ++ Q +     +  PPG  +EL+    DC  
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDC-- 240

Query: 246 LCRCLLRQNPVERITF 261
                 +++P +R TF
Sbjct: 241 -----WKEDPDDRPTF 251

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  122 bits (307), Expect = 2e-29
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 32/269 (11%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +GSG+   V  A+    G   AVK +D + +S    +    E+  L      +I++  E 
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 78  IETREK--------IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL---QVL- 125
              ++         I LVL+Y + GDL   I    K +     H      AGL   QVL 
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH-----EAGLLFIQVLL 154

Query: 126 -----QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLY 177
                  KH+IHRD+K  N+L+ +N +   +K+GDFGF++   +    D+  T CG+P Y
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGL---VKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           +APEI +   Y  KAD++S+G +L++L+T K PFDG N  ++    L     R+ P    
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG---RYDP-LPP 267

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKEFFN 266
            + P+  ++   LL  +P  R +  +  N
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLN 296

Length = 496

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  118 bits (297), Expect = 3e-29
 Identities = 84/297 (28%), Positives = 146/297 (49%), Gaps = 37/297 (12%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--------P 69
           IG GS+A V   R ++     A+K + K+L    V D+  ++I  + T  H        P
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKEL----VHDD--EDIDWVQTEKHVFEQASSNP 56

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            ++      +T  +++LV+EY +GGDL  ++ +  K+ E  AR +  ++   L  L E+ 
Sbjct: 57  FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKY 188
           +I+RDLK  N+L+  +     +K+ D+G  +  L P D   T CG+P Y+APEI++  +Y
Sbjct: 117 IIYRDLKLDNVLLDADGH---IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 189 DAKADLWSVGAILFQLVTGKPPF-------DGSNQLQLFQNILTSTELRFPPGAIEELHP 241
               D W++G ++F+++ G+ PF       D + +  LFQ IL    +R P      L  
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIP----RFLSV 228

Query: 242 DCVDLCRCLLRQNPVERI------TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
               + +  L ++P ER+       F +  +H F   +   +  E+  V P  KP +
Sbjct: 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL-LEKKQVTPPFKPQI 284

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  117 bits (296), Expect = 3e-29
 Identities = 80/288 (27%), Positives = 139/288 (48%), Gaps = 41/288 (14%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV +  HR  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVK 127

Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
           P N+LV++  E+    K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+W
Sbjct: 128 PSNILVNSRGEI----KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYTVQSDIW 182

Query: 196 SVGAILFQLVTGK---PPFDGSNQLQLFQNILTSTELRFP-------------PGAIEEL 239
           S+G  L ++  G+   PP D      +F   ++  E +               P AI EL
Sbjct: 183 SLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFEL 242

Query: 240 -----------------HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                              +  D     L++NP ER   KE   H F+
Sbjct: 243 LDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  117 bits (296), Expect = 4e-29
 Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 46/295 (15%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+F  V++ARH++    VA+K++  +          L+EI IL  + H N++   E
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 77  AIET--------REKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQVLQE 127
              T        +   YLV E+C+  DLA  + +K+ K + +  +  M+ L  GL  +  
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR 137

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEI 182
             ++HRD+K  N+L++ +    +LK+ DFG AR+ +    +     +       Y  PE+
Sbjct: 138 NKILHRDMKAANILITKDG---ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194

Query: 183 IQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTS------------ 226
           +   + Y    D+W  G I+ ++ T  P   G+    QL L   +  S            
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL 254

Query: 227 ---TELRFPPG----AIEELHP-----DCVDLCRCLLRQNPVERITFKEFFNHRF 269
               ++  P G      E L P       +DL   LL  +P +RI      NH F
Sbjct: 255 ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 4e-29
 Identities = 80/325 (24%), Positives = 131/325 (40%), Gaps = 90/325 (27%)

Query: 18  IGSGSFAVVWRAR--HRQLGIEVAVKEID-KKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G++  V++A+  + + G E A+K+    K     +S +  +EI++L  + H N++  
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 75  FEAI--ETREKIYLVLEYCDGGDLAAYIHKH-----GKVSEAVARHFMRQLAAGLQVLQE 127
            E       + +YL+ +Y +  DL   I  H       +  ++ +  + Q+  G+  L  
Sbjct: 68  VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126

Query: 128 KHLIHRDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---------- 176
             ++HRDLKP N+LV        V+KIGD G AR          L  +PL          
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR----------LFNAPLKPLADLDPVV 176

Query: 177 ----YMAPEIIQNHKYDAKA-DLWSVGAILFQLVTGKPPFDG------------SNQL-- 217
               Y APE++   ++  KA D+W++G I  +L+T +P F G             +QL  
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 218 -----------------------QLFQNILTST----------ELRFPPGAIEELHPDCV 244
                                   L ++  T T          E    P           
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD------SQGF 290

Query: 245 DLCRCLLRQNPVERITFKEFFNHRF 269
           DL R LL  +P +RIT +E   H +
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  116 bits (292), Expect = 5e-29
 Identities = 77/256 (30%), Positives = 131/256 (51%), Gaps = 12/256 (4%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GSF  V++    +    VA+K ID +    ++ D + +EI++LS    P + +++ 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYG 69

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + + G + E      +R++  GL  L  +  IHRD+K
Sbjct: 70  SYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADL 194
             N+L+S + EV    K+ DFG A  LT   +  +T  G+P +MAPE+I+   YD+KAD+
Sbjct: 129 AANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS+G    +L  G+PP    + +++   I  +     PP           +     L + 
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 240

Query: 255 PVERITFKEFFNHRFL 270
           P  R T KE   H+F+
Sbjct: 241 PSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 6e-29
 Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 16/206 (7%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+K + ++  SPK +  +L E  +++++ HP+++R
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVR 73

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I    ++ L+ +    G L  Y+  H   +      ++  Q+A G+  L+EK L+H
Sbjct: 74  LL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH 132

Query: 133 RDLKPQNLLVST-NEVTPVLKIGDFGFARSLTPQDLADTLCGS--PL-YMAPEIIQNHKY 188
           RDL  +N+LV T   V    KI DFG A+ L   +      G   P+ +MA E I +  Y
Sbjct: 133 RDLAARNVLVKTPQHV----KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188

Query: 189 DAKADLWSVGAILFQLVT-GKPPFDG 213
             K+D+WS G  +++L+T G  P++G
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  116 bits (292), Expect = 6e-29
 Identities = 78/260 (30%), Positives = 120/260 (46%), Gaps = 19/260 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G+   V++A H      +AVK I   + + ++   ++ E+ IL     P II F+ A
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                +I +  E+ DGG L  Y     K+ E V       +  GL  L    ++HRD+KP
Sbjct: 68  FFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP 123

Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSV 197
            N+LV+T      +K+ DFG +  L    +A T  G+  YMAPE I   +Y   +D+WS+
Sbjct: 124 SNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSL 179

Query: 198 GAILFQLVTGKPPFDG--SNQ-----LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           G    +L  G+ P+     NQ     LQL Q I+       P G   E     +  C   
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQC--- 236

Query: 251 LRQNPVERITFKEFFNHRFL 270
           +R+ P ER   +   +H F+
Sbjct: 237 MRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  115 bits (290), Expect = 8e-29
 Identities = 82/261 (31%), Positives = 129/261 (49%), Gaps = 17/261 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK-EISILSTISHPNIIRFF 75
           R+GSG++  V++AR+   G   AVK I    L P    +L++ EI ++    H NI+ +F
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            +  +REK+++ +EYC GG L    H  G +SE    +  R+   GL  L  K  +HRD+
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDI 132

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEII---QNHKYDAK 191
           K  N+L++ N     +K+ DFG A  +T       +  G+P +MAPE+    +N  Y+  
Sbjct: 133 KGANILLTDNG---DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189

Query: 192 ADLWSVGAILFQLVTGKPP-FDGSNQLQLFQNILTSTELRFPPGAIEELH--PDCVDLCR 248
            D+W+VG    +L   +PP FD      LF   L S     PP   ++        +  +
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLKDKTKWSSTFHNFVK 246

Query: 249 CLLRQNPVERITFKEFFNHRF 269
             L +NP +R T +    H F
Sbjct: 247 ISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  117 bits (295), Expect = 1e-28
 Identities = 94/320 (29%), Positives = 146/320 (45%), Gaps = 62/320 (19%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           +GSG++  V  A   + G +VA+K++ +   S   +    +E+ +L  + H N+I     
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E  + +YLV     G DL   + K  K+S+   +  + Q+  GL+ +    +I
Sbjct: 83  FTPASSLEDFQDVYLVTHLM-GADLNNIV-KCQKLSDDHIQFLVYQILRGLKYIHSAGII 140

Query: 132 HRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN--HKY 188
           HRDLKP N+ V+ + E    LKI DFG AR     D       +  Y APEI+ N  H Y
Sbjct: 141 HRDLKPSNIAVNEDCE----LKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMH-Y 193

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNI-----------LTSTELR---- 230
           +   D+WSVG I+ +L+TGK  F GS+   QL+   N+           ++S   R    
Sbjct: 194 NQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQ 253

Query: 231 -FP-----------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVH 278
             P            GA    +P  +DL   +L  +P +RIT  E   H +L        
Sbjct: 254 SLPQMPKKDFKEVFSGA----NPLAIDLLEKMLVLDPDKRITAAEALAHPYL-------- 301

Query: 279 AEQHSVVPETKPMVELLNSS 298
           AE H   PE +P+    + S
Sbjct: 302 AEYHD--PEDEPVAPPYDQS 319

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (288), Expect = 1e-28
 Identities = 67/256 (26%), Positives = 118/256 (46%), Gaps = 14/256 (5%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           E+ +  ++GSG F  VW    +   + VA+K +  K        +  KE+  L  + H +
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNR-VRVAIKIL--KSDDLLKQQDFQKEVQALKRLRHKH 63

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEK 128
           +I  F      E +Y++ E  + G L A++         VA       Q+A G+  L+E+
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNHK 187
           + IHRDL  +N+LV  + V    K+ DFG AR +     L+        + APE   +  
Sbjct: 124 NSIHRDLAARNILVGEDLVC---KVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT 180

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           +  K+D+WS G +L+++ T G+ P+ G N  +++  I     +  P    +E++     +
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY----KI 236

Query: 247 CRCLLRQNPVERITFK 262
                   P +R +FK
Sbjct: 237 MLECWAAEPEDRPSFK 252

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  113 bits (285), Expect = 2e-28
 Identities = 84/255 (32%), Positives = 126/255 (49%), Gaps = 23/255 (9%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           RIG G+F  V+  R R     VAVK   ++ L P +    L+E  IL   SHPNI+R   
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
               ++ IY+V+E   GGD   ++   G   KV E +    +   AAG++ L+ KH IHR
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELI--QMVENAAAGMEYLESKHCIHR 118

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPL-YMAPEIIQNHKYDA 190
           DL  +N LV+      VLKI DFG +R       A T  +   P+ + APE +   +Y +
Sbjct: 119 DLAARNCLVTEKN---VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           ++D+WS G +L++  + G  P+   +  Q  + I     L  P     EL PD   + R 
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP-----ELCPD--AVYRL 228

Query: 250 LLR---QNPVERITF 261
           + R    +P +R +F
Sbjct: 229 MERCWEYDPGQRPSF 243

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  114 bits (286), Expect = 3e-28
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 24/270 (8%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--NLLK-EISILSTISHPN 70
           +G  +G G+F  V+       G E+AVK++     SP+ S   N L+ EI +L  + H  
Sbjct: 6   LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65

Query: 71  IIRFFEAI-ETREK-IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           I++++  + +  E+ + + +E+  GG +   +  +G ++E V R + RQ+  G+  L   
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPLYMAPEIIQ 184
            ++HRD+K  N+L    +    +K+GDFG ++ L    L+ T    + G+P +M+PE+I 
Sbjct: 126 MIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS-TELRFPPGAIEELHPDC 243
              Y  KAD+WSVG  + +++T KPP+     +     I T  T    P        P  
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP--------PHV 234

Query: 244 VDLCRCLLRQNPVE---RITFKEFFNHRFL 270
            D CR  L++  VE   R +  E   H F+
Sbjct: 235 SDHCRDFLKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 5e-28
 Identities = 71/231 (30%), Positives = 116/231 (50%), Gaps = 14/231 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+F  V++   +    EVAVK   +  L P +    L+E  IL    HPNI++   
Sbjct: 2   KIGKGNFGDVYKGVLKG-NTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
               ++ IY+V+E   GG L  ++ K      V + +        AAG++ L+ K+ IHR
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL--QMSLDAAAGMEYLESKNCIHR 117

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ--DLADTLCGSPL-YMAPEIIQNHKYDA 190
           DL  +N LV  N    VLKI DFG +R        ++D L   P+ + APE +   +Y +
Sbjct: 118 DLAARNCLVGENN---VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           ++D+WS G +L++  + G  P+ G +  Q  + I +   +  P    EE++
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIY 225

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  113 bits (283), Expect = 6e-28
 Identities = 77/269 (28%), Positives = 132/269 (49%), Gaps = 26/269 (9%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEI----DKKLLSPKVSDNLLKEISILSTISHPN 70
           G  +G G+F  V+       G E+AVK++    D +  S +V + L  EI +L  + H  
Sbjct: 7   GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKNLRHDR 65

Query: 71  IIRFFEAIE--TREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           I++++  +     +K+ + +EY  GG +   +  +G ++E V R + RQ+  G+  L   
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPLYMAPEIIQ 184
            ++HRD+K  N+L    +    +K+GDFG ++ +    ++ T    + G+P +M+PE+I 
Sbjct: 126 MIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS-TELRFPPGAIEELHPDC 243
              Y  KAD+WSV   + +++T KPP+     +     I T  T+   P G         
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV-------- 234

Query: 244 VDLCRCLLRQNPVE---RITFKEFFNHRF 269
            D CR  L+Q  VE   R T +    H F
Sbjct: 235 SDACRDFLKQIFVEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  113 bits (285), Expect = 7e-28
 Identities = 75/259 (28%), Positives = 136/259 (52%), Gaps = 17/259 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  AR +  G +VAVK +D  L   +  + L  E+ I+    H N++  ++
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    E++++++E+  GG L   + +     E +A      L A L  L  + +IHRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA-LCYLHSQGVIHRDIK 144

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD--TLCGSPLYMAPEIIQNHKYDAKADL 194
             ++L++ +     +K+ DFGF   ++ +D+    +L G+P +MAPE+I    Y  + D+
Sbjct: 145 SDSILLTLDGR---VKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH---PDCVDLCRCLL 251
           WS+G ++ ++V G+PP+   + +Q  + +  S     PP  ++  H   P   D    +L
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-----PPPKLKNAHKISPVLRDFLERML 255

Query: 252 RQNPVERITFKEFFNHRFL 270
            + P ER T +E  +H FL
Sbjct: 256 TREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 8e-28
 Identities = 79/258 (30%), Positives = 133/258 (51%), Gaps = 24/258 (9%)

Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G F  V R R +  G   I+VA+K + K   S K   + L E SI+    HPNIIR 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +     + ++ EY + G L  ++ ++ GK +       +R +A+G++ L E + +HR
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHR 130

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCG-SPL-YMAPEIIQNHKYDA 190
           DL  +N+LV++N V    K+ DFG +R L   +    T  G  P+ + APE I   K+ +
Sbjct: 131 DLAARNILVNSNLVC---KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187

Query: 191 KADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDCVD 245
            +D+WS G +++++++   +P +D SNQ  + + +     L  P   P A+ +L  DC  
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKAVEDGYRLPPPMDCPSALYQLMLDC-- 244

Query: 246 LCRCLLRQNPVERITFKE 263
                 +++  ER TF +
Sbjct: 245 -----WQKDRNERPTFSQ 257

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  113 bits (284), Expect = 8e-28
 Identities = 76/257 (29%), Positives = 129/257 (50%), Gaps = 13/257 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+K+++ +   PK  + ++ EI ++    +PNI+ + +
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPK-KELIINEILVMRENKNPNIVNYLD 83

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   + +   + E       R+    L  L    +IHRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+  +     +K+ DFGF   +TP Q    T+ G+P +MAPE++    Y  K D+W
Sbjct: 143 SDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILT--STELRFPPGAIEELHPDCVDLCRCLLRQ 253
           S+G +  ++V G+PP+   N L+    I T  + EL+ P    E L     D     L  
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP----ERLSAVFRDFLNRCLEM 255

Query: 254 NPVERITFKEFFNHRFL 270
           +   R + KE   H FL
Sbjct: 256 DVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  112 bits (282), Expect = 1e-27
 Identities = 77/261 (29%), Positives = 133/261 (50%), Gaps = 17/261 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           RIGSG++  V++AR+   G   A+K I  KL   +    + +EI ++    H NI+ +F 
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +   R+K+++ +E+C GG L    H  G +SE+   +  R+   GL  L  K  +HRD+K
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA--DTLCGSPLYMAPEIIQNHK---YDAK 191
             N+L++ N     +K+ DFG +  +T   +A   +  G+P +MAPE+    +   Y+  
Sbjct: 134 GANILLTDNG---HVKLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 192 ADLWSVGAILFQLVTGKPP-FDGSNQLQLFQNILTSTELRFPPGAIEELH--PDCVDLCR 248
            D+W+VG    +L   +PP FD      LF  ++T +  + PP   +++          +
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALF--LMTKSNFQ-PPKLKDKMKWSNSFHHFVK 246

Query: 249 CLLRQNPVERITFKEFFNHRF 269
             L +NP +R T ++   H F
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  113 bits (283), Expect = 1e-27
 Identities = 89/297 (29%), Positives = 142/297 (47%), Gaps = 37/297 (12%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHP 69
           YI   ++G G++A V++ R +     VA+KEI  + +  +P  +   ++E+S+L  + H 
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA---IREVSLLKDLKHA 64

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEK 128
           NI+   + I T + + LV EY D  DL  Y+   G  ++    + F+ QL  GL     +
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEI-IQNH 186
            ++HRDLKPQNLL+  NE    LK+ DFG AR+ + P         +  Y  P+I + + 
Sbjct: 124 KVLHRDLKPQNLLI--NERGE-LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-TSTELRFP---------- 232
            Y  + D+W VG I +++ TG+P F GS    QL     IL T TE  +P          
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240

Query: 233 -------PGAIEELHP----DCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVH 278
                     +    P    D  +L   LL+    +RI+ +E   H +   L + +H
Sbjct: 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH 297

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  112 bits (282), Expect = 1e-27
 Identities = 74/257 (28%), Positives = 133/257 (51%), Gaps = 13/257 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+++++ +   PK  + ++ EI ++    +PNI+ + +
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPK-KELIINEILVMRENKNPNIVNYLD 84

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   + +   + E       R+    L+ L    +IHRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+  +     +K+ DFGF   +TP Q    T+ G+P +MAPE++    Y  K D+W
Sbjct: 144 SDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILT--STELRFPPGAIEELHPDCVDLCRCLLRQ 253
           S+G +  +++ G+PP+   N L+    I T  + EL+ P    E+L     D     L  
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----EKLSAIFRDFLNRCLDM 256

Query: 254 NPVERITFKEFFNHRFL 270
           +  +R + KE   H+FL
Sbjct: 257 DVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  112 bits (281), Expect = 2e-27
 Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 33/270 (12%)

Query: 18  IGSGSFAVVWRARHRQLGIE-----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+      L  E     VAVK + K+  S     +  +E  +L+   H NI+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHG--------------KVSEAVARHFMRQL 118
           +F+      +   +V EY + GDL  ++  HG              +++ +       Q+
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-- 176
           A+G+  L  +H +HRDL  +N LV  +    V+KIGDFG +R +   D    + G  +  
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDL---VVKIGDFGMSRDVYTTDYY-RVGGHTMLP 187

Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             +M PE I   K+  ++D+WS G +L+++ T GK P+ G +  ++ + I     L+ P 
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR 247

Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKE 263
               E++    D+     +++P +RI  K+
Sbjct: 248 TCPSEVY----DIMLGCWKRDPQQRINIKD 273

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  112 bits (281), Expect = 2e-27
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 38/288 (13%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNL 56
           E  R RL     +G  +G G+F  V +A    L        VAVK +        +SD L
Sbjct: 8   ELPRDRLT----LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-L 62

Query: 57  LKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--- 112
           + E+ ++  I  H NII           +Y+V+EY   G+L  ++       E  +    
Sbjct: 63  VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122

Query: 113 -------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA 159
                         F  Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG A
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH---VMKIADFGLA 179

Query: 160 RSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSN 215
           R +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G  
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239

Query: 216 QLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
             +LF+ +     +  P    +EL+     +  C   + P +R TFK+
Sbjct: 240 VEELFKLLKEGYRMEKPQNCTQELY---HLMRDC-WHEVPSQRPTFKQ 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 3e-27
 Identities = 65/249 (26%), Positives = 121/249 (48%), Gaps = 15/249 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           +G G F  V   + R  G   A K+++KK +  +  + + L E  IL  ++   ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A ET++ + LVL   +GGDL  +I+  G     E  A  +  ++  GL+ L  + +++RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           LKP+N+L+        ++I D G A  +   +      G+  YMAPE+++N +Y    D 
Sbjct: 128 LKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDW 184

Query: 195 WSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           W +G ++++++ GK PF    +     ++ + +    E        E+       +CR L
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY-----SEKFSEAARSICRQL 239

Query: 251 LRQNPVERI 259
           L ++P  R+
Sbjct: 240 LTKDPGFRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  111 bits (278), Expect = 3e-27
 Identities = 77/263 (29%), Positives = 128/263 (48%), Gaps = 24/263 (9%)

Query: 18  IGSGSFAVVWRARHRQ-LG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           +GSG+F  V+       LG     I VAVK + K     +  +  LKE  ++S  +HPNI
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHPNI 61

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL-------AAGLQV 124
           ++        E  Y+++E  +GGDL +Y+              +++L       A G   
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTP--VLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
           L++ H IHRDL  +N LVS        V+KIGDFG AR +   D         L   +MA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE + + K+  ++D+WS G ++++++T G+ P+   N  ++ Q++     L+ P    ++
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDK 241

Query: 239 LHPDCVDLCRCLLRQNPVERITF 261
           ++   +  C     Q+P ER TF
Sbjct: 242 IY-QLMTNC---WAQDPSERPTF 260

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  111 bits (279), Expect = 4e-27
 Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 36/290 (12%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y+   ++G GS+A V++   R  G  VA+K I  K     V    ++E S+L  + H NI
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANI 65

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHL 130
           +   + I T+E +  V EY    DLA Y+ +H G +     R FM QL  GL  +  +H+
Sbjct: 66  VLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNH-KY 188
           +HRDLKPQNLL+S       LK+ DFG AR+ + P     +   +  Y  P+++     Y
Sbjct: 125 LHRDLKPQNLLISY---LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 189 DAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILT----STELR------------- 230
            +  D+W  G I  +++ G+P F G S+  +  + I T     TE               
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241

Query: 231 -FPPGAIEELH---------PDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
            F P   ++L          P   DL   +L   P +RI+ ++   H + 
Sbjct: 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  111 bits (279), Expect = 4e-27
 Identities = 78/230 (33%), Positives = 125/230 (54%), Gaps = 16/230 (6%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHP 69
           Y+   ++G G++A V++ R +     VA+KEI  + +  +P  +   ++E+S+L  + H 
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---IREVSLLKNLKHA 63

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEK 128
           NI+   + I T   + LV EY D  DL  Y+   G + S    + FM QL  GL    ++
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEI-IQNH 186
            ++HRDLKPQNLL+  NE    LK+ DFG AR+ + P         +  Y  P++ + + 
Sbjct: 123 KILHRDLKPQNLLI--NEKGE-LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQL-FQNILTSTELRFP 232
           +Y    D+W VG IL+++ TG+P F GS    +L L F+ + T TE  +P
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 62/264 (23%), Positives = 119/264 (45%), Gaps = 25/264 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD----NLLKEISILSTISHPNIIR 73
           +G GSF +V+    + +        +  K ++   S       L E S++   +  +++R
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-------GKVSEAVARHFMR---QLAAGLQ 123
               + T +   +V+E    GDL +Y+            +     + F++   ++A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAP 180
            L  K  +HRDL  +N +V+ +     +KIGDFG  R +   D         L   +MAP
Sbjct: 134 YLAAKKFVHRDLAARNCMVAEDLT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           E +++  +  K+D+WS G +L+++ T  + P+ G +  ++ + ++    L  P    ++L
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKL 250

Query: 240 HPDCVDLCRCLLRQNPVERITFKE 263
                +L R   + NP  R TF E
Sbjct: 251 L----ELMRMCWQYNPKMRPTFLE 270

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  110 bits (278), Expect = 5e-27
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 17/269 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI-LSTISHPNIIRFFE 76
           +G G++ VV + RH   G  +AVK I   + S +    LL ++ I + ++  P  + F+ 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 77  AIETREKIYLVLEYCDGG--DLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEK-HLIH 132
           A+     +++ +E  D         ++  G  + E +       +   L+ L  K  +IH
Sbjct: 68  ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIH 127

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL-CGSPLYMAPEII---QNHK- 187
           RD+KP N+L++ N     +K+ DFG +  L    +A T+  G   YMAPE I    N K 
Sbjct: 128 RDVKPSNVLINRNGQ---VKLCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           YD K+D+WS+G  + +L TG+ P+D  +    FQ +    E   P    E+  P+  D  
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYD--SWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV 241

Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQT 276
              L++N  ER  + E   H F       
Sbjct: 242 NKCLKKNYKERPNYPELLQHPFFELHLSK 270

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  110 bits (276), Expect = 5e-27
 Identities = 77/255 (30%), Positives = 131/255 (51%), Gaps = 25/255 (9%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW   +     +VA+K + +  +SP   +  L E +++  + HP ++R + 
Sbjct: 13  KLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLY- 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR------QLAAGLQVLQEKHL 130
           A+ T+E IY++ EY + G L  ++    K  E +     +      Q+A G+  ++ K+ 
Sbjct: 68  AVVTQEPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPL-YMAPEIIQNHKY 188
           IHRDL+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +
Sbjct: 124 IHRDLRAANILVSE---TLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 189 DAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
             K+D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+    +L 
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELY----ELM 236

Query: 248 RCLLRQNPVERITFK 262
           R   ++ P ER TF+
Sbjct: 237 RLCWKEKPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  111 bits (280), Expect = 7e-27
 Identities = 85/300 (28%), Positives = 130/300 (43%), Gaps = 51/300 (17%)

Query: 18  IGSGSFAVVWRARH--RQLGIEVAVKEI----DKKLLSPKVSDNLLKEISILSTI-SHPN 70
           +G G++ +V  AR+        VA+K+I     KK+L+ +     L+E+ +L     H N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA----LRELKLLRHFRGHKN 63

Query: 71  IIRFFEA-IETREK---IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           I   ++  I        +YL  E  +  DL   I     +++A  + F+ Q+  GL+ + 
Sbjct: 64  ITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-----QDLADTLCGSPLYMAPE 181
             +++HRDLKP NLLV+ +     LKI DFG AR  +               +  Y APE
Sbjct: 123 SANVLHRDLKPGNLLVNAD---CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 182 I-IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-TSTE-------- 228
           I +    Y    D+WSVG IL +L+  KP F G +   QL     +L T  E        
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 229 ---------LRFPPG-AIEELHP----DCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                    L   P    E + P      +DL   LL  +P +RI+ +E   H +L    
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  110 bits (276), Expect = 8e-27
 Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 15/249 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           +G G F  V   + R  G   A K+++KK +  +  + + L E  IL  ++   ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A ET++ + LVL   +GGDL  +I+  G     E  A  +  +L  GL+ LQ + +++RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           LKP+N+L+        ++I D G A  +   +      G+  YMAPE+I N KY    D 
Sbjct: 128 LKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDW 184

Query: 195 WSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           W +G ++++++ G+ PF    +     ++ + +    E        E+   D   +CR L
Sbjct: 185 WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE-----EYSEKFSEDAKSICRML 239

Query: 251 LRQNPVERI 259
           L +NP ER+
Sbjct: 240 LTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  109 bits (275), Expect = 8e-27
 Identities = 72/263 (27%), Positives = 136/263 (51%), Gaps = 22/263 (8%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL- 68

Query: 77  AIETREK-IYLVLEYCDGGDLAAYIHKHGKVS-EAVARHFM-RQLAAGLQVLQEKHLIHR 133
            + TRE   Y++ E+   G+L  Y+ +  +    AV   +M  Q+++ ++ L++K+ IHR
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS--PL-YMAPEIIQNHKYDA 190
           DL  +N LV  N    ++K+ DFG +R +T  D      G+  P+ + APE +  +K+  
Sbjct: 129 DLAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G      P   +L R 
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGC----PPKVYELMRA 240

Query: 250 LLRQNPVERITFKEF---FNHRF 269
             + NP +R +F E    F   F
Sbjct: 241 CWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  110 bits (276), Expect = 9e-27
 Identities = 67/248 (27%), Positives = 129/248 (52%), Gaps = 13/248 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           +G G F  V   + R  G   A K+++KK +  +  +++ L E  IL  ++   ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVS--EAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A ET++ + LVL   +GGDL  +I+  G+    E  A  +  ++  GL+ L ++ +++RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           LKP+N+L+  +     ++I D G A  +          G+  YMAPE+++N +Y    D 
Sbjct: 128 LKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDW 184

Query: 195 WSVGAILFQLVTGKPPFDGSN---QLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           W++G +L++++ G+ PF       + +  + ++   +  +     E+  PD   LC+ LL
Sbjct: 185 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS----EKFSPDARSLCKMLL 240

Query: 252 RQNPVERI 259
            ++P ER+
Sbjct: 241 CKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  110 bits (275), Expect = 1e-26
 Identities = 79/274 (28%), Positives = 138/274 (50%), Gaps = 34/274 (12%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP--KVSDNLLKEISILSTIS-HPNIIRF 74
           IG G++  V++  +++ G + AVK     +L P   + + +  E +IL  +S HPN+++F
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-----ILDPIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 75  F-----EAIETREKIYLVLEYCDGG---DLAAYIHKHG-KVSEAVARHFMRQLAAGLQVL 125
           +     + ++  ++++LVLE C+GG   DL     K G ++ E +  + + +   GLQ L
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQ 184
                IHRD+K  N+L++T      +K+ DFG +  LT   L  +T  G+P +MAPE+I 
Sbjct: 141 HVNKTIHRDVKGNNILLTTEG---GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197

Query: 185 -----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE- 238
                +  YDA+ D+WS+G    +L  G PP    + ++    I      R PP  + + 
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI-----PRNPPPTLHQP 252

Query: 239 --LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                +  D  R  L ++  +R T  +   H F+
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 1e-26
 Identities = 71/262 (27%), Positives = 126/262 (48%), Gaps = 29/262 (11%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           E  +G  IG G F  V    +R  G +VAVK +         +   L E S+++T+ HPN
Sbjct: 7   ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPN 61

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEK 128
           +++    +     +Y+V EY   G L  Y+   G+  ++ A    F   +  G++ L+EK
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQN 185
           + +HRDL  +N+LVS + V    K+ DFG A+  +            L   + APE ++ 
Sbjct: 122 NFVHRDLAARNVLVSEDLVA---KVSDFGLAKEAS-----QGQDSGKLPVKWTAPEALRE 173

Query: 186 HKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHP 241
            K+  K+D+WS G +L+++ + G+ P+       +  ++     +  P   P  + ++  
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233

Query: 242 DCVDLCRCLLRQNPVERITFKE 263
           DC +L       +P +R TFK+
Sbjct: 234 DCWEL-------DPAKRPTFKQ 248

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  111 bits (278), Expect = 2e-26
 Identities = 87/299 (29%), Positives = 138/299 (46%), Gaps = 55/299 (18%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    LGI VAVK++ +   +   +    +E+ +L  ++H NII     
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +YLV+E  D  +L   IH    H ++S     + + Q+  G++ L   
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSA 142

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 143 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 199

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQL--------QL------FQNILTST------- 227
               D+WSVG I+ +LV G   F G++ +        QL      F N L  T       
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259

Query: 228 ELRFPPGAIEELHPDCV----------------DLCRCLLRQNPVERITFKEFFNHRFL 270
             ++P  + EEL PD +                DL   +L  +P +RI+  E   H ++
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  109 bits (272), Expect = 2e-26
 Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 16/264 (6%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN---LLKEISILSTISHPNI 71
           G  +G G+F  V+       G E+A K++     SP+ S     L  EI +L  + H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 72  IRFFEAIETR--EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           ++++  +  R  + + + +EY  GG +   +  +G ++E+V R + RQ+  G+  L    
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPLYMAPEIIQN 185
           ++HRD+K  N+L    +    +K+GDFG ++ L    ++ T    + G+P +M+PE+I  
Sbjct: 127 IVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
             Y  KAD+WS+G  + +++T KPP+     +     I T       P  I E      D
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE---HARD 240

Query: 246 LCRCLLRQNPVERITFKEFFNHRF 269
              C+  +    R + +E   H F
Sbjct: 241 FLGCIFVEAR-HRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  109 bits (273), Expect = 2e-26
 Identities = 63/232 (27%), Positives = 123/232 (53%), Gaps = 20/232 (8%)

Query: 51  KVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEA 109
           K +++   E  +L  +   P ++    A +T  K++L+L+Y +GG+L  ++++    +E+
Sbjct: 46  KTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES 105

Query: 110 VARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP--QDL 167
             R ++ ++   L  L +  +I+RD+K +N+L+ +      + + DFG ++      ++ 
Sbjct: 106 EVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG---HVVLTDFGLSKEFLAEEEER 162

Query: 168 ADTLCGSPLYMAPEIIQNHK--YDAKADLWSVGAILFQLVTGKPPF--DG--SNQLQLFQ 221
           A + CG+  YMAPE+I+     +D   D WS+G + F+L+TG  PF  DG  ++Q ++ +
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222

Query: 222 NILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITF---KEFFNHRFL 270
            IL S +  FP      +  +  D  + LL ++P +R+      E  NH F 
Sbjct: 223 RILKS-KPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  109 bits (274), Expect = 2e-26
 Identities = 75/288 (26%), Positives = 129/288 (44%), Gaps = 43/288 (14%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN------ 55
           + N    +GE      IGSG+   V++ R ++ G  +AVK++ +       + N      
Sbjct: 13  DLNDLENLGE------IGSGTCGQVYKMRFKKTGHVMAVKQMRR-------TGNKEENKR 59

Query: 56  LLKEISILSTISH--PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK-----HGKVSE 108
           +L ++ ++   SH  P I++ +    T   +++ +E      ++  + K      G + E
Sbjct: 60  ILMDLDVVLK-SHDCPYIVKCYGYFITDSDVFICMEL-----MSTCLDKLLKRIQGPIPE 113

Query: 109 AVARHFMRQLAAGLQVLQEKH-LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL 167
            +       +   L  L+EKH +IHRD+KP N+L+  +     +K+ DFG +  L     
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN---VKLCDFGISGRLVDSKA 170

Query: 168 ADTLCGSPLYMAPEII----QNHKYDAKADLWSVGAILFQLVTGKPPFDGSN-QLQLFQN 222
                G   YMAPE I     N KYD +AD+WS+G  L +L TG+ P+     + ++   
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK 230

Query: 223 ILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           IL       PP   E   PD        L ++  +R  ++E   H F+
Sbjct: 231 ILQEEPPSLPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  108 bits (272), Expect = 3e-26
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 37/285 (12%)

Query: 18  IGSGSFAVVWRARH-RQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL---STISHPNIIR 73
           IG G++  V++AR  +  G  VA+K +  +     +  + ++E+++L    T  HPN++R
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 74  FFEA-----IETREKIYLVLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQ 126
            F+       +   K+ LV E+ D  DL  Y+ K     V     +  M QL  GL  L 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              ++HRDLKPQN+LV++   +  +K+ DFG AR  + Q    ++  +  Y APE++   
Sbjct: 128 SHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT----------STELRFPPGA- 235
            Y    DLWSVG I  ++   KP F GS+ +     IL             ++  P  A 
Sbjct: 185 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244

Query: 236 -------IEELHPDCVDLCRCLLRQ----NPVERITFKEFFNHRF 269
                  IE+   D  +L + LL +    NP +RI+     +H +
Sbjct: 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 5e-26
 Identities = 67/254 (26%), Positives = 126/254 (49%), Gaps = 23/254 (9%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG F VV    WR +     I+VA+K I +  +S    D+ ++E  ++  +SHPN+++
Sbjct: 12  LGSGQFGVVHLGKWRGK-----IDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQ 63

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I++V EY   G L  Y+ +  GK+           +   ++ L+    IH
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL  +N LV  +    V+K+ DFG AR  L  Q  +      P+ +  PE+    ++ +
Sbjct: 124 RDLAARNCLVGEDN---VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D+WS G +++++ + GK P++  +  ++ +++     L  P  A  E++     +  C
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVY---TIMYSC 237

Query: 250 LLRQNPVERITFKE 263
              + P +R  FK+
Sbjct: 238 WH-EKPEDRPAFKK 250

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  109 bits (273), Expect = 5e-26
 Identities = 83/292 (28%), Positives = 130/292 (44%), Gaps = 40/292 (13%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF--- 74
           +GSG++  V  A  R+ G +VA+K++ +   S   +    +E+ +L  + H N+I     
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 75  FEAIETREKI---YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           F    + ++    YLV+ +  G DL   + KH K+SE   +  + Q+  GL+ +    +I
Sbjct: 83  FTPDLSLDRFHDFYLVMPFM-GTDLGK-LMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDA 190
           HRDLKP NL V  NE    LKI DFG AR    +     +  +  Y APE+I N   Y  
Sbjct: 141 HRDLKPGNLAV--NEDCE-LKILDFGLARQTDSEMTGYVV--TRWYRAPEVILNWMHYTQ 195

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNI--------------LTSTELRFPPGAI 236
             D+WSVG I+ +++TGKP F G + L     I              L S + +     +
Sbjct: 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255

Query: 237 EEL------------HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
                          +P  V++   +L  +   RIT  E   H +  E    
Sbjct: 256 PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  108 bits (270), Expect = 6e-26
 Identities = 70/261 (26%), Positives = 135/261 (51%), Gaps = 21/261 (8%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  +  G +VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L  L  + +IHRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++++     +K+ DFGF   ++ +     +L G+P +MAPE+I    Y  + D+W
Sbjct: 146 SDSILLTSDGR---IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP------DCVDLCRC 249
           S+G ++ +++ G+PP+     LQ  + I  +     PP  +++ H         +DL   
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN----LPP-RVKDSHKVSSVLRGFLDL--- 254

Query: 250 LLRQNPVERITFKEFFNHRFL 270
           +L + P +R T +E   H FL
Sbjct: 255 MLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  107 bits (269), Expect = 7e-26
 Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 38/286 (13%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS---HPNIIRF 74
           IG G++  V++AR    G  VA+K +  +     +  + ++E+++L  +    HPNI+R 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 75  FEAIET----RE-KIYLVLEYCDGGDLAAYIHK---HGKVSEAVARHFMRQLAAGLQVLQ 126
            +   T    RE K+ LV E+ D  DL  Y+ K    G  +E + +  MRQ   GL  L 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETI-KDLMRQFLRGLDFLH 125

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              ++HRDLKP+N+LV++      +K+ DFG AR  + Q     +  +  Y APE++   
Sbjct: 126 ANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDG---SNQL-QLFQNILTSTELRFP---------- 232
            Y    D+WSVG I  ++   KP F G   ++QL ++F  I    E  +P          
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAF 242

Query: 233 ----PGAIEELHPDC----VDLCRCLLRQNPVERITFKEFFNHRFL 270
               P  ++ + P+       L   +L  NP +RI+      H F 
Sbjct: 243 SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  108 bits (270), Expect = 8e-26
 Identities = 93/290 (32%), Positives = 140/290 (48%), Gaps = 27/290 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG GSF  V+ AR  +    VA+K++    K  + K  D ++KE+  L  + HPN I++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHPNTIQYR 81

Query: 76  EAIETREKIYLVLEYCDG--GDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                    +LV+EYC G   DL   +HK    +V  A   H   Q   GL  L   ++I
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQ---GLAYLHSHNMI 137

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII---QNHKY 188
           HRD+K  N+L+S      ++K+GDFG A  + P   A+   G+P +MAPE+I      +Y
Sbjct: 138 HRDVKAGNILLSE---PGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQY 191

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           D K D+WS+G    +L   KPP    N +    +I  +       G   E   + VD C 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC- 250

Query: 249 CLLRQNPVERITFKEFFNHRFLGELR-QTVHAEQHSVVPETKPMVELLNS 297
             L++ P +R T +    HRF+   R  TV  +   ++  TK  V  L++
Sbjct: 251 --LQKIPQDRPTSEVLLKHRFVLRERPPTVIMD---LIQRTKDAVRELDN 295

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  107 bits (269), Expect = 8e-26
 Identities = 78/284 (27%), Positives = 136/284 (47%), Gaps = 41/284 (14%)

Query: 13  IVGPRIGSGSFAVVWRARHRQL----GIE-VAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           ++G  +G G F  V +A   +L    G   VAVK + K+  S     +LL E ++L  ++
Sbjct: 3   VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLSEFNLLKQVN 61

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH-------------- 113
           HP++I+ + A      + L++EY   G L +++ +  KV  +                  
Sbjct: 62  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 114 ----------FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT 163
                     F  Q++ G+Q L E  L+HRDL  +N+LV+       +KI DFG +R + 
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR---KMKISDFGLSRDVY 178

Query: 164 PQD--LADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQL 219
            +D  +  +    P+ +MA E + +H Y  ++D+WS G +L+++VT G  P+ G    +L
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238

Query: 220 FQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
           F  + T   +  P    EE++    +L     +Q P +R TF +
Sbjct: 239 FNLLKTGYRMERPENCSEEMY----NLMLTCWKQEPDKRPTFAD 278

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  107 bits (268), Expect = 9e-26
 Identities = 66/252 (26%), Positives = 125/252 (49%), Gaps = 13/252 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           +G G F  V   + R  G   A K ++KK +  +  +++ L E  IL  ++   ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A ET++ + LVL   +GGDL  +I+  G     E  A  +  ++  GL+ L  ++ ++RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           LKP+N+L+        ++I D G A  +   +      G+  YMAPE++ N +Y    D 
Sbjct: 128 LKPENILLDDYGH---IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDY 184

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNI---LTSTELRFPPGAIEELHPDCVDLCRCLL 251
           W +G ++++++ G+ PF G  +    + +   +  TE  +     E    +   +C+ LL
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSE----EAKSICKMLL 240

Query: 252 RQNPVERITFKE 263
            ++P +R+  +E
Sbjct: 241 TKDPKQRLGCQE 252

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  106 bits (266), Expect = 1e-25
 Identities = 78/244 (31%), Positives = 130/244 (53%), Gaps = 28/244 (11%)

Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V   R +  G   I VA+K + K   + K   + L E SI+    HPNII  
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIH- 69

Query: 75  FEAIETREK-IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            E + T+ K + +V EY + G L A++ KH G+ +       +R +A+G++ L +   +H
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH 129

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLADTLCGS-PL-YMAPEIIQNHKY 188
           RDL  +N+LV++N V    K+ DFG +R L   P+    T  G  P+ + APE I   K+
Sbjct: 130 RDLAARNILVNSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 189 DAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEEL 239
            + +D+WS G +++++++   +P ++ SN     Q+++ + E   R P     P A+ +L
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIKAIEEGYRLPAPMDCPAALHQL 241

Query: 240 HPDC 243
             DC
Sbjct: 242 MLDC 245

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  107 bits (267), Expect = 1e-25
 Identities = 70/259 (27%), Positives = 132/259 (50%), Gaps = 13/259 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  +  G  VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L VL  + +IHRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++ +     +K+ DFGF   ++ +     +L G+P +MAPE+I    Y  + D+W
Sbjct: 144 SDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP--GAIEELHPDCVDLCRCLLRQ 253
           S+G ++ ++V G+PP+     L+  + I  +     PP    + ++ P        LL +
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----LPPKLKNLHKVSPSLKGFLDRLLVR 256

Query: 254 NPVERITFKEFFNHRFLGE 272
           +P +R T  E   H FL +
Sbjct: 257 DPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  108 bits (270), Expect = 1e-25
 Identities = 62/207 (29%), Positives = 116/207 (56%), Gaps = 9/207 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 131

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 132 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187

Query: 197 VGAILFQLVTGK---PPFDGSNQLQLF 220
           +G  L ++  G+   PP D      +F
Sbjct: 188 MGLSLVEMAIGRYPIPPPDAKELELMF 214

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  108 bits (272), Expect = 1e-25
 Identities = 69/288 (23%), Positives = 126/288 (43%), Gaps = 52/288 (18%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   R        A+K + K  +L    + ++  E  IL+   +  +++ + 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + + ++ +Y V++Y  GGD+ + + + G   E +AR ++ +L   ++ + +   IHRD+K
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK 128

Query: 137 PQNLLVSTNEVTPVLKIGDFGF------------------AR--SLTPQD---------- 166
           P N+L+  +     +K+ DFG                    R  S+ P +          
Sbjct: 129 PDNILIDRDGH---IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185

Query: 167 --------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFD 212
                         LA +L G+P Y+APE++    Y    D WSVG IL++++ G+PPF 
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245

Query: 213 GSNQLQLFQNILT-STELRFPPGAIEELHPDCVDLCRCLLRQNPVERI 259
                +    ++   T L  P  A  +L  +  DL   L      +R+
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQA--KLSREASDLILRLCC-GAEDRL 290

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 2e-25
 Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 27/260 (10%)

Query: 17  RIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
            +G G+F  V    +  +  +  +EVAVK + K+          L+E S+++ + HP I+
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKE-VEVAVKTL-KQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           R    +   E + LV+E    G L  Y+ K  ++  +  +    Q+A G+  L+ KH +H
Sbjct: 60  RLI-GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118

Query: 133 RDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHK 187
           RDL  +N LLV+ ++     KI DFG +R+L        A T    PL + APE I   K
Sbjct: 119 RDLAARNVLLVNRHQA----KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP---DC 243
           + +K+D+WS G  L++  + G  P+      ++   + +   L  P    +E++     C
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234

Query: 244 VDLCRCLLRQNPVERITFKE 263
                   +  P +R TF E
Sbjct: 235 -------WKYRPEDRPTFSE 247

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  105 bits (264), Expect = 2e-25
 Identities = 66/233 (28%), Positives = 120/233 (51%), Gaps = 14/233 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IGSG F +VW   +     +VA+K I +  +S    ++ ++E  ++  +SHP +++ +  
Sbjct: 12  IGSGQFGLVWLG-YWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 78  IETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
              R  I LV E+ + G L+ Y+  + GK S+         +  G+  L+  ++IHRDL 
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127

Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPL-YMAPEIIQNHKYDAKADL 194
            +N LV  N+   V+K+ DFG  R  L  Q  + T    P+ + +PE+    KY +K+D+
Sbjct: 128 ARNCLVGENQ---VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184

Query: 195 WSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEELHPDC 243
           WS G +++++ + GK P++  +  ++ + I     L   R    ++ EL   C
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  106 bits (266), Expect = 3e-25
 Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 46/277 (16%)

Query: 22  SFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLL----KEISILSTISHPNIIRFFEA 77
           +FA    A    L   VAVK     +L P  SDN      KE+ ILS +S PNI R    
Sbjct: 36  AFAENDNADAPVL---VAVK-----VLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV 87

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKH-----------GKVSEAVARHFMRQLAAGLQVLQ 126
                 + +++EY + GDL  ++ KH             +S +   +   Q+A+G++ L+
Sbjct: 88  CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE 147

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEII 183
             + +HRDL  +N LV  N     +KI DFG +R+L   D       +PL   +MA E +
Sbjct: 148 SLNFVHRDLATRNCLVGKNY---TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204

Query: 184 QNHKYDAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNIL-------TSTELRFPPG 234
              K+  K+D+W+ G  L++++T   + P++     Q+ +N             L  PP 
Sbjct: 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPN 264

Query: 235 AIEELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFL 270
             ++++    +L   C  R++  +R TF+E   H FL
Sbjct: 265 CPKDIY----ELMLEC-WRRDEEDRPTFREI--HLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  106 bits (265), Expect = 3e-25
 Identities = 86/303 (28%), Positives = 149/303 (49%), Gaps = 37/303 (12%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHP 69
           YI   ++G G++A V++ R +     VA+KEI  + +  +P  +   ++E+S+L  + H 
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---IREVSLLKDLKHA 64

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEK 128
           NI+   + + T + + LV EY D  DL  Y+   G + S    + F+ Q+  GL     +
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEI-IQNH 186
            ++HRDLKPQNLL+  NE    LK+ DFG AR+ + P         +  Y  P++ + + 
Sbjct: 124 KVLHRDLKPQNLLI--NERGE-LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL-TSTELRFPP-GAIEE--- 238
           +Y  + D+W VG I F++ +G+P F GS   ++L L   +L T TE  +P   + +E   
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240

Query: 239 -----------------LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQ 281
                            L  + ++L    L+    +RI+ +E   H +   L   +H+  
Sbjct: 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLP 300

Query: 282 HSV 284
            S+
Sbjct: 301 ESI 303

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  104 bits (261), Expect = 4e-25
 Identities = 65/224 (29%), Positives = 121/224 (54%), Gaps = 21/224 (9%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG F VV    WRA+     I+VA+K I++  +S    ++ ++E  ++  +SHP +++
Sbjct: 12  LGSGQFGVVHLGKWRAQ-----IKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQ 63

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     ++ +Y+V E+ + G L  Y+  + GK+S+ +     + +  G++ L+    IH
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LVS+   T V+K+ DFG  R +   D   +  G+     +  PE+    KY 
Sbjct: 124 RDLAARNCLVSS---TGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYS 179

Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           +K+D+WS G +++++ T GK PF+  +  ++ + I     L  P
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  104 bits (261), Expect = 4e-25
 Identities = 67/237 (28%), Positives = 124/237 (52%), Gaps = 12/237 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIE--VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++    E  VAVK +      P + D LL+E +++  + +P I+R  
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  ++ K+  V+E      + Q++ G++ L+E + +HRDL
Sbjct: 63  GICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE +  +K+ +K
Sbjct: 122 AARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178

Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++ Q I +   +  P     E++ D + LC
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY-DLMKLC 234

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  105 bits (262), Expect = 5e-25
 Identities = 77/251 (30%), Positives = 132/251 (52%), Gaps = 19/251 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKE---ISILSTISHPNIIR 73
           IG G F  V+  R    G   A+K +DKK +  K  + L L E   +S++ST   P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              A  T +K+  +L+  +GGDL  ++ +HG  SEA  R +  ++  GL+ +  + +++R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDAKA 192
           DLKP N+L+  +     ++I D G A   + +    ++ G+  YMAPE++Q    YD+ A
Sbjct: 122 DLKPANILLDEHG---HVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSA 177

Query: 193 DLWSVGAILFQLVTGKPPFDG---SNQLQLFQNILT-STELRFPPGAIEELHPDCVDLCR 248
           D +S+G +LF+L+ G  PF      ++ ++ +  LT + EL   P       P+   L  
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PD---SFSPELRSLLE 231

Query: 249 CLLRQNPVERI 259
            LL+++   R+
Sbjct: 232 GLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  105 bits (262), Expect = 6e-25
 Identities = 66/210 (31%), Positives = 112/210 (53%), Gaps = 22/210 (10%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFE 76
           IG G++  V++  +++ G   AVK +D       V + +  E +IL ++  HPN+++F+ 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDP---ISDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 77  AIETREK-----IYLVLEYCDGGDLAAYIH---KHG-KVSEAVARHFMRQLAAGLQVLQE 127
                +K     ++LVLE C+GG +   +      G ++ EA+  + +     GLQ L  
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQ-- 184
             +IHRD+K  N+L++T      +K+ DFG +  LT   L  +T  G+P +MAPE+I   
Sbjct: 147 NRIIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203

Query: 185 ---NHKYDAKADLWSVGAILFQLVTGKPPF 211
              ++ YDA+ D+WS+G    +L  G PP 
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (262), Expect = 6e-25
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 34/272 (12%)

Query: 18  IGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G F  V   R+       G +VAVK +       +   +  +EI IL T+ H NI++
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 74  FFEAIE--TREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHL 130
           +    E      + L++EY   G L  Y+ +H  +++      F  Q+  G+  L  +  
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRY 130

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNH 186
           IHRDL  +N+LV + +   ++KI DFG A+ L              SP+ + APE ++  
Sbjct: 131 IHRDLAARNILVESED---LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 187 KYDAKADLWSVGAILFQLVT-GKP-------------PFDGSNQLQLFQNILTSTE-LRF 231
           K+ + +D+WS G  L++L T G P                G   +     +L   E L  
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247

Query: 232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
           PP   +E++    DL +      P +R +F +
Sbjct: 248 PPSCPDEVY----DLMKLCWEAEPQDRPSFAD 275

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  104 bits (261), Expect = 6e-25
 Identities = 67/248 (27%), Positives = 119/248 (47%), Gaps = 12/248 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           +G G F  V   + +  G   A K++DKK L  K  + + L E  IL  ++ P I+    
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A E++  + LV+   +GGDL  +I+  G+    + R  H+  Q+  G+  L    +++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           +KP+N+L+         ++ D G A  L          G+  YMAPEI++   Y    D 
Sbjct: 121 MKPENVLLDDQGNC---RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDW 177

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTST---ELRFPPGAIEELHPDCVDLCRCLL 251
           +++G  ++++V G+ PF    +    + +   T   E++F      E   +  D+CR  L
Sbjct: 178 FAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTE---ESKDICRLFL 234

Query: 252 RQNPVERI 259
            + P +R+
Sbjct: 235 AKKPEDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  106 bits (267), Expect = 7e-25
 Identities = 88/307 (28%), Positives = 132/307 (42%), Gaps = 61/307 (19%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL------LKEISILSTISHPNI 71
           IG G+F VVW     + G  VA+K++      P V  NL       +E+ +L    H N+
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKM------PNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 72  IRFFEAIETR-----EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           +   + ++       E+IY+V E     DL   I     +S    + F+ Q+  GL+ L 
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG------SPLYMAP 180
              ++HRD+KP NLLV++N    VLKI DFG AR   P    D          +  Y AP
Sbjct: 121 SAGILHRDIKPGNLLVNSN---CVLKICDFGLARVEEP----DESKHMTQEVVTQYYRAP 173

Query: 181 EIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTSTELRFPPGAI 236
           EI+   + Y +  D+WSVG I  +L+  +  F   +   QL L  ++L +  L     A 
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233

Query: 237 EE---------LHPDCVD----------------LCRCLLRQNPVERITFKEFFNHRFLG 271
           E            P  +                 LCR +L  +P +RI+  +   H +L 
Sbjct: 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCR-MLVFDPDKRISAADALAHPYLD 292

Query: 272 ELRQTVH 278
           E R   H
Sbjct: 293 EGRLRYH 299

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  103 bits (259), Expect = 9e-25
 Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 16/250 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW   +     +VAVK +    +S +     L+E +++ T+ H  ++R + 
Sbjct: 13  KLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYA 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            +   E IY++ EY   G L  ++     GKV       F  Q+A G+  ++ K+ IHRD
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    + + KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 129 LRAANVLVSE---SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L+++VT GK P+ G +   +   +     +       +EL+    D+ +   
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY----DIMKTCW 241

Query: 252 RQNPVERITF 261
           ++   ER TF
Sbjct: 242 KEKAEERPTF 251

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 28/266 (10%)

Query: 18  IGSGSFAVVWRARHRQLGIEV-AVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRFF 75
           IG G+F  V +AR ++ G+ + A  +  K+  S     +   E+ +L  + H PNII   
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHK-------------HGKVSEAVARHFMR---QLA 119
            A E R  +YL +EY   G+L  ++ K             +   S   ++  +     +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-YM 178
            G+  L +K  IHRDL  +N+LV  N V    KI DFG +R      +  T+   P+ +M
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRG-QEVYVKKTMGRLPVRWM 178

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           A E +    Y   +D+WS G +L+++V+ G  P+ G    +L++ +     L  P    +
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKE 263
           E++    DL R   R+ P ER +F +
Sbjct: 239 EVY----DLMRQCWREKPYERPSFAQ 260

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (257), Expect = 2e-24
 Identities = 73/253 (28%), Positives = 124/253 (49%), Gaps = 21/253 (8%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW         +VAVK +    +SP   ++ L+E  I+  + H  +++ + 
Sbjct: 13  KLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLY- 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     +  K+   V      Q+AAG+  ++  + IH
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIERMNYIH 125

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV    V    KI DFG AR +   +  A      P+ + APE     ++  
Sbjct: 126 RDLRSANILVGDGLVC---KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D+WS G +L +LVT G+ P+ G N  ++ + +     +  P      LH    +L   
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLH----ELMLQ 238

Query: 250 LLRQNPVERITFK 262
             +++P ER TF+
Sbjct: 239 CWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  105 bits (263), Expect = 2e-24
 Identities = 83/317 (26%), Positives = 140/317 (44%), Gaps = 65/317 (20%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK--LLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G G+F  V  AR        A+K + KK  LL  +V+ ++  E  IL+   +  ++R +
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVA-HVKAERDILAEADNEWVVRLY 67

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + + ++ +Y V++Y  GGD+ + + + G   E +AR ++ +L   ++ + +   IHRD+
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDI 127

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARS---------------------------------- 161
           KP N+L+  +     +K+ DFG                                      
Sbjct: 128 KPDNILIDRDG---HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184

Query: 162 ----LTPQD----------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG 207
               L P +          LA +L G+P Y+APE++    Y    D WSVG IL++++ G
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244

Query: 208 KPPFDGSNQLQLFQNILT-STELRFPPGAIEELHPDCVDLCRCLLR-------QNPVERI 259
           +PPF     L+    ++   T L  PP A  +L P+  DL   L R       +N  + I
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQA--KLSPEASDLIIKLCRGPEDRLGKNGADEI 302

Query: 260 TFKEFFNH-RFLGELRQ 275
               FF    F  +LRQ
Sbjct: 303 KAHPFFKTIDFSSDLRQ 319

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  104 bits (260), Expect = 2e-24
 Identities = 61/207 (29%), Positives = 115/207 (55%), Gaps = 9/207 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV + +H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + +  ++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVK 131

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 132 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187

Query: 197 VGAILFQLVTGK---PPFDGSNQLQLF 220
           +G  L +L  G+   PP D      +F
Sbjct: 188 MGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  103 bits (257), Expect = 3e-24
 Identities = 68/252 (26%), Positives = 125/252 (49%), Gaps = 10/252 (3%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFE 76
           +G G F  V   + R  G   A K+++KK L   K  +  + E  IL+ +    I+    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A +T+  + LV+   +GGDL  +I+    ++    E  A  +  Q+ +GL+ L ++ +I+
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLKP+N+L+  +     ++I D G A  L   Q       G+P +MAPE++Q  +YD  
Sbjct: 121 RDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D +++G  L++++  + PF    + ++    L    L       ++  P     C  LL
Sbjct: 178 VDYFALGVTLYEMIAARGPFRARGE-KVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236

Query: 252 RQNPVERITFKE 263
            ++P +R+ F++
Sbjct: 237 AKDPEKRLGFRD 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  104 bits (261), Expect = 3e-24
 Identities = 85/308 (27%), Positives = 142/308 (46%), Gaps = 25/308 (8%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHP 69
           +Y V   IG G+F  V   RH+      A+K + K +++    S    +E  I++  + P
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            +++ F A +  + +Y+V+EY  GGDL   +  +  V E  A+ +  ++   L  +    
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA--DTLCGSPLYMAPEIIQNHK 187
           LIHRD+KP N+L+  +     LK+ DFG    +    +   DT  G+P Y++PE++++  
Sbjct: 163 LIHRDVKPDNMLLDKHG---HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 188 ----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-STELRFPPGAIEELHPD 242
               Y  + D WSVG  LF+++ G  PF   + +  +  I+     L FP       H  
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279

Query: 243 CVDLCRCL------LRQNPVERITFKEFFNHRFLG--ELRQTVHAEQHSVVPETKPMVEL 294
            + +C  L      L +N VE I    FF +       +R+T       VVPE    ++ 
Sbjct: 280 NL-ICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETA----APVVPELSSDIDS 334

Query: 295 LNSSTPED 302
            N    ED
Sbjct: 335 SNFDDIED 342

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  103 bits (258), Expect = 3e-24
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 33/267 (12%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTI-SHP 69
           G  +G+G+F  V  A    L    AV ++  K+L P       + L+ E+ I+S + +H 
Sbjct: 40  GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-----HFMRQLAAGLQV 124
           NI+    A      I ++ EYC  GDL  ++ +     E+         F  Q+A G+  
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAF 156

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS---PL-YMAP 180
           L  K+ IHRDL  +N+L++  ++    KI DFG AR +   D    + G+   P+ +MAP
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIV---KICDFGLARDIM-NDSNYVVKGNARLPVKWMAP 212

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG----SNQLQLFQNILTSTELRFPPGA 235
           E I N  Y  ++D+WS G +L+++ + G  P+ G    S   +L +      +    P  
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272

Query: 236 IEELHPDCVDLCRCLLRQNPVERITFK 262
           I ++   C D        +P++R TFK
Sbjct: 273 IYDIMKTCWDA-------DPLKRPTFK 292

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 3e-24
 Identities = 77/303 (25%), Positives = 128/303 (42%), Gaps = 67/303 (22%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK--------EISILSTISHP 69
           IG G+F  V   + +  G   A+K++ K       S+ L K        E  IL+   +P
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRK-------SEMLEKEQVAHVRAERDILAEADNP 61

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            +++ + + +    +YL++EY  GGD+   + K    +E   R ++ +    +  + +  
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFG------------FARSLT---PQDLADTLC-- 172
            IHRD+KP NLL+        +K+ DFG            F R L+   P +  D +   
Sbjct: 122 YIHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 173 ----------------------GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPP 210
                                 G+P Y+APE+     Y+ + D WS+G I+++++ G PP
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Query: 211 FDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDL-CRCL------LRQNPVERITFK 262
           F   N  + ++ I+   E L+FP      L P+  DL  R        L  N V  I   
Sbjct: 239 FCSDNPQETYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296

Query: 263 EFF 265
            FF
Sbjct: 297 PFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  104 bits (261), Expect = 4e-24
 Identities = 80/303 (26%), Positives = 134/303 (44%), Gaps = 27/303 (8%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   RH+      A+K + K +++    S    +E  I++  +   I++   
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +  + +Y+V+EY  GGDL   +  +  + E  AR +  ++   L  +     IHRD+K
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQNHKYDA---- 190
           P N+L+  +     LK+ DFG    +    +   DT  G+P Y++PE++++   D     
Sbjct: 170 PDNMLLDKSG---HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-STELRFPPGAIEELHPDCVDLCRC 249
           + D WSVG  L++++ G  PF   + +  +  I+     L FP     E+     DL   
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--EISKQAKDLICA 284

Query: 250 LLRQNPVE--RITFKEFFNHRFL-------GELRQTVHAEQHSVVPETKPMVELLNSSTP 300
            L    V   R    E  +H F          +R+TV      VVPE    ++  N    
Sbjct: 285 FLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETV----APVVPELSSDIDTSNFDDI 340

Query: 301 EDR 303
           ED 
Sbjct: 341 EDD 343

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  103 bits (257), Expect = 4e-24
 Identities = 89/289 (30%), Positives = 136/289 (47%), Gaps = 25/289 (8%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG GSF  V+ AR  +    VA+K++    K  + K  D ++KE+  L  I HPN I + 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIKHPNSIEYK 91

Query: 76  EAIETREKIYLVLEYCDG--GDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                    +LV+EYC G   DL   +HK    +V  A   H   Q   GL  L   ++I
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAITHGALQ---GLAYLHSHNMI 147

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII---QNHKY 188
           HRD+K  N+L++       +K+ DFG A   +P   A++  G+P +MAPE+I      +Y
Sbjct: 148 HRDIKAGNILLTE---PGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQY 201

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           D K D+WS+G    +L   KPP    N +    +I  +           +   + VD C 
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC- 260

Query: 249 CLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
             L++ P +R T +E   H F+  LR+        ++  TK  V  L++
Sbjct: 261 --LQKIPQDRPTSEELLKHMFV--LRERPETVLIDLIQRTKDAVRELDN 305

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  102 bits (256), Expect = 4e-24
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 28/266 (10%)

Query: 18  IGSGSFAVVWRARHRQLGIEV-AVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFF 75
           IG G+F  V RA  ++ G+++ A  ++ K+  S     +   E+ +L  +  HPNII   
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHK-------------HGKVSEAVARHFMR---QLA 119
            A E R  +Y+ +EY   G+L  ++ K             HG  S   ++  ++    +A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-YM 178
            G+Q L EK  IHRDL  +N+LV  N  +   KI DFG +R      +  T+   P+ +M
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLAS---KIADFGLSRG-EEVYVKKTMGRLPVRWM 185

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           A E +    Y  K+D+WS G +L+++V+ G  P+ G    +L++ +     +  P    +
Sbjct: 186 AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDD 245

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKE 263
           E++    +L R   R  P ER  F +
Sbjct: 246 EVY----ELMRQCWRDRPYERPPFAQ 267

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  102 bits (255), Expect = 4e-24
 Identities = 66/199 (33%), Positives = 109/199 (54%), Gaps = 9/199 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKE---ISILSTISHPNIIR 73
           IG G F  V+  R    G   A+K +DKK +  K  + L L E   +S++ST   P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              A  T +K+  +L+  +GGDL  ++ +HG  SE   R +  ++  GL+ +  + +++R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKA 192
           DLKP N+L+  +      +I D G A   + +    ++ G+  YMAPE++Q    YD+ A
Sbjct: 122 DLKPANILLDEHGHV---RISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDSSA 177

Query: 193 DLWSVGAILFQLVTGKPPF 211
           D +S+G +LF+L+ G  PF
Sbjct: 178 DWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  101 bits (253), Expect = 5e-24
 Identities = 65/256 (25%), Positives = 125/256 (48%), Gaps = 25/256 (9%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G+G F VV    WR ++     +VA+K I +  +S    D  ++E  ++  +SH  +++
Sbjct: 12  LGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQ 63

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM-RQLAAGLQVLQEKHLIH 132
            +     +  IY+V EY   G L  Y+ +HGK  +      M + +  G+  L+ K  IH
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LV        +K+ DFG +R +   +   ++ GS     +  PE++   K+ 
Sbjct: 124 RDLAARNCLVDDQG---CVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLYSKFS 179

Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           +K+D+W+ G +++++ + GK P++  N  +  + +     L  P  A E+++     +  
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYA----IMY 235

Query: 249 CLLRQNPVERITFKEF 264
               +   ER TF++ 
Sbjct: 236 SCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  102 bits (255), Expect = 7e-24
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 12/207 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           ++G GS+A V++ + +  G  VA+K I   ++  +P  +   ++E S+L  + H NI+  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---IREASLLKGLKHANIVLL 68

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
            + I T+E + LV EY    DL  Y+ KH G +     + F+ QL  GL  + +++++HR
Sbjct: 69  HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEI-IQNHKYDAK 191
           DLKPQNLL+S    T  LK+ DFG AR+ + P         +  Y  P++ + + +Y   
Sbjct: 128 DLKPQNLLISD---TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQ 218
            D+W VG I  +++ G   F G   +Q
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  101 bits (252), Expect = 1e-23
 Identities = 76/247 (30%), Positives = 131/247 (53%), Gaps = 32/247 (12%)

Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V R R +  G   I VA+K + K   + K   + L E SI+    HPNII  
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 75  FEAIETREK-IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            E + T+ + + ++ E+ + G L +++ ++ G+ +       +R +AAG++ L E + +H
Sbjct: 71  -EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-------YMAPEIIQN 185
           RDL  +N+LV++N V    K+ DFG +R L   D +D    S L       + APE I  
Sbjct: 130 RDLAARNILVNSNLVC---KVSDFGLSRFLE-DDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 186 HKYDAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAI 236
            K+ + +D+WS G +++++++   +P +D SN     Q+++ + E   R P     P A+
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAIEQDYRLPPPMDCPTAL 240

Query: 237 EELHPDC 243
            +L  DC
Sbjct: 241 HQLMLDC 247

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  101 bits (253), Expect = 2e-23
 Identities = 82/262 (31%), Positives = 121/262 (46%), Gaps = 23/262 (8%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG GSF  V+ A +      VAVK++    K  + K  D ++KE+  L  + HPN I + 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHPNTIEYK 87

Query: 76  EAIETREKIYLVLEYCDG--GDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                    +LV+EYC G   DL   +HK    +V  A   H   Q   GL  L   ++I
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAITHGALQ---GLAYLHSHNMI 143

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII---QNHKY 188
           HRD+K  N+L++       +K+ DFG A   +P   A++  G+P +MAPE+I      +Y
Sbjct: 144 HRDIKAGNILLTE---PGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQY 197

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           D K D+WS+G    +L   KPP    N +    +I  +           +     VD C 
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC- 256

Query: 249 CLLRQNPVERITFKEFFNHRFL 270
             L++ P ER    E   H F+
Sbjct: 257 --LQKIPQERPASAELLRHDFV 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  101 bits (252), Expect = 2e-23
 Identities = 83/272 (30%), Positives = 133/272 (48%), Gaps = 36/272 (13%)

Query: 18  IGSGSFAVVWRARHRQLGI--EVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRF 74
           IG G+F  V +AR ++ G+  + A+K + K+  S     +   E+ +L  +  HPNII  
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE-----AVAR------------HFMRQ 117
             A E R  +YL +EY   G+L  ++ K  +V E     A+A             HF   
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--LADTLCGSP 175
           +A G+  L +K  IHRDL  +N+LV  N V    KI DFG +R    Q+  +  T+   P
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRG---QEVYVKKTMGRLP 186

Query: 176 L-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
           + +MA E +    Y   +D+WS G +L+++V+ G  P+ G    +L++ +     L  P 
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246

Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFF 265
              +E++    DL R   R+ P ER +F +  
Sbjct: 247 NCDDEVY----DLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  102 bits (255), Expect = 2e-23
 Identities = 87/311 (27%), Positives = 148/311 (47%), Gaps = 28/311 (9%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHP 69
           +Y V   IG G+F  V   RH+      A+K + K +++    S    +E  I++  + P
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            +++ F A +    +Y+V+EY  GGDL   +  +  V E  AR +  ++   L  +    
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG 162

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA--DTLCGSPLYMAPEIIQNHK 187
            IHRD+KP N+L+   + +  LK+ DFG    +  + +   DT  G+P Y++PE++++  
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 188 ----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-STELRFPPGAIEELHPD 242
               Y  + D WSVG  L++++ G  PF   + +  +  I+     L FP     ++  +
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN--DISKE 277

Query: 243 CVDL-CRCL------LRQNPVERITFKEFF-NHRFLGE-LRQTVHAEQHSVVPETKPMVE 293
             +L C  L      L +N VE I    FF N ++  E LR TV      VVP+    ++
Sbjct: 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV----APVVPDLSSDID 333

Query: 294 LLN-SSTPEDR 303
             N     ED+
Sbjct: 334 TSNFDDIEEDK 344

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (249), Expect = 2e-23
 Identities = 71/253 (28%), Positives = 124/253 (49%), Gaps = 21/253 (8%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP+     L+E  ++  + H  +++ + 
Sbjct: 13  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY- 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 125

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 126 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH     +C+C
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---LMCQC 239

Query: 250 LLRQNPVERITFK 262
             R+ P ER TF+
Sbjct: 240 -WRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  100 bits (251), Expect = 2e-23
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 39/278 (14%)

Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V++              VA+K + +    PKV     +E  ++S + HPNI+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIV 71

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR----------------HFMR 116
                    +   ++ EY   GDL  ++ ++   S+  A                 H   
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
           Q+AAG++ L   H +HRDL  +N LV        +KI DFG +R +   D       S L
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGL---TVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 177 ---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
              +M PE I   K+  ++D+WS G +L+++ + G  P+ G +  ++ + I +   L  P
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP 248

Query: 233 ---PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
              P  +  L  +C +       + P  R  FK+    
Sbjct: 249 EDCPARVYALMIECWN-------EIPARRPRFKDIHTR 279

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 72/253 (28%), Positives = 124/253 (49%), Gaps = 21/253 (8%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW         +VA+K +    + P+     L+E  I+  + H  ++  + 
Sbjct: 13  KLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLY- 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V E+   G L  ++     K+ K+ + V      Q+A G+  ++  + IH
Sbjct: 68  AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIERMNYIH 125

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    KI DFG AR +   +  A      P+ + APE     ++  
Sbjct: 126 RDLRAANILVGDNLVC---KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D+WS G +L +LVT G+ P+ G    ++ + +     +  P G  E LH    +L + 
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH----ELMKL 238

Query: 250 LLRQNPVERITFK 262
             +++P ER TF+
Sbjct: 239 CWKKDPDERPTFE 251

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  100 bits (250), Expect = 4e-23
 Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 53/308 (17%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           R + ++ +  +IG G++  V++AR +  G  VA+K++             ++EI IL  +
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 67  SHPNIIRFFEAI----------ETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHF 114
           +H NI+   E +          + +   YLV EY D  DL   + + G V  SE   + F
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL-ESGLVHFSEDHIKSF 121

Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD----- 169
           M+QL  GL    +K+ +HRD+K  N+L++       +K+ DFG AR    ++        
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---QIKLADFGLARLYNSEESRPYTNKV 178

Query: 170 -TLCGSPLYMAPE-IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL 224
            TL     Y  PE ++   +Y    D+WS G IL +L T KP F  +    QL+L   + 
Sbjct: 179 ITL----WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234

Query: 225 TSTELRFPPGAI-------------------EELH---PDCVDLCRCLLRQNPVERITFK 262
            S      P  I                   EE        +DL   +L  +P +R T +
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 263 EFFNHRFL 270
           E  N  +L
Sbjct: 295 EALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  104 bits (261), Expect = 5e-23
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 12/210 (5%)

Query: 58  KEISILSTISHPNIIRFFEAIETREK-IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR 116
           +E ++ + + HPNI+   ++ E     ++ V EY  G  L   +   G +        M 
Sbjct: 27  RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLML 86

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL----- 171
           Q+   L     + ++HRDLKPQN++VS   V P  K+ DFG    L     AD       
Sbjct: 87  QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146

Query: 172 ---CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE 228
               G+P Y APE ++       +DL++ G I  + +TG+    G++  ++    L+  +
Sbjct: 147 TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVD 206

Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVER 258
           +  PP  I   HP    + R  L ++P +R
Sbjct: 207 VSLPP-WIAG-HP-LGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 73/239 (30%), Positives = 123/239 (51%), Gaps = 18/239 (7%)

Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V+R   +  G   + VA+K + K   + K   + L E SI+   SH NIIR 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   +   ++ EY + G L  Y+  H G+ S       +R +AAG++ L + + +HR
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR 131

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+LV++N      K+ DFG +R L   P+    T  G  P+ + APE I   K+ 
Sbjct: 132 DLAARNILVNSNLEC---KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDC 243
           + +D+WS G +++++++   +P +D SN  ++ + I     L  P   P A+ +L   C
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKAINDGFRLPAPMDCPSAVYQLMLQC 246

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 68/303 (22%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IGSG+  +V  A     G  VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83

Query: 78  ------IETREKIYLVLEYCDGGDLAAYIHK---HGKVSEAVARHFMRQLAAGLQVLQEK 128
                 +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 84  FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSA 137

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR------SLTPQDLADTLCGSPLYMAPEI 182
            +IHRDLKP N++V ++     LKI DFG AR       +TP  +      +  Y APE+
Sbjct: 138 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVV------TRYYRAPEV 188

Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL--------QL------FQNILTST- 227
           I    Y    D+WSVG I+ +++ G   F G++ +        QL      F + L  T 
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248

Query: 228 ------ELRFPPGAIEELHPDCV-----------------DLCRCLLRQNPVERITFKEF 264
                   ++   + EEL PD +                 DL   +L  +P +RI+  + 
Sbjct: 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308

Query: 265 FNH 267
             H
Sbjct: 309 LQH 311

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.3 bits (242), Expect = 1e-22
 Identities = 59/202 (29%), Positives = 111/202 (54%), Gaps = 17/202 (8%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G  IG G F  V +  +   G +VAVK I   +     +   L+E ++++ + H N++R
Sbjct: 10  LGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVR 63

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLI 131
               I     +Y+V+E    G+L  ++   G+   +V +   F   +A G++ L+ K L+
Sbjct: 64  LLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-YMAPEIIQNHKYDA 190
           HRDL  +N+LVS + V    K+ DFG AR +    + ++    P+ + APE +++ K+ +
Sbjct: 123 HRDLAARNILVSEDGVA---KVSDFGLAR-VGSMGVDNSKL--PVKWTAPEALKHKKFSS 176

Query: 191 KADLWSVGAILFQLVT-GKPPF 211
           K+D+WS G +L+++ + G+ P+
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 99.1 bits (247), Expect = 2e-22
 Identities = 76/223 (34%), Positives = 115/223 (51%), Gaps = 22/223 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--NLLKEISILSTISHPNIIRFF 75
           IG GS+ VV  A     G +VA+K+I+   +   VSD   +L+EI +L  + HP+I+   
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 76  EAI---ETRE--KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
             +     RE   IY+V E  +  DL   I  +  ++    + F+ QL   L+ +   ++
Sbjct: 66  HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANV 124

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL---TPQDLADT-LCGSPLYMAPEIIQNH 186
            HRDLKP+N+L + +     LKI DFG AR     TP  +  T    +  Y APE+  + 
Sbjct: 125 FHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 181

Query: 187 --KYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL 224
             KY    D+WS+G I  +++TGKP F G N   QL L  ++L
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 70/251 (27%), Positives = 122/251 (48%), Gaps = 30/251 (11%)

Query: 18  IGSGSFAVVWRAR-----HRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+ A        Q  I VAVK +  K  S     +  +E  +L+ + H +I+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAELLTNLQHEHIV 70

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-------------KVSEAVARHFMRQLA 119
           +F+      + + +V EY   GDL  ++  HG             +++++   H  +Q+A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL--- 176
           AG+  L  +H +HRDL  +N LV  N    ++KIGDFG +R +   D       + L   
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENL---LVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP--- 232
           +M PE I   K+  ++D+WS+G +L+++ T GK P+   +  ++ + I     L+ P   
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 247

Query: 233 PGAIEELHPDC 243
           P  + +L   C
Sbjct: 248 PKEVYDLMLGC 258

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           +PN I+ + ++ T +   L+++Y   GDL   + K GK+SEA  +  +RQL   L  L +
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNH 186
            ++IH D+K +N+L    +    + + D+G  + + TP     TL     Y +PE I+ H
Sbjct: 128 HNIIHNDIKLENVLYDRAKDR--IYLCDYGLCKIIGTPSCYDGTL----DYFSPEKIKGH 181

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL----RFPPGAIEELHPD 242
            YD   D W+VG + ++L+TGK PF            L    L    +     I+ +  +
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDE-----DEELDLESLLKRQQKKLPFIKNVSKN 236

Query: 243 CVDLCRCLLRQNPVER-ITFKEFFNHRFL 270
             D  + +L+ N   R   + E   H FL
Sbjct: 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 67/239 (28%), Positives = 119/239 (49%), Gaps = 20/239 (8%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    ++ R +Q  I+VA+K + K      V D +++E  I+  + +P I+R
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ--IDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
                E  E + LV+E   GG L  ++  K  +++ +     M Q++ G++ L+ K+ +H
Sbjct: 60  MIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKY 188
           RDL  +N+L+         KI DFG +++L   D    A +    PL + APE I   K+
Sbjct: 119 RDLAARNVLLVNQHYA---KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 189 DAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDC 243
            +++D+WS G  +++  + G+ P+      ++   I     L  P   P  +  L  DC
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 97.4 bits (242), Expect = 4e-22
 Identities = 61/207 (29%), Positives = 110/207 (53%), Gaps = 18/207 (8%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR---QLAAGLQVLQEKHL 130
               I     + L+ +    G L  Y+ +H       +++ +    Q+A G+  L+E+ L
Sbjct: 74  LL-GICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERRL 130

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHK 187
           +HRDL  +N+LV T +    +KI DFG A+ L   +      G  +   +MA E I +  
Sbjct: 131 VHRDLAARNVLVKTPQ---HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDG 213
           Y  ++D+WS G  +++L+T G  P+DG
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYDG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 96.3 bits (239), Expect = 4e-22
 Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 21/209 (10%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRFFE 76
           +G+G++  V++ RH + G   A+K +D   ++    + + +EI++L   SH  NI  ++ 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 77  AIETR------EKIYLVLEYCDGGDLAAYIH--KHGKVSEAVARHFMRQLAAGLQVLQEK 128
           A   +      ++++LV+E+C  G +   I   K   + E    +  R++  GL  L + 
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQ--- 184
            +IHRD+K QN+L++ N     +K+ DFG +  L       +T  G+P +MAPE+I    
Sbjct: 131 KVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPF 211
             +  YD K+DLWS+G    ++  G PP 
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.9 bits (238), Expect = 5e-22
 Identities = 73/251 (29%), Positives = 128/251 (50%), Gaps = 17/251 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW A + +   +VAVK +    +S +     L E +++ T+ H  +++   
Sbjct: 13  KLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKL-H 67

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ E+   G L  ++      K        F  Q+A G+  +++++ IHRD
Sbjct: 68  AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    + V KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 128 LRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G +  ++ + +     +  P    EEL+     + RC  
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN---IMMRC-W 240

Query: 252 RQNPVERITFK 262
           +  P ER TF+
Sbjct: 241 KNRPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.8 bits (238), Expect = 8e-22
 Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 33/270 (12%)

Query: 18  IGSGSFAVVWRARHRQLGIE-----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+ A    L  E     VAVK +  K  S     +  +E  +L+ + H +I+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIV 70

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR---------------HFMRQ 117
           RF+        + +V EY   GDL  ++  HG  ++ +A                    Q
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +A+G+  L   H +HRDL  +N LV       V+KIGDFG +R +   D       + L 
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYRVGGRTMLP 187

Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             +M PE I   K+  ++D+WS G +L+++ T GK P+   +  +  + I    EL  P 
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR 247

Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKE 263
               E++     + +   ++ P +R+  K+
Sbjct: 248 TCPPEVY----AIMQGCWQREPQQRMVIKD 273

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 95.5 bits (237), Expect = 9e-22
 Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRFFE 76
           +G+G++  V++ RH + G   A+K +D   ++    + +  EI++L   SH  NI  ++ 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 77  AIETR------EKIYLVLEYCDGGDLAAYIH--KHGKVSEAVARHFMRQLAAGLQVLQEK 128
           A   +      ++++LV+E+C  G +   +   K   + E    +  R++  GL  L   
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 129 HLIHRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQ-- 184
            +IHRD+K QN+L++ N EV    K+ DFG +  L       +T  G+P +MAPE+I   
Sbjct: 141 KVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 185 ---NHKYDAKADLWSVGAILFQLVTGKPPF 211
              +  YD ++D+WS+G    ++  G PP 
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 97.0 bits (241), Expect = 2e-21
 Identities = 68/279 (24%), Positives = 123/279 (44%), Gaps = 55/279 (19%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V  A         A+K + KK +L+     ++  E  IL+   +  +++ + 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + + ++ +Y V++Y  GGD+ + + +     E +AR ++ +L   ++ + +   IHRD+K
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK 128

Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR--------------------SLTPQD---------- 166
           P N+L+   ++   +K+ DFG                       S+ P D          
Sbjct: 129 PDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185

Query: 167 ------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGK 208
                             LA +L G+P Y+APE++    Y    D WSVG ILF+++ G+
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245

Query: 209 PPFDGSNQLQLFQNILT-STELRFPPGAIEELHPDCVDL 246
           PPF      +    ++     L  PP    +L P+ VDL
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQV--KLSPEAVDL 282

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 97.4 bits (242), Expect = 2e-21
 Identities = 88/313 (28%), Positives = 149/313 (47%), Gaps = 59/313 (18%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI 62
           PN++     Y +G  IG+GSF VV+ A       +VA+K++   L  P+  +   +E+ I
Sbjct: 64  PNKS-----YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDPQYKN---RELLI 112

Query: 63  LSTISHPNII-----RFFEAIETREK-IYL--VLEYCDGGDLAAYIHKHGK--------V 106
           +  ++H NII      + E  +  EK I+L  V+E+     +   +HK+ K        +
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF-----IPQTVHKYMKHYARNNHAL 167

Query: 107 SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
              + + +  QL   L  +  K + HRDLKPQNLL+  N  T  LK+ DFG A++L    
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN--THTLKLCDFGSAKNLLAGQ 225

Query: 167 LADTLCGSPLYMAPEI-IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQ 221
            + +   S  Y APE+ +    Y    DLWS+G I+ +++ G P F G +     +++ Q
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285

Query: 222 NILTSTE------------LRFP---PGAIEELHP-----DCVDLCRCLLRQNPVERITF 261
            + T TE            ++FP   P  ++++ P     D ++     L+  P++R+  
Sbjct: 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345

Query: 262 KEFFNHRFLGELR 274
            E     F  +LR
Sbjct: 346 IEALADPFFDDLR 358

Length = 440

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 74/256 (28%), Positives = 119/256 (46%), Gaps = 25/256 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G+F  V++   +     VAVK   K+ L  ++    L E  IL    HPNI++    
Sbjct: 3   LGKGNFGEVFKGTLKD-KTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR---QLAAGLQVLQEKHLIHRD 134
              R+ IY+V+E   GGD  +++ K  K  E   +  ++     AAG+  L+ K+ IHRD
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL------YMAPEIIQNHKY 188
           L  +N LV  N    VLKI DFG +R    Q+       S L      + APE +   +Y
Sbjct: 119 LAARNCLVGENN---VLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 189 DAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
            +++D+WS G +L++  + G  P+ G    Q  + +     +  P    ++++     + 
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK---VMQ 228

Query: 248 RCLLRQNPVERITFKE 263
           RC     P  R  F E
Sbjct: 229 RC-WDYKPENRPKFSE 243

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 16/206 (7%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W      + I VA+K I  +   PK +   + E  I++++ HP+++R
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               +     I LV +    G L  Y+H+H   +   +  ++  Q+A G+  L+E+ L+H
Sbjct: 74  LL-GVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132

Query: 133 RDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+LV S N V    KI DFG AR L   +      G  +   +MA E I   K+
Sbjct: 133 RDLAARNVLVKSPNHV----KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 189 DAKADLWSVGAILFQLVT-GKPPFDG 213
             ++D+WS G  +++L+T G  P+DG
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 71/280 (25%), Positives = 131/280 (46%), Gaps = 34/280 (12%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           + ++   +G G+F  V+ A    L      + VAVK +    L+ +   +  +E  +L+ 
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTN 63

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG----------------KVSEA 109
           + H +I++F+      + + +V EY   GDL  ++  HG                ++  +
Sbjct: 64  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 110 VARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
              H   Q+A+G+  L  +H +HRDL  +N LV  N    ++KIGDFG +R +   D   
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMSRDVYSTDYYR 180

Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
               + L   +M PE I   K+  ++D+WS G IL+++ T GK P+   +  ++ + I  
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240

Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFF 265
              L  P    +E++    D+     ++ P +R+  KE +
Sbjct: 241 GRVLERPRVCPKEVY----DIMLGCWQREPQQRLNIKEIY 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 94.6 bits (235), Expect = 4e-21
 Identities = 72/255 (28%), Positives = 133/255 (52%), Gaps = 21/255 (8%)

Query: 18  IGSGSFAVVWRARH---RQLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTISH-PNI 71
           +G+G++  V+  R       G   A+K + K  L    K  ++   E ++L  +   P +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +    A +T  K++L+L+Y  GG++  ++++    SE   R +  ++   L+ L +  ++
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV 127

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQNHKYD 189
           +RD+K +N+L+ + E   VL   DFG ++    ++   T   CG+  YMAPEII+     
Sbjct: 128 YRDIKLENILLDS-EGHVVLT--DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 190 AKA-DLWSVGAILFQLVTGKPPF----DGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
            KA D WS+G ++F+L+TG  PF    + + Q ++ + IL   +  FP      + P+  
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPS----FIGPEAQ 239

Query: 245 DLCRCLLRQNPVERI 259
           DL   LLR++P +R+
Sbjct: 240 DLLHKLLRKDPKKRL 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 14/204 (6%)

Query: 18  IGSGSFAVVWRA---RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G F  V++          I VAVK   K   SP V +  L+E  I+    HP+I++ 
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIH 132
              + T   +++V+E    G+L +Y+  + K S  +A    +  QL+  L  L+ K  +H
Sbjct: 73  I-GVITENPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVH 130

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHKYDA 190
           RD+  +N+LVS+ +    +K+GDFG +R L  +       G  P+ +MAPE I   ++ +
Sbjct: 131 RDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187

Query: 191 KADLWSVGAILFQ-LVTGKPPFDG 213
            +D+W  G  +++ L+ G  PF G
Sbjct: 188 ASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 94.7 bits (235), Expect = 7e-21
 Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 43/292 (14%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +  G   A+K + K  +L  +   ++  E  IL       +++ F 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + + +  +YL++E+  GGD+   + K   +SE   + ++ +    +  + +   IHRD+K
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128

Query: 137 PQNLLVSTNEVTPVLKIGDFG------------FARSLT---PQD--------------- 166
           P NLL+   +    +K+ DFG            F R+LT   P D               
Sbjct: 129 PDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185

Query: 167 ------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLF 220
                 LA +  G+P Y+APE+     Y+   D WS+G I+++++ G PPF      + +
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245

Query: 221 QNILTSTE-LRFPPGA-IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           + ++   E L FPP   I E   D + L  C   +N +     +E  +H F 
Sbjct: 246 RKVMNWKETLVFPPEVPISEKAKDLI-LRFCTDSENRIGSNGVEEIKSHPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 94.2 bits (234), Expect = 7e-21
 Identities = 86/294 (29%), Positives = 132/294 (44%), Gaps = 49/294 (16%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           +GSG++  V  A  ++ G +VA+K++ +   S   +    +E+++L  + H N+I     
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 74  FFEAIETRE--KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           F  A+   E    YLV+ Y    DL   +     +SE   ++ + Q+  GL+ +    +I
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQMLCGLKYIHSAGII 139

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT-LCG---SPLYMAPEIIQN-H 186
           HRDLKP NL V  NE    LKI DFG AR       AD  + G   +  Y APE+I N  
Sbjct: 140 HRDLKPGNLAV--NEDCE-LKILDFGLARH------ADAEMTGYVVTRWYRAPEVILNWM 190

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL----------------- 229
            Y+   D+WSVG I+ +++TGK  F G + L     IL  T +                 
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250

Query: 230 -----RFPPGAIEELHPDC----VDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                ++P      L P      VDL   +L  +  +R+T  E   H +    R
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 65/245 (26%), Positives = 113/245 (46%), Gaps = 20/245 (8%)

Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+   +R        ++VAVK +  +  S +   + L E  I+S  +H NI+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVAR---HFMRQLAAGLQVL 125
           R       R   +++LE   GGDL +++     +  + S    +      R +A G + L
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KI DFG AR +           + L   +M PE 
Sbjct: 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA 192

Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
             +  + +K D+WS G +L+++ + G  P+ G    ++ + +     L  P   PG +  
Sbjct: 193 FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYR 252

Query: 239 LHPDC 243
           +  DC
Sbjct: 253 IMTDC 257

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 93.6 bits (232), Expect = 1e-20
 Identities = 89/317 (28%), Positives = 145/317 (45%), Gaps = 56/317 (17%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   I K  K+++   +  + Q+  GL+ +    +I
Sbjct: 85  FTPARSLEEFNDVYLV-THLMGADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADII 142

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG---SPLYMAPEIIQN-HK 187
           HRDLKP NL V  NE    LKI DFG AR        D + G   +  Y APEI+ N   
Sbjct: 143 HRDLKPSNLAV--NEDCE-LKILDFGLARHT-----DDEMTGYVATRWYRAPEIMLNWMH 194

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNI-----------LTSTELR--- 230
           Y+   D+WSVG I+ +L+TG+  F G+   +QL+L   +           ++S   R   
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 231 -----FPPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQ 281
                 P      +    +P  VDL   +L  +  +RIT  +   H +         A+ 
Sbjct: 255 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF--------AQY 306

Query: 282 HSVVPETKPMVELLNSS 298
           H   P+ +P+ +  + S
Sbjct: 307 HD--PDDEPVADPYDQS 321

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 30/266 (11%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLL----KEISILSTISHPNIIR 73
           +G G F  V+ A+ + +  E     +  K L     +NL     +E+ +   +SH N++R
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR---------HFMRQLAAGLQV 124
                   E  Y++LEY D GDL  ++       E +               Q+A G+  
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 125 LQEKHLIHRDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMA 179
           L     +HRDL  +N LV S  EV    K+     ++ +   +   L + L   PL ++A
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREV----KVSLLSLSKDVYNSEYYKLRNALI--PLRWLA 186

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT-STELRFPPGAIE 237
           PE +Q   +  K+D+WS G +++++ T G+ PF G +  ++   +     EL  P G   
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKE 263
            L+     + RC    NP +R +F E
Sbjct: 247 RLYK---LMTRCWA-VNPKDRPSFSE 268

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 65/256 (25%), Positives = 137/256 (53%), Gaps = 22/256 (8%)

Query: 18  IGSGSFAVVWRARH---RQLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTISH-PNI 71
           +G+G++  V+  R       G   A+K + K  +    K +++   E  +L  I   P +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +    A +T  K++L+L+Y +GG+L  ++ +  +  E   + +  ++   L+ L +  +I
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII 127

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQ--NHK 187
           +RD+K +N+L+ +N     + + DFG ++     ++  A + CG+  YMAP+I++  +  
Sbjct: 128 YRDIKLENILLDSNG---HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 188 YDAKADLWSVGAILFQLVTGKPPF----DGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           +D   D WS+G ++++L+TG  PF    + ++Q ++ + IL S E  +P    +E+    
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYP----QEMSALA 239

Query: 244 VDLCRCLLRQNPVERI 259
            D+ + LL ++P +R+
Sbjct: 240 KDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 34/272 (12%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI-SILSTISHPNIIRFFE 76
           IG G+F  V +  H+  G  +AVK I +  +  K    LL ++  ++ +   P I++F+ 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 77  AIETREKIYLVLEYCDGG--DLAAYIHKH----------GKVSEAVARHFMRQLAAGLQV 124
           A+      ++ +E  D        Y+++           GK++ A  +         L  
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK--------ALNY 122

Query: 125 LQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL-CGSPLYMAPEI 182
           L+E+  +IHRD+KP N+L+  N     +K+ DFG +  L    +A T   G   YMAPE 
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGN---IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPER 178

Query: 183 I---QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL--QLFQNILTSTELRFPPGAIE 237
           I       YD ++D+WS+G  L+++ TGK P+   N +  QL Q ++             
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ-VVKGDPPILSNSEER 237

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
           E  P  V+     L ++  +R  +KE   H F
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 92.1 bits (228), Expect = 4e-20
 Identities = 66/264 (25%), Positives = 128/264 (48%), Gaps = 14/264 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +      A+K ++K ++L    +    +E  +L    +  I     
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV++Y  GGDL   + K   ++ E +AR ++ ++   +  + + H +HRD+
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDI 128

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQ-----NHKY 188
           KP N+L+  N     +++ DFG    L       +    G+P Y++PEI+Q       KY
Sbjct: 129 KPDNILMDMNG---HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
             + D WS+G  +++++ G+ PF   + ++ +  I+   E    P  + ++  D  DL R
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245

Query: 249 CLL--RQNPVERITFKEFFNHRFL 270
            L+  R++ + +   ++F  H F 
Sbjct: 246 RLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 90.3 bits (224), Expect = 8e-20
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 45/286 (15%)

Query: 18  IGSGSFAVVWRARHRQLGI-------EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           IG G+F  V++AR    G+        VAVK + K+  S  +  +  +E ++++   HPN
Sbjct: 13  IGQGAFGRVFQAR--APGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMAEFDHPN 69

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMR------------- 116
           I++        + + L+ EY   GDL  ++ H+  +   +++                  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 117 --------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL- 167
                   Q+AAG+  L E+  +HRDL  +N LV  N    V+KI DFG +R++   D  
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM---VVKIADFGLSRNIYSADYY 186

Query: 168 -ADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNIL 224
            A      P+ +M PE I  ++Y  ++D+W+ G +L+++ + G  P+ G    ++   + 
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR 246

Query: 225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
               L  P     EL+    +L R    + P +R +F     +R L
Sbjct: 247 DGNVLSCPDNCPLELY----NLMRLCWSKLPSDRPSFASI--NRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 91.6 bits (227), Expect = 8e-20
 Identities = 63/254 (24%), Positives = 115/254 (45%), Gaps = 41/254 (16%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +  G   A+K + K  +L  +   ++  E  IL       +++ F 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + + +  +YL++E+  GGD+   + K   ++E   + ++ +    +  + +   IHRD+K
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK 128

Query: 137 PQNLLVSTNEVTPVLKIGDFG------------FARSLT---PQD--------------- 166
           P NLL+ +      +K+ DFG            F R+L    P D               
Sbjct: 129 PDNLLLDSKG---HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185

Query: 167 ------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLF 220
                 LA +  G+P Y+APE+     Y+   D WS+G I+++++ G PPF      + +
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245

Query: 221 QNILTSTE-LRFPP 233
           + ++   E L FPP
Sbjct: 246 KKVMNWKETLIFPP 259

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 90.9 bits (225), Expect = 9e-20
 Identities = 70/214 (32%), Positives = 109/214 (50%), Gaps = 14/214 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   +L  +VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                +IE   ++YLV     G DL   I K  K+S+   +  + QL  GL+ +    +I
Sbjct: 83  FTPATSIENFNEVYLVTNLM-GADLNN-IVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDA 190
           HRDLKP N+ V  NE    L+I DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 141 HRDLKPSNVAV--NEDCE-LRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWMHYNQ 195

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             D+WSVG I+ +L+ GK  F G++ +   + I+
Sbjct: 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 91.3 bits (226), Expect = 1e-19
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 18/216 (8%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
               D+WSVG I+ +++ G   F G++ +  +  ++
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 24/204 (11%)

Query: 18  IGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI++
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVK 69

Query: 74  F----FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEK 128
           +    + A   R  + LV+EY   G L  Y+ KH  ++       +  Q+  G++ L  K
Sbjct: 70  YKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127

Query: 129 HLIHRDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEI 182
             +HRDL  +N+LV S N V    KIGDFG  + L PQD        P      + APE 
Sbjct: 128 RYVHRDLATRNILVESENRV----KIGDFGLTKVL-PQDKEYYKVREPGESPIFWYAPES 182

Query: 183 IQNHKYDAKADLWSVGAILFQLVT 206
           +   K+   +D+WS G +L++L T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 55/175 (31%), Positives = 97/175 (55%), Gaps = 11/175 (6%)

Query: 38  VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKIYLVLEYCDGGD 95
           VAVK + K+    + +    KEI+IL T+ H NI+++      +  + + L++EY   G 
Sbjct: 36  VAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94

Query: 96  LAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD 155
           L  Y+ KH K++ A    F +Q+  G+  L  +H IHRDL  +N+L+  +    ++KIGD
Sbjct: 95  LRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR---LVKIGD 150

Query: 156 FGFARSLTPQDLADTLC---GSPLY-MAPEIIQNHKYDAKADLWSVGAILFQLVT 206
           FG A+++        +     SP++  A E ++ +K+   +D+WS G  L++L+T
Sbjct: 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 64/271 (23%), Positives = 129/271 (47%), Gaps = 28/271 (10%)

Query: 13  IVGPRIGSGSFAVVWRARHRQ---LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
            +G  +G G F  V   +  Q     ++VAVK +   + +    +  L E + +    HP
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61

Query: 70  NIIRF----FEAIETREKI---YLVLEYCDGGDLAAYI--HKHGKVSEAVARH----FMR 116
           N+++     FEA  + +KI    ++L +   GDL +++   + G + E +       FM 
Sbjct: 62  NVMKLIGVCFEA-SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
            +A G++ L  ++ IHRDL  +N ++  +    V    DFG ++ +   D       + +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCV---ADFGLSKKIYSGDYYRQGRIAKM 177

Query: 177 ---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
              ++A E + +  Y +K+D+W+ G  ++++ T G+ P+ G    +++  +     L+ P
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237

Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
              ++EL+ D +  C    R +P +R TF +
Sbjct: 238 EDCLDELY-DLMYSC---WRADPKDRPTFTK 264

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 90.1 bits (223), Expect = 2e-19
 Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 21/234 (8%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 138

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 139 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 247

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 72/288 (25%), Positives = 123/288 (42%), Gaps = 63/288 (21%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK---EISILSTISHPNIIRF 74
           IG G+F  V   + +  G   A+K + K  +  K  D L     E  +L+    P ++  
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKK--DQLAHVKAERDVLAESDSPWVVSL 66

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           + + +  + +YL++E+  GGDL   + K+   SE V R +M +    ++ + +   IHRD
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---------------------------- 166
           +KP N+L+   +    +K+ DFG +     Q                             
Sbjct: 127 IKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183

Query: 167 --------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT 206
                               +A +  G+P Y+APEI     Y  + D WS+GAI+F+ + 
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243

Query: 207 GKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELH--PDCVDLCRCLL 251
           G PPF   N  + ++ I+   E L FP    +++H   +  DL R L+
Sbjct: 244 GWPPFCSENSHETYRKIINWRETLYFP----DDIHLSVEAEDLIRRLI 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 87.4 bits (216), Expect = 9e-19
 Identities = 80/291 (27%), Positives = 126/291 (43%), Gaps = 40/291 (13%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIE-------VAVKEIDKKLLSPKVSD 54
           E  R RL+    +G  +G G F  V  A    L  E       VAVK +        +SD
Sbjct: 14  EVPRDRLV----LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSD 69

Query: 55  NLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------------ 101
            L+ E+ ++  I  H NII    A      +Y+++EY   G+L  Y+             
Sbjct: 70  -LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128

Query: 102 -KHGKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG 157
                  +   +  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFG 185

Query: 158 FARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG 213
            AR +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G
Sbjct: 186 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245

Query: 214 SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
               +LF+ +     +  P     EL+    D    +    P +R TFK+ 
Sbjct: 246 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAV----PSQRPTFKQL 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 40/281 (14%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIE---------VAVKEIDKKLLSPKVSDNLLKEISILS 64
           +G  +G G F  V  A    LGI+         VAVK +        +SD L+ E+ ++ 
Sbjct: 19  LGKPLGEGCFGQVVMAE--ALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMK 75

Query: 65  TIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR------- 116
            I  H NII    A      +Y+++EY   G+L  Y+          +    R       
Sbjct: 76  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135

Query: 117 ---------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL 167
                    Q+A G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D 
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDVNNIDY 192

Query: 168 ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNI 223
                   L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252

Query: 224 LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
                +  P     EL+    D    +    P  R TFK+ 
Sbjct: 253 KEGHRMDKPANCTNELYMMMRDCWHAI----PSHRPTFKQL 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 87.8 bits (217), Expect = 1e-18
 Identities = 66/265 (24%), Positives = 129/265 (48%), Gaps = 16/265 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +      A+K ++K ++L    +    +E ++L       I     
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV++Y  GGDL   + K   ++ E +AR ++ ++   +  + + H +HRD+
Sbjct: 69  AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQNH-----KY 188
           KP N+L+  N     +++ DFG    +       +    G+P Y++PEI+Q       KY
Sbjct: 129 KPDNVLLDMNG---HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHPDCVDLC 247
             + D WS+G  +++++ G+ PF   + ++ +  I+   E RF  P  I ++  +  DL 
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-RFQFPSHITDVSEEAKDLI 244

Query: 248 RCLL--RQNPVERITFKEFFNHRFL 270
           + L+  R+  + +   ++F  H F 
Sbjct: 245 QRLICSRERRLGQNGIEDFKKHAFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 40/282 (14%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLGIE---------VAVKEIDKKLLSPKVSDNLLKEISIL 63
           ++G  +G G F  V RA     GI+         VAVK +        ++D L+ E+ ++
Sbjct: 15  VLGKPLGEGCFGQVVRAE--AYGIDKSRPDQTVTVAVKMLKDNATDKDLAD-LISEMELM 71

Query: 64  STIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-----------GKVSEAVA 111
             I  H NII           +Y+++EY   G+L  ++               KV E   
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 112 R-----HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
                     Q+A G++ L+ +  IHRDL  +N+LV+ +    V+KI DFG AR +   D
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN---VMKIADFGLARGVHDID 188

Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ 
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248

Query: 223 ILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
           +     +  P     EL+     L R      P +R TFK+ 
Sbjct: 249 LREGHRMDKPSNCTHELYM----LMRECWHAVPTQRPTFKQL 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.6 bits (209), Expect = 4e-18
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 19/200 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG G F  V    +R  G +VAVK I         +   L E S+++ + H N+++    
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGV 67

Query: 78  I-ETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           I E +  +Y+V EY   G L  Y+   G+  +       F   +   ++ L+  + +HRD
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L  +N+LVS + V    K+ DFG  +  +  QD        P+ + APE ++  K+  K+
Sbjct: 128 LAARNVLVSEDNVA---KVSDFGLTKEASSTQDTGKL----PVKWTAPEALREKKFSTKS 180

Query: 193 DLWSVGAILFQLVT-GKPPF 211
           D+WS G +L+++ + G+ P+
Sbjct: 181 DVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 85.8 bits (212), Expect = 4e-18
 Identities = 95/359 (26%), Positives = 148/359 (41%), Gaps = 66/359 (18%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIE---------VAVKEIDKKLLSPKV 52
           E +RTRL     +G  +G G F  V  A    +GI+         VAVK +        +
Sbjct: 8   ELSRTRLT----LGKPLGEGCFGQVVMAE--AIGIDKDKPNKPVTVAVKMLKDDATDKDL 61

Query: 53  SDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVA 111
           SD L+ E+ ++  I  H NII    A      +Y+++EY   G+L  Y+          +
Sbjct: 62  SD-LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120

Query: 112 RHFMR----------------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD 155
               +                Q+A G++ L  +  IHRDL  +N+LV+ +    V+KI D
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN---VMKIAD 177

Query: 156 FGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPF 211
           FG AR +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Query: 212 DGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG 271
            G    +LF+ +     +  P     EL+     + R      P +R TFK+        
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYM----IMRECWHAVPSQRPTFKQL------- 286

Query: 272 ELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPTNSSSKNPKSACSSACDKV 330
                   E    V       E L+ S P +++S     P    S    S+CSS  D V
Sbjct: 287 -------VEDLDRVLTVTSTDEYLDLSVPFEQYS-----PGCPDS---PSSCSSGDDSV 330

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 84.6 bits (209), Expect = 4e-18
 Identities = 62/257 (24%), Positives = 125/257 (48%), Gaps = 25/257 (9%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQ---LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           + +G  +G G F  V  A+ +       +VAVK +   + S    +  L+E + +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 69  PNIIRFFE-AIETREKIYL-----VLEYCDGGDLAAYI--HKHGK----VSEAVARHFMR 116
           PN+I+    ++ +R K  L     +L +   GDL  ++   + G+    +       FM 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
            +A+G++ L  K+ IHRDL  +N +++ N    V    DFG ++ +   D     C S L
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCV---ADFGLSKKIYSGDYYRQGCASKL 177

Query: 177 ---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
              ++A E + ++ Y   +D+W+ G  +++++T G+ P+ G    +++  ++    L+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237

Query: 233 PGAIEELHPDCVDLCRC 249
           P  +E+++     +C+C
Sbjct: 238 PDCLEDVYE---LMCQC 251

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 9e-18
 Identities = 66/264 (25%), Positives = 129/264 (48%), Gaps = 16/264 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +  G   A+K ++K ++L    +    +E  +L       I     
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV++Y  GGDL   + K   ++ E +AR ++ ++   +  + +   +HRD+
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDI 128

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL--CGSPLYMAPEIIQ-----NHKY 188
           KP N+L+  N     +++ DFG    L       +    G+P Y++PEI+Q       +Y
Sbjct: 129 KPDNVLLDKNG---HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRY 185

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDLC 247
             + D WS+G  +++++ G+ PF   + ++ +  I+   E  +FPP  + ++  +  DL 
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP-DVTDVSEEAKDLI 244

Query: 248 RCLL--RQNPVERITFKEFFNHRF 269
           R L+   +  + R   ++F +H F
Sbjct: 245 RRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 36/274 (13%)

Query: 18  IGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G F  V   R+       G +VAVK +  +     ++D L KEI IL  + H NI++
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVK 70

Query: 74  FFEAIETREK---IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           + + I T +    I L++E+   G L  Y+ ++  K++      +  Q+  G+  L  + 
Sbjct: 71  Y-KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----LADTLCGSPLYMAPEIIQN 185
            +HRDL  +N+LV   E    +KIGDFG  +++        + D L     + APE +  
Sbjct: 130 YVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 186 HKYDAKADLWSVGAILFQLVT-----GKP---------PFDGSNQLQLFQNILTSTE-LR 230
            K+   +D+WS G  L++L+T       P         P  G   +     +L   + L 
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246

Query: 231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            PP   EE++     L R      P +R TF+  
Sbjct: 247 RPPNCPEEVY----QLMRKCWEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 76/267 (28%), Positives = 114/267 (42%), Gaps = 39/267 (14%)

Query: 18  IGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G F  V+           I  AVK +++     +V    LKE  I+   SHPN++  
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVLSL 61

Query: 75  FEAIETREKIYLV-LEYCDGGDLAAYIHKHGK---VSEAVARHFMRQLAAGLQVLQEKHL 130
                  E   LV L Y   GDL  +I        V + +   F  Q+A G++ L  K  
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG--FGLQVAKGMEYLASKKF 119

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP----------LYMAP 180
           +HRDL  +N ++  +E +  +K+ DFG AR     D+ D    S            +MA 
Sbjct: 120 VHRDLAARNCML--DE-SFTVKVADFGLAR-----DIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAI 236
           E +Q  K+  K+D+WS G +L++L+T G PP+   +   +   +L    L  P   P  +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPL 231

Query: 237 EELHPDCVDLCRCLLRQNPVERITFKE 263
            E+   C           P  R TF E
Sbjct: 232 YEVMLSCWH-------PKPEMRPTFSE 251

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 16/206 (7%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W      + I VA+K + ++  SPK +  +L E  +++ +  P + R
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + LV +    G L  Y+ ++  ++      ++  Q+A G+  L+E  L+H
Sbjct: 74  LL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132

Query: 133 RDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+LV S N V    KI DFG AR L   +      G  +   +MA E I + ++
Sbjct: 133 RDLAARNVLVKSPNHV----KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 189 DAKADLWSVGAILFQLVT-GKPPFDG 213
             ++D+WS G  +++L+T G  P+DG
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 82.0 bits (202), Expect = 7e-17
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 24/216 (11%)

Query: 15  GPRIGSGSFAVVWRARHR--QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           G ++G G++  V++A+ +  +   E A+K+I+       +S +  +EI++L  + HPN+I
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIE----GTGISMSACREIALLRELKHPNVI 61

Query: 73  RFFEAI--ETREKIYLVLEYCDGGDLAAYI--HKHGKVSE-------AVARHFMRQLAAG 121
              +     +  K++L+ +Y +  DL   I  H+  K ++       ++ +  + Q+  G
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 122 LQVLQEKHLIHRDLKPQNLLV-STNEVTPVLKIGDFGFAR----SLTPQDLADTLCGSPL 176
           +  L    ++HRDLKP N+LV         +KI D GFAR     L P    D +  +  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 177 YMAPEIIQNHKYDAKA-DLWSVGAILFQLVTGKPPF 211
           Y APE++   ++  KA D+W++G I  +L+T +P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 29/269 (10%)

Query: 18  IGSGSFAVVWRARHR-----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R     +    VAVK +++   S +     L E S++   +  +++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL----YM 178
             L  K  +HRDL  +N +V+ +     +KIGDFG  R +   D      G  L    +M
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRK-GGKGLLPVRWM 188

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           APE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P    E
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPE 248

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKEFFN 266
            +     DL R   + NP  R TF E  N
Sbjct: 249 RVT----DLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 60/244 (24%), Positives = 110/244 (45%), Gaps = 24/244 (9%)

Query: 18  IGSGSFAVVWRAR-HRQLGI-EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG+G F  V     HR +    V VKE+ +   +P      L+E+     ++HPN+++  
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL------AAGLQVLQEKH 129
                     LVLE+C  GDL  Y+  + +   A               A+GL  L +  
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSN-RGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNH 186
            IH DL  +N  + T +++  +KIGD+G A    P+D     D       ++APE+++  
Sbjct: 121 FIHSDLALRNCQL-TADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 187 KYD-------AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
             D        K+++WS+G  +++L T    P+   +  Q+ + ++   +++ P   ++ 
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237

Query: 239 LHPD 242
            + D
Sbjct: 238 KYSD 241

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 14/165 (8%)

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS 174
           Q+A G++ L  +  IHRDL  +N+L+S N    V+KI DFG AR +   P  +       
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT-STELRF 231
           PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F   L   T +R 
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA 297

Query: 232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           P  A  E++     +  C    NP +R TF E      LG+L Q 
Sbjct: 298 PEYATPEIYS---IMLDC-WHNNPEDRPTFSELVEI--LGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 24/216 (11%)

Query: 15  GPRIGSGSFAVVWRARHR--QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           G ++G G++  V++A+ +  +   + A+K+I+       +S +  +EI++L  + HPN+I
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE----GTGISMSACREIALLRELKHPNVI 61

Query: 73  RFFEAIETR--EKIYLVLEYCDGGDLAAYI--HKHGKVSE-------AVARHFMRQLAAG 121
              +   +    K++L+ +Y +  DL   I  H+  K ++        + +  + Q+  G
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 122 LQVLQEKHLIHRDLKPQNLLV-STNEVTPVLKIGDFGFAR----SLTPQDLADTLCGSPL 176
           +  L    ++HRDLKP N+LV         +KI D GFAR     L P    D +  +  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 177 YMAPEIIQNHKYDAKA-DLWSVGAILFQLVTGKPPF 211
           Y APE++   ++  KA D+W++G I  +L+T +P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 31/205 (15%)

Query: 46  KLLSPKVSDN----LLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH 101
           K+L P  + N     LKE+ ILS +  PNIIR        + + ++ EY + GDL  ++ 
Sbjct: 52  KILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLS 111

Query: 102 KHG-------------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV 142
            H                     +S +   H   Q+A+G++ L   + +HRDL  +N LV
Sbjct: 112 SHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV 171

Query: 143 STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGA 199
             N     +KI DFG +R+L   D       + L   +MA E I   K+   +D+W+ G 
Sbjct: 172 GENL---TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228

Query: 200 ILFQL--VTGKPPFDGSNQLQLFQN 222
            L+++  +  + P+      Q+ +N
Sbjct: 229 TLWEILMLCKEQPYGELTDEQVIEN 253

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 67/263 (25%), Positives = 119/263 (45%), Gaps = 35/263 (13%)

Query: 18  IGSGSFAVVWRA-----RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G+G F  + R        R+L   VA+  + +   S K     L E   L    H NI+
Sbjct: 13  LGTGRFGELCRGCLKLPSKREL--PVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           R    I     + +V EY   G L +++ KH G++        +  LA+G++ L E   +
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG-SP-LYMAPEIIQNHKYD 189
           H+ L    +LV+++ V    KI  F   +    + +  T+ G SP L+ APE IQ H + 
Sbjct: 130 HKGLAAHKVLVNSDLVC---KISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFPPGA-----IEELH 240
           + +D+WS G +++++++   +P +D S      Q+++ + E   R P        + +L 
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKAVEDGFRLPAPRNCPNLLHQLM 241

Query: 241 PDCVDLCRCLLRQNPVERITFKE 263
            DC        ++   ER  F +
Sbjct: 242 LDC-------WQKERGERPRFSQ 257

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 22/180 (12%)

Query: 46  KLLSPKVSDN----LLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH 101
           K+L   V+       LKEI I+S + +PNIIR      + + + ++ EY + GDL  ++ 
Sbjct: 50  KMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS 109

Query: 102 KHG------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP 149
           +               VS A   +   Q+A+G++ L   + +HRDL  +N LV  +    
Sbjct: 110 QREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY--- 166

Query: 150 VLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT 206
            +KI DFG +R+L   D       + L   +MA E I   K+   +D+W+ G  L+++ T
Sbjct: 167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 34/243 (13%)

Query: 54  DNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH---------- 103
           ++ LKEI I+S +  PNIIR      T + + ++ EY + GDL  ++ +H          
Sbjct: 64  NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 104 -GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL 162
              +S +       Q+A+G++ L   + +HRDL  +N LV  N     +KI DFG +R+L
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY---TIKIADFGMSRNL 180

Query: 163 TPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT--GKPPFDG---- 213
              D       + L   +M+ E I   K+   +D+W+ G  L++++T   + P+      
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Query: 214 ---SNQLQLFQNILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFNHRF 269
               N  + F++      L  P      L PD +  L     R+N  ER +F+E   H  
Sbjct: 241 QVIENTGEFFRDQGRQVYLPKPA-----LCPDSLYKLMLSCWRRNAKERPSFQEI--HAT 293

Query: 270 LGE 272
           L E
Sbjct: 294 LLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 49/152 (32%), Positives = 83/152 (54%), Gaps = 9/152 (5%)

Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFM 115
           L E  +L  ++HP++IR  + + +     +VL +    DL  Y+ K    +    A    
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIE 163

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR--SLTPQDLADTLCG 173
           +Q+  GL+ L  + +IHRD+K +N+ +  N+V  V  IGD G A+   + P  L   L G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFI--NDVDQVC-IGDLGAAQFPVVAPAFLG--LAG 218

Query: 174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLV 205
           +    APE++   KY++KAD+WS G +LF+++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 65/275 (23%), Positives = 125/275 (45%), Gaps = 35/275 (12%)

Query: 14  VGPRIGSGSFAVVWRARHRQLG--IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           +G  +G G F  V   +  Q    ++VAVK +   + +    ++ L E   +    HPN+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 72  IRF----FEAIETR--EKIYLVLEYCDGGDLAAYI--HKHGKVSEAVARH----FMRQLA 119
           +R      + +E+       ++L +   GDL +++   + G   + +       FM  +A
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPL- 176
           +G++ L  K  IHRDL  +N +++ N    V    DFG ++ +   D      +   P+ 
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCV---ADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           ++A E + +  Y  K+D+WS G  ++++ T G+ P+ G    +++  +     L+ P   
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP--- 236

Query: 236 IEELHPDCVD-----LCRCLLRQNPVERITFKEFF 265
                PDC+D     +  C L  NP +R +F+   
Sbjct: 237 -----PDCLDGLYSLMSSCWL-LNPKDRPSFETLR 265

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 56/225 (24%), Positives = 107/225 (47%), Gaps = 30/225 (13%)

Query: 18  IGSGSFAVVWRARHRQLGIE----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G  +F  +++      G++    VA+K + K + +P+      +E S+++ + HPNI+ 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYI-------------HKHGKVSEAVAR----HFMR 116
               +   + + ++ EY + GDL  ++              + G V  ++      H   
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
           Q+AAG++ L     +H+DL  +N+L+        +KI D G +R +   D       S L
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQL---HVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 177 ---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SNQ 216
              +M PE I   K+ + +D+WS G +L+++ + G  P+ G SNQ
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 22/195 (11%)

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PN++   + I + + ++LVL++ +GG L ++I K   + E   + +  ++   L  L  +
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++ RDL P N+L+        +++  F     +      + +    +Y APE+    + 
Sbjct: 105 GIVCRDLNPNNILLDDRG---HIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGISEE 159

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQ----NILTSTELRFPPGAIEELHPDCV 244
               D WS+GAILF+L+TGK          L +     I T T L  P    E +  +  
Sbjct: 160 TEACDWWSLGAILFELLTGK---------TLVECHPSGINTHTTLNIP----EWVSEEAR 206

Query: 245 DLCRCLLRQNPVERI 259
            L + LL+ NP ER+
Sbjct: 207 SLLQQLLQFNPTERL 221

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 76.1 bits (187), Expect = 3e-14
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 5/149 (3%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNI 71
           IV P I  G+F  V+  R +      AVK + K  +++  +   +  E   L+    P I
Sbjct: 8   IVKP-ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFI 66

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +  + ++++   +YLV+EY  GGD+ + +H +G   E +A  ++ ++A  L  L    +I
Sbjct: 67  VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII 126

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
           HRDLKP N+L+S NE    +K+ DFG ++
Sbjct: 127 HRDLKPDNMLIS-NEGH--IKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 25/200 (12%)

Query: 38  VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLA 97
           VA+K +  K   P + +    E  + S + HPNI+     +   + + ++  YC   DL 
Sbjct: 38  VAIKTLKDKAEGP-LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96

Query: 98  AYI---HKHGKVSE-------------AVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLL 141
            ++     H  V               A   H + Q+AAG++ L   H++H+DL  +N+L
Sbjct: 97  EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156

Query: 142 VSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVG 198
           V        +KI D G  R +   D    +  S L   +M+PE I   K+   +D+WS G
Sbjct: 157 VFDKL---NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213

Query: 199 AILFQLVT-GKPPFDG-SNQ 216
            +L+++ + G  P+ G SNQ
Sbjct: 214 VVLWEVFSYGLQPYCGYSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 73.1 bits (179), Expect = 7e-14
 Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 14/164 (8%)

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS 174
           Q+A G++ L  +  IHRDL  +N+L+S N    V+KI DFG AR +   P  +       
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTSTELRF 231
           PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   T +R 
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303

Query: 232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           P     E++   +D C       P +R TF E   H  LG L Q
Sbjct: 304 PDYTTPEMYQTMLD-C---WHGEPSQRPTFSELVEH--LGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 59/191 (30%), Positives = 85/191 (44%), Gaps = 21/191 (10%)

Query: 55  NLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY--CDGGDLAAYIHKHGKVSEAVAR 112
              +EI IL TISH  II    A   +  + +V+    CD   L  Y+ + G +    A 
Sbjct: 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD---LFTYVDRSGPLPLEQAI 188

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-----TPQDL 167
              R+L   L  L  + +IHRD+K +N+ +   E   VL  GDFG A  L     TPQ  
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVL--GDFGAACKLDAHPDTPQCY 245

Query: 168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDG------SNQLQLFQ 221
                G+    +PE++    Y AK D+WS G +LF++        G      S+QL+   
Sbjct: 246 G--WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII 303

Query: 222 NILTSTELRFP 232
             +    L FP
Sbjct: 304 RCMQVHPLEFP 314

Length = 392

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 20/208 (9%)

Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSP---KVSDNLLKEISILSTISHPN 70
           +GSG F  V    W      + I VA+K I  +       +++D++L     + ++ H  
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA----MGSLDHAY 70

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           I+R    I     + LV +    G L  ++ +H   +      ++  Q+A G+  L+E  
Sbjct: 71  IVRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNH 186
           ++HR+L  +N+L+ ++    +++I DFG A  L P D             +MA E I   
Sbjct: 130 MVHRNLAARNILLKSDS---IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 187 KYDAKADLWSVGAILFQLVT-GKPPFDG 213
           +Y  ++D+WS G  ++++++ G  P+ G
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 60/269 (22%), Positives = 118/269 (43%), Gaps = 29/269 (10%)

Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    + +        VA+K +++   S +     L E S++   +  +++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 72

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHK-----HGKVSEAVAR-----HFMRQLAAGL 122
           R    +   +   +++E    GDL +Y+            +A            ++A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
             L     +HRDL  +N +V+ +     +KIGDFG  R +   D         L   +M+
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + ++    L  P      
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNC--- 246

Query: 239 LHPDCV-DLCRCLLRQNPVERITFKEFFN 266
             PD + +L R   + NP  R +F E  +
Sbjct: 247 --PDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 22/222 (9%)

Query: 56  LLKEISILSTISHPNIIRFFEA-IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-- 112
           LL+E  +L  +SH NI+      IE  E  +++  Y + G+L  ++ +         +  
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114

Query: 113 ------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
                 H   Q+A G+  L ++ +IH+D+  +N ++  +E   V KI D   +R L P D
Sbjct: 115 STQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI--DEELQV-KITDNALSRDLFPMD 171

Query: 167 ---LADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQ 221
              L D     P+ +MA E + N +Y + +D+WS G +L++L+T G+ P+   +  ++  
Sbjct: 172 YHCLGDNE-NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230

Query: 222 NILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
            +     L  P    +EL      +  C    +P ER +F +
Sbjct: 231 YLKDGYRLAQPINCPDELF----AVMACCWALDPEERPSFSQ 268

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 20/167 (11%)

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS 174
           Q+A G++ L  +  IHRDL  +N+L+S N    V+KI DFG AR +   P  +       
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTSTELRF 231
           PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F Q +   T +R 
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA 298

Query: 232 PPGAIEELHPDCVDLCRCLL---RQNPVERITFKEFFNHRFLGELRQ 275
           P  A  E++       R +L   + +P ER TF        LG+L Q
Sbjct: 299 PENATPEIY-------RIMLACWQGDPKERPTFSALV--EILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 52/225 (23%), Positives = 102/225 (45%), Gaps = 28/225 (12%)

Query: 18  IGSGSFAVVWRARHRQLG----------IEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           +G G+F  +++   R             + V +K +       + S    +  S++S +S
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLS 59

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQ 126
           H ++++ +      E I +V EY   G L  ++H+    VS        +QLA+ L  L+
Sbjct: 60  HKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE 118

Query: 127 EKHLIHRDLKPQNLLVS----TNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           +K L+H ++  +N+LV+         P +K+ D G   ++  ++  + +   P ++APE 
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE--ERVERIP-WIAPEC 175

Query: 183 IQN--HKYDAKADLWSVGAILFQLVT-GKPPF---DGSNQLQLFQ 221
           I+N        AD WS G  L ++ + G+ P      S + + +Q
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ 220

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 54/230 (23%), Positives = 110/230 (47%), Gaps = 33/230 (14%)

Query: 35  GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF----EAIETREKIYLVLEY 90
              V VKE+ K   S K  +  L++      + HPNI++      EAI       LV EY
Sbjct: 22  VARVVVKEL-KANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI----PYLLVFEY 76

Query: 91  CDGGDLAAYIHK---HGKVSEAVARHFMR-QLAAGLQVLQEKHLIHRDLKPQNLLVSTNE 146
           C+ GDL +Y+ +   H + S+ +    M  ++AAG+  + + + +H DL  +N  + T++
Sbjct: 77  CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL-TSD 135

Query: 147 VTPVLKIGDFGFARSLTPQDLADT---LCGSPLYMAPEII----------QNHKYDAKAD 193
           +T  +K+GD+G   S   +D  +T    C    ++APE++          +  K    ++
Sbjct: 136 LT--VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP---SN 190

Query: 194 LWSVGAILFQLV-TGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           +W++G  L++L      P+   +  ++  +++   +++     +E  + +
Sbjct: 191 VWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 61/306 (19%), Positives = 111/306 (36%), Gaps = 58/306 (18%)

Query: 18  IGSGSF--AVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLL---KEISILSTISHPNII 72
           IG       +V  A+H+     VAVK+I+   L     ++L    +EI     + HPNI+
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQLAAGLQVLQEKHL 130
            +  +     ++Y+V      G     +  H      E      ++ +   L  +  K  
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLY-------MAPEI 182
           IHR +K  ++L+S +       +    ++ S+         +   P         ++PE+
Sbjct: 123 IHRSVKASHILLSGDGKV---VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179

Query: 183 I-QN-HKYDAKADLWSVGAILFQLVTGKPPF-------------DGSNQLQLFQNILTST 227
           + QN   Y+ K+D++SVG    +L  G  PF              G+    L ++     
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239

Query: 228 ELRFPPGAIEELHP-------------------DCVDLCRCLLRQNPVERITFKEFFNHR 268
           E           HP                     V+LC   L+++P  R +  +  NH 
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELC---LQRDPESRPSASQLLNHS 296

Query: 269 FLGELR 274
           F  + +
Sbjct: 297 FFKQCK 302

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 55/223 (24%), Positives = 110/223 (49%), Gaps = 23/223 (10%)

Query: 18  IGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G G+F  +++   R++G        EV +K +DK       S++  +  S++S +SH +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKH 60

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKH 129
           ++  +      ++  +V EY   G L  Y+ K    ++ +      +QLA  L  L++K 
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 130 LIHRDLKPQNLLVSTNE-----VTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           L H ++  +N+L+   E       P +K+ D G + ++ P+++   L     ++ PE I+
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI---LLERIPWVPPECIE 177

Query: 185 NHKYDA-KADLWSVGAILFQLVTG--KP--PFDGSNQLQLFQN 222
           N +  +  AD WS G  L+++ +G  KP    D   +LQ +++
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED 220

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 12/155 (7%)

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
           F  Q+A G+  L  K+ IHRDL  +N+L++   +T   KI DFG AR +   D    + G
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIR-NDSNYVVKG 274

Query: 174 S---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE 228
           +   P+ +MAPE I N  Y  ++D+WS G +L+++ + G  P+ G      F  ++    
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY 334

Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
               P   E    +  D+ +     +P++R TFK+
Sbjct: 335 RMLSP---ECAPSEMYDIMKSCWDADPLKRPTFKQ 366

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.5 bits (157), Expect = 6e-11
 Identities = 38/106 (35%), Positives = 61/106 (57%), Gaps = 9/106 (8%)

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
            F  Q+A G+  L  K+ IHRD+  +N+L++   V    KI DFG AR +   D    + 
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIM-NDSNYVVK 271

Query: 173 GS---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG 213
           G+   P+ +MAPE I +  Y  ++D+WS G +L+++ + GK P+ G
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.1 bits (151), Expect = 7e-10
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 36/235 (15%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTIS 67
           +  Y +   IG G    V+ A        VA+K+I + L  +P +    L+E  I + + 
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK-----------HGKVSEAVARHFMR 116
           HP I+  +      + +Y  + Y +G  L + +               K S         
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVST-NEVTPVLKIGDFGFARS--LTPQDLADT--- 170
           ++ A ++ +  K ++HRDLKP N+L+    EV     I D+G A    L  +DL D    
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVV----ILDWGAAIFKKLEEEDLLDIDVD 176

Query: 171 --------------LCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPF 211
                         + G+P YMAPE +         D++++G IL+Q++T   P+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 2/97 (2%)

Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           G+P Y+APE++    +    D W++G  LF+ +TG PPF+     Q+FQNIL + ++ +P
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL-NRDIPWP 600

Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
            G  E+L  +  +    LL  +P +R   KE   H  
Sbjct: 601 EGE-EKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 41/116 (35%), Positives = 65/116 (56%), Gaps = 9/116 (7%)

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
           F  Q+A G++ L  K+ +HRDL  +N+L+   ++   +KI DFG AR +  +D      G
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKL---VKICDFGLARDIM-RDSNYISKG 299

Query: 174 S---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNIL 224
           S   PL +MAPE I N+ Y   +D+WS G +L+++ T G  P+      + F N +
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 10/154 (6%)

Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
           E  IL  I+HP+II+        +   L+L      DL  Y+     ++        R +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGS 174
              +Q L E  +IHRD+K +N+ +  N    V  +GDFG A    P D+         G+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFI--NHPGDVC-LGDFGAA--CFPVDINANKYYGWAGT 246

Query: 175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGK 208
               APE++    Y    D+WS G +LF++ T  
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 56/230 (24%), Positives = 108/230 (46%), Gaps = 25/230 (10%)

Query: 46  KLLSPK---VSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK 102
           K+L P    +S    +  S++  +SH +I+  +       +  +V E+ + G L  ++H+
Sbjct: 38  KVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR 97

Query: 103 HGKV-SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVS----TNEVTPVLKIGDFG 157
              V +        +QLA+ L  L++K L+H ++  +N+L++      E  P +K+ D G
Sbjct: 98  KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157

Query: 158 FARS-LTPQDLADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + L+ Q+  + +   P ++APE +++ K     AD WS G  L+++      ++G  
Sbjct: 158 IPITVLSRQECVERI---P-WIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNG-- 206

Query: 216 QLQLFQNILTSTELRFPPGAIEELHPDC---VDLCRCLLRQNPVERITFK 262
           ++ L    L   E RF  G    + P C    DL    +  +P +R  F+
Sbjct: 207 EIPLKDKTLAEKE-RFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFR 255

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 39/118 (33%), Positives = 64/118 (54%), Gaps = 9/118 (7%)

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
           F  Q+A G++ L  K+ +HRDL  +N+L++  +   ++KI DFG AR +   D      G
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGK---IVKICDFGLARDIM-HDSNYVSKG 297

Query: 174 SPL----YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTS 226
           S      +MAPE I ++ Y   +D+WS G +L+++ + G  P+ G      F N + S
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 14/208 (6%)

Query: 49  SPKVSDNLLKEISILSTISHPNIIR----FFEAIETREKIYLVLEYCDGGDLAAYIHKHG 104
              + D    EI  L  I   NI++      + ++   ++ L+LEYC  G L   + K  
Sbjct: 58  HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK 117

Query: 105 KVSEAVARHFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT 163
            +S             GL  L +  +  +++L   + LV+ N     LKI   G  + L+
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK---LKIICHGLEKILS 174

Query: 164 PQDLADTLCGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQ 221
                +      +Y + +++ +   +Y  K D++S+G +L+++ TGK PF+     +++ 
Sbjct: 175 SPPFKNV--NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD 232

Query: 222 NILTST-ELRFPPGAIEELHPDCVDLCR 248
            I+     L+ P     E+    V+ C 
Sbjct: 233 LIINKNNSLKLPLDCPLEIK-CIVEACT 259

Length = 283

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)

Query: 56  LLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAV-- 110
           L  EI  L  ++H NI++  E + +    Y++ +  D  DL ++++      K    +  
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQ 268

Query: 111 ARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG----FARSLTPQD 166
            R  M+QL   ++ + +K LIHRD+K +N+ ++ +       +GDFG    F +     D
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI---VLGDFGTAMPFEKEREAFD 325

Query: 167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT 206
                 G+    +PEI+    Y    D+WS G IL  +++
Sbjct: 326 YG--WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 50/223 (22%), Positives = 101/223 (45%), Gaps = 22/223 (9%)

Query: 37  EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL 96
           +V VKE+ +   S +     L+E     ++ H N+++            LV+E+C  GDL
Sbjct: 24  QVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL 82

Query: 97  AAYIHKHGKVSEAVA------RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPV 150
             Y+ +  + +E +       +    ++A GL  L + + IH DL  +N L++ +     
Sbjct: 83  KGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD---LT 138

Query: 151 LKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQN-H------KYDAKADLWSVGAI 200
           +KIGD+G + +   +D     D L     ++APE++   H          ++++WS+G  
Sbjct: 139 VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198

Query: 201 LFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           +++L   G  P+   +  Q+    +   +L+ P   ++    D
Sbjct: 199 IWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSD 241

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 41/229 (17%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN------- 70
           +G G+F  V  A  R+     AVK +      PK + +   EI  +  +   +       
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRN---VPKYTRDAKIEIQFMEKVRQADPADRFPL 193

Query: 71  --IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ-E 127
             I R+F+  ET     ++ +Y  G  L  +I KHG  S       + Q    L     E
Sbjct: 194 MKIQRYFQN-ETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250

Query: 128 KHLIHRDLKPQNLLVSTNE--VTPVLKIGDFGFARSLTPQDLADTLC------------- 172
            HL+H DLKP+N+L+ T++  V PV         R+L P      +C             
Sbjct: 251 LHLMHTDLKPENILMETSDTVVDPVTN-------RALPPDPCRVRICDLGGCCDERHSRT 303

Query: 173 ---GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ 218
               +  Y +PE++    +    D+WS+G I+++L TGK  +D  + L+
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352

Length = 467

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 70/337 (20%), Positives = 132/337 (39%), Gaps = 83/337 (24%)

Query: 18  IGSG--SFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG G  +   V+ ARH   G  V V+  D +  + +    L  E+ +     HPNI+  +
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 76  EAIETREKIYLV---LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               T   ++++   + Y     L       G +SEA+  + +     GL  L +   IH
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYIH 124

Query: 133 RDLKPQNLLVS---------TNEVTPVLKIG-------DF-GFARSLTPQDLADTLCGSP 175
           R++K  ++L+S          + +  +++ G       DF  F+ S+ P           
Sbjct: 125 RNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP----------- 173

Query: 176 LYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ-LFQNI--------- 223
            +++PE+++   + Y+ K+D++SVG    +L TG+ PF    + Q L Q +         
Sbjct: 174 -WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232

Query: 224 ----------------------------------LTSTELRFPPGAIEELHPDCVDLCRC 249
                                             +TS  LR P  + +   P   +L   
Sbjct: 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTP--SSKTFSPAFQNLVEL 290

Query: 250 LLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVP 286
            L+Q+P +R +     +H F  ++++       S++P
Sbjct: 291 CLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLP 327

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 5e-07
 Identities = 49/201 (24%), Positives = 91/201 (45%), Gaps = 25/201 (12%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           I  G     ++ +  + G++  VKEI+         +++   EI+ +  + HPNI++   
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEIND-------VNSIPSSEIADMGKLQHPNIVKLIG 750

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ---EKHLIHR 133
              + +  YL+ EY +G +L+  +     +S    R     +A  L+ L       ++  
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCG-SPLYMAPEIIQNHKYDAK 191
           +L P+ +++   +  P L++          P  L  DT C  S  Y+APE  +      K
Sbjct: 808 NLSPEKIIIDGKDE-PHLRLS--------LPGLLCTDTKCFISSAYVAPETRETKDITEK 858

Query: 192 ADLWSVGAILFQLVTGKPPFD 212
           +D++  G IL +L+TGK P D
Sbjct: 859 SDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)

Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVL-EYCDGGDLAAYIHKHGK-VSEAVARHFMR 116
           E  +L  +SHP ++   +         LVL +Y    DL  Y+    + +  A      R
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVAR 267

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG---FARSLTPQDLADTLCG 173
           QL + +  +  + +IHRD+K +N+LV+  E    + +GDFG   FAR          + G
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DICLGDFGAACFARGSWSTPFHYGIAG 324

Query: 174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQ 203
           +    APE++    Y    D+WS G ++F+
Sbjct: 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 7/97 (7%)

Query: 13  IVGPRIGSGSFAVVWRA-----RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           ++G  +GSG+F  V  A      H Q  ++VAVK +     S +    L+ E+ I+S + 
Sbjct: 40  VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-KQALMSELKIMSHLG 98

Query: 68  -HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH 103
            H NI+    A      IY++ EYC  GDL  Y+H++
Sbjct: 99  PHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRN 135

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 15/111 (13%)

Query: 55  NLLKEISILSTISH-----PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEA 109
           +  +E++IL  ++      P ++   E   +    YL++E+ +G  L        +  E 
Sbjct: 37  DREREVAILQLLARKGLPVPKVLASGE---SDGWSYLLMEWIEGETLD---EVSEEEKED 90

Query: 110 VARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
           +A      LA  L  L    L H DL P N+LV   ++  ++   D+ +A 
Sbjct: 91  IAEQLAELLAK-LHQLPLLVLCHGDLHPGNILVDDGKILGII---DWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 31/233 (13%)

Query: 46  KLLSPKVSDNLL---KEISILSTISHPNIIRFFEAIETR--EKIYLVLEYCDGGDLAAYI 100
           K+L P   D  L   +  S++S +SH ++  F   +  R  E I +V E+ + G L   +
Sbjct: 50  KVLDPSHRDIALAFFETASLMSQVSHIHLA-FVHGVCVRGSENI-MVEEFVEHGPLDVCL 107

Query: 101 HKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVS----TNEVTPVLKIGD 155
            K  G+V  A      +QLA+ L  L++K+L+H ++  +N+L++        +P +K+ D
Sbjct: 108 RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167

Query: 156 FGFA-RSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDG 213
            G +  +L+ ++  + +   P ++APE +   +     AD WS G  L ++      FDG
Sbjct: 168 PGVSFTALSREERVERI---P-WIAPECVPGGNSLSTAADKWSFGTTLLEIC-----FDG 218

Query: 214 SNQLQ----LFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFK 262
              L+      +      + R P  + +EL      L    L   P +R +F+
Sbjct: 219 EVPLKERTPSEKERFYEKKHRLPEPSCKEL----ATLISQCLTYEPTQRPSFR 267

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 13/222 (5%)

Query: 18  IGSG--SFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG G      V  AR++  G  V V+ I+ +  + ++   L  E+ +    +HPNI+ + 
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
                  ++++V  +   G     I  H    +SE    + ++ +   L  +     +HR
Sbjct: 66  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHR 125

Query: 134 DLKPQNLLVSTN------EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH- 186
            +K  ++L+S +       +   L + + G  R     D          +++PE++Q + 
Sbjct: 126 SVKASHILISVDGKVYLSGLRSNLSMINHG-QRLRVVHDFPKYSVKVLPWLSPEVLQQNL 184

Query: 187 -KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST 227
             YDAK+D++SVG    +L  G  PF      Q+    L  T
Sbjct: 185 QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 226

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 34/155 (21%), Positives = 60/155 (38%), Gaps = 16/155 (10%)

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           LQ L     +HR  K  N+L++ + +  +      G     TP+         P +MAPE
Sbjct: 24  LQCLGALRELHRQAKSGNILLTWDGLLKL-----DGSVAFKTPEQSR----PDPYFMAPE 74

Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQNIL-----TSTELRFPPGA 235
           +IQ   Y  KAD++S+G  L++ +  + P++   +L  + + +L          R     
Sbjct: 75  VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEG 134

Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +         +  C  R  P  R     +  H   
Sbjct: 135 VSAARSFEDFMRLCASRL-PQRREAANHYLAHCRA 168

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 110 VARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
           V +  MRQ+  GL+ L    ++HRD+KP+NLLV+   V   +KI DFG A  +      +
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFN 366

Query: 170 TLCG--SPLYMAPEIIQNHKYDAKADLWSVGAIL--FQLVTGKP 209
            L G   P Y  PE +   +   +A   ++ A+L  F  + G+P
Sbjct: 367 PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRP 410

Length = 507

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 5/96 (5%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTI-S 67
           ++G  +GSG+F  V       L     V ++  K+L P    +    L+ E+ I++ +  
Sbjct: 40  VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGP 99

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH 103
           H NI+    A      IY++ EYC  GDL  Y+HK+
Sbjct: 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKN 135

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 25/112 (22%), Positives = 39/112 (34%), Gaps = 12/112 (10%)

Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
           L ++    +          + +  +         A  + +  ++ E +    +  L A  
Sbjct: 105 LHSVPPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPA-- 162

Query: 123 QVLQEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFARSLTP--QDLADTL 171
                  L+H DL P NLLV     VT V+   DF  A  L     DLA  L
Sbjct: 163 ---LPLVLVHGDLHPGNLLVDPGGRVTGVI---DFEDAG-LGDPAYDLASLL 207

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 28/74 (37%), Positives = 37/74 (50%), Gaps = 14/74 (18%)

Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL------TPQD-L 167
           MRQ+   L  L    ++HRD+KPQN++ S  E +   KI D G A  L       P++ L
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFL 318

Query: 168 ADTLCGSPLYMAPE 181
            D     P Y APE
Sbjct: 319 LD-----PRYAAPE 327

Length = 566

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 40.4 bits (95), Expect = 0.003
 Identities = 56/210 (26%), Positives = 77/210 (36%), Gaps = 71/210 (33%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVK----------EIDKKLL--SPKVSDNLLKEISILST 65
           I S S A V RA  +  G EVAVK          E D KLL    ++   L      L  
Sbjct: 133 IASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDL 191

Query: 66  ISHPNIIRFFE---------------AIETRE-----------KIY--------LVLEYC 91
                ++  FE               A   RE           K+Y        L +E+ 
Sbjct: 192 ---VEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWI 248

Query: 92  DG---GDLAAYIHKHG----KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVST 144
           DG    D+AA +   G    +++E + R F+RQL             H D  P N+LV +
Sbjct: 249 DGIKISDIAA-LKSAGIDRKELAELLVRAFLRQLL-------RDGFFHADPHPGNILVRS 300

Query: 145 NEVTPVLKIGDFGFARSLTPQD---LADTL 171
           +    +L   DFG    L P+    LA+ L
Sbjct: 301 DGRIVLL---DFGIVGRLDPKFRRYLAELL 327

Length = 517

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	692
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.79
smart00090	237	RIO RIO-like kinase.	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
PF12063	238	DUF3543: Domain of unknown function (DUF3543); Int	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.38
KOG1243	690	consensus Protein kinase [General function predict	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
KOG3087	229	consensus Serine/threonine protein kinase [General	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.88
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.81
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.73
COG4248	637	Uncharacterized protein with protein kinase and he	98.63
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.62
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.46
PRK09902	216	hypothetical protein; Provisional	98.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.38
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.3
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.3
PF01636	239	APH: Phosphotransferase enzyme family This family	98.29
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.25
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.17
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.14
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.12
PLN02876	822	acyl-CoA dehydrogenase	98.03
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.94
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.93
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.93
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.77
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.73
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.44
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.33
PRK05231	319	homoserine kinase; Provisional	97.33
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.21
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.2
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.09
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.93
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.92
KOG2270	520	consensus Serine/threonine protein kinase involved	96.87
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.82
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.82
PRK12396	409	5-methylribose kinase; Reviewed	96.67
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.55
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.41
PLN02236	344	choline kinase	96.38
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.36
PLN02756	418	S-methyl-5-thioribose kinase	96.21
PRK10593	297	hypothetical protein; Provisional	96.13
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.98
PRK11768	325	serine/threonine protein kinase; Provisional	95.3
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.2
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.15
PTZ00384	383	choline kinase; Provisional	94.83
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.51
COG2334	331	Putative homoserine kinase type II (protein kinase	94.0
PRK06148	1013	hypothetical protein; Provisional	93.24
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	92.89
PTZ00296	442	choline kinase; Provisional	92.61
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	91.97

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-57  Score=475.08  Aligned_cols=268  Identities=53%  Similarity=0.929  Sum_probs=249.7

Q ss_pred             CCcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526            4 NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         4 ~~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      ...+.+++|.+.++||+|+||+||+|+++.++..||||.|.++.++.+..+.+..|++||+.++|||||+++++++.++.
T Consensus         4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            34567899999999999999999999999999999999999998899999999999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCC-CCc--CeEEEecccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTN-EVT--PVLKIGDFGFAR  160 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~-~~~--~~vKL~DFGlA~  160 (692)
                      +|+|||||+||||..||++++.++|..++.++.||+.||++||+++||||||||+||||+.. +..  +.+||+|||+|+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999876 333  789999999999


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      .+.+.....+.||+|.|||||++....|+.|+|+||+|+++|+|++|++||...+..+++..+.++....  +.....++
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~--~~~~~~~s  241 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV--PVLPAELS  241 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc--Cchhhhcc
Confidence            9999999999999999999999999999999999999999999999999999999999998776655432  22335677


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ..+.+++...|+.+|.+|.++.+.+.|+++..-
T Consensus       242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             CchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            888899999999999999999999999998643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-57  Score=474.68  Aligned_cols=265  Identities=32%  Similarity=0.597  Sum_probs=240.5

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-----VSDNLLKEISILSTISHPNIIRFFEAIETRE   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-----~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~   82 (692)
                      +.+.|.+.+.||+|+||.|.+|..+.||+.||||++.+......     ....+.+|++||++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            67889999999999999999999999999999999987644321     2234679999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      ..|+||||++||+|.+++-.++.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+...-.+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            99999999999999999999999999999999999999999999999999999999999988866668999999999999


Q ss_pred             CCCCCCCccCCCCCccChHhhhhcCC---CcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCCCCCcccc
Q 005526          163 TPQDLADTLCGSPLYMAPEIIQNHKY---DAKADLWSVGAILFQLVTGKPPFDGSNQLQ-LFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       163 ~~~~~~~~~~GT~~YmAPEvl~~~~y---s~ksDIWSLGviLyeLltG~~PF~~~~~~~-~~~~i~~~~~~~~p~~~~~~  238 (692)
                      .......+.||||.|.|||++.+.++   ..++||||+||+||-+++|.+||.+..... +.+.|.++ .+.|.+..|.+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G-~y~f~p~~w~~  408 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG-RYAFGPLQWDR  408 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC-cccccChhhhh
Confidence            88889999999999999999987653   457899999999999999999998877666 56666554 66777778899


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ++.+.++||.+||..||++|||+.|+|+||||+..
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            99999999999999999999999999999999754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-53  Score=468.27  Aligned_cols=255  Identities=38%  Similarity=0.704  Sum_probs=238.8

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .+|..++.||+|||+.||.+++..+|..||+|+|.+.. ......+.+.+|++|.++|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            45999999999999999999999999999999998754 35677889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~  167 (692)
                      |+|..++|..++++++.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+   |||+|||+|..+... +.
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~---VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN---VKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc---EEecccceeeeecCcccc
Confidence            99999999999999999999999999999999999999999999999999999998874   999999999988744 77


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ..+.||||.|+|||++...+.+..+||||+||++|-||+|+|||...+-.+.+.+|... .+.+|    ..++.+++|||
T Consensus       175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-~Y~~P----~~ls~~A~dLI  249 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-EYSMP----SHLSAEAKDLI  249 (592)
T ss_pred             cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-Ccccc----cccCHHHHHHH
Confidence            88999999999999999999999999999999999999999999999999999988664 45555    37899999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhhhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      .+||++||.+|||++++|.|+||..
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhC
Confidence            9999999999999999999999943

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-53  Score=442.94  Aligned_cols=266  Identities=34%  Similarity=0.616  Sum_probs=243.3

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .-.++|++++.||+|+||+||+++.+.+++.||+|++++.... .+..+..+.|..||.+++||+||+++..|++++.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            3468999999999999999999999999999999999887543 345678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccc-cCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS-LTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~-~~~  164 (692)
                      +|+||+.||+|...|++.+.++|+.++.|+..|+.||.|||++|||||||||+||||+.+|+   ++|+|||+++. ...
T Consensus       102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH---i~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH---IKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc---EEEeccccchhcccC
Confidence            99999999999999999999999999999999999999999999999999999999999985   99999999985 445


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      +..+.++|||+.|||||++.+.+|+..+|+||||+++|+|++|.+||.+.+..+.+++|.+..... ++   ..++.+++
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~-~p---~~ls~~ar  254 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL-PP---GYLSEEAR  254 (357)
T ss_pred             CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC-CC---ccCCHHHH
Confidence            567788999999999999999999999999999999999999999999999999999998875232 22   35789999


Q ss_pred             HHHHHhhccCCCCCC----CHHHHHhchhhhhhHhhhhh
Q 005526          245 DLCRCLLRQNPVERI----TFKEFFNHRFLGELRQTVHA  279 (692)
Q Consensus       245 dLI~~~L~~DP~~Rp----Ta~elL~Hpf~~~~~~~~~~  279 (692)
                      |+++++|.+||++|.    .+++|-+||||..+.+....
T Consensus       255 dll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~  293 (357)
T KOG0598|consen  255 DLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLL  293 (357)
T ss_pred             HHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHH
Confidence            999999999999996    79999999999988666443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-53  Score=442.83  Aligned_cols=256  Identities=33%  Similarity=0.628  Sum_probs=238.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE-KIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~-~l~LVm   88 (692)
                      ++.+.++.||+|..|+||+++|+.|++.+|+|+|.. ...+...+++.+|++|++..+||+||++|+.|..+. .++|+|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            477889999999999999999999999999999943 456778899999999999999999999999999988 599999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      |||+||+|.++++..++++|..+..++.++++||.|||+ ++||||||||+|||++..|   .|||||||.++.+... .
T Consensus       158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG---eVKicDFGVS~~lvnS-~  233 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG---EVKICDFGVSGILVNS-I  233 (364)
T ss_pred             hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC---CEEeccccccHHhhhh-h
Confidence            999999999999999999999999999999999999995 9999999999999999988   5999999999988766 8


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS-----NQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~-----~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      +.+++||..|||||.+.+..|+.++||||||++++|+.+|+.||...     +..+++..|+.+.....|..   .+|++
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~---~fS~e  310 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG---EFSPE  310 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc---cCCHH
Confidence            89999999999999999999999999999999999999999999875     77889999988776666653   58999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +++||..||++||.+|||++|+++|||+.+.
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            9999999999999999999999999999765

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-51  Score=444.14  Aligned_cols=263  Identities=32%  Similarity=0.635  Sum_probs=239.6

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKI   84 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l   84 (692)
                      +-.++|.+++.||+|+|++|++|+++.+++.||||++.+..+ ..+-.+.+.+|..+|.+| .||+|++|+-.|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            456899999999999999999999999999999999987654 333456788899999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      |+|+||+++|+|.++|++.+.|+|..++.|+.||+.||+|||++|||||||||+||||+.|+   .+||+|||.|+.+.+
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm---hikITDFGsAK~l~~  226 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG---HIKITDFGSAKILSP  226 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC---cEEEeeccccccCCh
Confidence            99999999999999999999999999999999999999999999999999999999999998   599999999998754


Q ss_pred             CCCC--------------CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 005526          165 QDLA--------------DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR  230 (692)
Q Consensus       165 ~~~~--------------~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~  230 (692)
                      ....              .+++||..|.+||++.....+..+|||+||||||+|+.|.+||.+.++.-++++|+.- .+.
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y~  305 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DYE  305 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-ccc
Confidence            3221              4589999999999999999999999999999999999999999999999999999874 556


Q ss_pred             CCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhhh
Q 005526          231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV  277 (692)
Q Consensus       231 ~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~~  277 (692)
                      ||+    .+++.+.|||+++|..||.+|+|+++|.+||||..+.+.-
T Consensus       306 fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  306 FPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             CCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            664    5678999999999999999999999999999998875543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-51  Score=415.30  Aligned_cols=262  Identities=32%  Similarity=0.638  Sum_probs=242.6

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      --..+|++.+.||.|+||.|.+++++.+|..||+|++++.. ..-+..+...+|..+|+.+.||+++++++.+.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            45689999999999999999999999999999999998754 34556778899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      +||||++||.|.+++++.++|+|..++.++.||+.||+|||+++|++|||||+||||+.+|+   +||+|||+|+.....
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~---iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH---IKITDFGFAKRVSGR  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc---EEEEeccceEEecCc
Confidence            99999999999999999999999999999999999999999999999999999999999995   999999999987644


Q ss_pred             CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                        +.+.||||.|+|||++...+|+.++|+|+|||++|||+.|++||...+..+++++|+.+ .+.||    ..++++++|
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-~v~fP----~~fs~~~kd  270 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-KVKFP----SYFSSDAKD  270 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-cccCC----cccCHHHHH
Confidence              78899999999999999999999999999999999999999999999999999999875 56777    478999999


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHhchhhhhhHhhhh
Q 005526          246 LCRCLLRQNPVERI-----TFKEFFNHRFLGELRQTVH  278 (692)
Q Consensus       246 LI~~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~~~~~  278 (692)
                      |+.++|++|-.+|.     -.++|.+||||....+..-
T Consensus       271 Ll~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  271 LLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             HHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence            99999999999994     5689999999997765543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-50  Score=436.89  Aligned_cols=259  Identities=41%  Similarity=0.747  Sum_probs=235.7

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS---PKVSDNLLKEISILSTIS-HPNIIRFFEAIETRE   82 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~---~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~   82 (692)
                      ...+.|.+++.||+|+||+|++|.+..+|..||+|++++....   ....+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            5678999999999999999999999999999999988765222   234667789999999999 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCC-CCcCeEEEeccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTN-EVTPVLKIGDFGFARS  161 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~-~~~~~vKL~DFGlA~~  161 (692)
                      .+|+|||||.||+|.+++...+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ +   .+||+|||++..
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~---~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG---NLKLSDFGLSAI  170 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC---CEEEeccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999998 5   499999999998


Q ss_pred             c-CCCCCCCccCCCCCccChHhhhhcC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccc
Q 005526          162 L-TPQDLADTLCGSPLYMAPEIIQNHK-YD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       162 ~-~~~~~~~~~~GT~~YmAPEvl~~~~-ys-~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~  238 (692)
                      . .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...++.+|.. ..+.+|....  
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~-~~~~~p~~~~--  247 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK-GEFKIPSYLL--  247 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-CCccCCCCcC--
Confidence            8 5677889999999999999999988 86 779999999999999999999999998888888655 4555664322  


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                       ++++.+|+.+||..||.+|+|+.++++||||+.
T Consensus       248 -S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  248 -SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence             999999999999999999999999999999975

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=411.42  Aligned_cols=272  Identities=32%  Similarity=0.580  Sum_probs=253.7

Q ss_pred             CCCC-CcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 005526            1 MEPN-RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE   79 (692)
Q Consensus         1 m~p~-~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~   79 (692)
                      |.++ ..++-++|.+-++||+|.|++||++.+..+|+.+|+|+|+...+.....+.+.+|++|-+.|+|||||++.+.+.
T Consensus         1 m~~d~~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~   80 (355)
T KOG0033|consen    1 MMNDASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   80 (355)
T ss_pred             CCCccccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence            4454 567889999999999999999999999999999999999888777777889999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccc
Q 005526           80 TREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA  159 (692)
Q Consensus        80 ~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA  159 (692)
                      .....|+|+|+++|++|..-|-.+.-++|..+-.+++||+.+|.|+|.+||||||+||.|+|+.......-+||+|||+|
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA  160 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLA  160 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceE
Confidence            99999999999999999887777777899999999999999999999999999999999999987766667999999999


Q ss_pred             cccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          160 RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       160 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      ..+.........+|||.|||||++...+|+..+|||+.||+||-|+.|++||.+.+...+++.|..+ .+.++...|..+
T Consensus       161 i~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-~yd~~~~~w~~i  239 (355)
T KOG0033|consen  161 IEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-AYDYPSPEWDTV  239 (355)
T ss_pred             EEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-ccCCCCcccCcC
Confidence            9998777888899999999999999999999999999999999999999999999999999999775 677888889999


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +++.++|+++||..||.+|+|+.|+|+|||+.+-
T Consensus       240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             CHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999999999653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.8e-50  Score=411.56  Aligned_cols=265  Identities=28%  Similarity=0.557  Sum_probs=232.2

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++.|+.+.++|+|+||+||+++++.||+.||||.+.....++...+-.++|+++|++++|+|+|.++++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            36799999999999999999999999999999999877777777888899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~  167 (692)
                      |||+..-|.++-.-..+++++.++.+++|++.|+.|+|++++|||||||+||||+.++   ++||||||+|+.+. +.+.
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g---vvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG---VVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC---cEEeccchhhHhhcCCcch
Confidence            9999854544444457899999999999999999999999999999999999999988   69999999999987 7777


Q ss_pred             CCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------------
Q 005526          168 ADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE------------------  228 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~------------------  228 (692)
                      ...++.|.||+|||.+.+ ..|+..+|||++||++.||++|.+.|+|..+.+++..|...-.                  
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            788999999999999877 7899999999999999999999999999998877766653210                  


Q ss_pred             CCCCC--------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          229 LRFPP--------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       229 ~~~p~--------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      +.+|.        .....++.-+.||+++||+.||++|++.+|+|.|+||..+...
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence            11121        1123566788999999999999999999999999999766544

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-50  Score=441.48  Aligned_cols=260  Identities=39%  Similarity=0.697  Sum_probs=243.5

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccC-CCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~-~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .-+|-|++++-||.|+-|.|.+|+|..||+.+|||+|.+. .........+.+|+-||+.+.||||+++|++++....+|
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly   88 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY   88 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence            3578899999999999999999999999999999999876 556666778999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      +|.||++||.|++++-++|+++|.++.++++||+.|+.|||..+|+||||||+|+||+..++   |||+|||+|....++
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPG  165 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCC
Confidence            99999999999999999999999999999999999999999999999999999999998875   999999999988888


Q ss_pred             CCCCccCCCCCccChHhhhhcCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~~~ys-~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      ....+.||+|.|.|||++.+.+|+ .++||||.|||||.|++|+.||++.+...++.++.++ .+.+|    ..++++++
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-~f~MP----s~Is~eaQ  240 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-VFEMP----SNISSEAQ  240 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-cccCC----CcCCHHHH
Confidence            899999999999999999999995 7899999999999999999999999999999888765 45555    57899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +||++||..||.+|+|.+||++|||+....
T Consensus       241 dLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  241 DLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HHHHHHhccCccccccHHHHhhCchhhcCC
Confidence            999999999999999999999999997654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.3e-49  Score=429.21  Aligned_cols=263  Identities=27%  Similarity=0.565  Sum_probs=236.7

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      -+++|+++++||+|+||.||+|+.+.||..||+|++++... .......++.|-.||....+|+||++|..|.+.+++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            35899999999999999999999999999999999987653 44567788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC--
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP--  164 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~--  164 (692)
                      ||||++|||+..+|.+.+.++|+.++.++.+++.|++-||+.|+|||||||+|+||+..|+   +||+|||++..+..  
T Consensus       219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH---iKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH---IKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC---Eeeccccccchhhhhh
Confidence            9999999999999999999999999999999999999999999999999999999999985   99999999853211  


Q ss_pred             --------------------C--------------------------CCCCccCCCCCccChHhhhhcCCCcchhhHHHH
Q 005526          165 --------------------Q--------------------------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVG  198 (692)
Q Consensus       165 --------------------~--------------------------~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLG  198 (692)
                                          .                          ..+...+|||-|||||++.+.+|+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                0                          012245799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCCC---HHHHHhchhhhhhH
Q 005526          199 AILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT---FKEFFNHRFLGELR  274 (692)
Q Consensus       199 viLyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpT---a~elL~Hpf~~~~~  274 (692)
                      ||+||||.|.+||.+.+..+.+.+|.... .+.+|..  ..++++++|||.+||. ||++|.-   ++||.+||||..+.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            99999999999999999999999998764 3556654  4678999999999999 9999994   99999999999876


Q ss_pred             hh
Q 005526          275 QT  276 (692)
Q Consensus       275 ~~  276 (692)
                      +.
T Consensus       453 W~  454 (550)
T KOG0605|consen  453 WD  454 (550)
T ss_pred             cc
Confidence            54

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-51  Score=413.65  Aligned_cols=258  Identities=31%  Similarity=0.600  Sum_probs=230.9

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEE-EEEe-CCEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE-AIET-REKIY   85 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~-~~~~-~~~l~   85 (692)
                      -..+|+|+++||+|+||+||++++..+|..+|.|.|+....+.+.++.+..|+.+|++|+|||||++++ .|.. +..++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            346799999999999999999999999999999999988889999999999999999999999999998 4544 44599


Q ss_pred             EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CcccCCCCCceEecCCCCcCeEEEeccc
Q 005526           86 LVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQE--KH--LIHRDLKPQNLLVSTNEVTPVLKIGDFG  157 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs--~g--IVHRDLKP~NILL~~~~~~~~vKL~DFG  157 (692)
                      ||||||.+|||...|+.    +..++|..+|.++.|++.||.++|.  .+  |+||||||.||+|+.+|   +|||+|||
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g---vvKLGDfG  173 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG---VVKLGDFG  173 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC---ceeeccch
Confidence            99999999999999874    3468999999999999999999998  45  99999999999999888   59999999


Q ss_pred             cccccCCCC-CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcc
Q 005526          158 FARSLTPQD-LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       158 lA~~~~~~~-~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~  236 (692)
                      +++.+.... .+.+.+|||.||+||++...+|+.|+||||+||++|||+.-++||.|.+-.++..+|..+...+.|   .
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p---~  250 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP---D  250 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc---H
Confidence            999987554 467899999999999999999999999999999999999999999999999999999877433333   2


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      ..+|.++..+|..|+.+||+.||+.     +|++..+...
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~~  285 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQSE  285 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHHH
Confidence            5789999999999999999999986     6777666543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-49  Score=431.87  Aligned_cols=260  Identities=35%  Similarity=0.642  Sum_probs=240.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      +++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+....++..+++.+|++|++.++|||||.++++|+....+|+|.
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            46899999999999999999999999999999999998888888999999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      |||.| +|..+|...+.++|+.++.+..|++.||+|||+++|+|||+||.|||+..++   .+|+||||+|+...... +
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~---~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG---TLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC---ceeechhhhhhhcccCcee
Confidence            99988 9999999999999999999999999999999999999999999999999887   59999999999876544 4


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ...+.|||.|||||++.+.+|+..+|+|||||++|||++|++||......++...|... +..+|    ...+..|++|+
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-~v~~p----~~~S~~f~nfl  231 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-PVKPP----STASSSFVNFL  231 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-CCCCc----ccccHHHHHHH
Confidence            56678999999999999999999999999999999999999999999988888888764 33333    37899999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhhhhhHhhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFLGELRQTV  277 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~~~~~~~~  277 (692)
                      +.+|.+||.+|.|..+++.|||+.+.....
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~  261 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKINIA  261 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhhhhh
Confidence            999999999999999999999997654433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-50  Score=428.55  Aligned_cols=265  Identities=31%  Similarity=0.542  Sum_probs=232.7

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-E
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETRE-K   83 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~-~   83 (692)
                      ..+.++|.+.++||.|+||.||+|+.+.+|..||||.++++...- ..---.||++.|++|+ ||||+++.+++.+.+ .
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            457899999999999999999999999999999999998775542 2233468999999998 999999999998888 9


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      +|+|||||+. +|.++++.++ .|+|..++.|+.||++||+|+|.+|++|||+||+|||+..+.   .|||+|||+||..
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~---~iKiaDFGLARev  160 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND---VIKIADFGLAREV  160 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc---eeEeccccccccc
Confidence            9999999987 9999998764 589999999999999999999999999999999999998655   6999999999999


Q ss_pred             CCCCCCCccCCCCCccChHhh-hhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 005526          163 TPQDLADTLCGSPLYMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS---------------  226 (692)
Q Consensus       163 ~~~~~~~~~~GT~~YmAPEvl-~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~---------------  226 (692)
                      ........++.|.||+|||++ +.+.|+.+.|||++|||++|+.+-++.|+|.+..+.+.+|+.-               
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            988888899999999999996 5677999999999999999999999999999999888888642               


Q ss_pred             ---cCCCCCCC-------cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          227 ---TELRFPPG-------AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       227 ---~~~~~p~~-------~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                         ..+.+|..       .....++++.+||.+||++||.+|||+.|+|+||||+....
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence               11223321       12346889999999999999999999999999999986543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=424.96  Aligned_cols=265  Identities=30%  Similarity=0.569  Sum_probs=239.9

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKI   84 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l   84 (692)
                      .-+.+|+++++||+|+||+|+++..+.+++.||||++++.. +.+...+..+.|.+|+... +||.++.++.+|.+.+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34689999999999999999999999999999999998864 4566678899999999877 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-  163 (692)
                      |+||||+.||+ ...++..+.|+|..++.|+..++.||+|||++||||||||.+|||+|.+|+   +||+|||+++... 
T Consensus       445 ~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh---~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  445 FFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH---VKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc---EEecccccccccCC
Confidence            99999999999 334445578999999999999999999999999999999999999999995   9999999998765 


Q ss_pred             CCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          164 PQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       164 ~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      .+..+.|+||||.|||||++.+..|+..+|+|||||+||||+.|+.||.|++..++++.|+.. +..+|    ..++.++
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-~~~yP----~~ls~ea  595 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-EVRYP----RFLSKEA  595 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCCC----CcccHHH
Confidence            667889999999999999999999999999999999999999999999999999999999764 34444    4789999


Q ss_pred             HHHHHHhhccCCCCCCC-----HHHHHhchhhhhhHhhhhhh
Q 005526          244 VDLCRCLLRQNPVERIT-----FKEFFNHRFLGELRQTVHAE  280 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpT-----a~elL~Hpf~~~~~~~~~~~  280 (692)
                      +++++++|.+||++|.-     +++|..||||+.+.+.....
T Consensus       596 ~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~  637 (694)
T KOG0694|consen  596 IAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN  637 (694)
T ss_pred             HHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh
Confidence            99999999999999994     68999999999887665443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-48  Score=416.21  Aligned_cols=263  Identities=31%  Similarity=0.533  Sum_probs=232.0

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EK   83 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~--~~   83 (692)
                      .+..+.|+.+++||+|.||.||+|++..+|+.||+|.++.+...+.......+|+.||++|+||||++|.+.+...  ..
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            3556789999999999999999999999999999999999887788888899999999999999999999998765  78


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      +|+|+|||+. ||..++... -+|++.+++.||+||+.||+|||++||+|||||.+||||+.+|   ++||+|||+|+++
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G---~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG---VLKIADFGLARFY  268 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC---CEEeccccceeec
Confidence            9999999998 899888764 4799999999999999999999999999999999999999888   5999999999977


Q ss_pred             CCCC--CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------C
Q 005526          163 TPQD--LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---------R  230 (692)
Q Consensus       163 ~~~~--~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~---------~  230 (692)
                      ....  .....+-|.||+|||++.+ ..|+.++|+||+||||.||++|++.|+|.+..+++.+|.+....         .
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            6554  3456678999999999876 57999999999999999999999999999999888888653211         1


Q ss_pred             CC---------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          231 FP---------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       231 ~p---------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      +|               .+....++..+.+|+..||..||.+|.|+.++|.|+||..
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            11               0112456788999999999999999999999999999943

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=406.17  Aligned_cols=257  Identities=33%  Similarity=0.630  Sum_probs=220.2

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE--KIYL   86 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~--~l~L   86 (692)
                      ..+|..++.||+|+||+||++.+..+|..+|||.+....  ....+.+.+|+.+|.+++|||||++++......  .++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            456999999999999999999999999999999997652  222677899999999999999999999854444  7999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecC-CCCcCeEEEeccccccccCC
Q 005526           87 VLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVST-NEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~-~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +|||+.||+|.+++++.+ +++|..++.+.+||++||.|||++|||||||||+|||++. ++   .+||+|||+++....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~---~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG---DVKLADFGLAKKLES  170 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC---eEEeccCcccccccc
Confidence            999999999999999987 7999999999999999999999999999999999999998 45   599999999987663


Q ss_pred             ----CCCCCccCCCCCccChHhhhhcCC-CcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCCCCcccc
Q 005526          165 ----QDLADTLCGSPLYMAPEIIQNHKY-DAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       165 ----~~~~~~~~GT~~YmAPEvl~~~~y-s~ksDIWSLGviLyeLltG~~PF~~-~~~~~~~~~i~~~~~~~~p~~~~~~  238 (692)
                          ........|||.|||||++..+.. ..++|||||||++.||+||++||.. ....+.+..+......  | ..+..
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~--P-~ip~~  247 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL--P-EIPDS  247 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC--C-CCCcc
Confidence                223446789999999999986333 3489999999999999999999988 4555545555444322  2 44567


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ++.+.++|+.+|+++||++|||+.++|+|||....
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence            99999999999999999999999999999998653

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9e-47  Score=412.46  Aligned_cols=266  Identities=33%  Similarity=0.661  Sum_probs=245.2

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTIS-HPNIIRFFEAIETREK   83 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~   83 (692)
                      ..+...|.+++.||+|.||+||+++++.+|+.||+|.|.+..... .....+.+|+.||+++. |||||.+++.|++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            446678999999999999999999999999999999998765432 34578899999999998 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC-cCeEEEecccccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV-TPVLKIGDFGFARSL  162 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~-~~~vKL~DFGlA~~~  162 (692)
                      +++|||+|.||+|.+.|... .++|..+..++.|++.+++|||+.||+||||||+|+|+..... ...+|++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999999887 4999999999999999999999999999999999999987654 347999999999998


Q ss_pred             CCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          163 TPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       163 ~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      .........+|||.|+|||++....|+..+||||+||++|.|++|.+||.+.+....+.++..+ .+.|+...|..++..
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-DFDFTSEPWDDISES  268 (382)
T ss_pred             cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-CCCCCCCCccccCHH
Confidence            8877788999999999999999999999999999999999999999999999999888888775 558888899999999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +++||++||..||.+|+|+.++|.|||+...
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999998654

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-47  Score=413.02  Aligned_cols=261  Identities=31%  Similarity=0.581  Sum_probs=244.3

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK-IYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~-l~LV   87 (692)
                      .++|.+++++|+|+||.+++++++.+++.|++|.|.........++...+|+.+++++.|||||.+++.|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            578999999999999999999999999999999999998888888999999999999999999999999988777 9999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           88 LEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |+||+||+|.+.|++.+  .++|+.+..|+.|++.|+.|||+++|+|||||+.||+++.++.   |||+|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~---VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK---VKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc---eeecchhhhhhcCCc
Confidence            99999999999998754  5899999999999999999999999999999999999999884   899999999999887


Q ss_pred             C-CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          166 D-LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       166 ~-~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      . .+.+++|||.||+||++.+.+|+.|+|||||||++|||++-+++|.+.+...+..+|......+.|    ..++.+++
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----~~ys~el~  235 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----SMYSSELR  235 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC----ccccHHHH
Confidence            7 899999999999999999999999999999999999999999999999999999999887644433    57789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      .+|..||+++|..||++.++|.+|.+......
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~~~  267 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLRYLVE  267 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhhHHHh
Confidence            99999999999999999999999998876643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=395.04  Aligned_cols=256  Identities=30%  Similarity=0.580  Sum_probs=227.3

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.+.||+|+||+||+|.+..+|+.||||++..... ..+..+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            479999999999999999999999999999999975432 2234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.....  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~---~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG---HIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---CEEEEecCcchhccCC--c
Confidence            9999999999999988999999999999999999999999999999999999998876   5999999999865432  3


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+... ...++    ...++.+.+||+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~----~~~~~~~~~li~  230 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-KLEFP----RHLDLYAKDLIK  230 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CcCCC----ccCCHHHHHHHH
Confidence            4567999999999999999999999999999999999999999999888877777654 23333    356889999999


Q ss_pred             HhhccCCCCCCC-----HHHHHhchhhhhhHh
Q 005526          249 CLLRQNPVERIT-----FKEFFNHRFLGELRQ  275 (692)
Q Consensus       249 ~~L~~DP~~RpT-----a~elL~Hpf~~~~~~  275 (692)
                      +||+.||.+|++     ++++++||||.....
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            999999999995     999999999976543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-46  Score=399.70  Aligned_cols=256  Identities=31%  Similarity=0.632  Sum_probs=228.9

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      .+++|.+.+.||+|+||+||+|+++.+++.||||++..... .....+.+.+|+.++++++||||+++++++..++.+|+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            46899999999999999999999999999999999975432 22345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||||.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++..... 
T Consensus        96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG---HVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC---CEEEeeccCceEcCCC-
Confidence            999999999999999988999999999999999999999999999999999999999877   5999999999876433 


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+... ...+|    ..++..+.+|
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~p----~~~~~~~~~l  245 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-RLKFP----NWFDGRARDL  245 (329)
T ss_pred             -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CcCCC----CCCCHHHHHH
Confidence             33568999999999999999999999999999999999999999998888777777654 33333    3478899999


Q ss_pred             HHHhhccCCCCCCC-----HHHHHhchhhhhh
Q 005526          247 CRCLLRQNPVERIT-----FKEFFNHRFLGEL  273 (692)
Q Consensus       247 I~~~L~~DP~~RpT-----a~elL~Hpf~~~~  273 (692)
                      |.+||+.||.+|++     ++++++||||...
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            99999999999997     7999999999764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.8e-47  Score=381.43  Aligned_cols=259  Identities=30%  Similarity=0.541  Sum_probs=229.3

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .+|...++||+|.||+||+|++..+|+.||||.|+.....+.......+|++.|+.++|+||+.++++|-..+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            57999999999999999999999999999999999887777777889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           90 YCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |++. +|+..|+... .++...++.|+.+++.||+|||.+.|+||||||.|+||+.+|   ++||+|||+|+.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g---~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG---QLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC---cEEeecccchhccCCCCcc
Confidence            9987 9999998654 589999999999999999999999999999999999999988   6999999999988755443


Q ss_pred             C-ccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----------------
Q 005526          169 D-TLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR----------------  230 (692)
Q Consensus       169 ~-~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~----------------  230 (692)
                      . ..+-|.||+|||.+.+ ..|+..+||||.||++.||+-|.+-|+|.++.+++..|...-..+                
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            3 3478999999998765 679999999999999999999999999999998888876532111                


Q ss_pred             ---CCC----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          231 ---FPP----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       231 ---~p~----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                         +|.    ..+...+.+..||+.+||..||.+|+|+.|+|+|+||..
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence               111    123345778899999999999999999999999999965

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.3e-46  Score=398.61  Aligned_cols=252  Identities=29%  Similarity=0.589  Sum_probs=222.3

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      +.||+|+||+||+|++..+|+.||||++.+... .......+.+|+.++++++||||+++++.+..++.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999976432 2334456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccCC
Q 005526           95 DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCG  173 (692)
Q Consensus        95 sL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~G  173 (692)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++... ........+|
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG---HIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC---CEEEeeCCCCcccccCCCcccceec
Confidence            9999999988999999999999999999999999999999999999998877   59999999997643 2233455789


Q ss_pred             CCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhcc
Q 005526          174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ  253 (692)
Q Consensus       174 T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~  253 (692)
                      |+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+..+... ...+|    ..+++++.+||.+||++
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05571         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCC----CCCCHHHHHHHHHHccC
Confidence            99999999999999999999999999999999999999998887777766543 33333    46789999999999999


Q ss_pred             CCCCCC-----CHHHHHhchhhhhhHh
Q 005526          254 NPVERI-----TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       254 DP~~Rp-----Ta~elL~Hpf~~~~~~  275 (692)
                      ||++||     ++.++++||||.....
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999     8999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-47  Score=415.87  Aligned_cols=256  Identities=30%  Similarity=0.580  Sum_probs=233.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ...|....+||+|+-|.||.|+...+++.||||.+.......  .+-+..|+.+|+..+|+|||++++.|...+.+|+||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            456888999999999999999999999999999998765544  467899999999999999999999998889999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      ||++||+|.+.+... .++|.++..++++++.||+|||.+||+|||||.+|||++.++.   +||+|||++..+.... .
T Consensus       350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~---vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS---VKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc---EEEeeeeeeeccccccCc
Confidence            999999999988665 5999999999999999999999999999999999999999985   9999999999887655 5


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ..+.+|||+|||||++....|+.|+||||||+|++||+-|++||-..+....+..|.......+.  ..+.+|+.++||+
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk--~~~klS~~~kdFL  503 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK--NPEKLSPELKDFL  503 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC--CccccCHHHHHHH
Confidence            67899999999999999999999999999999999999999999999888888877766554443  3468999999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhhhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      .+||+.|+.+|+++.|||.||||..
T Consensus       504 ~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  504 DRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHHhhcchhcCCCHHHHhcChhhhh
Confidence            9999999999999999999999953

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.6e-46  Score=387.80  Aligned_cols=258  Identities=32%  Similarity=0.549  Sum_probs=219.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|.+.+.||+|+||+||+|+++.+++.||||++..........+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            57999999999999999999999999999999997765555556778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--C
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--L  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--~  167 (692)
                      |++++.+..+......+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++......  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---cEEEeeccCccccccccccc
Confidence            999987776665567799999999999999999999999999999999999998877   59999999998764322  2


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------------CC
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST------------------EL  229 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~------------------~~  229 (692)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+....                  ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            334679999999999999899999999999999999999999999877655443332210                  00


Q ss_pred             CCCC---------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 RFPP---------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 ~~p~---------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .++.         .....++.++.+||++||++||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1110         0112367889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=399.91  Aligned_cols=260  Identities=27%  Similarity=0.540  Sum_probs=226.1

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            479999999999999999999999999999999975422 2344567788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--  166 (692)
                      |||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++......  
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~---~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG---HIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC---CEEEeecccceeccccccc
Confidence            9999999999999888999999999999999999999999999999999999999877   59999999987543211  


Q ss_pred             -------------------------------------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCC
Q 005526          167 -------------------------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKP  209 (692)
Q Consensus       167 -------------------------------------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~  209 (692)
                                                           .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 1123579999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCCC---HHHHHhchhhhhhHh
Q 005526          210 PFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT---FKEFFNHRFLGELRQ  275 (692)
Q Consensus       210 PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpT---a~elL~Hpf~~~~~~  275 (692)
                      ||.+.+..+.+.++.... ...++..  ..+++++.+||++||. +|.+|++   +++++.||||.....
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            999998887777776532 2233322  3578999999999997 9999998   999999999986543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.3e-46  Score=401.60  Aligned_cols=261  Identities=23%  Similarity=0.460  Sum_probs=224.9

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+... .......+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            479999999999999999999999999999999975422 2334567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--  166 (692)
                      |||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~---~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG---HVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC---CEEEeeccCcccccccccc
Confidence            9999999999999988999999999999999999999999999999999999998877   59999999987543211  


Q ss_pred             ----------------------------------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005526          167 ----------------------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFD  212 (692)
Q Consensus       167 ----------------------------------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~  212 (692)
                                                        .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                              1134689999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhc-cCCCCCCCcccccCHHHHHHHHHhhccCCC---CCCCHHHHHhchhhhhhHhh
Q 005526          213 GSNQLQLFQNILTS-TELRFPPGAIEELHPDCVDLCRCLLRQNPV---ERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       213 ~~~~~~~~~~i~~~-~~~~~p~~~~~~ls~el~dLI~~~L~~DP~---~RpTa~elL~Hpf~~~~~~~  276 (692)
                      +.+..+.+.++... ....+|+.  ..+++++.++|.+|+. +|.   .||+++|+++||||......
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         238 SETPQETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CCCHHHHHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence            99888888877653 23344432  2578999999999775 444   56899999999999876433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-46  Score=397.09  Aligned_cols=259  Identities=31%  Similarity=0.561  Sum_probs=227.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.+.||+|+||.||+|++..+++.||||++.+.... ......+.+|++++..++||||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            5799999999999999999999999999999999764322 234567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....  ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG---HIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---CEEEEeCcCCccccc--cc
Confidence            9999999999999888999999999999999999999999999999999999998877   599999999976543  34


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCc---ccccCHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA---IEELHPDCVD  245 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~---~~~ls~el~d  245 (692)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.........+..   ...++.++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            5678999999999999999999999999999999999999999998887777766543221111111   1256899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ||.+||..+|.+||+++++++||||...
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            9999999999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=393.89  Aligned_cols=265  Identities=28%  Similarity=0.470  Sum_probs=233.8

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      -.++|++..+||.|.-++||+|+...++..||||+++....+.. .+.+.+|+..|+.++||||++++..|..+..+|+|
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            45789999999999999999999999999999999998876655 78999999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           88 LEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |.||.+|++.++++..  .+++|..+..++++++.||.|||.+|-||||||+.||||+.+|   .|||+|||.+..+...
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG---~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG---TVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC---cEEEcCceeeeeeccc
Confidence            9999999999999875  5699999999999999999999999999999999999999998   5999999987655322


Q ss_pred             C----CC-CccCCCCCccChHhhh--hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----CCCC
Q 005526          166 D----LA-DTLCGSPLYMAPEIIQ--NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL-----RFPP  233 (692)
Q Consensus       166 ~----~~-~~~~GT~~YmAPEvl~--~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~-----~~p~  233 (692)
                      .    .. .+++|||+|||||++.  ..+|+.|+||||||++..||.+|..||......+.+-..+++...     .++.
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            1    11 6779999999999954  367999999999999999999999999999888877666665443     2233


Q ss_pred             CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       234 ~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      .....++..++.++..||++||.+|||+.++|+|+||+..+..
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            3345677899999999999999999999999999999876543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-45  Score=385.90  Aligned_cols=262  Identities=27%  Similarity=0.448  Sum_probs=220.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .|++.+.||+|+||+||+|.+..+|+.||||.+.+.... ......+.+|+.++++++|+||+++++.+..++.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            388999999999999999999999999999998765332 2233467789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           90 YCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||++|+|..++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.......
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~---~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG---HIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC---CEEEeeCCCcEEcCCCCe
Confidence            99999999888653  3689999999999999999999999999999999999998776   599999999987654444


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+.... ..........++.++.+|+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-hcccccCCccCCHHHHHHH
Confidence            456689999999999999999999999999999999999999998765432222221111 1111223346789999999


Q ss_pred             HHhhccCCCCCCC-----HHHHHhchhhhhhHhh
Q 005526          248 RCLLRQNPVERIT-----FKEFFNHRFLGELRQT  276 (692)
Q Consensus       248 ~~~L~~DP~~RpT-----a~elL~Hpf~~~~~~~  276 (692)
                      ++||+.||.+||+     ++++++||||......
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence            9999999999997     8999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-46  Score=388.10  Aligned_cols=266  Identities=32%  Similarity=0.515  Sum_probs=229.5

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET--RE   82 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~~   82 (692)
                      +.|-+++|+.+.+|++|+||.||+|+++.|++.||+|.++.........-.-.+|+.+|.+++|||||.+.+++..  -+
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            6678899999999999999999999999999999999998775444444567899999999999999999999754  45


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      .+|||||||+. ||..++..-+ +|.+.+++.++.|++.||+|||.+.|+||||||+|+|+...|   .+||+|||+||.
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G---~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG---ILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC---cEEecccchhhh
Confidence            79999999998 9999998765 899999999999999999999999999999999999999888   599999999998


Q ss_pred             cCCC-CCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-----------
Q 005526          162 LTPQ-DLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-----------  228 (692)
Q Consensus       162 ~~~~-~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~-----------  228 (692)
                      +... ......+.|.||+|||++.+ ..|+..+|+||+|||+.||+++++.|.|......+++|.+.-.           
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            7654 33456788999999999876 5699999999999999999999999999999888888764311           


Q ss_pred             -------CCCCCC-------ccc--ccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          229 -------LRFPPG-------AIE--ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       229 -------~~~p~~-------~~~--~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                             ..++..       .+.  .++....+|+..+|..||.+|.|++|.|+|.||.+..
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                   111110       011  2568889999999999999999999999999997643

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=403.04  Aligned_cols=261  Identities=33%  Similarity=0.617  Sum_probs=224.9

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH------------HHHHHHHHHHHHHhCCCCCcceE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK------------VSDNLLKEISILSTISHPNIIRF   74 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~------------~~~~i~~Ev~iL~~L~HpNIVkl   74 (692)
                      ..+++|++.+.||+|.||+|.+|++..+++.||||++.+.....+            ..+...+|+.||+++.|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            467999999999999999999999999999999999976543221            23578899999999999999999


Q ss_pred             EEEEEe--CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEE
Q 005526           75 FEAIET--REKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK  152 (692)
Q Consensus        75 ~~~~~~--~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vK  152 (692)
                      +++..+  .+.+|||+|||..|.+...-.....+++.+++.|+++++.||+|||.+|||||||||+|+||+.+|   +||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g---~VK  250 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG---TVK  250 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC---cEE
Confidence            999865  468999999999988765443333489999999999999999999999999999999999999987   699


Q ss_pred             EeccccccccCC------CCCCCccCCCCCccChHhhhhc---CC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 005526          153 IGDFGFARSLTP------QDLADTLCGSPLYMAPEIIQNH---KY-DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQN  222 (692)
Q Consensus       153 L~DFGlA~~~~~------~~~~~~~~GT~~YmAPEvl~~~---~y-s~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~  222 (692)
                      |+|||.+.....      .......+|||.|+|||.+..+   .| +.+.||||+||+||.|+.|+.||.+....+++.+
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            999999976522      2223447899999999998763   23 5679999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          223 ILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       223 i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      |... .+.||..  .++..+++|||.+||++||++|++..++..|||....
T Consensus       331 Ivn~-pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  331 IVND-PLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HhcC-cccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            9764 5666654  3678999999999999999999999999999998654

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-45  Score=395.23  Aligned_cols=260  Identities=30%  Similarity=0.622  Sum_probs=228.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|++++..++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            5799999999999999999999999999999999764322 244567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--  166 (692)
                      ||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~---~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG---HIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEeecCCCCccCcccCcc
Confidence            9999999999999888999999999999999999999999999999999999999887   59999999998665433  


Q ss_pred             ----------------------------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 005526          167 ----------------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ  218 (692)
Q Consensus       167 ----------------------------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~  218 (692)
                                                  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                        2345679999999999999999999999999999999999999999988877


Q ss_pred             HHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCCC-HHHHHhchhhhhhHh
Q 005526          219 LFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT-FKEFFNHRFLGELRQ  275 (692)
Q Consensus       219 ~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpT-a~elL~Hpf~~~~~~  275 (692)
                      ...++.... ...+|..  ..+++++.+||.+||. ||.+|++ ++++++||||.....
T Consensus       238 ~~~~i~~~~~~~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         238 TYNKIINWKESLRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             HHHHHhccCCcccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            777766521 2223322  2478999999999997 9999999 999999999986543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.1e-45  Score=390.34  Aligned_cols=260  Identities=29%  Similarity=0.499  Sum_probs=214.7

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----EKIY   85 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----~~l~   85 (692)
                      +|++.+.||+|+||.||+|++..+|+.||||.+............+.+|+++++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            69999999999999999999999999999999875433334456788999999999999999999987543     3589


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      +|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.....
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---cEEEccCccccccccc
Confidence            9999995 59999999888899999999999999999999999999999999999998877   5999999999764322


Q ss_pred             C----CCCccCCCCCccChHhhhh--cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------
Q 005526          166 D----LADTLCGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST------------  227 (692)
Q Consensus       166 ~----~~~~~~GT~~YmAPEvl~~--~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~------------  227 (692)
                      .    ......||+.|+|||++.+  ..++.++|||||||++|+|++|++||.+.+.......+....            
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1    2234679999999999876  678999999999999999999999998876544332221100            


Q ss_pred             -----------CCCCC---CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          228 -----------ELRFP---PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       228 -----------~~~~p---~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                                 ....+   .......++++.+++.+||+.||++|||++++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                       00000   011234678899999999999999999999999999997653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-45  Score=388.47  Aligned_cols=248  Identities=33%  Similarity=0.629  Sum_probs=219.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCH
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL   96 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL   96 (692)
                      ||+|+||+||+|++..+++.||+|++.... ........+.+|+.++++++||||+++++++..++.+|+|||||+||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999997542 2334456778899999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-CCCCCccCCCC
Q 005526           97 AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSP  175 (692)
Q Consensus        97 ~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-~~~~~~~~GT~  175 (692)
                      .+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.... .......+||+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG---HIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC---cEEEEECcccccCccCCCccccccCCc
Confidence            99999988999999999999999999999999999999999999998877   599999999976432 23345678999


Q ss_pred             CccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCC
Q 005526          176 LYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP  255 (692)
Q Consensus       176 ~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP  255 (692)
                      .|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+... ...++    ..+++++.+||.+||..||
T Consensus       158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFP----DGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCC----CcCCHHHHHHHHHHcCCCH
Confidence            999999999999999999999999999999999999998888877777653 23333    4678999999999999999


Q ss_pred             CCCC---CHHHHHhchhhhhh
Q 005526          256 VERI---TFKEFFNHRFLGEL  273 (692)
Q Consensus       256 ~~Rp---Ta~elL~Hpf~~~~  273 (692)
                      .+||   ++.++++||||...
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCC
Confidence            9997   58999999999865

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-45  Score=397.69  Aligned_cols=259  Identities=28%  Similarity=0.517  Sum_probs=222.1

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.++++||+|+||+||++++..+++.||||++.+... .......+.+|+++++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            479999999999999999999999999999999865422 2334567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--  166 (692)
                      |||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG---HIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC---CEEEeeccccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999998776   59999999986321100  


Q ss_pred             ----------------------------------------------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHH
Q 005526          167 ----------------------------------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAI  200 (692)
Q Consensus       167 ----------------------------------------------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGvi  200 (692)
                                                                    .....+||+.|+|||++.+..|+.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0013579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCC---CCHHHHHhchhhhhhH
Q 005526          201 LFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVER---ITFKEFFNHRFLGELR  274 (692)
Q Consensus       201 LyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~R---pTa~elL~Hpf~~~~~  274 (692)
                      +|||++|.+||.+.+..+.+..+.... ...+|.  ...++.++.+||.+||. +|.+|   +++.+++.||||....
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            999999999999988877777766432 223332  23578999999999998 77765   5999999999997643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-46  Score=390.02  Aligned_cols=264  Identities=31%  Similarity=0.550  Sum_probs=228.9

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CC
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET-----RE   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~-----~~   82 (692)
                      +...|...+.||+|+||+|+.+.++.+|+.||||.|.....+.-..++..+|+++|+.++|+||+.+++++..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4456666899999999999999999999999999998776677778899999999999999999999999854     35


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .+|+|+|+|+ .+|...|+....++++.++.+++||+.||+|+|+.||+||||||+|+|++.+..   +||||||+|+..
T Consensus       100 DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~---lKI~DFGLAR~~  175 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD---LKICDFGLARYL  175 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC---EEeccccceeec
Confidence            7999999995 499999998888999999999999999999999999999999999999999884   899999999988


Q ss_pred             CC---CCCCCccCCCCCccChHhhh-hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Q 005526          163 TP---QDLADTLCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---------  229 (692)
Q Consensus       163 ~~---~~~~~~~~GT~~YmAPEvl~-~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~---------  229 (692)
                      ..   ......++.|.||+|||++. ...|+..+||||+|||+.||++|++.|.|.+....++.|+.....         
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            64   44456788999999999964 567999999999999999999999999999877766665532111         


Q ss_pred             -------------CCCC----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          230 -------------RFPP----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       230 -------------~~p~----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                                   ..|+    ..+...++.++||+++||..||.+|+|++|+|.|||+.....
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd  318 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD  318 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence                         1111    223467899999999999999999999999999999987654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-45  Score=395.98  Aligned_cols=259  Identities=29%  Similarity=0.575  Sum_probs=227.8

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCC-cEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLG-IEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg-~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      ...++|.+.+.||+|+||.||+|.+..++ ..||+|.+.+... .......+.+|+.+++.++||||+++++++..++.+
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL  106 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence            34678999999999999999999876654 6899999865432 233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      |+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~---~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG---FIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC---CEEEecCCCCeecCC
Confidence            99999999999999999988999999999999999999999999999999999999998776   599999999987543


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      .  ..+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..+.... ..+|    ..+++.+.
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~  256 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFP----KFLDNNCK  256 (340)
T ss_pred             C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCC----CCCCHHHH
Confidence            2  345789999999999999999999999999999999999999999988887777776543 3333    35788999


Q ss_pred             HHHHHhhccCCCCCC-----CHHHHHhchhhhhhHh
Q 005526          245 DLCRCLLRQNPVERI-----TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       245 dLI~~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~~  275 (692)
                      ++|++||+.||.+|+     +++++++||||.....
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999999999995     8999999999986543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.8e-45  Score=399.04  Aligned_cols=259  Identities=25%  Similarity=0.510  Sum_probs=222.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+... .......+.+|+++++.++||||+++++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            479999999999999999999999999999999965322 2233466788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC---
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ---  165 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~---  165 (692)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++......   
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~---~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG---HIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC---CEEEEeCCCCccccccccc
Confidence            9999999999999988899999999999999999999999999999999999999877   5999999997532100   


Q ss_pred             -----------------------------------------CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHH
Q 005526          166 -----------------------------------------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQL  204 (692)
Q Consensus       166 -----------------------------------------~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeL  204 (692)
                                                               ......+||+.|||||++.+..++.++|||||||++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                     011235799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCC---CHHHHHhchhhhhhH
Q 005526          205 VTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERI---TFKEFFNHRFLGELR  274 (692)
Q Consensus       205 ltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~Rp---Ta~elL~Hpf~~~~~  274 (692)
                      ++|+.||.+.+..+....+.... ...++  ....+++++.++|.+|+ .+|.+|+   ++.++++||||....
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIP--SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCC--CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            99999999988776666554322 12222  23467899999999977 5999999   999999999998653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.2e-45  Score=382.87  Aligned_cols=257  Identities=31%  Similarity=0.540  Sum_probs=216.3

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.++||.|+||+||+|++..+++.||+|++..... ......+.+|+.++++++||||+++++++..++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            5789999999999999999999999999999999975432 223456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           89 EYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      ||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++...... 
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~---~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG---ELKLADFGLARAKSVPTK  158 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC---CEEECcCcceeeccCCCc
Confidence            99986 8999887654 479999999999999999999999999999999999998877   59999999997654322 


Q ss_pred             CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----------------
Q 005526          167 LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL----------------  229 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~----------------  229 (692)
                      ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......                
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2344678999999999865 56899999999999999999999999988876666554332110                


Q ss_pred             --CCCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 --RFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 --~~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                        .++.       .....++.+++|||.+||+.||.+|||++|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              0110       0113467899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.2e-45  Score=397.41  Aligned_cols=261  Identities=26%  Similarity=0.516  Sum_probs=222.6

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ..|++++.||+|+||+||+|++..+++.||||++.+... .......+.+|+++++.++||||+++++++.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            369999999999999999999999999999999976432 3345567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC---
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ---  165 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~---  165 (692)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.....   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~---~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG---HIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC---CEEEeeCcCCccccccccc
Confidence            9999999999999988999999999999999999999999999999999999998876   5999999997543100   


Q ss_pred             ---------------------------------------------CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHH
Q 005526          166 ---------------------------------------------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAI  200 (692)
Q Consensus       166 ---------------------------------------------~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGvi  200 (692)
                                                                   ....+.+||+.|+|||++.+..|+.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         01234679999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhh--ccCCCCCCCHHHHHhchhhhhhHh
Q 005526          201 LFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLL--RQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       201 LyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L--~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                      +|||++|++||...+......++.... ...++.  ...+++++.+||.+|+  ..+|..|+++.++++||||.+...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            999999999999888766665554322 223332  2357899999999965  455566999999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-46  Score=379.25  Aligned_cols=265  Identities=34%  Similarity=0.598  Sum_probs=240.4

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC------CChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL------LSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET   80 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~------~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~   80 (692)
                      +...|.-.+.||+|..++|.++.++.+|+++|+|+|....      ......+.-.+|+.||+++ .||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            4567888889999999999999999999999999996422      1233455667899999987 79999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           81 REKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        81 ~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                      +..+++|+|.|+.|.|+++|...-.++|...+.+|+||+.|++|||.++||||||||+|||++++.+   +||+|||+++
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~---i~isDFGFa~  171 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN---IKISDFGFAC  171 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc---eEEeccceee
Confidence            9999999999999999999999999999999999999999999999999999999999999998874   9999999999


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhh------cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQN------HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPG  234 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~------~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~  234 (692)
                      .+.+++.....||||+|+|||.+..      .+|+..+|+|++|||+|.|+.|.+||....+.-++..|+.+ .+.|...
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG-kyqF~sp  250 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG-KYQFRSP  250 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc-ccccCCc
Confidence            9999999999999999999999864      46888999999999999999999999988888777777664 6778888


Q ss_pred             cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       235 ~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      .|.+++.+.+|||.+||+.||.+|.|++|+|+||||.++.+.
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence            889999999999999999999999999999999999887654

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.6e-45  Score=389.23  Aligned_cols=259  Identities=28%  Similarity=0.564  Sum_probs=225.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.+.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            479999999999999999999999999999999976533 2334567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG---HIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC---CEEeccCCCCeECCCCCc
Confidence            999999999999886 6799999999999999999999999999999999999999877   599999999987654332


Q ss_pred             --CCccCCCCCccChHhhh------hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCcccc
Q 005526          168 --ADTLCGSPLYMAPEIIQ------NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEE  238 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~------~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~-~~~p~~~~~~  238 (692)
                        .....||+.|+|||++.      ...++.++|||||||++|+|++|+.||...+....+.++..... ..+|.  ...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~  235 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE--DPK  235 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCC--CCC
Confidence              23457999999999986      45688999999999999999999999999888877777765432 22332  235


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +++++.+||++||+ ||.+|||+.++++||||....
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            78999999999998 999999999999999998654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5e-45  Score=398.22  Aligned_cols=259  Identities=28%  Similarity=0.554  Sum_probs=222.8

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .+|+++++||+|+||+||+|++..+++.||||++.+... .......+.+|+++++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            369999999999999999999999999999999975432 2344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC---
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ---  165 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~---  165 (692)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.....   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g---~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG---HIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEEeECCCCccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999877   5999999997532100   


Q ss_pred             ---------------------------------------------CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHH
Q 005526          166 ---------------------------------------------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAI  200 (692)
Q Consensus       166 ---------------------------------------------~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGvi  200 (692)
                                                                   ....+.+||+.|+|||++.+..|+.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         01124579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCCC---HHHHHhchhhhhhH
Q 005526          201 LFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT---FKEFFNHRFLGELR  274 (692)
Q Consensus       201 LyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpT---a~elL~Hpf~~~~~  274 (692)
                      +|||++|++||.+.+..+...++.... ...+|.  ...+++++.++|.+|+ .+|.+|++   +.++++||||....
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC--cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            999999999999988777666665422 223332  2467899999999986 59999997   99999999997653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-46  Score=399.21  Aligned_cols=261  Identities=37%  Similarity=0.683  Sum_probs=243.3

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .++.|=|.+.+.||+|-|++|-+|+|.-||..||||+|.+..+..-....+++|++.|+..+|||||++|++......+|
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            46778899999999999999999999999999999999999888888889999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +|+|+-+||+|.+||.++ .++.|+.+++|+.||+.|+.|+|+.++|||||||+||++-+...  .|||+|||++..+.+
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlG--lVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLG--LVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecC--ceEeeeccccccCCC
Confidence            999999999999999776 57999999999999999999999999999999999999877644  799999999999999


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys~-ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      .....+.||+..|-|||++.+..|+. ++||||||||||.|++|++||+..+..+.+..|+.. .+..|    ..++.+|
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-KYtvP----shvS~eC  246 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-KYTVP----SHVSKEC  246 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-cccCc----hhhhHHH
Confidence            99999999999999999999999985 689999999999999999999999999999988764 33333    5789999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +|||+.||..||.+|.+.++|..|+|++.+
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            999999999999999999999999999754

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.8e-45  Score=378.41  Aligned_cols=257  Identities=31%  Similarity=0.510  Sum_probs=215.3

Q ss_pred             cCEEEEeEecccCceEEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----e
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQ-LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI---SHPNIIRFFEAIE-----T   80 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~-tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L---~HpNIVkl~~~~~-----~   80 (692)
                      .+|++.+.||+|+||+||+|++.. +++.||||.+............+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999864 478899999876544443445566777777765   6999999999875     3


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           81 REKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        81 ~~~l~LVmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      ...+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~---~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC---CEEEccccc
Confidence            456899999997 4899998764  4589999999999999999999999999999999999998877   599999999


Q ss_pred             ccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC-----
Q 005526          159 ARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP-----  233 (692)
Q Consensus       159 A~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~-----  233 (692)
                      ++............||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.++........+.     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            987665555566789999999999999999999999999999999999999999988877777765432211110     


Q ss_pred             -----------------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          234 -----------------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       234 -----------------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                                       .....+++.+.+|+.+||+.||++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             1113467888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1e-44  Score=387.36  Aligned_cols=252  Identities=28%  Similarity=0.589  Sum_probs=220.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      +.||+|+||.||++++..+|+.||+|++..... .......+.+|+++++.++||||+++++.+..++.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            469999999999999999999999999976432 2334456778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-CCCCCccCC
Q 005526           95 DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCG  173 (692)
Q Consensus        95 sL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-~~~~~~~~G  173 (692)
                      +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.... .......+|
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~g  157 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---HIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC---CEEecccHHhccccCCCCccccccC
Confidence            9999999888899999999999999999999999999999999999998877   599999999876432 223345689


Q ss_pred             CCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhcc
Q 005526          174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ  253 (692)
Q Consensus       174 T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~  253 (692)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ...+|    ..+++++.+||.+||++
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05595         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCC----CCCCHHHHHHHHHHccC
Confidence            99999999999999999999999999999999999999988877777666543 33333    46789999999999999


Q ss_pred             CCCCCC-----CHHHHHhchhhhhhHh
Q 005526          254 NPVERI-----TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       254 DP~~Rp-----Ta~elL~Hpf~~~~~~  275 (692)
                      ||.+|+     ++.++++||||.....
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            999998     8999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.7e-44  Score=384.01  Aligned_cols=260  Identities=27%  Similarity=0.498  Sum_probs=221.8

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.+.||+|+||+||++++..+|..||+|.+... ........+.+|+++++.++||||+++++++..++.+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            57999999999999999999999999999999999754 24455678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~-gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++   .+||+|||+++.... ..
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~-~~  158 (331)
T cd06649          83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLID-SM  158 (331)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC---cEEEccCcccccccc-cc
Confidence            9999999999999888899999999999999999999986 699999999999999877   599999999976543 23


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------------
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST--------------------  227 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~--------------------  227 (692)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....                    
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            455679999999999999999999999999999999999999998766544332211000                    


Q ss_pred             -----------------------CCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          228 -----------------------ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       228 -----------------------~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                             ....+......+++++.+||.+||++||++|||++++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                   0000111112467899999999999999999999999999999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-45  Score=393.67  Aligned_cols=250  Identities=31%  Similarity=0.553  Sum_probs=219.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcE-EEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIE-VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE-KIYL   86 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~-vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~-~l~L   86 (692)
                      ..+..+.+.||+|+||+||++...  |+. ||||++..........+.+.+|+.+|.+++|||||+|+|++..+. .++|
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            445566777999999999999987  666 999999887766666889999999999999999999999998887 7999


Q ss_pred             EEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           87 VLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~--~~~lse~~i~~il~QLl~gL~yLHs~g-IVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      ||||+++|+|..++.+  ...++...+..|+.||+.|+.|||+++ ||||||||+|||++.++  .++||+|||+++...
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREKV  195 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceeec
Confidence            9999999999999988  578999999999999999999999999 99999999999999876  369999999998876


Q ss_pred             CC-CCCCccCCCCCccChHhhh--hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCccccc
Q 005526          164 PQ-DLADTLCGSPLYMAPEIIQ--NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEEL  239 (692)
Q Consensus       164 ~~-~~~~~~~GT~~YmAPEvl~--~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~l  239 (692)
                      .. .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+....+....+.... ...+|    ...
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p----~~~  271 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP----KEC  271 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC----ccC
Confidence            54 3334478999999999999  6799999999999999999999999999999877666665333 33333    347


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ++.+..++.+||..||.+||++.+++.
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            899999999999999999999999865

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-44  Score=386.94  Aligned_cols=252  Identities=27%  Similarity=0.566  Sum_probs=220.8

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      +.||+|+||+||++++..+|+.||||++.+... .......+.+|+++++.++||||+++++.+..++.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999976432 2334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-CCCCCccCC
Q 005526           95 DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCG  173 (692)
Q Consensus        95 sL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-~~~~~~~~G  173 (692)
                      +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.... .......+|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG---HIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC---cEEEecCcCCccCCCcccccccccC
Confidence            9999998888899999999999999999999999999999999999999877   599999999876432 223445689


Q ss_pred             CCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhcc
Q 005526          174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ  253 (692)
Q Consensus       174 T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~  253 (692)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ...+|    ..+++++.+||++||++
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFP----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCC----CCCCHHHHHHHHHHcCC
Confidence            99999999999999999999999999999999999999988877766665432 33333    46789999999999999


Q ss_pred             CCCCCC-----CHHHHHhchhhhhhHh
Q 005526          254 NPVERI-----TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       254 DP~~Rp-----Ta~elL~Hpf~~~~~~  275 (692)
                      ||.+|+     ++.++++||||.....
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999997     8999999999976533

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-46  Score=390.84  Aligned_cols=258  Identities=35%  Similarity=0.647  Sum_probs=237.5

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .+-++|++.+.||+|.||+|-+|.....|+.||||.|+++...+ +..-.+.+|++||..|+||||+.+|++|+..+.+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            45688999999999999999999999999999999998876543 44568899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |||||..+|+|.+|+.+++.++|.+++.|++||+.|+.|+|.++++|||||.+|||++.+++   +||+|||++..+...
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N---iKIADFGLSNly~~~  206 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN---IKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC---eeeeccchhhhhccc
Confidence            99999999999999999999999999999999999999999999999999999999999986   999999999998888


Q ss_pred             CCCCccCCCCCccChHhhhhcCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKY-DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~~~y-s~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      ....++||+|.|.+||++.+.+| ++.+|-|||||+||.|+.|.+||+|.+...+...|..+... -|     ..+.++.
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-EP-----~~PSdA~  280 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-EP-----ETPSDAS  280 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-CC-----CCCchHH
Confidence            89999999999999999999999 57799999999999999999999999999888888766433 22     3456788


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      .||+.||..||++|.|++++-+|=|+...
T Consensus       281 gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  281 GLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             HHHHHHHhcCcccchhHHHHhhhheeecc
Confidence            99999999999999999999999998643

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-46  Score=369.53  Aligned_cols=257  Identities=32%  Similarity=0.630  Sum_probs=235.9

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      -+++|++++.||+|.||.||+|+.+.++-.||+|++.+... ...+..++.+|++|-..|+||||+++|++|.+...+|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            46899999999999999999999999999999999976543 34456788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           87 VLEYCDGGDLAAYIH--KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        87 VmEy~~GGsL~~~L~--~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ++||...|+|...|.  ...+++|...+.+++|++.||.|+|.++||||||||+|+|++.++   .+||+|||.+.... 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~---~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG---ELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC---CeeccCCCceeecC-
Confidence            999999999999998  667899999999999999999999999999999999999999887   59999999986544 


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      .....+.|||..|.+||...+..++.++|+|++|+++||++.|.+||......+++++|.+. .+.+|    ..++.++.
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~~~~p----~~is~~a~  250 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-DLKFP----STISGGAA  250 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-cccCC----cccChhHH
Confidence            66678899999999999999999999999999999999999999999999988999988764 45555    57889999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      |+|.+||.++|.+|.+..|++.|||+...
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            99999999999999999999999998653

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8e-45  Score=393.55  Aligned_cols=261  Identities=25%  Similarity=0.508  Sum_probs=225.7

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.... ........+.+|+.++..++||||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997532 23344567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--  166 (692)
                      |||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~---~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG---HVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC---CEEEeeccCCccccccccc
Confidence            9999999999999988999999999999999999999999999999999999998877   59999999987542110  


Q ss_pred             ----------------------------------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005526          167 ----------------------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFD  212 (692)
Q Consensus       167 ----------------------------------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~  212 (692)
                                                        .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                              1124579999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCC---CHHHHHhchhhhhhHhh
Q 005526          213 GSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERI---TFKEFFNHRFLGELRQT  276 (692)
Q Consensus       213 ~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~Rp---Ta~elL~Hpf~~~~~~~  276 (692)
                      +.+....+.++.... ...+|+.  ..++.++.+||.+|+. ||.+|+   +++++++||||......
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            998888877776532 2334432  2478999999999874 999998   58999999999876433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.7e-44  Score=382.60  Aligned_cols=257  Identities=30%  Similarity=0.606  Sum_probs=224.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHP-NIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~Hp-NIVkl~~~~~~~~~l~LVm   88 (692)
                      +|++.+.||+|+||.||+|++..+++.||||++.+... .....+.+..|.+++..+.|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999976432 233456778899999999765 5888999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~  167 (692)
                      |||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~---~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG---HIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC---CEEEeecCcceecCCCCCc
Confidence            9999999999999888999999999999999999999999999999999999999877   59999999987532 2233


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+... ...+|    ..+++++.+++
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~~----~~~~~~~~~li  232 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSYP----KSLSKEAVSIC  232 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCC----CCCCHHHHHHH
Confidence            44568999999999999999999999999999999999999999999888888777653 22333    46789999999


Q ss_pred             HHhhccCCCCCCCH-----HHHHhchhhhhhHh
Q 005526          248 RCLLRQNPVERITF-----KEFFNHRFLGELRQ  275 (692)
Q Consensus       248 ~~~L~~DP~~RpTa-----~elL~Hpf~~~~~~  275 (692)
                      .+||.+||.+|++.     +++++||||.....
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999976     89999999976543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-44  Score=380.24  Aligned_cols=261  Identities=29%  Similarity=0.515  Sum_probs=212.0

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|.+.+.||+|+||+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++..++..|+||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            47899999999999999999999999999999999754322 22345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-C
Q 005526           89 EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-D  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~  166 (692)
                      ||+. ++|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++..... .
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG---ELKLADFGLARAKSVPSH  158 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEECCCCcceeccCCCc
Confidence            9996 5788877654 5689999999999999999999999999999999999998877   5999999998754322 2


Q ss_pred             CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC----C---------C
Q 005526          167 LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQNILTSTEL----R---------F  231 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~-~~~~~i~~~~~~----~---------~  231 (692)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+......    .         +
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            3345678999999999865 45889999999999999999999999876432 222222211000    0         0


Q ss_pred             CCC--------------cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          232 PPG--------------AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       232 p~~--------------~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      .+.              .....++++.+|+.+||+.||.+|||++|+++||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            000              0012457889999999999999999999999999997653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-44  Score=385.34  Aligned_cols=252  Identities=32%  Similarity=0.605  Sum_probs=220.4

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|+++.+++.||||++.+... .......+..|..++..+ +||||+++++++...+.+|+|||||+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999975432 223455677888888876 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~---~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG---HCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC---cEEEeeCCCCeecCcCCCcccccc
Confidence            99999999988999999999999999999999999999999999999999887   59999999987643 223345568


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ..++    ..++.++.+|+++||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~L~  232 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYP----TWLSQDAVDILKAFMT  232 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCC----CCCCHHHHHHHHHHcc
Confidence            9999999999999999999999999999999999999999999888887776542 2222    3578999999999999


Q ss_pred             cCCCCCCCH------HHHHhchhhhhhHh
Q 005526          253 QNPVERITF------KEFFNHRFLGELRQ  275 (692)
Q Consensus       253 ~DP~~RpTa------~elL~Hpf~~~~~~  275 (692)
                      +||.+||++      +++++||||..+..
T Consensus       233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         233 KNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             cCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999998      99999999976543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=398.78  Aligned_cols=257  Identities=31%  Similarity=0.537  Sum_probs=231.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      -..|...+.||+|+||.||+|.+..+++.||+|++......+ ....+.+|+.+|.+++++||.++|+.|..+..++++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            456888899999999999999999999999999998765443 4678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-  167 (692)
                      |||.||++.+.++..+.+.|..+..++++++.||.|||.++.+|||||+.|||+..++   .+||+|||.+..+..... 
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g---~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG---DVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC---cEEEEecceeeeeechhhc
Confidence            9999999999999988889999999999999999999999999999999999999987   499999999988765443 


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ..+++|||.|||||++....|+.|+||||||++.+||.+|.+||....+...+..|    .-..||......++.+++|+
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----pk~~PP~L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----PKSAPPRLDGDFSPPFKEFV  243 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----cCCCCCccccccCHHHHHHH
Confidence            47899999999999999999999999999999999999999999988775444333    33445555568899999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ..||.+||+.||+|.++|+|+|++..
T Consensus       244 ~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            99999999999999999999999763

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.1e-44  Score=382.28  Aligned_cols=254  Identities=30%  Similarity=0.601  Sum_probs=220.1

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISIL---STISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL---~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      |++.+.||+|+||.||+|.+..+|+.||||++.+... .....+.+.+|++++   +.++||||+++++++..++.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            7899999999999999999999999999999975432 223345677777665   466899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-CC
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QD  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-~~  166 (692)
                      ||||+||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.... ..
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~---~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG---FVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC---cEEeCcccCCccCCCCCC
Confidence            999999999988854 5799999999999999999999999999999999999999887   599999999875432 23


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      .....+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ..+|    ..+++++.++
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~l  231 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYP----RFLSREAISI  231 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC----CCCCHHHHHH
Confidence            3456789999999999999999999999999999999999999999998888777776543 2233    3578999999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHhchhhhhhH
Q 005526          247 CRCLLRQNPVERI-----TFKEFFNHRFLGELR  274 (692)
Q Consensus       247 I~~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~  274 (692)
                      |.+||+.||.+||     ++.++++||||....
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            9999999999999     799999999997754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.3e-44  Score=390.49  Aligned_cols=261  Identities=27%  Similarity=0.486  Sum_probs=225.3

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      -.++|++.+.||+|+||+||++++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            35789999999999999999999999999999999975322 22334557789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++......
T Consensus       121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~---~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG---HLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC---CEEEEeccceeeccCCC
Confidence            99999999999988654 689999999999999999999999999999999999999877   59999999998765332


Q ss_pred             --CCCccCCCCCccChHhhhhc----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCccccc
Q 005526          167 --LADTLCGSPLYMAPEIIQNH----KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEEL  239 (692)
Q Consensus       167 --~~~~~~GT~~YmAPEvl~~~----~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~l  239 (692)
                        .....+||+.|+|||++.+.    .++.++|||||||++|+|++|++||.+.+....+.++.... ...+|.  ...+
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~  274 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD--DIEI  274 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC--cCCC
Confidence              23456899999999998653    47899999999999999999999999998888888876543 233333  2357


Q ss_pred             CHHHHHHHHHhhccCCCC--CCCHHHHHhchhhhhhH
Q 005526          240 HPDCVDLCRCLLRQNPVE--RITFKEFFNHRFLGELR  274 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~--RpTa~elL~Hpf~~~~~  274 (692)
                      +.++.+||++||+.+|.+  |++++++++||||....
T Consensus       275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            899999999999999988  99999999999997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.1e-44  Score=383.04  Aligned_cols=252  Identities=31%  Similarity=0.602  Sum_probs=216.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEIS-ILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~-iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+|+.||||++.+... .......+..|.. +++.++||||+++++.+...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            479999999999999999999999999975432 1222344555554 56789999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~  157 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG---HVVLTDFGLCKEGIEHSKTTSTFC  157 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC---cEEEeccCCCcccccCCCcccccc
Confidence            99999999888999999999999999999999999999999999999998877   59999999987543 233345568


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ...+    ..+++++.++|++||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~l~  232 (323)
T cd05575         158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLK----PNISVSARHLLEGLLQ  232 (323)
T ss_pred             CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHHHHhh
Confidence            9999999999999999999999999999999999999999988888877776542 2222    3568999999999999


Q ss_pred             cCCCCCCCH----HHHHhchhhhhhHh
Q 005526          253 QNPVERITF----KEFFNHRFLGELRQ  275 (692)
Q Consensus       253 ~DP~~RpTa----~elL~Hpf~~~~~~  275 (692)
                      +||.+||++    .++++||||.....
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            999999987    69999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=380.52  Aligned_cols=262  Identities=25%  Similarity=0.524  Sum_probs=221.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|++.+.||+|+||+||++++..+++.||||++.+.. ........+.+|+.++..++|+||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999997532 22334456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG---HIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC---CEEEEECCceeecCCCCC
Confidence            99999999999976 45799999999999999999999999999999999999998877   599999999876543322


Q ss_pred             --CCccCCCCCccChHhhhh-----cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCccccc
Q 005526          168 --ADTLCGSPLYMAPEIIQN-----HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEEL  239 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~-----~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~-~~~p~~~~~~l  239 (692)
                        ....+||+.|+|||++..     ..++.++|||||||++|+|++|+.||.+.+..+.+..+..... ..+++. ...+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~  236 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD-VTDV  236 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCc-cCCC
Confidence              223579999999999873     4578899999999999999999999999888777777765332 333332 2457


Q ss_pred             CHHHHHHHHHhhccCCC--CCCCHHHHHhchhhhhhHh
Q 005526          240 HPDCVDLCRCLLRQNPV--ERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~--~RpTa~elL~Hpf~~~~~~  275 (692)
                      +.++.+||++||..++.  .|++++++++||||.....
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            89999999999876444  3889999999999976543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.5e-44  Score=384.10  Aligned_cols=252  Identities=29%  Similarity=0.588  Sum_probs=220.1

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      +.||+|+||+||++++..+|+.||+|++.+... .......+.+|+++++.++||||+++++.+..++.+|+||||++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999976432 2334456778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           95 DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        95 sL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      +|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~  157 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG---HIKITDFGLCKEGIKDGATMKTFC  157 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC---CEEEecCCCCeecCCCCccccccc
Confidence            999999888899999999999999999999997 7999999999999999877   59999999987543 223344567


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+... ...+|    ..+++++.+|+++||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p----~~~~~~~~~li~~~L~  232 (325)
T cd05594         158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----RTLSPEAKSLLSGLLK  232 (325)
T ss_pred             CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCC----CCCCHHHHHHHHHHhh
Confidence            999999999999999999999999999999999999999988877776665433 33333    3578999999999999


Q ss_pred             cCCCCCC-----CHHHHHhchhhhhhHh
Q 005526          253 QNPVERI-----TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       253 ~DP~~Rp-----Ta~elL~Hpf~~~~~~  275 (692)
                      +||++|+     ++.++++||||.....
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999997     9999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4e-44  Score=382.54  Aligned_cols=251  Identities=31%  Similarity=0.596  Sum_probs=218.9

Q ss_pred             EeEecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           15 GPRIGSGSFAVVWRARHR---QLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~---~tg~~vAVK~i~~~~~--~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++.||+|+||+||++++.   .+++.||||++.....  .......+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   4689999999975422  22334567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-CCCC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-~~~~  168 (692)
                      |+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG---HVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---CEEEeeCcCCeecccCCCcc
Confidence            999999999999988999999999999999999999999999999999999998877   599999999875432 2334


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.... ..+|    ..+++++.+||+
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~li~  232 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLP----PYLTPEARDLLK  232 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHH
Confidence            45689999999999999899999999999999999999999999988887777776542 2333    457889999999


Q ss_pred             HhhccCCCCCC-----CHHHHHhchhhhhh
Q 005526          249 CLLRQNPVERI-----TFKEFFNHRFLGEL  273 (692)
Q Consensus       249 ~~L~~DP~~Rp-----Ta~elL~Hpf~~~~  273 (692)
                      +||++||++||     +++++++||||...
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.3e-44  Score=383.63  Aligned_cols=256  Identities=27%  Similarity=0.496  Sum_probs=215.4

Q ss_pred             CEEEEeEecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHR---QLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKI   84 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~---~tg~~vAVK~i~~~~~--~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l   84 (692)
                      +|++++.||+|+||+||++++.   .+++.||+|++.+...  .....+.+.+|+.+++.+ +||||+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5999999999999999999864   4789999999975422  223345678899999999 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ++|||||+||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~---~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG---HVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC---CEEEeeCcCCccccc
Confidence            99999999999999999888999999999999999999999999999999999999999877   599999999986543


Q ss_pred             CC--CCCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCCCCCccc
Q 005526          165 QD--LADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSN----QLQLFQNILTSTELRFPPGAIE  237 (692)
Q Consensus       165 ~~--~~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~----~~~~~~~i~~~~~~~~p~~~~~  237 (692)
                      ..  .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||....    .......+.. ....    ...
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~----~~~  232 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPP----FPS  232 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCC----CCC
Confidence            22  23456899999999999765 47889999999999999999999996432    2223333332 2222    234


Q ss_pred             ccCHHHHHHHHHhhccCCCCCC-----CHHHHHhchhhhhhH
Q 005526          238 ELHPDCVDLCRCLLRQNPVERI-----TFKEFFNHRFLGELR  274 (692)
Q Consensus       238 ~ls~el~dLI~~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~  274 (692)
                      .+++.+.+++.+||+.||++||     +++++++||||....
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            6789999999999999999999     899999999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.6e-44  Score=372.48  Aligned_cols=256  Identities=30%  Similarity=0.536  Sum_probs=213.5

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----CC
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI---SHPNIIRFFEAIET-----RE   82 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L---~HpNIVkl~~~~~~-----~~   82 (692)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+............+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            69999999999999999999999999999999976543333334556777777665   79999999998754     34


Q ss_pred             EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                      .+++||||+.+ +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~---~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEECccCccc
Confidence            68999999985 899888764  3489999999999999999999999999999999999998877   59999999998


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----CC----
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR----FP----  232 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~----~p----  232 (692)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|++||.+......+.++.......    ++    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            7665544556678999999999999999999999999999999999999999887766665554321100    00    


Q ss_pred             --------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          233 --------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       233 --------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                                    ......++.++.+++.+||++||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                          01123567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.6e-44  Score=385.45  Aligned_cols=261  Identities=28%  Similarity=0.507  Sum_probs=217.5

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----   81 (692)
                      .+.++|++.+.||+|+||+||++.+..+|+.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            567999999999999999999999999999999999976555555567788999999999999999999998644     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                       ..+|+||||+++ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~---~~kl~Dfg~a~  171 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLAR  171 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC---CEEEecCCCcc
Confidence             357999999976 5666664  3588999999999999999999999999999999999999877   59999999998


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-------------  227 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-------------  227 (692)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+....             
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            7655545556789999999999999999999999999999999999999999877654433322110             


Q ss_pred             --------CCCCC----------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          228 --------ELRFP----------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       228 --------~~~~p----------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                              ...++                .......++++.+||.+||+.||++|||+.|+|+||||...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence                    00000                00111246789999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.3e-44  Score=380.96  Aligned_cols=251  Identities=29%  Similarity=0.570  Sum_probs=220.2

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+++.||||++.+... .......+..|.+++..+ +||||+++++++..++.+|+|||||+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999976432 233445677888998865 899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG---HCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEEeecccceecccCCccccccc
Confidence            99999999888999999999999999999999999999999999999999877   59999999987643 223345568


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+..+.... ..+|    ..++.++.++|.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~ll~~~L~  232 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYP----VWLSKEAVSILKAFMT  232 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHHHHhc
Confidence            9999999999999999999999999999999999999999999888888776543 2233    3578899999999999


Q ss_pred             cCCCCCC-------CHHHHHhchhhhhhH
Q 005526          253 QNPVERI-------TFKEFFNHRFLGELR  274 (692)
Q Consensus       253 ~DP~~Rp-------Ta~elL~Hpf~~~~~  274 (692)
                      +||++|+       +++++++||||....
T Consensus       233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         233 KNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             cCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            9999999       999999999997653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.9e-44  Score=381.51  Aligned_cols=257  Identities=28%  Similarity=0.567  Sum_probs=224.3

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      +|.+.+.||+|+||+||+|++..+++.||||++.+... .......+..|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            68999999999999999999999999999999976432 223345567788888877 5899999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-CCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-~~~  167 (692)
                      ||++||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~---~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG---HIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC---cEEEccCCCceecCCCCCc
Confidence            9999999999999888999999999999999999999999999999999999999887   599999999975432 223


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+... ...+|    ..++.++.+++
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~p----~~~s~~~~~li  232 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYP----KSMSKEAVAIC  232 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCC----CcCCHHHHHHH
Confidence            45678999999999999999999999999999999999999999999888888777654 23333    35789999999


Q ss_pred             HHhhccCCCCCCC-----HHHHHhchhhhhhHh
Q 005526          248 RCLLRQNPVERIT-----FKEFFNHRFLGELRQ  275 (692)
Q Consensus       248 ~~~L~~DP~~RpT-----a~elL~Hpf~~~~~~  275 (692)
                      .+||++||.+|++     ..++++||||..+..
T Consensus       233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999997     489999999976543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-44  Score=383.54  Aligned_cols=253  Identities=28%  Similarity=0.576  Sum_probs=214.8

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+++.||||++++.... ......+.+|..++..+ +||||+++++++...+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999999999999999999765332 33456678899999988 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc-CCCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~-~~~~~~~~~~  172 (692)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.. .........+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG---HIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---CEEECcCccccccccCCCcccccc
Confidence            99999998888999999999999999999999999999999999999998876   5999999998753 2334455678


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN--------QLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~--------~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||....        ......+........+|    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            9999999999999999999999999999999999999996321        11222222223333333    35788999


Q ss_pred             HHHHHhhccCCCCCCC------HHHHHhchhhhhhHh
Q 005526          245 DLCRCLLRQNPVERIT------FKEFFNHRFLGELRQ  275 (692)
Q Consensus       245 dLI~~~L~~DP~~RpT------a~elL~Hpf~~~~~~  275 (692)
                      ++|++||++||.+|++      ++++++||||.....
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            9999999999999997      799999999976533

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.5e-44  Score=400.46  Aligned_cols=258  Identities=28%  Similarity=0.480  Sum_probs=213.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-------
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-------   81 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-------   81 (692)
                      .++|.+++.||+|+||+||+|.+..+++.||||.+....      ....+|+.+++.++||||+++++++...       
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            467999999999999999999999999999999885431      2345799999999999999999887432       


Q ss_pred             -CEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                       ..+++||||+++ +|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  .+||+||
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~--~vkL~DF  215 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH--TLKLCDF  215 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC--ceeeecc
Confidence             257799999986 67776643    457899999999999999999999999999999999999986653  5999999


Q ss_pred             ccccccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------
Q 005526          157 GFARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST--------  227 (692)
Q Consensus       157 GlA~~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~--------  227 (692)
                      |+++...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.++....        
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            99987765555556789999999999865 469999999999999999999999999987766655554311        


Q ss_pred             --------CCCCCCC--------cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          228 --------ELRFPPG--------AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       228 --------~~~~p~~--------~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                              ...++..        .....++++++||.+||++||.+|||+.|+++||||..++.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                    1111111        11245789999999999999999999999999999987654

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.9e-44  Score=380.26  Aligned_cols=252  Identities=31%  Similarity=0.597  Sum_probs=216.2

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEIS-ILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~-iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+|+.||+|++.+... .......+.+|.. +++.++||||+++++.+...+.+|+|||||+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999975432 2223344555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc-CCCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~-~~~~~~~~~~  172 (692)
                      |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.. .........+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG---HVVLTDFGLCKEGVEPEETTSTFC  157 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC---CEEEccCCCCccCCCCCCcccccc
Confidence            99999998888899999999999999999999999999999999999999877   5999999998753 2233345578


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+... ...++    ...+.++.+++.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~----~~~~~~~~~li~~~l~  232 (321)
T cd05603         158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLP----GGKTVAACDLLVGLLH  232 (321)
T ss_pred             CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCC----CCCCHHHHHHHHHHcc
Confidence            999999999999999999999999999999999999999999887777777653 23333    3567899999999999


Q ss_pred             cCCCCCCCH----HHHHhchhhhhhHh
Q 005526          253 QNPVERITF----KEFFNHRFLGELRQ  275 (692)
Q Consensus       253 ~DP~~RpTa----~elL~Hpf~~~~~~  275 (692)
                      +||.+|+++    .++++|+||.....
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            999999865    59999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.8e-44  Score=388.40  Aligned_cols=260  Identities=28%  Similarity=0.519  Sum_probs=223.1

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ..++|++.+.||+|+||.||++++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++..++.+|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            45789999999999999999999999999999999965322 22334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++......
T Consensus       121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~---~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG---HLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC---CEEEEecccceecccCC
Confidence            99999999999999654 689999999999999999999999999999999999999877   59999999998764332


Q ss_pred             C--CCccCCCCCccChHhhhhcC----CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCccccc
Q 005526          167 L--ADTLCGSPLYMAPEIIQNHK----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEEL  239 (692)
Q Consensus       167 ~--~~~~~GT~~YmAPEvl~~~~----ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~l  239 (692)
                      .  ..+.+||+.|+|||++.+..    ++.++|||||||++|+|++|++||.+.+....+.++.... ...+|..  ..+
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~  274 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEI  274 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc--ccC
Confidence            2  34678999999999997643    7889999999999999999999999998888888776543 2333332  367


Q ss_pred             CHHHHHHHHHhhccCCCC--CCCHHHHHhchhhhhh
Q 005526          240 HPDCVDLCRCLLRQNPVE--RITFKEFFNHRFLGEL  273 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~--RpTa~elL~Hpf~~~~  273 (692)
                      +..+++++.+||..++.+  |+++.++++||||+..
T Consensus       275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            899999999999866544  8999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-43  Score=378.29  Aligned_cols=252  Identities=29%  Similarity=0.568  Sum_probs=217.1

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILST-ISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~-L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||.||+|+++.+|+.||||++..... .......+..|..++.. ++||||+++++++...+.+|+|||||.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999976432 12234556778888875 4899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++..++.+++..+..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG---HIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---CEEeCccCCCeecccCCCceeccC
Confidence            99999999888999999999999999999999999999999999999999877   59999999987532 223345678


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... ..++    ..++.++.+|+++||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~li~~~l~  232 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHYP----RWITKESKDILEKLFE  232 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC----CCCCHHHHHHHHHHcc
Confidence            9999999999999999999999999999999999999999988877777665432 2222    3578899999999999


Q ss_pred             cCCCCCCCH-HHHHhchhhhhhHh
Q 005526          253 QNPVERITF-KEFFNHRFLGELRQ  275 (692)
Q Consensus       253 ~DP~~RpTa-~elL~Hpf~~~~~~  275 (692)
                      .||.+||++ .++++||||.....
T Consensus       233 ~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         233 RDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             CCHHHcCCChHHHHcCCCcCCCCH
Confidence            999999997 58999999977543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-43  Score=377.32  Aligned_cols=251  Identities=31%  Similarity=0.612  Sum_probs=216.2

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILST-ISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~-L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+++.||||+++.... .......+..|..++.. .+||||+++++++..++.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999976432 22233455667777764 4899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-CCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-~~~~~~~~  172 (692)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.... .......+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG---HIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC---CEEEccCcCCeECCCCCCcccccc
Confidence            99999999888999999999999999999999999999999999999998877   599999999976432 23445678


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+... ...+|    ..++.++.+|+.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~----~~~~~~~~~ll~~~l~  232 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFP----RWISKEAKDCLSKLFE  232 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCC----CCCCHHHHHHHHHHcc
Confidence            999999999999999999999999999999999999999999888777776543 22222    4578899999999999


Q ss_pred             cCCCCCCCH-HHHHhchhhhhhH
Q 005526          253 QNPVERITF-KEFFNHRFLGELR  274 (692)
Q Consensus       253 ~DP~~RpTa-~elL~Hpf~~~~~  274 (692)
                      .||.+||++ .++++||||....
T Consensus       233 ~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         233 RDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             CCHHHcCCChHHHHcCcccCCCC
Confidence            999999986 5899999997653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=383.71  Aligned_cols=263  Identities=29%  Similarity=0.529  Sum_probs=234.4

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .++|++++.||.|.-|+||+++.+.++..+|+|++.+..+. .+...++..|.+||..+.||.++.||..|+..+..|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            46788999999999999999999999999999999886543 44556777899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-
Q 005526           88 LEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-  164 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-  164 (692)
                      ||||+||+|..+++++  +.+++..++.|+.+++.||+|||-.|||+|||||+||||.++|+   |-|.||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH---IMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH---IMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc---EEeeeccccccCCCC
Confidence            9999999999999876  46999999999999999999999999999999999999999995   99999998643210 


Q ss_pred             ----------------------------------C----------------------CCCCccCCCCCccChHhhhhcCC
Q 005526          165 ----------------------------------Q----------------------DLADTLCGSPLYMAPEIIQNHKY  188 (692)
Q Consensus       165 ----------------------------------~----------------------~~~~~~~GT~~YmAPEvl~~~~y  188 (692)
                                                        .                      .....++||-.|+|||++.+.+-
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                              0                      01124578999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCC----HHHH
Q 005526          189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT----FKEF  264 (692)
Q Consensus       189 s~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpT----a~el  264 (692)
                      +.++|+|+|||++|||+.|..||.|.+..+.+.+|+.. .+.||...  ..+..++|||+++|.+||.+|..    +.||
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-PLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-CCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            99999999999999999999999999999999999875 56676543  77899999999999999999998    9999


Q ss_pred             HhchhhhhhHhhh
Q 005526          265 FNHRFLGELRQTV  277 (692)
Q Consensus       265 L~Hpf~~~~~~~~  277 (692)
                      ..||||..+.+.+
T Consensus       390 K~HpFF~gVnWaL  402 (459)
T KOG0610|consen  390 KRHPFFEGVNWAL  402 (459)
T ss_pred             hcCccccCCChhh
Confidence            9999999887764

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-43  Score=382.34  Aligned_cols=261  Identities=26%  Similarity=0.474  Sum_probs=218.5

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----   81 (692)
                      .+.++|.+.+.||+|+||+||++.+..+++.||||.+............+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            578999999999999999999999999999999999976655555567788999999999999999999988543     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                       ..+|+||||+++ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~---~~kl~Dfg~~~  167 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLAR  167 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC---CEEEeeCcccc
Confidence             357999999976 67776653  588999999999999999999999999999999999998877   59999999998


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL-----------  229 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~-----------  229 (692)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......           
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            766555556678999999999999999999999999999999999999999987765544433221100           


Q ss_pred             ---------------CCC-----------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          230 ---------------RFP-----------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       230 ---------------~~p-----------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                     .++           .......+.++.+||.+||+.||.+|||+.|+++||||...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                           000           01112245678999999999999999999999999999644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.7e-44  Score=376.91  Aligned_cols=262  Identities=35%  Similarity=0.634  Sum_probs=226.4

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC-----
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN-IIRFFEAIETRE-----   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN-IVkl~~~~~~~~-----   82 (692)
                      ...|..+++||+|+||+||+|+++.+|+.||+|.++.....+.......+|+.+|+.++|+| ||++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45688888999999999999999999999999999877554445567889999999999999 999999998777     


Q ss_pred             -EEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccc
Q 005526           83 -KIYLVLEYCDGGDLAAYIHKHG----KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG  157 (692)
Q Consensus        83 -~l~LVmEy~~GGsL~~~L~~~~----~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFG  157 (692)
                       .+++|+||++- +|..++....    .++...++.+++||+.||+|||++||+||||||+||||+++|   .+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G---~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG---VLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC---cEeeeccc
Confidence             89999999976 9999998765    588899999999999999999999999999999999999977   59999999


Q ss_pred             cccccC-CCCCCCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------
Q 005526          158 FARSLT-PQDLADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL------  229 (692)
Q Consensus       158 lA~~~~-~~~~~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~------  229 (692)
                      +|+... +.......++|.+|+|||++.+. .|+...||||+|||++||+++++.|++....+++..|.+....      
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999776 44556777899999999998776 7999999999999999999999999999998888777643211      


Q ss_pred             -----------CCCCCc--------ccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          230 -----------RFPPGA--------IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       230 -----------~~p~~~--------~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                                 .|+...        ....+++..+++.+||+.+|.+|.|++.+|.||||....
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                       111110        123346899999999999999999999999999998764

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-44  Score=380.53  Aligned_cols=251  Identities=31%  Similarity=0.583  Sum_probs=220.2

Q ss_pred             eEecccCceEEEEEEEc---CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           16 PRIGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~---~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      +.||+|+||.||++++.   .+|+.||+|++............+.+|++++++++||||+++++++..++.+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            67999999999999863   578999999997654443445567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CCCCcc
Q 005526           93 GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTL  171 (692)
Q Consensus        93 GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~~~~~  171 (692)
                      ||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++..... ......
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG---HIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC---cEEEeeccCCcccCCCCCceecc
Confidence            999999998888899999999999999999999999999999999999998877   5999999999765433 334457


Q ss_pred             CCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhh
Q 005526          172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL  251 (692)
Q Consensus       172 ~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L  251 (692)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+... ...+|    ..+++++.+||++||
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~-~~~~p----~~~~~~~~~li~~~l  233 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-KLGMP----QFLSPEAQSLLRALF  233 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-CCCCC----CCCCHHHHHHHHHHh
Confidence            8999999999999989999999999999999999999999998887777776543 23333    457899999999999


Q ss_pred             ccCCCCCCC-----HHHHHhchhhhhhH
Q 005526          252 RQNPVERIT-----FKEFFNHRFLGELR  274 (692)
Q Consensus       252 ~~DP~~RpT-----a~elL~Hpf~~~~~  274 (692)
                      ++||.+||+     +++++.||||....
T Consensus       234 ~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         234 KRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             hcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            999999999     78899999997653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.7e-44  Score=363.81  Aligned_cols=255  Identities=35%  Similarity=0.670  Sum_probs=217.8

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      |++++.||+|+||+||++++..+++.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999887554444445567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc-CCCCCCCc
Q 005526           92 DGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADT  170 (692)
Q Consensus        92 ~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~-~~~~~~~~  170 (692)
                      ++++|.+++...+.+++..++.++.||+.||.+||++||+||||||+||+++.++   .++|+|||.+... ........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~---~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG---EVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS---EEEESSGTTTEESTSTTSEBSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence            9999999999888999999999999999999999999999999999999999776   5899999999763 33344556


Q ss_pred             cCCCCCccChHhhh-hcCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          171 LCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       171 ~~GT~~YmAPEvl~-~~~ys~ksDIWSLGviLyeLltG~~PF~~~~---~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      ..+++.|+|||++. +..++.++||||||+++|+|++|..||....   ....+.+..... .............++.++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-LPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-HHHHTTSHTTSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc-ccccccccchhHHHHHHH
Confidence            78899999999998 8889999999999999999999999999873   333333322211 111111111224899999


Q ss_pred             HHHhhccCCCCCCCHHHHHhchhh
Q 005526          247 CRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      |.+||+.||++||++.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-43  Score=377.15  Aligned_cols=252  Identities=31%  Similarity=0.622  Sum_probs=219.8

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+++.||||++.+... .......+.+|.++++.+ +||||+++++++...+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999976432 223345677899999887 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG---HIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC---cEEecccCCCeecCcCCCccccee
Confidence            99999999888999999999999999999999999999999999999999877   59999999987532 223344567


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+... ...++    ..++.++.+||++||+
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-~~~~~----~~~~~~~~~li~~~l~  232 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-EVRYP----RWLSKEAKSILKSFLT  232 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCC----CcCCHHHHHHHHHHcc
Confidence            999999999999999999999999999999999999999998887777766543 22333    3578999999999999


Q ss_pred             cCCCCCCCH-----HHHHhchhhhhhHh
Q 005526          253 QNPVERITF-----KEFFNHRFLGELRQ  275 (692)
Q Consensus       253 ~DP~~RpTa-----~elL~Hpf~~~~~~  275 (692)
                      .||.+||++     .+++.||||.....
T Consensus       233 ~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         233 KNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999     99999999977543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-43  Score=382.79  Aligned_cols=261  Identities=25%  Similarity=0.460  Sum_probs=220.4

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----   81 (692)
                      .+.++|.+.+.||+|+||+||++.+..+++.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            467999999999999999999999999999999999976555555567788999999999999999999987543     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                       ..+|+||||+++ +|..++..  .+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---~~kL~DfG~a~  174 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLAR  174 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC---cEEEEeCCCcc
Confidence             368999999976 77777754  588999999999999999999999999999999999999877   59999999998


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC--------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP--------  232 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p--------  232 (692)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.+++.......+        
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            766555556678999999999999999999999999999999999999999988877666655432111000        


Q ss_pred             -----------------------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          233 -----------------------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       233 -----------------------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                                   .......+.++++||.+||+.||.+|||+.++|+||||...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                                         00111235678999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.6e-43  Score=377.71  Aligned_cols=252  Identities=30%  Similarity=0.604  Sum_probs=213.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+++.||+|++.+... .......+.+|+.++.++ +||||+++++++..++.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999976533 233456678899988876 899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~---~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG---HIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC---CEEEeeCCccccccCCCCcccccc
Confidence            99999998888999999999999999999999999999999999999999887   59999999997532 233345678


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCC--------C-HHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS--------N-QLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~--------~-~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||...        . .......+. .....+|    ..++.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p----~~~~~~~  232 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIP----RSLSVKA  232 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCC----CCCCHHH
Confidence            999999999999999999999999999999999999999521        1 112222232 2333333    4678899


Q ss_pred             HHHHHHhhccCCCCCCC------HHHHHhchhhhhhHh
Q 005526          244 VDLCRCLLRQNPVERIT------FKEFFNHRFLGELRQ  275 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpT------a~elL~Hpf~~~~~~  275 (692)
                      .++|++||+.||.+||+      +.++++||||.....
T Consensus       233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            99999999999999998      589999999976543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=370.81  Aligned_cols=259  Identities=26%  Similarity=0.445  Sum_probs=219.6

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .|++.+.||+|+||+||++.+..+++.||||++....... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4899999999999999999999999999999997543322 223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           90 YCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      |++||+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++   .++|+|||+++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG---HIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC---CEEEeeCCCceecCCCCc
Confidence            99999999888654  4589999999999999999999999999999999999998776   599999999987654444


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ....+|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+..... ..+......++..+.+||
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK-EDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-hcccccCcccCHHHHHHH
Confidence            4556899999999999988999999999999999999999999988765433333222111 112223346789999999


Q ss_pred             HHhhccCCCCCC-----CHHHHHhchhhhhh
Q 005526          248 RCLLRQNPVERI-----TFKEFFNHRFLGEL  273 (692)
Q Consensus       248 ~~~L~~DP~~Rp-----Ta~elL~Hpf~~~~  273 (692)
                      .+||..||.+||     +++++++||||...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999999999     99999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-44  Score=379.67  Aligned_cols=260  Identities=34%  Similarity=0.552  Sum_probs=223.1

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC---C--
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR---E--   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~---~--   82 (692)
                      ..-.|.-.+.+|.|+||+||+|....++..||||.+-.+.      +.-.+|+.+|+.+.|||||++..+|...   +  
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            4556899999999999999999999999999999875432      1234799999999999999999888532   2  


Q ss_pred             EEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      .+.+||||++. +|.++++.    +.+++...++-+++||++||.|||+.||+||||||.|||++.+..  .+||||||.
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg--~LKicDFGS  172 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG--VLKICDFGS  172 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC--eEEeccCCc
Confidence            45689999987 99999985    467999999999999999999999999999999999999988754  899999999


Q ss_pred             ccccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Q 005526          159 ARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST----------  227 (692)
Q Consensus       159 A~~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~----------  227 (692)
                      |+.+..++...++..|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.|.+...++..|.+.-          
T Consensus       173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            999998888889999999999999765 679999999999999999999999999998877776665321          


Q ss_pred             ------CCCCC---CC-----cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          228 ------ELRFP---PG-----AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       228 ------~~~~p---~~-----~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                            ...+|   ..     .....+++..||+.++|+.+|.+|.++.|++.||||.+++..
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                  11111   11     234578999999999999999999999999999999998765

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.3e-43  Score=376.99  Aligned_cols=261  Identities=24%  Similarity=0.498  Sum_probs=222.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.+.||+|+||+||++++..+++.||+|++.+.. ........+.+|+.++..++|+||+++++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999996532 22233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||++||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG---HIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC---CEEEEeccceeeccCCCc
Confidence            99999999999987 46789999999999999999999999999999999999998777   599999999976654332


Q ss_pred             --CCccCCCCCccChHhhhh-----cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCccccc
Q 005526          168 --ADTLCGSPLYMAPEIIQN-----HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEEL  239 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~-----~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~l  239 (692)
                        ....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+..+.+.++.... ...+|. ....+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~  236 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS-HITDV  236 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCC-ccccC
Confidence              234579999999999875     568889999999999999999999999988887777776542 233332 33567


Q ss_pred             CHHHHHHHHHhhccCCCC--CCCHHHHHhchhhhhhH
Q 005526          240 HPDCVDLCRCLLRQNPVE--RITFKEFFNHRFLGELR  274 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~--RpTa~elL~Hpf~~~~~  274 (692)
                      +.++.+++.+||..++.+  |++++++++||||....
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            899999999999876654  56999999999997653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-43  Score=376.40  Aligned_cols=252  Identities=31%  Similarity=0.565  Sum_probs=217.2

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILST-ISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~-L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+++.||||++..... ..........|..++.. ++||||+++++++.+++.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999976432 12233456677888875 5999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC-CCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~-~~~~~~~~  172 (692)
                      |+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++.... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG---HIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC---CEEEccCCcceECCCCCCceeeec
Confidence            99999999888899999999999999999999999999999999999999877   599999999875422 22344567


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ..++    ..++.++.+++.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~l~  232 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYP----RWLTREAKDILVKLFV  232 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC----ccCCHHHHHHHHHHhc
Confidence            9999999999999999999999999999999999999999988877777665432 2222    3578899999999999


Q ss_pred             cCCCCCCCHH-HHHhchhhhhhHh
Q 005526          253 QNPVERITFK-EFFNHRFLGELRQ  275 (692)
Q Consensus       253 ~DP~~RpTa~-elL~Hpf~~~~~~  275 (692)
                      +||.+||++. +++.||||.....
T Consensus       233 ~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         233 REPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             cCHhhcCCChHHHHcCcccCCCCH
Confidence            9999999996 9999999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.5e-43  Score=378.04  Aligned_cols=252  Identities=30%  Similarity=0.569  Sum_probs=216.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEIS-ILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~-iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+|+.||||++.+... .......+..|.. +++.++||||+++++.+..++.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999999999999999975432 2233345555655 46789999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~---~~kL~DfG~~~~~~~~~~~~~~~~  157 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG---HVVLTDFGLCKEGIAQSDTTTTFC  157 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---CEEEeecCCcccCCCCCCCccccc
Confidence            99999999888999999999999999999999999999999999999999887   59999999987543 233345678


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|++||...+..+.+.++.... ..++    ...+..+.+++++||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCC----CCCCHHHHHHHHHHhc
Confidence            9999999999999999999999999999999999999999988888877776542 2222    3578899999999999


Q ss_pred             cCCCCCCCH----HHHHhchhhhhhHh
Q 005526          253 QNPVERITF----KEFFNHRFLGELRQ  275 (692)
Q Consensus       253 ~DP~~RpTa----~elL~Hpf~~~~~~  275 (692)
                      +||.+||++    .++++||||.....
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            999999976    59999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4e-43  Score=383.22  Aligned_cols=260  Identities=28%  Similarity=0.513  Sum_probs=222.7

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++.+..++.+|+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            35799999999999999999999999999999999965322 22334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++......
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~---~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG---HLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC---CEEEEeCCceeEcCcCC
Confidence            99999999999998654 689999999999999999999999999999999999999877   59999999998765432


Q ss_pred             --CCCccCCCCCccChHhhhhcC----CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCccccc
Q 005526          167 --LADTLCGSPLYMAPEIIQNHK----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEEL  239 (692)
Q Consensus       167 --~~~~~~GT~~YmAPEvl~~~~----ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~-~~~p~~~~~~l  239 (692)
                        .....+||+.|+|||++....    ++.++|||||||++|+|++|++||.+.+....+.++..... ..+|.  ...+
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~  274 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD--DNDI  274 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC--cCCC
Confidence              234678999999999987543    78999999999999999999999999998888888775432 33332  3468


Q ss_pred             CHHHHHHHHHhhccCCCC--CCCHHHHHhchhhhhh
Q 005526          240 HPDCVDLCRCLLRQNPVE--RITFKEFFNHRFLGEL  273 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~--RpTa~elL~Hpf~~~~  273 (692)
                      +.++.++|.+||..++.+  |++++++++|+||...
T Consensus       275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            999999999999844443  7899999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.4e-43  Score=375.84  Aligned_cols=261  Identities=25%  Similarity=0.515  Sum_probs=221.8

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.++||+|+||+||+++++.+++.||+|++.+... .......+.+|+.++..++|+||+++++.+...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            479999999999999999999999999999999865321 2233445788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           89 EYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      ||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++...... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~---~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG---HIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC---CEEEeecchheecccCCc
Confidence            99999999999987 46789999999999999999999999999999999999998776   59999999997654322 


Q ss_pred             -CCCccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCccccc
Q 005526          167 -LADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEEL  239 (692)
Q Consensus       167 -~~~~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~-~~~p~~~~~~l  239 (692)
                       .....+||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+..+.+.++..... ..+|. ....+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~  236 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA-QVTDV  236 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCC-ccccC
Confidence             223467999999999986     34688999999999999999999999999988888887765432 22332 23467


Q ss_pred             CHHHHHHHHHhhccCCCC--CCCHHHHHhchhhhhhH
Q 005526          240 HPDCVDLCRCLLRQNPVE--RITFKEFFNHRFLGELR  274 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~--RpTa~elL~Hpf~~~~~  274 (692)
                      ++++.+|+++||..++.+  |++++++++||||..+.
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            999999999999765544  78999999999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-43  Score=367.74  Aligned_cols=254  Identities=26%  Similarity=0.472  Sum_probs=210.3

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCH
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL   96 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL   96 (692)
                      ||+|+||+||++.+..+|+.||||.+....... ...+.+..|+++++.++||||+++++++..+..+|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999999999999999987543322 2335677899999999999999999999999999999999999999


Q ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CCCcc
Q 005526           97 AAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTL  171 (692)
Q Consensus        97 ~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~~~~  171 (692)
                      ..++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++...... .....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG---NVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEeeCccceecCCCCcccccc
Confidence            988753    34689999999999999999999999999999999999998776   59999999997654332 23456


Q ss_pred             CCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhh
Q 005526          172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL  251 (692)
Q Consensus       172 ~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L  251 (692)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ...+......++.++.+++.+||
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-cccCCCCcccCCHHHHHHHHHHh
Confidence            79999999999999999999999999999999999999998654321111111110 11112223467899999999999


Q ss_pred             ccCCCCCC-----CHHHHHhchhhhhhHh
Q 005526          252 RQNPVERI-----TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       252 ~~DP~~Rp-----Ta~elL~Hpf~~~~~~  275 (692)
                      +.||++||     +++++++||||+....
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence            99999999     8899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5e-43  Score=376.17  Aligned_cols=261  Identities=26%  Similarity=0.497  Sum_probs=219.4

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..++|++.++||+|+||.||++.+..++..+|+|++.... .......+.+|+++++.++||||+++++++..++.+++|
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            3578999999999999999999999999999999987642 344567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~-gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||++||+|.+++...+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++   .+||+|||++..... .
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~---~~kL~Dfg~~~~~~~-~  157 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLID-S  157 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC---CEEEeeCCcchhhhh-h
Confidence            99999999999999888899999999999999999999985 799999999999998876   599999999876532 2


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------------
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-------------------  227 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-------------------  227 (692)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+....                   
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence            3345679999999999998899999999999999999999999998665433321110000                   


Q ss_pred             ----------------------CCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          228 ----------------------ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       228 ----------------------~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                            ....+......++.++.+|+.+||++||++|||+.|++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                  0000000112357889999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.7e-43  Score=374.54  Aligned_cols=256  Identities=29%  Similarity=0.600  Sum_probs=222.7

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      +|.+.+.||+|+||+||+|+++.+|+.||||++.+... .......+..|..++..+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999999999999999999976432 2233456778889998885 577888999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~  167 (692)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++..... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~---~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG---HIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEEeccccccccCCCCcc
Confidence            9999999999999988999999999999999999999999999999999999999877   5999999998764322 23


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.... ..+|    ..++.++.+++
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~li  232 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP----KSLSKEAVSIC  232 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC----ccCCHHHHHHH
Confidence            445679999999999999999999999999999999999999999998888777776532 2333    45788999999


Q ss_pred             HHhhccCCCCCCC-----HHHHHhchhhhhhH
Q 005526          248 RCLLRQNPVERIT-----FKEFFNHRFLGELR  274 (692)
Q Consensus       248 ~~~L~~DP~~RpT-----a~elL~Hpf~~~~~  274 (692)
                      .+||++||.+|++     .+++++||||....
T Consensus       233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            9999999999997     58999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.8e-43  Score=381.31  Aligned_cols=261  Identities=29%  Similarity=0.472  Sum_probs=219.3

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE-----KIY   85 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~-----~l~   85 (692)
                      +|.+.++||+|+||+||++.+..+|+.||||.+..........+.+.+|+++++.++||||+++++++...+     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            578999999999999999999999999999998765444455677889999999999999999999998776     899


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      +||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~---~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC---VLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC---CEEeccccceeecccC
Confidence            9999997 48999888888899999999999999999999999999999999999999877   5999999999865432


Q ss_pred             C--CCCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--------------
Q 005526          166 D--LADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE--------------  228 (692)
Q Consensus       166 ~--~~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~--------------  228 (692)
                      .  ......+++.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+....+..+.....              
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            2  23345689999999998764 589999999999999999999999998877665554432110              


Q ss_pred             --------CCCCC-----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          229 --------LRFPP-----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       229 --------~~~p~-----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                              ...+.     ......++++.+||.+||+.||.+|||+.++++||||.+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  296 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL  296 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence                    00010     112345789999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-42  Score=392.13  Aligned_cols=260  Identities=27%  Similarity=0.516  Sum_probs=226.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQL-GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~t-g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ...|.+.+.||+|+||.||+|.+..+ +..||+|.+...  .......+.+|+.+++.++||||+++++++..++.+|||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            45599999999999999999998887 788999977543  334456778899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           88 LEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        88 mEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      |||++||+|.+++..    ...+++..+..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++...
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~---~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG---IIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC---cEEEEeCcCceecC
Confidence            999999999988754    34689999999999999999999999999999999999999877   59999999998764


Q ss_pred             CCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          164 PQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       164 ~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.......++    ..++
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~s  296 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP----CPVS  296 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----ccCC
Confidence            332   245678999999999999999999999999999999999999999999888888877665433332    3578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhhh
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV  277 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~~  277 (692)
                      .++.++|.+||.+||++||++.+++.|+|+.......
T Consensus       297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~~~~  333 (478)
T PTZ00267        297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLF  333 (478)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHhCHHHHHHHHHH
Confidence            8999999999999999999999999999997664433

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-45  Score=370.54  Aligned_cols=261  Identities=29%  Similarity=0.538  Sum_probs=231.4

Q ss_pred             cceecCEEE-EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh-CCCCCcceEEEEEE----
Q 005526            6 TRLIGEYIV-GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST-ISHPNIIRFFEAIE----   79 (692)
Q Consensus         6 ~~~~~~Y~i-~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~-L~HpNIVkl~~~~~----   79 (692)
                      ..+.++|.+ -++||-|-.|.|..+.++.||+.+|+|++...       ....+|+++.-. -.|||||.++++|+    
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            347788988 46799999999999999999999999988653       456778887554 47999999999975    


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccc
Q 005526           80 TREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG  157 (692)
Q Consensus        80 ~~~~l~LVmEy~~GGsL~~~L~~~~~--lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFG  157 (692)
                      ....+.+|||.++||+|+..|+.++.  |+|.++..+++||..|+.|||+.+|.||||||+|+|++.......+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence            34578899999999999999998876  9999999999999999999999999999999999999988888899999999


Q ss_pred             cccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCCCC
Q 005526          158 FARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPG  234 (692)
Q Consensus       158 lA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~---~~~~~i~~~~~~~~p~~  234 (692)
                      +|+.........+.|.||+|.|||++...+|+..+|+||+||++|-|++|++||......   .-+..-+....+.||..
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            999887777788999999999999999999999999999999999999999999765432   22333345568899999


Q ss_pred             cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       235 ~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      .|..+|.+.+|+|+++|+.+|.+|.|++++++|||+...
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            999999999999999999999999999999999999654

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8e-43  Score=395.22  Aligned_cols=262  Identities=29%  Similarity=0.517  Sum_probs=229.1

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE----   82 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~----   82 (692)
                      ...++|.+.+.||+|+||+||+|++..+|+.||||++............+.+|+.++..++|+||+++++.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3458999999999999999999999999999999999877666666778889999999999999999988764322    


Q ss_pred             ----EEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEe
Q 005526           83 ----KIYLVLEYCDGGDLAAYIHKH----GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIG  154 (692)
Q Consensus        83 ----~l~LVmEy~~GGsL~~~L~~~----~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~  154 (692)
                          .+++||||+++|+|.++++.+    ..+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~---~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG---LVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC---CEEEE
Confidence                478999999999999998753    4689999999999999999999999999999999999999877   59999


Q ss_pred             ccccccccCC---CCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 005526          155 DFGFARSLTP---QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF  231 (692)
Q Consensus       155 DFGlA~~~~~---~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~  231 (692)
                      |||+++....   .......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+.++.......+
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL  265 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            9999976543   2334567899999999999999999999999999999999999999999988887777765543333


Q ss_pred             CCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       232 p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                      +    ..+++++.+++.+||+.||.+||++.++++|||++....
T Consensus       266 ~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        266 P----PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             C----CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence            3    467899999999999999999999999999999876543

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6e-43  Score=374.36  Aligned_cols=254  Identities=28%  Similarity=0.571  Sum_probs=215.8

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+++.||+|++.+... .....+.+.+|+.++.++ +||||+++++++...+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999976533 233456788899999888 699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG---HIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC---CEEEeccccceeccCCCCceeccc
Confidence            99999998888999999999999999999999999999999999999999877   49999999997532 333445678


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS------NQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~------~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||...      +...............+|    ..++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            999999999999999999999999999999999999999532      222222233333333333    4578899999


Q ss_pred             HHHhhccCCCCCCC------HHHHHhchhhhhhHhh
Q 005526          247 CRCLLRQNPVERIT------FKEFFNHRFLGELRQT  276 (692)
Q Consensus       247 I~~~L~~DP~~RpT------a~elL~Hpf~~~~~~~  276 (692)
                      +.+||.+||.+|++      ++++++||||..+...
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            99999999999997      5799999999876544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-43  Score=376.63  Aligned_cols=250  Identities=31%  Similarity=0.594  Sum_probs=214.6

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEI-SILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev-~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||+||+|++..+++.||+|++.+.... ......+..|. .+++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999999754321 12223444444 456789999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~---~~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG---HIVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---CEEEccCCCCcccccCCCCccccc
Confidence            99999999888899999999999999999999999999999999999998877   59999999997543 233345678


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.... ..+    ...+++.+.++|.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~----~~~~~~~~~~li~~~l~  232 (325)
T cd05602         158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQL----KPNITNSARHLLEGLLQ  232 (325)
T ss_pred             CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cCC----CCCCCHHHHHHHHHHcc
Confidence            9999999999999999999999999999999999999999988888777775532 222    24678999999999999


Q ss_pred             cCCCCCCCHH----HHHhchhhhhh
Q 005526          253 QNPVERITFK----EFFNHRFLGEL  273 (692)
Q Consensus       253 ~DP~~RpTa~----elL~Hpf~~~~  273 (692)
                      +||.+|+++.    ++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCC
Confidence            9999999865    89999999654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-43  Score=386.67  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=209.0

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|.+++.||+|+||.||+|++..+++.||+|....        ..+.+|++++++++||||+++++++..+...++|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            4689999999999999999999999999999996532        34678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC--C
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ--D  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~--~  166 (692)
                      ||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.....  .
T Consensus       163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~---~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG---DVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC---CEEEEeCCccccccccccc
Confidence            9996 58999998888899999999999999999999999999999999999998877   5999999999754322  2


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcc---C--------
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN-------QLQLFQNILTST---E--------  228 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~-------~~~~~~~i~~~~---~--------  228 (692)
                      .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||....       ....+..+....   .        
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            2345689999999999999999999999999999999999998875422       111111111100   0        


Q ss_pred             --------------CCCCC-----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          229 --------------LRFPP-----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       229 --------------~~~p~-----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                    ...+.     .....++.++.+||.+||+.||.+|||++|+|+||||+.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                          00000     0011346689999999999999999999999999999753

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.2e-43  Score=365.04  Aligned_cols=249  Identities=27%  Similarity=0.506  Sum_probs=208.8

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCH
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL   96 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL   96 (692)
                      ||+|+||+||+++++.+|+.||+|.+....... .....+..|++++++++||||+++++.+..+..+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999999999999997543322 2234556799999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCCC
Q 005526           97 AAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS  174 (692)
Q Consensus        97 ~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~GT  174 (692)
                      .+++...+  .+++..+..++.||+.||+|||++||+||||||+||+++.++   .+||+|||++.............|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG---NCRLSDLGLAVELKDGKTITQRAGT  157 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC---CEEEeeceeeeecCCCceeeccCCC
Confidence            99886543  588999999999999999999999999999999999998876   5999999999876544444456799


Q ss_pred             CCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCCCCCCCcccccCHHHHHHHHHh
Q 005526          175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFPPGAIEELHPDCVDLCRCL  250 (692)
Q Consensus       175 ~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~----~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~  250 (692)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||.+....    +........ ...+   ....++.++.+|+.+|
T Consensus       158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~li~~~  233 (277)
T cd05607         158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-EVKF---EHQNFTEESKDICRLF  233 (277)
T ss_pred             CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-cccc---ccccCCHHHHHHHHHH
Confidence            9999999999988999999999999999999999999765432    222222211 1111   1235789999999999


Q ss_pred             hccCCCCCCCH----HHHHhchhhhhh
Q 005526          251 LRQNPVERITF----KEFFNHRFLGEL  273 (692)
Q Consensus       251 L~~DP~~RpTa----~elL~Hpf~~~~  273 (692)
                      |++||.+||++    ++++.||||...
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCC
Confidence            99999999999    678899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.9e-43  Score=381.90  Aligned_cols=253  Identities=30%  Similarity=0.525  Sum_probs=210.8

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|.++++||+|+||+||+|++..+++.||||++.... .......+.+|+++++.++|+||+++++++..++.+|+||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            578999999999999999999999999999999986542 3455678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~  167 (692)
                      |||++|+|...    ...++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++..... ..
T Consensus       152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CEEEcccccceeccccccc
Confidence            99999998653    3467888999999999999999999999999999999999877   5999999999875432 22


Q ss_pred             CCccCCCCCccChHhhhh-----cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCCCCccccc
Q 005526          168 ADTLCGSPLYMAPEIIQN-----HKYDAKADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~-----~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~---~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      .....||+.|+|||++..     ..++.++|||||||++|+|++|+.||......   .....+...    .+......+
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~  300 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS----QPPEAPATA  300 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc----CCCCCCCcc
Confidence            345689999999998743     23456899999999999999999999743322   222222221    222233467


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +.++.+||.+||+.||++|||+.|+++||||...
T Consensus       301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            8999999999999999999999999999999653

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=356.02  Aligned_cols=255  Identities=29%  Similarity=0.547  Sum_probs=220.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP---KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~---~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      +.|.+.+.||+|+||.||++.+..+++.||+|.+.......   .....+.+|++++++++||||+++++++..++.+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999999999999999987543322   234578889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |+||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++   .++|+|||+++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~---~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG---NVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeecccceeccccc
Confidence            999999999999999888899999999999999999999999999999999999998776   59999999997654321


Q ss_pred             C----CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          167 L----ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       167 ~----~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      .    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+......++.....   ........+.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT---NPQLPSHVSPD  235 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC---CCCCCccCCHH
Confidence            1    1345688999999999998899999999999999999999999988766655544433221   22233567889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +.+++.+||.++|.+|||+.++++||||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1e-42  Score=368.06  Aligned_cols=262  Identities=29%  Similarity=0.529  Sum_probs=217.2

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..++|.+.++||+|+||+||+|+++.+++.||+|.+..... ......+.+|++++++++||||+++++++..++..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            35789999999999999999999999999999999975432 22234567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-
Q 005526           88 LEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-  165 (692)
                      |||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++..... 
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG---ELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEECccccceecCCCc
Confidence            999986 8888887654 579999999999999999999999999999999999999876   5999999999764332 


Q ss_pred             CCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----------------
Q 005526          166 DLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE----------------  228 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~----------------  228 (692)
                      .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.....                
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            22334578999999999865 5688999999999999999999999998876655444432110                


Q ss_pred             --CCCCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          229 --LRFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       229 --~~~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                        ..++.       .....+++++.+||++||+.||.+|||+.|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence              11111       11135688999999999999999999999999999997653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=374.37  Aligned_cols=250  Identities=29%  Similarity=0.582  Sum_probs=214.1

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI---SHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L---~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      ||+|+||+||+|++..+|+.||||++.+... ..........|..++...   .||||+++++.+...+.+|+||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999965432 222334455677777665   699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++... ........+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG---HIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC---CEEEecCCcCcCCCCCCCCccCcc
Confidence            99999999988999999999999999999999999999999999999999877   59999999997643 233345678


Q ss_pred             CCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhh
Q 005526          173 GSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL  251 (692)
Q Consensus       173 GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L  251 (692)
                      ||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++... ...++.   ..+++++.+||++||
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~---~~~~~~~~~li~~~L  233 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRFPK---NVLSDEGRQFVKGLL  233 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-CCCCCC---ccCCHHHHHHHHHHc
Confidence            99999999998754 5899999999999999999999999998888777776543 333332   247899999999999


Q ss_pred             ccCCCCCC----CHHHHHhchhhhhhH
Q 005526          252 RQNPVERI----TFKEFFNHRFLGELR  274 (692)
Q Consensus       252 ~~DP~~Rp----Ta~elL~Hpf~~~~~  274 (692)
                      ++||.+||    ++.++++||||....
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            99999998    799999999997653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.8e-42  Score=350.62  Aligned_cols=253  Identities=28%  Similarity=0.534  Sum_probs=224.8

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+++++.++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            58999999999999999999999999999999977655666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           91 CDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        91 ~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      ++|++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++...... .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~---~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD---NVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC---CEEEcccccceeccCccch
Confidence            9999999999875  5689999999999999999999999999999999999999876   59999999988765432 2


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+........    ...++.++.+++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i  233 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV----SQMYSQQLAQLI  233 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccccCHHHHHHH
Confidence            3456789999999999999999999999999999999999999998887777766655432222    236788999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ++||+.+|++||++.+++.|||+
T Consensus       234 ~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         234 DQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-43  Score=377.21  Aligned_cols=260  Identities=28%  Similarity=0.494  Sum_probs=216.1

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----   81 (692)
                      .+.++|.+.+.||+|+||+||+|.+..+++.||||.+............+.+|+++++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            467899999999999999999999999999999999976544444456678899999999999999999887533     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                       ...|+++|++ |++|..+++ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~---~~kl~Dfg~~~  166 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC---ELRILDFGLAR  166 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC---CEEEcCCccce
Confidence             4579999998 679988775 45799999999999999999999999999999999999999877   59999999998


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR---------  230 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~---------  230 (692)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......         
T Consensus       167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            7543  2345679999999999876 568999999999999999999999999877665555443211100         


Q ss_pred             -------------CCC----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          231 -------------FPP----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       231 -------------~p~----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                   .+.    ......++.+.+||.+||..||.+|||+.|+++||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                         010    1112456778999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.1e-42  Score=351.23  Aligned_cols=254  Identities=30%  Similarity=0.560  Sum_probs=226.2

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|++.+.||+|+||.||++.+..+++.+|||.+............+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            69999999999999999999999999999999987666666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           91 CDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        91 ~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      ++|++|.+++...  ..+++..++.++.|++.+|+|||++||+||||||+||+++.++.  .+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM--VVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEccCCCceecCCCccc
Confidence            9999999999764  34899999999999999999999999999999999999986553  6899999999877655545


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+.......++    ...+.++.+++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~  234 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS----DRYSPDLRQLIL  234 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC----CCcCHHHHHHHH
Confidence            5577899999999999888999999999999999999999999988877777666554333322    357889999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhh
Q 005526          249 CLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +||..||.+|||+.++++||||
T Consensus       235 ~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         235 SMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHccCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-42  Score=363.06  Aligned_cols=257  Identities=27%  Similarity=0.505  Sum_probs=217.5

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .|++.+.||+|+||+||++.+..+++.||||.+...... ......+.+|+.++++++|+||+++++.+..++.+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            478899999999999999999999999999998765333 2234567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           90 YCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++   .++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~---~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG---HIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC---CEEEeeccceeecCCCcc
Confidence            99999999998654  3589999999999999999999999999999999999998876   599999999976654444


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~---~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      .....|++.|+|||++.+..++.++||||+||++|+|++|+.||......   .....+....    +......+++++.
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  233 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----QEEYSEKFSPDAR  233 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----hhhcCccCCHHHH
Confidence            44567999999999999999999999999999999999999999875432   1222222211    1122346788999


Q ss_pred             HHHHHhhccCCCCCCC-----HHHHHhchhhhhhH
Q 005526          245 DLCRCLLRQNPVERIT-----FKEFFNHRFLGELR  274 (692)
Q Consensus       245 dLI~~~L~~DP~~RpT-----a~elL~Hpf~~~~~  274 (692)
                      +|+++||+.||.+|||     ++|+++||||.+..
T Consensus       234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             HHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence            9999999999999999     99999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-42  Score=357.90  Aligned_cols=258  Identities=28%  Similarity=0.554  Sum_probs=218.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++..........+.+.+|+.++++++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            57999999999999999999999999999999987554333444567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~  168 (692)
                      |++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++....... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG---QIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC---cEEECccccceecCCCcccc
Confidence            999999988887777899999999999999999999999999999999999998876   59999999998765433 23


Q ss_pred             CccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------------C
Q 005526          169 DTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE------------------L  229 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~------------------~  229 (692)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.....                  .
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            34568899999999876 5588999999999999999999999998776554443322100                  0


Q ss_pred             CCCC--------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 RFPP--------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 ~~p~--------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ..+.        .....++..+.+|+.+||+.||++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            1111        1123567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.8e-42  Score=349.96  Aligned_cols=253  Identities=31%  Similarity=0.587  Sum_probs=220.6

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEe
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET-REKIYLVLE   89 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~-~~~l~LVmE   89 (692)
                      +|++.+.||+|+||.||++.+..+++.||+|.+..........+.+.+|++++++++|+||+++++.+.. ...+|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5999999999999999999999999999999997765555666788999999999999999999998764 457899999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-C
Q 005526           90 YCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-D  166 (692)
Q Consensus        90 y~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~  166 (692)
                      |+++++|.+++...  ..+++.+++.++.|++.||.|||++||+||||||+||+++.++   .++|+|||+++..... .
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC---cEEEecccceEEecccCC
Confidence            99999999999763  4589999999999999999999999999999999999998776   5999999999766432 2


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......    .....++++.++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l  233 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP----MPKDYSPELGEL  233 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC----CccccCHHHHHH
Confidence            3345678999999999999999999999999999999999999999888766666555433211    224678999999


Q ss_pred             HHHhhccCCCCCCCHHHHHhchhh
Q 005526          247 CRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +.+||+.||.+|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         234 IATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-42  Score=389.48  Aligned_cols=259  Identities=23%  Similarity=0.371  Sum_probs=208.7

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC------CCcceEEEEEEeC-
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH------PNIIRFFEAIETR-   81 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~H------pNIVkl~~~~~~~-   81 (692)
                      .++|+++++||+|+||+||+|.+..+++.||||+++..   .........|+.+++.++|      ++|+++++++..+ 
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            47899999999999999999999999999999999643   2233455667777777654      4588898888654 


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCC-------------
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEV-------------  147 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~-------------  147 (692)
                      ..+|+|||++ |++|.+++.+++.+++..++.++.||+.||+|||+ .|||||||||+|||++.++.             
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            5789999998 67999999988899999999999999999999998 59999999999999987642             


Q ss_pred             cCeEEEeccccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 005526          148 TPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST  227 (692)
Q Consensus       148 ~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~  227 (692)
                      ...+||+|||.+....  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus       284 ~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        284 PCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             CceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence            1249999999886432  23346789999999999999999999999999999999999999999887665544332210


Q ss_pred             CCCCC---------------------------CC-----------cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchh
Q 005526          228 ELRFP---------------------------PG-----------AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF  269 (692)
Q Consensus       228 ~~~~p---------------------------~~-----------~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf  269 (692)
                      . .+|                           +.           .....++.+.|||.+||++||.+|||++|+|+|||
T Consensus       362 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        362 G-RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             C-CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            0 000                           00           00012456789999999999999999999999999


Q ss_pred             hhhhH
Q 005526          270 LGELR  274 (692)
Q Consensus       270 ~~~~~  274 (692)
                      |....
T Consensus       441 ~~~~~  445 (467)
T PTZ00284        441 VLKYY  445 (467)
T ss_pred             ccccC
Confidence            97653

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.6e-43  Score=389.90  Aligned_cols=259  Identities=32%  Similarity=0.480  Sum_probs=221.7

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeC
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-H-----PNIIRFFEAIETR   81 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-H-----pNIVkl~~~~~~~   81 (692)
                      +..+|.|++.||+|+||.|.+|.+..|++.||||+++.+   +....+...|+.||..++ |     -|||+++++|...
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            445899999999999999999999999999999999764   455677788999999997 4     3899999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccc
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA  159 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA  159 (692)
                      +++|||+|.+.- +|.++|+.+.  +++...++.++.||+.||.+||+.||||+||||+||||...+. ..|||+|||.+
T Consensus       261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKVIDFGSS  338 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKVIDFGSS  338 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeEEecccc
Confidence            999999999965 9999999874  5899999999999999999999999999999999999976553 37999999999


Q ss_pred             cccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----------
Q 005526          160 RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL----------  229 (692)
Q Consensus       160 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~----------  229 (692)
                      +.....-  .+++-+..|+|||++.+.+|+.+.||||||||++||++|.+.|+|.+..+++..|......          
T Consensus       339 c~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  339 CFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            8765433  3888999999999999999999999999999999999999999999988888777521100          


Q ss_pred             -----------------------------------------CCCCCcc------c-ccCHHHHHHHHHhhccCCCCCCCH
Q 005526          230 -----------------------------------------RFPPGAI------E-ELHPDCVDLCRCLLRQNPVERITF  261 (692)
Q Consensus       230 -----------------------------------------~~p~~~~------~-~ls~el~dLI~~~L~~DP~~RpTa  261 (692)
                                                               ..|....      . .....++||+.+||..||.+|+|+
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                                                     0010000      0 112468999999999999999999


Q ss_pred             HHHHhchhhhhh
Q 005526          262 KEFFNHRFLGEL  273 (692)
Q Consensus       262 ~elL~Hpf~~~~  273 (692)
                      .++|+||||...
T Consensus       497 ~qal~Hpfl~~~  508 (586)
T KOG0667|consen  497 AQALNHPFLTGT  508 (586)
T ss_pred             HHHhcCcccccc
Confidence            999999999754

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.7e-42  Score=358.66  Aligned_cols=261  Identities=25%  Similarity=0.454  Sum_probs=221.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .|++.+.||+|+||+||++.+..+++.||+|.+....... .....+.+|+++++.++|+||+++++.+..++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4788999999999999999999999999999997654332 234557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           90 YCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      |+++++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~---~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG---HIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC---CEEEecCCcceecCCCCc
Confidence            99999999888654  3689999999999999999999999999999999999998776   599999999976554444


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.... ..........++.++.+|+
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV-LETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh-hccccccCccCCHHHHHHH
Confidence            455689999999999998899999999999999999999999998876654444332211 1112223356788999999


Q ss_pred             HHhhccCCCCCCC-----HHHHHhchhhhhhHh
Q 005526          248 RCLLRQNPVERIT-----FKEFFNHRFLGELRQ  275 (692)
Q Consensus       248 ~~~L~~DP~~RpT-----a~elL~Hpf~~~~~~  275 (692)
                      .+||+.||.+||+     +.++++|+||.....
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            9999999999999     899999999987633

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-42  Score=354.79  Aligned_cols=259  Identities=31%  Similarity=0.565  Sum_probs=218.9

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS----PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~----~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      +|+.++.||+|+||.||++.+..+++.||+|++......    ....+.+.+|++++++++|+||+++++++..++.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588999999999999999999999999999999754321    2345788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.  .+||+|||++.......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~--~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARLAAKG  158 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEccccccccccccc
Confidence            9999999999999998888999999999999999999999999999999999999977653  59999999987664321


Q ss_pred             -----CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCH
Q 005526          167 -----LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       167 -----~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                           ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...........+.........+.....+++
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP  238 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence                 123456889999999998888999999999999999999999999765433222222221111222333356789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                      ++.+++.+||..||.+|||+.++++||||+
T Consensus       239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.9e-42  Score=350.31  Aligned_cols=257  Identities=30%  Similarity=0.552  Sum_probs=223.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++++.||.|+||+||+|....++..+++|++....... ....+.+|+++++.++|+||+++++.+..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            57999999999999999999999899999999997654443 56788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           90 YCDGGDLAAYIHKH---GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        90 y~~GGsL~~~L~~~---~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |++|++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+||++++++   .+||+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~---~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG---SVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC---CEEEcccchHHHhccCc
Confidence            99999999999764   4589999999999999999999999999999999999999876   49999999987655332


Q ss_pred             -----CCCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCc-cccc
Q 005526          167 -----LADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA-IEEL  239 (692)
Q Consensus       167 -----~~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~-~~~l  239 (692)
                           ......|++.|+|||++... .++.++|+|||||++|+|++|+.||...+..+.+.++.......++... ...+
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY  236 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence                 22445789999999998877 7899999999999999999999999988777666666554333332221 2367


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ++++.+++.+||+.||++||++.+++.||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            8899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.9e-42  Score=357.36  Aligned_cols=257  Identities=34%  Similarity=0.667  Sum_probs=226.9

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++..... .......+.+|++++++++||||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            479999999999999999999999999999999865432 2344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      ||+++++|.+++.+.+.+++..++.++.||+.||.|||++||+||||+|+|||++.++   .+||+|||+++.....  .
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~---~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG---YIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---CEEEeeCCCccccCCC--C
Confidence            9999999999999988999999999999999999999999999999999999998877   5999999999876544  4


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ...+|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+......++... ...++    ..++..+.++++
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~----~~~~~~l~~li~  230 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFP----SFFSPDAKDLIR  230 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCC----ccCCHHHHHHHH
Confidence            4567899999999998888899999999999999999999999988876666666533 23333    356889999999


Q ss_pred             HhhccCCCCCC-----CHHHHHhchhhhhhHhh
Q 005526          249 CLLRQNPVERI-----TFKEFFNHRFLGELRQT  276 (692)
Q Consensus       249 ~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~~~  276 (692)
                      +||..||.+|+     +++++++||||......
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence            99999999999     99999999999766443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.4e-42  Score=355.96  Aligned_cols=256  Identities=29%  Similarity=0.564  Sum_probs=212.6

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|++.+.||+|+||+||+|.+..++..||||.+............+.+|+.++++++||||+++++++..++.+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58999999999999999999999999999999976544444456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-C
Q 005526           91 CDGGDLAAYIHKH---GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-D  166 (692)
Q Consensus        91 ~~GGsL~~~L~~~---~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~  166 (692)
                      +. ++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++...... .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG---VIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC---cEEECcccceeecCCCcc
Confidence            98 5898888653   4689999999999999999999999999999999999999877   5999999999765432 2


Q ss_pred             CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----------------
Q 005526          167 LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL----------------  229 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~----------------  229 (692)
                      ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+......                
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            2234467899999999865 45788999999999999999999999887665443332211000                


Q ss_pred             --------CCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 --------RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 --------~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                              .........+++++.++|++||..||.+|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                    00001123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-42  Score=369.53  Aligned_cols=250  Identities=27%  Similarity=0.471  Sum_probs=204.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHR-----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET-R   81 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~-~   81 (692)
                      .++|+++++||+|+||+||+|.+.     .+++.||||++... ........+.+|+.++..+ +||||+++++++.. +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            368999999999999999999752     34578999998653 2334456789999999999 89999999998765 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc----------------------------------------------------------
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKH----------------------------------------------------------  103 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~----------------------------------------------------------  103 (692)
                      +.+++|||||+||+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            5689999999999999999753                                                          


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC---CCCccCCCCC
Q 005526          104 ----GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL  176 (692)
Q Consensus       104 ----~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~  176 (692)
                          ..+++..+..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++......   ......+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC---cEEEeecccccccccCcchhcccCCCCCcc
Confidence                2367888999999999999999999999999999999998876   59999999998653221   1223456678


Q ss_pred             ccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH-HHhccCCCCCCCcccccCHHHHHHHHHhhccC
Q 005526          177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN-ILTSTELRFPPGAIEELHPDCVDLCRCLLRQN  254 (692)
Q Consensus       177 YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~-i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~D  254 (692)
                      |+|||++.+..|+.++|||||||++|||++ |..||.+....+.+.. +........    ....++++.+++.+||+.|
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA----PENATPEIYRIMLACWQGD  317 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHccCC
Confidence            999999999999999999999999999997 9999988654433333 333222222    2456889999999999999


Q ss_pred             CCCCCCHHHHHh
Q 005526          255 PVERITFKEFFN  266 (692)
Q Consensus       255 P~~RpTa~elL~  266 (692)
                      |.+|||+.++++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.4e-41  Score=347.37  Aligned_cols=253  Identities=30%  Similarity=0.556  Sum_probs=225.8

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|++.+.||.|+||.||.+++..+++.+++|.+............+.+|+.++++++|+||+++++++...+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            69999999999999999999999999999999987766666777889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           91 CDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        91 ~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      |++++|.+++.+.  ..+++..+..++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~---~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG---LIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC---CEEECcCcceEEccccccc
Confidence            9999999999875  4589999999999999999999999999999999999999877   59999999998664433 3


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+........    ....+.++.+++
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i  233 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV----VSVYSSELISLV  233 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----ccccCHHHHHHH
Confidence            4456789999999999888899999999999999999999999999888777777765432221    246788999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .+||..||.+||+++++++|+|+
T Consensus       234 ~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         234 HSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHcccCcccCCCHHHHhhCcCC
Confidence            99999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.4e-42  Score=360.84  Aligned_cols=265  Identities=29%  Similarity=0.517  Sum_probs=218.9

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .+++|.+.++||.|+||.||+|++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++..++.+++|
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            46789999999999999999999999999999999865432 22334677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           88 LEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++.......
T Consensus        83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG---ELKLADFGLARAKSIPT  158 (301)
T ss_pred             Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC---cEEECcCcchhccCCCC
Confidence            999975 898888764 5689999999999999999999999999999999999999876   59999999997654222


Q ss_pred             -CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------------
Q 005526          167 -LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---------------  229 (692)
Q Consensus       167 -~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~---------------  229 (692)
                       ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+......               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             2334567899999999865 45788999999999999999999999988766555443321110               


Q ss_pred             ---CCCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhhh
Q 005526          230 ---RFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV  277 (692)
Q Consensus       230 ---~~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~~  277 (692)
                         .++.       .....+++++.+||.+||+.||.+|||+.|+++||||+.+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~  296 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI  296 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence               0110       11235688999999999999999999999999999998765443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=365.29  Aligned_cols=264  Identities=28%  Similarity=0.574  Sum_probs=240.3

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      -+++|..++.||+|.||+|.+++.+.+++.||+|++++... .......-..|-++|+..+||.+..+...|...+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            46889999999999999999999999999999999987643 34445566779999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc-CCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQ  165 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~-~~~  165 (692)
                      ||||..||.|.-+|.+...++|+..+.+-..|+.||.|||+++||.||||.+|+|++.+|+   +||+|||+++.. ...
T Consensus       246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH---IKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH---IKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc---eEeeecccchhccccc
Confidence            9999999999999999999999999999999999999999999999999999999999995   999999999864 345


Q ss_pred             CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                      ....++||||.|+|||++....|+..+|+|.+||++|||++|+.||...+...++.-|+. ..+.||    ..++++++.
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-ed~kFP----r~ls~eAkt  397 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-EDLKFP----RTLSPEAKT  397 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-hhccCC----ccCCHHHHH
Confidence            677899999999999999999999999999999999999999999999999888887765 467777    478999999


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHhchhhhhhHhhhhh
Q 005526          246 LCRCLLRQNPVERI-----TFKEFFNHRFLGELRQTVHA  279 (692)
Q Consensus       246 LI~~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~~~~~~  279 (692)
                      |+..+|.+||.+|.     .++|+..|+||..+.+...-
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~  436 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATY  436 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHH
Confidence            99999999999998     68999999999887665433

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.5e-42  Score=404.98  Aligned_cols=267  Identities=30%  Similarity=0.569  Sum_probs=225.8

Q ss_pred             CCcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 005526            4 NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET--R   81 (692)
Q Consensus         4 ~~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~   81 (692)
                      .+...+++|+++++||+|+||+||+|++..++..||+|++............+..|+.+++.++|||||+++++|..  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            45678899999999999999999999999999999999998766666667889999999999999999999998854  4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc-------CCcccCCCCCceEecCCC----
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKH----GKVSEAVARHFMRQLAAGLQVLQEK-------HLIHRDLKPQNLLVSTNE----  146 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~----~~lse~~i~~il~QLl~gL~yLHs~-------gIVHRDLKP~NILL~~~~----  146 (692)
                      ..+|||||||++|+|.++|...    +.+++..++.|+.||+.||.|||+.       +||||||||+||||+.+.    
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            6799999999999999998753    5799999999999999999999985       499999999999997531    


Q ss_pred             ----------CcCeEEEeccccccccCCCCCCCccCCCCCccChHhhhh--cCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005526          147 ----------VTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGS  214 (692)
Q Consensus       147 ----------~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~--~~ys~ksDIWSLGviLyeLltG~~PF~~~  214 (692)
                                ....+||+|||+++...........+||+.|+|||++..  ..++.++||||||||||+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                      123589999999987765555566789999999999864  45889999999999999999999999876


Q ss_pred             CHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          215 NQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       215 ~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +....+...+...    +.......+.++.+||..||..+|.+||++.|+|.|+|+....
T Consensus       247 ~~~~qli~~lk~~----p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        247 NNFSQLISELKRG----PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             CcHHHHHHHHhcC----CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            6544433333222    1111235688999999999999999999999999999997654

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9e-42  Score=350.96  Aligned_cols=253  Identities=32%  Similarity=0.593  Sum_probs=219.0

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-------HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-------KVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-------~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      +|.+++.||.|+||.||+|.+..+++.||+|.+.......       +..+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5889999999999999999999899999999886543321       234568889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      .++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~---~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG---GIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC---CEEecccCCCcccc
Confidence            999999999999999999888899999999999999999999999999999999999998776   59999999988664


Q ss_pred             CCC-------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcc
Q 005526          164 PQD-------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       164 ~~~-------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~  236 (692)
                      ...       ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+....+.++.......    ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~  233 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE----IP  233 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc----CC
Confidence            221       1123468899999999998889999999999999999999999999877666555544422222    22


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ...+..+.++|++||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            4578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-41  Score=360.15  Aligned_cols=258  Identities=27%  Similarity=0.507  Sum_probs=218.3

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.++||+|+||.||++.+..++..||+|.+... ........+.+|++++++++||||+++++.+..++.+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            4799999999999999999999999999999998654 234456678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |++|++|.+++++.+.+++..+..++.|++.||.|||+ ++|+||||||+|||++.++   .+||+|||++..... ...
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~-~~~  155 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLID-SMA  155 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC---cEEEccCCCcccccc-ccc
Confidence            99999999999988889999999999999999999997 5999999999999998876   599999999876532 234


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----------------
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF-----------------  231 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~-----------------  231 (692)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ .......                 
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF-GRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh-cCccccccccCCcccccCCCCCcc
Confidence            5568899999999998888999999999999999999999999766543332221 1110000                 


Q ss_pred             -----------------CCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          232 -----------------PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       232 -----------------p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                       |......++.++.+|+.+||..||++|||+.++++||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                             000012367889999999999999999999999999999653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=347.72  Aligned_cols=255  Identities=31%  Similarity=0.503  Sum_probs=219.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.+.||.|+||.||+|.+..+++.+++|++.....  ...+.+.+|+.++++++||||+++++.+..++.+|++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            689999999999999999999999999999999976532  245788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      |+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++....... .
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~---~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG---DVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC---CEEECccccchhhhhhhhc
Confidence            99999999999876 7899999999999999999999999999999999999999877   49999999997654332 2


Q ss_pred             CCccCCCCCccChHhhhhc---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNH---KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~---~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      .....++..|+|||.+...   .++.++|+|||||++|+|++|++||.+.+.......+................+.++.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            3446788999999999776   8899999999999999999999999887766555444333111111112234577899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRF  269 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf  269 (692)
                      +++++||..||.+|||+.+++.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.9e-42  Score=352.81  Aligned_cols=256  Identities=29%  Similarity=0.480  Sum_probs=214.4

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      -.++|++.+.||+|+||.||+|++..+++.||+|++.....  .....+.+|+.++++++||||+++++.+..++.+|+|
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            35689999999999999999999999999999999865422  2335678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++...... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~---~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG---DVKLADFGVAAKITATIA  161 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---CEEECcCccceeeccccc
Confidence            99999999999998888899999999999999999999999999999999999998776   49999999998654322 


Q ss_pred             CCCccCCCCCccChHhhh---hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC-CCcccccCHH
Q 005526          167 LADTLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHPD  242 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~---~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p-~~~~~~ls~e  242 (692)
                      ......|++.|+|||.+.   ...++.++||||+||++|+|++|+.||...........+... ....+ ......++..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  240 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-NFQPPKLKDKTKWSST  240 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-CCCCCCCccccccCHH
Confidence            234457899999999984   445788999999999999999999999766544333222221 11111 1112356889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRF  269 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf  269 (692)
                      +.+|+++||..||++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.8e-42  Score=354.21  Aligned_cols=256  Identities=27%  Similarity=0.457  Sum_probs=214.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|.+.+.||+|+||.||+|++..+++.||+|.++...  ......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            468999999999999999999999999999999986542  233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++....... .
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~---~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG---HVKLADFGVSAQITATIAK  162 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEECcceeeeEccCcccc
Confidence            9999999999999888999999999999999999999999999999999999998776   59999999987654322 2


Q ss_pred             CCccCCCCCccChHhhh---hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~---~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      .....|++.|+|||++.   ...++.++|||||||++|+|++|..||...........................++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            23457899999999974   456889999999999999999999999766544333322222111111111124678899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRF  269 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf  269 (692)
                      +++.+||+.||++|||+.++++|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=361.87  Aligned_cols=266  Identities=30%  Similarity=0.522  Sum_probs=231.9

Q ss_pred             eecCEEE-EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 005526            8 LIGEYIV-GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         8 ~~~~Y~i-~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~   85 (692)
                      +.+-|.+ .+.||+|+++.|--+....+|.+||||+|.+.  ....+.++.+|++++..+ .|+||++++++|+++.+.|
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY  152 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY  152 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence            3344555 46799999999999999999999999999876  455678999999999988 6999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      +|||-+.||+|...|+++..|+|.++..+++.|+.||+|||.+||.||||||+|||....+.-.-||||||.+.......
T Consensus       153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            99999999999999999999999999999999999999999999999999999999987665556999999987543211


Q ss_pred             --------CCCCccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhCCCCCCCC---------------CHH
Q 005526          166 --------DLADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGS---------------NQL  217 (692)
Q Consensus       166 --------~~~~~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG~~PF~~~---------------~~~  217 (692)
                              ....+.+|+..|||||+..     ...|+.++|.|||||+||-|+.|++||.|.               .+.
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN  312 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence                    1234568999999999863     356999999999999999999999999764               244


Q ss_pred             HHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          218 QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       218 ~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      .++..|.. ..+.||+..|..+|.+.+|++..+|.+|+.+|.++.++++|||++.....
T Consensus       313 ~LFesIQE-GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  313 KLFESIQE-GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHhc-cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            56666644 57899999999999999999999999999999999999999999876544

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-42  Score=353.44  Aligned_cols=257  Identities=29%  Similarity=0.561  Sum_probs=223.3

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|.+.+.||.|+||.||+|++..+++.||+|.+.... .......+.+|+.+++.++|+||+++++++..+..+|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            47999999999999999999999999999999987653 23344678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CCC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~~  168 (692)
                      |+++++|.+++... .+++..++.++.|++.||.|||++|++||||+|+||+++.++   .++|+|||+++..... ...
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~---~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG---DVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC---CEEEcccccceeeccccccc
Confidence            99999999999765 889999999999999999999999999999999999999877   5999999999876543 233


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ....+++.|+|||++.+..++.++|||||||++|+|++|++||...+.......+........+.   ..++.++.+++.
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~  232 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG---NKFSKPFKDFVS  232 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc---cccCHHHHHHHH
Confidence            45678899999999998889999999999999999999999998877666555554432222221   127889999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          249 CLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +||..||++|||++++++||||....
T Consensus       233 ~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         233 LCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             HHhhCChhhCcCHHHHhhChhhcCCC
Confidence            99999999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9e-42  Score=364.36  Aligned_cols=259  Identities=22%  Similarity=0.374  Sum_probs=212.1

Q ss_pred             EEeEeccc--CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           14 VGPRIGSG--SFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        14 i~~~LG~G--sFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      ++++||+|  +|++||+++++.+|+.||+|.+............+.+|+++++.++||||+++++++..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7899999999999999999999876555566678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC----
Q 005526           92 DGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----  165 (692)
Q Consensus        92 ~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~----  165 (692)
                      ++|+|.+++..+  ..+++..++.++.|++.||.|||++||+||||||+|||++.++   .++++|||........    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~---~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG---KVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC---cEEEcccchhhccccccccc
Confidence            999999999764  4589999999999999999999999999999999999998876   5899999875433211    


Q ss_pred             ----CCCCccCCCCCccChHhhhh--cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC------C-
Q 005526          166 ----DLADTLCGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF------P-  232 (692)
Q Consensus       166 ----~~~~~~~GT~~YmAPEvl~~--~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~------p-  232 (692)
                          .......++..|+|||++.+  ..|+.++|||||||++|+|++|+.||....................      + 
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                11123456778999999876  4689999999999999999999999987655444333322111000      0 


Q ss_pred             ----------------------------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          233 ----------------------------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       233 ----------------------------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                                                        ......+++++.+|+++||+.||++|||+.++++||||+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~  315 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  315 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence                                              0011235678999999999999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-41  Score=345.16  Aligned_cols=253  Identities=34%  Similarity=0.634  Sum_probs=222.5

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE--TREKIYLVL   88 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~--~~~~l~LVm   88 (692)
                      +|.+.+.||.|+||.||++.+..+++.||+|++..........+.+..|+++++.++||||+++++++.  .+..++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            589999999999999999999999999999999876666666778899999999999999999999875  356789999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCcccCCCCCceEecCCCCcCeEEEeccccc
Q 005526           89 EYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQ-----EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA  159 (692)
Q Consensus        89 Ey~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLH-----s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA  159 (692)
                      ||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+|+||||||+||+++.++   .+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~---~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN---NVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC---CEEEeccccc
Confidence            99999999999976    357899999999999999999999     99999999999999999876   5999999999


Q ss_pred             cccCCCCC-CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccc
Q 005526          160 RSLTPQDL-ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       160 ~~~~~~~~-~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~  238 (692)
                      ........ .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.......    ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~  233 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR----IPYR  233 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC----Cccc
Confidence            87764443 445678999999999998889999999999999999999999999888766666665443222    2346


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .+.++.+++.+||+.+|.+|||++++++|||+
T Consensus       234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         234 YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            78899999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=357.58  Aligned_cols=259  Identities=29%  Similarity=0.541  Sum_probs=224.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .+|.+.+.||+|+||+||+|.+..+++.||+|.+....... ...+.+.+|+++++.++||||+++++.+..++..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999997654432 35567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+.|++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++   .++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG---HIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC---CEEEeecchhhcccccc
Confidence            999999999999764  5689999999999999999999999999999999999999876   49999999987543211


Q ss_pred             ------------------------------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 005526          167 ------------------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ  216 (692)
Q Consensus       167 ------------------------------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~  216 (692)
                                                    ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          11234688999999999988899999999999999999999999998888


Q ss_pred             HHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCC----HHHHHhchhhhhhH
Q 005526          217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT----FKEFFNHRFLGELR  274 (692)
Q Consensus       217 ~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpT----a~elL~Hpf~~~~~  274 (692)
                      ...+.++... ...++..  ..++.++.+++.+||+.||++|||    ++++++||||+...
T Consensus       238 ~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         238 DETFSNILKK-EVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHHHHHhcC-CccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            7777666533 2223321  237899999999999999999999    99999999998654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.6e-42  Score=356.72  Aligned_cols=256  Identities=31%  Similarity=0.580  Sum_probs=210.9

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+............+.+|++++++++||||+++++++.+.+.+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            59999999999999999999999999999999976544444446678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CCC
Q 005526           91 CDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLA  168 (692)
Q Consensus        91 ~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~~  168 (692)
                      +.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++..... ...
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG---ELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC---cEEECccchhhccCCCCCCc
Confidence            975 78887765 46789999999999999999999999999999999999999876   5999999999765432 223


Q ss_pred             CccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccC---------------CC-
Q 005526          169 DTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTE---------------LR-  230 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF-~~~~~~~~~~~i~~~~~---------------~~-  230 (692)
                      ....+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+..+.....               .. 
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            345678999999998764 4789999999999999999988775 55554444443322110               00 


Q ss_pred             C---C-----CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          231 F---P-----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       231 ~---p-----~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +   +     ......+++++.+||++||+.||.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0   0     01123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.1e-42  Score=362.17  Aligned_cols=251  Identities=26%  Similarity=0.503  Sum_probs=196.1

Q ss_pred             EeEecccCceEEEEEEEcC--CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEec
Q 005526           15 GPRIGSGSFAVVWRARHRQ--LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET--REKIYLVLEY   90 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~~~l~LVmEy   90 (692)
                      +++||+|+||+||+|+++.  +++.||+|.+.....    ...+.+|++++++++||||+++++.+..  +..+|+||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            5789999999999999763  678999999865432    2456789999999999999999998853  5678999999


Q ss_pred             cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCC-CCcCeEEEecccccc
Q 005526           91 CDGGDLAAYIHKH---------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTN-EVTPVLKIGDFGFAR  160 (692)
Q Consensus        91 ~~GGsL~~~L~~~---------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~-~~~~~vKL~DFGlA~  160 (692)
                      +.+ +|..++...         ..+++..++.++.||+.||+|||++||+||||||+|||+..+ .....+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            965 888887632         248999999999999999999999999999999999999543 223369999999998


Q ss_pred             ccCCCC----CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHhc
Q 005526          161 SLTPQD----LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQ---------LQLFQNILTS  226 (692)
Q Consensus       161 ~~~~~~----~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~---------~~~~~~i~~~  226 (692)
                      ......    ......||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+...         ...+.++...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            754321    2345688999999999876 4589999999999999999999999975432         1112222111


Q ss_pred             cCCC----------CC-----------------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          227 TELR----------FP-----------------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       227 ~~~~----------~p-----------------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ....          .+                       .......+.++.+||++||+.||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0000          00                       00011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-42  Score=383.02  Aligned_cols=264  Identities=39%  Similarity=0.711  Sum_probs=243.8

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      ..+.++-|.+.+.||+|.|++|.+|++..++..||||+|++...+....+.+.+|+++|+.++|||||+++.+.+....+
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            34678899999999999999999999999999999999999988888888899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      |+||||+.+|.+++++.+++.+.+..++.++.|++.+++|||+++|||||||++||||+.+.+   +||+|||++..+..
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn---ikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN---IKIADFGFSTFFDY  207 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc---eeeeccccceeecc
Confidence            999999999999999999999999999999999999999999999999999999999998875   99999999999998


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys-~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      .....+.||++.|.|||++.+..|+ +.+|+||+|++||-|+.|..||++.+-.++....+.+ .+++|    ..++.+|
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g-k~rIp----~~ms~dc  282 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG-KYRIP----FYMSCDC  282 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-eeccc----ceeechh
Confidence            8999999999999999999998884 7899999999999999999999998877766665543 23333    4678899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      .++|+++|..+|.+|++.++++.|+|.......
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999999999766544

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.3e-41  Score=345.84  Aligned_cols=253  Identities=31%  Similarity=0.623  Sum_probs=223.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|++.+.||+|+||.||++++..+|+.||+|.+............+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            69999999999999999999999999999999976555555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           91 CDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        91 ~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      +.+++|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++   .++|+|||++....... .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG---TIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC---CEEEeeccceeecCcchhh
Confidence            99999999997643  578999999999999999999999999999999999998776   59999999997654332 2


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+...++..+.....    ...++.++.++|
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li  233 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV----SSHYSYDLRNLV  233 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC----cccCCHHHHHHH
Confidence            2345688999999999988899999999999999999999999998888777777765543222    246788999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .+||+.+|.+||++.+++.||||
T Consensus       234 ~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         234 SQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHhhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-41  Score=351.93  Aligned_cols=257  Identities=32%  Similarity=0.616  Sum_probs=218.7

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.++++++||||+++++++..+..+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            69999999999999999999999999999999987655555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--C
Q 005526           91 CDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--L  167 (692)
Q Consensus        91 ~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--~  167 (692)
                      + +++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++   .++|+|||++.......  .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~---~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG---VLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC---cEEEeeeeecccccCCCCCc
Confidence            9 99999998754 5689999999999999999999999999999999999999876   59999999998765433  2


Q ss_pred             CCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----------------
Q 005526          168 ADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR----------------  230 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~----------------  230 (692)
                      .....|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+.......                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            3345789999999998654 46899999999999999999999998887766655544321110                


Q ss_pred             --CCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          231 --FPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       231 --~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                        ++.       ......+.++.++|++||..||.+|||++++++||||.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              110       11134578899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-41  Score=347.18  Aligned_cols=254  Identities=27%  Similarity=0.560  Sum_probs=216.9

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC----ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL----SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~----~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      +|++++.||.|+||+||+|.+. +|+.+|+|.+.....    .......+.+|+++++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            6899999999999999999874 689999999875432    22344668899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC--
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP--  164 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~--  164 (692)
                      |+||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++   .+||+|||++.....  
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG---IIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC---eEEeccchhhHhhhhcc
Confidence            999999999999999888899999999999999999999999999999999999998776   599999999876431  


Q ss_pred             -----CCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          165 -----QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       165 -----~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                           ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... . .+.....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~~  234 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG-L-MPRLPDSF  234 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-C-CCCCCCCC
Confidence                 1223345789999999999998999999999999999999999999988766554444432211 1 12233467


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +.++.++|++||+++|.+||++.+++.||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.2e-42  Score=349.99  Aligned_cols=253  Identities=27%  Similarity=0.511  Sum_probs=221.2

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      +|.+.+.||.|+||.||+|.+..+++.||+|++.+... .....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999976543 23556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD  169 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~  169 (692)
                      |+.|++|..++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++   .++|+|||++..........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG---HVHITDFNIATKVTPDTLTT  157 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC---CEEEeecccccccCCCcccc
Confidence            999999999998888899999999999999999999999999999999999999877   59999999998766554445


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ--LQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~--~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ...|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.  ...+..........    .....+.++.++|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i  233 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL----YPATWSTEAIDAI  233 (258)
T ss_pred             ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc----CcccCcHHHHHHH
Confidence            56788999999999988899999999999999999999999988764  22222222222222    2245779999999


Q ss_pred             HHhhccCCCCCCCH--HHHHhchhh
Q 005526          248 RCLLRQNPVERITF--KEFFNHRFL  270 (692)
Q Consensus       248 ~~~L~~DP~~RpTa--~elL~Hpf~  270 (692)
                      ++||..||.+||++  +|+++||||
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=352.33  Aligned_cols=257  Identities=31%  Similarity=0.572  Sum_probs=221.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.++||.|+||+||++.+..++..||+|.+...  .....+.+.+|++++++++||||+++++.+..+...|+|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            5799999999999999999999989999999998654  34445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CC
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~  167 (692)
                      |+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++...... ..
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~---~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG---DVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC---CEEEccCccchhhcccccc
Confidence            99999999998774 4689999999999999999999999999999999999998876   5999999998665332 22


Q ss_pred             CCccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          168 ADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      .....|++.|+|||++.     ...++.++|||||||++|+|++|++||...+..+.+.++.......+.  ....++.+
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  237 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD--QPSKWSSS  237 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC--CcccCCHH
Confidence            34457899999999985     345778999999999999999999999988877766666544322221  12357889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +.+++.+||+.||.+||++.++++||||...
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=385.36  Aligned_cols=255  Identities=27%  Similarity=0.510  Sum_probs=227.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      +-|.|...||.|+||+||+|.++.++-..|.|+|..+  .....+.++-|++||..+.||+||+|++.|+.++.+||+.|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            4578889999999999999999999999999998654  45667788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCC
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~  167 (692)
                      ||.||-....+-.- ..++|.++..+++|++.||.|||+++|||||||..|||++-+|+   |+|+|||.+.... ....
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---EeeecccccccchhHHhh
Confidence            99999998887654 56899999999999999999999999999999999999999985   9999999875433 3345


Q ss_pred             CCccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          168 ADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      .+++.|||+|||||++.     ..+|+.++||||||++|.||..+.+|-...+....+-+|.+..+...-  .+...+..
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl--qPS~Ws~~  264 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL--QPSHWSRS  264 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc--CcchhhhH
Confidence            67899999999999864     578999999999999999999999999999999988888776544332  12467889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                      |.||+.+||.+||..||++.+||.|||++
T Consensus       265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             HHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            99999999999999999999999999997

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.8e-41  Score=342.34  Aligned_cols=254  Identities=34%  Similarity=0.598  Sum_probs=220.9

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL---SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~---~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      +|+..+.||+|+||+||+|.+..+++.|++|.+.....   ..+..+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            58889999999999999999998999999999865432   234567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      +||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+|+||+|+||+++.++   .+||+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~---~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG---VVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEccCccceecccccc
Confidence            99999999999999888899999999999999999999999999999999999998876   599999999987655444


Q ss_pred             CCccCCCCCccChHhhhhcC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~-ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      .....|++.|++||.+.... ++.++|+|||||++|+|++|+.||..........++......   +.....+++++.++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l  234 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---PPIPDHLSDEAKDF  234 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---CCcCCCcCHHHHHH
Confidence            45677899999999987766 899999999999999999999999877755555444332211   22234678999999


Q ss_pred             HHHhhccCCCCCCCHHHHHhchhh
Q 005526          247 CRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +.+||..+|.+||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=351.65  Aligned_cols=258  Identities=29%  Similarity=0.561  Sum_probs=219.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.+.||+|+||.||+|.+..+++.||||.++...........+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            57999999999999999999999999999999997665555566788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--C
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--L  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--~  167 (692)
                      |++++.+..++.+...+++..++.++.||+.||.|||++||+||||+|+||+++.++   .+||+|||++.......  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~---~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG---VLKLCDFGFARALRARPASP  157 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---CEEEEeeecccccCCCcccc
Confidence            999988877777777799999999999999999999999999999999999999876   59999999998765443  3


Q ss_pred             CCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------------
Q 005526          168 ADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE------------------  228 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~------------------  228 (692)
                      .....++..|+|||++... .++.++||||||+++|+|++|++||.+.+.......+.....                  
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            3456788999999999887 889999999999999999999999988765544333221000                  


Q ss_pred             CCCCC---------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          229 LRFPP---------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       229 ~~~p~---------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ..++.         .....++.++.+||++||..||++|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00000         0112347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=376.66  Aligned_cols=257  Identities=31%  Similarity=0.632  Sum_probs=235.2

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      .+.||.|-||+||-|+++++|+.||||+|.+-++..+....+..|+.||+++.||+||.+--.|++.+++++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            46899999999999999999999999999998888888899999999999999999999999999999999999999774


Q ss_pred             CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCC
Q 005526           95 DLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG  173 (692)
Q Consensus        95 sL~~~L~-~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~G  173 (692)
                      =|+..|. +.++++|...+.++.||+.||.|||.+||+|+||||+|||+.....-+++||||||+||.+.......+.+|
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence            4444443 468899999999999999999999999999999999999999888888999999999999998888999999


Q ss_pred             CCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhcc
Q 005526          174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ  253 (692)
Q Consensus       174 T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~  253 (692)
                      ||.|+|||++++++|+..-|+||+|||+|--+.|..||....+  +.+. +.+..+-+|+..|.+++++++|||..+|+.
T Consensus       729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQ-IQNAaFMyPp~PW~eis~~AidlIn~LLqV  805 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQ-IQNAAFMYPPNPWSEISPEAIDLINNLLQV  805 (888)
T ss_pred             CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHH-hhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999976543  2222 344577789999999999999999999999


Q ss_pred             CCCCCCCHHHHHhchhhhhhH
Q 005526          254 NPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       254 DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      .-.+|.+....|.|||+++..
T Consensus       806 km~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  806 KMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHhcchHhhccchhhhcch
Confidence            999999999999999998763

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.7e-41  Score=348.35  Aligned_cols=253  Identities=27%  Similarity=0.522  Sum_probs=212.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe------C
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET------R   81 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~------~   81 (692)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++....   .....+.+|+.+++++ +||||+++++++..      .
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            467999999999999999999999999999999986542   2245778899999998 79999999999865      2


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccc
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA  159 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA  159 (692)
                      ..+|+||||+.+++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~---~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA---EVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC---CEEEccCCCc
Confidence            4689999999999999999864  4589999999999999999999999999999999999999877   5999999999


Q ss_pred             cccCCC-CCCCccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 005526          160 RSLTPQ-DLADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP  233 (692)
Q Consensus       160 ~~~~~~-~~~~~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~  233 (692)
                      +..... .......|++.|+|||++.     ...|+.++|||||||++|+|++|..||...........+....   .+.
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~  235 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---APR  235 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC---CCC
Confidence            765432 2334567899999999986     3468889999999999999999999998766555444433322   111


Q ss_pred             CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       234 ~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ......+.++.+|+.+||..||.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            2223567899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-41  Score=371.48  Aligned_cols=256  Identities=25%  Similarity=0.354  Sum_probs=210.2

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcC--CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQ--LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      .+..+|.+++.||+|+||.||++....  +++.||+|.+...       ....+|+++++.++||||+++++++.....+
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            455689999999999999999997643  5688999988543       2345799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      |+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~---~~~l~DfG~a~~~~~  237 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE---NAVLGDFGAACKLDA  237 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC---CEEEccCccccccCc
Confidence            99999996 58999998788899999999999999999999999999999999999999877   599999999976543


Q ss_pred             CCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc---cCCCCCC--
Q 005526          165 QDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ---LQLFQNILTS---TELRFPP--  233 (692)
Q Consensus       165 ~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~---~~~~~~i~~~---~~~~~p~--  233 (692)
                      ...   .....||+.|+|||++....|+.++|||||||++|+|++|+.||.+...   ...+..+...   ....++.  
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            322   2346799999999999999999999999999999999999999976532   1122222111   1111110  


Q ss_pred             ----------------------C--cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          234 ----------------------G--AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       234 ----------------------~--~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                            .  ....++.++.+||.+||..||++|||+.++|+||||.+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                                  0  012346788999999999999999999999999999654

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3e-41  Score=351.47  Aligned_cols=252  Identities=29%  Similarity=0.506  Sum_probs=213.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.+.||+|+||+||+|++..+++.||+|.+.... .......+.+|++++++++||||+++++.+...+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            47889999999999999999999999999999986543 34455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD  169 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~  169 (692)
                      |+++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+|||++.++   .+||+|||++...... ...
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~---~~~l~dfg~~~~~~~~-~~~  151 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG---QVKLCDFGVSTQLVNS-IAK  151 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC---CEEEeeCCcceecccc-ccc
Confidence            9999999754    3678999999999999999999999999999999999999877   5999999999765432 344


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCCCCCCCcccccCHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ-------LQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~-------~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      ..+|++.|+|||++.+..++.++|+|||||++|+|++|+.||.....       ......+........   .....+++
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  228 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL---PVGQFSEK  228 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC---CCCcCCHH
Confidence            56899999999999998999999999999999999999999965321       122222222211111   12357889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +.+++.+||+.||++||++++++.||||...
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            9999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9e-41  Score=351.81  Aligned_cols=259  Identities=27%  Similarity=0.504  Sum_probs=221.1

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ....+|.+.+.||+|+||.||+|++..+++.|++|.+......  ....+.+|+.+++.++||||+++++.+..+...|+
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            3467999999999999999999999999999999999765433  24678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||||++|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+||+++.++   .+||+|||++.......
T Consensus        95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~---~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC---CEEECccccchhccccc
Confidence            9999999999999865 4689999999999999999999999999999999999998776   59999999987654332


Q ss_pred             -CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 -LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 -~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                       ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+......  +......++..+.+
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  248 (296)
T cd06654         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--ELQNPEKLSAIFRD  248 (296)
T ss_pred             cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC--CCCCccccCHHHHH
Confidence             223457899999999999888999999999999999999999999887765444333322211  11123467889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ++.+||.+||++|||+.+++.||||...
T Consensus       249 li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         249 FLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.2e-41  Score=353.06  Aligned_cols=260  Identities=27%  Similarity=0.519  Sum_probs=220.6

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..+.|+++++||.|+||.||+|++..+++.|++|.+...  .......+.+|+.+++.++||||+++++.+..++.+|+|
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            346799999999999999999999999999999998654  445567788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-
Q 005526           88 LEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-  165 (692)
                      |||++|++|..++.+ ...+++..++.++.||+.+|.|||++||+||||||+||+++.++   .+||+|||++...... 
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG---DIKLADFGVSAKNVKTL  164 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC---CEEEccCccceeccccc
Confidence            999999999988765 45689999999999999999999999999999999999998776   5999999998754322 


Q ss_pred             CCCCccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          166 DLADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      .......+++.|+|||++.     ...++.++|||||||++|+|++|.+||...+......++........  .....++
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  242 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--SQPSKWS  242 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC--CCCcccC
Confidence            2234456889999999884     34578899999999999999999999988776665555543322111  1224577


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      .++.+++.+||..||++||+++++++||||..+.
T Consensus       243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            8999999999999999999999999999997654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-43  Score=401.90  Aligned_cols=283  Identities=25%  Similarity=0.464  Sum_probs=241.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .++|.|++.||+|+||.|.+++++.+++.||+|++.+-.. .......|+.|-.||..-+.+.|++++..|.+++++|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            3689999999999999999999999999999999976322 233346788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      |||++||||..++.+.++++|+.++.|+..|+.||+-||+.|+|||||||+||||+..|+   |||+|||.+-.+..+..
T Consensus       154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH---ikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH---IKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc---EeeccchhHHhcCCCCc
Confidence            999999999999999999999999999999999999999999999999999999999985   99999999877764443


Q ss_pred             --CCccCCCCCccChHhhhh-----cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCCCCccccc
Q 005526          168 --ADTLCGSPLYMAPEIIQN-----HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS-TELRFPPGAIEEL  239 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~-----~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~-~~~~~p~~~~~~l  239 (692)
                        ....+|||-|++||+++.     +.|+..+|+||+||++|||+.|..||...+..+++.+|+.. ..+.||+.  ..+
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~--~~V  308 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE--TDV  308 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc--ccc
Confidence              456789999999999963     56899999999999999999999999999999999999865 35677743  359


Q ss_pred             CHHHHHHHHHhhccCCCCCCC---HHHHHhchhhhhhHhhh-hhhccccCCCCCchhcccCC
Q 005526          240 HPDCVDLCRCLLRQNPVERIT---FKEFFNHRFLGELRQTV-HAEQHSVVPETKPMVELLNS  297 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpT---a~elL~Hpf~~~~~~~~-~~~~~~~~p~~~~~~e~~~~  297 (692)
                      |.+.+|||++++. +|+.|..   ++++.+||||.++.+.- .....+.+|+.....+..+.
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF  369 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF  369 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence            9999999999886 6789998   99999999998876632 22234444444433333333

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.4e-41  Score=343.61  Aligned_cols=252  Identities=28%  Similarity=0.547  Sum_probs=217.7

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|.+.+.||.|+||.||+|++..+++.|++|.+....    ....+.+|++++++++||||+++++.+..+..+|+++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            68999999999999999999999889999999986542    26788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           90 YCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        90 y~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      |+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||+|+||+++.++   .+||+|||++....... .
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~---~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG---QAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC---cEEEcccccchhcccCccc
Confidence            9999999999976 45689999999999999999999999999999999999999877   59999999998765433 3


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.......+  .....++.++.+++
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i  233 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL--SDPEKWSPEFNDFV  233 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCC--CchhhcCHHHHHHH
Confidence            3445688999999999999999999999999999999999999988766554443322211111  12235678999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .+||+.||++|||+.+++.||||
T Consensus       234 ~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.7e-41  Score=341.26  Aligned_cols=256  Identities=33%  Similarity=0.570  Sum_probs=224.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.+.||.|+||.||+|.+..+++.|+||++...... .....+.+|+.++.+++|+||+++++++...+.+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            4799999999999999999999999999999999765432 456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++   .++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~---~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG---EVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC---CEEEccCccceecccCCCc
Confidence            99999999999988899999999999999999999999 9999999999999998877   5999999999876543332


Q ss_pred             -CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCCCCCcccc-cCHHH
Q 005526          169 -DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTELRFPPGAIEE-LHPDC  243 (692)
Q Consensus       169 -~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~---~~~~~~~~i~~~~~~~~p~~~~~~-ls~el  243 (692)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...   ...+....+........+    .. ++..+
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l  232 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP----AEEFSPEF  232 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCC----cccCCHHH
Confidence             3567889999999999999999999999999999999999999877   444555555433322222    23 78899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      .+++++||..+|++||++.++++|||++..
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.9e-41  Score=349.34  Aligned_cols=263  Identities=31%  Similarity=0.569  Sum_probs=217.7

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      +++|++.++||+|+||+||+|.++.+|+.||+|.+............+.+|++++++++||||+++++++..++.+|+||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            36899999999999999999999999999999998765444445567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-
Q 005526           89 EYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-  165 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~--lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-  165 (692)
                      ||+++ +|.+++.....  +++..++.++.||+.||+|||++||+||||||+||+++.++.  .+||+|||++...... 
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~--~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPV  157 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC--EEEEcccccccccCCCc
Confidence            99965 88888866543  588999999999999999999999999999999999986543  5899999999765332 


Q ss_pred             CCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------------
Q 005526          166 DLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR--------------  230 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~--------------  230 (692)
                      .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+....+.++.......              
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence            22234567899999999866 457899999999999999999999999887766655543211100              


Q ss_pred             ------CCC----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          231 ------FPP----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       231 ------~p~----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                            ++.    ......++++.+++.+||+.||++||++.+++.||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                  000    01235678899999999999999999999999999998764

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.7e-41  Score=354.37  Aligned_cols=265  Identities=32%  Similarity=0.533  Sum_probs=219.0

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--E   82 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~--~   82 (692)
                      +.+-+++|.+.+.||+|+||+||+|.+..+|+.||+|.+............+.+|+.++++++|+||+++++++...  +
T Consensus         2 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             CcccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            34568899999999999999999999999999999999976543333344567899999999999999999998654  5


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      .+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++   .+||+|||+++.
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~---~~kL~dfg~~~~  157 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG---CLKIADFGLART  157 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEECccceeee
Confidence            78999999975 888888763 6789999999999999999999999999999999999998876   599999999987


Q ss_pred             cCCCC-CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----------
Q 005526          162 LTPQD-LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL----------  229 (692)
Q Consensus       162 ~~~~~-~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~----------  229 (692)
                      ..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......          
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            65332 2233456788999999865 56789999999999999999999999998887777666542111          


Q ss_pred             --------CCCCC-------cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          230 --------RFPPG-------AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       230 --------~~p~~-------~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                              ..+..       .....++++.+||.+||+.||++|||+++++.||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                    00100       012357889999999999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.8e-41  Score=347.82  Aligned_cols=256  Identities=32%  Similarity=0.589  Sum_probs=220.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.+.||+|+||.||++.++.+++.||+|.+..... ......+.+|++++++++||||+++++.+...+.+++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            578999999999999999999999999999999876533 3556778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      |+.+++|.+++... ..+++..++.++.|++.||.|||+ .|++||||||+||+++.++   .+||+|||.+....... 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~---~~~l~d~g~~~~~~~~~-  155 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG---QIKLCDFGVSGQLVNSL-  155 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC---CEEEeecccchhhHHHH-
Confidence            99999999999876 789999999999999999999999 9999999999999999876   59999999987654322 


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS-----NQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~-----~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|..||...     ...+....+........+.   ..++.+
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (265)
T cd06605         156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS---GKFSPD  232 (265)
T ss_pred             hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh---hhcCHH
Confidence            22377889999999999999999999999999999999999999765     2333444444333222222   127889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +.++|.+||..||++|||+.+++.||||+..
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.3e-41  Score=346.06  Aligned_cols=257  Identities=29%  Similarity=0.553  Sum_probs=218.0

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC--------ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL--------SPKVSDNLLKEISILSTISHPNIIRFFEAIETRE   82 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~--------~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~   82 (692)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+.....        .....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68999999999999999999999999999998864211        1123456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      ..++||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++   .+||+|||+++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~---~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG---ICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC---eEEEeeccccccc
Confidence            9999999999999999999888999999999999999999999999999999999999998776   6999999999765


Q ss_pred             CCCC---CCCccCCCCCccChHhhhhcC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCCCCcc
Q 005526          163 TPQD---LADTLCGSPLYMAPEIIQNHK--YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS-TELRFPPGAI  236 (692)
Q Consensus       163 ~~~~---~~~~~~GT~~YmAPEvl~~~~--ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~-~~~~~p~~~~  236 (692)
                      ....   ......|+..|+|||.+....  ++.++|+||||+++|+|++|..||...+.......+... ....++....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS  238 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence            3221   233456889999999987654  889999999999999999999999876665444433322 2333444444


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ..++.++.+++.+||.+||.+|||++++++|||+
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            5678999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.5e-41  Score=345.28  Aligned_cols=255  Identities=26%  Similarity=0.495  Sum_probs=215.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS---PKVSDNLLKEISILSTISHPNIIRFFEAIET--REKI   84 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~---~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~~~l   84 (692)
                      .+|.+.+.||+|+||.||+|.+..+++.|++|.+......   .+....+.+|+.++++++||||+++++++..  +..+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4789999999999999999999999999999998654322   2345678889999999999999999998865  4678


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ++++||+++++|.+++...+.+++...+.++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~---~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG---NVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC---CEEEccCCCcccccc
Confidence            99999999999999998888899999999999999999999999999999999999998776   599999999876532


Q ss_pred             C----CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          165 Q----DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       165 ~----~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      .    .......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+....   ..+.....++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP---TNPQLPSHIS  235 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC---CCCCCchhcC
Confidence            1    11233568899999999998889999999999999999999999998876655554443222   1222234567


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                      +.+.+++ +||..+|++||+++|+++||||+
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            8899999 57778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.5e-41  Score=347.50  Aligned_cols=256  Identities=28%  Similarity=0.514  Sum_probs=210.6

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI-LSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~i-L~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|++.+.||+|+||.||++++..+|+.||||.+........ ...+..|+.+ ++.++||||+++++++..++.+|++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            479999999999999999999999999999999976544333 3445556665 66779999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           89 EYCDGGDLAAYIHKH----GKVSEAVARHFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~----~~lse~~i~~il~QLl~gL~yLHs~-gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      ||++ |+|.+++...    ..+++..++.++.||+.||.|||++ +++||||||+||+++.++   .+||+|||+++...
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~---~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG---QVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC---CEEEeecccccccc
Confidence            9997 4888877642    4689999999999999999999997 999999999999998877   59999999998765


Q ss_pred             CCCCCCccCCCCCccChHhhhh----cCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCCCCCcccc
Q 005526          164 PQDLADTLCGSPLYMAPEIIQN----HKYDAKADLWSVGAILFQLVTGKPPFDGS-NQLQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       164 ~~~~~~~~~GT~~YmAPEvl~~----~~ys~ksDIWSLGviLyeLltG~~PF~~~-~~~~~~~~i~~~~~~~~p~~~~~~  238 (692)
                      .........|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||... ...+.+..+.......++.   ..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~  232 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA---EK  232 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc---cc
Confidence            4333344678899999998864    45788999999999999999999999753 2233344443333333322   35


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ++.++.++|.+||..+|.+||++.+++.||||...
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            78899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-40  Score=341.01  Aligned_cols=255  Identities=33%  Similarity=0.631  Sum_probs=219.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|.+.+.||+|+||.||++.+..+++.|++|.+............+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            69999999999999999999998999999999987665556778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC---
Q 005526           91 CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL---  167 (692)
Q Consensus        91 ~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~---  167 (692)
                      +++++|.+++.....+++..++.++.|++.||.|||++||+|+||+|+||+++.++   .+||+|||++........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~---~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG---VIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEcccccccccCCCCCccc
Confidence            99999999998887899999999999999999999999999999999999999876   599999999977643322   


Q ss_pred             --CCccCCCCCccChHhhhhcC---CCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCCCCCcccccCH
Q 005526          168 --ADTLCGSPLYMAPEIIQNHK---YDAKADLWSVGAILFQLVTGKPPFDGSN-QLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~~~---ys~ksDIWSLGviLyeLltG~~PF~~~~-~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                        .....+++.|+|||++....   ++.++||||||+++|+|++|+.||.... .......+.......+|.  ....++
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  235 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD--SLQLSP  235 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc--ccccCH
Confidence              22356889999999998766   8899999999999999999999997663 333333333322222332  234588


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .+.+++++||+.||.+|||+.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-40  Score=343.29  Aligned_cols=254  Identities=26%  Similarity=0.521  Sum_probs=216.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL---SPKVSDNLLKEISILSTISHPNIIRFFEAIET--REKI   84 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~---~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~~~l   84 (692)
                      .+|.+++.||+|+||.||++.+..+++.||||.+.....   .......+.+|+.++++++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999999864322   23345678899999999999999999998865  3578


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ++||||++|++|.+++.+...+++..+..++.|++.||.|||++||+|+||||+||+++.++   .+||+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~---~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG---NVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC---CEEECcCcccccccc
Confidence            89999999999999999888899999999999999999999999999999999999998776   599999999876532


Q ss_pred             C----CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          165 Q----DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       165 ~----~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      .    .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........+..+.....   .+.....++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  235 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT---NPVLPPHVS  235 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC---CCCCchhhC
Confidence            1    122345688999999999888899999999999999999999999988766655554433221   122334677


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ..+.+++++||. +|++||++++++.|||+
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            889999999995 99999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-41  Score=368.42  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=203.6

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .+|++.+.||+|+||+||+|++..+++.||+|+....        ....|+.++++++||||+++++++..++..++|||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            5699999999999999999999999999999975432        23468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           90 YCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++........
T Consensus       138 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        138 HYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             ccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEEecCccccccccCccc
Confidence            9965 88888765 45689999999999999999999999999999999999998877   5999999999765444444


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHH---------HHHHHHHhcc---CCCCCC--
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG-KPPFDGSNQL---------QLFQNILTST---ELRFPP--  233 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG-~~PF~~~~~~---------~~~~~i~~~~---~~~~p~--  233 (692)
                      ....||+.|+|||++.+..|+.++|||||||++|||+++ .++|......         ..+.++....   ...++.  
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            567899999999999999999999999999999999985 4444432111         1111111110   001110  


Q ss_pred             ------------------------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          234 ------------------------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       234 ------------------------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                                              .....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                    001244667888999999999999999999999999975

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-40  Score=351.60  Aligned_cols=258  Identities=29%  Similarity=0.539  Sum_probs=222.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ..+|.+.+.||.|+||+||++.+..+++.|++|.+......  ..+.+.+|+++++.++||||+++++++..++.+|+|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            46799999999999999999999999999999999765332  3467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-  167 (692)
                      ||+++++|..++... .+++..+..++.|++.||.|||++|++||||||+||+++.++   .+||+|||++........ 
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~---~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG---SVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEccCccchhccccccc
Confidence            999999999988654 689999999999999999999999999999999999998876   599999999876554332 


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+.......  ......+++.+.++|
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li  249 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE--LQNPEKLSPIFRDFL  249 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc--cCCcccCCHHHHHHH
Confidence            334578999999999998889999999999999999999999999887765555444322111  122346788999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          248 RCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      ++||..||.+|||+.+++.||||...+
T Consensus       250 ~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         250 NRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            999999999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.9e-41  Score=341.51  Aligned_cols=254  Identities=35%  Similarity=0.637  Sum_probs=220.8

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|.+.+.||+|+||.||++.++.+|..||+|.+..........+.+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            58999999999999999999999999999999976544444556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           91 CDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        91 ~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      +++++|.+++....  .+++..+..++.|++.||.|||+++|+|+||||+||+++.++.  .+||+|||.+....... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM--VAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC--eEEecccccchhccCCccc
Confidence            99999999997654  4799999999999999999999999999999999999987653  57999999997664332 2


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+.......    .....+.++.+++
T Consensus       159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i  234 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP----ISPNFSRDLRSLI  234 (257)
T ss_pred             ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC----CCCCCCHHHHHHH
Confidence            334568999999999988889999999999999999999999999887766666554432211    2235678999999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .+||..+|++|||+.++++||||
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-41  Score=351.58  Aligned_cols=259  Identities=29%  Similarity=0.533  Sum_probs=217.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++++.||+|+||+||++++..+++.||+|.+... ........+.+|+.++++++||||+++++.+..++.+|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            4799999999999999999999999999999998654 344445788899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           90 YCDGGDLAAYIHKH---GKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        90 y~~GGsL~~~L~~~---~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |++|++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++   .+||+|||++..... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~-  155 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG---QVKLCDFGVSGNLVA-  155 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC---CEEEeecCCcccccC-
Confidence            99999999998764   378999999999999999999997 5999999999999999866   599999999876532 


Q ss_pred             CCCCccCCCCCccChHhhhhc------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          166 DLADTLCGSPLYMAPEIIQNH------KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~~------~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      .......+++.|+|||++.+.      .++.++|||||||++|+|++|+.||...........+...... .++.....+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (286)
T cd06622         156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPSGY  234 (286)
T ss_pred             CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCCccc
Confidence            234456788999999998543      3578999999999999999999999776554443332221111 122233458


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +.++.+|+.+||+.+|.+||++.++++||||...+
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            89999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.5e-41  Score=352.16  Aligned_cols=259  Identities=31%  Similarity=0.544  Sum_probs=218.1

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS---PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~---~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      +|.+.+.||+|+||.||+|.+..+|+.||||.+......   ......+..|++++++++|+||+++++++..++.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999999765443   34456678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-
Q 005526           88 LEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-  165 (692)
                      |||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++..... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~---~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG---VLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC---CEEEccceeeeeccCCC
Confidence            9999 889999998776 799999999999999999999999999999999999999876   5999999999876543 


Q ss_pred             CCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------------
Q 005526          166 DLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF-------------  231 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~-------------  231 (692)
                      .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+.++........             
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence            22334457888999999864 4578899999999999999999999988877666555543211000             


Q ss_pred             ------C----CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          232 ------P----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       232 ------p----~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                            +    .......+.++.++|.+||++||++|||+.+++.|+||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence                  0    01123457889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.8e-41  Score=361.15  Aligned_cols=261  Identities=26%  Similarity=0.493  Sum_probs=218.5

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----   81 (692)
                      .+.++|.+.+.||+|+||+||+|++..+|+.||||.+.+..........+.+|+.++++++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            467899999999999999999999999999999999876544455556788899999999999999999988543     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                       ...|+||||+.+ +|.+.+...  +++..++.++.|++.||+|||++||+||||||+||+++.++   .+||+|||+++
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~---~~kL~Dfg~~~  166 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLAR  166 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC---CEEEccCccce
Confidence             357999999975 888888654  89999999999999999999999999999999999999877   59999999998


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR----------  230 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~----------  230 (692)
                      ............+++.|+|||++.+..++.++|||||||++|+|++|+.||...+....+.++.......          
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            7665544455678999999999999999999999999999999999999999887665555443211000          


Q ss_pred             -------------------------CCCCc---ccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          231 -------------------------FPPGA---IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       231 -------------------------~p~~~---~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                               ++...   ....+..+.++|.+||+.||.+|||+.|+|.||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                                     00000   11345678999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1e-40  Score=351.59  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=206.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC----------------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcc
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ----------------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII   72 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~----------------tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIV   72 (692)
                      .++|++.++||+|+||+||+|.+..                ++..||+|.+.... .......+.+|++++.+++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence            4789999999999999999998532                34579999987542 344567789999999999999999


Q ss_pred             eEEEEEEeCCEEEEEEeccCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCccc
Q 005526           73 RFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-------------------KVSEAVARHFMRQLAAGLQVLQEKHLIHR  133 (692)
Q Consensus        73 kl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~-------------------~lse~~i~~il~QLl~gL~yLHs~gIVHR  133 (692)
                      ++++++...+..++||||+++|+|.+++....                   .+++..+..++.||+.||.|||++||+||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999999999999999986542                   35778899999999999999999999999


Q ss_pred             CCCCCceEecCCCCcCeEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh--CC
Q 005526          134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT--GK  208 (692)
Q Consensus       134 DLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt--G~  208 (692)
                      ||||+|||++.++   .+||+|||+++......   ......+++.|+|||++....++.++|||||||++|+|++  +.
T Consensus       163 dlkp~Nill~~~~---~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         163 DLATRNCLVGENL---TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             CcchhheEEcCCc---cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999876   59999999998654332   2234456788999999998899999999999999999986  67


Q ss_pred             CCCCCCCHHHHHHHHHhc---cCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHH
Q 005526          209 PPFDGSNQLQLFQNILTS---TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFF  265 (692)
Q Consensus       209 ~PF~~~~~~~~~~~i~~~---~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL  265 (692)
                      .||.+.+..+.+.++...   .............+..+.+|+.+||+.||.+|||+.++.
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            889887766655443221   111111112235678999999999999999999999983

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.3e-41  Score=349.33  Aligned_cols=254  Identities=29%  Similarity=0.549  Sum_probs=217.5

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      |++.++||.|+||.||++.+..++..+++|.+...  .......+.+|+++++.++||||+++++++..++..|+||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            68889999999999999999999999999998654  3445567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CCCC
Q 005526           92 DGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLAD  169 (692)
Q Consensus        92 ~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~~~  169 (692)
                      ++++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++   .+||+|||++...... ....
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~---~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG---DIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC---CEEEccccccccccccccccc
Confidence            99999998765 45789999999999999999999999999999999999998876   5999999998765322 2234


Q ss_pred             ccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          170 TLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      ...+++.|+|||++.     +..++.++|||||||++|+|++|++||...+..+...++........+  ....++.++.
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  239 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA--QPSRWSSEFK  239 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC--CccccCHHHH
Confidence            567899999999984     455788999999999999999999999988877666665544322211  2235688999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      +||.+||+.||.+||++.++++||||..
T Consensus       240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         240 DFLKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCCCEec
Confidence            9999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.9e-41  Score=350.68  Aligned_cols=258  Identities=28%  Similarity=0.562  Sum_probs=217.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47999999999999999999999899999999987654444455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~  168 (692)
                      |++++.|..+....+.+++..++.++.||+.||.|||++||+||||+|+||+++.++   .+||+|||++....... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~---~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG---VVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---cEEEEeeeeeeeccCCcccc
Confidence            999999998887777799999999999999999999999999999999999998877   59999999987654332 23


Q ss_pred             CccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------------C
Q 005526          169 DTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE------------------L  229 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~------------------~  229 (692)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+.....                  .
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            34568899999999875 4578899999999999999999999987766554444332100                  0


Q ss_pred             CCCC--------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 RFPP--------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 ~~p~--------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ..+.        .....++..+.+|+.+||..||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0010        1123567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=370.10  Aligned_cols=243  Identities=30%  Similarity=0.565  Sum_probs=214.6

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      +.++++||+|-||+||+|.... ...||+|.+......+   +.+.+|+++|++|+|+|||++++++..++.+||||||+
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            4557889999999999999874 4589999997654443   56779999999999999999999999988999999999


Q ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCC
Q 005526           92 DGGDLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD  169 (692)
Q Consensus        92 ~GGsL~~~L~~--~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~  169 (692)
                      +.|+|.++|+.  ...+...+...|+.||++|++||+++++|||||...|||++++.   ++||+|||+|+....++...
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~---~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL---VVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc---eEEEcccccccccCCCceee
Confidence            99999999987  45689999999999999999999999999999999999999887   79999999999655544433


Q ss_pred             ccCC--CCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          170 TLCG--SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       170 ~~~G--T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      ...+  ...|.|||.+....++.|+|||||||+||||+| |+.||.+.+..+.+..+.++..++-|+    ..++++-++
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~----~CP~~vY~l  436 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE----GCPDEVYEL  436 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC----CCCHHHHHH
Confidence            2222  346999999999999999999999999999999 999999999999999999888777664    568899999


Q ss_pred             HHHhhccCCCCCCCHHHHH
Q 005526          247 CRCLLRQNPVERITFKEFF  265 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL  265 (692)
                      +..||+.+|++|||++.+.
T Consensus       437 M~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  437 MKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHhhCCcccCCCHHHHH
Confidence            9999999999999998653

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-40  Score=351.67  Aligned_cols=259  Identities=32%  Similarity=0.603  Sum_probs=222.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.+.||+|+||.||++.+..+++.|++|.+...... ......+.+|+++++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4799999999999999999999999999999998765322 234567789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--  166 (692)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++......  
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~---~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG---HIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC---CEEEeeCCCccccCcCccc
Confidence            9999999999999888899999999999999999999999999999999999998876   59999999986421110  


Q ss_pred             --------------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 005526          167 --------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP  232 (692)
Q Consensus       167 --------------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p  232 (692)
                                    ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+....+.... ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~  236 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWP  236 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCC
Confidence                          1123467889999999988899999999999999999999999999888777777665432 2233


Q ss_pred             CCcccccCHHHHHHHHHhhccCCCCCCC---HHHHHhchhhhhh
Q 005526          233 PGAIEELHPDCVDLCRCLLRQNPVERIT---FKEFFNHRFLGEL  273 (692)
Q Consensus       233 ~~~~~~ls~el~dLI~~~L~~DP~~RpT---a~elL~Hpf~~~~  273 (692)
                      ... ...+.++.++|.+||++||++||+   +.++++||||...
T Consensus       237 ~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         237 EGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             Ccc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            222 257889999999999999999998   7999999999654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.5e-41  Score=343.66  Aligned_cols=249  Identities=33%  Similarity=0.682  Sum_probs=218.5

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCH
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL   96 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL   96 (692)
                      ||.|+||.||+|++..+++.||+|++.+.... ....+.+.+|+.+++.++||||+++++.+..++.+|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999999999999999999765432 34457789999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCCCCC
Q 005526           97 AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL  176 (692)
Q Consensus        97 ~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~  176 (692)
                      .+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++   .+||+|||+++............|++.
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~  157 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG---YVKLVDFGFAKKLKSGQKTWTFCGTPE  157 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC---CEEEeeCCcccccCcccccccccCCcC
Confidence            99999888899999999999999999999999999999999999998876   599999999987765444445678999


Q ss_pred             ccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhc-cCCCCCCCcccccCHHHHHHHHHhhcc
Q 005526          177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN--QLQLFQNILTS-TELRFPPGAIEELHPDCVDLCRCLLRQ  253 (692)
Q Consensus       177 YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~--~~~~~~~i~~~-~~~~~p~~~~~~ls~el~dLI~~~L~~  253 (692)
                      |++||.+.+..++.++|+||||+++|+|++|..||....  ....+.++... ....+|    ...+.++.++|.+||+.
T Consensus       158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHHHHccC
Confidence            999999988889999999999999999999999998776  66666666532 222233    34488999999999999


Q ss_pred             CCCCCCC-----HHHHHhchhhhhh
Q 005526          254 NPVERIT-----FKEFFNHRFLGEL  273 (692)
Q Consensus       254 DP~~RpT-----a~elL~Hpf~~~~  273 (692)
                      ||.+||+     ++|+++||||...
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChhhhCC
Confidence            9999999     9999999999754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.5e-41  Score=347.49  Aligned_cols=251  Identities=25%  Similarity=0.470  Sum_probs=216.1

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg-----~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      .++|++.+.||+|+||.||+|.+...+     ..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            468999999999999999999976655     689999886542 34456778999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC
Q 005526           84 IYLVLEYCDGGDLAAYIHKH----------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV  147 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~----------------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~  147 (692)
                      .|++|||+++++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||+++.++ 
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~-  161 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-  161 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC-
Confidence            99999999999999999865                4578899999999999999999999999999999999998876 


Q ss_pred             cCeEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005526          148 TPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNI  223 (692)
Q Consensus       148 ~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i  223 (692)
                        .+||+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+
T Consensus       162 --~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         162 --TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             --cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence              59999999997654322   2334566888999999998999999999999999999998 99999998887777766


Q ss_pred             HhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          224 LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       224 ~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      .......    .....++++.+|+.+||+.||.+||++.+++++
T Consensus       240 ~~~~~~~----~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLP----CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCC----CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5443222    234678999999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.6e-40  Score=336.94  Aligned_cols=253  Identities=36%  Similarity=0.680  Sum_probs=225.8

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|.+.+.||+|+||.||++.+..++..|++|++............+.+|+++++.++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            68999999999999999999999999999999987666556677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           91 CDGGDLAAYIHKH----GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        91 ~~GGsL~~~L~~~----~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      +++++|.+++...    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++   .++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC---cEEECCccceeecccCc
Confidence            9999999999874    6789999999999999999999999999999999999999876   59999999997765433


Q ss_pred             -CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 -LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 -~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                       ......|++.|+|||.+....++.++|+||+|+++|+|++|+.||...+..+....+........    ....+.++.+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  233 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI----PSQYSSELRN  233 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC----CCCCCHHHHH
Confidence             34556789999999999988899999999999999999999999998887777766655432222    2367889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHhchhh
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ++++||..+|++|||+.++++||||
T Consensus       234 ~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         234 LVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7e-41  Score=352.80  Aligned_cols=260  Identities=27%  Similarity=0.500  Sum_probs=220.6

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ...++|.+++.||.|+||.||++.+..+++.||+|.+......  ..+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            3458999999999999999999999999999999999754332  34667889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++   .+||+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~---~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEECcCccceEccCCc
Confidence            9999999999999865 4689999999999999999999999999999999999998776   59999999987654332


Q ss_pred             -CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 -LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 -~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                       ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+......  +......++..+.+
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  247 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--ELQNPERLSAVFRD  247 (297)
T ss_pred             cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC--CCCCccccCHHHHH
Confidence             233457899999999999988999999999999999999999999877654433322221111  11123467888999


Q ss_pred             HHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      |+.+||+.||++||++++++.||||...+
T Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         248 FLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            99999999999999999999999997554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.3e-41  Score=346.97  Aligned_cols=255  Identities=30%  Similarity=0.519  Sum_probs=213.2

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCH
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL   96 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL   96 (692)
                      ||+|+||+||+|.+..+|+.||+|++....... .....+..|++++++++||||+++++.+...+..|+||||++|++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999997643322 2344567899999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCCC
Q 005526           97 AAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS  174 (692)
Q Consensus        97 ~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~GT  174 (692)
                      .+++.+.+  .+++..+..++.|++.||.|||++|++||||+|+||+++.++   .+||+|||++.............++
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG---NVRISDLGLAVELKGGKKIKGRAGT  157 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC---CEEEccCcchhhhccCCccccccCC
Confidence            99998766  789999999999999999999999999999999999998877   5999999998766544444456788


Q ss_pred             CCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccC
Q 005526          175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN  254 (692)
Q Consensus       175 ~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~D  254 (692)
                      ..|+|||++.+..++.++|||||||++|+|++|+.||...........+... ....+......+++++.++|.+||+.|
T Consensus       158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-TLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-cccccccCCccCCHHHHHHHHHHccCC
Confidence            8999999998888999999999999999999999999876542222222211 111222333467899999999999999


Q ss_pred             CCCCC-----CHHHHHhchhhhhhHhh
Q 005526          255 PVERI-----TFKEFFNHRFLGELRQT  276 (692)
Q Consensus       255 P~~Rp-----Ta~elL~Hpf~~~~~~~  276 (692)
                      |.+||     ++.++++||||......
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCChh
Confidence            99999     89999999999765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.1e-40  Score=339.01  Aligned_cols=249  Identities=33%  Similarity=0.577  Sum_probs=217.0

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|.+.+.||.|+||.||++.+..+++.||+|.++... .....+.+.+|+.+++.++||||+++++.+..++.+|+||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            6899999999999999999999999999999986543 234457788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CC
Q 005526           91 CDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        91 ~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~  167 (692)
                      +++++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++   .++|+|||+++..... ..
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG---KVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC---cEEEcccCcceeecccccc
Confidence            9999999988753  3579999999999999999999999999999999999998876   5999999999766432 23


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+........+    ..++..+.+|+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li  232 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP----SHYSYELRSLI  232 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC----cccCHHHHHHH
Confidence            34567899999999999989999999999999999999999999988877776666554332222    35778999999


Q ss_pred             HHhhccCCCCCCCHHHHHhc
Q 005526          248 RCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~H  267 (692)
                      .+||+.||++|||+.++++-
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-40  Score=343.61  Aligned_cols=250  Identities=22%  Similarity=0.371  Sum_probs=212.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEc---CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~---~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .++|.+.+.||+|+||.||+|.++   ..+..||+|.++.. ........+.+|+.++++++||||+++++++..++..+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            467999999999999999999865   34678999998754 23444567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +||||+++|+|.+++... +.+++..++.++.||+.||.|||++|++||||||+|||++.++   .+|++|||.+.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~---~~~l~dfg~~~~~~~  159 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL---VCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC---cEEECCCcccccccc
Confidence            999999999999999875 5789999999999999999999999999999999999998876   599999998765433


Q ss_pred             CCCCC--ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCH
Q 005526          165 QDLAD--TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       165 ~~~~~--~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                      .....  ...+++.|+|||++.+..++.++|||||||++|++++ |..||.+.+..+....+........    ....+.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  235 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA----PRNCPN  235 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC----CCCCCH
Confidence            22221  2345678999999999999999999999999999775 9999999888777776654433222    346788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+.+++.+||+.+|.+||++++|++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-42  Score=375.64  Aligned_cols=249  Identities=30%  Similarity=0.580  Sum_probs=218.6

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCH
Q 005526           17 RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL   96 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL   96 (692)
                      +||+|.||+||.|++..+...+|||.|..+  ..+..+-+++|+.+.++|+|.|||+++|.+..++.+-|.||-++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            599999999999999999999999999654  344567789999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-CCCCCCccC
Q 005526           97 AAYIHKH-GKV--SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLC  172 (692)
Q Consensus        97 ~~~L~~~-~~l--se~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~~~~~~~~~  172 (692)
                      .+++... |++  +|..+-.+.+||++||+|||++.|||||||-+||||+.-  .+++||.|||-++.+. -...+.++.
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy--SGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY--SGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec--cceEEecccccchhhccCCccccccc
Confidence            9999876 556  899999999999999999999999999999999999654  3489999999998765 345688999


Q ss_pred             CCCCccChHhhhhc--CCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          173 GSPLYMAPEIIQNH--KYDAKADLWSVGAILFQLVTGKPPFDGSNQ--LQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       173 GT~~YmAPEvl~~~--~ys~ksDIWSLGviLyeLltG~~PF~~~~~--~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ||..|||||++..+  +|+.++|||||||++.||.||++||.....  ..+++    -.-+...+..+++++.+++.||.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk----VGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK----VGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh----hcceecCCCCcHHHHHHHHHHHH
Confidence            99999999999764  599999999999999999999999975433  23332    23344455666889999999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhhhhh
Q 005526          249 CLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +|+.+||.+||++.++|..||++..
T Consensus       814 rcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHcCCCcccCccHHHhccCcccccC
Confidence            9999999999999999999999755

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-40  Score=346.79  Aligned_cols=253  Identities=26%  Similarity=0.516  Sum_probs=212.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe------C
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET------R   81 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~------~   81 (692)
                      .+.|++.+.||.|+||.||+|.+..+++.||+|++...   ......+..|+.+++++ +||||+++++++..      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            47899999999999999999999999999999998653   23346678899999988 79999999999842      4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccc
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA  159 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA  159 (692)
                      +.+|++|||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .++|+|||++
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~---~~~l~dfg~~  168 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA---EVKLVDFGVS  168 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEeeCcch
Confidence            6889999999999999999764  4588999999999999999999999999999999999999876   5999999998


Q ss_pred             cccCCC-CCCCccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 005526          160 RSLTPQ-DLADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP  233 (692)
Q Consensus       160 ~~~~~~-~~~~~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~  233 (692)
                      +..... .......|++.|+|||++.     ...++.++|||||||++|+|++|..||...........+.......   
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---  245 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK---  245 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC---
Confidence            765422 2234567899999999975     3568889999999999999999999998776555444443322221   


Q ss_pred             CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       234 ~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ......+.++.+||++||..||.+|||+.|+++||||
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            1223578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=341.09  Aligned_cols=255  Identities=30%  Similarity=0.550  Sum_probs=214.4

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-----
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETR-----   81 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~-----   81 (692)
                      -.++|++.+.||.|+||.||+|.++.+++.|++|++....   ...+.+.+|+.+++++ .|+||+++++++...     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            3589999999999999999999999899999999987543   2346788999999999 799999999998654     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                       ..+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||+|+||+++.++   .+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~---~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA---EVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC---eEEECCC
Confidence             358999999999999999875    35789999999999999999999999999999999999999876   5999999


Q ss_pred             ccccccCCC-CCCCccCCCCCccChHhhhh-----cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 005526          157 GFARSLTPQ-DLADTLCGSPLYMAPEIIQN-----HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR  230 (692)
Q Consensus       157 GlA~~~~~~-~~~~~~~GT~~YmAPEvl~~-----~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~  230 (692)
                      |++...... .......|++.|+|||++..     ..++.++|||||||++|+|++|++||...........+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  237 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT  237 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence            998765432 22345678999999999853     347789999999999999999999998776665555554433222


Q ss_pred             CCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       231 ~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ...  ....+.++.+|+++||..||++|||+.+++.|||+
T Consensus       238 ~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 LKS--PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            211  12467899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-40  Score=346.78  Aligned_cols=259  Identities=32%  Similarity=0.566  Sum_probs=211.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE-----
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREK-----   83 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~-----   83 (692)
                      ++|.+.+.||+|+||.||+|++..+++.||||.+............+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            5799999999999999999999999999999998765433334467888999999995 6999999999876655     


Q ss_pred             EEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKH-----GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~-----~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  .+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~--~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC--eEEEeeccc
Confidence            8999999986 898888653     34799999999999999999999999999999999999987332  699999999


Q ss_pred             ccccCCC-CCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----C--
Q 005526          159 ARSLTPQ-DLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL----R--  230 (692)
Q Consensus       159 A~~~~~~-~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~----~--  230 (692)
                      ++..... .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+......++......    .  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8765332 22233467889999998865 45789999999999999999999999988776655554332110    0  


Q ss_pred             ----------CC-------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          231 ----------FP-------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       231 ----------~p-------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                                ++       ......++.++.+||.+||.+||.+||++.+++.||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                      00       011135788999999999999999999999999999983

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=341.12  Aligned_cols=251  Identities=31%  Similarity=0.602  Sum_probs=212.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISIL-STISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL-~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||.|+||.||+|.+..+|+.||||++.+.... ......+..|..++ ...+||||+++++++..++.+|+|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999999999999998754322 22223344554444 456899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG  173 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~G  173 (692)
                      ++|.++++..+.+++..+..++.|++.||.|||++||+||||+|+||+++.++   .+||+|||+++....   .....|
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG---HLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---cEEEeecccceeccc---cccCCC
Confidence            99999999888899999999999999999999999999999999999998876   599999999876433   334578


Q ss_pred             CCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhcc
Q 005526          174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ  253 (692)
Q Consensus       174 T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~  253 (692)
                      ++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+.+..+... ...++......+++++.++|.+||..
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~  234 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-RINWPEEVKEFCSPEAVDLINRLLCM  234 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-ccCCCCcccccCCHHHHHHHHHHccC
Confidence            89999999998888999999999999999999999999988887776665443 33344444456789999999999999


Q ss_pred             CCCCCC---CHHHHHhchhhhhh
Q 005526          254 NPVERI---TFKEFFNHRFLGEL  273 (692)
Q Consensus       254 DP~~Rp---Ta~elL~Hpf~~~~  273 (692)
                      ||++||   +++|+++||||...
T Consensus       235 ~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         235 DPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             CHHHccCCCcHHHHHcChHhhcC
Confidence            999999   55899999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.2e-40  Score=333.05  Aligned_cols=254  Identities=35%  Similarity=0.647  Sum_probs=222.1

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKIYLVL   88 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~--~~l~LVm   88 (692)
                      +|.+.+.||+|+||.||+|.+..+++.|++|++..........+.+.+|+.++++++||||+++++.+...  +.+++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            58899999999999999999999999999999977655556678899999999999999999999999888  8999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-  167 (692)
                      ||+++++|.+++.....+++..++.++.|++.+|.|||++|++|+||+|+||+++.++   .+||+|||.+........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC---CEEEcccccEEeccccccc
Confidence            9999999999999888999999999999999999999999999999999999999866   599999999987765543 


Q ss_pred             --CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 --ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN-QLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~-~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                        .....++..|+|||.+....++.++||||||+++|+|++|..||.... .......+...   ...+......+..+.
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~  234 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS---GEPPEIPEHLSEEAK  234 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc---CCCcCCCcccCHHHH
Confidence              455678999999999988889999999999999999999999998876 22333333221   112223345689999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +++.+||..||.+||++.+++.||||
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-40  Score=344.84  Aligned_cols=256  Identities=27%  Similarity=0.522  Sum_probs=211.8

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----e
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIE-----T   80 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~-----~   80 (692)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....   .....+..|+.+++.+ +||||+++++++.     .
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            45689999999999999999999999999999999875431   2235677899999999 6999999999873     3


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           81 REKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        81 ~~~l~LVmEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                      ++.+++||||++|++|.+++..    ...+++..++.++.|++.||.|||+++|+||||||+||+++.++   .+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~---~~kl~df  168 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG---GVKLVDF  168 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC---CEEEccC
Confidence            5679999999999999998753    34689999999999999999999999999999999999999877   4999999


Q ss_pred             ccccccCCCC-CCCccCCCCCccChHhhhh-----cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 005526          157 GFARSLTPQD-LADTLCGSPLYMAPEIIQN-----HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR  230 (692)
Q Consensus       157 GlA~~~~~~~-~~~~~~GT~~YmAPEvl~~-----~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~  230 (692)
                      |+++...... ......|++.|+|||++..     ..++.++|||||||++|+|++|+.||........+.++.......
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (286)
T cd06638         169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT  248 (286)
T ss_pred             CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence            9997664332 2344579999999999753     457889999999999999999999998876655444433222111


Q ss_pred             CCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       231 ~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .  ......+.++.+++.+||+.||++|||+.++++|+||
T Consensus       249 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         249 L--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             c--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            1  1123457789999999999999999999999999996

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.9e-41  Score=349.15  Aligned_cols=260  Identities=32%  Similarity=0.532  Sum_probs=216.8

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKI   84 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~--~~l   84 (692)
                      +.+++|++.+.||.|+||.||+|.+..+++.+++|.++...........+.+|+.++++++||||+++++++...  +..
T Consensus         2 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             cchhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            456789999999999999999999999999999999976544444445677899999999999999999998777  899


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           85 YLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      |+||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++   .+||+|||+++...
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---~~~l~d~g~~~~~~  157 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG---ILKICDFGLAREYG  157 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC---cEEEeecCceeecc
Confidence            999999985 9999887654 589999999999999999999999999999999999999876   59999999998765


Q ss_pred             CC-CCCCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC---------
Q 005526          164 PQ-DLADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP---------  232 (692)
Q Consensus       164 ~~-~~~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p---------  232 (692)
                      .. .......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||........+.++........+         
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            43 223345678899999998754 4688999999999999999999999988776666554332110000         


Q ss_pred             ----------------CCcccc--cCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          233 ----------------PGAIEE--LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       233 ----------------~~~~~~--ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                                      ......  +++.+.++|++||+.||++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                            001111  47889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.2e-41  Score=347.38  Aligned_cols=256  Identities=32%  Similarity=0.583  Sum_probs=213.7

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|++.+.||.|+||.||+|++..+|+.||||.+............+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48999999999999999999999999999999976554444556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-C
Q 005526           91 CDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        91 ~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~  167 (692)
                      +. ++|.+++...  ..+++..++.++.|++.||+|||++|++||||+|+||+++.++   .+||+|||+++...... .
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~---~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG---AIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEEeeccchhhcccCccc
Confidence            96 5899988653  5689999999999999999999999999999999999999877   59999999987654322 2


Q ss_pred             CCccCCCCCccChHhhhhcC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----------------
Q 005526          168 ADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL-----------------  229 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~-ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~-----------------  229 (692)
                      .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+......++......                 
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            23446788999999876544 688899999999999999999999887766554444322111                 


Q ss_pred             CCCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 RFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 ~~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .++.       .....+++++.++|.+||+.||.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0110       0112467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.3e-40  Score=347.43  Aligned_cols=261  Identities=28%  Similarity=0.513  Sum_probs=210.4

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE---   82 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~---   82 (692)
                      ...+++|.+.++||+|+||.||+|++..+++.||||.+............+.+|++++++++||||+++++++...+   
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY   87 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence            45678999999999999999999999999999999998755433333456678999999999999999999886543   


Q ss_pred             -----EEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           83 -----KIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        83 -----~l~LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                           ..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++   .+||+||
T Consensus        88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~---~~kl~df  163 (310)
T cd07865          88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG---ILKLADF  163 (310)
T ss_pred             cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC---cEEECcC
Confidence                 46999999975 8888876653 689999999999999999999999999999999999998877   5999999


Q ss_pred             ccccccCCCC-----CCCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--
Q 005526          157 GFARSLTPQD-----LADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE--  228 (692)
Q Consensus       157 GlA~~~~~~~-----~~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~--  228 (692)
                      |++.......     ......++..|+|||++.+. .++.++||||||+++|+|++|++||.+.+.......+.....  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9997654322     12334678899999988654 478899999999999999999999988776544433322110  


Q ss_pred             ----------------CCCCCCc---------ccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          229 ----------------LRFPPGA---------IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       229 ----------------~~~p~~~---------~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                                      ..++...         ....+..+.+||.+||..||.+|||+.++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                            0001000         01135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-40  Score=346.84  Aligned_cols=252  Identities=29%  Similarity=0.495  Sum_probs=205.1

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeccCCCChHH-HHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           17 RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV-SDNLLKEISILS---TISHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~-~~~i~~Ev~iL~---~L~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      .||+|+||.||++.+..+++.||+|.+......... .....+|..+++   ...||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999999765433221 223344544444   3479999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccC
Q 005526           93 GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC  172 (692)
Q Consensus        93 GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~  172 (692)
                      ||+|..++..++.+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~---~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG---HVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC---CEEEccCCcceeccccC-ccCcC
Confidence            999999999888999999999999999999999999999999999999998876   59999999987654322 23457


Q ss_pred             CCCCccChHhhh-hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCCCCCCCcccccCHHHHHHHHH
Q 005526          173 GSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL--QLFQNILTSTELRFPPGAIEELHPDCVDLCRC  249 (692)
Q Consensus       173 GT~~YmAPEvl~-~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~--~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~  249 (692)
                      |++.|+|||.+. +..++.++||||+||++|+|++|..||......  .......    ...+......++.++.++|.+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~  232 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----LTVNVELPDSFSPELKSLLEG  232 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----hcCCcCCccccCHHHHHHHHH
Confidence            999999999986 456899999999999999999999999754321  1222221    112223335678999999999


Q ss_pred             hhccCCCCCC-----CHHHHHhchhhhhhHhh
Q 005526          250 LLRQNPVERI-----TFKEFFNHRFLGELRQT  276 (692)
Q Consensus       250 ~L~~DP~~Rp-----Ta~elL~Hpf~~~~~~~  276 (692)
                      ||+.||.+||     +++++++||||+.....
T Consensus       233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             HhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence            9999999999     69999999999876433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=332.94  Aligned_cols=253  Identities=31%  Similarity=0.617  Sum_probs=224.0

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|.+.+.||+|+||.||++.+..+++.|++|.+............+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            58999999999999999999999999999999987766556678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-CC
Q 005526           91 CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-AD  169 (692)
Q Consensus        91 ~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-~~  169 (692)
                      +++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++........ ..
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG---VVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC---CEEEeccccceecCCCccccc
Confidence            99999999999888999999999999999999999999999999999999999866   599999999987654332 23


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC  249 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~  249 (692)
                      ...++..|+|||.+.+..++.++|||+||+++|+|++|..||...+......++.......+    ....+..+.+++.+
T Consensus       158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~  233 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL----PEGISPELKDFLMQ  233 (254)
T ss_pred             ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCC----CCCCCHHHHHHHHH
Confidence            45788999999999888889999999999999999999999988776555555443322222    24568899999999


Q ss_pred             hhccCCCCCCCHHHHHhchhh
Q 005526          250 LLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       250 ~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ||..+|++|||+.+++.||||
T Consensus       234 ~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         234 CFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHhCChhhCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.8e-40  Score=344.44  Aligned_cols=256  Identities=27%  Similarity=0.497  Sum_probs=214.5

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-----
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETR-----   81 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~-----   81 (692)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++++ +||||+++++++...     
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            4688999999999999999999999999999999986532   2245677899999998 899999999998643     


Q ss_pred             CEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccc
Q 005526           82 EKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG  157 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFG  157 (692)
                      +.+|+||||++|++|.++++.    ...+++..++.++.|++.||+|||++||+||||||+||+++.++   .+||+|||
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~---~~kl~dfg  173 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG---GVKLVDFG  173 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC---CEEEeecc
Confidence            468999999999999998863    35689999999999999999999999999999999999998876   49999999


Q ss_pred             cccccCCCC-CCCccCCCCCccChHhhhhc-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 005526          158 FARSLTPQD-LADTLCGSPLYMAPEIIQNH-----KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF  231 (692)
Q Consensus       158 lA~~~~~~~-~~~~~~GT~~YmAPEvl~~~-----~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~  231 (692)
                      ++....... ......|+..|+|||++...     .++.++|||||||++|+|++|++||...+.......+........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  253 (291)
T cd06639         174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL  253 (291)
T ss_pred             cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence            987654332 23345789999999998643     368899999999999999999999988877665555544322221


Q ss_pred             CCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       232 p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                      .  .....+..+.++|.+||+.||++||++.++++||||+
T Consensus       254 ~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         254 L--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             C--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            1  1235677899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-40  Score=343.60  Aligned_cols=253  Identities=32%  Similarity=0.553  Sum_probs=209.2

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEEE
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETR--EKIYLVL   88 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~--~~l~LVm   88 (692)
                      |++.++||+|+||.||+|.+..+++.||+|.+........ .....+|+.++.++. |+||+++++++.++  +.+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            7889999999999999999999999999999876533322 234457888898885 99999999999877  8999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||+++ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++. +   .+||+|||+++.......
T Consensus        80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~---~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D---ILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C---CeEEEecccccccccCCC
Confidence            99975 788877664 56899999999999999999999999999999999999988 4   599999999987655444


Q ss_pred             CCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------CC
Q 005526          168 ADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-----------------EL  229 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-----------------~~  229 (692)
                      .....+++.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....                 ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            455678999999998654 557889999999999999999999999887665554443211                 11


Q ss_pred             CCCCC-------cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 RFPPG-------AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 ~~p~~-------~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .++..       .....+.++.++|.+||++||.+|||+++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11111       113467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=365.88  Aligned_cols=269  Identities=29%  Similarity=0.488  Sum_probs=232.8

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH-HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .+.|+..++||+|+||.||-++.+.||+.||+|.+.++++..+ ...-.+.|..||.+++.+.||.+-..|++.+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            4678889999999999999999999999999999987765433 234567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           88 LEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |..|+||||.-+|...+  .|+|..+..|+.+|+.||++||..+||.|||||+|||+|+.|+   |+|.|.|+|..+...
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh---vRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH---VRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC---eEeeccceEEecCCC
Confidence            99999999999998776  7999999999999999999999999999999999999999985   999999999998887


Q ss_pred             CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                      ......+||.+|||||++.+..|+...|+|||||+||||+.|+.||...........+-+ .....+....+.+|+++++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr-r~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR-RTLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH-HHhcchhhcccccCHHHHH
Confidence            777777999999999999999999999999999999999999999976544332222211 1222344455789999999


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHhchhhhhhHhhhhhhc
Q 005526          246 LCRCLLRQNPVERI-----TFKEFFNHRFLGELRQTVHAEQ  281 (692)
Q Consensus       246 LI~~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~~~~~~~~  281 (692)
                      |++.+|++||.+|.     .+.++.+||||..+........
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleag  460 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAG  460 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhcc
Confidence            99999999999998     5679999999998765544433

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-40  Score=357.03  Aligned_cols=262  Identities=31%  Similarity=0.517  Sum_probs=217.4

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----E   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----~   82 (692)
                      +.++|.+.+.||+|+||+||+|++..+++.||||.+............+.+|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            45789999999999999999999999999999999876543444456778899999999999999999987544     3


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .+|+|+||+. ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++..
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~---~~kL~Dfg~~~~~  158 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLARTT  158 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC---CEEECcCcccccc
Confidence            5899999996 58999998888899999999999999999999999999999999999998876   5999999999876


Q ss_pred             CCC-CCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----------
Q 005526          163 TPQ-DLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL-----------  229 (692)
Q Consensus       163 ~~~-~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~-----------  229 (692)
                      ... .......++..|+|||.+.. ..++.++|||||||++|+|++|++||.+.+....+..+......           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            443 33445678999999998865 46889999999999999999999999887654433322211000           


Q ss_pred             ----------C-CC----CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          230 ----------R-FP----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       230 ----------~-~p----~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                . .+    ......+++++.+++++||+.||.+|||++++++||||..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                      0 00    01123578899999999999999999999999999999765

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.2e-40  Score=342.07  Aligned_cols=254  Identities=24%  Similarity=0.434  Sum_probs=216.0

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      .++|.+.+.||+|+||.||+|.+..     ++..|++|.+.... .......+.+|+.+++.++|+||+++++++...+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3679999999999999999999987     77899999886432 33445678889999999999999999999988889


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG-------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~-------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                      .++||||++|++|.+++...+       .+++..+..++.||+.||+|||++|++||||||+||+++.++....+||+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence            999999999999999998754       4889999999999999999999999999999999999987765557999999


Q ss_pred             ccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 005526          157 GFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP  232 (692)
Q Consensus       157 GlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p  232 (692)
                      |+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.......++
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~  243 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP  243 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            99987643222   112233567999999999999999999999999999997 99999988877766665544333332


Q ss_pred             CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       233 ~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                          ..++..+.+++++||+.||++||++.++++|
T Consensus       244 ----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         244 ----KGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             ----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                4568899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-40  Score=346.54  Aligned_cols=257  Identities=29%  Similarity=0.484  Sum_probs=218.8

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.+.||+|+||+||++.+..+|+.||+|++.... .......+.+|+++++.++||||+++++++...+.+++||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            468999999999999999999999999999999886542 3445678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||+++++|.+++.+.+.+++..++.++.|++.+|.|||+ .||+||||||+||+++.++   .++|+|||++..... ..
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---~~~l~d~gl~~~~~~-~~  158 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG---QIKLCDFGVSGELIN-SI  158 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC---cEEEccCCcccchhh-hc
Confidence            999999999999888889999999999999999999997 6999999999999998776   599999999865432 22


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhccCCCCCCCcc
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-----------QLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~-----------~~~~~i~~~~~~~~p~~~~  236 (692)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......           .....+.......++.   
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  235 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS---  235 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc---
Confidence            34567899999999998889999999999999999999999999865542           2223333222222211   


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ...+.++.+|+.+||++||.+|||+.|+++|+||.+.
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            2367889999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.4e-40  Score=345.26  Aligned_cols=240  Identities=21%  Similarity=0.333  Sum_probs=206.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEec
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIET----REKIYLVLEY   90 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~----~~~l~LVmEy   90 (692)
                      ..||+|++|.||+|..  +|+.||||.+...... ....+.+.+|+.+|++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999988  5899999999765332 2335678899999999999999999999866    4578999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCC
Q 005526           91 CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD  169 (692)
Q Consensus        91 ~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~-gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~  169 (692)
                      |+||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++   .+||+|||+++......  .
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~---~~kl~dfg~~~~~~~~~--~  178 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY---KLKIICHGLEKILSSPP--F  178 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC---cEEEcccchHhhhcccc--c
Confidence            99999999999888899999999999999999999984 999999999999999877   59999999998654322  3


Q ss_pred             ccCCCCCccChHhhhh--cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~--~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dL  246 (692)
                      ...|++.|+|||++.+  ..|+.++|||||||++|||++|+.||.+.+..+.+..+.... ...++    ...++++.+|
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~~l~~l  254 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP----LDCPLEIKCI  254 (283)
T ss_pred             cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC----CcCcHHHHHH
Confidence            4578899999999976  689999999999999999999999999988877777665432 22222    3568899999


Q ss_pred             HHHhhccCCCCCCCHHHHHh
Q 005526          247 CRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL~  266 (692)
                      +.+||+.||++|||+.+++.
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999975

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.7e-40  Score=342.52  Aligned_cols=256  Identities=29%  Similarity=0.544  Sum_probs=221.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ..|...++||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.+.||||+++++++..++..|+|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            568889999999999999999999999999999875432 3445788899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-C
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-A  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-~  168 (692)
                      |++|++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++   .++|+|||++........ .
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~---~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG---DVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC---CEEEcccccceeccCCcccc
Confidence            9999999999865 5789999999999999999999999999999999999998876   599999999977654332 2


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ....++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+....    ++......+..+.+++.
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~  234 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN----PPTLTGEFSKPFKEFID  234 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC----CCCCchhhhHHHHHHHH
Confidence            34568889999999998889999999999999999999999998877665554442221    22333467788999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          249 CLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +||+.+|++||++.+++.|+||....
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         235 ACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHcccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.1e-40  Score=337.36  Aligned_cols=253  Identities=28%  Similarity=0.570  Sum_probs=213.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .++|++.+.||+|+||.||+|++..+++.||||.+.... ........+.+|+++++.++||||+++++++...+..++|
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            368999999999999999999999999999999886532 3445556788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           88 LEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        88 mEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +||+++|+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++   .++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~---~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC---CEEECccccceecc
Confidence            999999999988853    34589999999999999999999999999999999999998876   49999999987764


Q ss_pred             CCC-CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCCCCCCcccccC
Q 005526          164 PQD-LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ--LQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       164 ~~~-~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~--~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      ... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ......+...   .+++......+
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  234 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---DYPPLPTEHYS  234 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC---CCCCCChhhcC
Confidence            332 22345788999999999888899999999999999999999999976532  3344433322   23333334677


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ..+.+++.+||..+|.+||++.++++.
T Consensus       235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         235 EKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            899999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-42  Score=372.00  Aligned_cols=251  Identities=30%  Similarity=0.493  Sum_probs=224.3

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      |.=++.||+|+||-||.|++..+...||||.+.... ....-...+.+|++.|++++|||++.+.++|..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            445788999999999999999999999999997653 2344567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCC
Q 005526           91 CDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD  169 (692)
Q Consensus        91 ~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~  169 (692)
                      |-| +-.+++.-+ .++-|.++..|+.+.+.||.|||+.+.||||||..|||+++.|   .|||+|||.|....   .+.
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g---~VKLaDFGSAsi~~---PAn  180 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG---LVKLADFGSASIMA---PAN  180 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC---eeeeccccchhhcC---chh
Confidence            976 888888754 5789999999999999999999999999999999999999888   69999999997655   356


Q ss_pred             ccCCCCCccChHhhh---hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~---~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      +++|||+|||||++.   .+.|+-|+||||||+++.||...+||+...+....+..|..+.....+.   .+.+..|..|
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS~~F~~F  257 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEWSDYFRNF  257 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chhHHHHHHH
Confidence            899999999999975   5789999999999999999999999999999988888887776555543   4678899999


Q ss_pred             HHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          247 CRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      +..||++-|.+|||.+++|.|+|+..
T Consensus       258 vd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HHHHHhhCcccCCcHHHHhhcchhcc
Confidence            99999999999999999999999853

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-40  Score=352.32  Aligned_cols=251  Identities=26%  Similarity=0.498  Sum_probs=194.4

Q ss_pred             EeEecccCceEEEEEEEcC--CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEec
Q 005526           15 GPRIGSGSFAVVWRARHRQ--LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE--TREKIYLVLEY   90 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~--~~~~l~LVmEy   90 (692)
                      +.+||+|+||+||+|+++.  ++..||+|.+.....    ...+.+|+++++.++||||+++++++.  .+..+++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            4689999999999999764  568999999865432    245678999999999999999999884  45688999999


Q ss_pred             cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCC-CcCeEEEecccccc
Q 005526           91 CDGGDLAAYIHKH---------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFAR  160 (692)
Q Consensus        91 ~~GGsL~~~L~~~---------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~-~~~~vKL~DFGlA~  160 (692)
                      +.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            976 788877532         2478999999999999999999999999999999999995432 23369999999998


Q ss_pred             ccCCCC----CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhc
Q 005526          161 SLTPQD----LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQL---------QLFQNILTS  226 (692)
Q Consensus       161 ~~~~~~----~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~---------~~~~~i~~~  226 (692)
                      ......    ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||......         ..+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            764322    2334678999999999876 45899999999999999999999999754321         111111100


Q ss_pred             cCC-------------CCC--------------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          227 TEL-------------RFP--------------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       227 ~~~-------------~~p--------------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ...             .++                    .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000             000                    00011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.7e-40  Score=334.68  Aligned_cols=252  Identities=31%  Similarity=0.542  Sum_probs=222.8

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|++.++||+|+||.||++++..+++.|++|.+............+.+|+++++.++|+||+++++++......|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            58999999999999999999999999999999987655566667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           91 CDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        91 ~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      +++++|.+++.+    ...+++..++.++.|++.||.|||++|++||||+|+||+++.++   .+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~---~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND---LVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC---cEEEeeccchhhhccC-
Confidence            999999999876    35689999999999999999999999999999999999999866   5999999999876544 


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.......    ....++.++.++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l  232 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP----IPPIYSQDLQNF  232 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CchhhCHHHHHH
Confidence            4445678999999999999999999999999999999999999999888776666554432222    223678899999


Q ss_pred             HHHhhccCCCCCCCHHHHHhchhh
Q 005526          247 CRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +.+||..+|++|||+.++++||++
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         233 IRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-40  Score=349.60  Aligned_cols=256  Identities=25%  Similarity=0.502  Sum_probs=218.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      +.|.....||+|+||.||++.+..++..||||.+...  .....+.+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            4566678899999999999999999999999998653  23445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CCC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~~  168 (692)
                      |+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++...... ...
T Consensus       100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658         100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG---RIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CEEEccCcchhhcccccccC
Confidence            9999999998854 5689999999999999999999999999999999999998876   5999999998754322 223


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....+..+........+  .....+..+.++++
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~  253 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK--DSHKVSSVLRGFLD  253 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc--cccccCHHHHHHHH
Confidence            4467899999999998889999999999999999999999999988776665554433222221  22356889999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhhhhh
Q 005526          249 CLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +||..||.+|||++++++||||...
T Consensus       254 ~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         254 LMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HHccCChhHCcCHHHHhhChhhhcc
Confidence            9999999999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.2e-40  Score=336.74  Aligned_cols=243  Identities=27%  Similarity=0.472  Sum_probs=208.1

Q ss_pred             eEecccCceEEEEEEE--cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARH--RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~--~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      ++||+|+||+||+|..  ..++..||+|++..........+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            3699999999999964  456889999998766555666788999999999999999999999875 4567999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC----CC
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL----AD  169 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~----~~  169 (692)
                      |+|.+++...+.+++..+..++.|++.||+|||++||+||||||.||+++.++   .+||+|||+++.......    ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH---YAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC---eEEECCCccccccCCCCCeeeecC
Confidence            99999998888899999999999999999999999999999999999999876   599999999987643321    12


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ...+++.|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+........|    ...++++.++|.
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~  232 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP----QRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC----CCCCHHHHHHHH
Confidence            2334578999999988889999999999999999998 99999988887777776654433333    467899999999


Q ss_pred             HhhccCCCCCCCHHHHHh
Q 005526          249 CLLRQNPVERITFKEFFN  266 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~  266 (692)
                      +||+.||++||++.+|..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999998843

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-40  Score=343.05  Aligned_cols=257  Identities=32%  Similarity=0.559  Sum_probs=208.7

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.+.||+|+||+||+|.++.+++.||||.+...... .....+.+|++++++++||||+++++++..++..++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            57899999999999999999999999999999998754322 22345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           89 EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      ||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++...... 
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG---ELKLADFGLARAKSVPSK  158 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC---CEEECccccccccCCCCc
Confidence            99986 999988765 4689999999999999999999999999999999999999877   59999999987643221 


Q ss_pred             CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCC---------------
Q 005526          167 LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSN-QLQLFQNILTSTEL---------------  229 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~-~~~~~~~i~~~~~~---------------  229 (692)
                      ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.. ..+....+......               
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1223456889999999865 558899999999999999999999997765 23333222211000               


Q ss_pred             ---CCC----C---CcccccC--HHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 ---RFP----P---GAIEELH--PDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 ---~~p----~---~~~~~ls--~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                         .++    .   .....++  .++.+++.+||+.||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence               000    0   0011234  788999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-40  Score=362.62  Aligned_cols=251  Identities=28%  Similarity=0.466  Sum_probs=206.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETRE   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg-----~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~   82 (692)
                      .++|.+++.||+|+||+||+|++..+|     ..||||++..... ......+.+|+++++.+ +||||+++++.+...+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            457999999999999999999865443     5799999975432 33456788999999999 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-----------------------------------------------------------
Q 005526           83 KIYLVLEYCDGGDLAAYIHKH-----------------------------------------------------------  103 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~-----------------------------------------------------------  103 (692)
                      .+++|||||++|+|.+++...                                                           
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            999999999999999998643                                                           


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC---CCC
Q 005526          104 -----------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LAD  169 (692)
Q Consensus       104 -----------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~---~~~  169 (692)
                                 ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++......   ...
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~---~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR---VAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC---eEEEeeceeeeeccCCcceeecc
Confidence                       1367888999999999999999999999999999999998766   69999999997654322   112


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ...+++.|||||++.+..|+.++|||||||++|+|++ |+.||........+........   ........++++.+++.
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~  349 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY---QMSRPDFAPPEIYSIMK  349 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc---CccCCCCCCHHHHHHHH
Confidence            2345667999999999999999999999999999997 9999988765544444433221   11122346899999999


Q ss_pred             HhhccCCCCCCCHHHHHh
Q 005526          249 CLLRQNPVERITFKEFFN  266 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~  266 (692)
                      +||+.||.+|||+.++++
T Consensus       350 ~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         350 MCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-40  Score=332.83  Aligned_cols=244  Identities=30%  Similarity=0.554  Sum_probs=215.0

Q ss_pred             eEecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           16 PRIGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      +.||+|+||.||+|.+...   +..|++|.+....... ..+.+.+|+++++.++|+||+++++++.....+++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            4799999999999999876   8999999997654433 46788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           93 GGDLAAYIHKH---------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        93 GGsL~~~L~~~---------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +++|.+++...         ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~---~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL---VVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC---cEEEcccccccccc
Confidence            99999999886         7789999999999999999999999999999999999999886   59999999998765


Q ss_pred             CCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          164 PQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       164 ~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      ...   ......+++.|+|||.+....++.++|||||||++|+|++ |..||......+....+........+    ..+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~  232 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP----EYC  232 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----ccC
Confidence            432   2344567889999999988899999999999999999999 69999999888777777654433333    456


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +.++.+++.+||+.||.+|||+.++++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.4e-40  Score=345.01  Aligned_cols=260  Identities=26%  Similarity=0.465  Sum_probs=213.1

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|...+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4677788999999999999999999999999998765433 44567889999999996 999999999999899999999


Q ss_pred             eccCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           89 EYCDGGDLAAYIH-----KHGKVSEAVARHFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        89 Ey~~GGsL~~~L~-----~~~~lse~~i~~il~QLl~gL~yLHs~-gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      ||+.+ ++.++..     ..+.+++..+..++.|++.||+|||+. ||+||||||+||+++.++   .+||+|||+++..
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~---~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG---NIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC---cEEEeecchhHHh
Confidence            99875 5555432     235799999999999999999999975 999999999999998876   5999999999766


Q ss_pred             CCCCCCCccCCCCCccChHhhhhc---CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCCCCCcccc
Q 005526          163 TPQDLADTLCGSPLYMAPEIIQNH---KYDAKADLWSVGAILFQLVTGKPPFDGSNQ-LQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       163 ~~~~~~~~~~GT~~YmAPEvl~~~---~ys~ksDIWSLGviLyeLltG~~PF~~~~~-~~~~~~i~~~~~~~~p~~~~~~  238 (692)
                      ..........|++.|+|||++.+.   .++.++|||||||++|+|++|+.||..... .+....+........+......
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            544444455789999999998776   689999999999999999999999976652 1222233222222233333345


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      ++.++.+|+.+||++||.+|||++++++||||....
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            789999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-39  Score=340.61  Aligned_cols=259  Identities=27%  Similarity=0.521  Sum_probs=214.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET--REKIYLV   87 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~~~l~LV   87 (692)
                      ++|++.++||.|++|.||++.+..+++.||+|.+..... ......+.+|++++++++||||+++++++..  .+.+|+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            579999999999999999999999999999999875432 3456778999999999999999999998854  4479999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           88 LEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        88 mEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      |||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++   .++|+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~---~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG---QVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC---eEEEeecccccccc
Confidence            999999999988754    34589999999999999999999999999999999999998776   59999999987654


Q ss_pred             CCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccCCCCCCCcc--
Q 005526          164 PQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS-----NQLQLFQNILTSTELRFPPGAI--  236 (692)
Q Consensus       164 ~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~-----~~~~~~~~i~~~~~~~~p~~~~--  236 (692)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|..||...     ...+....+........+....  
T Consensus       157 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         157 NS-LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             cc-ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            32 223456888999999999999999999999999999999999999865     2233333333322222211111  


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ...++++.+|+.+||+.||.+|||+.|++.||||...
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            2346789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-39  Score=328.26  Aligned_cols=252  Identities=31%  Similarity=0.617  Sum_probs=218.6

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|.+.+.||+|+||.||++.+..+++.|++|++.....  .....+.+|+++++.++|+||+++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            58999999999999999999998999999999976533  3457888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCC
Q 005526           91 CDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD  169 (692)
Q Consensus        91 ~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~  169 (692)
                      ++|++|.+++... ..+++..+..++.|++.+|.|||++|++||||+|+||+++.++   .++|+|||.+..........
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG---EVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC---eEEEeecccccccccccccc
Confidence            9999999999876 6789999999999999999999999999999999999999876   59999999998766544345


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC  249 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~  249 (692)
                      ...++..|+|||.+....++.++|+||||+++|+|++|+.||...+.......+........+.  ...++.++.+++.+
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~  233 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN--PEKWSDEFKDFLKK  233 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCc--ccccCHHHHHHHHH
Confidence            5678999999999988889999999999999999999999998876554444443322222221  12347899999999


Q ss_pred             hhccCCCCCCCHHHHHhchh
Q 005526          250 LLRQNPVERITFKEFFNHRF  269 (692)
Q Consensus       250 ~L~~DP~~RpTa~elL~Hpf  269 (692)
                      ||+.||.+|||+.+++.|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-40  Score=345.50  Aligned_cols=256  Identities=30%  Similarity=0.548  Sum_probs=218.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      +.|.+.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|++++++++||||+++++.+..++..|+|||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            457778889999999999999999999999999875432 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-C
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-A  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-~  168 (692)
                      |+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++   .+||+|||+++....... .
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG---DVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC---CEEEccccccccccCcchhh
Confidence            9999999998864 5789999999999999999999999999999999999998876   599999999977654332 2


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+....    ++......+.++.+++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~  234 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS----PPTLEGQYSKPFKEFVE  234 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC----CCCCCcccCHHHHHHHH
Confidence            34568899999999999899999999999999999999999998766555444332222    22222456788999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          249 CLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +||+.+|++||++.++++||||....
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         235 ACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHccCCcccCcCHHHHHHhHHHHHHh
Confidence            99999999999999999999997654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-40  Score=370.66  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ....|.+.+.||+|+||.||+|.+..+++.||||....        ..+.+|+++|++++|+|||++++++..++..++|
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            35689999999999999999999999999999996422        2356899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           88 LEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++   .+||+|||+++......
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~---~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DICLGDFGAACFARGSW  314 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC---CEEEcccCCceeccccc
Confidence            99996 5888888764 4699999999999999999999999999999999999998876   49999999997654322


Q ss_pred             ---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCC---CCC
Q 005526          167 ---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN--------QLQLFQNILTSTEL---RFP  232 (692)
Q Consensus       167 ---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~--------~~~~~~~i~~~~~~---~~p  232 (692)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|..|+....        ..++. +++.....   .++
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~-~~i~~~~~~~~~~~  393 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL-RIIRQAQVHVDEFP  393 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH-HHHHhhccccccCC
Confidence               2234679999999999999999999999999999999999876553221        12222 22221111   011


Q ss_pred             C---------------------------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          233 P---------------------------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       233 ~---------------------------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                      .                           .....++.++.+||.+||+.||.+|||+.|+|+||||+
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~  459 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ  459 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence            0                           01124567899999999999999999999999999995

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-41  Score=374.71  Aligned_cols=257  Identities=30%  Similarity=0.567  Sum_probs=221.4

Q ss_pred             ecCE-EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC--CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--E
Q 005526            9 IGEY-IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL--LSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE--K   83 (692)
Q Consensus         9 ~~~Y-~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~--~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~--~   83 (692)
                      .++| +...+||+|+|-+||+|.+..+|..||.-.++...  ..+...+.+..|+.+|+.|+||||+++|+.+.+..  .
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            3555 44678999999999999999999999987665433  34556689999999999999999999999997654  5


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH--LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~g--IVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      +.+|+|.+..|+|..|++++++++...++.|++||+.||.|||++.  |||||||++||+|+.+  .+.|||+|+|+|+.
T Consensus       118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~--~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN--LGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC--cCceeecchhHHHH
Confidence            8899999999999999999999999999999999999999999986  9999999999999654  45899999999988


Q ss_pred             cCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          162 LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       162 ~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~-~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      ..... +...+|||.|||||... ..|+..+||||||+++.||+|+..||.. .+..+++.++..+..   |.....-.+
T Consensus       196 ~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK---P~sl~kV~d  270 (632)
T KOG0584|consen  196 LRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK---PAALSKVKD  270 (632)
T ss_pred             hhccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC---HHHhhccCC
Confidence            76443 44589999999999987 8899999999999999999999999965 556677777766543   222223447


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +++++||.+||.. ..+|+|+.|+|+||||..-
T Consensus       271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999999999 9999999999999999753

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=343.24  Aligned_cols=255  Identities=31%  Similarity=0.573  Sum_probs=213.8

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      |++.+.||.|++|.||+|.++.+|+.||+|++............+.+|+++++.++||||+++++++..++..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67889999999999999999999999999999766544444567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CC
Q 005526           92 DGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LA  168 (692)
Q Consensus        92 ~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~  168 (692)
                      + ++|.+++....  .+++..+..++.|++.||+|||++|++||||+|+||+++.++   .++|+|||+++...... ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG---ALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC---cEEEeecccccccCCCcccc
Confidence            5 58999998765  789999999999999999999999999999999999999866   59999999997654222 22


Q ss_pred             CccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------------
Q 005526          169 DTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL------------------  229 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~------------------  229 (692)
                      ....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+......++......                  
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            334568899999987654 5788999999999999999999999887765554444321100                  


Q ss_pred             ------CCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 ------RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 ------~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                            .........++.++.++|.+||+.||.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                  00111234567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.7e-40  Score=334.69  Aligned_cols=246  Identities=27%  Similarity=0.536  Sum_probs=210.8

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ++|.+.+.||+|+||.||++..+. +..+|+|.+......   ...+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            579999999999999999998764 668999988654322   3568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+++.++   .+||+|||+++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~---~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG---VVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC---eEEECCCCCccccCCCcee
Confidence            99999999999754 5689999999999999999999999999999999999998776   5999999999765432221


Q ss_pred             --CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          169 --DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       169 --~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                        ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+........+    ...+.++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~  232 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP----KLASMTVYE  232 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC----CCCCHHHHH
Confidence              12235567999999988899999999999999999999 99999998888887777665433222    346788999


Q ss_pred             HHHHhhccCCCCCCCHHHHHh
Q 005526          246 LCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~  266 (692)
                      ++.+||+.||.+||++.++++
T Consensus       233 li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-40  Score=361.34  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=206.4

Q ss_pred             cCEEEEeEecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARH-----RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREK   83 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~-----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~   83 (692)
                      ++|++++.||+|+||+||+|.+     ..++..||||+++.... ....+.+.+|+.+++.+ +||||+++++++..++.
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            4799999999999999999974     34577899999865432 33456788999999999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-----------------------------------------------------------
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG-----------------------------------------------------------  104 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~-----------------------------------------------------------  104 (692)
                      .++|||||+||+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986532                                                           


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-
Q 005526          105 ----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus       105 ----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-  167 (692)
                                      .+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....... 
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~---~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR---ITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC---cEEEecCccceeccCcccc
Confidence                            367888999999999999999999999999999999998765   599999999986543321 


Q ss_pred             --CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 --ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                        .....++..|+|||++.+..++.++|||||||++|+|++ |..||........+.+........   ......+.++.
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  347 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM---LSPECAPSEMY  347 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC---CCCCCCCHHHH
Confidence              122345667999999999999999999999999999998 999998766544444443332111   11234578999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhc
Q 005526          245 DLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +|+.+||+.||++|||+.++++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-40  Score=337.29  Aligned_cols=249  Identities=22%  Similarity=0.457  Sum_probs=211.4

Q ss_pred             EEEEeEecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-----
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK-----   83 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~-----   83 (692)
                      |.+++.||+|+||+||+|....+   +..||||.+............+.+|+++++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            57889999999999999987653   4789999998765555666788999999999999999999998765443     


Q ss_pred             -EEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           84 -IYLVLEYCDGGDLAAYIHKH------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        84 -l~LVmEy~~GGsL~~~L~~~------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                       .+++|||+++|+|..++...      ..+++..++.++.|++.||.|||++||+||||||+||++++++   .+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM---TVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC---eEEECCc
Confidence             79999999999999998543      3589999999999999999999999999999999999998876   5999999


Q ss_pred             ccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 005526          157 GFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP  232 (692)
Q Consensus       157 GlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p  232 (692)
                      |+++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |.+||.+....+.+..+........+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99987643322   122345678999999988899999999999999999999 99999988887777777655443333


Q ss_pred             CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       233 ~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                          ...+.++.+++.+||+.||.+|||+.+++++
T Consensus       238 ----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         238 ----EDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                4678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-40  Score=355.63  Aligned_cols=263  Identities=32%  Similarity=0.575  Sum_probs=217.7

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE----TREK   83 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~----~~~~   83 (692)
                      +.++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.    ....
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            457899999999999999999999999999999999765444455677888999999999999999998875    3457


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++...
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~---~~kl~dfg~~~~~~  158 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC---ELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---cEEecccccceeec
Confidence            899999996 58999998888899999999999999999999999999999999999999877   59999999997654


Q ss_pred             CCC-----CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------
Q 005526          164 PQD-----LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL--------  229 (692)
Q Consensus       164 ~~~-----~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~--------  229 (692)
                      ...     ......|+..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+......        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            322     1234578999999999865 46889999999999999999999999887655443332221000        


Q ss_pred             -----------CCC---C----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          230 -----------RFP---P----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       230 -----------~~p---~----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                                 .++   .    ......+.++.++|++||+.||.+|||+.+++.||||.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence                       000   0    11234688999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.7e-40  Score=340.54  Aligned_cols=250  Identities=26%  Similarity=0.494  Sum_probs=214.0

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      .++|.+.+.||+|+||+||+|.+..     +++.||||.+.... .....+.+.+|+++++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4679999999999999999998753     36889999986543 33356788999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcC
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG--------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~--------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~  149 (692)
                      .++||||++|++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.++   
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~---  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL---  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC---
Confidence            999999999999999997653              378899999999999999999999999999999999999876   


Q ss_pred             eEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 005526          150 VLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT  225 (692)
Q Consensus       150 ~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~  225 (692)
                      .+||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            69999999997653322   2234456788999999999999999999999999999998 9999998888777777664


Q ss_pred             ccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       226 ~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.....    ....+..+.+++++||+.||++||++.|+++
T Consensus       240 ~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         240 GRLLQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCcCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            432222    2457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=339.66  Aligned_cols=255  Identities=32%  Similarity=0.570  Sum_probs=214.6

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE-----
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI---SHPNIIRFFEAIETREK-----   83 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L---~HpNIVkl~~~~~~~~~-----   83 (692)
                      |++.+.||+|+||.||+|+++.+++.||+|.+............+.+|+.+++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7899999999999999999998999999999976544444445666788877665   69999999999987776     


Q ss_pred             EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      ++++|||+.+ +|.+++....  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++   .+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~---~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC---CEEEeccCccee
Confidence            9999999985 8999887753  489999999999999999999999999999999999999886   599999999987


Q ss_pred             cCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----CC-----
Q 005526          162 LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR----FP-----  232 (692)
Q Consensus       162 ~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~----~p-----  232 (692)
                      ...........+++.|+|||++.+..++.++|||||||++|+|++|++||.+....+.+.++.......    ++     
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            655444445568899999999999999999999999999999999999999988777766665422110    00     


Q ss_pred             -------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          233 -------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       233 -------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                                   ......+++.+.++|++||+.||.+||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                         01112456788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.6e-40  Score=351.35  Aligned_cols=258  Identities=22%  Similarity=0.384  Sum_probs=210.2

Q ss_pred             eEeccc--CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSG--SFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~G--sFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      ..||+|  +||+||++++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  999999999999999999999987655566667889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC----
Q 005526           94 GDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL----  167 (692)
Q Consensus        94 GsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~----  167 (692)
                      ++|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++   .+|++|||.+........    
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~---~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG---LVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC---cEEEechHHHhhhhccCccccc
Confidence            9999999875  3589999999999999999999999999999999999998776   599999986543221110    


Q ss_pred             ----CCccCCCCCccChHhhhh--cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----------
Q 005526          168 ----ADTLCGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF----------  231 (692)
Q Consensus       168 ----~~~~~GT~~YmAPEvl~~--~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~----------  231 (692)
                          .....++..|+|||++.+  ..++.++|||||||++|+|++|++||.+.........+........          
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                111234567999999876  3578999999999999999999999988766555444332211000          


Q ss_pred             --------------------------------CCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          232 --------------------------------PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       232 --------------------------------p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                                                      ........++.+.+|+++||+.||++|||+.++++||||...+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                            001112356789999999999999999999999999999888765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-40  Score=353.12  Aligned_cols=261  Identities=31%  Similarity=0.540  Sum_probs=223.0

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE-----KIY   85 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~-----~l~   85 (692)
                      +|.+.+.||.|+||.||+|++..+++.||||.+..........+.+.+|+.+++.++||||+++++++...+     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            699999999999999999999999999999999765443455678889999999999999999999987765     799


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      +||||+.+ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++   .++|+|||++......
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~---~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC---DLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEcccCceEeeccc
Confidence            99999985 8999998888899999999999999999999999999999999999999886   5999999999876544


Q ss_pred             C----CCCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC-------
Q 005526          166 D----LADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP-------  233 (692)
Q Consensus       166 ~----~~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~-------  233 (692)
                      .    ......+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.+..+.+..+........+.       
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            2    23445789999999999887 88999999999999999999999999988777666555422111000       


Q ss_pred             -------------------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          234 -------------------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       234 -------------------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                                         .....++.++.++|++||++||.+|||+++++.||||...+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                               011246788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-40  Score=339.03  Aligned_cols=256  Identities=27%  Similarity=0.539  Sum_probs=216.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS---HPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~---HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++   ||||+++++++..+...|+|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            5888999999999999999999999999999987543 2334567888999999986   99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      |||++|++|.+++.. +.+++..++.++.|++.||.|||+.||+||||+|+||+++.++   .++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG---NVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC---CEEEccCCceeecCCCcc
Confidence            999999999999865 4789999999999999999999999999999999999999866   59999999997765433 


Q ss_pred             CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                      ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+....   .+.......+.++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  233 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKLLRE  233 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC---CCCCCcccCCHHHHH
Confidence            2344578999999999865 456889999999999999999999998877655444332221   111112237889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      ++.+||+.||++||++.+++.|+||++..
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-43  Score=356.27  Aligned_cols=253  Identities=30%  Similarity=0.562  Sum_probs=222.2

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      |.++++||+|+||.||+|+|+.+|..+|||.+...    ...+++.+|+.|+++++.|+||++|+.|.....+|||||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            66788999999999999999999999999988653    34688999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CCCC
Q 005526           92 DGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLAD  169 (692)
Q Consensus        92 ~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~~~  169 (692)
                      ..|+..+.+.- +..++|+++..+++.-+.||+|||...=||||||..|||++.+|   ..||+|||.|..+... ...+
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G---~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG---IAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc---hhhhhhccccchhhhhHHhhC
Confidence            99999999875 46799999999999999999999999999999999999999888   4899999999876543 2356


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC  249 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~  249 (692)
                      +..|||.|||||++...+|+.++||||||++..||..|++||........+..|-......|  ..++..+.++.||+++
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF--~KPE~WS~~F~DFi~~  265 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF--KKPEEWSSEFNDFIRS  265 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC--CChHhhhhHHHHHHHH
Confidence            78999999999999999999999999999999999999999988766544443322222222  2235678999999999


Q ss_pred             hhccCCCCCCCHHHHHhchhhhhh
Q 005526          250 LLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       250 ~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ||-++|++|-|+-++++|||++..
T Consensus       266 CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HhcCCHHHHHHHHHHhhhhhhcCC
Confidence            999999999999999999999753

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-39  Score=338.41  Aligned_cols=253  Identities=23%  Similarity=0.429  Sum_probs=211.7

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~   81 (692)
                      ...++|++.++||+|+||+||+|.+..     ++..||||.+.... .......+.+|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            346789999999999999999998652     35789999885432 233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeE
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHG----------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVL  151 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~~----------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~v  151 (692)
                      ...++||||+++++|.+++....          .+++..+..++.|++.||.|||++|++||||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~---~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC---CE
Confidence            99999999999999999997632          256788899999999999999999999999999999999876   59


Q ss_pred             EEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 005526          152 KIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTST  227 (692)
Q Consensus       152 KL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~  227 (692)
                      ||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG  238 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999876543222   122345778999999999999999999999999999999 799999888777776665543


Q ss_pred             CCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          228 ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       228 ~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ....+    ...+..+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LLDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32222    4567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.8e-40  Score=345.92  Aligned_cols=261  Identities=28%  Similarity=0.549  Sum_probs=211.8

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR----   81 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~----   81 (692)
                      ...+++|.+.++||.|+||.||+|.+..+++.||||++............+.+|+++++.++||||+++++++...    
T Consensus         4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            3458999999999999999999999999999999999876544333345667899999999999999999887433    


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           82 ----EKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        82 ----~~l~LVmEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                          ..+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+||
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~---~~~l~df  159 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG---ILKIADF  159 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEECcC
Confidence                357999999976 67776654 45799999999999999999999999999999999999999877   5999999


Q ss_pred             ccccccCCCCC------------CCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 005526          157 GFARSLTPQDL------------ADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNI  223 (692)
Q Consensus       157 GlA~~~~~~~~------------~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i  223 (692)
                      |+++.......            .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99976543221            123456888999998765 45889999999999999999999999988876655554


Q ss_pred             HhccCCC----------------------CCC---CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          224 LTSTELR----------------------FPP---GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       224 ~~~~~~~----------------------~p~---~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .......                      .++   .......+.+.++|++||+.||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            4321100                      000   0112445789999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.9e-40  Score=339.54  Aligned_cols=255  Identities=33%  Similarity=0.598  Sum_probs=212.5

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +|++.++||.|++|+||+|++..+|+.||||++...... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            589999999999999999999999999999999765322 2345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-C
Q 005526           91 CDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-D  166 (692)
Q Consensus        91 ~~GGsL~~~L~~~~---~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~  166 (692)
                      +++ +|.+++...+   .+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++..... .
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~---~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG---ELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC---cEEEeecchhhhhcCCcc
Confidence            986 8988887643   589999999999999999999999999999999999998876   5999999999765432 1


Q ss_pred             CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------------
Q 005526          167 LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR---------------  230 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~---------------  230 (692)
                      ......+++.|++||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......               
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            2234567889999999865 457889999999999999999999999887766655544321100               


Q ss_pred             --CCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          231 --FPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       231 --~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                        ++.       ......+.++.+++.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              000       0112457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.5e-40  Score=335.46  Aligned_cols=250  Identities=33%  Similarity=0.640  Sum_probs=217.7

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCH
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL   96 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL   96 (692)
                      ||.|+||.||++++..+|+.|++|++..... .......+.+|++++++++||||+++++.+..+...|+||||++|++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999976533 234456788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC---------C
Q 005526           97 AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---------L  167 (692)
Q Consensus        97 ~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~---------~  167 (692)
                      .+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++   .+||+|||++.......         .
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG---HLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC---CEEEEecccchhcccCccccccccccc
Confidence            99999888899999999999999999999999999999999999999877   59999999987654321         2


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      .....+++.|++||.+....++.++||||||+++|+|++|..||......+.+..+... ...++..  ...+..+.+++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~i  234 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG-KIEWPED--VEVSDEAIDLI  234 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CcCCCcc--ccCCHHHHHHH
Confidence            23456888999999998888999999999999999999999999988888777776553 2333322  23589999999


Q ss_pred             HHhhccCCCCCCCH---HHHHhchhhhhh
Q 005526          248 RCLLRQNPVERITF---KEFFNHRFLGEL  273 (692)
Q Consensus       248 ~~~L~~DP~~RpTa---~elL~Hpf~~~~  273 (692)
                      ++||+.+|.+|||+   .++++||||..+
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            99999999999999   999999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-39  Score=340.26  Aligned_cols=248  Identities=29%  Similarity=0.536  Sum_probs=212.1

Q ss_pred             cCEEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHR-----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      ++|.+.+.||+|+||+||++.+.     .++..||+|.+...  .......+.+|+.++++++||||+++++++...+.+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            57999999999999999999853     34567999988654  344567789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeE
Q 005526           85 YLVLEYCDGGDLAAYIHKHG-------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVL  151 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~-------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~v  151 (692)
                      ++||||+++++|.+++...+             .+++..+..++.||+.||+|||++|++||||||+|||++.++   .+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~---~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL---LV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC---cE
Confidence            99999999999999997654             389999999999999999999999999999999999998876   59


Q ss_pred             EEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 005526          152 KIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTST  227 (692)
Q Consensus       152 KL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~  227 (692)
                      ||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+....
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999997654322   1223445778999999998999999999999999999998 999999888877777776544


Q ss_pred             CCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          228 ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       228 ~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ....+    ...+.++.+|+.+||+.||.+|||+.++++
T Consensus       240 ~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         240 VLQRP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33222    356789999999999999999999999844

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.5e-40  Score=338.60  Aligned_cols=253  Identities=36%  Similarity=0.684  Sum_probs=221.7

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ++|.+.+.||+|+||.||++.+..+|+.||+|++.+... .......+.+|+++++++. ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            589999999999999999999999999999999976432 3344567889999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      |||+++++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||||+||+++.++   .++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~---~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM---HIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---CEEecCCccccccCCccc
Confidence            99999999999999988999999999999999999999999999999999999998877   49999999987654322 


Q ss_pred             --------------------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 005526          167 --------------------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS  226 (692)
Q Consensus       167 --------------------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~  226 (692)
                                          ......++..|+|||++....++.++|||||||++|++++|+.||........+..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                122345788999999998888999999999999999999999999988876666665532


Q ss_pred             cCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCH----HHHHhchhh
Q 005526          227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITF----KEFFNHRFL  270 (692)
Q Consensus       227 ~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa----~elL~Hpf~  270 (692)
                       ...++    ..+++.+.+|+++||..||.+||++    +++++||||
T Consensus       238 -~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 -EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             22233    3568899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-39  Score=334.80  Aligned_cols=248  Identities=25%  Similarity=0.511  Sum_probs=213.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ..+|.+.++||+|+||.||+|.+..+++.||+|.+...   ......+.+|+++++.++||||+++++++...+.+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            46799999999999999999999999999999998653   223467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~---~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---LVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC---cEEeCCCccccccccce
Confidence            9999999999997643  589999999999999999999999999999999999998776   59999999998765432


Q ss_pred             CCC--ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          167 LAD--TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       167 ~~~--~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      ...  ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.......    .....+.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  234 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME----RPEGCPPKV  234 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC----CCCCCCHHH
Confidence            211  2234567999999999999999999999999999998 999999988877777665443322    234678999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+++.+||+.||++|||+.++++
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.7e-40  Score=341.34  Aligned_cols=257  Identities=31%  Similarity=0.532  Sum_probs=206.4

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++++..++..|+||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3689999999999999999999999999999999865432 223345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-C
Q 005526           89 EYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-D  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~  166 (692)
                      ||+. ++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++..... .
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~---~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG---ELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC---cEEEeccccccccCCCCC
Confidence            9996 577776654 35678999999999999999999999999999999999998876   5999999998764322 2


Q ss_pred             CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCC--------------
Q 005526          167 LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQNILTSTELR--------------  230 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~-~~~~~i~~~~~~~--------------  230 (692)
                      ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.. +.+.++.......              
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            2344567899999999865 45788999999999999999999999865532 2222221100000              


Q ss_pred             ----C----CC---Ccc--cccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          231 ----F----PP---GAI--EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       231 ----~----p~---~~~--~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                          +    +.   ..+  ...+.++.+++.+||+.||.+|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                0    00   000  1235788999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-39  Score=335.81  Aligned_cols=250  Identities=28%  Similarity=0.527  Sum_probs=205.7

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      ...||+|+||+||+|++..++..|++|.+....  ....+.+.+|+.+++.++|+||+++++++..++..++|+||++++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            357999999999999999999999999886542  334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CCCc
Q 005526           95 DLAAYIHKH-GKV--SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADT  170 (692)
Q Consensus        95 sL~~~L~~~-~~l--se~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~~~  170 (692)
                      +|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++.+..  .+||+|||++....... ....
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--eEEEecchhheecccCCCcccc
Confidence            999999865 445  88899999999999999999999999999999999976432  69999999987654322 2334


Q ss_pred             cCCCCCccChHhhhhcC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          171 LCGSPLYMAPEIIQNHK--YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       171 ~~GT~~YmAPEvl~~~~--ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ..|++.|+|||++....  ++.++||||||+++|+|++|++||.............  ......+......++++.+|++
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~  246 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV--GMFKIHPEIPESLSAEAKNFIL  246 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh--hhhccCCCCCcccCHHHHHHHH
Confidence            56889999999986643  7889999999999999999999997644322111110  1111112233467889999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhh
Q 005526          249 CLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +||+.+|.+|||+.+++.||||
T Consensus       247 ~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         247 RCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-39  Score=344.93  Aligned_cols=251  Identities=29%  Similarity=0.498  Sum_probs=209.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcE--EEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIE--VAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~--vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~   85 (692)
                      .++|.+.+.||+|+||+||+|.+..++..  +++|.+... ........+.+|++++.++ +||||+++++++..++.+|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            47899999999999999999999887765  466665432 2344567788999999999 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcC
Q 005526           86 LVLEYCDGGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~  149 (692)
                      +||||+++++|.+++.+.+                .+++..++.++.||+.||+|||++||+||||||+|||++.++   
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~---  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC---
Confidence            9999999999999997643                478999999999999999999999999999999999998776   


Q ss_pred             eEEEeccccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 005526          150 VLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE  228 (692)
Q Consensus       150 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~  228 (692)
                      .+||+|||+++............++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  241 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  241 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence            599999999864322211222234667999999988889999999999999999998 9999998887766665533221


Q ss_pred             CCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       229 ~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ..    .....++++.+|+.+||+.+|++||++.+++.+
T Consensus       242 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         242 LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21    223567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-39  Score=336.32  Aligned_cols=249  Identities=22%  Similarity=0.438  Sum_probs=209.0

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCc--EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCE
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGI--EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET------REK   83 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~--~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~------~~~   83 (692)
                      |.+++.||+|+||+||+|....++.  .||+|.++.........+.+.+|+++++.++||||+++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578999999999999999887765  69999987765556667788999999999999999999997642      235


Q ss_pred             EEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKH------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG  157 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFG  157 (692)
                      .+++|||+.+|+|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM---NVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC---CEEECCCC
Confidence            78999999999999987432      3478999999999999999999999999999999999998776   59999999


Q ss_pred             cccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 005526          158 FARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP  233 (692)
Q Consensus       158 lA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~  233 (692)
                      +++.......   .....+++.|++||++.+..++.++|||||||++|+|++ |+.||.+....+....+........+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  236 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP-  236 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence            9987643322   223346778999999999999999999999999999999 89999988877777766654433332 


Q ss_pred             CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       234 ~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                         ...+..+.+++.+||+.||++|||+.+++++
T Consensus       237 ---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         237 ---PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               3567889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=333.71  Aligned_cols=254  Identities=26%  Similarity=0.518  Sum_probs=216.6

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL---LSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKI   84 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~---~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~--~~l   84 (692)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....   ........+.+|++++++++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999885432   1234456788999999999999999999998653  568


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ++++||++|++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++   .++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG---NVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC---CEEECcccccccccc
Confidence            99999999999999998888899999999999999999999999999999999999998776   599999999986532


Q ss_pred             C----CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          165 Q----DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       165 ~----~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      .    .......|+..|+|||++.+..++.++|+|||||++|+|++|++||..........++....   .++..+..++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~p~~~~  235 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP---TKPMLPDGVS  235 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC---CCCCCCcccC
Confidence            1    11234568999999999998889999999999999999999999998877666555554322   2223345788


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .++.+++++||. +|..||++.+++.|||.
T Consensus       236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.6e-39  Score=338.33  Aligned_cols=251  Identities=22%  Similarity=0.445  Sum_probs=212.0

Q ss_pred             ecCEEEEeEecccCceEEEEEEEc----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~----~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      ..+|++.++||+|+||+||+|...    .++..|++|.+.... .......+.+|+++++.++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            468999999999999999999853    356789999987532 334456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC
Q 005526           85 YLVLEYCDGGDLAAYIHKH-----------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV  147 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~-----------------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~  147 (692)
                      |+||||+++++|.+++...                 ..+++..+..++.|++.||.|||++||+||||||+|||++.++ 
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~-  161 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL-  161 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC-
Confidence            9999999999999998643                 2368889999999999999999999999999999999999776 


Q ss_pred             cCeEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005526          148 TPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNI  223 (692)
Q Consensus       148 ~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i  223 (692)
                        .+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+
T Consensus       162 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         162 --HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             --cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence              59999999998654332   2234456778999999988889999999999999999998 99999988776666665


Q ss_pred             HhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          224 LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       224 ~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      .......    .....++.+.+++.+||+.||.+||++.+++++
T Consensus       240 ~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQLLP----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCC----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5433332    224678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-39  Score=332.51  Aligned_cols=243  Identities=30%  Similarity=0.510  Sum_probs=205.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGD   95 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGs   95 (692)
                      +.||+|+||+||+|++..+++.||+|.+... ........+.+|++++++++||||+++++++...+.+++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4699999999999999999999999988643 344556788999999999999999999999999999999999999999


Q ss_pred             HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCC---cc
Q 005526           96 LAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD---TL  171 (692)
Q Consensus        96 L~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~---~~  171 (692)
                      |.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++..........   ..
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN---VLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC---cEEECccccCcccccccccccCCCC
Confidence            999997654 589999999999999999999999999999999999998776   59999999987654321111   11


Q ss_pred             CCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHh
Q 005526          172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL  250 (692)
Q Consensus       172 ~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~  250 (692)
                      .++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+........    ....+..+.+++.+|
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~  232 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC----PELCPDAVYRLMERC  232 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC----cccCCHHHHHHHHHH
Confidence            23456999999999999999999999999999998 9999988777665555544333222    345688999999999


Q ss_pred             hccCCCCCCCHHHHHh
Q 005526          251 LRQNPVERITFKEFFN  266 (692)
Q Consensus       251 L~~DP~~RpTa~elL~  266 (692)
                      |+.||++|||+.+++.
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-39  Score=340.23  Aligned_cols=257  Identities=26%  Similarity=0.536  Sum_probs=219.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .+|.-.+.||+|+||.||++.+..+++.|++|.+...  .....+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            3566678999999999999999999999999988643  22335668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~  168 (692)
                      |++|++|.+++.. +++++..++.++.|++.||.|||++||+||||+|+||+++.++   .++|+|||++....... ..
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~~l~d~g~~~~~~~~~~~~  172 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG---RVKLSDFGFCAQVSKEVPRR  172 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC---cEEEcccccchhhccCCccc
Confidence            9999999999977 6799999999999999999999999999999999999999876   59999999887543321 22


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+........  .....++..+.++++
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~  250 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL--KNLHKVSPRLRSFLD  250 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC--cccccCCHHHHHHHH
Confidence            345689999999999888899999999999999999999999988887766666554321111  112347789999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          249 CLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +||..||++|||+.++++||||...+
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHcccChhhCcCHHHHccCcccccCC
Confidence            99999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.7e-40  Score=344.03  Aligned_cols=262  Identities=29%  Similarity=0.485  Sum_probs=215.7

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE--   82 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~--   82 (692)
                      +.+..++|.+.+.||+|+||.||+|.++.+|+.||+|.++...........+.+|++++++++||||+++++++.+..  
T Consensus         2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            456789999999999999999999999999999999999765444444566788999999999999999999986554  


Q ss_pred             --------EEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEE
Q 005526           83 --------KIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKI  153 (692)
Q Consensus        83 --------~l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL  153 (692)
                              .+++|+||+++ ++..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---~~kl  157 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---QIKL  157 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---cEEe
Confidence                    89999999987 777777654 4689999999999999999999999999999999999998877   5999


Q ss_pred             eccccccccCCCC--CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 005526          154 GDFGFARSLTPQD--LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR  230 (692)
Q Consensus       154 ~DFGlA~~~~~~~--~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~  230 (692)
                      +|||++.......  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+.+..+.......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999997664332  1222356788999998865 457889999999999999999999999877666555544321110


Q ss_pred             C----C---------------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          231 F----P---------------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       231 ~----p---------------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .    +                     ...+..++..+.+++.+||+.||.+|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0    0                     01123468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.4e-40  Score=347.02  Aligned_cols=256  Identities=26%  Similarity=0.513  Sum_probs=217.9

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ..|.....||+|+||.||++.+..+++.||+|++.....  .....+.+|+.+++.++||||+++++++..++..|+|||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            445566789999999999999999999999999865432  234668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~  168 (692)
                      |+++++|..++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++....... ..
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~---~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG---RVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC---cEEEeechhHhhcccccccc
Confidence            9999999997755 5789999999999999999999999999999999999998877   59999999987554322 23


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+......  ........+.++.++++
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP--KLKNAHKISPVLRDFLE  252 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--CccccCCCCHHHHHHHH
Confidence            4567899999999999889999999999999999999999999887776666555332211  11223467889999999


Q ss_pred             HhhccCCCCCCCHHHHHhchhhhhh
Q 005526          249 CLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +||+.+|.+||++.++++||||.+.
T Consensus       253 ~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         253 RMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HHhcCCcccCcCHHHHhhChhhccC
Confidence            9999999999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-39  Score=342.04  Aligned_cols=250  Identities=28%  Similarity=0.471  Sum_probs=209.6

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCc--EEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGI--EVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~--~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ++|.+.+.||+|+||+||+|....++.  .+++|.+... ......+.+.+|+.++.++ +||||+++++++...+.+|+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            589999999999999999999887765  4688877532 2334456788999999999 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCe
Q 005526           87 VLEYCDGGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPV  150 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~  150 (692)
                      ||||+++++|.+++.+..                .+++..++.++.||+.||+|||++||+||||||+|||++.++   .
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~---~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL---A  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC---e
Confidence            999999999999997642                478899999999999999999999999999999999998876   5


Q ss_pred             EEEeccccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 005526          151 LKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTEL  229 (692)
Q Consensus       151 vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~  229 (692)
                      +||+|||++..............+..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~  237 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM  237 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence            99999999865332211122233457999999998899999999999999999997 99999998887777766544322


Q ss_pred             CCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          230 RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       230 ~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ..    ...++.++.+|+.+||+.||.+|||++++++.
T Consensus       238 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         238 EK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22    24578899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-39  Score=339.25  Aligned_cols=257  Identities=25%  Similarity=0.454  Sum_probs=213.6

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~   82 (692)
                      ..++|.+.++||+|+||.||+|.++.     .+..||+|.+.... .......+.+|+.+++.++||||+++++++..++
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34789999999999999999997652     35589999886543 2233456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEE
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHG----------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK  152 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~----------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vK  152 (692)
                      ..|+||||+++|+|.+++...+          .++...+..++.||+.||.|||++||+||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~---~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF---TVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC---cEE
Confidence            9999999999999999997532          246678899999999999999999999999999999999876   599


Q ss_pred             EeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 005526          153 IGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE  228 (692)
Q Consensus       153 L~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~  228 (692)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999976543221   122345678999999998899999999999999999998 8999998888777776655443


Q ss_pred             CCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh------chhhhh
Q 005526          229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN------HRFLGE  272 (692)
Q Consensus       229 ~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~------Hpf~~~  272 (692)
                      ...+    ...++.+.+++.+||+.||++|||+.++++      ||||..
T Consensus       240 ~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         240 LDQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            3332    355789999999999999999999999986      777654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-39  Score=339.33  Aligned_cols=249  Identities=30%  Similarity=0.513  Sum_probs=204.5

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeccCCCChHH-HHHHHHHH---HHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           17 RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV-SDNLLKEI---SILSTISHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~-~~~i~~Ev---~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      .||+|+||+||+|++..+++.||+|.+.+....... ......|.   .+++...||||+++++.+..++.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999999999999999999765433221 12233343   34455689999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccC
Q 005526           93 GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC  172 (692)
Q Consensus        93 GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~  172 (692)
                      ||+|..++...+.+++..++.++.|++.||.|||+++|+||||||+||+++.++   .+||+|||+++..... ......
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~---~~kl~dfg~~~~~~~~-~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG---HVRISDLGLACDFSKK-KPHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC---CEEEccCcCccccCcc-CCcCcC
Confidence            999999998888899999999999999999999999999999999999998876   5999999998765432 234567


Q ss_pred             CCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          173 GSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       173 GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~---~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      |++.|+|||++.+. .++.++||||+||++|+|++|+.||.+..   ..... .........+    ....+.++.+++.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~----~~~~s~~~~~li~  231 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVEL----PDSFSPELRSLLE  231 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhhccCCCC----CCcCCHHHHHHHH
Confidence            99999999998754 68999999999999999999999998763   22222 2222222222    2356899999999


Q ss_pred             HhhccCCCCCC-----CHHHHHhchhhhhhH
Q 005526          249 CLLRQNPVERI-----TFKEFFNHRFLGELR  274 (692)
Q Consensus       249 ~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~  274 (692)
                      +||..||.+||     ++.++++||||....
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999999     999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=335.12  Aligned_cols=251  Identities=25%  Similarity=0.469  Sum_probs=213.8

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~   82 (692)
                      ..++|.+.+.||+|+||.||++.++..     +..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            357899999999999999999988654     4889999986443 3344567889999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEE
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHG----------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK  152 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~----------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vK  152 (692)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.||.|||++||+||||||+|||++.++   .+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~---~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL---TVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC---CEE
Confidence            9999999999999999997532          367889999999999999999999999999999999999887   599


Q ss_pred             EeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 005526          153 IGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE  228 (692)
Q Consensus       153 L~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~  228 (692)
                      |+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            999999976543322   234456788999999988889999999999999999998 9999998888777776654433


Q ss_pred             CCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       229 ~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ...|    ...+.++.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 LDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3333    345889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=350.79  Aligned_cols=261  Identities=33%  Similarity=0.559  Sum_probs=211.2

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----E   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----~   82 (692)
                      +.++|.+.++||+|+||+||+|++..+|+.||||.+.... .......+.+|+.++++++||||+++++++...     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            5689999999999999999999999999999999986422 233456678899999999999999999886543     3


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .+|+|+||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++..
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~---~~kl~dfg~~~~~  156 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC---DLKICDFGLARIA  156 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC---CEEECcccceeec
Confidence            58999999975 88887744 5799999999999999999999999999999999999998877   5999999998765


Q ss_pred             CCCC----CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------
Q 005526          163 TPQD----LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL--------  229 (692)
Q Consensus       163 ~~~~----~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~--------  229 (692)
                      ....    ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+......        
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            4322    1234578999999998754 56889999999999999999999999877654433322211000        


Q ss_pred             -------------CCCC-----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          230 -------------RFPP-----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       230 -------------~~p~-----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                                   ....     ......++++.+++.+||+.||.+|||+.++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                         0000     01124578899999999999999999999999999997653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8e-40  Score=344.12  Aligned_cols=259  Identities=28%  Similarity=0.519  Sum_probs=219.8

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..++|.+.+.||+|+||+||++.+..+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            35899999999999999999999998999999999865422  2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      +||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++   .+||+|||++....... 
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~---~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC---CEEEccCcceeccccccc
Confidence            9999999999998654 688999999999999999999999999999999999998876   59999999987654333 


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dL  246 (692)
                      ......|++.|+|||.+....++.++|+|||||++|+|++|+.||...+.......+.......++  ....++..+.++
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l  248 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ--NPEKLSAIFRDF  248 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCC--CccccCHHHHHH
Confidence            233456889999999998888999999999999999999999999887665443333222222221  233567889999


Q ss_pred             HHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          247 CRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      +++||..+|.+||++.+++.|+||...+
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=333.15  Aligned_cols=250  Identities=26%  Similarity=0.455  Sum_probs=213.3

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ++|.+.+.||+|+||+||+|.+..+   ...||||.+.... .......+.+|+.++++++||||+++++.+..++..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            6799999999999999999998654   4579999886543 34455678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           87 VLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      ||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~---~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL---VCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC---CEEECccchhhccccc
Confidence            99999999999999764 4689999999999999999999999999999999999998876   5999999999876421


Q ss_pred             C-C--CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCH
Q 005526          166 D-L--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       166 ~-~--~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                      . .  .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+........    ....+.
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  235 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP----PMDCPS  235 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCH
Confidence            1 1  112334678999999998899999999999999999998 9999988887777766654432222    246788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      .+.+++.+||+.+|++||++.+++++
T Consensus       236 ~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         236 ALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.1e-40  Score=339.21  Aligned_cols=250  Identities=26%  Similarity=0.477  Sum_probs=206.4

Q ss_pred             eecCEEEEeEe--cccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEE
Q 005526            8 LIGEYIVGPRI--GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST-ISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         8 ~~~~Y~i~~~L--G~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~-L~HpNIVkl~~~~~~~~~l   84 (692)
                      +.++|.+.+.+  |.|+||.||++.++.++..||+|.+.......       .|+.+... .+||||+++++.+..++.+
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            45678887777  99999999999999999999999987543221       12222222 2799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      |+||||++|++|.+++..+..+++..++.++.|++.||.|||+.|++||||||+||+++.++.  .++|+|||+++....
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~  162 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD--RIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC--eEEEecCccceecCC
Confidence            999999999999999998889999999999999999999999999999999999999988763  599999999876543


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCCCCCCcccccCHHH
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~-~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      .   ....|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ...+....  ..+.......++.+
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  237 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNA  237 (267)
T ss_pred             C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHH
Confidence            2   345689999999999999999999999999999999999999986543321 11111111  11222334689999


Q ss_pred             HHHHHHhhccCCCCCCC-HHHHHhchhhh
Q 005526          244 VDLCRCLLRQNPVERIT-FKEFFNHRFLG  271 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpT-a~elL~Hpf~~  271 (692)
                      .+||.+||+.||.+||+ ++++++||||.
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            99999999999999996 69999999984

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-39  Score=336.60  Aligned_cols=254  Identities=28%  Similarity=0.543  Sum_probs=218.8

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      -|.+.++||.|+||.||+|.+..+++.||||.+..... ......+.+|+.++++++||||+++++.+..++..|+||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            47788999999999999999998999999999865432 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-CC
Q 005526           91 CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-AD  169 (692)
Q Consensus        91 ~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-~~  169 (692)
                      +++++|.+++.. +.+++..+..++.|++.+|.|||++|++|+||||+||+++.++   .++|+|||++........ ..
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~---~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG---EVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC---CEEEeecccceecccchhhhc
Confidence            999999999864 4689999999999999999999999999999999999998776   599999999876544322 23


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC  249 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~  249 (692)
                      ...++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....    +.....++.++.+++.+
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP----PTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC----CCCCcccCHHHHHHHHH
Confidence            45688999999999888889999999999999999999999988776655555433221    22234578899999999


Q ss_pred             hhccCCCCCCCHHHHHhchhhhhh
Q 005526          250 LLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       250 ~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ||+.+|.+||++.++++||||.+.
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhhh
Confidence            999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=342.69  Aligned_cols=259  Identities=28%  Similarity=0.520  Sum_probs=205.9

Q ss_pred             CEEEEeEecccCceEEEEEEEcC--CCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQ--LGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKIY   85 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~--tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~--~~l~   85 (692)
                      +|.+.++||+|+||.||+|.+..  +++.||+|.+.... ........+.+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  89999999997642 1223346678899999999999999999999887  8899


Q ss_pred             EEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCC-CcCeEEEeccccc
Q 005526           86 LVLEYCDGGDLAAYIHKH-----GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFA  159 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~-----~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~-~~~~vKL~DFGlA  159 (692)
                      +||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999976 777776532     2689999999999999999999999999999999999998722 1237999999999


Q ss_pred             cccCCCC----CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHh
Q 005526          160 RSLTPQD----LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ---------LFQNILT  225 (692)
Q Consensus       160 ~~~~~~~----~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~---------~~~~i~~  225 (692)
                      +......    ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.....         .+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            8654322    1234578899999998876 457899999999999999999999998654321         1111111


Q ss_pred             c-------------------------cCCCCCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          226 S-------------------------TELRFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       226 ~-------------------------~~~~~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .                         ....++.       ..+...+.++.+++.+||+.||++|||+.|++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            0                         0000110       0001466789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-39  Score=344.83  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=209.2

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcE----EEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIE----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~----vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      ..+|++.+.||+|+||+||+|++..++..    ||||.+... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            46899999999999999999998766554    899998643 3345567888999999999999999999988754 57


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           85 YLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      ++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~---~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC---cEEEcccccccccc
Confidence            8999999999999999875 4588999999999999999999999999999999999998876   59999999998765


Q ss_pred             CCCCC---CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          164 PQDLA---DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       164 ~~~~~---~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      .....   ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+........+    ...
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~  236 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP----PIC  236 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCC----CCC
Confidence            43321   22334668999999999999999999999999999997 99999988776655444333222222    356


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +.++.+++.+||..||.+||++.+++.+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.1e-39  Score=341.20  Aligned_cols=257  Identities=28%  Similarity=0.457  Sum_probs=214.3

Q ss_pred             CCCcceecCEEEEeEecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceE
Q 005526            3 PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQ-------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRF   74 (692)
Q Consensus         3 p~~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl   74 (692)
                      |......++|.+++.||+|+||.||++++..       +...||+|.+.... .......+.+|+++++.+ +||||+++
T Consensus        11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            4455566899999999999999999998643       23579999987543 334456788899999999 79999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 005526           75 FEAIETREKIYLVLEYCDGGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQ  138 (692)
Q Consensus        75 ~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~  138 (692)
                      ++++...+..|+||||+.+|+|.+++..+.                .+++..+..++.|++.||+|||++|++||||||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            999999999999999999999999997642                4788999999999999999999999999999999


Q ss_pred             ceEecCCCCcCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 005526          139 NLLVSTNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGS  214 (692)
Q Consensus       139 NILL~~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~  214 (692)
                      ||+++.++   .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       170 Nill~~~~---~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~  246 (307)
T cd05098         170 NVLVTEDN---VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  246 (307)
T ss_pred             heEEcCCC---cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence            99998876   599999999976543221   112234568999999998899999999999999999998 99999888


Q ss_pred             CHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          215 NQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       215 ~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +..+....+........    ....+.++.+|+.+||..+|.+|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         247 PVEELFKLLKEGHRMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CHHHHHHHHHcCCCCCC----CCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            87766666544432222    24678899999999999999999999999774

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-39  Score=338.41  Aligned_cols=254  Identities=28%  Similarity=0.496  Sum_probs=214.8

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIE   79 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~   79 (692)
                      ..-.++|.+.+.||+|+||.||++.+...     ...+|+|.+.... ..+....+.+|+.+++++ +|+||+++++++.
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34457899999999999999999987643     3789999987543 334456788999999999 8999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEec
Q 005526           80 TREKIYLVLEYCDGGDLAAYIHKH----------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVS  143 (692)
Q Consensus        80 ~~~~l~LVmEy~~GGsL~~~L~~~----------------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~  143 (692)
                      .++.++++|||+++|+|..++...                +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999999999999653                3578999999999999999999999999999999999998


Q ss_pred             CCCCcCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 005526          144 TNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQL  219 (692)
Q Consensus       144 ~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~  219 (692)
                      .++   .+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus       167 ~~~---~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         167 EDH---VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             CCC---eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            776   699999999987653321   122334567999999999999999999999999999997 9999999888777


Q ss_pred             HHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          220 FQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       220 ~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +..+........+    ...+.++.+|+.+||..||++|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEGYRMEKP----QNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcCCcCCCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            7766554333222    3567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-39  Score=349.45  Aligned_cols=263  Identities=30%  Similarity=0.523  Sum_probs=218.9

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE---   82 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~---   82 (692)
                      ..+.++|.+++.||+|+||.||++.+..+|+.||||++............+.+|+.+++.++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            35678999999999999999999999999999999998765445555667889999999999999999999986543   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccc
Q 005526           83 ---KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA  159 (692)
Q Consensus        83 ---~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA  159 (692)
                         .+++||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~---~~kl~dfg~~  165 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC---ELKILDFGLA  165 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeecccc
Confidence               468999999 7799888864 5799999999999999999999999999999999999998776   5999999999


Q ss_pred             cccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Q 005526          160 RSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR--------  230 (692)
Q Consensus       160 ~~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~--------  230 (692)
                      ......  .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+.++.......        
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            765432  234567899999999876 458899999999999999999999999887665555443321100        


Q ss_pred             -----------CC-------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          231 -----------FP-------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       231 -----------~p-------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                                 .+       .......++++.++|.+||+.||.+|||+.+++.||||+..+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                       00       0112356788999999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.4e-39  Score=331.15  Aligned_cols=247  Identities=28%  Similarity=0.509  Sum_probs=210.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|+++++||+|+||.||+|.+. ++..||+|.+....   ...+.+.+|+.++++++|+||+++++.+...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            578999999999999999999875 46789999876532   23567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+++++|.+++.+.  ..+++..+..++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL---MCKIADFGLARVIEDNE  157 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC---cEEECCCccceecCCCc
Confidence            999999999999764  4588999999999999999999999999999999999998876   59999999998764332


Q ss_pred             C--CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          167 L--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       167 ~--~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      .  .....++..|+|||++....++.++|||||||++|+|++ |+.||...........+......  +  ....++.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~  233 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM--P--RMENCPDEL  233 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--C--CCCCCCHHH
Confidence            1  122345678999999998889999999999999999998 99999988877777666544322  2  224678899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+++.+||..+|++||+++++.+
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999854

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.9e-39  Score=331.42  Aligned_cols=248  Identities=23%  Similarity=0.462  Sum_probs=210.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.+.||+|+||+||++.... +..+|||.+......   ...+.+|+.++++++||||+++++++...+.+++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            3679999999999999999998754 557999998754332   356889999999999999999999999889999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||+.+|+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++   .+||+|||.++.......
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~---~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG---CVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC---CEEECCCccceecCCCce
Confidence            999999999999774 4689999999999999999999999999999999999998776   599999999876543322


Q ss_pred             C--CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 A--DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 ~--~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      .  ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+.......+........+    ...+..+.
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  231 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP----HLASEKVY  231 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC----CCCCHHHH
Confidence            1  12234567999999998889999999999999999998 99999988877777766554332222    34678999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhc
Q 005526          245 DLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +++.+||+.||.+|||+.+++.+
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-39  Score=333.79  Aligned_cols=252  Identities=28%  Similarity=0.605  Sum_probs=212.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      +++|.+.+.||+|+||.||++++..+++.||||.+.... ........+.+|+.+++.++||||+++++++..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            368999999999999999999999999999999886532 2334456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           88 LEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        88 mEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      |||++|++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++   .++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~---~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---CEEECcchhhhccc
Confidence            999999999999874    34589999999999999999999999999999999999998776   59999999987654


Q ss_pred             CCC-CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCCCCCCcccccC
Q 005526          164 PQD-LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ--LQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       164 ~~~-~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~--~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      ... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+...  ......+...   ..++......+
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  234 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DYPPLPSDHYS  234 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC---CCCCCCccccc
Confidence            332 23345789999999999988899999999999999999999999976543  2333333322   22333334678


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .++.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         235 EELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            89999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-39  Score=341.58  Aligned_cols=256  Identities=27%  Similarity=0.462  Sum_probs=216.9

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ...+|.+.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+++++.++||||+++++++...+..|+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            4567999999999999999999999999999999986543 233445678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           87 VLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      ||||+.| +|.+++.. .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++   .+||+|||++......
T Consensus        93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~---~~kL~dfg~~~~~~~~  168 (307)
T cd06607          93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG---TVKLADFGSASLVSPA  168 (307)
T ss_pred             EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC---CEEEeecCcceecCCC
Confidence            9999975 77777654 45689999999999999999999999999999999999998877   5999999998765432


Q ss_pred             CCCCccCCCCCccChHhhh---hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          166 DLADTLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~---~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                         ....+++.|+|||++.   ...++.++||||||+++|+|++|++||.+.+.......+........+   ....+.+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  242 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS---SNDWSDY  242 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC---chhhCHH
Confidence               3457889999999874   456888999999999999999999999988776655555433222222   2346788


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +.+++.+||..||++||++.+++.||||...
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-39  Score=349.29  Aligned_cols=260  Identities=32%  Similarity=0.573  Sum_probs=212.8

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR------   81 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~------   81 (692)
                      +.++|.+.+.||.|+||+||+|.+..+|+.||+|.+.....  ...+.+.+|++++++++||||+++++++...      
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            46899999999999999999999999999999999866533  3456788999999999999999999876543      


Q ss_pred             --------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEE
Q 005526           82 --------EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKI  153 (692)
Q Consensus        82 --------~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL  153 (692)
                              ..+|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.  .+||
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~--~~kl  156 (342)
T cd07854          81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL--VLKI  156 (342)
T ss_pred             ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc--eEEE
Confidence                    358999999975 89888854 47899999999999999999999999999999999999976543  6899


Q ss_pred             eccccccccCCCC----CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 005526          154 GDFGFARSLTPQD----LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE  228 (692)
Q Consensus       154 ~DFGlA~~~~~~~----~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~  228 (692)
                      +|||+++......    ......++..|+|||++.. ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999997654221    1123467889999998754 5688899999999999999999999988876665555443221


Q ss_pred             CCCC-------------------------CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          229 LRFP-------------------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       229 ~~~p-------------------------~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ...+                         ......++.++.+|+++||+.||.+|||+.+++.||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            1100                         01123567889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.7e-39  Score=329.25  Aligned_cols=251  Identities=29%  Similarity=0.593  Sum_probs=212.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|.++... ........+.+|++++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999986533 33444678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           89 EYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        89 Ey~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.++   .++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~---~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG---VVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC---cEEEeccceeeeccC
Confidence            99999999999864    24589999999999999999999999999999999999998877   499999999876543


Q ss_pred             CC-CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCCCCCcccccCH
Q 005526          165 QD-LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN--QLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       165 ~~-~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~--~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                      .. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....  .......+.....   ++......+.
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY---PPLPADHYSE  235 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC---CCCChhhcCH
Confidence            32 2334578999999999998899999999999999999999999996543  2233344333222   2222235678


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ++.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-39  Score=338.02  Aligned_cols=251  Identities=23%  Similarity=0.427  Sum_probs=213.1

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      ..+|++.++||+|+||+||+|.+..+     ++.||||++.... .......+.+|+.++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            35688999999999999999987543     5789999997543 33455678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC
Q 005526           84 IYLVLEYCDGGDLAAYIHKH----------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV  147 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~----------------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~  147 (692)
                      .++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||++.++ 
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~-  161 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL-  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC-
Confidence            99999999999999998532                2478888999999999999999999999999999999998776 


Q ss_pred             cCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005526          148 TPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNI  223 (692)
Q Consensus       148 ~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i  223 (692)
                        .+||+|||+++.......   .....+++.|+|||.+....++.++|||||||++|||++ |..||.+....+....+
T Consensus       162 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         162 --NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             --ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence              499999999886543321   234456789999999988889999999999999999998 99999998888777777


Q ss_pred             HhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          224 LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       224 ~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ........+    ...+.++.+|+.+||+.+|.+||++.+++..
T Consensus       240 ~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQVLPCP----DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCcCCCC----CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            655433322    4678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.6e-40  Score=350.63  Aligned_cols=264  Identities=31%  Similarity=0.580  Sum_probs=218.0

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe--CC
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET--RE   82 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~--~~   82 (692)
                      .++.++|.+.+.||+|+||.||+|.+..+|+.||||.+............+.+|+.+++++ +||||+++++++..  +.
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            4678899999999999999999999998999999998865444444456778899999999 99999999998854  34


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .+|+||||+.+ +|..++... .+++...+.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++..
T Consensus        83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~---~~kl~d~g~~~~~  157 (337)
T cd07852          83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC---RVKLADFGLARSL  157 (337)
T ss_pred             eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---cEEEeeccchhcc
Confidence            78999999975 999998776 789999999999999999999999999999999999999887   5999999999765


Q ss_pred             CCCC------CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------
Q 005526          163 TPQD------LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL------  229 (692)
Q Consensus       163 ~~~~------~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~------  229 (692)
                      ....      ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            4322      2234578999999998754 55788999999999999999999999887665544443222110      


Q ss_pred             --------------------CCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          230 --------------------RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       230 --------------------~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                                          .........++.++.++|.+||+.||.+|||+.++++|||++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence                                001111234688999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.3e-39  Score=336.42  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=212.2

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCC----------------cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcc
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLG----------------IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII   72 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg----------------~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIV   72 (692)
                      .++|+++++||+|+||.||+|.+...+                ..||+|.+.... .......+.+|++++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            468999999999999999999876543                568999987543 335567889999999999999999


Q ss_pred             eEEEEEEeCCEEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceE
Q 005526           73 RFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-----------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLL  141 (692)
Q Consensus        73 kl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~-----------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NIL  141 (692)
                      ++++++..++..+++|||+.+++|.+++....           .+++..++.++.|++.||.|||++||+||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            99999999999999999999999999998765           6899999999999999999999999999999999999


Q ss_pred             ecCCCCcCeEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh--CCCCCCCCCH
Q 005526          142 VSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT--GKPPFDGSNQ  216 (692)
Q Consensus       142 L~~~~~~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt--G~~PF~~~~~  216 (692)
                      ++.++   .++|+|||+++......   ......+++.|+|||++.+..++.++|||||||++|+|++  |..||...+.
T Consensus       163 i~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         163 VGKNY---TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ecCCC---ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99876   59999999997654332   2334556788999999998889999999999999999998  7889988777


Q ss_pred             HHHHHHHHhcc---CCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          217 LQLFQNILTST---ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       217 ~~~~~~i~~~~---~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+.+.++....   ............+.++.+++.+||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66666554321   111111122356789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-40  Score=360.16  Aligned_cols=254  Identities=28%  Similarity=0.523  Sum_probs=213.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .+|+++++||+||-+.||++.... .+.||+|.+.....+......+..|+..|.+| .|.+||+++||-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            579999999999999999998754 67788888877778889999999999999999 5899999999998999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCH-HHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           89 EYCDGGDLAAYIHKHGKVSE-AVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse-~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      ||=+. ||..+|+++....+ -.++.+.+|++.+++++|+.||||.||||.|+|+-.+    .+||+|||+|..+..+. 
T Consensus       440 E~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG----~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG----RLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee----eEEeeeechhcccCcccc
Confidence            98655 99999998876543 6899999999999999999999999999999999754    59999999998876543 


Q ss_pred             --CCCccCCCCCccChHhhhhcC-----------CCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc-cCCCC
Q 005526          167 --LADTLCGSPLYMAPEIIQNHK-----------YDAKADLWSVGAILFQLVTGKPPFDGSN-QLQLFQNILTS-TELRF  231 (692)
Q Consensus       167 --~~~~~~GT~~YmAPEvl~~~~-----------ys~ksDIWSLGviLyeLltG~~PF~~~~-~~~~~~~i~~~-~~~~~  231 (692)
                        ...+.+||+.||+||.+....           .+.++||||||||||+|+.|++||.... ....+..|... ..+.|
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief  594 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF  594 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence              346789999999999986433           4578999999999999999999997654 33444444332 23344


Q ss_pred             CCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       232 p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      |...   -..+++++++.||++||++||++.++|+|||++-
T Consensus       595 p~~~---~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  595 PDIP---ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cCCC---CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            4321   1234999999999999999999999999999864

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=336.32  Aligned_cols=255  Identities=32%  Similarity=0.610  Sum_probs=216.5

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      |.+.+.||.|++|.||++.+..+++.+++|.+............+.+|+.++++++|+||+++++++..++.+++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999999999999999999776555455678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CCC
Q 005526           92 DGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LAD  169 (692)
Q Consensus        92 ~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~~  169 (692)
                      ++ +|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++   .+||+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~---~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG---VLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC---cEEEeeeeeeEecCCCccccc
Confidence            86 888887664 6789999999999999999999999999999999999999776   59999999997765443 223


Q ss_pred             ccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------------------
Q 005526          170 TLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR------------------  230 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~------------------  230 (692)
                      ...++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+.+.++.......                  
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            35678899999998876 78999999999999999999999999888766655543321110                  


Q ss_pred             CCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          231 FPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       231 ~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ++.       .....++.++.++|++||++||.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            000       1123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=335.95  Aligned_cols=255  Identities=36%  Similarity=0.662  Sum_probs=216.3

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      |++.+.||+|+||.||+|++..+++.||+|++..........+.+.+|+.++++++|+||+++++++...+.+++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67889999999999999999999999999999876544455577888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CCC
Q 005526           92 DGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LAD  169 (692)
Q Consensus        92 ~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~~  169 (692)
                      ++ +|.+++.+. ..+++..++.++.|++.||.|||++||+||||+|+||+++.++   .+||+|||+++...... ...
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~---~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG---VLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC---CEEEecCCcccccCCCccccC
Confidence            85 899999887 5799999999999999999999999999999999999999876   59999999997764332 233


Q ss_pred             ccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-----------------CCC
Q 005526          170 TLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-----------------LRF  231 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~  231 (692)
                      ...++..|+|||.+... .++.++|||||||++|+|++|++||.+.+....+.++.....                 ..+
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            44567889999998766 789999999999999999999999998887666555432110                 001


Q ss_pred             CC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          232 PP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       232 p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +.       .....++..+.+++++||..||.+||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            10       1122347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=334.42  Aligned_cols=255  Identities=33%  Similarity=0.592  Sum_probs=214.1

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEe
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKIYLVLE   89 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~--~~l~LVmE   89 (692)
                      |.+.++||.|+||.||+|.+..+++.||+|.+............+.+|+++++.++||||+++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            7889999999999999999999999999999987643444556788999999999999999999999887  89999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--  166 (692)
Q Consensus        90 y~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--  166 (692)
                      |+++ +|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++   .+||+|||++.......  
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~---~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG---VLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC---CEEEccccceeeccCCCcc
Confidence            9985 899888765 5799999999999999999999999999999999999999877   59999999998765443  


Q ss_pred             CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----CC--------
Q 005526          167 LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF----PP--------  233 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~----p~--------  233 (692)
                      ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+........    +.        
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            2233467889999998764 4678999999999999999999999998887666555543211100    00        


Q ss_pred             -------------Ccccc-cCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          234 -------------GAIEE-LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       234 -------------~~~~~-ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                                   ..... +++++.+++++||..||.+||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         00112 37899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.6e-39  Score=344.25  Aligned_cols=261  Identities=30%  Similarity=0.518  Sum_probs=213.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCC--CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CCE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQL--GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET----REK   83 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~t--g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~----~~~   83 (692)
                      +|.+.+.||+|+||.||++++..+  +..||+|.+............+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999988  89999999875443344456788899999999 59999999987533    246


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +|+++||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~---~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC---ELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC---CEEeCcCCCceecc
Confidence            889999986 58999998888899999999999999999999999999999999999998876   59999999997654


Q ss_pred             CCC-----CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-------
Q 005526          164 PQD-----LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR-------  230 (692)
Q Consensus       164 ~~~-----~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~-------  230 (692)
                      ...     ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.......       
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            321     1234578999999998765 568999999999999999999999998876554444332211000       


Q ss_pred             ---------------CC----CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          231 ---------------FP----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       231 ---------------~p----~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                                     .+    .......+..+.+|+.+||+.||.+|||+.+++.|||+++.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                           00    0112345789999999999999999999999999999977654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-39  Score=334.73  Aligned_cols=246  Identities=30%  Similarity=0.567  Sum_probs=206.9

Q ss_pred             EEEeEecccCceEEEEEEEc----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           13 IVGPRIGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~----~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .+.+.||.|.||.||+|...    ..+..|+||.+.. .......+.+.+|++++++++||||+++++++...+..++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence            46889999999999999988    3567899999954 334455788999999999999999999999999888899999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||++|+|.++|...  ..+++.....|+.||+.||.|||+++|+||||+++||+++.++   .+||+|||+++......
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~---~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG---QVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT---EEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc
Confidence            999999999999987  6799999999999999999999999999999999999999877   69999999998763222


Q ss_pred             ---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          167 ---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       167 ---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                         ......+...|+|||.+....++.++||||||+++|||++ |+.||...+..+....+........+    ...+..
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  233 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP----DNCPKD  233 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB----TTSBHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceec----cchhHH
Confidence               2233456778999999999999999999999999999999 78999999888888887655543333    457889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.+++.+||..||++|||+.++++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-39  Score=346.97  Aligned_cols=261  Identities=29%  Similarity=0.502  Sum_probs=214.8

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----   81 (692)
                      .+.++|.+.+.||+|+||.||++.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            456899999999999999999999999999999999976544444456788899999999999999999987543     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                       ...|++++++ |++|.++++. ..+++..++.++.|++.||+|||++||+||||||+||+++.++   .+||+|||+++
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---~~kl~dfg~~~  168 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC---ELKILDFGLAR  168 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC---CEEEecccccc
Confidence             3478888887 7799888765 4699999999999999999999999999999999999999877   59999999987


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL----------  229 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~----------  229 (692)
                      ....  ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+......          
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            6432  2344678999999999866 56889999999999999999999999887765554443321110          


Q ss_pred             ------------CCCC----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          230 ------------RFPP----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       230 ------------~~p~----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                                  ..+.    ......++++.+||.+||+.||.+||++.+++.||||.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence                        0000    11123578899999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-39  Score=341.89  Aligned_cols=250  Identities=20%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCHHHHHH
Q 005526           22 SFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH  101 (692)
Q Consensus        22 sFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~  101 (692)
                      ++|.||++++..+++.||||++............+.+|+++++.++||||+++++++...+..+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            44566777777789999999998765556667889999999999999999999999999999999999999999999998


Q ss_pred             Hc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--------CCCcc
Q 005526          102 KH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--------LADTL  171 (692)
Q Consensus       102 ~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--------~~~~~  171 (692)
                      ..  ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||.+.......        .....
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~---~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG---KVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC---ceEEecCccceeeccccccccccccccccc
Confidence            64  4689999999999999999999999999999999999999876   59999999886543221        12345


Q ss_pred             CCCCCccChHhhhh--cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------C-------------
Q 005526          172 CGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL------R-------------  230 (692)
Q Consensus       172 ~GT~~YmAPEvl~~--~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~------~-------------  230 (692)
                      .++..|+|||++..  ..|+.++||||+||++|+|++|+.||..............+...      .             
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            57788999999876  46889999999999999999999999876654433222211100      0             


Q ss_pred             ----------CCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          231 ----------FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       231 ----------~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                                .+......++.++.+|+++||..||++|||++++++||||...+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                      00001123356789999999999999999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-39  Score=347.85  Aligned_cols=261  Identities=30%  Similarity=0.534  Sum_probs=215.4

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----   81 (692)
                      ++.++|.+.+.||+|+||.||+|++..+|+.||||.+............+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            457899999999999999999999999999999999976544444456788999999999999999999998654     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           82 -EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 -~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                       ..+|+|+||+.+ +|..++  ...+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~---~~kL~dfg~~~  165 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC---ELKILDFGLAR  165 (342)
T ss_pred             CceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEeeCCCCc
Confidence             356999999975 777665  34689999999999999999999999999999999999999876   59999999987


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR---------  230 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~---------  230 (692)
                      ....  ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.......         
T Consensus       166 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         166 HADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            6532  2234577899999999876 468899999999999999999999999887665555444321110         


Q ss_pred             -------------CCCC----cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          231 -------------FPPG----AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       231 -------------~p~~----~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                                   ++..    .....++++.+||++||+.||.+||++.+++.||||...+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                         0100    11246788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-39  Score=331.68  Aligned_cols=250  Identities=25%  Similarity=0.462  Sum_probs=215.1

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      +--.+|.++++||.|+||.||+|.+.. ++.+++|.+....  ......+.+|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            345689999999999999999999987 8999999987643  2335678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           87 VLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~---~~kl~d~g~~~~~~~  156 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL---VCKVADFGLARLIKE  156 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc---eEEEccccchhhcCC
Confidence            99999999999999763  4589999999999999999999999999999999999998876   599999999976543


Q ss_pred             CCC-CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          165 QDL-ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       165 ~~~-~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      ... .....++..|+|||++....++.++|||||||++|+|++ |+.||.+.+..+.+..+........    ....+++
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  232 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC----PAKCPQE  232 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC----CCCCCHH
Confidence            221 223345678999999998899999999999999999998 8999999888777777664433222    2467889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         233 IYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.1e-39  Score=330.16  Aligned_cols=246  Identities=25%  Similarity=0.454  Sum_probs=207.8

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.++||+|+||+||+|++..+ ..||+|++......   ...+.+|+.+++.++||||+++++.+. .+..|+||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence            47899999999999999999988765 56999998754332   356788999999999999999999874 45689999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+++|+|.+++.+.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||.++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~---~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLARLIEDNE  156 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC---cEEeccCCceeeccccc
Confidence            999999999999764  3579999999999999999999999999999999999998876   59999999997664333


Q ss_pred             C--CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          167 L--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       167 ~--~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      .  .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+........    ....+..+
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l  232 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC----PPECPESL  232 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC----ccccCHHH
Confidence            2  123346678999999988899999999999999999999 8999998887777766654332222    24678899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+++.+||++||++||++.++++
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         233 HDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.3e-39  Score=335.46  Aligned_cols=249  Identities=27%  Similarity=0.511  Sum_probs=210.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      .++|.+.+.||+|+||.||+|.+..     ++..+++|.+...  .....+.+.+|++++++++||||+++++++..++.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            4679999999999999999998543     4567999988543  23344678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV  147 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~  147 (692)
                      .++||||+++++|.+++..++                .+++..++.++.||+.||.|||++||+||||||+|||++.++ 
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~-  160 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-  160 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-
Confidence            999999999999999997643                378999999999999999999999999999999999999876 


Q ss_pred             cCeEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 005526          148 TPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNI  223 (692)
Q Consensus       148 ~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i  223 (692)
                        .+||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+
T Consensus       161 --~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         161 --LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             --cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              59999999997654322   2234456788999999999999999999999999999998 99999888877766665


Q ss_pred             HhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          224 LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       224 ~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .......    .....+..+.+++.+||++||.+|||+.++++
T Consensus       239 ~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            4433222    22356789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-39  Score=328.77  Aligned_cols=247  Identities=25%  Similarity=0.445  Sum_probs=210.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|.++....   ..+.+.+|+.++++++||||+++++++...+..|+||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            3679999999999999999999754 67899999875432   2456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++......
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~---~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN---ICKVADFGLARVIKEDI  157 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC---CEEECCcceEEEccCCc
Confidence            9999999999997754  689999999999999999999999999999999999999877   59999999998765322


Q ss_pred             CCC--ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          167 LAD--TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       167 ~~~--~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      ...  ...++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+.......    .....+..+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  233 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP----CPPGCPKEL  233 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCcCCHHH
Confidence            111  1123457999999998899999999999999999999 999999988877777665443222    224568899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+++.+||+.||.+||++.+++.
T Consensus       234 ~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         234 YDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-39  Score=329.43  Aligned_cols=247  Identities=25%  Similarity=0.508  Sum_probs=209.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .+|++.+.||+|+||.||+++++ ++..+|+|.+......   ...+.+|+++++.++||||+++++++...+..|+|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            46899999999999999999886 4778999998654332   3467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |++|++|.+++..+ ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~---~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN---VVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC---cEEECCcccceeccccccc
Confidence            99999999999764 4689999999999999999999999999999999999999876   5999999999765432211


Q ss_pred             C--ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          169 D--TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       169 ~--~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                      .  ...++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+........+    ...+.++.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  232 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP----KLAPTEVYT  232 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHH
Confidence            1  1123457999999999999999999999999999999 89999988877776666544332222    357889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHhc
Q 005526          246 LCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ++.+||..+|++|||+.++++.
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.8e-39  Score=334.63  Aligned_cols=258  Identities=30%  Similarity=0.560  Sum_probs=222.9

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..+.|++.+.||.|+||.||++.+..++..|++|++.....   ....+.+|+++++.++|+||+++++.+..++..|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            45679999999999999999999998999999999976432   456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           88 LEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      +||++|++|.+++.... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++   .++|+|||++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG---SVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC---CEEECccchhhhhccch
Confidence            99999999999998876 899999999999999999999999999999999999999876   59999999986554322


Q ss_pred             -CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 -LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 -~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                       ......+++.|++||++.+..++.++|+|||||++|+|++|+.||...+.......+.........  ....++.++.+
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~  248 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK--NPEKWSPEFKD  248 (286)
T ss_pred             hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc--chhhCCHHHHH
Confidence             223456788999999999888999999999999999999999999988776655554433222221  12347889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +|.+||+.+|.+|||+.+++.|+||...
T Consensus       249 li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         249 FLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            9999999999999999999999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3e-39  Score=345.42  Aligned_cols=263  Identities=30%  Similarity=0.523  Sum_probs=215.8

Q ss_pred             ceecCEEE-EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH------------HHHHHHHHHHHHHhCCCCCcce
Q 005526            7 RLIGEYIV-GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK------------VSDNLLKEISILSTISHPNIIR   73 (692)
Q Consensus         7 ~~~~~Y~i-~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~------------~~~~i~~Ev~iL~~L~HpNIVk   73 (692)
                      .+.++|.. .+.||.|+||+||+|++..+++.||||.+........            ....+.+|+++++.++||||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            45678875 5779999999999999999999999999865432210            0124678999999999999999


Q ss_pred             EEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEE
Q 005526           74 FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKI  153 (692)
Q Consensus        74 l~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL  153 (692)
                      +++++..++..++||||+. |+|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++   .+||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~---~~kl  160 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG---ICKI  160 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC---CEEE
Confidence            9999999999999999997 59999998888899999999999999999999999999999999999998876   5999


Q ss_pred             eccccccccCCC---------------CCCCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 005526          154 GDFGFARSLTPQ---------------DLADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQL  217 (692)
Q Consensus       154 ~DFGlA~~~~~~---------------~~~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~  217 (692)
                      +|||+++.....               .......+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999765411               111233568889999998764 4689999999999999999999999998877


Q ss_pred             HHHHHHHhccCCC----CC----------------C---CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          218 QLFQNILTSTELR----FP----------------P---GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       218 ~~~~~i~~~~~~~----~p----------------~---~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ..+..+.......    ++                .   ......+.++.++|.+||+.||++|||+++++.||||+..
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            6665554321100    00                0   0112457889999999999999999999999999999643

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.9e-39  Score=336.88  Aligned_cols=257  Identities=27%  Similarity=0.456  Sum_probs=215.6

Q ss_pred             CCCcceecCEEEEeEecccCceEEEEEEEc-------CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceE
Q 005526            3 PNRTRLIGEYIVGPRIGSGSFAVVWRARHR-------QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRF   74 (692)
Q Consensus         3 p~~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~-------~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl   74 (692)
                      |......++|.+.+.||+|+||.||+|++.       .++..||+|.+.... .......+.+|+.+++.+ +||||+++
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhe
Confidence            445556789999999999999999999753       234579999886542 334457788999999999 89999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 005526           75 FEAIETREKIYLVLEYCDGGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQ  138 (692)
Q Consensus        75 ~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~  138 (692)
                      ++++......|+||||+.+|+|.+++....                .++...+..++.||+.||.|||++||+||||||+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  166 (304)
T cd05101          87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR  166 (304)
T ss_pred             eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence            999999999999999999999999997642                3678889999999999999999999999999999


Q ss_pred             ceEecCCCCcCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 005526          139 NLLVSTNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGS  214 (692)
Q Consensus       139 NILL~~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~  214 (692)
                      ||+++.++   .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       167 Nili~~~~---~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         167 NVLVTENN---VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             eEEEcCCC---cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99998776   599999999987643221   223445678999999999899999999999999999998 89999988


Q ss_pred             CHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          215 NQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       215 ~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +..+....+........    ....+.++.+|+.+||+.+|.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         244 PVEELFKLLKEGHRMDK----PANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CHHHHHHHHHcCCcCCC----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            88777776654433222    24678899999999999999999999999774

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-39  Score=348.40  Aligned_cols=260  Identities=30%  Similarity=0.513  Sum_probs=217.6

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE---
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK---   83 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~---   83 (692)
                      .+.++|.+.+.||+|+||+||+|++..+++.||||++............+.+|+.+++.++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            35689999999999999999999999999999999987654444455677889999999999999999988765544   


Q ss_pred             ---EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           84 ---IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        84 ---l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                         .++|+||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++.
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~---~~kL~dfg~~~  166 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC---ELKILDFGLAR  166 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---CEEEccccccc
Confidence               89999999 5699998875 5799999999999999999999999999999999999999876   59999999997


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF--------  231 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~--------  231 (692)
                      .....  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+........        
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65432  345578899999999865 4678999999999999999999999998877666655543221100        


Q ss_pred             --------------CC----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          232 --------------PP----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       232 --------------p~----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                                    ..    ......+.++.++|.+||..||.+|||+.+++.||||.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence                          00    0112458899999999999999999999999999999754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-38  Score=329.46  Aligned_cols=250  Identities=26%  Similarity=0.457  Sum_probs=211.8

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGI---EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .++|++.+.||+|+||.||+|.+..+++   .||||.+... ........+..|+.+++.++||||+++++++..++..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            4679999999999999999999887665   5999998654 34555678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~---~~kl~dfg~~~~~~~  158 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL---VCKVSDFGLSRFLED  158 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC---cEEECCCcccccccc
Confidence            999999999999999764 5689999999999999999999999999999999999998766   599999999876543


Q ss_pred             CCCCC----ccCC--CCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccc
Q 005526          165 QDLAD----TLCG--SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIE  237 (692)
Q Consensus       165 ~~~~~----~~~G--T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~  237 (692)
                      .....    ...+  +..|+|||.+....++.++|||||||++|||++ |..||...+.......+........    ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~  234 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP----PM  234 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC----cc
Confidence            22111    1111  347999999999999999999999999999886 9999998887777666644322222    24


Q ss_pred             ccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          238 ELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       238 ~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ..+..+.+++.+||+.+|.+||++++++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            56789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.8e-39  Score=330.59  Aligned_cols=252  Identities=31%  Similarity=0.605  Sum_probs=214.0

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccC---CCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~---~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      +|.+.+.||+|+||+||++.+..++..+++|+++..   .........+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            699999999999999999999888777777766532   22233345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           88 LEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        88 mEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.+    .+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~----~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN----LLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC----CEeecccCceeecC
Confidence            999999999998864    3568999999999999999999999999999999999999753    48999999987654


Q ss_pred             CC-CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          164 PQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       164 ~~-~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      .. .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.......    .....+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  232 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS----LPETYSRQ  232 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC----CcchhcHH
Confidence            32 33445678999999999988889999999999999999999999998877766666655433222    22467889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      +.++|.+||..||++||++.+++.||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=327.28  Aligned_cols=242  Identities=26%  Similarity=0.457  Sum_probs=204.9

Q ss_pred             eEecccCceEEEEEEEcCCC---cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           16 PRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg---~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      ++||+|+||.||+|+...++   ..||+|.+...... ...+.+.+|+.+++.+.||||+++++++. .+..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            47999999999999876654   78999999765443 45567889999999999999999999875 456899999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC----
Q 005526           93 GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA----  168 (692)
Q Consensus        93 GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~----  168 (692)
                      +|+|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++   .+||+|||+++........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~---~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH---QAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC---cEEeccccccceeecCCcccccc
Confidence            999999999888899999999999999999999999999999999999998877   5999999999866433211    


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI  247 (692)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+.......    .....+..+.+++
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li  231 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP----RPEECPQEIYSIM  231 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC----CCCCCCHHHHHHH
Confidence            11123467999999998899999999999999999998 999999888777666665443322    2246788999999


Q ss_pred             HHhhccCCCCCCCHHHHHh
Q 005526          248 RCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~  266 (692)
                      .+||..||++||++.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-39  Score=347.53  Aligned_cols=252  Identities=28%  Similarity=0.445  Sum_probs=205.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET-R   81 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~-~   81 (692)
                      .++|++++.||+|+||.||+|.+..     +++.||+|+++... .....+.+.+|+.++.++ +|+||+++++++.. +
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3589999999999999999997543     45789999987543 233456778899999999 89999999998754 5


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc----------------------------------------------------------
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKH----------------------------------------------------------  103 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~----------------------------------------------------------  103 (692)
                      ..++++|||+++++|.+++...                                                          
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            6789999999999999998642                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC---CCccCCCCCc
Q 005526          104 ---GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLY  177 (692)
Q Consensus       104 ---~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~Y  177 (692)
                         ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.......   .....++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~---~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC---cEEEeccccchhcccCcchhhccCCCCCccc
Confidence               2578899999999999999999999999999999999999766   599999999987543221   2234556789


Q ss_pred             cChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCC
Q 005526          178 MAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV  256 (692)
Q Consensus       178 mAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~  256 (692)
                      +|||++.+..++.++|||||||++|+|++ |..||.+....+.+..........   ......++++.+++.+||+.+|+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM---RAPEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC---CCCccCCHHHHHHHHHHccCChh
Confidence            99999999999999999999999999998 999998755444333333222111   11235678999999999999999


Q ss_pred             CCCCHHHHHhc
Q 005526          257 ERITFKEFFNH  267 (692)
Q Consensus       257 ~RpTa~elL~H  267 (692)
                      +||++.++++|
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.3e-39  Score=332.86  Aligned_cols=248  Identities=27%  Similarity=0.524  Sum_probs=211.1

Q ss_pred             cCEEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHR-----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      .+|.+.++||+|+||.||++...     .++..+++|.+...  .......+.+|+++++.++|+||+++++++..++..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            57889999999999999999743     35678999987643  345567889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcC
Q 005526           85 YLVLEYCDGGDLAAYIHKHG---------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~---------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~  149 (692)
                      +++|||+++++|.+++...+               .+++..+..++.||+.||.|||++||+||||||+|||+++++   
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~---  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL---  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC---
Confidence            99999999999999997653               478999999999999999999999999999999999998766   


Q ss_pred             eEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 005526          150 VLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT  225 (692)
Q Consensus       150 ~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~  225 (692)
                      .+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+..
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            599999999876543221   223345678999999999999999999999999999998 9999988887777776655


Q ss_pred             ccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       226 ~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ......+    ...++.+.+++.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~----~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         240 GRELERP----RTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CccCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5433322    357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-38  Score=329.94  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=209.2

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGI----EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      ...+|++.++||+|+||+||+|++..++.    .||+|++... ........+.+|+.+++.++||||+++++++.. ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            35789999999999999999999877766    4899988654 334456778899999999999999999998864 45


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .++++||+++|+|.+++..+ +.+++..+..++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~---~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN---HVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC---cEEECCCCceeec
Confidence            78999999999999999774 5689999999999999999999999999999999999998766   5999999999876


Q ss_pred             CCCCCC---CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccc
Q 005526          163 TPQDLA---DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       163 ~~~~~~---~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~  238 (692)
                      ......   ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+........    ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~  235 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ----PPI  235 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC----Ccc
Confidence            533221   22334678999999999999999999999999999998 9999988777665554443322222    235


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+.++.+++.+||+.||++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-39  Score=325.68  Aligned_cols=245  Identities=38%  Similarity=0.719  Sum_probs=216.1

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCH
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL   96 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL   96 (692)
                      ||.|+||.||++.+..+++.||+|++...... ......+..|+.++++++||||+++++.+..++.+|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999989999999999765432 23566888999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CCCCccCCCC
Q 005526           97 AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSP  175 (692)
Q Consensus        97 ~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~~~~~~GT~  175 (692)
                      .+++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++   .++|+|||++...... .......++.
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG---HIKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC---cEEEeecCcceecccCCCcccCCcCCc
Confidence            99999888899999999999999999999999999999999999998876   5999999999776543 3345567899


Q ss_pred             CccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCC
Q 005526          176 LYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP  255 (692)
Q Consensus       176 ~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP  255 (692)
                      .|++||.+.+..++.++|+||||+++|+|++|..||...+..+....+.. ....++    ...+..+.+++++||..||
T Consensus       158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~----~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFP----EFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCC----CCCCHHHHHHHHHHhcCCH
Confidence            99999999888889999999999999999999999988887666666654 223333    3558899999999999999


Q ss_pred             CCCCCH---HHHHhchhh
Q 005526          256 VERITF---KEFFNHRFL  270 (692)
Q Consensus       256 ~~RpTa---~elL~Hpf~  270 (692)
                      ++||++   +++++||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-38  Score=375.31  Aligned_cols=255  Identities=23%  Similarity=0.384  Sum_probs=210.2

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      +++|++.++||+|+||+||+|++..+|+.||||++..... .....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            4799999999999999999999999999999999976432 344567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           88 LEYCDGGDLAAYIHKH-----------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~-----------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                      |||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.++   .+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg---~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG---EVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC---CEEEEec
Confidence            9999999999998642           2345677889999999999999999999999999999999877   4999999


Q ss_pred             ccccccCCC-------------------CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 005526          157 GFARSLTPQ-------------------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL  217 (692)
Q Consensus       157 GlA~~~~~~-------------------~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~  217 (692)
                      |+++.....                   ......+||+.|||||++.+..++.++|||||||++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            999865211                   0112357999999999999999999999999999999999999999876554


Q ss_pred             HHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhch
Q 005526          218 QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHR  268 (692)
Q Consensus       218 ~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hp  268 (692)
                      ..............  .....+++.+.+++.+||+.||++|++..+.+.+.
T Consensus       238 ki~~~~~i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~  286 (932)
T PRK13184        238 KISYRDVILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQD  286 (932)
T ss_pred             hhhhhhhccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            33322111111111  11246788999999999999999999877666554

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-38  Score=328.14  Aligned_cols=250  Identities=27%  Similarity=0.459  Sum_probs=211.1

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGI---EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .++|++++.||+|+||.||+|.+..++.   .+|+|.+.... .......+.+|+.++++++||||+++++++..++..|
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            3689999999999999999999865443   79999886543 3445678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +||||++|++|.+++.+. +.+++..+..++.|++.||.|||++|++||||||+|||++.++   .+||+|||+++....
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~---~~~l~dfg~~~~~~~  158 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL---VCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC---eEEeCCCCccccccc
Confidence            999999999999999875 4689999999999999999999999999999999999998776   599999999987643


Q ss_pred             CCC----CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          165 QDL----ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       165 ~~~----~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      ...    .....++..|+|||.+.+..++.++|+|||||++|++++ |..||.+....+....+......  +  .....
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~--~--~~~~~  234 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL--P--APMDC  234 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC--C--CCCCC
Confidence            321    111223567999999998899999999999999999886 99999888777666666544222  2  22356


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ++.+.+++.+||+++|.+||++.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=325.45  Aligned_cols=244  Identities=28%  Similarity=0.520  Sum_probs=211.6

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.+.||.|+||.||+|...  |+.||+|.+.....   ..+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            468999999999999999999875  89999999975532   4577889999999999999999999999899999999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+++++|.+++....  .+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~---~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL---VAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC---CEEEccccccccccccc
Confidence            9999999999998765  689999999999999999999999999999999999998876   59999999998763222


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                        ....++..|+|||.+....++.++|||||||++|+|++ |..||...+.......+......    ......++++.+
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  230 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM----EAPEGCPPEVYK  230 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC----CCccCCCHHHHH
Confidence              23344567999999988889999999999999999997 99999988877766665443222    222457899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHh
Q 005526          246 LCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~  266 (692)
                      ++.+||..+|++|||+.++++
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-39  Score=366.01  Aligned_cols=263  Identities=21%  Similarity=0.316  Sum_probs=199.2

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCC-cEEEEEEe--------------cc-CCCChHHHHHHHHHHHHHHhCCCCC
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLG-IEVAVKEI--------------DK-KLLSPKVSDNLLKEISILSTISHPN   70 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg-~~vAVK~i--------------~~-~~~~~~~~~~i~~Ev~iL~~L~HpN   70 (692)
                      .+.++|+++++||+|+||+||++..+... ..+++|.+              .+ ..........+.+|+.+|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            46789999999999999999998765422 22222211              11 1112234456789999999999999


Q ss_pred             cceEEEEEEeCCEEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCC
Q 005526           71 IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-----GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTN  145 (692)
Q Consensus        71 IVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~-----~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~  145 (692)
                      |+++++++...+..|+|+|++.+ +|..++...     .......++.++.||+.||+|||++|||||||||+|||++.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            99999999999999999999965 777776542     234567788999999999999999999999999999999887


Q ss_pred             CCcCeEEEeccccccccCCCC--CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCC-CCCC--CHHHHH
Q 005526          146 EVTPVLKIGDFGFARSLTPQD--LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPP-FDGS--NQLQLF  220 (692)
Q Consensus       146 ~~~~~vKL~DFGlA~~~~~~~--~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~P-F~~~--~~~~~~  220 (692)
                      +   .+||+|||+++......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..+ |...  .....+
T Consensus       304 ~---~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        304 G---KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             C---CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            7   59999999998765432  23346899999999999999999999999999999999998754 4322  222222


Q ss_pred             HHHHhccC---CCCCCC------------------------cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          221 QNILTSTE---LRFPPG------------------------AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       221 ~~i~~~~~---~~~p~~------------------------~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      .+++....   ..++..                        ....++.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            22222110   001100                        001346678899999999999999999999999999653

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.5e-39  Score=333.71  Aligned_cols=257  Identities=26%  Similarity=0.493  Sum_probs=214.0

Q ss_pred             CEEEEeEecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHR---QLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKI   84 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~---~tg~~vAVK~i~~~~~--~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l   84 (692)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|++.....  .....+.+.+|+.+++++ +|+||+++++.+..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   4789999999865322  223346678899999999 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      |+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++   .+||+|||+++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC---CEEEeeCccceeccc
Confidence            99999999999999999888899999999999999999999999999999999999998876   599999999977644


Q ss_pred             CC--CCCccCCCCCccChHhhhh--cCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCCCCcc
Q 005526          165 QD--LADTLCGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       165 ~~--~~~~~~GT~~YmAPEvl~~--~~ys~ksDIWSLGviLyeLltG~~PF~~~~~----~~~~~~i~~~~~~~~p~~~~  236 (692)
                      ..  ......|+..|+|||.+..  ..++.++|||||||++|+|++|..||.....    ......+... ...    ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~----~~  232 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPP----YP  232 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCC----CC
Confidence            32  2234678999999999865  3477899999999999999999999975432    2222222221 112    22


Q ss_pred             cccCHHHHHHHHHhhccCCCCCC-----CHHHHHhchhhhhhHh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERI-----TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~Rp-----Ta~elL~Hpf~~~~~~  275 (692)
                      ..+++.+.+++++||+.||.+||     +++++++||||.....
T Consensus       233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            45788999999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.8e-39  Score=353.04  Aligned_cols=250  Identities=28%  Similarity=0.484  Sum_probs=205.7

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETRE   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~   82 (692)
                      .++|++++.||+|+||+||+|.+...     +..||||++... ......+.+.+|+++++++. ||||+++++++...+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            46788999999999999999987533     357999999654 23344567899999999996 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHc-----------------------------------------------------------
Q 005526           83 KIYLVLEYCDGGDLAAYIHKH-----------------------------------------------------------  103 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~-----------------------------------------------------------  103 (692)
                      .+|+|||||++|+|.++|.++                                                           
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            999999999999999988653                                                           


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCC
Q 005526          104 -------------------------------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE  146 (692)
Q Consensus       104 -------------------------------------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~  146 (692)
                                                           ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence                                                 1367888899999999999999999999999999999998876


Q ss_pred             CcCeEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 005526          147 VTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN  222 (692)
Q Consensus       147 ~~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~  222 (692)
                         .+||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........+..
T Consensus       275 ---~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         275 ---IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             ---EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence               59999999998654322   1233456788999999999999999999999999999997 9999987654433333


Q ss_pred             HHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          223 ILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       223 i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ..... ...    .....+.++.+++.+||+.||++|||+.++.+
T Consensus       352 ~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIKSGYRMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHhcCCCCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            32222 222    22467889999999999999999999988755

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-38  Score=336.33  Aligned_cols=251  Identities=27%  Similarity=0.472  Sum_probs=210.7

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQ-------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIE   79 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~   79 (692)
                      -.++|.++++||+|+||.||+|++..       .+..||+|.+.... .......+.+|+++++++ +||||+++++++.
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34789999999999999999998642       34579999987543 344466788999999999 6999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEec
Q 005526           80 TREKIYLVLEYCDGGDLAAYIHKH----------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVS  143 (692)
Q Consensus        80 ~~~~l~LVmEy~~GGsL~~~L~~~----------------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~  143 (692)
                      ..+.+|+||||+++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            999999999999999999999764                2478889999999999999999999999999999999998


Q ss_pred             CCCCcCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 005526          144 TNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQL  219 (692)
Q Consensus       144 ~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~  219 (692)
                      .++   .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       169 ~~~---~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         169 EDN---VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             CCC---cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            776   599999999986543221   122234567999999999999999999999999999999 9999998887777


Q ss_pred             HHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          220 FQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       220 ~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +..+........    ....+.++.+++.+||..||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLREGHRMDK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            776654432222    2456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-38  Score=322.84  Aligned_cols=246  Identities=32%  Similarity=0.594  Sum_probs=213.0

Q ss_pred             EEEeEecccCceEEEEEEEcCCC----cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg----~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .+.+.||.|+||.||++.+...+    ..||+|.+.... .......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            57789999999999999998766    899999996543 2225678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~--lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+++++|.+++.....  +++..++.++.|++.||.|||++|++||||||+||+++.++   .++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~---~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC---eEEEcccCCceeccccc
Confidence            99999999999987554  99999999999999999999999999999999999999877   59999999998765442


Q ss_pred             CCC--ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          167 LAD--TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       167 ~~~--~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      ...  ...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+........+    ...+.++
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  233 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP----ENCPPEI  233 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC----CcCCHHH
Confidence            222  1336789999999988889999999999999999998 89999988887777777655433332    3478899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+++.+||..||++|||+.++++
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      234 YKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHCcCChhhCcCHHHHHh
Confidence            99999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-38  Score=331.70  Aligned_cols=250  Identities=26%  Similarity=0.473  Sum_probs=211.4

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+... ........+.+|+.++++++||||+++++++..++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4689999999999999999998753     6789999998654 234455778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceE
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG----------------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLL  141 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~----------------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NIL  141 (692)
                      .++||||+++|+|.+++....                      .+++..++.++.||+.||.|||++|++||||||+||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            999999999999999997532                      3678889999999999999999999999999999999


Q ss_pred             ecCCCCcCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 005526          142 VSTNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQL  217 (692)
Q Consensus       142 L~~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~  217 (692)
                      ++.++   .+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus       163 ~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         163 VGENM---VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             ecCCC---ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            98876   599999999876543221   222345667999999998999999999999999999998 88999888877


Q ss_pred             HHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          218 QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       218 ~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +....+........+    ...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIYYVRDGNVLSCP----DNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            777666544332222    356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-38  Score=325.59  Aligned_cols=243  Identities=26%  Similarity=0.481  Sum_probs=207.3

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAI-ETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~-~~~~~l~LV   87 (692)
                      ..+|.+.+.||+|+||.||++...  |..||+|.+...    ...+.+.+|+.++++++|+||+++++++ ..++.+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            468999999999999999999765  788999998643    2345788999999999999999999975 456789999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           88 LEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |||+++++|.+++...+  .+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~---~~kl~dfg~~~~~~~~  155 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEASST  155 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC---cEEecCCccceecccc
Confidence            99999999999998754  378999999999999999999999999999999999998877   5999999998765432


Q ss_pred             CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                        .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+......    ......++.+.
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  229 (256)
T cd05082         156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----DAPDGCPPVVY  229 (256)
T ss_pred             --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCCHHHH
Confidence              233455678999999998899999999999999999997 99999988777666666443222    22346789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHh
Q 005526          245 DLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +++.+||+.||++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-38  Score=330.75  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=206.1

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGI----EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      .++|++.+.||+|+||+||+|.+..+++    .+++|.+... ........+..|+.++++++||||+++++++. +...
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            4789999999999999999999987776    4777776432 22344567788888999999999999999875 4567


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           85 YLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      ++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++   .+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~---~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS---IVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC---cEEEcCCccceecc
Confidence            8999999999999999764 5689999999999999999999999999999999999998776   59999999998654


Q ss_pred             CCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          164 PQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       164 ~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      ...   ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+........+    ...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~  236 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP----QIC  236 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC----CCC
Confidence            332   1233456778999999998899999999999999999998 99999988776555444333222211    245


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.++.+++.+||..||.+|||+.|+++
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            678999999999999999999999866

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-38  Score=336.01  Aligned_cols=253  Identities=26%  Similarity=0.529  Sum_probs=215.0

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      .-..+||+|+||.||++.+..+++.||||.+...  .......+.+|+.+++.++|+||+++++.+..++..++||||++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3346799999999999999999999999988543  23345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-CCCcc
Q 005526           93 GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTL  171 (692)
Q Consensus        93 GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-~~~~~  171 (692)
                      +++|.+++. .+.+++..++.++.|++.+|+|||++|++||||||+||+++.++   .++|+|||++....... .....
T Consensus       101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~---~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG---RVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC---CEEEcccccceeccccccccccc
Confidence            999999774 45789999999999999999999999999999999999999876   59999999987654322 23345


Q ss_pred             CCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhh
Q 005526          172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL  251 (692)
Q Consensus       172 ~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L  251 (692)
                      .|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+....+....+.......+.  ....+++.+.+++.+||
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l  254 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK--NLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccC--CcccCCHHHHHHHHHHH
Confidence            7899999999998888899999999999999999999999988776655544332222211  22457889999999999


Q ss_pred             ccCCCCCCCHHHHHhchhhhhh
Q 005526          252 RQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       252 ~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +.||.+||++.+++.||||...
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhcc
Confidence            9999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-38  Score=332.61  Aligned_cols=248  Identities=28%  Similarity=0.492  Sum_probs=207.6

Q ss_pred             CEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      +|++.+.||+|+||+||+|.+..     ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            58899999999999999998753     23578898886543 2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceE
Q 005526           86 LVLEYCDGGDLAAYIHKH------------------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLL  141 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~------------------------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NIL  141 (692)
                      +++||+.+++|.+++...                        ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            999999999999998653                        24788899999999999999999999999999999999


Q ss_pred             ecCCCCcCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 005526          142 VSTNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQL  217 (692)
Q Consensus       142 L~~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~  217 (692)
                      ++.++   .+||+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus       160 l~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         160 VAEGR---KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             EcCCC---cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            98776   599999999976533221   123345678999999988889999999999999999998 99999988877


Q ss_pred             HHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          218 QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       218 ~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +....+.......    .....+.++.+++.+||+.||.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         237 RLFNLLKTGYRME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHhCCCCCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            7666554332222    23467889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=347.92  Aligned_cols=262  Identities=30%  Similarity=0.584  Sum_probs=233.7

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~   85 (692)
                      ...+|..+.+||+|+||+|.+|..+.+...||||+++++.. .+...+--+.|.++|... +-|.+++++.+|.+-+++|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            45789999999999999999999999999999999987643 223334456677888766 5688999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-C
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-P  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-~  164 (692)
                      +||||+.||+|--.|++-+++-|..+..++..|+.||-+||++|||.||||.+|||++.+|+   |||+|||+++... .
T Consensus       427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH---iKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIFD  503 (683)
T ss_pred             eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc---eEeeecccccccccC
Confidence            99999999999999999999999999999999999999999999999999999999999984   9999999998644 4


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      ...+.++||||.|+|||++...+|+..+|+||+||+||||+.|++||+|.+..++++.|... ...+|    ..+|.++.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-nvsyP----KslSkEAv  578 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-NVSYP----KSLSKEAV  578 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-cCcCc----ccccHHHH
Confidence            45678899999999999999999999999999999999999999999999999999999764 34444    57899999


Q ss_pred             HHHHHhhccCCCCCCC-----HHHHHhchhhhhhHhhh
Q 005526          245 DLCRCLLRQNPVERIT-----FKEFFNHRFLGELRQTV  277 (692)
Q Consensus       245 dLI~~~L~~DP~~RpT-----a~elL~Hpf~~~~~~~~  277 (692)
                      ++|..+|.+.|.+|..     -+++-.||||+.+.+..
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence            9999999999999984     37899999999886654

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2e-38  Score=325.75  Aligned_cols=247  Identities=26%  Similarity=0.464  Sum_probs=208.5

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..++|++.++||+|+||.||+|.+. .+..||+|.+......   .+.+.+|+.++++++|+||+++++++. .+..|++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            4578999999999999999999876 4678999998765433   356889999999999999999999875 4568999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           88 LEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~---~~~l~dfg~~~~~~~~  155 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL---VCKIADFGLARLIEDN  155 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc---eEEeCCceeeeeccCc
Confidence            9999999999999764  3589999999999999999999999999999999999998876   6999999999765433


Q ss_pred             CCC--CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          166 DLA--DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       166 ~~~--~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      ...  ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.......    .....+..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  231 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP----CPQDCPIS  231 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCcCCHH
Confidence            221  12335567999999988889999999999999999999 999999888777777665443322    22467889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.+|+.+||.+||.+|||+.++.+
T Consensus       232 ~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         232 LHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-38  Score=334.99  Aligned_cols=252  Identities=27%  Similarity=0.465  Sum_probs=210.1

Q ss_pred             eecCEEEEeEecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARH-----RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETR   81 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~-----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~   81 (692)
                      ..++|.+.+.||+|+||.||++.+     ..++..||||.+.... .....+.+.+|+++++++ +||||+++++++...
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            346899999999999999999975     2345689999986543 234456788999999999 799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccc
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA  159 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA  159 (692)
                      +.+|+||||+.+|+|.+++....  .+++..+..++.|++.||.|||++||+|+||||+|||++.++   .+||+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC---eEEECCCccc
Confidence            99999999999999999997643  389999999999999999999999999999999999998766   6999999999


Q ss_pred             cccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCc
Q 005526          160 RSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA  235 (692)
Q Consensus       160 ~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~  235 (692)
                      +......   ......+++.|+|||.+....++.++|||||||++|+|++ |..||........+.+......   ....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~  265 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY---RMAQ  265 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC---cCCC
Confidence            7654322   1223456778999999999999999999999999999998 9999988776655554443321   1112


Q ss_pred             ccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          236 IEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       236 ~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ....++++.+++.+||.++|++|||+.+++.
T Consensus       266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-38  Score=325.30  Aligned_cols=250  Identities=27%  Similarity=0.454  Sum_probs=211.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGI---EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .++|...+.||+|+||.||+|+++.++.   .+|+|.+.... .....+.+.+|++++++++||||+++++++...+..|
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            3578999999999999999999876654   79999886543 3344677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +||||+++++|.+++..+ +.+++..+..++.|++.||+|||++|++||||||+||+++.++   .+||+|||++.....
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~---~~kl~dfg~~~~~~~  159 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL---ECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC---cEEECCCccceeccc
Confidence            999999999999999764 5789999999999999999999999999999999999998766   599999999876543


Q ss_pred             CCCC----CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          165 QDLA----DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       165 ~~~~----~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      ....    .....++.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+......  +  .....
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~--~--~~~~~  235 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL--P--APMDC  235 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC--C--CCCCC
Confidence            2211    11223457999999998899999999999999999997 99999888877777666543222  2  22457


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.++.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=328.73  Aligned_cols=243  Identities=30%  Similarity=0.521  Sum_probs=202.1

Q ss_pred             eEecccCceEEEEEEEcCCCc--EEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           16 PRIGSGSFAVVWRARHRQLGI--EVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~--~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      +.||+|+||.||+|++..++.  .+++|.+... ........+.+|++++.++ +||||+++++++...+.+|+||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            368999999999999988776  4688877532 2344556788999999999 89999999999999999999999999


Q ss_pred             CCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           93 GGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        93 GGsL~~~L~~~~----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                      +|+|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++   .+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~---~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---VAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC---eEEECCC
Confidence            999999997643                478999999999999999999999999999999999998876   5999999


Q ss_pred             ccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCc
Q 005526          157 GFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA  235 (692)
Q Consensus       157 GlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~  235 (692)
                      |+++.............+..|+|||++....++.++|||||||++|+|++ |..||.+.+.......+.......    .
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~----~  232 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE----K  232 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCC----C
Confidence            99864332211222234567999999988899999999999999999997 999998888777666654432222    2


Q ss_pred             ccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          236 IEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       236 ~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ....+.++.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-38  Score=339.61  Aligned_cols=257  Identities=27%  Similarity=0.456  Sum_probs=214.1

Q ss_pred             CCCcceecCEEEEeEecccCceEEEEEEEcCC-------CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceE
Q 005526            3 PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRF   74 (692)
Q Consensus         3 p~~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~t-------g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl   74 (692)
                      |.......+|.+++.||+|+||.||+|++...       +..||+|.+... ......+.+.+|+++++++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            44555567899999999999999999986432       236899988643 3344567889999999999 89999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCC
Q 005526           75 FEAIETREKIYLVLEYCDGGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQ  138 (692)
Q Consensus        75 ~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~  138 (692)
                      ++++..++.++++|||+++|+|.+++.+..                .++...+..++.|++.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999999999999999999999999997642                3677888999999999999999999999999999


Q ss_pred             ceEecCCCCcCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 005526          139 NLLVSTNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGS  214 (692)
Q Consensus       139 NILL~~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~  214 (692)
                      |||++.++   .+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       164 Nill~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         164 NVLVTEDN---VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             eEEEcCCC---cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99998776   599999999976543221   122334567999999999999999999999999999998 89999998


Q ss_pred             CHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          215 NQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       215 ~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +..+....+........    ....+.++.+++.+||+.+|.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         241 PVEELFKLLKEGHRMDK----PANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            88777776654432222    23567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=334.02  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=207.0

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCC--------------CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQL--------------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF   75 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~t--------------g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~   75 (692)
                      ++|++.++||+|+||.||++++..+              ...||+|.+... ........+.+|++++++++||||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            6899999999999999999987543              235999998754 3345566789999999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEec
Q 005526           76 EAIETREKIYLVLEYCDGGDLAAYIHKHG------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVS  143 (692)
Q Consensus        76 ~~~~~~~~l~LVmEy~~GGsL~~~L~~~~------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~  143 (692)
                      +++...+..++||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~  163 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG  163 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence            99999999999999999999999996542            367889999999999999999999999999999999998


Q ss_pred             CCCCcCeEEEeccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh--CCCCCCCCCHHH
Q 005526          144 TNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT--GKPPFDGSNQLQ  218 (692)
Q Consensus       144 ~~~~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt--G~~PF~~~~~~~  218 (692)
                      .++   .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++  |..||...+..+
T Consensus       164 ~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         164 NHY---TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             CCC---cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            776   599999999976543321   223345678999999998899999999999999999988  778998877666


Q ss_pred             HHHHHHhc---cCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          219 LFQNILTS---TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       219 ~~~~i~~~---~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ....+...   .............++.+.+|+.+||+.||++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            55544321   1111111122356789999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-39  Score=332.02  Aligned_cols=254  Identities=34%  Similarity=0.605  Sum_probs=211.3

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEec
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      |.+.+.||+|+||+||+|+...+++.|+||.+...... .......+|+..+++++ ||||+++++++..++..|+||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            78899999999999999999989999999998765332 22234457899999999 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           91 CDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        91 ~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      + +|+|.+++....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++   .++|+|||+++........
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~---~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC---CEEEeecccceeccCCCCc
Confidence            9 779999988765  789999999999999999999999999999999999999876   5999999999876654444


Q ss_pred             CccCCCCCccChHhhh-hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------------
Q 005526          169 DTLCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL------------------  229 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~-~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~------------------  229 (692)
                      ....++..|+|||++. ...++.++|+||||+++|+|++|++||........+.++......                  
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            5567899999999875 455789999999999999999999999887766555443321100                  


Q ss_pred             CCCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          230 RFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       230 ~~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      .++.       ......+.++.+++++||+.||++|||++|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0000       0112236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.8e-38  Score=323.19  Aligned_cols=243  Identities=29%  Similarity=0.517  Sum_probs=207.0

Q ss_pred             eEecccCceEEEEEEEcC-CCc--EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           16 PRIGSGSFAVVWRARHRQ-LGI--EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~-tg~--~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      +.||+|+||+||+|.+.. .++  .||||.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999999865 333  6999999776544 566788999999999999999999999887 89999999999


Q ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC----
Q 005526           93 GGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----  166 (692)
Q Consensus        93 GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~----  166 (692)
                      +++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++......    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD---KVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC---EEEecccccccccccccccee
Confidence            999999998764  689999999999999999999999999999999999999886   69999999998764422    


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+...... .  ......+..+.+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~  232 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-L--ERPEACPQDIYN  232 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-C--CCCccCCHHHHH
Confidence            1223457788999999999999999999999999999998 99999888877776666542211 1  122356789999


Q ss_pred             HHHHhhccCCCCCCCHHHHHh
Q 005526          246 LCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~  266 (692)
                      ++.+||+.+|++||++.++++
T Consensus       233 li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999865

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-40  Score=355.91  Aligned_cols=237  Identities=27%  Similarity=0.502  Sum_probs=206.9

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      ++-||.|+-|-||+|+..  ++.||||.++.         .-..+++-|++|+||||+.|.++|.....+|||||||..|
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            566999999999999986  78999997642         2235788999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCCC
Q 005526           95 DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS  174 (692)
Q Consensus        95 sL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~GT  174 (692)
                      -|...|+....++......|..+|+.|+.|||.+.|||||||.-||||+.++   +|||+|||-++..........++||
T Consensus       198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~~STkMSFaGT  274 (904)
T KOG4721|consen  198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---VVKISDFGTSKELSDKSTKMSFAGT  274 (904)
T ss_pred             cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---eEEeccccchHhhhhhhhhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999887   6999999999888766666789999


Q ss_pred             CCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccC
Q 005526          175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN  254 (692)
Q Consensus       175 ~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~D  254 (692)
                      ..|||||++++.+.+.|+|||||||+||||+||..||.+.+...++--+ ....+.+|  .+...+.-++-|++.||+..
T Consensus       275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-GsNsL~Lp--vPstcP~GfklL~Kqcw~sK  351 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-GSNSLHLP--VPSTCPDGFKLLLKQCWNSK  351 (904)
T ss_pred             HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-cCCccccc--CcccCchHHHHHHHHHHhcC
Confidence            9999999999999999999999999999999999999887765433211 11112222  22456778999999999999


Q ss_pred             CCCCCCHHHHHhch
Q 005526          255 PVERITFKEFFNHR  268 (692)
Q Consensus       255 P~~RpTa~elL~Hp  268 (692)
                      |.+||++++|+.|-
T Consensus       352 pRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  352 PRNRPSFRQILLHL  365 (904)
T ss_pred             CCCCccHHHHHHHH
Confidence            99999999999874

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.4e-38  Score=370.56  Aligned_cols=149  Identities=30%  Similarity=0.556  Sum_probs=138.0

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      +++|.+.++||+|+||+||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++...+.+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            689999999999999999999999999999999997543 3445567788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                      |||+.|++|.+++...+.+++..++.++.||+.||+|||.+||+||||||+||||+.++   .+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g---~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG---HIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC---CEEEEeCCCCc
Confidence            99999999999999888899999999999999999999999999999999999998776   59999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=322.70  Aligned_cols=248  Identities=27%  Similarity=0.477  Sum_probs=211.9

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..++|++.++||+|+||+||+|.+. .++.||||.+......   ...+.+|+.++++++||||+++++++......++|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            4578999999999999999999976 4688999998764332   35688999999999999999999999988999999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           88 LEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++.....
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~---~~~l~d~g~~~~~~~~  156 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL---VCKIADFGLARLIEDD  156 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC---CEEECccccceeccch
Confidence            99999999999997653  689999999999999999999999999999999999999876   5999999999776432


Q ss_pred             CC--CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          166 DL--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       166 ~~--~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      ..  .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+....+.++........+    ...+.+
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  232 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP----PNCPEE  232 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHH
Confidence            21  112234568999999998889999999999999999998 99999988887777777654332222    345789


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.+++.+||..||.+||++++++.
T Consensus       233 ~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         233 LYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=357.17  Aligned_cols=255  Identities=26%  Similarity=0.492  Sum_probs=220.6

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEcCCCc---E-EEEEEecc-CCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGI---E-VAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE   79 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~---~-vAVK~i~~-~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~   79 (692)
                      +....++-.+.++||+|+||.||+|+.+..+.   . ||||.... .........++++|+++|++++|||||++||+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            44556777888999999999999998776432   3 89998875 3466778899999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           80 TREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        80 ~~~~l~LVmEy~~GGsL~~~L~~~~~-lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      ....++||||+|.||+|.++|++.+. ++..+...++.+.+.||+|||++++|||||-.+|+|++.++   ++||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~---~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG---VVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC---eEEeCcccc
Confidence            99999999999999999999999875 99999999999999999999999999999999999999877   589999999


Q ss_pred             ccccCCCCCCCccC-CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-ccCCCCCCCc
Q 005526          159 ARSLTPQDLADTLC-GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT-STELRFPPGA  235 (692)
Q Consensus       159 A~~~~~~~~~~~~~-GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~-~~~~~~p~~~  235 (692)
                      ++...........+ -...|+|||.+...-|+.++|||||||++||+++ |..||.+....+...+|.. +.....|.  
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--  386 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--  386 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--
Confidence            98765333333223 3457999999999999999999999999999999 8999999999999999844 44444333  


Q ss_pred             ccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          236 IEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       236 ~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                        ..+.++..++.+||..||++|||+.++.+
T Consensus       387 --~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  387 --KTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             --CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence              56778899999999999999999999854

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-38  Score=330.66  Aligned_cols=250  Identities=25%  Similarity=0.405  Sum_probs=201.0

Q ss_pred             ecCE-EEEeEecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 005526            9 IGEY-IVGPRIGSGSFAVVWRAR----HRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET--R   81 (692)
Q Consensus         9 ~~~Y-~i~~~LG~GsFG~Vy~a~----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~   81 (692)
                      .++| .+.+.||+|+||+||++.    ...+++.||+|.+.... .......+.+|++++++++||||+++++++..  .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4677 999999999999998865    34568899999987542 23445678899999999999999999998754  3


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      ..+++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~~l~dfg~~~~  156 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKA  156 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC---cEEEeecccccc
Confidence            4689999999999999999764 699999999999999999999999999999999999998876   599999999986


Q ss_pred             cCCCCC----CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHH------------HHH
Q 005526          162 LTPQDL----ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL--QLF------------QNI  223 (692)
Q Consensus       162 ~~~~~~----~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~--~~~------------~~i  223 (692)
                      ......    .....++..|+|||++.+..++.++|||||||++|+|++|..||......  ...            ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            643221    22234567799999998888999999999999999999999998653321  000            000


Q ss_pred             HhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          224 LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       224 ~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ....   .........+.++.+++.+||+.||++|||+++++.
T Consensus       237 ~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         237 LERG---MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhcC---CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000   011122456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-40  Score=314.15  Aligned_cols=259  Identities=31%  Similarity=0.576  Sum_probs=223.7

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .+|.-.++||+|.||+||+|+++.+++.||+|.++.+...+.......+|+.+|+.++|.|||++++....+..+-+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            35777889999999999999999999999999999887777777889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CC
Q 005526           90 YCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~  167 (692)
                      ||.. +|..+... ++.++.+.++.++.|++.||.|+|+++++||||||.|+||..+|   .+|++|||+++.+.-. ..
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng---elkladfglarafgipvrc  157 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG---ELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC---cEEecccchhhhcCCceEe
Confidence            9976 88888876 46799999999999999999999999999999999999999988   5999999999876532 23


Q ss_pred             CCccCCCCCccChHhhhhc-CCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC----CCC---------
Q 005526          168 ADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTEL----RFP---------  232 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~----~~p---------  232 (692)
                      ....+.|.+|++|.++.+. -|+...|+||.||++.|+.. |++.|+|.+....+.+|...-..    .+|         
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            4455779999999998764 58999999999999999997 99999999988888777642111    111         


Q ss_pred             ------C-----CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          233 ------P-----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       233 ------~-----~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                            .     .....++..-+|+++++|.-+|.+|++++++++||||..
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence                  0     112344566799999999999999999999999999964

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.8e-38  Score=335.02  Aligned_cols=253  Identities=28%  Similarity=0.478  Sum_probs=215.8

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ..|...+.||+|+||.||++++..++..||+|.+.... ........+.+|+++++.++|||++++++++..++..|+||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            45888999999999999999999999999999987542 23345567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||+.| +|.+++.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++   .+||+|||++.....   
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~---~~kl~dfg~~~~~~~---  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG---QVKLADFGSASIASP---  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC---CEEEecCCCccccCC---
Confidence            99976 77777654 45689999999999999999999999999999999999998776   599999999865432   


Q ss_pred             CCccCCCCCccChHhhh---hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~---~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      .....|++.|+|||++.   ...++.++|||||||++|+|++|++||...+.......+........   .....++.+.
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~  254 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---QSNEWSDYFR  254 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC---CCccccHHHH
Confidence            23457899999999974   45688999999999999999999999988877766666655433222   2245678899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      +++.+||+.+|.+||++.++++|+|+..
T Consensus       255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         255 NFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            9999999999999999999999999843

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.1e-38  Score=331.49  Aligned_cols=261  Identities=25%  Similarity=0.492  Sum_probs=213.6

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~   85 (692)
                      .-.++|.+.+.||+|+||+||+|.+..+++.||||.+...... .....+.+|+.++.+. .||||+++++++......|
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            4468899999999999999999999999999999999765333 2345566677766666 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           86 LVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +||||+.+ .|.+++.. .+.+++..+..++.|++.||.|||+ +||+||||+|+||+++.++   .+||+|||++....
T Consensus        91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~---~~kL~dfg~~~~~~  166 (296)
T cd06618          91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG---NVKLCDFGISGRLV  166 (296)
T ss_pred             EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC---CEEECccccchhcc
Confidence            99999865 78777765 4578999999999999999999997 5999999999999998776   59999999997765


Q ss_pred             CCCCCCccCCCCCccChHhhhhcC----CCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCCCCCcccc
Q 005526          164 PQDLADTLCGSPLYMAPEIIQNHK----YDAKADLWSVGAILFQLVTGKPPFDGSNQ-LQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       164 ~~~~~~~~~GT~~YmAPEvl~~~~----ys~ksDIWSLGviLyeLltG~~PF~~~~~-~~~~~~i~~~~~~~~p~~~~~~  238 (692)
                      .........+++.|+|||.+.+..    ++.++||||||+++|+|++|+.||..... .+.+..+........+.  ...
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~  244 (296)
T cd06618         167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP--NEG  244 (296)
T ss_pred             CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC--CCC
Confidence            443334456788999999987553    78899999999999999999999976433 34444444433222222  124


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      ++.++.+|+.+||..||.+||++++++.||||...+
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            688999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.8e-38  Score=324.63  Aligned_cols=241  Identities=25%  Similarity=0.475  Sum_probs=202.0

Q ss_pred             EecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           17 RIGSGSFAVVWRARHR--QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~~--~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      .||+|+||+||+|.+.  .++..||+|++... ......+.+.+|+.++++++||||+++++++. .+..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            4899999999999765  44567999998654 23445577899999999999999999999875 45789999999999


Q ss_pred             CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC----CC
Q 005526           95 DLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL----AD  169 (692)
Q Consensus        95 sL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~----~~  169 (692)
                      +|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++   .+||+|||+++.......    ..
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH---YAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC---cEEeccCCccccccCCccceeccC
Confidence            99999975 45789999999999999999999999999999999999998776   599999999976543321    11


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHH
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~  248 (692)
                      ...+++.|+|||++....++.++|||||||++|+|++ |..||.+....+....+..+.....+    ...++++.+++.
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~  232 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP----AECPPEMYALMK  232 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC----CCCCHHHHHHHH
Confidence            1223578999999988889999999999999999996 99999988887777666655443333    356889999999


Q ss_pred             HhhccCCCCCCCHHHHHh
Q 005526          249 CLLRQNPVERITFKEFFN  266 (692)
Q Consensus       249 ~~L~~DP~~RpTa~elL~  266 (692)
                      +||..||++||++.++.+
T Consensus       233 ~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999854

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-38  Score=326.51  Aligned_cols=249  Identities=28%  Similarity=0.435  Sum_probs=211.1

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGI----EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      .++|++++.||+|+||+||+|.++.+|.    .||+|.+.... .......+.+|+.++++++||||+++++++.. ...
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            4789999999999999999999877664    58999886543 24455778899999999999999999999876 789


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           85 YLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++   .+||+|||+++...
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~---~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC---eEEECCCccccccc
Confidence            9999999999999999875 4689999999999999999999999999999999999998776   59999999998765


Q ss_pred             CCCCCC---ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          164 PQDLAD---TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       164 ~~~~~~---~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      ......   ...++..|+|||.+....++.++|||||||++|++++ |+.||.+....+....+........+    ...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~  236 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP----PIC  236 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC----CCC
Confidence            332211   1223567999999988899999999999999999998 99999998887777766654333332    346


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.++.+++.+||..||.+||++.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            788999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2e-38  Score=339.87  Aligned_cols=261  Identities=31%  Similarity=0.555  Sum_probs=213.9

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET-REKIY   85 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~-~~~l~   85 (692)
                      .+.++|.+.+.||.|+||.||+|.+..+++.||||++.+..........+.+|+++++.++||||+++++++.. ....|
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45789999999999999999999999999999999987654444556778899999999999999999999865 56789


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      +|+||+ +++|..+++. +.+++..+..++.||+.||.|||++||+||||||+||+++.++   .+||+|||+++.... 
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~---~~~l~dfg~~~~~~~-  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC---DLKICDFGLARIQDP-  160 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC---CEEeCccccccccCC-
Confidence            999999 5589888764 4688999999999999999999999999999999999998776   599999999976432 


Q ss_pred             CCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------c--
Q 005526          166 DLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS---------------T--  227 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~---------------~--  227 (692)
                       ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+.+.               .  
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence             2234567889999998765 56899999999999999999999999877654332221110               0  


Q ss_pred             ------C--CCCC-CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          228 ------E--LRFP-PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       228 ------~--~~~p-~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                            .  ...+ ......++.++.++|++||+.+|++|||+.+++.||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence                  0  0001 011234678999999999999999999999999999996543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=358.77  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=216.0

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      +....++..+++.||+|.||+||+|++-.   .||||+++.....+...+.|+.|+.++++-+|.||+-|.|++..... 
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            34455677899999999999999999864   79999999998889999999999999999999999999999987776 


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           85 YLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      .||+.+|+|-+|..+|+-. .+|.....+.|++||++|+.|||.++|||||||..||++.+++   .|||+|||++....
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~---kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL---KVKIGDFGLATVKT  539 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC---cEEEecccceeeee
Confidence            9999999999999999753 5789999999999999999999999999999999999999876   69999999986543


Q ss_pred             ---CCCCCCccCCCCCccChHhhhh---cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCccc
Q 005526          164 ---PQDLADTLCGSPLYMAPEIIQN---HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE  237 (692)
Q Consensus       164 ---~~~~~~~~~GT~~YmAPEvl~~---~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~  237 (692)
                         ...-.....|+..|||||+++.   .+|+..+|||||||++|||++|..||...+..+.+..+-++.-.........
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s  619 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS  619 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence               2333455678999999999874   5689999999999999999999999997666655544433321122222334


Q ss_pred             ccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          238 ELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       238 ~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ..++++++|+..||.+++++||.+.+||.
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            45669999999999999999999999876

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.6e-38  Score=334.90  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=215.5

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ..+.|...++||+|+||+||+|++..+++.|++|.+..... .......+.+|+++++.++||||+++++++.+.+..|+
T Consensus        19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34557778899999999999999999999999999875432 33445678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           87 VLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      ||||+.| +|.+++.. ...+++..+..++.||+.+|.|||++||+||||||+||+++.++   .+||+|||++....  
T Consensus        99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~---~~kL~dfg~~~~~~--  172 (313)
T cd06633          99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG---QVKLADFGSASKSS--  172 (313)
T ss_pred             EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC---CEEEeecCCCcccC--
Confidence            9999975 77777765 45689999999999999999999999999999999999998776   59999999986532  


Q ss_pred             CCCCccCCCCCccChHhhh---hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          166 DLADTLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~---~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                       ......|+..|+|||++.   ...++.++|||||||++|+|++|.+||...+......++.....   +......++..
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  248 (313)
T cd06633         173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS---PTLQSNEWTDS  248 (313)
T ss_pred             -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---CCCCccccCHH
Confidence             233567899999999984   45688899999999999999999999988877666655543322   22223456778


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      +.+|+.+||+++|.+||++.+++.||||...
T Consensus       249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         249 FRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.4e-38  Score=323.19  Aligned_cols=247  Identities=27%  Similarity=0.499  Sum_probs=208.8

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..++|+++++||+|+||.||+|... +++.||+|.+......   ...+.+|+.++++++||||+++++++. .+..+++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            4578999999999999999999865 5788999998765433   356788999999999999999998864 5678999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           88 LEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |||+.+++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++   .++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~---~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL---CCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC---CEEEccCcceeecCCC
Confidence            9999999999998764  3589999999999999999999999999999999999999876   5999999999766532


Q ss_pred             CC--CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          166 DL--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       166 ~~--~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      ..  .....++..|+|||++....++.++|||||||++|+|++ |++||.+.+..+....+.......    .....+.+
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  231 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----RPDNCPEE  231 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----CCCCCCHH
Confidence            22  123345678999999998899999999999999999999 999999888777666654433222    23456789


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.+++.+||..+|++|||++++++
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         232 LYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.4e-38  Score=325.97  Aligned_cols=250  Identities=23%  Similarity=0.391  Sum_probs=210.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET-REK   83 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~-~~~   83 (692)
                      .++|.+.+.||+|+||.||+|.+..    ++..|++|.+... ........+.+|+.++++++||||+++++++.. +..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            4689999999999999999999876    3588999988643 345556778899999999999999999998754 578


Q ss_pred             EEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEec
Q 005526           84 IYLVLEYCDGGDLAAYIHKH--------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD  155 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~--------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~D  155 (692)
                      .++++||+.+++|.+++...        ..+++..++.++.|++.||+|||++|++||||||+||+++.++   .+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~---~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL---QVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC---cEEECC
Confidence            99999999999999999764        3588999999999999999999999999999999999998776   599999


Q ss_pred             cccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 005526          156 FGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRF  231 (692)
Q Consensus       156 FGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~  231 (692)
                      ||+++.....+.   .....++..|+|||++.+..++.++|||||||++|++++ |++||...+..+....+....... 
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA-  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC-
Confidence            999986543321   223445678999999998899999999999999999999 999999888777665554432222 


Q ss_pred             CCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       232 p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                         .....++++.+++.+||..||++|||+.+++.
T Consensus       240 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 ---QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence               22456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-38  Score=318.85  Aligned_cols=242  Identities=28%  Similarity=0.471  Sum_probs=205.2

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGD   95 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGs   95 (692)
                      +.||+|+||.||+|... +++.||+|.+.... .......+.+|+++++.++||||+++++++...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            46999999999999865 58899999986543 34445678899999999999999999999999999999999999999


Q ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC--CCccC
Q 005526           96 LAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLC  172 (692)
Q Consensus        96 L~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~--~~~~~  172 (692)
                      |.+++... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++   .+||+|||++........  .....
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN---VLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC---eEEECCCccceeccccccccCCCCC
Confidence            99998764 4579999999999999999999999999999999999998776   599999999876443221  12234


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhh
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL  251 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L  251 (692)
                      +++.|+|||++....++.++|||||||++|+|++ |..||.+.........+........    ...++.++.+++.+||
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l  231 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC----PQKCPDDVYKVMQRCW  231 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHc
Confidence            4567999999998899999999999999999998 9999998887776666654433322    2457899999999999


Q ss_pred             ccCCCCCCCHHHHHh
Q 005526          252 RQNPVERITFKEFFN  266 (692)
Q Consensus       252 ~~DP~~RpTa~elL~  266 (692)
                      ..+|++||++.++++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999865

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.4e-38  Score=322.33  Aligned_cols=246  Identities=24%  Similarity=0.461  Sum_probs=206.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.++||+|+||.||+|.+..+ ..+|+|.+.....   ..+.+.+|++++++++||||+++++++. .+..++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            46799999999999999999988654 5699998865432   2356788999999999999999998875 45689999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+.+++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||++++++   .+||+|||+++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~---~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL---VCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC---eEEECCCccceEccCCc
Confidence            9999999999997643  478999999999999999999999999999999999998876   59999999997654332


Q ss_pred             C--CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          167 L--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       167 ~--~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                      .  .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+....+....+.......    .....+..+
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  232 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP----CPQGCPESL  232 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----CCcccCHHH
Confidence            2  122345678999999988889999999999999999999 999999888777776665432222    224678899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+++.+||++||.+||+++++++
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         233 HELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999998854

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=355.79  Aligned_cols=261  Identities=29%  Similarity=0.571  Sum_probs=240.2

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ..+..++..||-|+||.|-++........+|+|++++.. ...+..+.+..|.+||..++.|.||++|..|.+..++|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            456677888999999999999988766679999998754 4556678899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      ||-|-||.|+..+..++.|++..++.++..+++|++|||.+|||.|||||+|++++.+|.   +||.|||+|+.+.....
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy---~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY---LKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc---eEEeehhhHHHhccCCc
Confidence            999999999999999999999999999999999999999999999999999999999985   99999999999999999


Q ss_pred             CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCCCcccccCHHHHHH
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL-RFPPGAIEELHPDCVDL  246 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~-~~p~~~~~~ls~el~dL  246 (692)
                      +.++||||.|.|||++.+.+.+.++|.|+||+++|||++|.+||.+.++...++.|+++... .+|    ..+.....+|
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P----r~I~k~a~~L  651 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP----RRITKTATDL  651 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc----cccchhHHHH
Confidence            99999999999999999999999999999999999999999999999999999999987643 334    4678899999


Q ss_pred             HHHhhccCCCCCCC-----HHHHHhchhhhhhHhh
Q 005526          247 CRCLLRQNPVERIT-----FKEFFNHRFLGELRQT  276 (692)
Q Consensus       247 I~~~L~~DP~~RpT-----a~elL~Hpf~~~~~~~  276 (692)
                      |+++.+.+|.+|..     +.+|-+|.||....+.
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence            99999999999995     8999999999876554

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.3e-38  Score=319.16  Aligned_cols=247  Identities=26%  Similarity=0.527  Sum_probs=209.8

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .+|++.+.||+|+||.||++.+.. ++.+|+|.+......   ...+.+|++++++++||||+++++++......++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            589999999999999999998864 778999988754333   3467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        90 y~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |+++++|.+++... +.++++.++.++.|++.+|.|||++|++||||||+||+++.++   .+||+|||+++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~---~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ---VVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC---eEEECCCcceeecccCccc
Confidence            99999999999764 4689999999999999999999999999999999999998766   5999999998765433221


Q ss_pred             --CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          169 --DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       169 --~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                        ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+........+    ...+.++.+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  232 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP----RLASQSVYE  232 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC----CCCCHHHHH
Confidence              12234568999999998899999999999999999998 99999988877777666543222222    346789999


Q ss_pred             HHHHhhccCCCCCCCHHHHHhc
Q 005526          246 LCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~H  267 (692)
                      |+.+||+.+|++|||+.+++++
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999763

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=365.79  Aligned_cols=249  Identities=27%  Similarity=0.483  Sum_probs=209.7

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEE-EEE---e---C
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFE-AIE---T---R   81 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~-~~~---~---~   81 (692)
                      .+++|.+.|.+|||+.||+|++...|..||+|++-..  +....+.+++|+++|++|+ |+|||.|+| ...   .   .
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            4578899999999999999999998899999998655  6677889999999999996 999999999 332   1   2


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEecCCCCcCeEEEeccc
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKH--LIHRDLKPQNLLVSTNEVTPVLKIGDFG  157 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~g--IVHRDLKP~NILL~~~~~~~~vKL~DFG  157 (692)
                      ..++|+||||.||.|-+++..+  .+|+|.++.+|+.|+++|+.+||...  |||||||-+||||..++   .+||||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g---~~KLCDFG  191 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG---NYKLCDFG  191 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC---CEEeCccc
Confidence            3688999999999999999854  56999999999999999999999998  99999999999999988   49999999


Q ss_pred             cccccCCCC-CC---------CccCCCCCccChHhh---hhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 005526          158 FARSLTPQD-LA---------DTLCGSPLYMAPEII---QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL  224 (692)
Q Consensus       158 lA~~~~~~~-~~---------~~~~GT~~YmAPEvl---~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~  224 (692)
                      .|.-..... ..         -...-|+.|+|||.+   .+.+.++|+|||+|||+||-|+....||.+.....    |+
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Il  267 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----IL  267 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EE
Confidence            986432221 10         122468999999986   57789999999999999999999999998764432    33


Q ss_pred             hccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       225 ~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      . ..+.||+.  ..++..+.+||+.||+.||.+||++-+++.+-+.
T Consensus       268 n-g~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  268 N-GNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             e-ccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            3 35566653  5789999999999999999999999999876553

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-39  Score=378.30  Aligned_cols=257  Identities=30%  Similarity=0.590  Sum_probs=212.8

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~-----   81 (692)
                      |+..+|+.++.||+||||.||+++++-+|+.||||.|.... +.+....+.+|+..|.+|+|||||+++..+.+.     
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            68899999999999999999999999999999999998876 778889999999999999999999996322100     


Q ss_pred             --------------------------------------------------------------------------------
Q 005526           82 --------------------------------------------------------------------------------   81 (692)
Q Consensus        82 --------------------------------------------------------------------------------   81 (692)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CEEEEEEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHH
Q 005526           82 ----------------------------------EKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQ  126 (692)
Q Consensus        82 ----------------------------------~~l~LVmEy~~GGsL~~~L~~~~~l-se~~i~~il~QLl~gL~yLH  126 (692)
                                                        -.+||-||||+...|.+++.++... ....+|++++||+.||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              1378999999996666666655443 48889999999999999999


Q ss_pred             HcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-------------------CCCCCCccCCCCCccChHhhhhcC
Q 005526          127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-------------------PQDLADTLCGSPLYMAPEIIQNHK  187 (692)
Q Consensus       127 s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-------------------~~~~~~~~~GT~~YmAPEvl~~~~  187 (692)
                      ++|||||||||.||+++.+++   |||+|||+|+...                   ........+||..|+|||++.+..
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~---VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNS---VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCC---eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            999999999999999998874   9999999998621                   001234568999999999997654


Q ss_pred             ---CCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHH
Q 005526          188 ---YDAKADLWSVGAILFQLVTGKPPFDGSN-QLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE  263 (692)
Q Consensus       188 ---ys~ksDIWSLGviLyeLltG~~PF~~~~-~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~e  263 (692)
                         |+.|+|+||||++||||+.   ||...- ....+.++. ...++++...+....+.-..+|+.||+.||.+|||+.|
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence               9999999999999999985   675443 334444443 45555555555666778889999999999999999999


Q ss_pred             HHhchhhh
Q 005526          264 FFNHRFLG  271 (692)
Q Consensus       264 lL~Hpf~~  271 (692)
                      +|++.||.
T Consensus       868 LL~s~llp  875 (1351)
T KOG1035|consen  868 LLNSELLP  875 (1351)
T ss_pred             HhhccCCC
Confidence            99999997

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-41  Score=390.00  Aligned_cols=259  Identities=32%  Similarity=0.587  Sum_probs=226.8

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      +.-+|.-+-+||.|.||.||-|.+..+|...|+|.|.......+....+.+|..++..++|||+|++|++-...+.++|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            34567888899999999999999999999999999987655567778899999999999999999999999899999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC-
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~-  166 (692)
                      ||||+||+|.+++...+-.+|...+.+..|++.|+.|||++|||||||||.||+++.+|   .+|++|||.|..+.... 
T Consensus      1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g---~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG---LIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC---cEEeecccceeEecCchh
Confidence            99999999999999888889999999999999999999999999999999999999988   69999999998765432 


Q ss_pred             ----CCCccCCCCCccChHhhhhc---CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCCCCCcccc
Q 005526          167 ----LADTLCGSPLYMAPEIIQNH---KYDAKADLWSVGAILFQLVTGKPPFDGSNQ-LQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       167 ----~~~~~~GT~~YmAPEvl~~~---~ys~ksDIWSLGviLyeLltG~~PF~~~~~-~~~~~~i~~~~~~~~p~~~~~~  238 (692)
                          ......|||.|||||++.+.   +-..++|||||||++.||+||+.||...+. -+.+.++-.+...++|    +.
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P----~~ 1465 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP----ER 1465 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc----hh
Confidence                12356899999999999754   345689999999999999999999976544 4556666555555555    45


Q ss_pred             cCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       239 ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ++++..|||..||+.||++|.++.||++|.|-...
T Consensus      1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            99999999999999999999999999999986443

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7e-38  Score=323.27  Aligned_cols=246  Identities=24%  Similarity=0.440  Sum_probs=199.7

Q ss_pred             eEecccCceEEEEEEEcC--CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQ--LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      ++||+|+||+||+|....  ....+++|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            469999999999996543  34578888875432 344456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-
Q 005526           94 GDLAAYIHKHG-----KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus        94 GsL~~~L~~~~-----~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-  167 (692)
                      |+|.+++....     ..++..+..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL---SVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC---cEEEeccccccccccchhe
Confidence            99999997653     246788899999999999999999999999999999999877   599999999875433221 


Q ss_pred             --CCccCCCCCccChHhhhh-------cCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC-Ccc
Q 005526          168 --ADTLCGSPLYMAPEIIQN-------HKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP-GAI  236 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~-------~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~-~~~  236 (692)
                        .....+++.|+|||++..       ..++.++|||||||++|+|++ |..||......+.+..+.......++. ...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence              223345678999999753       356789999999999999999 889998887777666665555444433 233


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ...+..+.+++..|+ .||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            467888999999998 59999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.2e-38  Score=328.73  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=205.2

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC----------------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcc
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ----------------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII   72 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~----------------tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIV   72 (692)
                      .++|++.++||+|+||+||++.+..                ++..||+|.+.... .......+.+|+++++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            3579999999999999999986542                34579999986542 344567889999999999999999


Q ss_pred             eEEEEEEeCCEEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceE
Q 005526           73 RFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-----------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLL  141 (692)
Q Consensus        73 kl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~-----------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NIL  141 (692)
                      ++++++..++..++||||+++++|.+++....           .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999997643           3667889999999999999999999999999999999


Q ss_pred             ecCCCCcCeEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh--CCCCCCCCCH
Q 005526          142 VSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT--GKPPFDGSNQ  216 (692)
Q Consensus       142 L~~~~~~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt--G~~PF~~~~~  216 (692)
                      ++.++   .+||+|||+++......   ......+++.|++||+.....++.++|||||||++|||++  |..||...+.
T Consensus       163 i~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         163 VGKNY---TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EcCCC---CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            98766   59999999997654332   1223344678999999988899999999999999999998  7899987766


Q ss_pred             HHHHHHHHh---ccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          217 LQLFQNILT---STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       217 ~~~~~~i~~---~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+...+...   ..............++.+.+|+.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            555443311   11000011112346789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-38  Score=319.55  Aligned_cols=242  Identities=29%  Similarity=0.490  Sum_probs=205.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGD   95 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGs   95 (692)
                      ++||.|+||.||++.+.. ++.||+|.+...... .....+.+|++++++++||||+++++++......++||||+.|++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            479999999999999987 999999998765433 456788999999999999999999999999999999999999999


Q ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC---Ccc
Q 005526           96 LAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA---DTL  171 (692)
Q Consensus        96 L~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~---~~~  171 (692)
                      |.+++... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++   .+||+|||+++........   ...
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN---VLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC---cEEEeeccccccccCCcceeccccC
Confidence            99999764 5689999999999999999999999999999999999998876   5999999999765422111   122


Q ss_pred             CCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHh
Q 005526          172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL  250 (692)
Q Consensus       172 ~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~  250 (692)
                      .++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.......    .....+.++.+++.+|
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~  231 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP----APQLCPEEIYRLMLQC  231 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC----CCccCCHHHHHHHHHH
Confidence            34567999999988899999999999999999999 899998887766666554432222    2246788999999999


Q ss_pred             hccCCCCCCCHHHHHh
Q 005526          251 LRQNPVERITFKEFFN  266 (692)
Q Consensus       251 L~~DP~~RpTa~elL~  266 (692)
                      |..+|.+|||+.|+++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.4e-38  Score=328.38  Aligned_cols=257  Identities=26%  Similarity=0.495  Sum_probs=211.6

Q ss_pred             CEEEEeEecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHR---QLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKI   84 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~---~tg~~vAVK~i~~~~~--~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l   84 (692)
                      +|.+.+.||+|+||.||++++.   .+++.||||.+.+...  .....+.+.+|+.++.++ +||||+++++.+..+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   4678999999875422  123345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ++||||+.+|+|.+++...+.+++..++.++.|++.+|.|||+.|++||||||+||+++.++   .++|+|||+++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~---~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG---HVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEEEECcccccccc
Confidence            99999999999999998888899999999999999999999999999999999999998876   599999999876543


Q ss_pred             CCC--CCccCCCCCccChHhhhhcC--CCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCCCCcc
Q 005526          165 QDL--ADTLCGSPLYMAPEIIQNHK--YDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       165 ~~~--~~~~~GT~~YmAPEvl~~~~--ys~ksDIWSLGviLyeLltG~~PF~~~~~----~~~~~~i~~~~~~~~p~~~~  236 (692)
                      ...  .....|++.|+|||.+.+..  .+.++||||||+++|+|++|..||.....    ......+... ...    ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~----~~  232 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPP----FP  232 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCC----CC
Confidence            322  23456899999999987654  78899999999999999999999964332    2222222221 111    22


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCC---HHHHHhchhhhhhHh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERIT---FKEFFNHRFLGELRQ  275 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpT---a~elL~Hpf~~~~~~  275 (692)
                      ..++.++.+++.+||+.||++|||   +.++|+||||+....
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            457889999999999999999998   577899999977543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3e-38  Score=340.22  Aligned_cols=251  Identities=27%  Similarity=0.475  Sum_probs=203.3

Q ss_pred             ecCEEEEeEecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARH-----RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET-R   81 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~-----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~-~   81 (692)
                      .++|++++.||+|+||+||+|++     ..+++.||||+++.... ......+.+|+.++.++ +||||+++++++.. +
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            36899999999999999999984     34678999999975432 33456788999999999 68999999998754 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcC---------------------------------------------------------
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHG---------------------------------------------------------  104 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~~---------------------------------------------------------  104 (692)
                      ..+++|||||++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            57899999999999999986532                                                         


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC---CCCcc
Q 005526          105 ----------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTL  171 (692)
Q Consensus       105 ----------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~---~~~~~  171 (692)
                                .+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++......   .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC---cEEEEecccccccccCcchhhcCCC
Confidence                      357788889999999999999999999999999999998776   59999999997653221   11223


Q ss_pred             CCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhccCCCCCCCcccccCHHHHHHHHH
Q 005526          172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTSTELRFPPGAIEELHPDCVDLCRC  249 (692)
Q Consensus       172 ~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~-~~i~~~~~~~~p~~~~~~ls~el~dLI~~  249 (692)
                      .+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......+ ..+........+    ...++++.+++.+
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  317 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLD  317 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC----CCCCHHHHHHHHH
Confidence            45678999999999999999999999999999997 99999876543323 323232222222    3467899999999


Q ss_pred             hhccCCCCCCCHHHHHhc
Q 005526          250 LLRQNPVERITFKEFFNH  267 (692)
Q Consensus       250 ~L~~DP~~RpTa~elL~H  267 (692)
                      ||+.||.+|||+.++++|
T Consensus       318 cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         318 CWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.1e-38  Score=332.70  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=213.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      ...|...+.||+|+||.||+|++..++..+|+|.+.... ........+.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            355888899999999999999999999999999986532 2334456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           88 LEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |||+.| +|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++   .+||+|||++...... 
T Consensus        94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~---~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC---cEEECCcccceeecCc-
Confidence            999974 78777754 45689999999999999999999999999999999999998776   5999999998765432 


Q ss_pred             CCCccCCCCCccChHhhh---hcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHH
Q 005526          167 LADTLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~---~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el  243 (692)
                        ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+.......   ......+..+
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  243 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---LQSGHWSEYF  243 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC---cCcccccHHH
Confidence              3457889999999975   3567889999999999999999999998877655555554433222   1223577889


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          244 VDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       244 ~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      .+||.+||+++|.+||++.++++|||+..
T Consensus       244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             HHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            99999999999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.2e-38  Score=322.52  Aligned_cols=250  Identities=27%  Similarity=0.490  Sum_probs=210.0

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      ..+|.+.+.||+|+||.||+|.+...   ...|+||.+.... .....+.+.+|+.++++++||||+++++++.. +..|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            35799999999999999999987654   3568999886442 34556788999999999999999999998865 4578


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           86 LVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +||||+++|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++   .+||+|||+++....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~---~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC---CeEEccCceeeeccc
Confidence            9999999999999998754 589999999999999999999999999999999999998876   599999999976644


Q ss_pred             CCC--CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCH
Q 005526          165 QDL--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       165 ~~~--~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                      ...  .....+++.|+|||.+....++.++|||||||++|+|++ |..||.+....+....+........+    ...+.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~  235 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP----PNCPP  235 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCH
Confidence            322  122334567999999988889999999999999999986 99999988877777666554443333    46788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ++.+++.+||..+|.+|||+.+++..
T Consensus       236 ~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         236 TLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.9e-37  Score=318.92  Aligned_cols=248  Identities=25%  Similarity=0.466  Sum_probs=208.4

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ...++|.+.++||+|+||.||++.+. .+..+|+|.+...   ......+.+|++++++++|+||+++++.+.. ...++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            34688999999999999999999865 4677999988653   2335678889999999999999999999877 77899


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           87 VLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +|||+++++|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+||+++.++   .+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~---~~~l~d~~~~~~~~~  154 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVIED  154 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC---cEEECCCcceeeccC
Confidence            99999999999999764  3578889999999999999999999999999999999998776   599999999976543


Q ss_pred             CCC--CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCH
Q 005526          165 QDL--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       165 ~~~--~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                      ...  .....++..|+|||++....++.++|+|||||++|+|++ |+.||.+.+.......+.......    .....+.
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  230 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----RPENCPE  230 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC----CcccCCH
Confidence            221  122345667999999998889999999999999999998 999999888777666655432222    2246788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ++.+++.+||++||++||++.++++
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-38  Score=320.41  Aligned_cols=238  Identities=22%  Similarity=0.400  Sum_probs=195.2

Q ss_pred             eEecccCceEEEEEEEcCCC----------cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526           16 PRIGSGSFAVVWRARHRQLG----------IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg----------~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      +.||+|+||.||+|.+..++          ..+++|.+.....   ....+.+|+.+++.++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            46999999999999998766          3577887654321   15778899999999999999999999877 7789


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCC----CcCeEEEecccccc
Q 005526           86 LVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE----VTPVLKIGDFGFAR  160 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~----~~~~vKL~DFGlA~  160 (692)
                      +||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++    ....+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999999998766 789999999999999999999999999999999999998766    22359999999997


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhhc--CCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccc
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNH--KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIE  237 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~~--~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~  237 (692)
                      ....   .....++..|+|||++...  .++.++|||||||++|+|++ |..||...+..............  +    .
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~--~----~  227 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL--P----M  227 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCC--C----C
Confidence            7543   2344567789999999876  78999999999999999999 68888776543333322211111  1    1


Q ss_pred             ccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          238 ELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       238 ~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .....+.+++.+||..+|.+|||+.++++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            12378999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-39  Score=351.57  Aligned_cols=260  Identities=26%  Similarity=0.505  Sum_probs=222.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccC-CCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~-~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .-|..++.||-|+||.|.+++..+|...||+|.+++. .+........+.|..||.....+.||+||..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            4588899999999999999999999999999999764 344555667888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC-----
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-----  163 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-----  163 (692)
                      ||++||++-.+|.+.+-|.|+.++.|+..|..|++++|..|+|||||||+|||||.+|+   |||+|||++.-+.     
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH---IKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc---eeeeeccccccceecccc
Confidence            99999999999999999999999999999999999999999999999999999999994   9999999986321     


Q ss_pred             ----CC----------------------------------CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHH
Q 005526          164 ----PQ----------------------------------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLV  205 (692)
Q Consensus       164 ----~~----------------------------------~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLl  205 (692)
                          ..                                  -.+...+||+.|+|||++...+|+..+|+||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                00                                  0123457999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCC---CHHHHHhchhhhhhHh
Q 005526          206 TGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERI---TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       206 tG~~PF~~~~~~~~~~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~Rp---Ta~elL~Hpf~~~~~~  275 (692)
                      .|++||-.....+...++.... .+.++.  ...+++++.++|+++++ +++.|.   -++++.+||||+.+..
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~--~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPY--QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhcccccc--ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence            9999998877665555544332 233333  35899999999999654 678887   4678999999987743

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-37  Score=321.98  Aligned_cols=246  Identities=22%  Similarity=0.399  Sum_probs=198.1

Q ss_pred             eEecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHR--QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~--~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      +.||+|+||.||+|...  .++..+|+|.++.... ......+.+|+.++++++||||+++++++.+...+++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            46999999999999864  3457899998866532 23345788899999999999999999999988999999999999


Q ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-
Q 005526           94 GDLAAYIHKHG-----KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus        94 GsL~~~L~~~~-----~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-  167 (692)
                      |+|.+++....     ..++..+..++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~---~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL---TVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC---cEEECCccccccccCccee
Confidence            99999997532     356778889999999999999999999999999999998876   599999999975433221 


Q ss_pred             --CCccCCCCCccChHhhhhc-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC-cc
Q 005526          168 --ADTLCGSPLYMAPEIIQNH-------KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPG-AI  236 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~~-------~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~-~~  236 (692)
                        .....+++.|+|||++.+.       .++.++|||||||++|+|++ |..||......+............++.. ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              2234578889999998642       35789999999999999996 9999988776665554444333333322 22


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ...+..+.+++++|+ .+|++|||+++++.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            356788999999998 68999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-37  Score=322.47  Aligned_cols=251  Identities=24%  Similarity=0.442  Sum_probs=210.9

Q ss_pred             cCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      .+|.+.+.||+|+||+||+|+.+.     +.+.|++|.+.... .....+.+.+|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            679999999999999999999754     35679999886532 233567789999999999999999999999988999


Q ss_pred             EEEEeccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEec
Q 005526           85 YLVLEYCDGGDLAAYIHKHG---------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD  155 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~---------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~D  155 (692)
                      |+||||+++|+|.+++....         .+++..++.++.||+.||+|||++||+||||||+||+++.++   .++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~---~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR---EVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC---cEEEcc
Confidence            99999999999999998765         689999999999999999999999999999999999998877   489999


Q ss_pred             cccccccCCCC--CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 005526          156 FGFARSLTPQD--LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP  232 (692)
Q Consensus       156 FGlA~~~~~~~--~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p  232 (692)
                      ||+++......  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+... ...++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~  239 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-KLELP  239 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC-CcCCC
Confidence            99987543222  1233456778999999988889999999999999999998 89999877766665554322 22222


Q ss_pred             CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       233 ~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                        .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       240 --~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         240 --VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence              224678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-38  Score=325.43  Aligned_cols=241  Identities=24%  Similarity=0.439  Sum_probs=197.0

Q ss_pred             eEecccCceEEEEEEEcCCCc-------EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           16 PRIGSGSFAVVWRARHRQLGI-------EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~-------~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      +.||+|+||+||+|.+..++.       .|++|.+...  .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            469999999999999866544       3888877543  2344567888999999999999999999999989999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC-----cCeEEEecccccccc
Q 005526           89 EYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV-----TPVLKIGDFGFARSL  162 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~-----~~~vKL~DFGlA~~~  162 (692)
                      ||+++|+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+||+++.++.     .+.+|++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999999998754 5899999999999999999999999999999999999987653     235899999998655


Q ss_pred             CCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          163 TPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTG-KPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       163 ~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG-~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      ..   .....+++.|+|||++.+ ..++.++|||||||++|+|++| .+||...+........ . ....+|    ...+
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~-~~~~~~----~~~~  229 (258)
T cd05078         159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-E-DRHQLP----APKW  229 (258)
T ss_pred             CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-H-ccccCC----CCCc
Confidence            43   234578889999999976 4589999999999999999998 5777666554433322 1 222233    2456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      .++.+++.+||+.||++|||++++++.
T Consensus       230 ~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         230 TELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            789999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-37  Score=318.69  Aligned_cols=244  Identities=27%  Similarity=0.447  Sum_probs=199.7

Q ss_pred             eEecccCceEEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEecc
Q 005526           16 PRIGSGSFAVVWRARHRQ---LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE-TREKIYLVLEYC   91 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~-~~~~l~LVmEy~   91 (692)
                      +.||+|+||+||+|.+..   .+..||+|.+... ........+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999998653   3467999988542 23344567889999999999999999999765 456789999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC----
Q 005526           92 DGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----  166 (692)
Q Consensus        92 ~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~----  166 (692)
                      .+|+|.+++.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++......    
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~---~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF---TVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC---cEEECCccccccccCCcceee
Confidence            999999999765 3467888889999999999999999999999999999998876   59999999997654321    


Q ss_pred             -CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          167 -LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       167 -~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                       ......+++.|+|||.+....++.++|||||||++|+|++ |.+||...+.......+........+    ...+..+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  232 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP----EYCPDPLY  232 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC----CcCCHHHH
Confidence             1123345778999999988899999999999999999999 67788887777666665544332222    34678899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhc
Q 005526          245 DLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +++.+||+.+|++||++.+++..
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-37  Score=323.42  Aligned_cols=249  Identities=26%  Similarity=0.444  Sum_probs=200.1

Q ss_pred             cCEEEEeEecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCE
Q 005526           10 GEYIVGPRIGSGSFAVVWRAR----HRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET--REK   83 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~~~   83 (692)
                      .+|++.+.||+|+||+||++.    +..+++.||+|.+...  .....+.+.+|++++++++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            579999999999999999997    4457889999998654  34455778899999999999999999998743  457


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      +++||||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++..
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~---~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN---RVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC---eEEECCCcccccc
Confidence            89999999999999999765 4689999999999999999999999999999999999998876   5999999999876


Q ss_pred             CCCCC----CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHH
Q 005526          163 TPQDL----ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ---------------LFQNI  223 (692)
Q Consensus       163 ~~~~~----~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~---------------~~~~i  223 (692)
                      .....    .....++..|+|||++.+..++.++|||||||++|||++|..|+.......               .+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            43321    112234456999999998899999999999999999999887764332110               00111


Q ss_pred             HhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          224 LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       224 ~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .... ..++  .....+.++.+|+.+||..+|++|||+.++++
T Consensus       239 ~~~~-~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         239 LKNN-GRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HhcC-CcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1111 1111  22456789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-37  Score=318.72  Aligned_cols=242  Identities=27%  Similarity=0.500  Sum_probs=205.2

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .++|.+.+.||+|+||.||++..  +++.||+|.+...    .....+.+|+.+++.++||||+++++++..+ ..++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            47899999999999999999864  5889999998653    2345788899999999999999999998654 479999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           89 EYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ||+.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++   .+||+|||+++..... 
T Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~---~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG---VAKVSDFGLARVGSMG-  153 (254)
T ss_pred             ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC---cEEECCCccceecccc-
Confidence            9999999999998654  479999999999999999999999999999999999998876   5999999998764322 


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                       ......+..|+|||.+.+..++.++|+|||||++|+|++ |++||...+..+....+.......    .....+.++.+
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  228 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME----PPEGCPADVYV  228 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC----CCCcCCHHHHH
Confidence             223344568999999988899999999999999999997 999999888777666665432222    22467889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHh
Q 005526          246 LCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~  266 (692)
                      ++++||+.+|++||++.+++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999865

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-37  Score=321.25  Aligned_cols=249  Identities=22%  Similarity=0.453  Sum_probs=208.1

Q ss_pred             EEEEeEecccCceEEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQ---LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE------   82 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~------   82 (692)
                      |.+.+.||+|+||+||+|....   +++.||||++..........+.+.+|+++++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6788999999999999998653   5789999999876666666778899999999999999999999875432      


Q ss_pred             EEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKH------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                      ..++++||+.+|+|..++...      ..+++..++.++.|++.||+|||++||+||||||+||+++.++   .+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~---~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM---TVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC---CEEECcc
Confidence            357899999999999887532      2478999999999999999999999999999999999998766   5999999


Q ss_pred             ccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 005526          157 GFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP  232 (692)
Q Consensus       157 GlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p  232 (692)
                      |+++.......   .....+++.|++||.+....++.++|||||||++|+|++ |++||.+.+.......+........+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            99987643321   223345678999999999999999999999999999999 99999988877766666554433322


Q ss_pred             CCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       233 ~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                          ...+..+.+++.+||+.+|++||++.+++.+
T Consensus       238 ----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         238 ----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                3567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.4e-38  Score=326.39  Aligned_cols=249  Identities=25%  Similarity=0.417  Sum_probs=201.7

Q ss_pred             CEEEEeEecccCceEEEEEEE----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARH----RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKI   84 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~--~~l   84 (692)
                      -|.+++.||+|+||.||+++.    ..++..||+|.+.... .......+.+|+.+++.++||||+++++++...  ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            368899999999999999974    4568899999986542 344556789999999999999999999998764  678


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           85 YLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      ++||||++|++|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++   .+||+|||+++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~---~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC---CEEECCCccccccc
Confidence            99999999999999997653 589999999999999999999999999999999999998876   59999999998764


Q ss_pred             CCC----CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------------H-HHHHHHHH
Q 005526          164 PQD----LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN--------------Q-LQLFQNIL  224 (692)
Q Consensus       164 ~~~----~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~--------------~-~~~~~~i~  224 (692)
                      ...    ......++..|+|||++.+..++.++|||||||++|+|+++..|+....              . ......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            332    2234567778999999988889999999999999999999877653211              0 11111111


Q ss_pred             hccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       225 ~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ....  .  .....++.++.+|+.+||+.||.+|||+.+++++
T Consensus       241 ~~~~--~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         241 EGKR--L--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cCcc--C--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1111  1  1234578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.9e-38  Score=344.80  Aligned_cols=251  Identities=27%  Similarity=0.473  Sum_probs=207.3

Q ss_pred             ecCEEEEeEecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHR-----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETRE   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~   82 (692)
                      .++|.++++||+|+||.||+|++.     .+++.||||++.... .....+.+.+|+++|.++. ||||+++++++..++
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            467889999999999999999864     345789999997643 3334457889999999997 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC----------------------------------------------------------
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHG----------------------------------------------------------  104 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~----------------------------------------------------------  104 (692)
                      .+++|||||.+|+|.+++.+.+                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999997542                                                          


Q ss_pred             ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecC
Q 005526          105 ----------------------------------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVST  144 (692)
Q Consensus       105 ----------------------------------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~  144 (692)
                                                              .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~  274 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE  274 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence                                                    2566778889999999999999999999999999999987


Q ss_pred             CCCcCeEEEeccccccccCCCC---CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 005526          145 NEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF  220 (692)
Q Consensus       145 ~~~~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~  220 (692)
                      ++   .+||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus       275 ~~---~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         275 GK---LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             CC---EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            65   69999999997653221   1223457788999999998889999999999999999998 89999876655544


Q ss_pred             HHHHhcc-CCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          221 QNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       221 ~~i~~~~-~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ....... ...    .....+.++.+|+.+||..+|.+||++++++..
T Consensus       352 ~~~~~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         352 YNAIKRGYRMA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHcCCCCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433322 222    223568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-37  Score=320.24  Aligned_cols=251  Identities=28%  Similarity=0.546  Sum_probs=212.0

Q ss_pred             CEEEEeEecccCceEEEEEEEcC-CCcEEEEEEeccCC--------CChHHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQ-LGIEVAVKEIDKKL--------LSPKVSDNLLKEISILST-ISHPNIIRFFEAIET   80 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~-tg~~vAVK~i~~~~--------~~~~~~~~i~~Ev~iL~~-L~HpNIVkl~~~~~~   80 (692)
                      .|.+.+.||+|+||.||++++.. +++.+|+|.+....        ........+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 68899999886432        223345667788888875 799999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEec
Q 005526           81 REKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGD  155 (692)
Q Consensus        81 ~~~l~LVmEy~~GGsL~~~L~~----~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~D  155 (692)
                      ++..++||||++|++|.+++..    ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++   .+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~---~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD---KVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC---cEEEec
Confidence            9999999999999999998743    3468999999999999999999996 7899999999999998876   599999


Q ss_pred             cccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCc
Q 005526          156 FGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA  235 (692)
Q Consensus       156 FGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~  235 (692)
                      ||++.............|+..|+|||.+.+..++.++|+||||+++|+|++|++||...+.......+........   .
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~  234 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL---P  234 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC---C
Confidence            9999876655444566789999999999988899999999999999999999999988877666665544332211   1


Q ss_pred             ccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       236 ~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ....++++.+++++||+.||++||++.|+.++
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            23568899999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-37  Score=321.18  Aligned_cols=246  Identities=30%  Similarity=0.525  Sum_probs=204.6

Q ss_pred             eEecccCceEEEEEEEcCCC------cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           16 PRIGSGSFAVVWRARHRQLG------IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg------~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      +.||+|+||.||+|++...+      ..||||.+.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            36999999999999986543      789999886542 22345678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCC--CcCeEEEecccccc
Q 005526           90 YCDGGDLAAYIHKH-------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE--VTPVLKIGDFGFAR  160 (692)
Q Consensus        90 y~~GGsL~~~L~~~-------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~--~~~~vKL~DFGlA~  160 (692)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+++++|+||||+||+++.++  ....+||+|||+++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999999753       2378899999999999999999999999999999999998765  22369999999997


Q ss_pred             ccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcc
Q 005526          161 SLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       161 ~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~  236 (692)
                      .......   .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+........+    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~----  235 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP----  235 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc----
Confidence            6543221   123345678999999999999999999999999999998 99999988877766665443333222    


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ...+..+.+++.+||.++|.+||++.++++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            456789999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=324.74  Aligned_cols=240  Identities=22%  Similarity=0.384  Sum_probs=194.2

Q ss_pred             EecccCceEEEEEEEcCC------------------------CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcc
Q 005526           17 RIGSGSFAVVWRARHRQL------------------------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII   72 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~~~t------------------------g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIV   72 (692)
                      .||+|+||.||+|....+                        ...|++|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            699999999999975322                        245888888543  223446788899999999999999


Q ss_pred             eEEEEEEeCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC----
Q 005526           73 RFFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV----  147 (692)
Q Consensus        73 kl~~~~~~~~~l~LVmEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~----  147 (692)
                      ++++++..+...++|||||++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+.    
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999999999999876 467899999999999999999999999999999999999986532    


Q ss_pred             cCeEEEeccccccccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh
Q 005526          148 TPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLV-TGKPPFDGSNQLQLFQNILT  225 (692)
Q Consensus       148 ~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLl-tG~~PF~~~~~~~~~~~i~~  225 (692)
                      ...+|++|||++......   ....+++.|+|||.+.+ ..++.++|||||||++|||+ +|+.||.+....+....+..
T Consensus       160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  236 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK  236 (274)
T ss_pred             cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence            235899999998654322   23457888999998865 56899999999999999995 69999987765544332211


Q ss_pred             ccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       226 ~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                        ...++    ...++++.+++.+||+.+|++|||+.+++++
T Consensus       237 --~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 --KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             --ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence              12222    2346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=324.47  Aligned_cols=258  Identities=25%  Similarity=0.501  Sum_probs=221.7

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      +++..++..||.|+.|+||+++.+.+|...|||.+.+.. +....++++..+.++... .+|+||+.+|+|..+..++|.
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            455677888999999999999999999999999997754 344556777777776655 589999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           88 LEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      ||.|.. -++.++++ +++++|..+-++...++.||.||.+ +||+|||+||+|||+++.|+   +||||||++-++...
T Consensus       170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn---iKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC---EEeecccccceeecc
Confidence            999843 56666665 4679999999999999999999985 58999999999999999985   999999999888777


Q ss_pred             CCCCccCCCCCccChHhhh---hcCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCCCCCcccccCH
Q 005526          166 DLADTLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGS-NQLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~---~~~ys~ksDIWSLGviLyeLltG~~PF~~~-~~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                      .......|.+.|||||.+.   ...|+-++||||||++++||.||+.||.+. ...+.+.++++......+..  ..+|+
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~--~gFSp  323 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH--MGFSP  323 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc--cCcCH
Confidence            7777788999999999985   457999999999999999999999999984 45678888888665555543  24899


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ++.+|+..||.+|+.+||...++|+|||+...
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            99999999999999999999999999998644

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-38  Score=361.37  Aligned_cols=247  Identities=30%  Similarity=0.527  Sum_probs=218.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      .+-+..++||+|+||+||+|+-..     ....||||.++.+ ...+.+..|++|++++..++|||||+|+|+|..++.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            445778899999999999997543     3467999998654 3455789999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC----------C----CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCe
Q 005526           85 YLVLEYCDGGDLAAYIHKHG----------K----VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPV  150 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~----------~----lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~  150 (692)
                      |+|+|||..|||.+||..+.          .    ++..+...++.||+.|++||-++.+|||||-.+|+||.++-   +
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l---~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL---V  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce---E
Confidence            99999999999999997542          2    77889999999999999999999999999999999998776   6


Q ss_pred             EEEeccccccccCCCCCCCccC---CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 005526          151 LKIGDFGFARSLTPQDLADTLC---GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTS  226 (692)
Q Consensus       151 vKL~DFGlA~~~~~~~~~~~~~---GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~  226 (692)
                      |||+|||++|.....+......   -..+|||||.+..++|+.++||||+||+|||+++ |+.||.+....+.++.|..+
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g  721 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG  721 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence            9999999999887666544322   2457999999999999999999999999999999 99999999999999999887


Q ss_pred             cCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHH
Q 005526          227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF  264 (692)
Q Consensus       227 ~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~el  264 (692)
                      .-+..|    +..+.++.+|+..||+.+|.+||++.||
T Consensus       722 ~lL~~P----e~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  722 QLLSCP----ENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             CcccCC----CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            665555    5678899999999999999999999998

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.1e-39  Score=331.25  Aligned_cols=266  Identities=27%  Similarity=0.486  Sum_probs=213.6

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCC----cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET-R   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg----~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~-~   81 (692)
                      .....|++.++||+|.||.||+|..+.++    +.||||.++.............+|+.+++.++||||+.+..+|.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            34578999999999999999999766543    379999997664444555778899999999999999999999866 7


Q ss_pred             CEEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC-cCeEEEec
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKH-----GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV-TPVLKIGD  155 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~-----~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~-~~~vKL~D  155 (692)
                      ..+++++||.+. ||...|+.+     ..++...++.+++||+.|+.|||++=|+||||||.|||+..++. .+.|||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            899999999988 999999754     34899999999999999999999999999999999999987732 24799999


Q ss_pred             cccccccCCC----CCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 005526          156 FGFARSLTPQ----DLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQ---------LQLFQ  221 (692)
Q Consensus       156 FGlA~~~~~~----~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~---------~~~~~  221 (692)
                      ||++|.+...    ...+..+.|.||+|||.+.+ ..|+.+.|||++|||+.||++-.+.|.+...         ...+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999976532    23456788999999999876 5699999999999999999999999976421         23333


Q ss_pred             HHHhccCC----CC------CC----------Cc------------ccccCHHHHHHHHHhhccCCCCCCCHHHHHhchh
Q 005526          222 NILTSTEL----RF------PP----------GA------------IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF  269 (692)
Q Consensus       222 ~i~~~~~~----~~------p~----------~~------------~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf  269 (692)
                      +|++--..    .+      |+          ..            +...++...+|+.+||..||.+|+|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            34321100    01      10          00            1123566899999999999999999999999999


Q ss_pred             hhhh
Q 005526          270 LGEL  273 (692)
Q Consensus       270 ~~~~  273 (692)
                      |.+.
T Consensus       340 F~~d  343 (438)
T KOG0666|consen  340 FTED  343 (438)
T ss_pred             cccC
Confidence            9753

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=364.38  Aligned_cols=248  Identities=26%  Similarity=0.490  Sum_probs=216.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCc-----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGI-----EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~-----~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .-.+.+.||+|+||.||.|....-..     .||||.+.+. .+......|.+|..+|+.++|||||+++|++.+....+
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            45778999999999999998765332     4899988653 35566789999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           86 LVLEYCDGGDLAAYIHKH-------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~-------~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      |++|||+||||..+|++.       ..++......++.||++|++||+++++|||||..+|+||+...   +|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r---~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR---VVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC---cEEEcccch
Confidence            999999999999999876       2478999999999999999999999999999999999999875   799999999


Q ss_pred             ccccCCCCCCCcc-C--CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 005526          159 ARSLTPQDLADTL-C--GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPG  234 (692)
Q Consensus       159 A~~~~~~~~~~~~-~--GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~  234 (692)
                      |+.+...+..... .  -...|||||.+..+.++.|+|||||||+|||+++ |..||.+.+..+++..++.+..+..|. 
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~-  927 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS-  927 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC-
Confidence            9965544433221 1  1246999999999999999999999999999999 999999999999999888888666553 


Q ss_pred             cccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       235 ~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                         ..+..+.+++..||+.+|++||++..|++
T Consensus       928 ---~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  928 ---YCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ---CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence               56778889999999999999999999988

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.7e-37  Score=325.12  Aligned_cols=250  Identities=28%  Similarity=0.424  Sum_probs=206.7

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGI----EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      .++|++.+.||+|+||.||+|.+..+|.    .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            4789999999999999999999887776    47888876432 334445788999999999999999999988654 46


Q ss_pred             EEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           85 YLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      ++++||+++|+|.+++..+. .+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~---~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN---HVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC---ceEEcccccccccc
Confidence            79999999999999998754 589999999999999999999999999999999999998766   59999999998654


Q ss_pred             CCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          164 PQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       164 ~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      ....   .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+........    ....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  236 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ----PPIC  236 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC----CCCC
Confidence            3322   223345678999999999999999999999999999997 9999988776555444433322222    2346


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +.++.+++.+||..+|++||++.+++..
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.7e-37  Score=319.43  Aligned_cols=241  Identities=19%  Similarity=0.380  Sum_probs=194.3

Q ss_pred             eEecccCceEEEEEEEcC------------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 005526           16 PRIGSGSFAVVWRARHRQ------------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~------------tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~   83 (692)
                      +.||+|+||+||+|+...            ....+++|.+...  .......+.+|+.+++.++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            469999999999998532            2346888987553  23344577889999999999999999999998899


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC----cCeEEEecccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV----TPVLKIGDFGF  158 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~----~~~vKL~DFGl  158 (692)
                      .++||||+++|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.    ...+|++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999998764 56899999999999999999999999999999999999986542    12489999999


Q ss_pred             ccccCCCCCCCccCCCCCccChHhhh-hcCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhccCCCCCCCcc
Q 005526          159 ARSLTPQDLADTLCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLV-TGKPPFDGSNQLQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       159 A~~~~~~~~~~~~~GT~~YmAPEvl~-~~~ys~ksDIWSLGviLyeLl-tG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~  236 (692)
                      +......   ....++..|+|||++. +..++.++|||||||++|+|+ +|..||......+... .... ....    .
T Consensus       159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~-~~~~----~  229 (262)
T cd05077         159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG-QCML----V  229 (262)
T ss_pred             CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc-CccC----C
Confidence            8654322   3356788999999986 467899999999999999998 5899998765443322 2111 1111    1


Q ss_pred             cccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       237 ~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ...+.++.+|+.+||+.||.+||++.+|+.+
T Consensus       230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            2345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=340.98  Aligned_cols=264  Identities=29%  Similarity=0.485  Sum_probs=228.9

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-----hHHHHHHHHHHHHHHhCCCCCcceEEEEE-Ee
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-----PKVSDNLLKEISILSTISHPNIIRFFEAI-ET   80 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-----~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~-~~   80 (692)
                      .+.++|.++..||+|+|+.||+|.+....++||||+-.....+     ....+...+|.+|.+.|.||.||++|++| .+
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            4678999999999999999999999999999999987543322     22345678899999999999999999998 46


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           81 REKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH--LIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        81 ~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~g--IVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      .+.+|-|+|||+|.+|.-||+.+..++|.+++.|+.||+.||.||....  |||-||||.|||+..+...+.+||+|||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7789999999999999999999999999999999999999999999775  99999999999998877777899999999


Q ss_pred             ccccCCC--------CCCCccCCCCCccChHhhhhc----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Q 005526          159 ARSLTPQ--------DLADTLCGSPLYMAPEIIQNH----KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL---FQNI  223 (692)
Q Consensus       159 A~~~~~~--------~~~~~~~GT~~YmAPEvl~~~----~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~---~~~i  223 (692)
                      ++.++.+        +.+....||.||++||++.-+    +.+.|+||||+|||+|+++.|+.||......+.   ...|
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI  699 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI  699 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence            9987643        245667899999999997543    467899999999999999999999976643332   2346


Q ss_pred             HhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          224 LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       224 ~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      ++...+.||+.  ..+++++++||++||++.-++|....++-.||||..
T Consensus       700 lkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  700 LKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            77788888876  468999999999999999999999999999999854

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.5e-37  Score=322.48  Aligned_cols=258  Identities=16%  Similarity=0.222  Sum_probs=193.7

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHH---------HHHHHHHHHHHHhCCCCCcc
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKV---------SDNLLKEISILSTISHPNII   72 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~---------~~~i~~Ev~iL~~L~HpNIV   72 (692)
                      .....++|.+.+.||+|+||+||+|.+..+   +..+|+|+..........         ......+...+..+.|+||+
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            444567999999999999999999998877   677888865433211100         01122334455667899999


Q ss_pred             eEEEEEEeCC----EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCc
Q 005526           73 RFFEAIETRE----KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVT  148 (692)
Q Consensus        73 kl~~~~~~~~----~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~  148 (692)
                      ++++++....    ..++++|++.. ++.+.+......++..++.++.|++.||.|||++||+||||||+|||++.++  
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--  163 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--  163 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--
Confidence            9998765433    45788898754 7777777666678999999999999999999999999999999999998766  


Q ss_pred             CeEEEeccccccccCCCC--------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 005526          149 PVLKIGDFGFARSLTPQD--------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ-LQL  219 (692)
Q Consensus       149 ~~vKL~DFGlA~~~~~~~--------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~-~~~  219 (692)
                       .+||+|||+++......        ......||+.|+|||++.+..|+.++|||||||++|+|++|++||.+... ...
T Consensus       164 -~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        164 -RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             -cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence             48999999997653221        12335799999999999999999999999999999999999999987732 221


Q ss_pred             HHHHHhc--cCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          220 FQNILTS--TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       220 ~~~i~~~--~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .......  ..+..........++++.++++.|+..+|++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1111000  0000011112345788999999999999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.1e-37  Score=317.56  Aligned_cols=229  Identities=25%  Similarity=0.402  Sum_probs=193.2

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCHHHHH
Q 005526           21 GSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYI  100 (692)
Q Consensus        21 GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L  100 (692)
                      |.||.||+++++.+++.||+|.+....       ...+|...+....||||+++++++...+..++||||++||+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            899999999999999999999996642       2234455555667999999999999999999999999999999999


Q ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCCCCCccCh
Q 005526          101 HKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP  180 (692)
Q Consensus       101 ~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAP  180 (692)
                      .+...+++..+..++.|++.||.|||++||+||||||+||+++.++   .++++|||.+......  .....++..|+||
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~~l~df~~~~~~~~~--~~~~~~~~~y~aP  151 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG---HIQLTYFSRWSEVEDS--CDGEAVENMYCAP  151 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC---CEEEecccchhccccc--cccCCcCccccCC
Confidence            8888899999999999999999999999999999999999999877   4999999988665432  2344567889999


Q ss_pred             HhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCC
Q 005526          181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT  260 (692)
Q Consensus       181 Evl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpT  260 (692)
                      |.+....++.++|+||+||++|+|++|+.||......     +.......+|    ..+++.+.++|.+||+.||++||+
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~  222 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIP----EWVSEEARSLLQQLLQFNPTERLG  222 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCc----ccCCHHHHHHHHHHccCCHHHhcC
Confidence            9998888999999999999999999999988654321     1111112222    357889999999999999999998


Q ss_pred             H-----HHHHhchhh
Q 005526          261 F-----KEFFNHRFL  270 (692)
Q Consensus       261 a-----~elL~Hpf~  270 (692)
                      +     +++++||||
T Consensus       223 ~~~~~~~~~~~h~~~  237 (237)
T cd05576         223 AGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCccchHHHHcCCCC
Confidence            5     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=317.76  Aligned_cols=251  Identities=25%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCCEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE-----TREKI   84 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~-----~~~~l   84 (692)
                      +||+|.+.||+|||+.||++++..+++.||+|.|....  .+..+..++|++..++++||||++++++..     .....
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            68999999999999999999999999999999997664  456788999999999999999999998753     23469


Q ss_pred             EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           85 YLVLEYCDGGDLAAYIHKH----GKVSEAVARHFMRQLAAGLQVLQEKH--LIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~----~~lse~~i~~il~QLl~gL~yLHs~g--IVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      ||+++|...|+|.+.+...    ..++|.++.+|+.+|+.||++||+..  ..||||||.|||+.+.+   ..+|.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~---~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG---LPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC---ceEEEeccC
Confidence            9999999999999998753    35899999999999999999999999  99999999999999866   589999999


Q ss_pred             ccccCCCCC----------CCccCCCCCccChHhhhh---cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Q 005526          159 ARSLTPQDL----------ADTLCGSPLYMAPEIIQN---HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ-LFQNIL  224 (692)
Q Consensus       159 A~~~~~~~~----------~~~~~GT~~YmAPEvl~~---~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~-~~~~i~  224 (692)
                      ++...-.-.          ......|..|+|||.+.-   ...+.++|||||||+||.|+.|..||...-+.. -+.--.
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv  255 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV  255 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence            876532211          112346888999999864   346789999999999999999999996421100 000001


Q ss_pred             hccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       225 ~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ....+.+|...  .++..+.++|+.||++||.+||++.+++.+
T Consensus       256 ~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  256 QNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            22345555543  489999999999999999999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=351.03  Aligned_cols=244  Identities=30%  Similarity=0.503  Sum_probs=212.2

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~L   86 (692)
                      +..+|.+...+|.|+|++|..+.+..+++.+++|++.+..      ....+|+.++... +||||+++++.+.++...|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence            5678999999999999999999999999999999997752      2234567666554 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEec-CCCCcCeEEEeccccccccCCC
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVS-TNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~-~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |||++.|+.+.+.+.....+. .++..|+.||+.++.|||++|+|||||||+|||++ ..+   .++|+|||.++.....
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g---~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG---HLRLTYFGFWSELERS  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC---cEEEEEechhhhCchh
Confidence            999999999999887776565 78889999999999999999999999999999995 444   6999999999887665


Q ss_pred             CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~-~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                        ..+.|-|..|.|||++....|++++||||||++||+|++|+.||...... ++..++....       ....+|.+++
T Consensus       470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~-------~s~~vS~~AK  540 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK-------FSECVSDEAK  540 (612)
T ss_pred             --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc-------cccccCHHHH
Confidence              45667888999999999999999999999999999999999999876655 4554443221       1267899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      |||++||+.||.+|+++.++..||||
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999999

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-37  Score=317.85  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=204.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEc----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET--REK   83 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~----~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~--~~~   83 (692)
                      .+|.+.+.||+|+||.||+|+..    .+++.||||.+...... .....+.+|+++++.++||||+++++++..  +..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            56888999999999999999864    34889999999765433 456788999999999999999999999876  668


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .++||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++   .+||+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~---~~~l~dfg~~~~~  159 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED---LVKISDFGLAKVL  159 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC---CEEEccccccccc
Confidence            999999999999999997754 689999999999999999999999999999999999998876   5999999999876


Q ss_pred             CCCCC----CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHH
Q 005526          163 TPQDL----ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL--------------QLFQNIL  224 (692)
Q Consensus       163 ~~~~~----~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~--------------~~~~~i~  224 (692)
                      .....    .....++..|++||.+.+..++.++|||||||++|+|++|..||......              ......+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            53221    11234456799999998889999999999999999999999998654221              1112222


Q ss_pred             hccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       225 ~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      ... ...+  .....+.++.+++.+||+.+|.+|||+.++++
T Consensus       240 ~~~-~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEG-ERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcC-CcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            211 1111  12355688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-36  Score=314.41  Aligned_cols=246  Identities=22%  Similarity=0.420  Sum_probs=197.5

Q ss_pred             eEecccCceEEEEEEEcCC--CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQL--GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~t--g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      ++||+|+||+||++.....  ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            3699999999999975432  3456677665432 234467889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC---
Q 005526           94 GDLAAYIHKH----GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---  166 (692)
Q Consensus        94 GsL~~~L~~~----~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~---  166 (692)
                      |+|.+++.+.    ...++..++.++.||+.||+|||+++|+||||||+|||++.++   .+||+|||++.......   
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~---~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL---TVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc---cEEecccccccccCcchhhh
Confidence            9999999764    2357778899999999999999999999999999999998776   59999999986432221   


Q ss_pred             CCCccCCCCCccChHhhhh-------cCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC-CCccc
Q 005526          167 LADTLCGSPLYMAPEIIQN-------HKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP-PGAIE  237 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~-------~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p-~~~~~  237 (692)
                      .....++++.|+|||++..       ..++.++|||||||++|+|++ |..||...+..+.+..+........+ +....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence            2234578899999999753       245788999999999999997 68899888877777766555433322 23334


Q ss_pred             ccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          238 ELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       238 ~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .+++.+.++++.|| .+|++||+++++++
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            57889999999999 67999999999854

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=336.43  Aligned_cols=250  Identities=29%  Similarity=0.448  Sum_probs=199.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE-KIYLVL   88 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~-~l~LVm   88 (692)
                      ++|.-...||+|+||.||+|.... |+.||||.+.......  ..+|..|++++.+++|||+|+|+|||.+.+ ..+||+
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            456667899999999999999875 5999999876543321  456999999999999999999999999888 599999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           89 EYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKH---LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~g---IVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      ||+++|+|.++|....  .++|....+|+.+++.||+|||...   ||||||||+|||+|.+.   ..||+|||+|+...
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~---~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF---NAKLSDFGLAKLGP  228 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC---CEEccCccCcccCC
Confidence            9999999999998765  7899999999999999999999754   99999999999999887   48999999997655


Q ss_pred             C-CCCCCcc-CCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHhccCC-CCC-C
Q 005526          164 P-QDLADTL-CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQ---NILTSTEL-RFP-P  233 (692)
Q Consensus       164 ~-~~~~~~~-~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~---~~~~~~---~i~~~~~~-~~p-~  233 (692)
                      . .....+. .||.+|+|||++..+..+.|+|||||||+|.||++|+.+.+...   ...+..   ..+..... .+. +
T Consensus       229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~  308 (361)
T KOG1187|consen  229 EGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP  308 (361)
T ss_pred             ccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence            4 3333333 89999999999999999999999999999999999999887532   111111   11111111 111 1


Q ss_pred             Ccc-cccC-----HHHHHHHHHhhccCCCCCCCHHHHH
Q 005526          234 GAI-EELH-----PDCVDLCRCLLRQNPVERITFKEFF  265 (692)
Q Consensus       234 ~~~-~~ls-----~el~dLI~~~L~~DP~~RpTa~elL  265 (692)
                      ... ....     ..+..+..+|++.+|.+||++.|++
T Consensus       309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence            111 1222     2367788999999999999999973

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-39  Score=322.43  Aligned_cols=265  Identities=27%  Similarity=0.498  Sum_probs=217.5

Q ss_pred             CCcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 005526            4 NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET---   80 (692)
Q Consensus         4 ~~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~---   80 (692)
                      ...+.++.|+-..+||+|.||.||+|+.+.+|+.||+|++-........-....+|+++|..++|+|++.+++.|..   
T Consensus        11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            45567888999999999999999999999999999999876544344444567899999999999999999887642   


Q ss_pred             -----CCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEe
Q 005526           81 -----REKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIG  154 (692)
Q Consensus        81 -----~~~l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~  154 (692)
                           ...+|+||++|+. +|..++... .+++..+++.++++++.||.|+|.+.|+|||+||.|+||+.++   ++||+
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg---ilklA  166 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG---ILKLA  166 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc---eEEee
Confidence                 2358999999988 899988765 6799999999999999999999999999999999999999988   69999


Q ss_pred             ccccccccCCCC-----CCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Q 005526          155 DFGFARSLTPQD-----LADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-  227 (692)
Q Consensus       155 DFGlA~~~~~~~-----~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-  227 (692)
                      |||+++.+...+     .....+.|.+|++||.+.+ ..|+++.|||+.||++.||++|.+.|.+....+.+.-|..-. 
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            999998764332     1233456999999998765 679999999999999999999999999998877766553110 


Q ss_pred             --C-CC-----------------CCCCcc---------cccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          228 --E-LR-----------------FPPGAI---------EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       228 --~-~~-----------------~p~~~~---------~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                        . -.                 .+.+..         -..+++..||+.++|..||.+|+++.++++|.||..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence              0 00                 111100         012468899999999999999999999999999953

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=321.58  Aligned_cols=275  Identities=27%  Similarity=0.566  Sum_probs=234.3

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~   85 (692)
                      -.++|.++++||+|+|++|.++++++|.+.||+|++++...++ +..+-...|..+.... +||.+|-++.+|.++..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            4578999999999999999999999999999999998876543 3445666777777765 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccc-cCC
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS-LTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~-~~~  164 (692)
                      +|.||++||+|--.+++..+++|+.++.+-..|+.||.|||++|||.||||.+|||++..|   .+||+|+|+++. +.+
T Consensus       328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg---hikltdygmcke~l~~  404 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG---HIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC---ceeecccchhhcCCCC
Confidence            9999999999999999999999999999999999999999999999999999999999988   499999999986 456


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhccCCCCCCCccc
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDG-------SNQLQLFQNILTSTELRFPPGAIE  237 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~-------~~~~~~~~~i~~~~~~~~p~~~~~  237 (692)
                      .+.+.++||||.|.|||++++..|+..+|+|+|||+++||+.|+.||+-       .+-+.-+..++-...+++|.    
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----  480 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----  480 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----
Confidence            7789999999999999999999999999999999999999999999952       23333333344445566664    


Q ss_pred             ccCHHHHHHHHHhhccCCCCCC------CHHHHHhchhhhhhHhhhhhhccccCCCCCc
Q 005526          238 ELHPDCVDLCRCLLRQNPVERI------TFKEFFNHRFLGELRQTVHAEQHSVVPETKP  290 (692)
Q Consensus       238 ~ls~el~dLI~~~L~~DP~~Rp------Ta~elL~Hpf~~~~~~~~~~~~~~~~p~~~~  290 (692)
                      .++-....+++..|.+||.+|.      .+.++..|+||+.+.+.... +....|...|
T Consensus       481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le-qk~v~ppf~p  538 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE-QKQVLPPFQP  538 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh-hcccCCCCCC
Confidence            5677778899999999999997      47899999999977655433 3444444443

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=351.53  Aligned_cols=249  Identities=32%  Similarity=0.561  Sum_probs=204.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR------E   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~------~   82 (692)
                      .+-|...+.||+|+||.||+++++.+|+.||||.++... ..+..+...+|+++|++++|||||+++++-++.      .
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            356788899999999999999999999999999997643 445578889999999999999999999885443      3


Q ss_pred             EEEEEEeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCC-CcCeEEEecccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHK---HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGF  158 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~---~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~-~~~~vKL~DFGl  158 (692)
                      ...+|||||.||||...+++   +.+++|.++..++..+..||.|||++||+||||||.||++.... .....||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            56899999999999999975   46799999999999999999999999999999999999986554 345789999999


Q ss_pred             ccccCCCCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccC-----
Q 005526          159 ARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTE-----  228 (692)
Q Consensus       159 A~~~~~~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~----~~~~~i~~~~~-----  228 (692)
                      |+.+..+....+.+||+.|++||.+.. ..|+..+|.|||||++|++.||..||......    +....+.....     
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            999998888899999999999999984 88999999999999999999999999654332    23333322111     


Q ss_pred             ---------C----CCCCCcccccC----HHHHHHHHHhhccCCCCCCC
Q 005526          229 ---------L----RFPPGAIEELH----PDCVDLCRCLLRQNPVERIT  260 (692)
Q Consensus       229 ---------~----~~p~~~~~~ls----~el~dLI~~~L~~DP~~RpT  260 (692)
                               +    .+|.  ...++    ..+..++..+|..+|.+|..
T Consensus       251 ~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             eeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence                     0    1111  12333    34557788899999999983

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=331.36  Aligned_cols=262  Identities=29%  Similarity=0.476  Sum_probs=216.5

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC--CC----cceEEEEEE
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--PN----IIRFFEAIE   79 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~H--pN----IVkl~~~~~   79 (692)
                      ..+.++|.++..+|+|.||+|..+.+..++..||||+|+..   .+..+..+-|+++|.++.+  |+    +|++.++|+
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            44678999999999999999999999999999999999653   4556677789999999942  33    788888899


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC----------
Q 005526           80 TREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV----------  147 (692)
Q Consensus        80 ~~~~l~LVmEy~~GGsL~~~L~~~~--~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~----------  147 (692)
                      ..+..|||+|.+ |-++.++++.++  .++-..++.+.+||+.+++|||+++++|-||||+|||+.....          
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            999999999998 669999998864  5889999999999999999999999999999999999954211          


Q ss_pred             -------cCeEEEeccccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--
Q 005526          148 -------TPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ--  218 (692)
Q Consensus       148 -------~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~--  218 (692)
                             ...|||+|||.|+.....  ..+++.|..|+|||++.+.+++.++||||+||||+|+++|...|+..+..+  
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                   135899999999875433  367889999999999999999999999999999999999999999877555  


Q ss_pred             -HHHHHHhcc-----------------CCCCCCCcc---------------------cccCHHHHHHHHHhhccCCCCCC
Q 005526          219 -LFQNILTST-----------------ELRFPPGAI---------------------EELHPDCVDLCRCLLRQNPVERI  259 (692)
Q Consensus       219 -~~~~i~~~~-----------------~~~~p~~~~---------------------~~ls~el~dLI~~~L~~DP~~Rp  259 (692)
                       +++.|+...                 .+.++....                     .....++.||+++||..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence             455554211                 122221111                     11234689999999999999999


Q ss_pred             CHHHHHhchhhhhh
Q 005526          260 TFKEFFNHRFLGEL  273 (692)
Q Consensus       260 Ta~elL~Hpf~~~~  273 (692)
                      |+.|+|.||||...
T Consensus       399 Tl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  399 TLREALSHPFFARL  412 (415)
T ss_pred             cHHHHhcCHHhhcC
Confidence            99999999999754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2e-35  Score=294.94  Aligned_cols=243  Identities=44%  Similarity=0.823  Sum_probs=209.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCHHHHHH
Q 005526           22 SFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH  101 (692)
Q Consensus        22 sFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~  101 (692)
                      +||.||+|.+..+|+.+|+|++........ .+.+.+|++.+++++|+||+++++++......++++||+.+++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999998899999999976543322 5788999999999999999999999999999999999999999999998


Q ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCCCCCccChH
Q 005526          102 KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE  181 (692)
Q Consensus       102 ~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPE  181 (692)
                      ....+++..++.++.+++.+|.|||+.||+|+||+|+||+++.++   .++|+|||.+.............++..|++||
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG---HVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC---cEEEccccceeeeccccccccccCCcCCCCHH
Confidence            877799999999999999999999999999999999999999876   59999999998876655556677899999999


Q ss_pred             hhhhcCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCC
Q 005526          182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT  260 (692)
Q Consensus       182 vl~~~~ys~ksDIWSLGviLyeLltG~~PF~~-~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpT  260 (692)
                      .+....++.++|||+||+++|+|++|..||.. .+.......+ ......... ....++.++.+++.+||..+|++||+
T Consensus       157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI-GKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-hccCCCCcc-ccccCCHHHHHHHHHHccCCchhccC
Confidence            99988899999999999999999999999988 4444444433 322222211 11127789999999999999999999


Q ss_pred             HHHHHhchhh
Q 005526          261 FKEFFNHRFL  270 (692)
Q Consensus       261 a~elL~Hpf~  270 (692)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=333.56  Aligned_cols=254  Identities=28%  Similarity=0.480  Sum_probs=219.4

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCC-C--cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQL-G--IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~t-g--~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ++..+.++||+|+||+|++|.++.- |  -.||||+++...... ....|.+|+.+|.+|+|||+++|||++.+ ..+.+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            3456678999999999999988763 3  359999998776554 67899999999999999999999999887 77899


Q ss_pred             EEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           87 VLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~--~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      |||++++|+|.+.|.+  ...|.....+.|+.||+.|+.||..+++|||||...|||+-...   .|||+|||+.+.+..
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr---tVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR---TVKICDFGLMRALGE  264 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc---eeeeecccceeccCC
Confidence            9999999999999987  34578899999999999999999999999999999999998754   699999999998875


Q ss_pred             CCCCCccC----CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          165 QDLADTLC----GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       165 ~~~~~~~~----GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      .+......    -...|.|||.++...++.++|||++||++|||++ |..||.|....+++++|-.+..+.-|    ...
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP----k~c  340 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP----KYC  340 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC----CCC
Confidence            54333222    2446999999999999999999999999999999 99999999999999998766555544    466


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      +.++.+++..||..+|.+|||+..|.+.-++.+
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            889999999999999999999999876666554

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=337.59  Aligned_cols=257  Identities=26%  Similarity=0.519  Sum_probs=222.9

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----CC
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET-----RE   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~-----~~   82 (692)
                      -+-|+|.+.||.|.+|.||+++++++|+..|+|+.....   ...+++..|.+||+.. .|||++.++++|..     ++
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            356899999999999999999999999999999987653   3346778899999977 69999999999853     57


Q ss_pred             EEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                      .+|||||||.||+.-++++.-  .++.|+.+..+++.++.||.+||.+.++|||||-.|||++.++   .|||+|||.+.
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~---~VKLvDFGvSa  171 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA---EVKLVDFGVSA  171 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC---cEEEeeeeeee
Confidence            899999999999999999764  5689999999999999999999999999999999999999988   49999999998


Q ss_pred             ccCCC-CCCCccCCCCCccChHhhhhc-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 005526          161 SLTPQ-DLADTLCGSPLYMAPEIIQNH-----KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPG  234 (692)
Q Consensus       161 ~~~~~-~~~~~~~GT~~YmAPEvl~~~-----~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~  234 (692)
                      .++.. ....+.+|||.|||||++...     .|+..+|+||||++..||--|.+|+........+..|-+..+...  .
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL--k  249 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL--K  249 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc--c
Confidence            87654 346788999999999998643     478899999999999999999999999888776666654433222  2


Q ss_pred             cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       235 ~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      .+...+.++.|||..||.+|-.+||+..++|.|||+.+.
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            245678999999999999999999999999999999754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.9e-35  Score=336.10  Aligned_cols=256  Identities=21%  Similarity=0.329  Sum_probs=181.0

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCC----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEE------
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA------   77 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~t----g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~------   77 (692)
                      -.++|.+.++||+|+||+||+|++..+    +..||||.+......    +....|  .++...+.++..++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            467999999999999999999999988    999999987543211    111111  1222222333322221      


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Q 005526           78 IETREKIYLVLEYCDGGDLAAYIHKHGK--------------------VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP  137 (692)
Q Consensus        78 ~~~~~~l~LVmEy~~GGsL~~~L~~~~~--------------------lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP  137 (692)
                      ...+..+++||||+.+++|.+++.....                    ..+..++.++.||+.||+|||++||+||||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP  283 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP  283 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence            2456689999999999999999875421                    12345678999999999999999999999999


Q ss_pred             CceEecCCCCcCeEEEeccccccccCCC--CCCCccCCCCCccChHhhhhc----------------------CCCcchh
Q 005526          138 QNLLVSTNEVTPVLKIGDFGFARSLTPQ--DLADTLCGSPLYMAPEIIQNH----------------------KYDAKAD  193 (692)
Q Consensus       138 ~NILL~~~~~~~~vKL~DFGlA~~~~~~--~~~~~~~GT~~YmAPEvl~~~----------------------~ys~ksD  193 (692)
                      +|||++.+..  .+||+|||+++.....  ......++++.|||||.+...                      .++.++|
T Consensus       284 ~NILl~~~~~--~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        284 QNIIFSEGSG--SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHEEEeCCCC--cEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            9999986432  5999999999865322  234567899999999976432                      2445679


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----------CCC------CcccccCHHHHHHHHHhhccCCC
Q 005526          194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR-----------FPP------GAIEELHPDCVDLCRCLLRQNPV  256 (692)
Q Consensus       194 IWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~-----------~p~------~~~~~ls~el~dLI~~~L~~DP~  256 (692)
                      ||||||+||||+++..++.  +....+..++......           ..+      ..........+|||.+||++||.
T Consensus       362 VwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999999999766543  3322332222211110           000      00111234567999999999999


Q ss_pred             CCCCHHHHHhchhhhhh
Q 005526          257 ERITFKEFFNHRFLGEL  273 (692)
Q Consensus       257 ~RpTa~elL~Hpf~~~~  273 (692)
                      +|||+.++|+||||+..
T Consensus       440 kR~ta~e~L~Hpff~~~  456 (566)
T PLN03225        440 QRISAKAALAHPYFDRE  456 (566)
T ss_pred             cCCCHHHHhCCcCcCCC
Confidence            99999999999999653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.1e-36  Score=297.64  Aligned_cols=259  Identities=23%  Similarity=0.453  Sum_probs=214.4

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETR--EKI   84 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~--~~l   84 (692)
                      -+++|++.+++|+|.++.||.|++..++..++||+++..     -.+.+.+|++||..|. ||||+++++.+.+.  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            468899999999999999999999999999999998543     3568899999999996 99999999998765  467


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      .+|+||+++.+...+-   ..++...++.++.||+.||.|||+.||+|||+||.|++|+....  .++|+|+|+|.+..+
T Consensus       111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r--kLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc--eeeeeecchHhhcCC
Confidence            8999999987766543   46788899999999999999999999999999999999987654  699999999999888


Q ss_pred             CCCCCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhc------------cCCC
Q 005526          165 QDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTS------------TELR  230 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF-~~~~~~~~~~~i~~~------------~~~~  230 (692)
                      ....+..+.+..|--||.+-. ..|+..-|+|||||+|..|+..+.|| .|.+..+++.+|.+-            -.+.
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            877777788899999999765 56899999999999999999988887 455544444443211            0011


Q ss_pred             C--------------------CCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          231 F--------------------PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       231 ~--------------------p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      .                    +.+...-.++++.||+.++|..|-.+|+|++|++.||||...+..
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            1                    111112346999999999999999999999999999999876543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=303.22  Aligned_cols=257  Identities=24%  Similarity=0.401  Sum_probs=210.7

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS-TISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~-~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      +-+..||.|+||+|++..++.+|+..|||.|+.... .+...++..|.+... .-+.||||++||..-.++..||.||+|
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            346789999999999999999999999999987654 345567777777654 558999999999988889999999999


Q ss_pred             CCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           92 DGGDLAAYIH-----KHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        92 ~GGsL~~~L~-----~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      .- +|..+-+     ++..++|..+-.+....+.||.||.. .+|||||+||+|||++..|+   |||||||++..+...
T Consensus       146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~---vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD---VKLCDFGICGQLVDS  221 (361)
T ss_pred             hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC---EeeecccchHhHHHH
Confidence            65 6665543     34679999999999999999999985 58999999999999999885   999999999877655


Q ss_pred             CCCCccCCCCCccChHhhhh--cCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCC-CCCcccccCH
Q 005526          166 DLADTLCGSPLYMAPEIIQN--HKYDAKADLWSVGAILFQLVTGKPPFDGSNQ-LQLFQNILTSTELRF-PPGAIEELHP  241 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~~--~~ys~ksDIWSLGviLyeLltG~~PF~~~~~-~~~~~~i~~~~~~~~-p~~~~~~ls~  241 (692)
                      -.....+|...|||||.+..  .+|+-++|+||||++|||+.||..||.+.+. .+.+..+..+..... .+....+++.
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~  301 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF  301 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence            44555678899999999853  4699999999999999999999999988765 233334444332221 1222246789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      .+..+|.-||.+|-..||.+.+++++||++...
T Consensus       302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             HHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            999999999999999999999999999997654

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=318.20  Aligned_cols=245  Identities=26%  Similarity=0.501  Sum_probs=211.4

Q ss_pred             EEEeEecccCceEEEEEEEcCC--C--cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526           13 IVGPRIGSGSFAVVWRARHRQL--G--IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~t--g--~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      .+.+.||.|-||.||+|....-  |  --||||.-+.+... ...+.|+.|..+|++++||||++++|++. ....||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wivm  469 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVM  469 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEE
Confidence            4466799999999999985432  3  34888888665444 34789999999999999999999999976 45689999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           89 EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      |+++-|.|..||+.+ ..++......|+.||+.+|.|||+.++|||||..+|||+....   .|||+|||++|.+..+..
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~---CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ---CVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc---eeeecccchhhhccccch
Confidence            999999999999876 4689999999999999999999999999999999999999877   599999999998876655


Q ss_pred             CCccCC--CCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 ADTLCG--SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 ~~~~~G--T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      .....|  ...|||||-+.-..++.++|||-|||++||++. |..||.+-...+.+-.+.++..++.|+    ..++.+.
T Consensus       547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~----nCPp~LY  622 (974)
T KOG4257|consen  547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP----NCPPALY  622 (974)
T ss_pred             hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC----CCChHHH
Confidence            433333  446999999999999999999999999999887 999999988888888888888777775    5678889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHh
Q 005526          245 DLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .|+.+||+.||.+||++.+|..
T Consensus       623 slmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999988754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.3e-35  Score=320.29  Aligned_cols=260  Identities=31%  Similarity=0.477  Sum_probs=216.7

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC------CCcceEEEEE
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH------PNIIRFFEAI   78 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~H------pNIVkl~~~~   78 (692)
                      ++.+-++|.|....|+|-|++|.+|.+...|..||||+|+...   -..+.=+.|++||++|+.      -|+++|+-.|
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            4556789999999999999999999999999999999997653   334455789999999963      4799999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEec
Q 005526           79 ETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD  155 (692)
Q Consensus        79 ~~~~~l~LVmEy~~GGsL~~~L~~~~---~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~D  155 (692)
                      ...+++|||+|-+. .+|.+.|++.|   ++....++.|++||+.||..|..+||+|.||||+|||+.+..+  ++||||
T Consensus       504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~--iLKLCD  580 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN--ILKLCD  580 (752)
T ss_pred             hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc--eeeecc
Confidence            99999999999884 48999999876   4788899999999999999999999999999999999998776  799999


Q ss_pred             cccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC-
Q 005526          156 FGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPG-  234 (692)
Q Consensus       156 FGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~-  234 (692)
                      ||.|-.....++ ..+..+..|.|||++.+.+|+...|+||+||+||||+||+..|+|....+++.-.+.- .-.||.. 
T Consensus       581 fGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~-KGk~p~Km  658 (752)
T KOG0670|consen  581 FGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL-KGKFPNKM  658 (752)
T ss_pred             Cccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh-cCCCcHHH
Confidence            999977665554 4456677899999999999999999999999999999999999998776655432210 0000000 


Q ss_pred             -----------------------------------------c--------------ccccCHHHHHHHHHhhccCCCCCC
Q 005526          235 -----------------------------------------A--------------IEELHPDCVDLCRCLLRQNPVERI  259 (692)
Q Consensus       235 -----------------------------------------~--------------~~~ls~el~dLI~~~L~~DP~~Rp  259 (692)
                                                               .              ....-.++.+|+.+||..||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence                                                     0              001114689999999999999999


Q ss_pred             CHHHHHhchhhhh
Q 005526          260 TFKEFFNHRFLGE  272 (692)
Q Consensus       260 Ta~elL~Hpf~~~  272 (692)
                      |..++|.||||++
T Consensus       739 t~nqAL~HpFi~~  751 (752)
T KOG0670|consen  739 TVNQALKHPFITE  751 (752)
T ss_pred             CHHHHhcCCcccC
Confidence            9999999999964

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=315.16  Aligned_cols=256  Identities=26%  Similarity=0.413  Sum_probs=213.7

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ....++++||+|-||.|.++.-.. +..||||.++... ....+..|.+|+++|.+|+||||++++++|..++.+++|+|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            346789999999999999998754 7999999997643 44557899999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           90 YCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~--lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      |+++|+|.+++..+..  ..-.....++.||+.|++||.+.++|||||.+.|+|++.+.   .+||+|||++|.+...+.
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~---~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF---TIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc---cEEecCcccccccccCCc
Confidence            9999999999998843  33445566999999999999999999999999999999887   599999999998766554


Q ss_pred             C---CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhccC---CCCCCCccccc
Q 005526          168 A---DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE---LRFPPGAIEEL  239 (692)
Q Consensus       168 ~---~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt--G~~PF~~~~~~~~~~~i~~~~~---~~~p~~~~~~l  239 (692)
                      .   ...+-...|||||.+..++++.++|+|+||+++||+++  ...||......+...+......   .......+.-.
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c  772 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC  772 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence            3   23345678999999999999999999999999999765  8999998888877776543211   11112223456


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      +..+.+++.+||+.|-.+||+++++  |.+|++
T Consensus       773 p~~lyelml~Cw~~es~~RPsFe~l--h~~lq~  803 (807)
T KOG1094|consen  773 PQGLYELMLRCWRRESEQRPSFEQL--HLFLQE  803 (807)
T ss_pred             cHHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence            7889999999999999999999998  555554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-33  Score=319.14  Aligned_cols=258  Identities=21%  Similarity=0.347  Sum_probs=188.1

Q ss_pred             ecCEEEEeEecccCceEEEEEEEc----------------CCCcEEEEEEeccCCCCh------------HHHHHHHHHH
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHR----------------QLGIEVAVKEIDKKLLSP------------KVSDNLLKEI   60 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~----------------~tg~~vAVK~i~~~~~~~------------~~~~~i~~Ev   60 (692)
                      .++|.+.++||+|+||+||+|...                ..++.||||.+.......            ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            578999999999999999999752                245689999986532110            0111233466


Q ss_pred             HHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCCHHHHHHHcC-----------------------
Q 005526           61 SILSTISHPNI-----IRFFEAIET--------REKIYLVLEYCDGGDLAAYIHKHG-----------------------  104 (692)
Q Consensus        61 ~iL~~L~HpNI-----Vkl~~~~~~--------~~~l~LVmEy~~GGsL~~~L~~~~-----------------------  104 (692)
                      .++.+++|.++     ++++++|..        .+..|+||||+.+++|.++++...                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     667776642        356899999999999999886421                       


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCc--cCCCCCccChH
Q 005526          105 -KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPE  181 (692)
Q Consensus       105 -~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~--~~GT~~YmAPE  181 (692)
                       .+++..++.++.|++.+|.|||+++|+||||||+|||++.++   .+||+|||+++..........  ..+|+.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG---QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC---cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence             235677889999999999999999999999999999998876   599999999976543322222  33488999999


Q ss_pred             hhhhcC--------------------CC--cchhhHHHHHHHHHHHhCCC-CCCCCCHHH----HHHH------HHhccC
Q 005526          182 IIQNHK--------------------YD--AKADLWSVGAILFQLVTGKP-PFDGSNQLQ----LFQN------ILTSTE  228 (692)
Q Consensus       182 vl~~~~--------------------ys--~ksDIWSLGviLyeLltG~~-PF~~~~~~~----~~~~------i~~~~~  228 (692)
                      ++....                    |+  .+.||||+||++|+|++|.. ||.+.....    ....      ......
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            875322                    22  34799999999999999875 775422111    0000      111122


Q ss_pred             CCCCCCcccccCHHHHHHHHHhhccCC---CCCCCHHHHHhchhhh
Q 005526          229 LRFPPGAIEELHPDCVDLCRCLLRQNP---VERITFKEFFNHRFLG  271 (692)
Q Consensus       229 ~~~p~~~~~~ls~el~dLI~~~L~~DP---~~RpTa~elL~Hpf~~  271 (692)
                      ..++  .+...++..+||+.+||.++|   .+|+|+.|+|+||||.
T Consensus       461 ~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        461 YDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             CCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            2232  345678999999999999876   6899999999999994

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=324.19  Aligned_cols=251  Identities=26%  Similarity=0.468  Sum_probs=221.4

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGI---EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~   85 (692)
                      .....|.++||.|.||.|++|+.+..|+   .||||.++. ....+.+..|+.|+.||-++.||||++|.|++.....+.
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            3456789999999999999999887664   599999854 456778899999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      ||.|||++|+|..+|..+ +.|+..++..+++.|+.|++||-+.|.|||||..+|||++.+-   ++|++|||++|.+..
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL---vCKVsDFGLSRvled  783 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL---VCKVSDFGLSRVLED  783 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce---EEEeccccceeeccc
Confidence            999999999999999875 6799999999999999999999999999999999999998876   799999999998754


Q ss_pred             CC--CCCccCCC--CCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCccccc
Q 005526          165 QD--LADTLCGS--PLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       165 ~~--~~~~~~GT--~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~l  239 (692)
                      +.  ...+..|.  ..|.|||.+...+++.++||||+|+++||.++ |..||-.....+.++.|..+..++-|.    +.
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm----DC  859 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM----DC  859 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC----CC
Confidence            43  22333333  57999999999999999999999999999887 999999999999999998776655443    56


Q ss_pred             CHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       240 s~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      +..+..|+..||++|-.+||.+.+|+++
T Consensus       860 P~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  860 PAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            7889999999999999999999999774

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=307.69  Aligned_cols=244  Identities=25%  Similarity=0.514  Sum_probs=215.4

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      +.....+||-|-||.||.|.++....-||||.++.+.   ...++|+.|+.+|+.++|||+|+|+++|..+..+|||+||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            3455778999999999999999999999999987643   3468999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           91 CDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        91 ~~GGsL~~~L~~~~~--lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |..|+|.+||.++++  ++...+..++.||..|++||..+++|||||...|+|+.++.   +||++|||+++.+..+..+
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh---iVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---IVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc---eEEeeccchhhhhcCCcee
Confidence            999999999998754  78888999999999999999999999999999999999887   7999999999988755433


Q ss_pred             Cc--cCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          169 DT--LCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       169 ~~--~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                      ..  ..-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||+|.+..+.+.-+.++....-|    +.+++.+.+
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P----eGCPpkVYe  497 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP----EGCPPKVYE  497 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC----CCCCHHHHH
Confidence            21  122456999999999999999999999999999999 99999999998888877666555544    467889999


Q ss_pred             HHHHhhccCCCCCCCHHHH
Q 005526          246 LCRCLLRQNPVERITFKEF  264 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~el  264 (692)
                      |++.||+++|.+||++.|+
T Consensus       498 LMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHHhcCCcccCccHHHH
Confidence            9999999999999999987

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=299.34  Aligned_cols=262  Identities=31%  Similarity=0.548  Sum_probs=215.9

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEEEE
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE-----KIYLV   87 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~-----~l~LV   87 (692)
                      +-.+.||-|+||+||.+.+..+|+.||+|.+.....+-...+.+.+|.++|..++|.||+..++...-..     .+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999999999999999999998766555566788999999999999999999988865433     57888


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~  167 (692)
                      +|++.. +|...|-.-..++.+.++-+++||+.||+|||+.||+||||||.|+|++.|.   ++||||||+++....++.
T Consensus       136 TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC---vLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC---ILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc---eEEecccccccccchhhh
Confidence            999876 8888888888899999999999999999999999999999999999999887   699999999998765442


Q ss_pred             --CCccCCCCCccChHhhhh-cCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 005526          168 --ADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-----------------  227 (692)
Q Consensus       168 --~~~~~GT~~YmAPEvl~~-~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~-----------------  227 (692)
                        ....+.|-+|+|||++.+ ..|+.+.||||+|||+.||+.++..|...+..+.++-|..--                 
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence              334466889999999876 569999999999999999999999999887776666553210                 


Q ss_pred             -----CCCCCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhhhh
Q 005526          228 -----ELRFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVH  278 (692)
Q Consensus       228 -----~~~~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~~~  278 (692)
                           ..+-|.       ........+..+++..+|..||++|.+..+.+.|+++.+.+-..+
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~  354 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFH  354 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeee
Confidence                 001110       001123356889999999999999999999999999988765543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=297.35  Aligned_cols=258  Identities=27%  Similarity=0.479  Sum_probs=220.7

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE----   82 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~----   82 (692)
                      .+..+|.-++.+|.|+- .|..|.+.-+++.||+|.+.....+....++..+|..++..++|+||++++.+|....    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            45678999999999998 8888999999999999999877666666678899999999999999999999986443    


Q ss_pred             --EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526           83 --KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        83 --~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                        ..|+||||+.+ +|...+.  -.++-+.+..++.|++.|++|||+.||+||||||+||++..+.   .+||.|||+|+
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~---~lKi~dfg~ar  166 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC---TLKILDFGLAR  166 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh---heeeccchhhc
Confidence              58999999976 8888887  4678889999999999999999999999999999999998877   69999999999


Q ss_pred             ccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE------------  228 (692)
Q Consensus       161 ~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~------------  228 (692)
                      .....-....++.|..|+|||++.+..|.+.+||||+||++.||++|+..|.|.+....+.++...-.            
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            87766566778999999999999999999999999999999999999999999887777766643211            


Q ss_pred             ------------------CCCCCCccc-------ccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          229 ------------------LRFPPGAIE-------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       229 ------------------~~~p~~~~~-------~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                                        ..||...+.       .-...+.|++.+||..||++|.+++++|+|||+.
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                              012221111       2234678999999999999999999999999996

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3e-33  Score=339.90  Aligned_cols=242  Identities=19%  Similarity=0.324  Sum_probs=187.3

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ..|...+.||+|+||+||+|++..++..||||.+.....      ...+|++++++++|||||++++++...+..|+|||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            456667889999999999999998999999998864321      11346889999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ---EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLH---s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |+++|+|.++++   .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.   .++. ||.......  
T Consensus       764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---~~~~-~~~~~~~~~--  834 (968)
T PLN00113        764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---PHLR-LSLPGLLCT--  834 (968)
T ss_pred             CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---eEEE-ecccccccc--
Confidence            999999999995   3889999999999999999999   679999999999999987763   3443 555433221  


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhccC------CCCCC--
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ-----LQLFQNILTSTE------LRFPP--  233 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~-----~~~~~~i~~~~~------~~~p~--  233 (692)
                       .....||+.|||||++.+..|+.++|||||||++|||++|+.||.....     .+..........      .....  
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence             2234788999999999999999999999999999999999999954311     111110000000      00000  


Q ss_pred             CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       234 ~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ........++.+++.+||+.||++|||+.|+++.
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0011223467889999999999999999999764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=318.54  Aligned_cols=247  Identities=30%  Similarity=0.466  Sum_probs=198.9

Q ss_pred             EeEecccCce-EEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccC
Q 005526           15 GPRIGSGSFA-VVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        15 ~~~LG~GsFG-~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      .+.+|.|+-| .||+|...  |+.||||.+-.     .....+.+|+..|+.- .|||||++|+.-.+....||..|.|.
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            3568999998 58999875  89999997743     4456788999999977 79999999999889999999999998


Q ss_pred             CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCC--CCcCeEEEeccccccccCCCC
Q 005526           93 GGDLAAYIHKHGK----VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTN--EVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        93 GGsL~~~L~~~~~----lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~--~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      . +|.++++..+.    ......+.++.|++.||++||+.+||||||||.||||+..  .....++|+|||+++.+..+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            7 99999987521    1124568899999999999999999999999999999873  123468999999999886543


Q ss_pred             ----CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCH
Q 005526          167 ----LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       167 ----~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                          ...+..||-+|+|||++....-+.++|||||||++|+.++ |..||...-..  -.+|+.+..-.+.-.  .....
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~--~~~d~  741 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE--PLPDC  741 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec--cCchH
Confidence                2456789999999999999888889999999999999988 59999765332  234555433221111  11122


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHhchhhhhh
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~  273 (692)
                      ++.|||.+|+.+||..||++.++|+||||-..
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            89999999999999999999999999999544

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-32  Score=314.05  Aligned_cols=246  Identities=29%  Similarity=0.549  Sum_probs=208.8

Q ss_pred             EEEeEecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 005526           13 IVGPRIGSGSFAVVWRARHRQ-------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKI   84 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l   84 (692)
                      .+.+.||+|+||.|++|.-..       ....||||..+..... ...+.+..|+++|+.+ .|+||+.+++.+...+.+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            566799999999999997431       1467999998766544 6678999999999988 699999999999989999


Q ss_pred             EEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCc
Q 005526           85 YLVLEYCDGGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVT  148 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~----------------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~  148 (692)
                      ++|+|||..|+|..++..++                .++......+..||+.|++||++.++|||||-.+|||++.+.  
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~--  455 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK--  455 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC--
Confidence            99999999999999998776                378889999999999999999999999999999999999886  


Q ss_pred             CeEEEeccccccccCCCCCCC--ccCC--CCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCC-HHHHHHH
Q 005526          149 PVLKIGDFGFARSLTPQDLAD--TLCG--SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSN-QLQLFQN  222 (692)
Q Consensus       149 ~~vKL~DFGlA~~~~~~~~~~--~~~G--T~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~-~~~~~~~  222 (692)
                       ++||+|||+|+.....+...  ...|  ...|||||.+....|+.++||||+|++|||+++ |..||.+.. ..+++..
T Consensus       456 -~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~  534 (609)
T KOG0200|consen  456 -VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF  534 (609)
T ss_pred             -EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence             79999999999765544332  2222  235999999999999999999999999999999 999999865 5566665


Q ss_pred             HHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          223 ILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       223 i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +..+.....|    ...++++.++++.||+.+|++||++.++..
T Consensus       535 l~~G~r~~~P----~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  535 LKEGNRMEQP----EHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HhcCCCCCCC----CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            6555555444    356889999999999999999999999854

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-32  Score=292.56  Aligned_cols=135  Identities=27%  Similarity=0.472  Sum_probs=118.0

Q ss_pred             Cccee-cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-----C---CCcceEE
Q 005526            5 RTRLI-GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-----H---PNIIRFF   75 (692)
Q Consensus         5 ~~~~~-~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-----H---pNIVkl~   75 (692)
                      +..+. ++|.+.++||.|-|++||+|.+....+.||+|+++..   ....+....|+++|++++     |   .+||+|+
T Consensus        72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            45566 8999999999999999999999999999999998654   344567788999999883     3   3699999


Q ss_pred             EEEEe----CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCceEec
Q 005526           76 EAIET----REKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQ-EKHLIHRDLKPQNLLVS  143 (692)
Q Consensus        76 ~~~~~----~~~l~LVmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLH-s~gIVHRDLKP~NILL~  143 (692)
                      +.|..    +.++|+|+|+. |..|..+|+..  ++++...++.|++||+.||.||| ..||||-||||+|||+.
T Consensus       149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            99964    45899999999 66899999865  67999999999999999999999 56999999999999995

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-33  Score=312.98  Aligned_cols=259  Identities=27%  Similarity=0.480  Sum_probs=223.4

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      ..+|+++.++|.|.+|.||+++++.+++..|+|+++...  .....-+.+|+-+++..+|||||-+++.|...+.+||.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            578999999999999999999999999999999997653  233567788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CC
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~  167 (692)
                      |||.||+|.+.-+-.+.++|.++..+++..+.||+|||+.|=+|||||-.|||+++.++   +|++|||.+..+... ..
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQITATIAK  168 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhhhhhhh
Confidence            99999999998888899999999999999999999999999999999999999999885   999999998766533 23


Q ss_pred             CCccCCCCCccChHhh---hhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHH
Q 005526          168 ADTLCGSPLYMAPEII---QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       168 ~~~~~GT~~YmAPEvl---~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~  244 (692)
                      ...+.|||+|||||+.   +.++|..++|||++|++..|+-.-++|-....+.+.+.-..+....+..-......++.+.
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence            4568899999999985   4678999999999999999999989987776665554433333222222233346688899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       245 dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      +|++.+|-++|++||+++.+|.|||+..
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeecc
Confidence            9999999999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.6e-30  Score=250.57  Aligned_cols=211  Identities=40%  Similarity=0.787  Sum_probs=187.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCHH
Q 005526           18 IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLA   97 (692)
Q Consensus        18 LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL~   97 (692)
                      ||+|++|.||++....+++.+++|++....... ....+.+|+++++.++|++|+++++++......++++||+.|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999998889999999997653322 3567899999999999999999999999999999999999999999


Q ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecC-CCCcCeEEEeccccccccCCCC-CCCccCCC
Q 005526           98 AYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVST-NEVTPVLKIGDFGFARSLTPQD-LADTLCGS  174 (692)
Q Consensus        98 ~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~-~~~~~~vKL~DFGlA~~~~~~~-~~~~~~GT  174 (692)
                      +++... ..+++..++.++.+++.+|.+||++|++|+||+|.||+++. ++   .++|+|||.+....... ......+.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG---KVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC---cEEEecCCceEEccCCcchhhcccCC
Confidence            999876 57899999999999999999999999999999999999987 44   59999999997665432 23345678


Q ss_pred             CCccChHhhhhc-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhcc
Q 005526          175 PLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ  253 (692)
Q Consensus       175 ~~YmAPEvl~~~-~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~  253 (692)
                      ..|++||.+... .++.+.|+|++|+++++|                                    ..+.+++.+|+..
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------HHHHHHHHHHhhC
Confidence            899999999887 888999999999999999                                    6788999999999


Q ss_pred             CCCCCCCHHHHHhch
Q 005526          254 NPVERITFKEFFNHR  268 (692)
Q Consensus       254 DP~~RpTa~elL~Hp  268 (692)
                      ||.+||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.7e-30  Score=255.60  Aligned_cols=214  Identities=39%  Similarity=0.743  Sum_probs=186.3

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      |.+.+.||.|++|+||++.+..+++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            67889999999999999999988999999999765433 24678889999999999999999999999889999999999


Q ss_pred             CCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC--CC
Q 005526           92 DGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--LA  168 (692)
Q Consensus        92 ~GGsL~~~L~~~~~-lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~--~~  168 (692)
                      ++++|.+++..... +++..++.++.|++.+|.+||++|++|+||+|.||+++.++   .++|+|||++.......  ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~---~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG---LVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEeeCceeeEecCcccccc
Confidence            99999999988777 89999999999999999999999999999999999998875   59999999998765443  34


Q ss_pred             CccCCCCCccChHhh-hhcCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHHhccCC
Q 005526          169 DTLCGSPLYMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDG-SNQL-QLFQNILTSTEL  229 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl-~~~~ys~ksDIWSLGviLyeLltG~~PF~~-~~~~-~~~~~i~~~~~~  229 (692)
                      ....++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+.. ...+.+..+...
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence            556788899999998 667788899999999999999999999987 4444 555556554433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=298.53  Aligned_cols=246  Identities=29%  Similarity=0.439  Sum_probs=211.6

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGI----EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .+..++||.|+||+||+|.....|+    +||||++... ...+...++.+|+-+|.++.|||++++++++.... +.||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            4457789999999999998766554    5888888653 34556789999999999999999999999987655 8899


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           88 LEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      ++|+++|.|.++++.+ ..+-......|..||++|+.|||++++|||||-.+|||+..-+   .+||.|||+++.+....
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~---hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN---HVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC---eEEEEecchhhccCccc
Confidence            9999999999999875 5688889999999999999999999999999999999998776   59999999999887654


Q ss_pred             CCC---ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHH
Q 005526          167 LAD---TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       167 ~~~---~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~e  242 (692)
                      ...   .....+.|||=|.+....|+.++||||+||++||++| |..|+.+....++-+-+..+..+..|+    ..+.+
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPp----iCtiD  928 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPP----ICTID  928 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCC----CccHH
Confidence            332   2233567999999999999999999999999999999 999999999888777777776666654    55778


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHh
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       243 l~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      +.-++-+||..|+..||+++++.+
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            999999999999999999999754

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-32  Score=295.68  Aligned_cols=201  Identities=29%  Similarity=0.522  Sum_probs=178.7

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC------hHHHHHHHHHHHHHHhCC---CCCcceEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS------PKVSDNLLKEISILSTIS---HPNIIRFFEAIE   79 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~------~~~~~~i~~Ev~iL~~L~---HpNIVkl~~~~~   79 (692)
                      ..+|..++.+|.|+||.|++|.++.....|+||.|.+.+.=      ++-...+-.|+.||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            46799999999999999999999999999999999876431      112234556999999997   999999999999


Q ss_pred             eCCEEEEEEec-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           80 TREKIYLVLEY-CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        80 ~~~~l~LVmEy-~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      +++++||+||- -+|.+|+++|..+..++|.+++.+++|++.|+++||++||||||||-+||.++.+|   .+||+|||.
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g---~~klidfgs  716 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG---FVKLIDFGS  716 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC---eEEEeeccc
Confidence            99999999996 46779999999999999999999999999999999999999999999999999988   599999999


Q ss_pred             ccccCCCCCCCccCCCCCccChHhhhhcCCC-cchhhHHHHHHHHHHHhCCCCCCC
Q 005526          159 ARSLTPQDLADTLCGSPLYMAPEIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDG  213 (692)
Q Consensus       159 A~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys-~ksDIWSLGviLyeLltG~~PF~~  213 (692)
                      +.... ....+.++||..|.|||++.+.+|- ..-|||+||++||.++....||..
T Consensus       717 aa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            86544 4456789999999999999999884 569999999999999999888864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=255.95  Aligned_cols=217  Identities=27%  Similarity=0.511  Sum_probs=182.6

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      ..-+..||+|++|+|-+.++..+|+..|+|.+... .+.+...++.+|+.+..+. .+|.+|.||+.+.....+||.||.
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            34567899999999999999999999999999765 4556677888888887654 799999999999999999999999


Q ss_pred             cCCCCHHHH----HHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEecCCCCcCeEEEeccccccccCCC
Q 005526           91 CDGGDLAAY----IHKHGKVSEAVARHFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        91 ~~GGsL~~~----L~~~~~lse~~i~~il~QLl~gL~yLHs~-gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~  165 (692)
                      |.. +|..+    +++.+.++|..+-+++..++.||.|||++ .+||||+||+||||+.+|   +|||||||++-.+...
T Consensus       127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G---qVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG---QVKICDFGISGYLVDS  202 (282)
T ss_pred             hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC---cEEEcccccceeehhh
Confidence            965 77665    44567799999999999999999999976 899999999999999988   5999999999776544


Q ss_pred             CCCCccCCCCCccChHhhh----hcCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCCC
Q 005526          166 DLADTLCGSPLYMAPEIIQ----NHKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPP  233 (692)
Q Consensus       166 ~~~~~~~GT~~YmAPEvl~----~~~ys~ksDIWSLGviLyeLltG~~PF~~-~~~~~~~~~i~~~~~~~~p~  233 (692)
                      -......|...|||||.+.    ..+|+-++||||||++++||.+++.||+. ....+++..+........|.
T Consensus       203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~  275 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA  275 (282)
T ss_pred             hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence            3333367888999999875    34799999999999999999999999975 45667777777766555554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=5.8e-31  Score=280.44  Aligned_cols=261  Identities=27%  Similarity=0.436  Sum_probs=202.2

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQ---LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETRE   82 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~   82 (692)
                      .+.+.|.++.+||+|.|++||++.+..   ..++||+|.|....    ....+..|+++|..+ .+.||+++.+++..++
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            356789999999999999999998887   78999999986542    235688999999998 5899999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .+.+|+||++..+..++..   .++-.+++.+++.++.||.++|.+|||||||||+|+|++....  .-.|.|||+|...
T Consensus       109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~--rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ--RGVLVDFGLAQRY  183 (418)
T ss_pred             eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC--CceEEechhHHHH
Confidence            9999999999988777764   4668899999999999999999999999999999999987654  4678999998611


Q ss_pred             C-----------------C--C---------------C-----------CCCccCCCCCccChHhhhh-cCCCcchhhHH
Q 005526          163 T-----------------P--Q---------------D-----------LADTLCGSPLYMAPEIIQN-HKYDAKADLWS  196 (692)
Q Consensus       163 ~-----------------~--~---------------~-----------~~~~~~GT~~YmAPEvl~~-~~ys~ksDIWS  196 (692)
                      .                 .  .               .           ......||++|+|||++.. ...++++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            0                 0  0               0           0012359999999999765 55788999999


Q ss_pred             HHHHHHHHHhCCCCCCCC-CHHHHHHHHH--------------hcc-------C-------------C--------C---
Q 005526          197 VGAILFQLVTGKPPFDGS-NQLQLFQNIL--------------TST-------E-------------L--------R---  230 (692)
Q Consensus       197 LGviLyeLltG~~PF~~~-~~~~~~~~i~--------------~~~-------~-------------~--------~---  230 (692)
                      .|||+..+++++.||... +....+..|.              .+.       .             +        .   
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            999999999999998432 1111111000              000       0             0        0   


Q ss_pred             -CCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          231 -FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       231 -~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                       .........+..+.||+.+||..||.+|.|++++|+||||.+....
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence             0001112234588999999999999999999999999999865443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-30  Score=277.25  Aligned_cols=244  Identities=24%  Similarity=0.376  Sum_probs=187.8

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC----E
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST--ISHPNIIRFFEAIETRE----K   83 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~--L~HpNIVkl~~~~~~~~----~   83 (692)
                      ....+.+.||+|.||.||+|...  ++.||||++..     ...+.+..|.+|...  ++|+||++|++.-+...    .
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            34567889999999999999876  69999999854     446778888888874  58999999998865444    7


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCcccCCCCCceEecCCCCcCeEEEe
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK---------HLIHRDLKPQNLLVSTNEVTPVLKIG  154 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~---------gIVHRDLKP~NILL~~~~~~~~vKL~  154 (692)
                      ++||++|.+.|+|.+||+.+ .+++...++++.-+++||+|||+-         .|+|||||..|||+..|.   +..|+
T Consensus       283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl---TccIa  358 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL---TCCIA  358 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC---cEEee
Confidence            99999999999999999876 689999999999999999999943         499999999999999887   58999


Q ss_pred             ccccccccCCCC---CCCccCCCCCccChHhhhhcC-CC-----cchhhHHHHHHHHHHHhCCCCC------------CC
Q 005526          155 DFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHK-YD-----AKADLWSVGAILFQLVTGKPPF------------DG  213 (692)
Q Consensus       155 DFGlA~~~~~~~---~~~~~~GT~~YmAPEvl~~~~-ys-----~ksDIWSLGviLyeLltG~~PF------------~~  213 (692)
                      |||+|..+.+..   .....+||..|||||++.+.- ..     .++||||+|.+||||+++..-+            ..
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            999998876443   233478999999999997532 11     2599999999999999864333            21


Q ss_pred             -----CCHHHHHHHHHhcc-CCCCCCCccc-ccCHHHHHHHHHhhccCCCCCCCHHHH
Q 005526          214 -----SNQLQLFQNILTST-ELRFPPGAIE-ELHPDCVDLCRCLLRQNPVERITFKEF  264 (692)
Q Consensus       214 -----~~~~~~~~~i~~~~-~~~~p~~~~~-~ls~el~dLI~~~L~~DP~~RpTa~el  264 (692)
                           ....++...+++.. ...+|..... .--.-+.+.+..||..||+.|.|+.=+
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                 11222222233222 2233322111 123457899999999999999998654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-29  Score=271.54  Aligned_cols=246  Identities=26%  Similarity=0.478  Sum_probs=191.4

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC---
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST--ISHPNIIRFFEAIETRE---   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~--L~HpNIVkl~~~~~~~~---   82 (692)
                      +-.+..+.+.||+|-||.||+|+++  |..||||++...     ..+..++|.+|++.  |+|+||+.|++.-..++   
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            5567899999999999999999997  899999998643     24677889999885  59999999997753322   


Q ss_pred             -EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCcccCCCCCceEecCCCCcCeEEE
Q 005526           83 -KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK--------HLIHRDLKPQNLLVSTNEVTPVLKI  153 (692)
Q Consensus        83 -~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~--------gIVHRDLKP~NILL~~~~~~~~vKL  153 (692)
                       .+|||.+|.+.|+|.+||.+ ..++.+...+++..++.||.+||-.        .|.|||||..|||+..++   .+.|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~---~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG---TCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC---cEEE
Confidence             68999999999999999988 5789999999999999999999932        399999999999999988   5999


Q ss_pred             eccccccccCCCC-----CCCccCCCCCccChHhhhhcC----C-C-cchhhHHHHHHHHHHHhC----------CCCCC
Q 005526          154 GDFGFARSLTPQD-----LADTLCGSPLYMAPEIIQNHK----Y-D-AKADLWSVGAILFQLVTG----------KPPFD  212 (692)
Q Consensus       154 ~DFGlA~~~~~~~-----~~~~~~GT~~YmAPEvl~~~~----y-s-~ksDIWSLGviLyeLltG----------~~PF~  212 (692)
                      +|+|+|-......     ..+..+||..|||||++...-    + + ..+||||||.++||+..+          ++||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            9999997765431     245679999999999986432    1 1 249999999999998752          67885


Q ss_pred             C----CCHHHHHHHHHhccCCC-CCCCccccc--CHHHHHHHHHhhccCCCCCCCHHHH
Q 005526          213 G----SNQLQLFQNILTSTELR-FPPGAIEEL--HPDCVDLCRCLLRQNPVERITFKEF  264 (692)
Q Consensus       213 ~----~~~~~~~~~i~~~~~~~-~p~~~~~~l--s~el~dLI~~~L~~DP~~RpTa~el  264 (692)
                      +    +...+.+.++.-...++ ..+..|...  -..+..+++.||..||.-|.|+-.+
T Consensus       438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            4    23334444443322222 122222221  1346678999999999999998665

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.7e-29  Score=250.77  Aligned_cols=257  Identities=23%  Similarity=0.417  Sum_probs=202.4

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCCE
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEA-IETREK   83 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~-~~~~~~   83 (692)
                      ..+.+.|.|.+.||+|.||.+.+++|+.+++.+++|.+....   .....+.+|...--.| .|.||+.-|+. |+..+.
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            357789999999999999999999999999999999997653   3456788887765555 58999987766 788889


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +++++||++-|+|.+-+.. .++-|...+.++.|++.||+|+|++++||||||.+||||-..+.. .|||||||+.+..+
T Consensus        97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~-rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFY-RVKLCDFGLTRKVG  174 (378)
T ss_pred             EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCcc-EEEeeecccccccC
Confidence            9999999999999988765 468899999999999999999999999999999999999655433 79999999987643


Q ss_pred             CCCCCCccCCCCCccChHhhhhc-----CCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCCCCC
Q 005526          164 PQDLADTLCGSPLYMAPEIIQNH-----KYDAKADLWSVGAILFQLVTGKPPFDGSN----QLQLFQNILTSTELRFPPG  234 (692)
Q Consensus       164 ~~~~~~~~~GT~~YmAPEvl~~~-----~ys~ksDIWSLGviLyeLltG~~PF~~~~----~~~~~~~i~~~~~~~~p~~  234 (692)
                      ..  ....-.+..|.+||++...     ..++.+|+|.||+++|.++||.+||+...    ..-.+.+.........| .
T Consensus       175 ~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P-~  251 (378)
T KOG1345|consen  175 TT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP-K  251 (378)
T ss_pred             ce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc-h
Confidence            21  1222345669999987532     24678999999999999999999997432    22233344444444444 3


Q ss_pred             cccccCHHHHHHHHHhhccCCCCCC---CHHHHHhchhh
Q 005526          235 AIEELHPDCVDLCRCLLRQNPVERI---TFKEFFNHRFL  270 (692)
Q Consensus       235 ~~~~ls~el~dLI~~~L~~DP~~Rp---Ta~elL~Hpf~  270 (692)
                      .+..+++.+..+.++-|.++|++|.   +++.-....|.
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            4578899999999999999999994   44444455554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.5e-29  Score=300.05  Aligned_cols=204  Identities=17%  Similarity=0.280  Sum_probs=153.9

Q ss_pred             HhCCC-CCcceEEEEE-------EeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccC
Q 005526           64 STISH-PNIIRFFEAI-------ETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRD  134 (692)
Q Consensus        64 ~~L~H-pNIVkl~~~~-------~~~~~l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRD  134 (692)
                      +.++| +||++++++|       ...+.+++++||+ +++|.++|... ..+++.+++.+++||+.||.|||++||+|||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            34555 5788888877       2334677889987 55999999753 4699999999999999999999999999999


Q ss_pred             CCCCceEecCCC----------------CcCeEEEeccccccccCCCC-----------------CCCccCCCCCccChH
Q 005526          135 LKPQNLLVSTNE----------------VTPVLKIGDFGFARSLTPQD-----------------LADTLCGSPLYMAPE  181 (692)
Q Consensus       135 LKP~NILL~~~~----------------~~~~vKL~DFGlA~~~~~~~-----------------~~~~~~GT~~YmAPE  181 (692)
                      |||+||||+..+                ....+||+|||+++......                 .....+||++|||||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            999999996421                12357888888886432100                 011246899999999


Q ss_pred             hhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCH
Q 005526          182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITF  261 (692)
Q Consensus       182 vl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa  261 (692)
                      ++.+..|+.++|||||||+||||++|.+||.....  .+..+...   ..++.. ....+...+++.+||++||.+||++
T Consensus       186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~  259 (793)
T PLN00181        186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR---VLPPQI-LLNWPKEASFCLWLLHPEPSCRPSM  259 (793)
T ss_pred             hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh---hcChhh-hhcCHHHHHHHHHhCCCChhhCcCh
Confidence            99999999999999999999999999998764322  22222211   112211 1234567899999999999999999


Q ss_pred             HHHHhchhhhhhH
Q 005526          262 KEFFNHRFLGELR  274 (692)
Q Consensus       262 ~elL~Hpf~~~~~  274 (692)
                      .|+++||||.+.+
T Consensus       260 ~eil~h~~~~~~~  272 (793)
T PLN00181        260 SELLQSEFINEPR  272 (793)
T ss_pred             HHHhhchhhhhhh
Confidence            9999999997653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=2e-26  Score=234.02  Aligned_cols=254  Identities=35%  Similarity=0.627  Sum_probs=210.8

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH-HHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEISILSTISHP-NIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~~i~~Ev~iL~~L~Hp-NIVkl~~~~~~~~~l~LVmE   89 (692)
                      |.+.+.||.|+||.||++.+.   ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            889999999999999999987   7899999977655443 678899999999999988 79999999988888999999


Q ss_pred             ccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCC
Q 005526           90 YCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD  166 (692)
Q Consensus        90 y~~GGsL~~~L~~~~---~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~  166 (692)
                      |+.++++.+++....   .+++.....++.|++.++.|+|..|++|||+||+||+++..+.  .++++|||.++......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCCC
Confidence            999999998887765   7999999999999999999999999999999999999988763  48999999998654433


Q ss_pred             -------CCCccCCCCCccChHhhhh---cCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCC-C
Q 005526          167 -------LADTLCGSPLYMAPEIIQN---HKYDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTELR-F  231 (692)
Q Consensus       167 -------~~~~~~GT~~YmAPEvl~~---~~ys~ksDIWSLGviLyeLltG~~PF~~~~~----~~~~~~i~~~~~~~-~  231 (692)
                             ......||..|++||.+..   ..+....|+|++|++++++++|..||.....    ......+... ... .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-PTPSL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc-CCccc
Confidence                   3467789999999999987   5788899999999999999999999987763    3333333322 222 1


Q ss_pred             CCCccccc----CHHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          232 PPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       232 p~~~~~~l----s~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                      ........    ...+.+++.+++..+|..|.+..+...++|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~  279 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA  279 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence            11111111    25789999999999999999999998886654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-27  Score=249.30  Aligned_cols=250  Identities=23%  Similarity=0.383  Sum_probs=211.7

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCC-----cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCC
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAI-ETRE   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg-----~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~-~~~~   82 (692)
                      ..|+++.-.+-+|.||.||+|+++...     +.|-+|.++.. .++-....+..|.-++..+.|||+..+.++. ++..
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            356778888999999999999776533     34667766433 4555567888999999999999999999986 5677


Q ss_pred             EEEEEEeccCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEe
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHG--------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIG  154 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~--------~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~  154 (692)
                      ..++++.+..-|+|..++..++        .++..+...++.|++.|++|||+.||||.||..+|++|++.-   +|||+
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L---qVklt  438 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL---QVKLT  438 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe---eEEec
Confidence            8899999999999999998432        356778888999999999999999999999999999998764   79999


Q ss_pred             ccccccccCCCCC---CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 005526          155 DFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELR  230 (692)
Q Consensus       155 DFGlA~~~~~~~~---~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~~~~  230 (692)
                      |=.++|.+-+.+.   .+.......||+||.+.+..|+.++|+|||||+||||+| |+.|+...+..++..-+.++..+.
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla  518 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA  518 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence            9999987765543   334445667999999999999999999999999999999 999999999999998888887776


Q ss_pred             CCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHh
Q 005526          231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       231 ~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~  266 (692)
                      .|.    ..+.++..++..||+.+|++||+++|+..
T Consensus       519 QP~----NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  519 QPF----NCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCC----CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            653    56789999999999999999999999854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4.1e-27  Score=228.28  Aligned_cols=164  Identities=23%  Similarity=0.347  Sum_probs=131.4

Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccC
Q 005526           94 GDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC  172 (692)
Q Consensus        94 GsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~  172 (692)
                      |+|.+++..+ ..+++.+++.++.||+.||.|||+++      ||+|||++.++   .+|+  ||+++.....    ...
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~---~~~~--fG~~~~~~~~----~~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG---LLKL--DGSVAFKTPE----QSR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc---ceee--ccceEeeccc----cCC
Confidence            6899999874 45999999999999999999999999      99999998877   4788  9999775432    236


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCC--CcccccCH--HHHHHH
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQNILTSTELRFPP--GAIEELHP--DCVDLC  247 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~-~~~~~i~~~~~~~~p~--~~~~~ls~--el~dLI  247 (692)
                      ||+.|||||++.+..|+.++|||||||++|||++|+.||...... ..+..+........+.  ......+.  ++.+++
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            899999999999999999999999999999999999999765443 3333333322211111  11122333  699999


Q ss_pred             HHhhccCCCCCCCHHHHHhchhhhh
Q 005526          248 RCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       248 ~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      .+||..||.+||++.+++.|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=6.3e-28  Score=277.85  Aligned_cols=262  Identities=29%  Similarity=0.460  Sum_probs=209.9

Q ss_pred             cCE-EEEeEecccCceEEEEEEEcCCCcEEEEEEecc----CCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526           10 GEY-IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK----KLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus        10 ~~Y-~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~----~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      ..| .....+|.|++|.|+.+......+.++.|....    .....+....+..|+.+-..++|||++..+..+......
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            445 457789999999999988887777777776542    222223333477788888999999998887777766666


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +-+||||++ ||+.++...+.++..++..+++||+.|++|+|+.||.||||||+|++++.++   .+||+|||.+.....
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g---~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG---ILKIIDFGAASVFRY  472 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC---ceEEeecCcceeecc
Confidence            666999999 9999999988999999999999999999999999999999999999999988   699999999876532


Q ss_pred             C-----CCCCccCCCCCccChHhhhhcCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCCC---CCCC
Q 005526          165 Q-----DLADTLCGSPLYMAPEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQLQLF-QNILTSTELR---FPPG  234 (692)
Q Consensus       165 ~-----~~~~~~~GT~~YmAPEvl~~~~ys~k-sDIWSLGviLyeLltG~~PF~~~~~~~~~-~~i~~~~~~~---~p~~  234 (692)
                      .     -.....+|+..|+|||++.+..|++. .||||.|++++.|++|+.||......+.. ..........   -+..
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~  552 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR  552 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence            2     23456789999999999999999875 89999999999999999999765443221 1111111111   1233


Q ss_pred             cccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHh
Q 005526          235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       235 ~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~  275 (692)
                      .+..++.+.+.+|.+||+.||.+|.|+++|++.+||+.+..
T Consensus       553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            45577889999999999999999999999999999987643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=6.1e-25  Score=235.95  Aligned_cols=257  Identities=20%  Similarity=0.286  Sum_probs=199.1

Q ss_pred             eec-CEEEEeEecccCceEEEEEEEcCCC-cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC----CCcceEEEEE-Ee
Q 005526            8 LIG-EYIVGPRIGSGSFAVVWRARHRQLG-IEVAVKEIDKKLLSPKVSDNLLKEISILSTISH----PNIIRFFEAI-ET   80 (692)
Q Consensus         8 ~~~-~Y~i~~~LG~GsFG~Vy~a~~~~tg-~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~H----pNIVkl~~~~-~~   80 (692)
                      ... +|.+.++||+|+||.||+|.+..++ ..+|+|+.........  ..+..|..++..+..    +++.++++.+ ..
T Consensus        15 ~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~   92 (322)
T KOG1164|consen   15 KVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST   92 (322)
T ss_pred             ccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence            344 8999999999999999999998775 6899998765422211  156778888888863    6899999999 57


Q ss_pred             CCEEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCC--CcCeEEEecc
Q 005526           81 REKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE--VTPVLKIGDF  156 (692)
Q Consensus        81 ~~~l~LVmEy~~GGsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~--~~~~vKL~DF  156 (692)
                      +..-|+||+.+ |.+|.++....  +.++...+..++.|++.+|++||+.|++||||||.|+++....  ....+.|.||
T Consensus        93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            88899999988 77999988655  5799999999999999999999999999999999999998764  2247999999


Q ss_pred             cccc--ccCCCC--------C-CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 005526          157 GFAR--SLTPQD--------L-ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT  225 (692)
Q Consensus       157 GlA~--~~~~~~--------~-~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~  225 (692)
                      |+++  ......        . .....||..|.++.+..+...+.+.|+||++.++.+++.|..||.+........++..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence            9998  321111        1 2235599999999999999999999999999999999999999977664322222221


Q ss_pred             ccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       226 ~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ..............+.++..+...+-..+...+|....+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111111000222345678888888888899999998887654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=6.2e-25  Score=239.07  Aligned_cols=175  Identities=20%  Similarity=0.268  Sum_probs=136.2

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHHHHhCCCCCcce-EEEEEEeC
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQ-LGIEVAVKEIDKKLL---SPKVSDNLLKEISILSTISHPNIIR-FFEAIETR   81 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~-tg~~vAVK~i~~~~~---~~~~~~~i~~Ev~iL~~L~HpNIVk-l~~~~~~~   81 (692)
                      .+.++|.+.+.||+|+||+||+|+++. +++.||||++.....   .......+.+|+++|++++|+||+. +++    .
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence            467889999999999999999999876 678889998753311   2334567899999999999999985 443    2


Q ss_pred             CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCC-CCCceEecCCCCcCeEEEecccccc
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL-KPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 ~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDL-KP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                      +..|+|||||+|++|.. +..   ..   ...++.|++.+|.|||++||+|||| ||+|||++.++   .+||+|||+|+
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~---~ikLiDFGlA~  160 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG---EAAVIDFQLAS  160 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC---CEEEEECccce
Confidence            45899999999999973 211   11   1568899999999999999999999 99999998765   59999999998


Q ss_pred             ccCCCC---------CCCccCCCCCccChHhhhhcC------CCcchhhH
Q 005526          161 SLTPQD---------LADTLCGSPLYMAPEIIQNHK------YDAKADLW  195 (692)
Q Consensus       161 ~~~~~~---------~~~~~~GT~~YmAPEvl~~~~------ys~ksDIW  195 (692)
                      ......         ......+++.|+|||.+....      .+..+|-|
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            664332         113567888899999886432      22346666

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-24  Score=215.08  Aligned_cols=251  Identities=20%  Similarity=0.242  Sum_probs=205.4

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRFFEAIETREKI   84 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~H-pNIVkl~~~~~~~~~l   84 (692)
                      ..+.+.|.++++||.|+||.+|+|.+..+|..||||+-......    ..+..|.++.+.|++ .+|..+..++.+..+-
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            35789999999999999999999999999999999987654333    356778999999865 7888888888888999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           85 YLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      .+|||.. |.+|+++..-+ ..++...+..++.|++.-++|+|.+++|||||||+|+|+.-+.....+.++|||+|+...
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 77999998865 468999999999999999999999999999999999999877666679999999998754


Q ss_pred             CC--------CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCC
Q 005526          164 PQ--------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFP  232 (692)
Q Consensus       164 ~~--------~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~---~~~~~i~~~~~~~~p  232 (692)
                      ..        .......||..|.+=....+...+...|+-|+|.+|.++.-|..||++....   +.+++|....-...+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            22        1234567999999988877778888999999999999999999999986543   445555443222222


Q ss_pred             CCcccccCHHHHHHHHHhhccCCCCCCCH
Q 005526          233 PGAIEELHPDCVDLCRCLLRQNPVERITF  261 (692)
Q Consensus       233 ~~~~~~ls~el~dLI~~~L~~DP~~RpTa  261 (692)
                      ......++.++.-.+.-|-..--++-|..
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            33445778888888888877777777764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-25  Score=249.12  Aligned_cols=243  Identities=31%  Similarity=0.541  Sum_probs=209.0

Q ss_pred             EecccCceEEEEEEE---cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccC
Q 005526           17 RIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~---~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      .+|.|+||.|++++.   ...|..||+|+..+.....+.......|..++..++ ||.+|+++..++.+..++++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998753   345788999999876544333335566888888886 9999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccC
Q 005526           93 GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC  172 (692)
Q Consensus        93 GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~  172 (692)
                      ||+|...+.+...+++...+.+...++.+++++|+.||+|||+|++||+++.+|+   +|+.|||+.+.....+..   |
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh---i~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH---IKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc---cccCCchhhhHhHhhhhc---c
Confidence            9999999999999999999999999999999999999999999999999999994   999999999887655544   9


Q ss_pred             CCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhc
Q 005526          173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR  252 (692)
Q Consensus       173 GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~  252 (692)
                      ||..|||||++.  +....+|.||+|++.|+|++|..||.+    +....|.+. .+.+|    ..++..+.++++.++.
T Consensus       155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-~~~~p----~~l~~~a~~~~~~l~~  223 (612)
T KOG0603|consen  155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-ELEMP----RELSAEARSLFRQLFK  223 (612)
T ss_pred             cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-ccCCc----hhhhHHHHHHHHHHHh
Confidence            999999999998  677889999999999999999999998    455566553 23333    5788899999999999


Q ss_pred             cCCCCCCC-----HHHHHhchhhhhhHhh
Q 005526          253 QNPVERIT-----FKEFFNHRFLGELRQT  276 (692)
Q Consensus       253 ~DP~~RpT-----a~elL~Hpf~~~~~~~  276 (692)
                      ++|.+|.-     ..|+++|+||+.+.+.
T Consensus       224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  224 RNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             hCHHHHhccCcchhHHHhccchheeeeHh
Confidence            99999985     4799999999877544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=3.1e-23  Score=215.55  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=203.3

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~~l~   85 (692)
                      .+.-.|+|+++||+|+||+.+.|.+.-++..||||.-..+...    .++..|.+..+.| ..++|..+|.+...+.+-.
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            3456799999999999999999999999999999987655433    3566778888877 5699999998888888889


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCC--cCeEEEecccccccc
Q 005526           86 LVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV--TPVLKIGDFGFARSL  162 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~-~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~--~~~vKL~DFGlA~~~  162 (692)
                      ||||+. |.+|+++..-++ +|+...+..++.|++.-++|+|++++|.|||||+|+||...+.  .-.|.|+|||+|+..
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999998 779999998764 6999999999999999999999999999999999999975432  236999999999876


Q ss_pred             CCCC--------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCC
Q 005526          163 TPQD--------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTELRF  231 (692)
Q Consensus       163 ~~~~--------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~---~~~~~~~~i~~~~~~~~  231 (692)
                      ....        ......||..||+=....+...+.+.|+-|||-++++.+-|..||.|.   +..+.+++|-.......
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            4322        234567999999999988999999999999999999999999999875   45566666644433333


Q ss_pred             CCCcccccCHHHHHHHHHhhccCCCCCCCHH
Q 005526          232 PPGAIEELHPDCVDLCRCLLRQNPVERITFK  262 (692)
Q Consensus       232 p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~  262 (692)
                      .......++.++...++-.-..+-.+-|..+
T Consensus       260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             HHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            3344456677777777776666666667653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=8.1e-23  Score=236.96  Aligned_cols=226  Identities=31%  Similarity=0.573  Sum_probs=183.1

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      ..-.+|...+.|..|++|-||+++|+.+.+.+|+| |+++.+-.   ++      |+.....|.+|              
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil---Rn------ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL---RN------ILTFAGNPFVV--------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh---hc------cccccCCccee--------------
Confidence            45578999999999999999999999999999994 44432111   00      33333444444              


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-  165 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-  165 (692)
                             ||-...++.-+.++.+.        +.+++|||+.||+|||+||+|++|+.-|   .+|++|||+.+..... 
T Consensus       136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG---hiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG---HIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc---cccccchhhhhhhhhhc
Confidence                   56667777766776554        7899999999999999999999999887   5999999998753211 


Q ss_pred             --------------CC-CCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 005526          166 --------------DL-ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR  230 (692)
Q Consensus       166 --------------~~-~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~  230 (692)
                                    ++ ....||||.|+|||++...+|+..+|+|++|+|+|+.+.|..||.++..++++..++. ..+.
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis-d~i~  276 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-DDIE  276 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh-hhcc
Confidence                          11 2346999999999999999999999999999999999999999999999999988765 3566


Q ss_pred             CCCCcccccCHHHHHHHHHhhccCCCCCC---CHHHHHhchhhhhhHhh
Q 005526          231 FPPGAIEELHPDCVDLCRCLLRQNPVERI---TFKEFFNHRFLGELRQT  276 (692)
Q Consensus       231 ~p~~~~~~ls~el~dLI~~~L~~DP~~Rp---Ta~elL~Hpf~~~~~~~  276 (692)
                      +|++ ...+.++++++|.++|+.+|..|.   .+-++.+|+||+.+.+.
T Consensus       277 wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            7766 567899999999999999999998   57889999999876554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=2.3e-22  Score=200.56  Aligned_cols=141  Identities=27%  Similarity=0.220  Sum_probs=112.3

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHH------------------------HHHHHHHHHHHHhCCCCC
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV------------------------SDNLLKEISILSTISHPN   70 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~------------------------~~~i~~Ev~iL~~L~HpN   70 (692)
                      ...||+|+||+||+|.+. +|+.||||+++........                        .....+|++++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 8999999999764321111                        123345999999998888


Q ss_pred             cceEEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCCCCCceEecCCCCcC
Q 005526           71 IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL-QEKHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        71 IVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yL-Hs~gIVHRDLKP~NILL~~~~~~~  149 (692)
                      +.....+... + .+|||||++|+++...+...+.+++..+..++.|++.+|.++ |+.||+||||||+|||++. +   
T Consensus        81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~---  154 (190)
T cd05147          81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G---  154 (190)
T ss_pred             CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C---
Confidence            7544433222 2 389999999988876655567899999999999999999999 7999999999999999984 3   


Q ss_pred             eEEEecccccccc
Q 005526          150 VLKIGDFGFARSL  162 (692)
Q Consensus       150 ~vKL~DFGlA~~~  162 (692)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            4999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=4.5e-22  Score=203.49  Aligned_cols=174  Identities=16%  Similarity=0.132  Sum_probs=136.8

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH-HHHH------HHHHHHHHHhCCCCCcceEEEEEE
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDN------LLKEISILSTISHPNIIRFFEAIE   79 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~~------i~~Ev~iL~~L~HpNIVkl~~~~~   79 (692)
                      .+.++|++.+.||.|+||.||++..  ++..+|||++.......+ ....      +.+|+..+.++.||+|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            4678999999999999999999655  477899999975543322 2222      578999999999999999998865


Q ss_pred             eC--------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeE
Q 005526           80 TR--------EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVL  151 (692)
Q Consensus        80 ~~--------~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~v  151 (692)
                      ..        +..++||||++|.+|.++.    .+++    ..+.+++.+|..+|+.|++|||+||+||+++.++    +
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g----i  173 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG----L  173 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC----E
Confidence            43        3589999999999998873    2333    3466999999999999999999999999998765    8


Q ss_pred             EEeccccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHH
Q 005526          152 KIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLV  205 (692)
Q Consensus       152 KL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLl  205 (692)
                      +|+|||..+........           ..++....|+.++|+|+||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988665322211           11445566888999999999987664

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=1.9e-22  Score=233.94  Aligned_cols=246  Identities=24%  Similarity=0.340  Sum_probs=187.2

Q ss_pred             cCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC--CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL--LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        10 ~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~--~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .+|...+.||.+-|=+|.+|++.. |. |+||++-++.  .+-....+..+|++ ....+|||++.+..+-......|+|
T Consensus        23 ~e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   23 VECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             cceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            378899999999999999999874 44 9999986543  23333344455555 5667999999999887888889999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC--CC
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQ  165 (692)
Q Consensus        88 mEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~--~~  165 (692)
                      -+|... +|.+.|..+..+...+.++++.||+.||.-+|..||+|||||.+||||+.-+   .+.|+||..-+...  .+
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN---W~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN---WLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec---hhhhhcccccCCccCCCC
Confidence            999987 9999998888889999999999999999999999999999999999999876   68999999876532  11


Q ss_pred             C------CCCccCCCCCccChHhhhhc----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 005526          166 D------LADTLCGSPLYMAPEIIQNH----------K-YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTST  227 (692)
Q Consensus       166 ~------~~~~~~GT~~YmAPEvl~~~----------~-ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~~~i~~~~  227 (692)
                      +      ..++...-.+|+|||.+...          + .+++.||||+||+++||++ |++||.-.   ++ -....+.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL-~aYr~~~  251 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QL-LAYRSGN  251 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HH-HhHhccC
Confidence            1      12334445679999987542          1 5678999999999999998 89999521   11 1111110


Q ss_pred             CCCCCCCccc-ccCHHHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          228 ELRFPPGAIE-ELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       228 ~~~~p~~~~~-~ls~el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                       ...+....+ -.+..++.||..|++.||.+|.++++.|+.
T Consensus       252 -~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 -ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence             111110111 123468899999999999999999999875

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=3.7e-21  Score=191.36  Aligned_cols=143  Identities=25%  Similarity=0.196  Sum_probs=113.8

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh------------------------HHHHHHHHHHHHHHhCCCC
Q 005526           14 VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP------------------------KVSDNLLKEISILSTISHP   69 (692)
Q Consensus        14 i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~------------------------~~~~~i~~Ev~iL~~L~Hp   69 (692)
                      +.+.||+|+||+||+|.+. +|+.||||+++......                        .....+.+|.+.+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 89999999997652210                        0012345789999999999


Q ss_pred             CcceEEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCc
Q 005526           70 NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVT  148 (692)
Q Consensus        70 NIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~  148 (692)
                      +|.....+....  .|+||||++|+++.........+++..+..++.|++.+|.++|. +||+||||||+|||++ ++  
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--
Confidence            986555443332  48999999998655443345678899999999999999999999 9999999999999998 44  


Q ss_pred             CeEEEeccccccccC
Q 005526          149 PVLKIGDFGFARSLT  163 (692)
Q Consensus       149 ~~vKL~DFGlA~~~~  163 (692)
                       .++|+|||+++...
T Consensus       155 -~~~liDFG~a~~~~  168 (190)
T cd05145         155 -KPYIIDVSQAVELD  168 (190)
T ss_pred             -CEEEEEcccceecC
Confidence             59999999997764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=3.8e-21  Score=202.18  Aligned_cols=233  Identities=21%  Similarity=0.316  Sum_probs=153.6

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISH----------PNIIRFFEAIE   79 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ev~iL~~L~H----------pNIVkl~~~~~   79 (692)
                      .+..++.||.|+|+.||.+++..||+.+|||+....... ....+.+++|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            567889999999999999999999999999988655432 3345677776655544332          12333333322


Q ss_pred             ---------eC---C-----EEEEEEeccCCCCHHHHHH---HcCCC---CHHHH-HHHHHHHHHHHHHHHHcCCcccCC
Q 005526           80 ---------TR---E-----KIYLVLEYCDGGDLAAYIH---KHGKV---SEAVA-RHFMRQLAAGLQVLQEKHLIHRDL  135 (692)
Q Consensus        80 ---------~~---~-----~l~LVmEy~~GGsL~~~L~---~~~~l---se~~i-~~il~QLl~gL~yLHs~gIVHRDL  135 (692)
                               ..   .     +.+++|+-+.+ +|.+++.   .....   ....+ ..+..|++..+++||..||+|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     23678887755 8877754   33222   12233 345599999999999999999999


Q ss_pred             CCCceEecCCCCcCeEEEeccccccccCCCCCCCccCCCCCccChHhhhh--------cCCCcchhhHHHHHHHHHHHhC
Q 005526          136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN--------HKYDAKADLWSVGAILFQLVTG  207 (692)
Q Consensus       136 KP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~--------~~ys~ksDIWSLGviLyeLltG  207 (692)
                      ||+|++++.+|   .++|+||+.....+.....  ...+..|.+||....        ..++.+.|.|+||+++|.|++|
T Consensus       172 ~~~nfll~~~G---~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDG---GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS----EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCC---CEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999988   5999999988765433222  344578999998754        3578899999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCC
Q 005526          208 KPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVER  258 (692)
Q Consensus       208 ~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~R  258 (692)
                      ..||..........       ..|.. + .+++..+++||+++|++||.+|
T Consensus       247 ~lPf~~~~~~~~~~-------~~f~~-C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPE-------WDFSR-C-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSG-------GGGTT-S-S---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCcccccc-------ccchh-c-CCcCHHHHHHHHHHccCCcccC
Confidence            99998654321111       12221 2 2788899999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.6e-20  Score=187.52  Aligned_cols=187  Identities=18%  Similarity=0.153  Sum_probs=142.3

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh--HHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP--KVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~--~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .++..|++|+||+||++..  .+.+++.+.+.......  -....+.+|+++|+++. |++|++++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4678899999999998876  47888877775543311  12235789999999995 5889999886    34699999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCC-CCCceEecCCCCcCeEEEeccccccccCCCCC-
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL-KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDL-KP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-  167 (692)
                      |+.|.+|...+..      . ...++.|++.+|+++|++||+|||| ||+|||++.++   .++|+|||++........ 
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g---~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG---SPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC---CEEEEECCCceecCCcchH
Confidence            9999999764422      1 2357889999999999999999999 79999998776   499999999986543321 


Q ss_pred             ----C---------CccCCCCCccChHhhhhc-CCC-cchhhHHHHHHHHHHHhCCCCCCCCC
Q 005526          168 ----A---------DTLCGSPLYMAPEIIQNH-KYD-AKADLWSVGAILFQLVTGKPPFDGSN  215 (692)
Q Consensus       168 ----~---------~~~~GT~~YmAPEvl~~~-~ys-~ksDIWSLGviLyeLltG~~PF~~~~  215 (692)
                          .         .....++.|+.|+...-. ..+ ...++++.|+.+|.++|+..++-+++
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                0         112368889999975433 222 56899999999999999998876543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.8e-21  Score=202.88  Aligned_cols=192  Identities=27%  Similarity=0.427  Sum_probs=143.5

Q ss_pred             CCCCcceEEEEEEe---------------------------CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHH
Q 005526           67 SHPNIIRFFEAIET---------------------------REKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA  119 (692)
Q Consensus        67 ~HpNIVkl~~~~~~---------------------------~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl  119 (692)
                      +|||||++..+|.+                           +..+|+||..++. +|..++..+ ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            49999999877643                           2358999998877 899998765 466677888999999


Q ss_pred             HHHHHHHHcCCcccCCCCCceEecCC-CCcCeEEEeccccccccCCCC-------CCCccCCCCCccChHhhhhcCC---
Q 005526          120 AGLQVLQEKHLIHRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQD-------LADTLCGSPLYMAPEIIQNHKY---  188 (692)
Q Consensus       120 ~gL~yLHs~gIVHRDLKP~NILL~~~-~~~~~vKL~DFGlA~~~~~~~-------~~~~~~GT~~YmAPEvl~~~~y---  188 (692)
                      +|+.|||.+||.|||+|.+|||+.-+ +..+++.|+|||.+---....       ..-...|.-.-||||+....+-   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999998543 345789999999874322211       1123457778999999875431   


Q ss_pred             ---CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHH
Q 005526          189 ---DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE  263 (692)
Q Consensus       189 ---s~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~e  263 (692)
                         -.|+|.|+.|.+.||+++..-||.+.....+-..-.+..  ..| ......++.+++++..+|++||.+|++..-
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~--qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES--QLP-ALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh--hCC-CCcccCChHHHHHHHHHhcCCccccCCccH
Confidence               247999999999999999999998743221111111111  122 233577899999999999999999998643

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=4.1e-20  Score=187.33  Aligned_cols=137  Identities=18%  Similarity=0.285  Sum_probs=109.9

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE-
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-----SHPNIIRFFEAIETRE---KIY-   85 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-----~HpNIVkl~~~~~~~~---~l~-   85 (692)
                      .+.||+|+||.||.  ++.++.. +||++.....  ...+.+.+|+.+++.+     .||||++++++++++.   .++ 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            46899999999995  7777666 6998865422  2346789999999999     5799999999998763   434 


Q ss_pred             EEEec--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHcCCcccCCCCCceEecCCC-CcCeEEEeccccc
Q 005526           86 LVLEY--CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL-QVLQEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFA  159 (692)
Q Consensus        86 LVmEy--~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL-~yLHs~gIVHRDLKP~NILL~~~~-~~~~vKL~DFGlA  159 (692)
                      +|+||  +.+|+|.+++++. .+++.  ..++.|++.++ +|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  5689999999764 57666  36688888887 999999999999999999998643 2346999995544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=2.3e-19  Score=212.07  Aligned_cols=195  Identities=22%  Similarity=0.292  Sum_probs=159.3

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS---HPNIIRFFEAIETREKIY   85 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~---HpNIVkl~~~~~~~~~l~   85 (692)
                      ...|-|.+.||+|+||+||+|.+.. |+.||+|+-+....++-.+     =.+++.+|+   -+.|..+...+...+..+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3569999999999999999999987 9999999876554332111     112333333   255666666667788899


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCC----CCcCeEEEeccccccc
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTN----EVTPVLKIGDFGFARS  161 (692)
Q Consensus        86 LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~----~~~~~vKL~DFGlA~~  161 (692)
                      +|+||.+.|+|.++++..+.++|..+..+..|++..+++||..||||+||||+|+||...    .+..-++|+|||.+-.
T Consensus       771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            999999999999999988889999999999999999999999999999999999999642    2234699999999854


Q ss_pred             cC---CCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCC
Q 005526          162 LT---PQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKP  209 (692)
Q Consensus       162 ~~---~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~  209 (692)
                      +.   ........++|-.+-++|...+.+++..+|.|.|+.+++.||.|+.
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            43   2334455678999999999999999999999999999999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=5.7e-20  Score=201.77  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=171.7

Q ss_pred             ceecCEEEEeEecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEE-------
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE-------   76 (692)
Q Consensus         7 ~~~~~Y~i~~~LG~GsFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~-------   76 (692)
                      .....+.+.+..+.++++.+...+....   ...++.|.....  +-.......+++-.+....|-+..-+.+       
T Consensus       241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d--~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~  318 (516)
T KOG1033|consen  241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD--SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFE  318 (516)
T ss_pred             cccccccccccccccccCCchhhhhcccchhhhhccchhhhcc--chhhhhhhhhhhhheeccccCCcccccCCCCchhh
Confidence            3445566677777777777776554432   233443333222  1122334444555454444433332222       


Q ss_pred             EE-----EeCCEEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCc
Q 005526           77 AI-----ETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVT  148 (692)
Q Consensus        77 ~~-----~~~~~l~LVmEy~~GGsL~~~L~~~~---~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~  148 (692)
                      .+     ....++||.|++|+-.+|.++|.++.   ..+......++.|+..|++|   +|.+|||+||.||++..++  
T Consensus       319 ~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--  393 (516)
T KOG1033|consen  319 SSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--  393 (516)
T ss_pred             hccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--
Confidence            11     11336899999999999999997653   35678899999999999999   9999999999999998877  


Q ss_pred             CeEEEeccccccccCCCC-------CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 005526          149 PVLKIGDFGFARSLTPQD-------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF  220 (692)
Q Consensus       149 ~~vKL~DFGlA~~~~~~~-------~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLlt-G~~PF~~~~~~~~~  220 (692)
                       ++||+|||+........       ......||.+||+||.+.+..|+.|+|||+||++|+||+. -..+|...   ..+
T Consensus       394 -q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~  469 (516)
T KOG1033|consen  394 -QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATL  469 (516)
T ss_pred             -hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhh
Confidence             69999999998765544       3455689999999999999999999999999999999997 33333211   112


Q ss_pred             HHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhh
Q 005526          221 QNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       221 ~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~  270 (692)
                      ..+   ....+|+..+.+ .++-.+|+++||...|.+||++.+.--|.|.
T Consensus       470 ~d~---r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  470 TDI---RDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhh---hcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            222   223344444333 3455699999999999999987777667664

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.3e-19  Score=184.13  Aligned_cols=243  Identities=21%  Similarity=0.385  Sum_probs=195.5

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVm   88 (692)
                      +++..+..+|.+.--|..|+|+..  |..+++|++..........+.|..|.-.|+.+.||||+.+++.+.....+.++.
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            455667788999999999999987  677888988877777777788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526           89 EYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKH--LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        89 Ey~~GGsL~~~L~~~~~--lse~~i~~il~QLl~gL~yLHs~g--IVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      .|++-|+|...+.....  .+..++.+++.+++.|+.|||+..  |----|....++|+++-. ..+-.+|--++-..  
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlt-arismad~kfsfqe--  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT-ARISMADTKFSFQE--  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh-hheecccceeeeec--
Confidence            99999999999988755  477889999999999999999875  444568888999987752 34444553333211  


Q ss_pred             CCCCCccCCCCCccChHhhhhcCCC---cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCCCCCCCcccccC
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYD---AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNI-LTSTELRFPPGAIEELH  240 (692)
Q Consensus       165 ~~~~~~~~GT~~YmAPEvl~~~~ys---~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i-~~~~~~~~p~~~~~~ls  240 (692)
                          ......|.||+||.++..+-+   .++|+|||++++|||.|...||......+.--+| +.+-...+|    ..++
T Consensus       344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip----pgis  415 (448)
T KOG0195|consen  344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP----PGIS  415 (448)
T ss_pred             ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC----CCcc
Confidence                112347889999999877654   4699999999999999999999887776554444 344444445    4678


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHH
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEF  264 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~el  264 (692)
                      ..+..|+.-|+..||.+||.+..+
T Consensus       416 ~hm~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  416 RHMNKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             HHHHHHHHHHhcCCCCcCCCccee
Confidence            889999999999999999998765

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=5.6e-19  Score=182.24  Aligned_cols=145  Identities=25%  Similarity=0.217  Sum_probs=114.9

Q ss_pred             CEEEEeEecccCceEEEEEE-EcCCCcEEEEEEeccCCCCh----------------------HHHHHHHHHHHHHHhCC
Q 005526           11 EYIVGPRIGSGSFAVVWRAR-HRQLGIEVAVKEIDKKLLSP----------------------KVSDNLLKEISILSTIS   67 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~-~~~tg~~vAVK~i~~~~~~~----------------------~~~~~i~~Ev~iL~~L~   67 (692)
                      -|.+.+.||+|+||.||+|. +..+|+.||||+++......                      .....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47899999999999999998 77789999999997543110                      01234568999999997


Q ss_pred             CCC--cceEEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccCCCCCceEecC
Q 005526           68 HPN--IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLKPQNLLVST  144 (692)
Q Consensus        68 HpN--IVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~g-IVHRDLKP~NILL~~  144 (692)
                      +.+  +.++++.   . ..++||||++|++|.........+.+..+..++.||+.+|++||++| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            633  3444442   2 35899999999888776545556677778899999999999999999 99999999999998 


Q ss_pred             CCCcCeEEEeccccccccC
Q 005526          145 NEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus       145 ~~~~~~vKL~DFGlA~~~~  163 (692)
                      ++   .++|+|||.+....
T Consensus       184 ~~---~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DG---KVVIIDVSQSVELD  199 (237)
T ss_pred             CC---CEEEEEChhhhccC
Confidence            43   59999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.2e-18  Score=171.40  Aligned_cols=136  Identities=23%  Similarity=0.296  Sum_probs=113.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH------HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK------VSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~------~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      +.||+|++|.||+|++  .|..+++|..........      ....+.+|++++..+.|++|.....++...+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  578899998654332211      12457789999999999998877777777788899999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      |++|++|.+++.....    ....++.+++.+|.++|+.|++|||++|.|||++ ++   .++|+|||.++.
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~---~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG---KIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC---CEEEEECCcccC
Confidence            9999999999876432    7889999999999999999999999999999998 33   489999999865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.6e-20  Score=216.66  Aligned_cols=262  Identities=29%  Similarity=0.457  Sum_probs=215.1

Q ss_pred             ecCEEEEeEecccCceEEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ-LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsFG~Vy~a~~~~-tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~l~L   86 (692)
                      ...|.+.+.||+|+|+.|-.+.... ....+|+|.+............+..|..+-+.+. |+|++.+++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            5679999999999999999988754 4566788877665444455566667888888887 9999999999999999999


Q ss_pred             EEeccCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           87 VLEYCDGGDLAAYI-HKHG-KVSEAVARHFMRQLAAGLQVLQ-EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        87 VmEy~~GGsL~~~L-~~~~-~lse~~i~~il~QLl~gL~yLH-s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+.  .+|++|||+|....
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhcccc
Confidence            99999999999999 6555 6888899999999999999999 999999999999999998874  48999999998765


Q ss_pred             C-CC---CCCccCC-CCCccChHhhhhcC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCccc
Q 005526          164 P-QD---LADTLCG-SPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE  237 (692)
Q Consensus       164 ~-~~---~~~~~~G-T~~YmAPEvl~~~~-ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~  237 (692)
                      . ..   .....+| ++.|+|||...+.. .....|+||.|+++.-+++|..||...........-.......+....|.
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            5 22   2345678 99999999988854 46779999999999999999999987655432221122222233345667


Q ss_pred             ccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          238 ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       238 ~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      .++....+++.+++..+|..|.+.+++..++|+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            88999999999999999999999999999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.4e-17  Score=165.33  Aligned_cols=133  Identities=22%  Similarity=0.353  Sum_probs=107.1

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeccCCCC-h-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 005526           17 RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-P-----KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~-----~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy   90 (692)
                      .||+|+||+||++..  +|..+++|........ .     .....+.+|++++..+.|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999984  5789999986543221 1     1135677899999999988766555555566778999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           91 CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        91 ~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      ++|++|.+++.....       .++.|++.+|.+||+.|++|||++|.||+++ ++   .++++|||+++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~---~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD---KLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC---cEEEEECCCCcCC
Confidence            999999998765321       7899999999999999999999999999998 33   5999999998663

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=1.2e-17  Score=166.70  Aligned_cols=139  Identities=22%  Similarity=0.194  Sum_probs=109.8

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh--------------------HHHHHHHHHHHHHHhCCCCC-
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP--------------------KVSDNLLKEISILSTISHPN-   70 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~--------------------~~~~~i~~Ev~iL~~L~HpN-   70 (692)
                      |.+.+.||+|+||.||++.+. +|+.||||+++......                    .......+|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999875 79999999876532110                    01123567899999998874 


Q ss_pred             -cceEEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcC
Q 005526           71 -IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        71 -IVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~  149 (692)
                       +++.++    ....++||||++|++|......      .....++.+++.++.++|+.||+||||||+||+++.++   
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~---  162 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE---  162 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC---
Confidence             444443    2456899999999999765431      34567899999999999999999999999999998765   


Q ss_pred             eEEEeccccccccCC
Q 005526          150 VLKIGDFGFARSLTP  164 (692)
Q Consensus       150 ~vKL~DFGlA~~~~~  164 (692)
                      .++|+|||++.....
T Consensus       163 ~~~liDfg~~~~~~~  177 (198)
T cd05144         163 KIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEEECCccccCCC
Confidence            599999999966553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.72  E-value=2.5e-17  Score=183.65  Aligned_cols=200  Identities=25%  Similarity=0.433  Sum_probs=158.2

Q ss_pred             HHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-cccCCCCCce
Q 005526           63 LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHL-IHRDLKPQNL  140 (692)
Q Consensus        63 L~~L~HpNIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~-~~~lse~~i~~il~QLl~gL~yLHs~gI-VHRDLKP~NI  140 (692)
                      |+.+.|.|+.+|++.+.++...++|.+||.-|+|.+.+.. ..+++......+++.|+.||.|||..-| +|+.|+..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999987 4568889999999999999999998876 9999999999


Q ss_pred             EecCCCCcCeEEEeccccccccCCC---CCCCccCCCCCccChHhhhhcC-------CCcchhhHHHHHHHHHHHhCCCC
Q 005526          141 LVSTNEVTPVLKIGDFGFARSLTPQ---DLADTLCGSPLYMAPEIIQNHK-------YDAKADLWSVGAILFQLVTGKPP  210 (692)
Q Consensus       141 LL~~~~~~~~vKL~DFGlA~~~~~~---~~~~~~~GT~~YmAPEvl~~~~-------ys~ksDIWSLGviLyeLltG~~P  210 (692)
                      +++...   ++||+|||+.......   .......-...|.|||.+....       .+.+.||||+|++++|+++.+.|
T Consensus        81 lvd~~w---~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LVDSRW---VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             eeeeeE---EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            999877   6999999998765321   1111122345699999987642       35679999999999999999999


Q ss_pred             CCCCC----HHHHHHHHHhccCCCCCCCcc--cccCHHHHHHHHHhhccCCCCCCCHHHHH
Q 005526          211 FDGSN----QLQLFQNILTSTELRFPPGAI--EELHPDCVDLCRCLLRQNPVERITFKEFF  265 (692)
Q Consensus       211 F~~~~----~~~~~~~i~~~~~~~~p~~~~--~~ls~el~dLI~~~L~~DP~~RpTa~elL  265 (692)
                      |....    ..+.+..+.+.....+.+..+  .+..+++..+++.||..+|.+||+++++-
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            97632    234555555422222222221  25566899999999999999999998874

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=7.2e-17  Score=185.15  Aligned_cols=138  Identities=22%  Similarity=0.271  Sum_probs=110.5

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-Ch-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SP-----KVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~-----~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l   84 (692)
                      .|...+.||+|+||+||++....  ..+++|+...... ..     .....+.+|+++++.++|++|+..+.++......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34567899999999999998753  3445544322211 11     1235678899999999999999887777777788


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        85 ~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      ++||||++|++|.+++.        ....++.|++.+|.+||+.||+||||||+|||++ ++   .++|+|||+++..
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~---~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD---RLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC---cEEEEeCcccccC
Confidence            99999999999999885        3567899999999999999999999999999994 33   4899999999764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.2e-16  Score=155.04  Aligned_cols=138  Identities=25%  Similarity=0.254  Sum_probs=99.7

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHH----------------------HHHHHHHHHhCCCCC--
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----------------------LLKEISILSTISHPN--   70 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~----------------------i~~Ev~iL~~L~HpN--   70 (692)
                      ++.||+|+||+||+|.+. +|+.||||++............                      ...|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999987 7999999998754322111111                      135666666665443  


Q ss_pred             cceEEEEEEeCCEEEEEEeccCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCc
Q 005526           71 IIRFFEAIETREKIYLVLEYCDGGDLAA-YIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVT  148 (692)
Q Consensus        71 IVkl~~~~~~~~~l~LVmEy~~GGsL~~-~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~  148 (692)
                      +.+++++    ...++||||++|+.+.. .+.... .. ..++.++.+++.++.++|. +||+||||||+||+++ ++  
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~--  151 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG--  151 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--
Confidence            4555543    23589999999954321 111111 11 6688999999999999999 9999999999999999 44  


Q ss_pred             CeEEEeccccccccC
Q 005526          149 PVLKIGDFGFARSLT  163 (692)
Q Consensus       149 ~~vKL~DFGlA~~~~  163 (692)
                       .++|+|||.+....
T Consensus       152 -~~~liDfg~a~~~~  165 (187)
T cd05119         152 -KVYIIDVPQAVEID  165 (187)
T ss_pred             -cEEEEECccccccc
Confidence             58999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=3.4e-15  Score=154.30  Aligned_cols=136  Identities=17%  Similarity=0.295  Sum_probs=104.3

Q ss_pred             eEec-ccCceEEEEEEEcCCCcEEEEEEeccCCC-----------ChHHHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 005526           16 PRIG-SGSFAVVWRARHRQLGIEVAVKEIDKKLL-----------SPKVSDNLLKEISILSTISHPNI--IRFFEAIETR   81 (692)
Q Consensus        16 ~~LG-~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-----------~~~~~~~i~~Ev~iL~~L~HpNI--Vkl~~~~~~~   81 (692)
                      ..|| .|+.|+||.+...  +..++||.+.....           .......+.+|++++..+.|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7788888888764  78899998854321           11223567889999999998885  6777664332


Q ss_pred             -C---EEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           82 -E---KIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        82 -~---~l~LVmEy~~G-GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                       .   ..++||||++| .+|.+++.. ..+++..    +.||+.+|.+||++||+||||||.|||++.++   .++|+||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---~v~LIDf  186 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG---KFWLIDF  186 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---CEEEEEC
Confidence             2   23599999998 689988865 3566543    57899999999999999999999999998765   5999999


Q ss_pred             ccccc
Q 005526          157 GFARS  161 (692)
Q Consensus       157 GlA~~  161 (692)
                      |.++.
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=2.3e-15  Score=139.43  Aligned_cols=132  Identities=23%  Similarity=0.299  Sum_probs=111.9

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEecc
Q 005526           14 VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--PNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        14 i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~H--pNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      +++.||+|.++.||++...  +..+++|.+.....    ...+.+|+.+++.++|  .++++++.++...+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            4678999999999999985  37899999865432    4578889999999976  58999998888888999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           92 DGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK---HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        92 ~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~---gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      .|+.+..+       +......++.+++.+|.++|..   +++|+|++|.||+++..+   .+++.|||.++.
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~---~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK---ILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc---EEEEEecccccC
Confidence            99877654       5566778899999999999985   799999999999998754   599999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=3.3e-15  Score=167.00  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=201.0

Q ss_pred             eecCEEEEeEecc--cCceEEEEEEE--cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 005526            8 LIGEYIVGPRIGS--GSFAVVWRARH--RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETRE   82 (692)
Q Consensus         8 ~~~~Y~i~~~LG~--GsFG~Vy~a~~--~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~   82 (692)
                      +...+.+...+|.  |.+|.||.+..  ..++..+|+|.-......+.....-.+|+...+++ .|+|.++.+..++..+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3445677888999  99999999998  88999999998544433333334445677776776 5999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG  157 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~-lse~~i~~il~QLl~----gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFG  157 (692)
                      ..|+-+|+|. .+|..+...... +++..++..+.+...    ||.++|..+++|-|+||.||++..+..  ..+++|||
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~--s~~~~df~  268 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT--SCKLTDFG  268 (524)
T ss_pred             cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc--eeecCCcc
Confidence            9999999996 588888776544 899999999999999    999999999999999999999998842  58999999


Q ss_pred             cccccCCCCCCCc------cCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 005526          158 FARSLTPQDLADT------LCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF  231 (692)
Q Consensus       158 lA~~~~~~~~~~~------~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~  231 (692)
                      +...+........      .-|...|++||..+ +-++...|||++|.++.+-.++..++...-.    ..+........
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----~~W~~~r~~~i  343 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN----SSWSQLRQGYI  343 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC----CCccccccccC
Confidence            9988776653322      24677899999874 5578889999999999998887665543200    00111112224


Q ss_pred             CCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       232 p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      +.+.....+.++...+..|++.+|..|++++.+++|+++..
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            45555666777778999999999999999999999999863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=2.1e-15  Score=176.01  Aligned_cols=264  Identities=28%  Similarity=0.444  Sum_probs=210.4

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~L   86 (692)
                      -.+.+.+.+-+-+|+|+.++.+.-..+|...++|+..... +.....+.+..+-.++-.-.+|-+++..-.+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3567788889999999999999988888777777654321 111122334444444444456777766655556778999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC---
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT---  163 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~---  163 (692)
                      +++|..|++|...++.-+..+++-++.++..+...++|||...+.|||++|.|+|+..++.   .+++|||......   
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh---~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH---RPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC---cccCcccccccccccc
Confidence            9999999999999999888999999999999999999999999999999999999998884   8999998432110   


Q ss_pred             ------------------CC-----------CCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005526          164 ------------------PQ-----------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS  214 (692)
Q Consensus       164 ------------------~~-----------~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~  214 (692)
                                        ..           .......||+.|.+||...+..-...+|+|++|+++++.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                              00           0122356899999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHH---HHHhchhhhhhHhh
Q 005526          215 NQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFK---EFFNHRFLGELRQT  276 (692)
Q Consensus       215 ~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~---elL~Hpf~~~~~~~  276 (692)
                      ...+.+.+|... ...+|. .....+.+..+++..+|..+|.+|..+.   +.-.|+||+...+.
T Consensus      1039 tpq~~f~ni~~~-~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1039 TPQQIFENILNR-DIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred             chhhhhhccccC-CCCCCC-CccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence            999999888764 344443 3467899999999999999999999987   88999999876544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=7e-14  Score=156.49  Aligned_cols=255  Identities=21%  Similarity=0.271  Sum_probs=194.1

Q ss_pred             CcceecCEEEEeEecccCceEEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHR-QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETRE   82 (692)
Q Consensus         5 ~~~~~~~Y~i~~~LG~GsFG~Vy~a~~~-~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-~HpNIVkl~~~~~~~~   82 (692)
                      ..+..++|-.+..||.|.|+.|+.+... .++..|++|...+..........-..|+.+...+ .|.++++++..+...+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            4567889999999999999999987755 6789999998877655555445556777777766 6899999888888888


Q ss_pred             EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      ..|+-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..++  ...+++|||.+..+
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRL  417 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhcccccccccc
Confidence            8889999999999888775556688999999999999999999999999999999999998865  36899999998753


Q ss_pred             CCCCCCCccCCCCCcc--ChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccC
Q 005526          163 TPQDLADTLCGSPLYM--APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       163 ~~~~~~~~~~GT~~Ym--APEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls  240 (692)
                      ....  ......-+++  +++......+..++|+++||..+.+.+++.+.-....+-   ..+..+ .  .+..  ....
T Consensus       418 ~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~-~--~p~~--~~~~  487 (524)
T KOG0601|consen  418 AFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG-D--TPNL--PGLK  487 (524)
T ss_pred             ceec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc-c--ccCC--CchH
Confidence            3211  1122333444  555566677889999999999999999986543222211   112111 1  1111  1223


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       241 ~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                      .++..+.+.+..+++..|+.+.++..|+-|.
T Consensus       488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            6788899999999999999999998887653

>PF12063 DUF3543: Domain of unknown function (DUF3543); InterPro: IPR022708 This domain belonging to serine/threonine-protein kinases is functionally uncharacterised

Probab=99.46  E-value=8.7e-13  Score=135.83  Aligned_cols=178  Identities=27%  Similarity=0.443  Sum_probs=143.6

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHhcccc-------------------------------chhhhHHHHHHHHHHHHHHhhhc
Q 005526          472 TGLQLLHQYVHALTELAEAKYDAGLF-------------------------------LESFSVELVVLAIWKKALQICGS  520 (692)
Q Consensus       472 tr~~~l~~~~~~~~el~~e~~~~~~~-------------------------------lea~s~~lv~la~w~~al~~~~~  520 (692)
                      .+|..+-+-+.+|.++|..|..-=.-                               -|++-+-+=.|++|.+|++++..
T Consensus        13 ~~Le~~a~~a~~v~~~Ae~k~~ql~p~~p~~~~~~~~~~~~~~~~~~l~~~~~~~~~~E~LVLYvKaL~lLa~am~~a~~   92 (238)
T PF12063_consen   13 AKLEFLAAKADVVYEFAEVKYSQLIPLAPSSSSGLQRSSVSSAEDDDLTPDASEELSAEALVLYVKALSLLAKAMDIASA   92 (238)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhccccCCCCccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            46677777778888888888742111                               12333444489999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcchhhHHHHHHHHHHHHHHHhhhhc-----cCCCCCCCC
Q 005526          521 WLTSMSHGELPGPSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKLSYNI-----RDSDGAAEM  595 (692)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ae~~~~~~-----~~~~~~~~m  595 (692)
                      |.....++       ...-.|                =.+-..+..|+-.-|-.-+++||.+...+     .-.++...|
T Consensus        93 ~w~~~~~~-------~~~~~~----------------S~~vn~vVqwlr~rfneclekae~lr~~l~~~~~~l~~~~~~~  149 (238)
T PF12063_consen   93 WWYSKNRG-------SGSLNP----------------SSRVNQVVQWLRERFNECLEKAEFLRLRLQEAQKQLPDDHPSM  149 (238)
T ss_pred             HHHHhccc-------ccccCc----------------cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCccccccc
Confidence            98773322       000001                01334678999999999999999999998     225667789


Q ss_pred             ch-----HHHHHHHHHHhhccchhhhhhhc-chhhhHHHHHHHHHHHHHHHhcccccCCCCCCcCCchhHHHHHHHHHHH
Q 005526          596 PD-----AMEIIYQRALSVGKIGAVEEYMG-NKASASALYSKAMLLLSFIVGEAASLSLYPPFSLNPSDKKRIQGYINNL  669 (692)
Q Consensus       596 pd-----a~e~i~q~al~~g~~g~~~e~~~-~~~~a~~~y~ka~~ll~f~~~e~~~l~l~pp~~l~~~~~~r~~~y~~~~  669 (692)
                      |+     |-.+||+.||.++|.+|++||+| |.+.+...|.+|+.||..|+.++   .+++.-.++..||..|.+||+.+
T Consensus       150 ~~~~~itAekLiYdrALemsr~AA~~El~g~~~~~ce~~Y~tA~~lLe~Ll~~~---~~~~~~~~~~~Dr~~i~k~i~sI  226 (238)
T PF12063_consen  150 PSSSGITAEKLIYDRALEMSRTAAVDELFGENLEGCEQRYETAIWLLEALLDDD---DLEEENPLDEEDREIIKKYIDSI  226 (238)
T ss_pred             cCccccCHHHHHHHHHHHHHHHHHHHHHhCcCHhHHHHHHHHHHHHHHHHHhHh---hccccCCCCHHHHHHHHHHHHHH
Confidence            99     99999999999999999999999 99999999999999999999999   88999999999999999999999


Q ss_pred             hhcccc
Q 005526          670 QSHQSN  675 (692)
Q Consensus       670 ~~~~~~  675 (692)
                      ..||+.
T Consensus       227 ~~RL~~  232 (238)
T PF12063_consen  227 ENRLSA  232 (238)
T ss_pred             HHHHHH
Confidence            999874

This domain is found in eukaryotes. It is typically between 217 to 291 amino acids in length and is found associated with PF00069 from PFAM. This domain has a single completely conserved residue A that may be functionally important. ; GO: 0004674 protein serine/threonine kinase activity

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=9.9e-14  Score=158.08  Aligned_cols=148  Identities=24%  Similarity=0.347  Sum_probs=100.2

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC---------------------------C-h----HHHHH
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL---------------------------S-P----KVSDN   55 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~---------------------------~-~----~~~~~   55 (692)
                      +..+|.. +.||.|++|+||+|+.+.+|+.||||+++....                           . .    +..+.
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            4556776 789999999999999988899999999975421                           0 0    11122


Q ss_pred             H------HHHHHHHHhCC----CCCcceEEEEE-EeCCEEEEEEeccCCCCHHHH--HHHcC----CCCHHHHHHHHHHH
Q 005526           56 L------LKEISILSTIS----HPNIIRFFEAI-ETREKIYLVLEYCDGGDLAAY--IHKHG----KVSEAVARHFMRQL  118 (692)
Q Consensus        56 i------~~Ev~iL~~L~----HpNIVkl~~~~-~~~~~l~LVmEy~~GGsL~~~--L~~~~----~lse~~i~~il~QL  118 (692)
                      +      .+|+..+.++.    +.+.+.+-.++ +.....+||||||+|+.+.++  +...+    .+.+..+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence            2      23433333332    33333322333 224557899999999999874  33333    25555666666666


Q ss_pred             HHHHHHHHHcCCcccCCCCCceEecCCC-CcCeEEEeccccccccC
Q 005526          119 AAGLQVLQEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFARSLT  163 (692)
Q Consensus       119 l~gL~yLHs~gIVHRDLKP~NILL~~~~-~~~~vKL~DFGlA~~~~  163 (692)
                      +       ..|++|+|+||.||+++.++ ..+.++++|||++..++
T Consensus       277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            5       58999999999999998764 23469999999987764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.7e-14  Score=149.23  Aligned_cols=239  Identities=17%  Similarity=0.256  Sum_probs=159.0

Q ss_pred             EEEEEEEcCCCcEEEEEEeccCCC-ChHHHHH-HHHHHHHHHhCCCCCcceEEEEEEeC-----CEEEEEEeccCCCCHH
Q 005526           25 VVWRARHRQLGIEVAVKEIDKKLL-SPKVSDN-LLKEISILSTISHPNIIRFFEAIETR-----EKIYLVLEYCDGGDLA   97 (692)
Q Consensus        25 ~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~-i~~Ev~iL~~L~HpNIVkl~~~~~~~-----~~l~LVmEy~~GGsL~   97 (692)
                      .||++.+...|.+|+.-.++.... +.+...+ ...-+.-|-.+.|.|||+++.++.+.     ....++.||+..|+|.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            466777777777666554432211 1111111 11122335566799999999987543     3588999999999999


Q ss_pred             HHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccCCCCCceEecCCCCcCeEEEeccccccccC-----CCC
Q 005526           98 AYIHKH----GKVSEAVARHFMRQLAAGLQVLQEKH--LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-----PQD  166 (692)
Q Consensus        98 ~~L~~~----~~lse~~i~~il~QLl~gL~yLHs~g--IVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~-----~~~  166 (692)
                      .+|++.    ..+.....++|+-||+.||.|||+..  |+|+++.++-|++..++   .+||+---......     ...
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng---LIkig~~ap~s~h~s~~~~~~~  237 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG---LIKIGSVAPDSTHPSVNSTREA  237 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc---eEEecccCccccchhhhhhhHh
Confidence            999864    34788889999999999999999886  99999999999999776   46764321111100     001


Q ss_pred             CCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccCCCCCCCcccccCHHHHH
Q 005526          167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       167 ~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF-~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~d  245 (692)
                      ....-.+-++|.+||.=.....+.++|||++|.+..+|..+..-- .+......-.++.... +       .....--++
T Consensus       238 Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-~-------~len~lqr~  309 (458)
T KOG1266|consen  238 EKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI-I-------GLENGLQRG  309 (458)
T ss_pred             hhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-e-------eccCccccC
Confidence            112234678899999766666778899999999999998765432 2221111111111110 0       011222357


Q ss_pred             HHHHhhccCCCCCCCHHHHHhchhhhhhH
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       246 LI~~~L~~DP~~RpTa~elL~Hpf~~~~~  274 (692)
                      ++++||+..|..||++++++.||.+-+..
T Consensus       310 ~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  310 SITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             cCcccccCCCCCCcchhhhhcCceeeecc
Confidence            89999999999999999999999875543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=2.6e-12  Score=128.97  Aligned_cols=141  Identities=21%  Similarity=0.188  Sum_probs=103.4

Q ss_pred             EeEecccCceEEEEEEEcC------CCcEEEEEEeccCCC-----------C---------hHHHH----HHHHHHHHHH
Q 005526           15 GPRIGSGSFAVVWRARHRQ------LGIEVAVKEIDKKLL-----------S---------PKVSD----NLLKEISILS   64 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~------tg~~vAVK~i~~~~~-----------~---------~~~~~----~i~~Ev~iL~   64 (692)
                      ...||.|.-+.||.|....      .+..+|||+.+....           .         .....    ...+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998654      358999998843210           0         01112    2337999999


Q ss_pred             hCCC--CCcceEEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCCCCCceE
Q 005526           65 TISH--PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL-QEKHLIHRDLKPQNLL  141 (692)
Q Consensus        65 ~L~H--pNIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yL-Hs~gIVHRDLKP~NIL  141 (692)
                      ++..  -++.+++++    ..-+|||||+.++.+..-.-+...+++..+..+..|++.+|..| |+.||||+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            9854  456777754    45689999998754432222233466677788899999999998 8999999999999999


Q ss_pred             ecCCCCcCeEEEeccccccccC
Q 005526          142 VSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus       142 L~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +..+    .++|+|||.+....
T Consensus       158 ~~~~----~v~iIDF~qav~~~  175 (197)
T cd05146         158 WHDG----KVWFIDVSQSVEPT  175 (197)
T ss_pred             EECC----cEEEEECCCceeCC
Confidence            9754    38999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.38  E-value=1.9e-12  Score=145.10  Aligned_cols=140  Identities=25%  Similarity=0.339  Sum_probs=96.2

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----------------------------HHH----H------HHH
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----------------------------KVS----D------NLL   57 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~----------------------------~~~----~------~i~   57 (692)
                      +.||.|++|.||+|+.+ +|+.||||+.+......                            ...    .      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999875 69999999985432100                            000    0      233


Q ss_pred             HHHHHHHhCC-----CCCc--ceEEEEEEeCCEEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHHc
Q 005526           58 KEISILSTIS-----HPNI--IRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAA-GLQVLQEK  128 (692)
Q Consensus        58 ~Ev~iL~~L~-----HpNI--Vkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~-~~lse~~i~~il~QLl~-gL~yLHs~  128 (692)
                      +|++.+.++.     +++|  .+++.  ......++||||++|++|.++.... ...+   ...++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence            4555555542     3333  23332  2234578999999999998876532 1222   2345555555 47889999


Q ss_pred             CCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526          129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus       129 gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      |++|+|+||.||+++.++   .++|+|||++..+..
T Consensus       277 g~~H~D~hPgNilv~~~g---~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDG---KIIALDFGIVGRLSE  309 (437)
T ss_pred             CceeCCCCcccEEECCCC---cEEEEeCCCeeECCH
Confidence            999999999999998776   599999999977653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=8e-12  Score=141.48  Aligned_cols=183  Identities=21%  Similarity=0.311  Sum_probs=140.9

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~   91 (692)
                      |.+ ...+-++.+..-.|..+.++.+|.|..++...-  .....+.+-++-|+.++||||++|++.++..+.+|||+|.+
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV   91 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV   91 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc
Confidence            555 444444444333567778899999998865432  44566778889999999999999999999999999999998


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCC-CC
Q 005526           92 DGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ-EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-AD  169 (692)
Q Consensus        92 ~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLH-s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~-~~  169 (692)
                      .  .|..++++.+   ...+..-+.||+.||.||| +.+++|++|.-+.|+++..|   ..||++|.++........ ..
T Consensus        92 ~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G---eWkLggle~v~~~~~~~~~~~  163 (690)
T KOG1243|consen   92 R--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG---EWKLGGLELVSKASGFNAPAK  163 (690)
T ss_pred             c--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC---cEEEeeeEEEeccccCCcccc
Confidence            5  6888887755   7788889999999999997 77899999999999999988   499999999866543322 11


Q ss_pred             ccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhC
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG  207 (692)
Q Consensus       170 ~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG  207 (692)
                      ...---.|..|+.+....  -..|.|.|||++++++.|
T Consensus       164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            112222467777654333  447999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=3.9e-12  Score=122.49  Aligned_cols=128  Identities=19%  Similarity=0.183  Sum_probs=96.4

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCC
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI-IRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNI-Vkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      .+.|+.|.++.||++...  +..|++|+......   ....+.+|+.+++.+.+.++ .+++.+.  ....++||||++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            467899999999999875  78899998754321   12345789999998866554 4555543  2335799999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----cccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL-----IHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        94 GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gI-----VHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      .++...        ......++.+++.+|..||..++     +|+|++|.||+++. +   .++++|||.+..
T Consensus        76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~-~---~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD-G---RLWLIDWEYAGM  136 (170)
T ss_pred             Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC-C---eEEEEecccccC
Confidence            887643        11123467899999999999985     99999999999983 3   489999998854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=6.1e-11  Score=116.69  Aligned_cols=134  Identities=20%  Similarity=0.319  Sum_probs=103.9

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEe-ccCCCChHHH-----HHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEI-DKKLLSPKVS-----DNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i-~~~~~~~~~~-----~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      ..+++|+-+.+|.+...  |..+++|.= ++....+...     ..-.+|++++.++.--+|...+-+..+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35789999999999663  556777743 3333333333     344569999999876676665556677888899999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        90 y~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      |++|..|.+++...       ...++..+-.-+.-||..||+|+||.++||++..++    +.++|||++..-
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----EEEEECCccccc
Confidence            99999999888776       246778888888999999999999999999998765    899999998653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.17  E-value=3.4e-10  Score=111.12  Aligned_cols=146  Identities=21%  Similarity=0.200  Sum_probs=113.8

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeccCC-CChH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 005526           14 VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPK-----VSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        14 i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~-----~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~~l~LV   87 (692)
                      .+..|-+|+-+.|+++...  |+.+.||.=..+. ..+.     ...+..+|+++|.++.--+|.-..-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5677889999999999876  8888888543222 1222     345677899999998766776555567777788899


Q ss_pred             EeccCC-CCHHHHHHHcC-CCCH-HHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526           88 LEYCDG-GDLAAYIHKHG-KVSE-AVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        88 mEy~~G-GsL~~~L~~~~-~lse-~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      |||++| .++.+++.... .-.+ .....++++|-..+.-||.++|+|+||..+||++..+++...+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999988 46788887643 2233 33378999999999999999999999999999999998877779999999854

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=2.1e-10  Score=114.67  Aligned_cols=142  Identities=19%  Similarity=0.298  Sum_probs=105.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC--CcceEEEEEEeC---CEEEEEEec
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP--NIIRFFEAIETR---EKIYLVLEY   90 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~Hp--NIVkl~~~~~~~---~~l~LVmEy   90 (692)
                      +.||.|.++.||++.... |+.|++|+....... .....+.+|+++++.+.+.  ++.+++.+....   +..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            678999999999998753 689999988654321 2345678899999999763  457777776543   367899999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 005526           91 CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-------------------------------------------  127 (692)
Q Consensus        91 ~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-------------------------------------------  127 (692)
                      ++|.++...+.. ..+++.....++.+++..|.+||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999887765432 346666777777777777777773                                           


Q ss_pred             -------------cCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526          128 -------------KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       128 -------------~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                                   ..++|+|++|.||+++.++ ...+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-PRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-CcEEEEEecccccc
Confidence                         2369999999999998741 12588999998854

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=2.7e-09  Score=118.07  Aligned_cols=210  Identities=18%  Similarity=0.255  Sum_probs=155.3

Q ss_pred             eEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEEEEEEeccCC-CCHHH
Q 005526           24 AVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE----TREKIYLVLEYCDG-GDLAA   98 (692)
Q Consensus        24 G~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~----~~~~l~LVmEy~~G-GsL~~   98 (692)
                      .+.|++....+|..|++|++.-.+.  ........-+++++++.|+|||+|.++|.    ....+++|++|.++ ++|.+
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            5899999999999999999943221  11223345688999999999999999986    34579999999987 46666


Q ss_pred             HHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccC
Q 005526           99 YIH---------------KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        99 ~L~---------------~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~  163 (692)
                      +--               ...+.+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+.   .++|...|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~---RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM---RIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc---eEEEecccceeeec
Confidence            532               123478999999999999999999999999999999999998764   58888888776554


Q ss_pred             CCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhccCCCCCCCcccccCH
Q 005526          164 PQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPP-FDGSNQLQL-FQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       164 ~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~P-F~~~~~~~~-~~~i~~~~~~~~p~~~~~~ls~  241 (692)
                      .+.      +       |.+..   -.+-|.=.||.+++.|.||..- +......+. +..|.            ..++.
T Consensus       445 ~d~------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~------------~~yS~  496 (655)
T KOG3741|consen  445 EDP------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT------------TTYST  496 (655)
T ss_pred             CCC------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh------------hhhhH
Confidence            333      0       11111   1357999999999999998543 222222222 22221            35678


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHhc
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       242 el~dLI~~~L~~DP~~RpTa~elL~H  267 (692)
                      ++.++|.-+...++++ -++.+++-|
T Consensus       497 D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  497 DLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            8999999999999887 678888765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=1.1e-08  Score=107.88  Aligned_cols=135  Identities=13%  Similarity=0.078  Sum_probs=97.1

Q ss_pred             EEEEEEEcCCCcEEEEEEeccCCCChHH---------HHHHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCEEEEEE
Q 005526           25 VVWRARHRQLGIEVAVKEIDKKLLSPKV---------SDNLLKEISILSTISHPNI--IRFFEAIET-----REKIYLVL   88 (692)
Q Consensus        25 ~Vy~a~~~~tg~~vAVK~i~~~~~~~~~---------~~~i~~Ev~iL~~L~HpNI--Vkl~~~~~~-----~~~l~LVm   88 (692)
                      .|+++..  .|+.|.||...........         ...+.+|.+.+.++..-+|  ++++.+++.     ...-+||+
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555543  4778999976433211101         1147789999888854444  445555543     23578999


Q ss_pred             eccCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCC----CCcCeEEEeccccccc
Q 005526           89 EYCDGG-DLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTN----EVTPVLKIGDFGFARS  161 (692)
Q Consensus        89 Ey~~GG-sL~~~L~~--~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~----~~~~~vKL~DFGlA~~  161 (692)
                      |++++. +|.+++..  ....++.....++.+++..+.-||+.||+|+|++++|||++.+    ++...+.|+||+.++.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999986 79998864  3456677888999999999999999999999999999999852    2334799999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=5.9e-09  Score=104.16  Aligned_cols=128  Identities=23%  Similarity=0.279  Sum_probs=83.8

Q ss_pred             EEEEEEEcCCCcEEEEEEeccCCCC------------------------hHHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 005526           25 VVWRARHRQLGIEVAVKEIDKKLLS------------------------PKVSDNLLKEISILSTISHP--NIIRFFEAI   78 (692)
Q Consensus        25 ~Vy~a~~~~tg~~vAVK~i~~~~~~------------------------~~~~~~i~~Ev~iL~~L~Hp--NIVkl~~~~   78 (692)
                      .||.|... .|..+|||+.+.....                        ........+|++.|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999885 4889999988432110                        11234567899999999766  466776542


Q ss_pred             EeCCEEEEEEeccC--CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCCcccCCCCCceEecCCCCcCeEEEec
Q 005526           79 ETREKIYLVLEYCD--GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV-LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD  155 (692)
Q Consensus        79 ~~~~~l~LVmEy~~--GGsL~~~L~~~~~lse~~i~~il~QLl~gL~y-LHs~gIVHRDLKP~NILL~~~~~~~~vKL~D  155 (692)
                          .-+|||||++  |..+..+....  ++.+....++.+++..+.. +|..||+|+||.+.|||+++++    +.|+|
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~----~~iID  149 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGK----VYIID  149 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTC----EEE--
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecce----EEEEe
Confidence                2369999998  65554433222  2245567788888885544 6899999999999999998774    89999


Q ss_pred             cccccccC
Q 005526          156 FGFARSLT  163 (692)
Q Consensus       156 FGlA~~~~  163 (692)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99986543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=2.6e-08  Score=100.69  Aligned_cols=129  Identities=22%  Similarity=0.249  Sum_probs=97.4

Q ss_pred             CCcEEEEEEeccCCCCh-----HHHHHHHHHHHHHHhCCCCC--cceEEEEEEeC----CEEEEEEeccCCC-CHHHHHH
Q 005526           34 LGIEVAVKEIDKKLLSP-----KVSDNLLKEISILSTISHPN--IIRFFEAIETR----EKIYLVLEYCDGG-DLAAYIH  101 (692)
Q Consensus        34 tg~~vAVK~i~~~~~~~-----~~~~~i~~Ev~iL~~L~HpN--IVkl~~~~~~~----~~l~LVmEy~~GG-sL~~~L~  101 (692)
                      .++.|.+|.........     -......+|...+..+..-+  +.+.+.+.+..    ...++|+|+++|. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            46667777543221111     22346778888888775444  45566665542    2468999999984 7999998


Q ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526          102 KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus       102 ~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .....+......++.+++..+.-||++||+|+|+++.|||++.++....+.++||+-++..
T Consensus       111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            7656778888999999999999999999999999999999998875667999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.81  E-value=2.3e-09  Score=122.26  Aligned_cols=153  Identities=19%  Similarity=0.341  Sum_probs=113.5

Q ss_pred             HHHHHHHHHHHc-CCcccCCCCCceEecCCCCcCeEEEeccccccccCCC-CC----CC-----ccCCCCCccChHhhhh
Q 005526          117 QLAAGLQVLQEK-HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL----AD-----TLCGSPLYMAPEIIQN  185 (692)
Q Consensus       117 QLl~gL~yLHs~-gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~-~~----~~-----~~~GT~~YmAPEvl~~  185 (692)
                      +.+.|+.|+|.. ++||++|.|++|.++.++   .+||+.|+++...... +.    .+     ...-...|.|||++..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~---~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG---DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc---ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            334899999955 899999999999999888   4999999998654431 11    11     1123455999999999


Q ss_pred             cCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHH
Q 005526          186 HKYDAKADLWSVGAILFQLV-TGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF  264 (692)
Q Consensus       186 ~~ys~ksDIWSLGviLyeLl-tG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~el  264 (692)
                      ...+.++|+||+||++|.+. .|+..+.+......+..-....... -......+++++++=+.+++..++.-||++.++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-AFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-cccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence            88899999999999999999 5777776654332222111111110 112235788999999999999999999999999


Q ss_pred             Hhchhhhhh
Q 005526          265 FNHRFLGEL  273 (692)
Q Consensus       265 L~Hpf~~~~  273 (692)
                      +..|||++.
T Consensus       263 ~~~~ff~D~  271 (700)
T KOG2137|consen  263 LSIPFFSDP  271 (700)
T ss_pred             hcccccCCc
Confidence            999999754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.73  E-value=1.3e-09  Score=123.02  Aligned_cols=247  Identities=19%  Similarity=0.221  Sum_probs=174.3

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEec
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN-IIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN-IVkl~~~~~~~~~l~LVmEy   90 (692)
                      |......++|+++++++.+...+...+ .+.+...       ....-++++|.+++||| .+..++-++.++..+++++|
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            444556889999999999887655444 6666443       34556889999999999 77788888888999999999


Q ss_pred             cCCC-CHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEeccccccccCCCCCC
Q 005526           91 CDGG-DLAAYI-HKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA  168 (692)
Q Consensus        91 ~~GG-sL~~~L-~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~  168 (692)
                      |.++ +-.... ...-.+.+.+.....+.-..+++++|+.-=+|||    ||+..+..    .|.+||+....+......
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~----~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE----VKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc----cccccccCCcccCccccc
Confidence            9887 211111 1111233445556677778899999998778999    88887754    799999999888877677


Q ss_pred             CccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcc-cccCHHH-HHH
Q 005526          169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI-EELHPDC-VDL  246 (692)
Q Consensus       169 ~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~-~~ls~el-~dL  246 (692)
                      .+..+++.|+|||+.....+....|.|++|+--.+|--|-+|-.....  ....+  +....-+.... ...++.. .++
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~--g~~p~s~~L~~~~aw~~~~~~~~  463 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMI--GNGPNSPMLTDKSAWSPVFHRDF  463 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCC--CCCCCccccchhhhcCcccccCC
Confidence            888999999999999999999999999999887788777777543110  00000  00000000000 0001111 157


Q ss_pred             HHHhhccCCCCCCCHHHHHhchhhhhhHhhhh
Q 005526          247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVH  278 (692)
Q Consensus       247 I~~~L~~DP~~RpTa~elL~Hpf~~~~~~~~~  278 (692)
                      ...|+..-|..|+....++.|.+|..-....+
T Consensus       464 ~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~  495 (829)
T KOG0576|consen  464 PAPCLNGLPPTPKVHMGACFSKVFNGCPLRIH  495 (829)
T ss_pred             cccccCCCCCCCcchhhHHHHHHhccCcccce
Confidence            78899999999999999999999975544333

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.63  E-value=7.3e-07  Score=97.06  Aligned_cols=239  Identities=18%  Similarity=0.229  Sum_probs=156.0

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHH-hCCCCCcceEEEE------E-EeCCEEE
Q 005526           14 VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS-TISHPNIIRFFEA------I-ETREKIY   85 (692)
Q Consensus        14 i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~-~L~HpNIVkl~~~------~-~~~~~l~   85 (692)
                      .++.||+|+-+.+|-.-..   ...+.|++...-...+  .+   -+..|. .-.||-+-.-+.+      . ..+..+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~--aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ--AQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHH--HH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            4678999999999975432   2345677765432211  11   122233 3356644331111      1 1233478


Q ss_pred             EEEeccCCCC-HHHHH------HHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecccc
Q 005526           86 LVLEYCDGGD-LAAYI------HKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        86 LVmEy~~GGs-L~~~L------~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DFGl  158 (692)
                      +.|..+.|.. ...+.      +....+.+..+.+..+.|+.+...||..|-+-+|++++|+|+.+++   .|.|.|=..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~---~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS---KVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc---eEEEEcccc
Confidence            8899888752 22222      1223467899999999999999999999999999999999998877   588888655


Q ss_pred             ccccCCCCCCCccCCCCCccChHhhh-----hcCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHH----HHHH-HHHhc-
Q 005526          159 ARSLTPQDLADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTG-KPPFDGSNQL----QLFQ-NILTS-  226 (692)
Q Consensus       159 A~~~~~~~~~~~~~GT~~YmAPEvl~-----~~~ys~ksDIWSLGviLyeLltG-~~PF~~~~~~----~~~~-~i~~~-  226 (692)
                      ......+......+|.+.|.+||.-.     +..-+...|.|.||+++|+++.| +.||.|....    .-++ .|..+ 
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            44444444556678999999999754     34556789999999999999985 9999763211    0000 11111 


Q ss_pred             --------cCCCCCC--CcccccCHHHHHHHHHhhcc--CCCCCCCHHH
Q 005526          227 --------TELRFPP--GAIEELHPDCVDLCRCLLRQ--NPVERITFKE  263 (692)
Q Consensus       227 --------~~~~~p~--~~~~~ls~el~dLI~~~L~~--DP~~RpTa~e  263 (692)
                              .....++  ..+.-+++++..|..+|+..  ++.-|||++-
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                    1111111  22456789999999999864  4678999875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.62  E-value=1.3e-07  Score=98.34  Aligned_cols=139  Identities=19%  Similarity=0.222  Sum_probs=104.9

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCC--------------------hHHHHHHHHHHHHHHhCCCC--
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS--------------------PKVSDNLLKEISILSTISHP--   69 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~--------------------~~~~~~i~~Ev~iL~~L~Hp--   69 (692)
                      +.++.+||-|.-+.||.|.+. .|.++|||.=+.-..+                    .-.+....+|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457889999999999999987 5999999965321110                    11234677899999999655  


Q ss_pred             CcceEEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcC
Q 005526           70 NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        70 NIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~  149 (692)
                      .|.+.+++    +.-.+||||++|-.|...-     ++.+.+..++..|+.-+..+-..||||+|+.+-||+++++|+  
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--  240 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--  240 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence            67777654    4567999999997766432     234556666777777777667999999999999999999874  


Q ss_pred             eEEEeccccccccC
Q 005526          150 VLKIGDFGFARSLT  163 (692)
Q Consensus       150 ~vKL~DFGlA~~~~  163 (692)
                       +.++||-.+....
T Consensus       241 -~~vIDwPQ~v~~~  253 (304)
T COG0478         241 -IVVIDWPQAVPIS  253 (304)
T ss_pred             -EEEEeCcccccCC
Confidence             8999999876544

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.46  E-value=2.6e-06  Score=86.92  Aligned_cols=140  Identities=21%  Similarity=0.219  Sum_probs=92.8

Q ss_pred             eecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH-HHH------HHHHHHHHHHhCC---CCCcceEEEE
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSD------NLLKEISILSTIS---HPNIIRFFEA   77 (692)
Q Consensus         8 ~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~------~i~~Ev~iL~~L~---HpNIVkl~~~   77 (692)
                      +.++|.+.+.+-......|.+..-  +|+.|++|..+......+ ...      ...+++..+.++.   -..+..++-.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            567888888888888777777654  479999998765321111 111      1223334333433   2333333333


Q ss_pred             EE-----eCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEE
Q 005526           78 IE-----TREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK  152 (692)
Q Consensus        78 ~~-----~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vK  152 (692)
                      .+     -....+++|||++|..|.+...    +++    .+...+.+.+.-||+.|++|+|..|.|++++.++    ++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~----i~  174 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG----IR  174 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc----EE
Confidence            22     2245678999999988876542    333    2445677889999999999999999999999766    89


Q ss_pred             Eeccccccc
Q 005526          153 IGDFGFARS  161 (692)
Q Consensus       153 L~DFGlA~~  161 (692)
                      ++||+..+.
T Consensus       175 iID~~~k~~  183 (229)
T PF06176_consen  175 IIDTQGKRM  183 (229)
T ss_pred             EEECccccc
Confidence            999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.44  E-value=2.9e-06  Score=86.20  Aligned_cols=148  Identities=16%  Similarity=0.233  Sum_probs=106.9

Q ss_pred             CEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCC----CChHHHHHHHHHHHHHHhCCCCC--cceEEEEEE---e-
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL----LSPKVSDNLLKEISILSTISHPN--IIRFFEAIE---T-   80 (692)
Q Consensus        11 ~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~----~~~~~~~~i~~Ev~iL~~L~HpN--IVkl~~~~~---~-   80 (692)
                      ++.-.---|+||.+-|++....  |+.|-+|.-....    .-+--...+.+|+..|.++..-+  +.++. ++.   . 
T Consensus        19 ~wve~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~   95 (216)
T PRK09902         19 DWVEEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE   95 (216)
T ss_pred             ceecCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence            3333334567999999997654  4578888764221    11234567889999999885433  44544 222   1 


Q ss_pred             -CCEEEEEEeccCC-CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcCeEEEecc
Q 005526           81 -REKIYLVLEYCDG-GDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF  156 (692)
Q Consensus        81 -~~~l~LVmEy~~G-GsL~~~L~~~--~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~~vKL~DF  156 (692)
                       .-.-+||+|-+.| -+|.+++...  .+.++.....++.+++..+.-||+.|+.|+|+.+.||+++.++ ...++++||
T Consensus        96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDl  174 (216)
T PRK09902         96 GEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDL  174 (216)
T ss_pred             CceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEh
Confidence             2246899997765 5898888664  3457888889999999999999999999999999999998655 346999999


Q ss_pred             cccccc
Q 005526          157 GFARSL  162 (692)
Q Consensus       157 GlA~~~  162 (692)
                      .-++..
T Consensus       175 Ek~r~~  180 (216)
T PRK09902        175 EKSRRR  180 (216)
T ss_pred             hccchh
Confidence            877543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.38  E-value=2.9e-06  Score=101.88  Aligned_cols=205  Identities=23%  Similarity=0.292  Sum_probs=149.3

Q ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 005526           53 SDNLLKEISILSTISHPNIIRFFEAIETRE----KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK  128 (692)
Q Consensus        53 ~~~i~~Ev~iL~~L~HpNIVkl~~~~~~~~----~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~  128 (692)
                      .....-|.+.+.++.|+|++.++.+.....    ...+..+||...++...+..-+..+.+..+.+..+++.||.|+|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            344455777788899999999998864332    2335568999999999999999999999999999999999999999


Q ss_pred             CCcccCCCCCceEecCCCCcCeEEEe--ccccccccCCCCCCCccCCCCCccChHhhhhcCCCcc--hhhHHHHHHHHHH
Q 005526          129 HLIHRDLKPQNLLVSTNEVTPVLKIG--DFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK--ADLWSVGAILFQL  204 (692)
Q Consensus       129 gIVHRDLKP~NILL~~~~~~~~vKL~--DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~k--sDIWSLGviLyeL  204 (692)
                      ...|.-|..+-..-........+.++  ||+..+............-+..|.+||......+..+  .|+|.+|..+..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            76666555552222222222356666  9998887766655555566677888888776666554  7999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccC-HHHHHHHHHhhccCCCCCCCHHHHHhchhhhh
Q 005526          205 VTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH-PDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       205 ltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls-~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~  272 (692)
                      ..|..+-.-...   ...++            ...+ ....++..+|+..++++|+++.+++.|+|...
T Consensus       386 ~~~~~i~~~~~~---~~~~l------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  386 SQGEDISEKSAV---PVSLL------------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhcCcccccccc---hhhhh------------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            887654321111   11111            1111 16778999999999999999999999999853

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.30  E-value=2.4e-06  Score=97.54  Aligned_cols=142  Identities=25%  Similarity=0.316  Sum_probs=90.4

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCC----------------------------hHHHH----------HHH
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS----------------------------PKVSD----------NLL   57 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~----------------------------~~~~~----------~i~   57 (692)
                      +.|+.++-|.||+|+.+. |+.||||+.+.....                            ....+          .+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            568999999999999876 999999998533210                            00111          122


Q ss_pred             HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCCHHHH--HHHcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 005526           58 KEISILSTIS-----HPNIIRFFEAIETREKIYLVLEYCDGGDLAAY--IHKHGKVSEAVARHFMRQLAAGLQVLQEKHL  130 (692)
Q Consensus        58 ~Ev~iL~~L~-----HpNIVkl~~~~~~~~~l~LVmEy~~GGsL~~~--L~~~~~lse~~i~~il~QLl~gL~yLHs~gI  130 (692)
                      +|..-+.+++     .++|.-..=+++-...-.++|||++|-.+.+.  ++. .+++...+...+.++  -+..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence            3444444432     34433222223445667899999999988887  444 345433322222111  1222334899


Q ss_pred             cccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526          131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus       131 VHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      +|.|..|.||++..++   .+.+.|||+...+..
T Consensus       287 fHaDpHpGNi~v~~~g---~i~~lDfGi~g~l~~  317 (517)
T COG0661         287 FHADPHPGNILVRSDG---RIVLLDFGIVGRLDP  317 (517)
T ss_pred             cccCCCccceEEecCC---cEEEEcCcceecCCH
Confidence            9999999999999987   589999999876653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.30  E-value=7.7e-06  Score=84.13  Aligned_cols=72  Identities=13%  Similarity=0.146  Sum_probs=55.2

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeccCC
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN--IIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN--IVkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      ..||+|..+.||+.    .+..+++|......    ....+.+|.++++.+..-+  +.+.+++....+..++|||+++|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            57899999999983    25578899876432    2345688999999886444  47788888888888999999999


Q ss_pred             CC
Q 005526           94 GD   95 (692)
Q Consensus        94 Gs   95 (692)
                      .+
T Consensus        79 ~~   80 (226)
T TIGR02172        79 KR   80 (226)
T ss_pred             cc
Confidence            63

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.29  E-value=9.8e-06  Score=81.13  Aligned_cols=78  Identities=19%  Similarity=0.242  Sum_probs=58.1

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cceEEEEE---EeCCEEEEEEe
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN--IIRFFEAI---ETREKIYLVLE   89 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN--IVkl~~~~---~~~~~l~LVmE   89 (692)
                      ++.|+.|..+.||++....  ..+++|.....    .....+.+|..+++.+...+  +.+++...   ......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            5789999999999999875  59999987543    45577888999988885433  55676643   23446899999


Q ss_pred             ccCCCCHHH
Q 005526           90 YCDGGDLAA   98 (692)
Q Consensus        90 y~~GGsL~~   98 (692)
                      +++|..+..
T Consensus        76 ~i~g~~~~~   84 (239)
T PF01636_consen   76 YIPGRPLDD   84 (239)
T ss_dssp             EESSEEHHH
T ss_pred             Eeccccccc
Confidence            999987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.25  E-value=8.6e-06  Score=84.21  Aligned_cols=138  Identities=22%  Similarity=0.138  Sum_probs=94.3

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH----------------------HHHHHHHHHHHHHhCC--CCCc
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----------------------VSDNLLKEISILSTIS--HPNI   71 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~----------------------~~~~i~~Ev~iL~~L~--HpNI   71 (692)
                      ..|..|.-+.||+|.. .++..+|||+++.....-+                      ......+|+.-|+++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3677888889999987 3589999999854322111                      1112345777777774  4445


Q ss_pred             ceEEEEEEeCCEEEEEEeccCCCC-HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccCCCCCceEecCCCCcC
Q 005526           72 IRFFEAIETREKIYLVLEYCDGGD-LAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        72 Vkl~~~~~~~~~l~LVmEy~~GGs-L~~~L~~~~~lse~~i~~il~QLl~gL~yLHs-~gIVHRDLKP~NILL~~~~~~~  149 (692)
                      .+.+.+.    .-.|||||+.... -.-.|+.- .+..+++..+..++++.+.-|-. .|+||+||..-|||+.++    
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~----  203 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG----  203 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC----
Confidence            6666554    3468999996531 11112111 23334788889999999988876 999999999999999844    


Q ss_pred             eEEEeccccccccC
Q 005526          150 VLKIGDFGFARSLT  163 (692)
Q Consensus       150 ~vKL~DFGlA~~~~  163 (692)
                      .+.|+|||.|....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            38999999986654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.17  E-value=1.9e-07  Score=113.30  Aligned_cols=217  Identities=18%  Similarity=0.075  Sum_probs=148.8

Q ss_pred             CChHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHH
Q 005526           48 LSPKVSDNLLKEISILSTISHPNIIRFFEAIE--TREKIYLVLEYCDGGDLAAYIHKH----GKVSEAVARHFMRQLAAG  121 (692)
Q Consensus        48 ~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~--~~~~l~LVmEy~~GGsL~~~L~~~----~~lse~~i~~il~QLl~g  121 (692)
                      ..+...+-...|..-++...|+++.....-..  .....|.+++||.+|.+++.|-+.    ..+.+..+....++.+..
T Consensus      1268 LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~ 1347 (2724)
T KOG1826|consen 1268 LSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLN 1347 (2724)
T ss_pred             HhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhc
Confidence            33444444555666677788999887765543  345678999999999999998654    234555555556665778


Q ss_pred             HHHHHHcC-----CcccCCCCCceEecCCCCcCeEEEecccccc-ccCCCCCCCccCCCCCccChHhhhhcCCCcchhhH
Q 005526          122 LQVLQEKH-----LIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW  195 (692)
Q Consensus       122 L~yLHs~g-----IVHRDLKP~NILL~~~~~~~~vKL~DFGlA~-~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIW  195 (692)
                      ..-+|...     .+|++||+-|.+|..+.+   +|++++|+.+ ............+++.|+.|++.....++.++|+|
T Consensus      1348 ~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~---v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1348 RNVILSLTNLGNTNVSKSLKFTLPMIVTNYN---VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred             cchhhhcccCCccchhhhhhhhccceecCCc---ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence            88877542     699999999999988774   8999999999 33344456677889999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhh
Q 005526          196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       196 SLGviLyeLltG~~PF~~~~~~~~~~~i~~~~~~~~p~~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~  271 (692)
                      ..|+.+|.+..|..+|....+..+-..+........+.    ..+.+.-.....+|-..-..||.-...+.-+.+.
T Consensus      1425 r~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~----l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEK----LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccc----cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            99999999999998885443332222222222222221    1122222333333334446788877777766664

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.14  E-value=4.4e-05  Score=77.15  Aligned_cols=132  Identities=21%  Similarity=0.299  Sum_probs=96.5

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccCC--------------CChHHHHHHHHHHHHHHhCC------CCCcceEE
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL--------------LSPKVSDNLLKEISILSTIS------HPNIIRFF   75 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~--------------~~~~~~~~i~~Ev~iL~~L~------HpNIVkl~   75 (692)
                      ..||+|+.-.||.-  + .....+||++....              ......++..+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46899999999973  3 34567889887654              11122355666776666655      78899999


Q ss_pred             EEEEeCCEEEEEEeccCC------CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcC
Q 005526           76 EAIETREKIYLVLEYCDG------GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        76 ~~~~~~~~l~LVmEy~~G------GsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~  149 (692)
                      |+.+++....+|+|.+..      .+|.++++. +.+++ .   +...+-.-.+||-+++|+.+||+|.||++..+....
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            999999999999998754      258888844 45665 3   334444556788999999999999999998776554


Q ss_pred             -eEEEec
Q 005526          150 -VLKIGD  155 (692)
Q Consensus       150 -~vKL~D  155 (692)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             677777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.12  E-value=2.1e-05  Score=80.88  Aligned_cols=75  Identities=17%  Similarity=0.163  Sum_probs=54.0

Q ss_pred             EecccCc-eEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 005526           17 RIGSGSF-AVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGG   94 (692)
Q Consensus        17 ~LG~GsF-G~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNIVkl~~~~~~~~~l~LVmEy~~GG   94 (692)
                      .|-.|.. +.||++...  +..++||+.....     ...+.+|+++++.+. +--+.+++++...++..++|||+++|.
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            4445555 789999754  4688888875432     235677899888874 344668888777777789999999998


Q ss_pred             CHHH
Q 005526           95 DLAA   98 (692)
Q Consensus        95 sL~~   98 (692)
                      +|..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.03  E-value=4.4e-05  Score=92.59  Aligned_cols=147  Identities=14%  Similarity=0.254  Sum_probs=93.6

Q ss_pred             EEeEecccCceEEEEEEEcCCC--cEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEEE
Q 005526           14 VGPRIGSGSFAVVWRARHRQLG--IEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNI--IRFFEAIETR---EKIY   85 (692)
Q Consensus        14 i~~~LG~GsFG~Vy~a~~~~tg--~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~-HpNI--Vkl~~~~~~~---~~l~   85 (692)
                      -++.++.|.++.+|+......+  ..+++|+....... .....+.+|+++|+.+. |++|  .+++.++.+.   +..|
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            3678899999999998765432  47888876443211 12346789999999995 6665  7777777654   4678


Q ss_pred             EEEeccCCCCHHH--------------------HHH---HcC----CC---------CHHHHHHHHHH------------
Q 005526           86 LVLEYCDGGDLAA--------------------YIH---KHG----KV---------SEAVARHFMRQ------------  117 (692)
Q Consensus        86 LVmEy~~GGsL~~--------------------~L~---~~~----~l---------se~~i~~il~Q------------  117 (692)
                      +||||++|..+.+                    .+.   .-.    .+         -..++..|..|            
T Consensus       121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~  200 (822)
T PLN02876        121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR  200 (822)
T ss_pred             EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence            9999999864211                    111   100    00         11233333222            


Q ss_pred             ---HHHHHHHHHH-----------cCCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526          118 ---LAAGLQVLQE-----------KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus       118 ---Ll~gL~yLHs-----------~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                         +...+++|..           ..+||+|+++.|||++.++. .++-|.||+++..-
T Consensus       201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~-~v~aVLDWE~a~~G  258 (822)
T PLN02876        201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTED-RVIGILDWELSTLG  258 (822)
T ss_pred             ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCC-eEEEEEeeeccccC
Confidence               2233556632           34999999999999986432 25689999988654

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.94  E-value=0.0001  Score=74.54  Aligned_cols=127  Identities=17%  Similarity=0.218  Sum_probs=92.3

Q ss_pred             cCEEEEeEecccCc-eEEEEEEEcCCCcEEEEEEecc---CCC-------Ch---------HHHHHHHHHHHHHHhCC--
Q 005526           10 GEYIVGPRIGSGSF-AVVWRARHRQLGIEVAVKEIDK---KLL-------SP---------KVSDNLLKEISILSTIS--   67 (692)
Q Consensus        10 ~~Y~i~~~LG~GsF-G~Vy~a~~~~tg~~vAVK~i~~---~~~-------~~---------~~~~~i~~Ev~iL~~L~--   67 (692)
                      .+++.++.||.|.- |.||+++..  |+.||+|++..   ...       ..         ....-+..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 999999876  78999999321   110       00         11234667888777764  


Q ss_pred             -CCCc--ceEEEEEEeC------------------CEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 005526           68 -HPNI--IRFFEAIETR------------------EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ  126 (692)
Q Consensus        68 -HpNI--Vkl~~~~~~~------------------~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLH  126 (692)
                       +.++  |+++|+..-.                  ....||.||++...         .++    ..-+.+|..-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence             4556  9999997322                  12568899887643         122    234567888889999


Q ss_pred             HcCCcccCCCCCceEecCCCCcCeEEEeccccc
Q 005526          127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA  159 (692)
Q Consensus       127 s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA  159 (692)
                      ..||+-+|+++.|..   +|     ||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~G-----~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---GG-----KLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---CC-----EEEecccC
Confidence            999999999999987   33     89999964

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.93  E-value=4.8e-05  Score=75.04  Aligned_cols=129  Identities=26%  Similarity=0.314  Sum_probs=93.0

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEecc
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII-RFFEAIETREKIYLVLEYC   91 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIV-kl~~~~~~~~~l~LVmEy~   91 (692)
                      ++.+.||+|.+|+||++...  |..+|+|+-+.+    ..+..+..|+++|..+.--++- ++|.+..    .++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence            45678999999999999886  779999976544    3467889999999999877764 4554432    34459999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCC-CC-ceEecCCCCcCeEEEecccccccc
Q 005526           92 DGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK-PQ-NLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        92 ~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLK-P~-NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .|..|...-...   +    ++-+..+++.---|-..||-|+.|. |. ||++. ++   .+.|+||.-|+..
T Consensus        95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~---~~~iIDFd~At~k  156 (201)
T COG2112          95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR---DVYIIDFDSATFK  156 (201)
T ss_pred             cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CC---cEEEEEccchhhc
Confidence            998887654321   1    2344556666666778899999886 44 55554 43   3899999999743

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.93  E-value=5e-05  Score=86.84  Aligned_cols=143  Identities=24%  Similarity=0.299  Sum_probs=89.5

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-----------------------------HHHHH------HHHH
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-----------------------------KVSDN------LLKE   59 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-----------------------------~~~~~------i~~E   59 (692)
                      -+.||.-+.|.||+|+.+. |+.||||+-+......                             +..+.      +.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3579999999999999987 9999999875432110                             11111      2223


Q ss_pred             HHHHHh----CCCCC------cceEEEEEEeCCEEEEEEeccCCCCHHHH--HHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 005526           60 ISILST----ISHPN------IIRFFEAIETREKIYLVLEYCDGGDLAAY--IHKHGKVSEAVARHFMRQLAAGLQVLQE  127 (692)
Q Consensus        60 v~iL~~----L~HpN------IVkl~~~~~~~~~l~LVmEy~~GGsL~~~--L~~~~~lse~~i~~il~QLl~gL~yLHs  127 (692)
                      ++-..+    +.|-+      |.++|-  .......|+||||+|..+.+.  |.+. +++...+..-+-+..  ++-+=.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~--~~qIf~  319 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY--LEQIFK  319 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH--HHHHHh
Confidence            333222    23444      444432  234567899999999876544  4444 455443332222221  233346


Q ss_pred             cCCcccCCCCCceEecCCC-CcCeEEEeccccccccC
Q 005526          128 KHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFARSLT  163 (692)
Q Consensus       128 ~gIVHRDLKP~NILL~~~~-~~~~vKL~DFGlA~~~~  163 (692)
                      .|++|+|=.|.||+++.++ ....+.+-|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            7899999999999999542 33479999999987654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.77  E-value=9.7e-05  Score=75.87  Aligned_cols=72  Identities=15%  Similarity=0.172  Sum_probs=46.7

Q ss_pred             eEecccCce-EEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEEE
Q 005526           16 PRIGSGSFA-VVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP---NIIRFFEAIETR---EKIYLVL   88 (692)
Q Consensus        16 ~~LG~GsFG-~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~Hp---NIVkl~~~~~~~---~~l~LVm   88 (692)
                      +.|+.|+.. .||+.     +..+++|+....    .....+.+|.+++..+...   -+.++++.....   ...+++|
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence            567777776 59976     235788875432    1245788899999887532   345555544332   2458899


Q ss_pred             eccCCCCH
Q 005526           89 EYCDGGDL   96 (692)
Q Consensus        89 Ey~~GGsL   96 (692)
                      ++++|.++
T Consensus        74 ~~i~G~~l   81 (235)
T cd05155          74 RWLEGETA   81 (235)
T ss_pred             EeecCCCC
Confidence            99999665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.73  E-value=0.0033  Score=70.09  Aligned_cols=79  Identities=20%  Similarity=0.209  Sum_probs=55.6

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-----ChHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-----SPKVSDNLLKEISILSTIS---HPNIIRFFEAIETREKIYL   86 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-----~~~~~~~i~~Ev~iL~~L~---HpNIVkl~~~~~~~~~l~L   86 (692)
                      .+.||.|.+..||++.....++.|+||.-.....     .+-..+....|.+.|+.+.   ..++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4689999999999999875446899997532110     1223456677888888763   3467778765  4466789


Q ss_pred             EEeccCCCC
Q 005526           87 VLEYCDGGD   95 (692)
Q Consensus        87 VmEy~~GGs   95 (692)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.44  E-value=0.001  Score=67.82  Aligned_cols=75  Identities=16%  Similarity=0.178  Sum_probs=48.8

Q ss_pred             EeEecccCceEEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEeccC
Q 005526           15 GPRIGSGSFAVVWRARHRQ-LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN-IIRFFEAIETREKIYLVLEYCD   92 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~-tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN-IVkl~~~~~~~~~l~LVmEy~~   92 (692)
                      .+.|..|-...+|++.... .++.|++|+......  . .-...+|+.+++.+...+ .++++..+.  +  .+||||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--L-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--c-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence            4677888889999997543 357899997654211  1 122347888888885444 345554432  2  37999999


Q ss_pred             CCCH
Q 005526           93 GGDL   96 (692)
Q Consensus        93 GGsL   96 (692)
                      |.++
T Consensus        76 G~~l   79 (235)
T cd05157          76 GRTL   79 (235)
T ss_pred             CCcC
Confidence            8664

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.33  E-value=0.00079  Score=69.96  Aligned_cols=134  Identities=20%  Similarity=0.312  Sum_probs=78.2

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCCC
Q 005526           17 RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI-IRFFEAIETREKIYLVLEYCDGGD   95 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNI-Vkl~~~~~~~~~l~LVmEy~~GGs   95 (692)
                      .+..|-.+.+|+..  .+++.|++|........  ..-...+|.++++.+...++ .+++...  .  -++||||++|..
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence            35568888999987  34778999976432111  10124678889988865444 4444433  2  268999999865


Q ss_pred             HHH--------------HHHH-c--C----CCC-HHHHHHHHHHH---------HHHHHHHHH--------cCCcccCCC
Q 005526           96 LAA--------------YIHK-H--G----KVS-EAVARHFMRQL---------AAGLQVLQE--------KHLIHRDLK  136 (692)
Q Consensus        96 L~~--------------~L~~-~--~----~ls-e~~i~~il~QL---------l~gL~yLHs--------~gIVHRDLK  136 (692)
                      +..              .+.+ +  .    .++ ...+..+..++         ...++.+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            431              1111 1  0    111 11222222222         111222222        248999999


Q ss_pred             CCceEecCCCCcCeEEEecccccccc
Q 005526          137 PQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus       137 P~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      |.||+++.++    ++|+||+.+...
T Consensus       155 ~~Nil~~~~~----~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVVTPQG----LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEEeCCC----CEEEeccccCcC
Confidence            9999998765    689999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.33  E-value=0.0063  Score=65.22  Aligned_cols=137  Identities=18%  Similarity=0.171  Sum_probs=75.4

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC--CcceEEE------EEEeCCEEEE
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP--NIIRFFE------AIETREKIYL   86 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~Hp--NIVkl~~------~~~~~~~l~L   86 (692)
                      .+.|+.|....+|++...  +..+++|++. . ...   ..+..|+.+++.|...  .+.+++.      +....+..++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~   99 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA   99 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence            355777888899998754  3478999875 2 222   2333455555554321  2334442      1234667899


Q ss_pred             EEeccCCCCH-----------HHHHH---Hc-CCC--------CH----HHHH-----------HHHHH-HHHHHHHHH-
Q 005526           87 VLEYCDGGDL-----------AAYIH---KH-GKV--------SE----AVAR-----------HFMRQ-LAAGLQVLQ-  126 (692)
Q Consensus        87 VmEy~~GGsL-----------~~~L~---~~-~~l--------se----~~i~-----------~il~Q-Ll~gL~yLH-  126 (692)
                      +++|++|..+           ...+.   .. ..+        ..    ....           ..+.+ +-..++.+. 
T Consensus       100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  179 (319)
T PRK05231        100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS  179 (319)
T ss_pred             EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence            9999999642           11111   10 001        00    0000           11111 111122322 


Q ss_pred             ------HcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526          127 ------EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       127 ------s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                            ..++||+|+.|.|||++.+.   ...|+||+.+..
T Consensus       180 ~~~~~lp~~liHgD~~~~Nil~~~~~---~~~iIDf~~~~~  217 (319)
T PRK05231        180 AAWPALPRGVIHADLFRDNVLFEGDR---LSGFIDFYFACN  217 (319)
T ss_pred             cccccCCcccCCCCCCCCcEEEECCc---eEEEEecccccC
Confidence                  23799999999999998554   457999998743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.21  E-value=0.0041  Score=65.80  Aligned_cols=137  Identities=20%  Similarity=0.200  Sum_probs=82.9

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEEE
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN--IIRFFEA------IETREKIYL   86 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN--IVkl~~~------~~~~~~l~L   86 (692)
                      .+.|..|.-..+|+....  +..+++|+...  .   ....+..|++++..+.+.+  +.+++..      ...++..++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            556777888899998653  45799998754  1   1345667888888774332  4455432      234567789


Q ss_pred             EEeccCCCCHHH-----------HH---HHc-CCCC--------HHHHH------------HHHHHHHHHHHHHHH----
Q 005526           87 VLEYCDGGDLAA-----------YI---HKH-GKVS--------EAVAR------------HFMRQLAAGLQVLQE----  127 (692)
Q Consensus        87 VmEy~~GGsL~~-----------~L---~~~-~~ls--------e~~i~------------~il~QLl~gL~yLHs----  127 (692)
                      |++|++|..+..           .+   +.. ..+.        .....            .....+...+.++..    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999999866421           11   110 0000        00000            011112334444443    


Q ss_pred             ---cCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526          128 ---KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       128 ---~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                         .+++|+|+.|.|||++.++   .+.|+||+.+..
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~---~~~iIDfe~a~~  205 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDE---LSGVIDFYFACT  205 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCc---eEEEeehhhhcC
Confidence               4799999999999998765   468999998743

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.20  E-value=0.0038  Score=66.79  Aligned_cols=137  Identities=18%  Similarity=0.227  Sum_probs=80.2

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEEE
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN--IIRFFEA------IETREKIYL   86 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN--IVkl~~~------~~~~~~l~L   86 (692)
                      .+.++.|.-..+|++...  +..+++|+..... .   ...+..|.+++..|...+  +.+++..      ....+..++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            566777777899998643  4468889875421 1   234556677777664222  4444432      123567899


Q ss_pred             EEeccCCCCHH-----------HHH---HHc-CCCC--------HH---H--HH----------HHHHHHHHHHHHHH--
Q 005526           87 VLEYCDGGDLA-----------AYI---HKH-GKVS--------EA---V--AR----------HFMRQLAAGLQVLQ--  126 (692)
Q Consensus        87 VmEy~~GGsL~-----------~~L---~~~-~~ls--------e~---~--i~----------~il~QLl~gL~yLH--  126 (692)
                      +++|++|..+.           ..+   +.. ..++        ..   .  ..          .....+...++++.  
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            99999985421           111   110 0110        00   0  00          00112233455554  


Q ss_pred             -----HcCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526          127 -----EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus       127 -----s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                           ..+++|+|+++.||+++.++   .+.|+||+.+.
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~---~~~vIDfd~~~  216 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDS---VKGVIDFYFAC  216 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCc---eEEEeeccccc
Confidence                 26899999999999998765   46899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.09  E-value=0.00045  Score=74.05  Aligned_cols=137  Identities=20%  Similarity=0.227  Sum_probs=95.9

Q ss_pred             EEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChH--------------------HHHHHHHHHHHHHhCCCC--
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK--------------------VSDNLLKEISILSTISHP--   69 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~--------------------~~~~i~~Ev~iL~~L~Hp--   69 (692)
                      |.++.+||-|.-+.||.+-+.. |+++++|+-+.-+.+-.                    .+-...+|+..|+.|...  
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            6788999999999999998864 89999986533221111                    112345688888877432  


Q ss_pred             CcceEEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccCCCCCceEecCCCCcC
Q 005526           70 NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP  149 (692)
Q Consensus        70 NIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVHRDLKP~NILL~~~~~~~  149 (692)
                      -|.+.+++    +.-++|||++.|-.|...-+-      ..+..+...+..-+.-|-.+|+||+|..--||++++++   
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~---  239 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD---  239 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC---
Confidence            24455543    456899999999777654321      12334455556666778899999999999999999766   


Q ss_pred             eEEEecccccccc
Q 005526          150 VLKIGDFGFARSL  162 (692)
Q Consensus       150 ~vKL~DFGlA~~~  162 (692)
                      .++++||-..-..
T Consensus       240 ~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  240 KIVVIDFPQMVST  252 (465)
T ss_pred             CEEEeechHhhcc
Confidence            4899999876443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.93  E-value=0.0021  Score=64.33  Aligned_cols=98  Identities=18%  Similarity=0.187  Sum_probs=78.3

Q ss_pred             HHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCCHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCC
Q 005526           58 KEISILSTISH-PNIIRFFEAIETREKIYLVLEYCDGGDLAA---YIHKHGKVSEAVARHFMRQLAAGLQVLQE---KHL  130 (692)
Q Consensus        58 ~Ev~iL~~L~H-pNIVkl~~~~~~~~~l~LVmEy~~GGsL~~---~L~~~~~lse~~i~~il~QLl~gL~yLHs---~gI  130 (692)
                      .|.-+++.+.+ +++++++|+|    .-++|.||...+++..   .+......++....+++.+++..+++|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47888888876 6999999998    2367899998776642   12222356899999999999999999997   458


Q ss_pred             cccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526          131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus       131 VHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .-.|++|+|+-++.++   .+|++|.+.+-..
T Consensus        84 ~lcDv~~~nfgv~~~~---~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDG---RLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCC---cEEEEechhcchh
Confidence            8899999999999876   4999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.92  E-value=0.0049  Score=65.53  Aligned_cols=75  Identities=12%  Similarity=0.212  Sum_probs=48.8

Q ss_pred             EeEecccCceEEEEEEEcC------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEE
Q 005526           15 GPRIGSGSFAVVWRARHRQ------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI-IRFFEAIETREKIYLV   87 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~------tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNI-Vkl~~~~~~~~~l~LV   87 (692)
                      .+.|..|--..||++....      .++.|++|+.....   .......+|.+++..+...++ .+++.++. +   .+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            3556667778999987643      25889999875432   112345678888888754333 45555543 2   358


Q ss_pred             EeccCCCCH
Q 005526           88 LEYCDGGDL   96 (692)
Q Consensus        88 mEy~~GGsL   96 (692)
                      +||++|..+
T Consensus        76 ~e~i~G~~l   84 (302)
T cd05156          76 EEFIPSRTL   84 (302)
T ss_pred             hheeCCCcC
Confidence            999988765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.87  E-value=0.0065  Score=66.34  Aligned_cols=142  Identities=27%  Similarity=0.270  Sum_probs=95.5

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC----------------------Ch-H-HHHHHHHHHHHHHhCCCC
Q 005526           14 VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL----------------------SP-K-VSDNLLKEISILSTISHP   69 (692)
Q Consensus        14 i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~----------------------~~-~-~~~~i~~Ev~iL~~L~Hp   69 (692)
                      |-..|..|.-+.||.|... +|..+|||+++...+                      ++ + ..-...+|++-|++++.-
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4456778888999999775 588899998853221                      11 1 112345688888888766


Q ss_pred             CcceEEEEEEeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCCcccCCCCCceEecCCCCc
Q 005526           70 NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL-QEKHLIHRDLKPQNLLVSTNEVT  148 (692)
Q Consensus        70 NIVkl~~~~~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yL-Hs~gIVHRDLKP~NILL~~~~~~  148 (692)
                      +|...--+..  ..-.|||+|+.......=.-+.-.++...+..+-.|++.-+.-| |.+++||.||.--|+|+.++   
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG---  301 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG---  301 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC---
Confidence            6543221111  12358999996432222112333577788888888888887666 57899999999999999765   


Q ss_pred             CeEEEecccccccc
Q 005526          149 PVLKIGDFGFARSL  162 (692)
Q Consensus       149 ~~vKL~DFGlA~~~  162 (692)
                       .+.|+|-+.+...
T Consensus       302 -~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 -KLYIIDVSQSVEH  314 (520)
T ss_pred             -EEEEEEccccccC
Confidence             4899999877544

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.82  E-value=0.01  Score=65.29  Aligned_cols=76  Identities=21%  Similarity=0.159  Sum_probs=50.7

Q ss_pred             eEecccCceEEEEEEEcCCCcEEEEEEeccC-----CCChHHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 005526           16 PRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-----LLSPKVSDNLLKEISILSTIS--HP-NIIRFFEAIETREKIYLV   87 (692)
Q Consensus        16 ~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~-----~~~~~~~~~i~~Ev~iL~~L~--Hp-NIVkl~~~~~~~~~l~LV   87 (692)
                      ++||.|....||++.....++.|+||.-...     ...+-...+..-|.+.|+...  -| .+.++|  +.+.+...+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceeh
Confidence            3689999999999998644468999965311     112333455667888887653  24 455665  3456667799


Q ss_pred             EeccCC
Q 005526           88 LEYCDG   93 (692)
Q Consensus        88 mEy~~G   93 (692)
                      ||+++.
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.82  E-value=0.004  Score=70.30  Aligned_cols=169  Identities=18%  Similarity=0.220  Sum_probs=109.7

Q ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCcc
Q 005526           54 DNLLKEISILSTISHPNIIRFFEAIET-REKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH  132 (692)
Q Consensus        54 ~~i~~Ev~iL~~L~HpNIVkl~~~~~~-~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~gIVH  132 (692)
                      ..+.-...+++.+.|+|...++++... ..+..+|||++. .+|++++..+....+.-.               .+|+. 
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~~~s~~---------------~~~~~-   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLKDESLL---------------AHGVL-   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccchhhhc---------------ccccc-
Confidence            456667889999999999999988754 346889999995 599999877641111110               12221 


Q ss_pred             cCCCCCceEecCCCCcCeEEEeccccccccCCCCCCCccCCCCCccChHhhhhcCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005526          133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFD  212 (692)
Q Consensus       133 RDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YmAPEvl~~~~ys~ksDIWSLGviLyeLltG~~PF~  212 (692)
                          +-|+          ++++| -++   +..   .+..|                +|+|||++|.++.++.-|...|.
T Consensus        90 ----~~~~----------~~~td-~~~---t~~---~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   90 ----HLNI----------IYITD-HFL---TKY---PSPIG----------------PKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             ----eehh----------hhccc-ccc---ccC---CCCCC----------------cchhhhhHHHHHHHHHHhhHHHH
Confidence                1222          23334 011   100   11111                38999999999999999988887


Q ss_pred             CCCHHHHHHHHHhccCCCCCC-------CcccccCHHHHHHHHHhhccCCCCCCCHHHHHhchhhhhhHhh
Q 005526          213 GSNQLQLFQNILTSTELRFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT  276 (692)
Q Consensus       213 ~~~~~~~~~~i~~~~~~~~p~-------~~~~~ls~el~dLI~~~L~~DP~~RpTa~elL~Hpf~~~~~~~  276 (692)
                      .....+....+.+-.......       ...-..+..+.++..+|+-..|..||...++.+|+-|.+.-+.
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~  203 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKD  203 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhh
Confidence            666555555444322111100       0112446677889999999999999999999999999877444

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.67  E-value=0.01  Score=66.04  Aligned_cols=77  Identities=19%  Similarity=0.209  Sum_probs=53.5

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEecc----CCCChHHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDK----KLLSPKVSDNLLKEISILSTIS--HP-NIIRFFEAIETREKIYLV   87 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~----~~~~~~~~~~i~~Ev~iL~~L~--Hp-NIVkl~~~~~~~~~l~LV   87 (692)
                      .+.||.|.-..||++.+...++.|+||.-..    ....+-..++..-|.++|+...  .| .++++|  +.+.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence            6789999999999999854457799986421    1112334566777888888663  34 466665  3456677889


Q ss_pred             EeccCC
Q 005526           88 LEYCDG   93 (692)
Q Consensus        88 mEy~~G   93 (692)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999854

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.55  E-value=0.011  Score=62.79  Aligned_cols=32  Identities=28%  Similarity=0.429  Sum_probs=25.7

Q ss_pred             CCcccCCCCCceEecCCCCcCeEEEecccccccc
Q 005526          129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus       129 gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~  162 (692)
                      .++|+|++|.|||++.++  ...-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~--~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDA--RVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCC--CEEEEECcHhcccC
Confidence            489999999999998643  25679999988553

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.41  E-value=0.025  Score=61.29  Aligned_cols=146  Identities=15%  Similarity=0.257  Sum_probs=83.2

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCC--EEEEEE
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN--IIRFFEAIETRE--KIYLVL   88 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN--IVkl~~~~~~~~--~l~LVm   88 (692)
                      .+++++-.|--..+|.....  ++.+++. ...............+|.++++.+.---  +.+.++.+..+.  ..|.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            34455533333445555544  7888888 4322222334556678888888775323  334445554443  679999


Q ss_pred             eccCCCCH------------------HHHHHH-c-------------CCCCHHHHHHHHHHH--------------HHHH
Q 005526           89 EYCDGGDL------------------AAYIHK-H-------------GKVSEAVARHFMRQL--------------AAGL  122 (692)
Q Consensus        89 Ey~~GGsL------------------~~~L~~-~-------------~~lse~~i~~il~QL--------------l~gL  122 (692)
                      +|++|..+                  .++|.. +             +.....++..+..+.              ..-.
T Consensus       105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~  184 (321)
T COG3173         105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI  184 (321)
T ss_pred             EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence            99998321                  112210 0             001112222222222              2234


Q ss_pred             HHHHHc--------CCcccCCCCCceEecCCCCcCeEEEeccccccccCC
Q 005526          123 QVLQEK--------HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus       123 ~yLHs~--------gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~~~~  164 (692)
                      .+|+.+        .++|+|+.+.||+++.++.   +-+.||+++...++
T Consensus       185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~---~gVlDwe~~~lGDP  231 (321)
T COG3173         185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP---TGVLDWELATLGDP  231 (321)
T ss_pred             HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe---eEEEeccccccCCc
Confidence            555533        3899999999999998774   78899999876543

>PLN02236 choline kinase

Probab=96.38  E-value=0.025  Score=61.90  Aligned_cols=141  Identities=19%  Similarity=0.257  Sum_probs=82.8

Q ss_pred             EEEEeEecccCceEEEEEEEcC----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQ----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI-IRFFEAIETREKIYL   86 (692)
Q Consensus        12 Y~i~~~LG~GsFG~Vy~a~~~~----tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNI-Vkl~~~~~~~~~l~L   86 (692)
                      ..-.+.|-.|-...+|++....    .++.|++|+.....  ....+ -.+|..+++.+..-++ .++++.+..+    .
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~  110 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----R  110 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence            3345566558888999986432    34789999875532  22222 2678899888865555 3566665332    4


Q ss_pred             EEeccCCCCHHH--------------HHHH-c--C----C-C-CHHHHHHHHHHHH-----------------HHHHHH-
Q 005526           87 VLEYCDGGDLAA--------------YIHK-H--G----K-V-SEAVARHFMRQLA-----------------AGLQVL-  125 (692)
Q Consensus        87 VmEy~~GGsL~~--------------~L~~-~--~----~-l-se~~i~~il~QLl-----------------~gL~yL-  125 (692)
                      |.+|++|.+|..              .+.+ +  .    . . ..+.+..|+.++.                 ..+..| 
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            799998766431              1111 0  0    0 1 1233334432221                 111111 


Q ss_pred             ---H----HcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526          126 ---Q----EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       126 ---H----s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                         .    ...++|+|+++.|||+++++.  .++|+||..+..
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~--~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETR--AITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCC--cEEEEeehhccc
Confidence               1    235899999999999986432  599999998854

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.36  E-value=0.079  Score=56.25  Aligned_cols=29  Identities=24%  Similarity=0.484  Sum_probs=24.5

Q ss_pred             cCCcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526          128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus       128 ~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                      .+++|+|+.+.||+++.+    .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~----~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKDN----EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeCC----cEEEEECcccc
Confidence            578999999999999863    37899999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.21  E-value=0.043  Score=61.41  Aligned_cols=76  Identities=11%  Similarity=0.126  Sum_probs=52.2

Q ss_pred             EEeEecccCceEEEEEEEcCCCcEEEEEEeccCCC-----ChHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 005526           14 VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-----SPKVSDNLLKEISILSTIS---HPNIIRFFEAIETREKIY   85 (692)
Q Consensus        14 i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~-----~~~~~~~i~~Ev~iL~~L~---HpNIVkl~~~~~~~~~l~   85 (692)
                      ..+.||.|.-..||++.+.  +..|+||.-.....     .+-...+...|.+.|+.+.   ...+.+++.++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4778999999999999874  45699997652111     1113445556677777653   247888887765  5567


Q ss_pred             EEEeccCC
Q 005526           86 LVLEYCDG   93 (692)
Q Consensus        86 LVmEy~~G   93 (692)
                      ++|||+++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>PRK10593 hypothetical protein; Provisional

Probab=96.13  E-value=0.031  Score=59.92  Aligned_cols=105  Identities=15%  Similarity=0.130  Sum_probs=74.4

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEEE
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH---PNIIRFFEAIET---REKIYL   86 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~H---pNIVkl~~~~~~---~~~l~L   86 (692)
                      .-.+.||.|..+.||+..... + .+++|..+. ..   ....+..|.+.|+.+.-   -.|.++++++..   .+..+|
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            346689999999999986542 3 577787432 11   12467889999988853   357888887754   366899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK  128 (692)
Q Consensus        87 VmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~  128 (692)
                      |||+++|+++.+.     ..+......+..+++.+|.-||+.
T Consensus        91 VmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         91 LLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999877651     133444566777888888888874

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.98  E-value=0.047  Score=59.39  Aligned_cols=140  Identities=14%  Similarity=0.210  Sum_probs=80.6

Q ss_pred             EEEeEecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEE
Q 005526           13 IVGPRIGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI-IRFFEAIETREKIYLVL   88 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNI-Vkl~~~~~~~~~l~LVm   88 (692)
                      ...+.|..|=-..+|++.....   +..|++|+.....  .. .-.-.+|..+++.+..-++ .++++++. ++   +|.
T Consensus        17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~   89 (330)
T PLN02421         17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--DY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ   89 (330)
T ss_pred             eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc--Ce-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence            3345555587889999875432   3489999875431  11 1223568888888876555 45666553 22   489


Q ss_pred             eccCCCCHHH--------------HHHH-c-CC------C-CHHHHHHHHHHH----------------------HHHHH
Q 005526           89 EYCDGGDLAA--------------YIHK-H-GK------V-SEAVARHFMRQL----------------------AAGLQ  123 (692)
Q Consensus        89 Ey~~GGsL~~--------------~L~~-~-~~------l-se~~i~~il~QL----------------------l~gL~  123 (692)
                      +|++|..|..              .+.+ + ..      . ....+..++.++                      ..-+.
T Consensus        90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  169 (330)
T PLN02421         90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV  169 (330)
T ss_pred             hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence            9998765421              1111 1 01      1 122333333332                      11122


Q ss_pred             H---HH-HcC----CcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526          124 V---LQ-EKH----LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       124 y---LH-s~g----IVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      .   +. ..+    ++|+|+.+.|||++++++  .++++||..|..
T Consensus       170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~--~l~lID~EYag~  213 (330)
T PLN02421        170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEG--KLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHhccCCCCeEEEECCCCcccEEEeCCCC--cEEEEcccccCC
Confidence            2   21 122    799999999999975432  599999999854

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.30  E-value=0.51  Score=51.21  Aligned_cols=71  Identities=13%  Similarity=0.106  Sum_probs=43.3

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cceEE---E--EEEeCCEEEEEEeccCC
Q 005526           21 GSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN--IIRFF---E--AIETREKIYLVLEYCDG   93 (692)
Q Consensus        21 GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN--IVkl~---~--~~~~~~~l~LVmEy~~G   93 (692)
                      +.-..||++... +|..|++|+.+.....   ...+..|++.+..|....  |+...   +  ....++..+.|+++++|
T Consensus        36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         36 SYENRVYQFGDE-DGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             cccceEEEEecC-CCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            345678988753 4678999988644322   355667777777663211  22211   1  12335678889999988


Q ss_pred             CC
Q 005526           94 GD   95 (692)
Q Consensus        94 Gs   95 (692)
                      ..
T Consensus       112 ~~  113 (325)
T PRK11768        112 RA  113 (325)
T ss_pred             CC
Confidence            64

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.20  E-value=0.078  Score=58.88  Aligned_cols=62  Identities=24%  Similarity=0.413  Sum_probs=45.9

Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHcCCcccCCCCCceEecCCC
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL-QVLQEKHLIHRDLKPQNLLVSTNE  146 (692)
Q Consensus        84 l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL-~yLHs~gIVHRDLKP~NILL~~~~  146 (692)
                      ..++-+|..|.++..+++.. ..+|...+.+..--..+| +.|--.+++|.|+.|.||++..+.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            45677899999999998765 355556666665555554 555677899999999999997654

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.15  E-value=0.33  Score=52.03  Aligned_cols=30  Identities=20%  Similarity=0.126  Sum_probs=26.0

Q ss_pred             CCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526          129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       129 gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      +++|+|+.+.|||++.++   .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~---~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR---GGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC---CEEEEEhhhccc
Confidence            699999999999998776   478899998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=94.83  E-value=0.2  Score=55.87  Aligned_cols=77  Identities=13%  Similarity=0.169  Sum_probs=46.3

Q ss_pred             EEEeEecccCceEEEEEEEcCC-CcE-----EEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 005526           13 IVGPRIGSGSFAVVWRARHRQL-GIE-----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI-IRFFEAIETREKIY   85 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~t-g~~-----vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNI-Vkl~~~~~~~~~l~   85 (692)
                      ...+.|..|--..+|++..... +..     |.++....   .....-.-.+|+++++.+...++ .++++.+..    +
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g  125 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F  125 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence            4455665588899999975432 222     44443211   11111123568999999976665 456666532    5


Q ss_pred             EEEeccCCCCH
Q 005526           86 LVLEYCDGGDL   96 (692)
Q Consensus        86 LVmEy~~GGsL   96 (692)
                      +|.||++|..|
T Consensus       126 ~l~efIeGr~l  136 (383)
T PTZ00384        126 TIQEWVEGNTM  136 (383)
T ss_pred             EEEEEeccccC
Confidence            89999998765

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.51  E-value=0.33  Score=52.00  Aligned_cols=75  Identities=17%  Similarity=0.166  Sum_probs=47.9

Q ss_pred             EEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEe
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS---HPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        13 ~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~---HpNIVkl~~~~~~~~~l~LVmE   89 (692)
                      .-.+.||.|....+|+..  .+++.|.||+-...     ....+..|.+-|+.|.   .-.+.+++.+....+.-|||||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            335678999999999987  56889999987632     2245667888887773   4457889998877777899999


Q ss_pred             ccCCC
Q 005526           90 YCDGG   94 (692)
Q Consensus        90 y~~GG   94 (692)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.00  E-value=0.67  Score=50.65  Aligned_cols=135  Identities=20%  Similarity=0.222  Sum_probs=78.1

Q ss_pred             EecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC------cceEEE----EEEeCCEEEE
Q 005526           17 RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN------IIRFFE----AIETREKIYL   86 (692)
Q Consensus        17 ~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpN------IVkl~~----~~~~~~~l~L   86 (692)
                      .|.+ .-..||+.....  ..+++|+.+.. ..   ..++..|...|..|.-.+      |..+-|    .+..+.+.+-
T Consensus        33 ~l~s-~eN~~f~~~~~~--g~~iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          33 GLNS-EENSNFRVQTED--GRYILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             cccc-ccCceEEEEecC--CCeEEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            3444 456788887653  34499988765 22   355666777777663222      122111    1222237888


Q ss_pred             EEeccCCCCHHH------------HH---HHc-CC-----------CCHH----HH---------HHHHHHHHHHHHHHH
Q 005526           87 VLEYCDGGDLAA------------YI---HKH-GK-----------VSEA----VA---------RHFMRQLAAGLQVLQ  126 (692)
Q Consensus        87 VmEy~~GGsL~~------------~L---~~~-~~-----------lse~----~i---------~~il~QLl~gL~yLH  126 (692)
                      +++|++|..+..            .+   +.. ..           ..+.    ..         .....++...++.+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            999999987662            11   110 00           1111    00         112333444444444


Q ss_pred             --------HcC--CcccCCCCCceEecCCCCcCeEEEecccccc
Q 005526          127 --------EKH--LIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus       127 --------s~g--IVHRDLKP~NILL~~~~~~~~vKL~DFGlA~  160 (692)
                              ..+  +||+|+.|.||+++.+..  .+.++|||-+.
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~--~~g~iDFdDa~  227 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTD--VSGFIDFDDAG  227 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEcCCCC--eeeEEEccccc
Confidence                    234  999999999999998764  57899999874

>PRK06148 hypothetical protein; Provisional

Probab=93.24  E-value=1.6  Score=54.76  Aligned_cols=141  Identities=17%  Similarity=0.254  Sum_probs=77.3

Q ss_pred             EeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-------CCCCcceEE-----EEEEe-C
Q 005526           15 GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-------SHPNIIRFF-----EAIET-R   81 (692)
Q Consensus        15 ~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L-------~HpNIVkl~-----~~~~~-~   81 (692)
                      .+.|+ |..-.+|++... +|..|++|+.+... .   ...+..|...|..|       .-|.+++-.     ..... +
T Consensus        30 ~~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~-~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~  103 (1013)
T PRK06148         30 ATPLD-GERDLNFRLTTD-DGADYILKIVNPSE-P---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD  103 (1013)
T ss_pred             EeecC-CcCCceEEEEeC-CCCeEEEEEcCCcc-c---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence            35675 456888998753 57789999987542 2   12333344555433       223333311     11111 2


Q ss_pred             C--EEEEEEeccCCCCHHHH--------------H---HH----cC------CCCH-----------------HHHHHHH
Q 005526           82 E--KIYLVLEYCDGGDLAAY--------------I---HK----HG------KVSE-----------------AVARHFM  115 (692)
Q Consensus        82 ~--~l~LVmEy~~GGsL~~~--------------L---~~----~~------~lse-----------------~~i~~il  115 (692)
                      +  ..+-+++|++|..+.+.              +   ..    ..      .+.+                 ...+.++
T Consensus       104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l  183 (1013)
T PRK06148        104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV  183 (1013)
T ss_pred             CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence            2  56788999999776541              1   00    00      0101                 1112223


Q ss_pred             HHHHHHHHH-----HH--HcCCcccCCCCCceEecCCCCcCeEEEeccccccc
Q 005526          116 RQLAAGLQV-----LQ--EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       116 ~QLl~gL~y-----LH--s~gIVHRDLKP~NILL~~~~~~~~vKL~DFGlA~~  161 (692)
                      .+++..+.-     +.  ..++||+|+++.|||++.++.....-|+|||-+..
T Consensus       184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            333333221     11  24799999999999998775333456999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=92.89  E-value=0.023  Score=64.25  Aligned_cols=74  Identities=31%  Similarity=0.491  Sum_probs=63.0

Q ss_pred             cceecCEEEEeEecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET   80 (692)
Q Consensus         6 ~~~~~~Y~i~~~LG~GsFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIVkl~~~~~~   80 (692)
                      .|..+++..+..+|+|+||+|+.+.++.++..||||.|..+. .........+|+.-+..+.|++++++...|..
T Consensus        45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn-~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN-REESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhhhccccccccccccCccccCCccccccchhhHHHHhcccc-hhhhhhhhhccccchhhhcccchhhheeceec
Confidence            467788999999999999999999999989899999997653 34456778889999999999999998877753

>PTZ00296 choline kinase; Provisional

Probab=92.61  E-value=0.79  Score=52.07  Aligned_cols=75  Identities=16%  Similarity=0.200  Sum_probs=47.6

Q ss_pred             EEeEecccCceEEEEEEEcC--------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEE
Q 005526           14 VGPRIGSGSFAVVWRARHRQ--------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII-RFFEAIETREKI   84 (692)
Q Consensus        14 i~~~LG~GsFG~Vy~a~~~~--------tg~~vAVK~i~~~~~~~~~~~~i~~Ev~iL~~L~HpNIV-kl~~~~~~~~~l   84 (692)
                      -.+.|..|=--.+|++....        .++.|.+++.....  .... .-.+|..+++.+...+|- ++++.+. +   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-g---  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-G---  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--ccee-CHHHHHHHHHHHHHCCCCCceEEEeC-C---
Confidence            45667667778899987542        25689999875431  1111 335688888887665654 5665553 2   


Q ss_pred             EEEEeccCCCC
Q 005526           85 YLVLEYCDGGD   95 (692)
Q Consensus        85 ~LVmEy~~GGs   95 (692)
                      +.|.||++|..
T Consensus       182 g~I~efi~g~~  192 (442)
T PTZ00296        182 GRIEEWLYGDP  192 (442)
T ss_pred             CEEEEeeCCcc
Confidence            34789998863

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=91.97  E-value=0.52  Score=51.95  Aligned_cols=86  Identities=17%  Similarity=0.212  Sum_probs=59.8

Q ss_pred             CCcceEEEEE-EeCCEEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccCCCCCceEecCCC
Q 005526           69 PNIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVSTNE  146 (692)
Q Consensus        69 pNIVkl~~~~-~~~~~l~LVmEy~~GGsL~~~L~~~~~lse~~i~~il~QLl~gL~yLHs~-gIVHRDLKP~NILL~~~~  146 (692)
                      ++..+.+-+- ..+.+.|++|++- |+++.-    ......+++..|+++.+..++-+..+ .+-|||+.-.||||+ +|
T Consensus       285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G  358 (488)
T COG5072         285 VFLETLKVVSLDETLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG  358 (488)
T ss_pred             hhhhcceEEecCCceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence            3444433332 3345678888875 444432    12234677888899988888877755 589999999999999 55


Q ss_pred             CcCeEEEeccccccccC
Q 005526          147 VTPVLKIGDFGFARSLT  163 (692)
Q Consensus       147 ~~~~vKL~DFGlA~~~~  163 (692)
                      +   |.|+||-++|.-.
T Consensus       359 n---vtLIDfklsRl~~  372 (488)
T COG5072         359 N---VTLIDFKLSRLSY  372 (488)
T ss_pred             c---eEEEEeeeeeccc
Confidence            3   8999999998543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	692
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-53
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-52
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-52
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-52
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-51
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-51
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-51
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-51
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-51
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-49
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-41
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-40
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-39
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-39
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-39
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-39
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-39
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-38
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-38
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-38
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-38
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-38
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-38
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-38
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-37
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-37
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-37
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-37
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-37
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-37
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-37
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-37
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-37
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-36
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-36
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-36
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-36
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-36
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-36
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-36
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-36
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-36
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-36
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-36
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-36
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-36
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-36
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-36
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-36
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-36
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-36
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-36
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-36
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-36
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-36
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-36
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-35
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-35
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-35
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-35
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-35
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-35
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-35
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-35
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-35
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-35
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-35
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-35
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-35
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-35
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-35
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-35
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-35
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-35
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-35
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-35
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-35
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-35
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-35
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-35
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-35
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-35
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-35
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-35
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-35
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-35
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-35
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-35
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-35
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-35
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-35
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-35
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-35
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-35
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-35
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-34
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-34
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-34
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-34
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-34
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-34
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-34
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-34
3soa_A	444	Full-Length Human Camkii Length = 444		1e-34
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-34
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-34
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-34
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-34
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-34
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-34
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-34
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-34
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-34
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-34
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-34
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-34
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-34
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-34
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-34
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-34
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-34
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-34
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-34
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-34
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-34
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-34
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-34
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-34
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-34
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-34
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-34
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-34
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-34
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-34
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-34
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-34
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-34
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-34
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-34
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-34
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-34
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-34
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-34
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-34
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-34
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-34
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-34
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-34
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-34
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-34
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-34
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-34
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-34
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-34
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-34
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-34
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-34
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-34
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-34
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-34
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-33
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-33
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-33
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-33
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-33
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-33
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-33
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-33
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-33
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-33
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-33
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-33
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-33
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-33
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-33
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-33
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-33
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-33
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-33
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-33
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-33
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-33
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-33
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-33
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-33
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-33
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-33
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-33
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-33
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-33
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-33
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-33
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-33
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-33
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-33
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-33
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-32
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-32
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-32
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-32
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-32
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-32
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-32
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-32
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-32
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-32
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-32
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-32
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-32
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-31
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-31
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-31
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-31
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-31
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-31
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-31
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-31
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-31
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-31
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-31
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-31
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-31
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-31
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-31
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-31
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-30
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-30
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-30
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-30
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-30
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-30
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-30
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-30
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-30
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-30
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-30
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-30
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-29
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-29
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-29
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-29
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-29
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-29
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-29
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-29
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-29
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-29
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-29
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-29
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-29
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-29
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-29
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-29
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-29
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-29
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-29
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-29
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-29
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-29
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-29
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-29
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-28
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-28
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-28
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-28
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-28
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-28
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-28
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-28
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-28
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-28
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-28
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-28
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-28
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-28
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-28
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-28
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-28
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-28
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-27
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-27
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-27
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-27
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-27
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-27
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-27
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-27
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-27
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-27
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-27
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-27
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-27
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-27
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-27
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-27
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-27
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-27
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-27
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-27
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-27
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-27
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-27
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-27
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-27
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-27
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-27
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-27
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-27
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-27
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-27
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-27
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-27
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-27
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-27
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-27
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-27
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-27
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-27
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-27
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-27
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-27
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-27
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-27
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-27
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-26
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-26
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-26
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-26
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-26
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-26
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-26
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-26
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-26
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-26
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-26
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-26
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-26
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-26
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-26
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-26
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-25
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-25
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-25
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-25
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-25
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-25
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-25
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-25
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-25
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-25
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-25
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-25
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-25
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-25
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-25
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-25
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-25
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-25
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-25
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-25
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-25
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-25
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-25
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-25
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-25
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-25
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-25
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-25
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-25
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-25
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-25
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-25
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-25
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-25
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-25
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-25
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-25
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-25
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-25
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-25
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-25
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-25
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-25
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-25
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-25
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-25
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-25
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-25
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-25
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-25
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-25
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-25
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-25
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-24
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-24
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-24
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-24
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-24
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-24
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-24
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-24
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-24
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-24
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-24
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-24
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-24
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-24
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-24
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-24
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-24
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-24
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-24
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-24
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-24
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-24
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-24
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-24
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-24
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-24
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-24
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-24
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-24
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-24
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-24
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-24
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-23
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-23
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-23
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-23
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-23
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-23
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-23
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-23
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-23
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-23
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-23
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-23
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-23
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-23
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-23
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-23
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-23
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-23
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-23
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-23
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-23
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-23
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-23
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-23
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-23
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-23
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-23
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-23
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-23
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-23
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-22
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-22
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-22
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-22
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-22
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-22
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-22
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-22
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-22
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-22
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-22
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-22
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-22
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-22
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-22
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-22
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-22
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-22
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-22
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-22
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-22
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-22
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-22
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-22
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-22
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-22
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-22
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-22
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-22
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-22
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-22
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-22
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-22
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-22
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-22
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-22
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-21
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-21
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-21
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-21
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-21
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-21
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-21
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-21
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-21
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-21
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-21
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-21
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-21
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-21
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-21
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-21
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-21
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-21
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-21
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-21
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-21
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-21
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-21
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-21
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-21
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-21
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-21
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-21
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-21
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-21
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-21
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-21
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-21
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-21
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-21
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-21
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-21
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-20
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-20
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-20
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-20
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-20
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-20
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-20
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-20
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-20
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-20
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-20
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-20
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-20
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-20
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-20
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-20
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-20
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-20
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-20
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-20
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-20
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-20
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-20
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-20
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-20
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-20
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-20
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-20
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-20
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-20
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-20
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-20
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-20
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-20
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-20
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-20
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-20
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-20
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-20
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-20
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-20
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-20
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-20
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-20
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-20
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-20
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-20
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-20
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-20
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-20
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-20
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-20
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-20
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-20
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-20
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-20
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-20
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-20
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-20
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-20
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-20
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-20
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-20
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-20
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-20
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-20
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-20
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-20
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-20
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-20
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-19
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-19
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-19
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-19
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-19
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-19
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-19
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-19
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-19
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-19
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-19
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-19
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-19
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-19
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-19
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-19
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-19
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-19
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-19
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-19
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-19
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-19
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-19
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-19
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-19
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-19
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-19
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-19
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-19
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-19
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-19
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-19
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-19
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-19
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-19
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-19
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-19
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-19
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-19
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-19
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-19
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-19
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-19
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-19
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-19
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-19
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-19
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-19
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-19
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-19
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-19
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-19
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-19
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-19
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-19
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-19
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-19
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-19
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-19
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-19
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-19
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-19
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-19
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-19
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-19
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-19
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-18
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-18
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-18
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-18
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-18
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-18
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-18
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-18
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-18
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-18
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-18
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-18
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-18
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-18
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-18
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-18
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-18
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-18
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-18
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-18
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-18
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-18
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-18
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-18
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-18
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-18
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-18
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-17
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-17
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-17
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-17
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-17
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-16
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-16
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-16
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		9e-16
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-15
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-15
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-15
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-15
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-15
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-15
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-15
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-14
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-14
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-13
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-13
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-13

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  206 bits (524), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 113/286 (39%), Positives = 163/286 (56%), Gaps = 18/286 (6%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVA+K IDK  L+P     L +E+ I+  ++H
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 70
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YL++EY  GG++  Y+  HG++ E  AR   RQ+ + +Q   +K
Sbjct: 71  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 130
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T     DT CGSP Y APE+ Q  KY
Sbjct: 131 RIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 242
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
           +  L  NP++R T ++    R++       H E      E KP VE
Sbjct: 243 KRFLVLNPIKRGTLEQIMKDRWI----NAGHEED-----ELKPFVE 279

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  202 bits (514), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 111/286 (38%), Positives = 162/286 (56%), Gaps = 18/286 (6%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVA+K IDK  L+P     L +E+ I+  ++H
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YL++EY  GG++  Y+  HG++ E  AR   RQ+ + +Q   +K
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T     D  CG+P Y APE+ Q  KY
Sbjct: 134 RIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 245
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
           +  L  NP++R T ++    R++       H E      E KP VE
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWI----NAGHEED-----ELKPFVE 282

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  202 bits (514), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 111/284 (39%), Positives = 162/284 (57%), Gaps = 14/284 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVAVK IDK  L+      L +E+ I+  ++H
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YLV+EY  GG++  Y+  HG++ E  AR   RQ+ + +Q   +K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T  +  DT CGSP Y APE+ Q  KY
Sbjct: 133 FIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 244
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
           +  L  NP +R T ++    R++      V  E   + P  +P+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWM-----NVGHEDDELKPYVEPL 283

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  201 bits (512), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 111/284 (39%), Positives = 161/284 (56%), Gaps = 14/284 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVAVK IDK  L+      L +E+ I+  ++H
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YLV+EY  GG++  Y+  HG++ E  AR   RQ+ + +Q   +K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T  +  DT CGSP Y APE+ Q  KY
Sbjct: 133 FIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 244
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
           +  L  NP +R T ++    R++      V  E   + P   P+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWM-----NVGHEDDELKPYVAPL 283

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  201 bits (511), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 113/283 (39%), Positives = 167/283 (59%), Gaps = 14/283 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVAVK IDK  L+P     L +E+ I+  ++H
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YLV+EY  GG++  Y+  HG++ E  AR   RQ+ + +Q   +K
Sbjct: 74  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 133
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
           +++HRDLK +NLL+  +     +KI DFGF+   T  +  DT CGSP Y APE+ Q  KY
Sbjct: 134 YIVHRDLKAENLLLDGD---MNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 245
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKP 290
           + LL  NP++R + ++    R++      V  E+  + P T+P
Sbjct: 246 KKLLVLNPIKRGSLEQIMKDRWM-----NVGHEEEELKPYTEP 283

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  201 bits (511), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 110/284 (38%), Positives = 162/284 (57%), Gaps = 14/284 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVAV+ IDK  L+      L +E+ I+  ++H
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YLV+EY  GG++  Y+  HG++ E  AR   RQ+ + +Q   +K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T  +  DT CGSP Y APE+ Q  KY
Sbjct: 133 FIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 244
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
           +  L  NP +R T ++    R++      V  E   + P  +P+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWM-----NVGHEDDELKPYVEPL 283

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  200 bits (508), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 111/284 (39%), Positives = 161/284 (56%), Gaps = 14/284 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVAVK IDK  L+      L +E+ I+  ++H
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YLV+EY  GG++  Y+  HG + E  AR   RQ+ + +Q   +K
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T  +  DT CGSP Y APE+ Q  KY
Sbjct: 126 FIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 237
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
           +  L  NP +R T ++    R++      V  E   + P  +P+
Sbjct: 238 KKFLILNPSKRGTLEQIMKDRWM-----NVGHEDDELKPYVEPL 276

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  199 bits (506), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 109/284 (38%), Positives = 161/284 (56%), Gaps = 14/284 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVAVK IDK  L+      L +E+ I+  ++H
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YLV+EY  GG++  Y+  HG++ E  AR   RQ+ + +Q   +K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T  +  D  CG+P Y APE+ Q  KY
Sbjct: 133 FIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 244
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
           +  L  NP +R T ++    R++      V  E   + P  +P+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWM-----NVGHEDDELKPYVEPL 283

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  199 bits (505), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 109/284 (38%), Positives = 161/284 (56%), Gaps = 14/284 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVAV+ IDK  L+      L +E+ I+  ++H
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YLV+EY  GG++  Y+  HG++ E  AR   RQ+ + +Q   +K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T  +  D  CGSP Y APE+ Q  KY
Sbjct: 133 FIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  DC +L 
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YMSTDCENLL 244
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
           +  L  NP +R T ++    R++      V  E   + P  +P+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWM-----NVGHEDDELKPYVEPL 283

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  192 bits (489), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 109/284 (38%), Positives = 156/284 (54%), Gaps = 14/284 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           IG Y +   IG G+FA V  ARH   G EVAVK IDK  L+      L +E+ I   ++H
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           PNI++ FE IET + +YLV EY  GG++  Y+  HG+  E  AR   RQ+ + +Q   +K
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQK 132
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            ++HRDLK +NLL+  +     +KI DFGF+   T  +  D  CG+P Y APE+ Q  KY
Sbjct: 133 FIVHRDLKAENLLLDADX---NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 189 DA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           D  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P         DC +L 
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF----YXSTDCENLL 244
Query: 248 RCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
           +  L  NP +R T ++    R+       V  E   + P  +P+
Sbjct: 245 KKFLILNPSKRGTLEQIXKDRW-----XNVGHEDDELKPYVEPL 283

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  167 bits (423), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/288 (36%), Positives = 159/288 (55%), Gaps = 13/288 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVS-DNLLKEISILSTISHPNIIRF 74
           IG G+F+VV R  +R+ G + AVK +D  K   SP +S ++L +E SI   + HP+I+  
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLAAGLQVLQEKHL 130
            E   +   +Y+V E+ DG DL   I K        SEAVA H+MRQ+   L+   + ++
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQNHKYD 189
           IHRD+KP+N+L+++ E +  +K+GDFG A  L    L A    G+P +MAPE+++   Y 
Sbjct: 152 IHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211
Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
              D+W  G ILF L++G  PF G+ + +LF+ I+   + +  P     +     DL R 
Sbjct: 212 KPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKG-KYKMNPRQWSHISESAKDLVRR 269
Query: 250 LLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
           +L  +P ERIT  E  NH +L E R     + H  +PET   +   N+
Sbjct: 270 MLMLDPAERITVYEALNHPWLKE-RDRYAYKIH--LPETVEQLRKFNA 314

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  163 bits (412), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 144/265 (54%), Gaps = 11/265 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTIS 67
           I ++ VG  +G GSFA V+RA     G+EVA+K IDKK +    +   +  E+ I   + 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQ 126
           HP+I+  +   E    +YLVLE C  G++  Y+    K  SE  ARHFM Q+  G+  L 
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQN 185
              ++HRDL   NLL++ N     +KI DFG A  L  P +   TLCG+P Y++PEI   
Sbjct: 130 SHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
             +  ++D+WS+G + + L+ G+PPFD ++ ++   N +   +   P      L  +  D
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLNKVVLADYEMPSF----LSIEAKD 241
Query: 246 LCRCLLRQNPVERITFKEFFNHRFL 270
           L   LLR+NP +R++     +H F+
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  160 bits (404), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/288 (35%), Positives = 155/288 (53%), Gaps = 13/288 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVS-DNLLKEISILSTISHPNIIRF 74
           IG G F+VV R  +R+ G + AVK +D  K   SP +S ++L +E SI   + HP+I+  
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLAAGLQVLQEKHL 130
            E   +   +Y+V E+ DG DL   I K        SEAVA H+MRQ+   L+   + ++
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 153
Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQNHKYD 189
           IHRD+KP  +L+++ E +  +K+G FG A  L    L A    G+P +MAPE+++   Y 
Sbjct: 154 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 213
Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
              D+W  G ILF L++G  PF G+ + +LF+ I+   + +  P     +     DL R 
Sbjct: 214 KPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKG-KYKMNPRQWSHISESAKDLVRR 271
Query: 250 LLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
           +L  +P ERIT  E  NH +L E R     + H  +PET   +   N+
Sbjct: 272 MLMLDPAERITVYEALNHPWLKE-RDRYAYKIH--LPETVEQLRKFNA 316

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  160 bits (404), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 147/266 (55%), Gaps = 10/266 (3%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTIS 67
           IG YI+G  +G G+F  V   +H   G +VAVK +++ K+ S  V   + +EI  L    
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP+II+ ++ I T   I++V+EY  GG+L  YI K+G++ E  +R   +Q+ +G+     
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             ++HRDLKP+N+L+  +      KI DFG +  ++  +     CGSP Y APE+I    
Sbjct: 135 HMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRL 191
Query: 188 YDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           Y   + D+WS G IL+ L+ G  PFD  +   LF+ I     + + P   + L+P  + L
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTP---QYLNPSVISL 246
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGE 272
            + +L+ +P++R T K+   H +  +
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  160 bits (404), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 142/266 (53%), Gaps = 10/266 (3%)
Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEIS 61
           P R   I ++ +G  +G G F  V+ AR +Q    +A+K + K  L  + V   L +EI 
Sbjct: 8   PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 67
Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
           I S + HPNI+R +     R++IYL+LE+   G+L   + KHG+  E  +  FM +LA  
Sbjct: 68  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 127
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           L    E+ +IHRD+KP+NLL+        LKI DFG++    P      +CG+  Y+ PE
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKG---ELKIADFGWSVH-APSLRRRXMCGTLDYLPPE 183
Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP 241
           +I+   +D K DLW  G + ++ + G PPFD  +  +  + I+ + +L+FPP     L  
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-NVDLKFPPF----LSD 238
Query: 242 DCVDLCRCLLRQNPVERITFKEFFNH 267
              DL   LLR +P +R+  K    H
Sbjct: 239 GSKDLISKLLRYHPPQRLPLKGVMEH 264

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  159 bits (403), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/288 (35%), Positives = 155/288 (53%), Gaps = 13/288 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVS-DNLLKEISILSTISHPNIIRF 74
           IG G F+VV R  +R+ G + AVK +D  K   SP +S ++L +E SI   + HP+I+  
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLAAGLQVLQEKHL 130
            E   +   +Y+V E+ DG DL   I K        SEAVA H+MRQ+   L+   + ++
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQNHKYD 189
           IHRD+KP  +L+++ E +  +K+G FG A  L    L A    G+P +MAPE+++   Y 
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211
Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
              D+W  G ILF L++G  PF G+ + +LF+ I+   + +  P     +     DL R 
Sbjct: 212 KPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKG-KYKMNPRQWSHISESAKDLVRR 269
Query: 250 LLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
           +L  +P ERIT  E  NH +L E R     + H  +PET   +   N+
Sbjct: 270 MLMLDPAERITVYEALNHPWLKE-RDRYAYKIH--LPETVEQLRKFNA 314

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  156 bits (394), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 91/266 (34%), Positives = 141/266 (53%), Gaps = 10/266 (3%)
Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEIS 61
           P R   I ++ +   +G G F  V+ AR +Q    +A+K + K  L  + V   L +EI 
Sbjct: 7   PKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
           I S + HPNI+R +     R++IYL+LE+   G+L   + KHG+  E  +  FM +LA  
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           L    E+ +IHRD+KP+NLL+        LKI DFG++    P      +CG+  Y+ PE
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKG---ELKIADFGWSVH-APSLRRRXMCGTLDYLPPE 182
Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP 241
           +I+   +D K DLW  G + ++ + G PPFD  +  +  + I+ + +L+FPP     L  
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-NVDLKFPPF----LSD 237
Query: 242 DCVDLCRCLLRQNPVERITFKEFFNH 267
              DL   LLR +P +R+  K    H
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEH 263

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  156 bits (394), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 149/272 (54%), Gaps = 16/272 (5%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSD---NLLKEISILS 64
           EYI+   +GSG+   V  A  R+   +VA+K I K+   + S + +D   N+  EI IL 
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 65  TISHPNIIR---FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
            ++HP II+   FF+A    E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+   
Sbjct: 70  KLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 125
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           +Q L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+APE
Sbjct: 126 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 185
Query: 182 I---IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +   +    Y+   D WS+G ILF  ++G PPF         ++ +TS +  F P    E
Sbjct: 186 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 245
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +    +DL + LL  +P  R T +E   H +L
Sbjct: 246 VSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  156 bits (394), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 149/272 (54%), Gaps = 16/272 (5%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSD---NLLKEISILS 64
           EYI+   +GSG+   V  A  R+   +VA+K I K+   + S + +D   N+  EI IL 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  TISHPNIIR---FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
            ++HP II+   FF+A    E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+   
Sbjct: 71  KLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           +Q L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 182 I---IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +   +    Y+   D WS+G ILF  ++G PPF         ++ +TS +  F P    E
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +    +DL + LL  +P  R T +E   H +L
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  156 bits (394), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 149/272 (54%), Gaps = 16/272 (5%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSD---NLLKEISILS 64
           EYI+   +GSG+   V  A  R+   +VA+K I K+   + S + +D   N+  EI IL 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  TISHPNIIR---FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
            ++HP II+   FF+A    E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+   
Sbjct: 71  KLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           +Q L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 182 I---IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +   +    Y+   D WS+G ILF  ++G PPF         ++ +TS +  F P    E
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +    +DL + LL  +P  R T +E   H +L
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  156 bits (394), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 149/272 (54%), Gaps = 16/272 (5%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSD---NLLKEISILS 64
           EYI+   +GSG+   V  A  R+   +VA+K I K+   + S + +D   N+  EI IL 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  TISHPNIIR---FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
            ++HP II+   FF+A    E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+   
Sbjct: 71  KLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           +Q L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 182 I---IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +   +    Y+   D WS+G ILF  ++G PPF         ++ +TS +  F P    E
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +    +DL + LL  +P  R T +E   H +L
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  155 bits (393), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 149/272 (54%), Gaps = 16/272 (5%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSD---NLLKEISILS 64
           EYI+   +GSG+   V  A  R+   +VA+K I K+   + S + +D   N+  EI IL 
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 65  TISHPNIIR---FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
            ++HP II+   FF+A    E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+   
Sbjct: 77  KLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 132
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           +Q L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+APE
Sbjct: 133 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 192
Query: 182 I---IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +   +    Y+   D WS+G ILF  ++G PPF         ++ +TS +  F P    E
Sbjct: 193 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 252
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +    +DL + LL  +P  R T +E   H +L
Sbjct: 253 VSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  155 bits (392), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 141/266 (53%), Gaps = 10/266 (3%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTIS 67
           IG Y++G  +G G+F  V    H+  G +VAVK +++ K+ S  V   + +EI  L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP+II+ ++ I T    ++V+EY  GG+L  YI KHG+V E  AR   +Q+ + +     
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             ++HRDLKP+N+L+  +      KI DFG +  ++  +   T CGSP Y APE+I    
Sbjct: 130 HMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 186
Query: 188 YDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           Y   + D+WS G IL+ L+ G  PFD  +   LF+ I        P    E L+     L
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIP----EYLNRSVATL 241
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGE 272
              +L+ +P++R T K+   H +  +
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 96/275 (34%), Positives = 149/275 (54%), Gaps = 16/275 (5%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL---SPKVSD---NLLKEIS 61
           L  EYI+   +GSG+   V  A  R+   +VA++ I K+     S + +D   N+  EI 
Sbjct: 147 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 206
Query: 62  ILSTISHPNIIR---FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
           IL  ++HP II+   FF+A    E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+
Sbjct: 207 ILKKLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYM 178
              +Q L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+
Sbjct: 263 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 322
Query: 179 APEI---IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           APE+   +    Y+   D WS+G ILF  ++G PPF         ++ +TS +  F P  
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 382
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             E+    +DL + LL  +P  R T +E   H +L
Sbjct: 383 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 96/275 (34%), Positives = 149/275 (54%), Gaps = 16/275 (5%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL---SPKVSD---NLLKEIS 61
           L  EYI+   +GSG+   V  A  R+   +VA++ I K+     S + +D   N+  EI 
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 62  ILSTISHPNIIR---FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
           IL  ++HP II+   FF+A    E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+
Sbjct: 193 ILKKLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYM 178
              +Q L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 179 APEI---IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           APE+   +    Y+   D WS+G ILF  ++G PPF         ++ +TS +  F P  
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             E+    +DL + LL  +P  R T +E   H +L
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  153 bits (386), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 140/266 (52%), Gaps = 10/266 (3%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTIS 67
           IG Y++G  +G G+F  V    H+  G +VAVK +++ K+ S  V   + +EI  L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP+II+ ++ I T    ++V+EY  GG+L  YI KHG+V E  AR   +Q+ + +     
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             ++HRDLKP+N+L+  +      KI DFG +  ++  +     CGSP Y APE+I    
Sbjct: 130 HMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRL 186
Query: 188 YDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           Y   + D+WS G IL+ L+ G  PFD  +   LF+ I        P    E L+     L
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIP----EYLNRSVATL 241
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGE 272
              +L+ +P++R T K+   H +  +
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  152 bits (384), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 84/256 (32%), Positives = 135/256 (52%), Gaps = 2/256 (0%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +G GSF  V + + R    E AVK I+K     K +  +L+E+ +L  + HPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++ FE +E     Y+V E   GG+L   I K  + SE  A   ++Q+ +G+  + + +++
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N+L+ + E    +KI DFG +             G+  Y+APE+++   YD K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D+WS G IL+ L++G PPF G N+  + + + T  +  F       +  D  DL R +L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISDDAKDLIRKML 261
Query: 252 RQNPVERITFKEFFNH 267
             +P  RIT  +   H
Sbjct: 262 TFHPSLRITATQCLEH 277

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  152 bits (384), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 149/284 (52%), Gaps = 9/284 (3%)
Query: 6   TRLIGEYIVGPRI-GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV-SDNLLKEISIL 63
           T +  +   G R+ G GSF  V   + +  G E AVK I K+ +  K   ++LL+E+ +L
Sbjct: 45  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 104
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
             + HPNI++ +E  E +   YLV E   GG+L   I    + SE  A   +RQ+ +G+ 
Sbjct: 105 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT 164
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
            + +  ++HRDLKP+NLL+ +      ++I DFG +             G+  Y+APE++
Sbjct: 165 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 224
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
               YD K D+WS G IL+ L++G PPF+G+N+  + + +    +  F     +++    
Sbjct: 225 HG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESA 282
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSV-VP 286
            DL R +L   P  RI+ ++  +H ++    QT   EQ SV VP
Sbjct: 283 KDLIRKMLTYVPSMRISARDALDHEWI----QTYTKEQISVDVP 322

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  152 bits (384), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 149/284 (52%), Gaps = 9/284 (3%)
Query: 6   TRLIGEYIVGPRI-GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV-SDNLLKEISIL 63
           T +  +   G R+ G GSF  V   + +  G E AVK I K+ +  K   ++LL+E+ +L
Sbjct: 44  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 103
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
             + HPNI++ +E  E +   YLV E   GG+L   I    + SE  A   +RQ+ +G+ 
Sbjct: 104 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT 163
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
            + +  ++HRDLKP+NLL+ +      ++I DFG +             G+  Y+APE++
Sbjct: 164 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 223
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
               YD K D+WS G IL+ L++G PPF+G+N+  + + +    +  F     +++    
Sbjct: 224 HG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESA 281
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSV-VP 286
            DL R +L   P  RI+ ++  +H ++    QT   EQ SV VP
Sbjct: 282 KDLIRKMLTYVPSMRISARDALDHEWI----QTYTKEQISVDVP 321

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  152 bits (384), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 149/284 (52%), Gaps = 9/284 (3%)
Query: 6   TRLIGEYIVGPRI-GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV-SDNLLKEISIL 63
           T +  +   G R+ G GSF  V   + +  G E AVK I K+ +  K   ++LL+E+ +L
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
             + HPNI++ +E  E +   YLV E   GG+L   I    + SE  A   +RQ+ +G+ 
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
            + +  ++HRDLKP+NLL+ +      ++I DFG +             G+  Y+APE++
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
               YD K D+WS G IL+ L++G PPF+G+N+  + + +    +  F     +++    
Sbjct: 201 HG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESA 258
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSV-VP 286
            DL R +L   P  RI+ ++  +H ++    QT   EQ SV VP
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWI----QTYTKEQISVDVP 298

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  152 bits (383), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 142/258 (55%), Gaps = 2/258 (0%)
Query: 16  PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
            ++GSG++  V   R +   +E A+K I K  +S   +  LL+E+++L  + HPNI++ +
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           +  E +   YLV+E   GG+L   I    K +E  A   ++Q+ +G+  L + +++HRDL
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDL 162
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
           KP+NLL+ + E   ++KI DFG +     Q       G+  Y+APE+++  KYD K D+W
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVW 221
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G ILF L+ G PPF G    ++ + +    +  F     + +     DL + +L+ + 
Sbjct: 222 SIGVILFILLAGYPPFGGQTDQEILRKV-EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS 280
Query: 256 VERITFKEFFNHRFLGEL 273
             RI+ ++   H ++ E+
Sbjct: 281 QRRISAQQALEHPWIKEM 298

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  151 bits (382), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 11/259 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEISILSTIS 67
           IG Y +   +G GSF  V  A H   G +VA+K I+KK+L+   +   + +EIS L  + 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP+II+ ++ I+++++I +V+EY  G +L  YI +  K+SE  AR F +Q+ + ++    
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             ++HRDLKP+NLL+  +     +KI DFG +  +T  +   T CGSP Y APE+I    
Sbjct: 132 HKIVHRDLKPENLLLDEH---LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 188
Query: 188 YDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           Y   + D+WS G IL+ ++  + PFD  +   LF+NI ++     P    + L P    L
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-SNGVYTLP----KFLSPGAAGL 243
Query: 247 CRCLLRQNPVERITFKEFF 265
            + +L  NP+ RI+  E  
Sbjct: 244 IKRMLIVNPLNRISIHEIM 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  151 bits (382), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 11/259 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEISILSTIS 67
           IG Y +   +G GSF  V  A H   G +VA+K I+KK+L+   +   + +EIS L  + 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP+II+ ++ I+++++I +V+EY  G +L  YI +  K+SE  AR F +Q+ + ++    
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             ++HRDLKP+NLL+  +     +KI DFG +  +T  +   T CGSP Y APE+I    
Sbjct: 131 HKIVHRDLKPENLLLDEH---LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 187
Query: 188 YDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           Y   + D+WS G IL+ ++  + PFD  +   LF+NI ++     P    + L P    L
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-SNGVYTLP----KFLSPGAAGL 242
Query: 247 CRCLLRQNPVERITFKEFF 265
            + +L  NP+ RI+  E  
Sbjct: 243 IKRMLIVNPLNRISIHEIM 261

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/259 (32%), Positives = 137/259 (52%), Gaps = 2/259 (0%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +G GSF  V + + R    E AVK I+K     K +  +L+E+ +L  + HPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++ FE +E     Y+V E   GG+L   I K  + SE  A   ++Q+ +G+  + + +++
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N+L+ + E    +KI DFG +             G+  Y+APE+++   YD K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D+WS G IL+ L++G PPF G N+  + + + T  +  F       +  D  DL R +L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISDDAKDLIRKML 261
Query: 252 RQNPVERITFKEFFNHRFL 270
             +P  RIT  +   H ++
Sbjct: 262 TFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 84/259 (32%), Positives = 137/259 (52%), Gaps = 2/259 (0%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +G GSF  V + + R    E AVK I+K     K +  +L+E+ +L  + HPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++ FE +E     Y+V E   GG+L   I K  + SE  A   ++Q+ +G+  + + +++
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N+L+ + E    +KI DFG +             G+  Y+APE+++   YD K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D+WS G IL+ L++G PPF G N+  + + + T  +  F       +  D  DL R +L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISDDAKDLIRKML 261
Query: 252 RQNPVERITFKEFFNHRFL 270
             +P  RIT  +   H ++
Sbjct: 262 TFHPSLRITATQCLEHPWI 280

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 11/259 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEISILSTIS 67
           IG Y +   +G GSF  V  A H   G +VA+K I+KK+L+   +   + +EIS L  + 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP+II+ ++ I+++++I +V+EY  G +L  YI +  K+SE  AR F +Q+ + ++    
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             ++HRDLKP+NLL+  +     +KI DFG +  +T  +   T CGSP Y APE+I    
Sbjct: 126 HKIVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 182
Query: 188 YDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           Y   + D+WS G IL+ ++  + PFD  +   LF+NI ++     P    + L P    L
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-SNGVYTLP----KFLSPGAAGL 237
Query: 247 CRCLLRQNPVERITFKEFF 265
            + +L  NP+ RI+  E  
Sbjct: 238 IKRMLIVNPLNRISIHEIM 256

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 139/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P    DTLCG+  Y+ PE+
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEM 178
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 233
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 234 ARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 11/259 (4%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEISILSTIS 67
           IG Y +   +G GSF  V  A H   G +VA+K I+KK+L+   +   + +EIS L  + 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP+II+ ++ I+++++I +V+EY  G +L  YI +  K+SE  AR F +Q+ + ++    
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             ++HRDLKP+NLL+  +     +KI DFG +  +T  +   T CGSP Y APE+I    
Sbjct: 122 HKIVHRDLKPENLLLDEH---LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 188 YDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           Y   + D+WS G IL+ ++  + PFD  +   LF+NI ++     P    + L P    L
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-SNGVYTLP----KFLSPGAAGL 233
Query: 247 CRCLLRQNPVERITFKEFF 265
            + +L  NP+ RI+  E  
Sbjct: 234 IKRMLIVNPLNRISIHEIM 252

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 139/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G++   + K  K  E     ++ +LA  L
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 182
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 237
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 238 ARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  150 bits (378), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 15/262 (5%)
Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD---NLLKEISIL 63
           R IG YI+   +G GSF  V  A H +   +VA+K I ++LL  K SD    + +EIS L
Sbjct: 6   RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYL 63
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
             + HP+II+ ++ I T   I +V+EY  GG+L  YI +  +++E   R F +Q+   ++
Sbjct: 64  KLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
                 ++HRDLKP+NLL+  N     +KI DFG +  +T  +   T CGSP Y APE+I
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDN---LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 184 QNHKYDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
               Y   + D+WS G +L+ ++ G+ PFD      LF+ +  S     P    + L P 
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCVYVMP----DFLSPG 234
Query: 243 CVDLCRCLLRQNPVERITFKEF 264
              L R ++  +P++RIT +E 
Sbjct: 235 AQSLIRRMIVADPMQRITIQEI 256

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  149 bits (377), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR RQ    +A+K + K +L    V   L +E+ I
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  +  E     ++ +LA  L
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +N     LKI DFG++    P    DTLCG+  Y+ PE+
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSN---GELKIADFGWSVH-APSSRRDTLCGTLDYLPPEM 181
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + G PPF+     + ++ I +  E  FP    E     
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI-SRVEFTFPDFVTE----G 236
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ N  +R+T  E   H ++
Sbjct: 237 ARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  149 bits (377), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 1/255 (0%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           T+    Y V   +G G+F+VV R  H+  G+E A K I+ K LS +    L +E  I   
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + HPNI+R  ++I+     YLV +   GG+L   I      SEA A H ++Q+   +   
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
               ++HR+LKP+NLL+++      +K+ DFG A  +   +      G+P Y++PE+++ 
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
             Y    D+W+ G IL+ L+ G PPF   +Q +L+  I  +    +P    + + P+   
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKS 263
Query: 246 LCRCLLRQNPVERIT 260
           L   +L  NP +RIT
Sbjct: 264 LIDSMLTVNPKKRIT 278

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  149 bits (376), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P    D LCG+  Y+ PE+
Sbjct: 148 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEM 203
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 258
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 259 ARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  149 bits (375), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+
Sbjct: 148 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 203
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 258
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 259 ARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  149 bits (375), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 146/284 (51%), Gaps = 9/284 (3%)
Query: 6   TRLIGEYIVGPRI-GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISIL 63
           T +  +   G R+ G GSF  V   + +  G E AVK I K+ +  K   ++LL+E+ +L
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
             + HPNI + +E  E +   YLV E   GG+L   I    + SE  A   +RQ+ +G+ 
Sbjct: 81  KQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
              +  ++HRDLKP+NLL+ +      ++I DFG +             G+  Y+APE++
Sbjct: 141 YXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL 200
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
               YD K D+WS G IL+ L++G PPF+G+N+  + + +    +  F     +++    
Sbjct: 201 HG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESA 258
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSV-VP 286
            DL R  L   P  RI+ ++  +H ++    QT   EQ SV VP
Sbjct: 259 KDLIRKXLTYVPSXRISARDALDHEWI----QTYTKEQISVDVP 298

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  149 bits (375), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 137/255 (53%), Gaps = 3/255 (1%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFF 75
           ++GSG++  V   + +  G E A+K I K  + +   S  LL E+++L  + HPNI++ +
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           E  E +   YLV+E   GG+L   I    K SE  A   M+Q+ +G   L + +++HRDL
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDL 147
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
           KP+NLL+ +     ++KI DFG +             G+  Y+APE+++  KYD K D+W
Sbjct: 148 KPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK-KYDEKCDVW 206
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S G IL+ L+ G PPF G    ++ + +    +  F P    ++  +   L + +L   P
Sbjct: 207 SCGVILYILLCGYPPFGGQTDQEILKRV-EKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 265
Query: 256 VERITFKEFFNHRFL 270
            +RI+ +E  NH ++
Sbjct: 266 SKRISAEEALNHPWI 280

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  149 bits (375), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 19  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 78
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 79  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 138
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+
Sbjct: 139 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 194
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 249
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 250 ARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  149 bits (375), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 8/269 (2%)
Query: 15  GPRI-GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV-SDNLLKEISILSTISHPNII 72
           G R+ G GSF  V   + +  G E AVK I K+ +  K   ++LL+E+ +L  + HPNI+
Sbjct: 36  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 95
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           + +E  E +   YLV E   GG+L   I    + SE  A   +RQ+ +G+  + +  ++H
Sbjct: 96  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVH 155
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKA 192
           RDLKP+NLL+ +      ++I DFG +             G+  Y+APE++    YD K 
Sbjct: 156 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKC 214
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           D+WS G IL+ L++G PPF+G+N+  + + +    +  F     +++     DL R +L 
Sbjct: 215 DVWSTGVILYILLSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAKDLIRKMLT 273
Query: 253 QNPVERITFKEFFNHRFLGELRQTVHAEQ 281
             P  RI+ ++  +H ++    QT   EQ
Sbjct: 274 YVPSMRISARDALDHEWI----QTYTKEQ 298

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  149 bits (375), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 1/255 (0%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           T+    Y V   +G G+F+VV R  H+  G+E A K I+ K LS +    L +E  I   
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + HPNI+R  ++I+     YLV +   GG+L   I      SEA A H ++Q+   +   
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
               ++HR+LKP+NLL+++      +K+ DFG A  +   +      G+P Y++PE+++ 
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
             Y    D+W+ G IL+ L+ G PPF   +Q +L+  I  +    +P    + + P+   
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKS 240
Query: 246 LCRCLLRQNPVERIT 260
           L   +L  NP +RIT
Sbjct: 241 LIDSMLTVNPKKRIT 255

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  149 bits (375), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 135/253 (53%), Gaps = 3/253 (1%)
Query: 16  PRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRF 74
            ++GSG++  V   + +  G E A+K I K  + +   S  LL E+++L  + HPNI++ 
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           +E  E +   YLV+E   GG+L   I    K SE  A   M+Q+ +G   L + +++HRD
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           LKP+NLL+ +     ++KI DFG +             G+  Y+APE+++  KYD K D+
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK-KYDEKCDV 188
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS G IL+ L+ G PPF G    ++ + +    +  F P    ++  +   L + +L   
Sbjct: 189 WSCGVILYILLCGYPPFGGQTDQEILKRV-EKGKFSFDPPDWTQVSDEAKQLVKLMLTYE 247
Query: 255 PVERITFKEFFNH 267
           P +RI+ +E  NH
Sbjct: 248 PSKRISAEEALNH 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  148 bits (374), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 182
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 237
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 238 ARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  148 bits (374), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 97/283 (34%), Positives = 150/283 (53%), Gaps = 15/283 (5%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQ----LGIEVAVKEIDKKLLSPKVSDNLLKE 59
           NR  L   + V   +G G+ ++V+R + +       ++V  K +DKK++          E
Sbjct: 47  NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--------TE 98
Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
           I +L  +SHPNII+  E  ET  +I LVLE   GG+L   I + G  SE  A   ++Q+ 
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             +  L E  ++HRDLKP+NLL +T      LKI DFG ++ +  Q L  T+CG+P Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEE 238
           PEI++   Y  + D+WSVG I + L+ G  PF D      +F+ IL + E  F     +E
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL-NCEYYFISPWWDE 277
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL-GELRQTVHAE 280
           +  +  DL R L+  +P +R+T  +   H ++ G+    VH +
Sbjct: 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD 320

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  148 bits (374), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 139/271 (51%), Gaps = 10/271 (3%)
Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKE 59
           M   R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E
Sbjct: 3   MGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 62
Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
           + I S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 122
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             L     K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ 
Sbjct: 123 NALSYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLP 178
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PE+I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E  
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE-- 235
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                DL   LL+ NP +R   +E   H ++
Sbjct: 236 --GARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  148 bits (374), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 1/255 (0%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           T+    Y V   +G G+F+VV R  H+  G+E A K I+ K LS +    L +E  I   
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + HPNI+R  ++I+     YLV +   GG+L   I      SEA A H ++Q+   +   
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
               ++HR+LKP+NLL+++      +K+ DFG A  +   +      G+P Y++PE+++ 
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
             Y    D+W+ G IL+ L+ G PPF   +Q +L+  I  +    +P    + + P+   
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKS 240
Query: 246 LCRCLLRQNPVERIT 260
           L   +L  NP +RIT
Sbjct: 241 LIDSMLTVNPKKRIT 255

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  148 bits (374), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 180
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 235
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  148 bits (374), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 1/255 (0%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           T+    Y V   +G G+F+VV R  H+  G+E A K I+ K LS +    L +E  I   
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + HPNI+R  ++I+     YLV +   GG+L   I      SEA A H ++Q+   +   
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
               ++HR+LKP+NLL+++      +K+ DFG A  +   +      G+P Y++PE+++ 
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 180
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
             Y    D+W+ G IL+ L+ G PPF   +Q +L+  I  +    +P    + + P+   
Sbjct: 181 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKS 239
Query: 246 LCRCLLRQNPVERIT 260
           L   +L  NP +RIT
Sbjct: 240 LIDSMLTVNPKKRIT 254

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 139/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
           +R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 5   SRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P    D LCG+  Y+ PE+
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEM 180
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 235
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 140/276 (50%), Gaps = 3/276 (1%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           +  EY +   +G G+F+VV R      G E A K I+ K LS +    L +E  I   + 
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNI+R  ++I      YLV +   GG+L   I      SEA A H ++Q+   +     
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNH 186
             ++HRDLKP+NLL+++      +K+ DFG A  +   Q       G+P Y++PE+++  
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
            Y    D+W+ G IL+ L+ G PPF   +Q +L+Q I  +    FP    + + P+  DL
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKDL 240
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQH 282
              +L  NP +RIT  E   H ++ + R TV +  H
Sbjct: 241 INKMLTINPAKRITASEALKHPWICQ-RSTVASMMH 275

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GGD+ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GGD+ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISIL 63
           R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
               K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+I
Sbjct: 123 YCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMI 178
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           +   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E      
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----GA 233
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFL 270
            DL   LL+ NP +R   +E   H ++
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  147 bits (372), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 6/269 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y +G  +GSG FA+V + R +  G E A K I K+ LS        + + +E++IL  I 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNII   +  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           K + H DLKP+N +L+  N   P +K+ DFG A  +   +    + G+P ++APEI+   
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   NI ++    F             D 
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI-SAVNYDFDEEYFSNTSELAKDF 245
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQ 275
            R LL ++P  R+T  +   H ++  +R+
Sbjct: 246 IRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  147 bits (372), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 180
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 235
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  147 bits (372), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+
Sbjct: 121 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 176
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 231
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 232 ARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE 
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEX 182
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 237
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 238 ARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 138/271 (50%), Gaps = 10/271 (3%)
Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKE 59
           M   R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E
Sbjct: 4   MSKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
           + I S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             L     K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTDLCGTLDYLP 179
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PE+I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE-- 236
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                DL   LL+ NP +R   +E   H ++
Sbjct: 237 --GARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 136/261 (52%), Gaps = 10/261 (3%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHP 69
           ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I S + HP
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           NI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L     K 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYD 189
           +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+I+   +D
Sbjct: 126 VIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
            K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E       DL   
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----GARDLISR 236
Query: 250 LLRQNPVERITFKEFFNHRFL 270
           LL+ NP +R   +E   H ++
Sbjct: 237 LLKHNPSQRPMLREVLEHPWI 257

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 138/264 (52%), Gaps = 5/264 (1%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+F+ V  A  +  G   AVK I KK L  K S ++  EI++L  I H NI+   + 
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES-SIENEIAVLRKIKHENIVALEDI 88
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
            E+   +YLV++   GG+L   I + G  +E  A   +RQ+   +  L    ++HRDLKP
Sbjct: 89  YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKP 148
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSV 197
           +NLL  + +    + I DFG ++     D+  T CG+P Y+APE++    Y    D WS+
Sbjct: 149 ENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 208
Query: 198 GAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVE 257
           G I + L+ G PPF   N  +LF+ IL + E  F     +++     D  R L+ ++P +
Sbjct: 209 GVIAYILLCGYPPFYDENDSKLFEQILKA-EYEFDSPYWDDISDSAKDFIRNLMEKDPNK 267
Query: 258 RITFKEFFNHRFLG---ELRQTVH 278
           R T ++   H ++     L + +H
Sbjct: 268 RYTCEQAARHPWIAGDTALNKNIH 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 140/276 (50%), Gaps = 3/276 (1%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           +  EY +   +G G+F+VV R      G E A K I+ K LS +    L +E  I   + 
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNI+R  ++I      YLV +   GG+L   I      SEA A H ++Q+   +     
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNH 186
             ++HRDLKP+NLL+++      +K+ DFG A  +   Q       G+P Y++PE+++  
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
            Y    D+W+ G IL+ L+ G PPF   +Q +L+Q I  +    FP    + + P+  DL
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKDL 240
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQH 282
              +L  NP +RIT  E   H ++ + R TV +  H
Sbjct: 241 INKMLTINPAKRITASEALKHPWICQ-RSTVASMMH 275

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR RQ    +A+K + K +L    V   L +E+ I
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  +  E     ++ +LA  L
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +N     LKI DFG++    P     TLCG+  Y+ PE+
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSN---GELKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 181
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + G PPF+     + ++ I +  E  FP    E     
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI-SRVEFTFPDFVTE----G 236
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ N  +R+T  E   H ++
Sbjct: 237 ARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  146 bits (369), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI +FG++    P     TLCG+  Y+ PE+
Sbjct: 124 SYCHSKRVIHRDIKPENLLLGS---AGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEM 179
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 234
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 235 ARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  146 bits (369), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/243 (32%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  146 bits (368), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
           +R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 5   SRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRAALCGTLDYLPPEM 180
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 235
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  145 bits (367), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 4   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 124 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEM 179
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 234
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 235 ARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  145 bits (367), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI +FG++    P     TLCG+  Y+ PE+
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGS---AGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEM 180
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 235
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  145 bits (367), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLMIDQQ---GYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  145 bits (367), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 78/243 (32%), Positives = 139/243 (57%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +    TLCG+P Y+APEII +  Y+   D W+
Sbjct: 190 PENLLIDQQ---GYIQVTDFGFAKRV--KGATWTLCGTPEYLAPEIILSKGYNKAVDWWA 244
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 245 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 299
Query: 257 ERI 259
           +R 
Sbjct: 300 KRF 302

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  145 bits (367), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 78/243 (32%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +    TLCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--TLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  145 bits (367), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 137/267 (51%), Gaps = 10/267 (3%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISIL 63
           R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
               K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+I
Sbjct: 123 YCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTELCGTLDYLPPEMI 178
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           +   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E      
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----GA 233
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFL 270
            DL   LL+ NP +R   +E   H ++
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  145 bits (367), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEM 177
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 232
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  145 bits (367), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEM 178
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 233
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 234 ARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  145 bits (367), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 78/243 (32%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++Q+  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYQMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRAALCGTLDYLPPEM 177
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 232
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTXLCGTLDYLPPEM 177
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 232
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 125 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEM 180
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 235
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  145 bits (366), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 136/255 (53%), Gaps = 6/255 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IGSG+F V    R +Q    VAVK I++     K+ +N+ +EI    ++ HPNI+RF E 
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIER---GEKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
           I T   + +V+EY  GG+L   I   G+ SE  AR F +QL +G+       + HRDLK 
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 142
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-ADLWS 196
           +N L+  +   P LKI DFG+++S        +  G+P Y+APE++   +YD K AD+WS
Sbjct: 143 ENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWS 201
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            G  L+ ++ G  PF+   + + F+  +     +++       + P+C  L   +   +P
Sbjct: 202 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADP 261
Query: 256 VERITFKEFFNHRFL 270
            +RI+  E  NH + 
Sbjct: 262 AKRISIPEIRNHEWF 276

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  145 bits (366), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEM 177
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 232
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  145 bits (366), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  145 bits (365), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 141/243 (58%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-KVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   R R  G   A+K + K+++   K  ++   E  +LS ++HP IIR + 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             +  ++I+++++Y +GG+L + + K  +    VA+ +  ++   L+ L  K +I+RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+N+L+  N     +KI DFGFA+ +   D+   LCG+P Y+APE++    Y+   D WS
Sbjct: 134 PENILLDKNG---HIKITDFGFAKYVP--DVTYXLCGTPDYIAPEVVSTKPYNKSIDWWS 188
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
            G ++++++ G  PF  SN ++ ++ IL + ELRFPP   E    D  DL   L+ ++  
Sbjct: 189 FGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPFFNE----DVKDLLSRLITRDLS 243
Query: 257 ERI 259
           +R+
Sbjct: 244 QRL 246

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEM 177
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 232
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 78/243 (32%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 154
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +    TLCG+P Y+APEII +  Y+   D W+
Sbjct: 155 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--TLCGTPEYLAPEIILSKGYNKAVDWWA 209
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 210 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 264
Query: 257 ERI 259
           +R 
Sbjct: 265 KRF 267

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 78/243 (32%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  I   ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+VLEY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLLIDQQ---GYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 143/278 (51%), Gaps = 3/278 (1%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           TR   +Y +   +G G+F+VV R   +    E A K I+ K LS +    L +E  I   
Sbjct: 27  TRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRL 86
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + HPNI+R  ++I      YLV +   GG+L   I      SEA A H + Q+   +  +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHI 146
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPLYMAPEIIQ 184
            +  ++HRDLKP+NLL+++      +K+ DFG A  +  +  A     G+P Y++PE+++
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLR 206
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              Y    D+W+ G IL+ L+ G PPF   +Q +L+Q I  +    FP    + + P+  
Sbjct: 207 KDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI-KAGAYDFPSPEWDTVTPEAK 265
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQH 282
           +L   +L  NP +RIT  +   H ++ + R TV +  H
Sbjct: 266 NLINQMLTINPAKRITADQALKHPWVCQ-RSTVASMMH 302

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  145 bits (365), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  145 bits (365), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 162 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 216
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 217 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 271
Query: 257 ERI 259
           +R 
Sbjct: 272 KRF 274

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  145 bits (365), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  145 bits (365), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 190 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 244
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 245 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 299
Query: 257 ERI 259
           +R 
Sbjct: 300 KRF 302

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 136/255 (53%), Gaps = 6/255 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IGSG+F V    R +Q    VAVK I++     K++ N+ +EI    ++ HPNI+RF E 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIER---GEKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
           I T   + +V+EY  GG+L   I   G+ SE  AR F +QL +G+       + HRDLK 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 143
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-ADLWS 196
           +N L+  +   P LKI DFG+++S        +  G+P Y+APE++   +YD K AD+WS
Sbjct: 144 ENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWS 202
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            G  L+ ++ G  PF+   + + F+  +     +++       + P+C  L   +   +P
Sbjct: 203 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 256 VERITFKEFFNHRFL 270
            +RI+  E  NH + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 3   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P     TL G+  Y+ PE+
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEM 178
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 233
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 234 ARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 136/254 (53%), Gaps = 2/254 (0%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+F+ V  A  ++    VA+K I KK L  K   ++  EI++L  I HPNI+   + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
            E+   +YL+++   GG+L   I + G  +E  A   + Q+   ++ L +  ++HRDLKP
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 144
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSV 197
           +NLL  + +    + I DFG ++   P  +  T CG+P Y+APE++    Y    D WS+
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 198 GAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVE 257
           G I + L+ G PPF   N  +LF+ IL + E  F     +++     D  R L+ ++P +
Sbjct: 205 GVIAYILLCGYPPFYDENDAKLFEQILKA-EYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 258 RITFKEFFNHRFLG 271
           R T ++   H ++ 
Sbjct: 264 RFTCEQALQHPWIA 277

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 141/278 (50%), Gaps = 3/278 (1%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           TR   EY +   +G G+F+VV R      G E A   I+ K LS +    L +E  I   
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + HPNI+R  ++I      YL+ +   GG+L   I      SEA A H ++Q+   +   
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPLYMAPEIIQ 184
            +  ++HR+LKP+NLL+++      +K+ DFG A  +  +  A     G+P Y++PE+++
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              Y    DLW+ G IL+ L+ G PPF   +Q +L+Q I  +    FP    + + P+  
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAK 245
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQH 282
           DL   +L  NP +RIT  E   H ++   R TV +  H
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISH-RSTVASCMH 282

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLMIDQQ---GYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 146/265 (55%), Gaps = 10/265 (3%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y+   +IG GSF      +  + G +  +KEI+   +S K  +   +E+++L+ + HPN
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQLAAGLQVLQEK 128
           I+++ E+ E    +Y+V++YC+GGDL   I+    V   E     +  Q+   L+ + ++
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHK 187
            ++HRD+K QN+ ++ +     +++GDFG AR L    +LA    G+P Y++PEI +N  
Sbjct: 145 KILHRDIKSQNIFLTKD---GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           Y+ K+D+W++G +L++L T K  F+  +   L   I++ +   FPP ++   + D   L 
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS---FPPVSLHYSY-DLRSLV 257
Query: 248 RCLLRQNPVERITFKEFFNHRFLGE 272
             L ++NP +R +        F+ +
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAK 282

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADEPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 155
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 156 PENLLIDEQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 210
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 211 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 265
Query: 257 ERI 259
           +R 
Sbjct: 266 KRF 268

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 137/269 (50%), Gaps = 6/269 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y +G  +GSG FA+V + R +  G E A K I K+ L         + + +E++IL  I 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNII   +  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           K + H DLKP+N +L+  N   P +K+ DFG A  +   +    + G+P ++APEI+   
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 207
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   NI ++    F             D 
Sbjct: 208 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI-SAVNYDFDEEYFSNTSELAKDF 266
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQ 275
            R LL ++P  R+   +   H ++  +R+
Sbjct: 267 IRRLLVKDPKRRMXIAQSLEHSWIKAIRR 295

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 136/255 (53%), Gaps = 6/255 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG+G+F V    R +Q    VAVK I++     K+ +N+ +EI    ++ HPNI+RF E 
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIER---GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
           I T   + +V+EY  GG+L   I   G+ SE  AR F +QL +G+       + HRDLK 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKL 143
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-ADLWS 196
           +N L+  +   P LKI DFG++++        +  G+P Y+APE++   +YD K AD+WS
Sbjct: 144 ENTLLDGSP-APRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWS 202
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            G  L+ ++ G  PF+   + + F+  +     +++       + P+C  L   +   +P
Sbjct: 203 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 256 VERITFKEFFNHRFL 270
            +RI+  E  NH + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 139/272 (51%), Gaps = 3/272 (1%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +G G+F+VV R      G E A K I+ K LS +    L +E  I   + HPNI
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +R  ++I      YL+ +   GG+L   I      SEA A H ++Q+   +    +  ++
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPLYMAPEIIQNHKYDA 190
           HRDLKP+NLL+++      +K+ DFG A  +  +  A     G+P Y++PE+++   Y  
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 203
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
             DLW+ G IL+ L+ G PPF   +Q +L+Q I  +    FP    + + P+  DL   +
Sbjct: 204 PVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKDLINKM 262
Query: 251 LRQNPVERITFKEFFNHRFLGELRQTVHAEQH 282
           L  NP +RIT  E   H ++   R TV +  H
Sbjct: 263 LTINPSKRITAAEALKHPWISH-RSTVASCMH 293

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 137/268 (51%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ I
Sbjct: 7   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G++   + K  K  E     ++ +LA  L
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      L G+  Y+ PE+
Sbjct: 127 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRXXLXGTLDYLPPEM 182
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I +  E  FP    E     
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTE----G 237
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 238 ARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLIIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIIISKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 135/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y +G  +GSG FA+V + R +  G E A K I K+ LS        + + +E++IL  I 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNII   +  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           K + H DLKP+N +L+  N   P +K+ DFG A  +   +    + G+P ++APEI+   
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 193
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   NI ++    F             D 
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI-SAVNYDFDEEYFSNTSELAKDF 252
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P  R+   +   H ++
Sbjct: 253 IRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 76/236 (32%), Positives = 135/236 (57%), Gaps = 11/236 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQ 274

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 138/267 (51%), Gaps = 12/267 (4%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           +I   ++GSG+F  V     R  G+E  +K I+K   S    + +  EI +L ++ HPNI
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNI 82
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYI---HKHGK-VSEAVARHFMRQLAAGLQVLQE 127
           I+ FE  E    +Y+V+E C+GG+L   I      GK +SE      M+Q+   L     
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
           +H++H+DLKP+N+L         +KI DFG A      + +    G+ LYMAPE+ +   
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-D 201
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE--ELHPDCVD 245
              K D+WS G +++ L+TG  PF G++ L+  Q   T  E   P  A+E   L P  VD
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTS-LEEVQQKATYKE---PNYAVECRPLTPQAVD 257
Query: 246 LCRCLLRQNPVERITFKEFFNHRFLGE 272
           L + +L ++P  R +  +  +H +  +
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 162 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 216
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 217 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 271
Query: 257 ERI 259
           +R 
Sbjct: 272 KRF 274

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 138/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ +E  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 136/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLMIDQQ---GYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLMIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 134/261 (51%), Gaps = 6/261 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNH 267
            R LL ++P +R+T ++   H
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQH 272

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 190 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 244
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 245 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 299
Query: 257 ERI 259
           +R 
Sbjct: 300 KRF 302

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 250
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 136/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLMIDQQ---GYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 136/254 (53%), Gaps = 2/254 (0%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+F+ V  A  ++    VA+K I K+ L  K   ++  EI++L  I HPNI+   + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
            E+   +YL+++   GG+L   I + G  +E  A   + Q+   ++ L +  ++HRDLKP
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 144
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSV 197
           +NLL  + +    + I DFG ++   P  +  T CG+P Y+APE++    Y    D WS+
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 198 GAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVE 257
           G I + L+ G PPF   N  +LF+ IL + E  F     +++     D  R L+ ++P +
Sbjct: 205 GVIAYILLCGYPPFYDENDAKLFEQILKA-EYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 258 RITFKEFFNHRFLG 271
           R T ++   H ++ 
Sbjct: 264 RFTCEQALQHPWIA 277

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 136/254 (53%), Gaps = 2/254 (0%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+F+ V  A  ++    VA+K I K+ L  K   ++  EI++L  I HPNI+   + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
            E+   +YL+++   GG+L   I + G  +E  A   + Q+   ++ L +  ++HRDLKP
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 144
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSV 197
           +NLL  + +    + I DFG ++   P  +  T CG+P Y+APE++    Y    D WS+
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 198 GAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVE 257
           G I + L+ G PPF   N  +LF+ IL + E  F     +++     D  R L+ ++P +
Sbjct: 205 GVIAYILLCGYPPFYDENDAKLFEQILKA-EYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 258 RITFKEFFNHRFLG 271
           R T ++   H ++ 
Sbjct: 264 RFTCEQALQHPWIA 277

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 136/254 (53%), Gaps = 2/254 (0%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+F+ V  A  ++    VA+K I K+ L  K   ++  EI++L  I HPNI+   + 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
            E+   +YL+++   GG+L   I + G  +E  A   + Q+   ++ L +  ++HRDLKP
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 144
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSV 197
           +NLL  + +    + I DFG ++   P  +  T CG+P Y+APE++    Y    D WS+
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 198 GAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVE 257
           G I + L+ G PPF   N  +LF+ IL + E  F     +++     D  R L+ ++P +
Sbjct: 205 GVIAYILLCGYPPFYDENDAKLFEQILKA-EYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 258 RITFKEFFNHRFLG 271
           R T ++   H ++ 
Sbjct: 264 RFTCEQALQHPWIA 277

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 250
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 136/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLMIDQQ---GYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 134/261 (51%), Gaps = 6/261 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNH 267
            R LL ++P +R+T ++   H
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQH 272

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 134/261 (51%), Gaps = 6/261 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNH 267
            R LL ++P +R+T ++   H
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQH 272

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 84/255 (32%), Positives = 135/255 (52%), Gaps = 6/255 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IGSG+F V    R +Q    VAVK I++     K+ +N+ +EI    ++ HPNI+RF E 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIER---GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
           I T   + +V+EY  GG+L   I   G+ SE  AR F +QL +G+       + HRDLK 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 143
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-ADLWS 196
           +N L+  +   P LKI  FG+++S        +  G+P Y+APE++   +YD K AD+WS
Sbjct: 144 ENTLLDGSP-APRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWS 202
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            G  L+ ++ G  PF+   + + F+  +     +++       + P+C  L   +   +P
Sbjct: 203 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 256 VERITFKEFFNHRFL 270
            +RI+  E  NH + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 135/268 (50%), Gaps = 10/268 (3%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISI 62
            R   + ++ +G  +G G F  V+ AR +     +A+K + K +L    V   L +E+ I
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
            S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
                K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE+
Sbjct: 122 SYCHSKKVIHRDIKPENLLLGS---AGELKIADFGWSVH-APSSRRAALCGTLDYLPPEM 177
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           I+   +D K DLWS+G + ++ + GKPPF+ +     ++ I +  E  FP    E     
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI-SRVEFTFPDFVTE----G 232
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL   LL+ NP +R   +E   H ++
Sbjct: 233 ARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  142 bits (358), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 163
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 164 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 218
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 219 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 273
Query: 257 ERI 259
           +R 
Sbjct: 274 KRF 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  142 bits (358), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  142 bits (358), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  142 bits (357), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 134/261 (51%), Gaps = 6/261 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNH 267
            R LL ++P +R+T ++   H
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQH 272

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (357), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+AP II +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPAIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  142 bits (357), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 137/257 (53%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A++  G+  Y++PE++   
Sbjct: 150 IIHRDLKPENILLNED---MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 261
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 262 VEKLLVLDATKRLGCEE 278

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  142 bits (357), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  142 bits (357), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  142 bits (357), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 137/257 (53%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A++  G+  Y++PE++   
Sbjct: 154 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 265
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 266 VEKLLVLDATKRLGCEE 282

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  142 bits (357), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 133/261 (50%), Gaps = 6/261 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y +G  +GSG FA+V + R +  G+E A K I K+           + + +E+SIL  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNII   +  E R  + L+LE   GG+L  ++ +   +SE  A  F++Q+  G+  L  
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           K + H DLKP+N +L+  N   P +K+ DFG A  +        + G+P ++APEI+   
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   NI T+    F      +      D 
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFDEEFFSQTSELAKDF 252
Query: 247 CRCLLRQNPVERITFKEFFNH 267
            R LL +   +R+T +E   H
Sbjct: 253 IRKLLVKETRKRLTIQEALRH 273

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  142 bits (357), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 136/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 136/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +K+ DFG A+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLMIDQQ---GYIKVTDFGLAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 136/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 136/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/255 (32%), Positives = 134/255 (52%), Gaps = 6/255 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IGSG+F V    R +Q    VAVK I++     K+ +N+ +EI    ++ HPNI+RF E 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIER---GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
           I T   + +V+EY  GG+L   I   G+ SE  AR F +QL +G+       + HRDLK 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 143
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-ADLWS 196
           +N L+  +   P LKI  FG+++S           G+P Y+APE++   +YD K AD+WS
Sbjct: 144 ENTLLDGSP-APRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWS 202
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            G  L+ ++ G  PF+   + + F+  +     +++       + P+C  L   +   +P
Sbjct: 203 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADP 262
Query: 256 VERITFKEFFNHRFL 270
            +RI+  E  NH + 
Sbjct: 263 AKRISIPEIRNHEWF 277

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 151 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 262
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 263 VEKLLVLDATKRLGCEE 279

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 151 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 262
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 263 VEKLLVLDATKRLGCEE 279

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 154 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 265
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 266 VEKLLVLDATKRLGCEE 282

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 151 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 262
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 263 VEKLLVLDATKRLGCEE 279

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 153 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 264
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 265 VEKLLVLDATKRLGCEE 281

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 153 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 264
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 265 VEKLLVLDATKRLGCEE 281

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A++  G+  Y++PE++   
Sbjct: 153 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 264
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 265 VEKLLVLDATKRLGCEE 281

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 135/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+  E  AR +  Q+    + L    LI+RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +K+ DFGFA+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 170 PENLMIDQQ---GYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 257 ERI 259
           +R 
Sbjct: 280 KRF 282

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  141 bits (355), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 153 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 264
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 265 VEKLLVLDATKRLGCEE 281

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  141 bits (355), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 158 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 269
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 270 VEKLLVLDATKRLGCEE 286

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 150 IIHRDLKPENILLNED---MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 261
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 262 VEKLLVLDATKRLGCEE 278

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     L G+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLAGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 140/276 (50%), Gaps = 3/276 (1%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           +  EY +   IG G+F+VV R      G E A K I+ K LS +    L +E  I   + 
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           H NI+R  ++I      YLV +   GG+L   I      SEA A H ++Q+   +    +
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNH 186
             ++HRDLKP+NLL+++      +K+ DFG A  +   Q       G+P Y++PE+++  
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
            Y    D+W+ G IL+ L+ G PPF   +Q +L+Q I  +    FP    + + P+  +L
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI-KAGAYDFPSPEWDTVTPEAKNL 240
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQH 282
              +L  NP +RIT  E   H ++ + R TV +  H
Sbjct: 241 INQMLTINPAKRITAHEALKHPWVCQ-RSTVASMMH 275

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 135 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 246
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 247 VEKLLVLDATKRLGCEE 263

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     LCG+P  +APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLCGTPEALAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL 63
           R +   ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++
Sbjct: 5   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 64
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           S + HP  ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 124
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAP 180
            L  K +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++P
Sbjct: 125 YLHGKGIIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           E++        +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFF 236
Query: 241 PDCVDLCRCLLRQNPVERITFKE 263
           P   DL   LL  +  +R+  +E
Sbjct: 237 PKARDLVEKLLVLDATKRLGCEE 259

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL 63
           R +   ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++
Sbjct: 4   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 63
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           S + HP  ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 123
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAP 180
            L  K +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++P
Sbjct: 124 YLHGKGIIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           E++        +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFF 235
Query: 241 PDCVDLCRCLLRQNPVERITFKE 263
           P   DL   LL  +  +R+  +E
Sbjct: 236 PKARDLVEKLLVLDATKRLGCEE 258

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL 63
           R +   ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           S + HP  ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAP 180
            L  K +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++P
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           E++        +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFF 234
Query: 241 PDCVDLCRCLLRQNPVERITFKE 263
           P   DL   LL  +  +R+  +E
Sbjct: 235 PKARDLVEKLLVLDATKRLGCEE 257

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL 63
           R +   ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++
Sbjct: 2   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 61
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           S + HP  ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 121
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAP 180
            L  K +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++P
Sbjct: 122 YLHGKGIIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           E++        +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFF 233
Query: 241 PDCVDLCRCLLRQNPVERITFKE 263
           P   DL   LL  +  +R+  +E
Sbjct: 234 PKARDLVEKLLVLDATKRLGCEE 256

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 147/290 (50%), Gaps = 16/290 (5%)
Query: 9   IGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-----------KVSDNL 56
           IGE Y    ++GSG++  V   + +    E A+K I K                K  + +
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR 116
             EIS+L ++ HPNII+ F+  E ++  YLV E+ +GG+L   I    K  E  A + M+
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSP 175
           Q+ +G+  L + +++HRD+KP+N+L+        +KI DFG +   +    L D L G+ 
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-GTA 212
Query: 176 LYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
            Y+APE+++  KY+ K D+WS G I++ L+ G PPF G N   + + +    +  F    
Sbjct: 213 YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV-EKGKYYFDFND 270
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVV 285
            + +  +  +L + +L  +  +R T +E  N R++ +    ++      +
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTL 320

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 137/243 (56%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +     L G+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQ---GYIQVTDFGFAKRVKGRTW--XLXGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 136/243 (55%), Gaps = 11/243 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H + G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NL++        +++ DFG A+ +  +     LCG+P Y+APEII +  Y+   D W+
Sbjct: 169 PENLMIDQQ---GYIQVTDFGLAKRVKGRTW--XLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFP----SHFSSDLKDLLRNLLQVDLT 278
Query: 257 ERI 259
           +R 
Sbjct: 279 KRF 281

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  139 bits (351), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+    AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 151 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E+  P   DL
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----EKFFPKARDL 262
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 263 VEKLLVLDATKRLGCEE 279

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  139 bits (351), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 135/264 (51%), Gaps = 6/264 (2%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+ E   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+ ++    F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKDF 251
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  139 bits (350), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 132/242 (54%), Gaps = 15/242 (6%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y V   IG+GS+    + R +  G  +  KE+D   ++      L+ E+++L  + HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 71  IIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV-LQE 127
           I+R+++ I   T   +Y+V+EYC+GGDLA+ I K  K  + +   F+ ++   L + L+E
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 128 KH--------LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYM 178
            H        ++HRDLKP N+ +   +    +K+GDFG AR L   +D A    G+P YM
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +PE +    Y+ K+D+WS+G +L++L    PPF   +Q +L   I      R P    +E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 239 LH 240
           L+
Sbjct: 244 LN 245

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  139 bits (350), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 140/275 (50%), Gaps = 11/275 (4%)
Query: 1   MEPNRTRLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS------ 53
           MEP + + + + Y +G  +GSG FA+V + R +  G+E A K I K+    + S      
Sbjct: 2   MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVSR 59
Query: 54  DNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH 113
           + + +E+SIL  + H N+I   +  E R  + L+LE   GG+L  ++ +   +SE  A  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
           F++Q+  G+  L  K + H DLKP+N +L+  N   P +K+ DFG A  +        + 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           G+P ++APEI+       +AD+WS+G I + L++G  PF G  + +   NI TS    F 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFD 238
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                       D  R LL +   +R+T +E   H
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  139 bits (349), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 140/275 (50%), Gaps = 11/275 (4%)
Query: 1   MEPNRTRLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS------ 53
           MEP + + + + Y +G  +GSG FA+V + R +  G+E A K I K+    + S      
Sbjct: 2   MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVSR 59
Query: 54  DNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH 113
           + + +E+SIL  + H N+I   +  E R  + L+LE   GG+L  ++ +   +SE  A  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
           F++Q+  G+  L  K + H DLKP+N +L+  N   P +K+ DFG A  +        + 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           G+P ++APEI+       +AD+WS+G I + L++G  PF G  + +   NI TS    F 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFD 238
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                       D  R LL +   +R+T +E   H
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  139 bits (349), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 140/275 (50%), Gaps = 11/275 (4%)
Query: 1   MEPNRTRLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS------ 53
           MEP + + + + Y +G  +GSG FA+V + R +  G+E A K I K+    + S      
Sbjct: 2   MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVSR 59
Query: 54  DNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH 113
           + + +E+SIL  + H N+I   +  E R  + L+LE   GG+L  ++ +   +SE  A  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
           F++Q+  G+  L  K + H DLKP+N +L+  N   P +K+ DFG A  +        + 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           G+P ++APEI+       +AD+WS+G I + L++G  PF G  + +   NI TS    F 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFD 238
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                       D  R LL +   +R+T +E   H
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  138 bits (348), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 134/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 156 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP        P   DL
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFPAA----FFPKARDL 267
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 268 VEKLLVLDATKRLGCEE 284

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  138 bits (348), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 153 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +F  I+   E  FP    E+  P   DL
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII-KLEYDFP----EKFFPKARDL 264
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 265 VEKLLVLDATKRLGCEE 281

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  138 bits (348), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 141/275 (51%), Gaps = 11/275 (4%)
Query: 1   MEPNRTRLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS------ 53
           MEP + + + + Y +G  +GSG FA+V + R +  G+E A K I K+    + S      
Sbjct: 2   MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVSR 59
Query: 54  DNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH 113
           + + +E+SIL  + H N+I   +  E R  + L+LE   GG+L  ++ +   +SE  A  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
           F++Q+  G+  L  K + H DLKP+N +L+  N   P +K+ DFG A  +        + 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           G+P ++APEI+       +AD+WS+G I + L++G  PF G  + +   NI T+    F 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFD 238
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                +      D  R LL +   +R+T +E   H
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  138 bits (348), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 141/275 (51%), Gaps = 11/275 (4%)
Query: 1   MEPNRTRLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS------ 53
           MEP + + + + Y +G  +GSG FA+V + R +  G+E A K I K+    + S      
Sbjct: 2   MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVSR 59
Query: 54  DNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH 113
           + + +E+SIL  + H N+I   +  E R  + L+LE   GG+L  ++ +   +SE  A  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
           F++Q+  G+  L  K + H DLKP+N +L+  N   P +K+ DFG A  +        + 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           G+P ++APEI+       +AD+WS+G I + L++G  PF G  + +   NI T+    F 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFD 238
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                +      D  R LL +   +R+T +E   H
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 126/259 (48%), Gaps = 4/259 (1%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   IG GS+  V  A  +   I  A K+I K  +     D   +EI I+ ++ HPNI
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNI 85
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           IR +E  E    IYLV+E C GG+L   +       E+ A   M+ + + +    + ++ 
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 145
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N L  T+     LK+ DFG A    P  +  T  G+P Y++P++++   Y  +
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPE 204
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D WS G +++ L+ G PPF      ++   I   T   FP      + P    L R LL
Sbjct: 205 CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGT-FTFPEKDWLNVSPQAESLIRRLL 263
Query: 252 RQNPVERITFKEFFNHRFL 270
            ++P +RIT  +   H + 
Sbjct: 264 TKSPKQRITSLQALEHEWF 282

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 131/242 (54%), Gaps = 15/242 (6%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y V   IG+GS+    + R +  G  +  KE+D   ++      L+ E+++L  + HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 71  IIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV-LQE 127
           I+R+++ I   T   +Y+V+EYC+GGDLA+ I K  K  + +   F+ ++   L + L+E
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 128 KH--------LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYM 178
            H        ++HRDLKP N+ +   +    +K+GDFG AR L      A T  G+P YM
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +PE +    Y+ K+D+WS+G +L++L    PPF   +Q +L   I      R P    +E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 239 LH 240
           L+
Sbjct: 244 LN 245

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 135/260 (51%), Gaps = 5/260 (1%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +GSG+F VV R   +  G     K I+      K +  +  EISI++ + HP +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--VKNEISIMNQLHHPKL 110
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHL 130
           I   +A E + ++ L+LE+  GG+L   I     K+SEA   ++MRQ   GL+ + E  +
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +H D+KP+N++  T + + V KI DFG A  L P ++      +  + APEI+       
Sbjct: 171 VHLDIKPENIMCETKKASSV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
             D+W++G + + L++G  PF G + L+  QN+    +  F   A   + P+  D  + L
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-KRCDWEFDEDAFSSVSPEAKDFIKNL 288
Query: 251 LRQNPVERITFKEFFNHRFL 270
           L++ P +R+T  +   H +L
Sbjct: 289 LQKEPRKRLTVHDALEHPWL 308

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 12/257 (4%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHP 69
           ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  ++S + HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
             ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + L+ L  K 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQNH 186
           +IHRDLKP+N+L++ +     ++I DFG A+ L+P   Q  A+   G+  Y++PE++   
Sbjct: 153 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                +DLW++G I++QLV G PPF   N+  +F  I+   E  FP    E+  P   DL
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII-KLEYDFP----EKFFPKARDL 264
Query: 247 CRCLLRQNPVERITFKE 263
              LL  +  +R+  +E
Sbjct: 265 VEKLLVLDATKRLGCEE 281

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 126/259 (48%), Gaps = 4/259 (1%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   IG GS+  V  A  +   I  A K+I K  +     D   +EI I+ ++ HPNI
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNI 68
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           IR +E  E    IYLV+E C GG+L   +       E+ A   M+ + + +    + ++ 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N L  T+     LK+ DFG A    P  +  T  G+P Y++P++++   Y  +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPE 187
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D WS G +++ L+ G PPF      ++   I   T   FP      + P    L R LL
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGT-FTFPEKDWLNVSPQAESLIRRLL 246
Query: 252 RQNPVERITFKEFFNHRFL 270
            ++P +RIT  +   H + 
Sbjct: 247 TKSPKQRITSLQALEHEWF 265

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 138/266 (51%), Gaps = 6/266 (2%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK-EISILS 64
           T +   +I    +GSG+F+ V+  + R  G   A+K I K   SP   D+ L+ EI++L 
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK---SPAFRDSSLENEIAVLK 61
Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
            I H NI+   +  E+    YLV++   GG+L   I + G  +E  A   ++Q+ + ++ 
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           L E  ++HRDLKP+NLL  T E    + I DFG ++ +    +  T CG+P Y+APE++ 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLA 180
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              Y    D WS+G I + L+ G PPF    + +LF+ I       F     +++     
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI-KEGYYEFESPFWDDISESAK 239
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
           D    LL ++P ER T ++  +H ++
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 132/258 (51%), Gaps = 12/258 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IGSG+F V    R +     VAVK I++      + +N+ +EI    ++ HPNI+RF E 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
           I T   + +++EY  GG+L   I   G+ SE  AR F +QL +G+       + HRDLK 
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-ADLWS 196
           +N L+  +   P LKI DFG+++S        +  G+P Y+APE++   +YD K AD+WS
Sbjct: 145 ENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWS 203
Query: 197 VGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
            G  L+ ++ G  PF+   +     +  Q IL S +   P      + P+C  L   +  
Sbjct: 204 CGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL-SVKYSIPDDI--RISPECCHLISRIFV 260
Query: 253 QNPVERITFKEFFNHRFL 270
            +P  RI+  E   H + 
Sbjct: 261 ADPATRISIPEIKTHSWF 278

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 139/266 (52%), Gaps = 17/266 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVK--EIDKKLLSPK----VSDNLLKEISILSTIS-HPN 70
           IG G  +VV R  HR  G E AVK  E+  + LSP+    V +   +E  IL  ++ HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           II   ++ E+   ++LV +    G+L  Y+ +   +SE   R  MR L   +  L   ++
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ------ 184
           +HRDLKP+N+L+  N     +++ DFGF+  L P +    LCG+P Y+APEI++      
Sbjct: 222 VHRDLKPENILLDDNM---QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
           +  Y  + DLW+ G ILF L+ G PPF    Q+ + + I+   + +F     ++      
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG-QYQFSSPEWDDRSSTVK 337
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
           DL   LL+ +P  R+T ++   H F 
Sbjct: 338 DLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  137 bits (344), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 135/260 (51%), Gaps = 10/260 (3%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK-VSDNLLKEISILSTIS 67
           I ++ +G  +G G F  V+ AR ++    VA+K + K  +  + V   L +EI I + + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNI+R +     R +IYL+LEY   G+L   + K     E      M +LA  L     
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
           K +IHRD+KP+NLL+         KI DFG++    P     T+CG+  Y+ PE+I+   
Sbjct: 142 KKVIHRDIKPENLLLGLKGEL---KIADFGWSVH-APSLRRKTMCGTLDYLPPEMIEGRM 197
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           ++ K DLW +G + ++L+ G PPF+ ++  + ++ I+   +L+FP      +     DL 
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIV-KVDLKFPAS----VPTGAQDLI 252
Query: 248 RCLLRQNPVERITFKEFFNH 267
             LLR NP ER+   +   H
Sbjct: 253 SKLLRHNPSERLPLAQVSAH 272

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 130/242 (53%), Gaps = 15/242 (6%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y V   IG+GS+    + R +  G  +  KE+D   ++      L+ E+++L  + HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 71  IIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV-LQE 127
           I+R+++ I   T   +Y+V+EYC+GGDLA+ I K  K  + +   F+ ++   L + L+E
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 128 KH--------LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYM 178
            H        ++HRDLKP N+ +   +    +K+GDFG AR L      A    G+P YM
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +PE +    Y+ K+D+WS+G +L++L    PPF   +Q +L   I      R P    +E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 239 LH 240
           L+
Sbjct: 244 LN 245

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 118/215 (54%), Gaps = 10/215 (4%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           T+  G + +  R+G+G F  V R  H+  G +VA+K+  ++ LSPK  +    EI I+  
Sbjct: 11  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKK 69
Query: 66  ISHPNIIRFFEAIETREKI------YLVLEYCDGGDLAAYIHKHGK---VSEAVARHFMR 116
           ++HPN++   E  +  +K+       L +EYC+GGDL  Y+++      + E   R  + 
Sbjct: 70  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 129
Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
            +++ L+ L E  +IHRDLKP+N+++       + KI D G+A+ L   +L     G+  
Sbjct: 130 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 189
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPF 211
           Y+APE+++  KY    D WS G + F+ +TG  PF
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 118/215 (54%), Gaps = 10/215 (4%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           T+  G + +  R+G+G F  V R  H+  G +VA+K+  ++L SPK  +    EI I+  
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKK 68
Query: 66  ISHPNIIRFFEAIETREKI------YLVLEYCDGGDLAAYIHKHGK---VSEAVARHFMR 116
           ++HPN++   E  +  +K+       L +EYC+GGDL  Y+++      + E   R  + 
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
            +++ L+ L E  +IHRDLKP+N+++       + KI D G+A+ L   +L     G+  
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPF 211
           Y+APE+++  KY    D WS G + F+ +TG  PF
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 132/266 (49%), Gaps = 9/266 (3%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN--LLKEISILST 65
           ++  Y +   +G+G+F VV R   R  G   A K +    ++P  SD   + KEI  +S 
Sbjct: 49  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV----MTPHESDKETVRKEIQTMSV 104
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQV 124
           + HP ++   +A E   ++ ++ E+  GG+L   +  +H K+SE  A  +MRQ+  GL  
Sbjct: 105 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 164
Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           + E + +H DLKP+N++ +T      LK+ DFG    L P+       G+  + APE+ +
Sbjct: 165 MHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
                   D+WSVG + + L++G  PF G N  +  +N+  S +      A   +  D  
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSGISEDGK 282
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
           D  R LL  +P  R+T  +   H +L
Sbjct: 283 DFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 132/266 (49%), Gaps = 9/266 (3%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--NLLKEISILST 65
           ++  Y +   +G+G+F VV R   R  G   A K +    ++P  SD   + KEI  +S 
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV----MTPHESDKETVRKEIQTMSV 210
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQV 124
           + HP ++   +A E   ++ ++ E+  GG+L   +  +H K+SE  A  +MRQ+  GL  
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270
Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           + E + +H DLKP+N++ +T      LK+ DFG    L P+       G+  + APE+ +
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
                   D+WSVG + + L++G  PF G N  +  +N+  S +      A   +  D  
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNMDDSAFSGISEDGK 388
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
           D  R LL  +P  R+T  +   H +L
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 9/211 (4%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 180
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C +P Y+APE+
Sbjct: 181 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 240
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
           +   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 241 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 300
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 301 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 130/254 (51%), Gaps = 17/254 (6%)
Query: 34  LGIEVAVKEIDKKLLSPKVSDNLL-------KEISILSTISH-PNIIRFFEAIET----R 81
           LGI   V +I  K    K +  +L       +E+ +    S  P+I+R  +  E     R
Sbjct: 42  LGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 101
Query: 82  EKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQN 139
           + + +V+E  DGG+L + I   G    +E  A   M+ +   +Q L   ++ HRD+KP+N
Sbjct: 102 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 161
Query: 140 LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGA 199
           LL ++     +LK+ DFGFA+  T  +   T C +P Y+APE++   KYD   D+WS+G 
Sbjct: 162 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 221
Query: 200 ILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEELHPDCVDLCRCLLRQNPV 256
           I++ L+ G PPF  ++ L +   + T   +    FP     E+  +   L R LL+  P 
Sbjct: 222 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 281
Query: 257 ERITFKEFFNHRFL 270
           +R+T  EF NH ++
Sbjct: 282 QRMTITEFMNHPWI 295

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 149/295 (50%), Gaps = 46/295 (15%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           ++G+G++A V++  ++  G+ VA+KE+  D +  +P  +   ++EIS++  + H NI+R 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA---IREISLMKELKHENIVRL 68
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH--GKVSEAV----ARHFMRQLAAGLQVLQEK 128
           ++ I T  K+ LV E+ D  DL  Y+     G     +     ++F  QL  GL    E 
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK 187
            ++HRDLKPQNLL++       LK+GDFG AR+   P +   +   +  Y AP+++   +
Sbjct: 128 KILHRDLKPQNLLINKRG---QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSR 184
Query: 188 -YDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-TSTELRFP---------- 232
            Y    D+WS G IL +++TGKP F G+N   QL+L  +I+ T  E  +P          
Sbjct: 185 TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244
Query: 233 ---------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE 272
                          P   E L  + +D    LL+ NP  R++ K+  +H +  E
Sbjct: 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 9/211 (4%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C +P Y+APE+
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
           +   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 120/211 (56%), Gaps = 6/211 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISIL-STISHPNIIRFF 75
           IG GSF  V  ARH+   +  AVK + KK +L  K   +++ E ++L   + HP ++   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + +T +K+Y VL+Y +GG+L  ++ +     E  AR +  ++A+ L  L   ++++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           KP+N+L+ +      + + DFG  + ++       T CG+P Y+APE++    YD   D 
Sbjct: 166 KPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILT 225
           W +GA+L++++ G PPF   N  +++ NIL 
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 145/297 (48%), Gaps = 26/297 (8%)
Query: 2   EPNRTRLIGEYIVGPRI-GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           EP +  +  +Y +  ++ G G    V    HR+ G + A+K +     SPK    +    
Sbjct: 20  EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD---SPKARQEVDHH- 75
Query: 61  SILSTISHPNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHF 114
                   P+I+   +  E     +  + +++E  +GG+L + I + G    +E  A   
Sbjct: 76  --WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI 133
Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
           MR +   +Q L   ++ HRD+KP+NLL ++ E   VLK+ DFGFA+  T Q+   T C +
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYT 192
Query: 175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL---FQNILTSTELRF 231
           P Y+APE++   KYD   D+WS+G I++ L+ G PPF  +    +    +  +   +  F
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252
Query: 232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPET 288
           P     E+  D   L R LL+ +P ER+T  +F NH ++          Q  VVP+T
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN---------QSMVVPQT 300

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 9/211 (4%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C +P Y+APE+
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 188
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
           +   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 130/254 (51%), Gaps = 17/254 (6%)
Query: 34  LGIEVAVKEIDKKLLSPKVSDNLL-------KEISILSTISH-PNIIRFFEAIET----R 81
           LGI   V +I  K    K +  +L       +E+ +    S  P+I+R  +  E     R
Sbjct: 34  LGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 93
Query: 82  EKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQN 139
           + + +V+E  DGG+L + I   G    +E  A   M+ +   +Q L   ++ HRD+KP+N
Sbjct: 94  KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 153
Query: 140 LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGA 199
           LL ++     +LK+ DFGFA+  T  +   T C +P Y+APE++   KYD   D+WS+G 
Sbjct: 154 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 213
Query: 200 ILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEELHPDCVDLCRCLLRQNPV 256
           I++ L+ G PPF  ++ L +   + T   +    FP     E+  +   L R LL+  P 
Sbjct: 214 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 273
Query: 257 ERITFKEFFNHRFL 270
           +R+T  EF NH ++
Sbjct: 274 QRMTITEFMNHPWI 287

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 9/211 (4%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 129
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C +P Y+APE+
Sbjct: 130 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 189
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
           +   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 190 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 249
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 9/211 (4%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C +P Y+APE+
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 190
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
           +   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 191 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 130/254 (51%), Gaps = 17/254 (6%)
Query: 34  LGIEVAVKEIDKKLLSPKVSDNLL-------KEISILSTISH-PNIIRFFEAIET----R 81
           LGI   V +I  K    K +  +L       +E+ +    S  P+I+R  +  E     R
Sbjct: 33  LGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 92
Query: 82  EKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQN 139
           + + +V+E  DGG+L + I   G    +E  A   M+ +   +Q L   ++ HRD+KP+N
Sbjct: 93  KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 152
Query: 140 LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGA 199
           LL ++     +LK+ DFGFA+  T  +   T C +P Y+APE++   KYD   D+WS+G 
Sbjct: 153 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 212
Query: 200 ILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEELHPDCVDLCRCLLRQNPV 256
           I++ L+ G PPF  ++ L +   + T   +    FP     E+  +   L R LL+  P 
Sbjct: 213 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 272
Query: 257 ERITFKEFFNHRFL 270
           +R+T  EF NH ++
Sbjct: 273 QRMTITEFMNHPWI 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 9/211 (4%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 134
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C +P Y+APE+
Sbjct: 135 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 194
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
           +   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 195 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 254
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 9/211 (4%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C +P Y+APE+
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 190
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
           +   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 191 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 145/297 (48%), Gaps = 26/297 (8%)
Query: 2   EPNRTRLIGEYIVGPRI-GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           EP +  +  +Y +  ++ G G    V    HR+ G + A+K +     SPK    +    
Sbjct: 1   EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD---SPKARQEVDHH- 56
Query: 61  SILSTISHPNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHF 114
                   P+I+   +  E     +  + +++E  +GG+L + I + G    +E  A   
Sbjct: 57  --WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI 114
Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
           MR +   +Q L   ++ HRD+KP+NLL ++ E   VLK+ DFGFA+  T Q+   T C +
Sbjct: 115 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYT 173
Query: 175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL---FQNILTSTELRF 231
           P Y+APE++   KYD   D+WS+G I++ L+ G PPF  +    +    +  +   +  F
Sbjct: 174 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 233
Query: 232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPET 288
           P     E+  D   L R LL+ +P ER+T  +F NH ++          Q  VVP+T
Sbjct: 234 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN---------QSMVVPQT 281

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  132 bits (331), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 131/232 (56%), Gaps = 12/232 (5%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTIS 67
           +  + +  +IG G F+ V+RA     G+ VA+K++    L+  K   + +KEI +L  ++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-----VSEAVARHFMRQLAAGL 122
           HPN+I+++ +     ++ +VLE  D GDL+  I KH K     + E     +  QL + L
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPE 181
           + +  + ++HRD+KP N+ ++    T V+K+GD G  R  + +  A  +L G+P YM+PE
Sbjct: 150 EHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP 233
            I  + Y+ K+D+WS+G +L+++   + PF G +++ L+       +  +PP
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPP 257

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 124/220 (56%), Gaps = 13/220 (5%)
Query: 7   RLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK----EIS 61
           ++I E Y +  ++G G  + V+ A    L I+VA+K I    + P+  +  LK    E+ 
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVH 63
Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
             S +SH NI+   +  E  +  YLV+EY +G  L+ YI  HG +S   A +F  Q+  G
Sbjct: 64  NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMA 179
           ++   +  ++HRD+KPQN+L+ +N+    LKI DFG A++L+   L  T  + G+  Y +
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNK---TLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL 219
           PE  +    D   D++S+G +L++++ G+PPF+G   + +
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 113/211 (53%), Gaps = 9/211 (4%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +     C +P Y+APE+
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEV 188
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
           +   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 130/245 (53%), Gaps = 11/245 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTI-SHPNIIRFF 75
           +G GSF  V  AR ++ G   AVK + K  +L     +  + E  ILS   +HP + + F
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T ++++ V+E+ +GGDL  +I K  +  EA AR +  ++ + L  L +K +I+RDL
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+         K+ DFG  +      +   T CG+P Y+APEI+Q   Y    D 
Sbjct: 151 KLDNVLLDHEGHC---KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W++G +L++++ G  PF+  N+  LF+ IL   E+ +P      LH D   + +  + +N
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EVVYPTW----LHEDATGILKSFMTKN 262
Query: 255 PVERI 259
           P  R+
Sbjct: 263 PTMRL 267

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 5/256 (1%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G F  V +      G+++A K I  + +  K  + +  EIS+++ + H N+I+ ++A
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISVMNQLDHANLIQLYDA 154
Query: 78  IETREKIYLVLEYCDGGDL-AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
            E++  I LV+EY DGG+L    I +   ++E     FM+Q+  G++ + + +++H DLK
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+N+L   N     +KI DFG AR   P++      G+P ++APE++         D+WS
Sbjct: 215 PENILC-VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           VG I + L++G  PF G N  +   NIL +          +++  +  +    LL +   
Sbjct: 274 VGVIAYMLLSGLSPFLGDNDAETLNNIL-ACRWDLEDEEFQDISEEAKEFISKLLIKEKS 332
Query: 257 ERITFKEFFNHRFLGE 272
            RI+  E   H +L +
Sbjct: 333 WRISASEALKHPWLSD 348

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 130/266 (48%), Gaps = 10/266 (3%)
Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILST 65
           R +  Y+ G  +G G FA  +           A K + K  LL P   + +  EI+I  +
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + +P+++ F    E  + +Y+VLE C    L     +   V+E  AR+FMRQ   G+Q L
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQ 184
               +IHRDLK  NL ++ +     +KIGDFG A  +    +   TLCG+P Y+APE++ 
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLC 215
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              +  + D+WS+G IL+ L+ GKPPF+ S   + +  I    E   P      ++P   
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-KKNEYSVP----RHINPVAS 270
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
            L R +L  +P  R +  E     F 
Sbjct: 271 ALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 135/267 (50%), Gaps = 18/267 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID-------KKLLSPKVSDNLLKEISILSTIS-HP 69
           +G G  +VV R  H+    E AVK ID             ++ +  LKE+ IL  +S HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           NII+  +  ET    +LV +    G+L  Y+ +   +SE   R  MR L   +  L + +
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ----- 184
           ++HRDLKP+N+L+  +     +K+ DFGF+  L P +   ++CG+P Y+APEII+     
Sbjct: 145 IVHRDLKPENILLDDDM---NIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMND 201
Query: 185 NH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           NH  Y  + D+WS G I++ L+ G PPF    Q+ + + I+ S   +F     ++     
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-SGNYQFGSPEWDDYSDTV 260
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFL 270
            DL    L   P +R T +E   H F 
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  129 bits (325), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 131/248 (52%), Gaps = 14/248 (5%)
Query: 18  IGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSD--NLLKEISILSTISHPNII 72
           +G G +  V++ R       G   A+K + K ++     D  +   E +IL  + HP I+
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               A +T  K+YL+LEY  GG+L   + + G   E  A  ++ +++  L  L +K +I+
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLKP+N++++       +K+ DFG  + S+    +  T CG+  YMAPEI+    ++  
Sbjct: 145 RDLKPENIMLNHQ---GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA 201
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D WS+GA+++ ++TG PPF G N+ +    IL   +L  PP   +E      DL + LL
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL-KCKLNLPPYLTQEAR----DLLKKLL 256
Query: 252 RQNPVERI 259
           ++N   R+
Sbjct: 257 KRNAASRL 264

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  129 bits (324), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 134/267 (50%), Gaps = 18/267 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID-------KKLLSPKVSDNLLKEISILSTIS-HP 69
           +G G  +VV R  H+    E AVK ID             ++ +  LKE+ IL  +S HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           NII+  +  ET    +LV +    G+L  Y+ +   +SE   R  MR L   +  L + +
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ----- 184
           ++HRDLKP+N+L+  +     +K+ DFGF+  L P +    +CG+P Y+APEII+     
Sbjct: 145 IVHRDLKPENILLDDDM---NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 185 NH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           NH  Y  + D+WS G I++ L+ G PPF    Q+ + + I+ S   +F     ++     
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-SGNYQFGSPEWDDYSDTV 260
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFL 270
            DL    L   P +R T +E   H F 
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  129 bits (323), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 134/267 (50%), Gaps = 18/267 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID-------KKLLSPKVSDNLLKEISILSTIS-HP 69
           +G G  +VV R  H+    E AVK ID             ++ +  LKE+ IL  +S HP
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           NII+  +  ET    +LV +    G+L  Y+ +   +SE   R  MR L   +  L + +
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ----- 184
           ++HRDLKP+N+L+  +     +K+ DFGF+  L P +    +CG+P Y+APEII+     
Sbjct: 132 IVHRDLKPENILLDDDM---NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 185 NH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           NH  Y  + D+WS G I++ L+ G PPF    Q+ + + I+ S   +F     ++     
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-SGNYQFGSPEWDDYSDTV 247
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFL 270
            DL    L   P +R T +E   H F 
Sbjct: 248 KDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  129 bits (323), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 146/282 (51%), Gaps = 16/282 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + + E  +L    HP +     
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 135
Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++      T CG+P Y+APE+++++ Y    D W
Sbjct: 136 LENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 192
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 193 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 247
Query: 256 VERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +       Q  ++P  KP V
Sbjct: 248 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQV 288

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  129 bits (323), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 132/251 (52%), Gaps = 15/251 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFE 76
           +G GSF++  +  H++     AVK     ++S ++  N  KEI+ L     HPNI++  E
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
               +   +LV+E  +GG+L   I K    SE  A + MR+L + +  + +  ++HRDLK
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADLW 195
           P+NLL +       +KI DFGFAR   P +    T C +  Y APE++  + YD   DLW
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLW 193
Query: 196 SVGAILFQLVTGKPPFDGSNQ-------LQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           S+G IL+ +++G+ PF   ++       +++ + I    +  F   A + +  +  DL +
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFSFEGEAWKNVSQEAKDLIQ 252
Query: 249 CLLRQNPVERI 259
            LL  +P +R+
Sbjct: 253 GLLTVDPNKRL 263

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  128 bits (322), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 146/282 (51%), Gaps = 16/282 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + + E  +L    HP +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++      T CG+P Y+APE+++++ Y    D W
Sbjct: 133 LENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 244
Query: 256 VERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +       Q  ++P  KP V
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQV 285

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  128 bits (322), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 146/282 (51%), Gaps = 16/282 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + + E  +L    HP +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++      T CG+P Y+APE+++++ Y    D W
Sbjct: 133 LENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 244
Query: 256 VERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +       Q  ++P  KP V
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQV 285

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 129/266 (48%), Gaps = 10/266 (3%)
Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILST 65
           R +  Y+ G  +G G FA  +           A K + K  LL P   + +  EI+I  +
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + +P+++ F    E  + +Y+VLE C    L     +   V+E  AR+FMRQ   G+Q L
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQ 184
               +IHRDLK  NL ++ +     +KIGDFG A  +    +    LCG+P Y+APE++ 
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLC 215
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              +  + D+WS+G IL+ L+ GKPPF+ S   + +  I    E   P      ++P   
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-KKNEYSVP----RHINPVAS 270
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
            L R +L  +P  R +  E     F 
Sbjct: 271 ALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 129/266 (48%), Gaps = 10/266 (3%)
Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILST 65
           R +  Y+ G  +G G FA  +           A K + K  LL P   + +  EI+I  +
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + +P+++ F    E  + +Y+VLE C    L     +   V+E  AR+FMRQ   G+Q L
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQ 184
               +IHRDLK  NL ++ +     +KIGDFG A  +    +    LCG+P Y+APE++ 
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC 215
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              +  + D+WS+G IL+ L+ GKPPF+ S   + +  I    E   P      ++P   
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-KKNEYSVP----RHINPVAS 270
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
            L R +L  +P  R +  E     F 
Sbjct: 271 ALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 130/248 (52%), Gaps = 14/248 (5%)
Query: 18  IGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSD--NLLKEISILSTISHPNII 72
           +G G +  V++ R       G   A+K + K ++     D  +   E +IL  + HP I+
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               A +T  K+YL+LEY  GG+L   + + G   E  A  ++ +++  L  L +K +I+
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLKP+N++++       +K+ DFG  + S+    +    CG+  YMAPEI+    ++  
Sbjct: 145 RDLKPENIMLNHQ---GHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRA 201
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D WS+GA+++ ++TG PPF G N+ +    IL   +L  PP   +E      DL + LL
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL-KCKLNLPPYLTQEAR----DLLKKLL 256
Query: 252 RQNPVERI 259
           ++N   R+
Sbjct: 257 KRNAASRL 264

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 146/283 (51%), Gaps = 17/283 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   + +  G   A+K + K+++  K    + L E  +L    HP +     
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ-EKHLIHRDL 135
           + +T +++  V+EY +GG+L  ++ +    SE  AR +  ++ + L  L  EK++++RDL
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 278
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K +NL++  +     +KI DFG  +  +       T CG+P Y+APE+++++ Y    D 
Sbjct: 279 KLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 335
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++
Sbjct: 336 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----RTLGPEAKSLLSGLLKKD 390
Query: 255 PVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           P +R+       KE   HRF   +    H  +  + P  KP V
Sbjct: 391 PKQRLGGGSEDAKEIMQHRFFAGIVWQ-HVYEKKLSPPFKPQV 432

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 146/283 (51%), Gaps = 17/283 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   + +  G   A+K + K+++  K    + L E  +L    HP +     
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ-EKHLIHRDL 135
           + +T +++  V+EY +GG+L  ++ +    SE  AR +  ++ + L  L  EK++++RDL
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K +NL++  +     +KI DFG  +  +       T CG+P Y+APE+++++ Y    D 
Sbjct: 276 KLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----RTLGPEAKSLLSGLLKKD 387
Query: 255 PVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           P +R+       KE   HRF   +    H  +  + P  KP V
Sbjct: 388 PKQRLGGGSEDAKEIMQHRFFAGIVWQ-HVYEKKLSPPFKPQV 429

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 138/258 (53%), Gaps = 13/258 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 91
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 92  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 151
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 152 PSNILVNSR---GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 207
Query: 197 VGAILFQLVTGKPPF-DGSNQLQLFQ---NILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +G  L ++  G+ P   GS  + +F+    I+     + P G       D V+ C   L 
Sbjct: 208 MGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC---LI 264
Query: 253 QNPVERITFKEFFNHRFL 270
           +NP ER   K+   H F+
Sbjct: 265 KNPAERADLKQLMVHAFI 282

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 129/266 (48%), Gaps = 10/266 (3%)
Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILST 65
           R +  Y+ G  +G G FA  +           A K + K  LL P   + +  EI+I  +
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + +P+++ F    E  + +Y+VLE C    L     +   V+E  AR+FMRQ   G+Q L
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQ 184
               +IHRDLK  NL ++ +     +KIGDFG A  +    +    LCG+P Y+APE++ 
Sbjct: 143 HNNRVIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC 199
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              +  + D+WS+G IL+ L+ GKPPF+ S   + +  I    E   P      ++P   
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-KKNEYSVP----RHINPVAS 254
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
            L R +L  +P  R +  E     F 
Sbjct: 255 ALIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  127 bits (318), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 152/300 (50%), Gaps = 19/300 (6%)
Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKE 59
           M+P  T    EY+    +G G+F  V   + +  G   A+K + K+++  K    + L E
Sbjct: 3   MDPRVTMNEFEYL--KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 60
Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
             +L    HP +     + +T +++  V+EY +GG+L  ++ +    SE  AR +  ++ 
Sbjct: 61  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 120
Query: 120 AGLQVLQ-EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLY 177
           + L  L  EK++++RDLK +NL++  +     +KI DFG  +  +         CG+P Y
Sbjct: 121 SALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGATMKXFCGTPEY 177
Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           +APE+++++ Y    D W +G ++++++ G+ PF   +  +LF+ IL   E+RFP     
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----R 232
Query: 238 ELHPDCVDLCRCLLRQNPVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            L P+   L   LL+++P +R+       KE   HRF   +    H  +  + P  KP V
Sbjct: 233 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ-HVYEKKLSPPFKPQV 291

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 128/255 (50%), Gaps = 10/255 (3%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G FA  +           A K + K LL  P   + +  EISI  +++H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E  + +++VLE C    L     +   ++E  AR+++RQ+  G Q L    +IHRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             NL +  NE   V KIGDFG A  +    +   TLCG+P Y+APE++    +  + D+W
Sbjct: 145 LGNLFL--NEDLEV-KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVW 201
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G I++ L+ GKPPF+ S   + +  I    E   P    + ++P    L + +L+ +P
Sbjct: 202 SIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIP----KHINPVAASLIQKMLQTDP 256
Query: 256 VERITFKEFFNHRFL 270
             R T  E  N  F 
Sbjct: 257 TARPTINELLNDEFF 271

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 128/255 (50%), Gaps = 10/255 (3%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G FA  +           A K + K LL  P   + +  EISI  +++H +++ F  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E  + +++VLE C    L     +   ++E  AR+++RQ+  G Q L    +IHRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             NL +  NE   V KIGDFG A  +    +   TLCG+P Y+APE++    +  + D+W
Sbjct: 149 LGNLFL--NEDLEV-KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVW 205
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G I++ L+ GKPPF+ S   + +  I    E   P    + ++P    L + +L+ +P
Sbjct: 206 SIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIP----KHINPVAASLIQKMLQTDP 260
Query: 256 VERITFKEFFNHRFL 270
             R T  E  N  F 
Sbjct: 261 TARPTINELLNDEFF 275

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 128/255 (50%), Gaps = 10/255 (3%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G FA  +           A K + K LL  P   + +  EISI  +++H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E  + +++VLE C    L     +   ++E  AR+++RQ+  G Q L    +IHRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             NL +  NE   V KIGDFG A  +    +   TLCG+P Y+APE++    +  + D+W
Sbjct: 145 LGNLFL--NEDLEV-KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVW 201
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G I++ L+ GKPPF+ S   + +  I    E   P    + ++P    L + +L+ +P
Sbjct: 202 SIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIP----KHINPVAASLIQKMLQTDP 256
Query: 256 VERITFKEFFNHRFL 270
             R T  E  N  F 
Sbjct: 257 TARPTINELLNDEFF 271

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 145/282 (51%), Gaps = 16/282 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + + E  +L    HP +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++        CG+P Y+APE+++++ Y    D W
Sbjct: 133 LENLMLDKD---GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 244
Query: 256 VERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +       Q  ++P  KP V
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQV 285

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  126 bits (317), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 128/249 (51%), Gaps = 18/249 (7%)
Query: 18  IGSGSFAVVWRARH------RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           +G GSF  V+  +       RQL    A+K + K  L  +       E  IL  ++HP I
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQL---YAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++   A +T  K+YL+L++  GGDL   + K    +E   + ++ +LA  L  L    +I
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +RDLKP+N+L+        +K+ DFG ++ S+  +  A + CG+  YMAPE++    +  
Sbjct: 149 YRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
            AD WS G ++F+++TG  PF G ++ +    IL +       G  + L P+   L R L
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-----LGMPQFLSPEAQSLLRML 260
Query: 251 LRQNPVERI 259
            ++NP  R+
Sbjct: 261 FKRNPANRL 269

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTIS-HPNIIRFF 75
           IG GS+A V   R ++     A++ + K+L++     D +  E  +    S HP ++   
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T  +++ V+EY +GGDL  ++ +  K+ E  AR +  +++  L  L E+ +I+RDL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ +      +K+ D+G  +  L P D   T CG+P Y+APEI++   Y    D 
Sbjct: 180 KLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236
Query: 195 WSVGAILFQLVTGKPPFD--GSN-------QLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           W++G ++F+++ G+ PFD  GS+       +  LFQ IL   ++R P      L      
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIP----RSLSVKAAS 291
Query: 246 LCRCLLRQNPVERI------TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           + +  L ++P ER+       F +   H F   +   +  EQ  VVP  KP +
Sbjct: 292 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM-MEQKQVVPPFKPNI 343

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 145/282 (51%), Gaps = 16/282 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + + E  +L    HP +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++        CG+P Y+APE+++++ Y    D W
Sbjct: 133 LENLMLDKD---GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 244
Query: 256 VERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +       Q  ++P  KP V
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQV 285

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 145/282 (51%), Gaps = 16/282 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + + E  +L    HP +     
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 77
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 78  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 137
Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++        CG+P Y+APE+++++ Y    D W
Sbjct: 138 LENLMLDKD---GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWW 194
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 195 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 249
Query: 256 VERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +       Q  ++P  KP V
Sbjct: 250 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQV 290

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 145/282 (51%), Gaps = 16/282 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+++  K    + + E  +L    HP +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++        CG+P Y+APE+++++ Y    D W
Sbjct: 133 LENLMLDKD---GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKSLLAGLLKKDP 244
Query: 256 VERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
            +R+       KE   HRF   +       Q  ++P  KP V
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQV 285

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 145/283 (51%), Gaps = 17/283 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   + +  G   A+K + K+++  K    + L E  +L    HP +     
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ-EKHLIHRDL 135
           + +T +++  V+EY +GG+L  ++ +    SE  AR +  ++ + L  L  EK++++RDL
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 136
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K +NL++  +     +KI DFG  +  +         CG+P Y+APE+++++ Y    D 
Sbjct: 137 KLENLMLDKD---GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 193
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++
Sbjct: 194 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----RTLGPEAKSLLSGLLKKD 248
Query: 255 PVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           P +R+       KE   HRF   +    H  +  + P  KP V
Sbjct: 249 PKQRLGGGSEDAKEIMQHRFFAGIVWQ-HVYEKKLSPPFKPQV 290

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 128/249 (51%), Gaps = 18/249 (7%)
Query: 18  IGSGSFAVVWRARH------RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           +G GSF  V+  +       RQL    A+K + K  L  +       E  IL  ++HP I
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQL---YAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 89
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++   A +T  K+YL+L++  GGDL   + K    +E   + ++ +LA  L  L    +I
Sbjct: 90  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 149
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +RDLKP+N+L+        +K+ DFG ++ S+  +  A + CG+  YMAPE++    +  
Sbjct: 150 YRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 206
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
            AD WS G ++F+++TG  PF G ++ +    IL +       G  + L P+   L R L
Sbjct: 207 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-----LGMPQFLSPEAQSLLRML 261
Query: 251 LRQNPVERI 259
            ++NP  R+
Sbjct: 262 FKRNPANRL 270

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  126 bits (316), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 145/283 (51%), Gaps = 17/283 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   + +  G   A+K + K+++  K    + L E  +L    HP +     
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ-EKHLIHRDL 135
           + +T +++  V+EY +GG+L  ++ +    SE  AR +  ++ + L  L  EK++++RDL
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 135
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K +NL++  +     +KI DFG  +  +         CG+P Y+APE+++++ Y    D 
Sbjct: 136 KLENLMLDKD---GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 192
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++
Sbjct: 193 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFP----RTLGPEAKSLLSGLLKKD 247
Query: 255 PVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           P +R+       KE   HRF   +    H  +  + P  KP V
Sbjct: 248 PKQRLGGGSEDAKEIMQHRFFAGIVWQ-HVYEKKLSPPFKPQV 289

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  126 bits (316), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 128/249 (51%), Gaps = 18/249 (7%)
Query: 18  IGSGSFAVVWRARH------RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           +G GSF  V+  +       RQL    A+K + K  L  +       E  IL  ++HP I
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQL---YAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++   A +T  K+YL+L++  GGDL   + K    +E   + ++ +LA  L  L    +I
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +RDLKP+N+L+        +K+ DFG ++ S+  +  A + CG+  YMAPE++    +  
Sbjct: 149 YRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
            AD WS G ++F+++TG  PF G ++ +    IL +       G  + L P+   L R L
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-----LGMPQFLSPEAQSLLRML 260
Query: 251 LRQNPVERI 259
            ++NP  R+
Sbjct: 261 FKRNPANRL 269

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  125 bits (315), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 140/287 (48%), Gaps = 31/287 (10%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS+ VV++ R+R  G  VA+K+  +    P +    L+EI +L  + HPN++   E
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
               + +++LV EYCD   L         V E + +    Q    +    + + IHRD+K
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVK 129
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPE-IIQNHKYDAKADL 194
           P+N+L++ +    V+K+ DFGFAR LT P D  D    +  Y +PE ++ + +Y    D+
Sbjct: 130 PENILITKHS---VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186
Query: 195 WSVGAILFQLVTGKPPFDGS---NQLQLFQNILT----------STELRFPPGAI---EE 238
           W++G +  +L++G P + G    +QL L +  L           ST   F    I   E+
Sbjct: 187 WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPED 246
Query: 239 LHP----------DCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           + P            + L +  L  +P ER+T ++  +H +   +R+
Sbjct: 247 MEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  125 bits (315), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 139/299 (46%), Gaps = 16/299 (5%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPN 70
           Y+V   IG GS++   R  H+   +E AVK IDK    P       +EI IL     HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS------EEIEILLRYGQHPN 82
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           II   +  +  + +YLV E   GG+L   I +    SE  A   +  +   ++ L  + +
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 131 IHRDLKPQNLLVSTNEVTP-VLKIGDFGFARSLTPQD-LADTLCGSPLYMAPEIIQNHKY 188
           +HRDLKP N+L       P  L+I DFGFA+ L  ++ L  T C +  ++APE+++   Y
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDG--SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           D   D+WS+G +L+ ++ G  PF    S+  +     + S +     G    +     DL
Sbjct: 203 DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDL 262
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGE-----LRQTVHAEQHSVVPETKPMVELLNSSTP 300
              +L  +P +R+T K+   H ++ +       Q  H +   V          LNSS P
Sbjct: 263 VSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNSSKP 321

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  125 bits (314), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 137/270 (50%), Gaps = 19/270 (7%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK--LLSPKVSDNLLKEISILSTI 66
           I ++I+   +G GSF  V+ A  ++     A+K + K   L+   V   ++++  +    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            HP +   F   +T+E ++ V+EY +GGDL  +I    K   + A  +  ++  GLQ L 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQN 185
            K +++RDLK  N+L+  +     +KI DFG  +     D   +  CG+P Y+APEI+  
Sbjct: 136 SKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG 192
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
            KY+   D WS G +L++++ G+ PF G ++ +LF +I       F P  +E+   +  D
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--FYPRWLEK---EAKD 247
Query: 246 LCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           L   L  + P +R+  +        G++RQ
Sbjct: 248 LLVKLFVREPEKRLGVR--------GDIRQ 269

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 18/229 (7%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V E  DGG+L + I   G    +E  A    + +   +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAI 174
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C +P Y+APE+
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL---FQNILTSTELRFPPGAIEEL 239
           +   KYD   D WS+G I + L+ G PPF  ++ L +    +  +   +  FP     E+
Sbjct: 235 LGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV 294
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPET 288
             +   L R LL+  P +R T  EF NH ++          Q + VP+T
Sbjct: 295 SEEVKXLIRNLLKTEPTQRXTITEFXNHPWI---------XQSTKVPQT 334

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 139/299 (46%), Gaps = 16/299 (5%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPN 70
           Y+V   IG GS++   R  H+   +E AVK IDK    P       +EI IL     HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS------EEIEILLRYGQHPN 82
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           II   +  +  + +YLV E   GG+L   I +    SE  A   +  +   ++ L  + +
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 131 IHRDLKPQNLLVSTNEVTP-VLKIGDFGFARSLTPQD-LADTLCGSPLYMAPEIIQNHKY 188
           +HRDLKP N+L       P  L+I DFGFA+ L  ++ L  T C +  ++APE+++   Y
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDG--SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           D   D+WS+G +L+ ++ G  PF    S+  +     + S +     G    +     DL
Sbjct: 203 DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDL 262
Query: 247 CRCLLRQNPVERITFKEFFNHRFLGE-----LRQTVHAEQHSVVPETKPMVELLNSSTP 300
              +L  +P +R+T K+   H ++ +       Q  H +   V          LNSS P
Sbjct: 263 VSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNSSKP 321

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 10/255 (3%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G FA  +           A K + K LL  P   + +  EISI  +++H +++ F  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E  + +++VLE C    L     +   ++E  AR+++RQ+  G Q L    +IHRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             NL +  NE   V KIGDFG A  +    +    LCG+P Y+APE++    +  + D+W
Sbjct: 167 LGNLFL--NEDLEV-KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVW 223
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G I++ L+ GKPPF+ S   + +  I    E   P    + ++P    L + +L+ +P
Sbjct: 224 SIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIP----KHINPVAASLIQKMLQTDP 278
Query: 256 VERITFKEFFNHRFL 270
             R T  E  N  F 
Sbjct: 279 TARPTINELLNDEFF 293

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 136/264 (51%), Gaps = 19/264 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 133 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 197 VGAILFQLVTGK---PPFDGSNQ-------LQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           +G  L ++  G+   PP D            +L   I+     + P G       D V+ 
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 248
Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
           C   L +NP ER   K+   H F+
Sbjct: 249 C---LIKNPAERADLKQLMVHAFI 269

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 10/255 (3%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G FA  +           A K + K LL  P   + +  EISI  +++H +++ F  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E  + +++VLE C    L     +   ++E  AR+++RQ+  G Q L    +IHRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             NL +  NE   V KIGDFG A  +    +    LCG+P Y+APE++    +  + D+W
Sbjct: 169 LGNLFL--NEDLEV-KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVW 225
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G I++ L+ GKPPF+ S   + +  I    E   P    + ++P    L + +L+ +P
Sbjct: 226 SIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIP----KHINPVAASLIQKMLQTDP 280
Query: 256 VERITFKEFFNHRFL 270
             R T  E  N  F 
Sbjct: 281 TARPTINELLNDEFF 295

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 27/293 (9%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTIS-HPNIIRFF 75
           IG GS+A V   R ++     A+K + K+L++     D +  E  +    S HP ++   
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T  +++ V+EY +GGDL  ++ +  K+ E  AR +  +++  L  L E+ +I+RDL
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 132
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ +      +K+ D+G  +  L P D     CG+P Y+APEI++   Y    D 
Sbjct: 133 KLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 189
Query: 195 WSVGAILFQLVTGKPPFD--GSN-------QLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           W++G ++F+++ G+ PFD  GS+       +  LFQ IL   ++R P      L      
Sbjct: 190 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIP----RSLSVKAAS 244
Query: 246 LCRCLLRQNPVERI------TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           + +  L ++P ER+       F +   H F   +   +  EQ  VVP  KP +
Sbjct: 245 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM-MEQKQVVPPFKPNI 296

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 133/254 (52%), Gaps = 9/254 (3%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 76  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 135
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L   ++A+   G+  YM+PE +Q   Y  ++D+WS
Sbjct: 136 PSNILVNSRG---EIKLCDFGVSGQLI-DEMANEFVGTRSYMSPERLQGTHYSVQSDIWS 191
Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G  L ++  G+ P       +L   I+     + P         D V+ C   L +NP 
Sbjct: 192 MGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKC---LIKNPA 248
Query: 257 ERITFKEFFNHRFL 270
           ER   K+   H F+
Sbjct: 249 ERADLKQLMVHAFI 262

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 10/255 (3%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G FA  +           A K + K LL  P   + +  EISI  +++H +++ F  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E  + +++VLE C    L     +   ++E  AR+++RQ+  G Q L    +IHRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             NL +  NE   V KIGDFG A  +    +    LCG+P Y+APE++    +  + D+W
Sbjct: 143 LGNLFL--NEDLEV-KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVW 199
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G I++ L+ GKPPF+ S   + +  I    E   P    + ++P    L + +L+ +P
Sbjct: 200 SIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIP----KHINPVAASLIQKMLQTDP 254
Query: 256 VERITFKEFFNHRFL 270
             R T  E  N  F 
Sbjct: 255 TARPTINELLNDEFF 269

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 144/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+ D  DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 73  VIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 134/248 (54%), Gaps = 17/248 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHPNII- 72
           +G GSF  V  A  +      A+K + K ++   + D+     + E  +L+ +  P  + 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVV---IQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           +     +T +++Y V+EY +GGDL  +I + GK  E  A  +  +++ GL  L ++ +I+
Sbjct: 84  QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIY 143
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLK  N+++ +      +KI DFG  +  +         CG+P Y+APEII    Y   
Sbjct: 144 RDLKLDNVMLDSEGH---IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKS 200
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D W+ G +L++++ G+PPFDG ++ +LFQ+I+    + +P    + L  + V +C+ L+
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP----KSLSKEAVSICKGLM 255
Query: 252 RQNPVERI 259
            ++P +R+
Sbjct: 256 TKHPAKRL 263

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 27/293 (9%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTIS-HPNIIRFF 75
           IG GS+A V   R ++     A+K + K+L++     D +  E  +    S HP ++   
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T  +++ V+EY +GGDL  ++ +  K+ E  AR +  +++  L  L E+ +I+RDL
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ +      +K+ D+G  +  L P D     CG+P Y+APEI++   Y    D 
Sbjct: 137 KLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 195 WSVGAILFQLVTGKPPFD--GSN-------QLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           W++G ++F+++ G+ PFD  GS+       +  LFQ IL   ++R P      L      
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIP----RSLSVKAAS 248
Query: 246 LCRCLLRQNPVERI------TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           + +  L ++P ER+       F +   H F   +   +  EQ  VVP  KP +
Sbjct: 249 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM-MEQKQVVPPFKPNI 300

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 127/246 (51%), Gaps = 12/246 (4%)
Query: 18  IGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G GSF  V+  R       G   A+K + K  L  +       E  IL+ ++HP +++ 
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
             A +T  K+YL+L++  GGDL   + K    +E   + ++ +LA GL  L    +I+RD
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRD 155
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
           LKP+N+L+        +K+ DFG ++ ++  +  A + CG+  YMAPE++    +   AD
Sbjct: 156 LKPENILLDEE---GHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSAD 212
Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ 253
            WS G ++F+++TG  PF G ++ +    IL +       G  + L  +   L R L ++
Sbjct: 213 WWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAK-----LGMPQFLSTEAQSLLRALFKR 267
Query: 254 NPVERI 259
           NP  R+
Sbjct: 268 NPANRL 273

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 146/293 (49%), Gaps = 27/293 (9%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTIS-HPNIIRFF 75
           IG GS+A V   R ++     A+K + K+L++     D +  E  +    S HP ++   
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T  +++ V+EY +GGDL  ++ +  K+ E  AR +  +++  L  L E+ +I+RDL
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 147
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ +      +K+ D+G  +  L P D     CG+P Y+APEI++   Y    D 
Sbjct: 148 KLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW 204
Query: 195 WSVGAILFQLVTGKPPFD--GSN-------QLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           W++G ++F+++ G+ PFD  GS+       +  LFQ IL   ++R P      +      
Sbjct: 205 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIP----RSMSVKAAS 259
Query: 246 LCRCLLRQNPVERI------TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
           + +  L ++P ER+       F +   H F   +   +  EQ  VVP  KP +
Sbjct: 260 VLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDM-MEQKQVVPPFKPNI 311

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 77  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 136 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 192
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 193 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 252
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 253 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  122 bits (306), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 136/270 (50%), Gaps = 19/270 (7%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK--LLSPKVSDNLLKEISILSTI 66
           I ++ +   +G GSF  V+ A  ++     A+K + K   L+   V   ++++  +    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            HP +   F   +T+E ++ V+EY +GGDL  +I    K   + A  +  ++  GLQ L 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQN 185
            K +++RDLK  N+L+  +     +KI DFG  +     D   +  CG+P Y+APEI+  
Sbjct: 137 SKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
            KY+   D WS G +L++++ G+ PF G ++ +LF +I       F P  +E+   +  D
Sbjct: 194 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--FYPRWLEK---EAKD 248
Query: 246 LCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           L   L  + P +R+  +        G++RQ
Sbjct: 249 LLVKLFVREPEKRLGVR--------GDIRQ 270

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  122 bits (306), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 73  VIHTENKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  122 bits (306), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  122 bits (305), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 73  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  122 bits (305), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 71  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 74  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 133 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 190 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 249
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 250 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 77  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 136 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 192
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 193 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 252
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 253 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 73  VIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 73  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 72  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 131 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 71  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 72  VIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 131 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 72  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 131 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 69  VIHTENKLYLVFEHVH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 71  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 74  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 133 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 190 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 249
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 250 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 144/285 (50%), Gaps = 32/285 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++  V++A++R+    VA+K +        V  + L+EI +L  + H NI+R  +
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + + +K+ LV E+CD  DL  Y    +G +   + + F+ QL  GL     ++++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK-YDAKAD 193
           KPQNLL++ N     LK+ +FG AR+   P         +  Y  P+++   K Y    D
Sbjct: 128 KPQNLLINRNG---ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 194 LWSVGAILFQLVT-GKPPFDGS---NQLQ-LFQNILTSTELRFPP--------------- 233
           +WS G I  +L   G+P F G+   +QL+ +F+ + T TE ++P                
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 234 -----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                  + +L+    DL + LL+ NPV+RI+ +E   H +  + 
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++  V++A++R+    VA+K +        V  + L+EI +L  + H NI+R  +
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + + +K+ LV E+CD  DL  Y    +G +   + + F+ QL  GL     ++++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK-YDAKAD 193
           KPQNLL++ N     LK+ DFG AR+   P         +  Y  P+++   K Y    D
Sbjct: 128 KPQNLLINRNG---ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 194 LWSVGAILFQLVTGKPPF----DGSNQLQ-LFQNILTSTELRFPP--------------- 233
           +WS G I  +L     P     D  +QL+ +F+ + T TE ++P                
Sbjct: 185 MWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 234 -----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                  + +L+    DL + LL+ NPV+RI+ +E   H +  + 
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 16/263 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG GSF  V++    +  +EVA  E+  + L+        +E   L  + HPNI+RF+++
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 78  IETREK----IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH--LI 131
            E+  K    I LV E    G L  Y+ +       V R + RQ+  GLQ L  +   +I
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLK  N+ ++    T  +KIGD G A +L     A  + G+P + APE  +  KYD  
Sbjct: 154 HRDLKCDNIFITGP--TGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYE-EKYDES 209
Query: 192 ADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEELH-PDCVDLCRC 249
            D+++ G    +  T + P+ +  N  Q+++ + +  +    P + +++  P+  ++   
Sbjct: 210 VDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEVKEIIEG 265
Query: 250 LLRQNPVERITFKEFFNHRFLGE 272
            +RQN  ER + K+  NH F  E
Sbjct: 266 CIRQNKDERYSIKDLLNHAFFQE 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 124/224 (55%), Gaps = 12/224 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 143/283 (50%), Gaps = 32/283 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++A++   G   A+K+I  +     +    ++EISIL  + H NI++ ++
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            I T++++ LV E+ D  DL   +    G +    A+ F+ QL  G+    ++ ++HRDL
Sbjct: 68  VIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQ-NHKYDAKAD 193
           KPQNLL++       LKI DFG AR+   P         +  Y AP+++  + KY    D
Sbjct: 127 KPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 194 LWSVGAILFQLVTGKPPFDG---SNQLQLFQNILTS---------TEL-RFPPG------ 234
           +WSVG I  ++V G P F G   ++QL     IL +         TEL ++ P       
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 235 -----AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE 272
                 ++ L    +DL   +L+ +P +RIT K+   H +  E
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 73  VIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKP+NLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPENLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 143/283 (50%), Gaps = 32/283 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++A++   G   A+K+I  +     +    ++EISIL  + H NI++ ++
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            I T++++ LV E+ D  DL   +    G +    A+ F+ QL  G+    ++ ++HRDL
Sbjct: 68  VIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQ-NHKYDAKAD 193
           KPQNLL++       LKI DFG AR+   P         +  Y AP+++  + KY    D
Sbjct: 127 KPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 194 LWSVGAILFQLVTGKPPFDG---SNQLQLFQNILTS---------TEL-RFPPG------ 234
           +WSVG I  ++V G P F G   ++QL     IL +         TEL ++ P       
Sbjct: 184 IWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 235 -----AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE 272
                 ++ L    +DL   +L+ +P +RIT K+   H +  E
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 71  VIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKP+NLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPENLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 143/283 (50%), Gaps = 32/283 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++A++   G   A+K+I  +     +    ++EISIL  + H NI++ ++
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            I T++++ LV E+ D  DL   +    G +    A+ F+ QL  G+    ++ ++HRDL
Sbjct: 68  VIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQ-NHKYDAKAD 193
           KPQNLL++       LKI DFG AR+   P         +  Y AP+++  + KY    D
Sbjct: 127 KPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 194 LWSVGAILFQLVTGKPPFDG---SNQLQLFQNILTS---------TEL-RFPPG------ 234
           +WSVG I  ++V G P F G   ++QL     IL +         TEL ++ P       
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 235 -----AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE 272
                 ++ L    +DL   +L+ +P +RIT K+   H +  E
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 72  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKP+NLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 131 LKPENLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 138/269 (51%), Gaps = 12/269 (4%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEID-KKLLSPKVSDNLL--KEISILS 64
           L  +Y++   +G G F +V R       +E + K+    K +  K +D +L  KEISIL+
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRC------VETSSKKTYMAKFVKVKGTDQVLVKKEISILN 56
Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQ 123
              H NI+   E+ E+ E++ ++ E+  G D+   I+    +++E     ++ Q+   LQ
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
            L   ++ H D++P+N++  T   +  +KI +FG AR L P D    L  +P Y APE+ 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           Q+       D+WS+G +++ L++G  PF      Q+ +NI+ + E  F   A +E+  + 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-EYTFDEEAFKEISIEA 234
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGE 272
           +D    LL +    R+T  E   H +L +
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 71  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKP+NLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPENLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 143/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKP+NLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPENLLINTEG---AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 131/245 (53%), Gaps = 11/245 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTISHPNIIRFF 75
           +G GSF  V  +  +      AVK + K ++     V   ++++  +      P + +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T +++Y V+EY +GGDL  +I + G+  E  A  +  ++A GL  LQ K +I+RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+++ +      +KI DFG  + ++         CG+P Y+APEII    Y    D 
Sbjct: 148 KLDNVMLDSE---GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W+ G +L++++ G+ PF+G ++ +LFQ+I+    + +P    + +  + V +C+ L+ ++
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYP----KSMSKEAVAICKGLMTKH 259
Query: 255 PVERI 259
           P +R+
Sbjct: 260 PGKRL 264

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 133/282 (47%), Gaps = 32/282 (11%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFE 76
           +G G++A V  A   Q G E AVK I+K+  +      + +E+  L     + NI+   E
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQ--AGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E   + YLV E   GG + A+I K    +E  A   +R +AA L  L  K + HRDLK
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLK 138
Query: 137 PQNLLVSTNEVTPVLKIGDFGFA------RSLTPQDLAD--TLCGSPLYMAPEII----- 183
           P+N+L  + E    +KI DF          S TP    +  T CGS  YMAPE++     
Sbjct: 139 PENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTD 198
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGS---------------NQLQLFQNILTSTE 228
           Q   YD + DLWS+G +L+ +++G PPF G                 Q +LF++I    +
Sbjct: 199 QATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI-QEGK 257
Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             FP      +  +  DL   LL ++  +R++  +   H ++
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 131/245 (53%), Gaps = 11/245 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTISHPNIIRFF 75
           +G GSF  V  +  +      AVK + K ++     V   ++++  +      P + +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T +++Y V+EY +GGDL  +I + G+  E  A  +  ++A GL  LQ K +I+RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+++ +      +KI DFG  + ++         CG+P Y+APEII    Y    D 
Sbjct: 469 KLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W+ G +L++++ G+ PF+G ++ +LFQ+I+    + +P    + +  + V +C+ L+ ++
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYP----KSMSKEAVAICKGLMTKH 580
Query: 255 PVERI 259
           P +R+
Sbjct: 581 PGKRL 585

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 133/257 (51%), Gaps = 13/257 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+++++ +   PK  + ++ EI ++    +PNI+ + +
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPK-KELIINEILVMRENKNPNIVNYLD 84
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   + +   + E       R+    L+ L    +IHRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+  +     +K+ DFGF   +TP Q    T+ G+P +MAPE++    Y  K D+W
Sbjct: 144 SDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILT--STELRFPPGAIEELHPDCVDLCRCLLRQ 253
           S+G +  +++ G+PP+   N L+    I T  + EL+ P    E+L     D     L  
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----EKLSAIFRDFLNRCLDM 256
Query: 254 NPVERITFKEFFNHRFL 270
           +  +R + KE   H+FL
Sbjct: 257 DVEKRGSAKELLQHQFL 273

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 142/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+ +I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 142/289 (49%), Gaps = 32/289 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G++ VV++AR++  G  VA+ +I     +  V    ++EIS+L  ++HPNI++  +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            I T  K+YLV E+    DL  ++       +   + + ++ QL  GL       ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKYDAKA- 192
           LKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP---------------- 232
           D+WS+G I  ++VT +  F G +++    ++F+ + T  E+ +P                
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 233 ----PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
                  +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 137/284 (48%), Gaps = 7/284 (2%)
Query: 12  YIVGPR-IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHP 69
           YI+  + +G G FAVV +   +  G E A K + K+         +L EI++L    S P
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYI--HKHGKVSEAVARHFMRQLAAGLQVLQE 127
            +I   E  E   +I L+LEY  GG++ +         VSE      ++Q+  G+  L +
Sbjct: 90  RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
            +++H DLKPQN+L+S+      +KI DFG +R +        + G+P Y+APEI+    
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP 209
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
                D+W++G I + L+T   PF G +  + + NI +   + +       +     D  
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-SQVNVDYSEETFSSVSQLATDFI 268
Query: 248 RCLLRQNPVERITFKEFFNHRFLGE--LRQTVHAEQHSVVPETK 289
           + LL +NP +R T +   +H +L +       H E+ S   +T+
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQ 312

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 154/303 (50%), Gaps = 31/303 (10%)
Query: 1   MEPNRT-RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE 59
           ++PN    ++GE      +G G+F  V++A++++ G   A K I+ K  S +  ++ + E
Sbjct: 15  LDPNEVWEIVGE------LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVE 66
Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQL 118
           I IL+T  HP I++   A     K+++++E+C GG + A + +  + ++E   +   RQ+
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF-ARSLTPQDLADTLCGSPLY 177
              L  L  K +IHRDLK  N+L++   +   +++ DFG  A++L      D+  G+P +
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183
Query: 178 MAPEII-----QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           MAPE++     ++  YD KAD+WS+G  L ++   +PP    N +++   I  S     P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD----P 239
Query: 233 PGAI--EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE------LRQTVHAEQHSV 284
           P  +   +   +  D  +  L +NP  R +  +   H F+        LR+ V   +  V
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEV 299
Query: 285 VPE 287
           + E
Sbjct: 300 MEE 302

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 147/283 (51%), Gaps = 25/283 (8%)
Query: 1   MEPNRT-RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE 59
           ++PN    ++GE      +G G+F  V++A++++ G   A K I+ K  S +  ++ + E
Sbjct: 7   LDPNEVWEIVGE------LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVE 58
Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQL 118
           I IL+T  HP I++   A     K+++++E+C GG + A + +  + ++E   +   RQ+
Sbjct: 59  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 118
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF-ARSLTPQDLADTLCGSPLY 177
              L  L  K +IHRDLK  N+L++   +   +++ DFG  A++L      D+  G+P +
Sbjct: 119 LEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 175
Query: 178 MAPEII-----QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           MAPE++     ++  YD KAD+WS+G  L ++   +PP    N +++   I  S     P
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD----P 231
Query: 233 PGAI--EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
           P  +   +   +  D  +  L +NP  R +  +   H F+  +
Sbjct: 232 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 274

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 21/261 (8%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--NLLKEISILSTISHPNIIRF 74
           ++G GS+  V++A H++ G  VA+K++      P  SD   ++KEISI+     P+++++
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQV------PVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKHLIHR 133
           + +      +++V+EYC  G ++  I    K ++E      ++    GL+ L     IHR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNHKYDAKA 192
           D+K  N+L++T       K+ DFG A  LT      + + G+P +MAPE+IQ   Y+  A
Sbjct: 150 DIKAGNILLNTEGHA---KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVA 206
Query: 193 DLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE--ELHPD-CVDLCRC 249
           D+WS+G    ++  GKPP+   + ++    I T+     PP      EL  D   D  + 
Sbjct: 207 DIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-----PPPTFRKPELWSDNFTDFVKQ 261
Query: 250 LLRQNPVERITFKEFFNHRFL 270
            L ++P +R T  +   H F+
Sbjct: 262 CLVKSPEQRATATQLLQHPFV 282

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  118 bits (296), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 133/273 (48%), Gaps = 13/273 (4%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL 63
           N  +    Y V   IG GS++V  R  H+   +E AVK IDK    P       +EI IL
Sbjct: 16  NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEIL 69
Query: 64  STIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
                HPNII   +  +  + +Y+V E   GG+L   I +    SE  A   +  +   +
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTP-VLKIGDFGFARSLTPQD-LADTLCGSPLYMAP 180
           + L  + ++HRDLKP N+L       P  ++I DFGFA+ L  ++ L  T C +  ++AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPF-DGSNQL--QLFQNILTSTELRFPPGAIE 237
           E+++   YDA  D+WS+G +L+ ++TG  PF +G +    ++   I  S +     G   
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-GSGKFSLSGGYWN 248
Query: 238 ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
            +     DL   +L  +P +R+T      H ++
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 132/259 (50%), Gaps = 18/259 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           RIG GSF  V++         VA+K ID +       +++ +EI++LS    P I R+F 
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + K G + E      +R++  GL  L  +  IHRD+K
Sbjct: 85  SYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+S       +K+ DFG A  LT   +  +   G+P +MAPE+I+   YD KAD+W
Sbjct: 144 AANVLLSEQGD---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIW 200
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH----PDCVDLCRCLL 251
           S+G    +L  G+PP    + +++   I  ++     P  +E  H     + V+ C   L
Sbjct: 201 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-----PPTLEGQHSKPFKEFVEAC---L 252
Query: 252 RQNPVERITFKEFFNHRFL 270
            ++P  R T KE   H+F+
Sbjct: 253 NKDPRFRPTAKELLKHKFI 271

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS--PKVSDNLLKEISIL 63
            +LIG+Y++G  +G GS+  V      +     AVK + KK L   P    N+ KEI +L
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 64  STISHPNIIRFFEAI--ETREKIYLVLEYCDGGD---LAAYIHKHGKVSEAVARHFMRQL 118
             + H N+I+  + +  E ++K+Y+V+EYC  G    L +   K   V +A    +  QL
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA--HGYFCQL 118
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSP 175
             GL+ L  + ++H+D+KP NLL++T      LKI   G A +L P    D   T  GSP
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGG---TLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 176 LYMAPEIIQNHKYDA--KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP 233
            +  PEI       +  K D+WS G  L+ + TG  PF+G N  +LF+NI   +     P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI--P 233
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           G   +  P   DL + +L   P +R + ++   H + 
Sbjct: 234 G---DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 132/257 (51%), Gaps = 13/257 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+++++ +   PK  + ++ EI ++    +PNI+ + +
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPK-KELIINEILVMRENKNPNIVNYLD 84
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   + +   + E       R+    L+ L    +IHRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+  +     +K+ DFGF   +TP Q     + G+P +MAPE++    Y  K D+W
Sbjct: 144 SDNILLGMD---GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILT--STELRFPPGAIEELHPDCVDLCRCLLRQ 253
           S+G +  +++ G+PP+   N L+    I T  + EL+ P    E+L     D     L  
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----EKLSAIFRDFLNRCLEM 256
Query: 254 NPVERITFKEFFNHRFL 270
           +  +R + KE   H+FL
Sbjct: 257 DVEKRGSAKELLQHQFL 273

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 133/257 (51%), Gaps = 13/257 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+++++ +   PK  + ++ EI ++    +PNI+ + +
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPK-KELIINEILVMRENKNPNIVNYLD 85
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   + +   + E       R+    L+ L    +IHR++K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRNIK 144
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+  +     +K+ DFGF   +TP Q    T+ G+P +MAPE++    Y  K D+W
Sbjct: 145 SDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILT--STELRFPPGAIEELHPDCVDLCRCLLRQ 253
           S+G +  +++ G+PP+   N L+    I T  + EL+ P    E+L     D     L  
Sbjct: 202 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----EKLSAIFRDFLNRCLEM 257
Query: 254 NPVERITFKEFFNHRFL 270
           +  +R + KE   H+FL
Sbjct: 258 DVEKRGSAKELIQHQFL 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 132/257 (51%), Gaps = 13/257 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+++++ +   PK  + ++ EI ++    +PNI+ + +
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPK-KELIINEILVMRENKNPNIVNYLD 85
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   + +   + E       R+    L+ L    +IHRD+K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 144
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+  +     +K+ DFGF   +TP Q     + G+P +MAPE++    Y  K D+W
Sbjct: 145 SDNILLGMD---GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILT--STELRFPPGAIEELHPDCVDLCRCLLRQ 253
           S+G +  +++ G+PP+   N L+    I T  + EL+ P    E+L     D     L  
Sbjct: 202 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----EKLSAIFRDFLNRCLEM 257
Query: 254 NPVERITFKEFFNHRFL 270
           +  +R + KE   H+FL
Sbjct: 258 DVEKRGSAKELIQHQFL 274

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 129/255 (50%), Gaps = 10/255 (3%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           RIG GSF  V++    +    VA+K ID +       +++ +EI++LS      + +++ 
Sbjct: 30  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + + G   E      ++++  GL  L  +  IHRD+K
Sbjct: 89  SYLKGSKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+S       +K+ DFG A  LT   +  +T  G+P +MAPE+IQ   YD+KAD+W
Sbjct: 148 AANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 204
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G    +L  G+PP    + +++   I  +     PP  + +      +     L ++P
Sbjct: 205 SLGITAIELAKGEPPNSDMHPMRVLFLIPKNN----PPTLVGDFTKSFKEFIDACLNKDP 260
Query: 256 VERITFKEFFNHRFL 270
             R T KE   H+F+
Sbjct: 261 SFRPTAKELLKHKFI 275

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 132/257 (51%), Gaps = 13/257 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+++++ +   PK  + ++ EI ++    +PNI+ + +
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPK-KELIINEILVMRENKNPNIVNYLD 84
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   + +   + E       R+    L+ L    +IHRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             N+L+  +     +K+ DFGF   +TP Q     + G+P +MAPE++    Y  K D+W
Sbjct: 144 SDNILLGMD---GSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILT--STELRFPPGAIEELHPDCVDLCRCLLRQ 253
           S+G +  +++ G+PP+   N L+    I T  + EL+ P    E+L     D     L  
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----EKLSAIFRDFLNRCLDM 256
Query: 254 NPVERITFKEFFNHRFL 270
           +  +R + KE   H+FL
Sbjct: 257 DVEKRGSAKELLQHQFL 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 145/298 (48%), Gaps = 32/298 (10%)
Query: 13  IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           I+G  +G G+F  V++A++++  +  A K ID K  S +  ++ + EI IL++  HPNI+
Sbjct: 41  IIG-ELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIV 97
Query: 73  RFFEAIETREKIYLVLEYCDGGDL-AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +  +A      +++++E+C GG + A  +     ++E+  +   +Q    L  L +  +I
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGF-ARSLTPQDLADTLCGSPLYMAPEII-----QN 185
           HRDLK  N+L + +     +K+ DFG  A++       D+  G+P +MAPE++     ++
Sbjct: 158 HRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE--ELHPDC 243
             YD KAD+WS+G  L ++   +PP    N +++   I  S     PP   +      + 
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE----PPTLAQPSRWSSNF 270
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPE 301
            D  +  L +N   R T  +   H F+              V   KP+ EL+  +  E
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFV-------------TVDSNKPIRELIAEAKAE 315

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 145/298 (48%), Gaps = 32/298 (10%)
Query: 13  IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           I+G  +G G+F  V++A++++  +  A K ID K  S +  ++ + EI IL++  HPNI+
Sbjct: 41  IIG-ELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIV 97
Query: 73  RFFEAIETREKIYLVLEYCDGGDL-AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +  +A      +++++E+C GG + A  +     ++E+  +   +Q    L  L +  +I
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGF-ARSLTPQDLADTLCGSPLYMAPEII-----QN 185
           HRDLK  N+L + +     +K+ DFG  A++       D+  G+P +MAPE++     ++
Sbjct: 158 HRDLKAGNILFTLD---GDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE--ELHPDC 243
             YD KAD+WS+G  L ++   +PP    N +++   I  S     PP   +      + 
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE----PPTLAQPSRWSSNF 270
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPE 301
            D  +  L +N   R T  +   H F+              V   KP+ EL+  +  E
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFV-------------TVDSNKPIRELIAEAKAE 315

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 114/203 (56%), Gaps = 13/203 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-------LLSPKVSDNLLKEISILSTISHPN 70
           +GSG+F  VW A  ++   EV VK I K+       +  PK+    L EI+ILS + H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 71  IIRFFEAIETREKIYLVLE-YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           II+  +  E +    LV+E +  G DL A+I +H ++ E +A +  RQL + +  L+ K 
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYD 189
           +IHRD+K +N++++ +     +K+ DFG A  L    L  T CG+  Y APE++  + Y 
Sbjct: 151 IIHRDIKDENIVIAEDF---TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR 207
Query: 190 A-KADLWSVGAILFQLVTGKPPF 211
             + ++WS+G  L+ LV  + PF
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPF 230

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 109/214 (50%), Gaps = 9/214 (4%)
Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           +  N  +    Y V   IG GS++V  R  H+    E AVK IDK    P       +EI
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPT------EEI 66
Query: 61  SILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
            IL     HPNII   +  +  + +Y+V E   GG+L   I +    SE  A   +  + 
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTP-VLKIGDFGFARSLTPQD-LADTLCGSPLY 177
             ++ L  + ++HRDLKP N+L       P  ++I DFGFA+ L  ++ L  T C +  +
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANF 186
Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPF 211
           +APE+++   YDA  D+WS+G +L+  +TG  PF
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 130/256 (50%), Gaps = 12/256 (4%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GSF  V++    +    VA+K ID +       +++ +EI++LS    P + +++ 
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + + G + E      +R++  GL  L  +  IHRD+K
Sbjct: 93  SYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADL 194
             N+L+S + EV    K+ DFG A  LT   +  +T  G+P +MAPE+I+   YD+KAD+
Sbjct: 152 AANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 207
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS+G    +L  G+PP    + +++   I  +     PP           +     L + 
Sbjct: 208 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 263
Query: 255 PVERITFKEFFNHRFL 270
           P  R T KE   H+F+
Sbjct: 264 PSFRPTAKELLKHKFI 279

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 144/298 (48%), Gaps = 32/298 (10%)
Query: 13  IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           I+G  +G G+F  V++A++++  +  A K ID K  S +  ++ + EI IL++  HPNI+
Sbjct: 41  IIG-ELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIV 97
Query: 73  RFFEAIETREKIYLVLEYCDGGDL-AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +  +A      +++++E+C GG + A  +     ++E+  +   +Q    L  L +  +I
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 157
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGF-ARSLTPQDLADTLCGSPLYMAPEII-----QN 185
           HRDLK  N+L + +     +K+ DFG  A++       D   G+P +MAPE++     ++
Sbjct: 158 HRDLKAGNILFTLD---GDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE--ELHPDC 243
             YD KAD+WS+G  L ++   +PP    N +++   I  S     PP   +      + 
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE----PPTLAQPSRWSSNF 270
Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPE 301
            D  +  L +N   R T  +   H F+              V   KP+ EL+  +  E
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFV-------------TVDSNKPIRELIAEAKAE 315

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 130/256 (50%), Gaps = 12/256 (4%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GSF  V++    +    VA+K ID +       +++ +EI++LS    P + +++ 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + + G + E      +R++  GL  L  +  IHRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADL 194
             N+L+S + EV    K+ DFG A  LT   +  +T  G+P +MAPE+I+   YD+KAD+
Sbjct: 132 AANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS+G    +L  G+PP    + +++   I  +     PP           +     L + 
Sbjct: 188 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 243
Query: 255 PVERITFKEFFNHRFL 270
           P  R T KE   H+F+
Sbjct: 244 PSFRPTAKELLKHKFI 259

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 113/218 (51%), Gaps = 6/218 (2%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           I  Y    ++G G++  V++A        VA+K I  +     V    ++E+S+L  + H
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
            NII     I    +++L+ EY +  DL  Y+ K+  VS  V + F+ QL  G+     +
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 129 HLIHRDLKPQNLLVSTNEV--TPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQN 185
             +HRDLKPQNLL+S ++   TPVLKIGDFG AR+   P         +  Y  PEI+  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 186 HK-YDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ 221
            + Y    D+WS+  I  +++   P F G +++ QLF+
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  115 bits (288), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 132/253 (52%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y+++E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 134
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 135 LAARNCLVGENH---LVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 246
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 247 WQWNPSDRPSFAE 259

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 134 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 247
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 248 ENPSARITIPDIKKDRW 264

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 134
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 135 LAARNCLVGENH---LVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 246
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 247 WQWNPSDRPSFAE 259

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 136/259 (52%), Gaps = 17/259 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  AR +  G +VAVK +D  L   +  + L  E+ I+    H N++  ++
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    E++++++E+  GG L   + +     E +A      L A L  L  + +IHRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQA-LAYLHAQGVIHRDIK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQNHKYDAKADL 194
             ++L++ +     +K+ DFGF   ++ +D+     L G+P +MAPE+I    Y  + D+
Sbjct: 169 SDSILLTLD---GRVKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYATEVDI 224
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH---PDCVDLCRCLL 251
           WS+G ++ ++V G+PP+   + +Q  + +  S     PP  ++  H   P   D    +L
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-----PPPKLKNSHKVSPVLRDFLERML 279
Query: 252 RQNPVERITFKEFFNHRFL 270
            ++P ER T +E  +H FL
Sbjct: 280 VRDPQERATAQELLDHPFL 298

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 132/253 (52%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y+++E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 137 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 248
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 249 WQWNPSDRPSFAE 261

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 116/231 (50%), Gaps = 19/231 (8%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           EY +   IG+G++ VV  AR R  G +VA+K+I         +   L+E+ IL    H N
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 71  IIRFFEAIETR------EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
           II   + +         + +Y+VL+  +  DL   IH    ++    R+F+ QL  GL+ 
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-----QDLADTLCGSPLYMA 179
           +    +IHRDLKP NLLV+ N     LKIGDFG AR L       Q        +  Y A
Sbjct: 174 MHSAQVIHRDLKPSNLLVNEN---CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 180 PEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTS 226
           PE++ + H+Y    DLWSVG I  +++  +  F G N   QLQL   +L +
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 132/253 (52%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y+++E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 137 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 248
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 249 WQWNPSDRPSFAE 261

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 134 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 247
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 248 ENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 134 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 247
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 248 ENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 134 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 247
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 248 ENPSARITIPDIKKDRW 264

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 30  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 84
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 85  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 145 LRAANILVSD---TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 257
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 258 KERPEDRPTF 267

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 131/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I + ++H N+++F+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 134 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 247
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 248 ENPSARITIPDIKKDRW 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 28  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 82
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 83  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 143 LRAANILVSD---TLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 255
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 256 KERPEDRPTF 265

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 116/231 (50%), Gaps = 19/231 (8%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           EY +   IG+G++ VV  AR R  G +VA+K+I         +   L+E+ IL    H N
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 71  IIRFFEAIETR------EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
           II   + +         + +Y+VL+  +  DL   IH    ++    R+F+ QL  GL+ 
Sbjct: 116 IIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-----QDLADTLCGSPLYMA 179
           +    +IHRDLKP NLLV+ N     LKIGDFG AR L       Q        +  Y A
Sbjct: 175 MHSAQVIHRDLKPSNLLVNEN---CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 180 PEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTS 226
           PE++ + H+Y    DLWSVG I  +++  +  F G N   QLQL   +L +
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 282

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 74
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 135 LRAANILVSD---TLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 247
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 248 KERPEDRPTF 257

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 26  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 80
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 81  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 141 LRAANILVSD---TLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 253
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 254 KERPEDRPTF 263

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 137/280 (48%), Gaps = 24/280 (8%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y +   IGSG+ AVV  A       +VA+K I+ +     + D LLKEI  +S   HPN
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPN 74
Query: 71  IIRFFEAIETREKIYLVLEYCDGG---DLAAYI-----HKHGKVSEAVARHFMRQLAAGL 122
           I+ ++ +   +++++LV++   GG   D+  +I     HK G + E+     +R++  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL------TPQDLADTLCGSPL 176
           + L +   IHRD+K  N+L+  +     ++I DFG +  L      T   +  T  G+P 
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 177 YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           +MAPE++ Q   YD KAD+WS G    +L TG  P+     +++    L +       G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251
Query: 236 -----IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                +++       +    L+++P +R T  E   H+F 
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 26  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 80
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 81  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 141 LRAANILVSD---TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 253
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 254 KERPEDRPTF 263

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 25  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 80  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 140 LRAANILVSD---TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 252
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 253 KERPEDRPTF 262

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 92/289 (31%), Positives = 139/289 (48%), Gaps = 25/289 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG GSF  V+ AR  +    VA+K++    K  + K  D ++KE+  L  + HPN I++ 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHPNTIQYR 120
Query: 76  EAIETREKIYLVLEYCDGG--DLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                    +LV+EYC G   DL   +HK    +V  A   H   Q   GL  L   ++I
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQ---GLAYLHSHNMI 176
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII---QNHKY 188
           HRD+K  N+L+S      ++K+GDFG A  + P   A+   G+P +MAPE+I      +Y
Sbjct: 177 HRDVKAGNILLSE---PGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQY 230
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           D K D+WS+G    +L   KPP    N +    +I  +       G   E   + VD C 
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC- 289
Query: 249 CLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
             L++ P +R T +    HRF+  LR+        ++  TK  V  L++
Sbjct: 290 --LQKIPQDRPTSEVLLKHRFV--LRERPPTVIMDLIQRTKDAVRELDN 334

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 131
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 132 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 245
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 246 ENPSARITIPDIKKDRW 262

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 74
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 135 LRAANILVSD---TLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 247
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 248 KERPEDRPTF 257

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 74
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 135 LRAANILVSD---TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 247
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 248 KERPEDRPTF 257

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 21  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 75
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 76  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 136 LRAANILVSD---TLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 248
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 249 KERPEDRPTF 258

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 15  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 70  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 130 LRAANILVSD---TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 242
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 243 KERPEDRPTF 252

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 29  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 83
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 84  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 144 LRAANILVSD---TLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 256
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 257 KERPEDRPTF 266

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 22  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 77  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 137 LRAANILVSD---TLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 249
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 250 KERPEDRPTF 259

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 137/280 (48%), Gaps = 24/280 (8%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y +   IGSG+ AVV  A       +VA+K I+ +     + D LLKEI  +S   HPN
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPN 69
Query: 71  IIRFFEAIETREKIYLVLEYCDGG---DLAAYI-----HKHGKVSEAVARHFMRQLAAGL 122
           I+ ++ +   +++++LV++   GG   D+  +I     HK G + E+     +R++  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL------TPQDLADTLCGSPL 176
           + L +   IHRD+K  N+L+  +     ++I DFG +  L      T   +  T  G+P 
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 177 YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           +MAPE++ Q   YD KAD+WS G    +L TG  P+     +++    L +       G 
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 246
Query: 236 -----IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                +++       +    L+++P +R T  E   H+F 
Sbjct: 247 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 132/253 (52%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y+++E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 137
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 138 LAARNCLVGENH---LVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIK 193
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 249
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 250 WQWNPSDRPSFAE 262

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 142 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 253
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 254 WQWNPSDRPSFAE 266

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 134 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 247
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 248 ENPSARITIPDIKKDRW 264

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 134 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 247
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 248 ENPSARITIPDIKKDRW 264

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 132/253 (52%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y+++E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 142 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 253
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 254 WQWNPSDRPSFAE 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 137 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 248
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 249 WQWNPSDRPSFAE 261

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 92/289 (31%), Positives = 139/289 (48%), Gaps = 25/289 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG GSF  V+ AR  +    VA+K++    K  + K  D ++KE+  L  + HPN I++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHPNTIQYR 81
Query: 76  EAIETREKIYLVLEYCDGG--DLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                    +LV+EYC G   DL   +HK    +V  A   H   Q   GL  L   ++I
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQ---GLAYLHSHNMI 137
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII---QNHKY 188
           HRD+K  N+L+S      ++K+GDFG A  + P   A+   G+P +MAPE+I      +Y
Sbjct: 138 HRDVKAGNILLSE---PGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQY 191
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           D K D+WS+G    +L   KPP    N +    +I  +       G   E   + VD C 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC- 250
Query: 249 CLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
             L++ P +R T +    HRF+  LR+        ++  TK  V  L++
Sbjct: 251 --LQKIPQDRPTSEVLLKHRFV--LRERPPTVIMDLIQRTKDAVRELDN 295

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 137 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 248
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 249 WQWNPSDRPSFAE 261

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 129/256 (50%), Gaps = 12/256 (4%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GSF  V++    +    VA+K ID +       +++ +EI++LS    P + +++ 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + + G + E      +R++  GL  L  +  IHRD+K
Sbjct: 88  SYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADL 194
             N+L+S + EV    K+ DFG A  LT   +  +   G+P +MAPE+I+   YD+KAD+
Sbjct: 147 AANVLLSEHGEV----KLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS+G    +L  G+PP    + +++   I  +     PP           +     L + 
Sbjct: 203 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 258
Query: 255 PVERITFKEFFNHRFL 270
           P  R T KE   H+F+
Sbjct: 259 PSFRPTAKELLKHKFI 274

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 134
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 135 LAARNCLVGENH---LVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 246
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 247 WQWNPSDRPSFAE 259

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 147/298 (49%), Gaps = 52/298 (17%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +G G   +V+ A        VA+K+I   L  P+   + L+EI I+  + H NI++ FE 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 77  -------------AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
                        ++     +Y+V EY +  DLA  + + G + E  AR FM QL  GL+
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLK 134
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-----DLADTLCGSPLYM 178
            +   +++HRDLKP NL ++T ++  VLKIGDFG AR + P       L++ L  +  Y 
Sbjct: 135 YIHSANVLHRDLKPANLFINTEDL--VLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYR 191
Query: 179 APEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS----------- 226
           +P ++ + + Y    D+W+ G I  +++TGK  F G+++L+  Q IL S           
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE 251
Query: 227 ----------TELRFPPGAIEELHP----DCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                      ++  P   + +L P    + VD    +L  +P++R+T +E  +H ++
Sbjct: 252 LLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 129/256 (50%), Gaps = 12/256 (4%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GSF  V++    +    VA+K ID +       +++ +EI++LS    P + +++ 
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG  A  + + G + E      +R++  GL  L  +  IHRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLA-DTLCGSPLYMAPEIIQNHKYDAKADL 194
             N+L+S + EV    K+ DFG A  LT   +  +   G+P +MAPE+I+   YD+KAD+
Sbjct: 132 AANVLLSEHGEV----KLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS+G    +L  G+PP    + +++   I  +     PP           +     L + 
Sbjct: 188 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 243
Query: 255 PVERITFKEFFNHRFL 270
           P  R T KE   H+F+
Sbjct: 244 PSFRPTAKELLKHKFI 259

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K+ IHR+
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 344 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 455
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 456 WQWNPSDRPSFAE 468

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 142 LAARNCLVGENH---LVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 253
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 254 WQWNPSDRPSFAE 266

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 142 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 253
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 254 WQWNPSDRPSFAE 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 142 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 253
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 254 WQWNPSDRPSFAE 266

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 140
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 141 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 252
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 253 WQWNPSDRPSFAE 265

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 16  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 70
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHR+
Sbjct: 71  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN 130
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 131 LRAANILVSD---TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 243
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 244 KERPEDRPTF 253

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 139 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIK 194
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 250
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 251 WQWNPSDRPSFAE 263

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 137
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 138 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIK 193
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 249
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 250 WQWNPSDRPSFAE 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 139 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 250
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 251 WQWNPSDRPSFAE 263

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 149
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 150 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 205
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 206 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 261
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 262 WQWNPSDRPSFAE 274

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 143/294 (48%), Gaps = 47/294 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 135 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 194
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 195 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 250
Query: 197 VGAILFQLVTGK---PPFDGSNQLQLF------------------QNILTSTEL-RFPPG 234
           +G  L ++  G+   PP D      +F                     L+S  +   PP 
Sbjct: 251 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM 310
Query: 235 AIEELHPDCVD------------------LCRCLLRQNPVERITFKEFFNHRFL 270
           AI EL    V+                  + +CL++ NP ER   K+   H F+
Sbjct: 311 AIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFI 363

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 139 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 250
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 251 WQWNPSDRPSFAE 263

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 137 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 248
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 249 WQWNPSDRPSFAE 261

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 12/212 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++ +V+  R     + +A+KEI ++    + S  L +EI++   + H NI+++  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 78  IETREKIYLVLEYCDGGDLAAYIH-KHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                 I + +E   GG L+A +  K G  K +E     + +Q+  GL+ L +  ++HRD
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLYMAPEIIQN--HKYDAK 191
           +K  N+L++T   + VLKI DFG ++ L   +   +T  G+  YMAPEII      Y   
Sbjct: 148 IKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 192 ADLWSVGAILFQLVTGKPPFD--GSNQLQLFQ 221
           AD+WS+G  + ++ TGKPPF   G  Q  +F+
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFK 237

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 137 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 248
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 249 WQWNPSDRPSFAE 261

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 37/297 (12%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHP 69
           YI   ++G G++A V++ + +     VA+KEI  + +  +P  +   ++E+S+L  + H 
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA---IREVSLLKDLKHA 60
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEK 128
           NI+   + I T + + LV EY D  DL  Y+   G + +    + F+ QL  GL     +
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEI-IQNH 186
            ++HRDLKPQNLL++       LK+ DFG AR+ + P    D    +  Y  P+I + + 
Sbjct: 120 KVLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTSTELRFPPGAIE------ 237
            Y  + D+W VG I +++ TG+P F GS    QL     IL +      PG +       
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 238 ----------------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVH 278
                            L  D  DL   LL+     RI+ ++   H F   L + +H
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 143/294 (48%), Gaps = 47/294 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 133 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 197 VGAILFQLVTGK---PPFDGSNQLQLF------------------QNILTSTEL-RFPPG 234
           +G  L ++  G+   PP D      +F                     L+S  +   PP 
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM 248
Query: 235 AIEELHPDCVD------------------LCRCLLRQNPVERITFKEFFNHRFL 270
           AI EL    V+                  + +CL++ NP ER   K+   H F+
Sbjct: 249 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFI 301

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G+   V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + +CG+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 116/212 (54%), Gaps = 12/212 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++ +V+  R     + +A+KEI ++    + S  L +EI++   + H NI+++  +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIH-KHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                 I + +E   GG L+A +  K G  K +E     + +Q+  GL+ L +  ++HRD
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 133
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLYMAPEIIQN--HKYDAK 191
           +K  N+L++T   + VLKI DFG ++ L   +   +T  G+  YMAPEII      Y   
Sbjct: 134 IKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 192 ADLWSVGAILFQLVTGKPPFD--GSNQLQLFQ 221
           AD+WS+G  + ++ TGKPPF   G  Q  +F+
Sbjct: 192 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFK 223

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 143/294 (48%), Gaps = 47/294 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 133 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 197 VGAILFQLVTGK---PPFDGSNQLQLF------------------QNILTSTEL-RFPPG 234
           +G  L ++  G+   PP D      +F                     L+S  +   PP 
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM 248
Query: 235 AIEELHPDCVD------------------LCRCLLRQNPVERITFKEFFNHRFL 270
           AI EL    V+                  + +CL++ NP ER   K+   H F+
Sbjct: 249 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFI 301

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y++ E+   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHR+
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRN 382
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    ++K+ DFG +R +T  D      G+     + APE +  +K+  K
Sbjct: 383 LAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 438
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+++    +L R  
Sbjct: 439 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELMRAC 494
Query: 251 LRQNPVERITFKE 263
            + NP +R +F E
Sbjct: 495 WQWNPSDRPSFAE 507

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 138/309 (44%), Gaps = 55/309 (17%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    LGI VAVK++ +   +   +    +E+ +L  ++H NII     
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   IH    H ++S     + + Q+  G++ L   
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSA 143
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+ +   +      +  Y APE+I    Y
Sbjct: 144 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGY 200
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-----STELR------------- 230
               D+WSVG I+ +LV G   F G++ +  +  ++      S E               
Sbjct: 201 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVEN 260
Query: 231 ---FPPGAIEELHPDCV----------------DLCRCLLRQNPVERITFKEFFNHRFLG 271
              +P  A EEL PD +                DL   +L  +P +RI+  E   H ++ 
Sbjct: 261 RPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 320
Query: 272 ELRQTVHAE 280
                  AE
Sbjct: 321 VWYDPAEAE 329

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 143/294 (48%), Gaps = 47/294 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 133 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 197 VGAILFQLVTGK---PPFDGSNQLQLF------------------QNILTSTEL-RFPPG 234
           +G  L ++  G+   PP D      +F                     L+S  +   PP 
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM 248
Query: 235 AIEELHPDCVD------------------LCRCLLRQNPVERITFKEFFNHRFL 270
           AI EL    V+                  + +CL++ NP ER   K+   H F+
Sbjct: 249 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFI 301

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 143/294 (48%), Gaps = 47/294 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 132
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 133 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 197 VGAILFQLVTGK---PPFDGSNQLQLF------------------QNILTSTEL-RFPPG 234
           +G  L ++  G+   PP D      +F                     L+S  +   PP 
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM 248
Query: 235 AIEELHPDCVD------------------LCRCLLRQNPVERITFKEFFNHRFL 270
           AI EL    V+                  + +CL++ NP ER   K+   H F+
Sbjct: 249 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFI 301

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 133/258 (51%), Gaps = 15/258 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  +  G +VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L  L  + +IHRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++++     +K+ DFGF   ++ +      L G+P +MAPE+I    Y  + D+W
Sbjct: 169 SDSILLTSDGR---IKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL---CRCLLR 252
           S+G ++ +++ G+PP+     LQ  + I  S     PP  +++LH     L      +L 
Sbjct: 226 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDS----LPP-RVKDLHKVSSVLRGFLDLMLV 280
Query: 253 QNPVERITFKEFFNHRFL 270
           + P +R T +E   H FL
Sbjct: 281 REPSQRATAQELLGHPFL 298

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 145/295 (49%), Gaps = 49/295 (16%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 159
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+WS
Sbjct: 160 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 215
Query: 197 VGAILFQLVTGK---PPFDGSNQLQLFQNILTSTEL---------------RF-----PP 233
           +G  L ++  G+   PP D + +L+L        +                +F     PP
Sbjct: 216 MGLSLVEMAVGRYPIPPPD-AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274
Query: 234 GAIEELHPDCVD------------------LCRCLLRQNPVERITFKEFFNHRFL 270
            AI EL    V+                  + +CL++ NP ER   K+   H F+
Sbjct: 275 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK-NPAERADLKQLMVHAFI 328

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 131/272 (48%), Gaps = 24/272 (8%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLK--E 59
           +R     EY +GP +G G F  V+        ++VA+K I  ++ L    +SD++    E
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 60  ISILSTIS----HPNIIRFFEAIETREKIYLVLEY-CDGGDLAAYIHKHGKVSEAVARHF 114
           +++L  +     HP +IR  +  ET+E   LVLE      DL  YI + G + E  +R F
Sbjct: 85  VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144
Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
             Q+ A +Q    + ++HRD+K +N+L+         K+ DFG    L  +   D   G+
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGSGALLHDEPYTD-FDGT 201
Query: 175 PLYMAPEIIQNHKYDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP 233
            +Y  PE I  H+Y A  A +WS+G +L+ +V G  PF+        Q IL + EL FP 
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEA-ELHFP- 253
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFF 265
                + PDC  L R  L   P  R + +E  
Sbjct: 254 ---AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 138/309 (44%), Gaps = 55/309 (17%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    LGI VAVK++ +   +   +    +E+ +L  ++H NII     
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   IH    H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-----STEL-------------- 229
            A  D+WSVG I+ +LV G   F G++ +  +  ++      S E               
Sbjct: 203 AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVEN 262
Query: 230 --RFPPGAIEELHPDCV----------------DLCRCLLRQNPVERITFKEFFNHRFLG 271
             ++P    EEL PD +                DL   +L  +P +RI+  E   H ++ 
Sbjct: 263 RPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 322
Query: 272 ELRQTVHAE 280
                  AE
Sbjct: 323 VWYDPAEAE 331

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 138/293 (47%), Gaps = 36/293 (12%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G+F VV +A+ R    +VA+K+I+    S       + E+  LS ++HPNI++ + A
Sbjct: 16  VGRGAFGVVCKAKWR--AKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR------QLAAGLQVLQEKHLI 131
                 + LV+EY +GG L   +H    +    A H M       Q  A L  +Q K LI
Sbjct: 70  --CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP NLL+       VLKI DFG A  +      +   GS  +MAPE+ +   Y  K
Sbjct: 128 HRDLKPPNLLLVAGGT--VLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFEGSNYSEK 183
Query: 192 ADLWSVGAILFQLVTGKPPFD--GSNQLQLFQNILTSTE---LRFPPGAIEELHPDCVDL 246
            D++S G IL++++T + PFD  G    ++   +   T    ++  P  IE L      +
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL------M 237
Query: 247 CRCLLRQNPVERITFKEFFN------HRFLGELRQTVHAEQHSVVPETKPMVE 293
            RC   ++P +R + +E           F G      +  QHS+ P     VE
Sbjct: 238 TRC-WSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVE 289

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 138/293 (47%), Gaps = 36/293 (12%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G+F VV +A+ R    +VA+K+I+    S       + E+  LS ++HPNI++ + A
Sbjct: 17  VGRGAFGVVCKAKWR--AKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR------QLAAGLQVLQEKHLI 131
                 + LV+EY +GG L   +H    +    A H M       Q  A L  +Q K LI
Sbjct: 71  --CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP NLL+       VLKI DFG A  +      +   GS  +MAPE+ +   Y  K
Sbjct: 129 HRDLKPPNLLLVAGGT--VLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFEGSNYSEK 184
Query: 192 ADLWSVGAILFQLVTGKPPFD--GSNQLQLFQNILTSTE---LRFPPGAIEELHPDCVDL 246
            D++S G IL++++T + PFD  G    ++   +   T    ++  P  IE L      +
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL------M 238
Query: 247 CRCLLRQNPVERITFKEFFN------HRFLGELRQTVHAEQHSVVPETKPMVE 293
            RC   ++P +R + +E           F G      +  QHS+ P     VE
Sbjct: 239 TRC-WSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVE 290

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 137/318 (43%), Gaps = 52/318 (16%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK---KLLSPKVSDNLLKEISILSTIS 67
           +Y +   IG GS+ VV  A   Q     A+K ++K   + ++PK  + +  E+ ++  + 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-----KHGKVS--------------- 107
           HPNI R +E  E  + I LV+E C GG L   ++       GK +               
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 108 --------------------EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV 147
                               E +  + MRQ+ + L  L  + + HRD+KP+N L STN+ 
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 148 TPVLKIGDFGFARSLTPQDLAD-----TLCGSPLYMAPEIIQ--NHKYDAKADLWSVGAI 200
             + K+ DFG ++     +  +     T  G+P ++APE++   N  Y  K D WS G +
Sbjct: 207 FEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 201 LFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT 260
           L  L+ G  PF G N       +L + +L F       L P   DL   LL +N  ER  
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVL-NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 261 FKEFFNHRFLGELRQTVH 278
                 H ++ +    ++
Sbjct: 325 AMRALQHPWISQFSDKIY 342

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 126/253 (49%), Gaps = 17/253 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G +  V+    ++  + VAVK + +  +     +  LKE +++  I HPN+++   
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
                   Y+V EY   G+L  Y+ +  +  V+  V  +   Q+++ ++ L++K+ IHRD
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRD 155
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L  +N LV  N    V+K+ DFG +R +T  D      G+     + APE +  + +  K
Sbjct: 156 LAARNCLVGENH---VVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNTFSIK 211
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+W+ G +L+++ T G  P+ G +  Q++  +     +  P G      P   +L R  
Sbjct: 212 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGC----PPKVYELMRAC 267
Query: 251 LRQNPVERITFKE 263
            + +P +R +F E
Sbjct: 268 WKWSPADRPSFAE 280

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 130/257 (50%), Gaps = 9/257 (3%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  R  G  VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L VL  + +IHRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++ +     +K+ DFGF   ++ +      L G+P +MAPE+I    Y  + D+W
Sbjct: 275 SDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G ++ ++V G+PP+     L+  + I  +   R     + ++ P        LL ++P
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--KNLHKVSPSLKGFLDRLLVRDP 389
Query: 256 VERITFKEFFNHRFLGE 272
            +R T  E   H FL +
Sbjct: 390 AQRATAAELLKHPFLAK 406

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 127/250 (50%), Gaps = 17/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G    VW   +     +VAVK + +  +SP   D  L E +++  + H  ++R + 
Sbjct: 20  RLGAGQAGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY- 74
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ EY + G L  ++     +   + +      Q+A G+  ++E++ IHRD
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    T   KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 135 LRAANILVSD---TLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    EEL+     L R   
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----QLMRLCW 247
Query: 252 RQNPVERITF 261
           ++ P +R TF
Sbjct: 248 KERPEDRPTF 257

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 130/257 (50%), Gaps = 9/257 (3%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  R  G  VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L VL  + +IHRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++ +     +K+ DFGF   ++ +      L G+P +MAPE+I    Y  + D+W
Sbjct: 198 SDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           S+G ++ ++V G+PP+     L+  + I  +   R     + ++ P        LL ++P
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--KNLHKVSPSLKGFLDRLLVRDP 312
Query: 256 VERITFKEFFNHRFLGE 272
            +R T  E   H FL +
Sbjct: 313 AQRATAAELLKHPFLAK 329

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  R  G  VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L VL  + +IHRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++ +     +K+ DFGF   ++ +      L G+P +MAPE+I    Y  + D+W
Sbjct: 148 SDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH---PDCVDLCRCLLR 252
           S+G ++ ++V G+PP+     L+  + I  +     PP  ++ LH   P        LL 
Sbjct: 205 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----LPP-RLKNLHKVSPSLKGFLDRLLV 259
Query: 253 QNPVERITFKEFFNHRFLGE 272
           ++P +R T  E   H FL +
Sbjct: 260 RDPAQRATAAELLKHPFLAK 279

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 113/211 (53%), Gaps = 5/211 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G GS+ +V + R++  G  VA+K+  +      V    ++EI +L  + H N++   E 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
            + +++ YLV E+ D   L         +   V + ++ Q+  G+      ++IHRD+KP
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152
Query: 138 QNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPE-IIQNHKYDAKADLW 195
           +N+LVS    + V+K+ DFGFAR+L  P ++ D    +  Y APE ++ + KY    D+W
Sbjct: 153 ENILVSQ---SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVW 209
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTS 226
           ++G ++ ++  G+P F G + +    +I+  
Sbjct: 210 AIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  R  G  VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L VL  + +IHRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++ +     +K+ DFGF   ++ +      L G+P +MAPE+I    Y  + D+W
Sbjct: 155 SDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH---PDCVDLCRCLLR 252
           S+G ++ ++V G+PP+     L+  + I  +     PP  ++ LH   P        LL 
Sbjct: 212 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----LPP-RLKNLHKVSPSLKGFLDRLLV 266
Query: 253 QNPVERITFKEFFNHRFLGE 272
           ++P +R T  E   H FL +
Sbjct: 267 RDPAQRATAAELLKHPFLAK 286

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  R  G  VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L VL  + +IHRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++ +     +K+ DFGF   ++ +      L G+P +MAPE+I    Y  + D+W
Sbjct: 144 SDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH---PDCVDLCRCLLR 252
           S+G ++ ++V G+PP+     L+  + I  +     PP  ++ LH   P        LL 
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----LPP-RLKNLHKVSPSLKGFLDRLLV 255
Query: 253 QNPVERITFKEFFNHRFLGE 272
           ++P +R T  E   H FL +
Sbjct: 256 RDPAQRATAAELLKHPFLAK 275

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  A  R  G  VAVK++D  L   +  + L  E+ I+    H N++  + 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+E+ +GG L   +  H +++E         +   L VL  + +IHRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
             ++L++ +     +K+ DFGF   ++ +      L G+P +MAPE+I    Y  + D+W
Sbjct: 153 SDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH---PDCVDLCRCLLR 252
           S+G ++ ++V G+PP+     L+  + I  +      P  ++ LH   P        LL 
Sbjct: 210 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPRLKNLHKVSPSLKGFLDRLLV 264
Query: 253 QNPVERITFKEFFNHRFLGE 272
           ++P +R T  E   H FL +
Sbjct: 265 RDPAQRATAAELLKHPFLAK 284

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 137/272 (50%), Gaps = 44/272 (16%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G F VV+ A+++      A+K I   +++L   KV    ++E+  L+ + HP I+R+
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV----MREVKALAKLEHPGIVRY 68
Query: 75  FEAI---ETREKI---------YLVLEYCDGGDLAAYIHKHGKVSE---AVARHFMRQLA 119
           F A     T EK+         Y+ ++ C   +L  +++    + E   +V  H   Q+A
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL-------- 171
             ++ L  K L+HRDLKP N+  + ++V   +K+GDFG   ++   +   T+        
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 172 -----CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS 226
                 G+ LYM+PE I  + Y  K D++S+G ILF+L+    PF  S Q++  + +   
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF--STQMERVRTLTDV 240
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVER 258
             L+FPP    + +P    + + +L  +P+ER
Sbjct: 241 RNLKFPP-LFTQKYPCEYVMVQDMLSPSPMER 271

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + + G+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + + G+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + + G+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + + G+  Y+APE+++  ++ A+  D
Sbjct: 133 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 246
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 247 ENPSARITIPDIKKDRW 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H N+++F+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKP 137
                  YL LEYC GG+L   I     + E  A+ F  QL AG+  L    + HRD+KP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 138 QNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-AD 193
           +NLL+   +    LKI DFG A   R    + L + + G+  Y+APE+++  ++ A+  D
Sbjct: 134 ENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 190
Query: 194 LWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           +WS G +L  ++ G+ P+D  S+  Q + +         P   I+      + L   +L 
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP---LALLHKILV 247
Query: 253 QNPVERITFKEFFNHRF 269
           +NP  RIT  +    R+
Sbjct: 248 ENPSARITIPDIKKDRW 264

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 116/215 (53%), Gaps = 18/215 (8%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM---RQLAAGLQVLQ 126
           NI+  F    T+ ++ +V ++C+G  L  Y H H   ++   +  +   RQ A G+  L 
Sbjct: 81  NIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA---DTLCGSPLYMAPEII 183
            K +IHRDLK  N+ +  +     +KIGDFG A   +    +   + L GS L+MAPE+I
Sbjct: 138 AKSIIHRDLKSNNIFLHEDN---TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 184 Q---NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
           +   ++ Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 118/239 (49%), Gaps = 14/239 (5%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           + ++G +IG G+F  V+  R R     VAVK   ++ L P +    L+E  IL   SHPN
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPN 173
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           I+R       ++ IY+V+E   GGD   ++   G ++        +   AAG++ L+ K 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPL-YMAPEIIQNH 186
            IHRDL  +N LV+      VLKI DFG +R       A +  L   P+ + APE +   
Sbjct: 234 CIHRDLAARNCLVTEKN---VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 187 KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
           +Y +++D+WS G +L++  + G  P+   +  Q  + +     L  P     EL PD V
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP-----ELCPDAV 344

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/213 (35%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFE 76
           +G G+ A V    +     E AVK I+K+     +   + +E+ +L     H N++   E
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E  ++ YLV E   GG + ++IHK    +E  A   ++ +A+ L  L  K + HRDLK
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 137 PQNLLVS-TNEVTPVLKIGDFGFARSL----------TPQDLADTLCGSPLYMAPEIIQN 185
           P+N+L    N+V+PV KI DFG    +          TP+ L  T CGS  YMAPE+++ 
Sbjct: 139 PENILCEHPNQVSPV-KICDFGLGSGIKLNGDCSPISTPELL--TPCGSAEYMAPEVVEA 195
Query: 186 HK-----YDAKADLWSVGAILFQLVTGKPPFDG 213
                  YD + DLWS+G IL+ L++G PPF G
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 117/215 (54%), Gaps = 9/215 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +G+G+  VV + +HR  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ A
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLK 136
             +  +I + +E+ DGG L   + +  ++ E +       +  GL  L+EKH ++HRD+K
Sbjct: 83  FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVK 142
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P N+LV++      +K+ DFG +  L    +A++  G+  YMAPE +Q   Y  ++D+WS
Sbjct: 143 PSNILVNSRG---EIKLCDFGVSGQLI-DSMANSFVGTRSYMAPERLQGTHYSVQSDIWS 198
Query: 197 VGAILFQLVTGK---PPFDGSNQLQLFQNILTSTE 228
           +G  L +L  G+   PP D      +F   +   E
Sbjct: 199 MGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGE 233

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 118/239 (49%), Gaps = 14/239 (5%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           + ++G +IG G+F  V+  R R     VAVK   ++ L P +    L+E  IL   SHPN
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPN 173
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           I+R       ++ IY+V+E   GGD   ++   G ++        +   AAG++ L+ K 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPL-YMAPEIIQNH 186
            IHRDL  +N LV+      VLKI DFG +R       A +  L   P+ + APE +   
Sbjct: 234 CIHRDLAARNCLVTEKN---VLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 187 KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
           +Y +++D+WS G +L++  + G  P+   +  Q  + +     L  P     EL PD V
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP-----ELCPDAV 344

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 115/215 (53%), Gaps = 18/215 (8%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 12  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 68
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM---RQLAAGLQVLQ 126
           NI+  F    T+ ++ +V ++C+G  L  Y H H   ++   +  +   RQ A G+  L 
Sbjct: 69  NIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIARQTARGMDYLH 125
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEII 183
            K +IHRDLK  N+ +  +     +KIGDFG A      +     + L GS L+MAPE+I
Sbjct: 126 AKSIIHRDLKSNNIFLHEDN---TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182
Query: 184 Q---NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
           +   ++ Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 145/294 (49%), Gaps = 33/294 (11%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           L+ +Y    ++G G++ VV++A+  Q G  VA+K I        +    ++EIS+L  + 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQ 126
           HPNI+   + I +   + LV E+ +  DL   + ++   + ++  + ++ QL  G+    
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQ- 184
           +  ++HRDLKPQNLL++++     LK+ DFG AR+   P         +  Y AP+++  
Sbjct: 137 QHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDG---SNQLQLFQNILTSTELRFPPGAIE---- 237
           + KY    D+WS+G I  +++TGKP F G    +QL    +IL +   R  P   E    
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 238 --------ELHP----------DCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                   E  P          + +DL   +L  +P +RI+ ++  NH +  +L
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 145/294 (49%), Gaps = 33/294 (11%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           L+ +Y    ++G G++ VV++A+  Q G  VA+K I        +    ++EIS+L  + 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQ 126
           HPNI+   + I +   + LV E+ +  DL   + ++   + ++  + ++ QL  G+    
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQ- 184
           +  ++HRDLKPQNLL++++     LK+ DFG AR+   P         +  Y AP+++  
Sbjct: 137 QHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDG---SNQLQLFQNILTSTELRFPPGAIE---- 237
           + KY    D+WS+G I  +++TGKP F G    +QL    +IL +   R  P   E    
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 238 --------ELHP----------DCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                   E  P          + +DL   +L  +P +RI+ ++  NH +  +L
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 146/316 (46%), Gaps = 23/316 (7%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHP 69
           +Y V   IG G+F  V   RH+      A+K + K +++    S    +E  I++  + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            +++ F A +    +Y+V+EY  GGDL   +  +  V E  AR +  ++   L  +    
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG 193
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQNHK 187
            IHRD+KP N+L+     +  LK+ DFG    +  + +   DT  G+P Y++PE++++  
Sbjct: 194 FIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 188 ----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-STELRFPPG---AIEEL 239
               Y  + D WSVG  L++++ G  PF   + +  +  I+     L FP     + E  
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 310
Query: 240 HPDCVDLCRCLLR--QNPVERITFKEFF-NHRFLGE-LRQTVHAEQHSVVPETKPMVELL 295
           +  C  L    +R  +N VE I    FF N ++  E LR TV      VVP+    ++  
Sbjct: 311 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP----VVPDLSSDIDTS 366
Query: 296 NSSTPEDRHSLHSEHP 311
           N    E+        P
Sbjct: 367 NFDDLEEDKGEEETFP 382

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 146/316 (46%), Gaps = 23/316 (7%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHP 69
           +Y V   IG G+F  V   RH+      A+K + K +++    S    +E  I++  + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            +++ F A +    +Y+V+EY  GGDL   +  +  V E  AR +  ++   L  +    
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG 193
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQNHK 187
            IHRD+KP N+L+     +  LK+ DFG    +  + +   DT  G+P Y++PE++++  
Sbjct: 194 FIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 188 ----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-STELRFPPG---AIEEL 239
               Y  + D WSVG  L++++ G  PF   + +  +  I+     L FP     + E  
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 310
Query: 240 HPDCVDLCRCLLR--QNPVERITFKEFF-NHRFLGE-LRQTVHAEQHSVVPETKPMVELL 295
           +  C  L    +R  +N VE I    FF N ++  E LR TV      VVP+    ++  
Sbjct: 311 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP----VVPDLSSDIDTS 366
Query: 296 NSSTPEDRHSLHSEHP 311
           N    E+        P
Sbjct: 367 NFDDLEEDKGEEETFP 382

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 146/316 (46%), Gaps = 23/316 (7%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHP 69
           +Y V   IG G+F  V   RH+      A+K + K +++    S    +E  I++  + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            +++ F A +    +Y+V+EY  GGDL   +  +  V E  AR +  ++   L  +    
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG 188
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQNHK 187
            IHRD+KP N+L+     +  LK+ DFG    +  + +   DT  G+P Y++PE++++  
Sbjct: 189 FIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 188 ----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-STELRFPPG---AIEEL 239
               Y  + D WSVG  L++++ G  PF   + +  +  I+     L FP     + E  
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305
Query: 240 HPDCVDLCRCLLR--QNPVERITFKEFF-NHRFLGE-LRQTVHAEQHSVVPETKPMVELL 295
           +  C  L    +R  +N VE I    FF N ++  E LR TV      VVP+    ++  
Sbjct: 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP----VVPDLSSDIDTS 361
Query: 296 NSSTPEDRHSLHSEHP 311
           N    E+        P
Sbjct: 362 NFDDLEEDKGEEETFP 377

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 15/225 (6%)
Query: 11  EYIVGPRIGSGSFAVVWRARH-RQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL---STI 66
           +Y     IG G++  V++AR  +  G  VA+K +  +     +  + ++E+++L    T 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 67  SHPNIIRFFEAI-----ETREKIYLVLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLA 119
            HPN++R F+       +   K+ LV E+ D  DL  Y+ K     V     +  M QL 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
            GL  L    ++HRDLKPQN+LV++   +  +K+ DFG AR  + Q    ++  +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
           PE++    Y    DLWSVG I  ++   KP F GS+ +     IL
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 30/211 (14%)
Query: 69  PNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGL 122
           P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A   M+ +   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T                   
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------- 171
Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---RFPPGAIEEL 239
               KYD   D+WS+G I++ L+ G PPF  ++ L +   + T   +    FP     E+
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +   L R LL+  P +R+T  EF NH ++
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 123/249 (49%), Gaps = 20/249 (8%)
Query: 11  EYIVGPRIGSGSFAVVWRARH-RQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL---STI 66
           +Y     IG G++  V++AR  +  G  VA+K +  +     +  + ++E+++L    T 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 67  SHPNIIRFFEAIET----RE-KIYLVLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLA 119
            HPN++R F+        RE K+ LV E+ D  DL  Y+ K     V     +  M QL 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
            GL  L    ++HRDLKPQN+LV++   +  +K+ DFG AR  + Q    ++  +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PE++    Y    DLWSVG I  ++   KP F GS+ +     IL    L   PG  EE 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL---PG--EED 242
Query: 240 HPDCVDLCR 248
            P  V L R
Sbjct: 243 WPRDVALPR 251

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 123/249 (49%), Gaps = 20/249 (8%)
Query: 11  EYIVGPRIGSGSFAVVWRARH-RQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL---STI 66
           +Y     IG G++  V++AR  +  G  VA+K +  +     +  + ++E+++L    T 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 67  SHPNIIRFFEAIET----RE-KIYLVLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLA 119
            HPN++R F+        RE K+ LV E+ D  DL  Y+ K     V     +  M QL 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
            GL  L    ++HRDLKPQN+LV++   +  +K+ DFG AR  + Q    ++  +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PE++    Y    DLWSVG I  ++   KP F GS+ +     IL    L   PG  EE 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL---PG--EED 242
Query: 240 HPDCVDLCR 248
            P  V L R
Sbjct: 243 WPRDVALPR 251

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 115/215 (53%), Gaps = 18/215 (8%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM---RQLAAGLQVLQ 126
           NI+  F    T  ++ +V ++C+G  L  Y H H   ++   +  +   RQ A G+  L 
Sbjct: 81  NIL-LFMGYSTAPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA---DTLCGSPLYMAPEII 183
            K +IHRDLK  N+ +  +     +KIGDFG A   +    +   + L GS L+MAPE+I
Sbjct: 138 AKSIIHRDLKSNNIFLHEDN---TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 184 Q---NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
           +   ++ Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 37/284 (13%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEID---KKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G FA V++AR +     VA+K+I    +      ++   L+EI +L  +SHPNII  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEKHLIHR 133
            +A   +  I LV ++ +  DL   I  +  V + +  + +M     GL+ L +  ++HR
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 136
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK-YDAK 191
           DLKP NLL+  N    VLK+ DFG A+S  +P         +  Y APE++   + Y   
Sbjct: 137 DLKPNNLLLDENG---VLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVG 193
Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFP--------------P 233
            D+W+VG IL +L+   P   G + L    ++F+ + T TE ++P              P
Sbjct: 194 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 253
Query: 234 GAIEELH-------PDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           G    LH        D +DL + L   NP  RIT  +    ++ 
Sbjct: 254 GI--PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 138/285 (48%), Gaps = 34/285 (11%)
Query: 18  IGSGSFAVVWRARHRQLGI--EVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRF 74
           IG G+F  V +AR ++ G+  + A+K + K+  S     +   E+ +L  + H PNII  
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE-----AVAR------------HFMRQ 117
             A E R  +YL +EY   G+L  ++ K  +V E     A+A             HF   
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +A G+  L +K  IHRDL  +N+LV  N V    KI DFG +R      +  T+   P+ 
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRGQEVY-VKKTMGRLPVR 206
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           +MA E +    Y   +D+WS G +L+++V+ G  P+ G    +L++ +     L  P   
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 266
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFN--HRFLGELRQTVH 278
            +E++    DL R   R+ P ER +F +     +R L E +  V+
Sbjct: 267 DDEVY----DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 307

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 138/285 (48%), Gaps = 34/285 (11%)
Query: 18  IGSGSFAVVWRARHRQLGI--EVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRF 74
           IG G+F  V +AR ++ G+  + A+K + K+  S     +   E+ +L  + H PNII  
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE-----AVAR------------HFMRQ 117
             A E R  +YL +EY   G+L  ++ K  +V E     A+A             HF   
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +A G+  L +K  IHRDL  +N+LV  N V    KI DFG +R      +  T+   P+ 
Sbjct: 141 VARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRGQEVY-VKKTMGRLPVR 196
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           +MA E +    Y   +D+WS G +L+++V+ G  P+ G    +L++ +     L  P   
Sbjct: 197 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 256
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFN--HRFLGELRQTVH 278
            +E++    DL R   R+ P ER +F +     +R L E +  V+
Sbjct: 257 DDEVY----DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 297

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 145/308 (47%), Gaps = 25/308 (8%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHP 69
           +Y V   IG G+F  V   RH+      A+K + K +++    S    +E  I++  + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            +++ F A +  + +Y+V+EY  GGDL   +  +  V E  A+ +  ++   L  +    
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQNHK 187
           LIHRD+KP N+L+  +     LK+ DFG    +    +   DT  G+P Y++PE++++  
Sbjct: 195 LIHRDVKPDNMLLDKH---GHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 188 ----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-STELRFPPGAIEELHPD 242
               Y  + D WSVG  LF+++ G  PF   + +  +  I+     L FP  A    H  
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAK 311
Query: 243 CVDLCRCL------LRQNPVERITFKEFF-NHRF-LGELRQTVHAEQHSVVPETKPMVEL 294
            + +C  L      L +N VE I    FF N ++    +R+T       VVPE    ++ 
Sbjct: 312 NL-ICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAP----VVPELSSDIDS 366
Query: 295 LNSSTPED 302
            N    ED
Sbjct: 367 SNFDDIED 374

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 122/249 (48%), Gaps = 13/249 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG GSF  V   +        A+K ++K K +      N+ KE+ I+  + HP ++  + 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +  E +++V++   GGDL  ++ ++    E   + F+ +L   L  LQ + +IHRD+K
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMK 142
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK---YDAKAD 193
           P N+L+  +     + I DF  A  L  +    T+ G+  YMAPE+  + K   Y    D
Sbjct: 143 PDNILLDEH---GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199
Query: 194 LWSVGAILFQLVTGKPPF--DGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            WS+G   ++L+ G+ P+    S   +   +   +T + +P    +E+    V L + LL
Sbjct: 200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM----VSLLKKLL 255
Query: 252 RQNPVERIT 260
             NP +R +
Sbjct: 256 EPNPDQRFS 264

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 25/258 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G GSF  V R   +Q G + AVK++  ++          +E+   + ++ P I+  + 
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-------AEELMACAGLTSPRIVPLYG 152
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A+     + + +E  +GG L   + + G + E  A +++ Q   GL+ L  + ++H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDL------ADTLCGSPLYMAPEIIQNHKYDA 190
             N+L+S++     L   DFG A  L P  L       D + G+  +MAPE++     DA
Sbjct: 213 ADNVLLSSDGSHAALC--DFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDA 270
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           K D+WS   ++  ++ G  P+      Q F+  L       PP  + E+ P C  L    
Sbjct: 271 KVDVWSSCCMMLHMLNGCHPWT-----QFFRGPLCLKIASEPP-PVREIPPSCAPLTAQA 324
Query: 251 ----LRQNPVERITFKEF 264
               LR+ P+ R++  E 
Sbjct: 325 IQEGLRKEPIHRVSAAEL 342

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 93  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA---DTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A   +    +   + L GS L+MAPE+I+ 
Sbjct: 152 SIIHRDLKSNNIFLHED---LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 10  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 66
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 67  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A      +     + L GS L+MAPE+I+ 
Sbjct: 126 SIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 137/295 (46%), Gaps = 50/295 (16%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHPNIIR-- 73
           IG+GSF VV++A+    G  VA+K++  DK+  +        +E+ I+  + H NI+R  
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLR 117
Query: 74  --FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQV 124
             F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII- 183
           +    + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I 
Sbjct: 176 IHSFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 233
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TST 227
               Y +  D+WS G +L +L+ G+P F G + +     I+                  T
Sbjct: 234 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 293
Query: 228 ELRFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           E +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 294 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 348

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 125/250 (50%), Gaps = 16/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW   +     +VAVK +    +S +     L+E +++ T+ H  ++R + 
Sbjct: 20  RLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYA 75
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH--KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            +   E IY++ EY   G L  ++   + GKV       F  Q+A G+  ++ K+ IHRD
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 135
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    + + KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 136 LRAANVLVSE---SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L+++VT GK P+ G        +++T+    +    +E    +  D+ +   
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTN----ADVMTALSQGYRMPRVENCPDELYDIMKMCW 248
Query: 252 RQNPVERITF 261
           ++   ER TF
Sbjct: 249 KEKAEERPTF 258

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 28  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 84
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 85  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA---DTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A   +    +   + L GS L+MAPE+I+ 
Sbjct: 144 SIIHRDLKSNNIFLHED---LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 137/295 (46%), Gaps = 50/295 (16%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHPNIIR-- 73
           IG+GSF VV++A+    G  VA+K++  DK+  +        +E+ I+  + H NI+R  
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLR 158
Query: 74  --FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQV 124
             F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           +    + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I 
Sbjct: 217 IHSFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 274
Query: 185 NHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TST 227
               Y +  D+WS G +L +L+ G+P F G + +     I+                  T
Sbjct: 275 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 334
Query: 228 ELRFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           E +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 335 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 389

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 130/264 (49%), Gaps = 17/264 (6%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILS 64
           + L   Y +G  +G G  + V  AR  +L  +VAVK +   L   P       +E    +
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 65  TISHPNIIRFFEAIETREKI----YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
            ++HP I+  ++  E         Y+V+EY DG  L   +H  G ++   A   +     
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPL 176
            L    +  +IHRD+KP N+++S    T  +K+ DFG AR++     + T    + G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGA 235
           Y++PE  +    DA++D++S+G +L++++TG+PPF G + + + +Q++    E   PP A
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---REDPIPPSA 241
Query: 236 IEE-LHPDCVDLCRCLLRQNPVER 258
             E L  D   +    L +NP  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 25/258 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G GSF  V R   +Q G + AVK++  ++          +E+   + ++ P I+  + 
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-------AEELMACAGLTSPRIVPLYG 133
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A+     + + +E  +GG L   + + G + E  A +++ Q   GL+ L  + ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDL------ADTLCGSPLYMAPEIIQNHKYDA 190
             N+L+S++     L   DFG A  L P  L       D + G+  +MAPE++     DA
Sbjct: 194 ADNVLLSSDGSHAALC--DFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDA 251
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           K D+WS   ++  ++ G  P+      Q F+  L       PP  + E+ P C  L    
Sbjct: 252 KVDVWSSCCMMLHMLNGCHPWT-----QFFRGPLCLKIASEPP-PVREIPPSCAPLTAQA 305
Query: 251 ----LRQNPVERITFKEF 264
               LR+ P+ R++  E 
Sbjct: 306 IQEGLRKEPIHRVSAAEL 323

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 137/295 (46%), Gaps = 50/295 (16%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHPNIIR-- 73
           IG+GSF VV++A+    G  VA+K++  DK+  +        +E+ I+  + H NI+R  
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLR 115
Query: 74  --FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQV 124
             F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII- 183
           +    + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I 
Sbjct: 174 IHSFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 231
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TST 227
               Y +  D+WS G +L +L+ G+P F G + +     I+                  T
Sbjct: 232 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 291
Query: 228 ELRFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           E +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 292 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 346

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 115
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII-QN 185
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 174 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 231
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 35  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 91
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 92  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A      +     + L GS L+MAPE+I+ 
Sbjct: 151 SIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 70  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A      +     + L GS L+MAPE+I+ 
Sbjct: 129 SIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 93  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A      +     + L GS L+MAPE+I+ 
Sbjct: 152 SIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 109
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII-QN 185
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 168 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 225
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 226 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 285
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 286 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 338

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 70  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A      +     + L GS L+MAPE+I+ 
Sbjct: 129 SIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 113/213 (53%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 65  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA---DTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A   +    +   + L GS L+MAPE+I+ 
Sbjct: 124 SIIHRDLKSNNIFLHED---LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 123/252 (48%), Gaps = 16/252 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG+GSF  V RA     G +VAVK + ++    +  +  L+E++I+  + HPNI+ F  
Sbjct: 44  KIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR---QLAAGLQVLQEKH--LI 131
           A+     + +V EY   G L   +HK G   +   R  +     +A G+  L  ++  ++
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQNHKYDA 190
           HRDLK  NLLV        +K+ DFG +R      L +    G+P +MAPE++++   + 
Sbjct: 162 HRDLKSPNLLVDKKY---TVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNI-LTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D++S G IL++L T + P+   N  Q+   +      L  P      L+P    +   
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP----RNLNPQVAAIIEG 274
Query: 250 LLRQNPVERITF 261
                P +R +F
Sbjct: 275 CWTNEPWKRPSF 286

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 115
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII-QN 185
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 174 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 231
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 86
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 145 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 202
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 203 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 262
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 263 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 315

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T+ ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 65  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A      +     + L GS L+MAPE+I+ 
Sbjct: 124 SIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 74/213 (34%), Positives = 111/213 (52%), Gaps = 22/213 (10%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFE 76
           +G G+ A V    +     E AVK I+K+     +   + +E+ +L     H N++   E
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             E  ++ YLV E   GG + ++IHK    +E  A   ++ +A+ L  L  K + HRDLK
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 137 PQNLLVS-TNEVTPVLKIGDFGFARSL----------TPQDLADTLCGSPLYMAPEIIQN 185
           P+N+L    N+V+PV KI DF     +          TP+ L  T CGS  YMAPE+++ 
Sbjct: 139 PENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPISTPELL--TPCGSAEYMAPEVVEA 195
Query: 186 HK-----YDAKADLWSVGAILFQLVTGKPPFDG 213
                  YD + DLWS+G IL+ L++G PPF G
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 130/264 (49%), Gaps = 17/264 (6%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILS 64
           + L   Y +G  +G G  + V  AR  +L  +VAVK +   L   P       +E    +
Sbjct: 25  SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 84
Query: 65  TISHPNIIRFFEAIETREKI----YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
            ++HP I+  ++  E         Y+V+EY DG  L   +H  G ++   A   +     
Sbjct: 85  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 144
Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPL 176
            L    +  +IHRD+KP N+++S    T  +K+ DFG AR++     + T    + G+  
Sbjct: 145 ALNFSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGA 235
           Y++PE  +    DA++D++S+G +L++++TG+PPF G + + + +Q++    E   PP A
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---REDPIPPSA 258
Query: 236 IEE-LHPDCVDLCRCLLRQNPVER 258
             E L  D   +    L +NP  R
Sbjct: 259 RHEGLSADLDAVVLKALAKNPENR 282

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 140 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 14/217 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +GSG++  V  A   + G +VA+K++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 78  IETREKI------YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
               E +      YLV+ +  G DL   + KH K+ E   +  + Q+  GL+ +    +I
Sbjct: 93  FTPDETLDDFTDFYLVMPFM-GTDLGK-LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR    +     +  +  Y APE+I N  +Y  
Sbjct: 151 HRDLKPGNLAVNED---CELKILDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQ 205
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST 227
             D+WSVG I+ +++TGK  F GS+ L   + I+  T
Sbjct: 206 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 94
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 153 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 210
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 270
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 271 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 323

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 93
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 152 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 269
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 270 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 322

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 100
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 159 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 216
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 276
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 277 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 329

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 89
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 148 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 205
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 206 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 265
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 266 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 318

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 93
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 152 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 269
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 270 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 322

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 129/264 (48%), Gaps = 17/264 (6%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILS 64
           + L   Y +G  +G G  + V  AR  +L  +VAVK +   L   P       +E    +
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 65  TISHPNIIRFFEAIETREKI----YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
            ++HP I+  +   E         Y+V+EY DG  L   +H  G ++   A   +     
Sbjct: 68  ALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPL 176
            L    +  +IHRD+KP N+++S    T  +K+ DFG AR++     + T    + G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGA 235
           Y++PE  +    DA++D++S+G +L++++TG+PPF G + + + +Q++    E   PP A
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---REDPIPPSA 241
Query: 236 IEE-LHPDCVDLCRCLLRQNPVER 258
             E L  D   +    L +NP  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 138/285 (48%), Gaps = 34/285 (11%)
Query: 18  IGSGSFAVVWRARHRQLGI--EVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRF 74
           IG G+F  V +AR ++ G+  + A+K + K+  S     +   E+ +L  + H PNII  
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE-----AVAR------------HFMRQ 117
             A E R  +YL +EY   G+L  ++ K  +V E     A+A             HF   
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRK-SRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +A G+  L +K  IHR+L  +N+LV  N V    KI DFG +R      +  T+   P+ 
Sbjct: 148 VARGMDYLSQKQFIHRNLAARNILVGENYVA---KIADFGLSRGQEVY-VKKTMGRLPVR 203
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           +MA E +    Y   +D+WS G +L+++V+ G  P+ G    +L++ +     L  P   
Sbjct: 204 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 263
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFN--HRFLGELRQTVH 278
            +E++    DL R   R+ P ER +F +     +R L E +  V+
Sbjct: 264 DDEVY----DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 304

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 124/252 (49%), Gaps = 16/252 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG+GSF  V RA     G +VAVK + ++    +  +  L+E++I+  + HPNI+ F  
Sbjct: 44  KIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR---QLAAGLQVLQEKH--LI 131
           A+     + +V EY   G L   +HK G   +   R  +     +A G+  L  ++  ++
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPLYMAPEIIQNHKYDA 190
           HR+LK  NLLV        +K+ DFG +R      L+  +  G+P +MAPE++++   + 
Sbjct: 162 HRNLKSPNLLVDKKY---TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNI-LTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D++S G IL++L T + P+   N  Q+   +      L  P      L+P    +   
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP----RNLNPQVAAIIEG 274
Query: 250 LLRQNPVERITF 261
                P +R +F
Sbjct: 275 CWTNEPWKRPSF 286

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 9/199 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKE---ISILSTISHPNIIR 73
           IG G F  V+  R    G   A+K +DKK +  K  + L L E   +S++ST   P I+ 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              A  T +K+  +L+  +GGDL  ++ +HG  SEA  R +  ++  GL+ +  + +++R
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 315
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDAKA 192
           DLKP N+L+  +     ++I D G A   + +    ++ G+  YMAPE++Q    YD+ A
Sbjct: 316 DLKPANILLDEH---GHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSA 371
Query: 193 DLWSVGAILFQLVTGKPPF 211
           D +S+G +LF+L+ G  PF
Sbjct: 372 DWFSLGCMLFKLLRGHSPF 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 9/199 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKE---ISILSTISHPNIIR 73
           IG G F  V+  R    G   A+K +DKK +  K  + L L E   +S++ST   P I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              A  T +K+  +L+  +GGDL  ++ +HG  SEA  R +  ++  GL+ +  + +++R
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDAKA 192
           DLKP N+L+  +     ++I D G A   + +    ++ G+  YMAPE++Q    YD+ A
Sbjct: 317 DLKPANILLDEH---GHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSA 372
Query: 193 DLWSVGAILFQLVTGKPPF 211
           D +S+G +LF+L+ G  PF
Sbjct: 373 DWFSLGCMLFKLLRGHSPF 391

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 130/286 (45%), Gaps = 38/286 (13%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS---HPNIIRF 74
           IG G++  V++AR    G  VA+K +        +  + ++E+++L  +    HPN++R 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 75  FEAIET----RE-KIYLVLEYCDGGDLAAYIHKH---GKVSEAVARHFMRQLAAGLQVLQ 126
            +   T    RE K+ LV E+ D  DL  Y+ K    G  +E + +  MRQ   GL  L 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI-KDLMRQFLRGLDFLH 129
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              ++HRDLKP+N+LV++      +K+ DFG AR  + Q   D +  +  Y APE++   
Sbjct: 130 ANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQS 186
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---------------RF 231
            Y    D+WSVG I  ++   KP F G+++      I     L                F
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 246
Query: 232 PP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           PP         + E+      L   +L  NP +RI+      H +L
Sbjct: 247 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 9/199 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKE---ISILSTISHPNIIR 73
           IG G F  V+  R    G   A+K +DKK +  K  + L L E   +S++ST   P I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              A  T +K+  +L+  +GGDL  ++ +HG  SEA  R +  ++  GL+ +  + +++R
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDAKA 192
           DLKP N+L+  +     ++I D G A   + +    ++ G+  YMAPE++Q    YD+ A
Sbjct: 317 DLKPANILLDEH---GHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSA 372
Query: 193 DLWSVGAILFQLVTGKPPF 211
           D +S+G +LF+L+ G  PF
Sbjct: 373 DWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 111/199 (55%), Gaps = 9/199 (4%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKE---ISILSTISHPNIIR 73
           IG G F  V+  R    G   A+K +DKK +  K  + L L E   +S++ST   P I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              A  T +K+  +L+  +GGDL  ++ +HG  SEA  R +  ++  GL+ +  + +++R
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDAKA 192
           DLKP N+L+  +     ++I D G A   + +    ++ G+  YMAPE++Q    YD+ A
Sbjct: 317 DLKPANILLDEH---GHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSA 372
Query: 193 DLWSVGAILFQLVTGKPPF 211
           D +S+G +LF+L+ G  PF
Sbjct: 373 DWFSLGCMLFKLLRGHSPF 391

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 85
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 144 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 201
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 261
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 262 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 314

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 134/292 (45%), Gaps = 44/292 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV----ARHFMRQLAAGLQVLQE 127
           F+ + E ++++YL  VL+Y          H + +  + +     + +M QL   L  +  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I    
Sbjct: 141 FGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 188 -YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTELR 230
            Y +  D+WS G +L +L+ G+P F G + +     I+                  TE  
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFA 258
Query: 231 FPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 140 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 140 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 140 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 136/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 82
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 141 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 198
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 258
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 259 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 311

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 130/240 (54%), Gaps = 20/240 (8%)
Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V   R +  G   + VA+K + K   + K   + L E SI+    HPN++  
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTL-KVGYTEKQRRDFLCEASIMGQFDHPNVVH- 108
Query: 75  FEAIETREK-IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            E + TR K + +V+E+ + G L A++ KH G+ +       +R +AAG++ L +   +H
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVH 168
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLADTLCGS-PL-YMAPEIIQNHKY 188
           RDL  +N+LV++N V    K+ DFG +R +   P+ +  T  G  P+ + APE IQ  K+
Sbjct: 169 RDLAARNILVNSNLVC---KVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 189 DAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDC 243
            + +D+WS G +++++++   +P +D SNQ  + + I     L  P   P  + +L  DC
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEEGYRLPAPMDCPAGLHQLMLDC 284

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 14/213 (6%)
Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGLQVLQEK 128
           NI+  F    T  ++ +V ++C+G  L  ++H      E +      RQ A G+  L  K
Sbjct: 65  NIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYMAPEIIQ- 184
            +IHRDLK  N+ +  +     +KIGDFG A      +     + L GS L+MAPE+I+ 
Sbjct: 124 SIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
              + Y  ++D+++ G +L++L+TG+ P+   N
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 135/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQGKAFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++++YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 140 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
            FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 258 AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 97/322 (30%), Positives = 151/322 (46%), Gaps = 64/322 (19%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G++ VV  A H+  G  VA+K+I   DK L + +     L+EI IL    H NII  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIKILKHFKHENIITI 74
Query: 75  F-----EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           F     ++ E   ++Y++ E     DL   I     +S+   ++F+ Q    ++VL   +
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT------------LCGSPLY 177
           +IHRDLKP NLL+++N     LK+ DFG AR +  +  AD                +  Y
Sbjct: 133 VIHRDLKPSNLLINSN---CDLKVCDFGLAR-IIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 178 MAPEI-IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL----TSTEL 229
            APE+ + + KY    D+WS G IL +L   +P F G +   QL L   I+    +  +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 230 R----------------FPPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
           R                +P   +E++    +P  +DL + +L  +P +RIT KE   H +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 270 LGELRQTVHAEQHSVVPETKPM 291
           L    QT H       PE +P+
Sbjct: 309 L----QTYHDPNDE--PEGEPI 324

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 16  PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           PR+G GSF  V R + +Q G + AVK++  ++         ++E+   + +S P I+  +
Sbjct: 80  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLY 132
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            A+     + + +E  +GG L   I + G + E  A +++ Q   GL+ L  + ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC------GSPLYMAPEIIQNHKYD 189
           K  N+L+S++     L   DFG A  L P  L  +L       G+  +MAPE++     D
Sbjct: 193 KADNVLLSSDGSRAALC--DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 190 AKADLWSVGAILFQLVTGKPPF 211
           AK D+WS   ++  ++ G  P+
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 97/322 (30%), Positives = 151/322 (46%), Gaps = 64/322 (19%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G++ VV  A H+  G  VA+K+I   DK L + +     L+EI IL    H NII  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIKILKHFKHENIITI 74
Query: 75  F-----EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           F     ++ E   ++Y++ E     DL   I     +S+   ++F+ Q    ++VL   +
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT------------LCGSPLY 177
           +IHRDLKP NLL+++N     LK+ DFG AR +  +  AD                +  Y
Sbjct: 133 VIHRDLKPSNLLINSN---CDLKVCDFGLAR-IIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 178 MAPEI-IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL----TSTEL 229
            APE+ + + KY    D+WS G IL +L   +P F G +   QL L   I+    +  +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 230 R----------------FPPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
           R                +P   +E++    +P  +DL + +L  +P +RIT KE   H +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 270 LGELRQTVHAEQHSVVPETKPM 291
           L    QT H       PE +P+
Sbjct: 309 L----QTYHDPNDE--PEGEPI 324

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 16  PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           PR+G GSF  V R + +Q G + AVK++  ++         ++E+   + +S P I+  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLY 116
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            A+     + + +E  +GG L   I + G + E  A +++ Q   GL+ L  + ++H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC------GSPLYMAPEIIQNHKYD 189
           K  N+L+S++     L   DFG A  L P  L  +L       G+  +MAPE++     D
Sbjct: 177 KADNVLLSSDGSRAALC--DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 190 AKADLWSVGAILFQLVTGKPPF 211
           AK D+WS   ++  ++ G  P+
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPW 256

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 97/322 (30%), Positives = 151/322 (46%), Gaps = 64/322 (19%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G++ VV  A H+  G  VA+K+I   DK L + +     L+EI IL    H NII  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIKILKHFKHENIITI 74
Query: 75  F-----EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           F     ++ E   ++Y++ E     DL   I     +S+   ++F+ Q    ++VL   +
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT------------LCGSPLY 177
           +IHRDLKP NLL+++N     LK+ DFG AR +  +  AD                +  Y
Sbjct: 133 VIHRDLKPSNLLINSN---CDLKVCDFGLAR-IIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 178 MAPEI-IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL----TSTEL 229
            APE+ + + KY    D+WS G IL +L   +P F G +   QL L   I+    +  +L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 230 R----------------FPPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
           R                +P   +E++    +P  +DL + +L  +P +RIT KE   H +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 270 LGELRQTVHAEQHSVVPETKPM 291
           L    QT H       PE +P+
Sbjct: 309 L----QTYHDPNDE--PEGEPI 324

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 135/294 (45%), Gaps = 41/294 (13%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS--------------- 53
           + +Y +   IG GS+ VV  A +       A+K + KK L  +                 
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 54  ---------DNLLKEISILSTISHPNIIRFFEAIE--TREKIYLVLEYCDGGDLAAYIHK 102
                    + + +EI+IL  + HPN+++  E ++    + +Y+V E  + G +   +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 103 HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL 162
              +SE  AR + + L  G++ L  + +IHRD+KP NLLV  +     +KI DFG +   
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG---HIKIADFGVSNEF 187
Query: 163 TPQD-LADTLCGSPLYMAPEIIQNHK--YDAKA-DLWSVGAILFQLVTGKPPFDGSNQLQ 218
              D L     G+P +MAPE +   +  +  KA D+W++G  L+  V G+ PF    ++ 
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-MDERIM 246
Query: 219 LFQNILTSTELRFP--PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              + + S  L FP  P   E+L     DL   +L +NP  RI   E   H ++
Sbjct: 247 CLHSKIKSQALEFPDQPDIAEDLK----DLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 16  PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           PR+G GSF  V R + +Q G + AVK++  ++         ++E+   + +S P I+  +
Sbjct: 78  PRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLY 130
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            A+     + + +E  +GG L   I + G + E  A +++ Q   GL+ L  + ++H D+
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC------GSPLYMAPEIIQNHKYD 189
           K  N+L+S++     L   DFG A  L P  L  +L       G+  +MAPE++     D
Sbjct: 191 KADNVLLSSDGSRAALC--DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 190 AKADLWSVGAILFQLVTGKPPF 211
           AK D+WS   ++  ++ G  P+
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 135/293 (46%), Gaps = 46/293 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+    G  VA+K    K+L  K   N  +E+ I+  + H NI+R    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAV-----ARHFMRQLAAGLQVLQ 126
           F+ + E ++ +YL  VL+Y    +    + +H   ++        + +M QL   L  + 
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   S  Y APE+I   
Sbjct: 140 SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTEL 229
             Y +  D+WS G +L +L+ G+P F G + +     I+                  TE 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 230 RFPPGAIE--------ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +FP                P+ + LC  LL   P  R+T  E   H F  ELR
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 17/264 (6%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILS 64
           + L   Y +G  +G G  + V  AR  +   +VAVK +   L   P       +E    +
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 65  TISHPNIIRFFEAIETREKI----YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
            ++HP I+  ++  E         Y+V+EY DG  L   +H  G ++   A   +     
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPL 176
            L    +  +IHRD+KP N+++S    T  +K+ DFG AR++     + T    + G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGA 235
           Y++PE  +    DA++D++S+G +L++++TG+PPF G + + + +Q++    E   PP A
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---REDPIPPSA 241
Query: 236 IEE-LHPDCVDLCRCLLRQNPVER 258
             E L  D   +    L +NP  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 130/251 (51%), Gaps = 17/251 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW A + +   +VAVK +    +S    +  L E +++ T+ H  +++   
Sbjct: 195 KLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL-H 249
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ E+   G L  ++       + + +   F  Q+A G+  +++++ IHRD
Sbjct: 250 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    + V KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 310 LRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G +  ++ + +     +  P    EEL+     + RC  
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN---IMMRC-W 422
Query: 252 RQNPVERITFK 262
           +  P ER TF+
Sbjct: 423 KNRPEERPTFE 433

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 130/251 (51%), Gaps = 17/251 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW A + +   +VAVK +    +S    +  L E +++ T+ H  +++   
Sbjct: 22  KLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL-H 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ E+   G L  ++       + + +   F  Q+A G+  +++++ IHRD
Sbjct: 77  AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 136
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    + V KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 137 LRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           D+WS G +L ++VT G+ P+ G +  ++ + +     +  P    EEL+     + RC  
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN---IMMRC-W 249
Query: 252 RQNPVERITFK 262
           +  P ER TF+
Sbjct: 250 KNRPEERPTFE 260

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 130/264 (49%), Gaps = 17/264 (6%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILS 64
           + L   Y +G  +G G  + V  AR  +   +VAVK +   L   P       +E    +
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 65  TISHPNIIRFFEAIETREKI----YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
            ++HP I+  ++  E         Y+V+EY DG  L   +H  G ++   A   +     
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADT--LCGSPL 176
            L    +  +IHRD+KP N+L+S    T  +K+ DFG AR++  +   +  T  + G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANILISA---TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGA 235
           Y++PE  +    DA++D++S+G +L++++TG+PPF G + + + +Q++    E   PP A
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---REDPIPPSA 241
Query: 236 IEE-LHPDCVDLCRCLLRQNPVER 258
             E L  D   +    L +NP  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 124/245 (50%), Gaps = 7/245 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           +G G F  V   + R  G   A K+++KK +  +  + + L E  IL  ++   ++    
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVS--EAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A ET++ + LVL   +GGDL  +I+  G+    EA A  +  ++  GL+ L  + +++RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           LKP+N+L+  +     ++I D G A  +          G+  YMAPE+++N +Y    D 
Sbjct: 312 LKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDW 368
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W++G +L++++ G+ PF    + ++ +  +       P    E   P    LC  LL ++
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKK-KIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427
Query: 255 PVERI 259
           P ER+
Sbjct: 428 PAERL 432

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 64
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 65  LKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 181
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 234
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 235 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 281

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 93
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 94  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 210
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE------- 263
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 264 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 310

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--P 69
           Y +  +IGSG  + V++  + +  I  A+K ++ +    +  D+   EI+ L+ +     
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + +  
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN- 185
           ++H DLKP N L+    V  +LK+ DFG A  + P     + D+  G+  YM PE I++ 
Sbjct: 176 IVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 186 ----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILT-STELRFPP 233
                      K   K+D+WS+G IL+ +  GK PF    NQ+     I+  + E+ FP 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             I E   D  D+ +C L+++P +RI+  E   H ++
Sbjct: 292 --IPE--KDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 93
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 94  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 210
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE------- 263
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 264 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 310

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 127/254 (50%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V+EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 138 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 250
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 251 C-WRKDPEERPTFE 263

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 126/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  I H  +++ + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKIRHEKLVQLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 138 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 250
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 251 C-WRKDPEERPTFE 263

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP+     L+E  ++  + H  +++ + 
Sbjct: 274 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY- 328
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 386
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N    V K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 387 RDLRAANILVGENL---VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 499
Query: 249 CLLRQNPVERITFK 262
           C  R+ P ER TF+
Sbjct: 500 C-WRKEPEERPTFE 512

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 65
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 182
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 235
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 236 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 282

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 92
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 93  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 209
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE------- 262
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 263 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 309

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 127/254 (50%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V+EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 138 RDLRAANILVGENLVC---KVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 250
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 251 C-WRKDPEERPTFE 263

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--P 69
           Y +  +IGSG  + V++  + +  I  A+K ++ +    +  D+   EI+ L+ +     
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + +  
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN- 185
           ++H DLKP N L+    V  +LK+ DFG A  + P     + D+  G+  YM PE I++ 
Sbjct: 176 IVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 186 ----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILT-STELRFPP 233
                      K   K+D+WS+G IL+ +  GK PF    NQ+     I+  + E+ FP 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             I E   D  D+ +C L+++P +RI+  E   H ++
Sbjct: 292 --IPE--KDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 38/286 (13%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS---HPNIIRF 74
           IG G++  V++AR    G  VA+K +        +  + ++E+++L  +    HPN++R 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 75  FEAIET----RE-KIYLVLEYCDGGDLAAYIHKH---GKVSEAVARHFMRQLAAGLQVLQ 126
            +   T    RE K+ LV E+ D  DL  Y+ K    G  +E + +  MRQ   GL  L 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI-KDLMRQFLRGLDFLH 129
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              ++HRDLKP+N+LV++      +K+ DFG AR  + Q     +  +  Y APE++   
Sbjct: 130 ANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQS 186
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---------------RF 231
            Y    D+WSVG I  ++   KP F G+++      I     L                F
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 246
Query: 232 PP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           PP         + E+      L   +L  NP +RI+      H +L
Sbjct: 247 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 79
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 80  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 196
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 249
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 250 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 296

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 92
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 93  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 209
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 262
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 263 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 309

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 92
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 93  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 209
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE------- 262
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 263 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 309

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 80
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 81  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 197
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 250
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 251 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 297

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 124/245 (50%), Gaps = 7/245 (2%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-LKEISILSTISHPNIIRFFE 76
           +G G F  V   + R  G   A K+++KK +  +  + + L E  IL  ++   ++    
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVS--EAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A ET++ + LVL   +GGDL  +I+  G+    EA A  +  ++  GL+ L  + +++RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           LKP+N+L+  +     ++I D G A  +          G+  YMAPE+++N +Y    D 
Sbjct: 312 LKPENILLDDHGH---IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDW 368
Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W++G +L++++ G+ PF    + ++ +  +       P    E   P    LC  LL ++
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKK-KIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427
Query: 255 PVERI 259
           P ER+
Sbjct: 428 PAERL 432

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 107
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 108 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 224
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 277
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 278 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 324

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 136/277 (49%), Gaps = 28/277 (10%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--P 69
           Y +  +IGSG  + V++  + +  I  A+K ++ +    +  D+   EI+ L+ +     
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + +  
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN- 185
           ++H DLKP N L+    V  +LK+ DFG A  + P     + D+  G+  YM PE I++ 
Sbjct: 176 IVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 186 ----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTST-ELRFPP 233
                      K   K+D+WS+G IL+ +  GK PF    NQ+     I+    E+ FP 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              ++L     D+ +C L+++P +RI+  E   H ++
Sbjct: 292 IPEKDLQ----DVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILS 64
           + L   Y +G  +G G  + V  AR  +   +VAVK +   L   P       +E    +
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 65  TISHPNIIRFFEAIETREKI----YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
            ++HP I+  ++  E         Y+V+EY DG  L   +H  G ++   A   +     
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPL 176
            L    +  +IHRD+KP N+++S    T  +K+ DFG AR++     + T    + G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGA 235
           Y++PE  +    DA++D++S+G +L++++TG+PPF G +   + +Q++    E   PP A
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHV---REDPIPPSA 241
Query: 236 IEE-LHPDCVDLCRCLLRQNPVER 258
             E L  D   +    L +NP  R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 99
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 159
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 216
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 269
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 270 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 65
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 182
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 235
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 236 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 282

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 65
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 182
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 235
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 236 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 282

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 64
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 65  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 181
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 234
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 235 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 281

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 127/254 (50%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V+EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 138 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 250
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 251 C-WRKDPEERPTFE 263

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 124/250 (49%), Gaps = 16/250 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW   +     +VAVK +    +S +     L+E +++ T+ H  ++R + 
Sbjct: 19  KLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYA 74
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH--KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            +   E IY++ E+   G L  ++   + GKV       F  Q+A G+  ++ K+ IHRD
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 134
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAKA 192
           L+  N+LVS    + + KI DFG AR +   +  A      P+ + APE I    +  K+
Sbjct: 135 LRAANVLVSE---SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
           ++WS G +L+++VT GK P+ G     +   +  S   R P   +E    +  D+ +   
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSAL--SQGYRMP--RMENCPDELYDIMKMCW 247
Query: 252 RQNPVERITF 261
           ++   ER TF
Sbjct: 248 KEKAEERPTF 257

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 80
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 81  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 197
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE------- 250
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 251 -------CQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 297

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 127/253 (50%), Gaps = 30/253 (11%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           E ++  RIGSGSF  V++ +      +VAVK +     +P+       E+++L    H N
Sbjct: 37  EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN 93
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM-----RQLAAGLQVL 125
           I+  F    T++ + +V ++C+G  L    +KH  V E   + F      RQ A G+  L
Sbjct: 94  IL-LFMGYMTKDNLAIVTQWCEGSSL----YKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYMAPEI 182
             K++IHRD+K  N+ +        +KIGDFG A      +     +   GS L+MAPE+
Sbjct: 149 HAKNIIHRDMKSNNIFLHEG---LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 183 IQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTEL----RF 231
           I+   N+ +  ++D++S G +L++L+TG+ P+   N     + +      S +L    + 
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265
Query: 232 PPGAIEELHPDCV 244
            P A++ L  DCV
Sbjct: 266 CPKAMKRLVADCV 278

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 93
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 94  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 210
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXE------- 263
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 264 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 310

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP+     L+E  ++  + H  +++ + 
Sbjct: 191 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY- 245
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 303
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N    V K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 304 RDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 416
Query: 249 CLLRQNPVERITFK 262
           C  R+ P ER TF+
Sbjct: 417 C-WRKEPEERPTFE 429

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP+     L+E  ++  + H  +++ + 
Sbjct: 191 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY- 245
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 303
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N    V K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 304 RDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 416
Query: 249 CLLRQNPVERITFK 262
           C  R+ P ER TF+
Sbjct: 417 C-WRKEPEERPTFE 429

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 138 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 250
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 251 C-WRKDPEERPTFE 263

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 92
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 93  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 209
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXE------- 262
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 263 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 309

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 38/286 (13%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS---HPNIIRF 74
           IG G++  V++AR    G  VA+K +        +  + ++E+++L  +    HPN++R 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 75  FEAIET----RE-KIYLVLEYCDGGDLAAYIHKH---GKVSEAVARHFMRQLAAGLQVLQ 126
            +   T    RE K+ LV E+ D  DL  Y+ K    G  +E + +  MRQ   GL  L 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI-KDLMRQFLRGLDFLH 129
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              ++HRDLKP+N+LV++      +K+ DFG AR  + Q     +  +  Y APE++   
Sbjct: 130 ANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQS 186
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL---------------RF 231
            Y    D+WSVG I  ++   KP F G+++      I     L                F
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 246
Query: 232 PP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           PP         + E+      L   +L  NP +RI+      H +L
Sbjct: 247 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--P 69
           Y +  +IGSG  + V++  + +  I  A+K ++ +    +  D+   EI+ L+ +     
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + +  
Sbjct: 70  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN- 185
           ++H DLKP N L+    V  +LK+ DFG A  + P     + D+  G+  YM PE I++ 
Sbjct: 129 IVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 186 ----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILT-STELRFPP 233
                      K   K+D+WS+G IL+ +  GK PF    NQ+     I+  + E+ FP 
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              ++L     D+ +C L+++P +RI+  E   H ++
Sbjct: 245 IPEKDLQ----DVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 93
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 94  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 210
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXE------- 263
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 264 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 310

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 22  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY + G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DMSAQIASGMAYVERMNYVH 134
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 135 RDLRAANILVGENLVC---KVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 247
Query: 249 CLLRQNPVERITFK 262
           C  R+ P ER TF+
Sbjct: 248 C-WRKEPEERPTFE 260

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 138 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 250
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 251 C-WRKDPEERPTFE 263

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 16  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 70
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 128
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 129 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 186 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 241
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 242 C-WRKDPEERPTFE 254

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 14  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 68
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 126
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 127 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 184 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 239
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 240 C-WRKDPEERPTFE 252

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 79
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 80  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 196
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE------- 249
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 250 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 296

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 80
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 81  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 197
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE------- 250
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 251 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 297

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 112
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 113 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 172
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 173 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 229
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 230 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE------- 282
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 283 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 329

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 22  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 76
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY + G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DMSAQIASGMAYVERMNYVH 134
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 135 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 247
Query: 249 CLLRQNPVERITFK 262
           C  R+ P ER TF+
Sbjct: 248 C-WRKEPEERPTFE 260

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 87
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 88  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 147
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 148 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 204
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 205 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE------- 257
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 258 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 304

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI 62
           P+R     + I G  +G G F    +  HR+ G  + +KE+ +     +     LKE+ +
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKV 60
Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAG 121
           +  + HPN+++F   +   +++  + EY  GG L   I           R  F + +A+G
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-----PQDLAD------- 169
           +  L   ++IHRDL   N LV  N+   V    DFG AR +      P+ L         
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVV---ADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 170 ---TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLV 205
              T+ G+P +MAPE+I    YD K D++S G +L +++
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--P 69
           Y +  +IGSG  + V++  + +  I  A+K ++ +    +  D+   EI+ L+ +     
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + +  
Sbjct: 89  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN- 185
           ++H DLKP N L+    V  +LK+ DFG A  + P     + D+  G+  YM PE I++ 
Sbjct: 148 IVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 186 ----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILT-STELRFPP 233
                      K   K+D+WS+G IL+ +  GK PF    NQ+     I+  + E+ FP 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              ++L     D+ +C L+++P +RI+  E   H ++
Sbjct: 264 IPEKDLQ----DVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 39/294 (13%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 107
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 108 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 224
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE------- 277
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL---RQTVHAEQHSVVP 286
                  C  L R  L   P +R TF+E  NH ++ ++   ++T     HS+ P
Sbjct: 278 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 324

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVSDNLLKEISILSTIS---HPNI 71
           IG G++  V++AR    G  VA+K +   +       +  + ++E+++L  +    HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 72  IRFFEAIET----RE-KIYLVLEYCDGGDLAAYIHKH---GKVSEAVARHFMRQLAAGLQ 123
           +R  +   T    RE K+ LV E+ D  DL  Y+ K    G  +E + +  MRQ   GL 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI-KDLMRQFLRGLD 134
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
            L    ++HRDLKP+N+LV++      +K+ DFG AR  + Q     +  +  Y APE++
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL-------------- 229
               Y    D+WSVG I  ++   KP F G+++      I     L              
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR 251
Query: 230 -RFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             FPP         + E+      L   +L  NP +RI+      H +L
Sbjct: 252 GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--P 69
           Y +  +IGSG  + V++  + +  I  A+K ++ +    +  D+   EI+ L+ +     
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + +  
Sbjct: 89  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN- 185
           ++H DLKP N L+    V  +LK+ DFG A  + P     + D+  G+  YM PE I++ 
Sbjct: 148 IVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDM 203
Query: 186 ----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILT-STELRFPP 233
                      K   K+D+WS+G IL+ +  GK PF    NQ+     I+  + E+ FP 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              ++L     D+ +C L+++P +RI+  E   H ++
Sbjct: 264 IPEKDLQ----DVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 136/277 (49%), Gaps = 28/277 (10%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--P 69
           Y +  +IGSG  + V++  + +  I  A+K ++ +    +  D+   EI+ L+ +     
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + +  
Sbjct: 73  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 131
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN- 185
           ++H DLKP N L+    V  +LK+ DFG A  + P     + D+  G+  YM PE I++ 
Sbjct: 132 IVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 187
Query: 186 ----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTST-ELRFPP 233
                      K   K+D+WS+G IL+ +  GK PF    NQ+     I+    E+ FP 
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 247
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              ++L     D+ +C L+++P +RI+  E   H ++
Sbjct: 248 IPEKDLQ----DVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 18  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 72
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 73  AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 130
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 131 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 188 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 243
Query: 249 CLLRQNPVERITFK 262
           C  R+ P ER TF+
Sbjct: 244 C-WRKEPEERPTFE 256

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP+     L+E  ++  + H  +++ + 
Sbjct: 191 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY- 245
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 303
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N    V K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 304 RDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 416
Query: 249 CLLRQNPVERITFK 262
           C  R+ P ER TF+
Sbjct: 417 C-WRKEPEERPTFE 429

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 127/252 (50%), Gaps = 29/252 (11%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G+G F  VW A + +   +VAVK +    +S    +  L E +++ T+ H  +++   
Sbjct: 189 KLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL-H 243
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
           A+ T+E IY++ E+   G L  ++       + + +   F  Q+A G+  +++++ IHRD
Sbjct: 244 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 303
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAK 191
           L+  N+LVS    + V KI DFG AR            G+     + APE I    +  K
Sbjct: 304 LRAANILVS---ASLVCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTIK 349
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           +D+WS G +L ++VT G+ P+ G +  ++ + +     +  P    EEL+     + RC 
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN---IMMRC- 405
Query: 251 LRQNPVERITFK 262
            +  P ER TF+
Sbjct: 406 WKNRPEERPTFE 417

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 95
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +YLV  +  G DL   +      ++ +  +F+ Q+
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQHLSNDHIC-YFLYQI 153
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 136/277 (49%), Gaps = 28/277 (10%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--P 69
           Y +  +IGSG  + V++  + +  I  A+K ++ +    +  D+   EI+ L+ +     
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
            IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + +  
Sbjct: 69  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 127
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN- 185
           ++H DLKP N L+    V  +LK+ DFG A  + P     + D+  G+  YM PE I++ 
Sbjct: 128 IVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 183
Query: 186 ----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTST-ELRFPP 233
                      K   K+D+WS+G IL+ +  GK PF    NQ+     I+    E+ FP 
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 243
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              ++L     D+ +C L+++P +RI+  E   H ++
Sbjct: 244 IPEKDLQ----DVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 126/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 138 RDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 250
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 251 C-WRKDPEERPTFE 263

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 79
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL   N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 138 RDLAAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 250
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 251 C-WRKDPEERPTFE 263

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 16/226 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  +   + G+++AVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 119 FTPATSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 176
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 177 HRDLKPSNLAVNED---CELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNM 231
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI 236
             D+WSVG I+ +L+TG+  F G++ +   Q I+  T    PP ++
Sbjct: 232 TVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGT--PPASV 275

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 21/209 (10%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRFFE 76
           +G+G++  V++ RH + G   A+K +D   ++    + + +EI++L   SH  NI  ++ 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 77  AIETR------EKIYLVLEYCDGGDLAAYIH--KHGKVSEAVARHFMRQLAAGLQVLQEK 128
           A   +      ++++LV+E+C  G +   I   K   + E    +  R++  GL  L + 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPLYMAPEIIQ--- 184
            +IHRD+K QN+L++ N     +K+ DFG +  L       +T  G+P +MAPE+I    
Sbjct: 149 KVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 185 --NHKYDAKADLWSVGAILFQLVTGKPPF 211
             +  YD K+DLWS+G    ++  G PP 
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 125/254 (49%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP+     L+E  ++  + H  +++ + 
Sbjct: 192 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQLY- 246
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E IY+V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 247 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 304
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N    V K+ DFG  R +   +  A      P+ + APE     ++  
Sbjct: 305 RDLRAANILVGEN---LVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 362 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 417
Query: 249 CLLRQNPVERITFK 262
           C  R++P ER TF+
Sbjct: 418 C-WRKDPEERPTFE 430

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 30/251 (11%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+ A    L      I VAVK +  K  S     +  +E  +L+ + H +I+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAELLTNLQHEHIV 78
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-------------KVSEAVARHFMRQLA 119
           +F+      + + +V EY   GDL  ++  HG             +++++   H  +Q+A
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL--- 176
           AG+  L  +H +HRDL  +N LV  N    ++KIGDFG +R +   D       + L   
Sbjct: 139 AGMVYLASQHFVHRDLATRNCLVGEN---LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP--- 232
           +M PE I   K+  ++D+WS+G +L+++ T GK P+   +  ++ + I     L+ P   
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 255
Query: 233 PGAIEELHPDC 243
           P  + EL   C
Sbjct: 256 PQEVYELMLGC 266

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFF- 75
           +G G+ A V+R RH++ G   A+K  +    L P   D  ++E  +L  ++H NI++ F 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 76  --EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM---RQLAAGLQVLQEKHL 130
             E   TR K+ L++E+C  G L   + +           F+   R +  G+  L+E  +
Sbjct: 75  IEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 131 IHRDLKPQNLL-VSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ----- 184
           +HR++KP N++ V   +   V K+ DFG AR L   +   +L G+  Y+ P++ +     
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLR 193
Query: 185 ---NHKYDAKADLWSVGAILFQLVTGKPPF 211
                KY A  DLWS+G   +   TG  PF
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG AR L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 132/278 (47%), Gaps = 36/278 (12%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 60
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 121 EAVRHCHNXGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 177
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S E       
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE------- 230
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                  C  L R  L   P +R TF+E  NH ++ ++
Sbjct: 231 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 132/275 (48%), Gaps = 30/275 (10%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-----PKVSDNLLKEISILST 65
           +Y VGP +GSG F  V+        + VA+K ++K  +S     P     +  E+ +L  
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKK 63
Query: 66  IS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
           +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+   +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           +      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  PE 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSPPEW 180
Query: 183 IQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGAIEE 238
           I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E          
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE---------- 230
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
               C  L R  L   P +R TF+E  NH ++ ++
Sbjct: 231 ----CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 45/292 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---- 73
           IG+GSF VV++A+  +   EVA+K    K+L  K   N  +E+ I+  + HPN++     
Sbjct: 48  IGNGSFGVVFQAKLVE-SDEVAIK----KVLQDKRFKN--RELQIMRIVKHPNVVDLKAF 100
Query: 74  FFEAIETREKIYL--VLEYCDGGDLAAYIHKHGKVSEAVA----RHFMRQLAAGLQVLQE 127
           F+   + +++++L  VLEY       A  H + K+ + +     + +M QL   L  +  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN-H 186
             + HRD+KPQNLL+  +  + VLK+ DFG A+ L   +   +   S  Y APE+I    
Sbjct: 160 IGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGAT 217
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----------------TSTELR 230
            Y    D+WS G ++ +L+ G+P F G + +     I+                   E +
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277
Query: 231 FP---PGAIEELH-----PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           FP   P    ++      PD +DL   LL   P  R+T  E   H F  ELR
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 133/278 (47%), Gaps = 36/278 (12%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD--------NLLKEISI 62
           +Y VGP +GSG F  V+        + VA+K ++K     ++SD         +  E+ +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD----RISDWGELPNGTRVPMEVVL 60
Query: 63  LSTIS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLA 119
           L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+ 
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSP 177
Query: 180 PEIIQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGA 235
           PE I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E       
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 230
Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                  C  L R  L   P +R TF+E  NH ++ ++
Sbjct: 231 -------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 132/275 (48%), Gaps = 30/275 (10%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-----PKVSDNLLKEISILST 65
           +Y VGP +GSG F  V+        + VA+K ++K  +S     P     +  E+ +L  
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKK 66
Query: 66  IS--HPNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
           +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+   +
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 126
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           +      ++HRD+K +N+L+  N     LK+ DFG + +L    +     G+ +Y  PE 
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSPPEW 183
Query: 183 IQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQL---QLFQNILTSTELRFPPGAIEE 238
           I+ H+Y  + A +WS+G +L+ +V G  PF+   ++   Q+F     S+E          
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE---------- 233
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
               C  L R  L   P +R TF+E  NH ++ ++
Sbjct: 234 ----CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPN 70
           +++   +G G+ A V+R RH++ G   A+K  +    L P   D  ++E  +L  ++H N
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKN 68
Query: 71  IIRFF---EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM---RQLAAGLQV 124
           I++ F   E   TR K+ L++E+C  G L   + +           F+   R +  G+  
Sbjct: 69  IVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 125 LQEKHLIHRDLKPQNLL-VSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
           L+E  ++HR++KP N++ V   +   V K+ DFG AR L   +    L G+  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMY 187
Query: 184 Q--------NHKYDAKADLWSVGAILFQLVTGKPPF 211
           +          KY A  DLWS+G   +   TG  PF
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 117/228 (51%), Gaps = 23/228 (10%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 97  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG---SPLYMAPEIIQNH-K 187
           HRDLKP NL V+ +     LKI DFG AR       AD + G   +  Y APEI+ N   
Sbjct: 155 HRDLKPSNLAVNED---CELKILDFGLARH-----TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           Y+   D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 251

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           IGSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 95  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 152
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 153 HRDLKPSNLAVNEDX---ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 249

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 118/239 (49%), Gaps = 18/239 (7%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IGSG    V   R R   Q  + VA+K + K   + +   + L E SI+    HPNIIR 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIR- 114
Query: 75  FEAIETREKIYLVL-EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            E + TR ++ +++ EY + G L  ++  H G+ +       +R + AG++ L +   +H
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+LV +N V    K+ DFG +R L    D A T  G  +   + APE I    +
Sbjct: 175 RDLAARNVLVDSNLVC---KVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTF 231
Query: 189 DAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDC 243
            + +D+WS G ++++ L  G+ P+       +  ++     L  P   P A+ +L  DC
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDC 290

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KXQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNEDX---ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 117/228 (51%), Gaps = 23/228 (10%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 97  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG---SPLYMAPEIIQNH-K 187
           HRDLKP NL V+ +     LKI DFG AR       AD + G   +  Y APEI+ N   
Sbjct: 155 HRDLKPSNLAVNED---CELKILDFGLARH-----TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           Y+   D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 251

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 117/228 (51%), Gaps = 23/228 (10%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 97  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG---SPLYMAPEIIQNH-K 187
           HRDLKP NL V+ +     LKI DFG AR       AD + G   +  Y APEI+ N   
Sbjct: 155 HRDLKPSNLAVNED---CELKILDFGLARH-----TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           Y+   D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 251

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ K   S   +    +E+ +L  + H N+I   + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 102 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 159
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 160 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 256

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 142
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N    V K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 143 DLAARNILINSN---LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 200 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 254
Query: 241 PDC 243
            DC
Sbjct: 255 LDC 257

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 96  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 153
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 154 HRDLKPSNLAVNEDS---ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 250

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 125/243 (51%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G F  V   R +  G   I VA+K + K   + K   + L E SI+    HPNII  
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + ++ EY + G L A++ K+ G+ +       +R + +G++ L +   +HR
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 134
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+LV++N V    K+ DFG +R L   P+    T  G  P+ + APE I   K+ 
Sbjct: 135 DLAARNILVNSNLVC---KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 191
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFPPG-----AIEELH 240
           + +D+WS G +++++++   +P +D SN     Q+++ + E   R PP      A+ +L 
Sbjct: 192 SASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVIKAIEEGYRLPPPMDCPIALHQLM 246
Query: 241 PDC 243
            DC
Sbjct: 247 LDC 249

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 159
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 160 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 216
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 217 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 271
Query: 241 PDC 243
            DC
Sbjct: 272 LDC 274

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 125/243 (51%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G F  V   R +  G   I VA+K + K   + K   + L E SI+    HPNII  
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + ++ EY + G L A++ K+ G+ +       +R + +G++ L +   +HR
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 140
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+LV++N V    K+ DFG +R L   P+    T  G  P+ + APE I   K+ 
Sbjct: 141 DLAARNILVNSNLVC---KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 197
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFPPG-----AIEELH 240
           + +D+WS G +++++++   +P +D SN     Q+++ + E   R PP      A+ +L 
Sbjct: 198 SASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVIKAIEEGYRLPPPMDCPIALHQLM 252
Query: 241 PDC 243
            DC
Sbjct: 253 LDC 255

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 92  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 149
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 150 HRDLKPSNLAVNEDS---ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 246

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 95  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 152
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 153 HRDLKPSNLAVNEDX---ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 249

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 169
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 170 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 226
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 227 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 281
Query: 241 PDC 243
            DC
Sbjct: 282 LDC 284

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KXQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 125/243 (51%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G F  V   R +  G   I VA+K + K   + K   + L E SI+    HPNII  
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + ++ EY + G L A++ K+ G+ +       +R + +G++ L +   +HR
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHR 155
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+LV++N V    K+ DFG +R L   P+    T  G  P+ + APE I   K+ 
Sbjct: 156 DLAARNILVNSNLVC---KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 212
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFPPG-----AIEELH 240
           + +D+WS G +++++++   +P +D SN     Q+++ + E   R PP      A+ +L 
Sbjct: 213 SASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVIKAIEEGYRLPPPMDCPIALHQLM 267
Query: 241 PDC 243
            DC
Sbjct: 268 LDC 270

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 101 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 158
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 159 HRDLKPSNLAVNEDX---ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 213
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 214 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 255

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 128/255 (50%), Gaps = 25/255 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           R+G+G F  VW         +VA+K +    +SP   ++ L+E  I+  + H  +++ + 
Sbjct: 16  RLGNGQFGEVWMGTWNG-NTKVAIKTLKPGTMSP---ESFLEEAQIMKKLKHDKLVQLY- 70
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM---RQLAAGLQVLQEKHLIHR 133
           A+ + E IY+V EY + G L  ++ K G+       + +    Q+AAG+  ++  + IHR
Sbjct: 71  AVVSEEPIYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDAK 191
           DL+  N+LV    +    KI DFG AR +   +  A      P+ + APE     ++  K
Sbjct: 130 DLRSANILVGNGLIC---KIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDCVDLC 247
           +D+WS G +L +LVT G+ P+ G N  ++ + +     +  P   P ++ EL   C    
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHC---- 242
Query: 248 RCLLRQNPVERITFK 262
               +++P ER TF+
Sbjct: 243 ---WKKDPEERPTFE 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 118/239 (49%), Gaps = 18/239 (7%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IGSG    V   R R   Q  + VA+K + K   + +   + L E SI+    HPNIIR 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIR- 114
Query: 75  FEAIETREKIYLVL-EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            E + TR ++ +++ EY + G L  ++  H G+ +       +R + AG++ L +   +H
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+LV +N V    K+ DFG +R L    D A T  G  +   + APE I    +
Sbjct: 175 RDLAARNVLVDSNLVC---KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 189 DAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDC 243
            + +D+WS G ++++ L  G+ P+       +  ++     L  P   P A+ +L  DC
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDC 290

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 34/274 (12%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+ A    L      + VAVK +    L+ +   +  +E  +L+ + H +I+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 80
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKH----------------GKVSEAVARHFMR 116
           +F+      + + +V EY   GDL  ++  H                G++  +   H   
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
           Q+A+G+  L  +H +HRDL  +N LV  N    ++KIGDFG +R +   D       + L
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 177 ---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
              +M PE I   K+  ++D+WS G IL+++ T GK P+   +  ++ + I     L  P
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 257
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN 266
               +E++    D+     ++ P +R+  KE + 
Sbjct: 258 RVCPKEVY----DVMLGCWQREPQQRLNIKEIYK 287

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 127/243 (52%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 41/285 (14%)
Query: 13  IVGPRIGSGSFAVVWRA-----RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           ++G  +G G F  V +A     + R     VAVK + K+  SP    +LL E ++L  ++
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVN 84
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH-------------- 113
           HP++I+ + A      + L++EY   G L  ++ +  KV                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 114 ----------FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT 163
                     F  Q++ G+Q L E  L+HRDL  +N+LV+       +KI DFG +R + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR---KMKISDFGLSRDVY 201
Query: 164 PQD--LADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQL 219
            +D  +  +    P+ +MA E + +H Y  ++D+WS G +L+++VT G  P+ G    +L
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 220 FQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
           F  + T   +  P    EE++     L     +Q P +R  F + 
Sbjct: 262 FNLLKTGHRMERPDNCSEEMY----RLMLQCWKQEPDKRPVFADI 302

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 113 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 170
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 171 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMHYNQ 225
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 226 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 267

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 96  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 153
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 154 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 126/243 (51%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG  R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 41/285 (14%)
Query: 13  IVGPRIGSGSFAVVWRA-----RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           ++G  +G G F  V +A     + R     VAVK + K+  SP    +LL E ++L  ++
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVN 84
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH-------------- 113
           HP++I+ + A      + L++EY   G L  ++ +  KV                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 114 ----------FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT 163
                     F  Q++ G+Q L E  L+HRDL  +N+LV+       +KI DFG +R + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR---KMKISDFGLSRDVY 201
Query: 164 PQD--LADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQL 219
            +D  +  +    P+ +MA E + +H Y  ++D+WS G +L+++VT G  P+ G    +L
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 220 FQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
           F  + T   +  P    EE++     L     +Q P +R  F + 
Sbjct: 262 FNLLKTGHRMERPDNCSEEMY----RLMLQCWKQEPDKRPVFADI 302

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 96  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 153
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 154 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 250

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 138/295 (46%), Gaps = 41/295 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTIS-HP 69
           G  +G+G+F  V  A    LG E AV ++  K+L         + L+ E+ I+S +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE-----AVAR---------HFM 115
           NI+    A      + ++ EYC  GDL  ++ +  +V E     A+A          HF 
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS- 174
            Q+A G+  L  K+ IHRD+  +N+L++   V    KIGDFG AR +   D    + G+ 
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM-NDSNYIVKGNA 226
Query: 175 --PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG----SNQLQLFQNILTS 226
             P+ +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    S   +L ++    
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQ 281
            +  F P  I  +   C  L        P  R TF++  +  FL E  Q    E+
Sbjct: 287 AQPAFAPKNIYSIMQACWAL-------EPTHRPTFQQICS--FLQEQAQEDRRER 332

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 95  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 152
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 153 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 249

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 138/295 (46%), Gaps = 41/295 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTIS-HP 69
           G  +G+G+F  V  A    LG E AV ++  K+L         + L+ E+ I+S +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE-----AVAR---------HFM 115
           NI+    A      + ++ EYC  GDL  ++ +  +V E     A+A          HF 
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS- 174
            Q+A G+  L  K+ IHRD+  +N+L++   V    KIGDFG AR +   D    + G+ 
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM-NDSNYIVKGNA 226
Query: 175 --PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG----SNQLQLFQNILTS 226
             P+ +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    S   +L ++    
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQ 281
            +  F P  I  +   C  L        P  R TF++  +  FL E  Q    E+
Sbjct: 287 AQPAFAPKNIYSIMQACWAL-------EPTHRPTFQQICS--FLQEQAQEDRRER 332

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 109 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 166
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 167 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 221
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 222 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 263

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 97  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 155 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 251

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 77
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 135
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNT---TSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 92  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 149
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 150 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 246

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 95  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 152
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 153 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 249

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 89  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 146
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 147 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 201
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 202 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 243

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 102 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 159
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 160 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 256

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 102 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 159
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 160 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 256

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 110 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 167
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 168 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 222
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 264

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 101 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 158
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 159 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 213
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 214 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 255

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 113 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 170
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 171 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 225
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 226 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 267

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 92  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 149
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 150 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 246

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG F VV    W+ ++     +VAVK I +  +S    D   +E   +  +SHP +++
Sbjct: 16  LGSGQFGVVKLGKWKGQY-----DVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVK 67
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE-AVARHFMRQLAAGLQVLQEKHLIH 132
           F+        IY+V EY   G L  Y+  HGK  E +        +  G+  L+    IH
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARS-LTPQDLADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL  +N LV  +     +K+ DFG  R  L  Q ++      P+ + APE+    KY +
Sbjct: 128 RDLAARNCLVDRD---LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 191 KADLWSVGAILFQLVT-GKPPFD 212
           K+D+W+ G +++++ + GK P+D
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 41/285 (14%)
Query: 13  IVGPRIGSGSFAVVWRA-----RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           ++G  +G G F  V +A     + R     VAVK + K+  SP    +LL E ++L  ++
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVN 84
Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH-------------- 113
           HP++I+ + A      + L++EY   G L  ++ +  KV                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 114 ----------FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT 163
                     F  Q++ G+Q L E  L+HRDL  +N+LV+       +KI DFG +R + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGR---KMKISDFGLSRDVY 201
Query: 164 PQD--LADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQL 219
            +D  +  +    P+ +MA E + +H Y  ++D+WS G +L+++VT G  P+ G    +L
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 220 FQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
           F  + T   +  P    EE++     L     +Q P +R  F + 
Sbjct: 262 FNLLKTGHRMERPDNCSEEMY----RLMLQCWKQEPDKRPVFADI 302

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 126/246 (51%), Gaps = 30/246 (12%)
Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V     +  G   I VA+K + K   + K   + L E SI+    HPN+I  
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +     + ++ E+ + G L +++ ++ G+ +       +R +AAG++ L + + +HR
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 159
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-------YMAPEIIQNH 186
           DL  +N+LV++N V    K+ DFG +R L   D +D    S L       + APE IQ  
Sbjct: 160 DLAARNILVNSNLVC---KVSDFGLSRFLE-DDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 187 KYDAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIE 237
           K+ + +D+WS G +++++++   +P +D +N     Q+++ + E   R P     P A+ 
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVINAIEQDYRLPPPMDCPSALH 270
Query: 238 ELHPDC 243
           +L  DC
Sbjct: 271 QLMLDC 276

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 86  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 144 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 240

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 87  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 144
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 145 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 199
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 200 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 241

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 88  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 145
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 146 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 200
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 201 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 242

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 92  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 149
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 150 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 246

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 77
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 135
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 124/254 (48%), Gaps = 23/254 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 15  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY- 69
Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A+ + E I +V EY   G L  ++     K+ ++ + V      Q+A+G+  ++  + +H
Sbjct: 70  AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERMNYVH 127
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-ADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL+  N+LV  N V    K+ DFG AR +   +  A      P+ + APE     ++  
Sbjct: 128 RDLRAANILVGENLVC---KVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
           K+D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+
Sbjct: 185 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQ 240
Query: 249 CLLRQNPVERITFK 262
           C  R+ P ER TF+
Sbjct: 241 C-WRKEPEERPTFE 253

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 87  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 144
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 145 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 199
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 200 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 241

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KSQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG  R     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNEDS---ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 75
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 133
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 77
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 78  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 135
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 136 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 29  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 83
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 84  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 141
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 142 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 75
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 133
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 75
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 133
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----LADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 75
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 133
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----LADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 134/305 (43%), Gaps = 48/305 (15%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           + +Y    +IG G+F  V++ARHR+ G +VA+K++  +          L+EI IL  + H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 69  PNIIRFFEAIETRE--------KIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLA 119
            N++   E   T+          IYLV ++C+  DLA  +     K + +  +  M+ L 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT------PQDLADTLCG 173
            GL  +    ++HRD+K  N+L++ +    VLK+ DFG AR+ +      P    + +  
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDG---VLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 174 SPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTEL 229
           +  Y  PE++   + Y    DLW  G I+ ++ T  P   G+   +QL L   +  S   
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 230 RFPPGA-----IEELH-------------------PDCVDLCRCLLRQNPVERITFKEFF 265
              P        E+L                    P  +DL   LL  +P +RI   +  
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 266 NHRFL 270
           NH F 
Sbjct: 312 NHDFF 316

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 75
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 133
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----LADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 79
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 137
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 73
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 131
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 80
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 138
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 27  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 81
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 82  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 139
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 140 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 18  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 72
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 73  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 130
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 131 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 79
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 137
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 73
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 131
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYXQRTLREIKIL 79
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 137
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNT---TXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 95
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 153
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 79
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 137
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 80
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 138
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+K+I     SP          L+EI IL
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQRTLREIKIL 79
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   + K   +S     +F+ Q+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-KCQHLSNDHICYFLYQI 137
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 96/328 (29%), Positives = 142/328 (43%), Gaps = 69/328 (21%)
Query: 2   EPNRTRLIGE-------------YIVGPR------IGSGSFAVVWRARHRQLGIEVAVKE 42
           EP RT  +G              + VGPR      IG G++ +V  A        VA+K+
Sbjct: 16  EPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKK 75
Query: 43  IDKKLLSP----KVSDNLLKEISILSTISHPNIIRFFE-----AIETREKIYLVLEYCDG 93
           I     SP          L+EI IL    H N+I   +      +E    +Y+V +  + 
Sbjct: 76  I-----SPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET 130
Query: 94  GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKI 153
            DL   + K  ++S     +F+ Q+  GL+ +   +++HRDLKP NLL++T   T  LKI
Sbjct: 131 -DLYKLL-KSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINT---TCDLKI 185
Query: 154 GDFGFARSLTPQ----DLADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGK 208
            DFG AR   P+            +  Y APEI+ N K Y    D+WSVG IL ++++ +
Sbjct: 186 CDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
Query: 209 PPFDGSNQLQLFQNIL------------------TSTELRFPPG----AIEELHP----D 242
           P F G + L    +IL                      L+  P     A  +L P     
Sbjct: 246 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSK 305
Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
            +DL   +L  NP +RIT +E   H +L
Sbjct: 306 ALDLLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W      + I VA+K I  +   PK +   + E  I++++ HP+++R
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               +     I LV +    G L  Y+H+H   +   +  ++  Q+A G+  L+E+ L+H
Sbjct: 82  LL-GVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 140
Query: 133 RDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+LV S N V    KI DFG AR L   +      G  +   +MA E I   K+
Sbjct: 141 RDLAARNVLVKSPNHV----KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 189 DAKADLWSVGAILFQLVT-GKPPFDG 213
             ++D+WS G  +++L+T G  P+DG
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 126/243 (51%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V   R +  G   + VA+K + K   + K   + L E SI+    HPNII  
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V EY + G L  ++ K+ G+ +       +R ++AG++ L +   +HR
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHR 148
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + APE I   K+ 
Sbjct: 149 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFT 205
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +++++V+   +P ++ +N     Q+++ + E   R P     P A+ +L 
Sbjct: 206 SASDVWSYGIVMWEVVSYGERPYWEMTN-----QDVIKAVEEGYRLPSPMDCPAALYQLM 260
Query: 241 PDC 243
            DC
Sbjct: 261 LDC 263

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 119/244 (48%), Gaps = 33/244 (13%)
Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           ++ +Y +  ++G G++ +VW++  R+ G  VAVK+I     +   +    +EI IL+ +S
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 68  -HPNIIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM-RQLAAGLQ 123
            H NI+     +  +    +YLV +Y +  DL A I     + E V + ++  QL   ++
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR--ANILEPVHKQYVVYQLIKVIK 123
Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-------------------- 163
            L    L+HRD+KP N+L++       +K+ DFG +RS                      
Sbjct: 124 YLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 164 --PQDLADTLCGSPLYMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLF 220
              Q +      +  Y APEI+  + KY    D+WS+G IL +++ GKP F GS+ +   
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 221 QNIL 224
           + I+
Sbjct: 241 ERII 244

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI D+G AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 48/305 (15%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           + +Y    +IG G+F  V++ARHR+ G +VA+K++  +          L+EI IL  + H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 69  PNIIRFFEAIETRE--------KIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLA 119
            N++   E   T+          IYLV ++C+  DLA  + +   K + +  +  M+ L 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT------PQDLADTLCG 173
            GL  +    ++HRD+K  N+L++ +    VLK+ DFG AR+ +      P    + +  
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYXNRVV- 190
Query: 174 SPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTEL 229
           +  Y  PE++   + Y    DLW  G I+ ++ T  P   G+   +QL L   +  S   
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 230 RFPPGA-----IEELH-------------------PDCVDLCRCLLRQNPVERITFKEFF 265
              P        E+L                    P  +DL   LL  +P +RI   +  
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310
Query: 266 NHRFL 270
           NH F 
Sbjct: 311 NHDFF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 48/305 (15%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           + +Y    +IG G+F  V++ARHR+ G +VA+K++  +          L+EI IL  + H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 69  PNIIRFFEAIETRE--------KIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLA 119
            N++   E   T+          IYLV ++C+  DLA  + +   K + +  +  M+ L 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT------PQDLADTLCG 173
            GL  +    ++HRD+K  N+L++ +    VLK+ DFG AR+ +      P    + +  
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 174 SPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTEL 229
           +  Y  PE++   + Y    DLW  G I+ ++ T  P   G+   +QL L   +  S   
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 230 RFPPGA-----IEELH-------------------PDCVDLCRCLLRQNPVERITFKEFF 265
              P        E+L                    P  +DL   LL  +P +RI   +  
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 266 NHRFL 270
           NH F 
Sbjct: 312 NHDFF 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 48/305 (15%)
Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           + +Y    +IG G+F  V++ARHR+ G +VA+K++  +          L+EI IL  + H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 69  PNIIRFFEAIET--------REKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLA 119
            N++   E   T        +  IYLV ++C+  DLA  + +   K + +  +  M+ L 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT------PQDLADTLCG 173
            GL  +    ++HRD+K  N+L++ +    VLK+ DFG AR+ +      P    + +  
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 174 SPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTEL 229
           +  Y  PE++   + Y    DLW  G I+ ++ T  P   G+   +QL L   +  S   
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 230 RFPPGA-----IEELH-------------------PDCVDLCRCLLRQNPVERITFKEFF 265
              P        E+L                    P  +DL   LL  +P +RI   +  
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 266 NHRFL 270
           NH F 
Sbjct: 312 NHDFF 316

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR  T  ++A     +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH-TDDEMA-GFVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W      + I VA+K I  +   PK +   + E  I++++ HP+++R
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               +     I LV +    G L  Y+H+H   +   +  ++  Q+A G+  L+E+ L+H
Sbjct: 105 LL-GVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 163
Query: 133 RDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+LV S N V    KI DFG AR L   +      G  +   +MA E I   K+
Sbjct: 164 RDLAARNVLVKSPNHV----KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 189 DAKADLWSVGAILFQLVT-GKPPFDG 213
             ++D+WS G  +++L+T G  P+DG
Sbjct: 220 THQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR  T  ++A     +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH-TDDEMA-GFVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 86  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCAKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 144 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 86  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR  T  ++A     +  Y APEI+ N   Y+ 
Sbjct: 144 HRDLKPSNLAVNED---CELKILDFGLARH-TDDEMA-GFVATRWYRAPEIMLNWMHYNQ 198
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 240

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 14  VGPR------IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISIL 63
           VGPR      IG G++ +V  A      + VA+++I     SP          L+EI IL
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKI-----SPFEHQTYCQRTLREIKIL 79
Query: 64  STISHPNIIRFFE-----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
               H NII   +      IE  + +Y+V +  +  DL   +      ++ +  +F+ Q+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC-YFLYQI 137
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ----DLADTLCGS 174
             GL+ +   +++HRDLKP NLL++T   T  LKI DFG AR   P             +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 175 PLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             Y APEI+ N K Y    D+WSVG IL ++++ +P F G + L    +IL
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 96  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 153
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 154 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 250

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 119/240 (49%), Gaps = 29/240 (12%)
Query: 18  IGSGSFAVVWRARHRQLGIE---VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V R R +  G +   VA+K + K   + +     L E SI+    HPNIIR 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +     + ++ E+ + G L +++    G+ +       +R +A+G++ L E   +HR
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 140
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-----PL-YMAPEIIQNHK 187
           DL  +N+LV++N V    K+ DFG +R L       T   S     P+ + APE I   K
Sbjct: 141 DLAARNILVNSNLVC---KVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRK 197
Query: 188 YDAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFPPGAIEELHPDC 243
           + + +D WS G +++++++   +P +D SN     Q+++ + E   R PP       PDC
Sbjct: 198 FTSASDAWSYGIVMWEVMSFGERPYWDMSN-----QDVINAIEQDYRLPP------PPDC 246

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 110 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 167
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 168 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 222
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 264

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 100 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 157
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 158 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 212
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 213 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 254

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 18  IGSGSFAVVWRARHRQLGIE---VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V R R +  G +   VA+K + K   + +     L E SI+    HPNIIR 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +     + ++ E+ + G L +++    G+ +       +R +A+G++ L E   +HR
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 142
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLT-----PQDLADTLCGSPL-YMAPEIIQNHK 187
           DL  +N+LV++N V    K+ DFG +R L      P + +      P+ + APE I   K
Sbjct: 143 DLAARNILVNSNLVC---KVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 188 YDAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFPPGAIEELHPDC 243
           + + +D WS G +++++++   +P +D SN     Q+++ + E   R PP       PDC
Sbjct: 200 FTSASDAWSYGIVMWEVMSFGERPYWDMSN-----QDVINAIEQDYRLPP------PPDC 248

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 438 GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 496
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 497 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 553
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 554 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 609

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 18/210 (8%)
Query: 19  GSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR---FF 75
           G G+F  V   + +  G+ VA+K++   +  P+  +  L+ +  L+ + HPNI++   +F
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYF 88
Query: 76  EAIETREK--IYL--VLEYCDGG---DLAAYIHKHGKVSEAVARHFMRQL--AAGLQVLQ 126
             +  R++  IYL  V+EY           Y  +       + + F+ QL  + G   L 
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII-QN 185
             ++ HRD+KP N+LV  NE    LK+ DFG A+ L+P +       S  Y APE+I  N
Sbjct: 149 SVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN 206
Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
             Y    D+WSVG I  +++ G+P F G N
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 110 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 167
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 168 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMHYNQ 222
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 264

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 109 FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 166
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 167 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 221
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 222 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 263

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 437 GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 496 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 552
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 553 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 608

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 86  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DFG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 144 HRDLKPSNLAVNED---CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 240

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 137/256 (53%), Gaps = 22/256 (8%)
Query: 18  IGSGSFAVVWRARH---RQLGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTISH-PNI 71
           +G+G++  V+  R       G   A+K + K  +    K +++   E  +L  I   P +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +    A +T  K++L+L+Y +GG+L  ++ +  + +E   + ++ ++   L+ L +  +I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQ--NHK 187
           +RD+K +N+L+ +N     + + DFG ++     +   A   CG+  YMAP+I++  +  
Sbjct: 182 YRDIKLENILLDSN---GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 188 YDAKADLWSVGAILFQLVTGKPPF--DG--SNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           +D   D WS+G ++++L+TG  PF  DG  ++Q ++ + IL S     PP   +E+    
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----PPYP-QEMSALA 293
Query: 244 VDLCRCLLRQNPVERI 259
            DL + LL ++P +R+
Sbjct: 294 KDLIQRLLMKDPKKRL 309

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 93  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 151
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 152 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 208
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 209 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 264

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 79  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 138 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 194
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 195 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 250

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 6   TRLIGEYIVG--PRIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLK 58
           T LIGE  +    ++G GSF VV    W A   +  + VAVK +   +LS P+  D+ ++
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT-VSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQ 117
           E++ + ++ H N+IR +  + T   + +V E    G L   + KH G         +  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGS 174
           +A G+  L+ K  IHRDL  +NLL++T +   ++KIGDFG  R+L   D   +       
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           P  + APE ++   +   +D W  G  L+++ T G+ P+ G N  Q+   I    E R P
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLP 245
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITF 261
               E+   D  ++        P +R TF
Sbjct: 246 --RPEDCPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 6   TRLIGEYIVG--PRIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLK 58
           T LIGE  +    ++G GSF VV    W A   +  + VAVK +   +LS P+  D+ ++
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT-VSVAVKCLKPDVLSQPEAMDDFIR 64
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQ 117
           E++ + ++ H N+IR +  + T   + +V E    G L   + KH G         +  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGS 174
           +A G+  L+ K  IHRDL  +NLL++T +   ++KIGDFG  R+L   D   +       
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           P  + APE ++   +   +D W  G  L+++ T G+ P+ G N  Q+   I    E R P
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLP 239
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITF 261
               E+   D  ++        P +R TF
Sbjct: 240 --RPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 95  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 154 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 210
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 211 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 266

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 95  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 154 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 210
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 211 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 266

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 126/243 (51%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V E  + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 142
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N    V K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 143 DLAARNILINSN---LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 200 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 254
Query: 241 PDC 243
            DC
Sbjct: 255 LDC 257

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 6   TRLIGEYIVG--PRIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLK 58
           T LIGE  +    ++G GSF VV    W A   +  + VAVK +   +LS P+  D+ ++
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT-VSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQ 117
           E++ + ++ H N+IR +  + T   + +V E    G L   + KH G         +  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGS 174
           +A G+  L+ K  IHRDL  +NLL++T +   ++KIGDFG  R+L   D   +       
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHXVMQEHRKV 186
Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           P  + APE ++   +   +D W  G  L+++ T G+ P+ G N  Q+   I    E R P
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLP 245
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITF 261
               E+   D  ++        P +R TF
Sbjct: 246 --RPEDCPQDIYNVMVQCWAHKPEDRPTF 272

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 85  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 144 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 200
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 201 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 256

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 29/207 (14%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF--- 74
           IGSG F  V++A+HR  G    +K +  K  + K      +E+  L+ + H NI+ +   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRV--KYNNEKAE----REVKALAKLDHVNIVHYNGC 72
Query: 75  FEAIE----------TREK---IYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLA 119
           ++  +          +R K   +++ +E+CD G L  +I K    K+ + +A     Q+ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 120 AGLQVLQEKHLIHRDLKPQNL-LVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYM 178
            G+  +  K LI+RDLKP N+ LV T +V    KIGDFG   SL          G+  YM
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQV----KIGDFGLVTSLKNDGKRXRSKGTLRYM 188
Query: 179 APEIIQNHKYDAKADLWSVGAILFQLV 205
           +PE I +  Y  + DL+++G IL +L+
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 79  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 138 AARNVLLVTQHYA---KISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSK 194
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 195 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 250

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 73  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 131
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 132 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 188
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 189 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 244

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 118/240 (49%), Gaps = 18/240 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           IG G F  V+RA    +G EVAVK    D      +  +N+ +E  + + + HPNII   
Sbjct: 15  IGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL---IH 132
                   + LV+E+  GG L   +    ++   +  ++  Q+A G+  L ++ +   IH
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 133 RDLKPQNLLV-----STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
           RDLK  N+L+     + +    +LKI DFG AR    +    +  G+  +MAPE+I+   
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAPEVIRASM 190
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNI-LTSTELRFP---PGAIEELHPDC 243
           +   +D+WS G +L++L+TG+ PF G + L +   + +    L  P   P    +L  DC
Sbjct: 191 FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDC 250

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 120/237 (50%), Gaps = 12/237 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKE--IDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +GSG+F  V +  ++   +   V    +  +   P + D LL E +++  + +P I+R  
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRDL
Sbjct: 75  GICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDAK 191
             +N+L+ T       KI DFG +++L   +    A T    P+ + APE I  +K+ +K
Sbjct: 134 AARNVLLVTQHYA---KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D+WS G ++++  + G+ P+ G    ++   +     +  P G   E++ D ++LC
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY-DLMNLC 246

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 118/239 (49%), Gaps = 17/239 (7%)
Query: 6   TRLIGEYIVG--PRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLS-PKVSDNLLKE 59
           T LIGE  +    ++G GSF VV R          + VAVK +   +LS P+  D+ ++E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQL 118
           ++ + ++ H N+IR +  + T   + +V E    G L   + KH G         +  Q+
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSP 175
           A G+  L+ K  IHRDL  +NLL++T +   ++KIGDFG  R+L   D   +       P
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 176 L-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
             + APE ++   +   +D W  G  L+++ T G+ P+ G N  Q+   I    E R P
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLP 235

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 19/240 (7%)
Query: 6   TRLIGEYIVG--PRIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLK 58
           T LIGE  +    ++G GSF VV    W A   +  + VAVK +   +LS P+  D+ ++
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT-VSVAVKCLKPDVLSQPEAMDDFIR 64
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQ 117
           E++ + ++ H N+IR +  + T   + +V E    G L   + KH G         +  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGS 174
           +A G+  L+ K  IHRDL  +NLL++T +   ++KIGDFG  R+L   D   +       
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           P  + APE ++   +   +D W  G  L+++ T G+ P+ G N  Q+   I    E R P
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLP 239

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 126/243 (51%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V E  + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 121/238 (50%), Gaps = 26/238 (10%)
Query: 10  GEYIVGP-------RIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK 58
           G++++ P        IGSG F +V    W  + +     VA+K I +  +S    ++ ++
Sbjct: 3   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMS---EEDFIE 54
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQ 117
           E  ++  +SHP +++ +     +  I LV E+ + G L+ Y+  + G  +          
Sbjct: 55  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 114
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPL 176
           +  G+  L+E  +IHRDL  +N LV  N+   V+K+ DFG  R  L  Q  + T    P+
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQYTSSTGTKFPV 171
Query: 177 -YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
            + +PE+    +Y +K+D+WS G +++++ + GK P++  +  ++ ++I T   L  P
Sbjct: 172 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 229

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 115/223 (51%), Gaps = 19/223 (8%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           IGSG F +V    W  + +     VA+K I +  +S    D+ ++E  ++  +SHP +++
Sbjct: 35  IGSGQFGLVHLGYWLNKDK-----VAIKTIKEGSMS---EDDFIEEAEVMMKLSHPKLVQ 86
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I LV E+ + G L+ Y+  + G  +          +  G+  L+E  +IH
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 146
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL  +N LV  N+   V+K+ DFG  R  L  Q  + T    P+ + +PE+    +Y +
Sbjct: 147 RDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 203
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           K+D+WS G +++++ + GK P++  +  ++ ++I T   L  P
Sbjct: 204 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 246

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 125/246 (50%), Gaps = 30/246 (12%)
Query: 18  IGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG+G F  V     +  G   I VA+K + K   + K   + L E SI+    HPN+I  
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +     + ++ E+ + G L +++ ++ G+ +       +R +AAG++ L + + +HR
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 133
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-------YMAPEIIQNH 186
            L  +N+LV++N V    K+ DFG +R L   D +D    S L       + APE IQ  
Sbjct: 134 ALAARNILVNSNLVC---KVSDFGLSRFLE-DDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 187 KYDAKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIE 237
           K+ + +D+WS G +++++++   +P +D +N     Q+++ + E   R P     P A+ 
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVINAIEQDYRLPPPMDCPSALH 244
Query: 238 ELHPDC 243
           +L  DC
Sbjct: 245 QLMLDC 250

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI  FG AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 19/240 (7%)
Query: 6   TRLIGEYIVG--PRIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLK 58
           T LIGE  +    ++G GSF VV    W A   +  + VAVK +   +LS P+  D+ ++
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT-VSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQ 117
           E++ + ++ H N+IR +  + T   + +V E    G L   + KH G         +  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGS 174
           +A G+  L+ K  IHRDL  +NLL++T +   ++KIGDFG  R+L   D   +       
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           P  + APE ++   +   +D W  G  L+++ T G+ P+ G N  Q+   I    E R P
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLP 235

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 122/239 (51%), Gaps = 17/239 (7%)
Query: 18  IGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           IG+G F  V++   +    +  + VA+K + K   + K   + L E  I+   SH NIIR
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I   + + ++ EY + G L  ++  K G+ S       +R +AAG++ L   + +H
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLADTLCGS-PL-YMAPEIIQNHKY 188
           RDL  +N+LV++N V    K+ DFG +R L   P+    T  G  P+ + APE I   K+
Sbjct: 171 RDLAARNILVNSNLVC---KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 189 DAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDC 243
            + +D+WS G ++++++T G+ P+   +  ++ + I     L  P   P AI +L   C
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQC 286

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 126/243 (51%), Gaps = 26/243 (10%)
Query: 18  IGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G+G F  V   R +   +  I VA+K + K   + K   + L E SI+    HPNIIR 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              +   + + +V E  + G L +++ KH  + +       +R +A+G++ L +   +HR
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHR 171
Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTLCGS-PL-YMAPEIIQNHKYD 189
           DL  +N+L+++N V    K+ DFG +R L   P+    T  G  P+ + +PE I   K+ 
Sbjct: 172 DLAARNILINSNLVC---KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 190 AKADLWSVGAILFQLVT--GKPPFDGSNQLQLFQNILTSTE--LRFP-----PGAIEELH 240
           + +D+WS G +L+++++   +P ++ SN     Q+++ + +   R P     P A+ +L 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 241 PDC 243
            DC
Sbjct: 284 LDC 286

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 19/240 (7%)
Query: 6   TRLIGEYIVG--PRIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLK 58
           T LIGE  +    ++G GSF VV    W A   +  + VAVK +   +LS P+  D+ ++
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT-VSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQ 117
           E++ + ++ H N+IR +  + T   + +V E    G L   + KH G         +  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGS 174
           +A G+  L+ K  IHRDL  +NLL++T +   ++KIGDFG  R+L   D   +       
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           P  + APE ++   +   +D W  G  L+++ T G+ P+ G N  Q+   I    E R P
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RLP 235

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 127/264 (48%), Gaps = 14/264 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +      A+K ++K ++L    +    +E  +L       I     
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV++Y  GGDL   + K   ++ E +AR ++ ++   +  + + H +HRD+
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQ-----NHKY 188
           KP N+L+  N     +++ DFG    L       +    G+P Y++PEI+Q       +Y
Sbjct: 202 KPDNILMDMN---GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
             + D WS+G  +++++ G+ PF   + ++ +  I+   E    P  + ++  +  DL R
Sbjct: 259 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIR 318
Query: 249 CLL--RQNPVERITFKEFFNHRFL 270
            L+  R++ + +   ++F  H F 
Sbjct: 319 RLICSREHRLGQNGIEDFKKHPFF 342

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 183
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 184 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 292

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L+  I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQP 254

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI D G AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L+  I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQP 254

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI D G AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L+  I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMS-----YLLYQMLVGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQP 254

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 111/214 (51%), Gaps = 17/214 (7%)
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHF 114
           E  IL+ +    I+    A ET+  + LV+   +GGD+  +I+     +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCG 173
             Q+ +GL+ L ++++I+RDLKP+N+L+  +     ++I D G A  L   Q       G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTEL 229
           +P +MAPE++   +YD   D +++G  L++++  + PF    +     +L Q +L    +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-V 410
Query: 230 RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
            +P    ++  P   D C  LL+++P +R+ F++
Sbjct: 411 TYP----DKFSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 121/238 (50%), Gaps = 26/238 (10%)
Query: 10  GEYIVGP-------RIGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK 58
           G++++ P        IGSG F +V    W  + +     VA+K I +  +S    ++ ++
Sbjct: 1   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMS---EEDFIE 52
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQ 117
           E  ++  +SHP +++ +     +  I LV E+ + G L+ Y+  + G  +          
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPL 176
           +  G+  L+E  +IHRDL  +N LV  N+   V+K+ DFG  R  L  Q  + T    P+
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 177 -YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
            + +PE+    +Y +K+D+WS G +++++ + GK P++  +  ++ ++I T   L  P
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 227

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 33/270 (12%)
Query: 18  IGSGSFAVVWRARHRQLGIE-----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+ A    L  E     VAVK +  K  S     +  +E  +L+ + H +I+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 106
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH---------------FMRQ 117
           RFF        + +V EY   GDL  ++  HG  ++ +A                    Q
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +AAG+  L   H +HRDL  +N LV       V+KIGDFG +R +   D       + L 
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             +M PE I   K+  ++D+WS G +L+++ T GK P+   +  +    I    EL  P 
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP- 282
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKE 263
                  P+   + R   ++ P +R + K+
Sbjct: 283 ---RACPPEVYAIMRGCWQREPQQRHSIKD 309

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 111/214 (51%), Gaps = 17/214 (7%)
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHF 114
           E  IL+ +    I+    A ET+  + LV+   +GGD+  +I+     +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCG 173
             Q+ +GL+ L ++++I+RDLKP+N+L+  +     ++I D G A  L   Q       G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTEL 229
           +P +MAPE++   +YD   D +++G  L++++  + PF    +     +L Q +L    +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-V 410
Query: 230 RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
            +P    ++  P   D C  LL+++P +R+ F++
Sbjct: 411 TYP----DKFSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 111/214 (51%), Gaps = 17/214 (7%)
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHF 114
           E  IL+ +    I+    A ET+  + LV+   +GGD+  +I+     +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCG 173
             Q+ +GL+ L ++++I+RDLKP+N+L+  +     ++I D G A  L   Q       G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTEL 229
           +P +MAPE++   +YD   D +++G  L++++  + PF    +     +L Q +L    +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-V 410
Query: 230 RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
            +P    ++  P   D C  LL+++P +R+ F++
Sbjct: 411 TYP----DKFSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI D G AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L+  I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMS-----YLLYQMLVGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQP 254

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 115/223 (51%), Gaps = 19/223 (8%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           IGSG F +V    W  + +     VA+K I +  +S    ++ ++E  ++  +SHP +++
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQ 66
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I LV E+ + G L+ Y+  + G  +          +  G+  L+E  +IH
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIH 126
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL  +N LV  N+   V+K+ DFG  R  L  Q  + T    P+ + +PE+    +Y +
Sbjct: 127 RDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           K+D+WS G +++++ + GK P++  +  ++ ++I T   L  P
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 226

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 21/236 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L+  I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMS-----YLLYQMLVGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHPDC 243
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P  
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQPTV 256

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L+  I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQP 254

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSDXT---LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 83  LL-GICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 142 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 199 HQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 183
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 184 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 292

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPSPEFMKKLQP 254

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 111/214 (51%), Gaps = 17/214 (7%)
Query: 59  EISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK----HGKVSEAVARHF 114
           E  IL+ +    I+    A ET+  + LV+   +GGD+  +I+     +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCG 173
             Q+ +GL+ L ++++I+RDLKP+N+L+  +     ++I D G A  L   Q       G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ----LQLFQNILTSTEL 229
           +P +MAPE++   +YD   D +++G  L++++  + PF    +     +L Q +L    +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-V 410
Query: 230 RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
            +P    ++  P   D C  LL+++P +R+ F++
Sbjct: 411 TYP----DKFSPASKDFCEALLQKDPEKRLGFRD 440

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 93  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 146
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 147 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 204 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPCPEFMKKLQP 255

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 115/223 (51%), Gaps = 19/223 (8%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           IGSG F +V    W  + +     VA+K I +  +S    ++ ++E  ++  +SHP +++
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQ 66
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I LV E+ + G L+ Y+  + G  +          +  G+  L+E  +IH
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 126
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL  +N LV  N+   V+K+ DFG  R  L  Q  + T    P+ + +PE+    +Y +
Sbjct: 127 RDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           K+D+WS G +++++ + GK P++  +  ++ ++I T   L  P
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 226

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 94  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 147
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 148 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGY 204
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 205 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPCPEFMKKLQP 256

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 124/263 (47%), Gaps = 44/263 (16%)
Query: 15  GPRIGSGSFAVVWRAR-----HRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SH 68
           G  +GSG+F  V  A         + I+VAVK + +K  S +  + L+ E+ +++ + SH
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGSH 108
Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARH-------------- 113
            NI+    A      IYL+ EYC  GDL  Y+  K  K SE    +              
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 114 --------FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ 165
                   F  Q+A G++ L+ K  +HRDL  +N+LV+  +   V+KI DFG AR +   
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK---VVKICDFGLARDIMSD 225
Query: 166 DLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG----SNQL 217
                   + L   +MAPE +    Y  K+D+WS G +L+++ + G  P+ G    +N  
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 218 QLFQNILTSTELRFPPGAIEELH 240
           +L QN     +   P  A EE++
Sbjct: 286 KLIQNGFKMDQ---PFYATEEIY 305

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 115/223 (51%), Gaps = 19/223 (8%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           IGSG F +V    W  + +     VA+K I +  +S    ++ ++E  ++  +SHP +++
Sbjct: 13  IGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQ 64
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I LV E+ + G L+ Y+  + G  +          +  G+  L+E  +IH
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 124
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPL-YMAPEIIQNHKYDA 190
           RDL  +N LV  N+   V+K+ DFG  R  L  Q  + T    P+ + +PE+    +Y +
Sbjct: 125 RDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           K+D+WS G +++++ + GK P++  +  ++ ++I T   L  P
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSDXT---LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   +L  +VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                +IE   ++YLV     G DL   + K   +S+   +  + QL  GL+ +    +I
Sbjct: 96  FTPATSIEDFSEVYLVTTLM-GADLNNIV-KSQALSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP N  V+ NE +  L+I DFG AR    +        +  Y APEI+ N   Y+ 
Sbjct: 154 HRDLKPSN--VAVNEDSE-LRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             D+WSVG I+ +L+ GK  F GS+ +   + I+
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIM 242

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 146
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 147 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 255

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 86  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 145 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 202 HQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 144
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 145 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 201
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 202 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 253

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 146
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 147 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 255

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 139
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 140 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 248

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 139
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 140 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 248

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 83  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 142 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 199 HQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 97  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 150
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 151 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 207
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               DLWSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 208 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 259

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     + +    +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               DLWSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 85  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 144 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 201 HQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     + +    +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVI--EQLGTPCPAFMKKLQP 254

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 84  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 143 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 82  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 141 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 138
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 139 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 247

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 33/270 (12%)
Query: 18  IGSGSFAVVWRARHRQLGIE-----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+ A    L  E     VAVK +  K  S     +  +E  +L+ + H +I+
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 83
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR---------------HFMRQ 117
           RFF        + +V EY   GDL  ++  HG  ++ +A                    Q
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +AAG+  L   H +HRDL  +N LV       V+KIGDFG +R +   D       + L 
Sbjct: 144 VAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             +M PE I   K+  ++D+WS G +L+++ T GK P+   +  +    I    EL  P 
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP- 259
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKE 263
                  P+   + R   ++ P +R + K+
Sbjct: 260 ---RACPPEVYAIMRGCWQREPQQRHSIKD 286

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTIS-HP 69
           G  +G+G+F  V  A    LG E AV ++  K+L         + L+ E+ I+S +  H 
Sbjct: 43  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 102
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVAR--------HFMRQLA 119
           NI+    A      + ++ EYC  GDL  ++ +  +  + +   R        HF  Q+A
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS---PL 176
            G+  L  K+ IHRD+  +N+L++   V    KIGDFG AR +   D    + G+   P+
Sbjct: 163 QGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM-NDSNYIVKGNARLPV 218
Query: 177 -YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG----SNQLQLFQNILTSTELR 230
            +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    S   +L ++     +  
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 278
Query: 231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           F P  I  +   C  L        P  R TF++  +  FL E  Q
Sbjct: 279 FAPKNIYSIMQACWAL-------EPTHRPTFQQICS--FLQEQAQ 314

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 86  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 139
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 140 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               DLWSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 197 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 248

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 33/270 (12%)
Query: 18  IGSGSFAVVWRARHRQLGIE-----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+ A    L  E     VAVK +  K  S     +  +E  +L+ + H +I+
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIV 77
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH---------------FMRQ 117
           RFF        + +V EY   GDL  ++  HG  ++ +A                    Q
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +AAG+  L   H +HRDL  +N LV       V+KIGDFG +R +   D       + L 
Sbjct: 138 VAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             +M PE I   K+  ++D+WS G +L+++ T GK P+   +  +    I    EL  P 
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP- 253
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKE 263
                  P+   + R   ++ P +R + K+
Sbjct: 254 ---RACPPEVYAIMRGCWQREPQQRHSIKD 280

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   +L  +VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                +IE   ++YLV     G DL   + K   +S+   +  + QL  GL+ +    +I
Sbjct: 96  FTPATSIEDFSEVYLVTTLM-GADLNNIV-KCQALSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP N  V+ NE +  L+I DFG AR    +        +  Y APEI+ N   Y+ 
Sbjct: 154 HRDLKPSN--VAVNEDSE-LRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             D+WSVG I+ +L+ GK  F GS+ +   + I+
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIM 242

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTIS-HP 69
           G  +G+G+F  V  A    LG E AV ++  K+L         + L+ E+ I+S +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVAR--------HFMRQLA 119
           NI+    A      + ++ EYC  GDL  ++ +  +  + +   R        HF  Q+A
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS---PL 176
            G+  L  K+ IHRD+  +N+L++   V    KIGDFG AR +   D    + G+   P+
Sbjct: 171 QGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM-NDSNYIVKGNARLPV 226
Query: 177 -YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG----SNQLQLFQNILTSTELR 230
            +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    S   +L ++     +  
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 286
Query: 231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQ 281
           F P  I  +   C  L        P  R TF++  +  FL E  Q    E+
Sbjct: 287 FAPKNIYSIMQACWAL-------EPTHRPTFQQICS--FLQEQAQEDRRER 328

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               +++E  + +Y+V+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ +++ G   F G++ +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMS-----YLLYQMLXGIKHLHSA 138
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 139 GIIHRDLKPSNIVVKSDXT---LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 247

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMS-----YLLYQMLXGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSDXT---LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 42/220 (19%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG F  V++A+HR  G    ++ +  K  + K      +E+  L+ + H NI+ +   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRV--KYNNEKAE----REVKALAKLDHVNIVHYNGC 73
Query: 76  ------------EAIET------------REK---IYLVLEYCDGGDLAAYIHKHG--KV 106
                       +++E+            R K   +++ +E+CD G L  +I K    K+
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 107 SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNL-LVSTNEVTPVLKIGDFGFARSLTPQ 165
            + +A     Q+  G+  +  K LIHRDLKP N+ LV T +V    KIGDFG   SL   
Sbjct: 134 DKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQV----KIGDFGLVTSLKND 189
Query: 166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLV 205
                  G+  YM+PE I +  Y  + DL+++G IL +L+
Sbjct: 190 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 136/297 (45%), Gaps = 43/297 (14%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTIS-HP 69
           G  +G+G+F  V  A    LG E AV ++  K+L         + L+ E+ I+S +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK-------------HGKVSEAVAR---H 113
           NI+    A      + ++ EYC  GDL  ++ +             H    +  +R   H
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
           F  Q+A G+  L  K+ IHRD+  +N+L++   V    KIGDFG AR +   D    + G
Sbjct: 171 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM-NDSNYIVKG 226
Query: 174 S---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG----SNQLQLFQNIL 224
           +   P+ +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    S   +L ++  
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 286
Query: 225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQ 281
              +  F P  I  +   C  L        P  R TF++  +  FL E  Q    E+
Sbjct: 287 QMAQPAFAPKNIYSIMQACWAL-------EPTHRPTFQQICS--FLQEQAQEDRRER 334

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NII     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 76  ----EAIETREKIYLVLEYCDGGDLAAYIH---KHGKVSEAVARHFMRQLAAGLQVLQEK 128
               + +E  + +YLV+E  D  +L   I     H ++S     + + Q+  G++ L   
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMS-----YLLYQMLXGIKHLHSA 145
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I    Y
Sbjct: 146 GIIHRDLKPSNIVVKSDXT---LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHP 241
               D+WSVG I+ ++V  K  F G + +  +  ++   +L  P P  +++L P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI--EQLGTPCPEFMKKLQP 254

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 112/225 (49%), Gaps = 17/225 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   + G  VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                ++E    +YLV  +  G DL   + K  K+++   +  + Q+  GL+ +    +I
Sbjct: 90  FTPARSLEEFNDVYLV-THLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADII 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP NL V+ +     LKI DF  AR     D       +  Y APEI+ N   Y+ 
Sbjct: 148 HRDLKPSNLAVNED---CELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             D+WSVG I+ +L+TG+  F G++ +   + IL    L   PGA
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGA 244

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 119/270 (44%), Gaps = 32/270 (11%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           +GSG+   VW+ R R+ G  +AVK++ +     +    L+    +L +   P I++ F  
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 78  IETREKIYLVLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRD 134
             T   +++ +E    G  A  + K   G + E +       +   L  L+EKH +IHRD
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ-----NHKYD 189
           +KP N+L+        +K+ DFG +  L      D   G   YMAPE I         YD
Sbjct: 151 VKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP---------GAIEELH 240
            +AD+WS+G  L +L TG+ P+   N    F+ +LT      PP         G  +   
Sbjct: 208 IRADVWSLGISLVELATGQFPY--KNCKTDFE-VLTKVLQEEPPLLPGHMGFSGDFQSFV 264
Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
            DC       L ++  +R  + +   H F+
Sbjct: 265 KDC-------LTKDHRKRPKYNKLLEHSFI 287

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +      A+K ++K ++L    +    +E  +L       I     
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 157
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV++Y  GGDL   + K   K+ E +AR ++ ++   +  + + H +HRD+
Sbjct: 158 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDI 217
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQNH-----KY 188
           KP N+L+  N     +++ DFG    +       +    G+P Y++PEI+Q       KY
Sbjct: 218 KPDNVLLDVN---GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 274
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
             + D WS+G  +++++ G+ PF   + ++ +  I+   E    P  + ++  +  DL +
Sbjct: 275 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQ 334
Query: 249 CLL--RQNPVERITFKEFFNHRFL 270
            L+  R+  + +   ++F  H F 
Sbjct: 335 RLICSRERRLGQNGIEDFKKHAFF 358

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDXXK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 82  LL-GICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 141 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           +GSG++  V  A   +L  +VAVK++ +   S   +    +E+ +L  + H N+I   + 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 77  -----AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
                +IE   ++YLV     G DL   + K   +S+   +  + QL  GL+ +    +I
Sbjct: 88  FTPATSIEDFSEVYLVTTLM-GADLNNIV-KCQALSDEHVQFLVYQLLRGLKYIHSAGII 145
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-KYDA 190
           HRDLKP N  V+ NE    L+I DFG AR    +        +  Y APEI+ N   Y+ 
Sbjct: 146 HRDLKPSN--VAVNEDCE-LRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQ 200
Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             D+WSVG I+ +L+ GK  F GS+ +   + I+
Sbjct: 201 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIM 234

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 107 LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 165
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 166 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 222
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 223 HQSDVWSYGVTVWELMTFGSKPYDG 247

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDXXK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 88  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 146
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 147 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 203
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 204 HQSDVWSYGVTVWELMTFGSKPYDG 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 84  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 143 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 84  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 143 RDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 84  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 143 RDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 139/285 (48%), Gaps = 43/285 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           +G G+F  V +AR+       A+K+I  +    K+S  +L E+ +L++++H  ++R++  
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLS-TILSEVMLLASLNHQYVVRYYAA 70
Query: 76  -----------EAIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGL 122
                       A++ +  +++ +EYC+ G L   IH     +  +   R F RQ+   L
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-RQILEAL 129
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS---------LTPQDL---ADT 170
             +  + +IHRDLKP N+ +  +     +KIGDFG A++         L  Q+L   +D 
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 171 LC---GSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKPPFD-GSNQLQLFQNILT 225
           L    G+ +Y+A E++     Y+ K D++S+G I F+++    PF  G  ++ + +  L 
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK-LR 242
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           S  + FPP   +        + R L+  +P +R   +   N  +L
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +      A+K ++K ++L    +    +E  +L       I     
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 141
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV++Y  GGDL   + K   K+ E +AR ++ ++   +  + + H +HRD+
Sbjct: 142 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDI 201
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQNH-----KY 188
           KP N+L+  N     +++ DFG    +       +    G+P Y++PEI+Q       KY
Sbjct: 202 KPDNVLLDVN---GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 258
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
             + D WS+G  +++++ G+ PF   + ++ +  I+   E    P  + ++  +  DL +
Sbjct: 259 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQ 318
Query: 249 CLL--RQNPVERITFKEFFNHRFL 270
            L+  R+  + +   ++F  H F 
Sbjct: 319 RLICSRERRLGQNGIEDFKKHAFF 342

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 85  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 144 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 201 HQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 89  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 148 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 85  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 144 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 201 HQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 86  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 145 RDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 202 HQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 131/271 (48%), Gaps = 28/271 (10%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           ++ +G  +G G F  V  A+ +Q     ++VAVK +   +++    +  L+E + +    
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 68  HPNIIRFFE-AIETREKIYL-----VLEYCDGGDLAAYIHKHGKVSE-------AVARHF 114
           HP++ +    ++ +R K  L     +L +   GDL A++    ++ E            F
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-SRIGENPFNLPLQTLVRF 142
Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
           M  +A G++ L  ++ IHRDL  +N +++ +    V    DFG +R +   D     C S
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV---ADFGLSRKIYSGDYYRQGCAS 199
Query: 175 PL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELR 230
            L   ++A E + ++ Y   +D+W+ G  +++++T G+ P+ G    +++  ++    L+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 231 FPPGAIEELHPDCVDLCRCLLRQNPVERITF 261
            PP  +EE++    DL       +P +R +F
Sbjct: 260 QPPECMEEVY----DLMYQCWSADPKQRPSF 286

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 85  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 144 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 201 HQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 138/336 (41%), Gaps = 74/336 (22%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y +G  +G+GSF +V      + G   A+K++   L  P+  +   +E+ I+  + H N
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYKN---RELDIMKVLDHVN 61
Query: 71  IIRFFEAIET--------------------------------------REKIYLVLEYCD 92
           II+  +   T                                       + + +++EY  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 93  G---GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP 149
                 L ++I     +   +   ++ QL   +  +    + HRD+KPQNLLV++ + T 
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT- 180
Query: 150 VLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGK 208
            LK+ DFG A+ L P + +     S  Y APE++    +Y    DLWS+G +  +L+ GK
Sbjct: 181 -LKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 209 PPFDGSNQLQLFQNILT----------------STELRFPPGAIEE---LHPD-----CV 244
           P F G   +     I+                  TE+RFP    ++   + P+      +
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 245 DLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAE 280
           DL   +LR  P  RI   E   H F   LR +  +E
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESE 335

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 82  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 141 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 78  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 137 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLL 57
           R RL+    +G  +G G+F  V  A    L         +VAVK +        +SD L+
Sbjct: 68  RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 122
Query: 58  KEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KH 103
            E+ ++  I  H NII    A      +Y+++EY   G+L  Y+               H
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 104 GKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
               +  ++  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLAR 239
Query: 161 SLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQ 216
            +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G   
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            +LF+ +     +  P     EL+    D    +    P +R TFK+ 
Sbjct: 300 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAV----PSQRPTFKQL 343

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 92  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 150
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 151 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 207
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 208 HQSDVWSYGVTVWELMTFGSKPYDG 232

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 76  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 135 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDG 216

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 42  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 100
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 101 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 159
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 160 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 270

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 98  GKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 132 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRR 188
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 242

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 17  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 75
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 76  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 134
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 135 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 191
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 192 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 245

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 86
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 87  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 147 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 203
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 204 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 263
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 264 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 298

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 70  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 129 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 119/237 (50%), Gaps = 16/237 (6%)
Query: 18  IGSGSFAVVWRA--RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G G+F  V +   R R+  I+VA+K + K+      ++ +++E  I+  + +P I+R  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 76  EAIETREKIYLVLEYCDGGDLAAY-IHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
              +  E + LV+E   GG L  + + K  ++  +     + Q++ G++ L+EK+ +HRD
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDA 190
           L  +N+L+         KI DFG +++L   D    A +    PL + APE I   K+ +
Sbjct: 136 LAARNVLLVNRHYA---KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 191 KADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP---DC 243
           ++D+WS G  +++ L  G+ P+      ++   I     +  PP    EL+    DC
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 249

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 16  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 74
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 75  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 133
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 134 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 190
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 191 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 244

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 132 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 242

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 79  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVH 137
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 138 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 194
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 195 HQSDVWSYGVTVWELMTFGSKPYDG 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 132 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 242

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 98  GKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 105
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 166 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 82  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 141 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 84
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 85  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 145 DLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENN---VMKIADFGLARDINNIDYYK 201
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 202 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 261
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 262 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 296

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 89
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 90  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 150 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 206
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 207 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 266
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 267 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 301

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLL 57
           R RL+    +G  +G G+F  V  A    L         +VAVK +        +SD L+
Sbjct: 27  RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 81
Query: 58  KEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KH 103
            E+ ++  I  H NII    A      +Y+++EY   G+L  Y+               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSH 141
Query: 104 GKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
               +  ++  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLAR 198
Query: 161 SLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQ 216
            +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G   
Sbjct: 199 DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            +LF+ +     +  P     EL+     + R      P +R TFK+ 
Sbjct: 259 EELFKLLKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQL 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLL 57
           R RL+    +G  +G G+F  V  A    L         +VAVK +        +SD L+
Sbjct: 27  RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 81
Query: 58  KEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KH 103
            E+ ++  I  H NII    A      +Y+++EY   G+L  Y+               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSH 141
Query: 104 GKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
               +  ++  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLAR 198
Query: 161 SLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQ 216
            +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G   
Sbjct: 199 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            +LF+ +     +  P     EL+     + R      P +R TFK+ 
Sbjct: 259 EELFKLLKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQL 302

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLL 57
           R RL+    +G  +G G+F  V  A    L         +VAVK +        +SD L+
Sbjct: 19  RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 73
Query: 58  KEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KH 103
            E+ ++  I  H NII    A      +Y+++EY   G+L  Y+               H
Sbjct: 74  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 133
Query: 104 GKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
               +  ++  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR
Sbjct: 134 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLAR 190
Query: 161 SLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQ 216
            +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G   
Sbjct: 191 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 250
Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            +LF+ +     +  P     EL+     + R      P +R TFK+ 
Sbjct: 251 EELFKLLKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQL 294

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLL 57
           R RL+    +G  +G G+F  V  A    L         +VAVK +        +SD L+
Sbjct: 27  RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 81
Query: 58  KEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KH 103
            E+ ++  I  H NII    A      +Y+++EY   G+L  Y+               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 141
Query: 104 GKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
               +  ++  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLAR 198
Query: 161 SLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQ 216
            +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G   
Sbjct: 199 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            +LF+ +     +  P     EL+     + R      P +R TFK+ 
Sbjct: 259 EELFKLLKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQL 302

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 81
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 82  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 141
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 142 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLL 57
           R RL+    +G  +G G+F  V  A    L         +VAVK +        +SD L+
Sbjct: 27  RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 81
Query: 58  KEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KH 103
            E+ ++  I  H NII    A      +Y+++EY   G+L  Y+               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 141
Query: 104 GKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
               +  ++  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLAR 198
Query: 161 SLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQ 216
            +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G   
Sbjct: 199 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            +LF+ +     +  P     EL+     + R      P +R TFK+ 
Sbjct: 259 EELFKLLKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQL 302

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 12/229 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 512 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP  
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLL 57
           R RL+    +G  +G G+F  V  A    L         +VAVK +        +SD L+
Sbjct: 16  RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 70
Query: 58  KEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KH 103
            E+ ++  I  H NII    A      +Y+++EY   G+L  Y+               H
Sbjct: 71  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 130
Query: 104 GKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
               +  ++  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR
Sbjct: 131 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLAR 187
Query: 161 SLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQ 216
            +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G   
Sbjct: 188 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 247
Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            +LF+ +     +  P     EL+     + R      P +R TFK+ 
Sbjct: 248 EELFKLLKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQL 291

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 77
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 138 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLL 57
           R RL+    +G  +G G+F  V  A    L         +VAVK +        +SD L+
Sbjct: 20  RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 74
Query: 58  KEISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KH 103
            E+ ++  I  H NII    A      +Y+++EY   G+L  Y+               H
Sbjct: 75  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 134
Query: 104 GKVSEAVARHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
               +  ++  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR
Sbjct: 135 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLAR 191
Query: 161 SLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQ 216
            +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G   
Sbjct: 192 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 251
Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
            +LF+ +     +  P     EL+     + R      P +R TFK+ 
Sbjct: 252 EELFKLLKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQL 295

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 79
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 80  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 139
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 140 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 74
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 135 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 73
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 133
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 134 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 92
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 153 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 92
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 153 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 74
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 135 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 72
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 73  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 132
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 133 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 78
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 138
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 139 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 80
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 81  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 140
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 141 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V++I DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMRIADFGLARDINNIDYYK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 143
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++EY   G+L  Y+          +    R         
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 260
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 321 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 355

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 84  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 143 RDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 36/280 (12%)
Query: 13  IVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           ++G  +G G+F  V  A    L         +VAVK +        +SD L+ E+ ++  
Sbjct: 16  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKM 74
Query: 66  IS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-------------KHGKVSEAVA 111
           I  H NII    A      +Y+++EY   G+L  Y+               H    +  +
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 112 RHFMR---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA 168
           +  +    Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG AR +   D  
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHIDYY 191
Query: 169 DTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNIL 224
                  L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G    +LF+ + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
               +  P     EL+     + R      P +R TFK+ 
Sbjct: 252 EGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQL 287

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           + SG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+++    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 89  LL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 148 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 15/223 (6%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y+    +GSG++  V  A  ++ G +VA+K++ +   S   +    +E+ +L  + H N+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 72  IRFFE------AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           I   +      ++      YLV+ +    DL   +    K SE   ++ + Q+  GL+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYI 142
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
               ++HRDLKP NL V+ +     LKI DFG AR    +     +  +  Y APE+I +
Sbjct: 143 HSAGVVHRDLKPGNLAVNED---CELKILDFGLARHADAEMTGYVV--TRWYRAPEVILS 197
Query: 186 H-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST 227
              Y+   D+WSVG I+ +++TGK  F G + L     IL  T
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 82  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 141 RDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 50/298 (16%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTIS-HP 69
           G  +G+G+F  V  A    LG E AV ++  K+L         + L+ E+ I+S +  H 
Sbjct: 36  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 95
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-----------GKVSEAVAR------ 112
           NI+    A      + ++ EYC  GDL  ++ +            G+  E + +      
Sbjct: 96  NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPL 155
Query: 113 ------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
                 HF  Q+A G+  L  K+ IHRD+  +N+L++   V    KIGDFG AR +   D
Sbjct: 156 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIM-ND 211
Query: 167 LADTLCGS---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG----SNQL 217
               + G+   P+ +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    S   
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 271
Query: 218 QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           +L ++     +  F P  I  +   C  L        P  R TF++  +  FL E  Q
Sbjct: 272 KLVKDGYQMAQPAFAPKNIYSIMQACWAL-------EPTHRPTFQQICS--FLQEQAQ 320

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 89  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 148 RDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTI-SHP 69
           G  +G+G+F  V  A    L    A   +  K+L P       + L+ E+ +LS + +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH------GKVSEAV------------A 111
           NI+    A        ++ EYC  GDL  ++ +        K S A+             
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 112 RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL 171
             F  Q+A G+  L  K+ IHRDL  +N+L++   +T   KI DFG AR +   D    +
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIK-NDSNYVV 203
Query: 172 CGS---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSN-QLQLFQNILT 225
            G+   P+ +MAPE I N  Y  ++D+WS G  L++L + G  P+ G     + ++ I  
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
              +  P  A  E++    D+ +     +P++R TFK+
Sbjct: 264 GFRMLSPEHAPAEMY----DIMKTCWDADPLKRPTFKQ 297

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTI-SHP 69
           G  +G+G+F  V  A    L    A   +  K+L P       + L+ E+ +LS + +H 
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH------GKVSEAV------------A 111
           NI+    A        ++ EYC  GDL  ++ +        K S A+             
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 112 RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL 171
             F  Q+A G+  L  K+ IHRDL  +N+L++   +T   KI DFG AR +   D    +
Sbjct: 171 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIK-NDSNYVV 226
Query: 172 CGS---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSN-QLQLFQNILT 225
            G+   P+ +MAPE I N  Y  ++D+WS G  L++L + G  P+ G     + ++ I  
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 286
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
              +  P  A  E++    D+ +     +P++R TFK+
Sbjct: 287 GFRMLSPEHAPAEMY----DIMKTCWDADPLKRPTFKQ 320

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTI-SHP 69
           G  +G+G+F  V  A    L    A   +  K+L P       + L+ E+ +LS + +H 
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 103
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH------GKVSEAV------------A 111
           NI+    A        ++ EYC  GDL  ++ +        K S A+             
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 112 RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL 171
             F  Q+A G+  L  K+ IHRDL  +N+L++   +T   KI DFG AR +   D    +
Sbjct: 164 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIK-NDSNYVV 219
Query: 172 CGS---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSN-QLQLFQNILT 225
            G+   P+ +MAPE I N  Y  ++D+WS G  L++L + G  P+ G     + ++ I  
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 279
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
              +  P  A  E++    D+ +     +P++R TFK+
Sbjct: 280 GFRMLSPEHAPAEMY----DIMKTCWDADPLKRPTFKQ 313

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 119/237 (50%), Gaps = 16/237 (6%)
Query: 18  IGSGSFAVVWRA--RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G G+F  V +   R R+  I+VA+K + K+      ++ +++E  I+  + +P I+R  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 76  EAIETREKIYLVLEYCDGGDLAAY-IHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
              +  E + LV+E   GG L  + + K  ++  +     + Q++ G++ L+EK+ +HR+
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQNHKYDA 190
           L  +N+L+         KI DFG +++L   D    A +    PL + APE I   K+ +
Sbjct: 462 LAARNVLLVNRHYA---KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 191 KADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP---DC 243
           ++D+WS G  +++ L  G+ P+      ++   I     +  PP    EL+    DC
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 575

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 74
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 135 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTI-SHP 69
           G  +G+G+F  V  A    L    A   +  K+L P       + L+ E+ +LS + +H 
Sbjct: 46  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 105
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH------GKVSEAV------------A 111
           NI+    A        ++ EYC  GDL  ++ +        K S A+             
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 112 RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL 171
             F  Q+A G+  L  K+ IHRDL  +N+L++   +T   KI DFG AR +   D    +
Sbjct: 166 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIK-NDSNYVV 221
Query: 172 CGS---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSN-QLQLFQNILT 225
            G+   P+ +MAPE I N  Y  ++D+WS G  L++L + G  P+ G     + ++ I  
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 281
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
              +  P  A  E++    D+ +     +P++R TFK+
Sbjct: 282 GFRMLSPEHAPAEMY----DIMKTCWDADPLKRPTFKQ 315

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKV----SDNLLKEISILSTI-SHP 69
           G  +G+G+F  V  A    L    A   +  K+L P       + L+ E+ +LS + +H 
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH------GKVSEAV------------A 111
           NI+    A        ++ EYC  GDL  ++ +        K S A+             
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 112 RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL 171
             F  Q+A G+  L  K+ IHRDL  +N+L++   +T   KI DFG AR +   D    +
Sbjct: 171 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARHIK-NDSNYVV 226
Query: 172 CGS---PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSN-QLQLFQNILT 225
            G+   P+ +MAPE I N  Y  ++D+WS G  L++L + G  P+ G     + ++ I  
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 286
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
              +  P  A  E++    D+ +     +P++R TFK+
Sbjct: 287 GFRMLSPEHAPAEMY----DIMKTCWDADPLKRPTFKQ 320

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 120/262 (45%), Gaps = 15/262 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI-LSTISHPNIIRFFE 76
           +G G++ VV + RH   G  +AVK I +  ++ +    LL ++ I + T+  P  + F+ 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 77  AIETREKIYLVLEYCDGGDLAAY---IHKHGKVSEAVARHFMRQLAAGLQVLQEK-HLIH 132
           A+     +++ +E  D      Y   I K   + E +       +   L+ L  K  +IH
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ---NHK-Y 188
           RD+KP N+L+  N +  V K+ DFG +  L      D   G   YMAPE I    N K Y
Sbjct: 134 RDVKPSNVLI--NALGQV-KMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
             K+D+WS+G  + +L   + P+D       FQ +    E   P    ++   + VD   
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWG--TPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 248
Query: 249 CLLRQNPVERITFKEFFNHRFL 270
             L++N  ER T+ E   H F 
Sbjct: 249 QCLKKNSKERPTYPELMQHPFF 270

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 77
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++E+   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 138 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 15/223 (6%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y+    +GSG++  V  A  ++ G +VA+K++ +   S   +    +E+ +L  + H N+
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 103
Query: 72  IRFFE------AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           I   +      ++      YLV+ +    DL   +    + SE   ++ + Q+  GL+ +
Sbjct: 104 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGM--EFSEEKIQYLVYQMLKGLKYI 160
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
               ++HRDLKP NL V+ +     LKI DFG AR    +     +  +  Y APE+I +
Sbjct: 161 HSAGVVHRDLKPGNLAVNED---CELKILDFGLARHADAEMTGYVV--TRWYRAPEVILS 215
Query: 186 H-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST 227
              Y+   D+WSVG I+ +++TGK  F G + L     IL  T
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++ Y   G+L  Y+          +    R         
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 77
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+  H  ++       +  Q+  G++ L  K 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHRDL  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 138 YIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           + SG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 89  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 148 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 128/289 (44%), Gaps = 43/289 (14%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           IG G+F  V++AR   L        VAVK + K+  S  +  +  +E ++++   +PNI+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIV 113
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH------------------- 113
           +        + + L+ EY   GDL  ++      +     H                   
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 114 -----FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL- 167
                  RQ+AAG+  L E+  +HRDL  +N LV  N    V+KI DFG +R++   D  
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM---VVKIADFGLSRNIYSADYY 230
Query: 168 -ADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNIL 224
            AD     P+ +M PE I  ++Y  ++D+W+ G +L+++ + G  P+ G    ++   + 
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290
Query: 225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
               L  P     EL+    +L R    + P +R +F     HR L  +
Sbjct: 291 DGNILACPENCPLELY----NLMRLCWSKLPADRPSFCSI--HRILQRM 333

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           + SG+F  V    W     ++ I VA+KE+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 82  LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 141 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W     ++ I VA+ E+ ++  SPK +  +L E  +++++ +P++ R
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMEL-REATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ L+H
Sbjct: 116 LL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 174
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I +  Y 
Sbjct: 175 RDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 231
Query: 190 AKADLWSVGAILFQLVT-GKPPFDG 213
            ++D+WS G  +++L+T G  P+DG
Sbjct: 232 HQSDVWSYGVTVWELMTFGSKPYDG 256

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 12/229 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS    T  +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 512 FVHRDIAARNVLVSA---TDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP  
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 36/279 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           +G  +G G+F  V  A    +        + VAVK +        +SD L+ E+ ++  I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 67  S-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMR--------- 116
             H NII    A      +Y+++ Y   G+L  Y+          +    R         
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 117 -------QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD 169
                  QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYK 214
Query: 170 TLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                 L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +  
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEF 264
              +  P     EL+     + R      P +R TFK+ 
Sbjct: 275 GHRMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQL 309

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 12/234 (5%)
Query: 14  VGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           I++    I T   +++++E C  G+L +++  +   +  A    +  QL+  L  L+ K 
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHK 187
            +HRD+  +N+LVS    T  +K+GDFG +R +          G  P+ +MAPE I   +
Sbjct: 132 FVHRDIAARNVLVSA---TDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 188 YDAKADLWSVGAILFQ-LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           + + +D+W  G  +++ L+ G  PF G     +   I     L  PP     L+
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 242

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 138/285 (48%), Gaps = 43/285 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           +G G+F  V +AR+       A+K+I  +    K+S  +L E+ +L++++H  ++R++  
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLS-TILSEVMLLASLNHQYVVRYYAA 70
Query: 76  -----------EAIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGL 122
                       A++ +  +++ +EYC+   L   IH     +  +   R F RQ+   L
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-RQILEAL 129
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS---------LTPQDL---ADT 170
             +  + +IHRDLKP N+ +  +     +KIGDFG A++         L  Q+L   +D 
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 171 LC---GSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKPPFD-GSNQLQLFQNILT 225
           L    G+ +Y+A E++     Y+ K D++S+G I F+++    PF  G  ++ + +  L 
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK-LR 242
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           S  + FPP   +        + R L+  +P +R   +   N  +L
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++     + +   +  +EI IL ++ H NI+
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 75
Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 135
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEIIQ 184
            IHR+L  +N+LV   E    +KIGDFG  + L PQD        P      + APE + 
Sbjct: 136 YIHRNLATRNILV---ENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 185 NHKYDAKADLWSVGAILFQLVT 206
             K+   +D+WS G +L++L T
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 128/269 (47%), Gaps = 39/269 (14%)
Query: 36  IEVAVKEIDKKLLSPKVSD--------NLLKEISILSTIS--HPNIIRFFEAIETREKIY 85
           + VA+K ++K     ++SD         +  E+ +L  +S     +IR  +  E  +   
Sbjct: 77  LPVAIKHVEKD----RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 132
Query: 86  LVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVST 144
           L+LE  +   DL  +I + G + E +AR F  Q+   ++      ++HRD+K +N+L+  
Sbjct: 133 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 192
Query: 145 NEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK-ADLWSVGAILFQ 203
           N     LK+ DFG + +L    +     G+ +Y  PE I+ H+Y  + A +WS+G +L+ 
Sbjct: 193 NRGE--LKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 249
Query: 204 LVTGKPPFDGSNQL---QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERIT 260
           +V G  PF+   ++   Q+F     S+E              C  L R  L   P +R T
Sbjct: 250 MVCGDIPFEHDEEIIRGQVFFRQRVSSE--------------CQHLIRWCLALRPSDRPT 295
Query: 261 FKEFFNHRFLGEL---RQTVHAEQHSVVP 286
           F+E  NH ++ ++   ++T     HS+ P
Sbjct: 296 FEEIQNHPWMQDVLLPQETAEIHLHSLSP 324

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 17/263 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI-LSTISHPNIIRFFE 76
           +G G++ VV + RH   G  +AVK I +  ++ +    LL ++ I + T+  P  + F+ 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 77  AIETREKIYLVLEYCDGGDLAAY---IHKHGKVSEAVARHFMRQLAAGLQVLQEK-HLIH 132
           A+     +++ +E  D      Y   I K   + E +       +   L+ L  K  +IH
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 177
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL-CGSPLYMAPEIIQ---NHK- 187
           RD+KP N+L+  N +  V K+ DFG +  L    +A T+  G   YMAPE I    N K 
Sbjct: 178 RDVKPSNVLI--NALGQV-KMCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           Y  K+D+WS+G  + +L   + P+D       FQ +    E   P    ++   + VD  
Sbjct: 234 YSVKSDIWSLGITMIELAILRFPYDSWG--TPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 248 RCLLRQNPVERITFKEFFNHRFL 270
              L++N  ER T+ E   H F 
Sbjct: 292 SQCLKKNSKERPTYPELMQHPFF 314

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 122/254 (48%), Gaps = 25/254 (9%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G+G F VV    WR ++     +VA+K I +  +S    D  ++E  ++  +SH  +++
Sbjct: 32  LGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQ 83
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I+++ EY   G L  Y+ +   +          + +   ++ L+ K  +H
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LV+      V+K+ DFG +R +   +   ++ GS     +  PE++   K+ 
Sbjct: 144 RDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFS 199
Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           +K+D+W+ G +++++ + GK P++     +  ++I     L  P  A E+++     +  
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT----IMY 255
Query: 249 CLLRQNPVERITFK 262
               +   ER TFK
Sbjct: 256 SCWHEKADERPTFK 269

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 32  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHG------KVSEAVARHFMR----- 116
            N++    A  +    + +++E+C  G+L+ Y+          K  E + + F+      
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 117 ----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLADT 170
               Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +   
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPDXVRKG 208
Query: 171 LCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTST 227
               PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   T
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 228 ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
            +R P     E++   +D         P +R TF E   H  LG L Q
Sbjct: 269 RMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQ 310

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 122/254 (48%), Gaps = 25/254 (9%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G+G F VV    WR ++     +VA+K I +  +S    D  ++E  ++  +SH  +++
Sbjct: 23  LGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQ 74
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I+++ EY   G L  Y+ +   +          + +   ++ L+ K  +H
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 134
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LV+      V+K+ DFG +R +   +   ++ GS     +  PE++   K+ 
Sbjct: 135 RDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFS 190
Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           +K+D+W+ G +++++ + GK P++     +  ++I     L  P  A E+++     +  
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT----IMY 246
Query: 249 CLLRQNPVERITFK 262
               +   ER TFK
Sbjct: 247 SCWHEKADERPTFK 260

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 128/270 (47%), Gaps = 32/270 (11%)
Query: 9   IGEYIVGPR-------IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLL 57
           +G + + P+       +G+G F VV    WR ++     +VA+K I +  +S    D  +
Sbjct: 1   MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFI 52
Query: 58  KEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMR 116
           +E  ++  +SH  +++ +     +  I+++ EY   G L  Y+ +   +          +
Sbjct: 53  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 112
Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
            +   ++ L+ K  +HRDL  +N LV+      V+K+ DFG +R +   +   ++ GS  
Sbjct: 113 DVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSV-GSKF 168
Query: 177 ---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
              +  PE++   K+ +K+D+W+ G +++++ + GK P++     +  ++I     L  P
Sbjct: 169 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 228
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFK 262
             A E+++     +      +   ER TFK
Sbjct: 229 HLASEKVYT----IMYSCWHEKADERPTFK 254

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R +        VAVK +++   S +     L E S++   +  +++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 80
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
             L  K  +HRDL  +N +V+ +     +KIGDFG  R +   D         L   +MA
Sbjct: 141 AYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P    E 
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 257
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFN 266
           +     DL R   + NP  R TF E  N
Sbjct: 258 V----TDLMRMCWQFNPKMRPTFLEIVN 281

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 122/254 (48%), Gaps = 25/254 (9%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G+G F VV    WR ++     +VA+K I +  +S    D  ++E  ++  +SH  +++
Sbjct: 16  LGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQ 67
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I+++ EY   G L  Y+ +   +          + +   ++ L+ K  +H
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 127
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LV+      V+K+ DFG +R +   +   ++ GS     +  PE++   K+ 
Sbjct: 128 RDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFS 183
Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           +K+D+W+ G +++++ + GK P++     +  ++I     L  P  A E+++     +  
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT----IMY 239
Query: 249 CLLRQNPVERITFK 262
               +   ER TFK
Sbjct: 240 SCWHEKADERPTFK 253

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 129/306 (42%), Gaps = 50/306 (16%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDN-----LLKEISI 62
           Y V   I SGS+  V      + GI VA+K +   +   +    +SD+     +L+EI +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 63  LSTISHPNIIRFFEAIETRE-----KIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMR 116
           L+   HPNI+   +     E     K+YLV E     DLA  IH    V S    ++FM 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVS-TNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
            +  GL VL E  ++HRDL P N+L++  N++T    I DF  AR  T            
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDIT----ICDFNLAREDTADANKTHYVTHR 197
Query: 176 LYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGS---NQLQ------------- 218
            Y APE++   K +    D+WS G ++ ++   K  F GS   NQL              
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 219 -----------LFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                        +N L++   R     +    P  +DL   +L  NP  RI+ ++   H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 268 RFLGEL 273
            +   L
Sbjct: 318 PYFESL 323

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 122/254 (48%), Gaps = 25/254 (9%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G+G F VV    WR ++     +VA+K I +  +S    D  ++E  ++  +SH  +++
Sbjct: 12  LGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQ 63
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I+++ EY   G L  Y+ +   +          + +   ++ L+ K  +H
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LV+      V+K+ DFG +R +   +   ++ GS     +  PE++   K+ 
Sbjct: 124 RDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFS 179
Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           +K+D+W+ G +++++ + GK P++     +  ++I     L  P  A E+++     +  
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT----IMY 235
Query: 249 CLLRQNPVERITFK 262
               +   ER TFK
Sbjct: 236 SCWHEKADERPTFK 249

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R +        VAVK +++   S +     L E S++   +  +++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 83
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
             L  K  +HRDL  +N +V+ +     +KIGDFG  R +   D         L   +MA
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFN 266
           +     DL R   + NP  R TF E  N
Sbjct: 261 V----TDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 129/306 (42%), Gaps = 50/306 (16%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDN-----LLKEISI 62
           Y V   I SGS+  V      + GI VA+K +   +   +    +SD+     +L+EI +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 63  LSTISHPNIIRFFEAIETRE-----KIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMR 116
           L+   HPNI+   +     E     K+YLV E     DLA  IH    V S    ++FM 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVS-TNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
            +  GL VL E  ++HRDL P N+L++  N++T    I DF  AR  T            
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDIT----ICDFNLAREDTADANKTHYVTHR 197
Query: 176 LYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGS---NQLQ------------- 218
            Y APE++   K +    D+WS G ++ ++   K  F GS   NQL              
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 219 -----------LFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                        +N L++   R     +    P  +DL   +L  NP  RI+ ++   H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 268 RFLGEL 273
            +   L
Sbjct: 318 PYFESL 323

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R +        VAVK +++   S +     L E S++   +  +++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 83
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
             L  K  +HRDL  +N +V+ +     +KIGDFG  R +   D         L   +MA
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFN 266
           +     DL R   + NP  R TF E  N
Sbjct: 261 V----TDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R +        VAVK +++   S +     L E S++   +  +++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 82
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
             L  K  +HRDL  +N +V+ +     +KIGDFG  R +   D         L   +MA
Sbjct: 143 AYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P    E 
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 259
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFN 266
           +     DL R   + NP  R TF E  N
Sbjct: 260 V----TDLMRMCWQFNPKMRPTFLEIVN 283

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 122/254 (48%), Gaps = 25/254 (9%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G+G F VV    WR ++     +VA+K I +  +S    D  ++E  ++  +SH  +++
Sbjct: 32  LGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQ 83
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I+++ EY   G L  Y+ +   +          + +   ++ L+ K  +H
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LV+      V+K+ DFG +R +   +   ++ GS     +  PE++   K+ 
Sbjct: 144 RDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEETSSV-GSKFPVRWSPPEVLMYSKFS 199
Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           +K+D+W+ G +++++ + GK P++     +  ++I     L  P  A E+++     +  
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT----IMY 255
Query: 249 CLLRQNPVERITFK 262
               +   ER TFK
Sbjct: 256 SCWHEKADERPTFK 269

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R +        VAVK +++   S +     L E S++   +  +++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 83
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
             L  K  +HRDL  +N +V+ +     +KIGDFG  R +   D         L   +MA
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFN 266
           +     DL R   + NP  R TF E  N
Sbjct: 261 V----TDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 121/254 (47%), Gaps = 25/254 (9%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G+G F VV    WR ++     +VA+K I +  +S    D  ++E  ++  +SH  +++
Sbjct: 17  LGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQ 68
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
            +     +  I+++ EY   G L  Y+ +   +          + +   ++ L+ K  +H
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYD 189
           RDL  +N LV+      V+K+ DFG +R +   +   +  GS     +  PE++   K+ 
Sbjct: 129 RDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSR-GSKFPVRWSPPEVLMYSKFS 184
Query: 190 AKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
           +K+D+W+ G +++++ + GK P++     +  ++I     L  P  A E+++     +  
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT----IMY 240
Query: 249 CLLRQNPVERITFK 262
               +   ER TFK
Sbjct: 241 SCWHEKADERPTFK 254

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 71  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 131 IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 189
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 190 TVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 244
Query: 165 Q--DLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           +  D      G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 305 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 332

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + +++E+C  G+L+ Y+         + +  E + + F+     
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 153 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRK 209
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 269
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           T +R P     E++   +D         P +R TF E   H  LG L Q 
Sbjct: 270 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQA 313

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 13  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 72
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 73  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 131
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 132 TVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMLD 186
Query: 165 Q--DLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           +  D      G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 187 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 246
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 247 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 274

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 17  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 76
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 77  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 135
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 136 TVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 190
Query: 165 Q--DLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           +  D      G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 191 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 250
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 251 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 278

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 13  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 72
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 73  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 131
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 132 TVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 186
Query: 165 Q--DLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           +  D      G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 187 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 246
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 247 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 274

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + +++E+C  G+L+ Y+         +    E + + F+     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPDXVRK 207
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           T +R P     E++   +D         P +R TF E   H  LG L Q 
Sbjct: 268 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQA 311

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 12  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 71
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 72  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 130
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 131 TVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 185
Query: 165 Q--DLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           +  D      G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 186 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 246 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 273

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 127/258 (49%), Gaps = 19/258 (7%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVS--DNLLKEISILSTISHPNI 71
           +IG G F +V + R  +    VA+K +   D +  +  +       +E+ I+S ++HPNI
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLA-AYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH- 129
           ++ +  +    +  +V+E+   GDL    + K   +  +V    M  +A G++ +Q ++ 
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 130 -LIHRDLK-PQNLLVSTNEVTPVL-KIGDFGFARSLTPQDLADTLCGSPLYMAPEII--Q 184
            ++HRDL+ P   L S +E  PV  K+ DFG ++          L G+  +MAPE I  +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAE 201
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGAIEELHPDC 243
              Y  KAD +S   IL+ ++TG+ PFD  +  ++ F N++    LR  P   E+  P  
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--PTIPEDCPPRL 259
Query: 244 VDLCRCLLRQNPVERITF 261
            ++       +P +R  F
Sbjct: 260 RNVIELCWSGDPKKRPHF 277

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + +++E+C  G+L+ Y+         +    E + + F+     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDXVRK 207
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           T +R P     E++   +D         P +R TF E   H  LG L Q 
Sbjct: 268 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQA 311

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 124/269 (46%), Gaps = 29/269 (10%)
Query: 13  IVGPRIGSGSFAVVWRARHRQ---LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           I+G  +G G F  V     +Q     ++VAVK +     S +  +  L E + +   SHP
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 70  NIIRFFE-AIETRE----KIYLVLEYCDGGDLAAYIH--------KHGKVSEAVARHFMR 116
           N+IR     IE       K  ++L +   GDL  Y+         KH  +       FM 
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH--IPLQTLLKFMV 154
Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGS 174
            +A G++ L  ++ +HRDL  +N ++  +    V    DFG ++ +   D      +   
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV---ADFGLSKKIYSGDYYRQGRIAKM 211
Query: 175 PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
           P+ ++A E + +  Y +K+D+W+ G  ++++ T G  P+ G    +++  +L    L+ P
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP 271
Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITF 261
              ++EL+    ++     R +P++R TF
Sbjct: 272 EDCLDELY----EIMYSCWRTDPLDRPTF 296

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + +++E+C  G+L+ Y+         +    E + + F+     
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPDXVRK 198
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           T +R P     E++   +D         P +R TF E   H  LG L Q 
Sbjct: 259 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQA 302

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 10  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 69
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 70  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 128
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 129 TVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 183
Query: 165 Q--DLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           +  D      G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 184 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 243
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 244 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 271

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S ++H NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 291
Query: 239 LHPDC 243
           +   C
Sbjct: 292 IMTQC 296

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S ++H NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 277
Query: 239 LHPDC 243
           +   C
Sbjct: 278 IMTQC 282

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 12  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 71
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 72  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 130
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 131 TVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 185
Query: 165 Q--DLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           +  D      G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 186 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 246 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 273

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R +        VAVK +++   S +     L E S++   +  +++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 84
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
             L  K  +HR+L  +N +V+ +     +KIGDFG  R +   D         L   +MA
Sbjct: 145 AYLNAKKFVHRNLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P    E 
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 261
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFN 266
           +     DL R   + NP  R TF E  N
Sbjct: 262 V----TDLMRMCWQFNPNMRPTFLEIVN 285

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 258 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 317
Query: 239 LHPDC 243
           +   C
Sbjct: 318 IMTQC 322

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 277
Query: 239 LHPDC 243
           +   C
Sbjct: 278 IMTQC 282

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 30  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 89
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 90  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 148
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 149 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 203
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 204 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 263
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 264 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 291

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + +++E+C  G+L+ Y+         +    E + + F+     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRK 207
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           T +R P     E++   +D         P +R TF E   H  LG L Q 
Sbjct: 268 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQA 311

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 164 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 223
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 224 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 283
Query: 239 LHPDC 243
           +   C
Sbjct: 284 IMTQC 288

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 36/289 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + +++E+C  G+L+ Y+         +    E + + F+     
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRK 244
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           T +R P     E++   +D         P +R TF E   H  LG L Q
Sbjct: 305 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQ 347

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 36/289 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + ++ E+C  G+L+ Y+         +    E + + F+     
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPDXVRK 198
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           T +R P     E++   +D         P +R TF E   H  LG L Q
Sbjct: 259 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQ 301

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 291
Query: 239 LHPDC 243
           +   C
Sbjct: 292 IMTQC 296

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 175 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 234
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 235 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 294
Query: 239 LHPDC 243
           +   C
Sbjct: 295 IMTQC 299

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 127/258 (49%), Gaps = 19/258 (7%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVS--DNLLKEISILSTISHPNI 71
           +IG G F +V + R  +    VA+K +   D +  +  +       +E+ I+S ++HPNI
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLA-AYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH- 129
           ++ +  +    +  +V+E+   GDL    + K   +  +V    M  +A G++ +Q ++ 
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 130 -LIHRDLK-PQNLLVSTNEVTPVL-KIGDFGFARSLTPQDLADTLCGSPLYMAPEII--Q 184
            ++HRDL+ P   L S +E  PV  K+ DFG ++          L G+  +MAPE I  +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHS--VSGLLGNFQWMAPETIGAE 201
Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGAIEELHPDC 243
              Y  KAD +S   IL+ ++TG+ PFD  +  ++ F N++    LR  P   E+  P  
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--PTIPEDCPPRL 259
Query: 244 VDLCRCLLRQNPVERITF 261
            ++       +P +R  F
Sbjct: 260 RNVIELCWSGDPKKRPHF 277

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 174 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 233
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 234 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 293
Query: 239 LHPDC 243
           +   C
Sbjct: 294 IMTQC 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R +        VAVK +++   S +     L E S++   +  +++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 83
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMA 179
             L  K  +HR+L  +N +V+ +     +KIGDFG  R +   D         L   +MA
Sbjct: 144 AYLNAKKFVHRNLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P    E 
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFN 266
           +     DL R   + NP  R TF E  N
Sbjct: 261 V----TDLMRMCWQFNPNMRPTFLEIVN 284

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 88
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 149 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 208
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 209 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 268
Query: 239 LHPDC 243
           +   C
Sbjct: 269 IMTQC 273

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 10  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 69
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 70  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 128
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 129 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 183
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 184 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 243
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 244 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 271

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 12  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 71
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 72  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 130
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 131 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 185
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 186 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 246 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 273

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 276
Query: 239 LHPDC 243
           +   C
Sbjct: 277 IMTQC 281

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 184 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 243
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 244 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 303
Query: 239 LHPDC 243
           +   C
Sbjct: 304 IMTQC 308

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 87/347 (25%), Positives = 147/347 (42%), Gaps = 87/347 (25%)
Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           YI+   IG GS+  V+ A  +     VA+K++++          +L+EI+IL+ +    I
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 72  IRFFEAIETR-----EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           IR ++ I        +++Y+VLE  D  DL         ++E   +  +  L  G   + 
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-------DLADTLCGSP---- 175
           E  +IHRDLKP N L++ +     +K+ DFG AR++  +       DL +     P    
Sbjct: 147 ESGIIHRDLKPANCLLNQD---CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 176 ------------LYMAPE-IIQNHKYDAKADLWSVGAILFQLV----------TGK-PPF 211
                        Y APE I+    Y    D+WS G I  +L+          T + P F
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
Query: 212 DGS--------------------NQLQLFQNIL---TSTELR-------------FP--- 232
            GS                    +QL +  NI+   T  +L+             FP   
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323
Query: 233 PGAIEELHP----DCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           P  +++ +P    D ++L   +L+ NP +RIT  +  +H +L ++R+
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 130/288 (45%), Gaps = 34/288 (11%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHGK-----VSEAVARHFMR------ 116
            N++    A  +    + +++E+C  G+L+ Y+            E + + F+       
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 117 ---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--PQDLADTL 171
              Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +    
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPDXVRKGD 209
Query: 172 CGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTSTE 228
              PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   T 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           +R P     E++   +D         P +R TF E   H  LG L Q 
Sbjct: 270 MRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQA 311

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 12  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 71
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 72  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 130
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 131 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 185
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 186 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 246 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 273

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 7   LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 66
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 67  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 125
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 126 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 180
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 241 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 268

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 11  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 70
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 71  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 129
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 130 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 184
Query: 165 QDLADT--LCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 185 KEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 244
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 245 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 272

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 29/271 (10%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRFFE 76
           IG G++  V +  H+  G  +AVK I +  +  K    LL ++ ++   S  P I++F+ 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL----AAGLQVLQEK-HLI 131
           A+      ++ +E         Y + +  + + +    + ++       L  L+E   +I
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ----NHK 187
           HRD+KP N+L+   + +  +K+ DFG +  L          G   YMAPE I        
Sbjct: 149 HRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQL--QLFQNI------LTSTELRFPPGAIEEL 239
           YD ++D+WS+G  L++L TG+ P+   N +  QL Q +      L+++E R       E 
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER-------EF 258
Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
            P  ++     L ++  +R  +KE   H F+
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 31  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 90
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 91  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 149
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 150 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 204
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 205 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 264
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 265 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 11  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 70
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 71  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 129
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 130 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 184
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 185 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 244
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 245 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 272

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 9   LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 69  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 127
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 128 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 182
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 183 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 243 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 270

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 1   MEPNRTRLIGEYIVGPR---------IGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLL 48
           + P   + +   ++GP          IG G F  V+      +    I  AVK +++   
Sbjct: 4   LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 63
Query: 49  SPKVSDNLLKEISILSTISHPNIIRFFE-AIETREKIYLVLEYCDGGDLAAYIHKHG--- 104
             +VS   L E  I+   SHPN++      + +     +VL Y   GDL  +I       
Sbjct: 64  IGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 122
Query: 105 KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
            V + +   F  Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  
Sbjct: 123 TVKDLIG--FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD 177
Query: 165 QDL--ADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ 218
           ++        G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   
Sbjct: 178 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 237
Query: 219 LFQNILTSTELRFP---PGAIEELHPDC 243
           +   +L    L  P   P  + E+   C
Sbjct: 238 ITVYLLQGRRLLQPEYCPDPLYEVMLKC 265

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG G F  V    +R  G +VAVK I     +   +   L E S+++ + H N+++    
Sbjct: 29  IGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 78  I-ETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           I E +  +Y+V EY   G L  Y+   G+  +       F   +   ++ L+  + +HRD
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           L  +N+LVS + V    K+ DFG  +  +     DT      + APE ++  K+  K+D+
Sbjct: 143 LAARNVLVSEDNVA---KVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 195 WSVGAILFQLVT-GKPPF 211
           WS G +L+++ + G+ P+
Sbjct: 198 WSFGILLWEIYSFGRVPY 215

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 129/260 (49%), Gaps = 23/260 (8%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVS--DNLLKEISILSTISHPNI 71
           +IG G F +V + R  +    VA+K +   D +  +  +       +E+ I+S ++HPNI
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 72  IRFFEAIETREKIYLVLEYCDGGDLA-AYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH- 129
           ++ +  +    +  +V+E+   GDL    + K   +  +V    M  +A G++ +Q ++ 
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 130 -LIHRDLK-PQNLLVSTNEVTPVL-KIGDFGFARSLTPQDL--ADTLCGSPLYMAPEII- 183
            ++HRDL+ P   L S +E  PV  K+ DF    SL+ Q +     L G+  +MAPE I 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADF----SLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 184 -QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGAIEELHP 241
            +   Y  KAD +S   IL+ ++TG+ PFD  +  ++ F N++    LR  P   E+  P
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--PTIPEDCPP 257
Query: 242 DCVDLCRCLLRQNPVERITF 261
              ++       +P +R  F
Sbjct: 258 RLRNVIELCWSGDPKKRPHF 277

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           ++++E   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 291
Query: 239 LHPDC 243
           +   C
Sbjct: 292 IMTQC 296

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 132/287 (45%), Gaps = 36/287 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVA-----RHFMR------ 116
            N++    A  +    + +++E+C  G+L+ Y+    K +E V      + F+       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR--SKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 117 ---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTL 171
              Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +    
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKIXDFGLARDIYKDPDYVRKGD 205
Query: 172 CGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT-STE 228
              PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F   L   T 
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTR 265
Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           +R P     E++   +D C       P +R TF E   H  LG L Q
Sbjct: 266 MRAPDYTTPEMYQTMLD-C---WHGEPSQRPTFSELVEH--LGNLLQ 306

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG G F  V    +R  G +VAVK I     +   +   L E S+++ + H N+++    
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 78  I-ETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           I E +  +Y+V EY   G L  Y+   G+  +       F   +   ++ L+  + +HRD
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 127
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           L  +N+LVS + V    K+ DFG  +  +     DT      + APE ++  K+  K+D+
Sbjct: 128 LAARNVLVSEDNVA---KVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 195 WSVGAILFQLVT-GKPPF 211
           WS G +L+++ + G+ P+
Sbjct: 183 WSFGILLWEIYSFGRVPY 200

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           ++++E   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE 
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 276
Query: 239 LHPDC 243
           +   C
Sbjct: 277 IMTQC 281

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG G F  V    +R  G +VAVK I     +   +   L E S+++ + H N+++    
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 78  I-ETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           I E +  +Y+V EY   G L  Y+   G+  +       F   +   ++ L+  + +HRD
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-YMAPEIIQNHKYDAKAD 193
           L  +N+LVS + V    K+ DFG  +  +       L   P+ + APE ++  K+  K+D
Sbjct: 315 LAARNVLVSEDNVA---KVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFSTKSD 368
Query: 194 LWSVGAILFQLVT-GKPPF 211
           +WS G +L+++ + G+ P+
Sbjct: 369 VWSFGILLWEIYSFGRVPY 387

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 102/192 (53%), Gaps = 23/192 (11%)
Query: 35  GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKIYLVLEYCD 92
           G  VAVK + K+   P++     +EI IL T+ H +I+++    E +  + + LV+EY  
Sbjct: 38  GEMVAVKAL-KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 93  GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK 152
            G L  Y+ +H  V  A    F +Q+  G+  L  +H IHR L  +N+L+  +    ++K
Sbjct: 97  LGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDR---LVK 152
Query: 153 IGDFGFARSLTP-------QDLADTLCGSPLYM-APEIIQNHKYDAKADLWSVGAILFQL 204
           IGDFG A+++         ++  D    SP++  APE ++  K+   +D+WS G  L++L
Sbjct: 153 IGDFGLAKAVPEGHEYYRVREDGD----SPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208
Query: 205 VTGKPPFDGSNQ 216
           +T    +  SNQ
Sbjct: 209 LT----YCDSNQ 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 102/192 (53%), Gaps = 23/192 (11%)
Query: 35  GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR--EKIYLVLEYCD 92
           G  VAVK + K+   P++     +EI IL T+ H +I+++    E +  + + LV+EY  
Sbjct: 37  GEMVAVKAL-KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 93  GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK 152
            G L  Y+ +H  V  A    F +Q+  G+  L  +H IHR L  +N+L+  +    ++K
Sbjct: 96  LGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDR---LVK 151
Query: 153 IGDFGFARSLTP-------QDLADTLCGSPLYM-APEIIQNHKYDAKADLWSVGAILFQL 204
           IGDFG A+++         ++  D    SP++  APE ++  K+   +D+WS G  L++L
Sbjct: 152 IGDFGLAKAVPEGHEYYRVREDGD----SPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207
Query: 205 VTGKPPFDGSNQ 216
           +T    +  SNQ
Sbjct: 208 LT----YCDSNQ 215

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 36/289 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + ++ E+C  G+L+ Y+         +    E + + F+     
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRK 198
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           T +R P     E++   +D         P +R TF E   H  LG L Q
Sbjct: 259 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQ 301

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 23/203 (11%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G F  V    +   +   G  VAVK + K    P+      +EI IL T+ H +II+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 74  FFEAIETR--EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +    E +  + + LV+EY   G L  Y+ +H  +  A    F +Q+  G+  L  +H I
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQHYI 139
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-------QDLADTLCGSPLYM-APEII 183
           HR+L  +N+L+  + +   +KIGDFG A+++         ++  D    SP++  APE +
Sbjct: 140 HRNLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVREDGD----SPVFWYAPECL 192
Query: 184 QNHKYDAKADLWSVGAILFQLVT 206
           + +K+   +D+WS G  L++L+T
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 36/289 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHK-------HGKVSEAVARHFMR---- 116
            N++    A  +    + ++ E+C  G+L+ Y+         +    E + + F+     
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 117 -----QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLAD 169
                Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +  
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRK 198
Query: 170 TLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTS 226
                PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           T +R P     E++   +D         P +R TF E   H  LG L Q
Sbjct: 259 TRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQ 301

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 132/287 (45%), Gaps = 36/287 (12%)
Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEISILSTISHP 69
           +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+ IL  I H 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 70  -NIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVA-----RHFMR------ 116
            N++    A  +    + +++E+C  G+L+ Y+    K +E V      + F+       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR--SKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 117 ---QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL--TPQDLADTL 171
              Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +   P  +    
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRKGD 205
Query: 172 CGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLF-QNILTSTE 228
              PL +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G    + F + +   T 
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 265
Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           +R P     E++   +D         P +R TF E   H  LG L Q
Sbjct: 266 MRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH--LGNLLQ 306

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 34/289 (11%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS 64
           ++R   E+    +IGSG F  V++   R  G   A+K   K L       N L+E+   +
Sbjct: 2   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 61
Query: 65  TIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLA 119
            +  H +++R+F A    + + +  EYC+GG LA  I ++ ++     EA  +  + Q+ 
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEV----------------TPVLKIGDFGFARSLT 163
            GL+ +    L+H D+KP N+ +S   +                  + KIGD G    ++
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 181
Query: 164 PQDLADTLCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKP-PFDGSNQLQLFQ 221
              + +   G   ++A E++Q N+ +  KAD++++   +      +P P +G    ++ Q
Sbjct: 182 SPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWHEIRQ 238
Query: 222 NILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             L     R P    + L  +  +L + ++  +P  R +      H  L
Sbjct: 239 GRLP----RIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 15/224 (6%)
Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFF 75
           R+G GS+  V++ R ++ G   AVK        PK     L E+     +  HP  +R  
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           +A E    +YL  E C G  L  +    G  + EA    ++R     L  L  + L+H D
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           +KP N+ +         K+GDFG    L      +   G P YMAPE++Q   Y   AD+
Sbjct: 183 VKPANIFLGPRGRC---KLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADV 238
Query: 195 WSVGAILFQLVTG-KPPFDGSNQLQLFQNILT-------STELR 230
           +S+G  + ++    + P  G    QL Q  L        S+ELR
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELR 282

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 18  IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G GSF +V+    R +        VAVK +++   S +     L E S++   +  +++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 83
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSE------AVARHFMRQLAA----GL 122
           R    +   +   +V+E    GDL +Y+      +E            M Q+AA    G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC----GSPL-- 176
             L  K  +HRDL  +N +V+ +     +KIGDFG  R     D+ +T      G  L  
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTR-----DIYETAYYRKGGKGLLP 195
Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             +MAPE +++  +   +D+WS G +L+++ +  + P+ G +  Q+ + ++    L  P 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFN 266
              E +     DL R   + NP  R TF E  N
Sbjct: 256 NCPERV----TDLMRMCWQFNPKMRPTFLEIVN 284

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 23/203 (11%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G F  V    +   +   G  VAVK + K    P+      +EI IL T+ H +II+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 74  FFEAIETR--EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +    E +  + + LV+EY   G L  Y+ +H  +  A    F +Q+  G+  L  +H I
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYI 139
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-------QDLADTLCGSPLYM-APEII 183
           HR+L  +N+L+  + +   +KIGDFG A+++         ++  D    SP++  APE +
Sbjct: 140 HRNLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVREDGD----SPVFWYAPECL 192
Query: 184 QNHKYDAKADLWSVGAILFQLVT 206
           + +K+   +D+WS G  L++L+T
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G F  V    +   +   G  VAVK + K    P+      +EI IL T+ H +II+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 74  FFEAIETR--EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +    E      + LV+EY   G L  Y+ +H  +  A    F +Q+  G+  L  +H I
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYI 156
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-------QDLADTLCGSPLYM-APEII 183
           HRDL  +N+L+  +    ++KIGDFG A+++         ++  D    SP++  APE +
Sbjct: 157 HRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEXYRVREDGD----SPVFWYAPECL 209
Query: 184 QNHKYDAKADLWSVGAILFQLVT 206
           + +K+   +D+WS G  L++L+T
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 34/289 (11%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS 64
           ++R   E+    +IGSG F  V++   R  G   A+K   K L       N L+E+   +
Sbjct: 6   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 65
Query: 65  TIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLA 119
            +  H +++R+F A    + + +  EYC+GG LA  I ++ ++     EA  +  + Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEV----------------TPVLKIGDFGFARSLT 163
            GL+ +    L+H D+KP N+ +S   +                  + KIGD G    ++
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 164 PQDLADTLCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKP-PFDGSNQLQLFQ 221
              + +   G   ++A E++Q N+ +  KAD++++   +      +P P +G    ++ Q
Sbjct: 186 SPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
Query: 222 NILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             L     R P    + L  +  +L + ++  +P  R +      H  L
Sbjct: 243 GRLP----RIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 34/289 (11%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS 64
           ++R   E+    +IGSG F  V++   R  G   A+K   K L       N L+E+   +
Sbjct: 4   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 63
Query: 65  TIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLA 119
            +  H +++R+F A    + + +  EYC+GG LA  I ++ ++     EA  +  + Q+ 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEV----------------TPVLKIGDFGFARSLT 163
            GL+ +    L+H D+KP N+ +S   +                  + KIGD G    ++
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 164 PQDLADTLCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKP-PFDGSNQLQLFQ 221
              + +   G   ++A E++Q N+ +  KAD++++   +      +P P +G    ++ Q
Sbjct: 184 SPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 240
Query: 222 NILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             L     R P    + L  +  +L + ++  +P  R +      H  L
Sbjct: 241 GRLP----RIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 18  IGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIH-------KHGKVSEAVARHFMRQLAAGLQVL 125
           R           +++LE   GGDL +++        +   ++     H  R +A G Q L
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEI 182
           +E H IHRD+  +N L++      V KIGDFG A+ +           + L   +M PE 
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 183 IQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEE 238
                + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P   PG +  
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR 277
Query: 239 LHPDC 243
           +   C
Sbjct: 278 IMTQC 282

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 34/289 (11%)
Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS 64
           ++R   E+    +IGSG F  V++   R  G   A+K   K L       N L+E+   +
Sbjct: 4   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 63
Query: 65  TIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLA 119
            +  H +++R+F A    + + +  EYC+GG LA  I ++ ++     EA  +  + Q+ 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEV----------------TPVLKIGDFGFARSLT 163
            GL+ +    L+H D+KP N+ +S   +                  + KIGD G    ++
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 164 PQDLADTLCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKP-PFDGSNQLQLFQ 221
              + +   G   ++A E++Q N+ +  KAD++++   +      +P P +G    ++ Q
Sbjct: 184 SPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 240
Query: 222 NILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             L     R P    + L  +  +L + ++  +P  R +      H  L
Sbjct: 241 GRLP----RIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 44  DKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH 103
           D  L SP   D    +I  +   S  N +   +    +  +Y+ ++ C   +L  ++++ 
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 104 GKVSE---AVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
             + +    V  H   Q+A  ++ L  K L+HRDLKP N+  + ++V   +K+GDFG   
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVT 212
Query: 161 SLTPQDLADTL-------------CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG 207
           ++   +   T+              G+ LYM+PE I  + Y  K D++S+G ILF+L+  
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-- 270
Query: 208 KPPFDGSNQLQLFQNILTSTELRFP 232
              +  S Q++  + I     L+FP
Sbjct: 271 ---YSFSTQMERVRIITDVRNLKFP 292

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 43/285 (15%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF-- 75
           +G G+F  V +AR+       A+K+I  +    K+S  +L E+ +L++++H  ++R++  
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLS-TILSEVXLLASLNHQYVVRYYAA 70
Query: 76  -----------EAIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGL 122
                       A++ +  +++  EYC+   L   IH     +  +   R F RQ+   L
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-RQILEAL 129
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS---------LTPQDL---ADT 170
             +  + +IHR+LKP N+ +     +  +KIGDFG A++         L  Q+L   +D 
Sbjct: 130 SYIHSQGIIHRNLKPXNIFIDE---SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 171 LC---GSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKPPFD-GSNQLQLFQNILT 225
           L    G+  Y+A E++     Y+ K D +S+G I F+ +    PF  G  ++ + +  L 
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKK-LR 242
Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           S  + FPP   +        + R L+  +P +R   +   N  +L
Sbjct: 243 SVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 18  IGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G F  V   R+       G +VAVK +  +     ++D L KEI IL  + H NI++
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVK 87
Query: 74  FFEAIETREK---IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           + + I T +    I L++E+   G L  Y+ K+  K++      +  Q+  G+  L  + 
Sbjct: 88  Y-KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG---SPLYM-APEIIQN 185
            +HRDL  +N+LV +      +KIGDFG  +++       T+     SP++  APE +  
Sbjct: 147 YVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 186 HKYDAKADLWSVGAILFQLVT 206
            K+   +D+WS G  L +L+T
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 114/262 (43%), Gaps = 15/262 (5%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI-LSTISHPNIIRFFE 76
           +G G++ VV + RH   G   AVK I +  ++ +    LL ++ I   T+  P  + F+ 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI-RATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 77  AIETREKIYLVLEYCDGGDLAAY---IHKHGKVSEAVARHFMRQLAAGLQVLQEK-HLIH 132
           A+     +++  E  D      Y   I K   + E +       +   L+ L  K  +IH
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 160
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ---NHK-Y 188
           RD+KP N+L+  N +  V K  DFG +  L      D   G   Y APE I    N K Y
Sbjct: 161 RDVKPSNVLI--NALGQV-KXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
             K+D+WS+G    +L   + P+D       FQ +    E   P    ++   + VD   
Sbjct: 218 SVKSDIWSLGITXIELAILRFPYDSWG--TPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 275
Query: 249 CLLRQNPVERITFKEFFNHRFL 270
             L++N  ER T+ E   H F 
Sbjct: 276 QCLKKNSKERPTYPELXQHPFF 297

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 18  IGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G G F  V   R+       G +VAVK +  +     ++D L KEI IL  + H NI++
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVK 75
Query: 74  FFEAIETREK---IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           + + I T +    I L++E+   G L  Y+ K+  K++      +  Q+  G+  L  + 
Sbjct: 76  Y-KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG---SPLYM-APEIIQN 185
            +HRDL  +N+LV +      +KIGDFG  +++       T+     SP++  APE +  
Sbjct: 135 YVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 186 HKYDAKADLWSVGAILFQLVT 206
            K+   +D+WS G  L +L+T
Sbjct: 192 SKFYIASDVWSFGVTLHELLT 212

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 148/314 (47%), Gaps = 57/314 (18%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN--LLKEISILSTIS-HPNIIRF 74
           +  G FA V+ A+    G E A+K    +LLS +   N  +++E+  +  +S HPNI++F
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALK----RLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 75  FEAI-------ETREKIYLVLEYCDGGDLAAYIHK---HGKVSEAVARHFMRQLAAGLQV 124
             A        +T +  +L+L     G L  ++ K    G +S         Q    +Q 
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 125 L--QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA---------------RSLTPQDL 167
           +  Q+  +IHRDLK +NLL+S N+ T  +K+ DFG A               R+L  +++
Sbjct: 152 MHRQKPPIIHRDLKVENLLLS-NQGT--IKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 168 ADTLCGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL 224
             T   +P+Y  PEII    N     K D+W++G IL+ L   + PF+   +L+     +
Sbjct: 209 --TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----I 261
Query: 225 TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSV 284
            + +   PP   +  +     L R +L+ NP ER++  E  +   L E+     A   +V
Sbjct: 262 VNGKYSIPPHDTQ--YTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEI-----AAARNV 312
Query: 285 VPETKPMVELLNSS 298
            P++ P+ ELL  +
Sbjct: 313 NPKS-PITELLEQN 325

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG G F  V    +R  G +VAVK I     +   +   L E S+++ + H N+++    
Sbjct: 20  IGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 78  I-ETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           I E +  +Y+V EY   G L  Y+   G+  +       F   +   ++ L+  + +HRD
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 133
Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           L  +N+LVS + V    K+ DFG  +  +     DT      + APE ++   +  K+D+
Sbjct: 134 LAARNVLVSEDNVA---KVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 195 WSVGAILFQLVT-GKPPF 211
           WS G +L+++ + G+ P+
Sbjct: 189 WSFGILLWEIYSFGRVPY 206

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 18  IGSGSFAVV----WRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +GSG+F  V    W      + I VA+K + ++  SPK +  +L E  +++ +  P + R
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I     + LV +    G L  ++ ++ G++      ++  Q+A G+  L++  L+H
Sbjct: 84  LL-GICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVH 142
Query: 133 RDLKPQNLLV-STNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+LV S N V    KI DFG AR L   +      G  +   +MA E I   ++
Sbjct: 143 RDLAARNVLVKSPNHV----KITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 189 DAKADLWSVGAILFQLVT-GKPPFDG 213
             ++D+WS G  +++L+T G  P+DG
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYDG 224

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 137/316 (43%), Gaps = 31/316 (9%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSDNLLKEI 60
           N  + +  Y +   IG GSF  V +A  R     VA+K I  K   L   ++   LL+ +
Sbjct: 29  NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELM 88
Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGG--DLAAYIHKHGKVSEAVARHFMRQL 118
           +   T     I+        R  + LV E       DL    +  G VS  + R F +Q+
Sbjct: 89  NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQM 147
Query: 119 AAGLQVLQ--EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
              L  L   E  +IH DLKP+N+L+  N     +KI DFG +  L  Q +   +  S  
Sbjct: 148 CTALLFLATPELSIIHCDLKPENILLC-NPKRSAIKIVDFGSSCQLG-QRIYQXI-QSRF 204
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI 236
           Y +PE++    YD   D+WS+G IL ++ TG+P F G+N++     I+    L  PP  I
Sbjct: 205 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV--LGIPPAHI 262
Query: 237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLN 296
                         L Q P  R  F++  +  +   L++T   ++    P T+ +  +L 
Sbjct: 263 --------------LDQAPKARKFFEKLPDGTW--NLKKTKDGKREYKPPGTRKLHNILG 306
Query: 297 SST--PEDRHSLHSEH 310
             T  P  R +  S H
Sbjct: 307 VETGGPGGRRAGESGH 322

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 134/278 (48%), Gaps = 34/278 (12%)
Query: 18  IGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G F VV+   +    Q  I+ A+K + +     +V +  L+E  ++  ++HPN++  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV-EAFLREGLLMRGLNHPNVLAL 87
Query: 75  FEAIETREKI-YLVLEYCDGGDLAAYI---HKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
              +   E + +++L Y   GDL  +I    ++  V + ++  F  Q+A G++ L E+  
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS--FGLQVARGMEYLAEQKF 145
Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL----CGSPL-YMAPEIIQN 185
           +HRDL  +N ++  +     +K+ DFG AR +  ++            P+ + A E +Q 
Sbjct: 146 VHRDLAARNCMLDESFT---VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 186 HKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHP 241
           +++  K+D+WS G +L++L+T G PP+   +   L   +     L  P   P ++ ++  
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQ 262
Query: 242 DCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHA 279
            C +        +P  R TF+       +GE+ Q V A
Sbjct: 263 QCWE-------ADPAVRPTFRV-----LVGEVEQIVSA 288

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 108/249 (43%), Gaps = 34/249 (13%)
Query: 38  VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLA 97
           VA+K +  K   P + +    E  + + + HPN++     +   + + ++  YC  GDL 
Sbjct: 42  VAIKTLKDKAEGP-LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLH 100
Query: 98  AYIHKHGKVSEAVAR----------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLL 141
            ++      S+  +                 H + Q+AAG++ L   H++H+DL  +N+L
Sbjct: 101 EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 160
Query: 142 VSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVG 198
           V        +KI D G  R +   D    L  S L   +MAPE I   K+   +D+WS G
Sbjct: 161 VYDKL---NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 217
Query: 199 AILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDCVDLCRCLLRQN 254
            +L+++ + G  P+ G +   + + I     L  P   P  +  L  +C +       + 
Sbjct: 218 VVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWN-------EF 270
Query: 255 PVERITFKE 263
           P  R  FK+
Sbjct: 271 PSRRPRFKD 279

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 108/249 (43%), Gaps = 34/249 (13%)
Query: 38  VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLA 97
           VA+K +  K   P + +    E  + + + HPN++     +   + + ++  YC  GDL 
Sbjct: 59  VAIKTLKDKAEGP-LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLH 117
Query: 98  AYIHKHGKVSEAVAR----------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLL 141
            ++      S+  +                 H + Q+AAG++ L   H++H+DL  +N+L
Sbjct: 118 EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177
Query: 142 VSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVG 198
           V        +KI D G  R +   D    L  S L   +MAPE I   K+   +D+WS G
Sbjct: 178 VYDKL---NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 234
Query: 199 AILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP---PGAIEELHPDCVDLCRCLLRQN 254
            +L+++ + G  P+ G +   + + I     L  P   P  +  L  +C +       + 
Sbjct: 235 VVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWN-------EF 287
Query: 255 PVERITFKE 263
           P  R  FK+
Sbjct: 288 PSRRPRFKD 296

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 137/316 (43%), Gaps = 31/316 (9%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSDNLLKEI 60
           N  + +  Y +   IG GSF  V +A  R     VA+K I  K   L   ++   LL+ +
Sbjct: 48  NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELM 107
Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGG--DLAAYIHKHGKVSEAVARHFMRQL 118
           +   T     I+        R  + LV E       DL    +  G VS  + R F +Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQM 166
Query: 119 AAGLQVLQ--EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
              L  L   E  +IH DLKP+N+L+  N     +KI DFG +  L  Q +   +  S  
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQLG-QRIYQXI-QSRF 223
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI 236
           Y +PE++    YD   D+WS+G IL ++ TG+P F G+N++     I+    L  PP  I
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV--LGIPPAHI 281
Query: 237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLN 296
                         L Q P  R  F++  +  +   L++T   ++    P T+ +  +L 
Sbjct: 282 --------------LDQAPKARKFFEKLPDGTW--NLKKTKDGKREYKPPGTRKLHNILG 325
Query: 297 SST--PEDRHSLHSEH 310
             T  P  R +  S H
Sbjct: 326 VETGGPGGRRAGESGH 341

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 137/316 (43%), Gaps = 31/316 (9%)
Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK---LLSPKVSDNLLKEI 60
           N  + +  Y +   IG GSF  V +A  R     VA+K I  K   L   ++   LL+ +
Sbjct: 48  NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELM 107
Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGG--DLAAYIHKHGKVSEAVARHFMRQL 118
           +   T     I+        R  + LV E       DL    +  G VS  + R F +Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQM 166
Query: 119 AAGLQVLQ--EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
              L  L   E  +IH DLKP+N+L+  N     +KI DFG +  L  Q +   +  S  
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLC-NPKRXAIKIVDFGSSCQLG-QRIYQXI-QSRF 223
Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI 236
           Y +PE++    YD   D+WS+G IL ++ TG+P F G+N++     I+    L  PP  I
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV--LGIPPAHI 281
Query: 237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLN 296
                         L Q P  R  F++  +  +   L++T   ++    P T+ +  +L 
Sbjct: 282 --------------LDQAPKARKFFEKLPDGTW--NLKKTKDGKREYKPPGTRKLHNILG 325
Query: 297 SST--PEDRHSLHSEH 310
             T  P  R +  S H
Sbjct: 326 VETGGPGGRRAGESGH 341

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 14/222 (6%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F+ V   + +Q G   A+K ++K  +L         +E  +L       I +   
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV+EY  GGDL   + K G ++   +AR ++ ++   +  +     +HRD+
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188
Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL--CGSPLYMAPEIIQ-------NH 186
           KP N+L+        +++ DFG    L       +L   G+P Y++PEI+Q         
Sbjct: 189 KPDNILLDR---CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245
Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE 228
            Y  + D W++G   +++  G+ PF   +  + +  I+   E
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIE----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  LG      VAVK++      P    +  +EI IL  + H + I
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKAL-HSDFI 73
Query: 73  RFFEAIE---TREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEK 128
             +  +     R+ + LV+EY   G L  ++ +H  ++  +    +  Q+  G++ L  +
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEII 183
             +HRDL  +N+LV   E    +KI DFG A+ L P D    +   P      + APE +
Sbjct: 134 RCVHRDLAARNILV---ESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESL 189
Query: 184 QNHKYDAKADLWSVGAILFQLVT 206
            ++ +  ++D+WS G +L++L T
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIE----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  LG      VAVK++      P    +  +EI IL  + H + I
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKAL-HSDFI 86
Query: 73  RFFEAIE---TREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEK 128
             +  +     R+ + LV+EY   G L  ++ +H  ++  +    +  Q+  G++ L  +
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEII 183
             +HRDL  +N+LV   E    +KI DFG A+ L P D    +   P      + APE +
Sbjct: 147 RCVHRDLAARNILV---ESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 184 QNHKYDAKADLWSVGAILFQLVT 206
            ++ +  ++D+WS G +L++L T
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIE----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  LG      VAVK++      P    +  +EI IL  + H + I
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKAL-HSDFI 74
Query: 73  RFFEAIE---TREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEK 128
             +  +     R+ + LV+EY   G L  ++ +H  ++  +    +  Q+  G++ L  +
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEII 183
             +HRDL  +N+LV   E    +KI DFG A+ L P D    +   P      + APE +
Sbjct: 135 RCVHRDLAARNILV---ESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 184 QNHKYDAKADLWSVGAILFQLVT 206
            ++ +  ++D+WS G +L++L T
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 17  RIGSGSFAVVWRARHRQLGIE----VAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  LG      VAVK++      P    +  +EI IL  + H + I
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKAL-HSDFI 70
Query: 73  RFFEAIE---TREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEK 128
             +  +     R ++ LV+EY   G L  ++ +H  ++  +    +  Q+  G++ L  +
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP-----LYMAPEII 183
             +HRDL  +N+LV   E    +KI DFG A+ L P D    +   P      + APE +
Sbjct: 131 RCVHRDLAARNILV---ESEAHVKIADFGLAK-LLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 184 QNHKYDAKADLWSVGAILFQLVT 206
            ++ +  ++D+WS G +L++L T
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDK--KLLSPKVSDNLLKEISILSTISHPNII 72
           G ++G G F VV++         VAVK++     + + ++     +EI +++   H N++
Sbjct: 36  GNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYI-----------HKHGKVSEAVARHFMRQLAAG 121
                    + + LV  Y   G L   +           H   K+++  A         G
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------G 145
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS---LTPQDLADTLCGSPLYM 178
           +  L E H IHRD+K  N+L+   +     KI DFG AR+        +   + G+  YM
Sbjct: 146 INFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYM 202
Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLF 220
           APE ++  +   K+D++S G +L +++TG P  D   + QL 
Sbjct: 203 APEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDK--KLLSPKVSDNLLKEISILSTISHPNII 72
           G ++G G F VV++         VAVK++     + + ++     +EI +++   H N++
Sbjct: 36  GNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYI-----------HKHGKVSEAVARHFMRQLAAG 121
                    + + LV  Y   G L   +           H   K+++  A         G
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------G 145
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS---LTPQDLADTLCGSPLYM 178
           +  L E H IHRD+K  N+L+   +     KI DFG AR+        +   + G+  YM
Sbjct: 146 INFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYM 202
Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLF 220
           APE ++  +   K+D++S G +L +++TG P  D   + QL 
Sbjct: 203 APEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDK--KLLSPKVSDNLLKEISILSTISHPNII 72
           G ++G G F VV++         VAVK++     + + ++     +EI +++   H N++
Sbjct: 30  GNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYI-----------HKHGKVSEAVARHFMRQLAAG 121
                    + + LV  Y   G L   +           H   K+++  A         G
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------G 139
Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS---LTPQDLADTLCGSPLYM 178
           +  L E H IHRD+K  N+L+   +     KI DFG AR+        +   + G+  YM
Sbjct: 140 INFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYM 196
Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLF 220
           APE ++  +   K+D++S G +L +++TG P  D   + QL 
Sbjct: 197 APEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 18  IGSGSFAVVWRA---RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G F  V+      H+   I VAVK   KK  +    +  + E  I+  + HP+I++ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLI 131
              IE  E  ++++E    G+L  Y+ ++    KV   V   +  Q+   +  L+  + +
Sbjct: 79  IGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL--YSLQICKAMAYLESINCV 135
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPL-YMAPEIIQNHKYD 189
           HRD+  +N+LV++ E    +K+GDFG +R +  +D    ++   P+ +M+PE I   ++ 
Sbjct: 136 HRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 190 AKADLWSVGAILFQLVT-GKPPF 211
             +D+W     ++++++ GK PF
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPF 215

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 18  IGSGSFAVVWRA---RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G F  V+      H+   I VAVK   KK  +    +  + E  I+  + HP+I++ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLI 131
              IE  E  ++++E    G+L  Y+ ++    KV   V   +  Q+   +  L+  + +
Sbjct: 91  IGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL--YSLQICKAMAYLESINCV 147
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPL-YMAPEIIQNHKYD 189
           HRD+  +N+LV++ E    +K+GDFG +R +  +D    ++   P+ +M+PE I   ++ 
Sbjct: 148 HRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 190 AKADLWSVGAILFQLVT-GKPPF 211
             +D+W     ++++++ GK PF
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPF 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 18  IGSGSFAVVWRA---RHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G G F  V+      H+   I VAVK   KK  +    +  + E  I+  + HP+I++ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVLQEKHLI 131
              IE  E  ++++E    G+L  Y+ ++    KV   V   +  Q+   +  L+  + +
Sbjct: 75  IGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL--YSLQICKAMAYLESINCV 131
Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPL-YMAPEIIQNHKYD 189
           HRD+  +N+LV++ E    +K+GDFG +R +  +D    ++   P+ +M+PE I   ++ 
Sbjct: 132 HRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 190 AKADLWSVGAILFQLVT-GKPPF 211
             +D+W     ++++++ GK PF
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPF 211

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 91/185 (49%), Gaps = 7/185 (3%)
Query: 38  VAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDL 96
           VA+K   + L S P       +E      +  P+++   +  E   ++Y+     +G DL
Sbjct: 62  VALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDL 121
Query: 97  AAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDF 156
           AA + + G ++   A   +RQ+ + L         HRD+KP+N+LVS ++   ++   DF
Sbjct: 122 AAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLV---DF 178
Query: 157 GFARSLTPQDLAD--TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS 214
           G A + T + L       G+  Y APE         +AD++++  +L++ +TG PP+ G 
Sbjct: 179 GIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQG- 237
Query: 215 NQLQL 219
           +QL +
Sbjct: 238 DQLSV 242

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 112/229 (48%), Gaps = 25/229 (10%)
Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIE--VAVKEIDKKLLSPKVSDNLLKE 59
           E  R   + EY  G ++G G++  V++A+ +    +   A+K+I+       +S +  +E
Sbjct: 14  ERERVEDLFEY-EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACRE 68
Query: 60  ISILSTISHPNIIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHG---------KVSE 108
           I++L  + HPN+I   +        K++L+ +Y +  DL   I  H          ++  
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPR 127
Query: 109 AVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV-STNEVTPVLKIGDFGFAR----SLT 163
            + +  + Q+  G+  L    ++HRDLKP N+LV         +KI D GFAR     L 
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 164 PQDLADTLCGSPLYMAPEIIQNHKYDAKA-DLWSVGAILFQLVTGKPPF 211
           P    D +  +  Y APE++   ++  KA D+W++G I  +L+T +P F
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 11  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 69
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIXETD 186
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 187 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 246
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 247 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 2   PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 60
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 61  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIXETD 177
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 237
Query: 223 ILTSTELRFPPGAIEELHPD-CVDLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD  ++L R   + NP  R +F E  +
Sbjct: 238 VMEGGLLDKPDNC-----PDMLLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 90/388 (23%), Positives = 154/388 (39%), Gaps = 106/388 (27%)
Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
           IG+GS+  V  A  +     VA+K+I +          +L+EI+IL+ ++H ++++  + 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 78  I-----ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           +     E  +++Y+VLE  D  D          ++E   +  +  L  G++ +    ++H
Sbjct: 121 VIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILH 179
Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARS------------LTPQD-------------L 167
           RDLKP N LV+ +     +K+ DFG AR+            ++P++             L
Sbjct: 180 RDLKPANCLVNQD---CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236
Query: 168 ADTLCG---SPLYMAPE-IIQNHKYDAKADLWSVGAILFQLVT-----------GKPPFD 212
              L G   +  Y APE I+    Y    D+WS+G I  +L+              P F 
Sbjct: 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFP 296
Query: 213 GS-----------------------NQLQLFQNILTS----------------------- 226
           GS                       +QL +  NIL +                       
Sbjct: 297 GSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356
Query: 227 ---TEL--RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQ 281
              T+L  RFP  + + +H     L + +L  NP +RIT  E   H F  E+R     E 
Sbjct: 357 REGTDLAERFPASSADAIH-----LLKRMLVFNPNKRITINECLAHPFFKEVR-IAEVET 410
Query: 282 HSVVPETKPMVELLNSSTPEDRHSLHSE 309
           ++      P  + +N   P+ R++   E
Sbjct: 411 NATEKVRLPFNDWMNMDEPQLRYAFVKE 438

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 17  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 75
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETD 192
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 253 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 10  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 68
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETD 185
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 245
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 246 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 11  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 69
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETD 186
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 246
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 247 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 4   PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 62
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETD 179
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 239
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 240 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 279

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 10  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 68
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETD 185
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 245
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 246 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 8   PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 66
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 67  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETD 183
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 243
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 244 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 283

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 112/230 (48%), Gaps = 23/230 (10%)
Query: 11  EYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLLKEISIL 63
           + I    +G G+F  +++   R++G        EV +K +DK       S++  +  S++
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMM 66
Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-HFMRQLAAGL 122
           S +SH +++  +      ++  LV E+   G L  Y+ K+      + +    +QLAA +
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126
Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVT-----PVLKIGDFGFARSLTPQDLADTLCGSPLY 177
             L+E  LIH ++  +N+L+   E       P +K+ D G + ++ P+D+   L     +
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERIPW 183
Query: 178 MAPEIIQNHK-YDAKADLWSVGAILFQLVTG--KP--PFDGSNQLQLFQN 222
           + PE I+N K  +   D WS G  L+++ +G  KP    D   +LQ +++
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 126/282 (44%), Gaps = 30/282 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 39  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 97
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH------KHGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+       ++  V    
Sbjct: 98  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETD 214
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 274
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKE 263
           ++    L  P        PD + +L R   + NP  R +F E
Sbjct: 275 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLE 311

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 126/285 (44%), Gaps = 30/285 (10%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 17  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 75
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK------HGKVSEAV 110
           L E S++   +  +++R    +   +   +++E    GDL +Y+        +  V    
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 111 ARHFMRQLAA----GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           +   M Q+A     G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETD 192
Query: 167 LADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQN 222
                    L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + 
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252
Query: 223 ILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
           ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 253 VMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 127/288 (44%), Gaps = 36/288 (12%)
Query: 3   PNRTRLIGEYIVGPR-IGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNL 56
           P+   +  E I   R +G GSF +V+    + +        VA+K +++   S +     
Sbjct: 7   PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEF 65
Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH--- 113
           L E S++   +  +++R    +   +   +++E    GDL +Y+     +  A+A +   
Sbjct: 66  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS---LRPAMANNPVL 122
Query: 114 ----------FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT 163
                        ++A G+  L     +HRDL  +N +V+ +     +KIGDFG  R + 
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIY 179
Query: 164 PQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQL 219
             D         L   +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 239
Query: 220 FQNILTSTELRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFN 266
            + ++    L  P        PD + +L R   + NP  R +F E  +
Sbjct: 240 LRFVMEGGLLDKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIIS 282
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	692
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-102
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-100
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-98
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-96
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-96
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-92
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-92
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-90
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-89
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-89
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-89
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-88
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-88
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-88
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-87
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-86
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-86
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-86
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-86
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-86
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-86
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-85
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-85
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-85
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-85
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-85
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-84
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-84
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-83
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-83
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-83
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-82
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-82
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-82
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-82
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-82
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-82
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-82
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-81
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-81
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-80
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-80
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-80
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-80
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-80
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-79
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-78
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-78
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-77
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-77
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-77
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-76
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-76
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-75
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-73
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-71
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-71
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-71
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-70
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-68
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-67
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-67
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-66
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-65
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-64
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-63
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-62
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-61
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-61
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-61
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-60
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-60
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-60
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-57
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-57
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-57
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-57
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-57
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-56
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-56
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-56
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-56
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-56
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-55
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-55
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-55
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-55
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-55
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-55
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-55
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-54
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-53
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-53
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-53
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-53
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-53
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-53
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-52
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-52
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-52
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-52
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-52
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-52
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-52
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-52
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-51
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-51
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-51
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-51
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-51
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-51
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-50
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-50
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-50
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-50
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-50
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-49
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-49
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-49
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-49
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-49
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-49
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-49
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-48
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-48
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-46
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-46
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-45
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-45
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-45
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-44
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-44
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-44
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-44
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-43
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-42
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-42
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-42
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-42
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-42
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-41
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-41
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-41
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-41
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-41
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-40
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-39
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-39
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-39
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-38
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-38
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-38
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-38
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-37
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-37
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-37
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-36
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-35
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-35
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-35
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-30
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-30
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-30
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-29
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-29
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-22
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-05
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	2e-04

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  315 bits (808), Expect = e-102
 Identities = 69/313 (22%), Positives = 127/313 (40%), Gaps = 39/313 (12%)

Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL 63
           +++     +++   +G G+ A V+R RH++ G   A+K  +      +  D  ++E  +L
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVL 61

Query: 64  STISHPNIIRFFEAIE--TREKIYLVLEYCDGGDLAAYIHKHGK---VSEAVARHFMRQL 118
             ++H NI++ F   E  T     L++E+C  G L   + +      + E+     +R +
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFARSLTPQDLADTLCGSPLY 177
             G+  L+E  ++HR++KP N++    E    V K+ DFG AR L   +   +L G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 178 MAPEIIQ--------NHKYDAKADLWSVGAILFQLVTGKPPFD----GSNQLQLFQNILT 225
           + P++ +          KY A  DLWS+G   +   TG  PF          ++   I+T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 226 --------------------STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFF 265
                               S ++         L      +   +L  +  +   F +FF
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 266 NHRFLGELRQTVH 278
                   R   H
Sbjct: 302 AETSDILHRGNSH 314

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  322 bits (825), Expect = e-100
 Identities = 84/333 (25%), Positives = 147/333 (44%), Gaps = 29/333 (8%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS 64
            T+  G + +  R+G+G F  V R  H+  G +VA+K+  ++L SPK  +    EI I+ 
Sbjct: 9   PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMK 67

Query: 65  TISHPNIIRFFEAIETREKI------YLVLEYCDGGDLAAYIHKHGK---VSEAVARHFM 115
            ++HPN++   E  +  +K+       L +EYC+GGDL  Y+++      + E   R  +
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
             +++ L+ L E  +IHRDLKP+N+++       + KI D G+A+ L   +L     G+ 
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187

Query: 176 LYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
            Y+APE+++  KY    D WS G + F+ +TG  PF  + Q   +   +           
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247

Query: 236 IEE-------------------LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
            +                    L        +C+L  +  +R T  +  N      L   
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307

Query: 277 VHAEQHSVVPETKPMVELLNSSTPEDRHSLHSE 309
           +  +  SV+      V     +  E+  +L S 
Sbjct: 308 LSLKLLSVMNMVSGRVHTYPVTENENLQNLKSW 340

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  304 bits (780), Expect = 6e-98
 Identities = 81/348 (23%), Positives = 155/348 (44%), Gaps = 42/348 (12%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y +  +IGSG  + V++  + +     A+K ++ +    +  D+   EI+ L+ +   +
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 71  --IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
             IIR ++   T + IY+V+E     DL +++ K   +     + + + +   +  + + 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL---TPQDLADTLCGSPLYMAPEIIQN 185
            ++H DLKP N L+       +LK+ DFG A  +   T   + D+  G+  YM PE I++
Sbjct: 128 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 186 -----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTST-ELRFP 232
                       K   K+D+WS+G IL+ +  GK PF    NQ+     I+    E+ FP
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243

Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
                    D  D+ +C L+++P +RI+  E   H ++                +T P+ 
Sbjct: 244 DI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--------------QIQTHPVN 285

Query: 293 ELLNSSTPEDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNS 340
           ++   +T E ++ L      NS +   K+A +         + +  +S
Sbjct: 286 QMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSS 333

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  299 bits (769), Expect = 3e-97
 Identities = 84/268 (31%), Positives = 135/268 (50%), Gaps = 10/268 (3%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEIS 61
             R   + ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +E+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
           I S + HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           L     K +IHRD+KP+NLL+ +      LKI DFG++    P      LCG+  Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAG---ELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE 177

Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP 241
           +I+   +D K DLWS+G + ++ + GKPPF+ +   + ++ I    E  FP      +  
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-RVEFTFPD----FVTE 232

Query: 242 DCVDLCRCLLRQNPVERITFKEFFNHRF 269
              DL   LL+ NP +R   +E   H +
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLEHPW 260

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  300 bits (770), Expect = 8e-96
 Identities = 80/332 (24%), Positives = 150/332 (45%), Gaps = 42/332 (12%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
              Y +  +IGSG  + V++  + +     A+K ++ +    +  D+   EI+ L+ +  
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 69  PN--IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            +  IIR ++   T + IY+V+E     DL +++ K   +     + + + +   +  + 
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL---TPQDLADTLCGSPLYMAPEII 183
           +  ++H DLKP N L+       +LK+ DFG A  +   T   + D+  G+  YM PE I
Sbjct: 173 QHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 184 QN-----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTST-ELR 230
           ++            K   K+D+WS+G IL+ +  GK PF    NQ+     I+    E+ 
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288

Query: 231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKP 290
           FP         D  D+ +C L+++P +RI+  E   H ++                +T P
Sbjct: 289 FPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--------------QIQTHP 330

Query: 291 MVELLNSSTPEDRHSLHSEHPTNSSSKNPKSA 322
           + ++   +T E ++ L      NS +   K+A
Sbjct: 331 VNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 362

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  300 bits (770), Expect = 8e-96
 Identities = 76/379 (20%), Positives = 142/379 (37%), Gaps = 64/379 (16%)

Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL 63
           +++     +++   +G G+ A V+R RH++ G   A+K  +      +  D  ++E  +L
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVL 61

Query: 64  STISHPNIIRFFEAIE--TREKIYLVLEYCDGGDLAAYIHKHGK---VSEAVARHFMRQL 118
             ++H NI++ F   E  T     L++E+C  G L   + +      + E+     +R +
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNE-VTPVLKIGDFGFARSLTPQDLADTLCGSPLY 177
             G+  L+E  ++HR++KP N++    E    V K+ DFG AR L   +   +L G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 178 MAPEIIQ--------NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL 229
           + P++ +          KY A  DLWS+G   +   TG  PF      +  + ++     
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 230 RFPPGAI------------------------EELHPDCVDLCRCLLRQNPVERITFKEFF 265
             P GAI                          L      +   +L  +  +   F +FF
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 266 N---------------------HRFLGELRQTVHAEQHSVVPETKPMVE----LLNSSTP 300
                                 H+       T       V  +TK +      +      
Sbjct: 302 AETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRL 361

Query: 301 EDRHSLHSEHPTNSSSKNP 319
                  ++H   ++ +NP
Sbjct: 362 VLEPGRLAQHFPKTTEENP 380

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  296 bits (760), Expect = 9e-96
 Identities = 93/268 (34%), Positives = 144/268 (53%), Gaps = 10/268 (3%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEIS 61
           P R   I ++ +G  +G G F  V+ AR +Q    +A+K + K +L    V   L +EI 
Sbjct: 7   PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
           I S + HPNI+R +     R++IYL+LE+   G+L   + KHG+  E  +  FM +LA  
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           L    E+ +IHRD+KP+NLL+        LKI DFG++    P     T+CG+  Y+ PE
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKG---ELKIADFGWS-VHAPSLRRRTMCGTLDYLPPE 182

Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP 241
           +I+   +D K DLW  G + ++ + G PPFD  +  +  + I+ + +L+FPP     L  
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-NVDLKFPP----FLSD 237

Query: 242 DCVDLCRCLLRQNPVERITFKEFFNHRF 269
              DL   LLR +P +R+  K    H +
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  296 bits (759), Expect = 3e-95
 Identities = 76/309 (24%), Positives = 142/309 (45%), Gaps = 42/309 (13%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y +  +IGSG  + V++  + +     A+K ++ +    +  D+   EI+ L+ +   +
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 71  --IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
             IIR ++   T + IY+V+E C   DL +++ K   +     + + + +   +  + + 
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL---TPQDLADTLCGSPLYMAPEIIQN 185
            ++H DLKP N L+       +LK+ DFG A  +   T   + D+  G+  YM PE I++
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 186 -----------HKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTST-ELRFP 232
                       K   K+D+WS+G IL+ +  GK PF    NQ+     I+    E+ FP
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262

Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
                    D  D+ +C L+++P +RI+  E   H ++                +T P+ 
Sbjct: 263 DI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV--------------QIQTHPVN 304

Query: 293 ELLNSSTPE 301
           ++   +T E
Sbjct: 305 QMAKGTTEE 313

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  294 bits (754), Expect = 9e-95
 Identities = 80/267 (29%), Positives = 130/267 (48%), Gaps = 10/267 (3%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISIL 63
             R    Y+ G  +G G FA  +           A K + K  LL P   + +  EISI 
Sbjct: 10  DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
            +++H +++ F    E  + +++VLE C    L     +   ++E  AR+++RQ+  G Q
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEI 182
            L    +IHRDLK  NL ++ +     +KIGDFG A  +    +    LCG+P Y+APE+
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 186

Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           +    +  + D+WS+G I++ L+ GKPPF+ S   + +  I    E   P      ++P 
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-KNEYSIPK----HINPV 241

Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRF 269
              L + +L+ +P  R T  E  N  F
Sbjct: 242 AASLIQKMLQTDPTARPTINELLNDEF 268

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  292 bits (750), Expect = 2e-94
 Identities = 90/272 (33%), Positives = 139/272 (51%), Gaps = 11/272 (4%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKE 59
           +       I ++ VG  +G GSFA V+RA     G+EVA+K IDK  +    +   +  E
Sbjct: 2   LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61

Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQL 118
           + I   + HP+I+  +   E    +YLVLE C  G++  Y+    K  SE  ARHFM Q+
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA-RSLTPQDLADTLCGSPLY 177
             G+  L    ++HRDL   NLL++ N     +KI DFG A +   P +   TLCG+P Y
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNY 178

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           ++PEI     +  ++D+WS+G + + L+ G+PPFD          ++   +   P     
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-LADYEMPS---- 233

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
            L  +  DL   LLR+NP +R++     +H F
Sbjct: 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  294 bits (755), Expect = 3e-94
 Identities = 80/267 (29%), Positives = 130/267 (48%), Gaps = 10/267 (3%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISIL 63
             R    Y+ G  +G G FA  +           A K + K  LL P   + +  EISI 
Sbjct: 36  DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 95

Query: 64  STISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
            +++H +++ F    E  + +++VLE C    L     +   ++E  AR+++RQ+  G Q
Sbjct: 96  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEI 182
            L    +IHRDLK  NL ++ +     +KIGDFG A  +    +    LCG+P Y+APE+
Sbjct: 156 YLHRNRVIHRDLKLGNLFLNEDL---EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 212

Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
           +    +  + D+WS+G I++ L+ GKPPF+ S   + +  I    E   P      ++P 
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-KNEYSIPK----HINPV 267

Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRF 269
              L + +L+ +P  R T  E  N  F
Sbjct: 268 AASLIQKMLQTDPTARPTINELLNDEF 294

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  289 bits (742), Expect = 2e-92
 Identities = 104/269 (38%), Positives = 156/269 (57%), Gaps = 9/269 (3%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI 62
            +    IG Y +   IG G+FA V  ARH   G EVA+K IDK  L+P     L +E+ I
Sbjct: 8   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI 67

Query: 63  LSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
           +  ++HPNI++ FE IET + +YL++EY  GG++  Y+  HG++ E  AR   RQ+ + +
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127

Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           Q   +K ++HRDLK +NLL+  +     +KI DFGF+   T     D  CG+P Y APE+
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADM---NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184

Query: 183 IQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP 241
            Q  KYD  + D+WS+G IL+ LV+G  PFDG N  +L + +L   + R P      +  
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPFY----MST 239

Query: 242 DCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           DC +L +  L  NP++R T ++    R++
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  285 bits (732), Expect = 9e-92
 Identities = 89/271 (32%), Positives = 141/271 (52%), Gaps = 10/271 (3%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEI 60
           + +    IG Y++G  +G G+F  V    H+  G +VAVK +++ K+ S  V   + +EI
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
             L    HP+II+ ++ I T    ++V+EY  GG+L  YI KHG+V E  AR   +Q+ +
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP 180
            +       ++HRDLKP+N+L+  +      KI DFG +  ++  +   T CGSP Y AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHM---NAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179

Query: 181 EIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           E+I    Y   + D+WS G IL+ L+ G  PFD  +   LF+ I        P      L
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR-GGVFYIPE----YL 234

Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +     L   +L+ +P++R T K+   H + 
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  285 bits (731), Expect = 1e-90
 Identities = 76/316 (24%), Positives = 150/316 (47%), Gaps = 10/316 (3%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           + +Y+   +IG GSF      +  + G +  +KEI+   +S K  +   +E+++L+ + H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQLAAGLQVLQ 126
           PNI+++ E+ E    +Y+V++YC+GGDL   I+    V   E     +  Q+   L+ + 
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQN 185
           ++ ++HRD+K QN+ ++ +     +++GDFG AR L    +LA    G+P Y++PEI +N
Sbjct: 143 DRKILHRDIKSQNIFLTKDG---TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
             Y+ K+D+W++G +L++L T K  F+  +   L   I++ +              D   
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLH----YSYDLRS 255

Query: 246 LCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHS 305
           L   L ++NP +R +        F+ +  +   + Q               S     +  
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315

Query: 306 LHSEHPTNSSSKNPKS 321
              ++  +       +
Sbjct: 316 ASGQNSISVMPAQKIT 331

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  281 bits (720), Expect = 3e-89
 Identities = 94/320 (29%), Positives = 152/320 (47%), Gaps = 18/320 (5%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKE 59
           M  ++   IG YI+   +G GSF  V  A H +   +VA+K I +  L    +   + +E
Sbjct: 1   MAISKRH-IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE 59

Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
           IS L  + HP+II+ ++ I T   I +V+EY  GG+L  YI +  +++E   R F +Q+ 
Sbjct: 60  ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII 118

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
             ++      ++HRDLKP+NLL+  N     +KI DFG +  +T  +   T CGSP Y A
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNL---NVKIADFGLSNIMTDGNFLKTSCGSPNYAA 175

Query: 180 PEIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           PE+I    Y   + D+WS G +L+ ++ G+ PFD      LF+ + +      P      
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPD----F 230

Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL-----GELRQTVHAEQHSVVPE-TKPMV 292
           L P    L R ++  +P++RIT +E     +        LR     +           + 
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLG 290

Query: 293 ELLNSSTPEDRHSLHSEHPT 312
           E +  S      +L S+   
Sbjct: 291 EAMGFSEDYIVEALRSDENN 310

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  277 bits (712), Expect = 9e-89
 Identities = 83/282 (29%), Positives = 135/282 (47%), Gaps = 19/282 (6%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
             +Y V   IG+GS+    + R +  G  +  KE+D   ++      L+ E+++L  + H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 69  PNIIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGK----VSEAVARHFMRQLAAGL 122
           PNI+R+++ I   T   +Y+V+EYC+GGDLA+ I K  K    + E      M QL   L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 123 QVLQEKHL-----IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPL 176
           +    +       +HRDLKP N+ +   +    +K+GDFG AR L      A T  G+P 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPY 181

Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI 236
           YM+PE +    Y+ K+D+WS+G +L++L    PPF   +Q +L   I      R P    
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP---- 237

Query: 237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVH 278
                +  ++   +L      R + +E   +  + E     H
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  277 bits (711), Expect = 2e-88
 Identities = 80/260 (30%), Positives = 132/260 (50%), Gaps = 1/260 (0%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y V   +G G+F+VV R  H+  G+E A K I+ K LS +    L +E  I   + HPN
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           I+R  ++I+     YLV +   GG+L   I      SEA A H ++Q+   +       +
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +HR+LKP+NLL+++      +K+ DFG A  +   +      G+P Y++PE+++   Y  
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
             D+W+ G IL+ L+ G PPF   +Q +L+  I       +P    + + P+   L   +
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKSLIDSM 245

Query: 251 LRQNPVERITFKEFFNHRFL 270
           L  NP +RIT  +     ++
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  279 bits (715), Expect = 4e-88
 Identities = 87/295 (29%), Positives = 142/295 (48%), Gaps = 11/295 (3%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           ++         Y     IGSG+F V    R +     VAVK I++      + +N+ +EI
Sbjct: 11  LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREI 67

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
               ++ HPNI+RF E I T   + +++EY  GG+L   I   G+ SE  AR F +QL +
Sbjct: 68  INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP 180
           G+       + HRDLK +N L+  +   P LKI DFG+++S        +  G+P Y+AP
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 186

Query: 181 EIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT---STELRFPPGAI 236
           E++   +YD   AD+WS G  L+ ++ G  PF+   + + ++  +    S +   P    
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI- 245

Query: 237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHR-FLGELRQTVHAEQHSVVPETKP 290
             + P+C  L   +   +P  RI+  E   H  FL  L   +  E ++     +P
Sbjct: 246 -RISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  282 bits (723), Expect = 8e-88
 Identities = 99/321 (30%), Positives = 162/321 (50%), Gaps = 17/321 (5%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEI 60
           + +    IG YI+G  +G G+F  V   +H   G +VAVK +++ K+ S  V   + +EI
Sbjct: 8   KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
             L    HP+II+ ++ I T   I++V+EY  GG+L  YI K+G++ E  +R   +Q+ +
Sbjct: 68  QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP 180
           G+       ++HRDLKP+N+L+  +      KI DFG +  ++  +   T CGSP Y AP
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHM---NAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184

Query: 181 EIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           E+I    Y   + D+WS G IL+ L+ G  PFD  +   LF+ I        P      L
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG-IFYTPQ----YL 239

Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHR-FLGELRQTVHAEQHSVVPET------KPMV 292
           +P  + L + +L+ +P++R T K+   H  F  +L + +  E  S           K + 
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVC 299

Query: 293 ELLNSSTPEDRHSLHSEHPTN 313
           E    S  E    L++ +  +
Sbjct: 300 EKFECSEEEVLSCLYNRNHQD 320

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  275 bits (704), Expect = 8e-87
 Identities = 84/328 (25%), Positives = 150/328 (45%), Gaps = 22/328 (6%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDN---- 55
           +         +Y     +GSG+F  VW A  ++   EV VK I K K+L     ++    
Sbjct: 15  LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74

Query: 56  -LLKEISILSTISHPNIIRFFEAIETREKIYLVLE-YCDGGDLAAYIHKHGKVSEAVARH 113
            +  EI+ILS + H NII+  +  E +    LV+E +  G DL A+I +H ++ E +A +
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
             RQL + +  L+ K +IHRD+K +N++++ +     +K+ DFG A  L    L  T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF---TIKLIDFGSAAYLERGKLFYTFCG 191

Query: 174 SPLYMAPEIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP 232
           +  Y APE++  + Y   + ++WS+G  L+ LV  + PF         +  +    +  P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETV-EAAIHPP 244

Query: 233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMV 292
                 +  + + L   LL+  P  R T ++     ++ +           V    KP  
Sbjct: 245 Y----LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300

Query: 293 ELLNSSTPEDRHSLHSEHPTNSSSKNPK 320
            +L++++ E  +   S+          +
Sbjct: 301 GVLSAASLEMGNRSLSDVAQAQELCGGE 328

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  275 bits (705), Expect = 1e-86
 Identities = 80/260 (30%), Positives = 132/260 (50%), Gaps = 1/260 (0%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y V   +G G+F+VV R  H+  G+E A K I+ K LS +    L +E  I   + HPN
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           I+R  ++I+     YLV +   GG+L   I      SEA A H ++Q+   +       +
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +HR+LKP+NLL+++      +K+ DFG A  +   +      G+P Y++PE+++   Y  
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
             D+W+ G IL+ L+ G PPF   +Q +L+  I       +P    + + P+   L   +
Sbjct: 210 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKSLIDSM 268

Query: 251 LRQNPVERITFKEFFNHRFL 270
           L  NP +RIT  +     ++
Sbjct: 269 LTVNPKKRITADQALKVPWI 288

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  272 bits (697), Expect = 2e-86
 Identities = 79/269 (29%), Positives = 132/269 (49%), Gaps = 12/269 (4%)

Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
              + ++ +   +G G++  V  A +R     VAVK +D K       +N+ KEI I   
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKM 61

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           ++H N+++F+         YL LEYC GG+L   I     + E  A+ F  QL AG+  L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLYMAPEI 182
               + HRD+KP+NLL+        LKI DFG A   R    + L + +CG+  Y+APE+
Sbjct: 122 HGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 183 IQNHKYD-AKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELH 240
           ++  ++     D+WS G +L  ++ G+ P+D  S+  Q + +     +    P   +++ 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNP--WKKID 235

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRF 269
              + L   +L +NP  RIT  +    R+
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRW 264

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  272 bits (698), Expect = 4e-86
 Identities = 86/321 (26%), Positives = 149/321 (46%), Gaps = 16/321 (4%)

Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
              + ++ +   +G G++  V  A +R     VAVK +D K       +N+ KEI I   
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKM 61

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           ++H N+++F+         YL LEYC GG+L   I     + E  A+ F  QL AG+  L
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEI 182
               + HRD+KP+NLL+        LKI DFG A      +   L + +CG+  Y+APE+
Sbjct: 122 HGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 183 IQNHKYD-AKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELH 240
           ++  ++     D+WS G +L  ++ G+ P+D  S+  Q + +     +    P   +++ 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNP--WKKID 235

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTP 300
              + L   +L +NP  RIT  +    R+     + +          +  + E  +  + 
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRW---YNKPLKKGAKRPRVTSGGVSESPSGFSK 292

Query: 301 EDRHSLHSEHPTNSSSKNPKS 321
             + +L    P NS+S+ P S
Sbjct: 293 HIQSNLDFS-PVNSASRTPGS 312

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  270 bits (693), Expect = 5e-86
 Identities = 80/256 (31%), Positives = 124/256 (48%), Gaps = 4/256 (1%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   IG GS+  V  A  +   I  A K+I K  +     D   +EI I+ ++ HPNI
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFKQEIEIMKSLDHPNI 68

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           IR +E  E    IYLV+E C GG+L   +       E+ A   M+ + + +    + ++ 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N L  T+     LK+ DFG A    P  +  T  G+P Y++P++++   Y  +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPE 187

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D WS G +++ L+ G PPF      ++   I       FP      + P    L R LL
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-TFTFPEKDWLNVSPQAESLIRRLL 246

Query: 252 RQNPVERITFKEFFNH 267
            ++P +RIT  +   H
Sbjct: 247 TKSPKQRITSLQALEH 262

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  271 bits (694), Expect = 5e-86
 Identities = 84/256 (32%), Positives = 135/256 (52%), Gaps = 2/256 (0%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +G GSF  V + + R    E AVK I+K     K +  +L+E+ +L  + HPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++ FE +E     Y+V E   GG+L   I K  + SE  A   ++Q+ +G+  + + +++
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N+L+ + E    +KI DFG +             G+  Y+APE+++   YD K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D+WS G IL+ L++G PPF G N+  + + + T  +  F       +  D  DL R +L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISDDAKDLIRKML 261

Query: 252 RQNPVERITFKEFFNH 267
             +P  RIT  +   H
Sbjct: 262 TFHPSLRITATQCLEH 277

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  272 bits (697), Expect = 6e-86
 Identities = 95/316 (30%), Positives = 157/316 (49%), Gaps = 16/316 (5%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS------DNLLKEISILS 64
           EYI+   +GSG+   V  A  R+   +VA+K I K+  +   +       N+  EI IL 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
            ++HP II+     +  E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+   +Q 
Sbjct: 71  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189

Query: 185 NH---KYDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEELH 240
           +     Y+   D WS+G ILF  ++G PPF +   Q+ L   I +  +  F P    E+ 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-KYNFIPEVWAEVS 248

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVEL--LNSS 298
              +DL + LL  +P  R T +E   H +L +  + +  +   ++ E      L  + + 
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD--EDMKRKFQDLLSEENESTALPQVLAQ 306

Query: 299 TPEDRHSLHSEHPTNS 314
               R          +
Sbjct: 307 PSTSRKRPREGEAEGA 322

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  274 bits (702), Expect = 2e-85
 Identities = 92/287 (32%), Positives = 152/287 (52%), Gaps = 14/287 (4%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS------DNLLKEISILS 64
           EYI+   +GSG+   V  A  R+   +VA++ I K+  +   +       N+  EI IL 
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
            ++HP II+     +  E  Y+VLE  +GG+L   +  + ++ EA  + +  Q+   +Q 
Sbjct: 196 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           L E  +IHRDLKP+N+L+S+ E   ++KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314

Query: 185 NH---KYDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEELH 240
           +     Y+   D WS+G ILF  ++G PPF +   Q+ L   I +  +  F P    E+ 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-KYNFIPEVWAEVS 373

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPE 287
              +DL + LL  +P  R T +E   H +L +  + +  +   ++ E
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQD--EDMKRKFQDLLSE 418

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  269 bits (690), Expect = 6e-85
 Identities = 83/276 (30%), Positives = 139/276 (50%), Gaps = 7/276 (2%)

Query: 1   MEPNRTRLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS----DN 55
           MEP + + + + Y +G  +GSG FA+V + R +  G+E A K I K+           + 
Sbjct: 2   MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61

Query: 56  LLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM 115
           + +E+SIL  + H N+I   +  E R  + L+LE   GG+L  ++ +   +SE  A  F+
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
           +Q+  G+  L  K + H DLKP+N +L+  N   P +K+ DFG A  +        + G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181

Query: 175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPG 234
           P ++APEI+       +AD+WS+G I + L++G  PF G  + +   NI +     F   
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-SYDFDEE 240

Query: 235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                     D  R LL +   +R+T +E   H ++
Sbjct: 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  269 bits (689), Expect = 7e-85
 Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 22/276 (7%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLK--- 58
             +  L  +Y VGP +GSG F  V+        + VA+K ++K ++       N  +   
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95

Query: 59  EISILSTISH--PNIIRFFEAIETREKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFM 115
           E+ +L  +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
            Q+   ++      ++HRD+K +N+L+  N     LK+ DFG   +L    +     G+ 
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSG-ALLKDTVYTDFDGTR 212

Query: 176 LYMAPEIIQNHKYDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPG 234
           +Y  PE I+ H+Y    A +WS+G +L+ +V G  PF+   +      I+   ++ F   
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQR 265

Query: 235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
               +  +C  L R  L   P +R TF+E  NH ++
Sbjct: 266 ----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  270 bits (691), Expect = 8e-85
 Identities = 82/317 (25%), Positives = 128/317 (40%), Gaps = 52/317 (16%)

Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS---DNLLKEI 60
           +   L  +Y +   IG GS+ VV  A   Q     A+K ++K  +        + +  E+
Sbjct: 20  SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-------------- 106
            ++  + HPNI R +E  E  + I LV+E C GG L   ++                   
Sbjct: 80  RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139

Query: 107 --------------------------SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNL 140
                                      E +  + MRQ+ + L  L  + + HRD+KP+N 
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199

Query: 141 LVSTNEVTPVLKIGDFGFARSLTPQDLAD-----TLCGSPLYMAPEIIQ--NHKYDAKAD 193
           L STN+    +K+ DFG ++     +  +     T  G+P ++APE++   N  Y  K D
Sbjct: 200 LFSTNKSFE-IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258

Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ 253
            WS G +L  L+ G  PF G N       +L   +L F       L P   DL   LL +
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK-KLCFENPNYNVLSPLARDLLSNLLNR 317

Query: 254 NPVERITFKEFFNHRFL 270
           N  ER        H ++
Sbjct: 318 NVDERFDAMRALQHPWI 334

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  268 bits (687), Expect = 9e-85
 Identities = 83/275 (30%), Positives = 132/275 (48%), Gaps = 20/275 (7%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS--PKVSDNLLKEISILS 64
           +LIG+Y++G  +G GS+  V      +     AVK + KK L   P    N+ KEI +L 
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61

Query: 65  TISHPNIIRFFEAI--ETREKIYLVLEYCDGG--DLAAYIHKHGKVSEAVARHFMRQLAA 120
            + H N+I+  + +  E ++K+Y+V+EYC  G  ++   +    +     A  +  QL  
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLID 120

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFA---RSLTPQDLADTLCGSPLY 177
           GL+ L  + ++H+D+KP NLL++T      LKI   G A         D   T  GSP +
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGG---TLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 178 MAPEIIQNHK-YD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
             PEI      +   K D+WS G  L+ + TG  PF+G N  +LF+NI        P   
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG-KGSYAIPG-- 234

Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             +  P   DL + +L   P +R + ++   H + 
Sbjct: 235 --DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  268 bits (687), Expect = 1e-84
 Identities = 86/307 (28%), Positives = 137/307 (44%), Gaps = 29/307 (9%)

Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLK---E 59
           +R     EY +GP +G G F  V+        ++VA+K I + ++L      + +    E
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84

Query: 60  ISILSTIS----HPNIIRFFEAIETREKIYLVLEY-CDGGDLAAYIHKHGKVSEAVARHF 114
           +++L  +     HP +IR  +  ET+E   LVLE      DL  YI + G + E  +R F
Sbjct: 85  VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144

Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
             Q+ A +Q    + ++HRD+K +N+L+         K+ DFG   +L   +      G+
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLR--RGCAKLIDFGSG-ALLHDEPYTDFDGT 201

Query: 175 PLYMAPEIIQNHKYD-AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP 233
            +Y  PE I  H+Y    A +WS+G +L+ +V G  PF+   +      IL + EL FP 
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA-ELHFPA 254

Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
                + PDC  L R  L   P  R + +E     ++        AE   + P       
Sbjct: 255 H----VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM-----QTPAEDVPLNPSKGGPAP 305

Query: 294 LLNSSTP 300
           L  S  P
Sbjct: 306 LAWSLLP 312

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  274 bits (702), Expect = 1e-84
 Identities = 84/256 (32%), Positives = 135/256 (52%), Gaps = 2/256 (0%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +G GSF  V + + R    E AVK I+K     K +  +L+E+ +L  + HPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++ FE +E     Y+V E   GG+L   I K  + SE  A   ++Q+ +G+  + + +++
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+N+L+ + E    +KI DFG +             G+  Y+APE+++   YD K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D+WS G IL+ L++G PPF G N+  + + + T  +  F       +  D  DL R +L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISDDAKDLIRKML 261

Query: 252 RQNPVERITFKEFFNH 267
             +P  RIT  +   H
Sbjct: 262 TFHPSLRITATQCLEH 277

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  270 bits (693), Expect = 3e-83
 Identities = 80/257 (31%), Positives = 139/257 (54%), Gaps = 2/257 (0%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y    ++GSG++  V   R +   +E A+K I K  +S   +  LL+E+++L  + HPN
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           I++ ++  E +   YLV+E   GG+L   I    K +E  A   ++Q+ +G+  L + ++
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +HRDLKP+NLL+ + E   ++KI DFG +     Q       G+  Y+APE+++  KYD 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDE 216

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           K D+WS+G ILF L+ G PPF G    ++ + +    +  F     + +     DL + +
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG-KYTFDSPEWKNVSEGAKDLIKQM 275

Query: 251 LRQNPVERITFKEFFNH 267
           L+ +   RI+ ++   H
Sbjct: 276 LQFDSQRRISAQQALEH 292

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  263 bits (674), Expect = 4e-83
 Identities = 75/265 (28%), Positives = 128/265 (48%), Gaps = 18/265 (6%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           +I   ++GSG+F  V     R  G+E  +K I+K      +   +  EI +L ++ HPNI
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHPNI 82

Query: 72  IRFFEAIETREKIYLVLEYCDGGDL----AAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           I+ FE  E    +Y+V+E C+GG+L     +   +   +SE      M+Q+   L     
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
           +H++H+DLKP+N+L         +KI DFG A      + +    G+ LYMAPE+ +   
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RD 201

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV--- 244
              K D+WS G +++ L+TG  PF G++  ++ Q      E  +            +   
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-EPNYAV------ECRPLTPQ 254

Query: 245 --DLCRCLLRQNPVERITFKEFFNH 267
             DL + +L ++P  R +  +  +H
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHH 279

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  263 bits (674), Expect = 4e-83
 Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 6/261 (2%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS----DNLLKEISILSTIS 67
           Y +G  +GSG FA+V + R +  G E A K I K+ LS        + + +E++IL  I 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNII   +  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
           K + H DLKP+N +L+  N   P +K+ DFG A  +   +    + G+P ++APEI+   
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   NI       F             D 
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV-NYDFDEEYFSNTSELAKDF 245

Query: 247 CRCLLRQNPVERITFKEFFNH 267
            R LL ++P  R+T  +   H
Sbjct: 246 IRRLLVKDPKRRMTIAQSLEH 266

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  264 bits (678), Expect = 1e-82
 Identities = 91/267 (34%), Positives = 142/267 (53%), Gaps = 10/267 (3%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS---DNLLKEISILSTISH 68
           Y +   IG G F+VV R  +R+ G + AVK +D    +       ++L +E SI   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLAAGLQV 124
           P+I+   E   +   +Y+V E+ DG DL   I K        SEAVA H+MRQ+   L+ 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEII 183
             + ++IHRD+KP  +L+++ E +  +K+G FG A  L     +A    G+P +MAPE++
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           +   Y    D+W  G ILF L++G  PF G+ + +LF+ I+   + +  P     +    
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGII-KGKYKMNPRQWSHISESA 263

Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFL 270
            DL R +L  +P ERIT  E  NH +L
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWL 290

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  268 bits (688), Expect = 1e-82
 Identities = 81/258 (31%), Positives = 135/258 (52%), Gaps = 3/258 (1%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-DNLLKEISILSTISHP 69
            Y     +G GSF  V   + +  G E AVK I K+ +  K   ++LL+E+ +L  + HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           NI++ +E  E +   YLV E   GG+L   I    + SE  A   +RQ+ +G+  + +  
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYD 189
           ++HRDLKP+NLL+ +      ++I DFG +             G+  Y+APE++    YD
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYD 205

Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
            K D+WS G IL+ L++G PPF+G+N+  + + +    +  F     +++     DL R 
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYTFELPQWKKVSESAKDLIRK 264

Query: 250 LLRQNPVERITFKEFFNH 267
           +L   P  RI+ ++  +H
Sbjct: 265 MLTYVPSMRISARDALDH 282

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  262 bits (672), Expect = 2e-82
 Identities = 64/294 (21%), Positives = 131/294 (44%), Gaps = 39/294 (13%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           R   ++     +G G+F  V +AR+       A+K+I     + +    +L E+ +L+++
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASL 59

Query: 67  SHPNIIRFFEA-------------IETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVAR 112
           +H  ++R++ A             ++ +  +++ +EYC+ G L   IH            
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--------- 163
              RQ+   L  +  + +IHRDLKP N+ +  +     +KIGDFG A+++          
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLD 176

Query: 164 ------PQDLADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQ 216
                   D   +  G+ +Y+A E++     Y+ K D++S+G I F+++   P   G  +
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMER 234

Query: 217 LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           + + + + +   + FPP   +        + R L+  +P +R   +   N  +L
Sbjct: 235 VNILKKLRSV-SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  262 bits (672), Expect = 2e-82
 Identities = 82/279 (29%), Positives = 136/279 (48%), Gaps = 4/279 (1%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            +I    +GSG+F+ V+  + R  G   A+K I K         +L  EI++L  I H N
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHEN 67

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           I+   +  E+    YLV++   GG+L   I + G  +E  A   ++Q+ + ++ L E  +
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +HRDLKP+NLL  T E    + I DFG ++      ++ T CG+P Y+APE++    Y  
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEVLAQKPYSK 186

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
             D WS+G I + L+ G PPF    + +LF+ I       F     +++     D    L
Sbjct: 187 AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-YYEFESPFWDDISESAKDFICHL 245

Query: 251 LRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETK 289
           L ++P ER T ++  +H ++            SV  + +
Sbjct: 246 LEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQ 284

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  263 bits (674), Expect = 2e-82
 Identities = 80/261 (30%), Positives = 132/261 (50%), Gaps = 6/261 (2%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS----DNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132

Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+       F             D 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFEDEYFSNTSALAKDF 251

Query: 247 CRCLLRQNPVERITFKEFFNH 267
            R LL ++P +R+T ++   H
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQH 272

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  262 bits (672), Expect = 2e-82
 Identities = 75/290 (25%), Positives = 138/290 (47%), Gaps = 14/290 (4%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEID-KKLLSPKVSDNLLKEI 60
                  +  + +  +IG G F+ V+RA     G+ VA+K++    L+  K   + +KEI
Sbjct: 24  PDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK----VSEAVARHFMR 116
            +L  ++HPN+I+++ +     ++ +VLE  D GDL+  I    K    + E     +  
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSP 175
           QL + L+ +  + ++HRD+KP N+ ++   V   +K+GD G  R  + +   A +L G+P
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTP 200

Query: 176 LYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS--NQLQLFQNILTSTELRFPP 233
            YM+PE I  + Y+ K+D+WS+G +L+++   + PF G   N   L + I       +PP
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DYPP 257

Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHS 283
              +    +   L    +  +P +R      ++             E H 
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  263 bits (674), Expect = 2e-82
 Identities = 63/311 (20%), Positives = 120/311 (38%), Gaps = 49/311 (15%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL------------- 48
              + + I +Y +   +  G F  +            A+K+ +K LL             
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 49  --SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV 106
                  D+   E+ I++ I +   +     I   +++Y++ EY +   +  +      +
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 107 --------SEAVARHFMRQLAAGLQVL-QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG 157
                      V +  ++ +      +  EK++ HRD+KP N+L+  N     +K+ DFG
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG---RVKLSDFG 197

Query: 158 FARSLTPQDLADTLCGSPLYMAPEIIQNHK--YDAKADLWSVGAILFQLVTGKPPFDG-S 214
            +             G+  +M PE   N      AK D+WS+G  L+ +     PF    
Sbjct: 198 ES-EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 215 NQLQLFQNILTSTELRFP---------------PGAIEELHPDCVDLCRCLLRQNPVERI 259
           + ++LF NI  +  + +P                 +   L  + +D  +  LR+NP ERI
Sbjct: 257 SLVELFNNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315

Query: 260 TFKEFFNHRFL 270
           T ++   H +L
Sbjct: 316 TSEDALKHEWL 326

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  262 bits (671), Expect = 1e-81
 Identities = 84/276 (30%), Positives = 139/276 (50%), Gaps = 7/276 (2%)

Query: 1   MEPNRTRLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS----DN 55
           ME  + + + + Y +G  +GSG FA+V + R +  G+E A K I K+           + 
Sbjct: 2   METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61

Query: 56  LLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM 115
           + +E+SIL  + HPNII   +  E R  + L+LE   GG+L  ++ +   +SE  A  F+
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
           +Q+  G+  L  K + H DLKP+N +L+  N   P +K+ DFG A  +        + G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181

Query: 175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPG 234
           P ++APEI+       +AD+WS+G I + L++G  PF G  + +   NI       F   
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-SYDFDEE 240

Query: 235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              +      D  R LL +   +R+T +E   H ++
Sbjct: 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  263 bits (674), Expect = 5e-81
 Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 2/266 (0%)

Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           TR   EY +   +G G+F+VV R      G E A   I+ K LS +    L +E  I   
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           + HPNI+R  ++I      YL+ +   GG+L   I      SEA A H ++Q+   +   
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQ 184
            +  ++HR+LKP+NLL+++      +K+ DFG A  +   Q       G+P Y++PE+++
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186

Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              Y    DLW+ G IL+ L+ G PPF   +Q +L+Q I       FP    + + P+  
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG-AYDFPSPEWDTVTPEAK 245

Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
           DL   +L  NP +RIT  E   H ++
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWI 271

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  256 bits (656), Expect = 3e-80
 Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 37/297 (12%)

Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL--------------- 48
                + +Y +   IG GS+ VV  A +       A+K + KK L               
Sbjct: 7   GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGT 66

Query: 49  ---------SPKVSDNLLKEISILSTISHPNIIRFFEAIE--TREKIYLVLEYCDGGDLA 97
                         + + +EI+IL  + HPN+++  E ++    + +Y+V E  + G + 
Sbjct: 67  RPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM 126

Query: 98  AYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG 157
                   +SE  AR + + L  G++ L  + +IHRD+KP NLLV  +     +KI DFG
Sbjct: 127 EVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG---HIKIADFG 182

Query: 158 FARSLTPQD-LADTLCGSPLYMAPEIIQNHK--YD-AKADLWSVGAILFQLVTGKPPFDG 213
            +      D L     G+P +MAPE +   +  +     D+W++G  L+  V G+ PF  
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

Query: 214 SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              + L   I +   L FP     ++  D  DL   +L +NP  RI   E   H ++
Sbjct: 243 ERIMCLHSKIKSQ-ALEFPDQ--PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  263 bits (673), Expect = 4e-80
 Identities = 76/280 (27%), Positives = 139/280 (49%), Gaps = 13/280 (4%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-----------DNLLKE 59
            Y    ++GSG++  V   + +    E A+K I K                   + +  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
           IS+L ++ HPNII+ F+  E ++  YLV E+ +GG+L   I    K  E  A + M+Q+ 
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
           +G+  L + +++HRD+KP+N+L+        +KI DFG +   +         G+  Y+A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PE+++  KY+ K D+WS G I++ L+ G PPF G N   + + +    +  F     + +
Sbjct: 217 PEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG-KYYFDFNDWKNI 274

Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHA 279
             +  +L + +L  +  +R T +E  N R++ +    ++ 
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK 314

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  255 bits (653), Expect = 6e-80
 Identities = 69/297 (23%), Positives = 125/297 (42%), Gaps = 39/297 (13%)

Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
            R   ++     IGSG F  V++A+HR  G    +K +         ++   +E+  L+ 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAK 60

Query: 66  ISHPNIIRFFEAIE----------------TREKIYLVLEYCDGGDLAAYIHKH--GKVS 107
           + H NI+ +    +                  + +++ +E+CD G L  +I K    K+ 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 108 EAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL 167
           + +A     Q+  G+  +  K LI+RDLKP N+ +   +    +KIGDFG   SL     
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKNDGK 177

Query: 168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTS 226
                G+  YM+PE I +  Y  + DL+++G IL +L+      F+ S     F ++   
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDL--- 231

Query: 227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHS 283
            +        ++       L + LL + P +R    E      +   +     E+H+
Sbjct: 232 RDGIISDIFDKKEK----TLLQKLLSKKPEDRPNTSEILRTLTV-WKKSPEKNERHT 283

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  255 bits (654), Expect = 6e-80
 Identities = 85/273 (31%), Positives = 133/273 (48%), Gaps = 18/273 (6%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP-------KVSDNLLKEISILS 64
           Y     +G G  +VV R  H+    E AVK ID             ++ +  LKE+ IL 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 65  TIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
            +S HPNII+  +  ET    +LV +    G+L  Y+ +   +SE   R  MR L   + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
            L + +++HRDLKP+N+L+  +     +K+ DFGF+  L P +    +CG+P Y+APEII
Sbjct: 139 ALHKLNIVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195

Query: 184 QNH------KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           +         Y  + D+WS G I++ L+ G PPF    Q+ + + I++    +F     +
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-NYQFGSPEWD 254

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +      DL    L   P +R T +E   H F 
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  255 bits (654), Expect = 7e-80
 Identities = 71/270 (26%), Positives = 107/270 (39%), Gaps = 15/270 (5%)

Query: 4   NRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL 63
             +     +    R+G GS+  V++ R ++ G   AVK        PK     L E+   
Sbjct: 51  PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110

Query: 64  STI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAG 121
             +  HP  +R  +A E    +YL  E C G  L  +    G  + EA    ++R     
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
           L  L  + L+H D+KP N+ +         K+GDFG    L      +   G P YMAPE
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRG---RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226

Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKP-PFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
           ++Q   Y   AD++S+G  + ++      P  G    QL Q  L      F  G   EL 
Sbjct: 227 LLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP---EFTAGLSSELR 282

Query: 241 PDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                +   +L  +P  R T +       L
Sbjct: 283 ----SVLVMMLEPDPKLRATAEALLALPVL 308

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  255 bits (654), Expect = 1e-79
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 8/296 (2%)

Query: 1   MEPNRTRLIGEY--IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK 58
           +          +  +    +G G FAVV +   +  G E A K + K+         +L 
Sbjct: 18  LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH 77

Query: 59  EISILSTISH-PNIIRFFEAIETREKIYLVLEYCDGGDLAAYI--HKHGKVSEAVARHFM 115
           EI++L      P +I   E  E   +I L+LEY  GG++ +         VSE      +
Sbjct: 78  EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLI 137

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
           +Q+  G+  L + +++H DLKPQN+L+S+      +KI DFG +R +        + G+P
Sbjct: 138 KQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197

Query: 176 LYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGA 235
            Y+APEI+         D+W++G I + L+T   PF G +  + + NI     + +    
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-NVDYSEET 256

Query: 236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL--GELRQTVHAEQHSVVPETK 289
              +     D  + LL +NP +R T +   +H +L   +     H E+ S   +T+
Sbjct: 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQ 312

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  253 bits (649), Expect = 4e-78
 Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 5/275 (1%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +GSG+F VV R   +  G     K I+      K    +  EISI++ + HP +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHPKL 110

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEKHL 130
           I   +A E + ++ L+LE+  GG+L   I       SEA   ++MRQ   GL+ + E  +
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +H D+KP+N++  T + +  +KI DFG A  L P ++      +  + APEI+       
Sbjct: 171 VHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
             D+W++G + + L++G  PF G + L+  QN+    +  F   A   + P+  D  + L
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-DWEFDEDAFSSVSPEAKDFIKNL 288

Query: 251 LRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVV 285
           L++ P +R+T  +   H +L      + +   S  
Sbjct: 289 LQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  252 bits (645), Expect = 8e-78
 Identities = 83/272 (30%), Positives = 133/272 (48%), Gaps = 17/272 (6%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSD------NLLKEISILST 65
           Y     IG G  +VV R  HR  G E AVK ++                   +E  IL  
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 66  IS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
           ++ HP+II   ++ E+   ++LV +    G+L  Y+ +   +SE   R  MR L   +  
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           L   +++HRDLKP+N+L+  N     +++ DFGF+  L P +    LCG+P Y+APEI++
Sbjct: 216 LHANNIVHRDLKPENILLDDNM---QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272

Query: 185 ------NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
                 +  Y  + DLW+ G ILF L+ G PPF    Q+ + + I+   + +F     ++
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG-QYQFSSPEWDD 331

Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                 DL   LL+ +P  R+T ++   H F 
Sbjct: 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  251 bits (642), Expect = 1e-77
 Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 13/295 (4%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           +  N  +    Y V   IG GS++V  R  H+   +E AVK IDK    P       +EI
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEI 66

Query: 61  SILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
            IL     HPNII   +  +  + +Y+V E   GG+L   I +    SE  A   +  + 
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTP-VLKIGDFGFARSLTP-QDLADTLCGSPLY 177
             ++ L  + ++HRDLKP N+L       P  ++I DFGFA+ L     L  T C +  +
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNILTSTELRFPPG 234
           +APE+++   YDA  D+WS+G +L+ ++TG  PF         ++   I +  +     G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-KFSLSGG 245

Query: 235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETK 289
               +     DL   +L  +P +R+T      H ++    Q    + +       
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHL 300

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  250 bits (641), Expect = 2e-77
 Identities = 88/257 (34%), Positives = 134/257 (52%), Gaps = 6/257 (2%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           + V   +G G+ ++V+R + +      A+K + K          +  EI +L  +SHPNI
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNI 110

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           I+  E  ET  +I LVLE   GG+L   I + G  SE  A   ++Q+   +  L E  ++
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+NLL +T      LKI DFG ++ +  Q L  T+CG+P Y APEI++   Y  +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230

Query: 192 ADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
            D+WSVG I + L+ G  PF        +F+ IL   E  F     +E+  +  DL R L
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC-EYYFISPWWDEVSLNAKDLVRKL 289

Query: 251 LRQNPVERITFKEFFNH 267
           +  +P +R+T  +   H
Sbjct: 290 IVLDPKKRLTTFQALQH 306

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  248 bits (635), Expect = 8e-77
 Identities = 74/273 (27%), Positives = 131/273 (47%), Gaps = 6/273 (2%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y++   +G G F +V R            K +  K         + KEISIL+   H NI
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNI 63

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHL 130
           +   E+ E+ E++ ++ E+  G D+   I+    +++E     ++ Q+   LQ L   ++
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
            H D++P+N++  T   +  +KI +FG AR L P D    L  +P Y APE+ Q+     
Sbjct: 124 GHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
             D+WS+G +++ L++G  PF      Q+ +NI+ + E  F   A +E+  + +D    L
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-EYTFDEEAFKEISIEAMDFVDRL 241

Query: 251 LRQNPVERITFKEFFNHRFLGELRQTVHAEQHS 283
           L +    R+T  E   H +L +  + V  +   
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  253 bits (648), Expect = 7e-76
 Identities = 77/260 (29%), Positives = 128/260 (49%), Gaps = 5/260 (1%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   +G+G+F VV R   R  G   A K +     S K  + + KEI  +S + HP +
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTL 216

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           +   +A E   ++ ++ E+  GG+L   +  +H K+SE  A  +MRQ+  GL  + E + 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDA 190
           +H DLKP+N++ +T      LK+ DFG    L P+       G+  + APE+ +      
Sbjct: 277 VHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
             D+WSVG + + L++G  PF G N  +  +N+ +  +      A   +  D  D  R L
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSGISEDGKDFIRKL 394

Query: 251 LRQNPVERITFKEFFNHRFL 270
           L  +P  R+T  +   H +L
Sbjct: 395 LLADPNTRMTIHQALEHPWL 414

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  245 bits (628), Expect = 9e-76
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 15/268 (5%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPN 70
            +    +G GSF++  +  H++     AVK I K++       N  KEI+ L     HPN
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPN 67

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           I++  E    +   +LV+E  +GG+L   I K    SE  A + MR+L + +  + +  +
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLYMAPEIIQNHKYD 189
           +HRDLKP+NLL +       +KI DFGFAR   P +    T C +  Y APE++  + YD
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 187

Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQ-------LQLFQNILTSTELRFPPGAIEELHPD 242
              DLWS+G IL+ +++G+ PF   ++       +++ + I    +  F   A + +  +
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-DFSFEGEAWKNVSQE 246

Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFL 270
             DL + LL  +P +R+       + +L
Sbjct: 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWL 274

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  246 bits (629), Expect = 2e-75
 Identities = 76/262 (29%), Positives = 132/262 (50%), Gaps = 7/262 (2%)

Query: 12  YIVGPR--IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           Y V     +G G F  V +      G+++A K I  + +  K  + +  EIS+++ + H 
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISVMNQLDHA 146

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEK 128
           N+I+ ++A E++  I LV+EY DGG+L   I      ++E     FM+Q+  G++ + + 
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
           +++H DLKP+N+L    +    +KI DFG AR   P++      G+P ++APE++     
Sbjct: 207 YILHLDLKPENILCVNRDAKQ-IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR 248
               D+WSVG I + L++G  PF G N  +   NIL            +++  +  +   
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-RWDLEDEEFQDISEEAKEFIS 324

Query: 249 CLLRQNPVERITFKEFFNHRFL 270
            LL +    RI+  E   H +L
Sbjct: 325 KLLIKEKSWRISASEALKHPWL 346

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  238 bits (610), Expect = 1e-73
 Identities = 68/292 (23%), Positives = 133/292 (45%), Gaps = 38/292 (13%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           R + ++     +G G F VV+ A+++      A+K I          + +++E+  L+ +
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKL 60

Query: 67  SHPNIIRFFEAIETREK------------IYLVLEYCDGGDLAAYIHKHGKVS---EAVA 111
            HP I+R+F A   +              +Y+ ++ C   +L  +++    +     +V 
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120

Query: 112 RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL 171
            H   Q+A  ++ L  K L+HRDLKP N+  + ++V   +K+GDFG   ++   +   T+
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTV 177

Query: 172 -------------CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQ 218
                         G+ LYM+PE I  + Y  K D++S+G ILF+L+   P      +++
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVR 235

Query: 219 LFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              ++     L+FPP    + +P    + + +L  +P+ER        +   
Sbjct: 236 TLTDV---RNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  233 bits (596), Expect = 1e-71
 Identities = 63/293 (21%), Positives = 121/293 (41%), Gaps = 32/293 (10%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILS 64
           ++R   E+    +IGSG F  V++   R  G   A+K   K L       N L+E+   +
Sbjct: 6   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 65

Query: 65  TIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----SEAVARHFMRQLA 119
            +  H +++R+F A    + + +  EYC+GG LA  I ++ ++     EA  +  + Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTP----------------VLKIGDFGFARSLT 163
            GL+ +    L+H D+KP N+ +S   +                  + KIGD G    ++
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 164 PQDLADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQN 222
                    G   ++A E++Q +  +  KAD++++   +      +P          +  
Sbjct: 186 ---SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHE 239

Query: 223 ILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           I      R P    + L  +  +L + ++  +P  R +      H  L    +
Sbjct: 240 IRQGRLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  234 bits (599), Expect = 2e-71
 Identities = 82/277 (29%), Positives = 134/277 (48%), Gaps = 19/277 (6%)

Query: 2   EPNRTRLIGEYIVG-PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           EP +  +  +Y +    +G G    V    HR+ G + A+K +              +E+
Sbjct: 20  EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEV 72

Query: 61  SILSTIS-HPNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARH 113
                 S  P+I+   +  E     +  + +++E  +GG+L + I + G    +E  A  
Sbjct: 73  DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE 132

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
            MR +   +Q L   ++ HRD+KP+NLL ++ E   VLK+ DFGFA+  T   L  T C 
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCY 191

Query: 174 SPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST---ELR 230
           +P Y+APE++   KYD   D+WS+G I++ L+ G PPF  +    +   +       +  
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251

Query: 231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
           FP     E+  D   L R LL+ +P ER+T  +F NH
Sbjct: 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  232 bits (594), Expect = 6e-71
 Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 33/290 (11%)

Query: 11  EYIVG-PRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-H 68
            Y +    +G G+ A V    +     E AVK I+K+    +    + +E+ +L     H
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGH 70

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
            N++   E  E  ++ YLV E   GG + ++IHK    +E  A   ++ +A+ L  L  K
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD--------TLCGSPLYMAP 180
            + HRDLKP+N+L         +KI DF     +               T CGS  YMAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 181 EIIQNH-----KYDAKADLWSVGAILFQLVTGKPPFDGSN---------------QLQLF 220
           E+++        YD + DLWS+G IL+ L++G PPF G                 Q  LF
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250

Query: 221 QNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           ++I    +  FP      +     DL   LL ++  +R++  +   H ++
Sbjct: 251 ESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  233 bits (596), Expect = 3e-70
 Identities = 78/279 (27%), Positives = 136/279 (48%), Gaps = 20/279 (7%)

Query: 1   MEPNRTRLIGEY-IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE 59
           ++  +  +I +Y +    +G G    V +  +++   + A+K +              +E
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARRE 104

Query: 60  ISILSTIS-HPNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGKV--SEAVAR 112
           + +    S  P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A 
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
             M+ +   +Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224

Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN----QLQLFQNILTSTE 228
            +P Y+APE++   KYD   D+WS+G I++ L+ G PPF  ++       +   I    +
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-Q 283

Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
             FP     E+  +   L R LL+  P +R+T  EF NH
Sbjct: 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  224 bits (573), Expect = 7e-68
 Identities = 58/289 (20%), Positives = 102/289 (35%), Gaps = 32/289 (11%)

Query: 3   PNRTRLIGE--YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
                +I    Y+   ++G G F+ V        G   A+K I       +  +   +E 
Sbjct: 20  QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREA 77

Query: 61  SILSTISHPNIIRFFEAIETRE----KIYLVLEYCDGGDLAAYI----HKHGKVSEAVAR 112
            +    +HPNI+R             + +L+L +   G L   I     K   ++E    
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-------- 164
             +  +  GL+ +  K   HRDLKP N+L+          + D G               
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE---GQPVLMDLGSMNQACIHVEGSRQA 194

Query: 165 ---QDLADTLCGSPLYMAPEIIQNHKY---DAKADLWSVGAILFQLVTGKPPFDGSNQLQ 218
              QD A     +  Y APE+     +   D + D+WS+G +L+ ++ G+ P+D   Q  
Sbjct: 195 LTLQDWA-AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

Query: 219 LFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
               +    +L  P             L   ++  +P +R       + 
Sbjct: 254 DSVALAVQNQLSIPQSPR--HSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  222 bits (568), Expect = 2e-67
 Identities = 75/264 (28%), Positives = 131/264 (49%), Gaps = 16/264 (6%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
              IG GSF  V++    +  +EVA  E+  + L+        +E  +L  + HPNI+RF
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 75  F----EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL--QEK 128
           +      ++ ++ I LV E    G L  Y+ +   +   V R + RQ+  GLQ L  +  
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKY 188
            +IHRDLK  N+ ++    T  +KIGD G A        A  + G+P +MAPE+ +  KY
Sbjct: 151 PIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KY 206

Query: 189 DAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEELH-PDCVDL 246
           D   D+++ G  + ++ T + P+ +  N  Q+++ + +       P + +++  P+  ++
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV----KPASFDKVAIPEVKEI 262

Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
               +RQN  ER + K+  NH F 
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFF 286

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  222 bits (568), Expect = 3e-67
 Identities = 80/277 (28%), Positives = 136/277 (49%), Gaps = 18/277 (6%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEIS 61
             R +   ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E  
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
           ++S + HP  ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ + 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR---SLTPQDLADTLCGSPLYM 178
           L+ L  K +IHRDLKP+N+L++ +     ++I DFG A+     + Q  A++  G+  Y+
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +PE++        +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP      
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFPEK---- 254

Query: 239 LHPDCVDLCRCLLRQNPVERIT------FKEFFNHRF 269
             P   DL   LL  +  +R+       +     H F
Sbjct: 255 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  225 bits (574), Expect = 1e-66
 Identities = 84/445 (18%), Positives = 166/445 (37%), Gaps = 63/445 (14%)

Query: 3   PNRTRLIGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEIS 61
           PN  + +    +    +G GS   V   +    G  VAVK +          D  L EI 
Sbjct: 7   PNFEQSLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFC-----DIALMEIK 60

Query: 62  ILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAV-------ARH 113
           +L+    HPN+IR++ +  T   +Y+ LE C   +L   +       E +          
Sbjct: 61  LLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPV----------LKIGDFGFARSLT 163
            +RQ+A+G+  L    +IHRDLKPQN+LVST+               + I DFG  + L 
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 164 P-----QDLADTLCGSPLYMAPEIIQNH-------KYDAKADLWSVGAILFQLVT-GKPP 210
                 +   +   G+  + APE+++         +     D++S+G + + +++ GK P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 211 FDGSN--QLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHR 268
           F      +  + + I +  E++        L  +  DL   ++  +P++R T  +   H 
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

Query: 269 FLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPTNSSSKNPKSACSSACD 328
                     +++   + +    +E+ N   P                    +       
Sbjct: 298 LF-----WPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTF 352

Query: 329 KVILNTGDQGNSLSTRDLHEFIPNMA------CDRMKKSVGS------QYSSDQLKDLME 376
              L    + +S    DL   + N         + + + +G        Y + +  +L+ 
Sbjct: 353 MDNLERYRKYHSSKLMDLLRALRNKYHHFMDLPEDIAELMGPVPDGFYDYFTKRFPNLLI 412

Query: 377 SIEKEYVLINSHFASTDGFSFYLDA 401
            +   Y+++  + +       +L +
Sbjct: 413 GV---YMIVKENLSDDQILREFLYS 434

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  216 bits (553), Expect = 8e-65
 Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 19/266 (7%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
               PR+G GSF  V R + +Q G + AVK++        +    ++E+   + +S P I
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRI 112

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +  + A+     + + +E  +GG L   I + G + E  A +++ Q   GL+ L  + ++
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLA------DTLCGSPLYMAPEIIQN 185
           H D+K  N+L+S++       + DFG A  L P  L       D + G+  +MAPE++  
Sbjct: 173 HGDVKADNVLLSSDGS--RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHPDCV 244
              DAK D+WS   ++  ++ G  P+    +  L   I +        P       P   
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP---PSCAPLTA 287

Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
              +  LR+ PV R +  E       
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVGK 313

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  219 bits (559), Expect = 2e-64
 Identities = 65/283 (22%), Positives = 115/283 (40%), Gaps = 23/283 (8%)

Query: 2   EPNRTRLIG--EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE 59
           E     ++G   +     +G G+   +   R      +VAVK I  +           +E
Sbjct: 14  EETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADRE 67

Query: 60  ISILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQ 117
           + +L     HPN+IR+F   + R+  Y+ +E C    L  Y+ +             ++Q
Sbjct: 68  VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQ 126

Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK--IGDFGFARSLTPQDLA----DTL 171
             +GL  L   +++HRDLKP N+L+S       +K  I DFG  + L     +      +
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 172 CGSPLYMAPEIIQ---NHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTST 227
            G+  ++APE++            D++S G + + +++ G  PF  S Q Q   NIL   
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLGA 244

Query: 228 ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                    +       +L   ++  +P +R + K    H F 
Sbjct: 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  210 bits (536), Expect = 9e-63
 Identities = 72/276 (26%), Positives = 124/276 (44%), Gaps = 16/276 (5%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
             E      +G G++ +V+  R     + +A+KEI       + S  L +EI++   + H
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKH 78

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYI-HKHGK--VSEAVARHFMRQLAAGLQVL 125
            NI+++  +      I + +E   GG L+A +  K G    +E     + +Q+  GL+ L
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQ 184
            +  ++HRD+K  N+L++T     VLKI DFG ++ L       +T  G+  YMAPEII 
Sbjct: 139 HDNQIVHRDIKGDNVLINTYS--GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196

Query: 185 NHK--YDAKADLWSVGAILFQLVTGKPPF-DGSNQLQLFQNILTSTELRFPPGAIEELHP 241
                Y   AD+WS+G  + ++ TGKPPF +          +         P   E +  
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV---HPEIPESMSA 253

Query: 242 DCVD-LCRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           +    + +C    +P +R    +     FL    + 
Sbjct: 254 EAKAFILKCFEP-DPDKRACANDLLVDEFLKVSSKK 288

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  209 bits (534), Expect = 7e-62
 Identities = 79/258 (30%), Positives = 143/258 (55%), Gaps = 16/258 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  IL  ++ P +++   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+    + L    LI+RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+NLL+        +++ DFGFA+ +  +    TLCG+P  +APEII +  Y+   D W+
Sbjct: 169 PENLLIDQQG---YIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWA 223

Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
           +G +++++  G PPF     +Q+++ I+ S ++RFP         D  DL R LL+ +  
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH----FSSDLKDLLRNLLQVDLT 278

Query: 257 ERI-----TFKEFFNHRF 269
           +R         +  NH++
Sbjct: 279 KRFGNLKNGVNDIKNHKW 296

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  207 bits (528), Expect = 2e-61
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 14/256 (5%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +  +IG+GSF  V RA     G +VAVK + ++    +  +  L+E++I+  + HPNI+ 
Sbjct: 41  IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVL--QEK 128
           F  A+     + +V EY   G L   +HK G   ++ E         +A G+  L  +  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT-LCGSPLYMAPEIIQNHK 187
            ++HR+LK  NLLV        +K+ DFG +R      L+     G+P +MAPE++++  
Sbjct: 159 PIVHRNLKSPNLLVDKK---YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
            + K+D++S G IL++L T + P+   N  Q+   +      R        L+P    + 
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-KR--LEIPRNLNPQVAAII 272

Query: 248 RCLLRQNPVERITFKE 263
                  P +R +F  
Sbjct: 273 EGCWTNEPWKRPSFAT 288

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (526), Expect = 3e-61
 Identities = 90/296 (30%), Positives = 134/296 (45%), Gaps = 28/296 (9%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           E  V   +G G+F VV +A+ R    +VA+K    ++ S       + E+  LS ++HPN
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWR--AKDVAIK----QIESESERKAFIVELRQLSRVNHPN 62

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHFMRQLAAGLQVL-- 125
           I++ + A      + LV+EY +GG L   +H        + A A  +  Q + G+  L  
Sbjct: 63  IVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 126 -QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
            Q K LIHRDLKP NLL+       VLKI DFG A  +      +   GS  +MAPE+ +
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGG--TVLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFE 176

Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              Y  K D++S G IL++++T + PFD                 R  P  I+ L     
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--PPLIKNLPKPIE 234

Query: 245 DL-CRCLLRQNPVERITFKE------FFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
            L  RC   ++P +R + +E           F G      +  QHS+ P     VE
Sbjct: 235 SLMTRC-WSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVE 289

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  208 bits (532), Expect = 3e-61
 Identities = 67/264 (25%), Positives = 126/264 (47%), Gaps = 16/264 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG GSF  V   +        A+K ++K K +      N+ KE+ I+  + HP ++  + 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           + +  E +++V++   GGDL  ++ ++    E   + F+ +L   L  LQ + +IHRD+K
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMK 142

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK---YDAKAD 193
           P N+L+  +     + I DF  A  L  +    T+ G+  YMAPE+  + K   Y    D
Sbjct: 143 PDNILLDEH---GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199

Query: 194 LWSVGAILFQLVTGKPPFDG---SNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
            WS+G   ++L+ G+ P+     ++  ++     T+  + +P         + V L + L
Sbjct: 200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSA----WSQEMVSLLKKL 254

Query: 251 LRQNPVERI-TFKEFFNHRFLGEL 273
           L  NP +R     +  N  ++ ++
Sbjct: 255 LEPNPDQRFSQLSDVQNFPYMNDI 278

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  206 bits (527), Expect = 3e-61
 Identities = 82/258 (31%), Positives = 146/258 (56%), Gaps = 16/258 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G+GSF  V   R R  G   A+K + K  ++  K  ++   E  +LS ++HP IIR + 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
             +  ++I+++++Y +GG+L + + K  +    VA+ +  ++   L+ L  K +I+RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWS 196
           P+N+L+  N     +KI DFGFA+ +   D+  TLCG+P Y+APE++    Y+   D WS
Sbjct: 134 PENILLDKNG---HIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWS 188

Query: 197 VGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPV 256
            G ++++++ G  PF  SN ++ ++ IL + ELRFPP      + D  DL   L+ ++  
Sbjct: 189 FGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPF----FNEDVKDLLSRLITRDLS 243

Query: 257 ERI-----TFKEFFNHRF 269
           +R+       ++  NH +
Sbjct: 244 QRLGNLQNGTEDVKNHPW 261

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  206 bits (526), Expect = 2e-60
 Identities = 40/324 (12%), Positives = 79/324 (24%), Gaps = 60/324 (18%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE- 59
           +E          + G  +G         A  ++ G    V         P  +   +KE 
Sbjct: 64  VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 123

Query: 60  -------------------------ISILSTISHPNIIRFFEAIETREKIYLVLEY---- 90
                                      ++       +IR          +     Y    
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183

Query: 91  CD----GGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE 146
            +    G  L ++   H  +          Q+   L  L    L+H  L+P ++++    
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243

Query: 147 VTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH-----------KYDAKADLW 195
               + +  F                 S  +  PE+                     D W
Sbjct: 244 ---GVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
           ++G +++ +     P      L   + I   +    P             L    LR   
Sbjct: 298 ALGLVIYWIWCADLPITKDAALGGSEWIF-RSCKNIP--------QPVRALLEGFLRYPK 348

Query: 256 VERITFKEFFNHRFLGELRQTVHA 279
            +R+   +        +LR  + A
Sbjct: 349 EDRLLPLQAMETPEYEQLRTELSA 372

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  204 bits (522), Expect = 3e-60
 Identities = 78/318 (24%), Positives = 135/318 (42%), Gaps = 43/318 (13%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPN 70
             V   +  G FA V+ A+    G E A+K +       + +  +++E+  +  +S HPN
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPN 87

Query: 71  IIRFFEA-------IETREKIYLVLEYCDGGDLAAYIHK---HGKVSEAVARHFMRQLAA 120
           I++F  A        +T +  +L+L     G L  ++ K    G +S         Q   
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 121 GLQVL--QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ------------- 165
            +Q +  Q+  +IHRDLK +NLL+S       +K+ DFG A +++               
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 166 DLADTLCGSPLYMAPEII---QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQN 222
           +   T   +P+Y  PEII    N     K D+W++G IL+ L   + PF+   +L+    
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260

Query: 223 ILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQH 282
           I+ + +   PP   +        L R +L+ NP ER++  E  +     E+    +    
Sbjct: 261 IV-NGKYSIPPHDTQY--TVFHSLIRAMLQVNPEERLSIAEVVHQLQ--EIAAARNVNPK 315

Query: 283 SVVPETKPMVELLNSSTP 300
           S + E         S+T 
Sbjct: 316 SPITELLEQNGGYGSATL 333

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  205 bits (522), Expect = 6e-60
 Identities = 38/318 (11%), Positives = 78/318 (24%), Gaps = 44/318 (13%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKE 59
           ++   ++   +  +   +  G  +VV+  R  +   + A+K        S    + L + 
Sbjct: 53  VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112

Query: 60  ISILSTISHPNIIRFFEAI--------------------------ETREKIYLVLEYCDG 93
               + +   +     +                                   L++     
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV 172

Query: 94  ------GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV 147
                   L       G            QL      LQ K L+H    P NL +  +  
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG- 231

Query: 148 TPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK--YDAKADLWSVGAILFQLV 205
              L +GD                     Y   E +      +    + W +G  ++++ 
Sbjct: 232 --RLMLGDVSALWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 206 TGKPPFDGSNQLQLFQNILTSTELRFPP----GAIEELHPDCVDLCRCLLRQNPVERITF 261
               PF              S  +        G+   L      L    L  +   R+  
Sbjct: 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP 347

Query: 262 KEFFNHRFLGELRQTVHA 279
            E        +L+  + +
Sbjct: 348 LEAMETPEFLQLQNEISS 365

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  202 bits (515), Expect = 1e-59
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 41/279 (14%)

Query: 1   MEPNRTRLIGEY-IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE 59
           ++  +  +I +Y +    +G G    V +  +++   + A+K +              +E
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARRE 60

Query: 60  ISILSTIS-HPNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHGKV--SEAVAR 112
           + +    S  P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A 
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
             M+ +   +Q L   ++ HRD+KP+NLL ++     +LK+ DFGF              
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------- 166

Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTE 228
                 A E     KYD   D+WS+G I++ L+ G PPF  ++ L     +   I    +
Sbjct: 167 ------AKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-Q 218

Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
             FP     E+  +   L R LL+  P +R+T  EF NH
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  198 bits (505), Expect = 2e-58
 Identities = 64/263 (24%), Positives = 118/263 (44%), Gaps = 19/263 (7%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS-----DNLLKEISILSTISH 68
              +IG G F +V + R  +    VA+K +       +           +E+ I+S ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQE 127
           PNI++ +          +V+E+   GDL   +      +  +V    M  +A G++ +Q 
Sbjct: 83  PNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 128 KH--LIHRDLKPQNLLVSTN--EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
           ++  ++HRDL+  N+ + +         K+ DFG ++          L G+  +MAPE I
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETI 198

Query: 184 --QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGAIEELH 240
             +   Y  KAD +S   IL+ ++TG+ PFD  +  ++ F N++    LR  P   E+  
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--PTIPEDCP 256

Query: 241 PDCVDLCRCLLRQNPVERITFKE 263
           P   ++       +P +R  F  
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSY 279

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  198 bits (505), Expect = 4e-58
 Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 27/269 (10%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           I G  +G G F    +  HR+ G  + +KE+ +     +     LKE+ ++  + HPN++
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVL 70

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +F   +   +++  + EY  GG L   I     +   +    F + +A+G+  L   ++I
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD---------------TLCGSPL 176
           HRDL   N LV  N+    + + DFG AR +  +                   T+ G+P 
Sbjct: 131 HRDLNSHNCLVRENK---NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDG--SNQLQLFQNILTSTELRFPPG 234
           +MAPE+I    YD K D++S G +L +++             +    N+    +   PP 
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247

Query: 235 AIEELHPDCVDLCRCLLRQNPVERITFKE 263
                      +       +P +R +F +
Sbjct: 248 CPPSFF----PITVRCCDLDPEKRPSFVK 272

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  195 bits (498), Expect = 1e-57
 Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 17/260 (6%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHPNI 71
           +   IG G F  V+RA     G EVAVK    D      +  +N+ +E  + + + HPNI
Sbjct: 11  LEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-- 129
           I           + LV+E+  GG L   +    ++   +  ++  Q+A G+  L ++   
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 130 -LIHRDLKPQNLLVS-----TNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
            +IHRDLK  N+L+       +    +LKI DFG AR    +    +  G+  +MAPE+I
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAPEVI 186

Query: 184 QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           +   +   +D+WS G +L++L+TG+ PF G + L +   +  +  L              
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-LA--LPIPSTCPEPF 243

Query: 244 VDLCRCLLRQNPVERITFKE 263
             L       +P  R +F  
Sbjct: 244 AKLMEDCWNPDPHSRPSFTN 263

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  195 bits (497), Expect = 2e-57
 Identities = 52/260 (20%), Positives = 105/260 (40%), Gaps = 23/260 (8%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
              ++       +W+ R +  G ++ VK +  +  S + S +  +E   L   SHPN++ 
Sbjct: 14  FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 74  FFEAIET--REKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVL--QE 127
              A ++       L+  +   G L   +H+     V ++ A  F   +A G+  L   E
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             +    L  +++++  +      +I       S      +     +P ++APE +Q   
Sbjct: 132 PLIPRHALNSRSVMIDEDM---TARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKP 184

Query: 188 YDA---KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDC 243
            D     AD+WS   +L++LVT + PF   + +++   +         PPG    + P  
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG----ISPHV 240

Query: 244 VDLCRCLLRQNPVERITFKE 263
             L +  + ++P +R  F  
Sbjct: 241 SKLMKICMNEDPAKRPKFDM 260

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  197 bits (502), Expect = 3e-57
 Identities = 41/297 (13%), Positives = 98/297 (32%), Gaps = 40/297 (13%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
              V   +G G+FA V+ A    L       +  +K       +P       + +  L  
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-----VSEAVARHFMRQLAA 120
                 ++F+ A   +    LV E    G L   I+ +       + + +   F  ++  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 121 GLQVLQEKHLIHRDLKPQNLLV--------STNEVTPVLKIGDFGFARSLT---PQDLAD 169
            ++ + +  +IH D+KP N ++          ++++  L + D G +  +       +  
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL 229
             C +  +   E++ N  ++ + D + V A ++ ++ G      +   +     L     
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303

Query: 230 RFPPGAIEELHPDCVDLCRCLLRQNPVERIT--------FKEFFNHRFLGELRQTVH 278
                          +    +L       +          K+ F   +  ++R   +
Sbjct: 304 HLDM---------WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRN 351

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  197 bits (502), Expect = 3e-57
 Identities = 72/298 (24%), Positives = 134/298 (44%), Gaps = 53/298 (17%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
            +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P I+ F+ 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL-QEKHLIHRDL 135
           A  +  +I + +E+ DGG L   + K G++ E +       +  GL  L ++  ++HRD+
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158

Query: 136 KPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           KP N+LV++  E+    K+ DFG +  L    +A++  G+  YM+PE +Q   Y  ++D+
Sbjct: 159 KPSNILVNSRGEI----KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDI 213

Query: 195 WSVGAILFQLVTGKPPFDGSNQ-------------------------------------- 216
           WS+G  L ++  G+ P    +                                       
Sbjct: 214 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273

Query: 217 ----LQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                +L   I+     + P G       D V+ C   L +NP ER   K+   H F+
Sbjct: 274 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC---LIKNPAERADLKQLMVHAFI 328

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  195 bits (499), Expect = 4e-57
 Identities = 80/263 (30%), Positives = 134/263 (50%), Gaps = 19/263 (7%)

Query: 18  IGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSD--NLLKEISILSTISHPNII 72
           +G G +  V++ R       G   A+K + K ++     D  +   E +IL  + HP I+
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               A +T  K+YL+LEY  GG+L   + + G   E  A  ++ +++  L  L +K +I+
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLKP+N++++       +K+ DFG  + S+    +  T CG+  YMAPEI+    ++  
Sbjct: 145 RDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA 201

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D WS+GA+++ ++TG PPF G N+ +    IL   +L  PP     L  +  DL + LL
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-KLNLPPY----LTQEARDLLKKLL 256

Query: 252 RQNPVERI-----TFKEFFNHRF 269
           ++N   R+        E   H F
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPF 279

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  195 bits (498), Expect = 8e-57
 Identities = 71/259 (27%), Positives = 138/259 (53%), Gaps = 15/259 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   R +  G   A+K + K+ +++     + + E  +L    HP +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  + +++RD+K
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132

Query: 137 PQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLW 195
            +NL++  +     +KI DFG  +  ++      T CG+P Y+APE+++++ Y    D W
Sbjct: 133 LENLMLDKDG---HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189

Query: 196 SVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNP 255
            +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++P
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRT----LSPEAKSLLAGLLKKDP 244

Query: 256 VERI-----TFKEFFNHRF 269
            +R+       KE   HRF
Sbjct: 245 KQRLGGGPSDAKEVMEHRF 263

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  194 bits (496), Expect = 1e-56
 Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 17/261 (6%)

Query: 18  IGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           +G GSF  V+  +           A+K + K  L  +       E  IL  ++HP I++ 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
             A +T  K+YL+L++  GGDL   + K    +E   + ++ +LA  L  L    +I+RD
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
           LKP+N+L+        +K+ DFG ++ S+  +  A + CG+  YMAPE++    +   AD
Sbjct: 152 LKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 208

Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQ 253
            WS G ++F+++TG  PF G ++ +    IL + +L  P      L P+   L R L ++
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-KLGMPQF----LSPEAQSLLRMLFKR 263

Query: 254 NPVERI-----TFKEFFNHRF 269
           NP  R+       +E   H F
Sbjct: 264 NPANRLGAGPDGVEEIKRHSF 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  193 bits (492), Expect = 1e-56
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 15/258 (5%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H NI+ 
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           F     T  ++ +V ++C+G  L  ++H    K          RQ A G+  L  K +IH
Sbjct: 85  FMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL---CGSPLYMAPEIIQN---H 186
           RDLK  N+ +  +     +KIGDFG A   +    +       GS L+MAPE+I+    +
Sbjct: 144 RDLKSNNIFLHED---NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI-EELHPDCVD 245
            Y  ++D+++ G +L++L+TG+ P+   N       ++    L      +          
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260

Query: 246 LCRCLLRQNPVERITFKE 263
           L    L++   ER +F  
Sbjct: 261 LMAECLKKKRDERPSFPR 278

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  195 bits (497), Expect = 5e-56
 Identities = 39/327 (11%), Positives = 85/327 (25%), Gaps = 56/327 (17%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK------------------- 45
           R R     + G  +G         A  ++ G    V                        
Sbjct: 76  RPRT---LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132

Query: 46  ----KLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY-------CDGG 94
                + + K +   L+ I     +  P   +          ++++  +        +  
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192

Query: 95  D----LAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPV 150
                L ++   H  +          Q+   L  L    L+H  L+P ++++        
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG---G 249

Query: 151 LKIGDFGFARSL--TPQDLADTLCGSPLYMAPEIIQNHK-----YDAKADLWSVGAILFQ 203
           + +  F        +           P   A  ++   +          D W++G  ++ 
Sbjct: 250 VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309

Query: 204 LVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
           +     P      L   + I  S +   P             L    LR    +R+   +
Sbjct: 310 IWCADLPNTDDAALGGSEWIFRSCK-NIP--------QPVRALLEGFLRYPKEDRLLPLQ 360

Query: 264 FFNHRFLGELRQTVHAEQHSVVPETKP 290
                   +LR  + A       + +P
Sbjct: 361 AMETPEYEQLRTELSAALPLYQTDGEP 387

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  192 bits (491), Expect = 5e-56
 Identities = 52/266 (19%), Positives = 98/266 (36%), Gaps = 26/266 (9%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +G  IG G F  V+  R      EVA++ ID +  +        +E+       H N++ 
Sbjct: 37  IGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           F  A  +   + ++   C G  L + +      +     R   +++  G+  L  K ++H
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD------TLCGSPLYMAPEIIQNH 186
           +DLK +N+     +V     I DFG                     G   ++APEII+  
Sbjct: 154 KDLKSKNVFYDNGKV----VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 187 K---------YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
                     +   +D++++G I ++L   + PF       +   + T  +         
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ---I 266

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKE 263
            +  +  D+          ER TF +
Sbjct: 267 GMGKEISDILLFCWAFEQEERPTFTK 292

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  196 bits (500), Expect = 5e-56
 Identities = 72/260 (27%), Positives = 136/260 (52%), Gaps = 16/260 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G+F  V   + +  G   A+K + K+ +++     + L E  +L    HP +     
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDL 135
           + +T +++  V+EY +GG+L  ++ +    SE  AR +  ++ + L  L  +  +++RDL
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K +NL++  +     +KI DFG  +  +       T CG+P Y+APE+++++ Y    D 
Sbjct: 276 KLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L   LL+++
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRT----LGPEAKSLLSGLLKKD 387

Query: 255 PVERI-----TFKEFFNHRF 269
           P +R+       KE   HRF
Sbjct: 388 PKQRLGGGSEDAKEIMQHRF 407

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  193 bits (492), Expect = 6e-56
 Identities = 75/259 (28%), Positives = 128/259 (49%), Gaps = 17/259 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILST-ISHPNIIRFF 75
           +G GSF  V+ A  ++     A+K + K  +L     +  + E  +LS    HP +   F
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T+E ++ V+EY +GGDL  +I    K   + A  +  ++  GLQ L  K +++RDL
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+  +     +KI DFG  + ++      +T CG+P Y+APEI+   KY+   D 
Sbjct: 145 KLDNILLDKDGH---IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           WS G +L++++ G+ PF G ++ +LF +I       +P      L  +  DL   L  + 
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRW----LEKEAKDLLVKLFVRE 256

Query: 255 PVERITFKE------FFNH 267
           P +R+  +        F  
Sbjct: 257 PEKRLGVRGDIRQHPLFRE 275

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  191 bits (488), Expect = 7e-56
 Identities = 79/259 (30%), Positives = 133/259 (51%), Gaps = 18/259 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GSF  V++    +    VA+K ID +    ++ D + +EI++LS    P + +++ 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYG 87

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +     K+++++EY  GG     + + G + E      +R++  GL  L  +  IHRD+K
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146

Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
             N+L+S + EV    K+ DFG A  LT  Q   +T  G+P +MAPE+I+   YD+KAD+
Sbjct: 147 AANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 202

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP---DCVDLCRCLL 251
           WS+G    +L  G+PP    + +++   I  +     PP           + V+ C   L
Sbjct: 203 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEAC---L 255

Query: 252 RQNPVERITFKEFFNHRFL 270
            + P  R T KE   H+F+
Sbjct: 256 NKEPSFRPTAKELLKHKFI 274

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  192 bits (491), Expect = 2e-55
 Identities = 78/259 (30%), Positives = 137/259 (52%), Gaps = 15/259 (5%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILS-TISHPNIIRFF 75
           IG GSF  V  ARH+   +  AVK + KK +L  K   +++ E ++L   + HP ++   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
            + +T +K+Y VL+Y +GG+L  ++ +     E  AR +  ++A+ L  L   ++++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFA-RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           KP+N+L+ +      + + DFG    ++       T CG+P Y+APE++    YD   D 
Sbjct: 166 KPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W +GA+L++++ G PPF   N  +++ NIL    L+  P     +      L   LL+++
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPN----ITNSARHLLEGLLQKD 277

Query: 255 PVERI----TFKEFFNHRF 269
             +R+     F E  +H F
Sbjct: 278 RTKRLGAKDDFMEIKSHVF 296

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  190 bits (486), Expect = 3e-55
 Identities = 86/308 (27%), Positives = 140/308 (45%), Gaps = 54/308 (17%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK--VSDNLLKEISILS 64
             I  Y    ++G G++  V++A        VA+K I  +L   +  V    ++E+S+L 
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--RLEHEEEGVPGTAIREVSLLK 88

Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
            + H NII     I    +++L+ EY +  DL  Y+ K+  VS  V + F+ QL  G+  
Sbjct: 89  ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 125 LQEKHLIHRDLKPQNLLVSTNEV--TPVLKIGDFGFARSLTPQDLADTLCGSPL------ 176
              +  +HRDLKPQNLL+S ++   TPVLKIGDFG AR+           G P+      
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----------FGIPIRQFTHE 197

Query: 177 -----YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ--NIL-TS 226
                Y  PEI+  +  Y    D+WS+  I  +++   P F G +++ QLF+   +L   
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257

Query: 227 TE----------------LRFPPGAIEE-----LHPDCVDLCRCLLRQNPVERITFKEFF 265
            +                 +F    ++      L  + +DL   +L  +PV+RI+ K   
Sbjct: 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317

Query: 266 NHRFLGEL 273
            H +    
Sbjct: 318 EHPYFSHN 325

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  189 bits (483), Expect = 3e-55
 Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 19/265 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI-LSTISHPNIIRFF 75
            +G G++ VV + RH   G  +AVK I    ++ +    LL ++ I + T+  P  + F+
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 76  EAIETREKIYLVLEYCDGG---DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LI 131
            A+     +++ +E  D          I K   + E +       +   L+ L  K  +I
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132

Query: 132 HRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII----QNH 186
           HRD+KP N+L++   +V    K+ DFG +  L      D   G   YMAPE I       
Sbjct: 133 HRDVKPSNVLINALGQV----KMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
            Y  K+D+WS+G  + +L   + P+D      Q  + ++     + P         D   
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 248

Query: 246 LCRCLLRQNPVERITFKEFFNHRFL 270
            C   L++N  ER T+ E   H F 
Sbjct: 249 QC---LKKNSKERPTYPELMQHPFF 270

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  190 bits (484), Expect = 4e-55
 Identities = 74/315 (23%), Positives = 140/315 (44%), Gaps = 53/315 (16%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y    +IG GS+ VV++ R+R  G  VA+K+  +    P +    L+EI +L  + HPN
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKH 129
           ++   E    + +++LV EYCD   +   + ++ + V E + +    Q    +    + +
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------YM 178
            IHRD+KP+N+L++ +    V+K+ DFGFAR L            P            Y 
Sbjct: 123 CIHRDVKPENILITKHS---VIKLCDFGFARLL----------TGPSDYYDDEVATRWYR 169

Query: 179 APEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-TSTE----- 228
           +PE++  + +Y    D+W++G +  +L++G P + G +   QL L +  L          
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229

Query: 229 ---------LRFPP--------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG 271
                    ++ P              +    + L +  L  +P ER+T ++  +H +  
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

Query: 272 ELRQTVHAEQHSVVP 286
            +R+     +    P
Sbjct: 290 NIREIEDLAKEHDKP 304

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  190 bits (484), Expect = 4e-55
 Identities = 65/265 (24%), Positives = 117/265 (44%), Gaps = 20/265 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISIL-STISHPNIIRFF 75
            +GSG+   VW+ R R+ G  +AVK++ +   + + +  +L ++ ++  +   P I++ F
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRD 134
               T   +++ +E              G + E +       +   L  L+EKH +IHRD
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150

Query: 135 LKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ-----NHKY 188
           +KP N+L+    ++    K+ DFG +  L      D   G   YMAPE I         Y
Sbjct: 151 VKPSNILLDERGQI----KLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206

Query: 189 DAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELH--PDCVD 245
           D +AD+WS+G  L +L TG+ P+       ++   +L       PP     +    D   
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE----PPLLPGHMGFSGDFQS 262

Query: 246 LCRCLLRQNPVERITFKEFFNHRFL 270
             +  L ++  +R  + +   H F+
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFI 287

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  191 bits (487), Expect = 4e-55
 Identities = 78/244 (31%), Positives = 129/244 (52%), Gaps = 11/244 (4%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTI-SHPNIIRFF 75
           +G GSF  V  AR ++ G   AVK + K  +L     +  + E  ILS   +HP + + F
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T ++++ V+E+ +GGDL  +I K  +  EA AR +  ++ + L  L +K +I+RDL
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+         K+ DFG  +  +       T CG+P Y+APEI+Q   Y    D 
Sbjct: 151 KLDNVLLDHEGH---CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W++G +L++++ G  PF+  N+  LF+ IL   E+ +P      LH D   + +  + +N
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EVVYPT----WLHEDATGILKSFMTKN 262

Query: 255 PVER 258
           P  R
Sbjct: 263 PTMR 266

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  190 bits (485), Expect = 9e-55
 Identities = 73/260 (28%), Positives = 135/260 (51%), Gaps = 16/260 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTI-SHPNIIRFF 75
           +G GSF  V  +  +      AVK + K  ++     +  + E  +L+     P + +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T +++Y V+EY +GGDL  +I + G+  E  A  +  ++A GL  LQ K +I+RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+++ +      +KI DFG  + ++       T CG+P Y+APEII    Y    D 
Sbjct: 148 KLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W+ G +L++++ G+ PF+G ++ +LFQ+I+    + +P      +  + V +C+ L+ ++
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPKS----MSKEAVAICKGLMTKH 259

Query: 255 PVERI-----TFKEFFNHRF 269
           P +R+       ++   H F
Sbjct: 260 PGKRLGCGPEGERDIKEHAF 279

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  185 bits (473), Expect = 1e-53
 Identities = 82/284 (28%), Positives = 137/284 (48%), Gaps = 32/284 (11%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y +   IGSG+ AVV  A       +VA+K I+ +     + + LLKEI  +S   HPN
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPN 74

Query: 71  IIRFFEAIETREKIYLVLEYCDGG---DL-----AAYIHKHGKVSEAVARHFMRQLAAGL 122
           I+ ++ +   +++++LV++   GG   D+     A   HK G + E+     +R++  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 123 QVLQEKHLIHRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLT------PQDLADTLCGSP 175
           + L +   IHRD+K  N+L+  +  V    +I DFG +  L          +  T  G+P
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSV----QIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 176 LYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST--ELRFP 232
            +MAPE+++  + YD KAD+WS G    +L TG  P+     +++    L +    L   
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250

Query: 233 PGAIEELHP------DCVDLCRCLLRQNPVERITFKEFFNHRFL 270
               E L          + LC   L+++P +R T  E   H+F 
Sbjct: 251 VQDKEMLKKYGKSFRKMISLC---LQKDPEKRPTAAELLRHKFF 291

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  185 bits (473), Expect = 2e-53
 Identities = 74/310 (23%), Positives = 131/310 (42%), Gaps = 53/310 (17%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y     +G GS+ +V + R++  G  VA+K+  +      V    ++EI +L  + H N
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKH 129
           ++   E  + +++ YLV E+ D   +   +      +   V + ++ Q+  G+      +
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-----------YM 178
           +IHRD+KP+N+LVS +    V+K+ DFGFAR+L           +P            Y 
Sbjct: 145 IIHRDIKPENILVSQSG---VVKLCDFGFARTL----------AAPGEVYDDEVATRWYR 191

Query: 179 APEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-TSTE----- 228
           APE++  + KY    D+W++G ++ ++  G+P F G +   QL      L          
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251

Query: 229 ---------LRFPPGAIEE--------LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG 271
                    +R P     E        L    +DL +  L  +P +R    E  +H F  
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

Query: 272 ELRQTVHAEQ 281
                    Q
Sbjct: 312 MDGFAERFSQ 321

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  191 bits (488), Expect = 3e-53
 Identities = 67/249 (26%), Positives = 120/249 (48%), Gaps = 17/249 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G F  V   + R  G   A K+++KK +   K     L E  IL  ++   ++    
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQLAAGLQVLQEKHLIHRD 134
           A ET++ + LVL   +GGDL  +I+  G+    EA A  +  ++  GL+ L  + +++RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311

Query: 135 LKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKAD 193
           LKP+N+L+  +  +    +I D G A  +          G+  YMAPE+++N +Y    D
Sbjct: 312 LKPENILLDDHGHI----RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367

Query: 194 LWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
            W++G +L++++ G+ PF    +     ++ + +       +         P    LC  
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYSER----FSPQARSLCSQ 422

Query: 250 LLRQNPVER 258
           LL ++P ER
Sbjct: 423 LLCKDPAER 431

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  185 bits (473), Expect = 3e-53
 Identities = 75/270 (27%), Positives = 134/270 (49%), Gaps = 26/270 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTI-SHPNIIRFF 75
           IG GS+A V   R ++     A+K + K+ +   +  D +  E  +     +HP ++   
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T  +++ V+EY +GGDL  ++ +  K+ E  AR +  +++  L  L E+ +I+RDL
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ +      +K+ D+G  +  L P D   T CG+P Y+APEI++   Y    D 
Sbjct: 137 KLDNVLLDSEG---HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193

Query: 195 WSVGAILFQLVTGKPPF---------DGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           W++G ++F+++ G+ PF         D + +  LFQ IL   ++R P      L      
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRS----LSVKAAS 248

Query: 246 LCRCLLRQNPVERI------TFKEFFNHRF 269
           + +  L ++P ER+       F +   H F
Sbjct: 249 VLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  190 bits (485), Expect = 5e-53
 Identities = 72/319 (22%), Positives = 142/319 (44%), Gaps = 26/319 (8%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +G G F  V+  + +  G   A K+++KK L   K     + E  IL+ +    I+    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 77  AIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
           A ET+  + LV+   +GGD+  +I+     +    E  A  +  Q+ +GL+ L ++++I+
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFA-RSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           RDLKP+N+L+  +     ++I D G A      Q       G+P +MAPE++   +YD  
Sbjct: 313 RDLKPENVLLDDDGN---VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQL----QLFQNILTSTELRFPPGAIEELHPDCVDLC 247
            D +++G  L++++  + PF    +     +L Q +L    + +P        P   D C
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYPDK----FSPASKDFC 424

Query: 248 RCLLRQNPVERI-----TFKEFFNHRFLGELR-QTVHAEQHSVVPETKPMVELLNSSTPE 301
             LL+++P +R+     +      H    ++  + +  E   + P   P    + +   +
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL--EAGMLTPPFVPDSRTVYAKNIQ 482

Query: 302 DRHSLHSEHPTNSSSKNPK 320
           D  +  +         + +
Sbjct: 483 DVGAFSTVKGVAFEKADTE 501

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  184 bits (468), Expect = 8e-53
 Identities = 64/267 (23%), Positives = 115/267 (43%), Gaps = 19/267 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI-LSTISHPNIIRFF 75
            IG G++  V +  H+  G  +AVK I    +  K    LL ++ + + +   P I++F+
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIH----KHGKVSEAVARHFMRQLAAGLQVLQEKH-L 130
            A+      ++ +E         Y +        + E +           L  L+E   +
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147

Query: 131 IHRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLC-GSPLYMAPEIIQ---- 184
           IHRD+KP N+L+  +  +    K+ DFG +  L    +A T   G   YMAPE I     
Sbjct: 148 IHRDIKPSNILLDRSGNI----KLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDC 243
              YD ++D+WS+G  L++L TG+ P+   ++       ++     +       E  P  
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262

Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFL 270
           ++     L ++  +R  +KE   H F+
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFI 289

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  182 bits (464), Expect = 1e-52
 Identities = 73/258 (28%), Positives = 131/258 (50%), Gaps = 15/258 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+   V+ A     G EVA+++++ +   PK    ++ EI ++    +PNI+ + +
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKEL-IINEILVMRENKNPNIVNYLD 84

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    +++++V+EY  GG L   +     + E       R+    L+ L    +IHRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143

Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQNHKYDAKADL 194
             N+L+  +  V    K+ DFGF   +TP+     T+ G+P +MAPE++    Y  K D+
Sbjct: 144 SDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTST--ELRFPPGAIEELHPDCVDLCRCLLR 252
           WS+G +  +++ G+PP+   N L+    I T+   EL+ P         D ++ C   L 
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR-DFLNRC---LE 255

Query: 253 QNPVERITFKEFFNHRFL 270
            +  +R + KE   H+FL
Sbjct: 256 MDVEKRGSAKELLQHQFL 273

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  183 bits (468), Expect = 2e-52
 Identities = 89/314 (28%), Positives = 133/314 (42%), Gaps = 57/314 (18%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----- 55
           M  +       Y     +G G FA V++AR +     VA+K+I  KL     + +     
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRT 58

Query: 56  LLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHF 114
            L+EI +L  +SHPNII   +A   +  I LV ++ +  DL   I  +  V + +  + +
Sbjct: 59  ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY 117

Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
           M     GL+ L +  ++HRDLKP NLL+  N    VLK+ DFG A+S           GS
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG---VLKLADFGLAKSF----------GS 164

Query: 175 PL-----------YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQL 219
           P            Y APE++     Y    D+W+VG IL +L+   P   G +   QL  
Sbjct: 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 224

Query: 220 -FQNILTSTEL---------------RFPPGAIEE----LHPDCVDLCRCLLRQNPVERI 259
            F+ + T TE                 FP   +         D +DL + L   NP  RI
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284

Query: 260 TFKEFFNHRFLGEL 273
           T  +    ++    
Sbjct: 285 TATQALKMKYFSNR 298

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  191 bits (486), Expect = 2e-52
 Identities = 73/260 (28%), Positives = 135/260 (51%), Gaps = 16/260 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTI-SHPNIIRFF 75
           +G GSF  V  +  +      AVK + K  ++     +  + E  +L+     P + +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T +++Y V+EY +GGDL  +I + G+  E  A  +  ++A GL  LQ K +I+RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+++ +      +KI DFG  + ++       T CG+P Y+APEII    Y    D 
Sbjct: 469 KLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 525

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQN 254
           W+ G +L++++ G+ PF+G ++ +LFQ+I+    + +P      +  + V +C+ L+ ++
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPKS----MSKEAVAICKGLMTKH 580

Query: 255 PVERI-----TFKEFFNHRF 269
           P +R+       ++   H F
Sbjct: 581 PGKRLGCGPEGERDIKEHAF 600

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  182 bits (464), Expect = 3e-52
 Identities = 71/258 (27%), Positives = 132/258 (51%), Gaps = 15/258 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG GS  +V  AR +  G +VAVK +D  L   +  + L  E+ I+    H N++  ++
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           +    E++++++E+  GG L   I    +++E         +   L  L  + +IHRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168

Query: 137 PQNLLVSTN-EVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQNHKYDAKADL 194
             ++L++ +  V    K+ DFGF   ++       +L G+P +MAPE+I    Y  + D+
Sbjct: 169 SDSILLTLDGRV----KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224

Query: 195 WSVGAILFQLVTGKPPFDGSNQLQLFQNILTST--ELRFPPGAIEELHPDCVDLCRCLLR 252
           WS+G ++ ++V G+PP+   + +Q  + +  S   +L+        L  D ++     L 
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR-DFLERM---LV 280

Query: 253 QNPVERITFKEFFNHRFL 270
           ++P ER T +E  +H FL
Sbjct: 281 RDPQERATAQELLDHPFL 298

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  181 bits (461), Expect = 4e-52
 Identities = 88/302 (29%), Positives = 143/302 (47%), Gaps = 56/302 (18%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK--VSDNLLKEISILSTISH 68
           +Y    +IG G++ VV++A++   G   A+K+I  +L      +    ++EISIL  + H
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKI--RLEKEDEGIPSTTIREISILKELKH 59

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQE 127
            NI++ ++ I T++++ LV E+ D  DL   +    G +    A+ F+ QL  G+    +
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL----------- 176
           + ++HRDLKPQNLL++       LKI DFG AR+           G P+           
Sbjct: 119 RRVLHRDLKPQNLLINREG---ELKIADFGLARAF----------GIPVRKYTHEIVTLW 165

Query: 177 YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ--NIL-TSTE--- 228
           Y AP+++  + KY    D+WSVG I  ++V G P F G ++  QL +   IL T      
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225

Query: 229 -------------LRFPPGAIEE----LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG 271
                          + P   E     L    +DL   +L+ +P +RIT K+   H +  
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

Query: 272 EL 273
           E 
Sbjct: 286 EN 287

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  184 bits (470), Expect = 4e-52
 Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 18/263 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   RH+      A+K + K  ++    S    +E  I++  + P +++ F 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLK 136
           A +    +Y+V+EY  GGDL   +     V E  AR +  ++   L  +     IHRD+K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 137 PQNLLVSTNEVTPVLKIGDFGFARSLTPQ--DLADTLCGSPLYMAPEIIQNH----KYDA 190
           P N+L+  +     LK+ DFG    +  +     DT  G+P Y++PE++++      Y  
Sbjct: 196 PDNMLLDKSGH---LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 252

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVDLCRC 249
           + D WSVG  L++++ G  PF   + +  +  I+     L FP     ++  +  +L   
Sbjct: 253 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN--DISKEAKNLICA 310

Query: 250 LLRQNPVERIT---FKEFFNHRF 269
            L  +   R+     +E   H F
Sbjct: 311 FLT-DREVRLGRNGVEEIKRHLF 332

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  184 bits (468), Expect = 6e-52
 Identities = 74/270 (27%), Positives = 134/270 (49%), Gaps = 26/270 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTI-SHPNIIRFF 75
           IG GS+A V   R ++     A++ + K+ +   +  D +  E  +     +HP ++   
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
              +T  +++ V+EY +GGDL  ++ +  K+ E  AR +  +++  L  L E+ +I+RDL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFAR-SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADL 194
           K  N+L+ +      +K+ D+G  +  L P D   T CG+P Y+APEI++   Y    D 
Sbjct: 180 KLDNVLLDSEG---HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236

Query: 195 WSVGAILFQLVTGKPPF---------DGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           W++G ++F+++ G+ PF         D + +  LFQ IL   ++R P      L      
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPR----SLSVKAAS 291

Query: 246 LCRCLLRQNPVERI------TFKEFFNHRF 269
           + +  L ++P ER+       F +   H F
Sbjct: 292 VLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  180 bits (459), Expect = 1e-51
 Identities = 81/303 (26%), Positives = 143/303 (47%), Gaps = 57/303 (18%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK--VSDNLLKEISILSTISH 68
           +Y    ++G G++ VV++A+  Q G  VA+K I  +L +    +    ++EIS+L  + H
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRI--RLDAEDEGIPSTAIREISLLKELHH 78

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQE 127
           PNI+   + I +   + LV E+ +  DL   + ++     ++  + ++ QL  G+    +
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL----------- 176
             ++HRDLKPQNLL++++     LK+ DFG AR+           G P+           
Sbjct: 138 HRILHRDLKPQNLLINSDG---ALKLADFGLARAF----------GIPVRSYTHEVVTLW 184

Query: 177 YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ--NIL-TSTE--- 228
           Y AP+++  + KY    D+WS+G I  +++TGKP F G     QL +  +IL T      
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244

Query: 229 -----------LRFPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                        F           I     + +DL   +L  +P +RI+ ++  NH + 
Sbjct: 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

Query: 271 GEL 273
            +L
Sbjct: 305 KDL 307

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  182 bits (464), Expect = 3e-51
 Identities = 66/267 (24%), Positives = 118/267 (44%), Gaps = 20/267 (7%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F+ V   + +Q G   A+K ++K  +L         +E  +L       I +   
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV+EY  GGDL   + K G ++   +AR ++ ++   +  +     +HRD+
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQN-------H 186
           KP N+L+        +++ DFG    L       +    G+P Y++PEI+Q         
Sbjct: 189 KPDNILLDRCGH---IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVD 245
            Y  + D W++G   +++  G+ PF   +  + +  I+   E L  P    E +  +  D
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD-EGVPEEARD 304

Query: 246 LCRCLLRQNPVERIT---FKEFFNHRF 269
             + LL   P  R+      +F  H F
Sbjct: 305 FIQRLL-CPPETRLGRGGAGDFRTHPF 330

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  179 bits (456), Expect = 3e-51
 Identities = 77/314 (24%), Positives = 122/314 (38%), Gaps = 63/314 (20%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL-----LKEIS 61
                Y     IG G++  V++AR    G  VA+K +  ++ +            ++E++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVA 63

Query: 62  IL---STISHPNIIRFFEAIETRE-----KIYLVLEYCDGGDLAAYIHKHGKV--SEAVA 111
           +L       HPN++R  +   T       K+ LV E+ D  DL  Y+ K           
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122

Query: 112 RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL 171
           +  MRQ   GL  L    ++HRDLKP+N+LV++      +K+ DFG AR           
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---TVKLADFGLARI---------- 169

Query: 172 CGSPL----------YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQ 218
               +          Y APE++    Y    D+WSVG I  ++   KP F G++   QL 
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 229

Query: 219 L-FQNILTSTE--------------LRFPPGAIEE----LHPDCVDLCRCLLRQNPVERI 259
             F  I    E                  P  ++     +      L   +L  NP +RI
Sbjct: 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI 289

Query: 260 TFKEFFNHRFLGEL 273
           +      H +L + 
Sbjct: 290 SAFRALQHSYLHKD 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  179 bits (456), Expect = 5e-51
 Identities = 92/340 (27%), Positives = 146/340 (42%), Gaps = 59/340 (17%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISH 68
            YI   ++G G++A V++ + +     VA+KEI  + +  +P  +   ++E+S+L  + H
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA---IREVSLLKDLKH 59

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQE 127
            NI+   + I T + + LV EY D  DL  Y+   G + +    + F+ QL  GL     
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL----------- 176
           + ++HRDLKPQNLL++       LK+ DFG AR+             P            
Sbjct: 119 QKVLHRDLKPQNLLINERG---ELKLADFGLARAK----------SIPTKTYDNEVVTLW 165

Query: 177 YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ--NIL-TSTE--- 228
           Y  P+I+  +  Y  + D+W VG I +++ TG+P F GS    QL     IL T TE   
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225

Query: 229 -----------LRFPPGAIEELH-------PDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                        +P    E L         D  DL   LL+     RI+ ++   H F 
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

Query: 271 GELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEH 310
             L + +H  +         + E+        R + H  H
Sbjct: 286 LSLGERIH--KLPDTTSIFALKEIQLQKEASLRSAHHHHH 323

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  177 bits (452), Expect = 7e-51
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 56/303 (18%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK--VSDNLLKEISILSTISH 68
           +Y    +IG G++  V++A++R+    VA+K +  +L      V  + L+EI +L  + H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELKH 60

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQE 127
            NI+R  + + + +K+ LV E+CD  DL  Y           + + F+ QL  GL     
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL----------- 176
           ++++HRDLKPQNLL++ N     LK+ +FG AR+           G P+           
Sbjct: 120 RNVLHRDLKPQNLLINRNG---ELKLANFGLARAF----------GIPVRCYSAEVVTLW 166

Query: 177 YMAPEII-QNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQL-QLFQ--NIL-TSTE-- 228
           Y  P+++     Y    D+WS G I  +L   G+P F G++   QL +   +L T TE  
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 229 --------------LRFPPGAIEE----LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                         +     ++      L+    DL + LL+ NPV+RI+ +E   H + 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

Query: 271 GEL 273
            + 
Sbjct: 287 SDF 289

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  178 bits (453), Expect = 9e-51
 Identities = 90/308 (29%), Positives = 143/308 (46%), Gaps = 70/308 (22%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS----PKVSDNLLKEISILSTISHPNII 72
           ++G+G++A V++  ++  G+ VA+KE+  KL S    P  +   ++EIS++  + H NI+
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTA---IREISLMKELKHENIV 66

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV------SEAVARHFMRQLAAGLQVLQ 126
           R ++ I T  K+ LV E+ D  DL  Y+               + ++F  QL  GL    
Sbjct: 67  RLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---------- 176
           E  ++HRDLKPQNLL++       LK+GDFG AR+           G P+          
Sbjct: 126 ENKILHRDLKPQNLLINKRG---QLKLGDFGLARAF----------GIPVNTFSSEVVTL 172

Query: 177 -YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-QLFQ--NIL-TSTE-- 228
            Y AP+++  +  Y    D+WS G IL +++TGKP F G+N   QL    +I+ T  E  
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232

Query: 229 -----------------------LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFF 265
                                      P   E L  + +D    LL+ NP  R++ K+  
Sbjct: 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292

Query: 266 NHRFLGEL 273
           +H +  E 
Sbjct: 293 HHPWFAEY 300

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  177 bits (451), Expect = 1e-50
 Identities = 70/258 (27%), Positives = 129/258 (50%), Gaps = 10/258 (3%)

Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILS 64
             +   Y +  ++G G  + V+ A    L I+VA+K I        +      +E+   S
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66

Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
            +SH NI+   +  E  +  YLV+EY +G  L+ YI  HG +S   A +F  Q+  G++ 
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEI 182
             +  ++HRD+KPQN+L+ +N+    LKI DFG A++L+   L  T  + G+  Y +PE 
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNK---TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183

Query: 183 IQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILTSTELRFPPGAIEELHP 241
            +    D   D++S+G +L++++ G+PPF+G   + +  ++I     +      + +  P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI--QDSVPNVTTDVRKDIP 241

Query: 242 DCVD-LCRCLLRQNPVER 258
             +  +      ++   R
Sbjct: 242 QSLSNVILRATEKDKANR 259

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  177 bits (451), Expect = 2e-50
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 16/215 (7%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN------LLKEI 60
              G Y +   +G G    V+ A        VA+K     L+S  +S +      + +E 
Sbjct: 31  TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALK-----LMSETLSSDPVFRTRMQREA 85

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
                +  P+++   +  E   ++Y+ +   +G DLAA + + G ++   A   +RQ+ +
Sbjct: 86  RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYM 178
            L         HRD+KP+N+LVS ++      + DFG A + T + L       G+  YM
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADD---FAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDG 213
           APE         +AD++++  +L++ +TG PP+ G
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  181 bits (460), Expect = 2e-50
 Identities = 65/265 (24%), Positives = 126/265 (47%), Gaps = 18/265 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           IG G+F  V   + +      A+K ++K  +L    +    +E  +L       I     
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A +    +YLV++Y  GGDL   + K   ++ E +AR ++ ++   +  + + H +HRD+
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQ-----NHKY 188
           KP N+L+  N     +++ DFG    L       +    G+P Y++PEI+Q       +Y
Sbjct: 202 KPDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFP-PGAIEELHPDCVDLC 247
             + D WS+G  +++++ G+ PF   + ++ +  I+ + + RF  P  + ++  +  DL 
Sbjct: 259 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-NHKERFQFPTQVTDVSENAKDLI 317

Query: 248 RCLLRQNPVERIT---FKEFFNHRF 269
           R L+      R+     ++F  H F
Sbjct: 318 RRLICSRE-HRLGQNGIEDFKKHPF 341

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  186 bits (473), Expect = 2e-50
 Identities = 73/249 (29%), Positives = 122/249 (48%), Gaps = 17/249 (6%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTIS---HPNIIR 73
           IG G F  V+  R    G   A+K +DKK +   +     L E  +LS +S    P I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHR 133
              A  T +K+  +L+  +GGDL  ++ +HG  SEA  R +  ++  GL+ +  + +++R
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316

Query: 134 DLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ-NHKYDAKA 192
           DLKP N+L+  +     ++I D G A     +       G+  YMAPE++Q    YD+ A
Sbjct: 317 DLKPANILLDEHG---HVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSA 372

Query: 193 DLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           D +S+G +LF+L+ G  PF       + ++ +  LT   +  P        P+   L   
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDS----FSPELRSLLEG 427

Query: 250 LLRQNPVER 258
           LL+++   R
Sbjct: 428 LLQRDVNRR 436

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  176 bits (449), Expect = 3e-50
 Identities = 73/259 (28%), Positives = 135/259 (52%), Gaps = 17/259 (6%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G GS+  V++A H++ G  VA+K++    +   + + ++KEISI+     P++++++ 
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQE-IIKEISIMQQCDSPHVVKYYG 91

Query: 77  AIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           +      +++V+EYC  G ++  I  ++  ++E      ++    GL+ L     IHRD+
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151

Query: 136 KPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQNHKYDAKAD 193
           K  N+L++T        K+ DFG A  LT      +T+ G+P +MAPE+IQ   Y+  AD
Sbjct: 152 KAGNILLNTEGHA----KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVAD 207

Query: 194 LWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST--ELRFPPGAIEELHPDCVDLCRCLL 251
           +WS+G    ++  GKPP+   + ++    I T+     R P    +    D V  C   L
Sbjct: 208 IWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT-DFVKQC---L 263

Query: 252 RQNPVERITFKEFFNHRFL 270
            ++P +R T  +   H F+
Sbjct: 264 VKSPEQRATATQLLQHPFV 282

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  175 bits (445), Expect = 1e-49
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
            +G G+F  V++A++++ G   A K I+ K    ++ D  + EI IL+T  HP I++   
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELED-YIVEIEILATCDHPYIVKLLG 83

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
           A     K+++++E+C GG + A + +  +  +E   +   RQ+   L  L  K +IHRDL
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDL 143

Query: 136 KPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEII-----QNHKY 188
           K  N+L++   ++    ++ DFG +          D+  G+P +MAPE++     ++  Y
Sbjct: 144 KAGNVLMTLEGDI----RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST--ELRFPPGAIEELHPDCVDL 246
           D KAD+WS+G  L ++   +PP    N +++   I  S    L  P     E   D + +
Sbjct: 200 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR-DFLKI 258

Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
               L +NP  R +  +   H F+
Sbjct: 259 A---LDKNPETRPSAAQLLEHPFV 279

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  175 bits (447), Expect = 1e-49
 Identities = 88/340 (25%), Positives = 140/340 (41%), Gaps = 63/340 (18%)

Query: 1   ME-PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIE-VAVKEIDKKLLSPK--VSDNL 56
           ME     R   +Y     IG G++  V++AR  + G   VA+K +  ++ + +  +  + 
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLST 58

Query: 57  LKEISIL---STISHPNIIRFFEAIETRE-----KIYLVLEYCDGGDLAAYIHKHGKV-- 106
           ++E+++L    T  HPN++R F+           K+ LV E+ D  DL  Y+ K  +   
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117

Query: 107 SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
                +  M QL  GL  L    ++HRDLKPQN+LV+++     +K+ DFG AR      
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARI----- 169

Query: 167 LADTLCGSPL----------YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN- 215
                    +          Y APE++    Y    DLWSVG I  ++   KP F GS+ 
Sbjct: 170 -----YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

Query: 216 --QLQL-FQNILTSTE--------------LRFPPGAIEE----LHPDCVDLCRCLLRQN 254
             QL      I    E                     IE+    +     DL    L  N
Sbjct: 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284

Query: 255 PVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVEL 294
           P +RI+     +H +  +L +         +P ++   EL
Sbjct: 285 PAKRISAYSALSHPYFQDLERCKENLDSH-LPPSQNTSEL 323

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  176 bits (448), Expect = 1e-49
 Identities = 68/271 (25%), Positives = 134/271 (49%), Gaps = 27/271 (9%)

Query: 18  IGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSD--NLLKEISILSTISH-PNI 71
           +G+G++  V+  R       G   A+K + K  +  K     +   E  +L  I   P +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +    A +T  K++L+L+Y +GG+L  ++ +  + +E   + ++ ++   L+ L +  +I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARS--LTPQDLADTLCGSPLYMAPEIIQNHK-- 187
           +RD+K +N+L+ +N     + + DFG ++       + A   CG+  YMAP+I++     
Sbjct: 182 YRDIKLENILLDSNG---HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDG----SNQLQLFQNILTSTELRFPPGAIEELHPDC 243
           +D   D WS+G ++++L+TG  PF      ++Q ++ + IL S E  +P      +    
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQE----MSALA 293

Query: 244 VDLCRCLLRQNPVERI-----TFKEFFNHRF 269
            DL + LL ++P +R+        E   H F
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  174 bits (444), Expect = 3e-49
 Identities = 75/322 (23%), Positives = 141/322 (43%), Gaps = 52/322 (16%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFF 75
            +G+G++  V++ RH + G   A+K +D   ++    + + +EI++L   S H NI  ++
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 76  EA------IETREKIYLVLEYCDGG---DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            A          ++++LV+E+C  G   DL     K   + E    +  R++  GL  L 
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIAYICREILRGLSHLH 146

Query: 127 EKHLIHRDLKPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDL-ADTLCGSPLYMAPEIIQ 184
           +  +IHRD+K QN+L++ N EV    K+ DFG +  L       +T  G+P +MAPE+I 
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202

Query: 185 NHK-----YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
             +     YD K+DLWS+G    ++  G PP    + ++    I  +      P     L
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP----AP----RL 254

Query: 240 HP--------DCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPM 291
                       ++ C   L +N  +R   ++   H F+ +                  +
Sbjct: 255 KSKKWSKKFQSFIESC---LVKNHSQRPATEQLMKHPFIRDQPNERQV--------RIQL 303

Query: 292 VELLNSSTPEDRHSLHSEHPTN 313
            + ++ +  +      +E+  +
Sbjct: 304 KDHIDRTKKKRGEKDETEYEYS 325

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  175 bits (445), Expect = 3e-49
 Identities = 77/259 (29%), Positives = 114/259 (44%), Gaps = 15/259 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLL-KEISILSTISHPNIIRFF 75
            IG GSF  V+ AR  +    VA+K++             + KE+  L  + HPN I++ 
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
                    +LV+EYC G            + E            GL  L   ++IHRD+
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 180

Query: 136 KPQNLLVSTN-EVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK---YDAK 191
           K  N+L+S    V    K+GDFG A  + P   A++  G+P +MAPE+I       YD K
Sbjct: 181 KAGNILLSEPGLV----KLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGK 233

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D+WS+G    +L   KPP    N +    +I  +       G   E   + VD C   L
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC---L 290

Query: 252 RQNPVERITFKEFFNHRFL 270
           ++ P +R T +    HRF+
Sbjct: 291 QKIPQDRPTSEVLLKHRFV 309

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  176 bits (449), Expect = 4e-49
 Identities = 101/380 (26%), Positives = 157/380 (41%), Gaps = 65/380 (17%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHP 69
           Y     IG+GSF VV++A+    G  VA+K++  DK+           +E+ I+  + H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--------NRELQIMRKLDHC 107

Query: 70  NIIR----FFEAIETREK--IYLVLEYCDGGDLAAYIHKHGK----VSEAVARHFMRQLA 119
           NI+R    F+ + E +++  + LVL+Y     +      + +    +     + +M QL 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLYM 178
             L  +    + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +     +C S  Y 
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYYR 223

Query: 179 APEIIQN-HKYDAKADLWSVGAILFQLVTGKPPF---DGSNQLQLFQNIL---------- 224
           APE+I     Y +  D+WS G +L +L+ G+P F    G +QL     +L          
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283

Query: 225 ---TSTELRFP---PGAIEE-----LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                TE +FP        +       P+ + LC  LL   P  R+T  E   H F  EL
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

Query: 274 RQTVHAEQHSVVPETKPMVELLN------SSTPEDRHSLHSEH----PTNSSSKNPKSAC 323
           R     + +  +P  +    L N      SS P     L   H       S+  N  +A 
Sbjct: 344 R-----DPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAAS 398

Query: 324 SSACDKVILNTGDQGNSLST 343
            +              S S 
Sbjct: 399 DANTGDRGQTNNAASASASN 418

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  176 bits (448), Expect = 4e-49
 Identities = 94/352 (26%), Positives = 149/352 (42%), Gaps = 62/352 (17%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHP 69
           Y     IG+GSF VV++A+  +   EVA+K++  DK+           +E+ I+  + HP
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKR--------FKNRELQIMRIVKHP 92

Query: 70  NIIR----FFEAIETRE--KIYLVLEYCDGGDLAAYIHKHGK----VSEAVARHFMRQLA 119
           N++     F+   + ++   + LVLEY     +      + K    +   + + +M QL 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLYM 178
             L  +    + HRD+KPQNLL+  +  + VLK+ DFG A+ L   +     +C S  Y 
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSYIC-SRYYR 208

Query: 179 APEIIQN-HKYDAKADLWSVGAILFQLVTGKPPF---DGSNQLQLFQNIL---------- 224
           APE+I     Y    D+WS G ++ +L+ G+P F    G +QL     +L          
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268

Query: 225 ---TSTELRFP---PGAIEE-----LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
                 E +FP   P    +       PD +DL   LL   P  R+T  E   H F  EL
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

Query: 274 RQTVHAEQHSVVPETKPMVELLN------SSTPEDRHSLHSEHPTNSSSKNP 319
           R        + +P  + +  L N      S  P+    L  +H         
Sbjct: 329 R-----TGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRG 375

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  171 bits (435), Expect = 3e-48
 Identities = 69/273 (25%), Positives = 126/273 (46%), Gaps = 26/273 (9%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----- 55
           M      L   Y +G  +G G  + V  AR  +   +VAVK     +L   ++ +     
Sbjct: 4   MTTPSH-LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK-----VLRADLARDPSFYL 57

Query: 56  -LLKEISILSTISHPNIIRFF----EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAV 110
              +E    + ++HP I+  +             Y+V+EY DG  L   +H  G ++   
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117

Query: 111 ARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT 170
           A   +      L    +  +IHRD+KP N+++S       +K+ DFG AR++     + T
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVT 174

Query: 171 ----LCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL-FQNILT 225
               + G+  Y++PE  +    DA++D++S+G +L++++TG+PPF G + + + +Q++  
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-- 232

Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVER 258
             +   P    E L  D   +    L +NP  R
Sbjct: 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  171 bits (435), Expect = 4e-48
 Identities = 57/269 (21%), Positives = 114/269 (42%), Gaps = 25/269 (9%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEA 77
             +       + +     I +  +  D  L SP   D    +I  +   S  N +   + 
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129

Query: 78  IETREKIYLVLEYCDGGDLAAYIHKHGKVS---EAVARHFMRQLAAGLQVLQEKHLIHRD 134
              +  +Y+ ++ C   +L  ++++   +      V  H   Q+A  ++ L  K L+HRD
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL-------------CGSPLYMAPE 181
           LKP N+  + ++V   +K+GDFG   ++   +   T+              G+ LYM+PE
Sbjct: 190 LKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP 241
            I  + Y  K D++S+G ILF+L+          ++++  ++     L+FP     + +P
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVR---NLKFPLL-FTQKYP 300

Query: 242 DCVDLCRCLLRQNPVERITFKEFFNHRFL 270
               + + +L  +P ER    +   +   
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  167 bits (426), Expect = 2e-46
 Identities = 76/305 (24%), Positives = 132/305 (43%), Gaps = 49/305 (16%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           + V    G G+F  V   + +  G+ VA+K++   +  P+  +  L+ +  L+ + HPNI
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNI 81

Query: 72  IR---FFEAIETREK----IYLVLEYCDGGDLAAYIHKHGK----VSEAVARHFMRQLAA 120
           ++   +F  +  R++    + +V+EY     L      + +        + + F+ QL  
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 121 GLQVL--QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLY 177
            +  L     ++ HRD+KP N+LV  NE    LK+ DFG A+ L+P +     +C S  Y
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAYIC-SRYY 197

Query: 178 MAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPF---DGSNQLQLFQNIL--------- 224
            APE+I     Y    D+WSVG I  +++ G+P F   + + QL     +L         
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257

Query: 225 ----TSTELRFP-----------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
               + T++                   +   +  DL   LL+  P ER+   E   H +
Sbjct: 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317

Query: 270 LGELR 274
             EL 
Sbjct: 318 FDELH 322

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  165 bits (421), Expect = 5e-46
 Identities = 72/278 (25%), Positives = 135/278 (48%), Gaps = 30/278 (10%)

Query: 3   PN--RTRLIGEY--IVGPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSD 54
           PN    R++ E        +GSG+F  V++      G    I VA+KE+ ++  SPK + 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANK 62

Query: 55  NLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARH 113
            +L E  +++++ +P++ R    I     + L+ +    G L  Y+ +H   +      +
Sbjct: 63  EILDEAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
           +  Q+A G+  L+++ L+HRDL  +N+LV T +    +KI DFG A+ L  ++      G
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEG 178

Query: 174 S--PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTEL 229
              P+ +MA E I +  Y  ++D+WS G  +++L+T G  P+DG    ++   +     L
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238

Query: 230 RFPPGAIEELHPDCVDLCRCLLRQ----NPVERITFKE 263
             PP    +++         ++R+    +   R  F+E
Sbjct: 239 PQPPICTIDVY--------MIMRKCWMIDADSRPKFRE 268

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  165 bits (420), Expect = 1e-45
 Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 50/310 (16%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK--VSDNLLKEISILS 64
             + +Y    +IG G+F  V++ARHR+ G +VA+K++   + + K       L+EI IL 
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQ 71

Query: 65  TISHPNIIRFFEAI--------ETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFM 115
            + H N++   E            +  IYLV ++C+  DLA  + +   K + +  +  M
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
           + L  GL  +    ++HRD+K  N+L++ +    VLK+ DFG AR+ +    +     + 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 176 L-----YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL-T 225
                 Y  PE++     Y    DLW  G I+ ++ T  P   G+    QL L   +  +
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247

Query: 226 STE--------------LRFPPGAIEELH---------PDCVDLCRCLLRQNPVERITFK 262
            T               L    G   ++          P  +DL   LL  +P +RI   
Sbjct: 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 307

Query: 263 EFFNHRFLGE 272
           +  NH F   
Sbjct: 308 DALNHDFFWS 317

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  171 bits (434), Expect = 3e-45
 Identities = 59/268 (22%), Positives = 108/268 (40%), Gaps = 37/268 (13%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQL-GIEVAVKEIDKKLLSPKVSDNLLK- 58
           + P    + G+Y V   I  G    ++ A  R + G  V +K      L           
Sbjct: 72  LNPGDI-VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-----GLVHSGDAEAQAM 125

Query: 59  ---EISILSTISHPNIIRFFEAIETREKI-----YLVLEYCDGGDLAAYIHKHGKVSEAV 110
              E   L+ + HP+I++ F  +E  ++      Y+V+EY  G  L     +   V+EA+
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI 185

Query: 111 ARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT 170
           A  ++ ++   L  L    L++ DLKP+N++++  ++    K+ D G    +        
Sbjct: 186 A--YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQL----KLIDLGAVSRINS---FGY 236

Query: 171 LCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR 230
           L G+P + APEI++        D+++VG  L  L    P  +G               L 
Sbjct: 237 LYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGR----------YVDGLP 285

Query: 231 FPPGAIEELHPDCVDLCRCLLRQNPVER 258
                + + +     L R  +  +P +R
Sbjct: 286 EDDPVL-KTYDSYGRLLRRAIDPDPRQR 312

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  162 bits (413), Expect = 5e-45
 Identities = 72/308 (23%), Positives = 140/308 (45%), Gaps = 31/308 (10%)

Query: 15  GPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
              +GSG+F  V++      G    I VA+KE+ ++  SPK +  +L E  +++++ +P+
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPH 78

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           + R    I     + L+ +    G L  Y+ +H   +      ++  Q+A G+  L+++ 
Sbjct: 79  VCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNH 186
           L+HRDL  +N+LV T +    +KI DFG A+ L  ++      G  +   +MA E I + 
Sbjct: 138 LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 187 KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
            Y  ++D+WS G  +++L+T G  P+DG    ++   +     L  PP    +++     
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY----- 249

Query: 246 LCRCLLRQ----NPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPE 301
               ++ +    +   R  F+E        E  +     Q  +V +    + L + +   
Sbjct: 250 ---MIMVKCWMIDADSRPKFRELII-----EFSKMARDPQRYLVIQGDERMHLPSPTDSN 301

Query: 302 DRHSLHSE 309
              +L  E
Sbjct: 302 FYRALMDE 309

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  164 bits (416), Expect = 1e-44
 Identities = 75/345 (21%), Positives = 132/345 (38%), Gaps = 87/345 (25%)

Query: 1   MEPNRTRLIGEY-IVGPRIGSGSFAVVWRARHRQL--GIEVAVKEIDKKLLSPKVSDNLL 57
           +   R R+   +   G ++G G++  V++A+ +      + A+K+I+       +S +  
Sbjct: 11  LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----GISMSAC 66

Query: 58  KEISILSTISHPNIIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHG---------KV 106
           +EI++L  + HPN+I   +        K++L+ +Y +  DL   I  H          ++
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125

Query: 107 SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP-VLKIGDFGFARSLTPQ 165
              + +  + Q+  G+  L    ++HRDLKP N+LV         +KI D GFAR     
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR----- 180

Query: 166 DLADTLCGSPL--------------YMAPEII-QNHKYDAKADLWSVGAILFQLVTGKPP 210
                L  SPL              Y APE++     Y    D+W++G I  +L+T +P 
Sbjct: 181 -----LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235

Query: 211 FDGSN------------QL-------------------------QLFQNILTSTELRFPP 233
           F                QL                          L ++   +T      
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 295

Query: 234 GAIEELH-----PDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL 273
               E H          L + LL  +P++RIT ++     +  E 
Sbjct: 296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  160 bits (406), Expect = 2e-44
 Identities = 69/292 (23%), Positives = 133/292 (45%), Gaps = 23/292 (7%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRA--RHRQLGIEVAVKEIDKKLLSPKVSDNLLKE 59
             +R  L    +    +GSG+F  V +   + +++   VAVK +  +   P + D LL E
Sbjct: 12  YLDRKLLT---LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68

Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
            +++  + +P I+R    I   E   LV+E  + G L  Y+ ++  V +      + Q++
Sbjct: 69  ANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 127

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS---PL 176
            G++ L+E + +HRDL  +N+L+ T       KI DFG +++L   +           P+
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPV 184

Query: 177 -YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPG 234
            + APE I  +K+ +K+D+WS G ++++  + G+ P+ G    ++   +     +  P G
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 244

Query: 235 AIEELHPDCVDL-CRCLLRQNPVERITFKE---FFNHRFLGELRQTVHAEQH 282
              E++    DL   C    +   R  F        + +   + +  H   H
Sbjct: 245 CPREMY----DLMNLC-WTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH 291

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  163 bits (413), Expect = 2e-44
 Identities = 60/364 (16%), Positives = 124/364 (34%), Gaps = 66/364 (18%)

Query: 12  YIVGPRIGSG--SFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           Y +   IG G      V  AR++  G  V V+ I+ +  S ++   L  E+ +    +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYI--HKHGKVSEAVARHFMRQLAAGLQVLQE 127
           NI+ +        ++++V  +   G     I  H    ++E    + ++ +   L  +  
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146

Query: 128 KHLIHRDLKPQNLLVSTN-EVTPVLKIGDFGFARSL--------TPQDLADTLCGSPLYM 178
              +HR +K  ++L+S + +V     +       S+           D          ++
Sbjct: 147 MGYVHRSVKASHILISVDGKV----YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 179 APEIIQ--NHKYDAKADLWSVGAILFQLVTGKPPF--------------------DGSNQ 216
           +PE++Q     YDAK+D++SVG    +L  G  PF                      ++ 
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262

Query: 217 LQLFQNILTSTELRFPPGAIEELHP------------------------DCVDLCRCLLR 252
           +   +  ++ +      G  + L                            V+ C   L+
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC---LQ 319

Query: 253 QNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSLHSEHPT 312
           +NP  R +     NH F  ++++        ++    P+     S + +           
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNL 379

Query: 313 NSSS 316
               
Sbjct: 380 EELE 383

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  160 bits (408), Expect = 4e-44
 Identities = 88/309 (28%), Positives = 136/309 (44%), Gaps = 54/309 (17%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEID--KKLLSPKVSDNLLKEISILSTISHP 69
           + +   +G G++ VV  A H+  G  VA+K+I+   K L        L+EI IL    H 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL---RTLREIKILKHFKHE 69

Query: 70  NIIRFFEAI-----ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
           NII  F        E   ++Y++ E     DL   I     +S+   ++F+ Q    ++V
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLSDDHIQYFIYQTLRAVKV 127

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-------- 176
           L   ++IHRDLKP NLL+++N     LK+ DFG AR +      ++              
Sbjct: 128 LHGSNVIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184

Query: 177 ---YMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL----- 224
              Y APE++    KY    D+WS G IL +L   +P F G    +QL L   I+     
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244

Query: 225 -------TSTELR--------FPPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFF 265
                   S   R        +P   +E++    +P  +DL + +L  +P +RIT KE  
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304

Query: 266 NHRFLGELR 274
            H +L    
Sbjct: 305 EHPYLQTYH 313

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  161 bits (409), Expect = 5e-44
 Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 49/307 (15%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
            Y     IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H N
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85

Query: 71  IIRFFEAI------ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
           II            E  + +Y+V+E  D  +L   I    ++      + + Q+  G++ 
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKH 142

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           L    +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I 
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199

Query: 185 NHKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQL---------------------- 219
              Y    D+WSVG I+ +++ G   F G+   +Q                         
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259

Query: 220 ------------FQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                       F+ +             +       DL   +L  +  +RI+  E   H
Sbjct: 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319

Query: 268 RFLGELR 274
            ++    
Sbjct: 320 PYINVWY 326

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  158 bits (402), Expect = 8e-44
 Identities = 50/237 (21%), Positives = 86/237 (36%), Gaps = 33/237 (13%)

Query: 7   RLIGEYIV-GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           R +   I     +G G +  VWR   +  G  VAVK    +      S     E+     
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEK---SWFRETELYNTVM 58

Query: 66  ISHPNIIRFFEA----IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
           + H NI+ F  +      +  +++L+  Y + G L  Y+     +        +  +A+G
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASG 117

Query: 122 LQVLQEKHL--------IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL-- 171
           L  L  +           HRDLK +N+LV  N       I D G A   +       +  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG---QCCIADLGLAVMHSQSTNQLDVGN 174

Query: 172 ---CGSPLYMAPEIIQNH------KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL 219
               G+  YMAPE++             + D+W+ G +L+++             + 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  158 bits (401), Expect = 2e-43
 Identities = 81/313 (25%), Positives = 133/313 (42%), Gaps = 62/313 (19%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI--DKKLLSPKVSDNLLKEISILSTISHP 69
           Y+    +G G   +V+ A        VA+K+I               L+EI I+  + H 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA----LREIKIIRRLDHD 68

Query: 70  NIIRFFEAI--------------ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM 115
           NI++ FE +                   +Y+V EY +  DLA  + + G + E  AR FM
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFM 126

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
            QL  GL+ +   +++HRDLKP NL +  N    VLKIGDFG AR + P           
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMDPHYSHKGH---- 180

Query: 176 L--------YMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNI 223
           L        Y +P ++ + + Y    D+W+ G I  +++TGK  F G+    Q+QL    
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

Query: 224 L---TSTELRF---------------PPGAIEEL----HPDCVDLCRCLLRQNPVERITF 261
           +      + +                P   + +L      + VD    +L  +P++R+T 
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 262 KEFFNHRFLGELR 274
           +E  +H ++    
Sbjct: 301 EEALSHPYMSIYS 313

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  157 bits (400), Expect = 3e-43
 Identities = 62/274 (22%), Positives = 114/274 (41%), Gaps = 28/274 (10%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLL 57
               T L         +GSG F  V +      G    I V +K I +     +    + 
Sbjct: 9   IFKETELR----KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT 63

Query: 58  KEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMR 116
             +  + ++ H +I+R    +     + LV +Y   G L  ++ +H G +   +  ++  
Sbjct: 64  DHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
           Q+A G+  L+E  ++HR+L  +N+L+ +      +++ DFG A  L P D       +  
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPS---QVQVADFGVADLLPPDDKQLLYSEAKT 179

Query: 177 ---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFP 232
              +MA E I   KY  ++D+WS G  +++L+T G  P+ G    ++   +     L  P
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP 239

Query: 233 PGAIEELHP---DCVDLCRCLLRQNPVERITFKE 263
                +++     C          +   R TFKE
Sbjct: 240 QICTIDVYMVMVKC-------WMIDENIRPTFKE 266

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  157 bits (400), Expect = 1e-42
 Identities = 84/378 (22%), Positives = 141/378 (37%), Gaps = 89/378 (23%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +G  +G+GSF +V      + G   A+K++   L  P+      +E+ I+  + H NI
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYK---NRELDIMKVLDHVNI 62

Query: 72  IR----FFEAIETREK----------------------------------IYLVLEYCDG 93
           I+    F+   +   K                                  + +++EY   
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 94  GDLAAYIHKHGK----VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTP 149
             L   +    +    +   +   ++ QL   +  +    + HRD+KPQNLLV  N    
Sbjct: 123 -TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--NSKDN 179

Query: 150 VLKIGDFGFARSLTP-QDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTG 207
            LK+ DFG A+ L P +     +C S  Y APE++    +Y    DLWS+G +  +L+ G
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 208 KPPF---DGSNQLQLFQNIL-------------TSTELRFPPGAIEELH--------PDC 243
           KP F      +QL     I+               TE+RFP    ++             
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELR----QTVHAEQHSVVPETKPMVEL----- 294
           +DL   +LR  P  RI   E   H F   LR      V    +      + + +L     
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSP 358

Query: 295 --LNSSTPEDRHSLHSEH 310
             L+       + +  ++
Sbjct: 359 YELSIIPGNVLNRILPKN 376

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  155 bits (395), Expect = 2e-42
 Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 47/301 (15%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPN 70
           Y +  ++G G ++ V+ A +     +V VK +      P     + +EI IL  +   PN
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPN 92

Query: 71  IIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           II   + +         LV E+ +  D          +++   R +M ++   L      
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM 149

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK- 187
            ++HRD+KP N+++  +     L++ D+G A    P    +    S  +  PE++ +++ 
Sbjct: 150 GIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207

Query: 188 YDAKADLWSVGAILFQLVTGKPPF----DGSNQLQLFQNILTSTELR------------- 230
           YD   D+WS+G +L  ++  K PF    D  +QL     +L + +L              
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267

Query: 231 ----------------FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                                   + P+ +D    LLR +   R+T +E   H +   + 
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327

Query: 275 Q 275
           +
Sbjct: 328 K 328

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  156 bits (397), Expect = 2e-42
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 47/299 (15%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y+    +GSG++  V  A  ++ G +VA+K++ +   S   +    +E+ +L  + H N+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 72  IRFFEAI------ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           I   +              YLV+ +    DL   +    K SE   ++ + Q+  GL+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYI 142

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD---TLCGSPLYMAPEI 182
               ++HRDLKP NL V+ +     LKI DFG AR     ++     T      Y APE+
Sbjct: 143 HSAGVVHRDLKPGNLAVNED---CELKILDFGLARHADA-EMTGYVVTR----WYRAPEV 194

Query: 183 IQN-HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL---TSTELRF---- 231
           I +   Y+   D+WSVG I+ +++TGK  F G    +QL     +     +  ++     
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254

Query: 232 ------------PPGAIEELHP----DCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                       P     +L P       DL   +L  +  +R+T  +   H F    R
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  156 bits (397), Expect = 2e-42
 Identities = 79/306 (25%), Positives = 122/306 (39%), Gaps = 48/306 (15%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVS---DNL------LKEISI 62
           Y V   I SGS+  V      + GI VA+K +   +   +      +       L+EI +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 63  LSTISHPNIIRFFEAI-----ETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMR 116
           L+   HPNI+   +           K+YLV E     DLA  IH +   +S    ++FM 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
            +  GL VL E  ++HRDL P N+L++ N     + I DF  AR  T             
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADN---NDITICDFNLAREDTADANKTHYVTHRW 198

Query: 177 YMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL---TSTEL 229
           Y APE++     +    D+WS G ++ ++   K  F GS   NQL     ++      ++
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258

Query: 230 RF-----------------PPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHR 268
                              P  A   +     P  +DL   +L  NP  RI+ ++   H 
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318

Query: 269 FLGELR 274
           +   L 
Sbjct: 319 YFESLF 324

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  155 bits (393), Expect = 3e-42
 Identities = 63/289 (21%), Positives = 100/289 (34%), Gaps = 49/289 (16%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
             +IG G +  VW  + R  G +VAVK       +   S     EI     + H NI+ F
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGF 96

Query: 75  FEAIE----TREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
             A      +  ++YL+ +Y + G L  Y+     +             +GL  L  +  
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 131 --------IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL-----CGSPLY 177
                    HRDLK +N+LV  N       I D G A           +      G+  Y
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 178 MAPEII------QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE--- 228
           M PE++       + +    AD++S G IL+++           + QL  + L  ++   
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 229 -------------LRFPPG-AIEELHPDCVDLCRCLLRQNPVERITFKE 263
                          FP   + +E       L       NP  R+T   
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  156 bits (396), Expect = 3e-42
 Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 19/266 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           +IG G+F  V+  R R     VAVK   ++ L P +    L+E  IL   SHPNI+R   
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
               ++ IY+V+E   GGD   ++   G ++        +   AAG++ L+ K  IHRDL
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLY----MAPEIIQNHKYDAK 191
             +N LV+      VLKI DFG +R      +     G         APE +   +Y ++
Sbjct: 240 AARNCLVTEKN---VLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 192 ADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRC 249
           +D+WS G +L++  + G  P+   +  Q  + +     L  P    + +      L  +C
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF----RLMEQC 351

Query: 250 LLRQNPVERITFKEFFNHRFLGELRQ 275
                P +R +F     ++ L  +R+
Sbjct: 352 -WAYEPGQRPSFSTI--YQELQSIRK 374

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  155 bits (395), Expect = 4e-42
 Identities = 76/304 (25%), Positives = 127/304 (41%), Gaps = 56/304 (18%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y     +GSG++  V  A   + G +VA+K++ +   S   +    +E+ +L  + H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 72  IRFFEAI------ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           I   +        +     YLV+ +    DL   + KH K+ E   +  + Q+  GL+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-KHEKLGEDRIQFLVYQMLKGLRYI 144

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL--------Y 177
               +IHRDLKP NL V+ +     LKI DFG AR    +          +        Y
Sbjct: 145 HAAGIIHRDLKPGNLAVNED---CELKILDFGLARQADSE----------MTGYVVTRWY 191

Query: 178 MAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL---TSTELR 230
            APE+I N  +Y    D+WSVG I+ +++TGK  F GS   +QL+    +     +  ++
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251

Query: 231 F----------------PPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                                   +     P  V+L   +L  +  +R+T  E   H + 
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

Query: 271 GELR 274
             L 
Sbjct: 312 ESLH 315

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  152 bits (387), Expect = 8e-42
 Identities = 64/280 (22%), Positives = 128/280 (45%), Gaps = 21/280 (7%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLG--IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           I    +G G+F  V +  +R     I+VA+K + K+      ++ +++E  I+  + +P 
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPY 71

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           I+R    +   E + LV+E   GG L  ++     ++  +     + Q++ G++ L+EK+
Sbjct: 72  IVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS---PL-YMAPEIIQN 185
            +HRDL  +N+L+         KI DFG +++L   D   T   +   PL + APE I  
Sbjct: 131 FVHRDLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 186 HKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
            K+ +++D+WS G  +++ ++ G+ P+      ++   I     +  PP    EL+    
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY---- 243

Query: 245 DL-CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHS 283
            L   C       +R  F      + +     ++ ++   
Sbjct: 244 ALMSDC-WIYKWEDRPDFLTV--EQRMRACYYSLASKVEG 280

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  152 bits (385), Expect = 1e-41
 Identities = 42/259 (16%), Positives = 75/259 (28%), Gaps = 34/259 (13%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKL-LSPKVSDNLLKEIS 61
           P      G Y +    G       W+A    L  +VA+  +D +  L   V    L    
Sbjct: 24  PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL 83

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
            LS I  P + R  + + TR    +V E+  GG L            A+    M+ LAA 
Sbjct: 84  RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAA 141

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
                   +      P  + VS +     + +                        M   
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDG---DVVLAYPA-------------------TMPDA 179

Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPP--GAIEEL 239
                  + + D+  +GA L+ L+  + P   +            T  +         ++
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232

Query: 240 HPDCVDLCRCLLRQNPVER 258
                 +    ++ +   R
Sbjct: 233 PFQISAVAARSVQGDGGIR 251

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  154 bits (390), Expect = 2e-41
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 44/298 (14%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y     +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90

Query: 72  IRFFEAI------ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           I   +        E    +YLV       DL   + K  K+++   +  + Q+  GL+ +
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-KCQKLTDDHVQFLIYQILRGLKYI 148

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ--DLADTLCGSPLYMAPEII 183
               +IHRDLKP NL V+ +     LKI DFG AR    +      T      Y APEI+
Sbjct: 149 HSADIIHRDLKPSNLAVNED---CELKILDFGLARHTADEMTGYVATR----WYRAPEIM 201

Query: 184 QN-HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL---TSTELRF----- 231
            N   Y+   D+WSVG I+ +L+TG+  F G+   +QL+L   ++    +  L+      
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261

Query: 232 -----------PPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                      P      +    +P  VDL   +L  +  +RIT  +   H +  +  
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  151 bits (384), Expect = 2e-41
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 21/259 (8%)

Query: 17  RIGSGSFAVVWRARHRQLG---IEVAVKEI-DKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G GSF VV R          + VAVK +    L  P+  D+ ++E++ + ++ H N+I
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           R    +     + +V E    G L   + KH G         +  Q+A G+  L+ K  I
Sbjct: 85  RL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI 143

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DLADTLCGSPL---YMAPEIIQNHK 187
           HRDL  +NLL++T +   ++KIGDFG  R+L    D         +   + APE ++   
Sbjct: 144 HRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE-LRFPPGAIEELHPDCVD 245
           +   +D W  G  L+++ T G+ P+ G N  Q+   I    E L  P    ++++    +
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY----N 256

Query: 246 L-CRCLLRQNPVERITFKE 263
           +  +C     P +R TF  
Sbjct: 257 VMVQC-WAHKPEDRPTFVA 274

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  151 bits (383), Expect = 2e-41
 Identities = 66/269 (24%), Positives = 134/269 (49%), Gaps = 23/269 (8%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEIS 61
           E  RT +     +  ++G G +  V+    ++  + VAVK + +  +     +  LKE +
Sbjct: 9   EMERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAA 61

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLA 119
           ++  I HPN+++           Y++ E+   G+L  Y+ +  +   +     +   Q++
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL--- 176
           + ++ L++K+ IHRDL  +N LV  N    ++K+ DFG +R +T  D      G+     
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENH---LVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177

Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           + APE +  +K+  K+D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G 
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 237

Query: 236 IEELHPDCVDL-CRCLLRQNPVERITFKE 263
            E+++    +L   C  + NP +R +F E
Sbjct: 238 PEKVY----ELMRAC-WQWNPSDRPSFAE 261

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  150 bits (381), Expect = 4e-41
 Identities = 66/255 (25%), Positives = 116/255 (45%), Gaps = 18/255 (7%)

Query: 17  RIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
            IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+I++
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               + T   +++++E C  G+L +++      +  A    +  QL+  L  L+ K  +H
Sbjct: 81  L-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 139

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG-SPL-YMAPEIIQNHKYDA 190
           RD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   ++ +
Sbjct: 140 RDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
            +D+W  G  +++++  G  PF G     +   I     L  PP     L+     L  +
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY----SLMTK 252

Query: 249 CLLRQNPVERITFKE 263
           C    +P  R  F E
Sbjct: 253 C-WAYDPSRRPRFTE 266

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  155 bits (393), Expect = 4e-41
 Identities = 87/409 (21%), Positives = 152/409 (37%), Gaps = 100/409 (24%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y +   IG+GS+  V  A  +     VA+K+I +          +L+EI+IL+ ++H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114

Query: 72  IRFF-----EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           ++       + +E  +++Y+VLE  D  D          ++E   +  +  L  G++ + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---------- 176
              ++HRDLKP N LV+ +     +K+ DFG AR++   +  ++                
Sbjct: 174 SAGILHRDLKPANCLVNQD---CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 177 ------------------YMAPEIIQN-HKYDAKADLWSVGAILFQLVT----------- 206
                             Y APE+I     Y    D+WS+G I  +L+            
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

Query: 207 GKPPFDGS-----------------------NQLQLFQNIL-----------TSTELR-- 230
             P F GS                       +QL +  NIL              + +  
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350

Query: 231 ------FPPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAE 280
                      + E       D + L + +L  NP +RIT  E   H F  E+R     E
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR-IAEVE 409

Query: 281 QHSVVPETKPMVELLNSSTPEDRHSLHSE----HPTNSSSKNPKSACSS 325
            ++      P  + +N   P+ R++   E    HP     +   +  SS
Sbjct: 410 TNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEIQLPRRSPNRASS 458

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  152 bits (387), Expect = 5e-41
 Identities = 82/306 (26%), Positives = 127/306 (41%), Gaps = 56/306 (18%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEI---DKKLLSPKVSDNLLKEISILSTISH 68
           Y     IG G++ +V  A      + VA+K+I   + +    +     L+EI IL    H
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT----LREIKILLRFRH 84

Query: 69  PNIIRFFEAI-----ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
            NII   + I     E  + +Y+V +  +  DL   +     +S     +F+ Q+  GL+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLK 142

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL------- 176
            +   +++HRDLKP NLL++T      LKI DFG AR   P           L       
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGF----LTEYVATR 195

Query: 177 -YMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQNIL---TSTE 228
            Y APEI+ N   Y    D+WSVG IL ++++ +P F G    +QL     IL   +  +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

Query: 229 LRF----------------PPGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHR 268
           L                         L        +DL   +L  NP +RI  ++   H 
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315

Query: 269 FLGELR 274
           +L +  
Sbjct: 316 YLEQYY 321

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  154 bits (391), Expect = 8e-41
 Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 49/306 (16%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y     IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  ++H NI
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123

Query: 72  IRFFEAI------ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           I            E  + +YLV+E  D  +L   I    ++      + + Q+  G++ L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHL 180

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
               +IHRDLKP N++V ++     LKI DFG AR+     +      +  Y APE+I  
Sbjct: 181 HSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 237

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQL----------------------- 219
             Y    D+WSVG I+ ++V  K  F G    +Q                          
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297

Query: 220 -----------FQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHR 268
                      F  +   +         +       DL   +L  +P +RI+  +   H 
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357

Query: 269 FLGELR 274
           ++    
Sbjct: 358 YINVWY 363

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  150 bits (381), Expect = 2e-40
 Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 32/229 (13%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
           +   IG G F  VWR + R  G EVAVK    +      S     EI     + H NI+ 
Sbjct: 46  LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILG 100

Query: 74  FFEAIETRE----KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           F  A         +++LV +Y + G L  Y++++  V+           A+GL  L  + 
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 159

Query: 130 L--------IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL-----CGSPL 176
           +         HRDLK +N+LV  N       I D G A           +      G+  
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 177 YMAPEII------QNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQL 219
           YMAPE++      ++ +   +AD++++G + +++             QL
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  149 bits (378), Expect = 2e-40
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 29/276 (10%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLK 58
            P+   +         IG G F  V+           I  AVK +  ++         L 
Sbjct: 21  GPSSLIVH----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT 75

Query: 59  EISILSTISHPNIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHG---KVSEAVARHF 114
           E  I+   SHPN++        +     +VL Y   GDL  +I        V + +   F
Sbjct: 76  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GF 133

Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--LADTLC 172
             Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  ++        
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKF---TVKVADFGLARDMYDKEYYSVHNKT 190

Query: 173 GSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE 228
           G+ L   +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   +   +L    
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250

Query: 229 LRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
           L  P    + L+    ++  +C        R +F E
Sbjct: 251 LLQPEYCPDPLY----EVMLKC-WHPKAEMRPSFSE 281

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  148 bits (376), Expect = 2e-40
 Identities = 65/284 (22%), Positives = 121/284 (42%), Gaps = 35/284 (12%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEIS 61
             N   L     +   IG G F  V    +R  G +VAVK I K   + +     L E S
Sbjct: 17  ALNMKELK----LLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KNDATAQ---AFLAEAS 66

Query: 62  ILSTISHPNIIRFFEAIETREK--IYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQ 117
           +++ + H N+++    +   EK  +Y+V EY   G L  Y+   G+          F   
Sbjct: 67  VMTQLRHSNLVQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125

Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +   ++ L+  + +HRDL  +N+LVS +    V K+ DFG  +     + + T     L 
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDFGLTK-----EASSTQDTGKLP 177

Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             + APE ++  K+  K+D+WS G +L+++ + G+ P+       +   +    ++  P 
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 237

Query: 234 GAIEELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           G    ++    ++   C    +   R +F +      L  ++  
Sbjct: 238 GCPPAVY----EVMKNC-WHLDAAMRPSFLQL--REQLEHIKTH 274

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  148 bits (376), Expect = 2e-40
 Identities = 60/265 (22%), Positives = 112/265 (42%), Gaps = 38/265 (14%)

Query: 17  RIGSGSFAVVWRAR---HRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
            +G G F  V+      H+   I VAVK   KK  +    +  + E  I+  + HP+I++
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               I   E  ++++E    G+L  Y+ ++   +       +  Q+   +  L+  + +H
Sbjct: 78  L-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVH 136

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLY------------MAP 180
           RD+  +N+LV++ E    +K+GDFG +R +  +D          Y            M+P
Sbjct: 137 RDIAVRNILVASPE---CVKLGDFGLSRYIEDED----------YYKASVTRLPIKWMSP 183

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           E I   ++   +D+W     ++++++ GK PF       +   +     L  P      L
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL 243

Query: 240 HPDCVDL-CRCLLRQNPVERITFKE 263
           +     L  RC    +P +R  F E
Sbjct: 244 Y----TLMTRC-WDYDPSDRPRFTE 263

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  153 bits (388), Expect = 4e-40
 Identities = 65/272 (23%), Positives = 134/272 (49%), Gaps = 21/272 (7%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEIS 61
           E  RT +     +  ++G G +  V+    ++  + VAVK + +  +     +  LKE +
Sbjct: 216 EMERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAA 268

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLA 119
           ++  I HPN+++           Y++ E+   G+L  Y+ +  +   +     +   Q++
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 328

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPL-Y 177
           + ++ L++K+ IHR+L  +N LV  N    ++K+ DFG +R +T     A      P+ +
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENH---LVKVADFGLSRLMTGDTYTAHAGAKFPIKW 385

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAI 236
            APE +  +K+  K+D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 445

Query: 237 EELHPDCVDL-CRCLLRQNPVERITFKEFFNH 267
           E+++    +L   C  + NP +R +F E    
Sbjct: 446 EKVY----ELMRAC-WQWNPSDRPSFAEIHQA 472

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  148 bits (377), Expect = 4e-40
 Identities = 71/257 (27%), Positives = 117/257 (45%), Gaps = 19/257 (7%)

Query: 17  RIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
            IGSG    V   R R  G   + VA+K + K   + +   + L E SI+    HPNIIR
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               +       +V EY + G L  ++  H G+ +       +R + AG++ L +   +H
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+LV +N    V K+ DFG +R L    D A T  G  +   + APE I    +
Sbjct: 175 RDLAARNVLVDSNL---VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231

Query: 189 DAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL- 246
            + +D+WS G ++++++  G+ P+       +  ++     L  P G    LH     L 
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH----QLM 287

Query: 247 CRCLLRQNPVERITFKE 263
             C   ++  +R  F +
Sbjct: 288 LDC-WHKDRAQRPRFSQ 303

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  150 bits (380), Expect = 5e-40
 Identities = 73/295 (24%), Positives = 137/295 (46%), Gaps = 21/295 (7%)

Query: 17  RIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
            +G+G F  V   R +      I VA+K + K   + K   + L E SI+    HPNIIR
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               +   + + +V EY + G L +++ KH  + +       +R +A+G++ L +   +H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPL---YMAPEIIQNHKY 188
           RDL  +N+L+++N    V K+ DFG  R L    + A T  G  +   + +PE I   K+
Sbjct: 171 RDLAARNILINSNL---VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227

Query: 189 DAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL- 246
            + +D+WS G +L+++++ G+ P+   +   + + +     L  P      L+     L 
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY----QLM 283

Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPE 301
             C  +++   R  F++      L +L +   + +       +P   LL+ S  +
Sbjct: 284 LDC-WQKDRNNRPKFEQI--VSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVD 335

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  150 bits (380), Expect = 7e-40
 Identities = 77/331 (23%), Positives = 135/331 (40%), Gaps = 73/331 (22%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPN 70
           Y +  ++G G++ +VW++  R+ G  VAVK+I     +   +    +EI IL+ +S H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 71  IIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           I+     +  +    +YLV +Y +  DL A I +   +     ++ + QL   ++ L   
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSG 128

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL------------ 176
            L+HRD+KP N+L++       +K+ DFG +RS              +            
Sbjct: 129 GLLHRDMKPSNILLNAE---CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185

Query: 177 ----------YMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGS---NQLQLFQN 222
                     Y APEI+    KY    D+WS+G IL +++ GKP F GS   NQL+    
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245

Query: 223 IL---TSTELRF----------------PPGAIEEL--------------------HPDC 243
           ++   ++ ++                                              + + 
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305

Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           +DL   LL+ NP +RI+  +   H F+    
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFH 336

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  146 bits (371), Expect = 8e-40
 Identities = 67/266 (25%), Positives = 128/266 (48%), Gaps = 21/266 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
            IGSG F +V          +VA+K I +  +S    ++ ++E  ++  +SHP +++ + 
Sbjct: 15  EIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYG 70

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
               +  I LV E+ + G L+ Y+    G  +          +  G+  L+E  +IHRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKA 192
             +N LV  N+   V+K+ DFG  R +   D   +  G+     + +PE+    +Y +K+
Sbjct: 131 AARNCLVGENQ---VIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCL 250
           D+WS G +++++ + GK P++  +  ++ ++I T   L  P  A   ++     +   C 
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY----QIMNHC- 241

Query: 251 LRQNPVERITFKEFFNHRFLGELRQT 276
            R+ P +R  F      R L E+ ++
Sbjct: 242 WRERPEDRPAFSRL--LRQLAEIAES 265

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  148 bits (375), Expect = 9e-40
 Identities = 60/268 (22%), Positives = 115/268 (42%), Gaps = 31/268 (11%)

Query: 17  RIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
            +G GSF +V+    + +        VA+K +  +  S +     L E S++   +  ++
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR----------HFMRQLAAG 121
           +R    +   +   +++E    GDL +Y+                          ++A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YM 178
           +  L     +HRDL  +N +V+ +     +KIGDFG  R +   D         L   +M
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SNQLQLFQNILTSTELRFPPGAI 236
           +PE +++  +   +D+WS G +L+++ T  + P+ G SN+ Q+ + ++    L  P    
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNCP 266

Query: 237 EELHPDCVDL-CRCLLRQNPVERITFKE 263
           + L     +L   C  + NP  R +F E
Sbjct: 267 DMLF----ELMRMC-WQYNPKMRPSFLE 289

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  154 bits (391), Expect = 9e-40
 Identities = 66/255 (25%), Positives = 116/255 (45%), Gaps = 18/255 (7%)

Query: 17  RIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR 73
            IG G F  V +  +       + VA+K   K   S  V +  L+E   +    HP+I++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 74  FFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               + T   +++++E C  G+L +++      +  A    +  QL+  L  L+ K  +H
Sbjct: 456 L-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG-SPL-YMAPEIIQNHKYDA 190
           RD+  +N+LVS+N+    +K+GDFG +R +          G  P+ +MAPE I   ++ +
Sbjct: 515 RDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CR 248
            +D+W  G  +++++  G  PF G     +   I     L  PP     L+     L  +
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY----SLMTK 627

Query: 249 CLLRQNPVERITFKE 263
           C    +P  R  F E
Sbjct: 628 C-WAYDPSRRPRFTE 641

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (377), Expect = 1e-39
 Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 29/276 (10%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLK 58
            P+   +         IG G F  V+           I  AVK +  ++         L 
Sbjct: 85  GPSSLIVH----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT 139

Query: 59  EISILSTISHPNIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHGK---VSEAVARHF 114
           E  I+   SHPN++        +     +VL Y   GDL  +I        V + +   F
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--GF 197

Query: 115 MRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS 174
             Q+A G++ L  K  +HRDL  +N ++        +K+ DFG AR +  ++       +
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKF---TVKVADFGLARDMYDKEFDSVHNKT 254

Query: 175 ----PL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE 228
               P+ +MA E +Q  K+  K+D+WS G +L++L+T G PP+   N   +   +L    
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314

Query: 229 LRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
           L  P    + L+    ++  +C        R +F E
Sbjct: 315 LLQPEYCPDPLY----EVMLKC-WHPKAEMRPSFSE 345

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  146 bits (371), Expect = 1e-39
 Identities = 63/264 (23%), Positives = 122/264 (46%), Gaps = 27/264 (10%)

Query: 15  GPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
              IG G F VV+   +       I+ A+K +  ++   +  +  L+E  ++  ++HPN+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 72  IRFFEAIETREK--IYLVLEYCDGGDLAAYIHKHGK---VSEAVARHFMRQLAAGLQVLQ 126
           +     I    +   +++L Y   GDL  +I    +   V + +   F  Q+A G++ L 
Sbjct: 85  LALI-GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI--SFGLQVARGMEYLA 141

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS----PL-YMAPE 181
           E+  +HRDL  +N ++  +     +K+ DFG AR +  ++            P+ + A E
Sbjct: 142 EQKFVHRDLAARNCMLDESF---TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 182 IIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
            +Q +++  K+D+WS G +L++L+T G PP+   +   L   +     L  P    + L+
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258

Query: 241 PDCVDL-CRCLLRQNPVERITFKE 263
                +  +C    +P  R TF+ 
Sbjct: 259 ----QVMQQC-WEADPAVRPTFRV 277

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  147 bits (373), Expect = 1e-39
 Identities = 61/271 (22%), Positives = 125/271 (46%), Gaps = 28/271 (10%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
            +G  +G G F  V  A+ +Q     ++VAVK +   +++    +  L+E + +    HP
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 70  NIIRFF------EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVA------RHFMRQ 117
           ++ +         A        ++L +   GDL A++                   FM  
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +A G++ L  ++ IHRDL  +N +++ +     + + DFG +R +   D     C S L 
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDM---TVCVADFGLSRKIYSGDYYRQGCASKLP 202

Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             ++A E + ++ Y   +D+W+ G  +++++T G+ P+ G    +++  ++    L+ PP
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP 262

Query: 234 GAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
             +EE++    DL  +C    +P +R +F  
Sbjct: 263 ECMEEVY----DLMYQC-WSADPKQRPSFTC 288

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  146 bits (370), Expect = 2e-39
 Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 38/277 (13%)

Query: 15  GPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
              +G G F  V   R+   G     +VAVK + K         +L KEI IL  + H N
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHEN 84

Query: 71  IIRFFEAI---ETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQ 126
           I+++ + I   +    I L++E+   G L  Y+ K+  K++      +  Q+  G+  L 
Sbjct: 85  IVKY-KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEI 182
            +  +HRDL  +N+LV +      +KIGDFG  +++              SP+ + APE 
Sbjct: 144 SRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 183 IQNHKYDAKADLWSVGAILFQLVT---------------GKPPFDGSNQLQLFQNILTST 227
           +   K+   +D+WS G  L +L+T                 P        +L   +    
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260

Query: 228 ELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
            L  PP   +E++     L  +C     P  R +F+ 
Sbjct: 261 RLPCPPNCPDEVY----QLMRKC-WEFQPSNRTSFQN 292

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  145 bits (368), Expect = 2e-39
 Identities = 77/269 (28%), Positives = 130/269 (48%), Gaps = 25/269 (9%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEIS 61
           E  R  L     +  R+G+G F  VW   +     +VAVK + +  +SP   D  L E +
Sbjct: 9   EVPRETLK----LVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEAN 60

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLA 119
           ++  + H  ++R + A+ T+E IY++ EY + G L  ++     +   + +      Q+A
Sbjct: 61  LMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL--- 176
            G+  ++E++ IHRDL+  N+LVS        KI DFG AR +   +      G+     
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTL---SCKIADFGLARLIE-DNEYTAREGAKFPIK 175

Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA 235
           + APE I    +  K+D+WS G +L ++VT G+ P+ G    ++ QN+     +  P   
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235

Query: 236 IEELHPDCVDL-CRCLLRQNPVERITFKE 263
            EEL+     L   C  ++ P +R TF  
Sbjct: 236 PEELY----QLMRLC-WKERPEDRPTFDY 259

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  146 bits (371), Expect = 3e-39
 Identities = 75/294 (25%), Positives = 137/294 (46%), Gaps = 24/294 (8%)

Query: 17  RIGSGSFAVVWRAR----HRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
            IG+G F  V++        +  + VA+K + K   + K   + L E  I+   SH NII
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 73  RFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           R    I   + + ++ EY + G L  ++ +  G+ S       +R +AAG++ L   + +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD-TLCGSPL---YMAPEIIQNHK 187
           HRDL  +N+LV++N    V K+ DFG +R L     A  T  G  +   + APE I   K
Sbjct: 170 HRDLAARNILVNSNL---VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           + + +D+WS G ++++++T G+ P+   SN  ++ + I     L  P      ++     
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTPMDCPSAIY----Q 281

Query: 246 L-CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSS 298
           L  +C  +Q    R  F +      L +L +   + +     + +  + L ++S
Sbjct: 282 LMMQC-WQQERARRPKFADI--VSILDKLIRAPDSLKTLADFDPRVSIRLPSTS 332

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  145 bits (368), Expect = 3e-39
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 42/288 (14%)

Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++  +  + +   +  +EI IL ++ H NI+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----LADTLCGSPL-YMAPEIIQ 184
            IHRDL  +N+LV        +KIGDFG  + L PQD           SP+ + APE + 
Sbjct: 135 YIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 185 NHKYDAKADLWSVGAILFQLVT----------------GKPPFDGSNQLQLFQNILTSTE 228
             K+   +D+WS G +L++L T                G           L + +  +  
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250

Query: 229 LRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           L  P G  +E++     +   C    N  +R +F++      + ++R 
Sbjct: 251 LPRPDGCPDEIY----MIMTEC-WNNNVNQRPSFRDL--ALRVDQIRD 291

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  144 bits (366), Expect = 3e-39
 Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 28/287 (9%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEIS 61
           E  R  +     +   +GSG F VV   + +    +VAVK I +  +S    D   +E  
Sbjct: 4   ELKREEIT----LLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSE---DEFFQEAQ 55

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAA 120
            +  +SHP +++F+        IY+V EY   G L  Y+  HG  +  +        +  
Sbjct: 56  TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---Y 177
           G+  L+    IHRDL  +N LV  +     +K+ DFG  R +   D   +  G+     +
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDL---CVKVSDFGMTRYVL-DDQYVSSVGTKFPVKW 171

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAI 236
            APE+    KY +K+D+W+ G +++++ + GK P+D     ++   +     L  P  A 
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS 231

Query: 237 EELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQH 282
           + ++     +   C   + P +R TF++      +  LR+    ++H
Sbjct: 232 DTIY----QIMYSC-WHELPEKRPTFQQL--LSSIEPLRE---KDKH 268

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  146 bits (370), Expect = 4e-39
 Identities = 76/286 (26%), Positives = 129/286 (45%), Gaps = 41/286 (14%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKE 59
           R  L      G  +G+G+F  V  A    LG     ++VAVK + K        + L+ E
Sbjct: 45  RNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSE 99

Query: 60  ISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR------ 112
           + I+S +  H NI+    A      + ++ EYC  GDL  ++ +  +V E          
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159

Query: 113 --------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP 164
                   HF  Q+A G+  L  K+ IHRD+  +N+L++      V KIGDFG AR +  
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMN 216

Query: 165 QD--LADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG--SNQLQ 218
               +       P+ +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G   N  +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-K 275

Query: 219 LFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
            ++ +    ++  P  A + ++     +   C     P  R TF++
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIY----SIMQAC-WALEPTHRPTFQQ 316

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (368), Expect = 5e-39
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 27/270 (10%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           I+G  +G G F  V     +Q     ++VAVK +     S +  +  L E + +   SHP
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 70  NIIRFF-----EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVA------RHFMRQL 118
           N+IR        + +   K  ++L +   GDL  Y+      +            FM  +
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL-- 176
           A G++ L  ++ +HRDL  +N ++  +     + + DFG ++ +   D       + +  
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDM---TVCVADFGLSKKIYSGDYYRQGRIAKMPV 213

Query: 177 -YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPG 234
            ++A E + +  Y +K+D+W+ G  ++++ T G  P+ G    +++  +L    L+ P  
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED 273

Query: 235 AIEELHPDCVDL-CRCLLRQNPVERITFKE 263
            ++EL+    ++   C  R +P++R TF  
Sbjct: 274 CLDELY----EIMYSC-WRTDPLDRPTFSV 298

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  148 bits (376), Expect = 6e-39
 Identities = 80/346 (23%), Positives = 138/346 (39%), Gaps = 87/346 (25%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           YI+   IG GS+  V+ A  +     VA+K++++          +L+EI+IL+ +    I
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87

Query: 72  IRFFEAI-----ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           IR ++ I        +++Y+VLE  D  DL         ++E   +  +  L  G   + 
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---------- 176
           E  +IHRDLKP N L++ +     +K+ DFG AR++  +   + +               
Sbjct: 147 ESGIIHRDLKPANCLLNQD---CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 177 -------------YMAPEIIQN-HKYDAKADLWSVGAILFQLVTG-----------KPPF 211
                        Y APE+I     Y    D+WS G I  +L+              P F
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263

Query: 212 DGS--------------------NQLQLFQNIL---TSTELRF----------------P 232
            GS                    +QL +  NI+   T  +L+                  
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323

Query: 233 PGAIEEL----HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
           P  +++       D ++L   +L+ NP +RIT  +  +H +L ++R
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  145 bits (368), Expect = 7e-39
 Identities = 70/310 (22%), Positives = 128/310 (41%), Gaps = 36/310 (11%)

Query: 15  GPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
             ++G G+F  V   R+  LG      VAVK++  +   P    +  +EI IL  +    
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDF 85

Query: 71  IIRFFEAIET--REKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQE 127
           I+++        R+ + LV+EY   G L  ++ +H  ++  +    +  Q+  G++ L  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEII 183
           +  +HRDL  +N+LV +      +KI DFG A+ L       +      SP+ + APE +
Sbjct: 146 RRCVHRDLAARNILVESEA---HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 184 QNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNI----LTSTELRFPPGAIEE 238
            ++ +  ++D+WS G +L++L T        S +              + L      +EE
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL---LELLEE 259

Query: 239 LH-----PDCVDLCRCLLRQ----NPVERITFKEFFNHRFLGEL-RQTVHAEQHSVVPET 288
                  P C      L++     +P +R +F        L  L   +   E H+     
Sbjct: 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL--GPQLDMLWSGSRGCETHAFTAHP 317

Query: 289 KPMVELLNSS 298
           +     L+ S
Sbjct: 318 EGKHHSLSFS 327

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  145 bits (367), Expect = 1e-38
 Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 42/287 (14%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG--IEVAVKEIDKKLLSPKVSDNLLKE 59
             +   +         IG G+F  V +AR ++ G  ++ A+K + K+  S     +   E
Sbjct: 21  VLDWNDIK----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGE 75

Query: 60  ISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR------ 112
           + +L  +  HPNII    A E R  +YL +EY   G+L  ++ K   +    A       
Sbjct: 76  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135

Query: 113 ----------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL 162
                     HF   +A G+  L +K  IHRDL  +N+LV  N    V KI DFG +R  
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---VAKIADFGLSRG- 191

Query: 163 TPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SNQL 217
             Q++        L   +MA E +    Y   +D+WS G +L+++V+ G  P+ G +   
Sbjct: 192 --QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 248

Query: 218 QLFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
           +L++ +     L  P    +E++    DL  +C  R+ P ER +F +
Sbjct: 249 ELYEKLPQGYRLEKPLNCDDEVY----DLMRQC-WREKPYERPSFAQ 290

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  143 bits (364), Expect = 1e-38
 Identities = 65/274 (23%), Positives = 113/274 (41%), Gaps = 37/274 (13%)

Query: 17  RIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
            +G   F  V++              VA+K + K      + +    E  + + + HPN+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR----------------HFM 115
           +     +   + + ++  YC  GDL  ++      S+  +                 H +
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
            Q+AAG++ L   H++H+DL  +N+LV        +KI D G  R +   D    L  S 
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKL---NVKISDLGLFREVYAADYYKLLGNSL 191

Query: 176 L---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SNQLQLFQNILTSTELR 230
           L   +MAPE I   K+   +D+WS G +L+++ + G  P+ G SNQ  + + I     L 
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVVEMIRNRQVLP 250

Query: 231 FPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
            P      ++     L   C   + P  R  FK+
Sbjct: 251 CPDDCPAWVY----ALMIEC-WNEFPSRRPRFKD 279

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  148 bits (375), Expect = 1e-38
 Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 19/253 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 191 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 246

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
            + + E IY+V EY   G L  ++         + +      Q+A+G+  ++  + +HRD
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHKYDAKA 192
           L+  N+LV  N    V K+ DFG AR +   +         P+ + APE     ++  K+
Sbjct: 306 LRAANILVGENL---VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCL 250
           D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+C 
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQC- 417

Query: 251 LRQNPVERITFKE 263
            R+ P ER TF+ 
Sbjct: 418 WRKEPEERPTFEY 430

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (367), Expect = 1e-38
 Identities = 73/290 (25%), Positives = 128/290 (44%), Gaps = 42/290 (14%)

Query: 17  RIGSGSFAVVWRARHRQL----GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNII 72
           ++G G+F  V   R+  L    G  VAVK++  +  + +   +  +EI IL ++ H NI+
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 73  RFFEAIET--REKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           ++     +  R  + L++EY   G L  Y+ KH  ++       +  Q+  G++ L  K 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 165

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----LADTLCGSPL-YMAPEIIQ 184
            IHRDL  +N+LV        +KIGDFG  + L PQD           SP+ + APE + 
Sbjct: 166 YIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 185 NHKYDAKADLWSVGAILFQLVT----------------GKPPFDGSNQLQLFQNILTSTE 228
             K+   +D+WS G +L++L T                G           L + +  +  
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281

Query: 229 LRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
           L  P G  +E++     +   C    N  +R +F++      + ++R  +
Sbjct: 282 LPRPDGCPDEIY----MIMTEC-WNNNVNQRPSFRDL--ALRVDQIRDQM 324

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  150 bits (381), Expect = 1e-38
 Identities = 63/260 (24%), Positives = 122/260 (46%), Gaps = 19/260 (7%)

Query: 13  IVGPRIGSGSFAVVWRARHRQLG--IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           I    +G G+F  V +  +R     I+VA+K + K+      ++ +++E  I+  + +P 
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPY 397

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKH 129
           I+R    +   E + LV+E   GG L  ++     ++  +     + Q++ G++ L+EK+
Sbjct: 398 IVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS---PL-YMAPEIIQN 185
            +HR+L  +N+L+         KI DFG +++L   D   T   +   PL + APE I  
Sbjct: 457 FVHRNLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 186 HKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
            K+ +++D+WS G  +++ ++ G+ P+      ++   I     +  PP    EL+    
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY---- 569

Query: 245 DL-CRCLLRQNPVERITFKE 263
            L   C       +R  F  
Sbjct: 570 ALMSDC-WIYKWEDRPDFLT 588

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (362), Expect = 2e-38
 Identities = 60/253 (23%), Positives = 120/253 (47%), Gaps = 19/253 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
            +G+G F VV   + R    +VA+K I +  +S    D  ++E  ++  +SH  +++ + 
Sbjct: 31  ELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYG 86

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
               +  I+++ EY   G L  Y+ +   +          + +   ++ L+ K  +HRDL
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKA 192
             +N LV+      V+K+ DFG +R +   D   +  GS     +  PE++   K+ +K+
Sbjct: 147 AARNCLVNDQG---VVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCL 250
           D+W+ G +++++ + GK P++     +  ++I     L  P  A E+++     +   C 
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY----TIMYSC- 257

Query: 251 LRQNPVERITFKE 263
             +   ER TFK 
Sbjct: 258 WHEKADERPTFKI 270

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  143 bits (363), Expect = 3e-38
 Identities = 62/264 (23%), Positives = 116/264 (43%), Gaps = 23/264 (8%)

Query: 17  RIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
            +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-------HFMRQLAAGLQV 124
           +R           ++++E   GGDL +++ +        +        H  R +A G Q 
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPE 181
           L+E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215

Query: 182 IIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
                 + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P      ++
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY 275

Query: 241 PDCVDL-CRCLLRQNPVERITFKE 263
                +  +C  +  P +R  F  
Sbjct: 276 ----RIMTQC-WQHQPEDRPNFAI 294

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  142 bits (361), Expect = 4e-38
 Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 40/287 (13%)

Query: 17  RIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
            +G G+F  V+ A    L      + VAVK +  K  +     +  +E  +L+ + H +I
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAELLTNLQHEHI 79

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR----------------HFM 115
           ++F+      + + +V EY   GDL  ++  HG  +  +                  H  
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSP 175
            Q+A+G+  L  +H +HRDL  +N LV  N    ++KIGDFG +R +   D       + 
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 176 L---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SNQLQLFQNILTSTELR 230
           L   +M PE I   K+  ++D+WS G IL+++ T GK P+   SN  ++ + I     L 
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIECITQGRVLE 255

Query: 231 FPPGAIEELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFLGELRQT 276
            P    +E++    D+   C  ++ P +R+  KE   ++ L  L + 
Sbjct: 256 RPRVCPKEVY----DVMLGC-WQREPQQRLNIKEI--YKILHALGKA 295

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  143 bits (362), Expect = 4e-38
 Identities = 71/295 (24%), Positives = 118/295 (40%), Gaps = 38/295 (12%)

Query: 15  GPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
              +G G F  V    +          VAVK + K    P+      +EI IL T+ H +
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 71  IIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
           II++           + LV+EY   G L  Y+ +H  +  A    F +Q+  G+  L  +
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ 153

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPL-YMAPEIIQ 184
           H IHRDL  +N+L+  +    ++KIGDFG A+++              SP+ + APE ++
Sbjct: 154 HYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210

Query: 185 NHKYDAKADLWSVGAILFQLVT---------------GKPPFDGSNQLQLFQNILTSTEL 229
            +K+   +D+WS G  L++L+T                         L+L + +     L
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270

Query: 230 RFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHS 283
             P     E++     L   C        R TF+       L  + +    +  S
Sbjct: 271 PRPDKCPAEVY----HLMKNC-WETEASFRPTFENL--IPILKTVHEKYQGQAPS 318

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  142 bits (361), Expect = 5e-38
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 43/289 (14%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKE 59
           R RL      G  +G+G+F  V  A    L      + VAVK + K        + L+ E
Sbjct: 22  RNRLS----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSE 76

Query: 60  ISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR------ 112
           + +LS + +H NI+    A        ++ EYC  GDL  ++ +                
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 113 ------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR 160
                        F  Q+A G+  L  K+ IHRDL  +N+L++      + KI DFG AR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR---ITKICDFGLAR 193

Query: 161 SLTPQD--LADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SN 215
            +      +       P+ +MAPE I N  Y  ++D+WS G  L++L + G  P+ G   
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

Query: 216 QLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
             + ++ I     +  P  A  E++    D+   C    +P++R TFK+
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMY----DIMKTC-WDADPLKRPTFKQ 297

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  143 bits (363), Expect = 7e-38
 Identities = 68/294 (23%), Positives = 125/294 (42%), Gaps = 25/294 (8%)

Query: 17  RIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
            +G G+F  V+  +   +      ++VAVK +  ++ S +   + L E  I+S  +H NI
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR-------HFMRQLAAGLQV 124
           +R           +++LE   GGDL +++ +        +        H  R +A G Q 
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL---YMAPE 181
           L+E H IHRD+  +N L++      V KIGDFG AR +           + L   +M PE
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256

Query: 182 IIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
                 + +K D WS G +L+++ + G  P+   +  ++ + + +   +  P      ++
Sbjct: 257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY 316

Query: 241 PDCVDL-CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
                +  +C  +  P +R  F        +    Q       ++  E  P+VE
Sbjct: 317 ----RIMTQC-WQHQPEDRPNFAII--LERIEYCTQDPDVINTALPIEYGPLVE 363

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  141 bits (357), Expect = 9e-38
 Identities = 63/271 (23%), Positives = 116/271 (42%), Gaps = 44/271 (16%)

Query: 17  RIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
            +G G+F  +++   R++G        EV +K +DK       S++  +  S++S +SH 
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHK 72

Query: 70  NIIRFFEAIETREK-IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQE 127
           +++  +  +        LV E+   G L  Y+ K+   ++        +QLAA +  L+E
Sbjct: 73  HLVLNY-GVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 128 KHLIHRDLKPQNLLVSTNEVT-----PVLKIGDFGFARSLTPQDLADTLCGSPLY----- 177
             LIH ++  +N+L+   E       P +K+ D G + ++ P+D                
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------ILQERI 181

Query: 178 --MAPEIIQNHK-YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             + PE I+N K  +   D WS G  L+++ + G  P    +  +  Q      +L  P 
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK 241

Query: 234 GAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
            A  EL     +L   C +   P  R +F+ 
Sbjct: 242 AA--ELA----NLINNC-MDYEPDHRPSFRA 265

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  141 bits (359), Expect = 1e-37
 Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 49/294 (16%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKE 59
           R  L+    +G  +G G F  V +A    L        VAVK + K+  SP    +LL E
Sbjct: 22  RKNLV----LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSE 76

Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR------- 112
            ++L  ++HP++I+ + A      + L++EY   G L  ++ +  KV             
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 113 -----------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD 155
                             F  Q++ G+Q L E  L+HRDL  +N+LV+       +KI D
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR---KMKISD 193

Query: 156 FGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPF 211
           FG +R +  +D         +   +MA E + +H Y  ++D+WS G +L+++VT G  P+
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

Query: 212 DG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
            G   + +LF  + T   +  P    EE++     L  +C  +Q P +R  F +
Sbjct: 254 PGIPPE-RLFNLLKTGHRMERPDNCSEEMY----RLMLQC-WKQEPDKRPVFAD 301

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  145 bits (367), Expect = 1e-37
 Identities = 66/271 (24%), Positives = 119/271 (43%), Gaps = 33/271 (12%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEIS 61
             N   L     +   IG G F  V    +R  G +VAVK I K   + +     L E S
Sbjct: 189 ALNMKELK----LLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KNDATAQ---AFLAEAS 238

Query: 62  ILSTISHPNIIRFFEAIETREK--IYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQ 117
           +++ + H N+++    +   EK  +Y+V EY   G L  Y+   G+  +       F   
Sbjct: 239 VMTQLRHSNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297

Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL- 176
           +   ++ L+  + +HRDL  +N+LVS +    V K+ DFG  +     + + T     L 
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDFGLTK-----EASSTQDTGKLP 349

Query: 177 --YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             + APE ++  K+  K+D+WS G +L+++ + G+ P+       +   +    ++  P 
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 409

Query: 234 GAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
           G    ++    D+   C    +   R TF +
Sbjct: 410 GCPPAVY----DVMKNC-WHLDAATRPTFLQ 435

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  142 bits (359), Expect = 1e-37
 Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 39/286 (13%)

Query: 17  RIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
            +G G+F  V+ A    L      + VAVK +  K  S     +  +E  +L+ + H +I
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHI 105

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR---------------HFMR 116
           +RFF        + +V EY   GDL  ++  HG  ++ +A                    
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
           Q+AAG+  L   H +HRDL  +N LV       V+KIGDFG +R +   D       + L
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 177 ---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SNQLQLFQNILTSTELRF 231
              +M PE I   K+  ++D+WS G +L+++ T GK P+   SN  +    I    EL  
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EAIDCITQGRELER 281

Query: 232 PPGAIEELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFLGELRQT 276
           P     E++     +   C  ++ P +R + K+   H  L  L Q 
Sbjct: 282 PRACPPEVY----AIMRGC-WQREPQQRHSIKDV--HARLQALAQA 320

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (367), Expect = 3e-37
 Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 19/253 (7%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE 76
           ++G G F  VW          VA+K +    +SP   +  L+E  ++  + H  +++ + 
Sbjct: 274 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 329

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLAAGLQVLQEKHLIHRD 134
            + + E IY+V EY   G L  ++         + +      Q+A+G+  ++  + +HRD
Sbjct: 330 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-YMAPEIIQNHKYDAKA 192
           L+  N+LV  N    V K+ DFG AR +   +         P+ + APE     ++  K+
Sbjct: 389 LRAANILVGENL---VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 193 DLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCL 250
           D+WS G +L +L T G+ P+ G    ++   +     +  PP   E LH    DL C+C 
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH----DLMCQC- 500

Query: 251 LRQNPVERITFKE 263
            R+ P ER TF+ 
Sbjct: 501 WRKEPEERPTFEY 513

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  140 bits (355), Expect = 4e-37
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 35/223 (15%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLL--KEISILSTISHPNIIRF 74
               G F  VW+A+       VAVK     +   +   +     E+  L  + H NI++F
Sbjct: 31  VKARGRFGCVWKAQLL--NEYVAVK-----IFPIQDKQSWQNEYEVYSLPGMKHENILQF 83

Query: 75  FEAIETREKI----YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
             A +    +    +L+  + + G L+ ++  +  VS     H    +A GL  L E   
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIP 142

Query: 131 ----------IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADT--LCGSPLY 177
                      HRD+K +N+L+  N       I DFG A      +   DT    G+  Y
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLT---ACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 178 MAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
           MAPE+++           + D++++G +L++L +     DG  
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  140 bits (356), Expect = 4e-37
 Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 48/294 (16%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKE 59
           R  L      G  +GSG+F  V  A    +      I+VAVK + K+       + L+ E
Sbjct: 44  RENLE----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSE 98

Query: 60  ISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARH----- 113
           + +++ + SH NI+    A      IYL+ EYC  GDL  Y+    +             
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158

Query: 114 ------------------FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD 155
                             F  Q+A G++ L+ K  +HRDL  +N+LV+  +   V+KI D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK---VVKICD 215

Query: 156 FGFARSLTPQD--LADTLCGSPL-YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPF 211
           FG AR +      +       P+ +MAPE +    Y  K+D+WS G +L+++ + G  P+
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

Query: 212 DG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
            G       ++ I    ++  P  A EE++     +   C    +  +R +F  
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIY----IIMQSC-WAFDSRKRPSFPN 324

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  140 bits (354), Expect = 7e-37
 Identities = 77/291 (26%), Positives = 125/291 (42%), Gaps = 42/291 (14%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSD 54
           E  R +L     +G  +G G+F  V  A    +        + VAVK + K   + K   
Sbjct: 31  EFPRDKLT----LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLS 85

Query: 55  NLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR- 112
           +L+ E+ ++  I  H NII    A      +Y+++EY   G+L  Y+          +  
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145

Query: 113 ---------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG 157
                              QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFG 202

Query: 158 FARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG 213
            AR +   D         L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 214 SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
               +LF+ +     +  P     EL+     +   C     P +R TFK+
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNELY----MMMRDC-WHAVPSQRPTFKQ 308

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  140 bits (356), Expect = 8e-37
 Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 36/275 (13%)

Query: 17  RIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SH 68
            +G G F  V  A    +        + VAVK + K   + K   +L+ E+ ++  I  H
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR---------------- 112
            NII    A      +Y+++EY   G+L  Y+          +                 
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
               QLA G++ L  +  IHRDL  +N+LV+ N    V+KI DFG AR +   D      
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDINNIDYYKKTT 263

Query: 173 GSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTE 228
              L   +MAPE + +  Y  ++D+WS G +++++ T G  P+ G    +LF+ +     
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 323

Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
           +  P     EL+   +  C       P +R TFK+
Sbjct: 324 MDKPANCTNELY-MMMRDCW---HAVPSQRPTFKQ 354

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  140 bits (354), Expect = 9e-37
 Identities = 73/309 (23%), Positives = 131/309 (42%), Gaps = 51/309 (16%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNL 56
           E  R  +         IG G+F  V++AR   L        VAVK + K+  S  +  + 
Sbjct: 43  EYPRNNIE----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADF 97

Query: 57  LKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR---- 112
            +E ++++   +PNI++        + + L+ EY   GDL  ++      +         
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 113 --------------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK 152
                                  RQ+AAG+  L E+  +HRDL  +N LV  N    V+K
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM---VVK 214

Query: 153 IGDFGFARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GK 208
           I DFG +R++   D         +   +M PE I  ++Y  ++D+W+ G +L+++ + G 
Sbjct: 215 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274

Query: 209 PPFDG-SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKEFFN 266
            P+ G +++ ++   +     L  P     EL+    +L   C   + P +R +F     
Sbjct: 275 QPYYGMAHE-EVIYYVRDGNILACPENCPLELY----NLMRLC-WSKLPADRPSFCSI-- 326

Query: 267 HRFLGELRQ 275
           HR L  + +
Sbjct: 327 HRILQRMCE 335

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  137 bits (348), Expect = 3e-36
 Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 42/291 (14%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNL 56
           E  R RL     +G  +G G+F  V  A    +        VAVK + K+  +      L
Sbjct: 23  EFPRDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRAL 77

Query: 57  LKEISILSTI-SHPNIIRFFEAIETREK-IYLVLEYCDGGDLAAYIHKHGKVSEAVAR-- 112
           + E+ IL  I  H N++    A       + +++E+C  G+L+ Y+              
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137

Query: 113 --------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF 158
                          +  Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGL 194

Query: 159 ARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG- 213
           AR +           + L   +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G 
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254

Query: 214 SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
               +  + +   T +R P     E++         C     P +R TF E
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMY----QTMLDC-WHGEPSQRPTFSE 300

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (356), Expect = 4e-36
 Identities = 74/268 (27%), Positives = 134/268 (50%), Gaps = 23/268 (8%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEIS 61
           E  R  L     +  ++G+G F  VW A + +   +VAVK +    +S    +  L E +
Sbjct: 184 EIPRESLK----LEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSV---EAFLAEAN 235

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR--HFMRQLA 119
           ++ T+ H  +++   A+ T+E IY++ E+   G L  ++       + + +   F  Q+A
Sbjct: 236 VMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGS-PL-Y 177
            G+  +++++ IHRDL+  N+LVS +    V KI DFG AR +   +         P+ +
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVIEDNEYTAREGAKFPIKW 351

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAI 236
            APE I    +  K+D+WS G +L ++VT G+ P+ G +  ++ + +     +  P    
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 411

Query: 237 EELHPDCVDL-CRCLLRQNPVERITFKE 263
           EEL+    ++  RC  +  P ER TF+ 
Sbjct: 412 EELY----NIMMRC-WKNRPEERPTFEY 434

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  137 bits (348), Expect = 1e-35
 Identities = 80/314 (25%), Positives = 130/314 (41%), Gaps = 44/314 (14%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSD 54
           E  R RL+    +G  +G G+F  V  A    L         +VAVK + K   + K   
Sbjct: 65  ELPRDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLS 119

Query: 55  NLLKEISILSTI-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVAR- 112
           +L+ E+ ++  I  H NII    A      +Y+++EY   G+L  Y+          +  
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179

Query: 113 ---------------HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG 157
                              Q+A G++ L  K  IHRDL  +N+LV+ +    V+KI DFG
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFG 236

Query: 158 FARSLTPQDLADTLCGSPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG 213
            AR +   D         L   +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 214 SNQLQLFQNILTSTELRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKEFFNHRFLGE 272
               +LF+ +     +  P     EL+     +   C     P +R TFK+      L  
Sbjct: 297 VPVEELFKLLKEGHRMDKPSNCTNELY----MMMRDC-WHAVPSQRPTFKQL--VEDLDR 349

Query: 273 LRQTVHAEQHSVVP 286
           +      ++     
Sbjct: 350 IVALTSNQEMGYYH 363

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  135 bits (342), Expect = 3e-35
 Identities = 55/240 (22%), Positives = 90/240 (37%), Gaps = 46/240 (19%)

Query: 15  GPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI--LSTISHPNII 72
              IG G +  V++         VAVK     + S     N + E +I  +  + H NI 
Sbjct: 18  LELIGRGRYGAVYKGSLD--ERPVAVK-----VFSFANRQNFINEKNIYRVPLMEHDNIA 70

Query: 73  RFFEA-----IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           RF         + R +  LV+EY   G L  Y+  H       +      +  GL  L  
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHT 129

Query: 128 KHL---------IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD--------- 169
           +            HRDL  +N+LV  +       I DFG +  LT   L           
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDG---TCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 170 TLCGSPLYMAPEIIQN-------HKYDAKADLWSVGAILFQLV---TGKPPFDGSNQLQL 219
           +  G+  YMAPE+++             + D++++G I +++    T   P +   + Q+
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  135 bits (341), Expect = 9e-35
 Identities = 63/325 (19%), Positives = 123/325 (37%), Gaps = 70/325 (21%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-- 67
             YI+  ++G G F+ VW A+       VA+K +         ++    EI +L  ++  
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDA 75

Query: 68  ---------HPNIIRFFEAIETREKIY----LVLEYCDGGDLAAYIHK--HGKVSEAVAR 112
                      +I++  +    +        +V E   G +L A I K  H  +     +
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134

Query: 113 HFMRQLAAGLQVLQEK-HLIHRDLKPQNLLVS---TNEVTPVLKIGDFGFARSLTPQDLA 168
              +QL  GL  +  +  +IH D+KP+N+L+    + E    +KI D G A     +   
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHYT 193

Query: 169 DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDG-------SNQLQLFQ 221
           +++  +  Y +PE++    +   AD+WS   ++F+L+TG   F+         +   + Q
Sbjct: 194 NSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252

Query: 222 ---------------------------NILTSTELRFPP---------GAIEELHPDCVD 245
                                       +   ++L+F P            ++   +  D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312

Query: 246 LCRCLLRQNPVERITFKEFFNHRFL 270
               +L+ +P +R       NH +L
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWL 337

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  124 bits (313), Expect = 1e-30
 Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 20/229 (8%)

Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           +   Y V   IG GSF  V +A   ++   VA+K +  +    +      +EI IL  + 
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLR 151

Query: 68  H------PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK---VSEAVARHFMRQL 118
                   N+I   E    R  I +  E     +L   I K  K    S  + R F   +
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQGFSLPLVRKFAHSI 209

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYM 178
              L  L +  +IH DLKP+N+L+   +    +K+ DFG +     Q +   +  S  Y 
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSS-CYEHQRVYTYIQ-SRFYR 266

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL 224
           APE+I   +Y    D+WS+G IL +L+TG P   G +   QL     +L
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  122 bits (307), Expect = 3e-30
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 20/230 (8%)

Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
            +  Y +   IG GSF  V +A  R     VA+K I  K       +    E+ +L  ++
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMN 108

Query: 68  HP------NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLA 119
                    I+        R  + LV E     +L   +       VS  + R F +Q+ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 120 AGLQVLQEK--HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLY 177
             L  L      +IH DLKP+N+L+  N     +KI DFG +     Q +   +  S  Y
Sbjct: 168 TALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSS-CQLGQRIYQYIQ-SRFY 224

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNIL 224
            +PE++    YD   D+WS+G IL ++ TG+P F G+N   Q+     +L
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  120 bits (302), Expect = 6e-30
 Identities = 68/334 (20%), Positives = 118/334 (35%), Gaps = 70/334 (20%)

Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIE-VAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           L   Y +   +G G+F  V      + G   VAVK +       +  +    EI +L  +
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHL 68

Query: 67  SHP------NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQL 118
           +          ++  E  E    I +V E   G     +I ++G +       R    Q+
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPV----------------LKIGDFGFARSL 162
              +  L    L H DLKP+N+L   ++ T                  +K+ DFG A + 
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TY 186

Query: 163 TPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQL 219
             +  +  +  +  Y APE+I    +    D+WS+G IL +   G   F   +    L +
Sbjct: 187 DDEHHSTLVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245

Query: 220 FQNIL-----------------TSTELRFPPG-------------------AIEELHPDC 243
            + IL                     L +                      + +  H   
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305

Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
            DL + +L  +P +RIT +E   H F   L++++
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  118 bits (297), Expect = 5e-29
 Identities = 66/331 (19%), Positives = 113/331 (34%), Gaps = 72/331 (21%)

Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           L   ++V  ++G G+F  V   +H       AVK +       K + +   E  IL  I 
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQ 89

Query: 68  H-----PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQLAA 120
           +      NI+++       + + L+ E   G  L   I ++          + +  ++  
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148

Query: 121 GLQVLQEKHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADT---LC--GS 174
            L  L++  L H DLKP+N LL        ++ +      + +       T   L   G 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 175 PL--------------YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QL 217
                           Y APE+I N  +D  +D+WS G +L +L TG   F        L
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268

Query: 218 QLFQNIL----------------------TSTELRFP----------------PGAIEEL 239
            + ++I+                         +L +P                P      
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328

Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           H    D    +L+ +P  R +  E   H+FL
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  117 bits (295), Expect = 9e-29
 Identities = 67/327 (20%), Positives = 110/327 (33%), Gaps = 70/327 (21%)

Query: 8   LIGEYIVGPRIGSGSFAVVWRAR-HRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           L   Y +   +G G+F  V     H +   +VA+K I       K  +    EI++L  I
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKI 73

Query: 67  SHP------NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV--SEAVARHFMRQL 118
                      +   +       + +  E   G +   ++ ++          RH   QL
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQL 132

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPV----------------LKIGDFGFARSL 162
              L+ L E  L H DLKP+N+L   +E   +                +++ DFG A + 
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TF 191

Query: 163 TPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQL 219
             +     +  +  Y  PE+I    +    D+WS+G ILF+   G   F        L +
Sbjct: 192 DHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

Query: 220 FQNIL-----------------TSTELRFPPGAIEEL-------------------HPDC 243
            + IL                     L +   + +                     H   
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310

Query: 244 VDLCRCLLRQNPVERITFKEFFNHRFL 270
            DL R +L  +P +RIT  E   H F 
Sbjct: 311 FDLMRRMLEFDPAQRITLAEALLHPFF 337

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 97.3 bits (242), Expect = 9e-22
 Identities = 70/368 (19%), Positives = 120/368 (32%), Gaps = 112/368 (30%)

Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI- 66
             G Y V  ++G G F+ VW +   Q    VA+K + K   +   ++  L EI +L ++ 
Sbjct: 35  FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS--AEHYTETALDEIRLLKSVR 91

Query: 67  ----SHPN---IIRFFEAIETREK----IYLVLEYCDGGDLAAYIHK--HGKVSEAVARH 113
               + PN   +++  +  +        I +V E   G  L  +I K  +  +     + 
Sbjct: 92  NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK 150

Query: 114 FMRQLAAGLQVL-QEKHLIHRDLKPQNLLVSTNEVT------------------------ 148
            ++Q+  GL  L  +  +IH D+KP+N+L+S NE                          
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 149 ----------------------PVLKIGDFGFARSLTPQDLADTLCGSPL-YMAPEIIQN 185
                                   +KI D G A          T       Y + E++  
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIG 267

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSN---------QLQLFQNIL------------ 224
             Y+  AD+WS   + F+L TG   F+  +          + L   +L            
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327

Query: 225 -------TSTELRFPPGAI---------------EELHPDCVDLCRCLLRQNPVERITFK 262
                     +L+                     +E      D    +L   P +R T  
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387

Query: 263 EFFNHRFL 270
           E   H +L
Sbjct: 388 ECLRHPWL 395

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 14/156 (8%)

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
           +  Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +           
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRKGD 254

Query: 174 SPL---YMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDG-SNQLQLFQNILTSTE 228
           + L   +MAPE I +  Y  ++D+WS G +L+++ + G  P+ G     +  + +   T 
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314

Query: 229 LRFPPGAIEELHPDCVDL-CRCLLRQNPVERITFKE 263
           +R P     E++         C     P +R TF E
Sbjct: 315 MRAPDYTTPEMY----QTMLDC-WHGEPSQRPTFSE 345

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 32/154 (20%), Positives = 63/154 (40%), Gaps = 20/154 (12%)

Query: 5   RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDN----LLKEI 60
           R RL     +G  +G G+F  V  A    +      + +  K+L    + +    L+ E+
Sbjct: 21  RDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 76

Query: 61  SILSTI-SHPNIIRFFEA-IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQL 118
            IL  I  H N++    A  +    + +++E+C  G+L+ Y+             F+   
Sbjct: 77  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-------RNEFVPYK 129

Query: 119 AAGLQVLQEKHL---IHRDLKPQNLLVSTNEVTP 149
             G +  Q K     I  DLK +   +++++ + 
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 86.3 bits (214), Expect = 9e-19
 Identities = 64/279 (22%), Positives = 98/279 (35%), Gaps = 52/279 (18%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH- 68
             Y +G +IGSGSF  ++       G EVA+K    K   P     L  E  I   +   
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGG 64

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQE 127
             I          +   +V+E   G  L    +    K S         Q+ + ++ +  
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--------PQDLADTLCGSPLYMA 179
           K+ IHRD+KP N L+   +   ++ I DFG A+           P      L G+  Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 180 PEIIQNHKYDA---KADLWSVGAILFQLVTGKPPFDG---SNQLQLFQNIL-----TSTE 228
              I  H       + DL S+G +L     G  P+ G   + + Q ++ I      T  E
Sbjct: 184 ---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240

Query: 229 LRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                            LC+      P E   F  + N 
Sbjct: 241 ----------------VLCKGY----PSE---FATYLNF 256

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 35/215 (16%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFE- 76
           IG G F  V++   R  G +VA+K    +  S +  +    EI  LS   HP+++     
Sbjct: 47  IGHGVFGKVYKGVLRD-GAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGF 103

Query: 77  AIETREKIYLVLEYCDGGDLAAYIHKHG------------KVSEAVARHFMRQLAAGLQV 124
             E  E I L+ +Y + G+L  +++               ++    AR        GL  
Sbjct: 104 CDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------GLHY 154

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT-----LCGSPLYMA 179
           L  + +IHRD+K  N+L+  N V    KI DFG ++  T  D   T     + G+  Y+ 
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVP---KITDFGISKKGTELD--QTHLSTVVKGTLGYID 209

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS 214
           PE     +   K+D++S G +LF+++  +     S
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 83.5 bits (206), Expect = 5e-17
 Identities = 68/288 (23%), Positives = 107/288 (37%), Gaps = 55/288 (19%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           MEP   R+  ++ +G +IGSGSF  ++   + Q   EVA+K  + K   P     LL E 
Sbjct: 1   MEP---RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYES 53

Query: 61  SILSTIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQL 118
            I   +     I          +   LV++   G  L    +    K+S         Q+
Sbjct: 54  KIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 112

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT--------PQDLADT 170
              ++ +  K  +HRD+KP N L+        + I DFG A+           P      
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 171 LCGSPLYMAPEIIQNHKYDA---KADLWSVGAILFQLVTGKPPFDG---SNQLQLFQNIL 224
           L G+  Y +   +  H       + DL S+G +L   + G  P+ G     + Q ++ I 
Sbjct: 173 LTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229

Query: 225 -----TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
                TS E                 LCR      P E   F  +F++
Sbjct: 230 EKKVATSIE----------------ALCRGY----PTE---FASYFHY 254

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 39/231 (16%), Positives = 86/231 (37%), Gaps = 38/231 (16%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
            ++++G +IGSG F +++ A       + A   + K  +  + +  L  E+     ++  
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVK--VEYQENGPLFSELKFYQRVAKK 93

Query: 70  NI-----------------IRFFEAIETREKIY--LVLEYCDGGDLAAYIHKHGKVSEAV 110
           +                         E + + Y  +V+E   G DL     ++G   ++ 
Sbjct: 94  DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKST 152

Query: 111 ARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT------- 163
                 ++   L+ + E   +H D+K  NLL+       V    D+G +           
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA-DYGLSYRYCPNGNHKQ 211

Query: 164 -PQDLADTLCGSPLYMAPEIIQNHKYDA---KADLWSVGAILFQLVTGKPP 210
             ++      G+  + +   +  HK  A   ++D+  +G  + + + GK P
Sbjct: 212 YQENPRKGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 48/223 (21%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNL------LKEISILSTISHPN 70
           ++G G F VV++         VAVK    KL +              +EI +++   H N
Sbjct: 38  KMGEGGFGVVYKGYVN--NTTVAVK----KLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91

Query: 71  IIR---FFEAIETREKIYLVLEYCDGGDLAAYIHKHG-----------KVSEAVARHFMR 116
           ++    F  + +  +   LV  Y   G L   +               K+++  A     
Sbjct: 92  LVELLGF--SSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN---- 144

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT-----L 171
               G+  L E H IHRD+K  N+L+     T   KI DFG AR  + +  A T     +
Sbjct: 145 ----GINFLHENHHIHRDIKSANILL-DEAFTA--KISDFGLAR-ASEKF-AQTVMTSRI 195

Query: 172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS 214
            G+  YMAPE ++      K+D++S G +L +++TG P  D  
Sbjct: 196 VGTTAYMAPEALRGEITP-KSDIYSFGVVLLEIITGLPAVDEH 237

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 48/224 (21%)

Query: 18  IGSGSFAVVWRARHRQL--GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIR-- 73
           +G G F  V++ R   L  G  VAVK + ++  +         E+ ++S   H N++R  
Sbjct: 38  LGRGGFGKVYKGR---LADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 74  -FFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEA------------VARHFMRQLAA 120
            F   +   E++ LV  Y   G +A+ + +  +                 AR        
Sbjct: 94  GF--CMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR-------- 142

Query: 121 GLQVLQEK---HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD------LADTL 171
           GL  L +     +IHRD+K  N+L+   E      +GDFG A+ +  +D      +  T+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILL-DEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN 215
                ++APE +   K   K D++  G +L +L+TG+  FD + 
Sbjct: 200 G----HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 60/290 (20%), Positives = 108/290 (37%), Gaps = 54/290 (18%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           M      +   Y VG RIG GSF V++   +     +VA+K   ++  +P     L  E 
Sbjct: 1   MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEY 56

Query: 61  SILSTISH-PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQL 118
                ++    I   +   +      LV++   G  L   +   G+  S        +Q+
Sbjct: 57  RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQM 115

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLV--STNEVTPVLKIGDFGFARSLT--------PQDLA 168
            A +Q + EK L++RD+KP N L+    ++   ++ + DFG  +           P    
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

Query: 169 DTLCGSPLYMAPEIIQNHK-YDA--KADLWSVGAILFQLVTGKPPFDG---SNQLQLFQN 222
             L G+  YM+   I  H   +   + DL ++G +    + G  P+ G   +   Q ++ 
Sbjct: 176 KNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232

Query: 223 IL-----TSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
           I      T                   +LC       P E   F ++ ++
Sbjct: 233 IGEKKQSTPLR----------------ELCAGF----PEE---FYKYMHY 259

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 51/220 (23%), Positives = 84/220 (38%), Gaps = 25/220 (11%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVK-EIDKKLLSPKVSDNLLKEISILSTISH 68
             + VG +IG G+F  +   ++      VA+K E  K          L  E      +  
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-----QLHLEYRFYKQLGS 63

Query: 69  -PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQ 126
              I + +      +   +VLE   G  L           S         QL + ++ + 
Sbjct: 64  GDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 127 EKHLIHRDLKPQNLLVST--NEVTPVLKIGDFGFAR----SLT----PQDLADTLCGSPL 176
            K+LI+RD+KP+N L+    N+   V+ I DF  A+      T    P     +L G+  
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182

Query: 177 YMAPEIIQNHKYDA---KADLWSVGAILFQLVTGKPPFDG 213
           YM+   I  H       + DL ++G +    + G  P+ G
Sbjct: 183 YMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.5 bits (182), Expect = 2e-14
 Identities = 46/248 (18%), Positives = 70/248 (28%), Gaps = 66/248 (26%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEI------DKKLLSPKVSDNLLKEISILSTI----- 66
           IG G F  V++         VA+K I             K  + +L EI I   +     
Sbjct: 28  IGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 67  ----SHPNIIRFFEA------------------------------IETREKIYLVLEYCD 92
                    I                                       +++++VLE+  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 93  GG-DLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH-LIHRDLKPQNLLVSTNEVTPV 150
           GG DL     K    S A A+  + QL A L V +      HRDL   N+L+       +
Sbjct: 146 GGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT---SL 200

Query: 151 LKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPP 210
            K+      +S T        CG         +    Y           +   +   +  
Sbjct: 201 KKLHYTLNGKSST-----IPSCGL-------QVSIIDYTLSRLERDGIVVFCDVSMDEDL 248

Query: 211 FDGSNQLQ 218
           F G    Q
Sbjct: 249 FTGDGDYQ 256

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 43/232 (18%), Positives = 74/232 (31%), Gaps = 37/232 (15%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
             + VG  IG G F  ++ A        V         + P  +  L  E+      + P
Sbjct: 35  AAWKVGLPIGQGGFGCIYLAD-MNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP 93

Query: 70  NII-----------------RFFEAIETREKIY--LVLEYCDGGDLAAYIHKHG-KVSEA 109
             I                       +   K Y  ++++   G DL      +  + S  
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRK 152

Query: 110 VARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT------ 163
                  ++   L+ + E   +H D+K  NLL++      V  + D+G A          
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLV-DYGLAYRYCPEGVHK 211

Query: 164 --PQDLADTLCGSPLYMAPEIIQNHKYDA---KADLWSVGAILFQLVTGKPP 210
               D      G+  + +   I  H   A   + DL  +G  + Q +TG  P
Sbjct: 212 AYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 41/294 (13%), Positives = 90/294 (30%), Gaps = 59/294 (20%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGI--------EVAVK--------EIDKKLLSPKVS 53
            ++ +       +  +++ A               + ++K          ++        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 54  DNLLKEISILSTISH---PNIIRFFEAIETREKIY--LVLEYCDGGDLAAYIHKHGK--V 106
              + +   L +      P  + F       +  Y  LVL    G  L + +    K  +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFG----VHQDKYRFLVLPSL-GRSLQSALDVSPKHVL 156

Query: 107 SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-- 164
           SE        +L   L+ L E   +H ++  +N+ V   + + V     +GFA    P  
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLA-GYGFAFRYCPSG 215

Query: 165 ------QDLADTLCGSPLYMAPEIIQNHKYDA---KADLWSVGAILFQLVTGKPPFDGSN 215
                 +       G   +++   +  HK      ++DL S+G  + + + G  P     
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP----- 267

Query: 216 QLQLFQNILTSTELRFPPGAIEELH--PDCVDLCRCLLRQNPVERITFKEFFNH 267
               + N L +TE        + +      V  C     +        +++   
Sbjct: 268 ----WTNCLPNTE-DIMKQKQKFVDKPGPFVGPCG-HWIRPSET---LQKYLKV 312

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.4 bits (135), Expect = 3e-08
 Identities = 93/707 (13%), Positives = 204/707 (28%), Gaps = 238/707 (33%)

Query: 40  VKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK--IYLVLEYCDGGD-- 95
           V+++ K +LS +  D+++     +S       +R F  + ++++  +   +E     +  
Sbjct: 38  VQDMPKSILSKEEIDHIIMSKDAVS-----GTLRLFWTLLSKQEEMVQKFVEEVLRINYK 92

Query: 96  -LAAYIHKHGKVSEAVARHFMRQ---LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVL 151
            L + I    +    + R ++ Q   L    QV   K+ + R      L  +  E+ P  
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA-KYNVSRLQPYLKLRQALLELRPAK 151

Query: 152 KI---GDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKAD---LW-SVG------ 198
            +   G  G  ++                +A ++  ++K   K D    W ++       
Sbjct: 152 NVLIDGVLGSGKTW---------------VALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196

Query: 199 AILFQLVT--------GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC------V 244
            +L  L               D S+ ++L  + + +   R       + + +C      V
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL---LKSKPYENCLLVLLNV 253

Query: 245 ---------DL-CRCLLRQNPVERIT-FKEFFNHRFLGELRQTVHAEQHSVVPETKP-MV 292
                    +L C+ LL        T FK+  +  FL     T  +  H  +  T   + 
Sbjct: 254 QNAKAWNAFNLSCKILL-------TTRFKQVTD--FLSAATTTHISLDHHSMTLTPDEVK 304

Query: 293 ELLNSSTPEDRHSLHSEHPTNSSSKNPKSACSSACDKVILNTGDQGNSLSTRDLHEFIPN 352
            LL          L            P+                  N      + E I +
Sbjct: 305 SLLLKYLDCRPQDL------------PREVL-------------TTNPRRLSIIAESIRD 339

Query: 353 MAC--DRMKKSVGSQYSSDQLKDLME-SIEKEYVLINSHFASTDGFSFYLDASLQDNSMA 409
                D  K       + D+L  ++E S+                    L+ +       
Sbjct: 340 GLATWDNWK-----HVNCDKLTTIIESSLN------------------VLEPAEYRKMFD 376

Query: 410 KVSICPSKKNDHSAITMQT-----KDMPSDSASGAENSLFHVPAPLETSNRLFILKEVQG 464
           ++S+ P      + I          D+         N L              + K+ + 
Sbjct: 377 RLSVFP----PSAHIPTILLSLIWFDVIKSDVMVVVNKLH---------KYSLVEKQPKE 423

Query: 465 LTV-LHPSTGLQL-LHQYVHALTELAEAKYDAGLFLESFSVELVVLAIWKKALQICGSWL 522
            T+ +     + L L   +     L          ++ +++                   
Sbjct: 424 STISIP---SIYLELKVKLENEYAL-HRS-----IVDHYNIP------------------ 456

Query: 523 TSMSHGELPGPSSAYGHTPVQGGISSDPNSENNVDFSSPFSVSTWAEQGFILAFDRAEKL 582
                         +           D +     D   P+         +  +      +
Sbjct: 457 ------------KTF-----------DSD-----DLIPPY------LDQYFYSH-----I 477

Query: 583 SYNIRDSDGAAEMPDAMEIIYQ--RALSVGKIGAVEEYMGNKASASALYSKAMLLLSFIV 640
            +++++ +   E      +++   R L   KI         +  ++A  +   +L +   
Sbjct: 478 GHHLKNIE-HPERMTLFRMVFLDFRFLE-QKI---------RHDSTAWNASGSILNTLQQ 526

Query: 641 GEAASLSLYPPF-SLN-PSDKKRIQGYINNLQSHQSNFLIFQPSSNL 685
                L  Y P+   N P  ++ +   ++ L   + N LI    ++L
Sbjct: 527 -----LKFYKPYICDNDPKYERLVNAILDFLPKIEEN-LICSKYTDL 567

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 9e-06
 Identities = 61/428 (14%), Positives = 133/428 (31%), Gaps = 119/428 (27%)

Query: 333 NTGDQGNSLSTRDL-----HEFIPNMACDRMKKSVGSQYSSDQLKDLMES---IEKEYVL 384
            TG+       +D+       F+ N  C  ++    S  S +++  ++ S   +     L
Sbjct: 10  ETGEH--QYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67

Query: 385 INSHFAS-TDGFSFYLDASLQDNS---MAKVSICPSKKNDHSAITMQTKD-MPSDSASGA 439
             +  +   +    +++  L+ N    M+ +     + +  + + ++ +D + +D     
Sbjct: 68  FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND----- 122

Query: 440 ENSLF---HVPAP---LETSNRLFILKEVQGLTVLH--PSTGLQLLHQYVHALTELAEAK 491
            N +F   +V      L+    L  L+  + + ++     +G   +              
Sbjct: 123 -NQVFAKYNVSRLQPYLKLRQALLELRPAKNV-LIDGVLGSGKTWV-------------- 166

Query: 492 YDAGLFLESFSVELVVLAIWKKALQICGSWLT---SMSHGELPGPSSAYGHTPVQGGISS 548
             A     S+ V+       K   +I   WL      S   +        +         
Sbjct: 167 --ALDVCLSYKVQC------KMDFKI--FWLNLKNCNSPETVLEMLQKLLYQ-------I 209

Query: 549 DPNSENNVDFSSPFSVSTWAEQGFI--LAFDRAEKLSY----NIRDSDGAAEMPDAMEI- 601
           DPN  +  D SS   +   + Q  +  L   +  +       N+++    A+  +A  + 
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN----AKAWNAFNLS 265

Query: 602 ----IYQRALSV---------GKIGAVEEYMG-NKASASALYSKAM-------------- 633
               +  R   V           I      M        +L  K +              
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325

Query: 634 --LLLSFIVGEAASLSLYP----PFSLNPSDKKR--IQGYINNLQS--HQSNFL---IFQ 680
               LS I   A S+         +     DK    I+  +N L+   ++  F    +F 
Sbjct: 326 NPRRLSII---AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382

Query: 681 PSSNLSSD 688
           PS+++ + 
Sbjct: 383 PSAHIPTI 390

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 9e-05
 Identities = 31/206 (15%), Positives = 61/206 (29%), Gaps = 47/206 (22%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS----------PKVSDNLLKEISILSTIS 67
           I +   +++W    +   + V  K     L+           P +   L  ++     + 
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL- 445

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHF-----------MR 116
           H +I+  +   +T +   L+  Y D      Y + H      +  H             R
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQ-----YFYSH------IGHHLKNIEHPERMTLFR 494

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK-----IGDFGFARSLTPQDLADTL 171
            +    + L++K  I  D    N   S       LK     I D           + D L
Sbjct: 495 MVFLDFRFLEQK--IRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFL 552

Query: 172 --CGSPLYMAPE--IIQ---NHKYDA 190
                 L  +    +++     + +A
Sbjct: 553 PKIEENLICSKYTDLLRIALMAEDEA 578

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 21/152 (13%), Positives = 44/152 (28%), Gaps = 28/152 (18%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVK----------------EIDKKLLSPKVSDN 55
             +G  +G G  + V+     +   E  VK                +      S     +
Sbjct: 92  DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 56  LLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFM 115
              E   L  +    + + +          +++E  D  +L         V        +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYR-------VRVENPDEVL 199

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV 147
             +   +     + ++H DL   N+LVS   +
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	692
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-85
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-85
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-82
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-82
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-80
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-79
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-78
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-78
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-77
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-76
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-76
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-76
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-75
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-75
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-72
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-72
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-71
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-70
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-68
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-67
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-66
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-66
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-65
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-64
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-62
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-62
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-61
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-60
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-60
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-60
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-59
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-58
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-57
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-56
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-55
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-53
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-49
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-41
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-24

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  271 bits (693), Expect = 2e-85
 Identities = 86/321 (26%), Positives = 147/321 (45%), Gaps = 7/321 (2%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           +E     ++  Y +   +G+G+F VV R   R  G   A K +     S K  + + KEI
Sbjct: 17  VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEI 74

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLA 119
             +S + HP ++   +A E   ++ ++ E+  GG+L   +  +H K+SE  A  +MRQ+ 
Sbjct: 75  QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
            GL  + E + +H DLKP+N++ +T   +  LK+ DFG    L P+       G+  + A
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PE+ +        D+WSVG + + L++G  PF G N  +  +N+  S +      A   +
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-SCDWNMDDSAFSGI 252

Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQ--HSVVPETKPMVELLNS 297
             D  D  R LL  +P  R+T  +   H +L          Q   S   + +  ++    
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYD 312

Query: 298 STPEDRHSLHSEHPTNSSSKN 318
           + PE    L      +S  K+
Sbjct: 313 AWPEPLPPLGRISNYSSLRKH 333

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  268 bits (686), Expect = 3e-85
 Identities = 84/279 (30%), Positives = 140/279 (50%), Gaps = 2/279 (0%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y     +G+G+F+ V  A  ++    VA+K I KK L  K   ++  EI++L  I HPNI
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNI 69

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +   +  E+   +YL+++   GG+L   I + G  +E  A   + Q+   ++ L +  ++
Sbjct: 70  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAK 191
           HRDLKP+NLL  + +    + I DFG ++   P  +  T CG+P Y+APE++    Y   
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 192 ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLL 251
            D WS+G I + L+ G PPF   N  +LF+ IL   E  F     +++     D  R L+
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL-KAEYEFDSPYWDDISDSAKDFIRHLM 248

Query: 252 RQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKP 290
            ++P +R T ++   H ++            SV  + K 
Sbjct: 249 EKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (663), Expect = 3e-82
 Identities = 84/263 (31%), Positives = 135/263 (51%), Gaps = 10/263 (3%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTIS 67
           + ++ +G  +G G F  V+ AR +Q    +A+K + K  L    V   L +E+ I S + 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPNI+R +       ++YL+LEY   G +   + K  K  E     ++ +LA  L     
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
           K +IHRD+KP+NLL+ +      LKI DFG++    P     TLCG+  Y+ PE+I+   
Sbjct: 125 KRVIHRDIKPENLLLGSA---GELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           +D K DLWS+G + ++ + GKPPF+ +   + ++ I    E  FP      +     DL 
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-RVEFTFPD----FVTEGARDLI 235

Query: 248 RCLLRQNPVERITFKEFFNHRFL 270
             LL+ NP +R   +E   H ++
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPWI 258

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  261 bits (668), Expect = 7e-82
 Identities = 86/322 (26%), Positives = 151/322 (46%), Gaps = 11/322 (3%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           +E  +  +   Y +   +GSG+F VV R   +  G     K I+     P     +  EI
Sbjct: 20  VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEI 77

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLA 119
           SI++ + HP +I   +A E + ++ L+LE+  GG+L   I     K+SEA   ++MRQ  
Sbjct: 78  SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMA 179
            GL+ + E  ++H D+KP+N++  T +    +KI DFG A  L P ++      +  + A
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPDEIVKVTTATAEFAA 196

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PEI+         D+W++G + + L++G  PF G + L+  QN+    +  F   A   +
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-RCDWEFDEDAFSSV 255

Query: 240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSST 299
            P+  D  + LL++ P +R+T  +   H +L    +  H+   S +P ++     +    
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWL----KGDHSNLTSRIPSSR--YNKIRQKI 309

Query: 300 PEDRHSLHSEHPTNSSSKNPKS 321
            E      +  P      N  S
Sbjct: 310 KEKYADWPAPQPAIGRIANFSS 331

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (651), Expect = 3e-80
 Identities = 83/273 (30%), Positives = 143/273 (52%), Gaps = 13/273 (4%)

Query: 2   EPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEI 60
           +P + R   ++  G  +G GSF+ V  AR      E A+K ++K+ ++       + +E 
Sbjct: 1   QPRKKR-PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER 59

Query: 61  SILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
            ++S + HP  ++ +   +  EK+Y  L Y   G+L  YI K G   E   R +  ++ +
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLY 177
            L+ L  K +IHRDLKP+N+L++ +     ++I DFG A+ L+P+     A++  G+  Y
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESKQARANSFVGTAQY 176

Query: 178 MAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           ++PE++        +DLW++G I++QLV G PPF   N+  +FQ I+   E  FP    E
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFP----E 231

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +  P   DL   LL  +  +R+  +E   +  L
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (646), Expect = 2e-79
 Identities = 70/266 (26%), Positives = 131/266 (49%), Gaps = 14/266 (5%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           + +   +G G+F  V++A++++  +  A K ID K  S +  ++ + EI IL++  HPNI
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNI 71

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-VSEAVARHFMRQLAAGLQVLQEKHL 130
           ++  +A      +++++E+C GG + A + +  + ++E+  +   +Q    L  L +  +
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNH--- 186
           IHRDLK  N+L + +     +K+ DFG +   T      D+  G+P +MAPE++      
Sbjct: 132 IHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 187 --KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
              YD KAD+WS+G  L ++   +PP    N +++   I  S               +  
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ--PSRWSSNFK 246

Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
           D  +  L +N   R T  +   H F+
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFV 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (638), Expect = 1e-78
 Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 19/272 (6%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +Y V   IG+GS+    + R +  G  +  KE+D   ++      L+ E+++L  + HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 71  IIRFFEAI--ETREKIYLVLEYCDGGDLAAYIHKHGK----VSEAVARHFMRQLAAGLQV 124
           I+R+++ I   T   +Y+V+EYC+GGDLA+ I K  K    + E      M QL   L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 125 LQEKH-----LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-QDLADTLCGSPLYM 178
              +      ++HRDLKP N+ +   +    +K+GDFG AR L      A    G+P YM
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +PE +    Y+ K+D+WS+G +L++L    PPF   +Q +L   I      R P      
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY----R 237

Query: 239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
              +  ++   +L      R + +E   +  +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (642), Expect = 1e-78
 Identities = 79/320 (24%), Positives = 143/320 (44%), Gaps = 9/320 (2%)

Query: 8   LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           L  +Y++   +G G F +V R            K +  K         + KEISIL+   
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIAR 59

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQ 126
           H NI+   E+ E+ E++ ++ E+  G D+   I+    +++E     ++ Q+   LQ L 
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             ++ H D++P+N++  T   +  +KI +FG AR L P D    L  +P Y APE+ Q+ 
Sbjct: 120 SHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
                 D+WS+G +++ L++G  PF      Q+ +NI+ + E  F   A +E+  + +D 
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM-NAEYTFDEEAFKEISIEAMDF 237

Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPEDRHSL 306
              LL +    R+T  E   H +   L+Q +      V+   K           +    +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPW---LKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVV 294

Query: 307 HSEHPTNSSSKNPKSACSSA 326
            +   +   +   +   S A
Sbjct: 295 SAARISCGGAIRSQKGVSVA 314

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (631), Expect = 1e-77
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 14/266 (5%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
                 IG GSF  V++    +  +EVA  E+  + L+        +E  +L  + HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 72  IRFFEAIETREK----IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           +RF+++ E+  K    I LV E    G L  Y+ +   +   V R + RQ+  GLQ L  
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 128 KH--LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
           +   +IHRDLK  N+ ++    T  +KIGD G A  L     A  + G+P +MAPE+ + 
Sbjct: 131 RTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE 187

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGS-NQLQLFQNILTSTELRFPPGAIEELHPDCV 244
            KYD   D+++ G  + ++ T + P+    N  Q+++ +        P    +   P+  
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT---SGVKPASFDKVAIPEVK 243

Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
           ++    +RQN  ER + K+  NH F 
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (631), Expect = 2e-77
 Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 10/266 (3%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH 68
           + ++ +   +G G++  V  A +R     VAVK +D K  +    +N+ KEI I   ++H
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNH 62

Query: 69  PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
            N+++F+         YL LEYC GG+L   I     + E  A+ F  QL AG+  L   
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP---QDLADTLCGSPLYMAPEIIQN 185
            + HRD+KP+NLL+   +    LKI DFG A        + L + +CG+  Y+APE+++ 
Sbjct: 123 GITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 186 HKYDA-KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV 244
            ++ A   D+WS G +L  ++ G+ P+D  +      +     +    P   +++    +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPL 237

Query: 245 DLCRCLLRQNPVERITFKEFFNHRFL 270
            L   +L +NP  RIT  +    R+ 
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWY 263

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  246 bits (629), Expect = 1e-76
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 15/285 (5%)

Query: 17  RIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILSTISHPNIIRFF 75
            IG GSF  V+ AR  +    VA+K++      S +   +++KE+  L  + HPN I++ 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDL 135
                    +LV+EYC G            + E            GL  L   ++IHRD+
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141

Query: 136 KPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH---KYDAKA 192
           K  N+L+S      ++K+GDFG A  + P   A++  G+P +MAPE+I      +YD K 
Sbjct: 142 KAGNILLSEPG---LVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 193 DLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLR 252
           D+WS+G    +L   KPP    N +    +I  +       G          +     L+
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG---HWSEYFRNFVDSCLQ 252

Query: 253 QNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNS 297
           + P +R T +    HRF+  LR+        ++  TK  V  L++
Sbjct: 253 KIPQDRPTSEVLLKHRFV--LRERPPTVIMDLIQRTKDAVRELDN 295

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  245 bits (627), Expect = 3e-76
 Identities = 85/331 (25%), Positives = 153/331 (46%), Gaps = 27/331 (8%)

Query: 1   MEPNRTRLIGEY-IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKE 59
           ++  +  +I +Y +    +G G    V +  +++   + A+K +              +E
Sbjct: 2   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARRE 54

Query: 60  ISILSTIS-HPNIIRFFEAIET----REKIYLVLEYCDGGDLAAYIHKHG--KVSEAVAR 112
           + +    S  P+I+R  +  E     R+ + +V+E  DGG+L + I   G    +E  A 
Sbjct: 55  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 114

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC 172
             M+ +   +Q L   ++ HRD+KP+NLL ++     +LK+ DFGFA+  T  +   T C
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174

Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT---STEL 229
            +P Y+APE++   KYD   D+WS+G I++ L+ G PPF  ++ L +   + T     + 
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234

Query: 230 RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETK 289
            FP     E+  +   L R LL+  P +R+T  EF NH ++          Q + VP+T 
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI---------MQSTKVPQTP 285

Query: 290 PMVELLNSSTPEDRHSLHSEHPTNSSSKNPK 320
                +     E    +  E  +  ++    
Sbjct: 286 LHTSRVLKEDKERWEDVKEEMTSALATMRVD 316

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  243 bits (621), Expect = 4e-76
 Identities = 86/273 (31%), Positives = 134/273 (49%), Gaps = 18/273 (6%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-------PKVSDNLLKEISILS 64
           Y     +G G  +VV R  H+    E AVK ID             ++ +  LKE+ IL 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 65  TIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
            +S HPNII+  +  ET    +LV +    G+L  Y+ +   +SE   R  MR L   + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEII 183
            L + +++HRDLKP+N+L+  +     +K+ DFGF+  L P +    +CG+P Y+APEII
Sbjct: 125 ALHKLNIVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 184 Q------NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           +      +  Y  + D+WS G I++ L+ G PPF    Q+ + + I+ S   +F     +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-SGNYQFGSPEWD 240

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +      DL    L   P +R T +E   H F 
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (624), Expect = 7e-76
 Identities = 76/300 (25%), Positives = 137/300 (45%), Gaps = 45/300 (15%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           ++     +G+G+  VV++  H+  G+ +A K I  ++  P + + +++E+ +L   + P 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPY 65

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH- 129
           I+ F+ A  +  +I + +E+ DGG L   + K G++ E +       +  GL  L+EKH 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYD 189
           ++HRD+KP N+LV++      +K+ DFG +  L    +A++  G+  YM+PE +Q   Y 
Sbjct: 126 IMHRDVKPSNILVNSRG---EIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYS 181

Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE--------------------- 228
            ++D+WS+G  L ++  G+ P    +  +L        E                     
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 229 -LRFPPGAIEEL-----------------HPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
               PP AI EL                   +  D     L +NP ER   K+   H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 2e-75
 Identities = 69/260 (26%), Positives = 126/260 (48%), Gaps = 9/260 (3%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y    +IG G+   V+ A     G EVA+++++ +       + ++ EI ++    +PNI
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNI 79

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           + + ++    +++++V+EY  GG L   + +     E       R+    L+ L    +I
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQVI 138

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT-PQDLADTLCGSPLYMAPEIIQNHKYDA 190
           HRD+K  N+L+  +     +K+ DFGF   +T  Q    T+ G+P +MAPE++    Y  
Sbjct: 139 HRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 191 KADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCL 250
           K D+WS+G +  +++ G+PP+   N L+    I T+          E+L     D     
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAIFRDFLNRC 253

Query: 251 LRQNPVERITFKEFFNHRFL 270
           L  +  +R + KE   H+FL
Sbjct: 254 LDMDVEKRGSAKELLQHQFL 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (617), Expect = 3e-75
 Identities = 80/264 (30%), Positives = 135/264 (51%), Gaps = 6/264 (2%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL----SPKVSDNLLKEISILSTIS 67
           Y  G  +GSG FAVV + R +  G++ A K I K+           +++ +E+SIL  I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HPN+I   E  E +  + L+LE   GG+L  ++ +   ++E  A  F++Q+  G+  L  
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 128 KHLIHRDLKPQN-LLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
             + H DLKP+N +L+  N   P +KI DFG A  +   +    + G+P ++APEI+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
               +AD+WS+G I + L++G  PF G  + +   N+  +    F             D 
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-AVNYEFEDEYFSNTSALAKDF 250

Query: 247 CRCLLRQNPVERITFKEFFNHRFL 270
            R LL ++P +R+T ++   H ++
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWI 274

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 2e-72
 Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 17/276 (6%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
           G+  VG RIGSGSF  V++ +      +VAVK ++    +P+       E+ +L    H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 70  NIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEK 128
           NI+ F     T  ++ +V ++C+G  L  ++H    K          RQ A G+  L  K
Sbjct: 65  NILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQN 185
            +IHRDLK  N+ +  +     +KIGDFG A   +        + L GS L+MAPE+I+ 
Sbjct: 124 SIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 186 HK---YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI-EELHP 241
                Y  ++D+++ G +L++L+TG+ P+   N       ++    L      +      
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240

Query: 242 DCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
               L    L++   ER  F +      +  L +++
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILAS--IELLARSL 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  232 bits (593), Expect = 7e-72
 Identities = 67/261 (25%), Positives = 117/261 (44%), Gaps = 7/261 (2%)

Query: 6   TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILS 64
           + L   Y +G  +G G  + V  AR  +L  +VAVK +   L   P       +E    +
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 65  TISHPNIIRFFEAIETREK----IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
            ++HP I+  ++  E         Y+V+EY DG  L   +H  G ++   A   +     
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFG-FARSLTPQDLADTLCGSPLYMA 179
            L    +  +IHRD+KP N+++S      V+  G     A S         + G+  Y++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 180 PEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL 239
           PE  +    DA++D++S+G +L++++TG+PPF G + + +    +   +   P    E L
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPPSARHEGL 241

Query: 240 HPDCVDLCRCLLRQNPVERIT 260
             D   +    L +NP  R  
Sbjct: 242 SADLDAVVLKALAKNPENRYQ 262

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 5e-71
 Identities = 83/289 (28%), Positives = 142/289 (49%), Gaps = 13/289 (4%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEISILS-TI 66
           I ++I+   +G GSF  V+ A  ++     A+K + K  +L     +  + E  +LS   
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            HP +   F   +T+E ++ V+EY +GGDL  +I    K   + A  +  ++  GLQ L 
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LADTLCGSPLYMAPEIIQN 185
            K +++RDLK  N+L+  +      KI DFG  +     D   +T CG+P Y+APEI+  
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHI---KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 186 HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
            KY+   D WS G +L++++ G+ PF G ++ +LF +I       +P      L  +  D
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRW----LEKEAKD 232

Query: 246 LCRCLLRQNPVERITFK-EFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
           L   L  + P +R+  + +   H    E+      E+  + P  +P V+
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLFREINWE-ELERKEIDPPFRPKVK 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  228 bits (582), Expect = 8e-70
 Identities = 84/291 (28%), Positives = 159/291 (54%), Gaps = 17/291 (5%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTIS 67
           + ++ +   +G+GSF  V   R R  G   A+K + K+++   K  ++   E  +LS ++
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP IIR +   +  ++I+++++Y +GG+L + + K  +    VA+ +  ++   L+ L  
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
           K +I+RDLKP+N+L+  N     +KI DFGFA+ +   D+  TLCG+P Y+APE++    
Sbjct: 123 KDIIYRDLKPENILLDKN---GHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKP 177

Query: 188 YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC 247
           Y+   D WS G ++++++ G  PF  SN ++ ++ IL + ELRFPP      + D  DL 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPP----FFNEDVKDLL 232

Query: 248 RCLLRQNPVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
             L+ ++  +R+       ++  NH +  E+         ++    +P ++
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV-VWEKLLSRNIETPYEPPIQ 282

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 9e-68
 Identities = 73/269 (27%), Positives = 126/269 (46%), Gaps = 22/269 (8%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS----PKVSDNLLKEISILST 65
            +Y VGP +GSG F  V+        + VA+K ++K  +S          +  E+ +L  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 66  IS--HPNIIRFFEAIETREKIYLVLEYCDGG-DLAAYIHKHGKVSEAVARHFMRQLAAGL 122
           +S     +IR  +  E  +   L+LE  +   DL  +I + G + E +AR F  Q+   +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEI 182
           +      ++HRD+K +N+L+  N     LK+ DFG    L    +     G+ +Y  PE 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEW 180

Query: 183 IQNHKYDAK-ADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP 241
           I+ H+Y  + A +WS+G +L+ +V G  PF+   ++          ++ F       +  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQ----RVSS 229

Query: 242 DCVDLCRCLLRQNPVERITFKEFFNHRFL 270
           +C  L R  L   P +R TF+E  NH ++
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 5e-67
 Identities = 62/269 (23%), Positives = 117/269 (43%), Gaps = 21/269 (7%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           E  +   IG G F  V    +R  G +VAVK I         +   L E S+++ + H N
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSN 61

Query: 71  IIRFFEA-IETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQE 127
           +++     +E +  +Y+V EY   G L  Y+   G+  +       F   +   ++ L+ 
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
            + +HRDL  +N+LVS + V    K+ DFG  +  +     DT      + APE ++  K
Sbjct: 122 NNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKK 176

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           +  K+D+WS G +L+++ + G+ P+       +   +    ++  P G      P   ++
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG----CPPAVYEV 232

Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQ 275
            +     +   R +F +      L  ++ 
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ--LEHIKT 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 1e-66
 Identities = 62/254 (24%), Positives = 118/254 (46%), Gaps = 15/254 (5%)

Query: 17  RIGSGSFAVVWRARHR--QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
            +GSG+F  V +  ++  ++   VAVK +  +   P + D LL E +++  + +P I+R 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
               E  E   LV+E  + G L  Y+ ++  V +      + Q++ G++ L+E + +HRD
Sbjct: 74  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPLYMAPEIIQNHKYDA 190
           L  +N+L+ T       KI DFG +++L   +              + APE I  +K+ +
Sbjct: 133 LAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           K+D+WS G ++++  + G+ P+ G    ++   +     +  P G       +  DL   
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG----CPREMYDLMNL 245

Query: 250 LLRQNPVERITFKE 263
               +   R  F  
Sbjct: 246 CWTYDVENRPGFAA 259

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (560), Expect = 2e-66
 Identities = 76/292 (26%), Positives = 148/292 (50%), Gaps = 16/292 (5%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LLSPKVSDNLLKEISILSTIS 67
           + ++     +G G+F  V   R +  G   A+K + K+ +++     + + E  +L    
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           HP +     A +T +++  V+EY +GG+L  ++ +    +E  AR +  ++ + L+ L  
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNH 186
           + +++RD+K +NL++  +     +KI DFG  +   +      T CG+P Y+APE+++++
Sbjct: 124 RDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 187 KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
            Y    D W +G ++++++ G+ PF   +  +LF+ IL   E+RFP      L P+   L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-EEIRFPR----TLSPEAKSL 235

Query: 247 CRCLLRQNPVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
              LL+++P +R+       KE   HRF   +       Q  ++P  KP V 
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQVT 286

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  218 bits (556), Expect = 2e-65
 Identities = 79/304 (25%), Positives = 137/304 (45%), Gaps = 17/304 (5%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK----EISILS 64
           + ++ V   IG G F  V+  R    G   A+K +DKK +  K  + L       +S++S
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 65  TISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQV 124
           T   P I+    A  T +K+  +L+  +GGDL  ++ +HG  SEA  R +  ++  GL+ 
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQ 184
           +  + +++RDLKP N+L+  +     ++I D G A   + +    +  G+  YMAPE++Q
Sbjct: 123 MHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 178

Query: 185 NHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
               YD+ AD +S+G +LF+L+ G  PF         +  +    L       +   P+ 
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMAVELPDSFSPEL 236

Query: 244 VDLCRCLLRQNPVERIT-----FKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSS 298
             L   LL+++   R+       +E     F   L            P   P    +N++
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL-DWQMVFLQKYPPPLIPPRGEVNAA 295

Query: 299 TPED 302
              D
Sbjct: 296 DAFD 299

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 8e-65
 Identities = 74/311 (23%), Positives = 128/311 (41%), Gaps = 44/311 (14%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           +E      + +Y    +IG G+F  V++ARHR+ G +VA+K++  +          L+EI
Sbjct: 1   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60

Query: 61  SILSTISHPNIIRFFEAIETRE--------KIYLVLEYCDGGDLAAYIHKHGKVSEAVAR 112
            IL  + H N++   E   T+          IYLV ++C+        +   K + +  +
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120

Query: 113 HFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-----TPQDL 167
             M+ L  GL  +    ++HRD+K  N+L++ +    VLK+ DFG AR+      +  + 
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG---VLKLADFGLARAFSLAKNSQPNR 177

Query: 168 ADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT- 225
                 +  Y  PE++   + Y    DLW  G I+ ++ T  P   G+ +      I   
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 226 -----------------STELRFPPGAIEEL---------HPDCVDLCRCLLRQNPVERI 259
                              +L    G   ++          P  +DL   LL  +P +RI
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 260 TFKEFFNHRFL 270
              +  NH F 
Sbjct: 298 DSDDALNHDFF 308

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 4e-64
 Identities = 54/261 (20%), Positives = 114/261 (43%), Gaps = 15/261 (5%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +      +G+G F VV   + R    +VA+K I +  +S    D  ++E  ++  +SH  
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEK 60

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYI-HKHGKVSEAVARHFMRQLAAGLQVLQEKH 129
           +++ +     +  I+++ EY   G L  Y+     +          + +   ++ L+ K 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQNHK 187
            +HRDL  +N LV+      V+K+ DFG +R +   +   +        +  PE++   K
Sbjct: 121 FLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           + +K+D+W+ G +++++ + GK P++     +  ++I     L  P             +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----HLASEKVYTI 233

Query: 247 CRCLLRQNPVERITFKEFFNH 267
                 +   ER TFK   ++
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 4e-64
 Identities = 78/281 (27%), Positives = 123/281 (43%), Gaps = 31/281 (11%)

Query: 18  IGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS---PKVSDNLLKEISILSTISHPNIIRF 74
           +G G FA V++AR +     VA+K+I     S     ++   L+EI +L  +SHPNII  
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 75  FEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
            +A   +  I LV ++ +             ++ +  + +M     GL+ L +  ++HRD
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK-YDAKA 192
           LKP NLL+  N    VLK+ DFG A+S  +P         +  Y APE++   + Y    
Sbjct: 126 LKPNNLLLDENG---VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182

Query: 193 DLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL----TSTELRFP---------------- 232
           D+W+VG IL +L+   P   G + L     I     T TE ++P                
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242

Query: 233 ---PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
                       D +DL + L   NP  RIT  +    ++ 
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-62
 Identities = 70/258 (27%), Positives = 123/258 (47%), Gaps = 17/258 (6%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
              +  R+G+G F  VW   +     +VAVK + +  +SP   D  L E +++  + H  
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQR 69

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEK 128
           ++R +  + T+E IY++ EY + G L  ++      K++         Q+A G+  ++E+
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD--LADTLCGSPLYMAPEIIQNH 186
           + IHRDL+  N+LVS        KI DFG AR +   +    +       + APE I   
Sbjct: 129 NYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 187 KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
            +  K+D+WS G +L ++VT G+ P+ G    ++ QN+     +  P    +    +   
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQ 241

Query: 246 LCRCLLRQNPVERITFKE 263
           L R   ++ P +R TF  
Sbjct: 242 LMRLCWKERPEDRPTFDY 259

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 2e-62
 Identities = 61/270 (22%), Positives = 120/270 (44%), Gaps = 17/270 (6%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           E      IGSG F +V          +VA+K I +  +S    ++ ++E  ++  +SHP 
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPK 61

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV-SEAVARHFMRQLAAGLQVLQEKH 129
           +++ +     +  I LV E+ + G L+ Y+     + +          +  G+  L+E  
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 130 LIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQNHK 187
           +IHRDL  +N LV  N    V+K+ DFG  R +       +        + +PE+    +
Sbjct: 122 VIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           Y +K+D+WS G +++++ + GK P++  +  ++ ++I T   L  P             +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP----RLASTHVYQI 234

Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQT 276
                ++ P +R  F        L E+ ++
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQ--LAEIAES 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-62
 Identities = 58/254 (22%), Positives = 115/254 (45%), Gaps = 17/254 (6%)

Query: 18  IGSGSFAVVWRARHRQL--GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFF 75
           +G G+F  V +  +R     I+VA+K + +       ++ +++E  I+  + +P I+R  
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 76  EAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRD 134
              +    + LV+E   GG L  ++     ++  +     + Q++ G++ L+EK+ +HRD
Sbjct: 76  GVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134

Query: 135 LKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL----CGSPLYMAPEIIQNHKYDA 190
           L  +N+L+         KI DFG +++L   D   T          + APE I   K+ +
Sbjct: 135 LAARNVLLVNR---HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 191 KADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRC 249
           ++D+WS G  +++ ++ G+ P+      ++   I     +  PP    E  P+   L   
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP----ECPPELYALMSD 247

Query: 250 LLRQNPVERITFKE 263
                  +R  F  
Sbjct: 248 CWIYKWEDRPDFLT 261

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-62
 Identities = 81/281 (28%), Positives = 131/281 (46%), Gaps = 21/281 (7%)

Query: 6   TRLIGE--YIVGPRIGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLS-PKVSDNLLKE 59
           T LIGE    +  ++G GSF VV R          + VAVK +   +LS P+  D+ ++E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 60  ISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQL 118
           ++ + ++ H N+IR +  + T   + +V E    G L   + KH G         +  Q+
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----LADTLCGS 174
           A G+  L+ K  IHRDL  +NLL++T +   ++KIGDFG  R+L   D    + +     
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 175 PLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPP 233
             + APE ++   +   +D W  G  L+++ T G+ P+ G N  Q+   I      R P 
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-GERLPR 236

Query: 234 GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
              E+   D  ++        P +R TF       FL E +
Sbjct: 237 --PEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFLLEAQ 273

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 4e-62
 Identities = 81/293 (27%), Positives = 134/293 (45%), Gaps = 30/293 (10%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           +    +IG G++ VV++AR++  G  VA+K+I     +  V    ++EIS+L  ++HPNI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLA-AYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHL 130
           ++  + I T  K+YLV E+                +   + + ++ QL  GL       +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123

Query: 131 IHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHKY- 188
           +HRDLKPQNLL++T      +K+ DFG AR+   P         +  Y APEI+   KY 
Sbjct: 124 LHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 189 DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST-----------------ELRF 231
               D+WS+G I  ++VT +  F G +++     I  +                  +  F
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 232 PPGA-------IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTV 277
           P  A       +  L  D   L   +L  +P +RI+ K    H F  ++ + V
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 7e-61
 Identities = 84/337 (24%), Positives = 138/337 (40%), Gaps = 47/337 (13%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y     +GSG++  V  A   + G +VA+K++ +   S   +    +E+ +L  + H N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 72  IRFFEAIETREK------IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVL 125
           I   +     E        YLV+ +   G     + KH K+ E   +  + Q+  GL+ +
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQN 185
               +IHRDLKP NL V+ +     LKI DFG AR    +        +  Y APE+I N
Sbjct: 138 HAAGIIHRDLKPGNLAVNED---CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN 192

Query: 186 H-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNI--------------------- 223
             +Y    D+WSVG I+ +++TGK  F GS+ L   + I                     
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 224 -----LTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVH 278
                L   E +     +    P  V+L   +L  +  +R+T  E   H +   L  T  
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT-- 310

Query: 279 AEQHSVVPETKPMVELLNSSTPEDRHSLHSE----HP 311
            E    V +     + ++ +  E +   + E     P
Sbjct: 311 -EDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 8e-61
 Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 35/301 (11%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQL-GIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           R   +Y     IG G++  V++AR  +  G  VA+K +  +     +  + ++E+++L  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 66  IS---HPNIIRFFEAIETRE-----KIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMR 116
           +    HPN++R F+           K+ LV E+ D              V     +  M 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 117 QLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPL 176
           QL  GL  L    ++HRDLKPQN+LV+++      K+ DFG AR  + Q    ++  +  
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLW 180

Query: 177 YMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT----------- 225
           Y APE++    Y    DLWSVG I  ++   KP F GS+ +     IL            
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240

Query: 226 -----------STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                      S   +     + ++     DL    L  NP +RI+     +H +  +L 
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

Query: 275 Q 275
           +
Sbjct: 301 R 301

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (515), Expect = 1e-60
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 30/285 (10%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y    +IG G++ VV++A++   G   A+K+I  +     +    ++EISIL  + H NI
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           ++ ++ I T++++ LV E+ D           G +    A+ F+ QL  G+    ++ ++
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNH-KYD 189
           HRDLKPQNLL++       LKI DFG AR+   P         +  Y AP+++    KY 
Sbjct: 123 HRDLKPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 190 AKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL------------------------T 225
              D+WSVG I  ++V G P F G ++      I                         T
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL 270
             E       ++ L    +DL   +L+ +P +RIT K+   H + 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 1e-60
 Identities = 66/270 (24%), Positives = 131/270 (48%), Gaps = 17/270 (6%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
           +  +  ++G G +  V+    ++  + VAVK + +        +  LKE +++  I HPN
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPN 74

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEK 128
           +++           Y++ E+   G+L  Y+ +  +  VS  V  +   Q+++ ++ L++K
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAPEIIQNH 186
           + IHRDL  +N LV  N    ++K+ DFG +R +T               + APE +  +
Sbjct: 135 NFIHRDLAARNCLVGENH---LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 187 KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           K+  K+D+W+ G +L+++ T G  P+ G +  Q+++ +     +  P G  E+      +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK----VYE 247

Query: 246 LCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           L R   + NP +R +F E   H+    + Q
Sbjct: 248 LMRACWQWNPSDRPSFAEI--HQAFETMFQ 275

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-60
 Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 16/264 (6%)

Query: 11  EYIVGPRIGSGSFAVVWRARHR---QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
              +G  IG G F  V +  +       + VA+K   K   S  V +  L+E   +    
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFD 66

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQ 126
           HP+I++    I T   +++++E C  G+L +++      +  A    +  QL+  L  L+
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQ 184
            K  +HRD+  +N+LVS+N+    +K+GDFG +R +       A        +MAPE I 
Sbjct: 126 SKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 185 NHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC 243
             ++ + +D+W  G  +++++  G  PF G     +   I     L  PP       P  
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP----NCPPTL 238

Query: 244 VDLCRCLLRQNPVERITFKEFFNH 267
             L       +P  R  F E    
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-60
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 26/285 (9%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN 70
              +  ++G G F  VW          VA+K +    +SP+     L+E  ++  + H  
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73

Query: 71  IIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK--VSEAVARHFMRQLAAGLQVLQEK 128
           +++ +  + + E IY+V EY   G L  ++       +          Q+A+G+  ++  
Sbjct: 74  LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 129 HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQNH 186
           + +HRDL+  N+LV  N    V K+ DFG AR +   +            + APE     
Sbjct: 133 NYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 187 KYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD 245
           ++  K+D+WS G +L +L T G+ P+ G    ++   +     +  PP    E      D
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP----ECPESLHD 245

Query: 246 LCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKP 290
           L     R+ P ER TF+          L+  +     S  P+ +P
Sbjct: 246 LMCQCWRKEPEERPTFE---------YLQAFLEDYFTSTEPQYQP 281

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (515), Expect = 2e-60
 Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 19/266 (7%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           I    +   IG+G F  V     +  G   I VA+K +     + K   + L E SI+  
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQ 83

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQV 124
             HPN+I     +     + ++ E+ + G L +++    G+ +       +R +AAG++ 
Sbjct: 84  FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143

Query: 125 LQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL------CGSPLYM 178
           L + + +HRDL  +N+LV++N    V K+ DFG +R L       T            + 
Sbjct: 144 LADMNYVHRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIE 237
           APE IQ  K+ + +D+WS G +++++++ G+ P+       +   I     L  P     
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP----M 256

Query: 238 ELHPDCVDLCRCLLRQNPVERITFKE 263
           +       L     +++   R  F +
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (518), Expect = 4e-60
 Identities = 80/274 (29%), Positives = 145/274 (52%), Gaps = 16/274 (5%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDK-KLLSPKVSDNLLKEIS 61
              T  + ++     +G+GSF  V   +H++ G   A+K +DK K++  K  ++ L E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 62  ILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAG 121
           IL  ++ P +++   + +    +Y+V+EY  GG++ +++ + G+ SE  AR +  Q+   
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 122 LQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPE 181
            + L    LI+RDLKP+NLL+        +++ DFGFA+    +    TLCG+P  +APE
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKR--VKGRTWTLCGTPEALAPE 208

Query: 182 IIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHP 241
           II +  Y+   D W++G +++++  G PPF     +Q+++ I  S ++RFP         
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKVRFPS----HFSS 263

Query: 242 DCVDLCRCLLRQNPVERI-----TFKEFFNHRFL 270
           D  DL R LL+ +  +R         +  NH++ 
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 5e-60
 Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 28/273 (10%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLG--IEVAVKEIDKKLLSPKVSDNLLKEISILSTIS- 67
           +      IG G+F  V +AR ++ G  ++ A+K + K+  S     +   E+ +L  +  
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGH 69

Query: 68  HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH----------------GKVSEAVA 111
           HPNII    A E R  +YL +EY   G+L  ++ K                   +S    
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 112 RHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTL 171
            HF   +A G+  L +K  IHRDL  +N+LV  N    V KI DFG +R           
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEVYVKKTMG 186

Query: 172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELR 230
                +MA E +    Y   +D+WS G +L+++V+ G  P+ G    +L++ +     L 
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
            P         +  DL R   R+ P ER +F +
Sbjct: 247 KP----LNCDDEVYDLMRQCWREKPYERPSFAQ 275

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 1e-59
 Identities = 58/285 (20%), Positives = 96/285 (33%), Gaps = 24/285 (8%)

Query: 1   MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEI 60
           ME    R+   Y +G +IGSGSF  ++       G EVA+K    K         L  E 
Sbjct: 1   ME---LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIES 53

Query: 61  SILSTISHPNIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLA 119
            I   +     I          +   +V+E         +     K S         Q+ 
Sbjct: 54  KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMI 113

Query: 120 AGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD--------TL 171
           + ++ +  K+ IHRD+KP N L+   +   ++ I DFG A+                  L
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF 231
            G+  Y +       +   + DL S+G +L     G  P+ G       Q     +E + 
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233

Query: 232 PPGAIEELHPDC----VDLCRCLLRQNPVERITF---KEFFNHRF 269
               IE L                     ++  +   ++ F + F
Sbjct: 234 ST-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-59
 Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 40/290 (13%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLG-----IEVAVKEIDKKLLSPKVSDNLLKEISILST 65
               G  +GSG+F  V  A    +      I+VAVK + +K       + L+ E+ +++ 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQ 96

Query: 66  I-SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH--------------------- 103
           + SH NI+    A      IYL+ EYC  GDL  Y+                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 104 --GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS 161
               ++      F  Q+A G++ L+ K  +HRDL  +N+LV+      V+KI DFG AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKICDFGLARD 213

Query: 162 LTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQL 217
           +       +         +MAPE +    Y  K+D+WS G +L+++ + G  P+ G    
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 218 QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH 267
             F  ++ +    F          +   + +     +  +R +F    + 
Sbjct: 274 ANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 4e-59
 Identities = 70/312 (22%), Positives = 130/312 (41%), Gaps = 21/312 (6%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
           E+     +GSG+F  V++      G    I VA+KE+ ++  SPK +  +L E  +++++
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 68

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
            +P++ R      T     +      G  L         +      ++  Q+A G+  L+
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEII 183
           ++ L+HRDL  +N+LV T      +KI DFG A+ L  ++    A+       +MA E I
Sbjct: 129 DRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 184 QNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD 242
            +  Y  ++D+WS G  +++L+T G  P+DG    ++   +     L  PP        D
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP----ICTID 241

Query: 243 CVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVELLNSSTPED 302
              +       +   R  F+E           +     Q  +V +    + L + +    
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIE-----FSKMARDPQRYLVIQGDERMHLPSPTDSNF 296

Query: 303 RHSLHSEHPTNS 314
             +L  E   + 
Sbjct: 297 YRALMDEEDMDD 308

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-58
 Identities = 91/349 (26%), Positives = 140/349 (40%), Gaps = 54/349 (15%)

Query: 3   PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISI 62
           P+R + +  Y     IG+GSF VV++A+    G  VA+K++ +            +E+ I
Sbjct: 14  PDRPQEV-SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQI 66

Query: 63  LSTISHPNIIRFFEAIETREK------IYLVLEYCDGG---DLAAYIHKHGKVSEAVARH 113
           +  + H NI+R      +  +      + LVL+Y           Y      +     + 
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126

Query: 114 FMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCG 173
           +M QL   L  +    + HRD+KPQNLL+  +  T VLK+ DFG A+ L   +   +   
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVRGEPNVSYIC 184

Query: 174 SPLYMAP-EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS------ 226
           S  Y AP  I     Y +  D+WS G +L +L+ G+P F G + +     I+        
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

Query: 227 ----------TELRFPPGAIEELH--------PDCVDLCRCLLRQNPVERITFKEFFNHR 268
                     TE +FP                P+ + LC  LL   P  R+T  E   H 
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304

Query: 269 FLGELRQTVHAEQHSVVPETKPMVELLN------SSTPEDRHSLHSEHP 311
           F  ELR     + +  +P  +    L N      SS P     L   H 
Sbjct: 305 FFDELR-----DPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHA 348

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 3e-58
 Identities = 81/303 (26%), Positives = 124/303 (40%), Gaps = 41/303 (13%)

Query: 9   IGE-YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS 67
           +G  Y     IG G++ +V  A      + VA+K+I             L+EI IL    
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFR 64

Query: 68  HPNIIRFFEAIETRE----KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQ 123
           H NII   + I        K   ++ +  G DL   + K   +S     +F+ Q+  GL+
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLK 123

Query: 124 VLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP----QDLADTLCGSPLYMA 179
            +   +++HRDLKP NLL++T      LKI DFG AR   P             +  Y A
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTC---DLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 180 PEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT------------- 225
           PEI+ N   Y    D+WSVG IL ++++ +P F G + L    +IL              
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 226 ------STELRFPPGAIEELH-------PDCVDLCRCLLRQNPVERITFKEFFNHRFLGE 272
                 +  L  P       +          +DL   +L  NP +RI  ++   H +L +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

Query: 273 LRQ 275
              
Sbjct: 301 YYD 303

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (498), Expect = 7e-58
 Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 43/298 (14%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
                  IG G+F  V++AR   L        VAVK + ++  S  +  +  +E ++++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAE 72

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGK-------------------- 105
             +PNI++        + + L+ EY   GDL  ++                         
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 106 ----VSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS 161
               +S A      RQ+AAG+  L E+  +HRDL  +N LV  N    V+KI DFG +R+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN---MVVKIADFGLSRN 189

Query: 162 LTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQL 217
           +   D             +M PE I  ++Y  ++D+W+ G +L+++ + G  P+ G    
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 218 QLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
           ++   +     L  P    E    +  +L R    + P +R +F     HR L  + +
Sbjct: 250 EVIYYVRDGNILACP----ENCPLELYNLMRLCWSKLPADRPSFCSI--HRILQRMCE 301

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 1e-57
 Identities = 78/290 (26%), Positives = 135/290 (46%), Gaps = 30/290 (10%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y    +IG G++  V++A++R+    VA+K +        V  + L+EI +L  + H NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 72  IRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLI 131
           +R  + + + +K+ LV E+CD      +   +G +   + + F+ QL  GL     ++++
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 132 HRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-TPQDLADTLCGSPLYMAPEIIQNHK-YD 189
           HRDLKPQNLL++ N      K+ +FG AR+   P         +  Y  P+++   K Y 
Sbjct: 124 HRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 190 AKADLWSVGAILFQLVTGK-PPFDGSNQLQLFQNIL----TSTELRFP------------ 232
              D+WS G I  +L     P F G++     + I     T TE ++P            
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 233 --------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR 274
                      + +L+    DL + LL+ NPV+RI+ +E   H +  +  
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 2e-56
 Identities = 69/300 (23%), Positives = 140/300 (46%), Gaps = 20/300 (6%)

Query: 9   IGEYIVGPRIGSGSFAVVWRARH---RQLGIEVAVKEIDKKLLS--PKVSDNLLKEISIL 63
           I  + +   +G+G++  V+  R       G   A+K + K  +    K +++   E  +L
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 64  STISH-PNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGL 122
             I   P ++    A +T  K++L+L+Y +GG+L  ++ +  + +E   + ++ ++   L
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 123 QVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT--LCGSPLYMAP 180
           + L +  +I+RD+K +N+L+ +N     + + DFG ++     +       CG+  YMAP
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 181 EIIQNHK--YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +I++     +D   D WS+G ++++L+TG  PF    +      I     L+  P   +E
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-ILKSEPPYPQE 258

Query: 239 LHPDCVDLCRCLLRQNPVERI-----TFKEFFNHRFLGELRQTVHAEQHSVVPETKPMVE 293
           +     DL + LL ++P +R+        E   H F  ++          V    KP++ 
Sbjct: 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD-DLAAKKVPAPFKPVIR 317

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-56
 Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 30/278 (10%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQL-------GIEVAVKEIDKKLLSPKVSDNLLKEISIL 63
             ++G  +G G+F  V  A    L         +VAVK +     + K   +L+ E+ ++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMM 72

Query: 64  STIS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG----------------KV 106
             I  H NII    A      +Y+++EY   G+L  Y+                    ++
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 107 SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
           S         Q+A G++ L  K  IHRDL  +N+LV+ + V  +   G       +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
                     +MAPE + +  Y  ++D+WS G +L+++ T G  P+ G    +LF+ +  
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
              +  P         +   + R      P +R TFK+
Sbjct: 253 GHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQ 286

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 7e-56
 Identities = 75/327 (22%), Positives = 133/327 (40%), Gaps = 48/327 (14%)

Query: 12  YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI 71
           Y     +GSG++  V  A   + G+ VAVK++ +   S   +    +E+ +L  + H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 72  IRFFEAIETREKI-----YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQ 126
           I   +       +       ++ +  G D    I K  K+++   +  + Q+  GL+ + 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138

Query: 127 EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNH 186
              +IHRDLKP NL V+ +      KI DFG AR    +        +  Y APEI+ N 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCEL---KILDFGLARHTDDEM--TGYVATRWYRAPEIMLNW 193

Query: 187 K-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT-------------------- 225
             Y+   D+WSVG I+ +L+TG+  F G++ +   + IL                     
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253

Query: 226 --STELRFPPGAIEE----LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQTVHA 279
              +  + P           +P  VDL   +L  +  +RIT  +   H +  +       
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD---- 309

Query: 280 EQHSVVPETKPMVELLNSSTPEDRHSL 306
                 P+ +P+ +  + S       +
Sbjct: 310 ------PDDEPVADPYDQSFESRDLLI 330

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-55
 Identities = 68/282 (24%), Positives = 112/282 (39%), Gaps = 21/282 (7%)

Query: 18  IGSGSFAVVWRARHRQL---GIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF 74
           IG G F  V+           I  AVK +  ++         L E  I+   SHPN++  
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 75  FEA-IETREKIYLVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIH 132
               + +     +VL Y   GDL  +I  +    +      F  Q+A G++ L  K  +H
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 153

Query: 133 RDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLC-----GSPLYMAPEIIQNHK 187
           RDL  +N ++        +K+ DFG AR +  ++               +MA E +Q  K
Sbjct: 154 RDLAARNCMLDEK---FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210

Query: 188 YDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL 246
           +  K+D+WS G +L++L+T G PP+   N   +   +L    L  P    E       ++
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP----EYCPDPLYEV 266

Query: 247 CRCLLRQNPVERITFKEFFNHRFLGELRQTVHAEQHSVVPET 288
                      R +F E  +   +  +  T   E +  V  T
Sbjct: 267 MLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGEHYVHVNAT 306

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-55
 Identities = 57/272 (20%), Positives = 116/272 (42%), Gaps = 27/272 (9%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
           +  +   +G GSF +V+    + +        VA+K +++   S +     L E S++  
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKE 79

Query: 66  ISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKV----------SEAVARHFM 115
            +  +++R    +   +   +++E    GDL +Y+                S +      
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 116 RQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL---ADTLC 172
            ++A G+  L     +HRDL  +N +V+ +     +KIGDFG  R +   D         
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 173 GSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG-KPPFDGSNQLQLFQNILTSTELRF 231
               +M+PE +++  +   +D+WS G +L+++ T  + P+ G +  Q+ + ++    L  
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256

Query: 232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
           P    +       +L R   + NP  R +F E
Sbjct: 257 P----DNCPDMLFELMRMCWQYNPKMRPSFLE 284

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-55
 Identities = 69/311 (22%), Positives = 121/311 (38%), Gaps = 49/311 (15%)

Query: 7   RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
            ++  Y     IGSG+  +V  A    L   VA+K++ +   +   +    +E+ ++  +
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73

Query: 67  SHPNIIRFFEA------IETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAA 120
           +H NII           +E  + +YLV+E  D         +          + + Q+  
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLC 130

Query: 121 GLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAP 180
           G++ L    +IHRDLKP N++V ++      KI DFG AR+     +      +  Y AP
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 181 EIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS-------------- 226
           E+I    Y    D+WSVG I+ ++V  K  F G + +  +  ++                
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 227 ------------TELRFPPGAIEELHP-----------DCVDLCRCLLRQNPVERITFKE 263
                         L FP    + L P              DL   +L  +P +RI+  +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 264 FFNHRFLGELR 274
              H ++    
Sbjct: 308 ALQHPYINVWY 318

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 6e-54
 Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 29/278 (10%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
               G  +G+G+F  V  A    L      + VAVK +          + L+ E+ +LS 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSY 82

Query: 66  IS-HPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHG------------------KV 106
           +  H NI+    A        ++ EYC  GDL  ++ +                     +
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 107 SEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD 166
                  F  Q+A G+  L  K+ IHRDL  +N+L++   +T +   G     ++ +   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 167 LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILT 225
           +         +MAPE I N  Y  ++D+WS G  L++L + G  P+ G      F  ++ 
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

Query: 226 STELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKE 263
                F   + E    +  D+ +     +P++R TFK+
Sbjct: 263 E---GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  184 bits (468), Expect = 1e-53
 Identities = 50/269 (18%), Positives = 90/269 (33%), Gaps = 20/269 (7%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
             Y VG RIG GSF V++   +     +VA+K   ++      +  L  E      ++  
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGC 60

Query: 70  NII-RFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEK 128
             I   +   +      LV++               K S        +Q+ A +Q + EK
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 129 HLIHRDLKPQNLLVS--TNEVTPVLKIGDFGFARSL--------TPQDLADTLCGSPLYM 178
            L++RD+KP N L+    ++   ++ + DFG  +           P      L G+  YM
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 179 APEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEE 238
           +       +   + DL ++G +    + G  P+ G       Q      E +     + E
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-PLRE 239

Query: 239 LHPDC----VDLCRCLLRQNPVERITFKE 263
           L                         +  
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDY 268

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  185 bits (469), Expect = 2e-53
 Identities = 60/296 (20%), Positives = 116/296 (39%), Gaps = 47/296 (15%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HP 69
           +Y +  ++G G ++ V+ A +     +V VK +            + +EI IL  +   P
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGP 90

Query: 70  NIIRFFEAIETREK--IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE 127
           NII   + ++        LV E+ +  D          +++   R +M ++   L     
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS 147

Query: 128 KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHK 187
             ++HRD+KP N+++        L++ D+G A    P    +    S  +  PE++ +++
Sbjct: 148 MGIMHRDVKPHNVMIDHE--HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 188 -YDAKADLWSVGAILFQLVTGKPPFDGSN----QLQLFQNILTSTELR------------ 230
            YD   D+WS+G +L  ++  K PF   +    QL     +L + +L             
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 231 -----------------FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRF 269
                                    + P+ +D    LLR +   R+T +E   H +
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-51
 Identities = 65/263 (24%), Positives = 117/263 (44%), Gaps = 18/263 (6%)

Query: 11  EYIVGPRIGSGSFAVVWRARHR----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI 66
                  IG+G F  V++   +    +  + VA+K +     + K   + L E  I+   
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQF 66

Query: 67  SHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVL 125
           SH NIIR    I   + + ++ EY + G L  ++ +  G+ S       +R +AAG++ L
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 126 QEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADT----LCGSPLYMAPE 181
              + +HRDL  +N+LV++N    V K+ DFG +R L     A            + APE
Sbjct: 127 ANMNYVHRDLAARNILVNSNL---VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 182 IIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH 240
            I   K+ + +D+WS G ++++++T G+ P+   +  ++ + I     L  P     +  
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM----DCP 239

Query: 241 PDCVDLCRCLLRQNPVERITFKE 263
                L     +Q    R  F +
Sbjct: 240 SAIYQLMMQCWQQERARRPKFAD 262

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 8e-49
 Identities = 64/305 (20%), Positives = 110/305 (36%), Gaps = 49/305 (16%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
              ++   IG G F  VWR + R  G EVAVK    +       +    EI     + H 
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREA---EIYQTVMLRHE 57

Query: 70  NIIRFFEAIE----TREKIYLVLEYCDGGDLAAYIHKHG-------KVSEAVARHFMRQL 118
           NI+ F  A      T  +++LV +Y + G L  Y++++        K++ + A       
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117

Query: 119 AAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL-----TPQDLADTLCG 173
              +    +  + HRDLK +N+LV  N       I D G A        T     +   G
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 174 SPLYMAPEIIQ------NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST 227
           +  YMAPE++       + +   +AD++++G + +++             QL    L  +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234

Query: 228 E----------------LRFPPGAIEELHPDCV-DLCRCLLRQNPVERITFKEFFNHRFL 270
           +                   P           +  + R     N   R+T       + L
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI--KKTL 292

Query: 271 GELRQ 275
            +L Q
Sbjct: 293 SQLSQ 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-49
 Identities = 67/292 (22%), Positives = 117/292 (40%), Gaps = 36/292 (12%)

Query: 11  EYIVGPRIGSGSFAVVWRARHRQL-----GIEVAVKEIDKKLLSPKVSDNLLKEISILST 65
              +G  +G G+F  V  A    +        VAVK + +     +    + +   ++  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 66  ISHPNIIRFFEAI-ETREKIYLVLEYCDGGDLAAYIHKHGK----------------VSE 108
             H N++    A  +    + +++E+C  G+L+ Y+                     ++ 
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 109 AVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-- 166
                +  Q+A G++ L  +  IHRDL  +N+L+S      V+KI DFG AR +      
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDY 190

Query: 167 -LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG-KPPFDGSNQLQLFQNIL 224
                      +MAPE I +  Y  ++D+WS G +L+++ +    P+ G    + F   L
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250

Query: 225 TS-TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ 275
              T +R P    +   P+            P +R TF E   H  LG L Q
Sbjct: 251 KEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 296

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (387), Expect = 1e-41
 Identities = 54/322 (16%), Positives = 108/322 (33%), Gaps = 64/322 (19%)

Query: 10  GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHP 69
             YI+  ++G G F+ VW A+       VA+K +         ++    EI +L  ++  
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDA 69

Query: 70  NIIR---------------FFEAIETREKIYLVLEYCDGGDLAA-YIHKHGKVSEAVARH 113
           +  +               F         + +V E      LA    ++H  +     + 
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 114 FMRQLAAGLQVLQEKH-LIHRDLKPQNLLVSTNEVTPVL-KIGDFGFARSLTPQDLADTL 171
             +QL  GL  +  +  +IH D+KP+N+L+   +    L +I       +    +     
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 172 CGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGS---------NQLQLFQN 222
             +  Y +PE++    +   AD+WS   ++F+L+TG   F+           + +     
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 223 IL----------------------------------TSTELRFPPGAIEELHPDCVDLCR 248
           +L                                      L       ++   +  D   
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 249 CLLRQNPVERITFKEFFNHRFL 270
            +L+ +P +R       NH +L
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWL 331

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 99.1 bits (246), Expect = 2e-24
 Identities = 28/204 (13%), Positives = 58/204 (28%), Gaps = 40/204 (19%)

Query: 14  VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----------------VSDNLL 57
           +G  +G G  + V+     +   E  VK       S K                   +  
Sbjct: 4   IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 58  KEISILSTISHPNIIRFFEAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQ 117
            E   L  +    + + +          +++E            +  +V        +  
Sbjct: 63  NEFRALQKLQGLAVPKVYAWEGN----AVLMELI-------DAKELYRVRVENPDEVLDM 111

Query: 118 LAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLADTLCGSPLY 177
           +   +     + ++H DL   N+LVS   +     I DF  +  +  +   +      L 
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI----WIIDFPQSVEVGEEGWREI-----LE 162

Query: 178 MAPEIIQNH---KYDAKADLWSVG 198
                I  +    Y  + D+ S  
Sbjct: 163 RDVRNIITYFSRTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	692
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.69
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.41
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.5
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.33
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.3

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=429.82  Aligned_cols=264  Identities=28%  Similarity=0.537  Sum_probs=238.2

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf             40125789983851259648999999689938999993057799578999999999998079998133778998288899
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~   85 (692)
                      ..++++|++++.||+|+||.||+|+++.+|+.||||++...  .....+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             87865758988984076819999998899989999998452--4316999999999998679979992999999899999


Q ss_pred             EEEECCCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCC
Q ss_conf             9995159999999999-729999999999999999999999876984557888716861799857189800255324687
Q 005526           86 LVLEYCDGGDLAAYIH-KHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GgsL~~~L~-~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~  164 (692)
                      +|||||+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+.+ ..+||+|||+++.+..
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~-~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS-NELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS-CCEEECCCTTCEECCT
T ss_pred             EEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCC-CEEEEEECCHHEECCC
T ss_conf             999857998899999762378999999999999999999997569760001546736416889-8699954521044256


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
Q ss_conf             78777667988766757662037994125677999999998299999999989999998703677899975444588999
Q 005526          165 QDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCV  244 (692)
Q Consensus       165 ~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~  244 (692)
                      .......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+... ...++......+++++.
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCSCCGGGGGCCHHHH
T ss_pred             CCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC-CCCCCCCCCCCCCHHHH
T ss_conf             54320006862421889975899872676554659999998598998997999999999847-88989422358999999


Q ss_pred             HHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             99999500399999999999843334656
Q 005526          245 DLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       245 dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      +||.+||.+||.+|||+.|+|+||||+..
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf             99999756896679089998629132889

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=430.65  Aligned_cols=265  Identities=30%  Similarity=0.552  Sum_probs=239.1

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf             40125789983851259648999999689938999993057799578999999999998079998133778998288899
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~   85 (692)
                      +.+.++|++.+.||+|+||+||+|+++.+++.||||++....... ....+.+|+.+++.++||||+++++++.+++.+|
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             877666699889940658399999999999899999981577312-8999999999998679989991989999899888


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             99951599999999997299999999999999999999998769845578887168617998571898002553246877
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~  165 (692)
                      +|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+........+||+|||+++.....
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC
T ss_conf             98852689848886530367887899999999999987524130556870463001104688824998315435872589


Q ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             87776679887667576620379941256779999999982999999999899999987036778999754445889999
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~d  245 (692)
                      ......+||+.|||||++.+..|+.++||||+||++|+|++|++||.+.+..+....+.... ..++......+++++.+
T Consensus       164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE-YEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC-CCCCTTTTTTSCHHHHH
T ss_pred             CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCCCCHHHHH
T ss_conf             70440032842259188737999807873451599999985979999989999999986168-77787666678999999


Q ss_pred             HHHHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             999950039999999999984333465
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       246 LI~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                      |+.+||++||.+|||+.|+++||||+.
T Consensus       243 li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             999976089757918999862984479

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=427.09  Aligned_cols=263  Identities=30%  Similarity=0.562  Sum_probs=237.4

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf             01257899838512596489999996899389999930577995789999999999980799981337789982888999
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~L   86 (692)
                      .+.++|++.+.||+|+||+||+|+++.+|+.||+|++....  ......+.+|+.++++++||||+++++++.+++.+|+
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             85403599899931778299999998999799999988726--4679999999999986799798919999998999999


Q ss_pred             EEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             99515999999999972-99999999999999999999998769845578887168617998571898002553246877
Q 005526           87 VLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        87 VmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~  165 (692)
                      |||||+||+|.+++... .++++.+++.++.||+.||.|||++||+||||||+|||++.... ..+||+|||+++.....
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~-~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA-SSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC-CCEEECCCTTCEECCTT
T ss_pred             EEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCC-CEEEEEECCCCEECCCC
T ss_conf             99828998088889863899899999999999999999999779265131445531134678-84899525630343788


Q ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             87776679887667576620379941256779999999982999999999899999987036778999754445889999
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~d  245 (692)
                      .......|++.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+... ...++...+..+++++.+
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-DWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-CCCCCSSTTTTSCHHHHH
T ss_pred             CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC-CCCCCCCCCCCCCHHHHH
T ss_conf             7201004764534899974799897633389899999999688998997999999999847-889893002479999999


Q ss_pred             HHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             9999500399999999999843334656
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       246 LI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      ||.+||++||.+|||+.|+|+||||+..
T Consensus       262 li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             9999756996689189999609734888

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=422.58  Aligned_cols=260  Identities=27%  Similarity=0.571  Sum_probs=235.8

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf             12578998385125964899999968993899999305779-95789999999999980799981337789982888999
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~L   86 (692)
                      -+++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf             44742898898317684999999989998999999815654497999999999999986799988778764035642111


Q ss_pred             EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCC-C
Q ss_conf             995159999999999729999999999999999999999876984557888716861799857189800255324687-7
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-Q  165 (692)
Q Consensus        87 VmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~-~  165 (692)
                      |||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.... .
T Consensus        83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g---~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---HIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCSCCTT
T ss_pred             CEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC---CEEEEECCCCCCCCCCC
T ss_conf             000357986055553256775999999999996521134315962246477784765899---88882056520035678


Q ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             87776679887667576620379941256779999999982999999999899999987036778999754445889999
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~d  245 (692)
                      ......+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+++..+... ...+|    ..+++++.+
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-~~~~p----~~~s~~~~d  234 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFP----RTLSPEAKS  234 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCC----TTSCHHHHH
T ss_pred             CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC-CCCCC----CCCCHHHHH
T ss_conf             6205510088996666504898883331022306788998789999996999999998528-99898----668999999


Q ss_pred             HHHHHHCCCCCCCC-----CHHHHHHCHHHHHHHH
Q ss_conf             99995003999999-----9999984333465676
Q 005526          246 LCRCLLRQNPVERI-----TFKEFFNHRFLGELRQ  275 (692)
Q Consensus       246 LI~~mL~~DP~~RP-----Ta~eLL~HPfl~~~~~  275 (692)
                      ||++||++||.+|+     +++++++||||.++..
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCH
T ss_conf             99866638934422565234999972915036999

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=422.40  Aligned_cols=267  Identities=30%  Similarity=0.556  Sum_probs=240.5

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCH----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf             401257899838512596489999996899389999930577995----7899999999999807999813377899828
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP----KVSDNLLKEISILSTISHPNIIRFFEAIETR   81 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~   81 (692)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||||++.+.....    ...+.+.+|+.++++++||||+++++++.+.
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC
T ss_conf             88556779827981178959999999999989999998756632134068999999999999867998999388999979


Q ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC-CCEEEEECCCCCC
Q ss_conf             889999951599999999997299999999999999999999998769845578887168617998-5718980025532
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEV-TPVLKIGDFGFAR  160 (692)
Q Consensus        82 ~~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~-~~~iKL~DFGla~  160 (692)
                      +.+|+|||||+||+|.+++...+.+++..++.++.|++.||+|||+++|+||||||+|||++.++. ...+||+|||+++
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHH
T ss_conf             98999998677864310010356421557899999999998766625422113330127982589866646964334421


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             46877877766798876675766203799412567799999999829999999998999999870367789997544458
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       161 ~~~~~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls  240 (692)
                      ............|++.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+.+.++... ...++.......+
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s  244 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFEDEYFSNTS  244 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCCCHHHHTTSC
T ss_pred             HCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC-CCCCCCHHCCCCC
T ss_conf             057776312247777430999981899997665221409999997088998899999999999816-8888701047889


Q ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             899999999500399999999999843334656
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       241 ~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      +++.+||++||++||.+|||++|+|+||||+..
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf             999999999863896689199999619041888

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=422.64  Aligned_cols=255  Identities=33%  Similarity=0.622  Sum_probs=231.3

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             25789983851259648999999689938999993057799-57899999999999807999813377899828889999
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LV   87 (692)
                      +++|++++.||+|+||+||+|+++.+++.||+|++...... ......+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf             53769988985177858999999899949999998168856768999999999999856888888599999989998999


Q ss_pred             EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             95159999999999729999999999999999999999876984557888716861799857189800255324687787
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        88 mEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~~  167 (692)
                      ||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++..... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~---~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG---ELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEECCCCSCSCCCCC-C
T ss_pred             EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCC---CEEECCCCEEEECCCC-C
T ss_conf             85047985898875048999999999999999999999988946522023441466899---8711555633544888-5


Q ss_pred             CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             77667988766757662037994125677999999998299999999989999998703677899975444588999999
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~dLI  247 (692)
                      ....+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+.++... ...+|    ...++++.+|+
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~p----~~~s~~~~~li  235 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP----DFVTEGARDLI  235 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCC----TTSCHHHHHHH
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-CCCCC----CCCCHHHHHHH
T ss_conf             23557887634999975899893144046759999983299998889999999999718-99998----66899999999


Q ss_pred             HHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             9950039999999999984333465
Q 005526          248 RCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       248 ~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                      .+||++||.+|||++|+|+||||+.
T Consensus       236 ~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         236 SRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             9976479768909999971907078

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=422.77  Aligned_cols=263  Identities=26%  Similarity=0.486  Sum_probs=224.5

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf             01257899838512596489999996899389999930577995789999999999980799981337789982888999
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~L   86 (692)
                      ...++|++.++||+|+||+||+|+++.+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             87568889789712778099999998999699999987540-97899999999999986799999949999998999999


Q ss_pred             EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             99515999999999972999999999999999999999987-69845578887168617998571898002553246877
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        87 VmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~  165 (692)
                      |||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++   .+||+|||+|+.....
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~---~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC---CEEECCCCCCHHHHHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCC---CEEEEECCCCCCCCCC
T ss_conf             9976799868998742499999999999999999999999859997144577994687899---8999548776256788


Q ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH---C----------------
Q ss_conf             877766798876675766203799412567799999999829999999998999999870---3----------------
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILT---S----------------  226 (692)
Q Consensus       166 ~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~---~----------------  226 (692)
                       .....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..........   .                
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             -CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             -6211137714119468758998948889989999999998889989988789999998875177545774212333221


Q ss_pred             --------------------CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             --------------------677899975444588999999995003999999999998433346567
Q 005526          227 --------------------TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       227 --------------------~~~~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                                          .....+.......++++.||+.+||+.||.+|||++|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf             11122235413477887665026876676444899999999998689946790899996098647698

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=419.58  Aligned_cols=256  Identities=27%  Similarity=0.522  Sum_probs=229.5

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             25789983851259648999999689938999993057799578999999999998079998133778998288899999
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVm   88 (692)
                      .++|++.++||+|+||+||+|+++.+|+.||+|++.......  .+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHH--HHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             105388789812858299999998999899999984301727--999999999998679998805857798899989999


Q ss_pred             ECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC-CC
Q ss_conf             51599999999997299999999999999999999998769845578887168617998571898002553246877-87
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        89 Ey~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~-~~  167 (692)
                      |||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.+... ..
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~---~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCCTTCEECCSTTCC
T ss_pred             EECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC---CEEECCCHHHEEECCCCCC
T ss_conf             70379808988641-5999999999999999999999987972267768886887899---6864251564132136664


Q ss_pred             CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             77667988766757662037994125677999999998299999999989999998703677899975444588999999
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~dLI  247 (692)
                      ....+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+....+..+.......+  .....+++++.+|+
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li  250 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDFL  250 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SSGGGSCHHHHHHH
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC--CCCCCCCHHHHHHH
T ss_conf             4444447773682664479988012031372999998048899899799999999985799988--88553799999999


Q ss_pred             HHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             9950039999999999984333465
Q 005526          248 RCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       248 ~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                      .+||++||.+|||+.|+|+||||+.
T Consensus       251 ~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         251 NRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             9986699668909999964996577

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=412.83  Aligned_cols=260  Identities=30%  Similarity=0.594  Sum_probs=233.9

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf             012578998385125964899999968993899999305779-9578999999999998079998133778998288899
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~   85 (692)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+++++.++||||+++++++...+.++
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC
T ss_conf             87237089889611768089999998999899999982677458899999999999999748772740344443222223


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             99951599999999997299999999999999999999998769845578887168617998571898002553246877
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~  165 (692)
                      +||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.....
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g---~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG---YIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECSSC
T ss_pred             CCCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCC---CEEEEECEEEEECCCC
T ss_conf             2222334662266675158989999999999999989999859986176799993607789---7886101033322566


Q ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             87776679887667576620379941256779999999982999999999899999987036778999754445889999
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~d  245 (692)
                        ....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+....+.++.... ..+|    ..+++++.+
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~  267 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP----SHFSSDLKD  267 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC----TTCCHHHHH
T ss_pred             --CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-CCCC----CCCCHHHHH
T ss_conf             --643367635678899717998853311450078999975889989959999999986179-8897----668999999


Q ss_pred             HHHHHHCCCCCCCC-----CHHHHHHCHHHHHHHHH
Q ss_conf             99995003999999-----99999843334656765
Q 005526          246 LCRCLLRQNPVERI-----TFKEFFNHRFLGELRQT  276 (692)
Q Consensus       246 LI~~mL~~DP~~RP-----Ta~eLL~HPfl~~~~~~  276 (692)
                      |+++||.+||.+|+     |++++++||||+.+...
T Consensus       268 li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf             999983409986065534549999719051589989

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=419.23  Aligned_cols=262  Identities=28%  Similarity=0.486  Sum_probs=237.0

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf             01257899838512596489999996899389999930577995789999999999980799981337789982888999
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~L   86 (692)
                      .+.++|++++.||+|+||+||+|+++.+++.||+|++....   .....+.+|+++++.++||||+++++++++.+.+|+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf             87010588789831778399999998999699999975786---659999999999985799798909899988998899


Q ss_pred             EEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             995159999999999729-9999999999999999999998769845578887168617998571898002553246877
Q 005526           87 VLEYCDGGDLAAYIHKHG-KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        87 VmEy~~GgsL~~~L~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~  165 (692)
                      |||||+||+|.++++..+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||+++.....
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~-~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC-CCEEECCCTTCEECCTT
T ss_pred             EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC-EEEEECCCCHHHCCCCC
T ss_conf             99538998088998753899999999999999999999998769975135544434437885-18997644111003467


Q ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             87776679887667576620379941256779999999982999999999899999987036778999754445889999
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~d  245 (692)
                      ......++++.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+.++... ...++...+..+++++.+
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-EYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCCCHHHHTTSCHHHHH
T ss_pred             CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC-CCCCCHHHCCCCCHHHHH
T ss_conf             7532122332223402104877784011302799999998289999998999999999838-999880223678999999


Q ss_pred             HHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             9999500399999999999843334656
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       246 LI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      |+.+||.+||.+|||+.|+++||||.+.
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             9999866996689099999639965667

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=423.86  Aligned_cols=259  Identities=29%  Similarity=0.515  Sum_probs=224.2

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             12578998385125964899999968993899999305779957899999999999807999813377899828889999
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LV   87 (692)
                      .+++|++++.||+|+||+||+|+++.+++.||||++...... ...+.+.+|++++++++||||+++++++.+++.+|+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf             874608998972174809999999999979999998456641-2799999999999857998884696540467436798


Q ss_pred             EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC--
Q ss_conf             951599999999997299999999999999999999998769845578887168617998571898002553246877--
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ--  165 (692)
Q Consensus        88 mEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~--  165 (692)
                      ||||+||+|.++++..+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+|+.....  
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~---~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---CEEECCCTTCEECEETTE
T ss_pred             EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC---CEEECCCHHHEEECCCCC
T ss_conf             86458980899975379999999999999999999999975983575468997887899---879832314224046886


Q ss_pred             -CCCCCCCCCCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHH
Q ss_conf             -87776679887667576620379-9412567799999999829999999998999999870367789997544458899
Q 005526          166 -DLADTLCGSPLYMAPEIIQNHKY-DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       166 -~~~~~~~Gt~~Y~APEil~~~~y-s~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l  243 (692)
                       ......+||+.|||||++.+..| +.++||||+||++|+|++|++||.+.+................  ..+..+++++
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~  236 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDSAP  236 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS--TTGGGSCHHH
T ss_pred             CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC--CCCCCCCHHH
T ss_conf             53111325574742872861899999710161737999999829978888985999999986388878--8644699999


Q ss_pred             HHHHHHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             99999950039999999999984333465
Q 005526          244 VDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       244 ~dLI~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                      .+|+.+||++||.+|||++|+|+||||++
T Consensus       237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         237 LALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             99999976799668909999961984585

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=420.26  Aligned_cols=260  Identities=32%  Similarity=0.623  Sum_probs=232.6

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf             012578998385125964899999968993899999305779-9578999999999998079998133778998288899
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~   85 (692)
                      ..-++|++++.||+|+||+||+|+++.+++.||||++..... .....+.+.+|++++++++||||+++++++.+.+.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf             89987789889850879099999998999799999986577557778999999999998768888617999999899889


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             99951599999999997299999999999999999999998769845578887168617998571898002553246877
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        86 LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~  165 (692)
                      +|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.+...
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~---~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM---HIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---CEEECCCTTCEECC--
T ss_pred             EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCC---EEEECCCCCCEECCCC
T ss_conf             9997048987777653159999999999999999999762165088476774123668885---3886032102422567


Q ss_pred             C---CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHH
Q ss_conf             8---7776679887667576620379941256779999999982999999999899999987036778999754445889
Q 005526          166 D---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       166 ~---~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~  242 (692)
                      .   .....+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+.++... ...+|    ..++++
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~p----~~~s~~  236 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFP----EKFFPK  236 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCCC----TTCCHH
T ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC-CCCCC----CCCCHH
T ss_conf             7643335556775525844002689896662304569999980388998995999999999718-99998----547999


Q ss_pred             HHHHHHHHHCCCCCCCCCHHH------HHHCHHHHHHH
Q ss_conf             999999950039999999999------98433346567
Q 005526          243 CVDLCRCLLRQNPVERITFKE------FFNHRFLGELR  274 (692)
Q Consensus       243 l~dLI~~mL~~DP~~RPTa~e------LL~HPfl~~~~  274 (692)
                      +.+||++||++||.+|||++|      +++||||.++.
T Consensus       237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCC
T ss_conf             99999998557976891978973778987697647899

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=411.90  Aligned_cols=253  Identities=28%  Similarity=0.472  Sum_probs=228.0

Q ss_pred             CEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf             789983851259648999999689938999993057799-5789999999999980799981337789982888999995
Q 005526           11 EYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-PKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        11 ~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVmE   89 (692)
                      .|++.++||+|+||+||+|++..+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf             56762797018880999999989993999999844443588999999999999997789998238999998998899998


Q ss_pred             CCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf             15999999999972999999999999999999999987698455788871686179985718980025532468778777
Q 005526           90 YCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDLAD  169 (692)
Q Consensus        90 y~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~~~~  169 (692)
                      ||.||+|..++...+++++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++....   ..
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~---~~Kl~DFG~a~~~~~---~~  169 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAP---AN  169 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT---EEEECCCTTCBSSSS---BC
T ss_pred             ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCC---CEEEEECCCCCCCCC---CC
T ss_conf             069994578997379999999999999999999999868976667884217987999---789844365334677---87


Q ss_pred             CCCCCCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
Q ss_conf             6679887667576620---3799412567799999999829999999998999999870367789997544458899999
Q 005526          170 TLCGSPLYMAPEIIQN---HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDL  246 (692)
Q Consensus       170 ~~~Gt~~Y~APEil~~---~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~dL  246 (692)
                      ..+||+.|||||++.+   ..|+.++||||+||++|+|++|+.||.+.+..+.+.++.......++.   ..+++++.+|
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s~~~~~l  246 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS---GHWSEYFRNF  246 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC---TTSCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC---CCCCHHHHHH
T ss_conf             3134766368899834678886721454558999999987889999979999999998289998887---8889999999


Q ss_pred             HHHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             99950039999999999984333465
Q 005526          247 CRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       247 I~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                      +.+||++||.+|||+.|+|+||||..
T Consensus       247 i~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         247 VDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf             99977379657918999971997537

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=416.11  Aligned_cols=255  Identities=31%  Similarity=0.591  Sum_probs=230.9

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEE
Q ss_conf             257899838512596489999996899389999930577995789999999999980799981337789982--888999
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET--REKIYL   86 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~--~~~l~L   86 (692)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++......+...+.+.+|++++++++||||+++++++.+  .+.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33379967983088919999999999979999998746579799999999999999778999824899999178998999


Q ss_pred             EEECCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCCCEEEEECCC
Q ss_conf             9951599999999997----299999999999999999999998769-----8455788871686179985718980025
Q 005526           87 VLEYCDGGDLAAYIHK----HGKVSEAVARHFMRQLAAGLQVLQEKH-----LIHRDLKPQNLLVSTNEVTPVLKIGDFG  157 (692)
Q Consensus        87 VmEy~~GgsL~~~L~~----~~~lse~~i~~i~~QIl~aL~yLHs~g-----IiHrDIKP~NILl~~~~~~~~iKL~DFG  157 (692)
                      |||||+||+|.+++.+    .+.+++..++.++.|++.||+|||+++     |+||||||+|||++.++   .+||+|||
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~---~vkl~DFG  159 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFG  159 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS---CEEECCHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCC---CEEEEECC
T ss_conf             995689993899998515457899999999999999999999997167788788586765425747888---57980010


Q ss_pred             CCCCCCCC-CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             53246877-87776679887667576620379941256779999999982999999999899999987036778999754
Q 005526          158 FARSLTPQ-DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       158 la~~~~~~-~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~  236 (692)
                      +++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+...++........|    
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~----  235 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP----  235 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC----
T ss_pred             CEEECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCC----
T ss_conf             0032245777556677882327999983999993898875278999980188998998999999999718998897----


Q ss_pred             CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHH
Q ss_conf             4458899999999500399999999999843334
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFL  270 (692)
Q Consensus       237 ~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl  270 (692)
                      ..+++++.+|+.+||++||.+|||+.|+++|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf             4359999999999767995579189999729819

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=410.16  Aligned_cols=259  Identities=29%  Similarity=0.547  Sum_probs=223.9

Q ss_pred             CCCEECCE-EEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE---
Q ss_conf             74012578-99838512596489999996899389999930577995789999999999980799981337789982---
Q 005526            5 RTRLIGEY-IVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET---   80 (692)
Q Consensus         5 ~~~l~~~Y-~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~---   80 (692)
                      +....++| ++.++||+|+||+||+|.+..++..||+|.+..........+.+.+|++++++++||||+++++++++   
T Consensus         3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   82 (270)
T d1t4ha_           3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   82 (270)
T ss_dssp             EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             CCCCCCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
T ss_conf             84778877885169700828499999999999599999985122798999999999999985799985069999840334


Q ss_pred             -CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECC-CCCCCEEEEECC
Q ss_conf             -8889999951599999999997299999999999999999999998769--845578887168617-998571898002
Q 005526           81 -REKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKH--LIHRDLKPQNLLVST-NEVTPVLKIGDF  156 (692)
Q Consensus        81 -~~~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~-~~~~~~iKL~DF  156 (692)
                       ...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++. ++   .+||+||
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~---~~Kl~DF  159 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG---SVKIGDL  159 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS---CEEECCT
T ss_pred             CCCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCC---CEEEEEC
T ss_conf             5888999995789894899975135546999999999999999999978997996876743511667999---8898005


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHCCCCCCCCCC
Q ss_conf             553246877877766798876675766203799412567799999999829999999998-9999998703677899975
Q 005526          157 GFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQ-LQLFQNILTSTELRFPPGA  235 (692)
Q Consensus       157 Gla~~~~~~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~-~~~~~~I~~~~~~~~p~~~  235 (692)
                      |+++.... ......+||+.|||||++.+ .|+.++||||+||++|+|++|+.||.+... ...+..+....   .+...
T Consensus       160 Gla~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~---~~~~~  234 (270)
T d1t4ha_         160 GLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---KPASF  234 (270)
T ss_dssp             TGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC---CCGGG
T ss_pred             CCCEECCC-CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC---CCCCC
T ss_conf             76542368-76677553813008988478-999867110079999999878899987655999999997389---98656


Q ss_pred             CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHH
Q ss_conf             444588999999995003999999999998433346
Q 005526          236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       236 ~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~  271 (692)
                      ....++++.+|+.+||++||++|||+.|+|+||||+
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             755789999999997637975892999996775409

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=411.97  Aligned_cols=258  Identities=31%  Similarity=0.623  Sum_probs=233.5

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             2578998385125964899999968993899999305779-957899999999999807999813377899828889999
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLV   87 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LV   87 (692)
                      +++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf             54708888972076808999999899979999998457754889999999999999863696753303568528800567


Q ss_pred             EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             95159999999999729999999999999999999999876984557888716861799857189800255324687787
Q 005526           88 LEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        88 mEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~~  167 (692)
                      ||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++....  .
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g---~vkL~DFG~a~~~~~--~  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG---HIKITDFGFAKYVPD--V  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---CEEECCCSSCEECSS--C
T ss_pred             EEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCC---CEEEECCCCCEEECC--C
T ss_conf             65037863223432222111007999999998765541247677055681050386899---889831752167124--5


Q ss_pred             CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             77667988766757662037994125677999999998299999999989999998703677899975444588999999
Q 005526          168 ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLC  247 (692)
Q Consensus       168 ~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~dLI  247 (692)
                      ....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+.+.++.... ..+|    ..+++++.+++
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li  232 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFP----PFFNEDVKDLL  232 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHH
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-CCCC----CCCCHHHHHHH
T ss_conf             643457634359999838999804304653336899975989999969999999997089-8899----77899999999


Q ss_pred             HHHHCCCCCCCC-----CHHHHHHCHHHHHHHHH
Q ss_conf             995003999999-----99999843334656765
Q 005526          248 RCLLRQNPVERI-----TFKEFFNHRFLGELRQT  276 (692)
Q Consensus       248 ~~mL~~DP~~RP-----Ta~eLL~HPfl~~~~~~  276 (692)
                      .+||.+||.+|+     |++++++||||+++...
T Consensus       233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHH
T ss_conf             9995449976664310219999819351467989

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=416.09  Aligned_cols=256  Identities=27%  Similarity=0.520  Sum_probs=227.0

Q ss_pred             CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf             57899838512596489999996899389999930577995789999999999980799981337789982888999995
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVmE   89 (692)
                      +.|+++++||+|+||+||+|+++.++..||+|++....  ....+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf             37598479930778199999999999399999987289--9999999999999986799998849889800995899996


Q ss_pred             CCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC-CC
Q ss_conf             1599999999997-299999999999999999999998769845578887168617998571898002553246877-87
Q 005526           90 YCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-DL  167 (692)
Q Consensus        90 y~~GgsL~~~L~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~-~~  167 (692)
                      ||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++..... ..
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~---~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG---DIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---CEEECCCTTCEECHHHHHH
T ss_pred             CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCC---CEEEEECHHHHCCCCCCCC
T ss_conf             2799818899986289999999999999999999999988988714070031487899---9899716123035778641


Q ss_pred             CCCCCCCCCCCCHHHHH-----HCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHH
Q ss_conf             77667988766757662-----0379941256779999999982999999999899999987036778999754445889
Q 005526          168 ADTLCGSPLYMAPEIIQ-----NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPD  242 (692)
Q Consensus       168 ~~~~~Gt~~Y~APEil~-----~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~  242 (692)
                      ....+||+.|+|||++.     +..|+.++||||+||++|+|++|++||.+.+..+.+.++.......++  ....++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~s~~  244 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA--QPSRWSSN  244 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS--SGGGSCHH
T ss_pred             CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCC--CCCCCCHH
T ss_conf             0010256264799998320257888880665787899999982088999998999999999707998777--65669999


Q ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             999999950039999999999984333465
Q 005526          243 CVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       243 l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                      +.+|+.+||++||.+|||+.|+|+||||+.
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             999999976699668919999962923188

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=417.51  Aligned_cols=265  Identities=29%  Similarity=0.547  Sum_probs=228.9

Q ss_pred             CCCCCCEECCEEEEE-EECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHH-CCCCCCCEEEEEEE
Q ss_conf             999740125789983-8512596489999996899389999930577995789999999999980-79998133778998
Q 005526            2 EPNRTRLIGEYIVGP-RIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILST-ISHPNIIRFFEAIE   79 (692)
Q Consensus         2 ~p~~~~l~~~Y~i~~-~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~-L~HpnIvkl~~~~~   79 (692)
                      +-....++++|.+.. .||+|+||+||+|++..+++.||||++...       ..+.+|+.++.+ .+||||++++++++
T Consensus         3 ~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1           3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             CCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CCCCCCCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEE
T ss_conf             5789970148798107965454869999998899989999998974-------779999999998669999782989995


Q ss_pred             E----CCEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEE
Q ss_conf             2----88899999515999999999972--99999999999999999999998769845578887168617998571898
Q 005526           80 T----REKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKI  153 (692)
Q Consensus        80 ~----~~~l~LVmEy~~GgsL~~~L~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL  153 (692)
                      +    ...+|+|||||+||+|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++.++....+||
T Consensus        76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred             ECCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             03468978999997789984999998627877579999999999999999999769864441002201135555663113


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---HCCCCC
Q ss_conf             00255324687787776679887667576620379941256779999999982999999999899999987---036778
Q 005526          154 GDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNIL---TSTELR  230 (692)
Q Consensus       154 ~DFGla~~~~~~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~---~~~~~~  230 (692)
                      +|||+++...........+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.......+.   ......
T Consensus       156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~  235 (335)
T d2ozaa1         156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  235 (335)
T ss_dssp             CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC
T ss_conf             54551233368886432267756379277748988888888764516778865889988988778899999998538888


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             9997544458899999999500399999999999843334656
Q 005526          231 FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       231 ~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      +|......+++++.+|+++||++||.+|||+.|+++||||.+.
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCC
T ss_conf             8985434699999999999756996579099999709876178

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=408.06  Aligned_cols=262  Identities=28%  Similarity=0.462  Sum_probs=220.6

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf             25789983851259648999999689938999993057799----57899999999999807999813377899828889
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS----PKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l   84 (692)
                      +++|++.+.||+|+||.||+|++..+|+.||||++......    ........+++.+++.++||||+++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCC
Q ss_conf             99995159999999999729999999999999999999999876984557888716861799857189800255324687
Q 005526           85 YLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        85 ~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~  164 (692)
                      |+|||||+||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g---~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG---HVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS---CEEECCCTTCEECSS
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCC---CEEEEEECEEEECCC
T ss_conf             99999148983899987325532789999999999999999977962204442216785889---679822010233378


Q ss_pred             CCCCCCCCCCCCCCCHHHHHH-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHH
Q ss_conf             787776679887667576620-3799412567799999999829999999998999999870367789997544458899
Q 005526          165 QDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDC  243 (692)
Q Consensus       165 ~~~~~~~~Gt~~Y~APEil~~-~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l  243 (692)
                      . .....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+..........  ....+......+++++
T Consensus       160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~  236 (364)
T d1omwa3         160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSPEL  236 (364)
T ss_dssp             S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH--SSSCCCCCCSSSCHHH
T ss_pred             C-CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH--CCCCCCCCCCCCCHHH
T ss_conf             8-643311345542168760389998441046778999999859998888998999999986--0468887887789999


Q ss_pred             HHHHHHHHCCCCCCCCC-----HHHHHHCHHHHHHHHH
Q ss_conf             99999950039999999-----9999843334656765
Q 005526          244 VDLCRCLLRQNPVERIT-----FKEFFNHRFLGELRQT  276 (692)
Q Consensus       244 ~dLI~~mL~~DP~~RPT-----a~eLL~HPfl~~~~~~  276 (692)
                      .+||.+||++||.+|||     ++++++||||+++...
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf             99999985669888088743579999749102378987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=403.93  Aligned_cols=261  Identities=33%  Similarity=0.572  Sum_probs=235.2

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCC-------HHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf             25789983851259648999999689938999993057799-------578999999999998079-9981337789982
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS-------PKVSDNLLKEISILSTIS-HPNIIRFFEAIET   80 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~-------~~~~~~i~~Ei~iL~~L~-HpnIvkl~~~~~~   80 (692)
                      .++|++.+.||+|+||+||+|++..+++.||||++......       ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCC
Q ss_conf             88899999515999999999972999999999999999999999987698455788871686179985718980025532
Q 005526           81 REKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        81 ~~~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~  160 (692)
                      ++.+|+|||||+||+|.++++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~---~~kl~DFG~a~  158 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM---NIKLTDFGFSC  158 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---CEEECCCTTCE
T ss_pred             CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC---CEEECCCHHEE
T ss_conf             760599997689866899998659999999999999999999999875994323462548986899---83871240316


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHH------CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf             4687787776679887667576620------3799412567799999999829999999998999999870367789997
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQN------HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPG  234 (692)
Q Consensus       161 ~~~~~~~~~~~~Gt~~Y~APEil~~------~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~  234 (692)
                      ...........+||+.|+|||++.+      ..|+.++||||+||++|+|++|+.||.+.+.......+.... ..++..
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~  237 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-YQFGSP  237 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTT
T ss_pred             ECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCC-CCCCCC
T ss_conf             7268872134524678889888605344567889923318565602310322888988999999999998189-888985


Q ss_pred             CCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             544458899999999500399999999999843334656
Q 005526          235 AIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       235 ~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      ....+++++.+|+.+||++||.+|||+.|+|+||||++.
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHHH
T ss_conf             434689999999999765896689199999739787975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=405.51  Aligned_cols=259  Identities=30%  Similarity=0.573  Sum_probs=229.3

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCEEEE
Q ss_conf             2578998385125964899999968993899999305779-9578999999999998-0799981337789982888999
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILS-TISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~~Ei~iL~-~L~HpnIvkl~~~~~~~~~l~L   86 (692)
                      +++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|..++. .++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf             99718865894087828999999999989999998055533848999999999999984799968789889704983167


Q ss_pred             EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC-
Q ss_conf             9951599999999997299999999999999999999998769845578887168617998571898002553246877-
Q 005526           87 VLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ-  165 (692)
Q Consensus        87 VmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~-  165 (692)
                      |||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++..... 
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~---~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG---HIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---CEEECCCTTCBCCCCTT
T ss_pred             EEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC---CEECCCCCHHHHCCCCC
T ss_conf             775037980899864047899999999999999999999868934034765404444899---63015553023235665


Q ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             87776679887667576620379941256779999999982999999999899999987036778999754445889999
Q 005526          166 DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       166 ~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~d  245 (692)
                      ......+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+++.++... ...+|    ..+++++.+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~p----~~~s~~~~d  232 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYP----RWLEKEAKD  232 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCC----TTSCHHHHH
T ss_pred             CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC-CCCCC----CCCCHHHHH
T ss_conf             3345457877768999982799883232011227898987388999998999999999718-99897----567999999


Q ss_pred             HHHHHHCCCCCCCCCHH-HHHHCHHHHHHHH
Q ss_conf             99995003999999999-9984333465676
Q 005526          246 LCRCLLRQNPVERITFK-EFFNHRFLGELRQ  275 (692)
Q Consensus       246 LI~~mL~~DP~~RPTa~-eLL~HPfl~~~~~  275 (692)
                      |+++||.+||.+||++. ++++||||+++..
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HHHHHCCCCCCCCCCHHHHHHHCCHHCCCCH
T ss_conf             9999654489878388999980901315899

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=392.35  Aligned_cols=262  Identities=30%  Similarity=0.553  Sum_probs=223.1

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             25789983851259648999999689938999993057799578999999999998079998133778998288899999
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVm   88 (692)
                      +++|++.++||+|+||+||+|.+..+++.||||++............+.+|++++++++||||+++++++.+++.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf             99977651772376809999999999979999998022257589999999999998679983887445332243203788


Q ss_pred             ECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCC-C
Q ss_conf             51599999999997--29999999999999999999999876984557888716861799857189800255324687-7
Q 005526           89 EYCDGGDLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP-Q  165 (692)
Q Consensus        89 Ey~~GgsL~~~L~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~-~  165 (692)
                      |||.+ .+..++..  ...+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.... .
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~---~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG---AIKLADFGLARAFGVPV  156 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEECSTTHHHHHCCCS
T ss_pred             EECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCC---CCEECCCCCCEECCCCC
T ss_conf             62377-445554420256888899999999999999986528899213571140113467---62103578613436886


Q ss_pred             CCCCCCCCCCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC-------------
Q ss_conf             8777667988766757662037-99412567799999999829999999998999999870367789-------------
Q 005526          166 DLADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF-------------  231 (692)
Q Consensus       166 ~~~~~~~Gt~~Y~APEil~~~~-ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~-------------  231 (692)
                      .......|++.|+|||++.... ++.++||||+||++|+|++|+.||.+.+....+.++........             
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCC
T ss_conf             41001036521541122136657774221033331342796687998988999999999983289833314442224212


Q ss_pred             ----CC-------CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             ----99-------75444588999999995003999999999998433346567
Q 005526          232 ----PP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       232 ----p~-------~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                          +.       .....+++++.||+++||++||.+|||+.|+|+||||+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             434543222204441667899999999997639955791899996787014699

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=395.02  Aligned_cols=267  Identities=29%  Similarity=0.468  Sum_probs=223.7

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECCC-CCEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEE-
Q ss_conf             40125789983851259648999999689-93899999305779957899999999999807---99981337789982-
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQL-GIEVAVKEIDKKLLSPKVSDNLLKEISILSTI---SHPNIIRFFEAIET-   80 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~t-g~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIvkl~~~~~~-   80 (692)
                      .+..++|+++++||+|+||+||+|++..+ ++.||||++............+.+|+.+++.+   +||||+++++++.. 
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCCCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf             88758979888992155869999999888998999999802324516799999999999987425898802366322146


Q ss_pred             ----CCEEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEEC
Q ss_conf             ----8889999951599999999997-29999999999999999999999876984557888716861799857189800
Q 005526           81 ----REKIYLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD  155 (692)
Q Consensus        81 ----~~~l~LVmEy~~GgsL~~~L~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~D  155 (692)
                          ...++++|||+.++.+...... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++   .+||+|
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~---~~kl~d  159 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG---QIKLAD  159 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECS
T ss_pred             CCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCC---CEEECC
T ss_conf             66667469999974058714444430378999899999999999999999758898357986278985899---754210


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC----C
Q ss_conf             255324687787776679887667576620379941256779999999982999999999899999987036778----9
Q 005526          156 FGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR----F  231 (692)
Q Consensus       156 FGla~~~~~~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~----~  231 (692)
                      ||+++...........+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+.++.......    +
T Consensus       160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             HHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCC
T ss_conf             00101100234577765485114831001798881110003289999998787998998989999999984079961105


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHH
Q ss_conf             ------------------99754445889999999950039999999999984333465676
Q 005526          232 ------------------PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       232 ------------------p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~~  275 (692)
                                        ........++.+.+|+.+||++||.+|||+.|+|+||||+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCHH
T ss_conf             32111103330223456454404458999999999987489667918999966963407521

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=395.81  Aligned_cols=257  Identities=29%  Similarity=0.474  Sum_probs=219.6

Q ss_pred             EEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf             9838512596489999996899389999930577995---7899999999999807999813377899828889999951
Q 005526           14 VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSP---KVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEY   90 (692)
Q Consensus        14 i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVmEy   90 (692)
                      .++.||+|+||+||+|+++.+|+.||||++.......   .....+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542258740220455


Q ss_pred             CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCC-CCC
Q ss_conf             5999999999972999999999999999999999987698455788871686179985718980025532468778-777
Q 005526           91 CDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-LAD  169 (692)
Q Consensus        91 ~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~-~~~  169 (692)
                      |.|+++..+......+++..++.+++||+.||+|||++||+||||||+|||++.++   .+||+|||+++...... ...
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~---~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG---VLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECCCGGGSTTTSCCCCCC
T ss_pred             HCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCC---CCCCCCCCCCCCCCCCCCCCC
T ss_conf             34507765541266778999999999999999886316355035776258853778---411465761000578755433


Q ss_pred             CCCCCCCCCCHHHHHH-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC-----------------
Q ss_conf             6679887667576620-3799412567799999999829999999998999999870367789-----------------
Q 005526          170 TLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF-----------------  231 (692)
Q Consensus       170 ~~~Gt~~Y~APEil~~-~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~-----------------  231 (692)
                      ..+||+.|+|||++.. ..|+.++||||+||++|+|++|++||.+.+..+.+.++........                 
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             CEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHHC
T ss_conf             02047333639997267788805643630428999985969999999999999999851899725452100021344303


Q ss_pred             --CC----CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             --99----7544458899999999500399999999999843334656
Q 005526          232 --PP----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       232 --p~----~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                        +.    ......++++.+|+.+||++||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             478988678565689999999999763894569089999679965789

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=385.14  Aligned_cols=260  Identities=30%  Similarity=0.468  Sum_probs=217.8

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------C
Q ss_conf             1257899838512596489999996899389999930577995789999999999980799981337789982------8
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET------R   81 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~------~   81 (692)
                      ..-+|..+++||+|+||+||+|++..+++.||||++.....      ...+|++++++++||||+++++++..      .
T Consensus        18 ~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf             66776751698217683999999999997999999881606------899999999866898987387899744765773


Q ss_pred             CEEEEEEECCCCCCHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCC
Q ss_conf             8899999515999999999---9729999999999999999999999876984557888716861799857189800255
Q 005526           82 EKIYLVLEYCDGGDLAAYI---HKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGF  158 (692)
Q Consensus        82 ~~l~LVmEy~~GgsL~~~L---~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGl  158 (692)
                      .++|+|||||+++.+..+.   .....+++..++.+++|++.||+|||++||+||||||+|||++.++.  .+||+|||+
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~--~~kl~DFG~  169 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLCDFGS  169 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC--CEEECCCTT
T ss_pred             EEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCC--CEEEECCCC
T ss_conf             189999841688607888863103689999999999999999999998668764578860378735897--116733660


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHH-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC----------
Q ss_conf             324687787776679887667576620-379941256779999999982999999999899999987036----------
Q 005526          159 ARSLTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST----------  227 (692)
Q Consensus       159 a~~~~~~~~~~~~~Gt~~Y~APEil~~-~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~----------  227 (692)
                      ++...........+|++.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+....+.++....          
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             HHHCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHH
T ss_conf             54404776532002555556827764046888210002465277855028799898799999999999748981776543


Q ss_pred             ------CCCCCC--------CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHH
Q ss_conf             ------778999--------754445889999999950039999999999984333465676
Q 005526          228 ------ELRFPP--------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       228 ------~~~~p~--------~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~~  275 (692)
                            ...++.        ......++++.+|+.+||++||.+|||+.|+|+||||++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             06210110355445674444315689999999999976589557929999966984524667

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=383.82  Aligned_cols=260  Identities=30%  Similarity=0.522  Sum_probs=224.3

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----
Q ss_conf             125789983851259648999999689938999993057799578999999999998079998133778998288-----
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE-----   82 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~-----   82 (692)
                      +.++|+++++||+|+||+||+|.++.+|+.||||++..........+.+.+|+++++.++||||+++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47718998898017781999999999998999999852225969999999999999866898754799986357655554


Q ss_pred             -EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             -8999995159999999999729999999999999999999999876984557888716861799857189800255324
Q 005526           83 -KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        83 -~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                       .+|+||||| |.+|..+++ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+|++|||+++.
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~---~~kl~Dfg~a~~  170 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC---ELKILDFGLARQ  170 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEE
T ss_pred             CEEEEEEECC-CCCHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCC---CCCCCCCCCEEC
T ss_conf             1599998405-521899987-40226999999999999999998737876456685111121001---221134310220


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHH-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-----------
Q ss_conf             687787776679887667576620-37994125677999999998299999999989999998703677-----------
Q 005526          162 LTPQDLADTLCGSPLYMAPEIIQN-HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTEL-----------  229 (692)
Q Consensus       162 ~~~~~~~~~~~Gt~~Y~APEil~~-~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~-----------  229 (692)
                      ....  .....|++.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+....+..+......           
T Consensus       171 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             CCCC--CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCC
T ss_conf             6876--31024553335889981787899650103003899999978699888976899999985037884888865300


Q ss_pred             -----------CC----CCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             -----------89----9975444588999999995003999999999998433346567
Q 005526          230 -----------RF----PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       230 -----------~~----p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                                 ..    ........++++.||+.+||..||.+|||+.|+|+||||+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             034433115786665566775568999999999997729955792999996396237587

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=384.49  Aligned_cols=269  Identities=27%  Similarity=0.443  Sum_probs=225.1

Q ss_pred             CCCCCCCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf             99997401257899838512596489999996899389999930577995789999999999980799981337789982
Q 005526            1 MEPNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET   80 (692)
Q Consensus         1 m~p~~~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~   80 (692)
                      ||=+...-+++|+++++||+|+||+||+|++..+|+.||||++............+.+|++++++++||||+++++++..
T Consensus         1 ~~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~   80 (318)
T d3blha1           1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   80 (318)
T ss_dssp             CCCTTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEEC
T ss_conf             98999976279889999722748299999998999799999984222463789999999999998359996606765402


Q ss_pred             --------CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEE
Q ss_conf             --------888999995159999999999729999999999999999999999876984557888716861799857189
Q 005526           81 --------REKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK  152 (692)
Q Consensus        81 --------~~~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iK  152 (692)
                              .+.+|+|||||.++.+.........+++..++.+++|++.||+|||++||+||||||+|||++.++   .+|
T Consensus        81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~---~~k  157 (318)
T d3blha1          81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG---VLK  157 (318)
T ss_dssp             ----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS---CEE
T ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCC---CEE
T ss_conf             46544445763899985357874101222034433089999999999999885229988567672220366899---687


Q ss_pred             EECCCCCCCCCCC-----CCCCCCCCCCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC
Q ss_conf             8002553246877-----877766798876675766203-7994125677999999998299999999989999998703
Q 005526          153 IGDFGFARSLTPQ-----DLADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTS  226 (692)
Q Consensus       153 L~DFGla~~~~~~-----~~~~~~~Gt~~Y~APEil~~~-~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~  226 (692)
                      |+|||+++.....     ......+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+.......+...
T Consensus       158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~  237 (318)
T d3blha1         158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL  237 (318)
T ss_dssp             ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf             63135002235544432113566024978742899707999891787006786466174487998998999999999984


Q ss_pred             CCCCCCCCC---------------------------CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             677899975---------------------------4445889999999950039999999999984333465
Q 005526          227 TELRFPPGA---------------------------IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       227 ~~~~~p~~~---------------------------~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                      .....+...                           ....+++++||+.+||++||++|||++|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             1899825534432034443320133445550334044459989999999987389658909999974950156

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=383.39  Aligned_cols=262  Identities=26%  Similarity=0.484  Sum_probs=228.0

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC--
Q ss_conf             4012578998385125964899999968993899999305779-9578999999999998079998133778998288--
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETRE--   82 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~--   82 (692)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+++++.++||||+++++++...+  
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred             CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC
T ss_conf             57062069868996089929999999999989999998556646989999999999999856999887311435432688


Q ss_pred             --EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCC
Q ss_conf             --899999515999999999972999999999999999999999987698455788871686179985718980025532
Q 005526           83 --KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        83 --~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~  160 (692)
                        .+|+|||||+|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++   ..+++|||.+.
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~---~~~l~d~~~~~  159 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIAR  159 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS---CEEECCCTTCE
T ss_pred             CCEEEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC---CCEEEHHHHHH
T ss_conf             766999997788987101120358999999999999999999999857952763467556657543---20100344432


Q ss_pred             CCCCC----CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             46877----87776679887667576620379941256779999999982999999999899999987036778999754
Q 005526          161 SLTPQ----DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       161 ~~~~~----~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~  236 (692)
                      .....    ......+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+.++...... .+....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~  238 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PPSARH  238 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-CGGGTS
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-CCCHHC
T ss_conf             2123544333346425762436999983999996632026528999997697998996999999999846999-971003


Q ss_pred             CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHH
Q ss_conf             44588999999995003999999999998433346
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLG  271 (692)
Q Consensus       237 ~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~  271 (692)
                      ..+++++.+|+.+||.+||.+||+..+.+.|+|++
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf             47899999999998667976777399999999999

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=382.09  Aligned_cols=262  Identities=25%  Similarity=0.449  Sum_probs=226.0

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------C
Q ss_conf             1257899838512596489999996899389999930577995789999999999980799981337789982------8
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET------R   81 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~------~   81 (692)
                      +.++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.++++++||||+++++++..      .
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf             33775998896217585999999999998999999882336979999999999999864898764899897025643457


Q ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             88999995159999999999729999999999999999999999876984557888716861799857189800255324
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        82 ~~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                      ..+|+|||||.| ++.+.+  ...+++..++.++.|++.||.|||++||+||||||+|||++.++   .+|++|||+++.
T Consensus        95 ~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~---~~kl~df~~~~~  168 (355)
T d2b1pa1          95 QDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLART  168 (355)
T ss_dssp             CEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCCCC---
T ss_pred             CEEEEEEECCCH-HHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC---CEEEECHHHHHC
T ss_conf             626999841446-778765--03899999999999999999886522112456776321136544---313201023211


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-----------
Q ss_conf             687787776679887667576620379941256779999999982999999999899999987036778-----------
Q 005526          162 LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR-----------  230 (692)
Q Consensus       162 ~~~~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~-----------  230 (692)
                      ..........++|+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+......++.......           
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHH
T ss_conf             46665533221465555813314777787743335662578986598998889778899999972058987999876566


Q ss_pred             ----------CC----------------CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHH
Q ss_conf             ----------99----------------9754445889999999950039999999999984333465676
Q 005526          231 ----------FP----------------PGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       231 ----------~p----------------~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~~  275 (692)
                                ..                .......++++.||+++||.+||.+|||++|+|+||||++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf             77776417543566642126433354321013337999999999987699457908999966942087888

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=388.85  Aligned_cols=253  Identities=30%  Similarity=0.551  Sum_probs=217.5

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHH----HHHHHHHHHHHHHHCC--CCCCCEEEEEEEEC
Q ss_conf             12578998385125964899999968993899999305779957----8999999999998079--99813377899828
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPK----VSDNLLKEISILSTIS--HPNIIRFFEAIETR   81 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~----~~~~i~~Ei~iL~~L~--HpnIvkl~~~~~~~   81 (692)
                      +.++|++++.||+|+||+||+|++..+++.||||++........    ....+.+|+.++++++  ||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
T ss_conf             78837996798408783999999999997999999856884433455679999999999997435898812799998309


Q ss_pred             CEEEEEEECCCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCC
Q ss_conf             889999951599-9999999972999999999999999999999987698455788871686179985718980025532
Q 005526           82 EKIYLVLEYCDG-GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFAR  160 (692)
Q Consensus        82 ~~l~LVmEy~~G-gsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~  160 (692)
                      +..|+||||+.+ +++.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+..  .+||+|||+++
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~--~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCE
T ss_pred             CEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCC--EEEECCCCCCE
T ss_conf             9689999833686228999861589999999999999999999998779755667611147744788--48977546535


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             4687787776679887667576620379-941256779999999982999999999899999987036778999754445
Q 005526          161 SLTPQDLADTLCGSPLYMAPEIIQNHKY-DAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       161 ~~~~~~~~~~~~Gt~~Y~APEil~~~~y-s~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~l  239 (692)
                      .... ......+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+      .+... ...++    ..+
T Consensus       160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-~~~~~----~~~  227 (273)
T d1xwsa_         160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFR----QRV  227 (273)
T ss_dssp             ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCCS----SCC
T ss_pred             ECCC-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHC-CCCCC----CCC
T ss_conf             3244-455665658774799998489978865332554034536756889988736------77615-44778----779


Q ss_pred             CHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             88999999995003999999999998433346567
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       240 s~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                      ++++.+|+++||++||.+|||++|+++||||+++.
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             99999999997608975893999985398667887

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=384.53  Aligned_cols=260  Identities=30%  Similarity=0.509  Sum_probs=223.8

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             25789983851259648999999689938999993057799578999999999998079998133778998288899999
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVm   88 (692)
                      +++|++.++||+|+||+||+|+++ +++.||||++............+.+|+.++++++||||+++++.+...+..++++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEE
T ss_conf             999634318722778189999968-9999999998123268589999999999998679986876601204677315899


Q ss_pred             ECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCC-C
Q ss_conf             515999999999972999999999999999999999987698455788871686179985718980025532468778-7
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        89 Ey~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~-~  167 (692)
                      ||+.++.+..+....+.+++..++.++.|++.||+|||+++|+||||||+|||++.++   .+||+|||.+....... .
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~---~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG---ELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---CEEECCTTHHHHHCC----
T ss_pred             EEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCC---CEEECCCCCCEECCCCCCC
T ss_conf             7400456789986047751445689999999999986057488267877505686899---7873236643011467654


Q ss_pred             CCCCCCCCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC---------------
Q ss_conf             7766798876675766203-799412567799999999829999999998999999870367789---------------
Q 005526          168 ADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF---------------  231 (692)
Q Consensus       168 ~~~~~Gt~~Y~APEil~~~-~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~---------------  231 (692)
                      .....+++.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+.++........               
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCC
T ss_conf             10102431101378871788888410021117589999779799898898999999998638997110421233322143


Q ss_pred             ---------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             ---------99754445889999999950039999999999984333465
Q 005526          232 ---------PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       232 ---------p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                               ........++++.||+++||++||++|||++|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             33335676466651258999999999986689668909999856922074

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=381.32  Aligned_cols=261  Identities=25%  Similarity=0.494  Sum_probs=222.2

Q ss_pred             CCCCCCC------EECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEE
Q ss_conf             9999740------1257899838512596489999996899389999930577995789999999999980799981337
Q 005526            1 MEPNRTR------LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRF   74 (692)
Q Consensus         1 m~p~~~~------l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl   74 (692)
                      |+|+.+.      -.++|++.++||+|+||+||+|.++.+++.||||++......   .+.+.+|++++++++||||+++
T Consensus         2 ~~p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~   78 (287)
T d1opja_           2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQL   78 (287)
T ss_dssp             CCTTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCCCCCCCCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCH---HHHHHHHHHHHHHCCCCCEECC
T ss_conf             6979899765174579939865982088808999999999969999997776103---9999999999986799988267


Q ss_pred             EEEEEECCEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEE
Q ss_conf             78998288899999515999999999972--9999999999999999999999876984557888716861799857189
Q 005526           75 FEAIETREKIYLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLK  152 (692)
Q Consensus        75 ~~~~~~~~~l~LVmEy~~GgsL~~~L~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iK  152 (692)
                      ++++.+++.+++|||||++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++   .+|
T Consensus        79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~---~~K  155 (287)
T d1opja_          79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---LVK  155 (287)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG---CEE
T ss_pred             CCCEEECCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC---CEE
T ss_conf             75274578547876314676067775303554157999999999999978889878930576045768998999---289


Q ss_pred             EECCCCCCCCCCCCC--CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             800255324687787--7766798876675766203799412567799999999829-9999999989999998703677
Q 005526          153 IGDFGFARSLTPQDL--ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG-KPPFDGSNQLQLFQNILTSTEL  229 (692)
Q Consensus       153 L~DFGla~~~~~~~~--~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG-~~PF~g~~~~~~~~~I~~~~~~  229 (692)
                      |+|||+++.......  .....|++.|+|||++.+..|+.++||||+||++|+|++| .+||.+.+.......+......
T Consensus       156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~  235 (287)
T d1opja_         156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM  235 (287)
T ss_dssp             ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             ECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf             83244546537887221035566546669278727999810430217899999986799887742599999998558888


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             89997544458899999999500399999999999843334656
Q 005526          230 RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       230 ~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      ..+    ...++++.+|+.+||+.||.+|||+.++++  +|..+
T Consensus       236 ~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         236 ERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             CCC----CCCHHHHHHHHHHHCCCCHHHCCCHHHHHH--HHHHH
T ss_conf             887----433099999999975779768939999999--99999

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=380.55  Aligned_cols=250  Identities=24%  Similarity=0.448  Sum_probs=218.9

Q ss_pred             EEECCCCCEEEEEEEECC--CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
Q ss_conf             385125964899999968--993899999305779957899999999999807999813377899828889999951599
Q 005526           16 PRIGSGSFAVVWRARHRQ--LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLEYCDG   93 (692)
Q Consensus        16 ~~LG~GsfG~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVmEy~~G   93 (692)
                      ++||+|+||+||+|.+..  +++.||||++......+...+.+.+|++++++++||||+++++++..+ ..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCCC
T ss_conf             78345878299999981697385999999880108989999999999999867998985277775059-77999974788


Q ss_pred             CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCC----CCC
Q ss_conf             9999999972999999999999999999999987698455788871686179985718980025532468778----777
Q 005526           94 GDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD----LAD  169 (692)
Q Consensus        94 gsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~----~~~  169 (692)
                      |+|.+++.....+++..+..++.||+.||+|||+++|+||||||+|||++.++   .+||+|||+++......    ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~---~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCC---CCCCCCHHHHHHCCCCCCCCCCCC
T ss_conf             96899975225789999999999999997668747955677761131023567---512341345331343234432244


Q ss_pred             CCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             6679887667576620379941256779999999982-999999999899999987036778999754445889999999
Q 005526          170 TLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVDLCR  248 (692)
Q Consensus       170 ~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~dLI~  248 (692)
                      ...||+.|+|||++.+..|+.++||||+||++|||++ |++||.+.+..+....+..+.....|    ...++++.+|+.
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p----~~~~~~~~~li~  244 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP----AGCPREMYDLMN  244 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHH
T ss_pred             CCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC----CCCCHHHHHHHH
T ss_conf             5677842039166537999843443034031328965899999998999999999828999998----656799999999


Q ss_pred             HHHCCCCCCCCCHHHH---HHCHHHHHH
Q ss_conf             9500399999999999---843334656
Q 005526          249 CLLRQNPVERITFKEF---FNHRFLGEL  273 (692)
Q Consensus       249 ~mL~~DP~~RPTa~eL---L~HPfl~~~  273 (692)
                      +||..||.+|||+.++   |+|+|+.-+
T Consensus       245 ~cl~~dp~~RPs~~~i~~~L~~~~~~~~  272 (277)
T d1xbba_         245 LCWTYDVENRPGFAAVELRLRNYYYDVV  272 (277)
T ss_dssp             HHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             HHCCCCHHHCCCHHHHHHHHHCHHHHCC
T ss_conf             9758897689098999998528875047

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=378.92  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=221.9

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCC---EEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf             012578998385125964899999968993---89999930577995789999999999980799981337789982888
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGI---EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~   83 (692)
                      .-.++|++.+.||+|+||+||+|.++.+++   .||||.+... ......+.+.+|++++++++||||+++++++...+.
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             0800427856980278829999999579978899999997844-598999999999999985799888618999962887


Q ss_pred             EEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCC
Q ss_conf             99999515999999999972-99999999999999999999998769845578887168617998571898002553246
Q 005526           84 IYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        84 l~LVmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~  162 (692)
                      +++|||||+||+|.+++... +.+++.++..++.|++.||.|||+++|+||||||+|||++.++   .+||+|||+++..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~---~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL---VCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCC------
T ss_pred             EEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC---CEEECCCCCCEEC
T ss_conf             7999972279853002104567999999999999999988988527983576150448988999---1998884431575


Q ss_pred             CCCCCC------CCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf             877877------76679887667576620379941256779999999982-99999999989999998703677899975
Q 005526          163 TPQDLA------DTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGA  235 (692)
Q Consensus       163 ~~~~~~------~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~  235 (692)
                      ......      ....|++.|||||++.+..|+.++|||||||++|||++ |++||.+.+..+....+........+   
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~---  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP---  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---
T ss_pred             CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC---
T ss_conf             67777653650256668830038788836997861214453578999986799999999999999999737889997---


Q ss_pred             CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHC
Q ss_conf             44458899999999500399999999999843
Q 005526          236 IEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       236 ~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~H  267 (692)
                       ...+.++.+|+.+||++||.+|||+.|++++
T Consensus       256 -~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 -MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             -4226999999999758797689299999999

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=382.20  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=215.6

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCC-----EEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECC
Q ss_conf             2578998385125964899999968993-----899999305779957899999999999807-9998133778998288
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGI-----EVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETRE   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~-----~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIvkl~~~~~~~~   82 (692)
                      .++|+++++||+|+||+||+|++...++     .||+|.+.... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf             89939701983078819999998578855420499999966335-87899999999999997158996868778886299


Q ss_pred             EEEEEEECCCCCCHHHHHHHCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             8999995159999999999729-----------------------99999999999999999999987698455788871
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHG-----------------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQN  139 (692)
Q Consensus        83 ~l~LVmEy~~GgsL~~~L~~~~-----------------------~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~N  139 (692)
                      .+|+|||||+||+|.++++...                       .+++..++.++.|++.||+|||+++|+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHC
T ss_conf             58999972799959999986257775102210000122200125778999999999999999999973990505270321


Q ss_pred             EEECCCCCCCEEEEECCCCCCCCCCCCC---CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf             6861799857189800255324687787---776679887667576620379941256779999999982-999999999
Q 005526          140 LLVSTNEVTPVLKIGDFGFARSLTPQDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSN  215 (692)
Q Consensus       140 ILl~~~~~~~~iKL~DFGla~~~~~~~~---~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~  215 (692)
                      ||++.++   .+||+|||+|+.......   .....||+.|||||++.+..|+.++||||+||++|||++ |++||.+.+
T Consensus       195 ill~~~~---~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         195 VLVTHGK---VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             EEEETTT---EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCCCCCC---EEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf             4434598---2898514222204577861562343578765783887279999633030003999999838999999989


Q ss_pred             HHHHHHHHHHCC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHC
Q ss_conf             899999987036-7789997544458899999999500399999999999843
Q 005526          216 QLQLFQNILTST-ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       216 ~~~~~~~I~~~~-~~~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~H  267 (692)
                      ....+.++.... ....|    ...++++.+|+.+||+.||.+|||++|+++|
T Consensus       272 ~~~~~~~~~~~~~~~~~p----~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQP----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             899999998569989988----7678999999999758896689399999999

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=373.84  Aligned_cols=262  Identities=28%  Similarity=0.511  Sum_probs=226.3

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             25789983851259648999999689938999993057799578999999999998079998133778998288899999
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVL   88 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVm   88 (692)
                      +++|++.++||+|+||+||+|++..+++.||||+++...........+.+|+.+++.++||||+++++++...+..++|+
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf             99978626971286819999999999969999998032178689999999999998567578882135444443115886


Q ss_pred             ECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCC-C
Q ss_conf             515999999999972999999999999999999999987698455788871686179985718980025532468778-7
Q 005526           89 EYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQD-L  167 (692)
Q Consensus        89 Ey~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~-~  167 (692)
                      +++.|+++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||.++...... .
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~---~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG---ELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCCTTCEECCSCCSC
T ss_pred             EECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCC---CEEEEECCHHHCCCCCCCC
T ss_conf             3023322211212356540367899999999998774339986001467612113378---2665204601104688751


Q ss_pred             CCCCCCCCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHCCCCC---------------
Q ss_conf             77667988766757662037-99412567799999999829999-99999899999987036778---------------
Q 005526          168 ADTLCGSPLYMAPEIIQNHK-YDAKADLWSVGAILFQLVTGKPP-FDGSNQLQLFQNILTSTELR---------------  230 (692)
Q Consensus       168 ~~~~~Gt~~Y~APEil~~~~-ys~ksDIWSLGviLyeLltG~~P-F~g~~~~~~~~~I~~~~~~~---------------  230 (692)
                      .....+++.|+|||++.... ++.++||||+||++|+|++|+.| |.+.+..+.+.++.......               
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCC
T ss_conf             00103443101466750698888044402654188998518999988999999999998611899735513443222113


Q ss_pred             ---------CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             ---------9997544458899999999500399999999999843334656
Q 005526          231 ---------FPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       231 ---------~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                               ........+++.+.+|+++||++||.+|||++|+|+||||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             CCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             3444544310433065689999999999864996689099999649534079

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=376.44  Aligned_cols=262  Identities=30%  Similarity=0.483  Sum_probs=217.4

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----
Q ss_conf             0125789983851259648999999689938999993057799578999999999998079998133778998288----
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE----   82 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~----   82 (692)
                      .+..+|+++++||+|+||+||+|.++.+++.||||++.... .....+.+++|+.+++.++||||+++++++....    
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCC
T ss_conf             73898599789940648099999999999499999980310-95899999999999997689898858889950564554


Q ss_pred             -EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             -8999995159999999999729999999999999999999999876984557888716861799857189800255324
Q 005526           83 -KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        83 -~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                       .+|+++ |+.||+|.++++.. ++++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus        84 ~~~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~---~~kl~DfG~a~~  158 (345)
T d1pmea_          84 KDVYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC---DLKICDFGLARV  158 (345)
T ss_dssp             CCEEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---CEEECCCTTCEE
T ss_pred             CEEEEEE-EECCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC---CEEECCCCCEEE
T ss_conf             1499999-62598656644058-999999999999999999999978986777876437887999---778754570565


Q ss_pred             CCCCC----CCCCCCCCCCCCCHHHHH-HCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC------
Q ss_conf             68778----777667988766757662-0379941256779999999982999999999899999987036778------
Q 005526          162 LTPQD----LADTLCGSPLYMAPEIIQ-NHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELR------  230 (692)
Q Consensus       162 ~~~~~----~~~~~~Gt~~Y~APEil~-~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~------  230 (692)
                      .....    .....+|++.|+|||++. +..|+.++||||+||++|+|++|++||.+.+...............      
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHH
T ss_conf             04777641010110265200038786047888741010046701337766979978888899999876520699756642


Q ss_pred             -------------CCC-------CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             -------------999-------75444588999999995003999999999998433346567
Q 005526          231 -------------FPP-------GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       231 -------------~p~-------~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                                   .+.       .....+++++++|+.+||++||.+|||+.|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             3433222202446775577877783789999999999997648956790899986198655588

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=375.81  Aligned_cols=258  Identities=22%  Similarity=0.391  Sum_probs=215.6

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE--CCE
Q ss_conf             0125789983851259648999999689938999993057799578999999999998079-9981337789982--888
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIET--REK   83 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIvkl~~~~~~--~~~   83 (692)
                      ...++|+++++||+|+||+||+|+++.+++.||||++...     ..+.+.+|+.+++.++ ||||+++++++..  ...
T Consensus        32 ~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCC
T ss_conf             9986718978983174819999998899979999998889-----99999999999985157998767999998168771


Q ss_pred             EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCC
Q ss_conf             99999515999999999972999999999999999999999987698455788871686179985718980025532468
Q 005526           84 IYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        84 l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~  163 (692)
                      +++|||||.+++|..+   .+.+++..++.+++||+.||+|||++||+||||||+|||++.++.  .+||+|||+++...
T Consensus       107 ~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~--~vkl~DFG~a~~~~  181 (328)
T d3bqca1         107 PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCGGGCEECC
T ss_pred             EEEEEEECCCCCHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC--EEEECCCCCCEECC
T ss_conf             2688863179858997---468999999999999999998876433443456441237748998--36641565426646


Q ss_pred             CCCCCCCCCCCCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHC------------CCC
Q ss_conf             77877766798876675766203-799412567799999999829999999998-9999998703------------677
Q 005526          164 PQDLADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQ-LQLFQNILTS------------TEL  229 (692)
Q Consensus       164 ~~~~~~~~~Gt~~Y~APEil~~~-~ys~ksDIWSLGviLyeLltG~~PF~g~~~-~~~~~~I~~~------------~~~  229 (692)
                      ........++|+.|+|||++.+. .|+.++||||+||++|+|++|+.||..... ......+...            ...
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf             88744432248642476102688888845232335455587604889998876018999999998788415555542254


Q ss_pred             --------------------CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             --------------------899975444588999999995003999999999998433346567
Q 005526          230 --------------------RFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       230 --------------------~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                                          ..+......+++++.|||++||++||.+|||++|+|+||||+.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             CCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf             44743000003334331121155211244899999999998669956890899996493558879

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=373.85  Aligned_cols=254  Identities=22%  Similarity=0.441  Sum_probs=220.1

Q ss_pred             CCEEEEE-EECCCCCEEEEEEEECC--CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf             5789983-85125964899999968--99389999930577995789999999999980799981337789982888999
Q 005526           10 GEYIVGP-RIGSGSFAVVWRARHRQ--LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYL   86 (692)
Q Consensus        10 ~~Y~i~~-~LG~GsfG~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~L   86 (692)
                      ++|.+.+ +||+|+||+||+|.++.  ++..||||++... ......+.+.+|++++++++||||+++++++..+ .+|+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC-EEEE
T ss_conf             4718878487306080999999960897689999998820-3978999999999999867998880686560368-0799


Q ss_pred             EEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             99515999999999972-99999999999999999999998769845578887168617998571898002553246877
Q 005526           87 VLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQ  165 (692)
Q Consensus        87 VmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~  165 (692)
                      |||||+||+|.+++... +.+++..+..++.|++.||+|||+++|+||||||+|||++.++   .+||+|||+++.....
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~---~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEECTTC
T ss_pred             EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCC---CEEECCCHHHHCCCCC
T ss_conf             9980789968997521256999999999999999987899868810576764660454688---5420331342115543


Q ss_pred             C----CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             8----7776679887667576620379941256779999999982-9999999998999999870367789997544458
Q 005526          166 D----LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       166 ~----~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls  240 (692)
                      .    .....+|++.|+|||++.+..|+.++||||+||++|||++ |+.||.+.+..+....+..+.....|    ...+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p----~~~~  238 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP----PECP  238 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC----TTCC
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC----CCCC
T ss_conf             432113562113743358688727999954123220178999993899999997999999999818999999----7678


Q ss_pred             HHHHHHHHHHHCCCCCCCCCHHHH---HHCHHHHH
Q ss_conf             899999999500399999999999---84333465
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEF---FNHRFLGE  272 (692)
Q Consensus       241 ~~l~dLI~~mL~~DP~~RPTa~eL---L~HPfl~~  272 (692)
                      +++.+|+.+||..||.+|||+.++   |+|+|+.-
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf             99999999975779768909999999999999985

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=372.87  Aligned_cols=252  Identities=25%  Similarity=0.484  Sum_probs=221.6

Q ss_pred             CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf             57899838512596489999996899389999930577995789999999999980799981337789982888999995
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVmE   89 (692)
                      ++|++.++||+|+||+||+|++. ++..||||++......   .+.+.+|++++++++||||+++++++...+.+++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEE
T ss_conf             99588889820888299999988-9999999998788676---8999999999996689975653524315993379998


Q ss_pred             CCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCCC-
Q ss_conf             15999999999972-9999999999999999999999876984557888716861799857189800255324687787-
Q 005526           90 YCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus        90 y~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~~-  167 (692)
                      ||++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++   .+||+|||+++....... 
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~---~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ---VIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG---CEEECSCC-----------
T ss_pred             ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCC---CEEECCCCHHEECCCCCCE
T ss_conf             3699918997520134788999999999999987765316431044315326666887---7686553210023688733


Q ss_pred             -CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             -776679887667576620379941256779999999982-999999999899999987036778999754445889999
Q 005526          168 -ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       168 -~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~d  245 (692)
                       .....||+.|+|||++.+..|+.++||||+||++|||++ |.+||.+.+..+.+..+........|    ...++++.+
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p----~~~~~~l~~  233 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP----RLASTHVYQ  233 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC----TTSCHHHHH
T ss_pred             EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC----CCCCHHHHH
T ss_conf             5043001766678578607999840332105999999987898887789999999999806888995----436799999


Q ss_pred             HHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             99995003999999999998433346567
Q 005526          246 LCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       246 LI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                      |+.+||+.||.+|||++++++|  ++++.
T Consensus       234 li~~cl~~~p~~Rps~~~il~~--L~~i~  260 (263)
T d1sm2a_         234 IMNHCWKERPEDRPAFSRLLRQ--LAEIA  260 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHCCCCHHHCCCHHHHHHH--HHHHH
T ss_conf             9999765797689199999999--99998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=378.44  Aligned_cols=255  Identities=28%  Similarity=0.442  Sum_probs=216.6

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf             40125789983851259648999999689938999993057799578999999999998079998133778998288899
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~   85 (692)
                      +.-.++|++++.||+|+||+||+|+..   ..||||+++.........+.+.+|+.++++++||||+++++++. .+.++
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~   79 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA   79 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEE
T ss_conf             315451899889830788589999999---98999999734699899999999999998479987864567971-55899


Q ss_pred             EEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCC
Q ss_conf             999515999999999972-9999999999999999999999876984557888716861799857189800255324687
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~  164 (692)
                      +|||||+||+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++   .+||+|||+++....
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~---~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSR  156 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS---SEEECCCCCSCC---
T ss_pred             EEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCC---CEEECCCCCEEECCC
T ss_conf             99965899888999852357899999999999999998887509995161478997981899---788750022133355


Q ss_pred             CC---CCCCCCCCCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC-CCCCCCCCC
Q ss_conf             78---7776679887667576620---3799412567799999999829999999998999999870367-789997544
Q 005526          165 QD---LADTLCGSPLYMAPEIIQN---HKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTE-LRFPPGAIE  237 (692)
Q Consensus       165 ~~---~~~~~~Gt~~Y~APEil~~---~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~-~~~p~~~~~  237 (692)
                      ..   ......||+.|||||++.+   ..|+.++||||+||++|||++|+.||.+.+....+..+..... .+.......
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS  236 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHHCCC
T ss_conf             67763125665574317999995056899995315163599999999788998998969999999965888986000365


Q ss_pred             CCCHHHHHHHHHHHCCCCCCCCCHHHHHHC
Q ss_conf             458899999999500399999999999843
Q 005526          238 ELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       238 ~ls~~l~dLI~~mL~~DP~~RPTa~eLL~H  267 (692)
                      ..++++.+|+.+||..||.+|||+.+++++
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             554999999999758897689299999999

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=372.26  Aligned_cols=256  Identities=27%  Similarity=0.486  Sum_probs=221.1

Q ss_pred             CCCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf             74012578998385125964899999968993899999305779957899999999999807999813377899828889
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         5 ~~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l   84 (692)
                      ++.-.++|++.++||+|+||.||+|.++ ++..||||++......   .+.+.+|++++++++||||+++++++.. +.+
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             EECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEECC-CCE
T ss_conf             0038899388679810798289999999-9999999998647688---8999999999986799988578731045-976


Q ss_pred             EEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCC
Q ss_conf             9999515999999999972--99999999999999999999998769845578887168617998571898002553246
Q 005526           85 YLVLEYCDGGDLAAYIHKH--GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        85 ~LVmEy~~GgsL~~~L~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~  162 (692)
                      ++|||||++|+|.+++...  .++++..+..++.|++.||.|||+++|+||||||+|||++.++   .+||+|||+++..
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~---~~Kl~DFGla~~~  159 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL---SCKIADFGLARLI  159 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---CEEECCCTTCEEC
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCC---CEEECCCCCEEEC
T ss_conf             9999957898288887514789887889999999999999999748954675642251562024---4042341014773


Q ss_pred             CCCC--CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             8778--7776679887667576620379941256779999999982-999999999899999987036778999754445
Q 005526          163 TPQD--LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       163 ~~~~--~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~l  239 (692)
                      ....  ......|++.|+|||++.+..|+.++||||+||++|||++ |.+||...+..+.+..+........|    ...
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p----~~~  235 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP----DNC  235 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC----TTC
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC----CCC
T ss_conf             5886442035677444458289837999824564525799999996898888888999999999706888896----557


Q ss_pred             CHHHHHHHHHHHCCCCCCCCCHHHHHH--CHHHHH
Q ss_conf             889999999950039999999999984--333465
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFN--HRFLGE  272 (692)
Q Consensus       240 s~~l~dLI~~mL~~DP~~RPTa~eLL~--HPfl~~  272 (692)
                      ++++.+|+.+||+.||++|||+.++++  |+||..
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             19999999997588976893999999986113213

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=376.47  Aligned_cols=261  Identities=28%  Similarity=0.453  Sum_probs=222.4

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-----C
Q ss_conf             12578998385125964899999968993899999305779957899999999999807999813377899828-----8
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETR-----E   82 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~-----~   82 (692)
                      +-++|++.++||+|+||+||+|++..+|+.||||++..........+.+.+|+++++.++||||+++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf             89871888898317883999999999997999999882002868999999999999866898742599999634645668


Q ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCC
Q ss_conf             89999951599999999997299999999999999999999998769845578887168617998571898002553246
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        83 ~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~  162 (692)
                      ..+++++|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++   .+|++|||++...
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~---~~kl~dfg~a~~~  171 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC---ELKILDFGLARHT  171 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---CEEECCC----CC
T ss_pred             CEEEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHCCC
T ss_conf             64999996258862320022-4530999999999999999999738876516677633455432---2001321000125


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC----------
Q ss_conf             877877766798876675766203-799412567799999999829999999998999999870367789----------
Q 005526          163 TPQDLADTLCGSPLYMAPEIIQNH-KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRF----------  231 (692)
Q Consensus       163 ~~~~~~~~~~Gt~~Y~APEil~~~-~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~----------  231 (692)
                      ..  ......|++.|+|||++.+. .++.++||||+||++|+|++|++||.+.+.......+........          
T Consensus       172 ~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         172 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             TG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             CC--CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCH
T ss_conf             75--4444345435558355337756785512432058999997688997889889999999973079975773200102


Q ss_pred             ------------CC----CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             ------------99----75444588999999995003999999999998433346567
Q 005526          232 ------------PP----GAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       232 ------------p~----~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                                  +.    ......+++++|||++||+.||.+|||+.|+|+||||++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             44544430355787555662678999999999997758834593899985599548799

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=379.46  Aligned_cols=265  Identities=25%  Similarity=0.464  Sum_probs=222.8

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECC---CCCEEEEEEECCCCC--CHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEEC
Q ss_conf             12578998385125964899999968---993899999305779--95789999999999980799-9813377899828
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQ---LGIEVAVKEIDKKLL--SPKVSDNLLKEISILSTISH-PNIIRFFEAIETR   81 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~---tg~~VAIK~i~~~~~--~~~~~~~i~~Ei~iL~~L~H-pnIvkl~~~~~~~   81 (692)
                      -+++|+++++||+|+||+||+|++..   +|+.||||+++....  .....+.+.+|++++++++| |||+++++++.+.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             CHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf             51025999898328783999999876588794899999836772101689999999999998646798399962000248


Q ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             88999995159999999999729999999999999999999999876984557888716861799857189800255324
Q 005526           82 EKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        82 ~~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                      ..++++|||+.||+|.+++...+.+++..++.++.||+.||+|+|++||+||||||+|||++.++   .+||+|||+++.
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~---~vkL~DFG~a~~  178 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKE  178 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---CEEESCSSEEEE
T ss_pred             CCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCC---CEEEEECCCHHH
T ss_conf             73001231234117999987304543788888899999999885149989654773201246999---888741320222


Q ss_pred             CCCC--CCCCCCCCCCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             6877--877766798876675766203--799412567799999999829999999998999999870367789997544
Q 005526          162 LTPQ--DLADTLCGSPLYMAPEIIQNH--KYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTSTELRFPPGAIE  237 (692)
Q Consensus       162 ~~~~--~~~~~~~Gt~~Y~APEil~~~--~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~  237 (692)
                      ....  .......|++.|++||.+.+.  .++.++||||+||+||+|++|+.||.+.+.......+..... ...+....
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~  257 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQ  257 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCCCT
T ss_pred             HCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCC
T ss_conf             03444432212223333310687605776887132517777999999768999888877779999998335-68998865


Q ss_pred             CCCHHHHHHHHHHHCCCCCCCC-----CHHHHHHCHHHHHHHHH
Q ss_conf             4588999999995003999999-----99999843334656765
Q 005526          238 ELHPDCVDLCRCLLRQNPVERI-----TFKEFFNHRFLGELRQT  276 (692)
Q Consensus       238 ~ls~~l~dLI~~mL~~DP~~RP-----Ta~eLL~HPfl~~~~~~  276 (692)
                      ..++++.+|+.+||.+||.+||     |++|+++||||+++...
T Consensus       258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~  301 (322)
T d1vzoa_         258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  301 (322)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCHH
T ss_conf             47999999999974458988199974509999749723489988

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.35  Aligned_cols=247  Identities=22%  Similarity=0.444  Sum_probs=221.0

Q ss_pred             CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf             57899838512596489999996899389999930577995789999999999980799981337789982888999995
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIYLVLE   89 (692)
Q Consensus        10 ~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~LVmE   89 (692)
                      ++|+++++||+|+||+||+|+++ ++..||||.++.....   .+.+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
T ss_conf             99799689820788399999988-9989999998747577---8999999999996689860158899850781699997


Q ss_pred             CCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCCC-
Q ss_conf             1599999999997-29999999999999999999999876984557888716861799857189800255324687787-
Q 005526           90 YCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL-  167 (692)
Q Consensus        90 y~~GgsL~~~L~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~~-  167 (692)
                      |+++|+|..++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++....... 
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~---~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG---VVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC---CEEECCCSSCCBCSSSSCC
T ss_pred             CCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCC---CEEECCCHHHEECCCCCCE
T ss_conf             0489938886410246776899999999999999987546843466541358876998---4798861442023578722


Q ss_pred             -CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             -776679887667576620379941256779999999982-999999999899999987036778999754445889999
Q 005526          168 -ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELHPDCVD  245 (692)
Q Consensus       168 -~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~d  245 (692)
                       .....|++.|+|||++.+..|+.++||||+||++|||++ |+.||.+.+..+...++........|    ...++++.+
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p----~~~~~~l~~  232 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----HLASEKVYT  232 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC----TTCCHHHHH
T ss_pred             EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC----CCCCHHHHH
T ss_conf             5246578877578078637998852103364324673975599998899999999999807978996----546599999


Q ss_pred             HHHHHHCCCCCCCCCHHHHHHC
Q ss_conf             9999500399999999999843
Q 005526          246 LCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       246 LI~~mL~~DP~~RPTa~eLL~H  267 (692)
                      |+.+||+.||.+|||++++++|
T Consensus       233 li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         233 IMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHCCCCHHHCCCHHHHHHH
T ss_conf             9999766897689399999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.02  Aligned_cols=257  Identities=29%  Similarity=0.485  Sum_probs=224.9

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECCCCCE--EEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCEE
Q ss_conf             125789983851259648999999689938--99999305779957899999999999807-999813377899828889
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQLGIE--VAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIETREKI   84 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~--VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIvkl~~~~~~~~~l   84 (692)
                      -.++|++.++||+|+||+||+|.++.++..  ||||.+.... .....+.+.+|++++.++ +||||+++++++...+.+
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             CHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
T ss_conf             879968877982078828999999899969999999978233-8579999999999998622899883678888418736


Q ss_pred             EEEEECCCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCC
Q ss_conf             9999515999999999972----------------999999999999999999999987698455788871686179985
Q 005526           85 YLVLEYCDGGDLAAYIHKH----------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVT  148 (692)
Q Consensus        85 ~LVmEy~~GgsL~~~L~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~  148 (692)
                      ++|||||+||+|.++++..                ..+++..+..++.|++.||.|||+++|+||||||+|||++.++  
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~--  164 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--  164 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCC--
T ss_conf             999980289869999864035555512310123457899999999999999998766308954555052048986887--


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHCC
Q ss_conf             71898002553246877877766798876675766203799412567799999999829-99999999899999987036
Q 005526          149 PVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG-KPPFDGSNQLQLFQNILTST  227 (692)
Q Consensus       149 ~~iKL~DFGla~~~~~~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG-~~PF~g~~~~~~~~~I~~~~  227 (692)
                       .+||+|||+++............||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+.+..+....
T Consensus       165 -~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         165 -VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             -CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             -CEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
T ss_conf             -6387434432244422345530137755553875269999622153138899999836899999999999999998268


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             77899975444588999999995003999999999998433346567
Q 005526          228 ELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       228 ~~~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                      ....+    ..+++++.+|+.+||..||++|||+.++++|  +..+.
T Consensus       244 ~~~~~----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~--L~~i~  284 (309)
T d1fvra_         244 RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRML  284 (309)
T ss_dssp             CCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             CCCCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH--HHHHH
T ss_conf             88887----6678999999999767896689499999999--99998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.44  Aligned_cols=259  Identities=25%  Similarity=0.452  Sum_probs=223.9

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECCCC---CEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf             401257899838512596489999996899---38999993057799578999999999998079998133778998288
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE   82 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~   82 (692)
                      +.-.++|++++.||+|+||+||+|++..++   ..||||.+... ........+.+|+.++++++||||+++++++. .+
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             CCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CC
T ss_conf             76889969877993078829999999369964499999993656-68799999999999998689999856988995-37


Q ss_pred             EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             899999515999999999972-9999999999999999999999876984557888716861799857189800255324
Q 005526           83 KIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        83 ~l~LVmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                      .+|+|||||++|+|.+++... +.+++..++.++.|++.||.|||+++|+||||||+||+++.++   .+||+|||+++.
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~---~~Kl~DfG~a~~  157 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRY  157 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC------
T ss_pred             EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCC---CEEECCCHHHEE
T ss_conf             47999984069807765422478999999999999998775230226744141026553206789---678765034213


Q ss_pred             CCCCC--CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             68778--7776679887667576620379941256779999999982-99999999989999998703677899975444
Q 005526          162 LTPQD--LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       162 ~~~~~--~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~  238 (692)
                      .....  ......||+.|+|||++.+..|+.++||||+||++|||++ |.+||.+.+..+.+..+.......++    ..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~----~~  233 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP----PN  233 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC----TT
T ss_pred             CCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC----CC
T ss_conf             36776233054005831032667516998874524442478999982699998889999999999818999898----77


Q ss_pred             CCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHH
Q ss_conf             5889999999950039999999999984333465676
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       239 ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~~  275 (692)
                      .++++.+|+.+||..||.+|||+.++++|  +..+.+
T Consensus       234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~--L~~i~~  268 (273)
T d1mp8a_         234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ--LSTILE  268 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHHH--HHHHHH
T ss_conf             79999999999768797689299999999--999977

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.59  Aligned_cols=252  Identities=25%  Similarity=0.424  Sum_probs=217.6

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCC----CEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf             01257899838512596489999996899----38999993057799578999999999998079998133778998288
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLG----IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETRE   82 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~   82 (692)
                      .--.+|++.+.||+|+||.||+|.++.++    ..||||.+... ........+.+|++++++++||||+++++++...+
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf             78899686159811779099999996899878799999998844-59689999999999998568987832367783388


Q ss_pred             EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             899999515999999999972-9999999999999999999999876984557888716861799857189800255324
Q 005526           83 KIYLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        83 ~l~LVmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                      .+++|||||.++++.+++... +.+++..+..++.|++.||+|||+++|+||||||+|||++.++   .+||+|||+++.
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~---~~Kl~DFGla~~  159 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL---VCKVSDFGLSRV  159 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC---CEEECCCCC---
T ss_pred             CEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCC---EEEECCCCHHHC
T ss_conf             03899972135740222102345420899999999999854121212342576564427888998---499845510300


Q ss_pred             CCCCC----CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             68778----7776679887667576620379941256779999999982-999999999899999987036778999754
Q 005526          162 LTPQD----LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAI  236 (692)
Q Consensus       162 ~~~~~----~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~  236 (692)
                      .....    ......||+.|+|||++.+..|+.++||||+||++|||++ |.+||.+.+..+.+..+........+    
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~----  235 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP----  235 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC----
T ss_pred             CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC----
T ss_conf             3578765267426777734348888704999973556344898999996798865568999999998635789985----


Q ss_pred             CCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf             445889999999950039999999999984
Q 005526          237 EELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       237 ~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~  266 (692)
                      ...+.++.+|+.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         236 MDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             045799999999977679768939999999

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=362.05  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=217.5

Q ss_pred             CCEEEEEEECCCCCEEEEEEEECCCCC----EEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf             578998385125964899999968993----8999993057799578999999999998079998133778998288899
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGI----EVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKIY   85 (692)
Q Consensus        10 ~~Y~i~~~LG~GsfG~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l~   85 (692)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|.+... ......+.+.+|++++++++||||+++++++.+++ .+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-EE
T ss_conf             99978319820899299999995899889899999996513-49799999999999998679988815899996198-36


Q ss_pred             EEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCC
Q ss_conf             999515999999999972-9999999999999999999999876984557888716861799857189800255324687
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTP  164 (692)
Q Consensus        86 LVmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~  164 (692)
                      +++||+.+|+|.+++... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++   .+||+|||+++....
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~---~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCCSHHHHTTT
T ss_pred             EEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCC---CEEEECCCCCEECCC
T ss_conf             99984268740101113345799999999999999999999876950476212031167998---758602552223354


Q ss_pred             CCC---CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             787---776679887667576620379941256779999999982-9999999998999999870367789997544458
Q 005526          165 QDL---ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       165 ~~~---~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls  240 (692)
                      ...   .....||+.|+|||++.+..|+.++||||+||++|||++ |.+||.+.+..+....+..+.....|    ...+
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p----~~~~  239 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP----PICT  239 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC----TTBC
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC----CCCC
T ss_conf             445322365105864467088746999835654407999999997799999999989999999759989998----5568


Q ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHCHH
Q ss_conf             89999999950039999999999984333
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRF  269 (692)
Q Consensus       241 ~~l~dLI~~mL~~DP~~RPTa~eLL~HPf  269 (692)
                      +++.+|+.+||..||.+|||+.+++.|..
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             99999999847899346919999999999

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.15  Aligned_cols=255  Identities=24%  Similarity=0.446  Sum_probs=218.9

Q ss_pred             CCCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf             74012578998385125964899999968993899999305779957899999999999807999813377899828889
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         5 ~~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l   84 (692)
                      ++.-.++|++++.||+|+||+||+|++.. +..||||++......   .+.+.+|+.++++++||||+++++++.+ +..
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~   86 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI   86 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             EECCHHHEEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCE
T ss_conf             07477997984699307980999999999-999999998804488---8999999999986666788689999823-975


Q ss_pred             EEEEECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCC
Q ss_conf             999951599999999997--299999999999999999999998769845578887168617998571898002553246
Q 005526           85 YLVLEYCDGGDLAAYIHK--HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSL  162 (692)
Q Consensus        85 ~LVmEy~~GgsL~~~L~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~  162 (692)
                      ++|||||++|+|..++..  .+.+++..+..++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~---~~kl~DfGla~~~  163 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLARLI  163 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG---CEEECCCCTTC--
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCC---CEEECCCCHHHHC
T ss_conf             9999944799435420000355305999999999999999987541143353123079998999---2998442555425


Q ss_pred             CCCC--CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             8778--7776679887667576620379941256779999999982-999999999899999987036778999754445
Q 005526          163 TPQD--LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEEL  239 (692)
Q Consensus       163 ~~~~--~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~l  239 (692)
                      ....  ......|++.|+|||++....++.++||||+||++|||++ |++||.+....+.+..+........+    ...
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~----~~~  239 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP----PEC  239 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC----TTS
T ss_pred             CCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC----CCC
T ss_conf             6887335245455665458089837998917741323589999986899999888899999999826899998----323


Q ss_pred             CHHHHHHHHHHHCCCCCCCCCHHHHHH--CHHHH
Q ss_conf             889999999950039999999999984--33346
Q 005526          240 HPDCVDLCRCLLRQNPVERITFKEFFN--HRFLG  271 (692)
Q Consensus       240 s~~l~dLI~~mL~~DP~~RPTa~eLL~--HPfl~  271 (692)
                      ++++.+|+.+||+.||++||++.++++  |+||.
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf             7999999999756697589199999998766623

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.38  Aligned_cols=256  Identities=29%  Similarity=0.488  Sum_probs=223.1

Q ss_pred             CCCCCEECCEEEEEEECCCCCEEEEEEEECCCC-------CEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEE
Q ss_conf             997401257899838512596489999996899-------3899999305779957899999999999807-99981337
Q 005526            3 PNRTRLIGEYIVGPRIGSGSFAVVWRARHRQLG-------IEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRF   74 (692)
Q Consensus         3 p~~~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg-------~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIvkl   74 (692)
                      |..+.-.++|++++.||+|+||.||+|++..++       ..||||++.... .......+.+|...+.++ +||||+++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEEC
T ss_conf             7672258996970098516782899999857875556675499999988112-868899999999999981399969734


Q ss_pred             EEEEEECCEEEEEEECCCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             789982888999995159999999999729----------------9999999999999999999998769845578887
Q 005526           75 FEAIETREKIYLVLEYCDGGDLAAYIHKHG----------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQ  138 (692)
Q Consensus        75 ~~~~~~~~~l~LVmEy~~GgsL~~~L~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~  138 (692)
                      ++++.+++.+++|||||++|+|.+++....                .+++..+..++.||+.||+|||+++|+||||||+
T Consensus        85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~  164 (299)
T d1fgka_          85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  164 (299)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCC
T ss_conf             65220188689999736999099999860677643222334574346799999999999999998766379786302210


Q ss_pred             CEEECCCCCCCEEEEECCCCCCCCCCCC---CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCC
Q ss_conf             1686179985718980025532468778---7776679887667576620379941256779999999982-99999999
Q 005526          139 NLLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGS  214 (692)
Q Consensus       139 NILl~~~~~~~~iKL~DFGla~~~~~~~---~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~  214 (692)
                      |||++.++   .+||+|||+++......   ......+++.|+|||++.+..|+.++|||||||++|+|++ |.+||.+.
T Consensus       165 NiLl~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~  241 (299)
T d1fgka_         165 NVLVTEDN---VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  241 (299)
T ss_dssp             GEEECTTC---CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CEEECCCC---CEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf             22454789---767622111011355555431466788846632667517988825554775888887401798989999


Q ss_pred             CHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf             9899999987036778999754445889999999950039999999999984
Q 005526          215 NQLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       215 ~~~~~~~~I~~~~~~~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~  266 (692)
                      +..+.+..+........|    ...++++.+|+.+||++||.+|||+.|+++
T Consensus       242 ~~~~~~~~i~~~~~~~~p----~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         242 PVEELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CHHHHHHHHHTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHCCCCCCCC----CCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             999999999728888987----435299999999976679767939999999

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=359.47  Aligned_cols=255  Identities=26%  Similarity=0.449  Sum_probs=221.4

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf             2578998385125964899999968-----99389999930577995789999999999980799981337789982888
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIETREK   83 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~   83 (692)
                      .++|++.++||+|+||+||+|+.+.     +++.||||++... ........+.+|+.++++++||||+++++++...+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH-CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf             8893886798207883999999888765778829999998821-085799999999999996689976552466605980


Q ss_pred             EEEEEECCCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             999995159999999999729------------------------99999999999999999999987698455788871
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG------------------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQN  139 (692)
Q Consensus        84 l~LVmEy~~GgsL~~~L~~~~------------------------~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~N  139 (692)
                      .++||||+++|+|.+++....                        .+++..+..++.|++.||+|||+++|+||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCC
T ss_conf             38999815899299999852755421000011100121034678898999999999999998554135786854884011


Q ss_pred             EEECCCCCCCEEEEECCCCCCCCCCCC---CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCC
Q ss_conf             686179985718980025532468778---77766798876675766203799412567799999999829-99999999
Q 005526          140 LLVSTNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG-KPPFDGSN  215 (692)
Q Consensus       140 ILl~~~~~~~~iKL~DFGla~~~~~~~---~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG-~~PF~g~~  215 (692)
                      ||++.++   .+||+|||+++......   ......|++.|+|||++.+..|+.++||||+||++|||++| .+||.+.+
T Consensus       171 ILld~~~---~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         171 CLVGENM---VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             EEECGGG---CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             EEECCCC---CEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCC
T ss_conf             6898999---2898331442113677641115777767676798997268898056302523629999806899999989


Q ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             8999999870367789997544458899999999500399999999999843334656
Q 005526          216 QLQLFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       216 ~~~~~~~I~~~~~~~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      ..+....+........|    ..+++++.+|+.+||+.||.+|||+.|+++  +++.+
T Consensus       248 ~~e~~~~v~~~~~~~~p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~i  299 (301)
T d1lufa_         248 HEEVIYYVRDGNILACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM  299 (301)
T ss_dssp             HHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             HHHHHHHHHCCCCCCCC----CCCHHHHHHHHHHHCCCCHHHCCCHHHHHH--HHHHH
T ss_conf             99999999739978887----325299999999974889657939999999--99984

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.52  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=211.6

Q ss_pred             EECCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE-
Q ss_conf             12578998385125964899999968-----993899999305779957899999999999807-99981337789982-
Q 005526            8 LIGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET-   80 (692)
Q Consensus         8 l~~~Y~i~~~LG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIvkl~~~~~~-   80 (692)
                      -.++|+++++||+|+||.||+|.+..     +++.||||++.... .....+.+.+|..++.++ +|+||+.+++++.. 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf             679979844984167839999998677755578399999986001-7178999999999988614998499741154047


Q ss_pred             CCEEEEEEECCCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
Q ss_conf             88899999515999999999972----------------99999999999999999999998769845578887168617
Q 005526           81 REKIYLVLEYCDGGDLAAYIHKH----------------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVST  144 (692)
Q Consensus        81 ~~~l~LVmEy~~GgsL~~~L~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~  144 (692)
                      ...+++|||||+||+|.+++...                ..+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
T ss_conf             97579999845899299999853666665322202332146899999999999999999887379717867731065779


Q ss_pred             CCCCCEEEEECCCCCCCCCCCC---CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCHHHHH
Q ss_conf             9985718980025532468778---77766798876675766203799412567799999999829-9999999989999
Q 005526          145 NEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG-KPPFDGSNQLQLF  220 (692)
Q Consensus       145 ~~~~~~iKL~DFGla~~~~~~~---~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG-~~PF~g~~~~~~~  220 (692)
                      ++   .+||+|||+++......   ......||+.|+|||++.+..|+.++||||+||++|||+++ .+||.+......+
T Consensus       170 ~~---~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         170 KN---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             GG---CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CC---CEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf             98---289845752001135665222475166721020368646889966322136789999986889999899989999


Q ss_pred             HH-HHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             99-870367789997544458899999999500399999999999843334656
Q 005526          221 QN-ILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       221 ~~-I~~~~~~~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      .. +........|    ...++++.+|+.+||+.||.+|||+.|+++|  +..+
T Consensus       247 ~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~i  294 (299)
T d1ywna1         247 CRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNL  294 (299)
T ss_dssp             HHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             HHHHHCCCCCCCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH--HHHH
T ss_conf             9999638988888----6578999999999767796679199999999--9799

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.11  Aligned_cols=253  Identities=24%  Similarity=0.465  Sum_probs=221.6

Q ss_pred             CCCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE-ECCE
Q ss_conf             740125789983851259648999999689938999993057799578999999999998079998133778998-2888
Q 005526            5 RTRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIE-TREK   83 (692)
Q Consensus         5 ~~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~-~~~~   83 (692)
                      ++.-.++|++.+.||+|+||.||+|+++  |+.||||+++..    ...+.+.+|++++++++||||+++++++. ..+.
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   75 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             CCCCHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCH----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCC
T ss_conf             9557899488579820798089999999--909999998857----7799999999999867898985498788723892


Q ss_pred             EEEEEECCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             999995159999999999729--999999999999999999999876984557888716861799857189800255324
Q 005526           84 IYLVLEYCDGGDLAAYIHKHG--KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus        84 l~LVmEy~~GgsL~~~L~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                      +|+||||+++|+|.+++...+  .+++..+..++.|++.||.|||+++|+||||||+|||++.++   .+||+|||+++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~---~~kl~dfg~s~~  152 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDFGLTKE  152 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS---CEEECCCCC---
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCC---CEEECCCCCCEE
T ss_conf             89999636999899998745788889999999999998523211337655366656760146899---776324560034


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             687787776679887667576620379941256779999999982-9999999998999999870367789997544458
Q 005526          162 LTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEELH  240 (692)
Q Consensus       162 ~~~~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~ls  240 (692)
                      ....  .....+++.|+|||++.+..|+.++|||||||++|||++ |++||.+.+..+....+.......++    ...+
T Consensus       153 ~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~  226 (262)
T d1byga_         153 ASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP----DGCP  226 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC----TTCC
T ss_pred             CCCC--CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC----CCCC
T ss_conf             4787--765566646778178727988858877757999999997899999999999999999808999997----6579


Q ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf             8999999995003999999999998433346567
Q 005526          241 PDCVDLCRCLLRQNPVERITFKEFFNHRFLGELR  274 (692)
Q Consensus       241 ~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~  274 (692)
                      +++.+|+++||..||.+|||+.+++++  ++.++
T Consensus       227 ~~~~~li~~cl~~dP~~Rps~~~l~~~--L~~i~  258 (262)
T d1byga_         227 PAVYEVMKNCWHLDAAMRPSFLQLREQ--LEHIK  258 (262)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHHH--HHHHH
T ss_conf             999999999756697689399999999--99998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.94  Aligned_cols=254  Identities=22%  Similarity=0.421  Sum_probs=221.1

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf             4012578998385125964899999968-----99389999930577995789999999999980799981337789982
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQ-----LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET   80 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~   80 (692)
                      +.-.++|.++++||+|+||+||+|.+..     +++.||||+++.. ........+.+|+.++++++||||+++++++..
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf             4268991883598207881899999878644778968999998701-286899999999999997699988412547842


Q ss_pred             CCEEEEEEECCCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCE
Q ss_conf             88899999515999999999972----------99999999999999999999998769845578887168617998571
Q 005526           81 REKIYLVLEYCDGGDLAAYIHKH----------GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPV  150 (692)
Q Consensus        81 ~~~l~LVmEy~~GgsL~~~L~~~----------~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~  150 (692)
                      .+..++|||||++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++   .
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~---~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---T  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC---C
T ss_pred             CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCC---E
T ss_conf             8810677760489988999875033211344468879999999999999999987647965432867754035996---4


Q ss_pred             EEEECCCCCCCCCCCC---CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHC
Q ss_conf             8980025532468778---77766798876675766203799412567799999999829-9999999989999998703
Q 005526          151 LKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTG-KPPFDGSNQLQLFQNILTS  226 (692)
Q Consensus       151 iKL~DFGla~~~~~~~---~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG-~~PF~g~~~~~~~~~I~~~  226 (692)
                      +||+|||+++......   ......|++.|+|||.+.+..|+.++||||+||++|||++| .+||.+.+..+.+..+...
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
T ss_conf             99942454202357763031340231632378888736998833344437899999996899999998999999999808


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHC
Q ss_conf             67789997544458899999999500399999999999843
Q 005526          227 TELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNH  267 (692)
Q Consensus       227 ~~~~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~H  267 (692)
                      .....|    ...++.+.+++.+||+.||.+|||+.+++++
T Consensus       252 ~~~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         252 GLLDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCC----CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             888886----3353999999999757796589399999999

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.17  Aligned_cols=253  Identities=27%  Similarity=0.439  Sum_probs=216.7

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEEC-----CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
Q ss_conf             01257899838512596489999996-----8993899999305779957899999999999807-99981337789982
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHR-----QLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTI-SHPNIIRFFEAIET   80 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIvkl~~~~~~   80 (692)
                      .-.++|+++++||+|+||.||+|.+.     .+++.||||++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf             7789969854982068829999998066447788699999987424-877999999999998762699988789989831


Q ss_pred             CCEEEEEEECCCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf             888999995159999999999729------------------99999999999999999999987698455788871686
Q 005526           81 REKIYLVLEYCDGGDLAAYIHKHG------------------KVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLV  142 (692)
Q Consensus        81 ~~~l~LVmEy~~GgsL~~~L~~~~------------------~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl  142 (692)
                      .+.+++|||||++|+|.+++.+..                  .+++..+..++.|++.||+|||+++++||||||+||++
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCC
T ss_conf             99789999737998799999853566544444533222334588999999999999999998875792666241021000


Q ss_pred             CCCCCCCEEEEECCCCCCCCCCCC---CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHH
Q ss_conf             179985718980025532468778---7776679887667576620379941256779999999982-999999999899
Q 005526          143 STNEVTPVLKIGDFGFARSLTPQD---LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQ  218 (692)
Q Consensus       143 ~~~~~~~~iKL~DFGla~~~~~~~---~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~  218 (692)
                      +.++   .+|++|||.++......   .....+|++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+
T Consensus       179 ~~~~---~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         179 THGR---ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             ETTT---EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             CCCC---CCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf             0257---5210234010233678861586201359687677886179999740010258999999858998877899899


Q ss_pred             HHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf             999987036778999754445889999999950039999999999984
Q 005526          219 LFQNILTSTELRFPPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFN  266 (692)
Q Consensus       219 ~~~~I~~~~~~~~p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~  266 (692)
                      .+.++.......   ......++++.+|+.+||++||.+|||+.++++
T Consensus       256 ~~~~~i~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         256 KFYKMIKEGFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHCCCCC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             999998668988---985436599999999975779657929999999

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=351.25  Aligned_cols=260  Identities=20%  Similarity=0.236  Sum_probs=209.9

Q ss_pred             CCEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCC-CEEEEEEEECCEE
Q ss_conf             401257899838512596489999996899389999930577995789999999999980799981-3377899828889
Q 005526            6 TRLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNI-IRFFEAIETREKI   84 (692)
Q Consensus         6 ~~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-vkl~~~~~~~~~l   84 (692)
                      .++.++|+++++||+|+||+||+|++..+++.||||++......    ..+.+|+++++.++|+++ +.+..++...+..
T Consensus         3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CEECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEE
T ss_conf             71888899968985078809999999889989999997210058----88999999999703899601799999519877


Q ss_pred             EEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCC
Q ss_conf             999951599999999997-2999999999999999999999987698455788871686179985718980025532468
Q 005526           85 YLVLEYCDGGDLAAYIHK-HGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GgsL~~~L~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~  163 (692)
                      ++||||+.+ ++...+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+....+||+|||+++.+.
T Consensus        79 ~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          79 VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEEEECCC-CHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf             899987387-1333244306887689999999999999999997994426678766064335777615650467513425


Q ss_pred             CCC--------CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC--CCCCC-
Q ss_conf             778--------7776679887667576620379941256779999999982999999999899999987036--77899-
Q 005526          164 PQD--------LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQLQLFQNILTST--ELRFP-  232 (692)
Q Consensus       164 ~~~--------~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~~~~~~I~~~~--~~~~p-  232 (692)
                      ...        .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+....  ....+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCH
T ss_conf             54455410001357767873532999991899898321886177899998498766553057799999985235678983


Q ss_pred             CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHH---HHCHHH
Q ss_conf             97544458899999999500399999999999---843334
Q 005526          233 PGAIEELHPDCVDLCRCLLRQNPVERITFKEF---FNHRFL  270 (692)
Q Consensus       233 ~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eL---L~HPfl  270 (692)
                      +.....+++++.+|+.+||+.||.+||++.++   |+|+|.
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             57534788999999999843995579199999999999999

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.99  Aligned_cols=255  Identities=29%  Similarity=0.503  Sum_probs=217.3

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCC-C--CEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf             25789983851259648999999689-9--3899999305779-957899999999999807999813377899828889
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQL-G--IEVAVKEIDKKLL-SPKVSDNLLKEISILSTISHPNIIRFFEAIETREKI   84 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~t-g--~~VAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~~~~l   84 (692)
                      .++|++.+.||+|+||.||+|++... +  ..||||++..... .....+.+.+|+.++++++||||+++++++.++ .+
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CH
T ss_conf             48919978980388839999999889990799999999835557989999999999999868999987898777401-00


Q ss_pred             EEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCC
Q ss_conf             9999515999999999972-999999999999999999999987698455788871686179985718980025532468
Q 005526           85 YLVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLT  163 (692)
Q Consensus        85 ~LVmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~  163 (692)
                      ++|||||++|++.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~---~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEECC
T ss_pred             HEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCC---CEEECCCHHHHHCC
T ss_conf             114654238612544421268999999999999999999875217875205668881565565---43325611555303


Q ss_pred             CCC----CCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             778----7776679887667576620379941256779999999982-99999999989999998703677899975444
Q 005526          164 PQD----LADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVT-GKPPFDGSNQLQLFQNILTSTELRFPPGAIEE  238 (692)
Q Consensus       164 ~~~----~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLlt-G~~PF~g~~~~~~~~~I~~~~~~~~p~~~~~~  238 (692)
                      ...    ......|++.|+|||++.+..|+.++||||+|+++|||++ |++||.+.+..+...++.......   .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~  239 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---PRPED  239 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---CCCTT
T ss_pred             CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC---CCCCC
T ss_conf             588752654763257310799998379999421566148999999968999999969999999998479999---98544


Q ss_pred             CCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHH
Q ss_conf             5889999999950039999999999984333465
Q 005526          239 LHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGE  272 (692)
Q Consensus       239 ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~  272 (692)
                      +++.+.+|+.+||..||++|||+.+++  .++.+
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~--~~L~~  271 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALR--DFLLE  271 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHH--HHHHH
T ss_conf             539999999997688966792999999--99996

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.29  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=210.7

Q ss_pred             EEEEEECCCCCEEEEEEEECCCC---CEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEEE
Q ss_conf             99838512596489999996899---389999930577995789999999999980799981337789982-88899999
Q 005526           13 IVGPRIGSGSFAVVWRARHRQLG---IEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPNIIRFFEAIET-REKIYLVL   88 (692)
Q Consensus        13 ~i~~~LG~GsfG~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIvkl~~~~~~-~~~l~LVm   88 (692)
                      ...++||+|+||+||+|.+..++   ..||||.++. .........+.+|++++++++||||+++++++.. ++.+++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf             266698136880999999977998799999999884-3697899999999999986789998678678980699438999


Q ss_pred             ECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             515999999999972-9999999999999999999999876984557888716861799857189800255324687787
Q 005526           89 EYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARSLTPQDL  167 (692)
Q Consensus        89 Ey~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~~~~~~~  167 (692)
                      |||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++   .+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~---~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF---TVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC---CEEECSSGGGCCTTTTTC
T ss_pred             EEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCC---CEEEECCCCHHHCCCCCC
T ss_conf             87406741442101345404899999999988765200336762577668757677999---889910652322556655


Q ss_pred             -----CCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf             -----7766798876675766203799412567799999999829999999-9989999998703677899975444588
Q 005526          168 -----ADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDG-SNQLQLFQNILTSTELRFPPGAIEELHP  241 (692)
Q Consensus       168 -----~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g-~~~~~~~~~I~~~~~~~~p~~~~~~ls~  241 (692)
                           .....|++.|+|||++....++.++||||+|+++|||++|..||.. .+..+....+..+.....|    ...++
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p----~~~~~  261 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP----EYCPD  261 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC----TTCCH
T ss_pred             CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC----CCCCH
T ss_conf             53100256555645567688743799974574661999999997899998889999999999808988996----44759


Q ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHH
Q ss_conf             9999999950039999999999984333465676
Q 005526          242 DCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       242 ~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~~  275 (692)
                      ++.+|+.+||+.||++||++.|+++|  +..+..
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~--L~~i~~  293 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR--ISAIFS  293 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             HHHHHHHHHCCCCHHHCCCHHHHHHH--HHHHHH
T ss_conf             99999999768897689399999999--999997

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=336.63  Aligned_cols=260  Identities=19%  Similarity=0.259  Sum_probs=211.5

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCEEE
Q ss_conf             01257899838512596489999996899389999930577995789999999999980799-98133778998288899
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH-PNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIvkl~~~~~~~~~l~   85 (692)
                      .+.++|+++++||+|+||+||+|++..+++.||||++......    ..+.+|++.+..+.| +|++.+++++......+
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCE
T ss_conf             7898069979984178829999999889979999997502582----999999999999648999877999960188117


Q ss_pred             EEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC--CCCEEEEECCCCCCCC
Q ss_conf             999515999999999972-9999999999999999999999876984557888716861799--8571898002553246
Q 005526           86 LVLEYCDGGDLAAYIHKH-GKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNE--VTPVLKIGDFGFARSL  162 (692)
Q Consensus        86 LVmEy~~GgsL~~~L~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~--~~~~iKL~DFGla~~~  162 (692)
                      +||||+ |++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++...  ....+||+|||+++..
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf             999964-8887999975203110689999999999999999977966266771315234754344795687236605771


Q ss_pred             CCC--------CCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHCCCCCC
Q ss_conf             877--------87776679887667576620379941256779999999982999999999---8999999870367789
Q 005526          163 TPQ--------DLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSN---QLQLFQNILTSTELRF  231 (692)
Q Consensus       163 ~~~--------~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~---~~~~~~~I~~~~~~~~  231 (692)
                      ...        ......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+..   ....+..+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf             46766541110246762775102679896488888699989831999999869876788530219999999970567999


Q ss_pred             CCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHH
Q ss_conf             997544458899999999500399999999999843334656
Q 005526          232 PPGAIEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGEL  273 (692)
Q Consensus       232 p~~~~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~  273 (692)
                      +......+++++.+++..|+..+|.+||+++.+.+  +|.++
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~--~l~~~  276 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKV  276 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHH
T ss_pred             HHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHH
T ss_conf             58965799899999999984399300859999999--99999

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=331.17  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=196.2

Q ss_pred             ECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHH--HHHHHHHCCCCCCCEEEEEEEECC----
Q ss_conf             25789983851259648999999689938999993057799578999999--999998079998133778998288----
Q 005526            9 IGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLK--EISILSTISHPNIIRFFEAIETRE----   82 (692)
Q Consensus         9 ~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~--Ei~iL~~L~HpnIvkl~~~~~~~~----   82 (692)
                      ..+|.+.++||+|+||+||+|++.  |+.||||++....     ...+.+  |+..+..++||||+++++++...+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEEC--CEEEEEEEECCCC-----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
T ss_conf             868999889820788199999999--9899999987200-----467999999999962799868326889983798604


Q ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEECCCCCCCEEEEE
Q ss_conf             899999515999999999972999999999999999999999987--------698455788871686179985718980
Q 005526           83 KIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE--------KHLIHRDLKPQNLLVSTNEVTPVLKIG  154 (692)
Q Consensus        83 ~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs--------~gIiHrDIKP~NILl~~~~~~~~iKL~  154 (692)
                      .+|+|||||++|+|.+++++. .+++.....++.|++.||.|+|.        +||+||||||+|||++.++   .+||+
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~---~~Kl~  150 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG---TCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS---CEEEC
T ss_pred             EEEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCC---CEEEE
T ss_conf             899999646698989998658-99989999999999999999887665204689866153173135786887---76887


Q ss_pred             CCCCCCCCCCCC-----CCCCCCCCCCCCCHHHHHHC------CCCCCHHHHHHHHHHHHHHHCCCCCCCCC--------
Q ss_conf             025532468778-----77766798876675766203------79941256779999999982999999999--------
Q 005526          155 DFGFARSLTPQD-----LADTLCGSPLYMAPEIIQNH------KYDAKADLWSVGAILFQLVTGKPPFDGSN--------  215 (692)
Q Consensus       155 DFGla~~~~~~~-----~~~~~~Gt~~Y~APEil~~~------~ys~ksDIWSLGviLyeLltG~~PF~g~~--------  215 (692)
                      |||+++......     ......||+.|+|||++.+.      .++.++|||||||++|||++|.+||....        
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH
T ss_conf             63866234677762001355250354767822105654546777675012201599999996289988766311241012


Q ss_pred             ------HHHHHHHHHHCCCC--CCCCCC-CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHH
Q ss_conf             ------89999998703677--899975-4445889999999950039999999999984333465676
Q 005526          216 ------QLQLFQNILTSTEL--RFPPGA-IEELHPDCVDLCRCLLRQNPVERITFKEFFNHRFLGELRQ  275 (692)
Q Consensus       216 ------~~~~~~~I~~~~~~--~~p~~~-~~~ls~~l~dLI~~mL~~DP~~RPTa~eLL~HPfl~~~~~  275 (692)
                            ..............  .++... .......+.+|+.+||+.||.+|||+.|++++  +.++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~--L~~i~~  297 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQ  297 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH--HHHHHH
T ss_conf             2556430999999875024688877655776899999999999760698589599999999--998888

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=329.76  Aligned_cols=265  Identities=21%  Similarity=0.358  Sum_probs=205.3

Q ss_pred             CCCCEE-CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----------CCCC
Q ss_conf             974012-5789983851259648999999689938999993057799578999999999998079-----------9981
Q 005526            4 NRTRLI-GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-----------HPNI   71 (692)
Q Consensus         4 ~~~~l~-~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnI   71 (692)
                      .|+.+. ++|+++++||+|+||+||+|++..+|+.||||+++..   ....+.+.+|+++++.+.           |+||
T Consensus         6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCE
T ss_conf             88884478579989975077818999999999979999998343---133689999999999840145555542276764


Q ss_pred             CEEEEEEE--ECCEEEEEEECCCCCCH-HHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCC
Q ss_conf             33778998--28889999951599999-99999--72999999999999999999999987-698455788871686179
Q 005526           72 IRFFEAIE--TREKIYLVLEYCDGGDL-AAYIH--KHGKVSEAVARHFMRQLAAGLQVLQE-KHLIHRDLKPQNLLVSTN  145 (692)
Q Consensus        72 vkl~~~~~--~~~~l~LVmEy~~GgsL-~~~L~--~~~~lse~~i~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~  145 (692)
                      +++++++.  .....+++++++.++.. .....  ....+++..++.++.|++.||.|||+ .||+||||||+|||++.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECC
T ss_conf             78998763125652023432000354200000122346786899999999999998887640586465677057056305


Q ss_pred             CCC---CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHH-----
Q ss_conf             985---718980025532468778777667988766757662037994125677999999998299999999989-----
Q 005526          146 EVT---PVLKIGDFGFARSLTPQDLADTLCGSPLYMAPEIIQNHKYDAKADLWSVGAILFQLVTGKPPFDGSNQL-----  217 (692)
Q Consensus       146 ~~~---~~iKL~DFGla~~~~~~~~~~~~~Gt~~Y~APEil~~~~ys~ksDIWSLGviLyeLltG~~PF~g~~~~-----  217 (692)
                      +..   ..++++|||.+.....  .....+|++.|+|||++.+..|+.++||||+||++++|++|+.||.+....     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCCCCCCEEEEEECCCCCCCCC--CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf             7656443056753144212344--54223665210571321466777643201237899999878899898755432102


Q ss_pred             -HHHHH---HHHCC-------------------C-CCC--------------CCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf             -99999---87036-------------------7-789--------------9975444588999999995003999999
Q 005526          218 -QLFQN---ILTST-------------------E-LRF--------------PPGAIEELHPDCVDLCRCLLRQNPVERI  259 (692)
Q Consensus       218 -~~~~~---I~~~~-------------------~-~~~--------------p~~~~~~ls~~l~dLI~~mL~~DP~~RP  259 (692)
                       .....   ++...                   . ...              ........++++.||+.+||++||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf             68999999983799878862453220001320122024323577644421000156743589999999998779945790


Q ss_pred             CHHHHHHCHHHHHH
Q ss_conf             99999843334656
Q 005526          260 TFKEFFNHRFLGEL  273 (692)
Q Consensus       260 Ta~eLL~HPfl~~~  273 (692)
                      |++|+|+||||++.
T Consensus       321 ta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         321 DAGGLVNHPWLKDT  334 (362)
T ss_dssp             CHHHHHTCGGGTTC
T ss_pred             CHHHHHCCCCCCCC
T ss_conf             89999669340789

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=3e-24  Score=175.97  Aligned_cols=168  Identities=16%  Similarity=0.172  Sum_probs=125.1

Q ss_pred             EEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCC----------------HHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf             89983851259648999999689938999993057799----------------57899999999999807999813377
Q 005526           12 YIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLS----------------PKVSDNLLKEISILSTISHPNIIRFF   75 (692)
Q Consensus        12 Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~----------------~~~~~~i~~Ei~iL~~L~HpnIvkl~   75 (692)
                      |.++++||+|+||+||+|.+. +|+.||||+++.....                ......+.+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf             022778024856599999979-9999999998604434666556563000888999999778999999981699914499


Q ss_pred             EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCEEEEEC
Q ss_conf             89982888999995159999999999729999999999999999999999876984557888716861799857189800
Q 005526           76 EAIETREKIYLVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQEKHLIHRDLKPQNLLVSTNEVTPVLKIGD  155 (692)
Q Consensus        76 ~~~~~~~~l~LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~~~~iKL~D  155 (692)
                      +..  .  .+++|||++++.+.       .+++..+..++.|++.+|.|||++||+||||||+|||++.++    ++|+|
T Consensus        81 ~~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~----~~liD  145 (191)
T d1zara2          81 AWE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIID  145 (191)
T ss_dssp             EEE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE----EEECC
T ss_pred             EEC--C--CEEEEEEECCCCCC-------CHHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECCC----EEEEE
T ss_conf             862--8--88999950456542-------001578999999999999998268889836890361142898----99987


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHH-----HHHCCCCCCHHHHHHHHHHH
Q ss_conf             255324687787776679887667576-----62037994125677999999
Q 005526          156 FGFARSLTPQDLADTLCGSPLYMAPEI-----IQNHKYDAKADLWSVGAILF  202 (692)
Q Consensus       156 FGla~~~~~~~~~~~~~Gt~~Y~APEi-----l~~~~ys~ksDIWSLGviLy  202 (692)
                      ||.|.........       .|....+     +....|+.++|+||+.--+.
T Consensus       146 FG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             CCCCCCCCCCCCH-------HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf             7884308998709-------99987799999997578998446899999874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.69  E-value=9e-08  Score=66.74  Aligned_cols=143  Identities=15%  Similarity=0.156  Sum_probs=96.6

Q ss_pred             CEECCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEE
Q ss_conf             0125789983851259648999999689938999993057799578999999999998079-998133778998288899
Q 005526            7 RLIGEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-HPNIIRFFEAIETREKIY   85 (692)
Q Consensus         7 ~l~~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIvkl~~~~~~~~~l~   85 (692)
                      .++..|++.+..+.++.+.||+...  ++..+.+|.........  ...+.+|...+..+. +--+.+++.+...++..+
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCCC--HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf             7513527997678998771899990--89869999848876532--5569999999998760699872899975089649


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q ss_conf             999515999999999972999999999999999999999987--------------------------------------
Q 005526           86 LVLEYCDGGDLAAYIHKHGKVSEAVARHFMRQLAAGLQVLQE--------------------------------------  127 (692)
Q Consensus        86 LVmEy~~GgsL~~~L~~~~~lse~~i~~i~~QIl~aL~yLHs--------------------------------------  127 (692)
                      +||++.+|..+......     ......+..++...+..||+                                      
T Consensus        87 lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred             EEEEECCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf             99986043343543344-----0269999998999999985568421435764465655577899877655554303323


Q ss_pred             ---------------------CCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             ---------------------6984557888716861799857189800255324
Q 005526          128 ---------------------KHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       128 ---------------------~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                                           ..++|+|+.|.||+++.++   .+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~---~~~lIDwe~a~~  213 (263)
T d1j7la_         162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK---VSGFIDLGRSGR  213 (263)
T ss_dssp             CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE---EEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCC---EEEEEECHHCCC
T ss_conf             2005799999999844986781789860047642364996---599960231441

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.41  E-value=1.1e-06  Score=59.54  Aligned_cols=80  Identities=20%  Similarity=0.168  Sum_probs=52.4

Q ss_pred             EEEEECCCCCEEEEEEEECCCCCEEEEEEECCC-CC----CHHHHHHHHHHHHHHHHCC-C--CCCCEEEEEEEECCEEE
Q ss_conf             983851259648999999689938999993057-79----9578999999999998079-9--98133778998288899
Q 005526           14 VGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKK-LL----SPKVSDNLLKEISILSTIS-H--PNIIRFFEAIETREKIY   85 (692)
Q Consensus        14 i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~-~~----~~~~~~~i~~Ei~iL~~L~-H--pnIvkl~~~~~~~~~l~   85 (692)
                      -.+.||.|....||++.+...++.|++|.-... +.    .+........|.+.++.+. +  ..+++++.+  +.+..+
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCE
T ss_conf             699807985276899995799848999617713034677788877899999999998650579885528998--598877


Q ss_pred             EEEECCCCCC
Q ss_conf             9995159999
Q 005526           86 LVLEYCDGGD   95 (692)
Q Consensus        86 LVmEy~~Ggs   95 (692)
                      +|||++.+..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEECCCCCC
T ss_conf             9871357765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=2e-05  Score=51.13  Aligned_cols=141  Identities=18%  Similarity=0.144  Sum_probs=81.1

Q ss_pred             CEEEEEEECCCC-CEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC--CCCCEEEEEEEECCEEEEE
Q ss_conf             789983851259-6489999996899389999930577995789999999999980799--9813377899828889999
Q 005526           11 EYIVGPRIGSGS-FAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH--PNIIRFFEAIETREKIYLV   87 (692)
Q Consensus        11 ~Y~i~~~LG~Gs-fG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIvkl~~~~~~~~~l~LV   87 (692)
                      .+... .+..|. .+.||+.... .+..+.+|.......     ..+..|...++.+..  -.+.+++....+++..++|
T Consensus        12 g~~~~-~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          12 GYDWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             TCEEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCCEE-ECCCCCCCCEEEEEEEC-CCCEEEEEECCCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEE
T ss_conf             98358-76786547758999938-987899995896677-----689999999999986599988613222456615999


Q ss_pred             EECCCCCCHHH--------------HHHH-C------CCC--CHHH-HHHHHH-------------------HHHHHHHH
Q ss_conf             95159999999--------------9997-2------999--9999-999999-------------------99999999
Q 005526           88 LEYCDGGDLAA--------------YIHK-H------GKV--SEAV-ARHFMR-------------------QLAAGLQV  124 (692)
Q Consensus        88 mEy~~GgsL~~--------------~L~~-~------~~l--se~~-i~~i~~-------------------QIl~aL~y  124 (692)
                      |++++|.++..              .+.+ +      .++  .... ......                   .....+..
T Consensus        85 ~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          85 LGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             EECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             EEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHH
T ss_conf             87441355432212689999999999998736885448875541246889999998754110113401121379999999


Q ss_pred             HHHC-------CCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             9876-------984557888716861799857189800255324
Q 005526          125 LQEK-------HLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       125 LHs~-------gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                      +..+       .++|+|+.|.||+++.++   .+.|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~---~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGR---FSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTE---EEEECCCTTCEE
T ss_pred             HHHHCCCCCCCEEEECCCCCCCEEEECCC---EEEEEECHHCCC
T ss_conf             98718765795678678887635773796---589998533265

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.50  E-value=0.0018  Score=38.30  Aligned_cols=132  Identities=15%  Similarity=0.161  Sum_probs=73.8

Q ss_pred             CCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC---C--CCCEEE--EEEEECCEEEEEEECCCC
Q ss_conf             596489999996899389999930577995789999999999980799---9--813377--899828889999951599
Q 005526           21 GSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISH---P--NIIRFF--EAIETREKIYLVLEYCDG   93 (692)
Q Consensus        21 GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H---p--nIvkl~--~~~~~~~~l~LVmEy~~G   93 (692)
                      +.-..||++.. .+|..|++|+......+   ..++..|...+..|..   |  ..+..-  ..+...+..+.++++++|
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             CCCCEEEEEEC-CCCCEEEEEEECCCCCC---HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf             61202699983-89997999984787788---999999999999998559987875206898056653479999865277


Q ss_pred             CCH-----HHH------H---HH----------------------------CCCCCHH---HHHHHHHHHHHHHHHHH--
Q ss_conf             999-----999------9---97----------------------------2999999---99999999999999998--
Q 005526           94 GDL-----AAY------I---HK----------------------------HGKVSEA---VARHFMRQLAAGLQVLQ--  126 (692)
Q Consensus        94 gsL-----~~~------L---~~----------------------------~~~lse~---~i~~i~~QIl~aL~yLH--  126 (692)
                      ..+     ..+      +   ..                            ...++..   .....+.++...+.-.-  
T Consensus       109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~  188 (325)
T d1zyla1         109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  188 (325)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf             68899999999998999999886303578655677897887665689998747699889899999999999999984545


Q ss_pred             --HCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             --76984557888716861799857189800255324
Q 005526          127 --EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       127 --s~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                        ..+++|+|+.+.|||++. +    ..++||+.+..
T Consensus       189 ~~p~~liHgDlh~~NvL~~~-~----~~~IDFdd~~~  220 (325)
T d1zyla1         189 DFTVLRLHGDCHAGNILWRD-G----PMFVDLDDARN  220 (325)
T ss_dssp             CSCCEECCSSCSGGGEEESS-S----EEECCCTTCCE
T ss_pred             CCCCEEECCCCCCCCEEEEC-C----CEEEECHHCCC
T ss_conf             68712024788804287838-9----35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.33  E-value=0.0014  Score=39.02  Aligned_cols=75  Identities=15%  Similarity=0.142  Sum_probs=50.0

Q ss_pred             EEEEEECCCCCEEEEEEEECC-------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC-CCEEEEEEEECCEE
Q ss_conf             998385125964899999968-------9938999993057799578999999999998079998-13377899828889
Q 005526           13 IVGPRIGSGSFAVVWRARHRQ-------LGIEVAVKEIDKKLLSPKVSDNLLKEISILSTISHPN-IIRFFEAIETREKI   84 (692)
Q Consensus        13 ~i~~~LG~GsfG~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Ivkl~~~~~~~~~l   84 (692)
                      ..+++|+.|---.+|++....       ..+.|.+++.... ..   .....+|..+++.+.-.+ ..++++++.  +  
T Consensus        45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--  116 (395)
T d1nw1a_          45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--  116 (395)
T ss_dssp             EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-CH---HHHHHHHHHHHHHHHHCCCCCEEEEECC--C--
T ss_conf             69999178533434899968877544578981799965996-11---6589999999999975799980899818--9--


Q ss_pred             EEEEECCCCCC
Q ss_conf             99995159999
Q 005526           85 YLVLEYCDGGD   95 (692)
Q Consensus        85 ~LVmEy~~Ggs   95 (692)
                      .+|+||++|..
T Consensus       117 g~I~efi~g~~  127 (395)
T d1nw1a_         117 GRLEEYIPSRP  127 (395)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEECCCC
T ss_conf             56999734554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.30  E-value=0.00086  Score=40.36  Aligned_cols=143  Identities=17%  Similarity=0.132  Sum_probs=75.9

Q ss_pred             CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----CCCCCEEE---EEEEEC
Q ss_conf             5789983851259648999999689938999993057799578999999999998079-----99813377---899828
Q 005526           10 GEYIVGPRIGSGSFAVVWRARHRQLGIEVAVKEIDKKLLSPKVSDNLLKEISILSTIS-----HPNIIRFF---EAIETR   81 (692)
Q Consensus        10 ~~Y~i~~~LG~GsfG~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----HpnIvkl~---~~~~~~   81 (692)
                      ++..-.+.|..|--.+.|++....  ..|++|++.... .   ...+..|++++..+.     .|..+...   ......
T Consensus        18 g~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~-~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~   91 (316)
T d2ppqa1          18 GSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   91 (316)
T ss_dssp             CCEEEEEEECC---EEEEEEEESS--CCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             CCCEEEECCCCCCCCCEEEEEECC--CCEEEEECCCCC-C---HHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEE
T ss_conf             985685237888526738999789--728999807899-9---8899999999875430255545564104897621341


Q ss_pred             CEEEEEEECCCCCCH-----HH---------HHHHCC---------C------------------CCHHHHHHHHHHHHH
Q ss_conf             889999951599999-----99---------999729---------9------------------999999999999999
Q 005526           82 EKIYLVLEYCDGGDL-----AA---------YIHKHG---------K------------------VSEAVARHFMRQLAA  120 (692)
Q Consensus        82 ~~l~LVmEy~~GgsL-----~~---------~L~~~~---------~------------------lse~~i~~i~~QIl~  120 (692)
                      .....++.+..|...     ..         .+....         .                  .........+..+..
T Consensus        92 ~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  171 (316)
T d2ppqa1          92 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  171 (316)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_conf             25502453114655333204678888899876454443202453101110120024567777653114127999999987


Q ss_pred             HHHHHH----HCCCCCCCCCCCCEEECCCCCCCEEEEECCCCCCC
Q ss_conf             999998----76984557888716861799857189800255324
Q 005526          121 GLQVLQ----EKHLIHRDLKPQNLLVSTNEVTPVLKIGDFGFARS  161 (692)
Q Consensus       121 aL~yLH----s~gIiHrDIKP~NILl~~~~~~~~iKL~DFGla~~  161 (692)
                      .+....    ..|++|+|+.++||+++.+.   +.-++||+.+..
T Consensus       172 ~~~~~~~~~L~~giIHgDl~~dNvl~~~~~---v~gvIDF~~~~~  213 (316)
T d2ppqa1         172 YLAAHWPKDLPAGVIHADLFQDNVFFLGDE---LSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTE---EEEECCCTTCEE
T ss_pred             HHHCCCCCCCCCCCCCCCCCHHHHHCCCCC---CEEEECCCCCCC
T ss_conf             642048554545033378636564020454---126742221236